PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Casey, SE; Cannon, A; Balikubirhi, BM; Muyisa, JB; Amsalu, R; Tsolka, M				Casey, Sara E.; Cannon, Amy; Balikubirhi, Benjamin Mushagalusa; Muyisa, Jean-Bosco; Amsalu, Ribka; Tsolka, Maria			Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo	PLOS ONE			English	Article							QUALITY-OF-CARE; REPRODUCTIVE HEALTH; DEVELOPING-COUNTRIES; DISCONTINUATION; UGANDA	Context Despite the inclusion of sexual and reproductive health (SRH) services in the minimum standards of health care in humanitarian settings, access to SRH services, and especially to contraception, is often compromised in war. Very little is known about continuation and switching of contraceptive methods in these settings. An evaluation of a contraceptive services program in North Kivu, Democratic Republic of the Congo (DRC) was conducted to measure 12-month contraceptive continuation by type of contraceptive method (short-acting or long-acting). Methods A stratified systematic sample of women who initiated a contraceptive method 12-18 months prior to data collection was selected retrospectively from facility registers. A total of 548 women was interviewed about their contraceptive use: 304 who began a short-acting method (pills, injectables) and 244 who began a long-acting method (intra-uterine devices, implants). Key characteristics of short-acting method versus long-acting method acceptors were compared using chi-square statistics for categorical data and t-tests for continuous data. Unadjusted and adjusted Cox proportional hazard ratios were estimated to assess factors associated with discontinuation. Results At 12 months, 81.6% women reported using their baseline contraceptive method continuously, with more long-acting than short-acting contraceptive acceptors (86.1% versus 78.0%, p =.02) continuing contraceptive use. Use of a short-acting method (Hazard ratio (HR) 1.74 [95% CI 1.13 - 2.67]) and desiring a child within two years (HR 2.58 [95% CI 1.45 - 4.54]) were associated with discontinuation within the first 12 months of use. The vast majority (88.3%) of women reported no prior contraceptive use. Conclusion This is the first study of contraceptive continuation in a humanitarian setting. The high percentages of women continuing contraceptive use found here demonstrates that women will choose to initiate and continue use of their desired contraceptive method, even in a difficult, unstable and low contraceptive prevalence setting like North Kivu.	[Casey, Sara E.] Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, RAISE Initiat, New York, NY 10027 USA; [Cannon, Amy; Amsalu, Ribka; Tsolka, Maria] Save Children USA, Washington, DC USA; [Balikubirhi, Benjamin Mushagalusa; Muyisa, Jean-Bosco] Save Children, Goma, DEM REP CONGO	Columbia University; Save the Children; Save the Children	Casey, SE (corresponding author), Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, RAISE Initiat, New York, NY 10027 USA.	sec42@columbia.edu		Casey, Sara/0000-0002-8476-0327; AMSALU, Dr. RIBKA/0000-0001-8077-7685	Save the Children Innovation Fund (IDEA)	Save the Children Innovation Fund (IDEA)	This study was funded by the Save the Children Innovation Fund (IDEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Gasseer N, 2004, J MIDWIFERY WOM HEAL, V49, P7, DOI 10.1016/j.jmwh.2004.05.001; Alberti KP, 2010, CONFL HEALTH, V4, P1; ALI M, 1995, INT FAM PLAN PERSPEC, V21, P92, DOI 10.2307/2133181; Ali M., 2012, CAUSES CONSEQUENCES; [Anonymous], 2007, REPR HLTH ASS TOOLK; Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Barden-O'Fallon J, 2011, STUD FAMILY PLANN, V42, P11, DOI 10.1111/j.1728-4465.2011.00260.x; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Bradley SE., 2009, DHS ANAL STUDIES; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Casey SE, 2013, GLOB PUBLIC HEALTH, V8, P284, DOI 10.1080/17441692.2012.758302; CASEY SE, 2015, CONFL HEALTH S1, V9; Castle S, 2015, CONTRACEPTIVE DISCON, DOI DOI 10.1108/JHASS-09-2019-0056/FULL/HTML; Chynoweth SK, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-I1; Curry DW, 2015, GLOB HEALTH, V3, P14, DOI 10.9745/GHSP-D-14-00164; Curry DW, 2015, GLOB HEALTH, V3, P25, DOI 10.9745/GHSP-D-14-00112; du Plan Ministere, 2014, ENQ DEM SANT REP DEM; Greaney P, 2011, SPHERE PROJECT HUMAN; Halpern V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub4; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Kruk ME, 2010, SOC SCI MED, V70, P89, DOI 10.1016/j.socscimed.2009.09.042; Mukaba T, 2015, GLOB HEALTH, V3, P163, DOI 10.9745/GHSP-D-14-00244; Nanda K, 2011, CONTRACEPTION, V83, P542, DOI 10.1016/j.contraception.2010.09.003; Power J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001326.pub2; Raine TR, 2011, OBSTET GYNECOL, V117, P363, DOI 10.1097/AOG.0b013e31820563d3; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Tanabe M, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S2; Tolley E, 2005, INT FAM PLAN PERSPEC, V31, P15, DOI 10.1363/3101505; Vitzthum VJ, 2005, STUD FAMILY PLANN, V36, P13, DOI 10.1111/j.1728-4465.2005.00038.x; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	31	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182744	10.1371/journal.pone.0182744	http://dx.doi.org/10.1371/journal.pone.0182744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886016	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100010
J	Kaido, M; Kawashima, M; Shigeno, Y; Yamada, Y; Tsubota, K				Kaido, Minako; Kawashima, Motoko; Shigeno, Yuta; Yamada, Yoshiaki; Tsubota, Kazuo			Relation of accommodative microfluctuation with dry eye symptoms in short tear break-up time dry eye	PLOS ONE			English	Article							FUNCTIONAL VISUAL-ACUITY; FILM; FLUCTUATIONS; ASSOCIATION; POPULATION; PREVALENCE; FATIGUE; SIGNS	Purpose To investigate accommodative microfluctuations (AMFs) and visual function in short tear break-up time (BUT)-type dry eye (DE) and non-DE subjects. Methods This prospective comparative study included 48 volunteers with DE symptoms (mean age 34.8-5.5 years, age range 25-42 years) and 73 without DE symptoms (mean age 30.6-4.7 years, age range 25-42 years). The eyes were divided into two groups: (1) DE group with DE symptoms and BUT <= 5 s and (2) non-DE group without DE symptoms and BUT > 5 s. We excluded eyes with Schirmer score <= 5 mm and positive keratoconjunctival epithelial damage. Tear evaluation, AMF, and functional visual acuity (VA) examinations were performed. AMF parameters included total high-frequency component (HFC), HFC with low accommodation for the task of staring into the distance (HFC1), and HFC with high accommodation for deskwork (HFC2). Functional VA parameters included starting VA, functional VA, visual maintenance ratio, and blink frequency. Results A total of 33 and 34 eyes were categorized in the DE and non-DE groups, respectively. Mean blink frequency and HFC1 values were significantly higher in the DE group than they were in the non-DE group. Conclusions DEs with symptoms showed abnormal AMF and visual function, which may be associated with DE symptoms.	[Kaido, Minako; Kawashima, Motoko; Shigeno, Yuta; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Kaido, Minako] Shinanozaka Clin, Tokyo, Japan; [Yamada, Yoshiaki] Santen Pharmaceut Co Ltd, Osaka, Japan	Keio University; Santen Pharmaceutical Co Ltd	Kaido, M (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.	fwiw1193@mb.infoweb.ne.jp	Tsubota, Kazuo/M-1915-2013	Tsubota, Kazuo/0000-0002-8874-7111	Santen Pharmaceutical Co., Ltd, Osaka	Santen Pharmaceutical Co., Ltd, Osaka	Provision of facilities and transport of equipment were supported by Santen Pharmaceutical Co., Ltd, Osaka. The funder provided support in the form of salary for one author [YY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Belmonte Carlos, 2015, Curr Ophthalmol Rep, V3, P111; Bron A J, 2004, Ocul Surf, V2, P149; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CAMPBELL FW, 1958, J OPT SOC AM, V48, P669, DOI 10.1364/JOSA.48.000669; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; COLLINS M, 1995, VISION RES, V35, P2491; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Foulks Gary N, 2003, Ocul Surf, V1, P107; Hua R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005296; Ibrahim OMA, 2011, INVEST OPHTH VIS SCI, V52, P2194, DOI 10.1167/iovs.10-5986; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2017, CLIN OPHTHALMOL, V11, P861, DOI 10.2147/OPTH.S128939; Kaido M, 2016, INVEST OPHTH VIS SCI, V57, P914, DOI 10.1167/iovs.15-18447; Kaido M, 2015, BRIT J OPHTHALMOL, V99, P1488, DOI 10.1136/bjophthalmol-2015-306640; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Kaido M, 2012, CORNEA, V31, P1009, DOI 10.1097/ICO.0b013e31823f8cfc; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Kajita M, 2001, Fukushima J Med Sci, V47, P13; Keech A, 2013, CURR EYE RES, V38, P428, DOI 10.3109/02713683.2013.763987; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; OWENS DA, 1987, INVEST OPHTH VIS SCI, V28, P743; Parra A, 2014, PAIN, V155, P1481, DOI 10.1016/j.pain.2014.04.025; Rolando M, 2001, SURV OPHTHALMOL, V45, pS203, DOI 10.1016/S0039-6257(00)00203-4; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Schmidl D, 2015, INVEST OPHTH VIS SCI, V56, P1467, DOI 10.1167/iovs.14-15814; Shimazaki S., 2006, J EYE, V24, P181; Shimazaki-Den S, 2013, CORNEA, V32, P1211, DOI 10.1097/ICO.0b013e318295a2a5; TODA I, 1995, OPHTHALMOLOGY, V102, P302; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029; Uchino Y, 2014, JAMA OPHTHALMOL, V132, P985, DOI 10.1001/jamaophthalmol.2014.1008; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Watanabe Hitoshi, 2002, Cornea, V21, pS17, DOI 10.1097/00003226-200203001-00005; WINN B, 1990, CURR EYE RES, V9, P971, DOI 10.3109/02713689009069933; Yamamoto Yuji, 2012, Nippon Ganka Gakkai Zasshi, V116, P1137; Yokoi N, 2015, AM J OPHTHALMOL, V159, P748, DOI 10.1016/j.ajo.2014.12.019	42	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184296	10.1371/journal.pone.0184296	http://dx.doi.org/10.1371/journal.pone.0184296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886090	gold, Green Submitted, Green Published			2022-12-26	WOS:000410001100093
J	Kayamba, V; Shibemba, A; Zyambo, K; Heimburger, DC; Morgan, DR; Kelly, P				Kayamba, Violet; Shibemba, Aaron; Zyambo, Kanekwa; Heimburger, Douglas C.; Morgan, Douglas R.; Kelly, Paul			High prevalence of gastric intestinal metaplasia detected by confocal laser endomicroscopy in Zambian adults	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ENDOSCOPIC FINDINGS; PRECANCEROUS CONDITIONS; ANTIRETROVIRAL THERAPY; HIV-INFECTION; IN-VIVO; DIAGNOSIS; STOMACH; DISEASE; IMMUNODEFICIENCY	Background Confocal laser endomicroscopy (CLE) may increase the detection of gastric premalignant lesions, and facilitate targeted biopsies for histology. The study aim was to analyse premalignant lesions in Zambian adults using CLE. Methods Using CLE and histology we analysed the antral mucosa for gastric premalignant lesions in asymptomatic adults living with HIV and in HIV seronegative adults. Fasting gastric pH and the presence of Helicobacter pylori (H. pylori) were also evaluated. Results We enrolled 84 HIV seropositive participants (median age 43 years; 55 (65%) female), of whom 32 (38%) were anti-retroviral therapy (ART)-naive. Also enrolled were 22 HIV seronegative controls (median age 39 years, 12 (55%) females). Hypochlorhydria was found in 48 (57%) HIV positive and 8 (38%) HIV negative controls (P = 0.14). Detection of gastric intestinal metaplasia (GIM) was higher (P = 0.007) using CLE (49, 54%) than histology (9, 9%) and, using CLE, GIM was similar between HIV positive (41, 60%) and negative groups (8, 36%; P = 0.08). Gastric luminal fluorescein leakage was significantly associated with the presence of GIM [OR 8.2; 95% CI 2.5-31, P<0.001]. Conclusion CLE is useful for the detection of GIM, and luminal fluorescein leakage may represent a novel CLE marker for GIM. GIM is common in Zambian adults, and is highly prevalent irrespective of HIV infection or use of ART.	[Kayamba, Violet; Zyambo, Kanekwa; Kelly, Paul] Univ Zambia, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Sch Med, Lusaka, Zambia; [Shibemba, Aaron] Canc Dis Hosp, Pathol Sect, Lusaka, Zambia; [Heimburger, Douglas C.; Morgan, Douglas R.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Kelly, Paul] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England	University of Zambia; Vanderbilt University; University of London; Queen Mary University London	Kayamba, V (corresponding author), Univ Zambia, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Sch Med, Lusaka, Zambia.	viojole@yahoo.com	Kayamba, Violet/AEQ-9806-2022	Kayamba, Violet/0000-0002-6521-2501; Kelly, Paul/0000-0003-0844-6448	NIH Research Training Grant - Fogarty International Center, Office of the Director, National Institutes of Health [R25 TW009337]; National Heart, Blood, and Lung Institute; National Institute of Mental Health; Fogarty International Center of the National Institutes of Health grant [D43 TW009744]; FOGARTY INTERNATIONAL CENTER [D43TW009744] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center, Office of the Director, National Institutes of Health; National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty International Center of the National Institutes of Health grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH Research Training Grant # R25 TW009337 funded by the Fogarty International Center, Office of the Director, National Institutes of Health, the National Heart, Blood, and Lung Institute, and the National Institute of Mental Health and the Fogarty International Center of the National Institutes of Health grant # D43 TW009744. https://www.fic.nih gov/FUNDING/pages/fogarty-funding-opps.aspx.	Ankouane F, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.52.5887; Bok GH, 2013, GASTROINTEST ENDOSC, V77, P899, DOI 10.1016/j.gie.2013.01.018; Boukhris SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082646; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; El-Zimaity HMT, 1999, HUM PATHOL, V30, P72, DOI 10.1016/S0046-8177(99)90303-9; Emura Fabian, 2013, Rev. gastroenterol. Perú, V33, P52; Fernando N, 2001, J CLIN MICROBIOL, V39, P1323, DOI 10.1128/JCM.39.4.1323-1327.2001; Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13; Geraghty J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132043; Guo YT, 2008, ENDOSCOPY, V40, P547, DOI 10.1055/s-2007-995633; Hunt RH, 2015, GUT, V64, P1650, DOI 10.1136/gutjnl-2014-307595; Kayamba V, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0353-8; Kelly P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004600; Kelly P, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-72; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kim HM, 2013, SCAND J GASTROENTERO, V48, P1371, DOI 10.3109/00365521.2013.838606; Korac M, 2009, HEPATO-GASTROENTEROL, V56, P1675; Lee SK, 2015, CLIN ENDOSC, V48, P511, DOI 10.5946/ce.2015.48.6.511; Li Z, 2014, ENDOSCOPY, V46, P282, DOI 10.1055/s-0033-1359215; Lim LG, 2013, SURG ENDOSC, V27, P4649, DOI 10.1007/s00464-013-3098-x; Mach T, 2007, MED SCI MONITOR, V13, pCR14; Mansour-Ghanaei F, 2012, ASIAN PAC J CANCER P, V13, P1407, DOI 10.7314/APJCP.2012.13.4.1407; Newton Robert, 2006, Infect Agent Cancer, V1, P5, DOI 10.1186/1750-9378-1-5; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Nkuize M, 2012, HELICOBACTER, V17, P153, DOI 10.1111/j.1523-5378.2011.00929.x; Olmos M, 2004, DIGEST DIS SCI, V49, P1836, DOI 10.1007/s10620-004-9580-5; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; SHAFFER RT, 1992, AM J GASTROENTEROL, V87, P1777; Udoh M O, 2012, East Afr Med J, V89, P408; Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632; Wang FW, 2011, WORLD J GASTROENTERO, V17, P1199, DOI 10.3748/wjg.v17.i9.1199; Wilcox CM, 1999, GUT, V44, P101, DOI 10.1136/gut.44.1.101; World Health Organization, GLOB HLTH OBS HIV AI	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184272	10.1371/journal.pone.0184272	http://dx.doi.org/10.1371/journal.pone.0184272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886101	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100090
J	Lorant, A; Pedersen, S; Holst, I; Hufford, MB; Winter, K; Piperno, D; Ross-Ibarra, J				Lorant, Anne; Pedersen, Sarah; Holst, Irene; Hufford, Matthew B.; Winter, Klaus; Piperno, Dolores; Ross-Ibarra, Jeffrey			The potential role of genetic assimilation during maize domestication	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; PHENOTYPIC PLASTICITY; APICAL DOMINANCE; EVOLUTION; SELECTION; PATTERNS; ORIGIN; EXPRESSION; HISTORY	Domestication research has largely focused on identification of morphological and genetic differences between extant populations of crops and their wild relatives. Little attention has been paid to the potential effects of environment despite substantial known changes in climate from the time of domestication to modern day. In recent research, the exposure of teosinte (i.e., wild maize) to environments similar to the time of domestication, resulted in a plastic induction of domesticated phenotypes in teosinte. These results suggest that early agriculturalists may have selected for genetic mechanisms that cemented domestication phenotypes initially induced by a plastic response of teosinte to environment, a process known as genetic assimilation. To better understand this phenomenon and the potential role of environment in maize domestication, we examined differential gene expression in maize (Zea mays ssp. mays) and teosinte (Zea mays ssp. parviglumis) between past and present conditions. We identified a gene set of over 2000 loci showing a change in expression across environmental conditions in teosinte and invariance in maize. In fact, overall we observed both greater plasticity in gene expression and more substantial changes in co-expressionnal networks in teosinte across environments when compared to maize. While these results suggest genetic assimilation played at least some role in domestication, genes showing expression patterns consistent with assimilation are not significantly enriched for previously identified domestication candidates, indicating assimilation did not have a genome-wide effect.	[Lorant, Anne; Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Pedersen, Sarah; Hufford, Matthew B.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Holst, Irene; Winter, Klaus; Piperno, Dolores] Smithsonian Trop Res Inst, Panama City, Panama; [Piperno, Dolores] Smithsonian Natl Museum Nat Hist, Dept Anthropol, Washington, DC USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; Iowa State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California Davis; University of California System; University of California Davis	Ross-Ibarra, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	rossibarra@ucdavis.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954	US National Science Foundation [IOS-0922703, IOS-1238014]; USDA [CA-D-PLS-2066-H]; Smithsonian Institution; Division Of Integrative Organismal Systems [1238014] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Smithsonian Institution(Smithsonian Institution); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded from the US National Science Foundation https://www.nsf.gov/ (IOS-0922703 and IOS-1238014) JRI, USDA https://usdasearch.usda.gov/ (Hatch project CA-D-PLS-2066-H) JRI, and the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to acknowledge funding support from the US National Science Foundation (IOS-0922703 and IOS-1238014), USDA (Hatch project CA-D-PLS-2066-H) and the Smithsonian Institution. We would like to acknowledge Milton Garcia for his technical assistance. We would also like to thank members of the Ross-Ibarra lab for comments on earlier drafts of the manuscript.	Ahn J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004415; Alter P, 2016, PLANT PHYSIOL, V172, P389, DOI 10.1104/pp.16.00285; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Beadle George W., 1972, FIELD MUSEUM NATURAL; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Bush Mark B, 2009, CLIMATE VARIABILITY, P113; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Diggle PK, 2013, AM J BOT, V100, P1050, DOI 10.3732/ajb.1200647; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; Footitt S, 2013, PLANT J, V74, P1003, DOI 10.1111/tpj.12186; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gilbert Scott F, 2009, ECOLOGICAL DEV BIOL; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hendry AP, 2016, J HERED, V107, P25, DOI 10.1093/jhered/esv060; Hirsch Candice N, PALNT CELL; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Hubbard L, 2002, GENETICS, V162, P1927; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hufford Matthew B, 2012, PLOS ONE, V7; Jane West-Eberhard Mary, 2003, DEV PLASTICITY EVOLU; Kebrom TH, 2013, TRENDS PLANT SCI, V18, P41, DOI 10.1016/j.tplants.2012.07.001; Kuzawa CW, 2012, CURR ANTHROPOL, V53, pS369, DOI 10.1086/667410; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Lawit Shai J, 2010, PLANT CELL PHYSL, V51, P1854; Ledon-Rettig Cris C, 1700, P BIOL SCI, V277, P3569; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magalhaes IS, 2009, J EVOLUTION BIOL, V22, P260, DOI 10.1111/j.1420-9101.2008.01637.x; Marais DLD, 2013, ANNU REV ECOL EVOL S, V44, P5, DOI 10.1146/annurev-ecolsys-110512-135806; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Michael Lawrence, 2013, PLOS COMPUT BIOL, V9; Miller Jeremy A, 2010, P NATL ACAD SCI USA, V107, P12698; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Paul Gepts, 2012, BIODIVERSITY AGR DOM; Pfennig DW, 2010, PHILOS T R SOC B, V365, P577, DOI 10.1098/rstb.2009.0244; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Piperno Dolores R, 2015, QUATERN INT, V363, P65; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Restrepo A, 2012, ECOLOGY, V93, P1853, DOI 10.1890/11-1545.1; Schlichting CD, 2014, EVOLUTION, V68, P656, DOI 10.1111/evo.12348; Schneider RF, 2014, MOL ECOL, V23, P4511, DOI 10.1111/mec.12851; Sergi Munne A-Bosch, 2013, PLANT PHYSIOL, V161, P5; Silin Zhong, 2011, COLD SPRING HARB PRO, P940; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Sultan SE, 2009, ECOLOGY, V90, P1831, DOI 10.1890/08-1064.1; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Walworth NG, 2016, P NATL ACAD SCI USA, V113, pE7367, DOI 10.1073/pnas.1605202113; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Whipple CJ, 2011, P NATL ACAD SCI USA, V108, pE506, DOI 10.1073/pnas.1102819108; Wills David M, 2013, PLOS GENET, V9; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu Thomas D, 2016, METHOD MOL BIOL, V1418, P283	67	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184202	10.1371/journal.pone.0184202	http://dx.doi.org/10.1371/journal.pone.0184202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886108	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100079
J	Mekango, DE; Alemayehu, M; Gebregergs, GB; Medhanyie, AA; Goba, G				Mekango, Dejene Ermias; Alemayehu, Mussie; Gebregergs, Gebremedhin Berhe; Medhanyie, Araya Abrha; Goba, Gelila			Determinants of maternal near miss among women in public hospital maternity wards in Northern Ethiopia: A facility based case-control study	PLOS ONE			English	Article							NEAR-MISS; MORBIDITY; BRAZIL; CARE	Background In Ethiopia, 20,000 women die each year from complications related to pregnancy, childbirth and post- partum. For every woman that dies, 20 more experience injury, infection, disease, or disability. "Maternal near miss" (MNM), defined by the World Health Organization (WHO) as a woman who nearly dies, but survives a complication during pregnancy, childbirth or within 42 days of a termination, is a proxy indicator of maternal mortality and quality of obstetric care. In Ethiopia, few studies have examined MNM. This study aims to identify determinants of MNM among a small population of women in Tigray, Ethiopia. Methods Unmatched case- control study was conducted in hospitals in Tigray Region, Northern Ethiopia, from January 30- March 30, 2016. The sample included 103 cases and 205 controls recruited from among women seeking obstetric care at six (6) public hospitals. Clients with life- threatening obstetric complications, including hemorrhage, hypertensive diseases of pregnancy, dystocia, infection, and anemia or clinical signs of severe anemia (in women without hemorrhage) were taken as cases and those with normal obstetric outcomes were controls. Cases were selected based on proportion to size allocation while systematic sampling was employed for controls. Binary and multiple variable logistic regression ("odds ratio") analyses were calculated at 95% CI. Results Roughly 90% of cases and controls were married and 25% experienced their first pregnancy before the age of 16 years. About two-thirds of controls and 45.6% of cases had gestational ages between 37-41 weeks. Among cases, severe obstetric hemorrhage (44.7%), hypertensive disorders (38.8%), dystocia (17.5%), sepsis (9.7%) and severe anemia (2.9%) were leading causes of MNM. Histories of chronic maternal medical problems like hypertension, diabetes were reported in 55.3% of cases and 33.2% of controls. Women with no formal education [AOR = 3.2; 95% CI:1.24, 8.12], being less than 16 years of age at first pregnancy [AOR = 2.5; 95% CI:1.12,5.63], induced labor[AOR = 3.0; 95% CI:1.44, 6.17], history of cesarean section[AOR = 4.6; 95% CI:1.98, 7.61] or chronic medical disorder[AOR = 3.5; 95% CI:1.78, 6.93], and women who traveled more than 60 minutes before reaching their final place of care[AOR = 2.8; 95% CI:1.19,6.35] had higher odds of experiencing MNM. Conclusions Macro-developments like increasing road and health facility access as well as expanding education will all help reduce MNM. Work should be continued to educate women and providers about common predictors of MNM like history of C-section and chronic illness as well as teenage pregnancy. These efforts should be carried out at the facility, community, and individual levels. Targeted follow-up with women with history of chronic disease and C-section could also help reduce MNM.	[Mekango, Dejene Ermias] Wachemo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Hosanna, Ethiopia; [Alemayehu, Mussie; Gebregergs, Gebremedhin Berhe; Medhanyie, Araya Abrha] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Goba, Gelila] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL USA	Mekelle University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mekango, DE (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Hosanna, Ethiopia.	dj.ermi2005@gmail.com	Dangal, Ganesh/O-1989-2017; Alemayehu, Mussie/AAH-3016-2019	Dangal, Ganesh/0000-0002-5834-5525; Alemayehu, Mussie/0000-0002-0035-631X	Mekelle University's College of Health Sciences	Mekelle University's College of Health Sciences	We would like to thank Mekelle University's College of Health Sciences for funding this research.	Adeoye IA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-93; [Anonymous], 2012, ETHIOPIAN J REPROD H; Assarag B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116675; Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213; Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; Pacheco AJC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-91; Dile M A T, 2015, GYNECOL OBSTET SUNNY, V5; Federal Ministry of Health, 2015, HLTH SECT PLAN 2015; Federal Ministry of Health, 2014, MAT DEATH SURV RESP; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Filippi V, 2009, BEST PRACT RES CL OB, V23, P389, DOI 10.1016/j.bpobgyn.2008.12.006; Gedefaw M., 2014, OPEN J EPIDEMIOLOGY, V4, P199, DOI [10.4236/ojepi.2014.44026, DOI 10.4236/OJEPI.2014.44026]; Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Galvao LPL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-25; Lotufo FA, 2012, CLINICS, V67, P225, DOI 10.6061/clinics/2012(03)04; Luexay P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-945; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; de Moraes APP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-11; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Tigray Regional Health Bureau, 2014, GOVT NAT STAT TIGR R; WHO UNICEF, 2011, TRENDS MAT MORT 1990; WHO UNICEF UNFPA, 2014, WORLD BANK UN POP DI; Wianwiset W., 2012, THAI J OBSTET GYNAEC, V20, P69; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG; Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	31	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183886	10.1371/journal.pone.0183886	http://dx.doi.org/10.1371/journal.pone.0183886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886034	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100043
J	Okahara, K; Nagata, N; Shimada, T; Joya, A; Hayashida, T; Gatanaga, H; Oka, S; Sakurai, T; Uemura, N; Akiyama, J				Okahara, Koki; Nagata, Naoyoshi; Shimada, Takayuki; Joya, Akane; Hayashida, Tsunefusa; Gatanaga, Hiroyuki; Oka, Shinichi; Sakurai, Toshiyuki; Uemura, Naomi; Akiyama, Junichi			Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REAL-TIME PCR; INFECTION; CELLS; CMV; TRANSPLANTATION; MANAGEMENT; DIAGNOSIS; BIOPSY; TISSUE	Background We aimed to identify the risk factors associated with colonic cytomegalovirus (CMV) infection in ulcerative colitis (UC) and to compare the clinical course between antiviral therapy-treated and-untreated groups in mucosal CMV-polymerase chain reaction (PCR)-positive cases. Methods We retrospectively selected 46 UC patients (> 15 years old) in active phase who underwent colonoscopy with biopsy and were analyzed for CMV infection by mucosal PCR between October 2011 and December 2015 at our institution. Colonic CMV in inflamed mucosa was detected using quantitative real-time PCR. The clinical course was evaluated, including need for drug therapy/ surgery or drug therapy intensification. In addition, we evaluated the clinical course between CMV-DNA-cases and CMV-DNA+ cases with low viral load. Results At baseline, CMV-DNA+ patients were significantly older, had higher endoscopic scores, and required higher corticosteroid doses during the past 4 weeks than CMV-DNA-patients (p<0.05). No significant differences were observed in disease duration, disease distribution, laboratory data, or use of other medication between CMV-DNA+ and CMV-DNA-patients. In the anti-CMV-treated group with a median (range) DNA load of 16,000 (9,000-36,400), 3patients achieved remission without additional UC therapy, 2 required additional UC therapy, and 1 required colectomy despite azathioprine and infliximab therapy. In the CMV-untreated group with a median (range) DNA load of 919 (157-5,480), all patients achieved remission with UC therapy alone. No significant difference was observed in the clinical course between CMV-DNA-cases and CMV-DNA+ cases with low viral loads. Conclusions Aging, endoscopic UC activity, and corticosteroid dose predispose to colonic CMV infection, as determined by mucosal PCR, in UC. UC treatment without anti-CMV therapy may be warranted, particularly in patients with low-load CMV-DNA. Anti-CMV therapy alone does not always achieve clinical response in UC even in cases with high-load PCR.	[Okahara, Koki; Nagata, Naoyoshi; Shimada, Takayuki; Sakurai, Toshiyuki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Okahara, Koki] Juntendo Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Joya, Akane; Hayashida, Tsunefusa; Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, Dept AIDS Clin Ctr, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; Juntendo University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [29-2001]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant for Research from the National Center for Global Health and Medicine (29-2001). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre K, 2009, J CROHNS COLITIS, V3, P141, DOI 10.1016/j.crohns.2009.03.002; Bonta J, 2016, EUR J GASTROEN HEPAT, V28, P1329, DOI 10.1097/MEG.0000000000000716; Campos Sara T., 2017, INT J COLORECTAL DIS, V32, P645; Fukuchi T, 2013, J CROHNS COLITIS, V7, P803, DOI 10.1016/j.crohns.2012.12.003; GOODGAME RW, 1993, ANN INTERN MED, V119, P924, DOI 10.7326/0003-4819-119-9-199311010-00010; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Lu SH, 2011, J CELL MOL MED, V15, P587, DOI 10.1111/j.1582-4934.2010.01017.x; Machida U, 2000, J CLIN MICROBIOL, V38, P2536, DOI 10.1128/JCM.38.7.2536-2542.2000; Martonez-Montiel MP, 2013, CLIN GASTEROENTEROLH, V11, P673; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; Mills AM, 2013, AM J SURG PATHOL, V37, P995, DOI 10.1097/PAS.0b013e31827fcc33; Nagata N, 2013, CLIN GASTROENTEROL H, V11, P673, DOI 10.1016/j.cgh.2012.12.034; Nagata N, 2011, WORLD J GASTROENTERO, V17, P1185, DOI 10.3748/wjg.v17.i9.1185; Pillet S, 2016, WORLD J GASTROENTERO, V22, P2030, DOI 10.3748/wjg.v22.i6.2030; Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013; Roblin X, 2011, AM J GASTROENTEROL, V106, P2001, DOI 10.1038/ajg.2011.202; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Suzuki H, 2010, WORLD J GASTROENTERO, V16, P1245, DOI 10.3748/wjg.v16.i10.1245; Takahashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133589; Thorn M, 2016, SCAND J GASTROENTERO, V51, P1075, DOI 10.3109/00365521.2016.1156154; Tremaine WJ, 1997, NETH J MED, V50, pS12, DOI 10.1016/S0300-2977(96)00065-4; Widmann T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003634; Yoshino T, 2007, INFLAMM BOWEL DIS, V13, P1516, DOI 10.1002/ibd.20253; Zagorowicz E, 2016, J CROHNS COLITIS, V10, P1205, DOI 10.1093/ecco-jcc/jjw071	24	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183951	10.1371/journal.pone.0183951	http://dx.doi.org/10.1371/journal.pone.0183951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886066	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100046
J	Khaparde, S; Raizada, N; Nair, SA; Denkinger, C; Sachdeva, KS; Paramasivan, CN; Salhotra, VS; Vassall, A; van't Hoog, A				Khaparde, Sunil; Raizada, Neeraj; Nair, Sreenivas Achuthan; Denkinger, Claudia; Sachdeva, Kuldeep Singh; Paramasivan, Chinnambedu Nainarappan; Salhotra, Virender Singh; Vassall, Anna; van't Hoog, Anja			Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis	PLOS ONE			English	Article							COST-EFFECTIVENESS; DIAGNOSIS	Background India is considering the scale-up of the Xpert MTB/RIF assay for detection of tuberculosis (TB) and rifampicin resistance. We conducted an economic analysis to estimate the costs of different strategies of Xpert implementation in India. Methods Using a decision analytical model, we compared four diagnostic strategies for TB patients: (i) sputum smear microscopy (SSM) only; (ii) Xpert as a replacement for the rapid diagnostic test currently used for SSM-positive patients at risk of drug resistance (i.e. line probe assay (LPA)); (iii) Upfront Xpert testing for patients at risk of drug resistance; and (iv) Xpert as a replacement for SSM for all patients. Results The total costs associated with diagnosis for 100,000 presumptive TB cases were: (i) US$619,042 for SSM-only; (ii) US$575,377 in the LPA replacement scenario; (iii) US$720,523 in the SSM replacement scenario; and (iv) US$1,639,643 in the Xpert-for-all scenario. Total cohort costs, including treatment costs, increased by 46% from the SSM-only to the Xpert-for-all strategy, largely due to the costs associated with second-line treatment of a higher number of rifampicin-resistant patients due to increased drug-resistant TB (DR-TB) case detection. The diagnostic costs for an estimated 7.64 million presumptive TB patients would comprise (i) 19%, (ii) 17%, (iii) 22% and (iv) 50% of the annual TB control budget. Mean total costs, expressed per DR-TB case initiated on treatment, were lowest in the Xpert-for-all scenario (US$11,099). Conclusions The Xpert-for-all strategy would result in the greatest increase of TB and DR-TB case detection, but would also have the highest associated costs. The strategy of using Xpert only for patients at risk for DR-TB would be more affordable, but would miss DR-TB cases and the cost per true DR-TB case detected would be higher compared to the Xpert-for-all strategy. As such expanded Xpert strategy would require significant increased TB control budget to ensure that increased case detection is followed by appropriate care.	[Khaparde, Sunil; Sachdeva, Kuldeep Singh] Govt India, Cent TB Div, New Delhi, India; [Raizada, Neeraj; Paramasivan, Chinnambedu Nainarappan] Fdn Innovat New Diagnost, New Delhi, India; [Nair, Sreenivas Achuthan] WHO, Delhi, India; [Denkinger, Claudia] Fdn Innovat New Diagnost, Geneva, Switzerland; [Salhotra, Virender Singh] Minist Hlth & Family Welf, Addit DDG, Cent TB Div, New Delhi, India; [Vassall, Anna; van't Hoog, Anja] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands; [Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	Foundation For Innovative New Diagnostics; World Health Organization; Foundation For Innovative New Diagnostics; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com		Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Vassall, Anna/0000-0002-2911-1375	UK government through a Department for International Development (DFID) [204074-101]	UK government through a Department for International Development (DFID)	This work was supported by the UK government through a Department for International Development (DFID) grant to FIND (grant number 204074-101). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Central TB Division DGoHSMoH& FW, 2012, REV NAT TUB CONTR PR; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P437, DOI 10.2471/BLT.05.024109; Goodchild M, 2011, INT J TUBERC LUNG D, V15, P358; Joint Monitoring Mission, 2015, 2015 REP IND REV NAT; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P705; Pantoja A, 2013, EUR RESPIR J, V42, P708, DOI 10.1183/09031936.00147912; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Revill P, 2014, 98 CHE U YORK; Revised National Tuberculosis Control Program (RNTCP), 2010, TRAIN MOD MED PRACT; Rupert S, 2017, INT J TUBERC LUNG DI; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walusimbi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-507; WHO, 2014, GLOB TUB REP 2014; WHO, 2011, POL STAT AUT REAL TI; World Health Organization, CHOOSING INT AR COST	25	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184270	10.1371/journal.pone.0184270	http://dx.doi.org/10.1371/journal.pone.0184270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880875	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000409467200045
J	Takase, H; Kurihara, Y; Yokoyama, T; Kawahara, N; Takei, K				Takase, Hajime; Kurihara, Yuji; Yokoyama, Taka-akira; Kawahara, Nobutaka; Takei, Kohtaro			LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; FUNCTIONAL RECOVERY; NOGO-A; STROKE RECOVERY; MOUSE MODEL; ADULT RATS; OCCLUSION; FORELIMB; BLOCKADE; CORTEX	Nogo receptor-1 (NgR1) and its ligands inhibit neuronal plasticity and limit functional recovery after brain damage such as ischemic stroke. We have previously shown that lateral olfactory tract usher substance (LOTUS) antagonizes NgR1-mediated signaling. Here, we investigated whether LOTUS enhances neuronal plasticity and functional recovery after brain focal ischemia in adult mice. Focal ischemic infarcts were induced in wild-type and LOTUS-overexpressing transgenic mice via middle cerebral artery occlusion. Endogenous LOTUS expression was increased in brain and cervical spinal cord of the contralateral side of ischemia in the chronic phase after brain ischemia. LOTUS overexpression accelerated midline-crossing axonal sprouting from the contralateral side to the ipsilateral side of ischemia in the medullar reticular formation and gray matter of denervated cervical spinal cord. Importantly, LOTUS overexpression improved neurological score highly correlated with laterality ratio of corticoreticular fibers of the medulla oblongata, indicating that LOTUS overexpression may overcome the inhibitory environment induced by NgR1 signaling for damaged motor pathway reconstruction after ischemic stroke. Thus, our data suggest that LOTUS overexpression accelerates neuronal plasticity in the brainstem and cervical spinal cord after stroke and LOTUS administration is useful for future therapeutic strategies.	[Takase, Hajime; Yokoyama, Taka-akira; Kawahara, Nobutaka] Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa, Japan; [Takase, Hajime; Kurihara, Yuji; Yokoyama, Taka-akira; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University	Kawahara, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa, Japan.; Takei, K (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa, Japan.	nkawa@yokohama-cu.ac.jp; kohtaro@yokohama-cu.ac.jp		Takei, Kohtaro/0000-0001-6938-0812; Takase, Hajime/0000-0001-5813-1386	Ministry of Education, Culture, Sport, Science and Technology of Japan [15H04951]; Mihara Cerebrovascular Disorder Research Promotion Fund; Japan Brain Foundation [2584]; Yokohama Academic Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mihara Cerebrovascular Disorder Research Promotion Fund; Japan Brain Foundation; Yokohama Academic Foundation	This work received support from The Ministry of Education, Culture, Sport, Science and Technology of Japan (Grant number; 15H04951, http://www.mext.go.jp/en/); Mihara Cerebrovascular Disorder Research Promotion Fund(no grant number, http://square.umin.ac.jp/mihara/index_j.html); Japan Brain Foundation (Grant Number; 2584, http://jbf.or.jp//; and Yokohama Academic Foundation(no Grant Number, https://www.hamakko.or.jp/similar to yokogaku/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37823; [Anonymous], 2010, NATURE PRECEDINGS; Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Baker SN, 2015, PROG BRAIN RES, V218, P389, DOI 10.1016/bs.pbr.2014.12.010; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Egawa N, 2016, TRANSL STROKE RES; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Fisher KM, 2012, J PHYSIOL-LONDON, V590, P4045, DOI 10.1113/jphysiol.2011.226209; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Hetze S, 2012, J NEUROSCI METH, V206, P7, DOI 10.1016/j.jneumeth.2012.02.001; Jang SH, 2014, SOMATOSENS MOT RES, V31, P204, DOI 10.3109/08990220.2014.917292; Jiang W, 2009, TRANSL RES, V154, P40, DOI 10.1016/j.trsl.2009.04.005; Jolkkonen J, 2016, TRANSL STROKE RES, V7, P331, DOI 10.1007/s12975-016-0461-y; Kilic E, 2010, J CEREBR BLOOD F MET, V30, P969, DOI 10.1038/jcbfm.2009.268; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kurihara Y, 2014, MOL CELL NEUROSCI, V61, P211, DOI 10.1016/j.mcn.2014.07.001; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; PASSINGHAM RE, 1983, BRAIN, V106, P675, DOI 10.1093/brain/106.3.675; Raineteau O, 1999, EUR J NEUROSCI, V11, P1486, DOI 10.1046/j.1460-9568.1999.00560.x; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Sozmen EG, 2016, P NATL ACAD SCI USA, V113, pE8453, DOI 10.1073/pnas.1615322113; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Takakusaki K, 2015, J NEURAL TRANSM VIEN; Takiguchi M, 2015, NEUROSCIENCE, V304, P349, DOI 10.1016/j.neuroscience.2015.07.046; Tamura M, 2001, BRAIN RES, V890, P170, DOI 10.1016/S0006-8993(00)03168-1; Tosolini AP, 2012, NEUROSCIENCE, V200, P19, DOI 10.1016/j.neuroscience.2011.10.054; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Ye YL, 2012, BIOL PHARM BULL, V35, P355, DOI 10.1248/bpb.35.355; Yuan FL, 2012, J NEUROTRAUM, V29, P1499, DOI 10.1089/neu.2011.2105; Zaleska MM, 2009, NEUROPHARMACOLOGY, V56, P329, DOI 10.1016/j.neuropharm.2008.10.006; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006	50	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184258	10.1371/journal.pone.0184258	http://dx.doi.org/10.1371/journal.pone.0184258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880879	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200044
J	Georgiou, A; Demetriou, CA; Heraclides, A; Christou, YP; Leonidou, E; Loukaides, P; Yiasoumi, E; Panagiotou, D; Manoli, P; Thomson, P; Loizidou, MA; Hadjisavvas, A; Zamba-Papanicolaou, E				Georgiou, Andrea; Demetriou, Christiana A.; Heraclides, Alexandros; Christou, Yiolanda P.; Leonidou, Eleni; Loukaides, Panayiotis; Yiasoumi, Elena; Panagiotou, Dimitris; Manoli, Panayiotis; Thomson, Pippa; Loizidou, Maria A.; Hadjisavvas, Andreas; Zamba-Papanicolaou, Eleni			Mitochondrial superclusters influence age of onset of Parkinson's disease in a gender specific manner in the Cypriot population: A case-control study	PLOS ONE			English	Article							SPANISH POPULATION; DNA POLYMORPHISMS; RISK; ASSOCIATION; METAANALYSIS; HAPLOGROUPS; VARIANTS; ESTROGEN; PD	Background Despite evidence supporting an involvement of mitochondrial dysfunction in the pathogenesis of some neurodegenerative disorders, there are inconsistent findings concerning mitochondrial haplogroups and their association to neurodegenerative disorders, including idiopathic Parkinson's disease (PD). Methods To test this hypothesis for the Greek-Cypriot population, a cohort of 230 PD patients and 457 healthy matched controls were recruited. Mitochondrial haplogroup distributions for cases and controls were determined. Association tests were carried out between mitochondrial haplogroups and PD. Results Mitochondrial haplogroup U was associated with a reduced PD risk in the Cypriot population. After pooling mitochondrial haplogroups together into haplogroup clusters and superclusters, association tests demonstrated a significantly protective effect of mitochondrial haplogroup cluster N (xR) and supercluster LMN for PD risk only in females. In addition, for female PD cases belonging to UKJT and R (xH, xUKJT) haplogroup, the odds of having a later age of onset of PD were 13 and 15 times respectively higher than the odds for female cases with an H haplogroup. Conclusion Statistically significant associations regarding PD risk and PD age of onset were mostly detected for females thus suggesting that gender is a risk modifier between mitochondrial haplogroups and PD status/PD age of onset. The biological mechanisms behind this gender specificity remain to be determined.	[Georgiou, Andrea; Demetriou, Christiana A.; Christou, Yiolanda P.; Zamba-Papanicolaou, Eleni] Cyprus Inst Neurol & Genet, Neurol Clin D, Nicosia, Cyprus; [Georgiou, Andrea; Demetriou, Christiana A.; Loizidou, Maria A.; Hadjisavvas, Andreas; Zamba-Papanicolaou, Eleni] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus; [Heraclides, Alexandros] Univ Nicosia, Dept Primary Care & Populat Hlth, Med Sch, Nicosia, Cyprus; [Christou, Yiolanda P.] Cyprus Inst Neurol & Genet, Neurol Clin B, Nicosia, Cyprus; [Leonidou, Eleni] Cyprus Inst Neurol & Genet, Neurol Clin C, Nicosia, Cyprus; [Loukaides, Panayiotis] Limassol Gen Hosp, Limassol, Cyprus; [Yiasoumi, Elena] Private Neurol Clin, Larnax, Cyprus; [Panagiotou, Dimitris] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Manoli, Panayiotis] Cyprus Inst Neurol & Genet, Dept Cardiovasc Genet, Nicosia, Cyprus; [Manoli, Panayiotis] Cyprus Inst Neurol & Genet, Lab Forens Genet, Nicosia, Cyprus; [Thomson, Pippa] Univ Edinburgh, MRC Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Loizidou, Maria A.; Hadjisavvas, Andreas] Cyprus Inst Neurol & Genet, Electron Microscopy & Mol Pathol Dept, Nicosia, Cyprus	University of Nicosia; University of Cyprus; University of Edinburgh	Zamba-Papanicolaou, E (corresponding author), Cyprus Inst Neurol & Genet, Neurol Clin D, Nicosia, Cyprus.; Zamba-Papanicolaou, E (corresponding author), Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus.	ezamba@cing.ac.cy	Heraclides, Alexandros/AFN-4638-2022; Loizidou, Maria A/C-6607-2009	Heraclides, Alexandros/0000-0002-1304-3275; Demetriou, Christiana A./0000-0003-4002-2880	Cyprus Institute of Neurology and Genetics; Cyprus School of Molecular Medicine; A. G. Leventis Foundation	Cyprus Institute of Neurology and Genetics; Cyprus School of Molecular Medicine; A. G. Leventis Foundation	The study consumables and direct expenses were funded by the Cyprus Institute of Neurology and Genetics and the Cyprus School of Molecular Medicine. Andrea Georgiou received funding from A. G. Leventis Foundation. All other authors received no specific funding for this work.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; [Anonymous], 2008, AUTOPHAGY, V4, P372; Arnold S, 2012, J STEROID BIOCHEM, V131, P2, DOI 10.1016/j.jsbmb.2012.01.012; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; Chu Q, 2015, FEMALE GENETIC DISTR, V5, P17170; Ciccone S, 2013, INT J MOL SCI, V14, P2388, DOI 10.3390/ijms14022388; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Ebner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135622; Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276; Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Groger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084081; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Irwin J, 2008, INT J LEGAL MED, V122, P87, DOI 10.1007/s00414-007-0173-7; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Latsoudis H, 2008, J HUM GENET, V53, P349, DOI 10.1007/s10038-008-0259-1; Lubbe S, 2014, J NEUROL, V261, P259, DOI 10.1007/s00415-013-7003-2; Marom S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43449; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Schapira AHV, 2011, MT SINAI J MED, V78, P872, DOI 10.1002/msj.20303; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Velarde Michael C, 2014, Longev Healthspan, V3, P2, DOI 10.1186/2046-2395-3-2	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183444	10.1371/journal.pone.0183444	http://dx.doi.org/10.1371/journal.pone.0183444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877188	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200033
J	Murray, K; Godbole, S; Natarajan, L; Full, K; Hipp, JA; Glanz, K; Mitchell, J; Laden, F; James, P; Quante, M; Kerr, J				Murray, Kate; Godbole, Suneeta; Natarajan, Loki; Full, Kelsie; Hipp, J. Aaron; Glanz, Karen; Mitchell, Jonathan; Laden, Francine; James, Peter; Quante, Mirja; Kerr, Jacqueline			The relations between sleep, time of physical activity, and time outdoors among adult women	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OLDER-ADULTS; CHILD-CARE; LATER LIFE; EXERCISE; QUALITY; METAANALYSIS; HEALTH; DURATION; INSOMNIA	Physical activity and time spent outdoors may be important non-pharmacological approaches to improve sleep quality and duration (or sleep patterns) but there is little empirical research evaluating the two simultaneously. The current study assesses the role of physical activity and time outdoors in predicting sleep health by using objective measurement of the three variables. A convenience sample of 360 adult women (mean age = 55.38 +/- 9.89 years; mean body mass index = 27.74 +/- 6.12) was recruited from different regions of the U.S. Participants wore a Global Positioning System device and ActiGraph GT3X+ accelerometers on the hip for 7 days and on the wrist for 7 days and 7 nights to assess total time and time of day spent outdoors, total minutes in moderate-to-vigorous physical activity per day, and 4 measures of sleep health, respectively. A generalized mixed-effects model was used to assess temporal associations between moderate-to-vigorous physical activity, outdoor time, and sleep at the daily level (days = 1931) within individuals. There was a significant interaction (p = 0.04) between moderate-to-vigorous physical activity and time spent outdoors in predicting total sleep time but not for predicting sleep efficiency. Increasing time outdoors in the afternoon (versus morning) predicted lower sleep efficiency, but had no effect on total sleep time. Time spent outdoors and the time of day spent outdoors may be important moderators in assessing the relation between physical activity and sleep. More research is needed in larger populations using experimental designs.	[Murray, Kate] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia; [Murray, Kate; Godbole, Suneeta; Natarajan, Loki; Full, Kelsie; Kerr, Jacqueline] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Hipp, J. Aaron] North Carolina State Univ, Dept Pk Recreat & Tourism Management, Raleigh, NC 27695 USA; [Hipp, J. Aaron] North Carolina State Univ, Ctr Geospatial Analyt, Raleigh, NC 27695 USA; [Hipp, J. Aaron] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Glanz, Karen] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Glanz, Karen] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Mitchell, Jonathan] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Laden, Francine] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Laden, Francine] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Laden, Francine] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Laden, Francine] Harvard Med Sch, Boston, MA USA; [James, Peter] Harvard Med Sch, Dept Populat Med, Div Chron Dis Res Lifecourse CoRAL, Boston, MA USA; [James, Peter] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Quante, Mirja] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Boston, MA USA; [Quante, Mirja] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; [Quante, Mirja] Univ Tubingen, Dept Neonatol, Tubingen, Germany	Queensland University of Technology (QUT); University of California System; University of California San Diego; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Eberhard Karls University of Tubingen	Kerr, J (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	jkerr@ucsd.edu	Hipp, J. Aaron/AAF-9869-2021	Hipp, J. Aaron/0000-0002-2394-7112; Murray, Kate/0000-0002-9935-8170; Mitchell, Jonathan/0000-0003-3765-2419	National Cancer Institute Centers for Transdisciplinary Research on Energetics and Cancer [U01 CM 16850, U54 CM 55496, U54 CM 55626, U54 CA155435, U54 CA155850]; National Institutes of Health [UM1 CM 76726, R01 ES017017]; American Cancer Society [MRSG-13-069-01-CPPB]; Harvard National Heart Lung and Blood Institute Cardiovascular Epidemiology Training Grant [T32 HL 098048]; Max Kade Foundation; National Cancer Institute [F32CA162847, K99CA201542]; NATIONAL CANCER INSTITUTE [U54CA155850, U54CA155626, U01CA116850, U54CA155435, UM1CA176726, F32CA162847, U54CA155496, K99CA201542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017017] Funding Source: NIH RePORTER	National Cancer Institute Centers for Transdisciplinary Research on Energetics and Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Harvard National Heart Lung and Blood Institute Cardiovascular Epidemiology Training Grant; Max Kade Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: National Cancer Institute (http://www.cancer.gov/) Centers for Transdisciplinary Research on Energetics and Cancer grants U01 CM 16850, U54 CM 55496, U54 CM 55626, U54 CA155435, U54 CA155850; National Institutes of Health (https://www.nih.gov/) grants UM1 CM 76726 and R01 ES017017; American Cancer Society (http://www.cancer.org/) grant MRSG-13-069-01-CPPB (KM); Harvard National Heart Lung and Blood Institute (http://www.nhibtnih.gov/) Cardiovascular Epidemiology Training Grant T32 HL 098048 (PJ); Max Kade Foundation (http://maxkadefoundation.org/grants.html) scholarship (MQ); National Cancer Institute (http://www.cancer.gov/) grant F32CA162847 (JM) and K99CA201542 (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge and thank all of the people who participated in this research. This work was supported by: National Cancer Institute (https://www.cancer.gov/) Centers for Transdisciplinary Research on Energetics and Cancer grants U01 CA116850, U54 CA155496, U54 CA155626, U54 CA155435, U54 CA155850; National Institutes of Health (https://www. nih.gov/) grants UM1 CA176726 and RO1 ES017017; American Cancer Society (https://www.cancer.org/) grant MRSG-13-069-01-CPPB (KM); Harvard National Heart Lung and Blood Institute (http://www.nhibtnih.gov/) Cardiovascular Epidemiology Training Grant T32 HL 098048 (PJ); Max Kade Foundation (http://maxkadefoundation.org/grants.html) scholarship (MQ); National Cancer Institute (http://www.cancer.gov/) grant F32CA162847 (JM) and K99CA201542 (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron KG, 2013, J CLIN SLEEP MED, V9, P819, DOI 10.5664/jcsm.2930; Bruyneel M, 2015, MATURITAS, V81, P406, DOI 10.1016/j.maturitas.2015.04.017; Buman MP, 2014, SLEEP MED, V15, P755, DOI 10.1016/j.sleep.2014.01.008; Buman MP, 2010, AM J LIFESTYLE MED, V4, P500, DOI 10.1177/1559827610375532; Buxton OM, 1997, J BIOL RHYTHM, V12, P568, DOI 10.1177/074873049701200611; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.008; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Guimaraes LHDT, 2008, SLEEP MED, V9, P488, DOI 10.1016/j.sleep.2007.06.009; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Du SZ, 2015, INT J NURS STUD, V52, P368, DOI 10.1016/j.ijnurstu.2014.05.009; Dzierzewski JM, 2014, J SLEEP RES, V23, P61, DOI 10.1111/jsr.12078; Fairbrother K, 2014, VASC HEALTH RISK MAN, V10, P691, DOI 10.2147/VHRM.S73688; Hunter RF, 2015, SOC SCI MED, V124, P246, DOI 10.1016/j.socscimed.2014.11.051; Jackson CL, 2015, ANNU REV PUBL HEALTH, V36, P417, DOI 10.1146/annurev-publhealth-031914-122838; Kerr J, 2012, INT J ENV RES PUB HE, V9, P4615, DOI 10.3390/ijerph9124615; Klinker CD, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00020; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Lambiase MJ, 2013, MED SCI SPORT EXER, V45, P2362, DOI 10.1249/MSS.0b013e31829e4cea; Lauderdale DS, 2014, J GERONTOL B-PSYCHOL, V69, pS125, DOI 10.1093/geronb/gbu092; Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001; Mitchell JA, 2016, MED SCI SPORT EXER, V48, P1950, DOI 10.1249/MSS.0000000000001000; Monk TH, 2003, CHRONOBIOL INT, V20, P97, DOI 10.1081/CBI-120017812; Montgomery P, 2004, SLEEP MED REV, V8, P47, DOI 10.1016/S1087-0792(03)00026-1; Moraes W, 2014, SLEEP MED, V15, P401, DOI 10.1016/j.sleep.2013.11.791; Mustian KM, 2013, J CLIN ONCOL, V31, P3233, DOI 10.1200/JCO.2012.43.7707; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Nowakowski Sara, 2013, Sleep Med Res, V4, P1; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Passos GS, 2011, SLEEP MED, V12, P1018, DOI 10.1016/j.sleep.2011.02.007; Patterson RE, 2013, CANCER CAUSE CONTROL, V24, P695, DOI 10.1007/s10552-013-0150-z; Ram S, 2010, SLEEP BREATH, V14, P63, DOI 10.1007/s11325-009-0281-3; Viana VAR, 2012, EUR J APPL PHYSIOL, V112, P2403, DOI 10.1007/s00421-011-2219-2; Sarris J, 2011, SLEEP MED REV, V15, P99, DOI 10.1016/j.smrv.2010.04.001; Slater JA, 2015, SLEEP BIOL RHYTHMS, V13, P172, DOI 10.1111/sbr.12103; Sternfeld B, 2014, MENOPAUSE, V21, P330, DOI 10.1097/GME.0b013e31829e4089; Tandon PS, 2013, AM J PREV MED, V44, P85, DOI 10.1016/j.amepre.2012.09.052; Tandon PS, 2012, ACAD PEDIATR, V12, P475, DOI 10.1016/j.acap.2012.06.010; Tsunoda K, 2015, AM J PREV MED, V48, P662, DOI 10.1016/j.amepre.2014.12.006; Venn S, 2013, SOC SCI MED, V79, P117, DOI 10.1016/j.socscimed.2012.09.037; Weinert D, 2007, PHYSIOL BEHAV, V90, P246, DOI 10.1016/j.physbeh.2006.09.003; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Xu QY, 2014, MATURITAS, V79, P401, DOI 10.1016/j.maturitas.2014.09.011; Yamanaka Y, 2015, AM J PHYSIOL-REG I, V309, pR1112, DOI 10.1152/ajpregu.00127.2015; Yang PY, 2012, J PHYSIOTHER, V58, P157, DOI 10.1016/S1836-9553(12)70106-6; Youngstedt Shawn D., 2016, Journal of Circadian Rhythms, V14, P2, DOI 10.5334/jcr.137	52	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182013	10.1371/journal.pone.0182013	http://dx.doi.org/10.1371/journal.pone.0182013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877192	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200010
J	Rasch, S; Notzel, B; Phillip, V; Lahmer, T; Schmid, RM; Algul, H				Rasch, Sebastian; Noetzel, Baerbel; Phillip, Veit; Lahmer, Tobias; Schmid, Roland M.; Alguel, Hana			Management of pancreatic pseudocysts-A retrospective analysis	PLOS ONE			English	Article							ENDOSCOPIC DRAINAGE; TRANSMURAL DRAINAGE; SINGLE-STEP; EUS; EPIDEMIOLOGY	Background Pancreatic pseudocysts arise mostly in patients with alcohol induced chronic pancreatitis causing various symptoms and complications. However, data on the optimal management are rare. To address this problem, we analysed patients with pancreatic pseudocysts treated at our clinic retrospectively. Methods We searched our clinical database for the diagnosis pancreatitis from 2004 till 2014, selected patients with pseudocysts larger than 10 mm and entered all relevant information in a database for statistical analysis. Results In total, 129 patients with pancreatic pseudocysts were treated at our institution during the study period. Most patients suffered from alcohol induced chronic pancreatitis (43.4%; 56/129). Pseudocysts were more frequent in female than in male (2:1) and were mainly located in the pancreatic head (47.3%; 61/129). Local complications like obstructive jaundice were associated with the diameter of the cysts (AUC 0.697 in ROC-curve analysis). However, even cysts up to a diameter of 160 mm can regress spontaneously. Besides a lower re-intervention rate in surgically treated patients, endoscopic, percutaneous and surgical drainage are equally effective. Most treatment related complications occur in large pseudocysts located in the pancreatic head. Conclusion Conservative management of large pseudocysts is successful in many patients. Therefore, indication for treatment should be made carefully considering the presence and risk of local complications. Endoscopic and surgical drainage are equally effective.	[Rasch, Sebastian; Noetzel, Baerbel; Phillip, Veit; Lahmer, Tobias; Schmid, Roland M.; Alguel, Hana] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 2, Munich, Germany	Technical University of Munich	Rasch, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 2, Munich, Germany.	sebastian.rasch@mri.tum.de	Phillip, Veit/ABE-4899-2021; Lahmer, Tobias/AAD-3838-2021	Phillip, Veit/0000-0002-0921-2523; Algul, Hana/0000-0002-5067-7031; Rasch, Sebastian/0000-0002-7917-8017				Aghdassi Alexander A, 2006, HPB (Oxford), V8, P432, DOI 10.1080/13651820600748012; Akshintala VS, 2014, GASTROINTEST ENDOSC, V79, P921, DOI 10.1016/j.gie.2013.10.032; AMMANN RW, 1984, GASTROENTEROLOGY, V86, P820; Ardengh JC, 2008, DIGEST DIS, V26, P370, DOI 10.1159/000177024; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; BARTHET M, 1993, GASTROEN CLIN BIOL, V17, P270; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADLEY EL, 1976, ANN SURG, V184, P734, DOI 10.1097/00000658-197612000-00013; Bradley EL, 1992, ARCH SURG; Cannon JW, 2009, J AM COLL SURGEONS, V209, P385, DOI 10.1016/j.jamcollsurg.2009.04.017; Gumaste V V, 1996, Gastroenterologist, V4, P33; Gurusamy KS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011392.pub2; Johnson MD, 2008, J CLIN GASTROENTEROL, V43, p586 ; Jupp J, 2010, BEST PRACT RES CL GA, V24, P219, DOI 10.1016/j.bpg.2010.03.005; Keane MG, 2016, SURG ENDOSC, V30, P3730, DOI 10.1007/s00464-015-4668-x; Lankisch PG, 2002, PANCREATOLOGY, V2, P469, DOI 10.1159/000064713; Lerch MM, 2009, DTSCH ARZTEBL INT, V106, P614, DOI 10.3238/arztebl.2009.0614; LONDON NJM, 1989, GUT, V30, P397, DOI 10.1136/gut.30.3.397; Maringhini A, 1999, DIGEST DIS SCI, V44, P1669, DOI 10.1023/A:1026691700511; Melman L, 2009, SURG ENDOSC, V23, P267, DOI 10.1007/s00464-008-0196-2; OMALLEY VP, 1985, AM J SURG, V150, P680, DOI 10.1016/0002-9610(85)90407-6; Park DH, 2009, ENDOSCOPY, V41, P842, DOI 10.1055/s-0029-1215133; Rasch S, 2016, PANCREATOLOGY, V16, P708, DOI 10.1016/j.pan.2016.08.004; Ruckert F, 2017, PANCREATOLOGY, V17, P555, DOI 10.1016/j.pan.2017.06.002; Ryu JK, 2005, DIGESTION, V72, P207, DOI 10.1159/000089414; Sadik R, 2011, WORLD J GASTROENTERO, V17, P499, DOI 10.3748/wjg.v17.i4.499; Spanler BWM, 2008, EUR J GASTROEN HEPAT, V20, P653, DOI 10.1097/MEG.0b013e3282f52f83; Tao N, 2003, ALCOHOL CLIN EXP RES, V27, P1798, DOI 10.1097/01.ALC.0000095862.30777.D9; Varadarajulu S, 2008, GASTROINTEST ENDOSC, V68, P1102, DOI 10.1016/j.gie.2008.04.028; Varadarajulu S, 2013, GASTROENTEROLOGY, V145, P583, DOI 10.1053/j.gastro.2013.05.046; Varadarajulu S, 2011, J GASTROINTEST SURG, V15, P2080, DOI 10.1007/s11605-011-1621-8; Yuan HC, 2015, PANCREAS, V44, P570, DOI 10.1097/MPA.0000000000000307	32	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184374	10.1371/journal.pone.0184374	http://dx.doi.org/10.1371/journal.pone.0184374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877270	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200094
J	Rick, F; Niyibizi, AA; Shroufi, A; Onami, K; Steele, SJ; Kuleile, M; Muleya, I; Chiller, T; Walker, T; Van Cutsem, G				Rick, Fernanda; Niyibizi, Aline Aurore; Shroufi, Amir; Onami, Kazumi; Steele, Sarah-Jane; Kuleile, Malehlohonolo; Muleya, Innocent; Chiller, Tom; Walker, Tiffany; Van Cutsem, Gilles			Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; EARLY MORTALITY; AMPHOTERICIN-B; MENINGITIS; PROGRAM; DISEASE; COST	Introduction Cryptococcal meningitis is one of the leading causes of death among people with HIV in Africa, primarily due to delayed presentation, poor availability and high cost of treatment. Routine cryptococcal antigen (CrAg) screening of patients with a CD4 count less than 100 cells/mm 3, followed by pre-emptive therapy if positive, might reduce mortality in high prevalence settings. Using the cryptococcal antigen (CrAg) lateral flow assay (LFA), screening is possible at the point of care (POC). However, critical shortages of health staff may limit adoption. This study investigates the feasibility of lay counsellors conducting CrAg LFA screening in rural primary care clinics in Lesotho. Methods From May 2014 to June 2015, individuals who tested positive for HIV were tested for CD4 count and those with CD4 < 100 cells/mm(3) were screened with CrAg LFA. All tests were performed by lay counsellors. CrAg-positive asymptomatic patients received fluconazole, while symptomatic patients were referred to hospital. Lay counsellors were trained and supervised by a laboratory technician and counsellor activity supervisor. Additionally, nurses and doctors were trained on CrAg screening and appropriate treatment. Results During the study period, 1,388 people were newly diagnosed with HIV, of whom 129 (9%) presented with a CD4 count < 100 cells/mm(3). Of these, 128 (99%) were screened with CrAg LFA and 14/128 (11%) tested positive. Twelve of the 14 (86%) were asymptomatic, and received outpatient fluconazole. All commenced ART with a median time to initiation of 15.5 days [IQR: 14-22]. Of the asymptomatic patients, nine (75%) remained asymptomatic after a median time of 5 months [IQR; 3-6] of follow up. One (8%) became co-infected with tuberculosis and died and two were transferred out. The two patients with symptomatic cryptococcal meningitis (CM) were referred to hospital, where they later died. Conclusions CrAg LFA screening by lay counsellors followed by pre-emptive fluconazole treatment for asymptomatic cases, or referral to hospital for symptomatic cases, proved feasible. However, regular follow-up to ensure proper management of cryptococcal disease was needed. These early results support the wider use of CrAg LFA screening in remote primary care settings where upper cadres of healthcare staff may be in short supply.	[Rick, Fernanda; Niyibizi, Aline Aurore; Shroufi, Amir; Steele, Sarah-Jane; Van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Onami, Kazumi; Kuleile, Malehlohonolo; Muleya, Innocent] Med Sans Frontieres, Maseru, Lesotho; [Chiller, Tom; Walker, Tiffany] Ctrs Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Walker, Tiffany] Ctr Dis Control & Prevent CDC, Epidem Intelligence Serv, Atlanta, GA USA; [Van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Cape Town	Shroufi, A (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	MSFOCB-Capetown-MedCo@brussels.msf.org	Van Cutsem, Gilles/ABB-1171-2021; hlupeni, admire/M-1539-2018; Rick, Fernanda/AAR-5551-2020	Van Cutsem, Gilles/0000-0002-8972-4480; Rick, Fernanda/0000-0002-0817-094X	Medecins sans Frontieres	Medecins sans Frontieres	All necessary funds were provided by Medecins sans Frontieres. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610; Binnicker MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1988, DOI 10.1128/CVI.00446-12; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Govender NP, 2012, SAMJ S AFR MED J, V102, P914, DOI [10.7196/samj.6228, 10.7196/SAMJ.6228]; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2010, CLIN INFECT DIS, V51, P1463, DOI 10.1086/657405; Jarvis JN, 2010, AIDS, V24, P1233, DOI 10.1097/QAD.0b013e3283383aeb; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kaplan JE, 2015, J ACQUIR IMMUNE D S3, V68, P331; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lanternier F, 2008, CLIN MICROBIOL INFEC, V14, P71, DOI 10.1111/j.1469-0691.2008.01984.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lesotho G, 2014, NATL GUIDELINES USE, V7, P78; Lesotho Ministry of Health, 2014, 2014 LES DEM HLTH SU; Lesotho Ministry Of Health, 2014, NAT GUID HIV AIDS CA; Lessells RJ, 2011, SAMJ S AFR MED J, V101, P251, DOI 10.7196/SAMJ.4378; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Magambo KA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19040; McMullan BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049541; Meya David, 2015, Curr Trop Med Rep, V2, P81; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Rex JH, 1999, CLIN INFECT DIS, V29, P1408, DOI 10.1086/313555; Rugemalila J, 2013, TROP MED INT HEALTH, V18, P1075, DOI 10.1111/tmi.12157; Walker NF, 2015, HIV AIDS-RES PALLIAT, V7, P49, DOI 10.2147/HIV.S42328; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2	27	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183656	10.1371/journal.pone.0183656	http://dx.doi.org/10.1371/journal.pone.0183656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877182	gold, Green Published			2022-12-26	WOS:000409391200036
J	Feldman, LA; Fabre, MS; Grasso, C; Reid, D; Broaddus, WC; Lanza, GM; Spiess, BD; Garbow, JR; McConnell, MJ; Herst, PM				Feldman, Lisa A.; Fabre, Marie-Sophie; Grasso, Carole; Reid, Dana; Broaddus, William C.; Lanza, Gregory M.; Spiess, Bruce D.; Garbow, Joel R.; McConnell, Melanie J.; Herst, Patries M.			Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; PHASE-III; GLIOBLASTOMA; CELLS; RADIOTHERAPY; TEMOZOLOMIDE; RESISTANCE; HYPOXIA; CHEMORADIOTHERAPY; CONCOMITANT	Background Tumour hypoxia limits the effectiveness of radiation therapy. Delivering normobaric or hyperbaric oxygen therapy elevates pO(2) in both tumour and normal brain tissue. However, pO2 levels return to baseline within 15 minutes of stopping therapy. Aim To investigate the effect of perfluorocarbon (PFC) emulsions on hypoxia in subcutaneous and intracranial mouse gliomas and their radiosensitising effect in orthotopic gliomas in mice breathing carbogen (95% O-2 and 5% CO2). Results PFC emulsions completely abrogated hypoxia in both subcutaneous and intracranial GL261 models and conferred a significant survival advantage orthotopically (Mantel Cox: p = 0.048) in carbogen breathing mice injected intravenously (IV) with PFC emulsions before radiation versus mice receiving radiation alone. Carbogen alone decreased hypoxia levels substantially and conferred a smaller but not statistically significant survival advantage over and above radiation alone. Conclusion IV injections of PFC emulsions followed by 1h carbogen breathing, radiosensitises GL261 intracranial tumors.	[Feldman, Lisa A.; Broaddus, William C.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Feldman, Lisa A.; Grasso, Carole; McConnell, Melanie J.; Herst, Patries M.] Malaghan Inst Med Res, Wellington, New Zealand; [Fabre, Marie-Sophie; Reid, Dana; McConnell, Melanie J.] Victoria Univ, Sch Biol Sci, Wellington, New Zealand; [Lanza, Gregory M.] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA; [Spiess, Bruce D.] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA; [Garbow, Joel R.] Washington Univ, Sch Med, Mallinckrodt Inst, St Louis, MO USA; [Herst, Patries M.] Univ Otago, Dept Radiat Therapy, Wellington, New Zealand	Virginia Commonwealth University; Malaghan Institute; Victoria University Wellington; Victoria University Wellington; Washington University (WUSTL); State University System of Florida; University of Florida; Washington University (WUSTL); University of Otago	Herst, PM (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.; Herst, PM (corresponding author), Univ Otago, Dept Radiat Therapy, Wellington, New Zealand.	patries.herst@otago.ac.nz	Broaddus, William/ABF-8984-2020	Broaddus, William/0000-0001-9614-8162; Herst, Patries/0000-0002-2173-2513	University of Otago; Wellington Division of the New Zealand Cancer Society; Malaghan Institute of Medical Research; NATIONAL CANCER INSTITUTE [U54CA199092] Funding Source: NIH RePORTER	University of Otago; Wellington Division of the New Zealand Cancer Society; Malaghan Institute of Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by a Van Wagenen Fellowship (LF), University of Otago (Dean's Grant), the Wellington Division of the New Zealand Cancer Society, and the Malaghan Institute of Medical Research.	An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Bao S, 2006, NAT LETT, V444, P4; Barbosa FT, 2009, SAO PAULO MED J, V127, P97, DOI 10.1590/S1516-31802009000200008; Bartek J, 2012, J NEUROL NEUROSUR PS, V83, P753, DOI 10.1136/jnnp-2011-300709; Beeman SC, 2016, MAGN RESON MED, V75, P2442, DOI 10.1002/mrm.25821; Bernsen HJJA, 2000, J NEUROSURG, V93, P449, DOI 10.3171/jns.2000.93.3.0449; Bourgeois M, 2011, NUCL MED REV, V14, P90, DOI 10.5603/NMR.2011.00022; Burgi S, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00029; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Christen T, 2012, RADIOLOGY, V262, P495, DOI 10.1148/radiol.11110518; Clarke JL, 2009, J CLIN ONCOL, V27, P3861, DOI 10.1200/JCO.2008.20.7944; Clarke RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111199; Evans RG, 1990, INT J RAD ONCOLOGY B, V19; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Evans SM, 2009, RADIAT RES, V170, P677; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Grasso C, 2014, FRONT ONCOL, V4, DOI [10.3389/fonc.2014.003560, 10.3389/fonc.2014.00356]; Hallac RR, 2014, MAGN RESON MED, V71, P1863, DOI 10.1002/mrm.24846; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; He X, 2008, MAGN RESON MED, V60, P882, DOI 10.1002/mrm.21719; Herst PM, 2016, TRANSL CANCER RES, V5, pS815, DOI 10.21037/tcr.2016.10.71; Horsman MR, 2016, J RADIAT RES, P1; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; Hunn MK, 2012, CLIN CANCER RES, V18, P6446, DOI 10.1158/1078-0432.CCR-12-0704; Ichikawa T, 2016, PHENOTYPIC TRANSITIO, P387; Janssens GO, 2012, J CLIN ONCOL, V30, P1777, DOI 10.1200/JCO.2011.35.9315; Khan N, 2009, INT J RADIAT ONCOL, V73, P878, DOI 10.1016/j.ijrobp.2008.10.025; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; Kohshi K, 2013, UNDERSEA HYPERBAR M, V40, P351; Krause BJ, 2006, Q J NUCL MED MOL IM, V50, P28; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; MARTIN DF, 1987, INT J RADIAT ONCOL, V13, P747, DOI 10.1016/0360-3016(87)90294-X; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Ogawa K, 2013, INT J CLIN ONCOL, V18, P364, DOI 10.1007/s10147-013-0537-6; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Olive PL, 2000, BRIT J CANCER, V83, P1525, DOI 10.1054/bjoc.2000.1489; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Pape A, 2007, BEST PRACT RES-CLIN, V21, P221, DOI 10.1016/j.bpa.2007.02.004; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; ROCKWELL S, 1992, INT J RADIAT ONCOL, V22, P87, DOI 10.1016/0360-3016(92)90986-R; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; Spahn DR, 2001, NEWS PHYSIOL SCI, V16, P38; Spahn DR, 1999, CRIT CARE, V3, pR91, DOI 10.1186/cc363; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun S, 2012, J NEURO-ONCOL, V109, P467, DOI 10.1007/s11060-012-0923-3; Teicher BA, 1993, RAD ONCOL INVESTIG, V1, P14; Wang XD, 2014, CHEM SOC REV, V43, P3666, DOI 10.1039/c4cs00039k; Wenzl T, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-171; Wouters B.G., 2009, BASIC CLIN RADIOBIOL, Vfourth, P11; Yahara K, 2016, J RADIAT RES, P1; Zhou ZW, 2008, NEUROSURGERY, V63, P799, DOI 10.1227/01.NEU.0000325493.51900.53	54	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184250	10.1371/journal.pone.0184250	http://dx.doi.org/10.1371/journal.pone.0184250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873460	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800064
J	Huo, ZX; Luo, XG; Zhan, X; Chu, QH; Xu, Q; Yao, J; Pang, H				Huo, Zhixin; Luo, Xiaoguang; Zhan, Xiaoni; Chu, Qiaohong; Xu, Qin; Yao, Jun; Pang, Hao			Genetic analysis of indel markers in three loci associated with Parkinson's disease	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; DJ-1 GENE; LINKAGE DISEQUILIBRIUM; DELETION POLYMORPHISM; RISK; GIGYF2; SUSCEPTIBILITY; VARIANTS; ACE; RS12817488	The causal mutations and genetic polymorphisms associated with susceptibility to Parkinson's disease (PD) have been extensively described. To explore the potential contribution of insertion (I)/deletion (D) polymorphisms (indels) to the risk of PD in a Chinese population, we performed genetic analyses of indel loci in ACE, DJ-1, and GIGYF2 genes. Genomic DNA was extracted from venous blood of 348 PD patients and 325 age-and sex-matched controls without neurodegenerative disease. Genotyping of the indel loci was performed by fragment length analysis after PCR and DNA sequencing. Our results showed a statistically significant association for both allele X (alleles without 5) vs. 5 (odds ratio = 1.378, 95% confidence interval = 1.112-1.708, P = 0.003) and genotype 5/X+X/X vs. 5/5 (odds ratio = 1.681, 95% confidence interval = 1.174-2.407, P = 0.004) in the GIGYF2 locus; however, no significant differences were detected for the ACE and DJ-1 indels. After stratification by gender, no significant differences were observed in any indels. These results indicate that the GIGYF2 indel may be associated with increased risk of PD in northern China.	[Huo, Zhixin; Zhan, Xiaoni; Chu, Qiaohong; Xu, Qin; Yao, Jun; Pang, Hao] China Med Univ, Shenyang North New Area, Dept Forens Genet & Biol, Shenyang, Liaoning, Peoples R China; [Luo, Xiaoguang] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Pang, H (corresponding author), China Med Univ, Shenyang North New Area, Dept Forens Genet & Biol, Shenyang, Liaoning, Peoples R China.	hpang@cmu.edu.cn	Luo, Xiao-Guang/N-8971-2018	Luo, Xiao-Guang/0000-0001-9828-0626	National Natural Science Foundation of China [81471826]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (81471826).; This work was supported by a grant from the National Natural Science Foundation of China (81471826 to Dr. Hao Pang).	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Benitez BA, 2010, J GENET, V89, P229, DOI 10.1007/s12041-010-0030-1; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bras J, 2009, HUM MOL GENET, V18, P341, DOI 10.1093/hmg/ddn340; Cao L, 2010, PARKINSONISM RELAT D, V16, P294, DOI 10.1016/j.parkreldis.2009.11.009; Chen Wenjun, 2008, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V25, P566; Chu QH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17170; Cummings JL, 2011, BRAIN, V134, P3146, DOI 10.1093/brain/awr177; De Marco EV, 2010, CLIN GENET, V77, P183, DOI 10.1111/j.1399-0004.2009.01310.x; Eerola J, 2003, NEUROLOGY, V61, P1000, DOI 10.1212/01.WNL.0000083992.28066.7E; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Firouzabadi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153667; Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Glanzmann B, 2014, J NEURAL TRANSM, V121, P135, DOI 10.1007/s00702-013-1094-x; Guella I, 2011, NEUROBIOL AGING, V32, P1994, DOI 10.1016/j.neurobiolaging.2009.12.016; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Higashi S, 2010, J NEUROCHEM, V115, P423, DOI 10.1111/j.1471-4159.2010.06930.x; Jones L, 2017, LANCET NEUROL, V16, P88, DOI 10.1016/S1474-4422(16)30350-7; Kaur P, 2015, ACS CHEM NEUROSCI, V6, P508, DOI 10.1021/cn500363g; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Kolsch H, 2005, NEUROSCI LETT, V377, P37, DOI 10.1016/j.neulet.2004.11.062; Kraus-Perrotta Cara, 2016, Cerebellum Ataxias, V3, P20; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; Li L, 2010, NEUROSCI LETT, V479, P245, DOI 10.1016/j.neulet.2010.05.071; Lieb K, 2002, NEUROPSYCHOBIOLOGY, V45, P2, DOI 10.1159/000049254; Lin JJ, 2002, J NEUROL SCI, V199, P25, DOI 10.1016/S0022-510X(02)00081-3; Lin R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167918; Liu RR, 2014, EUR NEUROL, V71, P77, DOI 10.1159/000354333; Lu YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23991; MARSDEN CD, 1994, J NEUROL NEUROSUR PS, V57, P672, DOI 10.1136/jnnp.57.6.672; Martinez-Rodriguez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065700; Mellick GD, 1999, EUR NEUROL, V41, P103, DOI 10.1159/000008012; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Morris CM, 2003, NEUROSCI LETT, V352, P151, DOI 10.1016/j.neulet.2003.08.037; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nichols WC, 2009, NEUROLOGY, V72, P1886, DOI 10.1212/01.wnl.0000346517.98982.1b; Pankratz N, 2003, AM J HUM GENET, V72, P1053, DOI 10.1086/374383; Papapetropoulos Spiridon, 2008, Open Neurol J, V2, P66, DOI 10.2174/1874205X00802010066; Pascale E, 2009, J NEUROL SCI, V276, P18, DOI 10.1016/j.jns.2008.08.017; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rozenkrantz L, 2016, J MOL NEUROSCI, V59, P343, DOI 10.1007/s12031-016-0738-3; Sadhukhan T, 2012, DIS MARKERS, V33, P127, DOI 10.1155/2012/467085; Saunders-Pullman R, 2011, NEUROSCI LETT, V496, P125, DOI 10.1016/j.neulet.2011.03.098; Simunovic F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008856; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Song GG, 2015, J RENIN-ANGIO-ALDO S, V16, P434, DOI 10.1177/1470320313495909; Tan EK, 2009, HUM GENET, V126, P425, DOI 10.1007/s00439-009-0678-x; van der Merwe C, 2015, EUR J NEUROSCI, V41, P1113, DOI 10.1111/ejn.12872; van Duijn C. M., 2001, American Journal of Human Genetics, V69, P629, DOI 10.1086/322996; Verma D, 2014, PROG NEURO-PSYCHOPH, V50, P11, DOI 10.1016/j.pnpbp.2013.11.010; von Otter M, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0131-4; Wang LY, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000072; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Yang XL, 2016, GENET TEST MOL BIOMA, V20, P753, DOI 10.1089/gtmb.2016.0149; Yu RL, 2015, J CLIN NEUROSCI, V22, P1002, DOI 10.1016/j.jocn.2014.11.024; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	59	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184269	10.1371/journal.pone.0184269	http://dx.doi.org/10.1371/journal.pone.0184269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873462	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800066
J	Morsica, G; Bagaglio, S; Spagnuolo, V; Castagna, A; Di Serio, C; Galli, A; Della Torre, L; Andolina, A; Pramov, A; Uberti-Foppa, C				Morsica, Giulia; Bagaglio, Sabrina; Spagnuolo, Vincenzo; Castagna, Antonella; Di Serio, Clelia; Galli, Andrea; Della Torre, Liviana; Andolina, Andrea; Pramov, Alexander; Uberti-Foppa, Caterina			Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study	PLOS ONE			English	Article							VIRUS-INFECTION; HBV VACCINE; C VIRUS; COHORT; ADULTS; RECOMMENDATIONS; IMMUNOGENICITY; PROTECTION; EFFICACY; CARE	Background and aim Antibodies against hepatitis B core antigen (anti-HBc) are found in 14-44% of patients with HIV infection, but it is still unclear whether hepatitis B virus (HBV) vaccination should be recommended for HIV-positive subjects with isolated anti-HBc (IAHBc). We examined the rate of anamnestic and primary responses (ARs and PRs) and associated factors in a group of HIV-infected patients with an IAHBc profile. Methods This prospective study recruited 25 HIV-positive patients with anti-HBc alone who were vaccinated against HBV infection. Those without an AR (anti-hepatitis B envelope antigen [antiHBs] levels of <10 U/L) or who were hypo-responsiveness (anti-HBs levels of >10 but <100 U/L) four weeks after the first dose of vaccine underwent a full course of vaccinations. Their clinical and virological data, including the presence of occult hepatitis B infection (OBI), were evaluated in accordance with the vaccination schedule. Results Six of the 25 patients (24%) showed an AR, four of whom had anti-HBs levels of <100 U/L. Ten of 19 (52.6%) remaining patients became seroprotected after the third dose. OBI was detected in four of the six patients with an AR, two of the 10 patients with a PR, and none of the nine patients who did not respond. Multivariate analysis showed that an AR was associated with the presence of OBI (P = 0.0162), and a PR was associated with HCV antibody status. (P = 0.0191). Conclusions Our data suggest that testing for anti-HBc alone may not be a reliable means of assessing protection from HBV infection in HIV-positive patients. OBI-positive patients may benefit from a single vaccine dose. Anti-HCV serostatus may affect PRs.	[Morsica, Giulia; Bagaglio, Sabrina; Galli, Andrea; Della Torre, Liviana; Andolina, Andrea] Osped San Raffaele, IRCCS, Div Infect Dis, Milan, Italy; [Spagnuolo, Vincenzo; Castagna, Antonella; Uberti-Foppa, Caterina] Univ Vita Salute San Raffaele, Milan, Italy; [Di Serio, Clelia; Pramov, Alexander] CUSSB, Vita Salute San Raffaele Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University	Morsica, G (corresponding author), Osped San Raffaele, IRCCS, Div Infect Dis, Milan, Italy.	morsica.giulia@hsr.it	Bagaglio, Sabrina/AAC-5624-2019; Castagna, Antonella/K-3280-2018; Torre, Liviana Della/AAO-5181-2020; Foppa, Caterina Uberti/ABH-3089-2020; Di Serio, Clelia/AAO-5494-2020; Morsica, Giulia/AAC-4993-2019	Castagna, Antonella/0000-0002-8338-9714; Torre, Liviana Della/0000-0003-2867-4296; Foppa, Caterina Uberti/0000-0001-5271-9138; Morsica, Giulia/0000-0003-4891-5376; BAGAGLIO, Sabrina/0000-0002-3671-6022; Spagnuolo, Vincenzo/0000-0002-9656-7217; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	Gilead Science Italy, Fellowship Program	Gilead Science Italy, Fellowship Program	The study was funded by the Gilead Science Italy, Fellowship Program 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Awofeso N, 2001, VACCINE, V19, P4245, DOI 10.1016/S0264-410X(01)00172-4; Bahari Ali, 2015, Middle East J Dig Dis, V7, P233; Borzooy Zohreh, 2015, Germs, V5, P134, DOI 10.11599/germs.2015.1081; Cassini R, 2013, J VIRAL HEPATITIS, V20, P42, DOI 10.1111/j.1365-2893.2012.01623.x; Chakvetadze C, 2010, CLIN INFECT DIS, V50, P1184, DOI 10.1086/651422; DIENSTAG JL, 1984, ANN INTERN MED, V101, P34, DOI 10.7326/0003-4819-101-1-34; Fuster F, 2016, VACCINE, V34, P1889, DOI 10.1016/j.vaccine.2016.02.055; Gandhi RT, 2005, J INFECT DIS, V191, P1435, DOI 10.1086/429302; Hadler S C, 1992, Curr Clin Top Infect Dis, V12, P282; Kaech C, 2012, J INFECTION, V65, P157, DOI 10.1016/j.jinf.2012.03.009; Kamath GR, 2014, VACCINE, V32, P2265, DOI 10.1016/j.vaccine.2014.02.072; Kim HN, 2009, INT J STD AIDS, V20, P595, DOI 10.1258/ijsa.2009.009126; Landrum ML, 2009, VACCINE, V27, P4731, DOI 10.1016/j.vaccine.2009.04.016; Lee SD, 1999, J MED VIROL, V59, P463, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;463::AID-JMV7&gt;3.0.CO;2-5; LOK ASF, 1988, HEPATOLOGY, V8, P766, DOI 10.1002/hep.1840080411; Minniti F, 1999, VACCINE, V17, P3083, DOI 10.1016/S0264-410X(99)00143-7; Morsica G, 2009, INFECTION, V37, P445, DOI 10.1007/s15010-008-8194-9; Navarro JF, 1996, AM J NEPHROL, V16, P95, DOI 10.1159/000168977; Neau D, 2005, CLIN INFECT DIS, V40, P750, DOI 10.1086/427882; Pettit NN, 2010, HIV CLIN TRIALS, V11, P332, DOI 10.1310/hct1105-332; Piroth L, 2016, J INFECT DIS; Potsch DV, 2012, VACCINE, V30, P5973, DOI 10.1016/j.vaccine.2012.07.028; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Santos EA, 2003, EUR J CLIN MICROBIOL, V22, P92, DOI 10.1007/s10096-002-0868-0; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f; SZMUNESS W, 1982, NEW ENGL J MED, V307, P1481, DOI 10.1056/NEJM198212093072403; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; Wiedmann M, 2000, HEPATOLOGY, V31, P230, DOI 10.1002/hep.510310134; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173; Zuckerman NJ, S IMM 7 BERL SPRING, V998, P15	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184128	10.1371/journal.pone.0184128	http://dx.doi.org/10.1371/journal.pone.0184128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863182	gold, Green Published, Green Submitted			2022-12-26	WOS:000408816900027
J	Mota-Vargas, C; Galindo-Gonzalez, J; Rojas-Soto, OR				Mota-Vargas, Claudio; Galindo-Gonzalez, Jorge; Rojas-Soto, Octavio R.			Crumble analysis of the historic sympatric distribution between Dendrortyx macroura and D-barbatus (Aves: Galliformes)	PLOS ONE			English	Article							GEOGRAPHIC DISTRIBUTIONS; SPECIES DISTRIBUTION; SYSTEMATICS; EVOLUTION; MODELS; MEXICO; NICHES	In Mexico, the Long-tailed Wood-Partridge (Dendrortyx macroura) is distributed in the mountains of the Trans-Mexican Volcanic Belt, Sierra Madre del Sur and Sierra Norte de Oaxaca; while the Bearded Wood-Partridge (D. barbatus) is distributed in the Sierra Madre Oriental (SMO). There is a controversial overlap in distribution (sympatry) between these two species (on the Cofre de Perote and Pico de Orizaba volcanoes, SMO and Sierra Norte de Oaxaca), based on the ambiguity and current lack of information regarding the distribution of these two species. In order to disentangle the possible presence of both species in the area of sympatry, we conducted a crumble analysis of the historic knowledge regarding the geographic distribution of both species, based on a review of scientific literature, database records, the specimen examination (in ornithological collections), field work and a reconstruction of the distribution range based on Ecological Niche Modeling. Our results support the presence of only one of these two species in the overlapping area, rejecting the existence of such an area of sympatry between the two species. We discuss alternative hypotheses that could explain the historically reported distribution pattern: 1) an error in the single existing historical record; 2) a possible local extinction of the species and 3) the past existence of interspecific competition that has since been resolved under the principle of competitive exclusion. We propose that the Santo Domingo River in northern Oaxaca and western slope of the Sierra Madre Oriental, mark the distribution limits between these species.	[Mota-Vargas, Claudio; Galindo-Gonzalez, Jorge] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico; [Mota-Vargas, Claudio; Rojas-Soto, Octavio R.] Inst Ecol AC, Red Biol Evolut, Lab Bioclimatol, Xalapa, Veracruz, Mexico	Universidad Veracruzana; Instituto de Ecologia - Mexico	Galindo-Gonzalez, J (corresponding author), Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico.	jgalindo@uv.mx	Galindo-González, Jorge/M-2585-2014; Rojas-Soto, Octavio/Q-6252-2018; Mota-Vargas, Claudio/Q-5663-2018	Galindo-González, Jorge/0000-0003-2583-2754; Rojas-Soto, Octavio/0000-0002-0201-1454; Mota-Vargas, Claudio/0000-0003-2641-8512	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [231395]; Institute de Ecologia A.C. (INECOL); CONACYT; INECOL, A. C.	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Institute de Ecologia A.C. (INECOL); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INECOL, A. C.	The Consejo Nacional de Ciencia y Tecnologia (CONACYT) provided a scholarship (231395) to CM-V. The Institute de Ecologia A.C. (INECOL) and CONACYT provided financial support to visit bird collections. OR-S received a salary from INECOL, and JGG from Universidad Veracruzana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. Villa, P. Parra, and P. Mota helped with fieldwork. A. Navarro, A. Castro-Luna, E. Ruelas, and M. Arteaga, provided valuable comments to drafts of this manuscript. A. Navarro (MZFC), Laura Villasenor (UMSNH), P. Escalante (CNA-IBUNAM), J. McCormack (MLZ), R. Corado and L. Hall (WFVZ), R. K. Bowie (MVZ), P. Sweet and L. M. Garetano (AMNH), and B. K. Schmidt (NMNH) provided access to specimens deposited in different bird collections. CONACYT provided a doctoral scholarship to CMV, INECOL, A. C. and CONACYT provided financial support to visit bird collections. Our manuscript benefited with the exhaustive reviewed by K. MacMillan.	Aguilar S., 2003, CONSERVACION AVES EX, P167; Aguilar-Rodriguez Sergio H., 2000, Huitzil, V1, P9; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1992, THREATENED BIRDS AM; Barve N, 2008, TOOL PARTIAL ROC; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Begon M., 2009, ECOLOGY INDIVIDUALS; Beristain S, 1898, MEMORIAS SOC CIENTIF, V7, P199; Binford LC, 1989, ORNITHOLOGICAL MONOG; Carroll J, 1995, ANN REV WORLD PHEASA, V1, P67; Chavez-Leon G, 2004, J FIELD ORNITHOL, V75, P345, DOI 10.1648/0273-8570-75.4.345; Chavez-Leon G, 2004, BIODIVERS CONSERV, V13, P1943, DOI 10.1023/B:BIOC.0000035877.77979.46; Chavez-Leon G., 2010, LONG TAILED WOOD PAR; Chávez-León Gilberto, 2010, Huitzil, V11, P66; Cowley MJR, 2000, J APPL ECOL, V37, P60, DOI 10.1046/j.1365-2664.2000.00526.x; Eitniear J. C., 2001, VIDA SILVESTRE NEOTR, V10, P1; Environmental Systems Research Institute ESRI, 1999, ARCVIEW GIS V 3 2; Friedmann Herbert, 1943, JOUR WASHINGTON ACAD SCI, V33, P272; FUTUYMA D., 2009, EVOLUTION; Gallardo JC, 2011, BIODIVERSIDAD VERACR, VII, P559; Garcia-Romero A, 2010, INTERCIENCIA, V35, P321; Gause G. F., 1934, STRUGGLE EXISTENCE; Grunwald Christoph I., 2015, Mesoamerican Herpetology, V2, P388; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hellmayr CE, 1942, ZOOLOGICAL SERIES FI, V13, P225; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosner PA, 2015, J BIOGEOGR, V42, P1883, DOI 10.1111/jbi.12555; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jardine B. W., 1828, ILLUSTRATIONS ORNITH; Jardine BW, 1934, NATURALISTS LIB OR 2, VIV, P105; JOHNSGARD P A, 1972, Animals (London), V14, P486; Johnsgard PA, 1973, GROUSE QUAILS N AM; Paniagua LL, 2009, J BIOGEOGR, V36, P1939, DOI 10.1111/j.1365-2699.2009.02134.x; Leopold AS., 1959, WILDLIFE MEXICO GAME, DOI 10.1525/9780520326422; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Martinez-Meyer E, 2004, P ROY SOC B-BIOL SCI, V271, P1151, DOI 10.1098/rspb.2003.2564; Martinez-Meyer Enrique, 2005, Biodiversity Informatics, V2, P42; Montejo Diaz J, 2006, N AM ORN C; Morales-Mavil JE, 2000, FORESTA VERACRUZANA, V2, P35; Mota-Vargas C, 2016, J NAT CONSERV, V29, P1, DOI 10.1016/j.jnc.2015.10.003; Mota-Vargas C, 2013, BIRD CONSERV INT, V23, P371, DOI 10.1017/S0959270912000329; Mota-Vargas C, 2012, J NAT CONSERV, V20, P10, DOI 10.1016/j.jnc.2011.07.002; Navarro S. Adolfo G., 2003, Bulletin of the British Ornithologists' Club, V123A, P207; Nelson E. W., 1897, Auk, Vxiv, P42; Nelson EW, 1900, AM ORNITHOLOGISTS UN, V17, P253; Ogilvie-Grant W. R., 1897, HDB GAME BIRDS; Parra-Olea G, 2005, HERPETOLOGICA, V61, P145, DOI 10.1655/03-02; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson A. Townsend, 2004, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V75, P439; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips A. R., 1966, Bulletin of the British Ornithologists' Club, V86, P86; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pianka ER, 1978, EVOL ECOL, V2nd; Ridgway R, 1946, BIRD N MIDDLE AM; SALVIN O., 1897, BIOL CENTRALI AM AVE, V3; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell D.R.B., 1992, MATH COMPUT SIMULAT, V32, P249, DOI DOI 10.1016/0378-4754(92)90126-2; Straub R., 2006, SITE GUIDE BIRDS VER; Sullivan J, 1997, SYST BIOL, V46, P426, DOI 10.2307/2413690; Sumichrast F., 1882, NATURALEZA, V5, P227; Sumichrast F., 1875, NATURALEZA, V2, P29; Villers LE, 2008, INT J REMOTE SENS, V29, P171; WARNER D. W., 1959, WILSON BULL, V71, P307; Watson DM, 2003, BIOL CONSERV, V111, P283, DOI 10.1016/S0006-3207(02)00271-9; Wiens JA, 1994, ECOLOGY BIRDS COMMUN, V2	69	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183996	10.1371/journal.pone.0183996	http://dx.doi.org/10.1371/journal.pone.0183996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863140	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900015
J	Bian, A; Shi, MJ; Flores, B; Gillings, N; Li, P; Yan, SX; Levine, B; Xing, CY; Hu, MC				Bian, Ao; Shi, Mingjun; Flores, Brianna; Gillings, Nancy; Li, Peng; Yan, Shirley Xiao; Levine, Beth; Xing, Changying; Hu, Ming Chang			Downregulation of autophagy is associated with severe ischemia-reperfusion-induced acute kidney injury in overexpressing C-reactive protein mice	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; PROXIMAL TUBULAR CELLS; IN-VIVO; INFLAMMATION; DISEASE; KLOTHO; MECHANISMS; MORTALITY; FIBROSIS; DEATH	C-mreactive protein (CRP), was recently reported to be closely associated with poor renal function in patients with acute kidney injury (AKI), but whether CRP is pathogenic or a mere biomarker in AKI remains largely unclear. Impaired autophagy is known to exacerbate renal ischemia-mreperfusion injury (IRI). We examined whether the pathogenic role of CRP in AKI is associated with reduction of autophagy. We mated transgenic rabbit CRP over-mexpressing mice (Tg-mCRP) with two autophagy reporter mouse lines, Tg-mGFP-mLC3 mice (LC3) and TgRFP-GFP-mLC3 mice (RG-mLC3) respectively to generate Tg-mCRP-mGFP-mLC3 mice (PLC3) and Tg-mCRP-mRFP-mGFP-mLC3 mice (PRG-mLC3). AKI was induced by IRI. Compared with LC3 mice, PLC3 mice developed more severe kidney damage after IRI. Renal tubules were isolated from LC3 mice at baseline for primary culture. OKP cells were transiently transfected with GFP-mLC3 plasmid. CRP addition exacerbated lactate dehydrogenase release from both cell types. Immunoblots showed lower LC-3 II/I ratios and higher levels of p62, markers of reduced autophagy flux, in the kidneys of PLC3 mice compared to LC3 mice after IRI, and in primary cultured renal tubules and OKP cells treated with CRP and H2O2 compared to H2O2 alone. Immunohistochemistry showed much fewer LC-m3 punctae, and electron microscopy showed fewer autophagosomes in kidneys of PLC3 mice compared to LC3 mice after IRI. Similarly, CRP addition reduced GFP-mLC3 punctae induced by H2O2 in primary cultured proximal tubules and in GFP-mLC3 plasmid transfected OKP cells. Rapamycin, an autophagy inducer, rescued impaired autophagy and reduced renal injury in vivo. In summary, it was suggested that CRP be more than mere biomarker in AKI, and render the kidney more susceptible to ischemic/oxidative injury, which is associated with down-mregulating autophagy flux.	[Bian, Ao; Li, Peng; Xing, Changying] Nanjing Med Univ, Affiliated Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Bian, Ao; Shi, Mingjun; Flores, Brianna; Gillings, Nancy; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Yan, Shirley Xiao] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Levine, Beth; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA	Nanjing Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xing, CY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China.; Hu, MC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA.; Hu, MC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	cyxing62@126.com; ming-chang.hu@utsouthwestern.edu		Hu, Ming Chang/0000-0002-3235-8301	National Natural Science Foundation of China [81170660H0509, 81270408H0220]; The First Affiliated Hospital of Nanjing Medical University; Provincial Natural Science Foundation of Jiangsu, China [BK2011849]; National Institutes of Health [R01-DK091392, R01-DK092461, R01-CA109618]; University of Texas Southwestern Medical Center; The George M.O' Brien Kidney Research Center/UT Southwestern Medical Center [P30-DK-07938]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092461] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The First Affiliated Hospital of Nanjing Medical University; Provincial Natural Science Foundation of Jiangsu, China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Medical Center; The George M.O' Brien Kidney Research Center/UT Southwestern Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: 1. National Natural Science Foundation of China (81170660H0509, 81270408H0220), http://www.nsfc.gov.cn/, The First Affiliated Hospital of Nanjing Medical University, CX; 2. Provincial Natural Science Foundation of Jiangsu, China (BK2011849), http.//www.jstd.gov.cn/, The First Affiliated Hospital of Nanjing Medical University, CX; 3. National Institutes of Health (R01-DK091392, R01-DK092461 and R01-CA109618), University of Texas Southwestern Medical Center, MCH; and 4. The George M.O' Brien Kidney Research Center/UT Southwestern Medical Center (P30-DK-07938), MCH.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Bravo-San Pedro JM, 2015, AUTOPHAGY, V11, P452, DOI 10.1080/15548627.2015.1017191; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Ding Y, 2014, SEMIN NEPHROL, V34, P62, DOI 10.1016/j.semnephrol.2013.11.009; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gao F, 2011, AM J NEPHROL, V34, P203, DOI 10.1159/000329534; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2013, KIDNEY INT, V84, P468, DOI 10.1038/ki.2013.149; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Isaka Y, 2011, AUTOPHAGY, V7, P1085, DOI 10.4161/auto.7.9.16465; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kaushal GP, 2004, KIDNEY INT, V66, P500, DOI 10.1111/j.1523-1755.2004.761_6.x; Kaushal GP, 2012, KIDNEY INT, V82, P1250, DOI 10.1038/ki.2012.337; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Li L, 2014, J AM SOC NEPHROL, V25, P305, DOI 10.1681/ASN.2013040374; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Liu KD, 2008, CRIT CARE MED, V36, pS187, DOI 10.1097/CCM.0b013e318168ca4a; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Livingston MJ, 2014, SEMIN NEPHROL, V34, P17, DOI 10.1016/j.semnephrol.2013.11.004; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Marquez RT, 2012, AM J CANCER RES, V2, P214; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mulvihill NT, 2002, HEART, V87, P201, DOI 10.1136/heart.87.3.201; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pegues MA, 2013, AM J PHYSIOL-RENAL, V304, pF1358, DOI 10.1152/ajprenal.00476.2012; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Roshdy A, 2012, INT UROL NEPHROL, V44, P1251, DOI 10.1007/s11255-011-0098-4; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; Schetz M, 2015, INTENS CARE MED, V41, P1648, DOI 10.1007/s00134-015-3946-3; Schwartz R, 2007, CIRC RES, V100, P1452, DOI 10.1161/01.RES.0000267745.03488.47; Shi M., 2015, J AM SOC NEPHROL; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tang Y, 2014, CLIN SCI, V126, P645, DOI 10.1042/CS20130471; Tanigaki K, 2013, DIABETES, V62, P721, DOI 10.2337/db12-0133; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; Valdivieso JRP, 2008, ARCH MED RES, V39, P326, DOI 10.1016/j.arcmed.2007.11.010; Vongpatanasin W, 2007, CIRCULATION, V115, P1020, DOI 10.1161/CIRCULATIONAHA.106.664854; Vuppalapati KK, 2015, J BONE MINER RES, V30, P2249, DOI 10.1002/jbmr.2575; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Xia DY, 1997, P NATL ACAD SCI USA, V94, P2575, DOI 10.1073/pnas.94.6.2575; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30; Xu X, 2015, CLIN J AM SOC NEPHRO, V10, P1510, DOI 10.2215/CJN.02140215; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608	72	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0181848	10.1371/journal.pone.0181848	http://dx.doi.org/10.1371/journal.pone.0181848			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886014	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100003
J	Sacristan, HJ; Rodriguez, YE; Pereira, ND; Greco, LSL; Lovrich, GA; Gimenez, AVF				Javier Sacristan, Hernan; Eliana Rodriguez, Yamila; De los Angeles Pereira, Nair; Lopez Greco, Laura Susana; Alejandro Lovrich, Gustavo; Fernandez Gimenez, Analia Veronica			Energy reserves mobilization: Strategies of three decapod species	PLOS ONE			English	Article							CHERAX-QUADRICARINATUS DECAPODA; SHORT-TERM STARVATION; PACIFIC WHITE SHRIMP; PROLONGED STARVATION; BIOCHEMICAL-CHANGES; PENAEUS-ESCULENTUS; REDCLAW CRAYFISH; HIGH-PROTEIN; TIGER PRAWN; BODY-WEIGHT	In food deprivation assays, several different responses have been observed in crustaceans. However, studying energy reserves utilization among more than one species during the same starvation period has not yet been performed, particularly to discern whether the responses are due to intrinsic and/or environmental factors. We hypothesize that decapod species with similar feeding habits have the same strategies in the use of energetic reserves during starvation, even though they inhabit different environments. The aim of this study was to compare the energy reserves mobilization of three decapods species (Cherax quadricarinatus, Palaemon argentinus and Munida gregaria) with similar feeding habits, exposed to similar food deprivation conditions. The crayfish, shrimp and squat-lobster were experimentally kept at continuous feeding or continuous starvation throughout 15 days. Every 3rd day, the midgut gland index (MGI), and the glycogen, lipid and protein contents were measured in the midgut gland (MG) and pleon muscle. Palaemon argentinus mobilized more reserves during starvation, followed by C. quadricarinatus, and the last M. gregaria. The starved shrimps presented low MGI, whereas MG showed a reduction in glycogen (from day 6 to 15), lipid (from day 3 to 15), and protein levels (at day 9 and 15) while in their muscle, lipid reserves decreased at days 3 and 6. In C. quadricarinatus, the most affected parameters in the MG were MGI, glycogen (from day 6 to 15), and lipids (at day 12 and 15). In the MG of M. gregaria only the glycogen was reduced during fasting from 3 to 15 days. Even though the three studied species have similar feeding habitats, we found that their energetic profile utilization is different and it could be explained by the habitat, life span, temperature, organ/tissue, and metabolism of the species. Our results may be useful to understand the several different responses of crustaceans during starvation.	[Javier Sacristan, Hernan; Alejandro Lovrich, Gustavo] Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient, Houssay, Ushuaia, Argentina; [Eliana Rodriguez, Yamila; De los Angeles Pereira, Nair; Fernandez Gimenez, Analia Veronica] Univ Nacl Mar del Plata, CONICET, Inst Invest Marinas & Costeras, FCEyN, Mar Del Plata, Buenos Aires, Argentina; [Lopez Greco, Laura Susana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Lab Biol Reprod & Crecimiento Crustaceos, Ciudad Univ, Buenos Aires, DF, Argentina; [Lopez Greco, Laura Susana] Univ Buenos Aires, CONICET, IBBEA, Ciudad Univ, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sacristan, HJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient, Houssay, Ushuaia, Argentina.	sacristanh@gmail.com		Rodriguez, Yamila/0000-0002-4596-3586	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-01333, PICT 2012-0554, PICT 2012-0137, 2015-2968]; Universidad Nacional de Mar del Plata [EXA 773/16]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata)	Funds for this research were provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012-01333 to LSLG; PICT 2012-0554 to GAL, PICT 2012-0137 to AVFG, and 2015-2968 to HJS). Additional funds were provided by the Universidad Nacional de Mar del Plata, EXA 773/16 to AVFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Mariano Diez and Sr. Marcelo Perez for field assistance with Munida gregaria. We also thank Lic. Amir Dyzenchauz for language revision. Funds for this research were provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012-01333 to LSLG; PICT 2012-0554 to GAL, 2012-0137 to AVFG, and 2015-2968 to HJS). Additional funds were provided by the Universidad Nacional de Mar del Plata, EXA 773/16	Albentosa M, 2007, COMP BIOCHEM PHYS B, V146, P241, DOI 10.1016/j.cbpb.2006.10.109; Auerswald L, 2015, POLAR BIOL, V38, P763, DOI 10.1007/s00300-014-1638-z; Baba K, 2008, CATALOGUE SQUAT LOBS, P220; Baden S, 1994, MARINE ECOLOGY PROGR; BARCLAY MC, 1983, J EXP MAR BIOL ECOL, V68, P229, DOI 10.1016/0022-0981(83)90055-2; Boudet LC, 2011, ECOTOXICOL ENV CONT, V6; BOURDIER GG, 1989, J PLANKTON RES, V11, P1201, DOI 10.1093/plankt/11.6.1201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugnot AB, 2009, AQUACULTURE, V295, P292, DOI 10.1016/j.aquaculture.2009.07.021; Calvo NS, 2012, AQUAT BIOL, V16, P287, DOI 10.3354/ab00451; Calvo NS, 2011, AQUACULTURE, V319, P355, DOI 10.1016/j.aquaculture.2011.06.033; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; CLIFFORD HC, 1983, COMP BIOCHEM PHYS A, V74, P561, DOI 10.1016/0300-9629(83)90548-0; Collins PA, 1999, J CRUSTACEAN BIOL, V19, P485, DOI 10.2307/1549257; CUZON G, 1973, CR SOC BIOL, V167, P66; Cuzon G., 1980, Proceedings of the Annual Meeting of the World Mariculture Society, V11, P410; DALL W, 1987, MAR BIOL, V95, P509, DOI 10.1007/BF00393094; Faria SC, 2017, ECOL EVOL, V7, P3167, DOI 10.1002/ece3.2741; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRINGS CS, 1970, AM J CLIN PATHOL, V53, P89; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZLETT B. A., 1975, CRUSTACEANA, V28, P11, DOI DOI 10.1163/156854075X00801; Hu MH, 2010, J EXP MAR BIOL ECOL, V395, P112, DOI 10.1016/j.jembe.2010.08.023; JALIHAL DR, 1993, CRUSTACEANA, V65, P363, DOI 10.1163/156854093X00793; Sacristan HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150854; Jones CM, 1995, AQUACULTURE, V138, P239, DOI 10.1016/0044-8486(95)00069-0; Jones PL, 2000, J CRUSTACEAN BIOL, V20, P431, DOI 10.1651/0278-0372(2000)020[0431:EOSASR]2.0.CO;2; Kawai T, 2016, GLOBAL OVERVIEW CONS, P430; Levi T, 1999, J CRUSTACEAN BIOL, V19, P477, DOI 10.2307/1549256; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Moore LE, 2000, J EXP MAR BIOL ECOL, V244, P131, DOI 10.1016/S0022-0981(99)00127-6; Morales AE, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P281; Morrone Juan J., 1995, Neotropica (La Plata), V41, P3; Neiland KA, 1953, PHYSL COMP OECOL, V2, P198; Neves CA, 2004, DIS AQUAT ORGAN, V58, P209, DOI 10.3354/dao058209; Oliveira GT, 2004, COMP BIOCHEM PHYS A, V137, P383, DOI 10.1016/j.cbpb.2003.10.017; Parrish C, 2013, ISRN OCEANOGRAPHY; Parslow-Williams PJ, 1998, NEPHROPS NORVEGICUS; Perez-Barros P, 2007, J EXP MAR BIOL ECOL, V352, P35, DOI 10.1016/j.jembe.2007.06.035; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Powell ML, 2010, J WORLD AQUACULT SOC, V41, P71, DOI 10.1111/j.1749-7345.2009.00314.x; Romero M., 2003, THESIS; Romero MC, 2004, J MAR BIOL ASSOC UK, V84, P359, DOI 10.1017/S0025315404009282h; De Bock MS, 2010, AQUACULT INT, V18, P231, DOI 10.1007/s10499-008-9239-x; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Saoud IP, 2013, J WORLD AQUACULT SOC, V44, P1, DOI 10.1111/jwas.12011; SCHAFER H J, 1968, FAO (Food and Agriculture Organization of the United Nations) Fisheries Reports, V57, P393; Schram Frederick R., 2009, Crustacean Issues, V18, P3; Signorell N, 2003, Z JAGDWISS, V49, P249, DOI [10.1590/S0073-47212003000300004, 10.1007/s10344-003-0022-z, 10.1007/BF02189633]; Speck U, 1969, Z VERGL PHYSIOL, P410; STEWART JE, 1972, J FISH RES BOARD CAN, V29, P439, DOI 10.1139/f72-072; Stuck KC, 1996, MAR BIOL, V125, P33, DOI 10.1007/BF00350758; Stumpf L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139372; Stumpf L, 2014, J CRUSTACEAN BIOL, V34, P639, DOI 10.1163/1937240X-00002259; Stumpf L, 2010, AQUACULTURE, V304, P34, DOI 10.1016/j.aquaculture.2010.03.011; Sugumar V, 2013, SAUDI J BIOL SCI, V20, P93, DOI 10.1016/j.sjbs.2012.10.003; Tapella F., 2002, THESIS; Tropea C, 2010, AQUACULTURE, V302, P49, DOI 10.1016/j.aquaculture.2010.01.027; Vazquez FJ, 2008, INVERTEBR BIOL, V127, P433, DOI 10.1111/j.1744-7410.2008.00148.x; Vinagre AS, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2797-3; VINAGRE AS, 1992, COMP BIOCHEM PHYS A, V102, P579, DOI 10.1016/0300-9629(92)90213-A; Vogt G, 2012, ZOOL ANZ, V251, P1, DOI 10.1016/j.jcz.2011.05.003; Watts AJR, 2014, J EXP MAR BIOL ECOL, V457, P81, DOI 10.1016/j.jembe.2014.03.020; Zuur Alain F., 2009, P1; [No title captured]	67	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184060	10.1371/journal.pone.0184060	http://dx.doi.org/10.1371/journal.pone.0184060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886062	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100061
J	May, ML; Gregoire, JA; Gregoire, SM; Lubertazzi, MA; Matthews, JH				May, Michael L.; Gregoire, John A.; Gregoire, Suzanne M.; Lubertazzi, Maria Aliberti; Matthews, John H.			Emergence phenology, uncertainty, and the evolution of migratory behavior in Anax junius (Odonata: Aeshnidae)	PLOS ONE			English	Article							DRAGONFLIES ODONATA; DISPERSAL; MIGRATIONS; RANGE	Mass migrations by Odonata, although less studied than those of Monarch butterflies and plague locusts, have provoked comment and study for many years. Relatively recently, increasing interest in dragonflies, supported by new technologies, has resulted in more detailed knowledge of the species involved, behavioral mechanisms, and geographic extent. In this paper we examine, in four independent but complementary studies, how larval habitat and emergence phenology interact with climate to shape the evolution of migratory strategy in Anax junius, a common species throughout much of the eastern United States and southern Canada. In brief, we argue that fish predation on larvae, coupled with the need for ample emergent vegetation for oviposition and adult eclosion, dictates that larval development and survival is optimal in ponds that are neither permanent nor extremely ephemeral. Coupled with annual variation in regional weather and winters in much of their range too cold for adult survival, conditions facing newly emerged A. junius may unpredictably favor either local reproduction or long-distance movement to more favorable areas. Both temperature and hydroperiod tend to favor local reproduction early in the adult activity period and migration later, so late emerging adults are more likely to migrate. No single pond is always predictably suitable or unsuitable, however, so ovipositing females also may spread the risk to their offspring by ovipositing at multiple sites that, for migrants, may be distributed over very long distances.	[May, Michael L.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA; [Gregoire, John A.; Gregoire, Suzanne M.] Kestrel Haven Avian Migrat Observ, Burdett, NY USA; [Lubertazzi, Maria Aliberti] Rhode Isl Sch Design, Concentrat Hist Philosophy & Social Sci, Providence, RI 02903 USA; [Matthews, John H.] Alliance Global Water Adaptat, Corvallis, OR USA	Rutgers State University New Brunswick	May, ML (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA.	may@aesop.rutgers.edu			New Jersey Agricultural Experiment Station Project [08190]; University of Rhode Island College of the Environment and Life Sciences; NSF [DEB-0423834]; New Jersey Agricultural Experiment Station State; U.S. Hatch Act funds; University of Texas at Austin Section of Integrative Biology	New Jersey Agricultural Experiment Station Project; University of Rhode Island College of the Environment and Life Sciences; NSF(National Science Foundation (NSF)); New Jersey Agricultural Experiment Station State; U.S. Hatch Act funds; University of Texas at Austin Section of Integrative Biology	This research was funded in part by New Jersey Agricultural Experiment Station Project 08190 to MLM; a graduate student grant from the University of Rhode Island College of the Environment and Life Sciences to MAL; and a NSF Grant DEB-0423834, New Jersey Agricultural Experiment Station State and U.S. Hatch Act funds, and a graduate student grant from the University of Texas at Austin Section of Integrative Biology to JHM. No specific funding was received by JAG and SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Dennis Paulson for access to his extensive data, for being an unstinting source of ideas and advice, and for serving as a sounding board for half-formed ideas on many occasions; to John Abbott for providing formatted data on Anax observation from Odonata Central; to Richard Orr and Holliday Obrecht for logistical and physical assistance and suggestions throughout the course of work at Patuxent Research Refuge; to Bill Mauffray for access to data and specimens from the Florida State Collection of Arthropods; to Bob Barber and Jim Johnson for discussion and advice at various stages of this project; and to many email correspondents who shared their observations with us. Special thanks to Dr. Ulf Norling for supplying us with Kitegraph software for plotting the course of larval development. Supported in part by NSF Grant DEB-0423834 and New Jersey Agricultural Experiment Station State and U.S. Hatch Act funds.	Abtew W, 2006, S FLORIDA ENV REPORT, VI, p[5, 5]; Aliberti Lubertazzi MA, 2009, THESIS U RHODE ISLAN; Anderson RC, 2009, J TROP ECOL, V25, P347, DOI 10.1017/S0266467409006087; [Anonymous], 2007, FRESHWATER FISH DIST; [Anonymous], 2016, US CLIMATE DATA; [Anonymous], 2014, DRAG DAMS NEW JERS; [Anonymous], 2020, ECONOMIST 0326; [Anonymous], 2016, INSECT PHYSL BIOCH; Biggs K., 2012, ODONATA 1 ARCH; BUTLER T, 1975, CAN ENTOMOL, V107, P1253, DOI 10.4039/Ent1071253-12; CALVERT PHILIP P., 1934, PROC AMER PHILOSOPH SOC, V73, P1; Catling PM, 2003, ONT ODONATA, V4, P9; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; ClimaTemps, 2016, CLIMATEMPS; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; CORBET PS, 1957, J ANIM ECOL, V26, P1, DOI 10.2307/1781; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Daigle J. J., 1991, ARGIA, V3, P8; Dorn NJ, 2008, HYDROBIOLOGIA, V605, P209, DOI 10.1007/s10750-008-9355-7; Fincke O., 2010, MASS FLIGHT S CENTRA; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Hu G, 2016, SCIENCE, V354, P1584, DOI 10.1126/science.aah4379; Jaramillo A., 2016, CALODES; JOHNSON D M, 1980, Odonatologica, V9, P297; Johnson D.M., 1989, Advances in Odonatology, V4, P27; KIME JB, 1974, THESIS U WASHINGTON; KOENIG W D, 1987, Odonatologica, V16, P249; Lubertazzi MAA, 2009, NORTHEAST NAT, V16, P141; Matthews JH, 2004, REPORT ANAX JUNIUS E, V5, P12; Matthews JH, 2007, ODONATE CONSERVATION, P183; Matthews JH, 2007, RES MOTION PATTERNS, P33; Matthews JH, 2007, RES MOTION PATTERNS, P7; Matthews JH, 2007, RES MOTION PATTERNS, P62; May ML, 2013, J INSECT CONSERV, V17, P1, DOI 10.1007/s10841-012-9540-x; May Michael L., 2008, P63; McCauley SJ, 2007, OIKOS, V116, P121, DOI 10.1111/j.2006.0030-1299.15105.x; McCauley SJ, 2006, ECOGRAPHY, V29, P585, DOI 10.1111/j.0906-7590.2006.04787.x; MCPEEK MA, 1989, OIKOS, V56, P187, DOI 10.2307/3565335; MCPEEK MA, 1990, ECOLOGY, V71, P83, DOI 10.2307/1940249; MICHIELS NK, 1991, ECOL ENTOMOL, V16, P449, DOI 10.1111/j.1365-2311.1991.tb00238.x; National Oceanic and Atmospheric Administration, 2016, CLIM DAT ONL; Needham JG, 1901, B ILLINOIS STATE LAB, V6, P1; Panek FM, 2013, NORTHEAST NAT, V20, P37, DOI 10.1656/045.020.0103; Parkos JJ, 2011, OIKOS, V120, P1519, DOI 10.1111/j.1600-0706.2011.19178.x; Paulson D.R., 2011, DRAGONFLIES E; Paulson D. R., 2010, CALODES; Paulson D. R, 2009, DRAGONFLIES W; Paulson DR, 1996, BYU STUDIES, V4, P7; Paulson DR, 1999, OCCASIONAL PAPERS SL; Paulson DR, 2009, TEXODES; Paulson DR., 1999, NOTES MEXICAN ODONAT; Russell, 2005, INTERACTIONS MIGRATI, V9, P327; Russell RW, 1998, AM MIDL NAT, V140, P325, DOI 10.1674/0003-0031(1998)140[0325:MSMODO]2.0.CO;2; Schenk K, 2004, ANIM BEHAV, V68, P599, DOI 10.1016/j.anbehav.2003.12.010; Shannon HJ, 1916, SCI MON, V3, P227; Sommer A., 2011, PIMEPHALES PROMELAS; Sprandel GL, 2001, FLA ENTOMOL, V84, P234, DOI 10.2307/3496172; Stacey BJ., 2013, OFFSHORE DARNERS; Suhling F, 2016, AUSTRAL ECOLOGY; TROTTIER R, 1966, CAN ENTOMOL, V98, P794, DOI 10.4039/Ent98794-8; TROTTIER R, 1971, CAN ENTOMOL, V103, P1671, DOI 10.4039/Ent1031671-12; USGS (United States Geological Survey), 2016, NAT WAT INF SYST WEB; Walker E.M., 1958, ODONATA CANADA ALASK; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; WHITE HB, 1970, CAN ENTOMOL, V102, P498, DOI 10.4039/Ent102498-4; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; WISSINGER S A, 1988, Journal of the North American Benthological Society, V7, P13, DOI 10.2307/1467827; YOUNG AM, 1967, CAN ENTOMOL, V99, P886, DOI 10.4039/Ent99886-8; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812	70	8	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183508	10.1371/journal.pone.0183508	http://dx.doi.org/10.1371/journal.pone.0183508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886032	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100028
J	Nwankwo, O; Glatting, G; Wenz, F; Fleckenstein, J				Nwankwo, Obioma; Glatting, Gerhard; Wenz, Frederik; Fleckenstein, Jens			A single-source photon source model of a linear accelerator for Monte Carlo dose calculation	PLOS ONE			English	Article							VIRTUAL SOURCE MODEL; PHASE-SPACE; QUANTITATIVE-EVALUATION; BEAM; RADIOTHERAPY; DISTRIBUTIONS; METAANALYSIS; SIMULATION; VALIDATION	Purpose To introduce a new method of deriving a virtual source model (VSM) of a linear accelerator photon beam from a phase space file (PSF) for Monte Carlo (MC) dose calculation. Materials and methods A PSF of a 6 MV photon beam was generated by simulating the interactions of primary electrons with the relevant geometries of a Synergy linear accelerator (Elekta AB, Stockholm, Sweden) and recording the particles that reach a plane 16 cm downstream the electron source. Probability distribution functions (PDFs) for particle positions and energies were derived from the analysis of the PSF. These PDFs were implemented in the VSM using inverse transform sampling. To model particle directions, the phase space plane was divided into a regular square grid. Each element of the grid corresponds to an area of 1 mm 2 in the phase space plane. The average direction cosines, Pearson correlation coefficient (PCC) between photon energies and their direction cosines, as well as the PCC between the direction cosines were calculated for each grid element. Weighted polynomial surfaces were then fitted to these 2D data. The weights are used to correct for heteroscedasticity across the phase space bins. The directions of the particles created by the VSM were calculated from these fitted functions. The VSM was validated against the PSF by comparing the doses calculated by the two methods for different square field sizes. The comparisons were performed with profile and gamma analyses. Results The doses calculated with the PSF and VSM agree to within 3%/1 mm (>95% pixel pass rate) for the evaluated fields. Conclusion A new method of deriving a virtual photon source model of a linear accelerator from a PSF file for MC dose calculation was developed. Validation results show that the doses calculated with the VSM and the PSF agree to within 3%/1 mm.	[Nwankwo, Obioma; Wenz, Frederik; Fleckenstein, Jens] Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany; [Nwankwo, Obioma; Glatting, Gerhard] Heidelberg Univ, Med Fac Mannheim, Med Radiat Phys Radiat Protect, Mannheim, Germany; [Glatting, Gerhard] Ulm Univ, Dept Nucl Med, Med Radiat Phys, Ulm, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University	Nwankwo, O (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany.; Nwankwo, O (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Radiat Phys Radiat Protect, Mannheim, Germany.	Charles.Nwankwo@medma.uni-heidelberg.de	Glatting, Gerhard/ABF-2506-2020	Glatting, Gerhard/0000-0001-7916-1576; Nwankwo, Obioma/0000-0002-3190-8885	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1; Chen JT, 2005, EUR J OPER RES, V167, P226, DOI 10.1016/j.ejor.2003.12.027; Chetty I, 2000, MED PHYS, V27, P166, DOI 10.1118/1.598881; Chetty IJ, 2007, MED PHYS, V34, P4818, DOI 10.1118/1.2795842; Clausen S, 2012, Z MED PHYS; Deng J, 2004, PHYS MED BIOL, V49, P1689, DOI 10.1088/0031-9155/49/9/007; Deng J, 2000, PHYS MED BIOL, V45, P411, DOI 10.1088/0031-9155/45/2/311; Depuydt T, 2002, RADIOTHER ONCOL, V62, P309, DOI 10.1016/S0167-8140(01)00497-2; Fedewa MV, 2014, AM J PREV MED, V47, P641, DOI 10.1016/j.amepre.2014.07.035; Fippel M, 2003, MED PHYS, V30, P301, DOI 10.1118/1.1543152; Fix MK, 2004, MED PHYS, V31, P3106, DOI 10.1118/1.1803431; Fix MK, 2000, MED PHYS, V27, P2739, DOI 10.1118/1.1318220; Fix MK, 2001, PHYS MED BIOL, V46, P1407, DOI 10.1088/0031-9155/46/5/307; Fleckenstein J, 2013, Z MED PHYS, V23, P33, DOI 10.1016/j.zemedi.2012.08.002; Giles M., 2011, GPU COMPUTING GEMS, P109; Grevillot L, 2011, PHYS MED BIOL, V56, P903, DOI 10.1088/0031-9155/56/4/002; Havranek T, 2010, REV WORLD ECON, V146, P241, DOI 10.1007/s10290-010-0050-1; Kletting P, 2013, MED PHYS, V40, DOI 10.1118/1.4820367; Lewis JB, 2005, POLIT ANAL, V13, P345, DOI 10.1093/pan/mpi026; Libby B, 1999, MED PHYS, V26, P1476, DOI 10.1118/1.598643; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Ma CM, 1998, RADIAT PHYS CHEM, V53, P329, DOI 10.1016/S0969-806X(98)00113-3; Martinez WL, 2015, COMPUTATIONAL STAT H; Mathworks, 2017, RAND NUMB SPEC RANG; Nelson JP, 2006, INT REV LAW ECON, V26, P195, DOI 10.1016/j.irle.2006.08.005; Nelson J, 2009, ENVIRON RESOUR ECON, V42, P345, DOI 10.1007/s10640-008-9253-5; Nwankwo O, 2013, PHYS MED BIOL, V58, P2363, DOI 10.1088/0031-9155/58/7/2363; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SAXONHOUSE GR, 1976, AM ECON REV, V66, P178; Sempau J, 2001, PHYS MED BIOL, V46, P1163, DOI 10.1088/0031-9155/46/4/318; Siebers JV, 1999, PHYS MED BIOL, V44, P3009, DOI 10.1088/0031-9155/44/12/311; Sikora M, 2007, PHYS MED BIOL, V52, P4449, DOI 10.1088/0031-9155/52/15/006; Sikora M, 2009, PHYS MED BIOL, V54, P7329, DOI 10.1088/0031-9155/54/24/006; Spezi E, 2011, MED PHYS, V38, P5254, DOI 10.1118/1.3626574; Spezi E, 2008, RADIAT PROT DOSIM, V131, P123, DOI 10.1093/rpd/ncn277; von Wittenau AES, 1999, MED PHYS, V26, P1196, DOI 10.1118/1.598613; Weisstein E. W, 2017, MATHWORLD WOLFRAM WE; WILLEMAIN TR, 1993, J STAT COMPUT SIM, V45, P23; Zorn ME, 1997, ANAL CHEM, V69, P3069, DOI 10.1021/ac970082i	40	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183486	10.1371/journal.pone.0183486	http://dx.doi.org/10.1371/journal.pone.0183486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886048	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100025
J	Zamparo, P; Carrara, S; Cesari, P				Zamparo, Paola; Carrara, Stefano; Cesari, Paola			Movement evaluation of front crawl swimming: Technical skill versus aesthetic quality	PLOS ONE			English	Article							PROPELLING EFFICIENCY; ACTION ANTICIPATION; BASKETBALL PLAYERS; BIOLOGICAL MOTION; VISUAL-PERCEPTION; RESONANCE	The study aim was to compare expert with non-expert swimmers' rating of the aesthetic and technical qualities of front crawl in video-taped recordings of swimmers with low, middle, and high level proficiency. The results suggest that: i) observers' experience affects their judgment: only the expert observers correctly rated the swimmers' proficiency level; ii) evaluation of movement (technical and aesthetic scores) is correlated with the level of skill as expressed in the kinematics of the observed action (swimming speed, stroke frequency, and stroke length); iii) expert and non-expert observers use different strategies to rate the aesthetic and technical qualities of movement: equating the technical skill with the aesthetic quality is a general rule non-expert observers follow in the evaluation of human movement.	[Zamparo, Paola; Carrara, Stefano; Cesari, Paola] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy	University of Verona	Zamparo, P (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	paola.zamparo@univr.it	Zamparo, Paola/AAF-7700-2020	Zamparo, Paola/0000-0002-6919-6721; Cesari, Paola/0000-0002-1705-6065				Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Best D., 1974, BRIT J AESTHET, V14, P197, DOI DOI 10.1093/BJAESTHETICS/14.3.197; CRAIG AB, 1979, MED SCI SPORT EXER, V11, P278; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Lan C, 2008, EXERCISE INTENSITY T, P12; Peterson Silveria R, 2016, INT J SPORT PHYSIOL, V13, P21; SCULLY DM, 1986, HUM MOVEMENT SCI, V5, P185, DOI 10.1016/0167-9457(86)90024-2; Tomeo E, 2013, CEREB CORTEX, V23, P2765, DOI 10.1093/cercor/bhs279; TOUSSAINT HM, 1988, J APPL PHYSIOL, V65, P2506, DOI 10.1152/jappl.1988.65.6.2506; TOUSSAINT HM, 1992, SPORTS MED, V13, P8, DOI 10.2165/00007256-199213010-00002; TOUSSAINT HM, 1990, MED SCI SPORT EXER, V22, P409; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Zamparo P, 2005, EUR J APPL PHYSIOL, V94, P134, DOI 10.1007/s00421-004-1281-4; Zamparo P, 2011, EUR J APPL PHYSIOL, V111, P367, DOI [10.1007/s00421-010-1433-7, 10.1007/s00421-010-1396-8]; Zamparo P, PLOS ONE, V10	16	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184171	10.1371/journal.pone.0184171	http://dx.doi.org/10.1371/journal.pone.0184171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886063	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100075
J	Zhu, Q; Liao, BY; Li, P; Li, JC; Deng, XM; Hu, XS; Chen, XY				Zhu, Qin; Liao, Bo-Yong; Li, Pei; Li, Jun-Cheng; Deng, Xiao-Mei; Hu, Xin-Sheng; Chen, Xiao-Yang			Phylogeographic pattern suggests a general northeastward dispersal in the distribution of Machilus pauhoi in South China	PLOS ONE			English	Article							MICROSATELLITE LOCI; GENETIC-STRUCTURE; TEMPERATE PLANTS; EAST-ASIA; LAURACEAE; DISTANCE; POPULATIONS; DIVERSITY; MARKERS; PALAEOVEGETATION	Machilus pauhoi Kanehira is an important timber species in China. A provenance trial was recently set up to evaluate the growth performance of trees from different localities, with the aim of designing seed transfer guidelines. Here, we tested twelve nuclear microsatellite markers derived from other species of the Lauraceae family and investigated population genetic structure in M. pauhoi. Both the number of observed alleles per locus (N-a) and the polymorphic information content (PIC) significantly decreased against the latitude, but showed an insignificant decrease against the longitude. Heterozygosity (Ho) and gene diversity (h) exhibited a weak correlation with geographic location. Private alleles were present in multiple populations, and a moderate level of population genetic differentiation was detected (G(st) = 0.1691). The joint pattern of genetic diversity (N-a, PIC, H-o, and h) suggests that general northeastward dispersal led to the current distribution of M. pauhoi. Significant but weak effects of isolation-by-distance (IBD) occurred, implicating the mountain ranges as the major barrier to gene flow. Both STRUCTURE and hierarchical clustering analyses showed three distinct groups of populations related to the physical connectivity among mountain ranges. A priority in designing genetic conservation should be given to the populations at the southwest side of the species' distribution. This conservation strategy can also be combined with the pattern of adaptive genetic variation from the provenance trial for comprehensive genetic resource management of native M. pauhoi.	[Zhu, Qin; Li, Pei; Li, Jun-Cheng; Deng, Xiao-Mei; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China; [Zhu, Qin; Li, Pei; Li, Jun-Cheng; Deng, Xiao-Mei; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Zhu, Qin] Jiaying Univ, Sch Life Sci, Meizhou, Peoples R China; [Liao, Bo-Yong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Liao, Bo-Yong] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; Jiaying University; Sun Yat Sen University; Sun Yat Sen University	Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China.	xinsheng@scau.edu.cn; xychen@scau.edu.cn		Hu, Xin-Sheng/0000-0002-8049-9491	National Science & Technology Pillar Program [2012BAD01B04]; Forestry Science and Technology Innovation Project of Guangdong Province [2011KJCX002]; South China Agricultural University [4400-K16013]	National Science & Technology Pillar Program; Forestry Science and Technology Innovation Project of Guangdong Province; South China Agricultural University	The authors acknowledge the funding by the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2012BAD01B04) and Forestry Science and Technology Innovation Project of Guangdong Province (2011KJCX002) to XYC, and the startup funding from South China Agricultural University (4400-K16013) to XSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrizani RC, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200516; [Anonymous], [No title captured]; [Anonymous], 1994, J TROP SUBTROP BOT; Borrone JW, 2007, MOL ECOL NOTES, V7, P439, DOI 10.1111/j.1471-8286.2006.01611.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Carpenter RJ, 2010, J BIOGEOGR, V37, P1202, DOI 10.1111/j.1365-2699.2010.02279.x; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chen Dong-Mei, 2011, Bulletin of Botanical Research, V31, P623; Chung MG, 2000, HEREDITY, V85, P490, DOI 10.1046/j.1365-2540.2000.00781.x; Ci XQ, 2008, PLANT SYST EVOL, V273, P237, DOI 10.1007/s00606-008-0012-4; Cui ZJ, 1984, J GLACIOL GEOCRYOL, V6, P77; Danieli-Silva A, 2013, PLANT SPEC BIOL, V28, P31, DOI 10.1111/j.1442-1984.2011.00354.x; DRINNAN AN, 1990, BOT GAZ, V151, P370, DOI 10.1086/337838; Ennos RA, 1998, FORESTRY, V71, P1, DOI 10.1093/forestry/71.1.1-a; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gibson JP, 1996, AM J BOT, V83, P890, DOI 10.2307/2446266; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gross-German E, 2013, TREE GENET GENOMES, V9, P539, DOI 10.1007/s11295-012-0577-5; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Guo XiaoMin, 1999, Acta Agriculturae Universitatis Jiangxiensis, V21, P391; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hu Xin-sheng, 2001, Forest Research, V14, P1; Hu XinSheng, 2001, Forest Genetics, V8, P225; Kameyama Y, 2012, AM J BOT, V99, pE1, DOI 10.3732/ajb.1100231; Kaneko Y, 2012, AM J BOT, V99, pE265, DOI 10.3732/ajb.1100560; Kumar P, 2009, PLANT OMICS, V2, P141; Li HongYing, 2011, Journal of Northeast Forestry University, V39, P28; Li X., 2016, THESIS; Li XW, 2000, HIGHER PLANTS CHINA, V3, p282 ; Li YJ, 2016, J GUANGXI TEACHERS E, V37, P67; Liu L, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200549; Mantel N., 1967, CANCER RES, V27, P109; Martins E, 2015, CONSERV GENET, V16, P1, DOI 10.1007/s10592-014-0635-7; Martins EM, 2014, GENET MOL RES, V13, P5138, DOI 10.4238/2014.July.7.6; Moraes Pedro Luís Rodrigues de, 2002, Biota Neotrop., V2, P1, DOI [10.1590/S1676-06032002000100005, 10.1590/S1676-06032002000200005]; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Poole I, 2000, IAWA J, V21, P463, DOI 10.1163/22941932-90000262; Pritchard JK, 2000, GENETICS, V155, P945; Qi C, 1992, J CENTRAL S FORESTRY, V12, P1; Qian H, 2001, NATURE, V413, P130, DOI 10.1038/35093169; Salmela MJ, 2010, FORESTRY, V83, P535, DOI 10.1093/forestry/cpq036; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi M, 2014, SYST BOT, V39, P715, DOI 10.1600/036364414X681464; Tsuneki S, 2009, CONSERV GENET, V10, P2009, DOI 10.1007/s10592-009-9881-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang GuoPing, 2014, Journal of South China Agricultural University, V35, P56; Wang ZS, 2005, ANN BOT-LONDON, V95, P305, DOI 10.1093/aob/mci027; Watanabe S, 2016, PLANT SPEC BIOL, V31, P29, DOI 10.1111/1442-1984.12078; Wattier R, 1998, MOL ECOL, V7, P1569, DOI 10.1046/j.1365-294x.1998.00477.x; Weir BS, 1996, GENETIC DATA ANALYSI; Wen SF, 2008, GUANGDONG FORESTRY S, V24, P115; WHEELWRIGHT NT, 1991, BIOTROPICA, V23, P29, DOI 10.2307/2388685; Wu GX, 2008, JIANGXI FORESTRY SCI, V4, p14 ; Xiong B, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600088; Xu F, 2003, GUANGDONG FORESTRY S, V19, P61; [杨彦伶 Yang Yanling], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1134; Yeh F.C., 1999, MICROSOFT WINDOWS BA; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang R, 2012, BIOCHEM SYST ECOL, V44, P317, DOI 10.1016/j.bse.2012.06.007; Zhao HM, 2005, JIANGXI FORESTRY SCI, V4, P8; Zhong QuanLin, 2008, Acta Agriculturae Universitatis Jiangxiensis, V30, P257	68	7	10	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184456	10.1371/journal.pone.0184456	http://dx.doi.org/10.1371/journal.pone.0184456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886133	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100126
J	Bester-van der Merwe, AE; Bitalo, D; Cuevas, JM; Ovenden, J; Hernandez, S; da Silva, C; McCord, M; Roodt-Wilding, R				Bester-van der Merwe, Aletta E.; Bitalo, Daphne; Cuevas, Juan M.; Ovenden, Jennifer; Hernandez, Sebastian; da Silva, Charlene; McCord, Meaghen; Roodt-Wilding, Rouvay			Population genetics of Southern Hemisphere tope shark (Galeorhinus galeus): Intercontinental divergence and constrained gene flow at different geographical scales	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; SCHOOL SHARK; MICROSATELLITE LOCI; DEMOGRAPHIC HISTORY; MUSTELUS-HENLEI; PHYLOGEOGRAPHY; SOFTWARE; ATLANTIC; IDENTIFICATION; PERFORMANCE	The tope shark (Galeorhinus galeus Linnaeus, 1758) is a temperate, coastal hound shark found in the Atlantic and Indo-Pacific oceans. In this study, the population structure of Galeorhinus galeus was determined across the entire Southern Hemisphere, where the species is heavily targeted by commercial fisheries, as well as locally, along the South African coastline. Analysis was conducted on a total of 185 samples using 19 microsatellite markers and a 671 bp fragment of the NADH dehydrogenase subunit 2 (ND2) gene. Across the Southern Hemisphere, three geographically distinct clades were recovered, including one from South America (Argentina, Chile), one from Africa (all the South African collections) and an Australia-New Zealand clade. Nuclear data revealed significant population subdivisions (F-ST = 0.192 to 0.376, p<0.05) indicating limited gene flow for tope sharks across ocean basins. Marked population connectivity was however evident across the Indian Ocean based on Bayesian clustering analysis. More locally in South Africa, F-statistics and multivariate analysis supported moderate to high gene flow across the Atlantic/Indian Ocean boundary (F-ST = 0.035 to 0.044, p<0.05), with exception of samples from Struisbaai and Port Elizabeth which differed significantly from the rest. Discriminant and Bayesian clustering analysis indicated admixture in all sampling populations, decreasing from west to east, corroborating possible restriction to gene flow across regional oceanographic barriers. Mitochondrial sequence data recovered seven haplotypes (h = 0.216, pi = 0.001) for South Africa, with one major haplotype shared by 87% of the individuals and at least one private haplotype for each sampling location except Port Elizabeth. As with many other coastal shark species with cosmopolitan distribution, this study confirms the lack of both historical dispersal and inter-oceanic gene flow while also implicating contemporary factors such as oceanic currents and thermal fronts to drive local genetic structure of G. galeus on a smaller spatial scale.	[Bester-van der Merwe, Aletta E.; Bitalo, Daphne; Roodt-Wilding, Rouvay] Stellenbosch Univ, Dept Genet, Stellenbosch, South Africa; [Cuevas, Juan M.] UNLP, Div Zool Vertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina; [Ovenden, Jennifer] Queensland Govt, Mol Fisheries Lab, St Lucia, Qld, Australia; [Hernandez, Sebastian] Univ Catolica Norte, Fac Ciencias Mar, Sala Colecc Biol, Coquimbo, Chile; [Hernandez, Sebastian] Veritas Univ, Ctr Int Programs, Mol Biol Lab, San Jose, Costa Rica; [da Silva, Charlene] Dept Agr Forestry & Fisheries, Fisheries Res, Cape Town, South Africa; [McCord, Meaghen] Old Harbour Museum, South African Shark Conservancy, Hermanus, South Africa	Stellenbosch University; National University of La Plata; Museo La Plata; Universidad Catolica del Norte	Bester-van der Merwe, AE (corresponding author), Stellenbosch Univ, Dept Genet, Stellenbosch, South Africa.	aeb@sun.ac.za	Bitalo, Daphne/Q-4350-2018; der Merwe, Bester-van/AAL-6644-2021; Ovenden, Jenny/A-3717-2010	Bitalo, Daphne/0000-0002-3396-5920; Ovenden, Jenny/0000-0001-7538-1504; van der Merwe, Aletta/0000-0002-0332-7864; Roodt-Wilding, Rouvay/0000-0002-3528-7932; Cuevas, juan/0000-0003-0086-5963	National Research Foundation of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa)	This study was funded by the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the following individuals, organisations and institutions for providing biological samples: Jayson Semmens from Australia, South African Department of Agriculture, Forestry and Fisheries (DAFF), and the Viking Fishing Group. Simo Maduna is especially thanked for assistance with clustering analyses as well as two anonymous reviewers for many helpful comments on an earlier draft of this manuscript. This study was funded by the National Research Foundation of South Africa.	Andreotti S, 2016, J BIOGEOGR, V43, P328, DOI 10.1111/jbi.12641; Ashe JL, 2015, MAR ECOL PROG SER, V520, P203, DOI 10.3354/meps11069; Benavides MT, 2011, MAR FRESHWATER RES, V62, P861, DOI 10.1071/MF10236; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard AM, 2016, MOL ECOL, V25, P5312, DOI 10.1111/mec.13845; Best LN, 2013, AFR ZOOL, V48, P201, DOI 10.3377/004.048.0201; Bitalo DN, 2015, FISH RES, V172, P190, DOI 10.1016/j.fishres.2015.07.003; BRIGGS J C, 1974, P475; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY, V14; Camargo SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155623; Chabot CL, 2015, J FISH BIOL, V87, P371, DOI 10.1111/jfb.12727; Chabot CL, 2009, MOL ECOL, V18, P545, DOI 10.1111/j.1365-294X.2008.04047.x; Chabot CL, 2015, ECOL EVOL, V5, P1585, DOI 10.1002/ece3.1458; Chabot CL, 2012, CONSERV GENET RESOUR, V4, P23, DOI 10.1007/s12686-011-9464-x; Chabot CL, 2011, CONSERV GENET RESOUR, V3, P553, DOI 10.1007/s12686-011-9402-y; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Chiaramonte GE, 1998, MAR FRESHWATER RES, V49, P601, DOI 10.1071/MF97136; Chiaramonte GE., 2015, THESIS; Clarke CR, 2015, MAR BIOL, V162, P945, DOI 10.1007/s00227-015-2636-6; Coates AG, 2004, GEOL SOC AM BULL, V116, P11; COMPAGNO L J V, 1984, FAO (Food and Agriculture Organization of the United Nations) Fisheries Synopsis, P1; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Cuevas JM, 2014, ANIM BIOTELEM, V2, P1; Cunha RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049196; da Silva C, 2015, AFR J MAR SCI, V37, P233, DOI 10.2989/1814232X.2015.1044471; Ferrette BLD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117549; Daly-Engel TS, 2012, PLOS ONE, V7, P279, DOI 10.1371/journal.pone.0029986; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elias I, 2004, J NW ATL FISH SCI, V37, P261; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrell ED, 2009, ICES J MAR SCI, V66, P561, DOI 10.1093/icesjms/fsn218; Feutry P, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0232-x; Francis MP, 2010, NZ FISHERIES ASSESSM, V2010, P1; Fu YX, 1997, GENETICS, V147, P915; Garcia G., 2012, PHYLOGEOGRAPHY S W A; Geraghty PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075169; Giresi M, 2012, CONSERV GENET RESOUR, V4, P101, DOI 10.1007/s12686-011-9484-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hernandez S, 2015, FISH RES, V167, P132, DOI 10.1016/j.fishres.2015.02.010; Hernandez S, 2010, REV BIOL MAR OCEANOG, V45, P695, DOI 10.4067/S0718-19572010000400013; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucifora LO, 2004, ENVIRON BIOL FISH, V71, P199, DOI 10.1007/s10641-004-0305-6; Maduna SN, 2017, ECOL EVOL, V7, P1462, DOI 10.1002/ece3.2770; Maduna SN, 2016, MAR ECOL PROG SER, V544, P183, DOI 10.3354/meps11596; McCord M.E., 2005, ASPECTS ECOLOGY MANA; Musick JA, 2004, CRC MAR BIOL SER, P33; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piola A.R., 2001, ENCY OCEAN SCI, P340; Portnoy DS, 2016, ICES J MAR SCI, V73, P2322, DOI 10.1093/icesjms/fsw098; Pritchard JK, 2000, GENETICS, V155, P945; Punt AE, 2000, MAR FRESHWATER RES, V51, P205, DOI 10.1071/MF99124; Punt Andre E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P387; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Sebastian H, 2008, J FISH BIOL, V73, P2293, DOI 10.1111/j.1095-8649.2008.02016.x; Spaet JLY, 2015, ECOL EVOL, V5, P2317, DOI 10.1002/ece3.1515; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; Taguchi M, 2015, MAR FRESHWATER RES, V66, P267, DOI 10.1071/MF14075; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; von Bonde C., 1934, INVESTIGATIONAL REPO, V2, P1; Walker T., 1999, GALEORHINUS GALEUS F; Walker T. I., 2006, IUCN RED LIST THREAT; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	84	28	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184481	10.1371/journal.pone.0184481	http://dx.doi.org/10.1371/journal.pone.0184481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880905	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200074
J	Nyaoke, BA; Mutua, GN; Sajabi, R; Nyasani, D; Mureithi, MW; Anzala, OA				Nyaoke, Borna A.; Mutua, Gaudensia N.; Sajabi, Rose; Nyasani, Delvin; Mureithi, Marianne W.; Anzala, Omu A.			Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya	PLOS ONE			English	Article							EXPERIENCES	Background 1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer motivators for enrolment, retention and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase enrolment of volunteers in future HIV vaccine clinical trials. The health belief model classifies motivators into social benefits such as 'advancing research' and collaboration with science, and personal benefits such as health benefits and financial interests. Method A thematic analysis was carried out on data obtained from four HIV clinical trials conducted at KAVI-Institute of Clinical Research in Nairobi Kenya from 2009 to 2015. Responses were obtained from a Questionnaire administered to the volunteers during their screening visit at the research site. Results Of the 281 healthy, HIV-uninfected volunteers participating in this study; 38% were motivated by personal benefits including, 31% motivated by health benefits and 7% motivated by possible financial gains. In addition, 62% of the volunteers were motivated by social benefits with 20% of who were seeking to help their family/society/world while 42% were interested in advancing research. Conclusion The majority of volunteers in the HIV vaccine trials at our site were motivated by social benefits, suggesting that altruism can be a major contributor to participation in HIV vaccine studies. Personal benefits were a secondary motivator for the volunteers. The motivators to volunteer in HIV clinical trials were similar across ages, education level and gender.	[Nyaoke, Borna A.; Mutua, Gaudensia N.; Sajabi, Rose; Nyasani, Delvin; Mureithi, Marianne W.; Anzala, Omu A.] Univ Nairobi, ICR, KAVI, Nairobi, Kenya	University of Nairobi	Nyaoke, BA (corresponding author), Univ Nairobi, ICR, KAVI, Nairobi, Kenya.	bnyaoke@kaviuon.org			International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of the Netherlands; Irish Aid; Government of Japan; European Union; United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); KAVI-ICR	International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of the Netherlands; Irish Aid(CGIAR); Government of Japan; European Union(European Commission); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); KAVI-ICR	The HIV vaccine studies were funded by the International AIDS Vaccine Initiative (IAVI) and its donors. IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of the Netherlands; Irish Aid; Government of Japan; the Ministry of Foreign Affairs of the Netherlands; European Union; the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the volunteers who took part in the HIV clinical trials at the KAVI-ICR sites; all of whom were already involved in clinical trials but were still willing to contribute to further HIV research by participating in this sub-study. We would also like to thank all the staff of KAVI-ICR with a special mention to the Kangemi staff for their diligent work in conducting the HIV vaccine trials and International AIDS Vaccine Initiative (IAVI) for providing KAVI-ICR with funding and support to conduct the trials.	African Population and Health Research Center (APHRC), 2014, REP NAIR CROSS SECT; Almeida L, 2007, EUR J CLIN PHARMACOL, V63, P1085, DOI 10.1007/s00228-007-0368-3; Andanda P, 2007, MAJENGO HIV AIDS RES; Bass SB, 2016, AIDS CARE, V28, P528, DOI 10.1080/09540121.2015.1112352; Bhutta ZA, 2002, B WORLD HEALTH ORGAN, V80, P114; Center for Disease Control, 2015, CTR DIS CONTR PREV K; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Dhalla S, 2014, AIDS BEHAV, V18, P263, DOI 10.1007/s10461-013-0519-8; Dong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111321; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Greco Dirceu, 2008, J Int Bioethique, V19, P143; Isler MR, 2012, AIDS BEHAV, V16, P1895, DOI 10.1007/s10461-012-0151-z; Kass NE, 2007, CLIN PHARMACOL THER, V82, P219, DOI 10.1038/sj.clpt.6100192; Kochhar S, 2013, HUM VACC IMMUNOTHER, V9, P924, DOI 10.4161/hv.23405; Krueger R. A., 2015, FOCUS GROUPS PRACTIC; Liamputtong P, 2015, J HIV-AIDS SOC SERV, V14, P239, DOI 10.1080/15381501.2014.912175; Linkedin Corporation, 2015, 2014 CHIN WORKPL STR; Mehrotra P, 2009, AIDS EDUC PREV, V21, P39, DOI 10.1521/aeap.2009.21.1.39; Nappo SA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-19; National AIDS and STI control Programme Ministry of Health, 2009, HIV AIDS DEC GUID; National AIDS Control Council Ministry of Health, 2014, KEN AIDS STRAT FRAM; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; Rimer B, 1997, THEORY GLANCE GUIDE; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; Sahay S, 2014, HUM VACC IMMUNOTHER, V10, P485, DOI 10.4161/hv.26799; Stunkel L, 2011, CONTEMP CLIN TRIALS, V32, P342, DOI 10.1016/j.cct.2010.12.003; Suhadev M, 2006, INDIAN J MED RES, V124, P631; Tarimo EAM, 2016, BMC PUBLIC HEALTH, P16; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Volk JE, 2014, INT J STD AIDS, V25, P332, DOI 10.1177/0956462413506892	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183788	10.1371/journal.pone.0183788	http://dx.doi.org/10.1371/journal.pone.0183788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880880	Green Submitted, gold, Green Published			2022-12-26	WOS:000409467200025
J	Suarez, R; Paolino, A; Kozulin, P; Fenlon, LR; Morcom, LR; Englebright, R; O'Hara, PJ; Murray, PJ; Richards, LJ				Suarez, Rodrigo; Paolino, Annalisa; Kozulin, Peter; Fenlon, Laura R.; Morcom, Laura R.; Englebright, Robert; O'Hara, Patricia J.; Murray, Peter J.; Richards, Linda J.			Development of body, head and brain features in the Australian fat-tailed dunnart (Sminthopsis crassicaudata; Marsupialia: Dasyuridae); A postnatal model of forebrain formation	PLOS ONE			English	Article							WALLABY MACROPUS-EUGENII; EUTHERIAN MAMMALS; INTERHEMISPHERIC MIDLINE; ANTERIOR COMMISSURE; OLFACTORY SYSTEM; TAMMAR WALLABY; HETEROCHRONY; EVOLUTION; MOUSE; SEQUENCES	Most of our understanding of forebrain development comes from research of eutherian mammals, such as rodents, primates, and carnivores. However, as the cerebral cortex forms largely prenatally, observation and manipulation of its development has required invasive and/or ex vivo procedures. Marsupials, on the other hand, are born at comparatively earlier stages of development and most events of forebrain formation occur once attached to the teat, thereby permitting continuous and non-invasive experimental access. Here, we take advantage of this aspect of marsupial biology to establish and characterise a resourceful laboratory model of forebrain development: the fat-tailed dunnart (Sminthopsis crassicaudata), a mouse-sized carnivorous Australian marsupial. We present an anatomical description of the postnatal development of the body, head and brain in dunnarts, and provide a staging system compatible with human and mouse developmental stages. As compared to eutherians, the orofacial region develops earlier in dunnarts, while forebrain development is largely protracted, extending for more than 40 days versus ca. 15 days in mice. We discuss the benefits of fat-tailed dunnarts as laboratory animals in studies of developmental biology, with an emphasis on how their accessibility in the pouch can help address new experimental questions, especially regarding mechanisms of brain development and evolution.	[Suarez, Rodrigo; Paolino, Annalisa; Kozulin, Peter; Fenlon, Laura R.; Morcom, Laura R.; Richards, Linda J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Englebright, Robert; O'Hara, Patricia J.; Murray, Peter J.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Richards, Linda J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Suarez, R; Richards, LJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Richards, LJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	rsuarezsaa@gmail.com; richards@uq.edu.au	Murray, Peter/AAO-5884-2021; Murray, Peter J/D-3628-2013; Suarez, Rodrigo/J-1529-2014; Fenlon, Laura/N-6719-2017; Kozulin, Peter/B-7238-2011; Richards AO, Linda/P-6372-2014	Murray, Peter/0000-0003-1143-1706; Suarez, Rodrigo/0000-0001-5153-5652; Paolino, Annalisa/0000-0002-2117-2819; Fenlon, Laura/0000-0002-5132-2419; Kozulin, Peter/0000-0002-7872-9884; Morcom, Laura/0000-0001-6683-4356; Richards AO, Linda/0000-0002-7590-7390	National Health and Medical Research Council (NHMRC) Principal Research Fellowship [1005751]; Australian Research Council (ARC) Discovery Project [160103958]; ARC Discovery Early Career Researcher Award Fellowship [160101394]; NHMRC CJ Martin Early Career Fellowship; Australian Postgraduate Award; UQ-QBI Doctoral scholarship	National Health and Medical Research Council (NHMRC) Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Discovery Project(Australian Research Council); ARC Discovery Early Career Researcher Award Fellowship(Australian Research Council); NHMRC CJ Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); UQ-QBI Doctoral scholarship	This work was funded by the National Health and Medical Research Council (NHMRC) Principal Research Fellowship 1005751 (LJR); Australian Research Council (ARC) Discovery Project 160103958 (LJR, RS); ARC Discovery Early Career Researcher Award Fellowship 160101394 (RS); NHMRC CJ Martin Early Career Fellowship (PK); Australian Postgraduate Award (LRF, LRM); UQ-QBI Doctoral scholarship (AP). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of any of the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00402; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P216, DOI 10.1159/000119711; Ashwell KWS, 1996, J COMP NEUROL, V366, P478; Ashwell KWS, 1996, BRAIN BEHAV EVOLUT, V47, P8, DOI 10.1159/000113225; Chew KY, 2014, DEV DYNAM, V243, P324, DOI 10.1002/dvdy.24062; Conhaim J, 2011, J PHYSIOL-LONDON, V589, P2529, DOI 10.1113/jphysiol.2010.202382; Cummings DM, 1997, J NEUROBIOL, V32, P403; Darlington RB, 1999, J COMP NEUROL, V411, P359; de Frutos CA, 2016, NEURON, V92, P435, DOI 10.1016/j.neuron.2016.09.020; DREHER B, 1988, BRAIN BEHAV EVOLUT, V31, P369, DOI 10.1159/000116602; Dunlop SA, 1997, J COMP NEUROL, V384, P26; Dunlop SA, 1996, EXP NEUROL, V137, P294, DOI 10.1006/exnr.1996.0028; Easton CR, 2014, J NEUROSCI, V34, P3854, DOI 10.1523/JNEUROSCI.3811-13.2014; Gobius I, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0086-1; Gobius I, 2016, CELL REP, V17, P735, DOI 10.1016/j.celrep.2016.09.033; Godfrey GK, 1971, INT ZOO YB, V11, P33, DOI [10.1111/J.1748-1090.1971.TB01839.X, DOI 10.1111/J.1748-1090.1971.TB01839.X]; Goswami A, 2016, INTEGR COMP BIOL, V56, P404, DOI 10.1093/icb/icw039; Halley AC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0219; Halley AC, 2016, BRAIN BEHAV EVOLUT, V88, P14, DOI 10.1159/000447254; Jeffery JE, 2002, SYST BIOL, V51, P478, DOI 10.1080/10635150290069904; Kelly EM, 2011, J MAMMAL, V92, P1038, DOI 10.1644/10-MAMM-A-425.1; Keyte AL, 2014, SEMIN CELL DEV BIOL, V34, P99, DOI 10.1016/j.semcdb.2014.06.015; McCrady E., 1938, American Anatomical Memoir Philadelphia (Wistar Inst), Vno. 16, P1; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.3.CO;2-M; Molnar Z, 1998, J COMP NEUROL, V398, P491; Morton SR, 1978, AUST WILDLIFE RES, V5, P183; NELSON JE, 1992, ANAT EMBRYOL, V185, P335; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Oelschlager HA, 1987, ANN NY ACAD SCI, V519, P447, DOI DOI 10.1111/J.1749-6632.1987.TB36316.X; PASSINGHAM RE, 1985, BRAIN BEHAV EVOLUT, V26, P167, DOI 10.1159/000118773; POILEY S. M., 1960, PROC ANIMAL CARE PANEL, V10, P159; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ramachandran VS., 2014, CLAUSTRUM STRUCTURAL, P119, DOI [10.1016/B978-0-12-404566-8.00004-0, DOI 10.1016/B978-0-12-404566-8.00004-0]; RENFREE MB, 1982, BRAIN BEHAV EVOLUT, V20, P57, DOI 10.1159/000121581; Rowe TB, 2016, J COMP NEUROL, V524, P471, DOI 10.1002/cne.23802; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sanchez-Villagra MR, 2002, J EXP ZOOL, V294, P264, DOI 10.1002/jez.10147; Schneider NY, 2009, REPRODUCTION, V138, P849, DOI 10.1530/REP-09-0145; Shang F, 1997, J COMP NEUROL, V387, P507, DOI 10.1002/(SICI)1096-9861(19971103)387:4<507::AID-CNE3>3.0.CO;2-6; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; Streeter G., 1957, DEV HORIZONS HUMAN E; Suarez R., 2017, EVOLUTION NERVOUS SY, P205, DOI 10.1016/B978-0-12-804042-3.00042-7; Suarez R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00497; Suarez R, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00050; Thieler K., 1989, HOUSE MOUSE ATLAS EM; Watson C, 2017, J COMP NEUROL, V525, P1499, DOI 10.1002/cne.24034; Weisbecker V, 2008, EVOLUTION, V62, P2027, DOI 10.1111/j.1558-5646.2008.00424.x; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; Werneburg I, 2013, J ANAT, V222, P2, DOI 10.1111/j.1469-7580.2012.01509.x; Werneburg I, 2011, ACTA ZOOL-STOCKHOLM, V92, P75, DOI 10.1111/j.1463-6395.2009.00447.x; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184450	10.1371/journal.pone.0184450	http://dx.doi.org/10.1371/journal.pone.0184450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880940	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000409467200071
J	Henry, CC; Martin, KS; Ward, BB; Handsfield, GG; Peirce, SM; Blemker, SS				Henry, Catherine C.; Martin, Kyle S.; Ward, Bridget B.; Handsfield, Geoffrey G.; Peirce, Shayn M.; Blemker, Silvia S.			Spatial and age-related changes in the microstructure of dystrophic and healthy diaphragms	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE FIBERS; DEFICIENT MDX MICE; RAT DIAPHRAGM; SARCOMERE-LENGTH; CANINE DIAPHRAGM; MOUSE DIAPHRAGM; CAT DIAPHRAGM; BLOOD-FLOW; REGENERATION	Duchenne muscular dystrophy (DMD) is a progressive degenerative disease that results in fibrosis and atrophy of muscles. The main cause of death associated with DMD is failure of the diaphragm. The diaphragm is a dome-shaped muscle with a fiber microstructure that differs across regions of the muscle. However, no studies to our knowledge have examined spatial variations of muscle fibers in dystrophic diaphragm or how aging affects those variations in DMD. In this study, diaphragms were obtained from mdx and healthy mice at ages three, seven, and ten months in the dorsal, midcostal, and ventral regions. Through immunostaining and confocal imaging, we quantified sarcomere length, interstitial space between fibers, fiber branching, fiber cross sectional area (CSA), and fiber regeneration measured by centrally located nuclei. Because DMD is associated with chronic inflammation, we also investigated the number of macrophages in diaphragm muscle cross-sections. We saw regional differences in the number of regenerating fibers and macrophages during the progression of DMD in the mdx diaphragm. Additionally, the number of regenerating fibers increased with age, while CSA and the number of branching fibers decreased. Dystrophic diaphragms had shorter sarcomere lengths than age-matched controls. Our results suggest that the dystrophic diaphragm in the mdx mouse is structurally heterogeneous and remodels non-uniformly over time. Understanding regional changes in dystrophic diaphragms over time will facilitate the development of targeted therapies to prevent or minimize respiratory failure in DMD patients.	[Henry, Catherine C.; Martin, Kyle S.; Ward, Bridget B.; Handsfield, Geoffrey G.; Peirce, Shayn M.; Blemker, Silvia S.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Handsfield, Geoffrey G.] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Peirce, Shayn M.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Blemker, Silvia S.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA	University of Virginia; University of Auckland; University of Virginia; University of Virginia	Peirce, SM (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.; Peirce, SM (corresponding author), Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA.	shayn@virginia.edu		Peirce, Shayn/0000-0001-5857-5606; Henry, Catherine/0000-0002-4608-7557	Beckman Scholars Program; University of Virginia; NSF [1235244]; NIH [U01AR069393]	Beckman Scholars Program; University of Virginia; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.C.H. was supported by the Beckman Scholars Program (http://www.beckman-foundation.org) and the Harrison Undergraduate Research Award at the University of Virginia (http://www.Virginia.edu/cue/harrison.html). Research funding was provided by NSF Grant #1235244 (https://www.nsf.gov) and NIH Grant #U01AR069393 awarded to S.S.B. and S.M.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; ASHMORE CR, 1988, EXP NEUROL, V101, P221, DOI 10.1016/0014-4886(88)90005-2; BELL CD, 1968, J NEUROL SCI, V7, P529, DOI 10.1016/0022-510X(68)90058-0; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Boriek AM, 1998, J APPL PHYSIOL, V84, P318; Boriek AM, 2001, AM J PHYSIOL-REG I, V280, pR33, DOI 10.1152/ajpregu.2001.280.1.R33; BRANCATISANO A, 1991, J APPL PHYSIOL, V71, P583, DOI 10.1152/jappl.1991.71.2.583; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carberry S, 2012, INT J MOL MED, V30, P229, DOI 10.3892/ijmm.2012.1006; *CDCP, 2009, MMWR-MORBID MORTAL W, P58; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chan S, 2007, AM J PHYSIOL-CELL PH, V293, pC985, DOI 10.1152/ajpcell.00128.2007; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; DETROYER A, 1982, J APPL PHYSIOL, V53, P30, DOI 10.1152/jappl.1982.53.1.30; Duchenne G., 1868, ARCH GEN MED, V11, P305; Duchenne G., 1868, ARCH GEN MED 6 SER, V11, P179; Duchenne G., 1868, ARCH GEN MED, V11, P421; Duchenne G., 1868, ARCH GEN MED, V11, P5; Duchenne G., 1868, ARCH GEN MED, V11, P552; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; FOURNIER M, 1988, J APPL PHYSIOL, V64, P291, DOI 10.1152/jappl.1988.64.1.291; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; GOSSELIN LE, 1994, AM J RESP CRIT CARE, V150, P174, DOI 10.1164/ajrccm.150.1.8025746; Greising SM, 2015, MUSCLE NERVE, V52, P76, DOI 10.1002/mus.24641; Greising SM, 2013, EXP GERONTOL, V48, P881, DOI 10.1016/j.exger.2013.06.001; Gutpell KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117306; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOLM S, 1979, SCAND J STAT, V6, P65; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Li W, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-40; LOUBOUTIN JP, 1993, NEUROMUSCULAR DISORD, V3, P463, DOI 10.1016/0960-8966(93)90098-5; MALTIN CA, 1985, MUSCLE NERVE, V8, P211, DOI 10.1002/mus.880080306; MARGULIES SS, 1991, J APPL PHYSIOL, V70, P2663, DOI 10.1152/jappl.1991.70.6.2663; MARGULIES SS, 1990, J APPL PHYSIOL, V69, P1702, DOI 10.1152/jappl.1990.69.5.1702; Martin K.S., 2016, ANN BIOMED ENG; Martin KS, 2015, J APPL PHYSIOL, V118, P1299, DOI 10.1152/japplphysiol.01150.2014; Mathur S, 2010, ARCH PHYS MED REHAB, V91, P1051, DOI 10.1016/j.apmr.2010.03.024; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; Meryon E, 1852, Med Chir Trans, V35, P73; METZGER JM, 1985, J APPL PHYSIOL, V58, P1085, DOI 10.1152/jappl.1985.58.4.1085; Mojumdar K, 2014, EMBO MOL MED, V6, P1476, DOI 10.15252/emmm.201403967; Murphy KT, 2010, AM J PATHOL, V176, P2425, DOI 10.2353/ajpath.2010.090932; ONTELL M, 1982, ANAT REC, V204, P199, DOI 10.1002/ar.1092040304; PARTRIDGE T, 1991, NEUROPATH APPL NEURO, V17, P353, DOI 10.1111/j.1365-2990.1991.tb00735.x; Pessina P, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-7; PETROF BJ, 1993, AM J PHYSIOL, V265, pC834; Pichavant C, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-9; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Poole DC, 1997, MED SCI SPORT EXER, V29, P738, DOI 10.1097/00005768-199706000-00003; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Powers SK, 1996, J APPL PHYSIOL, V80, P445, DOI 10.1152/jappl.1996.80.2.445; POWERS SK, 1990, J APPL PHYSIOL, V69, P648, DOI 10.1152/jappl.1990.69.2.648; SCHMALBRUCH H, 1976, TISSUE CELL, V8, P673, DOI 10.1016/0040-8166(76)90039-2; SEXTON WL, 1995, RESP PHYSIOL, V101, P171, DOI 10.1016/0034-5687(95)00033-A; SIECK GC, 1983, J APPL PHYSIOL, V55, P1386, DOI 10.1152/jappl.1983.55.5.1386; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Terada M, 2010, CELLS TISSUES ORGANS, V191, P248, DOI 10.1159/000240245; Virgilio KM, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0080; WAIT JL, 1995, J APPL PHYSIOL, V78, P1030, DOI 10.1152/jappl.1995.78.3.1030; WALKER SM, 1974, ANAT RECORD, V178, P63, DOI 10.1002/ar.1091780107; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; ZHAN WZ, 1995, J APPL PHYSIOL, V79, P941, DOI 10.1152/jappl.1995.79.3.941	70	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183853	10.1371/journal.pone.0183853	http://dx.doi.org/10.1371/journal.pone.0183853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877195	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200046
J	Magill, DJ; Krylov, VN; Shaburova, OV; McGrath, JW; Allen, CCR; Quinn, JP; Kulakov, LA				Magill, Damian J.; Krylov, Victor N.; Shaburova, Olga V.; McGrath, John W.; Allen, Christopher C. R.; Quinn, John P.; Kulakov, Leonid A.			Pf16 and phiPMW: Expanding the realm of Pseudomonas putida bacteriophages	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; TRANSFER-RNA GENES; WEB SERVER; HOST-RANGE; PHAGE; PROTEIN; ALIGNMENT; TMRNA; BACTERIAL; DEPOLYMERASES	We present the analysis of two novel Pseudomonas putida phages, pf16 and phiPMW. Pf16 represents a peripherally related T4-like phage, and is the first of its kind infecting a Pseudomonad, with evidence suggesting cyanophage origins. Extensive divergence has resulted in pf16 occupying a newly defined clade designated as the pf16-related phages, lying at the interface of the Schizo T-Evens and Exo T-Evens. Recombination with an ancestor of the P. putida phage AF is likely responsible for the tropism of this phage. phiPMW represents a completely novel Pseudomonas phage with a genome containing substantial genetic novelty through its many hypothetical proteins. Evidence suggests that this phage has been extensively shaped through gene transfer events and vertical evolution. Phylogenetics shows that this phage has an evolutionary history involving FelixO1-related viruses but is in itself highly distinct from this group.	[Magill, Damian J.; McGrath, John W.; Allen, Christopher C. R.; Quinn, John P.; Kulakov, Leonid A.] Queens Univ Belfast, Sch Biol Sci, Med Biol Ctr, Belfast, Antrim, North Ireland; [Krylov, Victor N.; Shaburova, Olga V.] II Mechnikov Res Inst Vaccines & Sera, Dept Microbiol, Lab Genet Bacteriophages, Moscow, Russia	Queens University Belfast; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS	Kulakov, LA (corresponding author), Queens Univ Belfast, Sch Biol Sci, Med Biol Ctr, Belfast, Antrim, North Ireland.	l.kulakov@qub.ac.uk	Shaburova, Olga/AAK-2332-2021; Krylov, Victor N/J-9405-2013	, Olga/0000-0003-0368-3794; Allen, Christopher/0000-0002-2435-4327				Adriaenssens EM, 2012, J VIROL, V86, P6369, DOI 10.1128/JVI.00641-12; Adriaenssens EM, 2014, APPL ENVIRON MICROB, V80, P4470, DOI 10.1128/AEM.00878-14; Andrews S., 2010, FASTQC QUALITY CONTR; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Baker JR, 2002, BIOCHEM J, V365, P317, DOI 10.1042/BJ20020149; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger A, 2014, TRIMMOMATIC FLEXIBLE; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Bushnell B., 2016, BBMAP SHORT READ ALI; Butina TV, 2010, FEMS MICROBIOL LETT, V309, P122, DOI 10.1111/j.1574-6968.2010.02025.x; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; CHAKRABA.AM, 1967, VIROLOGY, V32, P532, DOI 10.1016/0042-6822(67)90305-4; CHAKRABARTY AM, 1968, P NATL ACAD SCI USA, V60, P168, DOI 10.1073/pnas.60.1.168; Clarke BR, 2000, J BACTERIOL, V182, P3761, DOI 10.1128/JB.182.13.3761-3766.2000; Comeau AM, 2007, VIROLOGY, V362, P384, DOI 10.1016/j.virol.2006.12.031; Cornelissen A, 2012, VIROLOGY, V434, P251, DOI 10.1016/j.virol.2012.09.030; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Domotor D, 2012, J VIROL, V86, P10899, DOI 10.1128/JVI.01870-12; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Eller MR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-7; Federici L, 2001, P NATL ACAD SCI USA, V98, P13425, DOI 10.1073/pnas.231473698; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Glukhov AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051163; Goldsmith DB, 2011, APPL ENVIRON MICROB, V77, P7730, DOI 10.1128/AEM.05531-11; Hadd A, 2014, J MOL BIOL, V426, P3619, DOI 10.1016/j.jmb.2014.08.006; Henry M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117163; Hjorleifsdottir S, 2014, EXTREMOPHILES, V18, P261, DOI 10.1007/s00792-013-0613-x; Ishikawa S, 1998, J BACTERIOL, V180, P1375, DOI 10.1128/JB.180.6.1375-1380.1998; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Jin J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-793; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIM SK, 1993, J BACTERIOL, V175, P1316, DOI 10.1128/JB.175.5.1316-1324.1993; Kovalyova IV, 2003, VIROLOGY, V311, P305, DOI 10.1016/S0042-6822(03)00124-7; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kropinski AM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-76; KRYLOV VN, 1981, GENETIKA+, V17, P239; KULAKOV LA, 1981, GENETIKA+, V17, P1737; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEE LF, 1966, J BACTERIOL, V92, P1821, DOI 10.1128/JB.92.6.1821-1827.1966; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Magill DJ, 2015, FEMS MICROBIOL LETT, P362; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mcshan WM, 1997, MOL MICROBIOL, V23, P719, DOI 10.1046/j.1365-2958.1997.2591616.x; Mizuno CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003987; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Miller ES, 2003, J BACTERIOL, V185, P5220, DOI 10.1128/JB.185.17.5220-5233.2003; MILLER ES, 1994, MOL BIOL BACTERIOP T, V4, P193; Mishra Seema, 2012, BMC Res Notes, V5, P495, DOI 10.1186/1756-0500-5-495; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nguyen HTD, 2012, J MICROBIOL METH, V91, P514, DOI 10.1016/j.mimet.2012.09.032; Nimmich W, 1991, FEMS MICROBIOL LETT; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto K, 2003, J BIOSCI BIOENG, V95, P633, DOI 10.1263/jbb.95.633; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Pires DP, 2016, APPL MICROBIOL BIOT, V100, P2141, DOI 10.1007/s00253-015-7247-0; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; RIEGERHUG D, 1981, VIROLOGY, V113, P363, DOI 10.1016/0042-6822(81)90162-8; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rombouts S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00279; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; Scher F.M., 1986, ANONYMOUS IRON SIDER, P109; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Shaburova OV, 2009, RUSS J GENET+, V45, P161, DOI 10.1134/S1022795409020057; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Truncaite L, 2012, ARCH VIROL, V157, P2431, DOI 10.1007/s00705-012-1449-x; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; WEISS SB, 1968, P NATL ACAD SCI USA, V61, P114, DOI 10.1073/pnas.61.1.114; Whichard JM, 2010, VIRUSES-BASEL, V2, P710, DOI 10.3390/v2030710; WILSON JH, 1973, J MOL BIOL, V74, P753, DOI 10.1016/0022-2836(73)90065-X; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwieb C, 2003, NUCLEIC ACIDS RES, V31, P446, DOI 10.1093/nar/gkg019	97	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184307	10.1371/journal.pone.0184307	http://dx.doi.org/10.1371/journal.pone.0184307			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877269	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200084
J	Wang, XY; Li, W; Zhang, YH; Feng, YY; Zhao, XL; He, YH; Zhang, J; Chen, LN				Wang, Xinyan; Li, Wan; Zhang, Yihua; Feng, Yuyan; Zhao, Xilei; He, Yuehan; Zhang, Jun; Chen, Lina			Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information	PLOS ONE			English	Article							GENOME; DATABASE; POLYMORPHISMS; ASSOCIATION; PREDICTION; FIBROSIS; ARCHIVE; UPDATE; COPD	Chronic obstructive pulmonary disease (COPD) is a multi-factor disease, in which metabolic disturbances played important roles. In this paper, functional information was integrated into a COPD-related metabolic network to assess similarity between genes. Then a gene prioritization method was applied to the COPD-related metabolic network to prioritize COPD candidate genes. The gene prioritization method was superior to ToppGene and ToppNet in both literature validation and functional enrichment analysis. Top-ranked genes prioritized from the metabolic perspective with functional information could promote the better understanding about the molecular mechanism of this disease. Top 100 genes might be potential markers for diagnostic and effective therapies.	[Wang, Xinyan] Harbin Med Univ, Affiliated Hosp 2, Dept Resp, Harbin, Heilongjiang, Peoples R China; [Li, Wan; Zhang, Yihua; Feng, Yuyan; Zhao, Xilei; He, Yuehan; Chen, Lina] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Zhang, Jun] Heilongjiang Prov Land Reclamat Headquarters Gen, Dept Pharm, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Chen, LN (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang, Peoples R China.; Zhang, J (corresponding author), Heilongjiang Prov Land Reclamat Headquarters Gen, Dept Pharm, Harbin, Heilongjiang, Peoples R China.	zhangjun13902003@163.com; chenlina@ems.hrbmu.edu.cn		Li, Wan/0000-0002-9797-0315; Chen, Lina/0000-0002-4576-6814	National Natural Science Foundation of China [61272388]; Natural Science Foundation of Heilongjiang Province [H2015096]; Science AMP; Technology Research Project of the Heilongjiang Ministry of Education [12541356]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Science AMP; Technology Research Project of the Heilongjiang Ministry of Education	This work was supported by the National Natural Science Foundation of China (Grant No. 61272388), the Natural Science Foundation of Heilongjiang Province (Grant No. H2015096), and the Science & Technology Research Project of the Heilongjiang Ministry of Education (Grant No. 12541356).	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; [Anonymous], [No title captured]; Arif E, 2007, CLIN CHIM ACTA, V382, P37, DOI 10.1016/j.cca.2007.03.013; Balgoma D, 2016, EUR RESPIR J, V47, P1645, DOI 10.1183/13993003.01080-2015; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Blais EM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14250; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Breyer MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098013; Busch R, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0459-8; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Demeo DL, 2008, AM J RESP CELL MOL, V38, P114, DOI 10.1165/rcmb.2007-0107OC; Diez D, 2014, AM J RESP CRIT CARE, V190, P981, DOI 10.1164/rccm.201403-0421PP; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fathy EM, 2016, INT J CHRONIC OBSTR, V11, P2447, DOI 10.2147/COPD.S109788; Fourtounis J, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-92; Harada E, 2015, BIOCHEMISTRY-US, V54, P340, DOI 10.1021/bi5009694; Hodge G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00617; Hoffmann J, 2014, AM J RESP CRIT CARE, V190, P98, DOI 10.1164/rccm.201401-0037OC; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jamalkandi SA, 2015, BBA-MOL CELL BIOL L, V1851, P1383, DOI 10.1016/j.bbalip.2015.07.005; Jiang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153006; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur-Knudsen D, 2012, CURR VASC PHARMACOL, V10, P512, DOI 10.2174/157016112800812746; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kim YS, 2015, J IMMUNOL, V194, P3361, DOI 10.4049/jimmunol.1402268; Konings GFJ, 2017, MOL CELL ENDOCRINOL, V443, P23, DOI 10.1016/j.mce.2016.12.001; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Li MJ, 2016, NUCLEIC ACIDS RES, V44, pD869, DOI 10.1093/nar/gkv1317; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mateu-Jimenez M, 2016, MOL MED, V22, DOI 10.2119/molmed.2015.00199; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mirrakhimov AE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-132; Nakajima T, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4093870; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Pouwels SD, 2014, MUCOSAL IMMUNOL, V7, P215, DOI 10.1038/mi.2013.77; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Romero P, 2005, GENOME BIOL, V6; Schols AMWJ, 2003, EUR RESPIR J, V22, p81S, DOI 10.1183/09031936.03.00004611; Shang DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104934; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang Q, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-67; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yang LP, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/956750; Yang L, 2017, CHEST, V151, P555, DOI 10.1016/j.chest.2016.10.058; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184299	10.1371/journal.pone.0184299	http://dx.doi.org/10.1371/journal.pone.0184299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873096	gold, Green Submitted, Green Published			2022-12-26	WOS:000409282800071
J	Li, M; Wang, YH; Jia, LM				Li, Man; Wang, Yanhui; Jia, Limin			The modeling of attraction characteristics regarding passenger flow in urban rail transit network based on field theory	PLOS ONE			English	Article							SUBWAY	Aimed at the complicated problems of attraction characteristics regarding passenger flow in urban rail transit network, the concept of the gravity field of passenger flow is proposed in this paper. We establish the computation methods of field strength and potential energy to reveal the potential attraction relationship among stations from the perspective of the collection and distribution of passenger flow and the topology of network. As for the computation methods of field strength, an optimum path concept is proposed to define betweenness centrality parameter. Regarding the computation of potential energy, Compound Simpson's Rule Formula is applied to get a solution to the function. Taking No. 10 Beijing Subway as a practical example, an analysis of simulation and verification is conducted, and the results shows in the following ways. Firstly, the bigger field strength value between two stations is, the stronger passenger flow attraction is, and the greater probability of the formation of the largest passenger flow of section is. Secondly, there is the greatest passenger flow volume and circulation capacity between two zones of high potential energy.	[Li, Man; Wang, Yanhui; Jia, Limin] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China; [Li, Man; Wang, Yanhui; Jia, Limin] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Wang, Yanhui; Jia, Limin] Beijing Jiaotong Univ, Beijing Res Ctr Urban Traff Informat Sensing & Se, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Jiaotong University	Wang, YH (corresponding author), Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China.; Wang, YH (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.; Wang, YH (corresponding author), Beijing Jiaotong Univ, Beijing Res Ctr Urban Traff Informat Sensing & Se, Beijing, Peoples R China.	zhxywyh@126.com			Key Research and Development Project of Safety Assurance Technology of Urban Rail System under China National 13th Five-Year Plan [2016YFB1200402]	Key Research and Development Project of Safety Assurance Technology of Urban Rail System under China National 13th Five-Year Plan	This work was supported by Key Research and Development Project of Safety Assurance Technology of Urban Rail System under China National 13th Five-Year Plan; Award Number 2016YFB1200402; Grant Recipient: Yanhui Wang.	Angeloudis P, 2006, PHYSICA A, V367, P553, DOI 10.1016/j.physa.2005.11.007; Crucitti P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036125; De-Los-Santos A, 2012, TRANSPORT RES C-EMER, V20, P34, DOI 10.1016/j.trc.2010.09.002; Deng Runfei, 2015, Journal of Southeast University (Natural Science Edition), V45, P178, DOI 10.3969/j.issn.1001-0505.2015.01.031; Derrible S, 2010, PHYSICA A, V389, P3678, DOI 10.1016/j.physa.2010.04.008; Derrible S, 2010, TRANSPORTATION, V37, P275, DOI 10.1007/s11116-009-9227-7; Ding C, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8111100; Duan LW, 2012, RAILWAY TRANSPORT EC, V8; [高圣国 Gao Shengguo], 2011, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V11, P124; Goh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089980; Hong Ling, 2011, Journal of Tongji University (Natural Science), V39, P1485, DOI 10.3969/j.issn.0253-374x.2011.10.013; Kang LJ, 2015, TRANSPORT RES B-METH, V72, P112, DOI 10.1016/j.trb.2014.09.003; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Li Mu, 2017, THESIS, P5; Li W, 2016, J TRAFFIC TRANSP ENG, V3, P364, DOI 10.1016/j.jtte.2015.09.009; Li Y, 2017, TRANSPORT RES C-EMER, V77, P306, DOI 10.1016/j.trc.2017.02.005; Lu ZM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162289; Ma XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117294; Ma XL, 2012, J ZHEJIANG U-SCI C, V13, P750, DOI 10.1631/jzus.C12a0049; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2014, J TRANSP ENG, V140, DOI 10.1061/(ASCE)TE.1943-5436.0000714; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Ou WY, 1983, FIELD MATH DESCRIPTI; Porta S, 2012, URBAN STUD, V49, P1471, DOI 10.1177/0042098011422570; Raveau S, 2011, TRANSPORT RES A-POL, V45, P138, DOI 10.1016/j.tra.2010.12.004; [尚斌 Shang Bin], 2013, [西南交通大学学报, Journal of Southwest Jiaotong University], V48, P539; Soh H, 2010, PHYSICA A, V389, P5852, DOI 10.1016/j.physa.2010.08.015; Sun HJ, 2016, TRANSPORT RES A-POL, V94, P62, DOI 10.1016/j.tra.2016.09.006; Sun LL, 2013, TRANSPORT RES REC, P76, DOI 10.3141/2352-09; Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080178; Wang ZG, 1990, ACTA GEOGR SIN, V1, P90; Xu Ruihua, 2014, China Railway Science, V35, P127, DOI 10.3969/j.issn.1001-4632.2014.05.18; Yang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022557; [姚向明 Yao Xiangming], 2012, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V12, P52; Yu Bin, 2014, Journal of Tongji University (Natural Science), V42, P246, DOI 10.3969/j.issn.0253-374x.2014.02.012; Zhang C., 2006, THESIS; Zhang JH, 2013, PHYSICA A, V392, P1538, DOI 10.1016/j.physa.2012.11.036; Zhang JH, 2011, PHYSICA A, V390, P4562, DOI 10.1016/j.physa.2011.06.022; Zhang Y., 2009, THESIS; [赵冰 Zhao Bing], 2010, [大连海事大学学报, Journal of Dalian Maritime University], V36, P59; Zhu R, 2011, THESIS LANZHOU U LAN	42	2	2	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184131	10.1371/journal.pone.0184131	http://dx.doi.org/10.1371/journal.pone.0184131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF3ON	28863175	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900028
J	Damps, T; Laskowska, AK; Kowalkowski, T; Prokopowicz, M; Puszko, AK; Sosnowski, P; Czuwara, J; Konop, M; Rozycki, K; Borkowska, JK; Misicka, A; Rudnicka, L				Damps, Tatsiana; Laskowska, Anna Katarzyna; Kowalkowski, Tomasz; Prokopowicz, Monika; Puszko, Anna Katarzyna; Sosnowski, Piotr; Czuwara, Joanna; Konop, Marek; Rozycki, Krzysztof; Borkowska, Joanna Karolina; Misicka, Aleksandra; Rudnicka, Lidia			The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; ACTINIC KERATOSIS; INGENOL MEBUTATE; CONSENSUS; DICLOFENAC; DIAGNOSIS; GEL	Squamous cell carcinoma of the skin is the second most common cutaneous malignancy. Despite various available treatment methods and advances in noninvasive diagnostic techniques, the incidence of metastatic cutaneous squamous cell carcinoma is rising. Deficiency in effective preventive or treatment methods of transformed keratinocytes leads to necessity of searching for new anticancer agents. The present study aims to evaluate the possibility of using wool hydrolysates as such agents. Commercially available compounds such as 5-fluorouracil, ingenol mebutate, diclofenac sodium salt were also used in this study. The process of wool degradation was based on chemical pre-activation and enzymatic digestion of wool. The effect of mentioned compounds on cell viability of squamous carcinoma cell line and healthy keratinocytes was evaluated. The obtained data show a significantly stronger effect of selected wool hydrolysates compared to commercial compounds (p<0.05) on viability of cells. The wool hydrolysates decreased squamous cell carcinoma cells viability by up to 67% comparing to untreated cells. These results indicate bioactive properties of wool hydrolysates, which affect the viability of squamous carcinoma cells and decrease their number. We hypothesize that these agents may be used topically for treatment of transformed keratinocytes in actinic keratosis and invasive squamous skin cancer in humans.	[Damps, Tatsiana; Laskowska, Anna Katarzyna; Sosnowski, Piotr; Misicka, Aleksandra; Rudnicka, Lidia] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neuropeptides, Warsaw, Poland; [Kowalkowski, Tomasz] Nicolaus Copernicus Univ, Chair Environm Chem & Bioanalyt, Fac Chem, Torun, Poland; [Kowalkowski, Tomasz] Nicolaus Copernicus Univ, Interdisciplinary Ctr Modern Technol, Torun, Poland; [Prokopowicz, Monika; Rozycki, Krzysztof] Polish Acad Sci, Mossakowski Med Res Ctr, Lab Chem Synth, CePT, Warsaw, Poland; [Puszko, Anna Katarzyna] Univ Warsaw, Fac Chem, Warsaw, Poland; [Czuwara, Joanna; Konop, Marek] Med Univ Warsaw, Dept Dermatol, Warsaw, Poland; [Borkowska, Joanna Karolina] Polish Acad Sci, Dept Human Epigenet, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Nicolaus Copernicus University; Nicolaus Copernicus University; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Damps, T (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neuropeptides, Warsaw, Poland.	kazlovatatsiana@gmail.com	Kowalkowski, Tomasz/C-6986-2008; Konop, Marek/AAM-6033-2020; Laskowska, Anna/AAA-5536-2020; Rudnicka, Lidia/L-7529-2019; Kowalkowski, Tomasz/L-5187-2019; Czuwara, Joanna/AAK-4504-2020; Borkowska, Joanna/A-9671-2019	Kowalkowski, Tomasz/0000-0001-8866-0246; Konop, Marek/0000-0002-3914-6934; Laskowska, Anna/0000-0002-0575-2514; Rudnicka, Lidia/0000-0002-8308-1023; Kowalkowski, Tomasz/0000-0001-8866-0246; Czuwara, Joanna/0000-0001-6139-7281; Sosnowski, Piotr/0000-0003-4261-269X; Puszko, Anna/0000-0001-7863-6146; Misicka, Aleksandra/0000-0001-7446-2396; Borkowska, Joanna/0000-0001-8585-8716	Leading National Research Centre - Mossakowski Medical Research Centre (KNOW-MMRC) Project; EU from European Regional Development Fund under the Operational Programme Innovative Economy	Leading National Research Centre - Mossakowski Medical Research Centre (KNOW-MMRC) Project; EU from European Regional Development Fund under the Operational Programme Innovative Economy	The research was supported by the Leading National Research Centre - Mossakowski Medical Research Centre (KNOW-MMRC) Project.; We are very grateful to the late Professor Andrzej W. Lipkowski, whose great knowledge and experience gave idea for this work, but who was unfortunately unable to finish it. The biological studies were performed in Toxicology Research Laboratory, CePT, Mossakowski Medical Research Centre. Wool hydrolysis was done in Laboratory of Chemical Synthesis, CePT, Mossakowski Medical Research Centre, both established within the project co-financed by EU from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013. The imaging studies were performed in Laboratory of Advanced Microscopy Techniques, Mossakowski Medical Research Centre, Polish Academy of Sciences.	Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Burton KA, 2016, AM J CLIN DERMATOL, V17, P491, DOI 10.1007/s40257-016-0207-3; Cassarino DS, 2006, J CUTAN PATHOL, V33, P261, DOI 10.1111/j.0303-6987.2006.00516.x; Costa C, 2015, J DERMATOL CASE REP, V9, P28, DOI 10.3315/jdcr.2015.1199; Dirschka T., 2016, J DERMATOL TREAT, V28, P1; Gracia-Cazana T, 2016, ACTAS DERMO-SIFILOGR, V107, P730, DOI 10.1016/j.ad.2016.04.019; Javor S, 2016, GIORN ITAL DERMAT V, V151, P275; John SM, 2016, J EUR ACAD DERMATOL, V30, P38, DOI 10.1111/jdv.13608; Kauvar ANB, 2015, DERMATOL SURG, V41, P1214, DOI 10.1097/DSS.0000000000000478; Kessler GM, 2006, AM J DERMATOPATH, V28, P537, DOI 10.1097/01.dad.0000245196.73224.cb; Kircik Leon, 2016, J Clin Aesthet Dermatol, V9, P39; Li JS, 2013, FOOD CHEM TOXICOL, V57, P338, DOI 10.1016/j.fct.2013.03.047; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Lipkowski AW, 2009, POLIMERY-W, V54, P386, DOI 10.14314/polimery.2009.386; Lipkowski AW, 2016, United States Patent, Patent No. [9,365,633 B2, 9365633]; Malhotra S, 2013, J CUTAN PATHOL, V40, P371, DOI 10.1111/cup.12090; Marinescu A, 2016, ROM J MORPHOL EMBRYO, V57, P691; Markowicz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098073; Micali G, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.12.045; Nayak D, 2015, J COLLOID INTERF SCI, V457, P329, DOI 10.1016/j.jcis.2015.07.012; Nistico S, 2016, INT J IMMUNOPATH PH, V29, P796, DOI 10.1177/0394632016648707; Peris K, 2016, J EUR ACAD DERMATOL, V30, P1077, DOI 10.1111/jdv.13648; Reinhold U, 2016, J EUR ACAD DERMATOL; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; SLOMINSKI AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI DOI 10.2174/18715206113139990308; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Ulrich M, 2016, J DRUGS DERMATOL, V15, P1181; Ulrich M, 2014, EUR J DERMATOL, V24, P158, DOI 10.1684/ejd.2014.2286; Voiculescu V, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4517492; Warszawik-Hendzel O, 2015, J DERMATOL CASE REP, V9, P89, DOI 10.3315/jdcr.2015.1221; Wu Jian, 2015, Asian Pac J Cancer Prev, V16, P2813; Yan W, 2011, AM J CANCER RES, V1, P275; Zarchi K, 2015, CURR PROBL DERMATOL, V46, P136, DOI 10.1159/000366549; Zhang J, 2013, POWDER TECHNOL, V246, P356, DOI 10.1016/j.powtec.2013.05.037	34	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184034	10.1371/journal.pone.0184034	http://dx.doi.org/10.1371/journal.pone.0184034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859143	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500061
J	Kim, SB; Lee, EJ; Han, JC; Kee, C				Kim, Si Bum; Lee, Eun Jung; Han, Jong Chul; Kee, Changwon			Comparison of peripapillary vessel density between preperimetric and perimetric glaucoma evaluated by OCT-angiography	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; FLUORESCEIN FILLING DEFECTS; LASER SPECKLE FLOWGRAPHY; OCULAR BLOOD-FLOW; DISC PERFUSION; VISUAL-FIELD; VELOCITY	Purpose To determine peripapillary vessel density in eyes with perimetric glaucoma (PG) or preperimetric glaucoma (PPG) compared to normal controls using optical coherence tomographyangiography (OCT-A). Methods We recruited 13 patients with unilateral perimetric normal-tension glaucoma (NTG) and fellow preperimetric NTG showing only inferotemporal retinal nerve fiber layer (RNFL) defect in red-free RNFL photography in both eyes. We also enrolled 9 healthy controls. Using OCT-A, radial peripapillary capillary densities at inferotemporal and superotemporal regions were evaluated. Paired comparison of peripapillary vessel density was performed for PG eye, PPG eye, and normal eye. Results A total of 26 eyes of the 13 patients with unilateral PG and fellow PPG eyes and 18 eyes of 9 normal controls were analyzed. Vessel densities at the whole peripapillary region and inferotemporal region in PG eyes were significantly lower than those in PPG eyes (P = 0.001, P<0.001, respectively). Comparison between PPG and normal eyes showed no significant difference in the whole peripapillary region or the inferotemporal region (P = 0.654, P = 0.174, respectively). There was no significant (P = 0.288) difference in vessel density at superotemporal region among the three types of eyes (PG eye, PPG eye, and normal eye). Conclusion PPG eyes and normal eyes were found to have the similar densities of peripapillary microvasculature at the area with nerve fiber layer defect, whereas in PG eye, there was a significant decrease in vessel density at the area of RNFL thinning. This provides evidence that microvascular compromise in the retina might be a secondary change to nerve fiber layer degeneration in the pathogenesis of NTG.	[Kim, Si Bum; Lee, Eun Jung; Han, Jong Chul; Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kee, C (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	ckee@skku.edu		Kee, Changwon/0000-0002-7419-0316				Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; Bathija Renuka, 2000, Clin Exp Optom, V83, P180; Bojikian KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154691; Chen CL, 2016, INVEST OPHTH VIS SCI, V57, pOCT475, DOI 10.1167/iovs.15-18909; Chen CL, 2016, QUANT IMAG MED SURG, V6, P125, DOI 10.21037/qims.2016.03.05; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; GASSER P, 1991, AM J OPHTHALMOL, V111, P585, DOI 10.1016/S0002-9394(14)73703-1; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P2329; Hendargo HC, 2011, BIOMED OPT EXPRESS, V2, P2175, DOI 10.1364/BOE.2.002175; HITCHINGS RA, 1977, BRIT J OPHTHALMOL, V61, P126, DOI 10.1136/bjo.61.2.126; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Kim KE, 2015, AM J OPHTHALMOL, V159, P160, DOI 10.1016/j.ajo.2014.10.010; Lee EJ, 2017, J GLAUCOMA, V26, P216, DOI 10.1097/IJG.0000000000000587; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Mammo Z, 2016, AM J OPHTHALMOL, V170, P41, DOI 10.1016/j.ajo.2016.07.015; Michelson G, 1996, J GLAUCOMA, V5, P99; Mozaffarieh M, 2013, CURR OPIN PHARMACOL, V13, P43, DOI 10.1016/j.coph.2012.10.001; Nicolela MT, 1996, J GLAUCOMA, V5, P308; Park HYL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120000; Plange N, 2004, ARCH OPHTHALMOL-CHIC, V122, P195, DOI 10.1001/archopht.122.2.195; Plange N, 2003, BRIT J OPHTHALMOL, V87, P731, DOI 10.1136/bjo.87.6.731; Quaranta L, 1997, OPHTHALMOLOGY, V104, P653, DOI 10.1016/S0161-6420(97)30256-5; QUIGLEY HA, 1984, INVEST OPHTH VIS SCI, V25, P918; Rao HL, 2016, AM J OPHTHALMOL, V171, P75, DOI 10.1016/j.ajo.2016.08.030; SCHWARTZ B, 1977, ARCH OPHTHALMOL-CHIC, V95, P1961; Shiga Y, 2016, CURR EYE RES, V41, P1447, DOI 10.3109/02713683.2015.1127974; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Suh MH, 2016, OPHTHALMOLOGY, V123, P2309, DOI 10.1016/j.ophtha.2016.07.023; TALUSAN E, 1977, ARCH OPHTHALMOL-CHIC, V95, P2166; Trible J R, 1993, Trans Am Ophthalmol Soc, V91, P245; TRIBLE JR, 1994, OPHTHALMOLOGY, V101, P340; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Yoshida A, 2003, AM J OPHTHALMOL, V135, P356, DOI 10.1016/S0002-9394(02)01949-9; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	42	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184297	10.1371/journal.pone.0184297	http://dx.doi.org/10.1371/journal.pone.0184297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859176	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500081
J	Yu, ZY; Cohen, JB				Yu, Zhiyi; Cohen, Jonathan B.			Enantiomeric barbiturates bind distinct inter- and intrasubunit binding sites in a nicotinic acetylcholine receptor (nAChR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN; ION-CHANNEL; ALLOSTERIC MODULATION; IDENTIFICATION; AGONIST; ANTAGONISTS; ETOMIDATE; PROTEINS; SUBUNIT; STATE	Nicotinic acetylcholine receptors (nAChRs) and gamma-aminobutyric acid type A receptors (GABA(A)Rs) are members of the pentameric ligand-gated ion channel superfamily. Drugs acting as positive allosteric modulators of muscle-type alpha 2 beta gamma delta nAChRs, of use in treatment of neuromuscular disorders, have been hard to identify. However, identification of nAChR allosteric modulator binding sites has been facilitated by using drugs developed as photoreactive GABA(A)R modulators. Recently, R-1-methyl-5-allyl-5-(m-trifluoromethyl-diazirinylphenyl) barbituric acid (R-mTFD-MPAB), an anesthetic and GABA(A)R potentiator, has been shown to inhibit Torpedo alpha 2 beta gamma delta nAChRs, binding in the ion channel and to a gamma(+) - alpha(-) subunit interface site similar to its GABA(A)R intersubunit binding site. In contrast, S-1-methyl-5-propyl- 5-(m-trifluoromethyl-diazirinylphenyl) barbituric acid (S-mTFD-MPPB) acts as a convulsant and GABA(A)R inhibitor. Photolabeling studies established that S-mTFD-MPPB binds to the same GABA(A)R intersubunit binding site as R-mTFD-MPAB, but with negative rather than positive energetic coupling to GABA binding. We now show that S-mTFD-MPPB binds with the same state (agonist) dependence as R-mTFD-MPAB within the nAChR ion channel, but it does not bind to the intersubunit binding site. Rather, S-mTFD-MPPB binds to intrasubunit sites within the alpha and delta subunits, photolabeling alpha Val-218 (alpha M1), delta Phe-232(delta M1), delta Thr-274 (delta M2), and delta Ile-288 (delta M3). Propofol, a general anesthetic that binds to GABA(A)R intersubunit sites, inhibited [H-3] S-mTFD-MPPB photolabeling of these nAChR intrasubunit binding sites. These results demonstrate that in an nAChR, the subtle difference in structure between S-mTFD-MPPB and R-mTFD-MPAB (chirality; 5-propyl versus 5-allyl) determines selectivity for intra-versus intersubunit sites, in contrast to GABAARs, where this difference affects state dependence of binding to a common site.	[Yu, Zhiyi; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]; Edward and Anne Lefler Center of Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward and Anne Lefler Center of Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grant GM-58448 (to J. B. C.) and by the Edward and Anne Lefler Center of Harvard Medical School. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2003, INT REV NEUROBIOL, V54, P1, DOI 10.1016/S0074-7742(03)54002-8; Arias HR, 2003, BIOCHEMISTRY-US, V42, P7358, DOI 10.1021/bi034052n; Arias HR, 2001, MOL PHARMACOL, V60, P497; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Cohen J. B., 1986, MOL CELLULAR MECHANI, P111; DEARMENDI AJ, 1993, ANESTHESIOLOGY, V79, P1033, DOI 10.1097/00000542-199311000-00022; Desai R, 2015, J PHYSIOL-LONDON, V593, P4943, DOI 10.1113/JP270971; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Fourati Z, 2017, J BIOL CHEM, V292, P1550, DOI 10.1074/jbc.M116.766964; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Hamouda AK, 2015, MOL PHARMACOL, V88, P1, DOI 10.1124/mol.115.098913; Hamouda AK, 2014, J MOL NEUROSCI, V53, P480, DOI 10.1007/s12031-013-0150-1; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hamouda AK, 2008, BIOCHEMISTRY-US, V47, P12787, DOI 10.1021/bi801476j; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Katz EJ, 1997, TOXICOL APPL PHARM, V146, P227, DOI 10.1006/taap.1997.8201; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MOORE MA, 1995, BBA-BIOMEMBRANES, V1235, P336, DOI 10.1016/0005-2736(95)80022-8; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nemecz A, 2016, NEURON, V90, P452, DOI 10.1016/j.neuron.2016.03.032; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Pandhare A, 2012, BIOCHEMISTRY-US, V51, P2425, DOI 10.1021/bi300101r; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Puthenkalam R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00044; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p	55	1	1	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17258	17271		10.1074/jbc.M117.808592	http://dx.doi.org/10.1074/jbc.M117.808592			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28878016	Green Published, hybrid			2022-12-26	WOS:000414009300010
J	Schultz, DJ; Muluhngwi, P; Alizadeh-Rad, N; Green, MA; Rouchka, EC; Waigel, SJ; Klinge, CM				Schultz, David J.; Muluhngwi, Penn; Alizadeh-Rad, Negin; Green, Madelyn A.; Rouchka, Eric C.; Waigel, Sabine J.; Klinge, Carolyn M.			Genome-wide miRNA response to anacardic acid in breast cancer cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; MESSENGER-RNA; LUNG-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; UP-REGULATION; MESENCHYMAL TRANSITION; INHIBITS PROLIFERATION; MIR-1247 FUNCTIONS	MicroRNAs are biomarkers and potential therapeutic targets for breast cancer. Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor alpha (ER alpha) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC(50)s of 13.5 and 35 mu M, respectively. To identify potential mediators of AnAc action in breast cancer, we profiled the genome-wide microRNA transcriptome (microRNAome) in these two cell lines altered by the AnAc 24: 1n5 congener. Whole genome expression profiling (RNAseq) and subsequent network analysis in MetaCore Gene Ontology (GO) algorithm was used to characterize the biological pathways altered by AnAc. In MCF-7 cells, 69 AnAc-responsive miRNAs were identified, e.g., increased let-7a and reduced miR-584. Fewer, i.e., 37 AnAc-responsive miRNAs were identified in MDA-MB-231 cells, e.g., decreased miR23b and increased miR-1257. Only two miRNAs were increased by AnAc in both cell lines: miR-612 and miR-20b; however, opposite miRNA arm preference was noted: miR-20b-3p and miR-20b-5p were upregulated in MCF-7 and MDA-MB-231, respectively. miR-20b-5p target EFNB2 transcript levels were reduced by AnAc in MDA-MB-231 cells. AnAc reduced miR-378g that targets VIM (vimentin) and VIM mRNA transcript expression was increased in AnAc-treated MCF-7 cells, suggesting a reciprocal relationship. The top three enriched GO terms for AnAc-treated MCF-7 cells were B cell receptor signaling pathway and ribosomal large subunit biogenesis and S-adenosylmethionine metabolic process for AnActreated MDA-MB-231 cells. The pathways modulated by these AnAc-regulated miRNAs suggest that key nodal molecules, e.g., Cyclin D1, MYC, c-FOS, PPAR., and SIN3, are targets of AnAc activity.	[Schultz, David J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Muluhngwi, Penn; Alizadeh-Rad, Negin; Green, Madelyn A.; Klinge, Carolyn M.] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Rouchka, Eric C.] Dept Comp Engn & Comp Sci, Bioinformat & Biomed Comp Lab, Louisville, KY USA; [Waigel, Sabine J.] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Klinge, CM (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	carolyn.klinge@louisville.edu		Klinge, Carolyn/0000-0002-3358-4378	University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot; University of Louisville School of Medicine; University of Louisville Executive Vice President for Research and Innovation; National Institutes of Health [P20GM103436]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot; University of Louisville School of Medicine; University of Louisville Executive Vice President for Research and Innovation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a grant from the University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot Grant to D.J.S.; a grant from the University of Louisville School of Medicine to C.M.K., and by a University of Louisville Executive Vice President for Research and Innovation grant to C.M.K. Bioinformatics support for this work by E.C.R. and S.J.W. was provided by National Institutes of Health grants P20GM103436 (Kentucky IDeA Networks of Biomedical Research Excellence, Nigel Cooper, PI).; We thank Brandie N. Radde for performing the cell treatments and isolating the RNA for RNA seq. This research was funded by a grant from the University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot Grant to D.J.S.; a grant from the University of Louisville School of Medicine to C.M.K., and by a University of Louisville Executive Vice President for Research and Innovation grant to C.M.K. Bioinformatics support for this work by E.C.R. and S.J.W. was provided by National Institutes of Health grants P20GM103436 (Kentucky IDeA Networks of Biomedical Research Excellence, Nigel Cooper, PI).	Abedi N, 2015, TUMOR BIOL, V36, P9895, DOI 10.1007/s13277-015-3738-y; Adachi S, 2014, NUCLEIC ACIDS RES, V42, P10037, DOI 10.1093/nar/gku652; Andrews S., 2014, FASTQC QUALITY CONTR; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Antolin S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1238-5; Ao X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.367; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bao YZ, 2017, CLIN EXP MED, V17, P51, DOI 10.1007/s10238-015-0398-6; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolser DM, 2012, NUCLEIC ACIDS RES, V40, pD1250, DOI 10.1093/nar/gkr1099; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/nnodpathol.2016.157, 10.1038/modpathol.2016.157]; Bose M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12200; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Caussy C, 2016, ATHEROSCLEROSIS, V246, P280, DOI 10.1016/j.atherosclerosis.2016.01.010; Chen B, 2015, BIOMED PHARMACOTHER, V75, P1, DOI 10.1016/j.biopha.2015.08.012; Chen G, 2016, BIOCHEM BIOPH RES CO, V473, P1144, DOI 10.1016/j.bbrc.2016.04.030; Chen MT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16229; Chen WC, 2012, EXP THER MED, V3, P1039, DOI 10.3892/etm.2012.531; Chen XD, 2014, TUMOR BIOL, V35, P11081, DOI 10.1007/s13277-014-2405-z; Cho JG, 2016, ONCOTARGET, V7, P31177, DOI 10.18632/oncotarget.8870; Chong GO, 2015, ANTICANCER RES, V35, P2611; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; Cinegaglia NC, 2016, ONCOTARGET, V7, P28920, DOI 10.18632/oncotarget.8713; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Debeb BG, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw026; Deng ZQ, 2013, J BIOL CHEM, V288, P319, DOI 10.1074/jbc.M112.418830; Dimri M, 2015, J BIOL CHEM, V290, P3033, DOI 10.1074/jbc.M114.615179; Ding Z, 2015, MEDICINE, V94, pe1327; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Duan H, 2009, MOL ENDOCRINOL, V23, P497, DOI 10.1210/me.2008-0296; Ell B, 2014, J BIOL CHEM, V289, P21888, DOI 10.1074/jbc.M114.582866; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Finlay-Schultz J, 2015, ONCOGENE, V34, P3676, DOI 10.1038/onc.2014.298; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gerhauser C, 2013, TOP CURR CHEM, V329, P73, DOI 10.1007/128_2012_360; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Giraud-Triboult K, 2011, PHYSIOL GENOMICS, V43, P77, DOI 10.1152/physiolgenomics.00077.2010; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Haldrup C, 2014, DRUG DELIV TRANSL RE, V4, P19, DOI 10.1007/s13346-013-0169-4; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; Hayes EL, 2015, BREAST CANCER RES, V17, P542; He J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013558; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Hinske LC, 2014, DATABASE, V2014; Hisaoka M, 2012, AM J PATHOL, V180, P2076, DOI 10.1016/j.ajpath.2012.01.042; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Hong SB, 2016, THYROID, V26, P1733, DOI 10.1089/thy.2015.0578; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Hu W, 2015, CARDIOVASC RES, V107, P534, DOI 10.1093/cvr/cvv160; Huang WZ, 2016, BIOMED PHARMACOTHER, V81, P431, DOI 10.1016/j.biopha.2016.04.034; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jarret A, 2016, NAT MED, V22, P1475, DOI 10.1038/nm.4211; Jiao L, 2014, J CELL PHYSIOL, V229, P834, DOI 10.1002/jcp.24510; Kalabus JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048622; Kanlikilicer P, 2016, CANCER RES, V76, P7194, DOI 10.1158/0008-5472.CAN-16-0714; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Klinge CM, 2015, MOL CELL ENDOCRINOL, V418, P273, DOI 10.1016/j.mce.2015.01.035; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee YM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3059; Li DP, 2013, ONCOTARGET, V4, P1373, DOI 10.18632/oncotarget.1165; Li J, 2017, AM J TRANSL RES, V9, P146; Li P, 2017, CANCER MED-US, V6, P662, DOI 10.1002/cam4.1024; Li TS, 2015, ONCOTARGET, V6, P21428, DOI 10.18632/oncotarget.4077; Li XB, 2016, ONCOTARGET, V7, P45385, DOI 10.18632/oncotarget.9978; Litchfield LM, 2014, MOL CELL ENDOCRINOL, V382, P358, DOI 10.1016/j.mce.2013.10.010; Liu CH, 2015, J CANCER RES CLIN, V141, P431, DOI 10.1007/s00432-014-1836-7; Liu JB, 2015, TUMOR BIOL, V36, P219, DOI 10.1007/s13277-014-2622-5; Liu K, 2015, INT J ONCOL, V46, P2526, DOI 10.3892/ijo.2015.2949; Liu W, 2010, ONCOGENE, V29, P4914, DOI 10.1038/onc.2010.237; Liu Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.282; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Ma F, 2017, ONCOTARGET; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Madhavan D, 2016, CARCINOGENESIS, V37, P461, DOI 10.1093/carcin/bgw008; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mammoto A, 2000, J BIOL CHEM, V275, P13167, DOI 10.1074/jbc.C000096200; Marrale M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090947; Martinez-Sanchez A, 2013, J BIOL CHEM, V288, P30802, DOI 10.1074/jbc.M113.496729; McGuire A, 2015, CANCER METAST REV, V34, P145, DOI 10.1007/s10555-015-9551-7; Meijer HA, 2014, BIOCHEM SOC T, V42, P1135, DOI 10.1042/BST20140142; Misund K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076234; Mody HR, 2016, MOL CANCER RES, V14, P1124, DOI 10.1158/1541-7786.MCR-16-0083; Muluhngwi P, 2017, CANCER LETT, V388, P230, DOI 10.1016/j.canlet.2016.12.007; Munari E, 2014, HUM PATHOL, V45, P1130, DOI 10.1016/j.humpath.2014.01.013; Nakazawa K, 2014, FEBS J, V281, P2937, DOI 10.1111/febs.12831; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Othman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081735; Oztemur Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126837; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Paris O, 2012, ONCOGENE, V31, P4196, DOI 10.1038/onc.2011.583; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pellegrino Loredana, 2013, Bioarchitecture, V3, P119; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Pennanen PI, 2009, STEROIDS, V74, P404, DOI 10.1016/j.steroids.2008.12.005; Pieper LA, 2017, BIOTECHNOL BIOENG, V114, P1310, DOI 10.1002/bit.26263; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Pinweha P, 2016, COMPUT STRUCT BIOTEC, V14, P223, DOI 10.1016/j.csbj.2016.05.005; Planel S, 2010, ONCOGENE, V29, P5989, DOI 10.1038/onc.2010.341; Radde B. N., 2016, J CELL BIOCH; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Scaravilli M, 2015, PROSTATE, V75, P798, DOI 10.1002/pros.22961; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz DJ, 2006, J AGR FOOD CHEM, V54, P7522, DOI 10.1021/jf061481u; Schultz David J., 2006, V40, P131; Schultz DJ, 2010, MOL CANCER THER, V9, P594, DOI 10.1158/1535-7163.MCT-09-0978; Shen ZY, 2016, J ORAL PATHOL MED, V45, P523, DOI 10.1111/jop.12404; Sheng L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.184; Shi S, 2014, CURR MOL MED, V14, P316, DOI 10.2174/1566524014666140228120014; Shi XG, 2015, ONCOTARGET, V6, P19043, DOI 10.18632/oncotarget.4232; Shimomura A, 2016, CANCER SCI, V107, P326, DOI 10.1111/cas.12880; Sripada L, 2017, J MOL MED, V95, P641, DOI 10.1007/s00109-017-1517-5; Tan ZY, 2016, ONCOTARGET, V7, P24076, DOI 10.18632/oncotarget.8119; Tang J, 2014, BIOCHEM BIOPH RES CO, V447, P210, DOI 10.1016/j.bbrc.2014.03.135; Tao ZH, 2013, J EXP MED, V210, P789, DOI 10.1084/jem.20120153; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuno S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03852; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; van Kampen JGM, 2017, CANCER RES, V77, P2008, DOI 10.1158/0008-5472.CAN-16-2609; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Vejdovszky K, 2017, TOXICOL LETT, V267, P45, DOI 10.1016/j.toxlet.2016.12.011; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040; Vilquin P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0515-1; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164105; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang P, 2017, BIOCHEM BIOPH RES CO, V482, P935, DOI 10.1016/j.bbrc.2016.11.136; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Wang Y, 2013, CANCER GENET-NY, V206, P340, DOI 10.1016/j.cancergen.2013.09.005; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wei XF, 2016, RNA BIOL, V13, P1300, DOI 10.1080/15476286.2016.1239008; Wei ZT, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0842-9; Weng ZH, 2011, EXP THER MED, V2, P951, DOI 10.3892/etm.2011.288; Wolter M, 2016, BRAIN PATHOL, V26, P344, DOI 10.1111/bpa.12294; Wu Q, 2015, J CELL MOL MED, V19, P2874, DOI 10.1111/jcmm.12681; Xin JX, 2017, ONCOTARGETS THER, V10, P1, DOI 10.2147/OTT.S124201; Xing F, 2015, ONCOGENE, V34, P4890, DOI 10.1038/onc.2014.412; Xu K, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.21832; Xu YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065123; Xue TM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/325176; Yan L, 2015, AM J CANCER RES, V5, P1447; Yang FL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100031, 10.1371/journal.pone.0076458]; Yang HY, 2016, TUMOR BIOL, V37, P1051, DOI 10.1007/s13277-015-3898-9; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yang Y, 2015, INT J CLIN EXP MED, V8, P18123; Yao TT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-175; Yao YS, 2015, ONCOL REP, V33, P2504, DOI 10.3892/or.2015.3866; Yoo JK, 2012, STEM CELLS DEV, V21, P2049, DOI 10.1089/scd.2011.0500; Yoon S, 2014, MOL CELLS, V37, P314, DOI 10.14348/molcells.2014.2360; Yu S, 2016, ONCOTARGET, V7, P84165, DOI 10.18632/oncotarget.12389; Zawada AM, 2017, IMMUNOBIOLOGY, V222, P587, DOI 10.1016/j.imbio.2016.11.006; Zekavati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102625; Zhan Y, 2016, MOL ONCOL, V10, P838, DOI 10.1016/j.molonc.2016.02.002; Zhang GQ, 2016, ONCOL RES, V24, P233, DOI 10.3727/096504016X14648701447977; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhang J, 2016, INT J OPHTHALMOL-CHI, V9, P1, DOI 10.18240/ijo.2016.01.01; Zhang WC, 2014, TUMOR BIOL, V35, P6235, DOI 10.1007/s13277-014-2202-8; Zhang Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2350-x; Zhao FY, 2015, INT J CLIN EXP PATHO, V8, P1451; Zhou Y, 2016, CANCER RES, V76, P5777, DOI 10.1158/0008-5472.CAN-15-2936; Zhu H, 2015, BIOCHEM BIOPH RES CO, V459, P340, DOI 10.1016/j.bbrc.2015.02.116	179	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184471	10.1371/journal.pone.0184471	http://dx.doi.org/10.1371/journal.pone.0184471			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886127	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100133
J	Topalovic, V; Krstic, A; Schwirtlich, M; Dolfini, D; Mantovani, R; Stevanovic, M; Mojsin, M				Topalovic, Vladanka; Krstic, Aleksandar; Schwirtlich, Marija; Dolfini, Diletta; Mantovani, Roberto; Stevanovic, Milena; Mojsin, Marija			Epigenetic regulation of human SOX3 gene expression during early phases of neural differentiation of NT2/D1 cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; HISTONE ACETYLATION; DNA METHYLATION; TRANSCRIPTION FACTORS; CHROMATIN-STRUCTURE; RESPONSE ELEMENT; CHICKEN SOX2; CPG ISLANDS; IN-VITRO	Sox3/SOX3 is one of the earliest neural markers in vertebrates. Together with the Sox1/SOX1 and Sox2/SOX2 genes it is implicated in the regulation of stem cell identity. In the present study, we performed the first analysis of epigenetic mechanisms (DNA methylation and histone marks) involved in the regulation of the human SOX3 gene expression during RA-induced neural differentiation of NT2/D1 cells. We show that the promoter of the human SOX3 gene is extremely hypomethylated both in undifferentiated NT2/D1 cells and during the early phases of RA-induced neural differentiation. By employing chromatin immunopre-cipitation, we analyze several histone modifications across different regions of the SOX3 gene and their dynamics following initiation of differentiation. In the same timeframe we investigate profiles of selected histone marks on the promoters of human SOX1 and SOX2 genes. We demonstrate differences in histone signatures of SOX1, SOX2 and SOX3 genes. Considering the importance of SOXB1 genes in the process of neural differentiation, the present study contributes to a better understanding of epigenetic mechanisms implicated in the regulation of pluripotency maintenance and commitment towards the neural lineage.	[Topalovic, Vladanka; Schwirtlich, Marija; Stevanovic, Milena; Mojsin, Marija] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Krstic, Aleksandar] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Dolfini, Diletta; Mantovani, Roberto] Univ Milan, Dept Biosci, Milan, Italy; [Stevanovic, Milena] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Stevanovic, Milena] Serbian Acad Arts & Sci, Belgrade, Serbia	University of Belgrade; University College Dublin; University of Milan; University of Belgrade; Serbian Academy of Sciences & Arts	Mojsin, M (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.	mojsin@imgge.bg.ac.rs		Mojsin, Marija/0000-0001-8775-0522; Schwirtlich, Marija/0000-0002-2183-0164; DOLFINI, DILETTA/0000-0002-5346-6096; Krstic, Aleksandar/0000-0002-7128-5707; Stevanovic, Milena/0000-0003-4286-7334	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]	Ministry of Education, Science and Technological Development, Republic of Serbia	This experimental work was supported by Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051, http://www.mon.gov.rs/). Authors who received this funding were A.K., M.S. and M.M. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051). We thank Prof. Paul J. Scotting (University of Nottingham, UK) for excellent technical assistance with pyrosequencing and valuable input during the preparation of the manuscript. We thank Prof. Peter W. Andrews (University of Sheffield, UK) for NT2/D1 cells and dr Natasa Anastasov (Helmholtz Zentrum Munchen, Munich, Germany) for anti-caspase-3 antibody.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1990, DIFFERENTIATION, V43, P131, DOI 10.1111/j.1432-0436.1990.tb00439.x; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Barrand S, 2010, BIOCHEM BIOPH RES CO, V391, P762, DOI 10.1016/j.bbrc.2009.11.134; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brunelli S, 2003, GENESIS, V36, P12, DOI 10.1002/gene.10193; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Collignon J, 1996, DEVELOPMENT, V122, P509; Cruickshank MN, 2010, AMINO ACIDS, V39, P1087, DOI 10.1007/s00726-010-0530-6; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Goodfellow CE, 2011, J NEUROSCI RES, V89, P1685, DOI 10.1002/jnr.22692; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grujicic NK, 2005, GENE, V344, P287, DOI 10.1016/j.gene.2004.11.006; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-257; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kovacevic-Grujicic N, 2014, BMB REP, V47, P197, DOI 10.5483/BMBRep.2014.47.4.084; Krstic A, 2007, ARCH BIOCHEM BIOPHYS, V467, P163, DOI 10.1016/j.abb.2007.08.029; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liao RQ, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0135-3; Lin YW, 2013, GYNECOL ONCOL, V131, P174, DOI 10.1016/j.ygyno.2013.07.111; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; McAninch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113361; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milivojevic Milena N G, 2010, ARCH BIOL SCI, V62, P199; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Mojsin M, 2006, NEUROSCI RES, V56, P409, DOI 10.1016/j.neures.2006.08.010; Mojsin M, 2015, HISTOCHEM CELL BIOL, V144, P429, DOI 10.1007/s00418-015-1352-0; Mojsin M, 2010, BIOCHEM J, V425, P107, DOI 10.1042/BJ20090694; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Nikcevic G, 2011, PHYSIOL RES, V60, pS83, DOI 10.33549/physiolres.932184; Nikcevic G, 2008, J NEUROCHEM, V107, P1206, DOI 10.1111/j.1471-4159.2008.05670.x; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Olynik Brendan M., 2012, Frontiers in Genetics, V3, P81, DOI 10.3389/fgene.2012.00081; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Przyborski SA, 2000, EUR J NEUROSCI, V12, P3521, DOI 10.1046/j.1460-9568.2000.00230.x; Rahmatpanah FB, 2009, EPIGENOMICS-UK, V1, P39, DOI 10.2217/EPI.09.10; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Rogers CD, 2009, MECH DEVELOP, V126, P42, DOI 10.1016/j.mod.2008.10.005; Rogers N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095356; Rogers N, 2013, GENE EXPR PATTERNS, V13, P240, DOI 10.1016/j.gep.2013.04.004; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stevanovic M, 2003, MOL BIOL REP, V30, P127, DOI 10.1023/A:1023961009869; STEVANOVIC M, 1993, HUM MOL GENET, V2, P2013, DOI 10.1093/hmg/2.12.2013; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; Terranova C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123380; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Topalovic V, 2017, BIOCHEMISTRY-MOSCOW+, V82, P715, DOI 10.1134/S0006297917060086; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	91	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184099	10.1371/journal.pone.0184099	http://dx.doi.org/10.1371/journal.pone.0184099			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886103	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100067
J	van Berlaer, G; Elsafti, AM; Al Safadi, M; Saeed, SS; Buyl, R; Debacker, M; Redwan, A; Hubloue, I				van Berlaer, Gerlant; Elsafti, Abdallah Mohamed; Al Safadi, Mohammad; Saeed, Saad Souhil; Buyl, Ronald; Debacker, Michel; Redwan, Atef; Hubloue, Ives			Diagnoses, infections and injuries in Northern Syrian children during the civil war: A crosssectional study	PLOS ONE			English	Article							ASYLUM SEEKERS; CHRONIC DISEASES; IRAQI REFUGEES; HEALTH; JORDAN; IMPACT; RISK; EMERGENCIES; ASSISTANCE; SPECTRUM	Background The civil war in Syria including the deliberate targeting of healthcare services resulted in a complex humanitarian emergency, seriously affecting children's health. The objectives of this study are to document diagnoses and disease categories in Northern Syrian children after four years of conflict, and to document infectious diseases and injuries in this vulnerable population. Methods In a prospective cross-sectional observational sample study conducted in May 2015, healthcare workers registered demographics, comorbidities, and diagnoses (categorised according to the International Classification of Diseases version 10) in children visited at home and in internally displaced persons camps in four Syrian governorates. Results Of 1080 filled-out records, 1002 were included. Children originated from Aleppo (41%), Idleb (36%), Hamah (15%) and Lattakia (8%). Median age was 6 years (0-15; IQR 3-11), 61% were boys, 40% were younger than 5 years old. Children suffered from respiratory (29%), neurological (19%), digestive (17%), eye (5%) and skin (5%) diseases. Clinical malnutrition was seen in 4%, accidental injury in 3%, intentional injury in 1%, and mental disorders in 2%. Overall, 64% had features of infectious diseases (OR 0.635; CI 0.605-0.665). Most common comorbidities were chronic respiratory diseases (14, malnutrition (5%), acute flaccid paralysis (5%), and epilepsy (4%). Logistic regression analysis indicated that the risk for children to have communicable diseases was higher in Aleppo than in Idleb (OR 1.7; CI 1.2-2.3), Hamah (OR 4.9; CI 3.3-7.5), or Lattakia (OR 5.5; CI 3.3-9.3). Children in Aleppo and Lattakia were more at risk to be injured than in Idleb (OR 5.6; CI 2.1-14.3), or in Hamah (OR 5.9; CI 1.4-25.6), but more often from intentional violence in Lattakia. Mental problems were more prominent in Hamah. Conclusions Four years far in the conflict, 64% of the studied children in four Northern Syrian governorates suffer from infections, mostly from respiratory, neurological and digestive origin, while 4% was injured or victim of intentional aggression. Substandard living conditions and the lack of paediatric healthcare put Syrian children at risk for serious infections, epidemics and morbidity, and ask for urgent international humanitarian relief efforts.	[van Berlaer, Gerlant; Debacker, Michel; Hubloue, Ives] Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium; [van Berlaer, Gerlant; Debacker, Michel; Hubloue, Ives] Vrije Univ Brussel, Res Grp Emergency & Disaster Med, Brussels, Belgium; [Elsafti, Abdallah Mohamed] Hamad Med Corp, Dept Emergency Med, Doha, Qatar; [Al Safadi, Mohammad] Turkey Mission, Med Off Turkey & Syria, Qatar Red Crescent, Doha, Qatar; [Saeed, Saad Souhil] Hamad Gen Hosp, Dept Paediat Cardiol, Doha, Qatar; [Buyl, Ronald] Vrije Univ Brussel, Dept Publ Hlth, Biostat & Med Informat Res Grp, Brussels, Belgium; [Redwan, Atef] Zagazig Univ, Fac Med, Dept Crit Care, Zagazig, Egypt	University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Hamad Medical Corporation; Hamad Medical Corporation; Hamad General Hospital; Vrije Universiteit Brussel; Egyptian Knowledge Bank (EKB); Zagazig University	van Berlaer, G (corresponding author), Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium.; van Berlaer, G (corresponding author), Vrije Univ Brussel, Res Grp Emergency & Disaster Med, Brussels, Belgium.	gerlant.vanberlaer@uzbrussel.be	Hubloue, Ives/GYR-0901-2022; Buyl, Ronald/F-3862-2015	Buyl, Ronald/0000-0002-6598-9505; van Berlaer, Gerlant/0000-0003-3674-9083; Debacker, Michel/0000-0003-1901-6865				Abou-Zeid AHA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-133; Al-Assil B, 2013, AM J INFECT CONTROL, V41, P597, DOI 10.1016/j.ajic.2012.09.016; Alberer M, 2016, DEUT MED WOCHENSCHR, V141, pE8, DOI 10.1055/s-0041-106907; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P193; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], JOINT STAT OV 20 MIL; Bellos Anna, 2010, Confl Health, V4, P3, DOI 10.1186/1752-1505-4-3; Ben Taleb Z, 2015, INT J PUBLIC HEALTH, V60, pS63, DOI 10.1007/s00038-014-0586-2; Bilukha OO, 2014, MMWR-MORBID MORTAL W, V63, P638; Bischoff A, 2009, EUR J PUBLIC HEALTH, V19, P59, DOI 10.1093/eurpub/ckn113; Bottcher S, 2015, INT J MED MICROBIOL, V305, P601, DOI 10.1016/j.ijmm.2015.08.008; Burnett A, 2001, BRIT MED J, V322, P544, DOI 10.1136/bmj.322.7285.544; Celikel A, 2015, J FORENSIC LEG MED, V34, P1, DOI 10.1016/j.jflm.2015.04.021; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Connolly MA, 2005, COMMUNICABLE DIS CON, P204; Debacker M., 2012, PLOS CURRENTS DISAST, DOI [DOI 10.1371/4F6CF3E8DF15A, 10.1371/4f6cf3e8df15a]; Devakumar D, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0061-6; Doganay M, 2016, HEALTH SECUR, V14, P220, DOI 10.1089/hs.2016.0054; Doocy S, 2016, INT J HEALTH PLAN M, V31, P97, DOI 10.1002/hpm.2336; Doocy S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2429-3; Doocy Shannon, 2015, Confl Health, V9, P33, DOI 10.1186/s13031-015-0060-7; Doocy S, 2011, SOC SCI MED, V72, P273, DOI 10.1016/j.socscimed.2010.10.023; Elfaituri SS, 2016, INT J DERMATOL, V55, P1000, DOI 10.1111/ijd.13115; Elsafti AM, 2016, DISASTER MED PUBLIC, V10, P874, DOI 10.1017/dmp.2016.165; Escobio F, 2015, LANCET, V386, P2475, DOI 10.1016/S0140-6736(15)01240-4; Gammouh OS, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140424; Guha-Sapir D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4736; Institute for Health Metrics and Evaluation, GLOBAL BURDEN OF DIS; Kassem DF, 2017, EMERG INFECT DIS, V23, P166, DOI 10.3201/eid2301.161204; Kherallah Mazen, 2012, Avicenna J Med, V2, P51; Lam E, 2015, HUM VACC IMMUNOTHER, V11, P2627, DOI 10.1080/21645515.2015.1096457; Marquardt L, 2016, TROP MED INT HEALTH, V21, P210, DOI 10.1111/tmi.12649; Mateen FJ, 2012, B WORLD HEALTH ORGAN, V90, P444, DOI 10.2471/BLT.11.097048; McKenzie ED, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0038-5; Mockenhaupt FP, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.10.30160; Moss WJ, 2006, B WORLD HEALTH ORGAN, V84, P58, DOI 10.2471/BLT.04.019570; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; Petersen E, 2013, INT J INFECT DIS, V17, pE666, DOI 10.1016/j.ijid.2013.06.001; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148196; Ratnayake Ruwan, 2014, Confl Health, V8, P7, DOI 10.1186/1752-1505-8-7; Roberts L, 2014, SCIENCE, V343, P1302, DOI 10.1126/science.343.6177.1302; Saroufim M, 2014, EMERG INFECT DIS, V20, P1712, DOI 10.3201/eid2010.140288; Sen K, 2013, INT J HEALTH PLAN M, V28, P290, DOI 10.1002/hpm.2193; Sharara SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004438; Sirin S, 2015, YOUNG CHILD IN PRESS; Tabbaa D, 2013, VET ITAL, V49, P19; The Sphere Project, 2011, SPH HDB; Touma J, 2016, CHILDREN SYRIA REPOR; UNHCR, 2014, GLANC HLTH DAT SYR R; van Berlaer G, 2016, EUR J EMERG MED; van Berlaer G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013963; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; World Health Organisation, SYR AR REP WHO STAT; World Health Organization, 2016, E MED REG FRAM HLTH; World Health Organization, 2010, INT STAT CLASS DIS H; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yaman H, 2002, SCAND J PRIM HEALTH, V20, P85, DOI 10.1080/02813430215550	58	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182770	10.1371/journal.pone.0182770	http://dx.doi.org/10.1371/journal.pone.0182770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886038	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100011
J	Andrade, AL; Afonso, ET; Minamisava, R; Bierrenbach, AL; Cristo, EB; Morais-Neto, OL; Policena, GM; Domingues, CMAS; Toscano, CM				Andrade, Ana Lucia; Afonso, Eliane T.; Minamisava, Ruth; Bierrenbach, Ana Luiza; Cristo, Elier B.; Morais-Neto, Otaliba L.; Policena, Gabriela M.; Domingues, Carla M. A. S.; Toscano, Cristiana M.			Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SYSTEMATIC ANALYSIS; NATIONAL CAUSES; LATIN-AMERICA; CHILDREN; ADMISSIONS; MORTALITY; DISEASE; SURVEILLANCE; IMMUNIZATION		[Andrade, Ana Lucia; Afonso, Eliane T.; Bierrenbach, Ana Luiza; Morais-Neto, Otaliba L.; Policena, Gabriela M.; Toscano, Cristiana M.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Afonso, Eliane T.] Univ Fed Goias, Fac Med, Goiania, Go, Brazil; [Afonso, Eliane T.] Pontifical Catholic Univ Goias, Dept Med, Goiania, Go, Brazil; [Minamisava, Ruth] Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil; [Cristo, Elier B.] Minist Hlth, Brasilia, DF, Brazil; [Domingues, Carla M. A. S.] Minist Hlth, Secretariat Hlth Surveillance, Natl Immunizat Program, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Andrade, AL (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	alssandrade@gmail.com	Toscano, Cristiana Maria/N-4019-2014; B. Cristo, Elier/L-3512-2017; Bierrenbach, Ana L/F-3185-2014	B. Cristo, Elier/0000-0003-2233-1313; Bierrenbach, Ana L/0000-0002-6837-0636; Minamisava, Ruth/0000-0001-9352-5567; TOSCANO, CRISTIANA/0000-0002-9453-2643	Ministry of Health of Brazil, National Immunization Program [01/2012]; Brazilian National Council for Scientific and Technological Development (CNPq) [313286/2014-0, 312532/2014-8]	Ministry of Health of Brazil, National Immunization Program; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This investigation was supported by the Ministry of Health of Brazil, National Immunization Program (grant #01/2012). ALA (#313286/2014-0) and CMT (#312532/2014-8) receive scientific productivity scholarships from the Brazilian National Council for Scientific and Technological Development (CNPq).	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Andrade AL, 2012, PEDIATR INFECT DIS J, V31, P1312, DOI 10.1097/INF.0b013e31826a8ee5; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brazil. DATASUS, 2016, EP MORB; Brazil. DATASUS, 2017, HLTH INF VACC COV; Brazil. DATASUS, 2015, SIGTAP SYST MAN TABL; Brazil. DATASUS, 2017, FIL TRANSF SERV; Brazil. DATASUS. BPS. Health care price database, 2016, HLTH CAR PRIC DAT; Brazil. IBGE, 2017, STAT BRAZ CENS; Brazil. IBGE, 2016, NAT IND PRIC CONS BR; Brazil. Ministry of health, 2010, NAT IMM PROGR TECHN; Brazilian Institute of Geography and Statistics-IBGE, 2013, NAT HLTH RES 2013 AC; Bruhn CAW, 2017, P NATL ACAD SCI USA, V114, P1524, DOI 10.1073/pnas.1612833114; Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; Cui YDA, 2017, HUM VACC IMMUNOTHER, V13, P1229, DOI 10.1080/21645515.2016.1277300; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Drummond MF, 2005, J MENTAL HLTH POLICY; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hortal M, 2014, PLOS ONE, P9; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Jit M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0446-9; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Menzies RI, 2015, CLIN INFECT DIS, V61, P927, DOI 10.1093/cid/civ429; Montgomery D. C., 2015, INTRO TIME SERIES AN; Morettin P., 2006, ANALISE SERIES TEMPO; Nair H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1693-x; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Nunes S, 2013, VALUE HEALTH, V16, pA724, DOI 10.1016/j.jval.2013.08.2261; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Panik, 2012, STAT INFERENCE SHORT; Poolman JT, 2013, EXPERT REV VACCINES, V12, P1379; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Sgambatti S, 2015, EPIDEMIOL INFECT, V143, P334, DOI 10.1017/S0950268814000922; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Sinha A, 2008, REV PANAM SALUD PUBL, V24, P304, DOI 10.1590/S1020-49892008001100002; Smith PJ, 2007, PEDIATRICS, V120, pE1165, DOI 10.1542/peds.2007-0037; Snedecor GW, 1980, STAT METHODS, V7th; Toscano C, 2016, 10 INT S PNEUM PNEUM; van der Putten IM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1638-0; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; World bank, 2016, THE WORLD BANK; World Health Organization, 2016, INT CLASS DIS ICD 10; Zhang S, 2016, J GLOB HEALTH, P6	50	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184204	10.1371/journal.pone.0184204	http://dx.doi.org/10.1371/journal.pone.0184204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880953	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200040
J	Berghuijs, HNC; Yin, XY; Ho, QT; Retta, MA; Verboven, P; Nicolai, BM; Struik, PC				Berghuijs, Herman N. C.; Yin, Xinyou; Ho, Q. Tri; Retta, Moges A.; Verboven, Pieter; Nicolai, Bart M.; Struik, Paul C.			Localization of (photo) respiration and CO2 re-assimilation in tomato leaves investigated with a reaction-diffusion model	PLOS ONE			English	Article							COMBINED GAS-EXCHANGE; MESOPHYLL CONDUCTANCE; CHLOROPHYLL FLUORESCENCE; PHOTORESPIRATORY CO2; ISOTOPE DISCRIMINATION; PHOTOSYNTHESIS MODEL; LEAF PHOTOSYNTHESIS; 3-DIMENSIONAL MODEL; CRITICAL-APPRAISAL; C-3 PLANTS	The rate of photosynthesis depends on the CO2 partial pressure near Rubisco, C-c, which is commonly calculated by models using the overall mesophyll resistance. Such models do not explain the difference between the CO2 level in the intercellular air space and Cc mechanistically. This problem can be overcome by reaction-diffusion models for CO2 transport, production and fixation in leaves. However, most reaction-diffusion models are complex and unattractive for procedures that require a large number of runs, like parameter optimisation. This study provides a simpler reaction-diffusion model. It is parameterized by both leaf physiological and leaf anatomical data. The anatomical data consisted of the thickness of the cell wall, cytosol and stroma, and the area ratios of mesophyll exposed to the intercellular air space to leaf surfaces and exposed chloroplast to exposed mesophyll surfaces. The model was used directly to estimate photosynthetic parameters from a subset of the measured light and CO2 response curves; the remaining data were used for validation. The model predicted light and CO2 response curves reasonably well for 15 days old tomato (cv. Admiro) leaves, if (photo) respiratory CO2 release was assumed to take place in the inner cytosol or in the gaps between the chloroplasts. The model was also used to calculate the fraction of CO2 produced by (photo) respiration that is re-assimilated in the stroma, and this fraction ranged from 56 to 76%. In future research, the model should be further validated to better understand how the re-assimilation of (photo) respired CO2 is affected by environmental conditions and physiological parameters.	[Berghuijs, Herman N. C.; Yin, Xinyou; Retta, Moges A.; Struik, Paul C.] Wageningen Univ & Res, Ctr Crop Syst Anal, Droevendaalsesteeg 1, Wageningen, Netherlands; [Berghuijs, Herman N. C.; Yin, Xinyou; Struik, Paul C.] BioSolar Cells, Wageningen, Netherlands; [Berghuijs, Herman N. C.; Ho, Q. Tri; Retta, Moges A.; Verboven, Pieter; Nicolai, Bart M.] Katholieke Univ Leuven, Flanders Ctr Postharvest Technol BIOSYST MeBioS, Willem de Croylaan 42, Leuven, Belgium	Wageningen University & Research; KU Leuven	Berghuijs, HNC (corresponding author), Wageningen Univ & Res, Ctr Crop Syst Anal, Droevendaalsesteeg 1, Wageningen, Netherlands.; Berghuijs, HNC (corresponding author), BioSolar Cells, Wageningen, Netherlands.; Berghuijs, HNC (corresponding author), Katholieke Univ Leuven, Flanders Ctr Postharvest Technol BIOSYST MeBioS, Willem de Croylaan 42, Leuven, Belgium.	herman.berghuijs@wur.nl	; Nicolai, Bart/L-6129-2013	Ho, Quang Tri/0000-0003-3766-0283; Yin, Xinyou/0000-0001-8273-8022; Nicolai, Bart/0000-0001-5267-1920; Struik, Paul/0000-0003-2196-547X; Berghuijs, Herman/0000-0002-1754-5061; Verboven, Pieter/0000-0001-9542-8285	BioSolar Cells programme (project C3B3); Research Council of the KU Leuven [C16/16/002]	BioSolar Cells programme (project C3B3); Research Council of the KU Leuven(KU Leuven)	Wageningen-based authors thank the BioSolar Cells programme (project C3B3) for financial support. Leuven-based authors thank the Research Council of the KU Leuven (project C16/16/002) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto T, 2002, PLANT CELL ENVIRON, V25, P1399, DOI 10.1046/j.0016-8025.2002.00906.x; Aalto T, 2001, BOREAL ENVIRON RES, V6, P53; Aalto T, 1999, J THEOR BIOL, V196, P115, DOI 10.1006/jtbi.1998.0820; Berghuijs HNC, 2016, PLANT SCI, V252, P62, DOI 10.1016/j.plantsci.2016.05.016; Berghuijs HNC, 2015, PLANT SCI, V238, P297, DOI 10.1016/j.plantsci.2015.06.022; Busch FA, 2013, PLANT CELL ENVIRON, V36, P200, DOI 10.1111/j.1365-3040.2012.02567.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; EVANS JR, 1994, AUST J PLANT PHYSIOL, V21, P475, DOI 10.1071/PP9940475; Fanta SW, 2012, J FOOD ENG, V108, P393, DOI 10.1016/j.jfoodeng.2011.09.010; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gielwanowska I, 2015, ARCT ANTARCT ALP RES, V47, P17, DOI 10.1657/AAAR0014-019; Gu JF, 2012, J EXP BOT, V63, P5137, DOI 10.1093/jxb/ers170; Gu LH, 2014, PLANT CELL ENVIRON, V37, P1231, DOI 10.1111/pce.12232; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Hatakeyama Y, 2016, PLANT PROD SCI, V19, P540, DOI 10.1080/1343943X.2016.1212667; Haupt-Herting S, 2001, PLANT PHYSIOL, V126, P388, DOI 10.1104/pp.126.1.388; Ho QT, 2010, J EXP BOT, V61, P2071, DOI 10.1093/jxb/erq026; Juurola E, 2005, NEW PHYTOL, V166, P205, DOI 10.1111/j.1469-8137.2004.01317.x; KOK B., 1948, ENZYMOLOGIA [HAGUE], V13, P1; KOK B, 1949, BIOCHIM BIOPHYS ACTA, V3, P625, DOI 10.1016/0006-3002(49)90136-5; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Loreto F, 1999, AUST J PLANT PHYSIOL, V26, P733, DOI 10.1071/PP99096; Moser T, 2015, PLANT CELL ENVIRON, V38, P1347, DOI 10.1111/pce.12483; Niinemets U, 2009, J EXP BOT, V60, P2271, DOI 10.1093/jxb/erp063; Nobel PS, 2009, PHYSICOCHEMICAL AND ENVIRONMENTAL PLANT PHYSIOLOGY, 4TH EDITION, P1; Pachepsky LB, 1995, J BIOGEOGR, V22, P209, DOI 10.2307/2845912; PARKHURST DF, 1977, J THEOR BIOL, V67, P471, DOI 10.1016/0022-5193(77)90050-9; PARKHURST DF, 1990, PLANT PHYSIOL, V94, P1024, DOI 10.1104/pp.94.3.1024; Parnik T, 2007, PHYSIOL PLANTARUM, V129, P34, DOI 10.1111/j.1399-3054.2006.00824.x; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Ho QT, 2016, PLANT CELL ENVIRON, V39, P50, DOI 10.1111/pce.12590; Ho QT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048376; Retta M, 2016, PLANT SCI, V246, P37, DOI 10.1016/j.plantsci.2016.02.003; Sage TL, 2009, PLANT CELL PHYSIOL, V50, P756, DOI 10.1093/pcp/pcp033; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; THAIN JF, 1983, J EXP BOT, V34, P87, DOI 10.1093/jxb/34.1.87; Tholen D, 2014, PLANT CELL ENVIRON, V37, P2456, DOI 10.1111/pce.12401; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; Tholen D, 2011, PLANT PHYSIOL, V156, P90, DOI 10.1104/pp.111.172346; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Tosens T, 2012, J EXP BOT, V63, P5105, DOI 10.1093/jxb/ers171; Van Riel N, MATLAB IMPLEMENTATIO; Vesala T, 1996, NEW PHYTOL, V132, P235, DOI 10.1111/j.1469-8137.1996.tb01843.x; von Caemmerer S, 2013, PLANT CELL ENVIRON, V36, P1617, DOI 10.1111/pce.12098; Walker BJ, 2016, PLANT CELL ENVIRON, V39, P1198, DOI 10.1111/pce.12722; Watte R, 2015, OPT EXPRESS, V23, P17467, DOI 10.1364/OE.23.017467; Yin XY, 2017, PHOTOSYNTH RES, V132, P211, DOI 10.1007/s11120-017-0340-8; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038; Yin XY, 2009, PLANT CELL ENVIRON, V32, P1513, DOI 10.1111/j.1365-3040.2009.02016.x; Yin XY, 2009, PLANT CELL ENVIRON, V32, P448, DOI 10.1111/j.1365-3040.2009.01934.x	58	11	11	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183746	10.1371/journal.pone.0183746	http://dx.doi.org/10.1371/journal.pone.0183746			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880924	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200024
J	Couvineau, P; de Almeida, H; Maigret, B; Llorens-Cortes, C; Iturrioz, X				Couvineau, Pierre; de Almeida, Hugo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier			Involvement of arginine 878 together with Ca2+ in mouse aminopeptidase A substrate specificity for N-terminal acidic amino-acid residues	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; EXOPEPTIDASE SPECIFICITY; CATALYTIC-ACTIVITY; RAT-BRAIN; INHIBITORS; IDENTIFICATION; CALCIUM; PURIFICATION; HYPERTENSION; CONTRIBUTES	Aminopeptidase A (APA) is a membrane-bound zinc metalloprotease cleaving, in the brain, the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the control of blood pressure in hypertensive animals. Using a refined APA structure derived from the human APA crystal structure, we docked the specific and selective APA inhibitor, EC33 in the presence of Ca2+. We report the presence in the S1 subsite of Arg-887 (Arg-878 in mouse APA), the guanidinium moiety of which established an interaction with the electronegative sulfonate group of EC33. Mutagenic replacement of Arg-878 with an alanine or a lysine residue decreased the affinity of the recombinant enzymes for the acidic substrate, alpha-L-glutamyl-beta-naphthylamide, with a slight decrease in substrate hydrolysis velocity either with or without Ca2+. In the absence of Ca2+, the mutations modified the substrate specificity of APA for the acidic substrate, the mutated enzymes hydrolyzing more efficiently basic and neutral substrates, although the addition of Ca2+ partially restored the acidic substrate specificity. The analysis of the 3D models of the Arg-878 mutated APAs revealed a change in the volume of the S1 subsite, which may impair the binding and/or the optimal positioning of the substrate in the active site as well as its hydrolysis. These findings demonstrate the key role of Arg-878 together with Ca2+ in APA substrate specificity for N-terminal acidic amino acid residues by ensuring the optimal positioning of acidic substrates during catalysis.	[Couvineau, Pierre; de Almeida, Hugo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier] INSERM, U1050, Lab Cent Neuropeptides Regulat Body Fluid Homeost, Paris, France; [Couvineau, Pierre; de Almeida, Hugo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier] Coll France, CIRB, Paris, France; [Couvineau, Pierre; de Almeida, Hugo; Maigret, Bernard; Llorens-Cortes, Catherine; Iturrioz, Xavier] CNRS, UMR 7241, Paris, France; [Maigret, Bernard] Lab Lorrain Rech Informat & Ses Applicat LORIA, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Llorens-Cortes, C; Iturrioz, X (corresponding author), INSERM, U1050, Lab Cent Neuropeptides Regulat Body Fluid Homeost, Paris, France.; Llorens-Cortes, C; Iturrioz, X (corresponding author), Coll France, CIRB, Paris, France.; Llorens-Cortes, C; Iturrioz, X (corresponding author), CNRS, UMR 7241, Paris, France.	c.llorens-cortes@college-de-france.fr; xavier.iturrioz@college-de-france.fr	Llorens-Cortès, catherine/AAL-3893-2021; Iturrioz, Xavier/AAS-3555-2020; Llorens-Cortes, Catherine/E-5839-2016; ITURRIOZ, Xavier/Q-4406-2017	Llorens-Cortès, catherine/0000-0002-7667-0401; Iturrioz, Xavier/0000-0001-7143-8323; Llorens-Cortes, Catherine/0000-0002-7667-0401; ITURRIOZ, Xavier/0000-0001-7143-8323; de Almeida Silva, Hugo/0000-0003-3773-3251; Couvineau, Pierre/0000-0002-4905-7740	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; College de France; Agence Nationale pour la Recherche RPIB; LabCom; Labex MemoLife (Paris Sciences et Lettres); NC3Rs CRACK IT Scheme	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); College de France; Agence Nationale pour la Recherche RPIB(French National Research Agency (ANR)); LabCom; Labex MemoLife (Paris Sciences et Lettres); NC3Rs CRACK IT Scheme(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the College de France. P. C. and H. D. A. were supported by fellowships from the Agence Nationale pour la Recherche RPIB and LabCom. P.C. has been also supported by a fellowship from Labex MemoLife (Paris Sciences et Lettres). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by the NC3Rs CRACK IT Scheme. Emma O'Callaghan, Ben Allison and David Craig of Actual Analytics contributed to the successful development of this technology. We would like to thank Heiden Bliss and Anthony Carson of BioMark for their assistance in developing the system described here. We thank Chris Pollard and Mark Pilling for helpful comments on the manuscript. We would also like to acknowledge the contribution of various colleagues in Laboratory Animal Sciences (LAS) at AstraZeneca. This publication is dedicated to the memory of Liz Beard (LAS, AstraZeneca), who played a small but crucial role during the early phase of this project.	Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bodineau L, 2008, HYPERTENSION, V51, P1318, DOI 10.1161/HYPERTENSIONAHA.107.098772; CHAUVEL EN, 1994, J MED CHEM, V37, P2950, DOI 10.1021/jm00044a016; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; Claperon C, 2009, J BIOL CHEM, V284, P10618, DOI 10.1074/jbc.M806783200; DANIELSEN EM, 1980, BIOCHEM J, V189, P591, DOI 10.1042/bj1890591; FERACCI H, 1981, BIOCHIM BIOPHYS ACTA, V658, P148, DOI 10.1016/0005-2744(81)90258-8; Ferreira AJ, 2008, HYPERTENSION, V51, P1273, DOI 10.1161/HYPERTENSIONAHA.107.109561; Fournie-Zaluski MC, 2004, P NATL ACAD SCI USA, V101, P7775, DOI 10.1073/pnas.0402312101; Gao J, 2014, CLIN SCI, V127, P135, DOI 10.1042/CS20130396; GLENNER GG, 1962, NATURE, V194, P867, DOI 10.1038/194867a0; Goto Y, 2007, J BIOL CHEM, V282, P37074, DOI 10.1074/jbc.M707251200; HEALY DP, 1993, BRAIN RES, V606, P295, DOI 10.1016/0006-8993(93)90997-2; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2004, PROTEAS BIOL DIS, P229; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES HC, 1988, J PHYSIOL-LONDON, V402, P579, DOI 10.1113/jphysiol.1988.sp017223; LALU K, 1986, BIOCHIM BIOPHYS ACTA, V873, P190, DOI 10.1016/0167-4838(86)90045-2; LEJCZAK B, 1993, J ENZYM INHIB, V7, P97, DOI 10.3109/14756369309040752; LOJDA Z, 1980, HISTOCHEMISTRY, V67, P267, DOI 10.1007/BF00692761; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marc Y, 2012, HYPERTENSION, V60, P411, DOI 10.1161/HYPERTENSIONAHA.112.190942; NAGATSU I, 1970, BIOCHIM BIOPHYS ACTA, V198, P255, DOI 10.1016/0005-2744(70)90058-6; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; ROBERTSON WG, 1981, CRC CR REV CL LAB SC, V15, P85, DOI 10.3109/10408368109105869; Rozenfeld R, 2004, J BIOL CHEM, V279, P43285, DOI 10.1074/jbc.M404369200; Rozenfeld R, 2002, J BIOL CHEM, V277, P29242, DOI 10.1074/jbc.M204406200; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Yang Y, 2013, J BIOL CHEM, V288, P25638, DOI 10.1074/jbc.M113.494955; Zini S, 1997, NEUROSCIENCE, V78, P1187, DOI 10.1016/S0306-4522(96)00660-4; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	37	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184237	10.1371/journal.pone.0184237	http://dx.doi.org/10.1371/journal.pone.0184237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877217	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200077
J	Wang, YH; Hsiao, YW; Lee, KH; Tseng, HY; Lin, YP; Komaki, S; Lin, SM				Wang, Ying-Han; Hsiao, Yu-Wei; Lee, Ko-Huan; Tseng, Hui-Yun; Lin, Yen-Po; Komaki, Shohei; Lin, Si-Min			Acoustic differentiation and behavioral response reveals cryptic species within Buergeria treefrogs (Anura, Rhacophoridae) from Taiwan	PLOS ONE			English	Article							SEXUAL SELECTION; CHARACTER DISPLACEMENT; INTEGRATIVE TAXONOMY; THERMAL TOLERANCE; MICROHYLA-ORNATA; SPECIATION; AMPHIBIA; COMPETITION; RANIDAE; FROGS	Buergeria japonica is a widely distributed treefrog occurring from Ryukyu Archipelago to Taiwan. Across this wide distributional range, we combined molecular, acoustic, morphological, and behavioral characters to clarify the taxonomic status among these insular populations. Genetic differentiation in mitochondrial sequences indicated an over 16% divergence among two deeply divergent clades: Japanese clade distributes in Ryukyu Archipelago and northwestern drainages of Taiwan, while Taiwanese clade distributes in the remaining drainages on Taiwan. The Taiwanese clade can be distinguished from the nominative species not only by molecular and morphological differences, but also distinguishable by considerable acoustic differentiation, which is extraordinarily noticeable for an additional type of long call that never recorded from Japanese clade. The two clades form a parapatric distribution pattern with narrow contact zones both in western and eastern Taiwan. Playback experiments indicated that male frogs show significantly stronger defensiveness against conspecific calls rather than heterospecific calls, indicating that these signals play a crucial role in species recognition. Here we describe the Taiwanese clade as a new species; the behavioral response and the magnitude of gene flow across their contact zones are especially worth for detailed studies.	[Wang, Ying-Han; Hsiao, Yu-Wei; Lee, Ko-Huan; Lin, Si-Min] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Wang, Ying-Han] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan; [Tseng, Hui-Yun] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Lin, Yen-Po] Taiwan Endem Species Res Inst, Div Zool, Nantou, Taiwan; [Komaki, Shohei] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Div Dev Sci, Hiroshima, Japan; [Komaki, Shohei] Hiroshima Univ, Global Career Design Ctr, Hiroshima, Japan	National Taiwan Normal University; National Taiwan University; Hiroshima University; Hiroshima University	Lin, SM (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.; Komaki, S (corresponding author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, Div Dev Sci, Hiroshima, Japan.; Komaki, S (corresponding author), Hiroshima Univ, Global Career Design Ctr, Hiroshima, Japan.	cynops00pyrrhogaster@gmail.com; lizard.dna@gmail.com	Lee, Ko-Huan/AAQ-5309-2021	Lee, Ko-Huan/0000-0001-5577-8619; Lin, Si-Min/0000-0001-7080-706X	Japan Society for the Promotion of Science (JSPS) [25-5065]; Ministry of Science and Technology, Taiwan [MOST 105-2621-B-003-001-MY3, MOST 105-2621-B-003-002-MY3]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This international collaboration was supported by the grant from Japan Society for the Promotion of Science (JSPS) given to S. Komaki (Grant-in-Aid for JSPS Fellows No. 25-5065), and by Ministry of Science and Technology, Taiwan given to S.-M. Lin (MOST 105-2621-B-003-001-MY3 and MOST 105-2621-B-003-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Wen-Hao Chou, the deputy director of NMNS, who encouraged us to accomplish his early interests on Buergeria frogs. We also appreciate Dr. Takeshi Igawa and Dr. Masayuki Sumida for their long term collaborations on relevant issues. Y.-H. Wang wants to deliver her special thanks to Dr. Yu-Teh Kirk Lin for his kind support on this research; and we thank all the lab members from National Taiwan Normal University and National Taiwan University for their assists. This international collaboration was supported by the grant from Japan Society for the Promotion of Science (JSPS) given to S. Komaki (Grant-in-Aid for JSPS Fellows No. 25-5065), and by Ministry of Science and Technology, Taiwan given to S.-M. Lin (MOST 105-2621-B-003-001-MY3 and MOST 105-2621-B-003-002-MY3).	Albert AYK, 2007, BIOL J LINN SOC, V91, P37, DOI 10.1111/j.1095-8312.2007.00777.x; Alstrom Per, 2008, Zoological Journal of the Linnean Society, V154, P291, DOI 10.1111/j.1096-3642.2008.00418.x; [Anonymous], 1985, SPECIES SPECIATION; ARTHUR W, 1982, ADV ECOL RES, V12, P127, DOI 10.1016/S0065-2504(08)60078-1; Bee MA, 2010, ETHOLOGY, V116, P564, DOI 10.1111/j.1439-0310.2010.01773.x; Biju SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145727; Chen TC, 2001, ZOOL SCI, V18, P591, DOI 10.2108/zsj.18.591; Delorme Magali, 2005, Bulletin Mensuel de la Societe Linneenne de Lyon, V74, P165; Domingos FMCB, 2017, MOL PHYLOGENET EVOL, V107, P455, DOI 10.1016/j.ympev.2016.12.009; Frost D.R., 2017, AMPHIBIAN SPECIES WO; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallowell E., 1861, P ACAD NAT SCI PHILA, V12, P480; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Jang-Liaw NH, 2008, ZOOL SCI, V25, P68, DOI 10.2108/zsj.25.68; Jang-Liaw NH, 2009, ZOOL SCI, V26, P608, DOI 10.2108/zsj.26.608; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Komaki S, 2017, J BIOGEOGRAPHY; Komaki S, 2016, HERPETOL J, V26, P207; Kuramoto Mitsuru, 2006, Current Herpetology, V25, P15, DOI 10.3105/1345-5834(2006)25[15:MAACOM]2.0.CO;2; Lin HD, 2012, MOL PHYLOGENET EVOL, V62, P251, DOI 10.1016/j.ympev.2011.09.022; MATSUI M, 1994, ZOOL J LINN SOC-LOND, V111, P385, DOI 10.1111/j.1096-3642.1994.tb01489.x; Matsui M., 1984, MORPHOMETRIC VARIATI, V26, P208; Matsui M, 2005, ZOOL SCI, V22, P489, DOI 10.2108/zsj.22.489; Matsui M, 2013, ZOOTAXA, V3670, P579, DOI 10.11646/zootaxa.3670.4.9; Matsui Masafumi, 2011, Zootaxa, V2814, P33; Myers CW, 1982, NEW SPECIES HYLA CER; Oseen KL, 2002, OECOLOGIA, V133, P616, DOI 10.1007/s00442-002-1067-5; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Ota H., 2000, TROPICS, V10, P51, DOI [10.3759/tropics.10.51, DOI 10.3759/TROPICS.10.51]; OTA H, 1999, TROPICAL ISLAND HERP; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Paterson H.E.H., 1993, EVOLUTION RECOGNITIO; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poyarkov NA, 2015, RUSS J HERPETOL, V22, P241; Poyarkov NA, 2014, RUSS J HERPETOL, V21, P89; Rambaut A., 2009, TRACER MCMC TRACE AN; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Savage JM, 1967, STUDIES NEOTROPICAL, V5, P111; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Tominaga A, 2015, ZOOL SCI, V32, P240, DOI 10.2108/zs140227; Ultsch GR, 1999, TADPOLES, P189; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wilkinson Jeffery A., 2000, Contemporary Herpetology, V2000, pUnpaginated; Wu CS, 2005, HERPETOLOGICA, V61, P35, DOI 10.1655/04-50	50	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184005	10.1371/journal.pone.0184005	http://dx.doi.org/10.1371/journal.pone.0184005			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877201	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200053
J	Andreatos, N; Grigoras, C; Shehadeh, F; Pliakos, EE; Stoukides, G; Port, J; Flokas, ME; Mylonakis, E				Andreatos, Nikolaos; Grigoras, Christos; Shehadeh, Fadi; Pliakos, Elina Eleftheria; Stoukides, Georgianna; Port, Jenna; Flokas, Myrto Eleni; Mylonakis, Eleftherios			The impact of HIV infection and socioeconomic factors on the incidence of gonorrhea: A county-level, US-wide analysis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SOUTHEASTERN UNITED-STATES; IMMUNODEFICIENCY-VIRUS; PREEXPOSURE PROPHYLAXIS; EPIDEMIOLOGIC SYNERGY; SEX; POVERTY; RATES; MEN; RECOMMENDATIONS	Background Gonorrhea is the second most commonly reported identifiable disease in the United States (U.S.). Importantly, more than 25% of gonorrheal infections demonstrate antibiotic resistance, leading the Centers for Disease Control and Prevention (CDC) to classify gonorrhea as an "urgent threat". Methods We examined the association of gonorrhea infection rates with the incidence of HIV and socioeconomic factors. A county-level multivariable model was then constructed. Results Multivariable analysis demonstrated that HIV incidence [Coefficient (Coeff): 1.26, 95% Confidence Interval (CI): 0.86, 1.66, P<0.001] exhibited the most powerful independent association with the incidence of gonorrhea and predicted 40% of the observed variation in gonorrhea infection rates. Sociodemographic factors like county urban ranking (Coeff: 0.12, 95% CI: 0.03, 0.20, P = 0.005), percentage of women (Coeff: 0.41, 95% CI: 0.28, 0.53, P<0.001) and percentage of individuals under the poverty line (Coeff: 0.45, 95% CI: 0.32, 0.57, P<0.001) exerted a secondary impact. A regression model that incorporated these variables predicted 56% of the observed variation in gonorrhea incidence (Pmodel<0.001, R-2 model = 0.56). Conclusions Gonorrhea and HIV infection exhibited a powerful correlation thus emphasizing the benefits of comprehensive screening for sexually transmitted infections (STIs) and the value of pre-exposure prophylaxis for HIV among patients visiting an STI clinic. Furthermore, sociodemographic factors also impacted gonorrhea incidence, thus suggesting another possible focus for public health initiatives.	[Andreatos, Nikolaos; Grigoras, Christos; Shehadeh, Fadi; Pliakos, Elina Eleftheria; Stoukides, Georgianna; Port, Jenna; Flokas, Myrto Eleni; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02903 USA.	emylonakis@lifespan.org	Pliakos, Elina/L-2322-2019; Andreatos, Nikolaos/P-2304-2019	Pliakos, Elina/0000-0003-3345-2655; Shehadeh, Fadi/0000-0002-9552-4004; , Jenna/0000-0003-2729-5446; Mylonakis, Eleftherios/0000-0002-4624-0777				Adekeye OA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161560; Barbee LA, 2015, SEX TRANSM DIS, V42, P590, DOI 10.1097/OLQ.0000000000000320; Cattley C., 2015, ADV INFECT DIS, V5, DOI [10.4236/aid.2015.54020, DOI 10.4236/AID.2015.54020]; Centers for Disease Control and Prevention (CDC), ANT RES THREAT LEV; Centers for Disease Control and Prevention (CDC), NCHHSTP ATL; Centers for Disease Control and Prevention (CDC), 2015, SEX TRANSM DIS SURV; Cerda M, 2010, EPIDEMIOLOGY, V21, P482, DOI 10.1097/EDE.0b013e3181e13539; Da Belsley K E, 2005, REGRESSION DIAGNOSTI, P85; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Devoe JE, 2007, ANN FAM MED, V5, P511, DOI 10.1370/afm.748; Du P, 2009, SEX TRANSM DIS, V36, P430, DOI 10.1097/OLQ.0b013e31819b8c2f; ESRI, ARCGIS; Farley TA, 2006, SEX TRANSM DIS, V33, pS58, DOI 10.1097/01.olq.0000175378.20009.5a; Ferguson HB, 2007, PAED CHILD HEALT-CAN, V12, P701, DOI 10.1093/pch/12.8.701; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Goyal MK, 2014, J PEDIATR-US, V165, P343, DOI 10.1016/j.jpeds.2014.04.009; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Gullette DL, 2009, J COMMUN HEALTH NURS, V26, P121, DOI 10.1080/07370010903034425; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Hanson J, 2005, ANN EPIDEMIOL, V15, P13, DOI 10.1016/j.annepidem.2004.05.001; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Holtgrave D, 2007, CLIN INFECT DIS, V45, pS240, DOI 10.1086/522544; Kirkcaldy RD, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6507a1; Krieger N, 2000, INT J HEALTH SERV, V30, P211, DOI 10.2190/672J-1PPF-K6QT-9N7U; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lutz AR, 2015, LGBT HEALTH, V2, P27, DOI 10.1089/lgbt.2014.0056; Marrazzo JM, 2014, JAMA-J AM MED ASSOC, V312, P390, DOI 10.1001/jama.2014.7999; McCarthy B, 2014, ARCH SEX BEHAV, V43, P1379, DOI 10.1007/s10508-014-0281-7; Ng BE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001220.pub3; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; RICE RJ, 1991, AM J PUBLIC HEALTH, V81, P1252, DOI 10.2105/AJPH.81.10.1252; ROTHENBERG RB, 1983, AM J EPIDEMIOL, V117, P688, DOI 10.1093/oxfordjournals.aje.a113602; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schackman BR, 2015, MED CARE, V53, P293, DOI 10.1097/MLR.0000000000000308; See I, 2017, CLIN INFECT DIS, V64, P597, DOI 10.1093/cid/ciw808; Solomon MM, 2014, CLIN INFECT DIS, V59, P1020, DOI 10.1093/cid/ciu450; Springer YP, 2010, AM J PUBLIC HEALTH, V100, P1060, DOI 10.2105/AJPH.2009.172965; Stillwaggon E, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19844; Taylor MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002328; Thomas JC, 1996, AM J EPIDEMIOL, V143, P269, DOI 10.1093/oxfordjournals.aje.a008738; Thomas JC, 2003, ETHNIC DIS, V13, P362; U.S. Preventive Services Task Force, 2014, ANN INTERN MED, V161, P1; US Census Bureau, US 1 YEAR 3 YEAR 5 Y; Valdez A, 2007, AM J DRUG ALCOHOL AB, V33, P595, DOI 10.1080/00952990701407637; Walker CK, 2011, INT J WOMENS HEALTH, V3, P197, DOI 10.2147/IJWH.S13427; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001	49	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183938	10.1371/journal.pone.0183938	http://dx.doi.org/10.1371/journal.pone.0183938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF3ON	28863154	gold, Green Published, Green Submitted			2022-12-26	WOS:000408816900013
J	Lam, C; Chen, PL; Kang, JH; Cheng, KF; Chen, RJ; Hung, KS				Lam, Carlos; Chen, Ping-Ling; Kang, Jiunn-Horng; Cheng, Kuang-Fu; Chen, Ray-Jade; Hung, Kuo-Sheng			Risk factors for 14-day rehospitalization following trauma with new traumatic spinal cord injury diagnosis: A 10-year nationwide study in Taiwan	PLOS ONE			English	Article							CERVICAL-SPINE; BLUNT TRAUMA; NEUROLOGICAL DETERIORATION; ASSOCIATION; SURGERY; MANAGEMENT; INSTABILITY; CLEARANCE; SECONDARY; ETIOLOGY	Objectives Fourteen-day rehospitalization with new traumatic spinal cord injury (tSCI) diagnosis is used as an indicator for the diagnostic quality of the first hospitalization. In this nationwide population-based cohort study, we identified risk factors for this indicator. Methods We conducted a nested case-control study by using the data of patients who received a first hospitalization for trauma between 2001 and 2011. The data were retrieved from Taiwan's National Health Insurance Research Database. Variables including demographic and trauma characteristics were compared between patients diagnosed with tSCI at the first hospitalization and those receiving a 14-day rehospitalization with new tSCI diagnosis. Results Of the 23 617 tSCI patients, 997 had 14-day rehospitalization with new tSCI diagnosis (incidence rate, 4.22%). The risk of 14-day rehospitalization with new tSCI diagnosis was significantly lower in patients with severe (injury severity score [ISS] = 16-24; odds ratio [OR], 0.17; 95% confidence interval [CI], 0.13-0.21) and profound (ISS > 24; OR, 0.11; 95% CI, 0.07-0.18) injuries. Interhospital transfer (OR, 8.20; 95% CI, 6.48-10.38) was a significant risk factor, along with injuries at the thoracic (OR, 1.62; 95% CI, 1.21-2.18), lumbar (OR, 1.30; 95% CI, 1.02-1.65), and multiple (OR, 3.23; 95% CI, 1.86-5.61) levels. Brain (OR, 2.82), chest (OR, 2.99), and abdominal (OR, 2.74) injuries were also identified as risk factors. In addition, the risk was higher in patients treated at the orthopedic department (OR, 2.26; 95% CI, 1.78-2.87) and those of other surgical disciplines (OR, 1.89; 95% CI, 1.57-2.28) than in those treated at the neurosurgery department. Conclusions Delayed tSCI diagnoses are not uncommon, particularly among trauma patients with ISSs < 16 or those who are transferred from lower-level hospitals. Further validation and implementation of evidence-based decision rules is essential for improving the diagnostic quality of traumatic thoracolumbar SCI.	[Lam, Carlos] Taipei Med Univ, Wan Fang Hosp, Dept Emergency & Crit Care Med, Emergency Dept, Taipei, Taiwan; [Lam, Carlos; Chen, Ping-Ling; Hung, Kuo-Sheng] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lam, Carlos] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Cheng, Kuang-Fu] Taipei Med Univ, Coll Management, Biostat Ctr, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ, Sch Med, Dept Surg, Coll Med, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Hung, KS (corresponding author), Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan.; Chen, RJ (corresponding author), Taipei Med Univ, Sch Med, Dept Surg, Coll Med, Taipei, Taiwan.; Chen, RJ (corresponding author), Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Hung, KS (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan.	rayjchen@tmu.edu.tw; kshung25@gmail.com	Chen, Ray/GRJ-6736-2022	Lam, Carlos/0000-0002-8051-7485	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan [E1020766]	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan	This research was supported by grants from the Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan (Grant number E1020766). PLC received the funding. The funder's website is http://www.hpa.gov.tw/Bhpnet/Web/Index/Index.aspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 1996, ACAD EMERG MED, V3, P832, DOI 10.1111/j.1553-2712.1996.tb03527.x; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; BICKNELL JM, 1992, AM J EMERG MED, V10, P336, DOI 10.1016/0735-6757(92)90015-P; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; Cason B, 2016, J TRAUMA ACUTE CARE, V80, P125, DOI 10.1097/TA.0000000000000884; Cirera E, 2014, INJURY PREV, V20, P401, DOI 10.1136/injuryprev-2014-041199; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; Delfini R, 1999, SURG NEUROL, V51, P588, DOI 10.1016/S0090-3019(99)00020-8; Diaz JJ, 2007, J TRAUMA, V63, P709, DOI 10.1097/TA.0b013e318142d2db; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Flabouris A, 2001, INJURY, V32, P569, DOI 10.1016/S0020-1383(01)00071-7; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Grossman MD, 1999, J TRAUMA, V47, P684, DOI 10.1097/00005373-199910000-00012; Harris JH, 2002, J TRAUMA, V53, P392, DOI 10.1097/00005373-200208000-00041; Hicks CW, 2014, JAMA SURG, V149, P642, DOI 10.1001/jamasurg.2014.166; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Inaba K, 2015, J TRAUMA ACUTE CARE, V78, P459, DOI 10.1097/TA.0000000000000560; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lekovic GP, 2007, NEUROSURGERY, V60, P516, DOI 10.1227/01.NEU.0000255337.80285.39; Levi AD, 2006, SPINE, V31, P451, DOI 10.1097/01.brs.0000199927.78531.b5; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; McCormack RA, 2012, SPINE, V37, P1260, DOI 10.1097/BRS.0b013e318245f561; Middleton PM, 2012, INJURY, V43, P480, DOI 10.1016/j.injury.2011.12.010; Nance ML., NATL TRAUMA DATA BAN; National Health Insurance Administration Ministry of Health and Welfare, HEALTHC QUAL IND GLO; National Health Insurance Administration Ministry of Health and Welfare, NHIA ORG CHART; O'Connor E, 2009, EMERG MED AUSTRALAS, V21, P94, DOI 10.1111/j.1742-6723.2009.01164.x; Poonnoose PM, 2002, J TRAUMA, V53, P314, DOI 10.1097/00005373-200208000-00021; Quigley RS, 2015, SPINE, V40, P851, DOI 10.1097/BRS.0000000000000878; RAVICHANDRAN G, 1982, BRIT MED J, V284, P953, DOI 10.1136/bmj.284.6320.953; REID DC, 1987, J TRAUMA, V27, P980, DOI 10.1097/00005373-198709000-00005; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; SCHNEIDER RC, 1954, J NEUROSURG, V11, P546, DOI 10.3171/jns.1954.11.6.0546; Sears JM, 2014, INJURY, V45, P16, DOI 10.1016/j.injury.2012.12.024; Shah VM, 2007, SPINE, V32, pE168, DOI 10.1097/01.brs.0000257355.27053.4c; Sixta S, 2012, J TRAUMA ACUTE CARE, V73, pS326, DOI 10.1097/TA.0b013e31827559b8; Stein DM, 2012, NEUROCRIT CARE, V17, P102, DOI 10.1007/s12028-012-9759-0; Stephan K, 2015, SPINE J, V15, P1994, DOI 10.1016/j.spinee.2015.04.041; Todd NV, 2015, BONE JOINT J, V97B, P527, DOI 10.1302/0301-620X.97B4.34328; TOSCANO J, 1988, PARAPLEGIA, V26, P143, DOI 10.1038/sc.1988.23; Wu JC, 2012, J NEUROTRAUM, V29, P889, DOI 10.1089/neu.2011.1777; Yang NP, 2008, INJURY, V39, P443, DOI 10.1016/j.injury.2007.12.007; Yang TY, 2015, SPINE, V40, P147, DOI 10.1097/BRS.0000000000000704	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184253	10.1371/journal.pone.0184253	http://dx.doi.org/10.1371/journal.pone.0184253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863195	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900043
J	Shier, MK; Iles, JC; El-Wetidy, MS; Ali, HH; Al Qattan, MM				Shier, Medhat K.; Iles, James C.; El-Wetidy, Mohammad S.; Ali, Hebatallah H.; Al Qattan, Mohammad M.			Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; GENETIC DIVERSITY; GENOTYPE 4; HCV; NS5B; SUBTYPES; CLASSIFICATION; IDENTIFICATION; POLYMORPHISMS	The source of HCV transmission in Saudi Arabia is unknown. This study aimed to determine HCV genotypes in a representative sample of chronically infected patients in Saudi Arabia. All HCV isolates were genotyped and subtyped by sequencing of the HCV core region and 54 new HCV isolates were identified. Three sets of primers targeting the core region were used for both amplification and sequencing of all isolates resulting in a 326 bp fragment. Most HCV isolates were genotype 4 (85%), whereas only a few isolates were recognized as genotype 1 (15%). With the assistance of Genbank database and BLAST, subtyping results showed that most of genotype 4 isolates were 4d whereas most of genotype 1 isolates were 1b. Nucleotide conservation and variation rates of HCV core sequences showed that 4a and 1b have the highest levels of variation. Phylogenetic analysis of sequences by Maximum Likelihood and Bayesian Coalescent methods was used to explore the source of HCV transmission by investigating the relationship between Saudi Arabia and other countries in the Middle East and Africa. Coalescent analysis showed that transmissions of HCV from Egypt to Saudi Arabia are estimated to have occurred in three major clusters: 4d was introduced into the country before 1900, the major 4a clade's MRCA was introduced between 1900 and 1920, and the remaining lineages were introduced between 1940 and 1960 from Egypt and Middle Africa. Results showed that no lineages seem to have crossed from Egypt to Saudi Arabia in the last 15 years. Finally, sequencing and characterization of new HCV isolates from Saudi Arabia will enrich the HCV database and help further studies related to treatment and management of the virus.	[Shier, Medhat K.; El-Wetidy, Mohammad S.; Ali, Hebatallah H.; Al Qattan, Mohammad M.] King Saud Univ, Coll Med, Res Ctr, Riyadh, Saudi Arabia; [Shier, Medhat K.] Menoufia Univ, Dept Med Microbiol & Immunol, Coll Med, Menoufia, Egypt; [Iles, James C.] Imperial Coll, Sch Publ Hlth, Fac Med, London, England; [Al Qattan, Mohammad M.] King Saud Univ, Dept Surg, Coll Med, Riyadh, Saudi Arabia	King Saud University; Egyptian Knowledge Bank (EKB); Menofia University; Imperial College London; King Saud University	Shier, MK (corresponding author), King Saud Univ, Coll Med, Res Ctr, Riyadh, Saudi Arabia.; Shier, MK (corresponding author), Menoufia Univ, Dept Med Microbiol & Immunol, Coll Med, Menoufia, Egypt.	mshier3@gmail.com	El-Wetidy, mohammad/O-2210-2015	El-Wetidy, Mohammad/0000-0003-2725-4708				Abdel-Moneim AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029781; Al Ashgar HI, 2013, SAUDI J GASTROENTERO, V19, P28, DOI 10.4103/1319-3767.105920; Al Traif I, 2013, ANN SAUDI MED, V33, P10, DOI 10.5144/0256-4947.2013.10; Albenmousa A, 2016, J INFECT DIS THER, V4, P266; AlFaleh FZ, 1997, ANN SAUDI MED, V17, P77, DOI 10.5144/0256-4947.1997.77; Alhamlan FS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-91; Aljumah AA, 2016, SAUDI J GASTROENTERO, V22, P269, DOI 10.4103/1319-3767.187609; Beaulieu Pierre L, 2004, Curr Opin Investig Drugs, V5, P838; Benedet M, 2014, J CLIN VIROL, V60, P301, DOI 10.1016/j.jcv.2014.04.005; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cai QX, 2013, INT J MOL MED, V31, P347, DOI 10.3892/ijmm.2012.1209; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Chen Y, 2012, ALIMENT PHARM THER, V36, P91, DOI 10.1111/j.1365-2036.2012.05131.x; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Di Maio VC, 2014, ANTIMICROB AGENTS CH, V58, P2781, DOI 10.1128/AAC.02386-13; Domingo Esteban, 1994, P161; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EL Hadad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178225; Fakeeh M, 1999, AM J TROP MED HYG, V61, P889, DOI 10.4269/ajtmh.1999.61.889; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gotte M, 2012, CURR OPIN VIROL, V2, P644, DOI 10.1016/j.coviro.2012.08.004; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Gonzalez-Horta EE, 2011, EUR REV MED PHARMACO, V15, P1320; Hathorn E, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000112; Hogan CA, 2016, J INFECT DIS; Iles JC, 2014, VIROLOGY, V464, P233, DOI 10.1016/j.virol.2014.07.006; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kanwal S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-171; Khan A, 2017, INFECT GENET EVOL, V52, P82, DOI 10.1016/j.meegid.2017.04.024; Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lamoury FMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131437; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Le Guillou-Guillemette H, 2007, WORLD J GASTROENTERO, V13, P2416, DOI 10.3748/wjg.v13.i17.2416; McCormick AL, 2015, J CLIN VIROL, V66, P56, DOI 10.1016/j.jcv.2015.03.006; Nagarapu R, 2013, INT J ADV RES, V1, P439; Ndong-Atome GR, 2009, J CLIN VIROL, V45, P349, DOI 10.1016/j.jcv.2009.04.017; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; Nigel T., 1991, IRANIAN J HLTH; Osoba AO, 2000, ANN SAUDI MED, V20, P394, DOI 10.5144/0256-4947.2000.394; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Pollicita M, 2013, J VIROL METHODS, V193, P205, DOI 10.1016/j.jviromet.2013.06.002; Polyak SJ, 2006, HEPATITIS C VIRUSES; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Rose R, 2013, INFECT GENET EVOL, V20, P418, DOI 10.1016/j.meegid.2013.09.029; Shier MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103160; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Svicher V, 2011, DIGEST LIVER DIS, V43, P975, DOI 10.1016/j.dld.2011.07.002; Tamalet C, 2003, J MED VIROL, V71, P391, DOI 10.1002/jmv.10505; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; *WHO, 2000, HEP C; Wu Jim Zhen, 2003, Current Drug Targets - Infectious Disorders, V3, P207, DOI 10.2174/1568005033481114; Zwickl D. J, 2006, GENETIC ALGORITHM AP	59	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184163	10.1371/journal.pone.0184163	http://dx.doi.org/10.1371/journal.pone.0184163			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863156	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900035
J	Monasta, L; Pierobon, C; Princivalle, A; Martelossi, S; Marcuzzi, A; Pasini, F; Perbellini, L				Monasta, Lorenzo; Pierobon, Chiara; Princivalle, Andrea; Martelossi, Stefano; Marcuzzi, Annalisa; Pasini, Francesco; Perbellini, Luigi			Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry	PLOS ONE			English	Article							PEDIATRIC CROHNS-DISEASE; NITRIC-OXIDE; PATHOGENIC BACTERIA; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; OXIDATIVE STRESS; GUT MICROBIOTA; DIAGNOSIS; VALIDATION; METABOLISM	Inflammatory bowel diseases (IBD) profoundly affect quality of life and have been gradually increasing in incidence, prevalence and severity in many areas of the world, and in children in particular. Patients with suspected IBD require careful history and clinical examination, while definitive diagnosis relies on endoscopic and histological findings. The aim of the present study was to investigate whether the alveolar air of pediatric patients with IBD presents a specific volatile organic compounds' (VOCs) pattern when compared to controls. Patients 10-17 years of age, were divided into four groups: Crohn's disease (CD), ulcerative colitis (UC), controls with gastrointestinal symptomatology, and surgical controls with no evidence of gastrointestinal problems. Alveolar breath was analyzed by ion molecule reaction mass spectrometry. Four models were built starting from 81 molecules plus the age of subjects as independent variables, adopting a penalizing LASSO logistic regression approach: 1) IBDs vs. controls, finally based on 18 VOCs plus age (sensitivity = 95%, specificity = 69%, AUC = 0.925); 2) CD vs. UC, finally based on 13 VOCs plus age (sensitivity = 94%, specificity = 76%, AUC = 0.934); 3) IBDs vs. gastroenterological controls, finally based on 15 VOCs plus age (sensitivity = 94%, specificity = 65%, AUC = 0.918); 4) IBDs vs. controls, built starting from the 21 directly or indirectly calibrated molecules only, and finally based on 12 VOCs plus age (sensitivity = 94%, specificity = 71%, AUC = 0.888). The molecules identified by the models were carefully studied in relation to the concerned outcomes. This study, with the creation of models based on VOCs profiles, precise instrumentation and advanced statistical methods, can contribute to the development of new non-invasive, fast and relatively inexpensive diagnostic tools, with high sensitivity and specificity. It also represents a crucial step towards gaining further insights on the etiology of IBD through the analysis of specific molecules which are the expression of the particular metabolism that characterizes these patients.	[Monasta, Lorenzo; Pierobon, Chiara; Martelossi, Stefano; Marcuzzi, Annalisa] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Princivalle, Andrea; Pasini, Francesco; Perbellini, Luigi] Univ Verona, Dept Publ Hlth & Community Med, Occupat Med, Verona, Italy	IRCCS Burlo Garofolo; University of Verona	Monasta, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	lorenzo.monasta@burlo.trieste.it	Marcuzzi, Annalisa/AAA-6038-2020; Monasta, Lorenzo/B-1388-2012	Marcuzzi, Annalisa/0000-0003-3427-618X; Monasta, Lorenzo/0000-0001-7774-548X; PRINCIVALLE, Andrea/0000-0001-7047-0639				Ajibola OA, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.26; Albert JG, 2005, GUT, V54, P1721, DOI 10.1136/gut.2005.069427; Arasaradnam RP, 2016, DIGEST LIVER DIS, V48, P148, DOI 10.1016/j.dld.2015.10.013; Arasaradnam RP, 2013, INFLAMM BOWEL DIS, V19, P999, DOI 10.1097/MIB.0b013e3182802b26; Bajtarevic A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-348; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bennett L, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046002; Bevc S, 2017, CLIN NEPHROL; Bhatt A, 2015, GASTROINTEST ENDOSC; Boots AW, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027108; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Brannelly NT, 2016, CRIT REV ANAL CHEM, V46, P490, DOI 10.1080/10408347.2016.1153949; Buijck M, 2016, J PEDIAT GASTROENTER; Carbonero F, 2012, NAT REV GASTRO HEPAT, V9, P504, DOI 10.1038/nrgastro.2012.85; Day AS, 2012, WORLD J GASTROENTERO, V18, P5862, DOI 10.3748/wjg.v18.i41.5862; de Meij Tim G J, 2014, J Crohns Colitis, DOI 10.1016/j.crohns.2014.09.004; Defoort F, 2014, BIOMASS BIOENERG, V65, P64, DOI 10.1016/j.biombioe.2014.04.001; DeLano FA, 2017, SHOCK; Elamin EE, 2013, NUTR REV, V71, P483, DOI 10.1111/nure.12027; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Esiringu F, 2016, DRUG DELIV, V23, P2318, DOI 10.3109/10717544.2014.982773; Filipiak W, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-17; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Griffiths AM, 2004, BEST PRACT RES CL GA, V18, P509, DOI 10.1016/j.bpg.2004.01.002; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Hibbard T, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037101; Hicks LC, 2015, J CROHNS COLITIS, V9, P731, DOI 10.1093/ecco-jcc/jjv102; Hill RJ, 2011, INFLAMM BOWEL DIS, V17, P1223, DOI 10.1002/ibd.21471; Hornuss C, 2007, ANESTHESIOLOGY, V106, P665, DOI 10.1097/01.anes.0000264746.01393.e0; Huang J, 2008, 392 U IOW DEP STAT A; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; Jang A, 2003, J ENVIRON SCI HEAL A, V38, P2955, DOI 10.1081/ESE-120025844; Jardine KJ, 2010, ENVIRON SCI TECHNOL, V44, P2454, DOI 10.1021/es903544p; Jiang YD, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0165-5; Joyce SA, 2014, CURR OPIN GASTROEN, V30, P120, DOI 10.1097/MOG.0000000000000039; Judd C. M., 2009, DATA ANAL MODEL COMP, DOI [10.4324/9781315744131, DOI 10.4324/9781315744131]; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kearney DJ, 2002, DIGEST DIS SCI, V47, P2523, DOI 10.1023/A:1020568227868; Kostakis ID, 2013, DIGEST DIS SCI, V58, P309, DOI 10.1007/s10620-012-2347-5; Kurada S, 2015, ALIMENT PHARM THER, V41, P329, DOI 10.1111/apt.13050; KUZMA J, 1995, CURR MICROBIOL, V30, P97, DOI 10.1007/BF00294190; Larsen AG, 1997, J APPL MICROBIOL, V83, P111, DOI 10.1046/j.1365-2672.1997.00196.x; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Lourenco C, 2014, METABOLITES, V4, P465, DOI 10.3390/metabo4020465; Markar SR, 2015, J CLIN GASTROENTEROL, V49, P1, DOI 10.1097/MCG.0000000000000247; Minh TDC, 2011, AM J PHYSIOL-ENDOC M, V300, pE1166, DOI 10.1152/ajpendo.00634.2010; Moretti M, 2004, AM J OBSTET GYNECOL, V190, P1184, DOI 10.1016/j.ajog.2003.11.008; Mussap M, 2013, CLIN CHIM ACTA, V426, P127, DOI 10.1016/j.cca.2013.08.020; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Navaneethan U, 2015, GASTROINTEST ENDOSC, V81, P943, DOI 10.1016/j.gie.2014.09.041; Netzer M, 2009, BIOINFORMATICS, V25, P941, DOI 10.1093/bioinformatics/btp093; Nonose S, 2014, J PHYS CHEM B, V118, P9651, DOI 10.1021/jp505621f; Patel N, 2014, ALIMENT PHARM THER, V40, P498, DOI 10.1111/apt.12861; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips M, 2004, CLIN CHIM ACTA, V344, P189, DOI 10.1016/j.cccn.2004.02.025; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026001; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Probert CSJ, 2011, BIOCHEM SOC T, V39, P1079, DOI 10.1042/BST0391079; Quenon L, 2013, J CROHNS COLITIS, V7, P644, DOI 10.1016/j.crohns.2012.09.021; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Reinders CI, 2007, SCAND J GASTROENTERO, V42, P1151, DOI 10.1080/00365520701320505; Roediger WEW, 2008, ALIMENT PHARM THER, V27, P531, DOI 10.1111/j.1365-2036.2008.03612.x; ROEDIGER WEW, 1986, DIGESTION, V35, P199, DOI 10.1159/000199368; ROGERS B H G, 1971, Journal of Chronic Diseases, V24, P743, DOI 10.1016/0021-9681(71)90087-7; Rosias PP, 2008, EUR RESPIR J, V31, P934, DOI 10.1183/09031936.00073207; Sahakian AB, 2010, DIGEST DIS SCI, V55, P2135, DOI 10.1007/s10620-009-1012-0; Salvo P, 2015, MED ENG PHYS, V37, P539, DOI 10.1016/j.medengphy.2015.03.013; Sanei Mohammad H, 2014, Adv Biomed Res, V3, P193, DOI 10.4103/2277-9175.140666; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Singh S, 2015, ADV EXP MED BIOL, V815, P281, DOI 10.1007/978-3-319-09614-8_16; Soldavini J, 2013, DIGEST DIS SCI, V58, P2756, DOI 10.1007/s10620-013-2744-4; Sukul P, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/4/047105; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turner D, 2007, GASTROENTEROLOGY, V133, P423, DOI 10.1053/j.gastro.2007.05.029; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; van de Kant KDG, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-117; Van Nuenen MHMC, 2004, DIGEST DIS SCI, V49, P485, DOI 10.1023/B:DDAS.0000020508.64440.73; Wagner WP, 2000, J NAT PROD, V63, P37, DOI 10.1021/np990286p; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; ZECHMAN JM, 1986, J CHROMATOGR, V377, P49, DOI 10.1016/S0378-4347(00)80760-4; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	85	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184118	10.1371/journal.pone.0184118	http://dx.doi.org/10.1371/journal.pone.0184118			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859138	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500068
J	Ueda, A; Takasawa, A; Akimoto, T; Takasawa, K; Aoyama, T; Ino, Y; Nojima, M; Ono, Y; Murata, M; Osanai, M; Hasegawa, T; Saito, T; Sawada, N				Ueda, Asako; Takasawa, Akira; Akimoto, Taishi; Takasawa, Kumi; Aoyama, Tomoyuki; Ino, Yoshihiko; Nojima, Masanori; Ono, Yusuke; Murata, Masaki; Osanai, Makoto; Hasegawa, Tadashi; Saito, Tsuyoshi; Sawada, Norimasa			Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; HISTOLOGICAL SUBTYPE; C-MET; CANCER; EXPRESSION; OVEREXPRESSION; C-ERBB-2; SURVIVAL; IMPACT	Prognostic factors and therapeutic targets are needed for the patients with cervical adenocarcinoma because they have a poor prognosis. Recently, co-expression of multiple receptor tyrosine kinases (RTKs) has been found to be associated with aggressive biological behavior and poor prognosis of several types of malignancy. To evaluate the significance of the expression of multiple RTKs in uterine cervical cancers, we examined the expression profile of RTKs (EGFR, HER2 and c-Met) and the correlation of their expression with clinicopathological features and prognosis of patients with cervical adenocarcinomas. AIS and adenocarcinoma showed strong expression of a single RTK (EGFR, HER2 or c-Met) on the cell membrane in 41 (77.4%) of 53 cases. Twenty (46%) of the 43 adenocarcinoma cases were positive for double or triple RTKs (P = 0.034). Positivity for EGFR and double positivity for EGFR and HER2 (EGFR+/HER2+/c-Met+ and EGFR+/HER2+/c-Met-) were significantly correlated with lymph node metastasis (P = 0.010 for single and P = 0.013 for double) and UICC stage (P = 0.021 for single and P = 0.007 for double). Positivity for HER2 was significantly correlated with tumor size (P = 0.029). Relapse-free survival (RFS) was significantly shorter in patients who were double positive for EGFR and HER2. Our results suggest that EGFR and HER2 are potential therapeutic targets and that their co-expression is a prognostic factor for cervical adenocarcinoma.	[Ueda, Asako; Takasawa, Akira; Takasawa, Kumi; Aoyama, Tomoyuki; Ono, Yusuke; Murata, Masaki; Osanai, Makoto; Sawada, Norimasa] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido, Japan; [Akimoto, Taishi; Ino, Yoshihiko; Saito, Tsuyoshi] Sapporo Med Univ, Dept Obstet & Gynecol, Sch Med, Sapporo, Hokkaido, Japan; [Aoyama, Tomoyuki; Hasegawa, Tadashi] Sapporo Med Univ, Dept Surg Pathol, Sch Med, Sapporo, Hokkaido, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci, Div Adv Med Promot, Adv Clin Res Ctr, Tokyo, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; University of Tokyo	Takasawa, A (corresponding author), Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido, Japan.	atakasawa@sapmed.ac.jp	Nojima, Masanori/ABE-2237-2020	Nojima, Masanori/0000-0002-8788-2522	Japan Society for the Promotion of Science KAKENHI [JP16K08693, JP16K21250, JP26460421]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp/) Grant numbers JP16K08693 to NS, JP16K21250 to TA and JP26460421 to AT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2016, HISTOL HISTOPATHOL, V31, P921, DOI 10.14670/HH-11-729; Baltazar F, 2007, INT J GYNECOL PATHOL, V26, P235, DOI 10.1097/pgp.0b013e31802f1996; Barbu I, 2013, ROM J MORPHOL EMBRYO, V54, P519; Baykal C, 2003, GYNECOL ONCOL, V88, P123, DOI 10.1016/S0090-8258(02)00073-2; Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; Bodner K, 2011, ARCH GYNECOL OBSTET, V283, P611, DOI 10.1007/s00404-010-1464-7; Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH; Carlsson J, 2013, ONCOL LETT, V5, P208, DOI 10.3892/ol.2012.996; Carlsson J, 2015, RADIOL ONCOL, V49, P50, DOI 10.2478/raon-2014-0015; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Fuchs I, 2007, ANTICANCER RES, V27, P959; Fuse N, 2016, GASTRIC CANCER, V19, P183, DOI 10.1007/s10120-015-0471-6; Gien LT, 2010, GYNECOL ONCOL, V116, P140, DOI 10.1016/j.ygyno.2009.09.040; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; HALE RJ, 1992, J CLIN PATHOL, V45, P594, DOI 10.1136/jcp.45.7.594; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kersemaekers AMF, 1999, CLIN CANCER RES, V5, P577; KIHANA T, 1994, CANCER, V73, P148, DOI 10.1002/1097-0142(19940101)73:1<148::AID-CNCR2820730125>3.0.CO;2-C; Kim GE, 2004, CLIN CANCER RES, V10, P1366, DOI 10.1158/1078-0432.CCR-0497-03; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Lindstrom AK, 2009, ANTICANCER RES, V29, P2577; Mabuchi S, 2012, GYNECOL ONCOL, V127, P114, DOI 10.1016/j.ygyno.2012.06.021; MANDAI M, 1995, CANCER, V75, P2523, DOI 10.1002/1097-0142(19950515)75:10<2523::AID-CNCR2820751019>3.0.CO;2-L; McCluggage WG, 2013, HISTOPATHOLOGY, V62, P138, DOI 10.1111/his.12012; Miekus K, 2015, ONCOTARGET, V6, P10086, DOI 10.18632/oncotarget.3161; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nakajima M, 1999, CANCER, V85, P1894; Noordhuis MG, 2009, CLIN CANCER RES, V15, P7389, DOI 10.1158/1078-0432.CCR-09-1149; Peng JF, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/6594016; Perez-Regadera J, 2011, AM J CLIN ONCOL, V34; Perez-Regadera J, 2009, ONCOLOGY-BASEL, V76, P133, DOI 10.1159/000195539; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Shafizadeh N, 2010, HUM PATHOL, V41, P485, DOI 10.1016/j.humpath.2009.10.002; Shen L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-232; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Soonthornthum T, 2011, ANN ONCOL, V22, P2166, DOI 10.1093/annonc/mdq723; Takasawa A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33582; Tsai HW, 2006, HUM PATHOL, V37, P198, DOI 10.1016/j.humpath.2005.10.012; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U; Wright TC., 2002, BLAUSTEINS PATHOLOGY, P325; Yokoi E, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e19	41	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184123	10.1371/journal.pone.0184123	http://dx.doi.org/10.1371/journal.pone.0184123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859123	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500069
J	Reynoso, E; Liu, H; Li, L; Yuan, AL; Chen, S; Wang, ZG				Reynoso, Eduardo; Liu, Hua; Li, Lin; Yuan, Anthony L.; Chen, She; Wang, Zhigao			Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; TUMOR-NECROSIS-FACTOR; NECROTIC CELL-DEATH; PROGRAMMED NECROSIS; TNF-ALPHA; OXIDATIVE STRESS; ACTIVATION; RIP3; APOPTOSIS	Necroptosis is an immunogenic cell death program that is associated with a host of human diseases, including inflammation, infections, and cancer. Receptor-interacting protein kinase 3 (RIPK3) and its substrate mixed lineage kinase domain-like protein (MLKL) are required for necroptosis activation. Specifically, RIPK3-dependent MLKL phosphorylation promotes the assembly of disulfide bond-dependent MLKL polymers that drive the execution of necroptosis. However, how MLKL disulfide bond formation is regulated is not clear. In this study we discovered that the MLKL-modifying compound necrosulfonamide cross-links cysteine 86 of human MLKL to cysteine 32 of the thiol oxidoreductase thioredoxin-1 (Trx1). Recombinant Trx1 preferentially binds to monomeric MLKL and blocks MLKL disulfide bond formation and polymerization in vitro. Inhibition of MLKL polymer formation requires the reducing activity of Trx1. Importantly, shRNA-mediated knockdown of Trx1 promotes MLKL polymerization and sensitizes cells to necroptosis. Furthermore, pharmacological inhibition of Trx1 with compound PX-12 induces necroptosis in multiple cancer cell lines. Altogether, these findings demonstrate that Trx1 is a critical regulator of necroptosis that suppresses cell death by maintaining MLKL in a reduced inactive state. Our results further suggest new directions for targeted cancer therapy in which thioredoxin inhibitors like PX-12 could potentially be used to specifically target cancers expressing high levels of MLKL or MLKL short isoforms.	[Reynoso, Eduardo; Liu, Hua; Yuan, Anthony L.; Wang, Zhigao] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Liu, Hua] Jiangxi Univ Tradit Chinese Med, Sch Pharm, Nanchang 330006, Jiangxi, Peoples R China; [Li, Lin; Chen, She] Natl Inst Biol Sci, Prote Facil, Beijing 102206, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Jiangxi University of Traditional Chinese Medicine; National Institute of Biological Sciences, Beijing	Wang, ZG (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhigao.wang@utsouthwestern.edu	Wang, Zhigao/ABE-9411-2021	Wang, Zhigao/0000-0002-6544-4302	Welch Foundation [I-1827]; F31 fellowship [GM111049-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM111049] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); F31 fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Welch Foundation (I-1827) and an F31 fellowship (GM111049-01A1; to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galmarini CM, 2006, CURR OPIN INVESTIG D, V7, P1108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang DL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00497-16; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kirkpatrick DL, 1998, BIOCHEM PHARMACOL, V55, P987, DOI 10.1016/S0006-2952(97)00597-2; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Liu SZ, 2017, P NATL ACAD SCI USA, V114, pE7450, DOI 10.1073/pnas.1707531114; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Najafov A, 2017, TRENDS CANCER, V3, P294, DOI 10.1016/j.trecan.2017.03.002; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Quarato G, 2016, MOL CELL, V61, P589, DOI 10.1016/j.molcel.2016.01.011; Ramanathan RK, 2012, INVEST NEW DRUG, V30, P1591, DOI 10.1007/s10637-011-9739-9; Ramanathan RK, 2011, CANCER CHEMOTH PHARM, V67, P503, DOI 10.1007/s00280-010-1343-8; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Xu YF, 2015, J AM SOC NEPHROL, V26, P2647, DOI 10.1681/ASN.2014080741; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14329; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	51	20	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17514	17524		10.1074/jbc.M117.799353	http://dx.doi.org/10.1074/jbc.M117.799353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28878015	hybrid, Green Published			2022-12-26	WOS:000414009300031
J	Shah, DD; Singh, SM; Dzieciatkowska, M; Mallela, KMG				Shah, Dinen D.; Singh, Surinder M.; Dzieciatkowska, Monika; Mallela, Krishna M. G.			Biophysical analysis of the effect of chemical modification by 4-oxononenal on the structure, stability, and function of binding immunoglobulin protein (BiP)	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; GLUCOSE-REGULATED PROTEINS; FREE-ENERGY CHANGES; HEAVY-CHAIN; IN-VITRO; LINEAR EXTRAPOLATION; MOLECULAR CHAPERONES; CITRATE SYNTHASE; ATPASE ACTIVITY; M-VALUES	Binding immunoglobulin protein (BiP) is a molecular chaperone important for the folding of numerous proteins, which include millions of immunoglobulins in human body. It also plays a key role in the unfolded protein response (UPR) in the endoplasmic reticulum. Free radical generation is a common phenomenon that occurs in cells under healthy as well as under stress conditions such as ageing, inflammation, alcohol consumption, and smoking. These free radicals attack the cell membranes and generate highly reactive lipid peroxidation products such as 4-oxononenal (4-ONE). BiP is a key protein that is modified by 4-ONE. In this study, we probed how such chemical modification affects the biophysical properties of BiP. Upon modification, BiP shows significant tertiary structural changes with no changes in its secondary structure. The protein loses its thermodynamic stability, particularly, that of the nucleotide binding domain (NBD) where ATP binds. In terms of function, the modified BiP completely loses its ATPase activity with decreased ATP binding affinity. However, modified BiP retains its immunoglobulin binding function and its chaperone activity of suppressing non-specific protein aggregation. These results indicate that 4-ONE modification can significantly affect the structure-function of key proteins such as BiP involved in cellular pathways, and provide a molecular basis for how chemical modifications can result in the failure of quality control mechanisms inside the cell.	[Shah, Dinen D.; Singh, Surinder M.; Mallela, Krishna M. G.] Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Dzieciatkowska, Monika] Univ Colorado Anschutz Med Campus, Biol Mass Spectrometry Facil, Sch Med, Aurora, CO USA; [Mallela, Krishna M. G.] Univ Colorado Anschutz Med Campus, Program Struct Biol & Biochem, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mallela, KMG (corresponding author), Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA.; Mallela, KMG (corresponding author), Univ Colorado Anschutz Med Campus, Program Struct Biol & Biochem, Aurora, CO 80045 USA.	krishna.mallela@ucdenver.edu		Mallela, Krishna/0000-0001-8308-5318				Arakawa A, 2011, PROTEIN SCI, V20, P1367, DOI 10.1002/pro.663; Arthur KK, 2015, J PHARM SCI-US, V104, P1548, DOI 10.1002/jps.24313; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cai J., 2008, ADV COMPUT MATH, P1; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Daugherty DL, 1998, J BIOL CHEM, V273, P33961, DOI 10.1074/jbc.273.51.33961; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fritz KS, 2013, FREE RADICAL BIO MED, V59, P85, DOI 10.1016/j.freeradbiomed.2012.06.025; Fritz KS, 2011, CHEM RES TOXICOL, V24, P1411, DOI 10.1021/tx200169n; Galligan JJ, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/207594; Galligan JJ, 2014, FREE RADICAL BIO MED, V73, P411, DOI 10.1016/j.freeradbiomed.2014.06.002; Galligan JJ, 2012, CHEM RES TOXICOL, V25, P1012, DOI 10.1021/tx300002q; GAUT JR, 1993, J BIOL CHEM, V268, P7248; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Gething MJ, 1995, COLD SPRING HARB SYM, V60, P417, DOI 10.1101/SQB.1995.060.01.046; Gorbatyuk MS., 2013, J GENET SYNDR GENE T, V4; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Halliwell B, 1988, Agents Actions Suppl, V26, P223; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; HENDERSHOT L, 1987, IMMUNOL TODAY, V8, P111, DOI 10.1016/0167-5699(87)90861-9; Katanasaka Y, 2010, INT J CANCER, V127, P2685, DOI 10.1002/ijc.25276; KNARR G, 1995, J BIOL CHEM, V270, P27589, DOI 10.1074/jbc.270.46.27589; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lamb HK, 2006, J BIOL CHEM, V281, P8796, DOI 10.1074/jbc.M503964200; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Lin D, 2008, ADV BIOACTIVATION RE, P1; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Pace C N, 1986, Methods Enzymol, V131, P266; Park KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44723; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Roede JR, 2008, CHEM RES TOXICOL, V21, P2289, DOI 10.1021/tx800244u; Rosenes Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044927; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; Smathers RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038459; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Soulages JL, 1998, BIOPHYS J, V75, P484, DOI 10.1016/S0006-3495(98)77537-X; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; TOLEDO H, 1993, P NATL ACAD SCI USA, V90, P2505, DOI 10.1073/pnas.90.6.2505; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wen J, 2012, J PHARM SCI-US, V101, P955, DOI 10.1002/jps.22820; Xu GZ, 1999, CHEM RES TOXICOL, V12, P862, DOI 10.1021/tx9900573; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	72	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183975	10.1371/journal.pone.0183975	http://dx.doi.org/10.1371/journal.pone.0183975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886061	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100050
J	Huang, JYX; Wang, RW; Gao, YT; Yuan, JM				Huang, Joyce Yongxu; Wang, Renwei; Gao, Yu-Tang; Yuan, Jian-Min			ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study	PLOS ONE			English	Article							HUMAN GASTRIC EPITHELIUM; GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI; GROUP ANTIGENS; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; EXPRESSION; BLADDER; LESIONS; TAIWAN	ABO blood type is an inherited characteristic. The associations between ABO blood type and risk of all cancer and specific cancers were examined in a prospective cohort study of 18,244 Chinese men enrolled in 1986. During the 25 years of follow-up, 3,973 men developed cancer including 964 lung cancers, 624 colorectal cancers, 560 gastric cancers, 353 liver cancers, and 172 urinary bladder cancers. Hazard ratios (HR) for all cancer and specific cancers by ABO blood type were calculated using Cox proportional hazards models. Compared with blood type A, blood type B was associated with statistically significant reduced risk of all cancers (HR, 0.91, 95% CI:0.84, 0.99). Both blood types B and AB were associated with significantly lower risk of gastrointestinal cancer and colorectal cancer, respectively. Blood type B was also associated with significantly lower risk of stomach cancer and bladder cancer, while blood type AB was associated with significantly increased risk of liver cancer. By histological type, blood types B and AB were associated with lower risk of epidermoid carcinoma and adenocarcinoma, but were not associated with risk of sarcoma, lymphoma, leukemia or other cell types of cancer. The findings of this study support a role of genetic traits related to ABO blood type in the development of cancers in the gastrointestinal and urinary tracts.	[Huang, Joyce Yongxu; Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA; [Huang, Joyce Yongxu; Yuan, Jian-Min] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University	Yuan, JM (corresponding author), Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.; Yuan, JM (corresponding author), Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.	yuanj@upmc.edu	Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022	Yuan, Jian-Min/0000-0002-4620-3108	United States National Institutes of Health [R01CA144034, R01 CA043092, UM1 CA182876]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States National Institutes of Health (R01CA144034, R01 CA043092, and UM1 CA182876) to J.-M.Y. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; AIRD I, 1954, Br Med J, V2, P315; Alkout AM, 1997, GASTROENTEROLOGY, V112, P1179, DOI 10.1016/S0016-5085(97)70129-X; Alkout AM, 2000, J INFECT DIS, V181, P1364, DOI 10.1086/315375; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Berg JW, 1996, CANC EPIDEMIOLOGY PR, P28; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; FALK P, 1993, P NATL ACAD SCI USA, V90, P2035, DOI 10.1073/pnas.90.5.2035; Garratty G, 2004, TRANSFUSION, V44, P703, DOI 10.1111/j.1537-2995.2004.03338.x; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Harmening Denise M., 1994, P86; Hsiao LT, 2015, ASIA-PAC J CLIN ONCO, V11, pE31, DOI 10.1111/ajco.12253; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; LABARRIERE N, 1994, CANCER RES, V54, P6275; MELDGAARD P, 1995, INT J CANCER, V63, P341, DOI 10.1002/ijc.2910630306; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; NEWMAN E, 1961, BRIT MED J, V1, P92, DOI 10.1136/bmj.1.5219.92; Nieters A, 2005, CANCER, V103, P740, DOI 10.1002/cncr.20842; OKADA Y, 1987, CANCER-AM CANCER SOC, V60, P345, DOI 10.1002/1097-0142(19870801)60:3<345::AID-CNCR2820600311>3.0.CO;2-T; OKADA Y, 1987, J NATL CANCER I, V78, P19, DOI 10.1093/jnci/78.1.19; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; Reid ME, 2004, SEMIN HEMATOL, V41, P93, DOI 10.1053/j.seminhematol.2004.01.001; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Su M, 2001, WORLD J GASTROENTERO, V7, P657; Sun WJ, 2015, CANCER EPIDEMIOL, V39, P150, DOI 10.1016/j.canep.2014.12.006; VOGEL F, 1970, AM J HUM GENET, V22, P464; Whitlock SA, 2010, IMMUNOHEMATOLOGY MED, P87; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; YAMADA T, 1991, CANCER, V67, P1661, DOI 10.1002/1097-0142(19910315)67:6<1661::AID-CNCR2820670630>3.0.CO;2-E; You WC, 2000, INT J EPIDEMIOL, V29, P405, DOI 10.1093/ije/29.3.405; Yuan JM, 2006, JNCI-J NATL CANCER I, V98, P482, DOI 10.1093/jnci/djj104; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zhang SL, 1997, INT J CANCER, V73, P50, DOI 10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.3.CO;2-O	35	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184295	10.1371/journal.pone.0184295	http://dx.doi.org/10.1371/journal.pone.0184295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880901	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200047
J	Lin, JS; Jeon, JS; Fan, QF; Wong, HN; Palmer, MB; Holzman, LB				Lin, Jamie S.; Jeon, Jin Seok; Fan, Qingfeng; Wong, Hetty N.; Palmer, Matthew B.; Holzman, Lawrence B.			ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CONGENITAL NEPHROTIC SYNDROME; GTP-BINDING PROTEINS; SLIT DIAPHRAGM; DOWNSTREAM ACTIVATION; ACTIN CYTOSKELETON; GLOMERULAR PODOCYTES; DIABETIC-NEPHROPATHY; PLASMA-MEMBRANE	ADP-ribosylation factor 6 (ARF6) is a small GTPase necessary for regulating cellular structure, motility, and vesicle trafficking. In several cellular systems, ARF6 was shown to regulate actin dynamics in coordination with Rac1, a Rho small GTPase. We examined the function of ARF6 in the kidney podocyte because Rac1 was implicated in kidney diseases involving this cell. We found that ARF6 expression was enriched in human podocytes and that it modulated podocyte cytoskeletal dynamics through a functional interaction with nephrin, an intercellular junction protein necessary for podocyte injury-induced signaling requiring activation by tyrosine phosphorylation of its cytoplasmic domain. ARF6 was necessary for nephrin activation-induced ruffling and focal adhesion turnover, possibly by altering Rac1 activity. In podocyte-specific Arf6 (ARF6_PodKO) knockout mice, ARF6 deficiency did not result in a spontaneous kidney developmental phenotype or proteinuria after aging. However, ARF6_PodKO mice exhibited distinct phenotypes in two in vivo glomerular injury models. In the protamine sulfate perfusion model, which induced acute podocyte effacement, ARF6_PodKO mice were protected from podocyte effacement. In the nephrotoxic serum nephritis model, which induced immune-complex mediated injury, ARF6_PodKO mice exhibited aggravated proteinuria. Together, these observations suggest that while ARF6 is necessary for nephrin tyrosine phosphorylation-induced cytoskeletal dynamics in cultured podocytes, ARF6 has pleotropic podocyte roles in vivo, where glomerular injury-specific mechanisms might activate distinct signaling pathways that dictate whether ARF6 activity is beneficial or deleterious for maintaining the integrity of the glomerular filtration barrier.	[Lin, Jamie S.] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Dept Emergency Med, Div Internal Med, Houston, TX 77030 USA; [Jeon, Jin Seok] Soonchunhyang Univ Hosp, Div Nephrol, Dept Med, Seoul, South Korea; [Fan, Qingfeng; Wong, Hetty N.; Holzman, Lawrence B.] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Palmer, Matthew B.] Hosp Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA	University of Texas System; UTMD Anderson Cancer Center; Soonchunhyang University; Soonchunhyang University Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzman, LB (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	lholzman@mail.med.upenn.edu	; Lin, Jamie/F-4278-2015	Holzman, Lawrence/0000-0002-8961-234X; Fan, Qingfeng/0000-0002-7100-7766; Lin, Jamie/0000-0002-7073-9658	National Institute of Diabetes and Digestive and Kidney Diseases [DK080751-11, DK007006-43, DK108566-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007006, R01DK080751, F32DK108566] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases: DK080751-11 (LBH); DK007006-43 (LBH, JSL); DK108566-01(JSL); https://www.niddk.nih.gov gov/.	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Akiyama M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5744; Akiyama M, 2010, DEV DYNAM, V239, P3416, DOI 10.1002/dvdy.22481; Attias O, 2010, NEPHRON EXP NEPHROL, V114, pE93, DOI 10.1159/000262317; Auguste David, 2016, Small GTPases, V7, P107, DOI 10.1080/21541248.2015.1113353; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Beltcheva O, 2001, HUM MUTAT, V17, P368, DOI 10.1002/humu.1111; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Eng DG, 2015, KIDNEY INT, V88, P999, DOI 10.1038/ki.2015.152; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hongu Tsunaki, 2014, Advances in Biological Regulation, V54, P59, DOI 10.1016/j.jbior.2013.09.014; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Hu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035542; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Ichikawa L, 2005, CURR OPIN NEPHROL HY, V14, P205; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li XZ, 2015, J AM SOC NEPHROL, V26, P2361, DOI 10.1681/ASN.2014040405; Lin JS, 2015, J PATHOLOGY; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1999, J CELL SCI, V112, P855; Robins R, 2017, RAC1 ACTIVATION PODO; Rudiger F, 1999, KIDNEY INT, V56, P1700, DOI 10.1046/j.1523-1755.1999.00729.x; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Subramanian B, 2016, KIDNEY INT, V90, P363, DOI 10.1016/j.kint.2016.04.020; Tian XF, 2016, NEPHROL DIAL TRANSPL, V31, P1577, DOI 10.1093/ndt/gfw021; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Verma R, 2016, MOL CELL BIOL, V36, P596, DOI 10.1128/MCB.00956-15; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	79	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184575	10.1371/journal.pone.0184575	http://dx.doi.org/10.1371/journal.pone.0184575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880939	Green Submitted, gold, Green Published			2022-12-26	WOS:000409467200078
J	Liu, YX; Ma, JC; Ding, WC; He, WT; Lei, QL; Gao, Q; He, P				Liu, Yingxia; Ma, Jinchuan; Ding, Wencheng; He, Wentian; Lei, Qiuliang; Gao, Qiang; He, Ping			Temporal and spatial variation of potassium balance in agricultural land at national and regional levels in China	PLOS ONE			English	Article							NUTRIENT BALANCES; FARMING SYSTEMS; SOIL FERTILITY; MANAGEMENT; FLOWS; PHOSPHORUS; AFRICA; AUDITS; FIELD; AGROECOSYSTEMS	Linking potassium (K) balance to soil fertility creates a valuable indicator for sustainability assessment in agricultural land-use systems. It is crucial for the efficient use of K resources, food security and resource sustainability to realize soil K balance status in China. Therefore, temporal and spatial changes of K balance for farmland in China from 1980 to 2015 were analyzed at national and regional levels using statistical data and related parameters. At the national scale, K input increased from 6.78 Mt K2O in 1980 to 23.44 Mt K2O in 2015 with an average annual increment of 0.48 Mt K2O, and output changed from 8.10 Mt in 1980 to 21.31 Mt in 2015 with an average annual increment of 0.38 Mt K2O as well. On average, K balance was -24.17, -5.92, 21.31 and 19.50 kg K2O ha(-1) in 1980s, 1990s, 2000s and 2010s, respectively. Moreover, the average balance of six regions was considerably different which were -21.37, 1.25, 13.70, -22.79, 99.22 and 7.18 kg K2O ha(-1) from 1980 to 2015. The potassium use efficiency (KUE) decreased with time which were 127.09, 104.35, 87.69 and 89.69% in 1980s, 1990s, 2000s and 2010s, respectively, and the decline of slope could also reflect the variation tendency of KUE. Great variation of K balance across different regions demonstrated that fertilizer application and management practices need to be adjusted to local conditions.	[Liu, Yingxia; Ma, Jinchuan; Ding, Wencheng; He, Wentian; Lei, Qiuliang; He, Ping] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Gao, Qiang] Jilin Agr Univ, Coll Resources & Environm, Changchun, Jilin, Peoples R China; [He, Ping] CAAS IPNI Joint Lab Plant Nutr Innovat Res, Int Plant Nutr Inst IPNI China Program, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Jilin Agricultural University	He, P (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; He, P (corresponding author), CAAS IPNI Joint Lab Plant Nutr Innovat Res, Int Plant Nutr Inst IPNI China Program, Beijing, Peoples R China.	heping02@caas.cn	He, Wentian/ABD-5067-2021; He, Ping/HGD-5389-2022	He, Ping/0000-0003-1786-6858; He, Wentian/0000-0002-4239-9377	National Key Research & Development Plan [2016YFD0200101]; National Natural Science Foundation of China [31471942, 31272243]; central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research [Y2017PT35, 1610132016011]; central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab	National Key Research & Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research; central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab	This research was supported by the National Key Research & Development Plan (2016YFD0200101), National Natural Science Foundation of China (No. 31471942 and 31272243), and central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab for Plant Nutrition Innovation Research (Y2017PT35, 1610132016011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by, and done at, the central Research Institutes of Basic Research and Public Service Special Operations for CAAS-IPNI Joint Lab.	[Anonymous], 2016, THESIS; Bach M, 1998, Z PFLANZ BODENKUNDE, V161, P385, DOI 10.1002/jpln.1998.3581610406; Bahr E, 2015, NUTR CYCL AGROECOSYS, V101, P55, DOI 10.1007/s10705-014-9662-5; Bengtsson H, 2003, EUR J AGRON, V20, P101, DOI 10.1016/S1161-0301(03)00079-0; Bindraban PS, 2000, AGR ECOSYST ENVIRON, V81, P103, DOI 10.1016/S0167-8809(00)00184-5; Buciene A, 2003, EUR J AGRON, V20, P53, DOI 10.1016/S1161-0301(03)00073-X; Calonego JC, 2013, NUTR CYCL AGROECOSYS, V96, P123, DOI 10.1007/s10705-013-9581-x; Cobo JG, 2010, AGR ECOSYST ENVIRON, V136, P1, DOI 10.1016/j.agee.2009.11.006; de Jager A, 2005, LAND USE POLICY, V22, P57, DOI 10.1016/j.landusepol.2003.06.002; Defoer T, 1998, AGR ECOSYST ENVIRON, V71, P215, DOI 10.1016/S0167-8809(98)00142-X; Dobermann A, 1998, FIELD CROP RES, V56, P113, DOI 10.1016/S0378-4290(97)00124-X; Fagerberg B, 1996, SWED J AGR RES, V26, P169; Gaj R., 2012, Agricultural Sciences, V3, P317, DOI 10.4236/as.2012.32036; Grote U, 2005, ENVIRON SCI POLICY, V8, P439, DOI 10.1016/j.envsci.2005.05.001; Haileslassie A, 2007, AGR SYST, V94, P459, DOI 10.1016/j.agsy.2006.11.013; Harris FMA, 1998, AGR ECOSYST ENVIRON, V71, P201, DOI 10.1016/S0167-8809(98)00141-8; He P, 2015, FIELD CROP RES, V173, P49, DOI 10.1016/j.fcr.2015.01.003; Hedlund A, 2003, EUR J AGRON, V20, P71, DOI 10.1016/S1161-0301(03)00076-5; Hu RF, 2007, AGR SYST, V94, P331, DOI 10.1016/j.agsy.2006.10.002; Huang SW, 2007, COMMUN SOIL SCI PLAN, V38, P959, DOI 10.1080/00103620701277973; Jha S. K., 2011, Asian Journal of Soil Science, V6, P181; Ji-yun J., 1997, BETTER CROPS INT, V11, P16; Ju XT, 2005, SCI CHINA SER C, V48, P965, DOI [10.1360/062005-288, 10.1007/BF03187135]; Li GH, 2016, NUTR CYCL AGROECOSYS, V104, P341, DOI 10.1007/s10705-015-9736-z; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Limin Sun, 2011, Frontiers of Agriculture in China, V5, P563, DOI 10.1007/s11703-011-1140-0; Liu R.L., 2000, SOILS FERT, V1, P9; Liu XM, 2009, GEODERMA, V152, P23, DOI 10.1016/j.geoderma.2009.05.022; [刘义国 Liu Yiguo], 2013, [中国农学通报, Chinese Agricultural Science Bulletin], V29, P131; Liu YX, 2017, NUTR CYCL AGROECOSYS, V107, P247, DOI 10.1007/s10705-017-9833-2; Malo DD, 2005, SOIL TILL RES, V81, P277, DOI 10.1016/j.still.2004.09.015; Ministry of Agriculture PRC, 1981, CHIN AGR STAT REP; Niu JF, 2013, FIELD CROP RES, V140, P69, DOI 10.1016/j.fcr.2012.10.008; Oelofse M, 2010, NUTR CYCL AGROECOSYS, V87, P455, DOI 10.1007/s10705-010-9351-y; Sanchez PA, 1997, EUR J AGRON, V7, P15, DOI 10.1016/S1161-0301(97)00034-8; Sheldrick WF, 2004, FOOD POLICY, V29, P61, DOI 10.1016/j.foodpol.2004.01.004; Sheldrick WF, 2003, AGR ECOSYST ENVIRON, V94, P341, DOI 10.1016/S0167-8809(02)00038-5; Sheldrick WF, 2002, NUTR CYCL AGROECOSYS, V62, P61, DOI 10.1023/A:1015124930280; Shen RP, 2005, PEDOSPHERE, V15, P347; Smaling EMA, 2000, OUTLOOK AGR, V29, P193, DOI 10.5367/000000000101293239; Smaling EMA, 1996, COMMUN SOIL SCI PLAN, V27, P365, DOI 10.1080/00103629609369562; Spiess E, 2011, NUTR CYCL AGROECOSYS, V91, P351, DOI 10.1007/s10705-011-9466-9; Stoorvogel JJ, 1998, NUTR CYCL AGROECOSYS, V50, P151, DOI 10.1023/A:1009732126336; Tan DS, 2012, AGR ECOSYST ENVIRON, V148, P65, DOI 10.1016/j.agee.2011.11.016; Tan DeShui, 2007, Scientia Agricultura Sinica, V40, P133, DOI 10.1016/S1671-2927(07)60035-2; Wang HJ, 2008, NUTR CYCL AGROECOSYS, V81, P203, DOI 10.1007/s10705-007-9157-8; Wang HongTing, 2010, Plant Nutrition and Fertilizer Science, V16, P801; Wang SJ, 1999, J CHEM FERT IND, V26, P12; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Wang XL, 2014, AGR ECOSYST ENVIRON, V193, P42, DOI 10.1016/j.agee.2014.04.027; Wijnhoud JD, 2003, AGR ECOSYST ENVIRON, V100, P119, DOI 10.1016/S0167-8809(03)00180-4; Wortmann CS, 1998, AGR ECOSYST ENVIRON, V71, P115, DOI 10.1016/S0167-8809(98)00135-2; Xu Y, 2014, THESIS; Yan Xiang, 2008, Scientia Agricultura Sinica, V41, P450; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang HM, 2010, NUTR CYCL AGROECOSYS, V88, P341, DOI 10.1007/s10705-010-9359-3	56	10	12	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184156	10.1371/journal.pone.0184156	http://dx.doi.org/10.1371/journal.pone.0184156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873448	gold, Green Submitted, Green Published			2022-12-26	WOS:000409282800056
J	Phelps, QE; Tripp, SJ; Bales, KR; James, D; Hrabik, RA; Herzog, DP				Phelps, Quinton E.; Tripp, Sara J.; Bales, Kyle R.; James, Daniel; Hrabik, Robert A.; Herzog, David P.			Incorporating basic and applied approaches to evaluate the effects of invasive Asian Carp on native fishes: A necessary first step for integrated pest management	PLOS ONE			English	Article							SILVER CARP; ENVIRONMENTAL IMPACTS; HYPOPHTHALMICHTHYS-MOLITRIX; COMMON CARP; BACI; COMPETITION; DESIGNS; USA	Numerous studies throughout North America allege deleterious associations among invasive Asian Carp and native fishes; however, no empirical evidence on a system-wide scale exists. We used Mississippi River Basin fish community data collected by the Long Term Resource Monitoring program and the Missouri Department of Conservation to evaluate possible interaction between Asian Carp and native fishes. Results from two decades of long-term monitoring throughout much of the Mississippi River suggest that Silver Carp relative abundance has increased while relative abundance (Bigmouth Buffalo [F (3, 8240) = 6.44, P<0.01] and Gizzard Shad [F (3, 8240) = 31.04, P<0.01]) and condition (Bigmouth Buffalo [slope = -0.11; t = -1.71; P = 0.1014] and Gizzard Shad [slope = -0.39; t = -3.02; P = 0.0073]) of native planktivores have declined. Floodplain lake qualitative evaluations yielded similar results; floodplain lake fish communities were likely altered (i.e., reductions in native species) by Silver Carp. Furthermore, laboratory experiments corroborated field evidence; Silver Carp negatively influence native planktivores through competition for prey (all comparisons, P > 0.05). To this end, this study provides evidence that Silver Carp are likely adversely influencing native fishes; however, mere presence of Silver Carp in the system does not induce deleterious effects on native fishes. To the best of our knowledge, this evaluation is the first to describe the effects of Asian Carp throughout the Mississippi River Basin and could be used to reduce the effects of Asian Carp on native biota through an integrated pest management program as suggested by congressional policy. Despite the simplicity of the data analyzed and approach used, this study provides a framework for beginning to identify the interactions of invasive fish pests on native fishes (i.e., necessary first step of integrated pest management). However, knowledge gaps remain. We suggest future efforts should conduct more in depth analyses (i.e., multivariate statistical approaches) that investigate the influence on all native species.	[Phelps, Quinton E.] West Virginia Univ, Div Forestry & Nat Resources, 322 Percival Hall, Morgantown, WV 26506 USA; [Tripp, Sara J.; Hrabik, Robert A.; Herzog, David P.] Missouri Dept Conservat, 3815 East Jackson Blvd, Jackson, MO USA; [Bales, Kyle R.] Iowa Dept Nat Resources, 206 Rose St, Bellevue, IA USA; [James, Daniel] US Fish & Wildlife Serv, Great Plains Fish & Wildlife Conservat Off, Pierre, SD USA	West Virginia University; United States Department of the Interior; US Fish & Wildlife Service	Phelps, QE (corresponding author), West Virginia Univ, Div Forestry & Nat Resources, 322 Percival Hall, Morgantown, WV 26506 USA.	quinton.phelps@mail.wvu.edu						Berg L.S., 1964, FRESHWATER FISHES US, V2; BITTERLICH G, 1985, HYDROBIOLOGIA, V121, P173, DOI 10.1007/BF00008721; BURKE JS, 1986, AQUACULTURE, V55, P59, DOI 10.1016/0044-8486(86)90056-6; Chadderton WL, 2003, MANAGING INVASIVE FRESHWATER FISH IN NEW ZEALAND, P71; COSTAPIERCE BA, 1992, REV AQUAT SCI, V6, P257; Crowder L.B., 1990, P609; DE BACH P., 1964, Biological control of insect pests and weeds; Ehrlich PR, 1984, ECOLOGY BIOL INVASIO, P79, DOI [10.1007/978-1-4612-4988-7_5, DOI 10.1007/978-1-4612-4988-7_5]; Fremling C. R., 1989, P LAG RIV S, P309; Fuller PL, 1999, NONINDIGENOUS FISHES; Garvey J.E., 2006, GROWTH FECUNDITY DIE; Gause G. F., 1934, STRUGGLE EXISTENCE; GUTREUTER S, 1995, LONG TERM RESOURCE M; Hoover JJ, 2012, AQUATIC INVADERS; Ickes BS, 2005, 2005T005 US GEOL SUR; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Koehn JD, 2004, NEW ZEAL J MAR FRESH, V38, P457, DOI 10.1080/00288330.2004.9517253; Kogan M, 1998, ANNU REV ENTOMOL, V43, P243, DOI 10.1146/annurev.ento.43.1.243; Kolar C.S., 2005, ASIAN CARPS GENUS HY, V5, P1; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Li ZY, 2002, INVASIVE ALIEN SPECI, P51; Lowe S., 2000, ENCY BIOL INVASIONS; Lu M, 2002, HYDROBIOLOGIA, V487, P19, DOI 10.1023/A:1022940716736; Mills MD, 2004, OECOLOGIA, V141, P713, DOI 10.1007/s00442-004-1695-z; Milstein A, 2006, AQUACULTURE, V258, P439, DOI 10.1016/j.aquaculture.2006.04.045; Newsom LD, 1968, ADV PRODUCTION UTILI, P367; Noatch MR, 2012, NONPHYSICAL BARRIERS; Norris R. F., 2003, CONCEPTS INTEGRATED, V1; Pavlovskaya LP, 1995, INLAND FISHERIES IMP, V894, P42; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Ratcliff E.N., 2014, 2014P001 LTRMP, P88; Sampson SJ, 2009, BIOL INVASIONS; Sass GG, 2014, J GREAT LAKES RES; SAWYER AJ, 1980, CAN J FISH AQUAT SCI, V37, P2081, DOI 10.1139/f80-249; Schofield P.J., 2005, 20055041 US GEOL SUR, P103, DOI DOI 10.3996/112012-JFWM-101/SUPPL_FILE/10.3996_112012-JFWM-101.S1.PDF; Schramm H, AM FISH SOC S BOOK; Schrank SJ, 2003, T AM FISH SOC, V132, P1222, DOI 10.1577/T02-071; Seibert JR, 2015, MANAG BIOL INVASION, V6, P295, DOI 10.3391/mbi.2015.6.3.08; Seiler SM, 2009, CAN J FISH AQUAT SCI, V66, P133, DOI 10.1139/F08-194; SINGH SB, 1967, P NATL A SCI INDIA B, V37, P320; SPATARU P, 1977, AQUACULTURE, V11, P137, DOI 10.1016/0044-8486(77)90071-0; SPATARU P, 1985, HYDROBIOLOGIA, V120, P53, DOI 10.1007/BF00034590; STERN VERNON M., 1959, HILGARDIA, V29, P81; Taylor J.N., 1984, P322; Thresher RE, 2014, BIOL INVASIONS, V16, P1201, DOI 10.1007/s10530-013-0477-0; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; United States Fish and Wildlife Service, 2012, 1 ANN C SUMM ACT EXP; United States Geological Survey, 1998, EC STAT TRENDS UPP M; Vetter BJ, 2015, BIOL INVASIONS; Weber MJ, 2011, ECOL FRESHW FISH, V20, P270, DOI 10.1111/j.1600-0633.2011.00493.x; Wilcox D B, 1993, AQUATIC HABITAT CLAS; Xie P, 2000, J PLANKTON RES, V22, P1757, DOI 10.1093/plankt/22.9.1757; Xie P., 2003, SILVER CARP BIGHEAD	57	22	23	9	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184081	10.1371/journal.pone.0184081	http://dx.doi.org/10.1371/journal.pone.0184081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873472	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800048
J	Ruggles, KV; Patel, AR; Schensul, S; Schensul, J; Nucifora, K; Zhou, QL; Bryant, K; Braithwaite, RS				Ruggles, Kelly V.; Patel, Anik R.; Schensul, Stephen; Schensul, Jean; Nucifora, Kimberly; Zhou, Qinlian; Bryant, Kendall; Braithwaite, R. Scott			Betting on the fastest horse: Using computer simulation to design a combination HIV intervention for future projects in Maharashtra, India	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; COST-EFFECTIVENESS; ANTIRETROVIRAL THERAPY; BEHAVIORAL INTERVENTIONS; CLINICAL IMPACT; ALCOHOL-USE; METAANALYSIS; PREVENTION; ADHERENCE; RISK	Objective To inform the design of a combination intervention strategy targeting HIV-infected unhealthy alcohol users in Maharashtra, India, that could be tested in future randomized control trials. Methods Using probabilistic compartmental simulation modeling we compared intervention strategies targeting HIV-infected unhealthy alcohol users on antiretroviral therapy (ART) in Maharashtra, India. We tested interventions targeting four behaviors (unhealthy alcohol consumption, risky sexual behavior, depression and antiretroviral adherence), in three formats (individual, group based, community) and two durations (shorter versus longer). A total of 5,386 possible intervention combinations were tested across the population for a 20-year time horizon and intervention bundles were narrowed down based on incremental cost-effectiveness analysis using a two-step probabilistic uncertainty analysis approach. Results Taking into account uncertainty in transmission variables and intervention cost and effectiveness values, we were able to reduce the number of possible intervention combinations to be used in a randomized control trial from over 5,000 to less than 5. The most robust intervention bundle identified was a combination of three interventions: long individual alcohol counseling; weekly Short Message Service (SMS) adherence counseling; and brief sex risk group counseling. Conclusions In addition to guiding policy design, simulation modeling of HIV transmission can be used as a preparatory step to trial design, offering a method for intervention pre-selection at a reduced cost.	[Ruggles, Kelly V.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Patel, Anik R.] Univ British Columbia, Fac Med, Dept Expt Med, Vancouver, BC, Canada; [Schensul, Stephen] Univ Connecticut, Hlth Ctr, Dept Community Med & Hlth Care, Farmington, CT USA; [Schensul, Jean] Inst Community Res, Hartford, CT USA; [Nucifora, Kimberly; Zhou, Qinlian; Braithwaite, R. Scott] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Bryant, Kendall] Natl Inst Alcohol Abuse & Alcoholism, Bethesda, MD USA	New York University; University of British Columbia; University of Connecticut; New York University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Ruggles, KV (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	Kelly.ruggles@nyumc.org		Braithwaite, Ronald Scott/0000-0001-7067-3655; Ruggles, Kelly/0000-0002-0152-0863	National Institute of Alcohol Abuse and Alcoholism [U01AA021990-01]	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U01AA021990-01 from National Institute of Alcohol Abuse and Alcoholism, https://www.niaaa.nih.gov/. Funding received by SS and JS.	Abuelezam NN, 2016, AM J EPIDEMIOL, V184, P239, DOI 10.1093/aje/kwv344; Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; Allam RR, 2014, T ROY SOC TROP MED H, V108, P198, DOI 10.1093/trstmh/tru025; [Anonymous], 2017, WORLD FACTBOOK; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braithwaite RS, 2007, ANN INTERN MED, V146, P133, DOI 10.7326/0003-4819-146-2-200701160-00008; Braithwaite RS, 2014, ALCOHOL CLIN EXP RES, V38, P1059, DOI 10.1111/acer.12332; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Brown JL, 2014, CURR HIV-AIDS REP, V11, P363, DOI 10.1007/s11904-014-0228-6; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Cuadros DF, 2014, COMPUT BIOL MED, V50, P1, DOI 10.1016/j.compbiomed.2014.03.008; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Foxcroft DR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007025.pub4; Foxcroft DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007025.pub2; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Gibson E., 2016, J MARK ACCESS HLTH P, V4; Gold MR, 2006, COST EFFECTIVENESS H; Holford NHG, 2000, ANNU REV PHARMACOL, V40, P209, DOI 10.1146/annurev.pharmtox.40.1.209; Huang Xiaoli, 2006, AMIA Annu Symp Proc, P359; Kagaayi J, 2016, CURR HIV-AIDS REP, V13, P187, DOI 10.1007/s11904-016-0318-8; Kessler J, 2015, ALCOHOL CLIN EXP RES, V39, P2179, DOI 10.1111/acer.12890; Kessler J, 2014, AIDS, V28, P2683, DOI 10.1097/QAD.0000000000000460; Kessler J, 2013, CURR OPIN HIV AIDS, V8, P544, DOI 10.1097/COH.0000000000000005; Kessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073269; Kroese D, 2013, STAT MODELING COMPUT; Mahanta J, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000343764.62455.9e; MARCUS R, 1993, AM J MED, V94, P363, DOI 10.1016/0002-9343(93)90146-G; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mehendale SM, 2002, AIDS RES HUM RETROV, V18, P1175, DOI 10.1089/08892220260387913; Mills EJ, 2014, LANCET HIV, V1, pE104, DOI 10.1016/S2352-3018(14)00003-4; Moreno R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003363.pub3; NACO, 2014, ANN REP 2013 2014; NACO, 2013, ANN REP 2012 2013; Nag M., 1995, HLTH T REV, V5, P293; Nagy L, 2016, PHARMACOECONOMICS, V34, P939, DOI 10.1007/s40273-016-0430-z; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Obot S.I., 2005, ALCOHOL GENDER DRINK; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Scott-Sheldon LAJ, 2011, JAIDS-J ACQ IMM DEF, V58, P489, DOI 10.1097/QAI.0b013e31823554d7; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Spies G, 2013, J AFFECT DISORDERS, V150, P171, DOI 10.1016/j.jad.2013.04.018; Tadios Yonas, 2006, Ethiop Med J, V44, P237; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Venkatesh KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064604; Volle J, 2009, BASELINE SURVEY MULT; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Yu WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102872	65	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184179	10.1371/journal.pone.0184179	http://dx.doi.org/10.1371/journal.pone.0184179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873452	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800060
J	Liu, HT; Shen, W; Shu, JY; Kou, ZH; Jin, X				Liu, Haitao; Shen, Wei; Shu, Jiayi; Kou, Zhihua; Jin, Xia			A novel polyepitope vaccine elicited HIV peptide specific CD4+T cell responses in HLA-A2/DRB1 transgenic mice	PLOS ONE			English	Article							EPITOPES; DESIGN	Human immunodeficiency (HIV) infection is a leading global health problem that causes approximately one million deaths each year. Although antiretroviral therapy can slow down the disease progression and improve the quality of life of infected individuals, it cannot eradicate the virus. A successful vaccine is one of the most cost-effective alternatives to control the incidence and mortality of HIV infection. CD4+ T cells play a key role in orchestrating other forms of human immune responses, therefore, an HIV vaccine that includes a component capable of eliciting CD4+ T cell responses is highly desirable. To this end, we have previously designed a polypeptide vaccine comprised of multiple CD4+ T cell epitopes. In the current study, we tested the immunogenicity of this vaccine in mouse models by using IFN-gamma ELISPOT and intracellular cytokine staining assays. We found that several epitopes in this vaccine elicited CD4+ T cell immune responses in both congenic mice and human HLA-A2/DRB1 transgenic mice. These new epitopes may be further tested for their ability to augment immune responses elicited by other forms of HIV vaccines.	[Liu, Haitao; Shen, Wei; Shu, Jiayi; Jin, Xia] Chinese Acad Sci, Viral Dis & Vaccine Translat Res Unit, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Liu, Haitao] East China Normal Univ, Inst Mol Ecol & Evolut, Shanghai, Peoples R China; [Shu, Jiayi] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Shu, Jiayi] Fudan Univ, Inst Biomed Sci, Key Lab Med Mol Virol, Minist Educ Hlth, Shanghai, Peoples R China; [Kou, Zhihua] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); East China Normal University; Fudan University; Fudan University; Beijing Institute of Microbiology & Epidemiology	Jin, X (corresponding author), Chinese Acad Sci, Viral Dis & Vaccine Translat Res Unit, Inst Pasteur Shanghai, Shanghai, Peoples R China.	xjin@ips.ac.cn			National Major Program Project Grant Against Infectious Diseases [2013ZX10001002-002-002]	National Major Program Project Grant Against Infectious Diseases	The work was funded by the National Major Program Project Grant Against Infectious Diseases (Grant No.2013ZX10001002-002-002). XIA JIN received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2016, GLOBAL AIDS UPDATE 2; Bedoui S, 2016, IMMUNOL REV, V272, P52, DOI 10.1111/imr.12426; Blancou P, 2007, J IMMUNOL, V178, P7458, DOI 10.4049/jimmunol.178.11.7458; Borrow P, 2017, IMMUNOL REV, V275, P62, DOI 10.1111/imr.12504; BURSHTYN DN, 1993, J IMMUNOL, V151, P3082; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; He W, 2017, CAN J MICROBIOL, V63, P493, DOI 10.1139/cjm-2016-0528; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Korber B, 2017, IMMUNOL REV, V275, P230, DOI 10.1111/imr.12516; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Muixi L, 2008, J IMMUNOL, V181, P795, DOI 10.4049/jimmunol.181.1.795; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Peter K, 2001, VACCINE, V19, P4121, DOI 10.1016/S0264-410X(01)00179-7; Reguzova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116412; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sharma K, 2014, ANN NEUROSCI, V21, P150, DOI 10.5214/ans.0972.7531.210407; Shu J, 2014, DESIGNING PEPTIDE BA, V2014; Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Zhang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171217	24	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184207	10.1371/journal.pone.0184207	http://dx.doi.org/10.1371/journal.pone.0184207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863168	Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900040
J	Balachandran, M; Giannone, RJ; Bemis, DA; Kania, SA				Balachandran, Manasi; Giannone, Richard J.; Bemis, David A.; Kania, Stephen A.			Molecular basis of surface anchored protein A deficiency in the Staphylococcus aureus strain Wood 46	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; ENTEROTOXIN-D GENE; CELL-WALL ANCHOR; EXTRACELLULAR PROTEIN; IMMUNE EVASION; ALPHA-TOXIN; IMMUNOLOGICAL REAGENT; ANTIINFECTIVE THERAPY; REGULATORY ELEMENTS; BINDING PROTEINS	Protein A in Staphylococcus aureus is encoded by the spa (staphylococcal protein A) gene and binds to immunoglobulin (Ig). The S. aureus strain Wood 46 has been variously reported as protein A-deficient and/or spa negative and used as a control in animal models of staphylococcal infections. The results of this study indicate that Wood 46 has normal spa expression but transcribes very low levels of the srtA gene which encodes the sortase A (SrtA) enzyme. This is consistent with unique mutations in the srtA promoter. In this study, a low level of sortase A explains deficient anchoring of proteins with an LPXTG motif, such as protein A, fibrinogen-binding protein and fibronectin-binding proteins A and B on to the peptidoglycan cell wall. The activity of secreted protein A is an important consideration for use of Wood 46 in functional experiments and animal models.	[Balachandran, Manasi; Bemis, David A.; Kania, Stephen A.] Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Giannone, Richard J.] Oakridge Natl Labs, Div Chem Sci, Mass Spectrometry & Laser Spectrometry, Oakridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Kania, SA (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	skania@utk.edu	Giannone, Richard/ABC-8247-2020; Kania, Stephen/ABF-6920-2021	Giannone, Richard/0000-0001-8551-0138; Balachandran, Manasi/0000-0002-9804-7426; Kania, Stephen/0000-0002-4490-7347	Tennessee Center of Excellence in Livestock Diseases and Human Health	Tennessee Center of Excellence in Livestock Diseases and Human Health	This work was supported by the Tennessee Center of Excellence in Livestock Diseases and Human Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Ali B, 1977, J GEN MICROBIOL, V99, P277; ABBASALI B, 1977, BIOCHEM SOC T, V5, P420, DOI 10.1042/bst0050420; AMEND A, 1984, ZBL BAKT-INT J MED M, V258, P472, DOI 10.1016/S0176-6724(84)80024-3; Becker S, 2014, P NATL ACAD SCI USA, V111, P1574, DOI 10.1073/pnas.1317181111; Black CC, 2011, VET MICROBIOL, V151, P345, DOI 10.1016/j.vetmic.2011.03.026; Chan AH, 2013, CHEM BIOL DRUG DES, V82, P418, DOI 10.1111/cbdd.12167; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; COLEMAN G, 1977, INFECT IMMUN, V17, P278, DOI 10.1128/IAI.17.2.278-281.1977; COLEMAN G, 1985, J GEN MICROBIOL, V131, P405; COLEMAN G, 1981, J GEN MICROBIOL, V122, P11; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; DOSSETT JH, 1969, J IMMUNOL, V103, P1405; DUGGLEBY CJ, 1983, NUCLEIC ACIDS RES, V11, P3065, DOI 10.1093/nar/11.10.3065; Fenton MS, 2001, P NATL ACAD SCI, V98; FORSGREN A, 1970, Infection and Immunity, V2, P672; FORSGREN A, 1966, J IMMUNOL, V97, P822; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5; Fournier B, 2004, MICROBIOL-SGM, V150, P3807, DOI 10.1099/mic.0.27194-0; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Gemmell CG, 2002, J ANTIMICROB CHEMOTH, V50, P665, DOI 10.1093/jac/dkf192; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Goodyear CS, 2005, SPRING SEM IMM; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Kim HK, 2011, FASEB J, V25, P3605, DOI 10.1096/fj.11-187963; KRISTIANSEN SV, 1994, J IMMUNOL, V153, P2974; KRONVALL G, 1970, Journal of Immunology, V104, P273; KRONVALL G, 1970, IMMUNOCHEMISTRY, V7, P124, DOI 10.1016/0019-2791(70)90036-4; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; MOVITZ J, 1976, EUR J BIOCHEM, V68, P291, DOI 10.1111/j.1432-1033.1976.tb10788.x; NICKERSON DS, 1970, J EXP MED, V131, P1039, DOI 10.1084/jem.131.5.1039; Novick RP, 2000, PATHOGENICITY FACTOR, P392; O'Halloran DP, 2015, INFECT IMMUN, V83, P1598, DOI 10.1128/IAI.03122-14; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; PALMER DA, 1994, ANALYST, V119, P2769, DOI 10.1039/an9941902769; Palmqvist N, 2005, MICROBES INFECT, V7, P1501, DOI 10.1016/j.micinf.2005.05.008; PETERSSO.BA, 1972, EUR J BIOCHEM, V29, P579; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; SAIKI O, 1993, J IMMUNOL, V150, P3224; Saravia-Otten P, 2007, J INFECT DIS, V196, P748, DOI 10.1086/520537; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Silverman GJ, 2002, CLIN IMMUNOL, V102, P117, DOI 10.1006/clim.2001.5143; SJOQUIST J, 1972, EUR J BIOCHEM, V30, P190, DOI 10.1111/j.1432-1033.1972.tb02086.x; Smith EJ, 2011, INFECT IMMUN, V79, P3801, DOI 10.1128/IAI.05075-11; STRANEY R, 1994, J BACTERIOL, V176, P5999, DOI 10.1128/jb.176.19.5999-6006.1994; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Tseng CW, 2004, J BACTERIOL, V186, P1793, DOI 10.1128/JB.186.6.1793-1801.2004; Zhang J, 2014, P NATL ACAD SCI USA, V111, P13517, DOI 10.1073/pnas.1408601111; Zhang SP, 2000, J BACTERIOL, V182, P2321, DOI 10.1128/JB.182.8.2321-2325.2000	60	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183913	10.1371/journal.pone.0183913	http://dx.doi.org/10.1371/journal.pone.0183913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859130	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500046
J	Wang, R; Niu, L; Li, Q; Liu, QD; Zuo, H				Wang, Rong; Niu, Lin; Li, Qun; Liu, Qida; Zuo, Hong			The peritubular reinforcement effect of porous dentine microstructure	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; FINITE-ELEMENT; MICROMECHANICS MODEL; HUMAN TEETH; BEHAVIOR; TUBULES; INTERFACE; MODULUS; AGE	In the current study, we evaluate the equivalent stiffness of peritubular reinforcement effect (PRE) of porous dentine optimized by the thickness of peritubular dentine (PTD). Few studies to date have evaluated or quantitated the effect of PRE on composite dentine. The miscrostructure of porous dentine is captured by scanning electron microscope images, and then finite element modeling is used to quantitate the deformation and stiffness of the porous dentine structure. By optimizing the radius of PTD and dentine tubule (DT), the proposed FE model is able to demonstrate the effect of peritubular reinforcement on porous dentine stiffness. It is concluded that the dentinal equivalent stiffness is reduced and degraded with the increase of the radius of DT (i.e., porosity) in the certain ratio value of E-p/E-i and certain radius of PTD, where E-p is the PTD modulus and E-i is the intertubular dentine modulus. So in order to ensure the whole dentinal equivalent stiffness is not loss, the porosity should get some value while the Ep/Ei is certain. Thus, PTD prevents the stress concentration around DTs and reduces the risk of DTs failure. Mechanically, the overall role of PTD appears to enhance the stiffness of the dentine composite structure. These results provide some new and significant insights into the biological evolution of the optimal design for the porous dentine microstructure. These findings on the biological microstructure design of dentine materials are applicable to other engineering structural designs aimed at increasing the overall structural strength.	[Wang, Rong; Li, Qun; Liu, Qida; Zuo, Hong] Xi An Jiao Tong Univ, State Key Lab Strength & Vibrat Mech Struct, Sch Aerosp, Xian, Shaanxi, Peoples R China; [Niu, Lin] Xi An Jiao Tong Univ, Coll Stomatol Hosp, Clin Reaserch Ctr Shaanxi Prov Dent & Maxillofaci, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zuo, H (corresponding author), Xi An Jiao Tong Univ, State Key Lab Strength & Vibrat Mech Struct, Sch Aerosp, Xian, Shaanxi, Peoples R China.; Niu, L (corresponding author), Xi An Jiao Tong Univ, Coll Stomatol Hosp, Clin Reaserch Ctr Shaanxi Prov Dent & Maxillofaci, Xian, Shaanxi, Peoples R China.	niulin@mail.xjtu.edu.cn; zuohong@mail.xjtu.edu.cn	Liu, Qida/AAX-1916-2021; liu, qida/J-5878-2013	liu, qida/0000-0001-6473-428X	National Natural Science Foundation of China [11572235, 11472205, 81100787]; Programs for Science and Technology Development of Shaanxi province [2016 SF-236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for Science and Technology Development of Shaanxi province	This work was supported by the National Natural Science Foundation of China (11572235, 11472205, and 81100787) and the Programs for Science and Technology Development of Shaanxi province (2016 SF-236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2013, ACS APPL MATER INTER, V5, P12052, DOI 10.1021/am4038678; Balooch G, 2004, J BIOMECH, V37, P1223, DOI 10.1016/j.jbiomech.2003.12.012; Borcic J, 2005, J ORAL REHABIL, V32, P504, DOI 10.1111/j.1365-2842.2005.01455.x; Camilleri J, 2014, CLIN ORAL INVEST, V18, P1437, DOI 10.1007/s00784-013-1124-y; Currey JD, 1999, J EXP BIOL, V202, P3285; Dorvee JR, 2016, ARCH ORAL BIOL, V62, P93, DOI 10.1016/j.archoralbio.2015.11.008; Dutra-Correa M, 2007, ARCH ORAL BIOL, V52, P850, DOI 10.1016/j.archoralbio.2007.03.003; Gibson LJ, 1997, CELLULAR SOLIDS STRU; Gotliv BA, 2006, J STRUCT BIOL, V156, P320, DOI 10.1016/j.jsb.2006.02.005; Han CF, 2012, J MECH BEHAV BIOMED, V12, P1, DOI 10.1016/j.jmbbm.2012.03.009; Jin XZ, 2016, DENT MATER, V32, pE238, DOI 10.1016/j.dental.2016.07.005; Johnson WW, 2002, J PROSTHODONT, V11, P224; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103; Kinney JH, 1999, ARCH ORAL BIOL, V44, P813, DOI 10.1016/S0003-9969(99)00080-1; Kishen A, 2007, DENT MATER, V23, P1296, DOI 10.1016/j.dental.2006.11.018; Kishen A, 2005, J BIOMED MATER RES A, V73A, P192, DOI 10.1002/jbm.a.30288; Kishen A, 2000, J BIOMED MATER RES, V51, P650, DOI 10.1002/1097-4636(20000915)51:4<650::AID-JBM13>3.0.CO;2-H; Lin M, 2010, DENT MATER, V26, P501, DOI 10.1016/j.dental.2010.02.009; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Martini AP, 2009, J APPL ORAL SCI, V17, P19, DOI 10.1590/S1678-77572009000700005; Misra A, 2005, J R SOC INTERFACE, V2, P145, DOI 10.1098/rsif.2005.0029; Misra A, 2004, J BIOMED MATER RES B, V70B, P56, DOI 10.1002/jbm.b.30012; Mjor IA, 1996, ARCH ORAL BIOL, V41, P401, DOI 10.1016/0003-9969(96)00008-8; Nanci A., 2008, 10 CATES ORAL HISTOL; Nazari A, 2009, J MECH BEHAV BIOMED, V2, P550, DOI 10.1016/j.jmbbm.2009.01.008; Qin QH, 2004, BIOMATERIALS, V25, P5081, DOI 10.1016/j.biomaterials.2003.12.042; Ryou H, 2015, J MECH BEHAV BIOMED, V42, P229, DOI 10.1016/j.jmbbm.2014.11.021; Senawongse P, 2006, ARCH ORAL BIOL, V51, P457, DOI 10.1016/j.archoralbio.2005.11.006; Toledano M, 2016, J MECH BEHAV BIOMED, V54, P33, DOI 10.1016/j.jmbbm.2015.09.003; Vennat E, 2009, DENT MATER, V25, P729, DOI 10.1016/j.dental.2008.12.002; Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096; Xu CQ, 2012, ARCH ORAL BIOL, V57, P383, DOI 10.1016/j.archoralbio.2011.09.008; Ziskind D, 2010, DENT MATER, V26, P179, DOI 10.1016/j.dental.2009.09.012	33	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183982	10.1371/journal.pone.0183982	http://dx.doi.org/10.1371/journal.pone.0183982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859165	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500054
J	Bankston, JR; DeBerg, HA; Stoll, S; Zagotta, WN				Bankston, John R.; DeBerg, Hannah A.; Stoll, Stefan; Zagotta, William N.			Mechanism for the inhibition of the cAMP dependence of HCN ion channels by the auxiliary subunit TRIP8b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; PACEMAKER CHANNELS; STRUCTURAL BASIS; PROTEIN TRIP8B; TRAFFICKING; MODULATION; EXPRESSION; SITES; BRAIN; DEER	TRIP8b, an accessory subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels, alters both the cell surface expression and cyclic nucleotide dependence of these channels. However, the mechanism by which TRIP8b exerts these dual effects is still poorly understood. In addition to binding to the carboxyl-terminal tripeptide of HCN channels, TRIP8b also binds directly to the cyclic nucleotide-binding domain (CNBD). That interaction, which requires a small central portion of TRIP8b termed TRIP8bcore, is both necessary and sufficient for reducing the cAMP-dependent regulation ofHCN channels. Here, using fluorescence anisotropy, we report that TRIP8b binding to the CNBD of HCN2 channels decreases the apparent affinity of cAMP for the CNBD. We explored two possible mechanisms for this inhibition. A noncompetitive mechanism in which TRIP8b inhibits the conformational change of the CNBD associated with cAMP regulation and a competitive mechanism in which TRIP8b and cAMP compete for the same binding site. To test these two mechanisms, we used a combination of fluorescence anisotropy, biolayer interferometry, and double electron-electron resonance spectroscopy. Fitting these models to our fluorescence anisotropy binding data revealed that, surprisingly, the TRIP8b-dependent reduction of cAMP binding to the CNBD can largely be explained by partial competition between TRIP8b and cAMP. On the basis of these findings, we propose that TRIP8b competes with a portion of the cAMP-binding site or distorts the binding site by making interactions with the binding pocket, thus acting predominantly as a competitive antagonist that inhibits the cyclic-nucleotide dependence of HCN channels.	[Bankston, John R.; DeBerg, Hannah A.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA; [DeBerg, Hannah A.; Stoll, Stefan] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@uw.edu	Bankston, John/I-7429-2019; Stoll, Stefan/C-5225-2008	Bankston, John/0000-0002-9478-2335; Stoll, Stefan/0000-0003-4255-9550	NIGMS, National Institutes of Health Grant [P41GM103311]; NATIONAL EYE INSTITUTE [K99EY024267, R01EY010329, R00EY024267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074053] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Tom Hinds for technical assistance and Dr. Ning Zheng for the use of the Octet Red96 system. Chimera is developed by the Resource of Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health Grant P41GM103311).	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Collauto A, 2017, PHYS CHEM CHEM PHYS, V19, P15324, DOI 10.1039/c7cp01925d; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DeBerg HA, 2015, STRUCTURE, V23, P734, DOI 10.1016/j.str.2015.02.007; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Georgieva ER, 2012, J MAGN RESON, V216, P69, DOI 10.1016/j.jmr.2012.01.004; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hu L, 2013, J GEN PHYSIOL, V142, P599, DOI 10.1085/jgp.201311013; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	30	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17794	17803		10.1074/jbc.M117.800722	http://dx.doi.org/10.1074/jbc.M117.800722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28864772	Green Published, hybrid			2022-12-26	WOS:000414013000017
J	Eitas, TK; Stepp, W; Sjeklocha, L; Long, C; Riley, C; Callahan, J; Sanchez, Y; Gough, P; Knowlin, L; van Duin, D; Ortiz-Pujols, S; Jones, S; Maile, R; Hong, Z; Berger, S; Cairns, B				Eitas, Timothy K.; Stepp, Wesley; Sjeklocha, Lucas; Long, Clayton; Riley, Caitlin; Callahan, James; Sanchez, Yolanda; Gough, Peter; Knowlin, Laquanda; van Duin, David; Ortiz-Pujols, Shiara; Jones, Samuel; Maile, Robert; Hong, Zhi; Berger, Scott; Cairns, Bruce			Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 MCP-1; FAILURE ASSESSMENT SCORE; ACUTE KIDNEY INJURY; BARDOXOLONE METHYL; INFLAMMASOME ACTIVATION; CDDO-ME; POLYMORPHISMS; PREVENTION; EXPRESSION; BIOMARKERS	Burn patients suffer from immunological dysfunction for which there are currently no successful interventions. Similar to previous observations, we find that burn shock patients (>= 15% Total Burn Surface Area (TBSA) injury) have elevated levels of the innate immune cytokines Interleukin-6 (IL-6) and Monocyte Chemoattractant Protein-1 (MCP-1)/CC-motif Chemokine Ligand 2(CCL2) early after hospital admission (0-48 Hours Post-hospital Admission (HPA). Functional immune assays with patient Peripheral Blood Mononuclear Cells (PBMCs) revealed that burn shock patients (>= 15% TBSA) produced elevated levels of MCP-1/CCL2 after innate immune stimulation ex vivo relative to mild burn patients. Interestingly, treatment of patient PBMCs with the Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) agonist, CDDO-Me(bardoxolone methyl), reduced MCP-1 production but not IL-6 or Interleukin-10 (IL-10) secretion. In enriched monocytes from healthy donors, CDDO-Me (bardoxolone methyl) also reduced LPS-induced MCP1/CCL2 production but did not alter IL-6 or IL-10 secretion. Similar immunomodulatory effects were observed with Compound 7, which activates the NRF2 pathway through a different and non-covalent Mechanism Of Action (MOA). Hence, our findings with CDDO-Me(bardoxolone methyl) and Compound 7 are likely to reflect a generalizable aspect of NRF2 activation. These observed effects were not specific to LPS-induced immune responses, as NRF2 activation also reduced MCP1/CCL2 production after stimulation with IL-6. Pharmacological NRF2 activation reduced Mcp-1/Ccl2 transcript accumulation without inhibiting either II-6 or II-10 transcript levels. Hence, we describe a novel aspect of NRF2 activation that may contribute to the beneficial effects of NRF2 agonists during disease. Our work also demonstrates that the NRF2 pathway is retained and can be modulated to regulate important immunomodulatory functions in burn patient immune cells.	[Eitas, Timothy K.; Gough, Peter; Berger, Scott] GlaxoSmithKline, Infect Dis Therapy Area Unit, Host Def Discovery Performance Unit, Collegeville, PA 19426 USA; [Stepp, Wesley; Sjeklocha, Lucas; Long, Clayton; Riley, Caitlin; Knowlin, Laquanda; Ortiz-Pujols, Shiara; Jones, Samuel; Maile, Robert; Cairns, Bruce] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA; [Callahan, James; Sanchez, Yolanda] GlaxoSmithKline, Resp Therapy Area Unit, Stress & Repair Discovery Performance Unit, Upper Merion, PA USA; [van Duin, David] Univ North Carolina Chapel Hill, Div Infect Dis, Chapel Hill, NC USA; [Hong, Zhi] GlaxoSmithKline, Infect Dis Therapy Area Unit, Durham, NC USA	GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline	Berger, S (corresponding author), GlaxoSmithKline, Infect Dis Therapy Area Unit, Host Def Discovery Performance Unit, Collegeville, PA 19426 USA.; Cairns, B (corresponding author), Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA.	scott.b.berger@gsk.com; bruce_cairns@med.unc.edu	van Duin, David/AAH-7085-2019	van Duin, David/0000-0003-4784-3227; Sjeklocha, Lucas/0000-0003-0658-3377; Stepp, Wesley/0000-0003-2213-1872; Maile, Robert/0000-0002-9126-4188	GlaxoSmithKline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008450, K08GM109106] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors (TKE, JC, YS, PG, ZH, SB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Biswas P, 1998, BLOOD, V91, P258, DOI 10.1182/blood.V91.1.258.258_258_265; Brenner D, 2006, STROKE, V37, P1691, DOI 10.1161/01.STR.0000226565.76113.6c; Chen Z, 2016, ONCOTARGET, P8189; Davies TG, 2016, J MED CHEM, V59, P3991, DOI 10.1021/acs.jmedchem.6b00228; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eba S, 2013, AM J RESP CELL MOL, V49, P324, DOI 10.1165/rcmb.2011-0396OC; Franz MG, 2007, CURR PROB SURG, V44, P691, DOI 10.1067/j.cpsurg.2007.07.001; Furukawa K, 2002, ANN SURG, V236, P112, DOI 10.1097/00000658-200207000-00017; Gopal S, 2017, MULT SCLER; Grunwell JR, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1052-0; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Ishikawa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00383; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; JESCHKE MG, 2007, CRIT CARE, V11, P45501; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Maile R, 2015, AM J PHYSIOL-LUNG C, V308, pL855, DOI 10.1152/ajplung.00321.2014; Martin-Ventura JL, 2009, REV ESP CARDIOL, V62, P677, DOI 10.1016/S0300-8932(09)71335-1; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Noel S, 2014, SHOCK, V42, P392, DOI 10.1097/SHK.0000000000000236; Pandharipande PP, 2009, CRIT CARE MED, V37, P1317, DOI 10.1097/CCM.0b013e31819cefa9; Peck M, 2009, B WORLD HEALTH ORGAN, V87, P802, DOI 10.2471/BLT.08.059733; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Ramnath RD, 2008, INT IMMUNOPHARMACOL, V8, P810, DOI 10.1016/j.intimp.2008.01.033; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; Rowan MP, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0961-2; Ruiz-Castilla M, 2016, SHOCK, V45, P117, DOI 10.1097/SHK.0000000000000497; Ruotsalainen AK, 2013, CARDIOVASC RES, V98, P107, DOI 10.1093/cvr/cvt008; Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248; Shimoyama Y, 2014, INT J MED SCI, V11, P726, DOI 10.7150/ijms.8590; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Walsh J, 2014, J PROTEOMICS, V108, P171, DOI 10.1016/j.jprot.2014.05.007; Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872; Wise RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163716; Wu J, 2014, TOXICOLOGY, V318, P22, DOI 10.1016/j.tox.2014.01.008; Yeh FL, 2000, BURNS, V26, P454, DOI 10.1016/S0305-4179(99)00174-6; Yore MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022862; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114	47	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184164	10.1371/journal.pone.0184164	http://dx.doi.org/10.1371/journal.pone.0184164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886135	gold, Green Submitted, Green Published			2022-12-26	WOS:000410001100073
J	Guan, WJ; Yuan, JJ; Huang, Y; Li, HM; Chen, RC; Zhong, NS				Guan, Wei-jie; Yuan, Jing-jing; Huang, Yan; Li, Hui-min; Chen, Rong-chang; Zhong, Nan-shan			Residual volume/total lung capacity ratio confers limited additive significance to lung clearance index for assessment of adults with bronchiectasis	PLOS ONE			English	Article							INERT-GAS WASHOUT; PULMONARY-FUNCTION; CYSTIC-FIBROSIS; COPD PATIENTS; HYPERINFLATION; CHILDREN; DISEASE; RESPONSIVENESS; TESTS; FLOW	Background Mosaicism and hyperinflation are common pathophysiologic features of bronchiectasis. The magnitude of ventilation heterogeneity might have been affected by the degree of hyperinflation. Some studies have evaluated the discriminative performance of lung clearance index (LCI) in bronchiectasis patients, but the additive diagnostic value of hyperinflation metrics to LCI is unknown. Objective To compare LCI and the ratio of residual volume to total lung capacity (RV/TLC), along with the LCI normalized with RV/TLC, in terms of discriminative performance, correlation and concordance with clinical variables in adults with bronchiectasis. Methods Measurement items included chest high-resolution computed tomography, multiple-breath nitrogen washout test, spirometry, and sputum culture. We analyzed bronchodilator responses by stratifying LCI and RV/TLC according to their median levels (LCIHigh/RV/TLCHigh, LCILow/RV/TLCHigh, LCIHigh/RV/TLCLow, and LCILow/RV/TLCLow). Results Data from 127 adults with clinically stable bronchiectasis were analyzed. LCI had greater diagnostic value than RV/TLC in discriminating moderate-to-severe from mild bronchiectasis, had greater concordance in reflecting clinical characteristics (including the number of bronchiectatic lobes, radiological severity score, and the presence of cystic bronchiectasis). Normalization of LCI with RV/TLC did not contribute to greater discriminative performance or concordance with clinical variables. The LCI, before and after normalization with RV/TLC, correlated statistically with age, sex, HRCT score, Pseudomonas aeruginosa colonization, cystic bronchiectasis, and ventilation heterogeneity (all P < 0.05). Different bronchodilator responses were not significant among the four subgroups of bronchiectasis patients, including those with discordant LCI and RV/TLC levels. Conclusion LCI is superior to RV/TLC for bronchiectasis assessment. Normalization with RV/TLC is not required. Stratification of LCI and RV/TLC is not associated with significantly different bronchodilator responses.	[Guan, Wei-jie; Yuan, Jing-jing; Huang, Yan; Li, Hui-min; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Guan, Wei-jie] Guangzhou Med Univ, Sino French Hoffmann Inst, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Guan, WJ; Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China.; Guan, WJ (corresponding author), Guangzhou Med Univ, Sino French Hoffmann Inst, Guangzhou, Guangdong, Peoples R China.	battery203@.163.com; chenrc@vip.163.com	Guan, Wei-jie/K-8257-2019		National Natural Science Foundation [81400010, 81500006]; Pearl River S&T Nova Program of Guangzhou [201710010097]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Pearl River S&T Nova Program of Guangzhou; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer	This study was supported by National Natural Science Foundation no. 81400010, Pearl River S&T Nova Program of Guangzhou no. 201710010097, and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme 2017 (to Dr. Guan), National Natural Science Foundation no. 81500006 (to Dr. Gao), Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer no. 2013BAI09B09 (to Profs. Zhong and Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrill J, 2001, AM J RESP CRIT CARE, V164, P1628, DOI 10.1164/ajrccm.164.9.2105083; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chen CL, 2016, INT J CHRONIC OBSTR, V11, P2519, DOI 10.2147/COPD.S110021; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Gonem S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-59; Grillo L, 2015, EUR RESPIR J, V46, P1645, DOI 10.1183/13993003.00152-2015; Guan WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28467; Guan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113373; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Haidopoulou K, 2012, RESP PHYSIOL NEUROBI, V180, P247, DOI 10.1016/j.resp.2011.11.016; Irving SJ, 2013, AM J RESP CRIT CARE, V188, P545, DOI 10.1164/rccm.201304-0800OC; Kraemer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-138; Martinez-Garcia MA, 2007, RESP MED, V101, P2248, DOI 10.1016/j.rmed.2007.06.028; McCartney CT, 2016, RESP CARE, V61, P1505, DOI 10.4187/respcare.04323; O'Neill K, 2016, CHEST, V150, P1323, DOI 10.1016/j.chest.2016.06.029; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Rossi A, 2015, RESP MED, V109, P785, DOI 10.1016/j.rmed.2015.03.010; Rowan SA, 2014, AM J RESP CRIT CARE, V189, P586, DOI 10.1164/rccm.201310-1747OC; Stahl M, 2017, AM J RESP CRIT CARE, V195, P349, DOI 10.1164/rccm.201604-0893OC; Verbanck S, 2012, J APPL PHYSIOL, V112, P782, DOI 10.1152/japplphysiol.01221.2011; Zhang W, 2015, RESPIROLOGY, V20, P618, DOI 10.1111/resp.12504; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50; Zheng L, 2002, EUR RESPIR J, V20, P170, DOI 10.1183/09031936.02.00282402	26	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183779	10.1371/journal.pone.0183779	http://dx.doi.org/10.1371/journal.pone.0183779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886040	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100038
J	Lackermair, K; Clauss, S; Voigt, T; Klier, I; Summo, C; Hildebrand, B; Nickel, T; Estner, L; Kaab, S; Wakili, R; Wilbert-Lampen, U				Lackermair, K.; Clauss, S.; Voigt, T.; Klier, I.; Summo, C.; Hildebrand, B.; Nickel, T.; Estner, L.; Kaeaeb, S.; Wakili, R.; Wilbert-Lampen, U.			Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation	PLOS ONE			English	Article							WORLD-CUP SOCCER; AUTONOMIC DENERVATION; ARRHYTHMOGENIC ACTION; CATHETER ABLATION; HEART-FAILURE; STRESS; TRIAL; ASSOCIATION; PREDICTOR; DISEASE	Background The relation between arrhythmias and stress is known. The aim of our current study was to elucidate whether plasma levels of previously described stress parameters are altered in highly symptomatic patients with atrial fibrillation (AF) per se and in patients undergoing ablation therapy by pulmonary vein isolation (PVI). Methods 96 patients with AF undergoing PVI were recruited. Plasma levels of Endothelin-1 (ET-1), MCP-1 and Chromogranin-A (CGA) were measured before and three months after ablation completed with clinical follow-up with respect to AF recurrence. Additionally, we examined 40 healthy age-and sex-matched volunteers as a reference. Results Symptomatic AF patients showed increased levels of ET-1 compared to healthy controls (2.62pg/ml vs. 1.57pg/ml; p<0.01). Baseline levels of ET-1 were higher in patients presenting with AF after PVI (2.96pg/ml vs. 2.57pg/ml; p = 0.02). The temporal comparison revealed decreased ET-1 levels in patients without (2.57pg/ml vs. 2.33pg/ml; p< 0.01) and unchanged ET-1 levels in patients with AF after PVI. Baseline MCP-1 was increased in AF patients vs. controls (268pg/ml vs. 227 pg/ml; p = 0.03). Both groups, with and without AF after PVI, showed an increase of MCP-1 compared to baseline (268pg/ml vs. 349pg/ml; p< 0.01; 281pg/ml vs. 355pg/ml; p = 0.03). CGA was lower in AF patients compared to healthy controls (13.8ng/ml vs. 25.6ng/ml; p< 0.01). Over time patients without AF after PVI showed an increase of CGA (14.2ng/ml vs. 20.7ng/ml; p< 0.01). No change was observed in patients with AF after PVI. Conclusion Our study demonstrated dysregulated levels of ET-1, MCP-1 and CGA in symptomatic AF patients. We could demonstrate an association between ET-1 to presence or absence of AF. Furthermore, we could show that a decrease of ET-1 as well as an increase of CGA after PVI, representing a trend towards control cohort levels, were both associated with restoration of sinus rhythm. These results provide new insights into the role of stress-related biomarkers in AF and AF treatment by ablation therapy.	[Lackermair, K.; Clauss, S.; Voigt, T.; Klier, I.; Summo, C.; Hildebrand, B.; Nickel, T.; Estner, L.; Kaeaeb, S.; Wakili, R.; Wilbert-Lampen, U.] Univ Munich LMU, Dept Med 1, Klinikum Grosshadern, Munich, Germany; [Clauss, S.; Wakili, R.] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site Munich, Munich, Germany; [Wakili, R.] Univ Duisburg Essen, Univ Essen, Dept Cardiol & Vasc Med, West German Heart & Vasc Ctr Essen,Med Sch, Essen, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Duisburg Essen	Wakili, R (corresponding author), Univ Munich LMU, Dept Med 1, Klinikum Grosshadern, Munich, Germany.; Wakili, R (corresponding author), DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site Munich, Munich, Germany.; Wakili, R (corresponding author), Univ Duisburg Essen, Univ Essen, Dept Cardiol & Vasc Med, West German Heart & Vasc Ctr Essen,Med Sch, Essen, Germany.	reza.wakili@uk-essen.de	Carmine, Summo/ABC-6239-2021; Clauss, Sebastian/HDL-7189-2022	Clauss, Sebastian/0000-0002-5675-6128	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK) [81X2600210, 81X2600204]; European Union's Horizon research and innovation programme [633193]	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; German Centre for Cardiovascular Research (DZHK); European Union's Horizon research and innovation programme	Dr. Clauss was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352). Dres. Clauss, Wakili and Kaab were supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204). Dres. Wakili and Kaab received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 633193 (CATCH ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Clauss was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352). Dres. Clauss, Wakili and Ka E a E b were supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204). Dres. Wakili and Ka E a E b received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 633193 (CATCH ME).	Afzal MR, 2017, EXPERT REV CARDIOVAS, V15, P227, DOI 10.1080/14779072.2017.1294064; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Burg MM, 2011, MOL MED, V17, P495, DOI 10.2119/molmed.2010.00083; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; COUMEL P, 1994, EUR HEART J, V15, P9, DOI 10.1093/eurheartj/15.suppl_A.9; COUMEL P, 1994, ARCH MAL COEUR VAISS, V87, P55; Di Comite G, 2011, J HYPERTENS, V29, P409, DOI 10.1097/HJH.0b013e328341a429; Endoh M, 1998, LIFE SCI, V62, P1485, DOI 10.1016/S0024-3205(98)00094-0; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Fabritz L, 2016, NAT REV CARDIOL, V13, P230, DOI 10.1038/nrcardio.2015.194; Hansson Anders, 2004, BMC Cardiovasc Disord, V4, P13, DOI 10.1186/1471-2261-4-13; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047; Katritsis GD, 2014, ARRHYTH ELECTROPHYSI, V3, P113, DOI 10.15420/aer.2014.3.2.113; Kurotobi T, 2015, HEART RHYTHM, V12, P470, DOI 10.1016/j.hrthm.2014.11.033; Lau DH, 2016, EUR HEART J, V37, P1573, DOI 10.1093/eurheartj/ehv375; Lewicka E, 2014, INT J CARDIOL; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Lyman GH, 2016, NEW ENGL J MED, V375, P4, DOI 10.1056/NEJMp1604033; Maryniak A, 2006, KARDIOL POL, V64; Maryniak Agnieszka, 2006, Kardiol Pol, V64, P1102; Mattioli AV, 2005, EUROPACE, V7, P211, DOI 10.1016/j.eupc.2004.02.006; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Merkely B, 2000, CARDIOVASC RES, V48, P357, DOI 10.1016/S0008-6363(00)00200-5; Merkely B, 2000, J CARDIOVASC PHARM, V36, pS314; Miyazaki S, 2016, HEART RHYTHM, V13, P1010, DOI 10.1016/j.hrthm.2015.12.031; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Nakazawa Y, 2009, HEART RHYTHM, V6, P725, DOI 10.1016/j.hrthm.2009.02.027; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nickel T, 2012, ATHEROSCLEROSIS, V220, P219, DOI 10.1016/j.atherosclerosis.2011.09.036; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Pugazhendhi Vijayaraman SAW, 2016, J INTERVENTIONAL CAR, V45, P246; Qin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164989; Rosjo H, 2010, EUR J HEART FAIL, V12, P549, DOI 10.1093/eurjhf/hfq055; Sarah Worsnick P, 2016, GEISINGER HLTH SYSTE, pS48; Schonfelder A RP, 2006, SCHWEIZ MED FORUM, P45; Trautmann A, 2000, J PATHOL, V190, P100, DOI 10.1002/(SICI)1096-9896(200001)190:1<100::AID-PATH496>3.0.CO;2-Q; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Wakili R, 2016, ONE YEAR CLIN OUT CO; Wakili R, 2014, CLIN RES CARDIOL, V103, P97, DOI 10.1007/s00392-013-0625-7; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wang H, 2012, HERZ, V37, P919, DOI 10.1007/s00059-012-3626-9; Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427; Wilbert-Lampen U, 2010, J AM COLL CARDIOL, V55, P637, DOI 10.1016/j.jacc.2009.07.073; Workman AJ, 2010, N-S ARCH PHARMACOL, V381, P235, DOI 10.1007/s00210-009-0474-0; Wozakowska-Kaplon B, 2010, CARDIOL J, V17, P471; Xu FQ, 2017, PACING CLIN ELECTROP; YORIKANE R, 1991, J CARDIOVASC PHARM, V17, pS159, DOI 10.1097/00005344-199100177-00044	51	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184337	10.1371/journal.pone.0184337	http://dx.doi.org/10.1371/journal.pone.0184337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886122	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100099
J	Marangu, D; Mwaniki, H; Nduku, S; Maleche-Obimbo, E; Jaoko, W; Babigumira, J; John-Stewart, G; Rao, D				Marangu, Diana; Mwaniki, Hannah; Nduku, Salome; Maleche-Obimbo, Elizabeth; Jaoko, Walter; Babigumira, Joseph; John-Stewart, Grace; Rao, Deepa			Stakeholder perspectives for optimization of tuberculosis contact investigation in a high-burden setting	PLOS ONE			English	Article							CHILD CONTACTS	Introduction Optimal tuberculosis contact investigation impacts TB prevention, timely case finding and linkage to care, however data on routine implementation in high burden contexts is limited. Materials and methods In a multi-method qualitative study based on individual interviews with TB patients, facility observations and focus group discussions with health workers (HWs) in 13 public health facilities, and key informant interviews with governmental and non-governmental experts, we describe TB contact investigation in the context of an urban setting in Kenya and identify opportunities for optimization. Results Invitation of TB patients to bring close contacts by HWs was key for all patient decisions that led to contact screening in addition to patients' understanding of TB transmission and desire to avoid contacts suffering from TB. Sub-optimal HW enquiry of TB patients and contacts presenting at the facility were missed opportunities which stemmed from lack of standardized operational procedures, documentation tools and HW training. Stakeholders proposed provision of fast tracked and holistic health packages for contacts seeking TB screening, and sustainable government led funding for the requisite infrastructure and workforce. Conclusion TB contact invitation by HWs leading to contact screening occurs in this context. Stake-holder perspectives inform the design of an operational framework for optimized delivery.	[Marangu, Diana; Maleche-Obimbo, Elizabeth] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya; [Marangu, Diana] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Mwaniki, Hannah] Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya; [Nduku, Salome] Semant Africa Ltd, Nairobi, Kenya; [Jaoko, Walter] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Babigumira, Joseph; John-Stewart, Grace; Rao, Deepa] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Paediat, Seattle, WA 98195 USA; [Rao, Deepa] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Nairobi; University of Nairobi; University of Nairobi; University of Nairobi; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Marangu, D (corresponding author), Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya.; Marangu, D (corresponding author), Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya.	dmarangu@uonbi.ac.ke	Jaoko, Walter/AAN-5048-2020; Babigumira, Joseph/T-4208-2019; John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	Marangu, Diana/0000-0003-3895-2210; John-Stewart, Grace/0000-0002-4301-1573; Jaoko, Walter/0000-0002-7134-6581	International AIDS Research Training Program (IARTP); Fogarty International Centre, National Institutes of Health (NIH) [1 D43 TW009580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009580] Funding Source: NIH RePORTER	International AIDS Research Training Program (IARTP); Fogarty International Centre, National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Diana Marangu is a recipient of the International AIDS Research Training Program (IARTP) MPH-PhD Implementation Science Scholarship funded by the Fogarty International Centre, National Institutes of Health (NIH) (1 D43 TW009580). Grace John-Stewart holds an NIH K24 Mentoring Award (K24 HD54314). Hannah Mwaniki and Salome Nduku received funding from the study budget as research assistants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, KEN NAT STRAT PLAN T; [Anonymous], 2015, GLOB TUB REP; [Anonymous], 2011, GUID INT TUB CAS FIN; [Anonymous], 2016, GLOB TUB REP; Assefa D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129135; Faccini M, 2015, EPIDEMIOLOGY INFECT; Fair E, 2015, INT J TUBERC LUNG D, V19, P269, DOI 10.5588/ijtld.14.0512; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Gerald LB, 2003, INT J TUBERC LUNG D, V7, pS369; Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645; Khaparde Kshitij, 2015, Tuberc Res Treat, V2015, P670167, DOI 10.1155/2015/670167; Kumwenda M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154103; Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933; Marangu D, 2016, ADAPTING STIGMA SCAL; Matsumoto Kenji, 2014, Kekkaku, V89, P515; Ottmani S., 2009, Eastern Mediterranean Health Journal, V15, P494; Thanh THT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-713; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2012, REC INV CONT PERS IN; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183749	10.1371/journal.pone.0183749	http://dx.doi.org/10.1371/journal.pone.0183749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886072	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100035
J	Ostermann, AI; Waindok, P; Schmidt, MJ; Chiu, CY; Smyl, C; Rohwer, N; Weylandt, KH; Schebb, NH				Ostermann, Annika I.; Waindok, Patrick; Schmidt, Moritz J.; Chiu, Cheng-Ying; Smyl, Christopher; Rohwer, Nadine; Weylandt, Karsten-H.; Schebb, Nils Helge			Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; EPOXIDE HYDROLASE INHIBITORS; ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; CYTOCHROME-P450 ENZYMES; QUANTITATIVE-ANALYSIS; OMEGA-3 INDEX; HUMAN PLASMA; RISK-FACTOR	Dietary intervention and genetic fat-1 mice are two models for the investigation of effects associated with omega-3 polyunsaturated fatty acids (n3-PUFA). In order to assess their power to modulate the fatty acid and oxylipin pattern, we thoroughly compared fat-1 and wild-type C57BL/6 mice on a sunflower oil diet with wild-type mice on the same diet enriched with 1% EPA and 1% DHA for 0, 7, 14, 30 and 45 days. Feeding led after 14-30 days to a high steady state of n3-PUFA in all tissues at the expense of n6-PUFAs. Levels of n3-PUFA achieved by feeding were higher compared to fat-1 mice, particularly for EPA (max. 1.7% in whole blood of fat-1 vs. 7.8% following feeding). Changes in PUFAs were reflected in most oxylipins in plasma, brain and colon: Compared to wild-type mice on a standard diet, arachidonic acid metabolites were overall decreased while EPA and DHA oxylipins increased with feeding more than in fat-1 mice. In plasma of n3-PUFA fed animals, EPA and DHA metabolites from the lipoxygenase and cytochrome P450 pathways dominated over ARA derived counterparts. Fat-1 mice show n3-PUFA level which can be reached by dietary interventions, supporting the applicability of this model in n3-PUFA research. However, for specific questions, e.g. the role of EPA derived mediators or concentration dependent effects of (individual) PUFA, feeding studies are necessary.	[Ostermann, Annika I.; Waindok, Patrick; Schmidt, Moritz J.; Schebb, Nils Helge] Univ Vet Med Hannover, Inst Food Toxicol, Hannover, Germany; [Ostermann, Annika I.; Schebb, Nils Helge] Univ Wuppertal, Fac Math & Nat Sci, Food Chem, Wuppertal, Germany; [Waindok, Patrick] Univ Vet Med Hannover, Inst Parasitol, Ctr Infect Med, Hannover, Germany; [Chiu, Cheng-Ying; Smyl, Christopher; Rohwer, Nadine; Weylandt, Karsten-H.] Charite, Div Hepatol & Gastroenterol Including Metab Dis, Med Dept, Campus Virchow Klinikum, Berlin, Germany; [Weylandt, Karsten-H.] Charite, Expt & Clin Res Ctr, Campus Buch, Berlin, Germany; [Weylandt, Karsten-H.] Brandenburg Med Sch, Div Gastroenterol Oncol Hematol Rheumatol & Diabe, Med Dept, Ruppiner Kliniken, Neuruppin, Germany	University of Veterinary Medicine Hannover, Foundation; University of Wuppertal; University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruppiner Kliniken GmbH	Schebb, NH (corresponding author), Univ Vet Med Hannover, Inst Food Toxicol, Hannover, Germany.; Schebb, NH (corresponding author), Univ Wuppertal, Fac Math & Nat Sci, Food Chem, Wuppertal, Germany.	nils@schebb-web.de		Chiu, Cheng-Ying/0000-0002-7075-1446; Rohwer, Nadine/0000-0001-6170-1327; Schmidt, Moritz Jonathan/0000-0001-9719-6967; Schebb, Nils Helge/0000-0003-1299-6629	German Research Foundation (DFG) [SCHE 1801]; KHW [WE 2908]	German Research Foundation (DFG)(German Research Foundation (DFG)); KHW	This study was supported by grants of the German Research Foundation (DFG) to NHS (SCHE 1801) and KHW (WE 2908).	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Astarita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096221; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Brossard N, 1996, AM J CLIN NUTR, V64, P577, DOI 10.1093/ajcn/64.4.577; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Camuesco D, 2005, J NUTR, V135, P687, DOI 10.1093/jn/135.4.687; Chiu CY, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010009; CRASKE JD, 1988, J AM OIL CHEM SOC, V65, P1190; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Harris TR, 2016, J NUTR BIOCHEM, V38, P93, DOI 10.1016/j.jnutbio.2016.08.010; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Kelton D, 2013, PROSTAG LEUKOTR ESS, V89, P169, DOI [10.1016/j.plefa.201, 10.1016/j.plefa.2013.08.002]; Kutzner L, 2017, J AGR FOOD CHEM, V65, P139, DOI 10.1021/acs.jafc.6b03745; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; Olson MV, 2013, INFLAMM RES, V62, P1003, DOI 10.1007/s00011-013-0658-4; Ostermann AI, 2017, FOOD FUNCT, V8, P2355, DOI [10.1039/c7fo00403f, 10.1039/C7FO00403F]; Ostermann AI, 2015, ANAL BIOANAL CHEM, V407, P1403, DOI 10.1007/s00216-014-8377-4; Ostermann AI, 2014, PROSTAG LEUKOTR ESS, V91, P235, DOI 10.1016/j.plefa.2014.10.002; Panigrahy D, 2011, CANCER METAST REV, V30, P525, DOI 10.1007/s10555-011-9315-y; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Schebb NH, 2014, PROSTAG OTH LIPID M, V113, P21, DOI 10.1016/j.prostaglandins.2014.05.002; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Schuchardt JP, 2014, PROSTAG OTH LIPID M, V109, P23, DOI 10.1016/j.prostaglandins.2014.03.001; Schuchardt JP, 2014, PROSTAG LEUKOTR ESS, V90, P27, DOI 10.1016/j.plefa.2013.12.008; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; Volker DH, 2000, J NUTR, V130, P559, DOI 10.1093/jn/130.3.559; von Schacky C, 2011, PROSTAG OTH LIPID M, V96, P94, DOI 10.1016/j.prostaglandins.2011.06.008; Wang W, 2016, PROSTAGLANDINS OTHER; Wang WC, 2014, PROSTAG OTH LIPID M, V113, P13, DOI 10.1016/j.prostaglandins.2014.07.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Westphal C, 2015, ADV EXP MED BIOL, V851, P151, DOI 10.1007/978-3-319-16009-2_6; Weylandt K. H., 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/143109, DOI 10.1155/2015/143109]; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Weylandt KH, 2011, CARCINOGENESIS, V32, P897, DOI 10.1093/carcin/bgr049; Weylandt KH, 2008, BBA-MOL BASIS DIS, V1782, P634, DOI 10.1016/j.bbadis.2008.08.011; Willenberg I, 2016, INFLAMM RES, V65, P133, DOI 10.1007/s00011-015-0897-7; Willenberg I, 2015, ANAL BIOANAL CHEM, V407, P2675, DOI 10.1007/s00216-014-8369-4; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	63	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184470	10.1371/journal.pone.0184470	http://dx.doi.org/10.1371/journal.pone.0184470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886129	Green Accepted, gold, Green Published			2022-12-26	WOS:000410001100132
J	Kim, YS; Kim, C; Jung, KH; Kwon, HM; Heo, SH; Kim, BJ; Kim, YD; Kim, JM; Lee, SH				Kim, Young Seo; Kim, Chulho; Jung, Keun-Hwa; Kwon, Hyung-Min; Heo, Sung Hyuk; Kim, Beom Joon; Kim, Young Dae; Kim, Jeong-Min; Lee, Seung-Hoon			Range of glucose as a glycemic variability and 3-month outcome in diabetic patients with acute ischemic stroke	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; ASYMPTOMATIC HYPOGLYCEMIA; POSTSTROKE HYPERGLYCEMIA; INDEPENDENT PREDICTOR; MORTALITY; TRIAL; COMPLICATIONS; ASSOCIATION	Glycemic variability (GV) is reportedly a predictor for poor outcome in various clinical conditions. We aimed to assess whether GV during hospital admission is associated with poor outcomes in patients with acute ischemic stroke (AIS) and diabetes. We prospectively enrolled consecutive patients with AIS from the registry of 6 tertiary hospitals between January 2013 and December 2014. For the GV index, we used a glucose level range that was divided into 4 quartiles. Multivariable binary and ordinal logistic regression analyses were performed to determine the association between GV and the modified Rankin Scale score (3-6) at 3 months. We enrolled 1,504 patients with AIS and diabetes (mean age, 68.1 years; male, 57.2%), of which 35.1% had poor outcomes at 3 months. An increasing glucose range quartile was positively associated with initial neurologic severity and development of hypoglycemia during hospital admission. Multivariable analysis showed that the glucose level range quartile was associated with poor outcomes, even after adjusting for the number of glucose measurement and hypoglycemia (odds ratio [OR] Q2 vs. Q1: 1.50, 95% confidence interval [CI]: 1.02-2.18; OR Q3 vs. Q1: 2.01, 95% CI: 1.34-3.01; OR Q4 vs. Q1: 1.98, 95% CI: 1.22-3.23). These associations remained significant after dichotomization according to glycated hemoglobin levels at admission. An increasing glucose level range as a GV index during hospital admission was associated with poor functional outcomes at 3 months in patients with AIS and diabetes.	[Kim, Young Seo] Hanyang Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Kim, Chulho] Chuncheon Sacred Heart Hosp, Dept Neurol, Chunchon, South Korea; [Jung, Keun-Hwa; Lee, Seung-Hoon] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Kwon, Hyung-Min] Seoul Natl Univ, Dept Neurol, Seoul Metropolitan Govt Boramae Med Ctr, Seoul, South Korea; [Heo, Sung Hyuk] Kyung Hee Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Kim, Beom Joon] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea; [Kim, Beom Joon] Seoul Natl Univ, Cerebrovasc Ctr, Bundang Hosp, Seongnam, South Korea; [Kim, Young Dae] Yonsei Univ, Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Jeong-Min] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea	Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Kyung Hee University; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital	Kim, C (corresponding author), Chuncheon Sacred Heart Hosp, Dept Neurol, Chunchon, South Korea.	gumdol52@naver.com	Kim, Jeong-Min/ABH-2469-2021; Kim, Beom Joon/C-2904-2011; Heo, Sung Hyuk/P-3529-2019; Kim, Chulho/AAC-8708-2022	Kim, Beom Joon/0000-0002-2719-3012; Heo, Sung Hyuk/0000-0002-9215-5119; Kim, Chulho/0000-0001-8762-8340; Kim, Young Dae/0000-0001-5750-2616; Kwon, Hyung-Min/0000-0002-6101-7127; Jung, Keun-Hwa/0000-0003-1433-8005; Kim, Jeong-Min/0000-0001-7213-5527	Hallym University Specialization Fund [HRF-S-53]; Cerebrovascular Research Society Fund [2015-01]	Hallym University Specialization Fund; Cerebrovascular Research Society Fund	The present study was supported by research grants from the Hallym University Specialization Fund (HRF-S-53) and from the Cerebrovascular Research Society Fund (2015-01). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation for the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Allport L, 2006, DIABETES CARE, V29, P1839, DOI 10.2337/dc06-0204; [Anonymous], 1995, DIABETES, V44, P968; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Calderon-Larranaga A, 2016, INT J CARDIOL, V207, P310, DOI 10.1016/j.ijcard.2016.01.069; Camara-Lemarroy CR, 2017, J NEUROL SCI, V373, P242, DOI 10.1016/j.jns.2017.01.015; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Christensen H, 2004, J NEUROL SCI, V217, P175, DOI 10.1016/j.jns.2003.09.013; Cueni-Villoz N, 2011, CRIT CARE MED, V39, P2225, DOI 10.1097/CCM.0b013e31822572c9; DeVries JH, 2013, DIABETES, V62, P1405, DOI 10.2337/db12-1610; Dossett LA, 2008, AM SURGEON, V74, P679; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Engoren M, 2014, J CRIT CARE, V29, P611, DOI 10.1016/j.jcrc.2014.03.014; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Gonzalez-Moreno EI, 2014, TRANSL STROKE RES, V5, P638, DOI 10.1007/s12975-014-0365-7; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Hirsch IB, 2005, J DIABETES COMPLICAT, V19, P178, DOI 10.1016/j.jdiacomp.2004.10.001; Ishihara M, 2005, AM HEART J, V150, P814, DOI 10.1016/j.ahj.2004.12.020; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kaarisalo MM, 2005, DIABETES RES CLIN PR, V69, P293, DOI 10.1016/j.diabres.2005.02.001; Kim BJ, 2015, J STROKE, V17, P38, DOI 10.5853/jos.2015.17.1.38; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Kurtz P, 2014, CRIT CARE IN PRESS; Lin BW, 2000, NEUROSCI LETT, V278, P1, DOI 10.1016/S0304-3940(99)00889-7; Lipska KJ, 2012, CIRC-CARDIOVASC QUAL, V5, P550, DOI 10.1161/CIRCOUTCOMES.111.963298; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Monnier L, 2011, DIABETES TECHNOL THE, V13, P813, DOI 10.1089/dia.2011.0049; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; Qu YM, 2012, DIABETES TECHNOL THE, V14, P1008, DOI 10.1089/dia.2012.0099; Ribo M, 2005, STROKE, V36, P1705, DOI 10.1161/01.STR.0000173161.05453.90.9f; Rizk NN, 2005, BRAIN RES, V1053, P1, DOI 10.1016/j.brainres.2005.05.036; Rodbard David, 2012, J Diabetes Sci Technol, V6, P712; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang JS, 2016, DIABETES RES CLIN PR, V113, P108, DOI 10.1016/j.diabres.2015.12.010; Weir CJ, 1997, BMJ-BRIT MED J, V314, P1303, DOI 10.1136/bmj.314.7090.1303; Williams LS, 2002, NEUROLOGY, V59, P67, DOI 10.1212/WNL.59.1.67	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183894	10.1371/journal.pone.0183894	http://dx.doi.org/10.1371/journal.pone.0183894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880933	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200027
J	Nier, A; Engstler, AJ; Maier, IB; Bergheim, I				Nier, Anika; Engstler, Anna Janina; Maier, Ina Barbara; Bergheim, Ina			Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; FRUCTOSE-INDUCED STEATOSIS; INSULIN-RESISTANCE; GUT MICROBIOTA; MICE ROLE; CIRRHOSIS; OBESITY; MODEL; CD14	Background & aims Recent studies have shown that patients with manifest non-alcoholic fatty liver disease (NAFLD), e.g. steatosis grade 3 or steatohepatitis with or without beginning fibrosis frequently show altered fecal microbiota composition and elevated bacterial endotoxin levels. However, if these alterations are signs of a progressing disease or are already found in initial disease stages has not yet been clarified. Methods Twenty children with simple steatosis (grade 1) diagnosed by ultrasound and 29 normal weight healthy control children (age < 10 years) were included in the study (mean age 7.6 +/- 1.1 years). Metabolic parameters, markers of intestinal barrier function and inflammation were determined. Results Activity of alanine aminotransferase, concentrations of some markers of inflammation and insulin resistance were significantly higher in plasma of NAFLD children than in controls. When compared to controls, plasma bacterial endotoxin and lipopolysaccharide-binding protein (LBP) levels were significantly higher in NAFLD children (+ 50% and + 24%, respectively), while soluble CD14 serum and D-lactate plasma levels as well as the prevalence of small intestinal bacterial overgrowth did not differ between groups. Plasma endotoxin and LBP levels were positive associated with proinflammatory markers like plasminogen activator inhibitor-1, c-reactive protein, interleukin-6 and leptin while no associations with markers of insulin resistance were found. Conclusions Taken together, our results indicate that even in juvenile patients with early stages of NAFLD e.g. simple steatosis grade 1, plasma endotoxin concentrations are already elevated further suggesting that intestinal barrier dysfunction might be present already in the initial phases of the disease.	[Nier, Anika; Engstler, Anna Janina; Bergheim, Ina] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Vienna, Austria; [Nier, Anika; Engstler, Anna Janina; Bergheim, Ina] Friedrich Schiller Univ Jena, SD Model Syst Mol Nutr, Inst Nutr, Jena, Germany; [Maier, Ina Barbara] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany	University of Vienna; Friedrich Schiller University of Jena; University Hohenheim	Bergheim, I (corresponding author), Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Vienna, Austria.; Bergheim, I (corresponding author), Friedrich Schiller Univ Jena, SD Model Syst Mol Nutr, Inst Nutr, Jena, Germany.	ina.bergheim@univie.ac.at			German Ministry of Education and Science (BMBF) [FKZ: 01EA1305]; University of Vienna	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Vienna	The work was supported in part by the German Ministry of Education and Science (BMBF), FKZ: 01EA1305 (IB). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Open access funding provided by University of Vienna.	Agiasotelli D, 2017, LIVER INT, V37, P576, DOI 10.1111/liv.13264; Akcam M, 2013, CLIN IMAG, V37, P504, DOI 10.1016/j.clinimag.2012.07.011; Alisi A, 2010, J PEDIATR GASTR NUTR, V50, P645, DOI 10.1097/MPG.0b013e3181c7bdf1; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Campbell DI, 2002, BRIT J NUTR, V88, P499, DOI 10.1079/BJN2002697; Chen YY, 2014, J CHIN MED ASSOC, V77, P68, DOI 10.1016/j.jcma.2013.10.006; de Courten B, 2016, MOL NUTR FOOD RES, V60, P103, DOI 10.1002/mnfr.201500102; Engen PA, 2015, ALCOHOL RES-CURR REV, V37, P223; Engstler AJ, 2016, GUT, V65, P1564, DOI 10.1136/gutjnl-2014-308379; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Guercio Nuzio S, 2016, PEDIAT OBES; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hocking MP, 1998, DIGEST DIS SCI, V43, P2493, DOI 10.1023/A:1026698602714; Jin CJ, 2017, J GASTROEN HEPATOL, V32, P708, DOI 10.1111/jgh.13488; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kanuri G, 2011, LAB INVEST, V91, P885, DOI 10.1038/labinvest.2011.44; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Maier IB, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-14; Fernandez-Real JM, 2011, DIABETES, V60, P2179, DOI 10.2337/db10-1210; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Nardone G, 2010, AM J PHYSIOL-GASTR L, V299, pG669, DOI 10.1152/ajpgi.00188.2010; Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1; Nobili V, 2016, ARCH MED SCI; De Loera-Rodriguez CO, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0039-y; Papp M, 2012, LIVER INT, V32, P603, DOI 10.1111/j.1478-3231.2011.02689.x; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Ruan Peng, 2004, Hepatobiliary Pancreat Dis Int, V3, P58; Saad RJ, 2014, CLIN GASTROENTEROL H, V12, P1964, DOI 10.1016/j.cgh.2013.09.055; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75; Thorgersen EB, 2010, FASEB J, V24, P712, DOI 10.1096/fj.09-140798; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; van den Berg EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171502; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Volynets V, 2013, EUR J NUTR, V52, P527, DOI 10.1007/s00394-012-0355-z; Volynets V, 2010, J LIPID RES, V51, P3414, DOI 10.1194/jlr.M007179; Wagnerberger S, 2013, J NUTR BIOCHEM, V24, P531, DOI 10.1016/j.jnutbio.2012.01.014; Weiss J, 2014, DTSCH ARZTEBL INT, V111, P447, DOI 10.3238/arztebl.2014.0447; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhu JZ, 2016, WORLD J GASTROENTERO, V22, P8226, DOI 10.3748/wjg.v22.i36.8226	47	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183282	10.1371/journal.pone.0183282	http://dx.doi.org/10.1371/journal.pone.0183282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880885	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200015
J	Turner, RE; Rabalais, NN; Justic, D				Turner, R. Eugene; Rabalais, Nancy N.; Justic, Dubravko			Trends in summer bottom-water temperatures on the northern Gulf of Mexico continental shelf from 1985 to 2015	PLOS ONE			English	Article							SEDIMENT TRANSPORT; MISSISSIPPI RIVER; CLIMATE-CHANGE; LOUISIANA; HYPOXIA; OCEAN; SEA; CIRCULATION; ECOSYSTEMS; ASSEMBLAGE	We quantified trends in the 1985 to 2015 summer bottom-water temperature on the northern Gulf of Mexico (nGOM) continental shelf for data collected at 88 stations with depths ranging from 3 to 63 m. The analysis was supplemented with monthly data collected from 1963 to 1965 in the same area. The seasonal summer peak in average bottom-water temperature varied concurrently with air temperature, but with a 2- to 5-month lag. The summer bottom-water temperature declined gradually with depth from 30 degrees C at stations closest to the shore, to 20 degrees C at the offshore edge of the study area, and increased an average 0.051 degrees C y(-)1 between1963 and 2015. The bottom-water warming in summer for all stations was 1.9 times faster compared to the rise in local summer air temperatures, and 6.4 times faster than the concurrent increase in annual global ocean sea surface temperatures. The annual rise in average summer bottom-water temperatures on the subtropical nGOM continental shelf is comparable to the few published temperature trend estimates from colder environments. These recent changes in the heat storage on the nGOM continental shelf will affect oxygen and carbon cycling, spatial distribution of fish and shrimp, and overall species diversity.	[Turner, R. Eugene; Rabalais, Nancy N.; Justic, Dubravko] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Rabalais, Nancy N.] Louisiana Univ Marine Consortium, Chauvin, LA 70344 USA	Louisiana State University System; Louisiana State University	Turner, RE (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	euturne@lsu.edu	Rabalais, Nancy N./AAD-2119-2021	Rabalais, Nancy N./0000-0002-1514-837X	National Oceanic and Atmospheric Administration over the last 3 decades, and most recently through Center for Sponsored Coastal Ocean Research [NA09NOS4780204, NA09NOS4780230]	National Oceanic and Atmospheric Administration over the last 3 decades, and most recently through Center for Sponsored Coastal Ocean Research	Sampling was supported by grants from the National Oceanic and Atmospheric Administration over the last 3 decades, and most recently through Center for Sponsored Coastal Ocean Research (www.cop.noaa gov), under awards NA09NOS4780204 to Louisiana Universities Marine Consortium and award NA09NOS4780230 to Louisiana State University.	Altieri AH, 2015, GLOBAL CHANGE BIOL, V21, P1395, DOI 10.1111/gcb.12754; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Carstensen J, 2014, P NATL ACAD SCI USA, V111, P5628, DOI 10.1073/pnas.1323156111; Cochrane JD, 1986, EOS T AM GEOPHYS UN, V64, P1021; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DINNEL SP, 1986, CONT SHELF RES, V6, P765, DOI 10.1016/0278-4343(86)90036-1; Dunn D.E., 1996, 964113 US GEOL SURV; Etter PC, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001820; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Gore R.H., 1992, GULF MEXICO TREASURY; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hunter-Cevera KR, 2016, SCIENCE, V354, P326, DOI 10.1126/science.aaf8536; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Kuffner IB, 2015, ESTUAR COAST, V38, P1085, DOI 10.1007/s12237-014-9875-5; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Montagna PA, 2011, COASTAL IMPACTS IMPA; NOAA, 2013, NAT COAST POP REP PO; Notz D, 2016, SCIENCE, V354, P747, DOI 10.1126/science.aag2345; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pachauri R. K. Team, 2007, CLIMATE CHANGE 2007, P104; Pinsky M, 2015, SCIENCE, V341, P1239; Powell EJ, 2015, J CLIMATE, V28, P1592, DOI 10.1175/JCLI-D-14-00410.1; Quinones-Rivera ZJ, 2007, MAR ECOL PROG SER, V342, P69, DOI 10.3354/meps342069; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Santos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050666; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; Strauss BH, 2013, P NATL ACAD SCI USA, V110, P13699, DOI 10.1073/pnas.1312464110; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Temple RF, 1977, SSRF707 NOAA NMFS; Turner RE, 2012, MAR POLLUT BULL, V64, P319, DOI 10.1016/j.marpolbul.2011.11.008; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; UNESCO IOC SCOR and IAPSO, 2010, INT THERM EQ SEAW 20; Walker N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017555; Walker ND, 2005, J COASTAL RES, V21, P1228, DOI 10.2112/04-0347.1; Walker ND, 2001, ESTUARIES, V24, P498, DOI 10.2307/1353252; Walker ND, 2000, J COASTAL RES, V16, P996; White DA, 2016, AQUAT BOT, V132, P5, DOI 10.1016/j.aquabot.2016.02.007; Wiseman WJ, 2004, NATO SCI S SS IV EAR, V36, P359; Wiseman WJ, 1997, J MARINE SYST, V12, P237, DOI 10.1016/S0924-7963(96)00100-5	43	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184350	10.1371/journal.pone.0184350	http://dx.doi.org/10.1371/journal.pone.0184350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880893	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200054
J	Irazola, V; Rubinstein, A; Bazzano, L; Calandrelli, M; Chung-Shiuan, C; Elorriaga, N; Gutierrez, L; Lanas, F; Manfredi, JA; Mores, N; Olivera, H; Poggio, R; Ponzo, J; Seron, P; He, J				Irazola, Vilma; Rubinstein, Adolfo; Bazzano, Lydia; Calandrelli, Matias; Chung-Shiuan, Chen; Elorriaga, Natalia; Gutierrez, Laura; Lanas, Fernando; Manfredi, Jose A.; Mores, Nora; Olivera, Hector; Poggio, Rosana; Ponzo, Jacqueline; Seron, Pamela; He, Jiang			Prevalence, awareness, treatment and control of diabetes and impaired fasting glucose in the Southern Cone of Latin America	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; DISEASE; ARGENTINA; CARMELA	Aims To determine the prevalence, treatment and control of diabetes mellitus (DM) and impaired fasting glucose (IFG) as well as associated factors in the adult population of four cities of the Southern Cone of Latin America (SCLA). Methods This is a cross-sectional population-based study that included 7407 adults between 35 and 74 years old in four cities of the SCLA: Temuco (Chile), Marcos Paz and Bariloche (Argentina), and Pando-Barros Blancos (Uruguay). DM was defined as fasting plasma glucose >= 126 mg/dL or self-reported history of diabetes. Awareness, treatment, and control of DM were defined as subjects self-reporting a DM previous diagnosis, the use of a prescription medication or nonpharmacological intervention for DM, and fasting plasma glucose < 126 mg/dl, respectively. Results Prevalence of DM varied among cities, between 8.4% in Bariloche and 14.3% in Temuco. Prevalence of IFG varied at different sites, from 3.5% in Barros Blancos to 6.8% in Marcos Paz. Of the total number of people with diabetes, 20% were newly diagnosed at the time of the study. Overall, 79.8% of patients with diabetes were aware of their condition. The treatment and control rate were 58.8% and 46.2%, respectively. Older age, family history of diabetes, lower educational attainment, overweight, obesity, central obesity, low physical activity, hypertension, hypercholesterolemia and hypertriglyceridemia were all significantly associated with an increased risk of diabetes. Conclusions The prevalence of DM and IFG in the adult population of the SCLA is high and varies among cities. These conditions represent a public health challenge since the rates of awareness, treatment, and control are still low.	[Irazola, Vilma; Rubinstein, Adolfo; Elorriaga, Natalia; Gutierrez, Laura; Poggio, Rosana] IECS, Inst Clin Effectiveness & Hlth Policy, CESCAS, South Amer Ctr Excellence Cardiovasc Hlth, Buenos Aires, DF, Argentina; [Bazzano, Lydia; Chung-Shiuan, Chen; He, Jiang] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Bazzano, Lydia; Chung-Shiuan, Chen; He, Jiang] Tulane Univ, Dept Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Calandrelli, Matias] Sanat San Carlos, San Carlos De Bariloche, Rio Negro, Argentina; [Lanas, Fernando; Seron, Pamela] Univ La Frontera, CIGES, Temuco, Chile; [Manfredi, Jose A.; Ponzo, Jacqueline] Univ Republ, Ctr Civ Salvador Allende, Fac Med, Canelones, Uruguay; [Mores, Nora; Olivera, Hector] Municipalidad Marcos Paz, Buenos Aires, DF, Argentina	Tulane University; Tulane University; Universidad de La Frontera; Universidad de la Republica, Uruguay	Irazola, V (corresponding author), IECS, Inst Clin Effectiveness & Hlth Policy, CESCAS, South Amer Ctr Excellence Cardiovasc Hlth, Buenos Aires, DF, Argentina.	virazola@iecs.org.ar	Seron, Pamela/AAN-3304-2021; He, Jiang/AAF-5303-2020; Ponzo, Jacqueline/B-5303-2019; Lanas, Fernando/AAE-8842-2022	Seron, Pamela/0000-0003-0190-8988; He, Jiang/0000-0002-8286-9652; Elorriaga, Natalia/0000-0001-5496-9835; Ponzo, Jacqueline/0000-0002-8329-7430; Lanas, Fernando/0000-0003-3595-9759; Calandrelli, Matias/0000-0002-8303-5078	NHLBI/NIH Global Health Initiative [U01 HD40477]	NHLBI/NIH Global Health Initiative	This work was supported by a grant from the NHLBI/NIH Global Health Initiative, to Combat Non-Communicable Chronic Cardiovascular and Pulmonary Diseases, NHLBI (U01 HD40477).	[Anonymous], 2006, NAT RISK FACT SURV; [Anonymous], 2005, NAT RISK FACT SURV; [Anonymous], 2001, GPE DISCUSSION PAPER, V31; [Anonymous], 2010, NAT HLTH SURV; [Anonymous], 2013, NAT RISK FACT SURV; [Anonymous], 2013, NAT RISK FACT SURV; [Anonymous], 2009, NAT RISK FACT SURV; Borch-Johnsen K, 2009, DIABETOLOGIA, V52, P2247, DOI 10.1007/s00125-009-1526-1; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Cho, IDF DIABETES ATLAS 2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daniels S. R., 2011, REV ARGENT SALUD PUB, V2, P34; Elorriaga N., 2014, PUBLIC HEALTH NUTR; Escobedo J, 2009, DIABETIC MED, V26, P864, DOI 10.1111/j.1464-5491.2009.02795.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerich John E, 2007, Clin Cornerstone, V8, P53, DOI 10.1016/S1098-3597(07)80028-7; Global Burden of Metabolic Risk Factors for Chronic Diseases C, 2010, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0(2014); Jahangir E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045053; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kilpatrick ES, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4432; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linetzky B, 2013, INT J PUBLIC HEALTH, V58, P277, DOI 10.1007/s00038-012-0371-z; Rubinstein AL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000126; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MORRISH NJ, 1991, DIABETOLOGIA, V34, P590, DOI 10.1007/BF00400279; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Perez-Escamilla R, 2014, SALUD PUBLICA MEXICO, V56, pS62; Plan and operation of the Third National Health and Nutrition Examination Survey, 1988, VITAL HLTH STAT, V1, P1; Rubinstein AL, 2015, INT J CARDIOL, V183, P82, DOI 10.1016/j.ijcard.2015.01.062; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Sikaris Ken, 2009, J Diabetes Sci Technol, V3, P429; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77; WHO, 2014, COUGH ET; WHO Consultation, 1999, DEF DIAGN CLASS DIAB; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20	39	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183953	10.1371/journal.pone.0183953	http://dx.doi.org/10.1371/journal.pone.0183953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877254	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200052
J	Link, MA; Lucke, K; Schmid, J; Schumacher, V; Eden, T; Rose-John, S; Mittrucker, HW				Link, Moritz Andreas; Luecke, Karsten; Schmid, Joanna; Schumacher, Valea; Eden, Thomas; Rose-John, Stefan; Mittruecker, Hans-Willi			The role of ADAM17 in the T-cell response against bacterial pathogens	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; REGULATORY FACTOR 4; LISTERIA-MONOCYTOGENES; FACTOR RECEPTOR; CUTTING EDGE; TNF-ALPHA; INFLAMMATORY RESPONSES; PROTECTION; INFECTION; MICE	ADAM17 is a member of the A Disintegrin And Metalloproteinase family of proteases. It is ubiquitously expressed and causes the shedding of a broad spectrum of surface proteins such as adhesion molecules, cytokines and cytokine receptors. By controlled shedding of these proteins from leukocytes, ADAM17 is able to regulate immune responses. Several ADAM17 targets on T cells have been implicated in T-cell migration, differentiation and effector functions. However, the role of ADAM17 in T-cell responses is still unclear. To characterize the function of ADAM17 in T cells, we used Adam17(fl/fl)xCD4cre(+) mice with a T-cell restricted inactivation of the Adam17 gene. Upon stimulation, ADAM17-deficient CD4(+) and CD8(+) T cells were impaired in shedding of CD62L, IL-6R alpha, TNF-alpha, TNFRI and TNFRII. Surprisingly, we could not detect profound changes in the composition of major T-cell subsets in Adam17(fl/fl)xCD4cre(+) mice. Following infection with Listeria monocytogenes, Adam17(fl/fl)xCD4cre(+) mice mounted regular listeria- specific CD4(+) T-H1 and CD8(+) T-cell responses and were able to control primary and secondary infections. In conclusion, our study indicates that ADAM17 is either not required in T cells under homoeostatic conditions and for control of listeria infection or can be effectively compensated by other mechanisms.	[Link, Moritz Andreas; Luecke, Karsten; Schmid, Joanna; Schumacher, Valea; Eden, Thomas; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Rose-John, Stefan] Univ Kiel, Med Fac, Inst Biochem, Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel	Mittrucker, HW (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	h.mittruecker@uke.de	Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279; Yan, Karsten/0000-0002-7343-2205; Mittrucker, Hans-Willi/0000-0001-6166-4191	Deutsche Forschungsgemeinschaft [SFB841, SFB877]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, grant SFB841 to H.-W.M and S.R.-J, and SFB877 to S.R.-J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft, grant SFB841 to H.-W.M and S.R.-J, and SFB877 to S.R.-J.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; DeBerge MP, 2015, J LEUKOCYTE BIOL, V98, P423, DOI 10.1189/jlb.3A0914-432RR; DeBerge MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079340; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dominitzki S, 2007, J IMMUNOL, V179, P2041, DOI 10.4049/jimmunol.179.4.2041; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; Long CM, 2012, J LEUKOCYTE BIOL, V92, P667, DOI 10.1189/jlb.0312112; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Mahnke J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35521; Marczynska J, 2014, J IMMUNOL, V193, P2753, DOI 10.4049/jimmunol.1302893; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Tang JJ, 2011, BLOOD, V118, P786, DOI 10.1182/blood-2010-11-321406; Torres D, 2005, AM J PATHOL, V167, P1677, DOI 10.1016/S0002-9440(10)61250-3; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; White DW, 2000, INFECT IMMUN, V68, P4470, DOI 10.1128/IAI.68.8.4470-4476.2000; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Yan I, 2016, J LEUKOCYTE BIOL, V99, P749, DOI 10.1189/jlb.3A0515-207R	40	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184320	10.1371/journal.pone.0184320	http://dx.doi.org/10.1371/journal.pone.0184320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877252	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200087
J	Pinegger, A; Hiebel, H; Wriessnegger, SC; Muller-Putz, GR				Pinegger, Andreas; Hiebel, Hannah; Wriessnegger, Selina C.; Mueller-Putz, Gernot R.			Composing only by thought: Novel application of the P300 brain-computer interface	PLOS ONE			English	Article							USER-CENTERED DESIGN; MENTAL PROSTHESIS; HEALTHY	The P300 event-related potential is a well-known pattern in the electroencephalogram (EEG). This kind of brain signal is used for many different brain-computer interface (BCI) applications, e.g., spellers, environmental controllers, web browsers, or for painting. In recent times, BCI systems are mature enough to leave the laboratories to be used by the end-users, namely severely disabled people. Therefore, new challenges arise and the systems should be implemented and evaluated according to user-centered design (USD) guidelines. We developed and implemented a new system that utilizes the P300 pattern to compose music. Our Brain Composing system consists of three parts: the EEG acquisition device, the P300-based BCI, and the music composing software. Seventeen musical participants and one professional composer performed a copy-spelling, a copy-composing, and a free-composing task with the system. According to the USD guidelines, we investigated the efficiency, the effectiveness and subjective criteria in terms of satisfaction, enjoyment, frustration, and attractiveness. The musical participants group achieved high average accuracies: 88.24% (copy-spelling), 88.58% (copy-composing), and 76.51% (free-composing). The professional composer achieved also high accuracies: 100% (copy-spelling), 93.62% (copy-composing), and 98.20% (free-composing). General results regarding the subjective criteria evaluation were that the participants enjoyed the usage of the Brain Composing system and were highly satisfied with the system. Showing very positive results with healthy people in this study, this was the first step towards a music composing system for severely disabled people.	[Pinegger, Andreas; Wriessnegger, Selina C.; Mueller-Putz, Gernot R.] Graz Univ Technol, Inst Neural Engn, Graz, Austria; [Hiebel, Hannah] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria	Graz University of Technology; University of Graz	Muller-Putz, GR (corresponding author), Graz Univ Technol, Inst Neural Engn, Graz, Austria.	gernot.mueller@tugraz.at		Wriessnegger, Selina Christin/0000-0003-4345-7310	European Community's, Seventh Framework Programme FP7, BackHome project [288566]	European Community's, Seventh Framework Programme FP7, BackHome project	The research leading to these results has received funding from the European Community's, Seventh Framework Programme FP7/2007-2013, BackHome project grant agreement number 288566. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Andreev A., 2016, RECREATIONAL APPL OP, P241, DOI [10.1002/9781119332428.ch14, DOI 10.1002/9781119332428.CH14]; Bernardos AM, 2016, J AMB INTEL HUM COMP, V7, P357, DOI 10.1007/s12652-016-0363-6; Botrel L, 2016, P 6 INT BCI M, P232; Breitwieser C, 2012, IEEE T BIO-MED ENG, V59, P852, DOI 10.1109/TBME.2011.2174637; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Daly I, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046022; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P1; Grierson M., 2014, GUIDE BRAIN COMPUTER, P43; Hader S, 2015, ARTIF INTELL MED, V63, P7, DOI 10.1016/j.artmed.2014.12.001; HART S G, 1988, P139; Hart S.G., 2006, P HUM FACT ERG SOC A, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Holz EM, 2015, ARCH PHYS MED REHAB, V96, pS16, DOI 10.1016/j.apmr.2014.03.035; Holz EM, 2013, P 5 INT BRAIN COMP I, P181; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-7; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kleih SC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00642; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112392; Laugwitz B, 2008, LECT NOTES COMPUT SC, V5298, P63, DOI 10.1007/978-3-540-89350-9_6; Lorenz R, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035007; Lynn JMD, 2016, J ASSIST TECHNOL, V10, P67, DOI 10.1108/JAT-01-2016-0002; Millan J. del R., 2010, FRONTIERS NEUROSCIEN, V4, P12; Miranda E. R., 2014, GUIDE BRAIN COMPUTER; Miranda ER, 2005, P SMC C 2005; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Newe A, 2015, PLOS ONE, V9, P1; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Pasqualotto E, 2015, NEUROREHAB NEURAL RE, V29, P950, DOI 10.1177/1545968315575611; Perelmouter J, 2000, IEEE T REHABIL ENG, V8, P227, DOI 10.1109/86.847824; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Pinegger A., 2013, BIOMEDICAL ENG, V58; Pinegger A, 2016, FRONTIERS NEUROSCIEN; Pinegger A, 2015, IEEE ENG MED BIO, P1053, DOI 10.1109/EMBC.2015.7318546; Pinegger A, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/014001; Pokorny C, 2013, ARTIF INTELL MED, V59, P81, DOI 10.1016/j.artmed.2013.07.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rosenboom, 1976, BIOFEEDBACK ARTS RES; Rosenboom D., 1997, LEONARDO MONOGRAPH S, P1; Rosenboom D., 1975, P INT COMP MUS C; Sellers EW, 2006, IEEE T NEUR SYS REH, V14, P221, DOI 10.1109/TNSRE.2006.875580; van de Laar B, 2011, INT J BIOELECTROMAG, V13, P157; Wu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064046; Wu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005915; Zickler C, 2013, ARTIF INTELL MED, V59, P99, DOI 10.1016/j.artmed.2013.08.003	51	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0181584	10.1371/journal.pone.0181584	http://dx.doi.org/10.1371/journal.pone.0181584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877175	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200008
J	Pratchett, MS; Cowan, ZL; Nadler, LE; Caballes, CF; Hoey, AS; Messmer, V; Fletcher, CS; Westcott, DA; Ling, SD				Pratchett, Morgan S.; Cowan, Zara-Louise; Nadler, Lauren E.; Caballes, Ciemon F.; Hoey, Andrew S.; Messmer, Vanessa; Fletcher, Cameron S.; Westcott, David A.; Ling, Scott D.			Body size and substrate type modulate movement by the western Pacific crown-of-thorns starfish, Acanthaster solaris	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SEA STAR; CF. SOLARIS; PLANCI L.; TUBE FEET; RESPONSES; OUTBREAKS; BEHAVIOR; FIELD; POPULATIONS	The movement capacity of the crown-of-thorns starfishes (Acanthaster spp.) is a primary determinant of both their distribution and impact on coral assemblages. We quantified individual movement rates for the Pacific crown-of-thorns starfish (Acanthaster solaris) ranging in size from 75-480 mm total diameter, across three different substrates (sand, flat consolidated pavement, and coral rubble) on the northern Great Barrier Reef. The mean (+/- SE) rate of movement for smaller (<150 mm total diameter) A. solaris was 23.99-1.02 cm/min and 33.41-1.49 cm/min for individuals >350 mm total diameter. Mean (+/- SE) rates of movement varied with substrate type, being much higher on sand (36.53 +/- 1.31 cm/min) compared to consolidated pavement (28.04 +/- 1.15 cm/min) and slowest across coral rubble (17.25 +/- 0.63 cm/min). If average rates of movement measured here can be sustained, in combination with strong directionality, displacement distances of adult A. solaris could range from 250-520 m/day, depending on the prevailing substrate. Sustained movement of A. solaris is, however, likely to be highly constrained by habitat heterogeneity, energetic constraints, resource availability, and diurnal patterns of activity, thereby limiting their capacity to move between reefs or habitats.	[Pratchett, Morgan S.; Cowan, Zara-Louise; Nadler, Lauren E.; Caballes, Ciemon F.; Hoey, Andrew S.; Messmer, Vanessa] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Nadler, Lauren E.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Fletcher, Cameron S.; Westcott, David A.] CSIRO Land & Water, Atherton, Qld, Australia; [Ling, Scott D.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	James Cook University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Pratchett, MS (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	morgan.pratchett@jcu.edu.au	Fletcher, Cameron S/B-8354-2008; Hoey, Andrew S/B-5457-2015; Westcott, David A/G-5559-2010; Pratchett, Morgan/AAW-5179-2020; Ling, Scott/J-7161-2014	Fletcher, Cameron S/0000-0001-5543-4330; Pratchett, Morgan/0000-0002-1862-8459; Ling, Scott/0000-0002-5544-8174; Cowan, Zara-Louise/0000-0002-3862-7111; Nadler, Lauren/0000-0001-8225-8344; Hoey, Andrew/0000-0002-4261-5594	Australian National Environmental Science Program's Tropical Water Quality Hub; Lizard Island CoTS Research Grants (MSP)	Australian National Environmental Science Program's Tropical Water Quality Hub; Lizard Island CoTS Research Grants (MSP)	This research was supported by the Australian National Environmental Science Program's Tropical Water Quality Hub (MSP, VN, DAW, CSF), as well as a Lizard Island CoTS Research Grants (MSP).; This research was supported by the Australian National Environmental Science Program's Tropical Water Quality Hub, as well as Lizard Island CoTS Research Grants awarded to MSP. The authors are grateful to staff at Lizard Island Research Station for logistic support. Movement data is publicly available (Licenced under CC BY: Attribution 3.0 AU) via the Tropical Data Hub http://dx.doi.org/10.4225/28/576dd643fff8	BARNES JOHN H., 1966, AUSTRALIA NATUR HIST, V15, P257; Beer S, 2016, VISION RES, V127, P28, DOI 10.1016/j.visres.2016.05.007; Bos AR, 2013, OCEAN COAST MANAGE, V71, P116, DOI 10.1016/j.ocecoaman.2012.09.011; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Campbell AC, 2001, BIOL BULL-US, V201, P175, DOI 10.2307/1543332; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; Clements CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171569; Dale J, 1997, BIOL BULL, V193, P210, DOI 10.1086/BBLv193n2p210; De'ath G, 1998, J EXP MAR BIOL ECOL, V220, P83, DOI 10.1016/S0022-0981(97)00085-3; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Endean R., 1973, Atoll Res Bull, VNo. 167, P1; Fletcher CS, 2015, J APPL ECOL, V52, P59, DOI 10.1111/1365-2664.12361; Fletcher CS, 2013, ECOL APPL, V23, P1881, DOI 10.1890/12-2059.1; Flukes EB, 2012, MAR ECOL PROG SER, V464, P179, DOI 10.3354/meps09881; Hall Margaret J, 2017, Natl Health Stat Report, P1; Harrison HB, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9010016; Haszprunar G, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9020022; Hock K, 2014, J APPL ECOL, V51, P1188, DOI 10.1111/1365-2664.12320; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; JOHNSON CR, 1991, MAR ECOL PROG SER, V71, P143, DOI 10.3354/meps071143; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; KEESING JK, 1992, J EXP MAR BIOL ECOL, V156, P89, DOI 10.1016/0022-0981(92)90018-6; Majer Alessandra Pereira, 2009, Marine Biodiversity Records, V2, pe102, DOI 10.1017/S1755267209001067; MCCALLUM HI, 1989, MAR ECOL PROG SER, V56, P29, DOI 10.3354/meps056029; McCormick MI, 2007, CORAL REEFS, V26, P571, DOI 10.1007/s00338-007-0221-2; MCCURLEY RS, 1995, BIOL BULL-US, V188, P197, DOI 10.2307/1542085; Messmer V, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9010012; Montgomery EM, 2012, BIOL BULL-US, V222, P222, DOI 10.1086/BBLv222n3p222; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Mueller B, 2011, AQUAT BIOL, V12, P157, DOI 10.3354/ab00326; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; ORMOND RFG, 1973, NATURE, V246, P167, DOI 10.1038/246167a0; PARKER DA, 1986, MAR BIOL, V93, P201, DOI 10.1007/BF00508257; Pearson R. G., 1969, Fish Notes Qd, V3, P27; Petie R, 2016, CORAL REEFS, V35, P1139, DOI 10.1007/s00338-016-1478-0; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; R. R Core Team, 2016, R LANG ENV STAT COMP; Rivera-posada Jairo, 2014, Journal of Coastal Life Medicine, V2, P187; Rivera-Posada J, 2014, OCEAN COAST MANAGE, V102, P383, DOI 10.1016/j.ocecoaman.2014.08.014; Rosenberg DL, 1972, U GUAM MAR LAB TECH, V3, P12; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Santos R, 2005, J EXP BIOL, V208, P2555, DOI 10.1242/jeb.01683; Sigl R, 2016, DIVERSITY-BASEL, V8, DOI 10.3390/d8040025; Sigl R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30834; SLOAN NA, 1980, J NAT HIST, V14, P469, DOI 10.1080/00222938000770411; SNYDER N, 1970, SCIENCE, V168, P276, DOI 10.1126/science.168.3928.276; Suzuki G, 2012, CORAL REEFS, V31, P821, DOI 10.1007/s00338-012-0906-z; THOMPSON GB, 1982, AUST J MAR FRESH RES, V33, P561, DOI 10.1071/MF9820561; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Westcott D.A., 2016, STRATEGY LINK RES MA; Yamaguchi M., 1973, P369	52	9	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0180805	10.1371/journal.pone.0180805	http://dx.doi.org/10.1371/journal.pone.0180805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877193	gold, Green Accepted, Green Published			2022-12-26	WOS:000409391200005
J	Zhang, YH; Li, DH; Han, RL; Wang, YB; Li, GX; Liu, XJ; Tian, YD; Kang, XT; Li, ZJ				Zhang, Yanhua; Li, Donghua; Han, Ruili; Wang, Yanbin; Li, Guoxi; Liu, Xiaojun; Tian, Yadong; Kang, Xiangtao; Li, Zhuanjian			Transcriptome analysis of the pectoral muscles of local chickens and commercial broilers using Ribo-Zero ribonucleic acid sequencing	PLOS ONE			English	Article							FALSE DISCOVERY RATE; GENE-EXPRESSION; LIM PROTEIN; GENOME; IDENTIFICATION; ASSOCIATION; METABOLISM; PROGRAM; NETWORK; REVEAL	Background The molecular mechanisms underlying meat quality and muscle growth are not clear. The meat quality and growth rates of local chickens and commercial broilers are very different. The Ribo-Zero RNA-Seq technology is an effective means of analyzing transcript groups to clarify molecular mechanisms. The aim of this study was to provide a reference for studies of the differences in the meat quality and growth of different breeds of chickens. Results Ribo-Zero RNA-Seq technology was used to analyze the pectoral muscle transcriptomes of Gushi chickens and AA broilers. Compared with AA broilers, 1649 genes with annotated information were significantly differentially expressed (736 upregulated and 913 downregulated) in Gushi chickens with Q <= 0.05 (Q is the P-value corrected by multiple assumptions test) at a fold change >= 2 or <= 0.5. In addition, 2540 novel significantly differentially expressed (SDE) genes (1405 upregulated and 1135 downregulated) were discovered. The results showed that the main signal transduction pathways that differed between Gushi chickens and AA broilers were related to amino acid metabolism. Amino acids are important for protein synthesis, and they regulate key metabolic pathways to improve the growth, development and reproduction of organisms. Conclusion This study showed that differentially expressed genes in the pectoral tissues of Gushi chickens and AA broilers were related to fat metabolism, which affects meat. Additionally, a large number of novel genes were found that may be involved in fat metabolism and thus may affect the formation of meat, which requires further study. The results of this study provide a reference for further studies of the molecular mechanisms of meat formation.	[Zhang, Yanhua; Li, Donghua; Han, Ruili; Wang, Yanbin; Li, Guoxi; Liu, Xiaojun; Tian, Yadong; Kang, Xiangtao; Li, Zhuanjian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China; [Han, Ruili; Wang, Yanbin; Li, Guoxi; Liu, Xiaojun; Tian, Yadong; Kang, Xiangtao; Li, Zhuanjian] Henan Innovat Engn Res Ctr Poultry Germplasm Reso, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Li, ZJ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China.; Li, ZJ (corresponding author), Henan Innovat Engn Res Ctr Poultry Germplasm Reso, Zhengzhou, Henan, Peoples R China.	lizhuanjian@163.com		Yanhua, Zhang/0000-0003-0732-5038	China Postdoctoral Science Foundation [2014M552004]; Ministry of Education [IRT16R23]; Key Science and Technology Research Project of Henan Province [151100110800]; National Natural Science Foundation of China [31572356]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Ministry of Education; Key Science and Technology Research Project of Henan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: 1: No. 2014M552004, http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx, The Project funded by China Postdoctoral Science Foundation, Zhuanjian Li; 2: IRT16R23, http://www.moe.gov.cn/, Program for Innovation Research Team of Ministry of Education, Zhuanjian Li; 3: No. 151100110800, http://www.hnkjt.gov.cn/, Key Science and Technology Research Project of Henan Province, Zhuanjian Li; 4: 31572356, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, Guoxi Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Barash IA, 2005, AM J PHYSIOL-CELL PH, V289, pC1312, DOI 10.1152/ajpcell.00117.2005; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cui HX, 2012, MOL BIOL REP, V39, P3479, DOI 10.1007/s11033-011-1120-8; Cui HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-213; Davis RVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122525; Dransfield E, 1999, POULTRY SCI, V78, P743, DOI 10.1093/ps/78.5.743; Feve B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007; Gao GL, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019119; Gordon A, 2010, FASTX TOOLKIT T; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030244; Huang YN, 2016, GENET MOL RES, V15, DOI DOI 10.1002/TOX.22302; Inazu A, 1996, Rinsho Byori, V44, P322; Jiang W, 2015, CELL REP, V11, P137, DOI 10.1016/j.celrep.2015.03.008; Knoll R, 2010, CIRC RES, V106, P695, DOI 10.1161/CIRCRESAHA.109.206243; Li H, 2010, POULTRY SCI, V89, P1825, DOI 10.3382/ps.2010-00699; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1943-0; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim KS, 2016, ANIMAL GENETICS; Liu GF, 2015, ANIM PROD SCI, V55, P1172, DOI 10.1071/AN14096; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ovilo C, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-413, 10.1186/s12863-014-0148-x]; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Resnyk CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139549; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roex NL, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0048792; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schunter C, 2014, MOL ECOL RESOUR, V14, P157, DOI 10.1111/1755-0998.12155; Shi HB, 2013, J DAIRY SCI, V96, P7844, DOI 10.3168/jds.2013-7105; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Sooknanan R, 2010, NAT METHODS, V7, pI, DOI 10.1038/nmeth.f.313; Sun X, 2015, J ANIM SCI, V93, P5648, DOI 10.2527/jas.2015-9562; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang CunBo, 2010, Chinese Journal of Veterinary Science, V30, P317; Wang Y, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0067-y; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Xian A, 2013, NATURE METHODS, V10, P623; Xu Huifen, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P1306; Yin FG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160751; Yu K, 2015, J CELL BIOCHEM, V116, P192, DOI 10.1002/jcb.24958; Zhang CL, 2015, BIOTECHNOL LETT, V37, P1747, DOI 10.1007/s10529-015-1854-9; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45564; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419; Zhao WM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08957; Zhou M, 2016, ONCOTARGET, V7, P12598, DOI 10.18632/oncotarget.7181; Zhu Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126699	65	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184115	10.1371/journal.pone.0184115	http://dx.doi.org/10.1371/journal.pone.0184115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863190	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900025
J	Song, C; Liang, L; Jin, Y; Li, Y; Liu, Y; Guo, L; Wu, C; Yun, CH; Yin, Y				Song, C.; Liang, L.; Jin, Y.; Li, Y.; Liu, Y.; Guo, L.; Wu, C.; Yun, C-H; Yin, Y.			RCC2 is a novel p53 target in suppressing metastasis	ONCOGENE			English	Article							CHROMOSOME CONDENSATION RCC1; EXTRACELLULAR-MATRIX CUES; CELL-MIGRATION; TRANSCRIPTION TARGET; COLORECTAL-CANCER; RHO-GTPASES; GENE; REGULATOR; INSTABILITY; EXPRESSION	RCC2 (also known as TD60) is a highly conserved protein involved in prognosis in colorectal cancer. However, its relationship with tumor development is less understood. Here we demonstrate a signaling pathway defining regulation of RCC2 and its functions in tumor progression. We report that p53 is a transcriptional regulator of RCC2 that acts through its binding to a palindromic motif in the RCC2 promoter. RCC2 physically interacts and deactivates a small GTPase Rac1 that is known to be involved in metastasis. We solved a high-resolution crystal structure of RCC2 and revealed one RCC1-like domain with a unique beta-hairpin that is requisite for RCC2 interaction with Rac1. p53 or RCC2 deficiency leads to activation of Rac1 and deterioration of extracellular matrix sensing (haptotaxis) of surface-bound gradients. Ectopic expression of RCC2 restores directional migration in p53-null cells. Our results demonstrate that p53 and RCC2 signaling is important for regulation of cell migration and suppression of metastasis. We propose that the p53/RCC2/Rac1 axis is a potential target for cancer therapy.	Peking Univ, Hlth Sci Ctr, Inst Syst Biomed,Peking Tsinghua Ctr Life Sci, Dept Pathol,Sch Basic Med Sci,Beijing Key Lab Tum, Beijing, Peoples R China; Peking Univ, Hlth Sci Ctr, Inst Syst Biomed,Peking Tsinghua Ctr Life Sci, Dept Biophys,Sch Basic Med Sci,Beijing Key Lab Tu, Beijing, Peoples R China	Peking University; Peking University	Yun, CH; Yin, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Dept Pathol, 38 XueYuan Rd, Beijing 100191, Peoples R China.	yunch@hsc.pku.edu.cn; yinyuxin@hsc.pku.edu.cn	云, 彩红/E-1437-2018		National Natural Science Foundation of China [81430056, 31420103905, 81301801, 81621063, 31270769]; National Key Research and Development Program of China [2016YFA0500302]; Beijing Natural Science Foundation [7161007]; Lam Chung Nin Foundation for Systems Biomedicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Lam Chung Nin Foundation for Systems Biomedicine	We thank the staff of the Argonne National Laboratory (ID19) and the Shanghai SSRF Beamline (BL17U1 and BL19U1) for technical assistance. We thank X Chen, L Yuan, D Lu, G Wang, J Feng, C Zhang and S He for technical assistance and critical discussion. This work was supported by the following grants to YY including: National Natural Science Foundation of China (Key Grants 81430056, 31420103905, 81301801 and 81621063), National Key Research and Development Program of China (Grant 2016YFA0500302), Beijing Natural Science Foundation (Key Grant 7161007) and the Lam Chung Nin Foundation for Systems Biomedicine. C-HY was supported by the grant 31270769 from the National Natural Science Foundation of China.	Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Bosco EE, 2010, BLOOD, V115, P3320, DOI 10.1182/blood-2009-02-202440; Bruun J, 2015, CLIN CANCER RES, V21, P3759, DOI 10.1158/1078-0432.CCR-14-3294; Chan KT, 2014, J CELL BIOL, V207, P299, DOI 10.1083/jcb.201404067; Davis MJ, 2013, P NATL ACAD SCI USA, V110, P912, DOI 10.1073/pnas.1220895110; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hompland T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983664; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Kim NG, 2002, ONCOGENE, V21, P5081, DOI 10.1038/sj.onc.1205703; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Liu YX, 2008, MOL CANCER RES, V6, P624, DOI 10.1158/1541-7786.MCR-07-2019; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mashimo T, 1998, P NATL ACAD SCI USA, V95, P11307, DOI 10.1073/pnas.95.19.11307; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYASHITA T, 1995, CELL, V80, P293; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Sun Z, 2014, CELL REP, V6, P844, DOI 10.1016/j.celrep.2014.01.030; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zhao RB, 2000, GENE DEV, V14, P981	41	18	20	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					8	17		10.1038/onc.2017.306	http://dx.doi.org/10.1038/onc.2017.306			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28869598	Green Published, hybrid			2022-12-26	WOS:000422625000002
J	Williams, B; Correnti, J; Oranu, A; Lin, A; Scott, V; Annoh, M; Beck, J; Furth, E; Mitchell, V; Senkal, CE; Obeid, L; Carr, RM				Williams, Bianca; Correnti, Jason; Oranu, Amanke; Lin, Annie; Scott, Victoria; Annoh, Maxine; Beck, James; Furth, Emma; Mitchell, Victoria; Senkal, Can E.; Obeid, Lina; Carr, Rotonya M.			A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis	FASEB JOURNAL			English	Article						PLIN2; glucose tolerance; CerS6; lipid droplet; alcohol; liver	DIFFERENTIATION-RELATED PROTEIN; COLON-CANCER CELLS; HEPATIC STEATOSIS; INSULIN-RESISTANCE; LIVER-DISEASE; INHIBITOR MYRIOCIN; FATTY LIVER; ETHANOL; MICE; STEATOHEPATITIS	Perilipin 2 (PLIN2) is a lipid-droplet protein that is up-regulated in alcoholic steatosis and associated with hepatic accumulation of ceramides, bioactive lipids implicated in alcoholic liver disease pathogenesis. The specific role of ceramide synthetic enzymes in the regulation of PLIN2 and promotion of hepatocellular lipid accumulation is not well understood. We examined the effects of pharmacologic ceramide synthesis inhibition on hepatic PLIN2 expression, steatosis, and glucose and lipid homeostasis in mice with alcoholic steatosis and in ethanol-incubated human hepatoma VL17A cells. In cells, pharmacologic inhibition of ceramide synthase reduced lipid accumulation by reducing PLIN2 RNA stability. The subtype ceramide synthase (CerS)6 was specifically up-regulated in experimental alcoholic steatosis in vivo and in vitro and was up-regulated in zone 3 hepatocytes in human alcoholic steatosis. In vivo ceramide reduction by inhibition of de novo ceramide synthesis reduced PLIN2 and hepatic steatosis in alcohol-fed mice, but only de novo synthesis inhibition, not sphingomyelin hydrolysis, improved glucose tolerance and dyslipidemia. These findings implicate CerS6 as a novel regulator of PLIN2 and suggest that ceramide synthetic enzymes may promote the earliest stage of alcoholic liver disease, alcoholic steatosis.	[Williams, Bianca; Correnti, Jason; Oranu, Amanke; Lin, Annie; Scott, Victoria; Annoh, Maxine; Beck, James; Mitchell, Victoria; Carr, Rotonya M.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Furth, Emma] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Senkal, Can E.; Obeid, Lina] SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina] Northport Vet Affairs Med Ctr, Northport, NY USA	University of Pennsylvania; University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carr, RM (corresponding author), Univ Penn, Div Gastroenterol, 907 Biomed Res Bldg,421 Curie Blvd, Philadelphia, PA 19104 USA.	rotonya.carr@uphs.upenn.edu			U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism [K08-AA021424]; Robert Wood Johnson Foundation; Harold Amos Medical Faculty Development Award [7158]; Institute for Diabetes, Obesity and Metabolism Diabetes Research Center Pilot Award [P30 DK019525]; Health Resources and Services Administration Grant, Center of Excellence for Diversity in Health Education and Research [D34HP24459]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [T32 DK007066]; NIH National Institute of General Medical Sciences Grant [R01 GM062887]; NIH/NIDDK [P30-DK050306]; NIH National Cancer Institute [P01-CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, T32DK007066, P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA021424, F32AA024347, R01AA026302] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Harold Amos Medical Faculty Development Award; Institute for Diabetes, Obesity and Metabolism Diabetes Research Center Pilot Award; Health Resources and Services Administration Grant, Center of Excellence for Diversity in Health Education and Research; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of General Medical Sciences Grant; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank the Lipidomics Core facility at the State University of New York (SUNY; Stony Brook, NY, USA), the Michael J. Palmieri Metabolic Laboratory (Philadelphia, PA, USA) for lipid analyses; the University of Pennsylvania Molecular Pathology/Imaging, Molecular Biology, and Mouse Phenotyping Cores (Philadelphia, PA, USA); and Dr. Dahn Clemens (University of Nebraska, Omaha, NE, USA) for VL17A cells. The authors acknowledge Amy Praestgaard (Biostatistics Analysis Center, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania), for her biostatistical analysis and support. This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant K08-AA021424; the Robert Wood Johnson Foundation; Harold Amos Medical Faculty Development Award (Grant 7158); the Institute for Diabetes, Obesity and Metabolism Diabetes Research Center Pilot Award P30 DK019525 (to R.M.C.); Health Resources and Services Administration Grant D34HP24459, Center of Excellence for Diversity in Health Education and Research; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant T32 DK007066 (to A.O.), NIH National Institute of General Medical Sciences Grant R01 GM062887 (to L.M.O.), and, in part, by NIH/NIDDK Grant P30-DK050306; its core facilities (University of Pennsylvania Molecular Pathology and Imaging Core, Molecular Biology/Gene Expression Core, Transgenic and Chimeric Mouse Core, and Cell Culture Core) and its pilot grant program; and NIH National Cancer Institute Grant P01-CA97132 (SUNY Stony Brook Lipidomics Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Beckmann N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00331; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Carr RM, 2017, CLIN GASTROENTEROL H, V15, P145, DOI 10.1016/j.cgh.2016.08.023; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Carr RM, 2015, ANN NY ACAD SCI, V1353, P1, DOI 10.1111/nyas.12787; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Carr RM, 2013, ALCOHOL CLIN EXP RES, V37, P1091, DOI 10.1111/acer.12075; Carr RM, 2012, AM J PHYSIOL-REG I, V302, pR996, DOI 10.1152/ajpregu.00177.2011; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Correnti JM, 2014, AM J PHYSIOL-GASTR L, V306, pG959, DOI 10.1152/ajpgi.00395.2013; Donohue TM, 2006, INT J BIOCHEM CELL B, V38, P92, DOI 10.1016/j.biocel.2005.07.010; Ghaeli P, 2004, J CLIN PSYCHOPHARM, V24, P386, DOI 10.1097/01.jcp.0000132441.27854.0d; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kasumov T, 2015, OBESITY, V23, P1414, DOI 10.1002/oby.21117; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liangpunsakul S, 2012, AM J PHYSIOL-GASTR L, V302, pG515, DOI 10.1152/ajpgi.00455.2011; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lizarazo D, 2013, J GASTROEN HEPATOL, V28, P1660, DOI 10.1111/jgh.12291; Longato L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/479348; Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x; Magne J, 2013, FASEB J, V27, P3090, DOI 10.1096/fj.13-228759; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Osna NA, 2005, HEPATOLOGY, V42, P1109, DOI 10.1002/hep.20909; Ramirez T, 2013, ALCOHOL ALCOHOLISM, V48, P39, DOI 10.1093/alcalc/ags106; Raynard B, 2002, HEPATOLOGY, V35, P635, DOI 10.1053/jhep.2002.31782; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Senthivinayagam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073696; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tong M, 2014, INT J EXP PATHOL, V95, P49, DOI 10.1111/iep.12052; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200	45	17	18	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					130	142		10.1096/fj.201601142R	http://dx.doi.org/10.1096/fj.201601142R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28864659	Green Published			2022-12-26	WOS:000419172700014
J	Siripurapu, P; Kankanamge, D; Ratnayake, K; Senarath, K; Karunarathne, A				Siripurapu, Praneeth; Kankanamge, Dinesh; Ratnayake, Kasun; Senarath, Kanishka; Karunarathne, Ajith			Two independent but synchronized G beta gamma subunit-controlled pathways are essential for trailing-edge retraction during macrophage migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; NUCLEOTIDE EXCHANGE FACTOR; PROTEIN-COUPLED RECEPTORS; IMMUNE CELL-MIGRATION; PHOSPHOLIPASE-C-BETA; NEUTROPHIL CHEMOTAXIS; ADENYLYL-CYCLASE; SMOOTH-MUSCLE; RHO-KINASE; SIGNALING PATHWAYS	Chemokine-induced directional cell migration is a universal cellular mechanism and plays crucial roles in numerous biological processes, including embryonic development, immune system function, and tissue remodeling and regeneration. During the migration of a stationary cell, the cell polarizes, forms lamel-lipodia at the leading edge (LE), and triggers the concurrent retraction of the trailing edge (TE). During cell migration governed by inhibitory G protein (G(i))-coupled receptors (GPCRs), G protein beta gamma (G beta gamma) subunits control the LE signaling. Interestingly, TE retraction has been linked to the activation of the small GTPase Ras homolog family member A (RhoA) by the G alpha(12/13) pathway. However, it is not clear how the activation of Gi-coupled GPCRs at the LE orchestrates the TE retraction in RAW264.7 macrophages. Here, using an optogenetic approach involving an opsin to activate the Gi pathway in defined subcellular regions of RAW cells, we show that in addition to their LE activities, free G beta gamma subunits also govern TE retraction by operating two independent, yet synchronized, pathways. The first pathway involves RhoA activation, which prevents dephosphorylation of the myosin light chain, allowing actomyosin contractility to proceed. The second pathway activates phospholipase C beta and induces myosin light chain phosphorylation to enhance actomyosin contractility through increasing cytosolic calcium. We further show that both of these pathways are essential, and inhibition of either one is sufficient to abolish the G(i)-coupled GPCR-governed TE retraction and subsequent migration of RAW cells.	[Siripurapu, Praneeth; Kankanamge, Dinesh; Ratnayake, Kasun; Senarath, Kanishka; Karunarathne, Ajith] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Karunarathne, A (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	Ajith.karunarathne@utoledo.edu		Kankanamge, Dinesh/0000-0001-9647-0258; Karunarathne, Ajith/0000-0003-3136-2015; Senarath, Kanishka/0000-0003-3326-9738	University of Toledo	University of Toledo	This work was supported by the University of Toledo. The authors declare that they have no conflicts of interest with the contents of this article.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Burdyga A, 2013, BBA-MOL CELL RES, V1833, P2664, DOI 10.1016/j.bbamcr.2013.06.011; Cai HQ, 2011, SEMIN CELL DEV BIOL, V22, P834, DOI 10.1016/j.semcdb.2011.07.020; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Chen CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002446; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Czepielewski RS, 2012, P NATL ACAD SCI USA, V109, P547, DOI 10.1073/pnas.1110996109; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Fogg VC, 2001, J BIOL CHEM, V276, P41797, DOI 10.1074/jbc.M107661200; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gether U, 2002, PHARMACOL TOXICOL, V91, P304, DOI 10.1034/j.1600-0773.2002.910607.x; Ghosh P., 2008, J CELL BIOL; Giri L, 2014, BIOPHYS J, V107, P242, DOI 10.1016/j.bpj.2014.05.020; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Hutchins BI, 2013, J NEUROSCI, V33, P11361, DOI 10.1523/JNEUROSCI.3758-12.2013; ISHIKAWA S, 1993, BIOCHEM BIOPH RES CO, V194, P287, DOI 10.1006/bbrc.1993.1817; ITOH H, 1984, J BIOCHEM-TOKYO, V96, P1721, DOI 10.1093/oxfordjournals.jbchem.a135004; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Karunarathne WKA, 2015, J CELL SCI, V128, P15, DOI 10.1242/jcs.154435; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1575, DOI 10.1073/pnas.1220755110; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kranenburg O., 1999, MOL, V12; Legler DF, 2014, INT J BIOCHEM CELL B, V54, P78, DOI 10.1016/j.biocel.2014.07.002; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liu LH, 2014, MOL BIOL CELL, V25, P1446, DOI 10.1091/mbc.E14-01-0037; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; Martini FJ, 2010, J NEUROSCI, V30, P8660, DOI 10.1523/JNEUROSCI.1962-10.2010; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nalli AD, 2014, J PHARMACOL EXP THER, V350, P89, DOI 10.1124/jpet.113.212522; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; O'Neill PR, 2016, MOL BIOL CELL, V27, P1442, DOI 10.1091/mbc.E15-12-0832; O'Neill PR, 2014, MOL BIOL CELL, V25, P2305, DOI 10.1091/mbc.E14-04-0870; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RIBEIRONETO FAP, 1989, P NATL ACAD SCI USA, V86, P2577, DOI 10.1073/pnas.86.8.2577; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Senarath K, 2016, ANAL CHEM, V88, P11450, DOI 10.1021/acs.analchem.6b02512; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yost EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116575; Zhao ZQ, 2014, NEURON, V84, P821, DOI 10.1016/j.neuron.2014.10.003	85	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17482	17495		10.1074/jbc.M117.787838	http://dx.doi.org/10.1074/jbc.M117.787838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28864771	Green Published, hybrid			2022-12-26	WOS:000414009300028
J	Cao, XD; MacNaughton, P; Laurent, JC; Allen, JG				Cao, Xiaodong; MacNaughton, Piers; Laurent, Jose Cedeno; Allen, Joseph G.			Radon-induced lung cancer deaths may be overestimated due to failure to account for confounding by exposure to diesel engine exhaust in BEIR VI miner studies	PLOS ONE			English	Article							INDOOR RADON; RESIDENTIAL RADON; TRUCKING INDUSTRY; RISK; METAANALYSIS	Background EPA reported that radon is the second leading cause of lung cancer in the United States, killing 21,100 people per year. EPA relies on the BEIR VI models, based on an evaluation of radon exposure and lung cancer risk in studies of miners. But these models did not account for co-exposure to diesel exhaust, a known human carcinogen recently classified by IARC. It is probable then that a portion of the lung cancer deaths in the miner cohorts are originally attributable to the exposure to diesel rather than radon. Objective To re-evaluate EPA's radon attributable lung cancer estimates accounting for diesel exposure information in the miner cohorts. Methods We used estimates of historical diesel concentrations, combined with diesel exposure-response functions, to estimate the risks of lung cancer attributable to diesel engine exhaust (DEE) exposure in the miner studies. We re-calculated the fatal lung cancer risk attributable to radon after accounting for risk from diesel and re-estimated the number of U.S. deaths associated with radon in the U.S. using EPA's methodology. Results Considering the probable confounding with DEE exposure and using the same estimate of baseline mortality from 1989-91 that the EPA currently uses in their calculations, we estimate that radon-induced lung cancer deaths per year are 15,600 (95% CI: 14,300, 17,000)-19,300 (95% CI: 18,800, 20,000) in the U.S. population, a reduction of 9%-26%. The death estimates would be 12,900-15,900 using 2014 baseline vital statistics. Conclusions We recommend further research on re-evaluating the health effects of exposure to radon that accounts for new information on diesel exhaust carcinogenicity in BEIR VI models, up-to-date vital statistics and new epidemiological evidence from residential studies.	[Cao, Xiaodong; MacNaughton, Piers; Laurent, Jose Cedeno; Allen, Joseph G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Allen, JG (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	jgallen@hsph.harvard.edu	Cao, Xiaodong/AAO-8483-2021	Cao, Xiaodong/0000-0002-0890-3306	post-doctoral fellowship at Harvard; NIEHS environmental epidemiology training grant [5T32ES007069-35]; Marilyn Hoffman program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069] Funding Source: NIH RePORTER	post-doctoral fellowship at Harvard; NIEHS environmental epidemiology training grant; Marilyn Hoffman program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Yan Chen for partially supporting a post-doctoral fellowship at Harvard for Xiaodong Cao. Piers MacNaughton's time was supported by NIEHS environmental epidemiology training grant 5T32ES007069-35. Jose Cedeno Laurent's funding is provided by the Marilyn Hoffman program. Joseph G. Allen's funding for this project comes from his faculty startup funds.; We thank the anonymous peer-reviewers for their excellent comments that have enhanced the manuscript. We thank Yan Chen for partially supporting a post-doctoral fellowship at Harvard for Xiaodong Cao. Piers MacNaughton's time was supported by NIEHS environmental epidemiology training grant 5T32ES007069-35. Jose Cedeno Laurent's funding is provided by the Marilyn Hoffman program. Joseph G. Allen's funding for this project comes from his faculty startup funds.We thank the anonymous peer-reviewers for their excellent comments that have enhanced the manuscript. We thank Yan Chen for partially supporting a post-doctoral fellowship at Harvard for Xiaodong Cao. Piers MacNaughton's time was supported by NIEHS environmental epidemiology training grant 5T32ES007069-35. Jose Cedeno Laurent's funding is provided by the Marilyn Hoffman program. Joseph G. Allen's funding for this project comes from his faculty startup funds.	Barros-Dios JM, 2012, CANC EPIDEMIOLOGY PR; Baysson H, 2004, EPIDEMIOLOGY, V15, P709, DOI 10.1097/01.ede.0000142150.60556.b8; Benbrahim-Tallaa L, 2012, LANCET ONCOL, V13, P663, DOI 10.1016/S1470-2045(12)70280-2; BLOT WJ, 1990, J NATL CANCER I, V82, P1025, DOI 10.1093/jnci/82.12.1025; Castorina R, 2003, ENVIRON HEALTH PERSP, V111, P1318, DOI 10.1289/ehp.6185; Catelinois O, 2006, ENVIRON HEALTH PERSP, V114, P1361, DOI 10.1289/ehp.9070; Cavallo AJ, 2000, J ENVIRON RADIOACTIV, V51, P99, DOI 10.1016/S0265-931X(00)00047-3; CDC, 2016, CDC WONDER HOM; Crump K, 2012, CRIT REV TOXICOL, V42, P599, DOI 10.3109/10408444.2012.689755; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Duan P, 2015, EUR J CANCER PREV, V24, P267, DOI 10.1097/CEJ.0000000000000066; EPA, EPA402K120022012; Garshick E, 2012, ENVIRON HEALTH PERSP, V120, P1301, DOI 10.1289/ehp.1204989; James AC, 2004, RADIAT PROT DOSIM, V108, P3, DOI 10.1093/rpd/nch007; Kim SH, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0093-4; Kreuzer M, 2002, INT J CANCER, V100, P706, DOI 10.1002/ijc.10549; Krewski D, 2006, J TOXICOL ENV HEAL A, V69, P533, DOI 10.1080/15287390500260945; Krewski D, 2005, EPIDEMIOLOGY, V16, P137, DOI 10.1097/01.ede.0000152522.80261.e3; Lagarde F, 2001, EPIDEMIOLOGY, V12, P396, DOI 10.1097/00001648-200107000-00009; Lubin JH, 1994, RADON LUNG CANC RISK; MARCINOWSKI F, 1994, HEALTH PHYS, V66, P699, DOI 10.1097/00004032-199406000-00009; Morfeld P, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0073-6; MSHA, 2006, 064494 MSHA; NRC (National Research Council), 1999, HLTH EFF EXP RAD BEI; Robert E., 2014, FY2015 APPROPRIATION; Sandler DP, 2006, J TOXICOL ENV HEAL A, V69, P633, DOI 10.1080/15287390500261117; Sheen S, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0094-3; Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034; Steenland K, 1998, AM J IND MED, V34, P220, DOI 10.1002/(SICI)1097-0274(199809)34:3<220::AID-AJIM3>3.0.CO;2-Z; Stewart PA, 2010, ANN OCCUP HYG, V54, P728, DOI 10.1093/annhyg/meq022; Turner MC, 2011, CANCER EPIDEM BIOMAR, V20, P438, DOI 10.1158/1055-9965.EPI-10-1153; USEPA Environmental Protection Agency, 2003, EPA ASS RISKS RAD HO; USHHS, 2014, HLTH CONS SMOK 50 YE; Verma DK, 2015, J ENV OCCUPATIONAL S, V4, P70; Vermeulen R, 2014, ENVIRON HEALTH PERSP, V122, P172, DOI 10.1289/ehp.1306880; Vermeulen R, 2010, ANN OCCUP HYG, V54, P774, DOI 10.1093/annhyg/meq025; Wang ZY, 2002, AM J EPIDEMIOL, V155, P554, DOI 10.1093/aje/155.6.554; Wichmann HE, 2005, HEALTH PHYS, V88, P71, DOI 10.1097/01.HP.0000142497.31627.86; Wilcox HB, 2008, RADIAT PROT DOSIM, V128, P169, DOI 10.1093/rpd/ncm330; World Health Organization (WHO), 2009, WHO HDB INDOOR RADON	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184298	10.1371/journal.pone.0184298	http://dx.doi.org/10.1371/journal.pone.0184298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886109	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100094
J	Huang, L; Liao, L; Wu, CH				Huang, Lei; Liao, Li; Wu, Cathy H.			Evolutionary analysis and interaction prediction for protein-protein interaction network in geometric space	PLOS ONE			English	Article								Prediction of protein-protein interaction (PPI) remains a central task in systems biology. With more PPIs identified, forming PPI networks, it has become feasible and also imperative to study PPIs at the network level, such as evolutionary analysis of the networks, for better understanding of PPI networks and for more accurate prediction of pairwise PPIs by leveraging the information gained at the network level. In this work we developed a novel method that enables us to incorporate evolutionary information into geometric space to improve PPI prediction, which in turn can be used to select and evaluate various evolutionary models. The method is tested with cross-validation using human PPI network and yeast PPI network data. The results show that the accuracy of PPI prediction measured by ROC score is increased by up to 14.6%, as compared to a baseline without using evolutionary information. The results also indicate that our modified evolutionary model DANEOsf-combining a gene duplication/neofunctionalization model and scale-free model-has a better fitness and prediction efficacy for these two PPI networks. The improved PPI prediction performance may suggest that our DANEOsf evolutionary model can uncover the underlying evolutionary mechanism for these two PPI networks better than other tested models. Consequently, of particular importance is that our method offers an effective way to select evolutionary models that best capture the underlying evolutionary mechanisms, evaluating the fitness of evolutionary models from the perspective of PPI prediction on real PPI networks.	[Huang, Lei; Liao, Li] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA	University of Delaware; University of Delaware	Liao, L (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA.	liliao@udel.edu		Wu, Cathy/0000-0001-6379-8601	Delaware INBRE program; National Institutes of Health [8P20GM103446-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	Delaware INBRE program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Delaware INBRE program supported by the grant 8P20GM103446-13 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Delaware INBRE program supported by the grant 8P20GM103446-13 from the National Institutes of Health. The authors thank the anonymous reviewers for their constructive comments and suggestions.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bishop C. M, 2006, PATTERN RECOGNITION; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cannistraci CV, 2010, BIOINFORMATICS, V26, pi531, DOI 10.1093/bioinformatics/btq376; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Hase T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000550; Higham DJ, 2008, BIOINFORMATICS, V24, P1093, DOI 10.1093/bioinformatics/btn079; Hinton G., 2003, ADV NEURAL INFORM PR, P857; Huang L, 2015, IEEE ACM T COMPUT BI, V12, P622, DOI 10.1109/TCBB.2014.2366748; Ispolatov I, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/145; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Jain S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-562; Jin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058134; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Milenkovic T, 2008, CANCER INFORM, V6, P257; Peterson GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039052; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Trevor F Cox MAAC, 1994, MULTIDIMENSIONAL SCA; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; You ZH, 2010, BIOINFORMATICS, V26, P2744, DOI 10.1093/bioinformatics/btq510; Zhang A., 2009, PROT INT NETW COMP; Zhu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058368	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183495	10.1371/journal.pone.0183495	http://dx.doi.org/10.1371/journal.pone.0183495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886027	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100027
J	Pelaez-Garcia, A; Yebenes, L; Berjon, A; Angulo, A; Zamora, P; Sanchez-Mendez, JI; Espinosa, E; Redondo, A; Heredia-Soto, V; Mendiola, M; Feliu, J; Hardisson, D				Pelaez-Garcia, Alberto; Yebenes, Laura; Berjon, Alberto; Angulo, Antonia; Zamora, Pilar; Sanchez-Mendez, Jose Ignacio; Espinosa, Enrique; Redondo, Andres; Heredia-Soto, Victoria; Mendiola, Marta; Feliu, Jaime; Hardisson, David			Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer	PLOS ONE			English	Article							RECURRENCE SCORE; GENE-EXPRESSION; DISTANT RECURRENCE; PAM50 RISK; ER; CHEMOTHERAPY; TARGETPRINT; CONCORDANCE; INFORMATION; BENEFIT	Purpose To compare the concordance in risk classification between the EndoPredict and the MammaPrint scores obtained for the same cancer samples on 40 estrogen-receptor positive/HER2-negative breast carcinomas. Methods Formalin-fixed, paraffin-embedded invasive breast carcinoma tissues that were previously analyzed with MammaPrint as part of routine care of the patients, and were classified as high-risk (20 patients) and low-risk (20 patients), were selected to be analyzed by the EndoPredict assay, a second generation gene expression test that combines expression of 8 genes (EP score) with two clinicopathological variables (tumor size and nodal status, EPclin score). Results The EP score classified 15 patients as low-risk and 25 patients as high-risk. EPclin re-classified 5 of the 25 EP high-risk patients into low-risk, resulting in a total of 20 high-risk and 20 low-risk tumors. EP score and MammaPrint score were significantly correlated (p = 0.008). Twelve of 20 samples classified as low-risk by MammaPrint were also low-risk by EP score (60%). 17 of 20 MammaPrint high-risk tumors were also high-risk by EP score. The overall concordance between EP score and MammaPrint was 72.5% (k = 0.45, (95% CI, 0.182 to 0.718)). EPclin score also correlated with MammaPrint results (p = 0.004). Discrepancies between both tests occurred in 10 cases: 5 MammaPrint low-risk patients were classified as EPclin high-risk and 5 high-risk MammaPrint were classified as low-risk by EPclin and overall concordance of 75%(k = 0.5, ( 95% CI, 0.232 to 0.768)). Conclusions This pilot study demonstrates a limited concordance between MammaPrint and EndoPredict. Differences in results could be explained by the inclusion of different gene sets in each platform, the use of different methodology, and the inclusion of clinicopathological parameters, such as tumor size and nodal status, in the EndoPredict test.	[Pelaez-Garcia, Alberto; Yebenes, Laura; Berjon, Alberto; Mendiola, Marta; Hardisson, David] Hosp Univ La Paz, Dept Pathol, IdiPAZ, Madrid, Spain; [Pelaez-Garcia, Alberto; Yebenes, Laura; Berjon, Alberto; Sanchez-Mendez, Jose Ignacio; Heredia-Soto, Victoria; Mendiola, Marta; Hardisson, David] Hosp Univ La Paz, Mol Pathol & Therapeut Targets Grp, IdiPAZ, Madrid, Spain; [Pelaez-Garcia, Alberto; Heredia-Soto, Victoria; Mendiola, Marta; Hardisson, David] Hosp Univ La Paz, INGEMM, IdiPAZ, Mol Pathol Diagnost Unit, Madrid, Spain; [Angulo, Antonia] Myriad Genet Espana SLU, Madrid, Spain; [Zamora, Pilar; Espinosa, Enrique; Redondo, Andres; Feliu, Jaime] Hosp Univ La Paz, IdiPAZ, Dept Med Oncol, Madrid, Spain; [Zamora, Pilar; Sanchez-Mendez, Jose Ignacio; Espinosa, Enrique; Redondo, Andres; Feliu, Jaime; Hardisson, David] Univ Autonoma Madrid, Fac Med, Madrid, Spain; [Zamora, Pilar; Espinosa, Enrique; Redondo, Andres; Feliu, Jaime] Hosp Univ La Paz, Translat Oncol Grp, IdiPAZ, Madrid, Spain; [Sanchez-Mendez, Jose Ignacio] Hosp Univ La Paz, Dept Obstet & Gynecol, IdiPAZ, Breast Canc Unit, Madrid, Spain; [Espinosa, Enrique; Heredia-Soto, Victoria; Feliu, Jaime] Minist Econ Ind & Competitividad, Inst Salud Carlos III, Ctr Invest Biorned Red Canc CIBERONC, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness	Hardisson, D (corresponding author), Hosp Univ La Paz, Dept Pathol, IdiPAZ, Madrid, Spain.; Hardisson, D (corresponding author), Hosp Univ La Paz, Mol Pathol & Therapeut Targets Grp, IdiPAZ, Madrid, Spain.; Hardisson, D (corresponding author), Hosp Univ La Paz, INGEMM, IdiPAZ, Mol Pathol Diagnost Unit, Madrid, Spain.; Hardisson, D (corresponding author), Univ Autonoma Madrid, Fac Med, Madrid, Spain.	david.hardisson@salud.madrid.org	Méndez, José Ignacio Sánchez/M-8025-2019; Hardisson, David/A-6259-2011; Hardisson, David/AAN-3833-2020; Hardisson, David/E-2832-2010; Zamora, Pilar/AAM-9336-2021	Méndez, José Ignacio Sánchez/0000-0003-2559-2500; Hardisson, David/0000-0002-2183-3699; Berjon, Alberto/0000-0002-3467-106X; Heredia-Soto, Victoria/0000-0002-0704-7958; Espinosa Arranz, Enrique/0000-0001-6562-7902; Redondo Sanchez, Andres/0000-0002-7257-5642	company Myriad Genetic Espana SLU	company Myriad Genetic Espana SLU	The study was supported by the company Myriad Genetic Espana SLU. The funder provided support in the form of salaries for author AA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bartlett JMS, 2016, JNCI-J NATL CANCER I, V108, P1, DOI DOI 10.1093/JNCI/DJW05; Buus R, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw149; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Dubsky P, 2013, BRIT J CANCER, V109, P2959, DOI 10.1038/bjc.2013.671; Dubsky P, 2013, ANN ONCOL, V24, P640, DOI 10.1093/annonc/mds334; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Gyorffy B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0514-2; Hagemann IS, 2016, ARCH PATHOL LAB MED, V140, P815, DOI 10.5858/arpa.2016-0051-RA; Henry LR, 2009, INFLUENCE GENE EXPRE, P319; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Kronenwett R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-456; Martin M, 2016, BREAST CANCER RES TR, V156, P81, DOI 10.1007/s10549-016-3725-z; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Roepman P, 2009, CLIN CANCER RES, V15, P7003, DOI 10.1158/1078-0432.CCR-09-0449; Stein RC, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20100; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Varga Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058483; Viale G, 2014, ANN ONCOL, V25, P816, DOI 10.1093/annonc/mdu026; Viale G, 2016, BREAST CANCER RES TR, V155, P463, DOI 10.1007/s10549-016-3690-6; Wesseling J, 2016, VIRCHOWS ARCH, V469, P297, DOI 10.1007/s00428-016-1979-9	25	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183452	10.1371/journal.pone.0183452	http://dx.doi.org/10.1371/journal.pone.0183452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886093	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100022
J	Ramos-Morales, E; de la Fuente, G; Nash, RJ; Braganca, R; Duval, S; Bouillon, ME; Lahmann, M; Newbold, CJ				Ramos-Morales, Eva; de la Fuente, Gabriel; Nash, Robert J.; Braganca, Radek; Duval, Stephane; Bouillon, Marc E.; Lahmann, Martina; Newbold, C. Jamie			Improving the antiprotozoal effect of saponins in the rumen by combination with glycosidase inhibiting iminosugars or by modification of their chemical structure	PLOS ONE			English	Article							STEVIA-REBAUDIANA; BACTERIAL PROTEIN; HEDERA-HELIX; TEA SAPONIN; FERMENTATION; BERTONI	The antiprotozoal effect of saponins is transitory, as when saponins are deglycosylated to sapogenins by rumen microorganisms they become inactive. We hypothesised that the combination of saponins with glycosidase-inhibiting iminosugars might potentially increase the effectiveness of saponins over time by preventing their deglycosylation in the rumen. Alternatively, modifying the structure of the saponins by substituting the sugar moiety with other small polar residues might maintain their activity as the sugar substitute would not be enzymatically cleaved. The aim of this in vitro study was to evaluate the acute antiprotozoal effect and the stability of this effect over a 24 h incubation period using ivy saponins, a stevia extract rich in iminosugars, ivy saponins with stevia extract, and a chemically modified ivy saponin, hederagenin bis-succinate (HBS). The effects on fermentation parameters and rumen bacterial communities were also studied. Ivy saponins with stevia and HBS had a greater antiprotozoal effect than ivy saponins, and this effect was maintained after 24 h of incubation (P<0.001). The combination of ivy and stevia extracts was more effective in shifting the fermentation pattern towards higher propionate (+39%) and lower butyrate (-32%) and lower ammonia concentration (-64%) than the extracts incubated separately. HBS caused a decrease in butyrate (-45%) and an increase in propionate (+43%) molar proportions. However, the decrease in ammonia concentration (-42%) observed in the presence of HBS was less than that caused by ivy saponins, either alone or with stevia. Whereas HBS and stevia impacted on bacterial population in terms of community structure, only HBS had an effect in terms of biodiversity (P<0.05). It was concluded that ivy saponins with stevia and the modified saponin HBS had a strong antiprotozoal effect, although they differed in their effects on fermentation parameters and bacteria communities. Ivy saponins combined with an iminosugar-rich stevia extract and/or HBS should be evaluated to determine their antiprotozoal effect in vivo.	[Ramos-Morales, Eva; de la Fuente, Gabriel; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Nash, Robert J.] PhytoQuest Ltd, Aberystwyth, Dyfed, Wales; [Braganca, Radek] Bangor Univ, BioComposites Ctr, Bangor, Gwynedd, Wales; [Duval, Stephane] DSM Nutr Prod Ltd, Ctr Rech Nutr Anim, St Louis, France; [Bouillon, Marc E.; Lahmann, Martina] Bangor Univ, Sch Chem, Bangor, Gwynedd, Wales; [de la Fuente, Gabriel] Univ Lleida, Dept Ciencia Anim, Lleida, Spain; [Newbold, C. Jamie] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Aberystwyth University; Bangor University; DSM NV; Bangor University; Universitat de Lleida; Scotland's Rural College	Ramos-Morales, E; Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.; Newbold, CJ (corresponding author), Scotlands Rural Coll, Edinburgh, Midlothian, Scotland.	evr1@aber.ac.uk; Jamie.Newbold@sruc.ac.uk	Nash, Robert/ABE-3575-2020; de la Fuente Oliver, Gabriel/M-6981-2019; Ramos-Morales, Eva/ABD-3707-2021; de la Fuente Oliver, Gabriel/B-3793-2015; Lahmann, Martina/A-3090-2010	de la Fuente Oliver, Gabriel/0000-0003-0083-776X; Ramos-Morales, Eva/0000-0002-7056-9097; de la Fuente Oliver, Gabriel/0000-0003-0083-776X; Lahmann, Martina/0000-0002-8513-1952; Nash, Robert/0000-0002-3272-640X	Innovate UK project "Ivy for ruminants" [101091]; Biotechnology and Biological Sciences Research Council, UK [BB/J0013/1]; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01B] Funding Source: researchfish; BBSRC [BBS/E/W/10964A01B] Funding Source: UKRI	Innovate UK project "Ivy for ruminants"(UK Research & Innovation (UKRI)Innovate UK); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financed by the Innovate UK project "Ivy for ruminants" Ref: 101091. SD (DSM Nutritional Products Ltd.) and RN (PhytoQuest Ltd.) were part of the project consortium and they contributed to the conceptualization of the project as well as to the funding acquisition and revision of the manuscript (as described in the author's contributions section). The before mentioned institutions did not provide any further funding. CJN acknowledges the support of the Biotechnology and Biological Sciences Research Council, UK via grant number BB/J0013/1.	Asano N, 2003, CURR TOP MED CHEM, V3, P471, DOI 10.2174/1568026033452438; Atteh JO, 2008, J ANIM PHYSIOL AN N, V92, P640, DOI 10.1111/j.1439-0396.2007.00760.x; Belanche A, 2012, J ANIM SCI, V90, P4495, DOI 10.2527/jas.2012-5118; Belanche A, 2016, J SCI FOOD AGR, V96, P3069, DOI 10.1002/jsfa.7481; Belanche A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; De la Fuente Gabriel, 2006, Zootaxa, V1377, P47; Debnath M, 2008, J MED PLANTS RES, V2, P45; Dehority BA, 1993, LABORATORY MANUAL FO; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Ghias Uddin, 2011, Middle East Journal of Scientific Research, V8, P198; Guo YQ, 2008, LETT APPL MICROBIOL, V47, P421, DOI 10.1111/j.1472-765X.2008.02459.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hongoh Y, 2003, FEMS MICROBIOL LETT, V221, P299, DOI 10.1016/S0378-1097(03)00218-0; Hu WL, 2005, ANIM FEED SCI TECH, V120, P333, DOI 10.1016/j.anifeedsci.2005.02.029; Jayanegara A, 2014, ASIAN AUSTRAL J ANIM, V27, P1426, DOI 10.5713/ajas.2014.14086; KOHDA H, 1976, PHYTOCHEMISTRY, V15, P981, DOI 10.1016/S0031-9422(00)84384-8; Lutsenko Y., 2010, Herba Polonica, V56, P83; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Michalik A, 2010, PHYTOCHEM LETT, V3, P136, DOI 10.1016/j.phytol.2010.04.004; Morgavi DP, 2004, FOOD ADDIT CONTAM A, V21, P871, DOI [10.1080/02652030400002188, 10.1080/0265-2030400002188]; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; NASH RJ, 1986, J CHROMATOGR, V366, P431, DOI 10.1016/S0021-9673(01)93497-1; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; Newbold CJ, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P47, DOI 10.1007/978-90-481-3297-3_4; Newbold CJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01313; Newbold CJ, 1997, BRIT J NUTR, V78, P237, DOI 10.1079/BJN19970143; Parvu M, 2015, NOT BOT HORTI AGROBO, V43, P53, DOI 10.15835/nbha4319644; Patra AK, 2009, NUTR RES REV, V22, P204, DOI 10.1017/S0954422409990163; Patra K. A., 2009, ANTON LEEUW INT J G, V96, P363, DOI [10.1007/s10482-009-9364-1, DOI 10.1007/S10482-009-9364-1]; Pielartzik H, 1985, METHODEN DER ORGANIS, P656; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Ramos-Morales E, 2016, UK patent application number, Patent No. [1620438.0, 1620438]; Ramos-Morales E, 2016, Patent PCT/ EP, Patent No. 2016062383; Ramos-Morales E, 2014, VITRO EFFECT OF THE, P116; Ramos-Morales E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00399; Seymour WM, 2005, ANIM FEED SCI TECH, V119, P155, DOI 10.1016/j.anifeedsci.2004.10.001; Skrivanova E, 2010, VET MICROBIOL, V144, P334, DOI 10.1016/j.vetmic.2010.01.013; STEWART CS, 1985, J GEN MICROBIOL, V131, P427; Sumit Ghosh, 2008, International Journal of Integrative Biology, V2, P27; Tedeschi LO, 2000, P CORN NUTR C FEED M; Tomita T, 1997, MICROBIOL IMMUNOL, V41, P1005, DOI 10.1111/j.1348-0421.1997.tb01961.x; Torres M, 2015, Compend. cienc. vet, V5, P32, DOI 10.18004/compend.cienc.vet.2015.05.02.32-37; Wallace RJ, 2007, J LIPID RES, V48, P2247, DOI 10.1194/jlr.M700271-JLR200; WALLACE RJ, 1987, BRIT J NUTR, V58, P313, DOI 10.1079/BJN19870098; Wang LS, 2014, ANIM FEED SCI TECH, V187, P104, DOI 10.1016/j.anifeedsci.2013.10.014; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Williams A.G., 1992, RUMEN PROTOZOA; Wina E, 2005, J AGR FOOD CHEM, V53, P8093, DOI 10.1021/jf048053d	50	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184517	10.1371/journal.pone.0184517	http://dx.doi.org/10.1371/journal.pone.0184517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886130	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100145
J	Coplan, JD; Gupta, NK; Karim, A; Rozenboym, A; Smith, ELP; Kral, JG; Rosenblum, LA				Coplan, Jeremy D.; Gupta, Nishant K.; Karim, Asif; Rozenboym, Anna; Smith, Eric L. P.; Kral, John G.; Rosenblum, Leonard A.			Maternal hypothalamic-pituitary-adrenal axis response to foraging uncertainty: A model of individual vs. social allostasis and the "Superorganism Hypothesis"	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CEREBROSPINAL-FLUID; NONHUMAN-PRIMATES; STRESS; ANXIETY; CORTISOL; RANK; FEAR; PATHOPHYSIOLOGY; GLUCOCORTICOIDS	Introduction Food insecurity is a major global contributor to developmental origins of adult disease. The allostatic load of maternal food uncertainty from variable foraging demand (VFD) activates corticotropin-releasing factor (CRF) without eliciting hypothalamic-pituitary-adrenal (HPA) activation measured on a group level. Individual homeostatic adaptations of the HPA axis may subserve second-order homeostasis, a process we provisionally term "social allostasis." We postulate that maternal food insecurity induces a "superorganism" state through coordination of individual HPA axis response. Methods Twenty-four socially-housed bonnet macaque maternal-infant dyads were exposed to 16 weeks of alternating two-week epochs of low or high foraging demand shown to compromise normative maternal-infant rearing. Cerebrospinal fluid (CSF) CRF concentrations and plasma cortisol were measured pre-and post-VFD. Dyadic distance was measured, and blinded observers performed pre-VFD social ranking assessments. Results Despite marked individual cortisol responses (mean change = 20%) there was an absence of maternal HPA axis group mean response to VFD (0%). Whereas individual CSF CRF concentrations change = 56%, group mean did increase 25% (p = 0.002). Our "dyadic vulnerability" index (low infant weight, low maternal weight, subordinate maternal social status and reduced dyadic distance) predicted maternal cortisol decreases (p < 0.0001) whereas relatively "advantaged" dyads exhibited maternal cortisol increases in response to VFD exposure. Comment In response to a chronic stressor, relative dyadic vulnerability plays a significant role in determining the directionality and magnitude of individual maternal HPA axis responses in the service of maintaining a "superorganism" version of HPA axis homeostasis, provisionally termed "social allostasis."	[Coplan, Jeremy D.; Smith, Eric L. P.; Rosenblum, Leonard A.] Suny Downstate Med Ctr, Biol Sci Unit, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA; [Gupta, Nishant K.; Karim, Asif] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Rozenboym, Anna] Kingsborough Community Coll, Brooklyn, NY USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Internal Med, Brooklyn, NY 11203 USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Coplan, JD (corresponding author), Suny Downstate Med Ctr, Biol Sci Unit, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA.	Jeremy.Coplan@downstate.edu			National Institute of Mental Health grant [R01MH59990A]	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health grant R01MH59990A (JDC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEMUS M, 1994, ARCH GEN PSYCHIAT, V51, P794; ANDREWS MW, 1991, CHILD DEV, V62, P686, DOI 10.1111/j.1467-8624.1991.tb01562.x; [Anonymous], 2008, ADAPTATION NATURAL S; BALTES PB, 1968, HUM DEV, V11, P145, DOI 10.1159/000270604; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Cavigelli SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0103; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Coplan JD, 1997, PSYCHOPHARMACOL BULL, V33, P193; Coplan JD, 2005, CNS SPECTRUMS, V10, P530, DOI 10.1017/S109285290001018X; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Coplan JD, 2014, FRONTIERS BEHAV NEUR, V8; Coplan JD, 1995, PSYCHIAT CLIN N AM; Coplan JD, 2006, ANN NY ACAD SCI, V1071, P525, DOI 10.1196/annals.1364.057; Coplan JD, 2006, PSYCHIAT RES-NEUROIM, V147, P27, DOI 10.1016/j.pscychresns.2005.12.011; Coplan JD, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00100; Coplan JD, 2010, NEUROSCI LETT, V480, P93, DOI 10.1016/j.neulet.2010.06.012; Czoty PW, 2009, J NEUROENDOCRINOL, V21, P68, DOI 10.1111/j.1365-2826.2008.01800.x; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Ginzburg K, 2008, PSYCHOSOMATICS, V49, P407, DOI 10.1176/appi.psy.49.5.407; JARETT LR, 1984, PSYCHONEUROENDOCRINO, V9, P21, DOI 10.1016/0306-4530(84)90018-0; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; KALIN NH, 1984, PROG NEURO-PSYCHOPH, V8, P459, DOI 10.1016/0278-5846(84)90122-2; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Kohn JN, 2016, PSYCHONEUROENDOCRINO, V74, P179, DOI 10.1016/j.psyneuen.2016.09.005; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Nanni V, 2014, AM J PSYCHIAT; Okasha S, 2012, J EVOLUTION BIOL, V25, P1127, DOI 10.1111/j.1420-9101.2012.02501.x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pornpattananangkul N., 2014, PSYCHOL SOCIAL STATU, P303; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Rakic P, 1995, CORTICOGENESIS HUMAN; Reiner W, 2014, INFLUENCE MATERNAL G; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; Rosenblum LA, 2002, PSYCHONEUROENDOCRINO, V27, P651, DOI 10.1016/S0306-4530(01)00056-7; Rosenblum LA, 1967, LAB OBSERVATIONS EAR; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Scharf BA, 1999, TOXICOL METHOD, V9, P25, DOI 10.1080/105172399242799; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; Schulkin J, 2003, RETHINKING HOMEOSTAS; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; SILK J B, 1980, Primates, V21, P100, DOI 10.1007/BF02383827; SILK JB, 1988, AM NAT, V132, P1, DOI 10.1086/284834; Snyder-Mackler N, 2016, ANIM BEHAV, V111, P307, DOI 10.1016/j.anbehav.2015.10.033; STANTON ME, 1985, PSYCHONEUROENDOCRINO, V10, P125, DOI 10.1016/0306-4530(85)90050-2; Sterling P., 1988, HDB LIFE STRESS COGN; Syed SA, 2017, NEUROSCI LETT, V647, P20, DOI 10.1016/j.neulet.2017.03.017; Weinbauer GF, 2008, TOXICOL PATHOL, V36, p7S, DOI 10.1177/0192623308327412; Wenseleers Tom, 2010, P132; YEHUDA R, 1990, J NERV MENT DIS, V178, P366, DOI 10.1097/00005053-199006000-00004	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184340	10.1371/journal.pone.0184340	http://dx.doi.org/10.1371/journal.pone.0184340			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880949	Green Published, gold			2022-12-26	WOS:000409467200051
J	Kovacs, JL; Wolf, C; Voisin, D; Wolf, S				Kovacs, Jennifer L.; Wolf, Candice; Voisin, Dene; Wolf, Seth			Aphid secondary symbionts do not affect prey attractiveness to two species of predatory lady beetles	PLOS ONE			English	Article							PEA APHID; CONFERRED PROTECTION; ACYRTHOSIPHON-PISUM; PARASITISM; INFECTION	Heritable symbionts have been found to mediate interactions between host species and their natural enemies in a variety of organisms. Aphids, their facultative symbionts, and their potential fitness effects have been particularly well-studied. For example, the aphid facultative symbiont Regiella can protect its host from infection from a fungal pathogen, and aphids with Hamiltonella are less likely to be parasitized by parasitic wasps. Recent work has also found there to be negative fitness effects for the larvae of two species of aphidophagous lady beetles that consumed aphids with facultative symbionts. In both species, larvae that consumed aphids with secondary symbionts were significantly less likely to survive to adulthood. In this study we tested whether adult Harmonia axyridis and Hippodamia convergens lady beetles avoided aphids with symbionts in a series of choice experiments. Adults of both lady beetle species were as likely to choose aphids with symbionts as those without, despite the potential negative fitness effects associated with consuming aphids with facultative symbionts. This may suggest that under natural conditions aphid secondary symbionts are not a significant source of selection for predatory lady beetles.	[Kovacs, Jennifer L.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Wolf, Candice; Wolf, Seth] Univ Vermont, Larner Coll Med, Burlington, VT USA; [Voisin, Dene] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	Spelman College; University of Vermont; University System of Georgia; Georgia State University	Kovacs, JL (corresponding author), Spelman Coll, Dept Biol, Atlanta, GA 30314 USA.	jkovacs@spelman.edu		Kovacs, Jennifer/0000-0002-9130-176X; Voisin, Dene/0000-0003-2523-1756	Spelman College; NSF HBCU-UP ASPIRE Project through Spelman College [0714553]; HHMI's SMART Scholars program at Spelman College	Spelman College; NSF HBCU-UP ASPIRE Project through Spelman College; HHMI's SMART Scholars program at Spelman College	JK was supported by start-up funds by Spelman College. CNGW was supported by NSF HBCU-UP ASPIRE Project Award #0714553 through Spelman College. DV was supported by HHMI's SMART Scholars program at Spelman College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cayetano L, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2333; Cayetano L, 2015, ECOL ENTOMOL, V40, P85, DOI 10.1111/een.12161; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Cohen J., 1977, CONCEPTS POWER ANAL, P1; Costopoulos K, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-5; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Erdfelder E, 1994, GPOWER GEN POWER ANA; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Kovacs JL, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0136-x; Laughton AM, 2016, J INSECT PHYSIOL, V86, P17, DOI 10.1016/j.jinsphys.2015.12.005; Loxdale HD, 2008, AGR FOREST ENTOMOL, V10, P81, DOI 10.1111/j.1461-9563.2008.00364.x; Martinez AJ, 2014, MOL ECOL, V23, P1594, DOI 10.1111/mec.12550; McCornack BP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1001; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, MYCOL SER, V27, P129; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Oliver KM, 2014, FUNCT ECOL; Polin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143728; Polin S, 2014, ECOL EVOL, V4, P826, DOI 10.1002/ece3.991; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611	27	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184150	10.1371/journal.pone.0184150	http://dx.doi.org/10.1371/journal.pone.0184150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880922	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200036
J	Hystad, EM; Salmela, H; Amdam, GV; Munch, D				Hystad, Eva Marit; Salmela, Heli; Amdam, Gro Vang; Munch, Daniel			Hemocyte-mediated phagocytosis differs between honey bee (Apis mellifera) worker castes	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; CELL-CYCLE; SENESCENCE; ONTOGENY; IMMUNITY; ARTHROPODS; PHYSIOLOGY; INFECTION; MICROBES; MOSQUITO	Honey bees as other insects rely on the innate immune system for protection against diseases. The innate immune system includes the circulating hemocytes (immune cells) that clear pathogens from hemolymph (blood) by phagocytosis, nodulation or encapsulation. Honey bee hemocyte numbers have been linked to hemolymph levels of vitellogenin. Vitellogenin is a multifunctional protein with immune-supportive functions identified in a range of species, including the honey bee. Hemocyte numbers can increase via mitosis, and this recruitment process can be important for immune system function and maintenance. Here, we tested if hemocyte mediated phagocytosis differs among the physiologically different honey bee worker castes (nurses, foragers and winter bees), and study possible interactions with vitellogenin and hemocyte recruitment. To this end, we adapted phagocytosis assays, which-together with confocal microscopy and flow cytometry-allow qualitative and quantitative assessment of hemocyte performance. We found that nurses are more efficient in phagocytic uptake than both foragers and winter bees. We detected vitellogenin within the hemocytes, and found that winter bees have the highest numbers of vitellogenin-positive hemocytes. Connections between phagocytosis, hemocyte-vitellogenin and mitosis were worker caste dependent. Our results demonstrate that the phagocytic performance of immune cells differs significantly between honey bee worker castes, and support increased immune competence in nurses as compared to forager bees. Our data, moreover, provides support for roles of vitellogenin in hemocyte activity.	[Hystad, Eva Marit] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Salmela, Heli] Univ Helsinki, Dept Biosci, Ctr Excellence Biol Interact, Helsinki, Finland; [Amdam, Gro Vang; Munch, Daniel] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Amdam, Gro Vang] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Norwegian University of Life Sciences; University of Helsinki; Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe	Hystad, EM (corresponding author), Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway.	eva.hystad@nmbu.no		Salmela, Heli/0000-0002-6917-2922	Research Council of Norway [213976]; Academy of Finland [265971]	Research Council of Norway(Research Council of Norway); Academy of Finland(Academy of Finland)	The Research Council of Norway (213976 to EMH, GVA and DM) and Academy of Finland (265971 to HS) supported this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AKAI H, 1971, J INSECT PHYSIOL, V17, P1665, DOI 10.1016/0022-1910(71)90062-X; Alaux Cedric, 2010, Biol Lett, V6, P562, DOI 10.1098/rsbl.2009.0986; Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Behrends A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00015; Behrends A, 2009, ANIM COGN, V12, P249, DOI 10.1007/s10071-008-0187-7; Borges AR, 2008, MICRON, V39, P486, DOI 10.1016/j.micron.2007.01.007; Brown JW, 2004, TOXICON, V43, P841, DOI 10.1016/j.toxicon.2004.03.017; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010; Coggins SA, 2012, DEV COMP IMMUNOL, V37, P390, DOI 10.1016/j.dci.2012.01.005; Cooper D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00539; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Gatschenberger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066415; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; Gardiner EMM, 2000, ARCH INSECT BIOCHEM, V43, P147, DOI 10.1002/(SICI)1520-6327(200004)43:4&lt;147::AID-ARCH1&gt;3.0.CO;2-J; GILLIAM M, 1967, J INVERTEBR PATHOL, V9, P387, DOI 10.1016/0022-2011(67)90074-2; Giulianini PG, 2003, TISSUE CELL, V35, P243, DOI 10.1016/S0040-8166(03)00037-5; Havukainen H, 2013, J BIOL CHEM, V288, P28369, DOI 10.1074/jbc.M113.465021; Hillyer JF, 2002, HISTOCHEM CELL BIOL, V117, P431, DOI 10.1007/s00418-002-0408-0; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Khongphinitbunjong K, 2015, J INSECT PHYSIOL, V72, P28, DOI 10.1016/j.jinsphys.2014.11.005; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Mackenzie DK, 2011, EXP GERONTOL, V46, P853, DOI 10.1016/j.exger.2011.07.004; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Marringa WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108486; Milutinovic B, 2016, ZOOLOGY, V119, P254, DOI 10.1016/j.zool.2016.03.006; Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0; Munch D, 2013, J EXP BIOL, V216, P1638, DOI 10.1242/jeb.078915; Negri P, 2014, APIDOLOGIE, V45, P610, DOI 10.1007/s13592-014-0279-0; Oliver JD, 2011, J INVERTEBR PATHOL, V108, P126, DOI 10.1016/j.jip.2011.07.004; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; PRICE CD, 1974, Z ZELLFORSCH MIK ANA, V147, P537, DOI 10.1007/BF00307254; Remolina SC, 2007, J INSECT PHYSIOL, V53, P1027, DOI 10.1016/j.jinsphys.2007.05.015; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Amaral IMR, 2010, MICRON, V41, P123, DOI 10.1016/j.micron.2009.10.003; Salmela H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005015; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2006, EXP GERONTOL, V41, P1117, DOI 10.1016/j.exger.2006.08.004; Seeley TD, 1995, WISDOM HIVE SOCIAL P, VXIV; SILVERSTEIN SC, 1995, TRENDS CELL BIOL, V5, P141, DOI 10.1016/S0962-8924(00)88967-9; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; Speth MT, 2015, EXP GERONTOL, V65, P46, DOI 10.1016/j.exger.2015.03.006; Stoepler TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070978; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Winston ML, 1987, BIOL HONEY BEE, VVIII; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	62	18	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184108	10.1371/journal.pone.0184108	http://dx.doi.org/10.1371/journal.pone.0184108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877227	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000409391200064
J	Mathes, RW; Ito, K; Lane, K; Matte, TD				Mathes, Robert W.; Ito, Kazuhiko; Lane, Kathryn; Matte, Thomas D.			Real-time surveillance of heat-related morbidity: Relation to excess mortality associated with extreme heat	PLOS ONE			English	Article							NEW-YORK-CITY; SYNDROMIC SURVEILLANCE; WAVE; TEMPERATURE; IMPACT	The impact of heat on mortality is well documented but deaths tend to occur after (or lag) extreme heat events, and mortality data is generally not available for timely surveillance during extreme heat events. Recently, systems for near-real time surveillance of heat illness have been reported but have not been validated as predictors of non-external cause of deaths associated with extreme heat events. We analyzed associations between daily weather conditions, emergency medical system (EMS) calls flagged as heat-related by EMS dispatchers, emergency department (ED) visits classified as heat-related based on chief complaint text, and excess non-external cause mortality in New York City. EMS and ED data were obtained from data reported daily to the city health department for syndromic surveillance. We fit generalized linear models to assess the relationships of daily counts of heat related EMS and ED visits to non-external cause deaths after adjustment for weather conditions during the months of May-September between 1999 and 2013. Controlling for temporal trends, a 7% (95% confidence interval (CI): 2-12) and 6% (95% CI: 3-10) increase in non-external cause mortality was associated with an increase from the 50th percentile to 99th percentile of same-day and one-day lagged heat-related EMS calls and ED visits, respectively. After controlling for both temporal trends and weather, we observed a 7% (95% CI: 3-12) increase in non-external cause mortality associated with one-day lagged heat-related EMS calls and a 5% mortality increase with one-day lagged ED visits (95% CI: 2-8). Heat-related illness can be tracked during extreme heat events using EMS and ED data which are indicators of heat associated excess non-external cause mortality during the warm weather season.	[Mathes, Robert W.; Ito, Kazuhiko; Lane, Kathryn; Matte, Thomas D.] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Mathes, RW (corresponding author), New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA.	rmathes@health.nyc.gov			Center for Disease Control and Prevention [5 UE1 EH 001120-03]; Environmental Protection Agency [RD-83489802]; Center for Disease Control and Prevention (CDC) [5 UE1 EH 001120-03]; Environmental Protection Agency (EPA) [RD-83489802]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [UE1EH001120] Funding Source: NIH RePORTER	Center for Disease Control and Prevention; Environmental Protection Agency(United States Environmental Protection Agency); Center for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was in part funded by Center for Disease Control and Prevention (www.cdc.gov) grant 5 UE1 EH 001120-03 and Environmental Protection Agency (www.epa.gov) grant RD-83489802. Both grants partially funded KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Center for Disease Control and Prevention or Environmental Protection Agency.; This study was in part funded by Center for Disease Control and Prevention (CDC) grant 5 UE1 EH 001120-03 and Environmental Protection Agency (EPA) grant RD-83489802. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or EPA.	Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Basu R, 2008, EPIDEMIOLOGY, V19, P138, DOI 10.1097/EDE.0b013e31815c1da7; Berko Jeffrey, 2014, Natl Health Stat Report, P1; Chau PH, 2009, INT J BIOMETEOROL, V53, P461, DOI 10.1007/s00484-009-0232-5; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dolney TJ, 2006, ENVIRON RES, V101, P94, DOI 10.1016/j.envres.2005.08.008; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Johnson Helen, 2005, Health Stat Q, P6; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; Madrigano J, 2015, ENVIRON HEALTH PERSP, V123, P672, DOI 10.1289/ehp.1408178; Matte TD, 2016, HEALTH SECUR, V14, P64, DOI 10.1089/hs.2015.0059; Metzger KB, 2010, ENVIRON HEALTH PERSP, V118, P80, DOI 10.1289/ehp.0900906; Nitschke M, 2007, MED J AUSTRALIA, V187, P662, DOI 10.5694/j.1326-5377.2007.tb01466.x; Rothfusz L.P., 1990, HEAT INDEX EQUATION; Schaffer A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-3; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Wheeler K, 2013, MMWR-MORBID MORTAL W, V62, P617; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Zhang K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-11	22	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184364	10.1371/journal.pone.0184364	http://dx.doi.org/10.1371/journal.pone.0184364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877241	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200091
J	Monamele, GC; Vernet, MA; Njankouo, MR; Victoir, K; Akoachere, JF; Anong, D; Njouom, R				Monamele, Gwladys C.; Vernet, Marie-Astrid; Njankouo, Mohammed R.; Victoir, Kathleen; Akoachere, Jane Francis; Anong, Damian; Njouom, Richard			Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons	PLOS ONE			English	Article							A H3N2 VIRUSES; HEMAGGLUTININ; OSELTAMIVIR; MUTATIONS; IDENTIFICATION; CIRCULATION; RESISTANCE; SITES	The first outbreak of influenza A(H3N2) occurred in 1968 and caused the third flu pandemic of the 20th century. It has affected multiple countries over time. The best strategy to reduce the burden of influenza is through vaccination whose efficacy varies with respect to the circulating strains. This study was performed to better understand the molecular evolution of influenza A(H3N2) and assess vaccine efficacy in Cameroon. Complete sequences of three gene segments were obtained from 2014 to 2016 influenza seasons in Cameroon. Hemagglutinin (HA), Neuraminidase (NA) and matrix (M) genes of 35 A(H3N2) virus strains were amplified and sequenced. Predicted vaccine efficacy was measured using the Pepitope model. Phylogenetic analysis of the HA gene showed that all Cameroonian strains had evolved away from the 3C. 1-A/Texas/50/2012-like clade. Globally, 2014 virus strains clustered with the 2015-2016 vaccine strain, 3C. 3a-A/Switzerland/9715293/2013, whereas 2015 and 2016 virus strains clustered with the 2016-2017 vaccine strain, 3C. 2a-A/HongKong/4801/2014. In order to determine the genotypic drug susceptibility to neuraminidase inhibitors and amantadine, the NA and M2 protein coding sequences were analyzed. There was no strain with characteristic mutation for resistance to neuraminidase inhibitors, per contra; all strains possessed the substitution S31N, peculiar of resistance to adamantanes. There was drift in influenza A(H3N2) dominant epitopes B (2014 and 2015) to epitopes A (2016) with a theoretical efficiency in vaccine ranging from low to moderate. The presence of several antigenic site mutations among H3N2 virus strains between 2014-2016 influenza seasons in Cameroon confirms the progressing evolution of circulating H3N2 strains.	[Monamele, Gwladys C.; Vernet, Marie-Astrid; Njankouo, Mohammed R.; Njouom, Richard] Ctr Pasteur Cameroun, Natl Influenza Ctr, Yaounde, Cameroon; [Monamele, Gwladys C.; Akoachere, Jane Francis; Anong, Damian] Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon; [Victoir, Kathleen] Inst Pasteur Paris, Paris, France	Centre Pasteur du Cameroun; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Njouom, R (corresponding author), Ctr Pasteur Cameroun, Natl Influenza Ctr, Yaounde, Cameroon.	njouom@pasteur-yaounde.org			U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes [6 DESP060001-01-01]	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes	This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes.; We are grateful to Yong Poovorawan and Nipaporn Tewawong for their helpful assistance in P<INF>epitope</INF> calculation. We are also thankful to Matthieu Schoenhals for editing this manuscript. This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes.	Abed Y, 2006, ANTIVIR THER, V11, P971; Abed Y, 2009, J INFECT DIS, V199, P180, DOI 10.1086/595736; [Anonymous], 2004, PREDICTION N GLYCOSY; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bedford T, 2015, NATURE, V523, P217, DOI 10.1038/nature14460; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Carr S, 2011, PEDIATR INFECT DIS J, V30, P284, DOI 10.1097/INF.0b013e3181ff863b; Chambers BS, 2015, CELL REP, V12, P1, DOI 10.1016/j.celrep.2015.06.005; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Escorcia M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-15; Eshaghi A, 2014, INFLUENZA OTHER RESP, V8, P250, DOI 10.1111/irv.12219; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Hanon E, 2009, Bull Mem Acad R Med Belg, V164, P283; Hodgson D, 2017, LANCET PUBLIC HEALTH, V2, pE74, DOI 10.1016/S2468-2667(16)30044-5; Horm SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110713; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lee HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117822; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; McAnerney JM, 2015, INFLUENZA OTHER RESP, V9, P209, DOI 10.1111/irv.12314; Melidou A, 2009, EUROSURVEILLANCE B E, V14; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; Okomo-Adhiambo M, 2010, ANTIMICROB AGENTS CH, V54, P1834, DOI 10.1128/AAC.01608-09; Potdar VA, 2014, INDIAN J MED RES, V140, P244; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10; Tewawong N, 2016, VIRUS GENES, V52, P711, DOI 10.1007/s11262-016-1347-5; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Wedde M, 2015, INT J MED MICROBIOL, V305, P762, DOI 10.1016/j.ijmm.2015.08.030; WHO, 2016, INFL SEAS MED; WHO, 2015, 00498114 WHO; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, WHO REC COMP INFL VI; Zaraket H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00262	36	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184411	10.1371/journal.pone.0184411	http://dx.doi.org/10.1371/journal.pone.0184411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877235	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200099
J	Jowett, S; Barton, P; Roalfe, A; Fletcher, K; Hobbs, FDR; McManus, RJ; Mant, J				Jowett, Sue; Barton, Pelham; Roalfe, Andrea; Fletcher, Kate; Hobbs, F. D. Richard; McManus, Richard J.; Mant, Jonathan			Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease	PLOS ONE			English	Article							HYPERTENSION; STRATEGY; SURVIVAL; PROFILE; DEATH	Background Clinical trials suggest that use of fixed-dose combination therapy ('polypills') can improve adherence to medication and control of risk factors of people at high risk of cardiovascular disease (CVD) compared to usual care, but cost-effectiveness is unknown. Objective To determine whether a polypill is cost-effective compared to usual care and optimal guide-line-recommended treatment for primary prevention in people already on statins and/or blood pressure lowering therapy. Methods A Markov model was developed to perform a cost-utility analysis with a one year time cycle and a 10 year time horizon to compare the polypill with usual care and optimal implementation of NICE Guidelines, using patient level data from a retrospective cross-sectional study. The model was run for ten age (40 years+) and gender-specific sub-groups on treatment for raised CVD risk with no history of CVD. Published sources were used to estimate impact of different treatment strategies on risk of CVD events. Results A polypill strategy was potentially cost-effective compared to other strategies for most subgroups ranging from dominance to up to 18,811 pound per QALY depending on patient subgroup. Optimal implementation of guidelines was most cost-effective for women aged 40-49 and men aged 75+. Results were sensitive to polypill cost, and if the annual cost was less than 150 pound, this approach was cost-effective compared to the other strategies. Conclusions For most people already on treatment to modify CVD risk, a polypill strategy may be cost-effective compared with optimising treatment as per guidelines or their current care, as long as the polypill cost is sufficiently low.	[Jowett, Sue; Barton, Pelham] Univ Birmingham, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, W Midlands, England; [Roalfe, Andrea; Fletcher, Kate] Univ Birmingham, Inst Appl Hlth Res, Primary Care Clin Sci, Birmingham, W Midlands, England; [Hobbs, F. D. Richard; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Mant, Jonathan] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, Cambs, England	University of Birmingham; University of Birmingham; University of Oxford; University of Cambridge	Mant, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, Cambs, England.	jm677@medschl.cam.ac.uk	Jowett, Sue/AAO-4198-2021	Jowett, Sue/0000-0001-8936-3745; Mant, Jonathan/0000-0002-9531-0268	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme [RP-PG-0606-1153]; National Institute for Health Research [NF-SI-0611-10273, RP-PG-0606-1153, NIHR-RP-02-12-015, IS-SPC-0514-10043] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	NThis paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (grant number: RP-PG-0606-1153). The funders did not influence the study design or the writing of this article. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2013, BRIT NATL FORMULARY; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barrios V, 2017, REV ESP CARDIOL, V70, P42, DOI [10.1016/j.recesp.2016.05.011, 10.1016/j.rec.2016.05.009]; Bautista LE, 2013, HEALTH AFFAIR, V32, P155, DOI 10.1377/hlthaff.2011.0948; Becerra V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007111; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Castellano JM, 2014, J AM COLL CARDIOL, V64, P613, DOI 10.1016/j.jacc.2014.06.009; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cooper A, 2008, CLIN GUIDELINES EVID; Curtis L., 2012, UNIT COSTS HLTH SOCI; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Giuli F, 2005, EUR J HEART FAIL, V7, P295, DOI 10.1016/j.ejheart.2004.10.017; Department of Health, 2012, NHS REF COSTS 2011 1; Elley CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052145; Franco OH, 2006, J EPIDEMIOL COMMUN H, V60, P213, DOI 10.1136/jech.2005.040253; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; HM Treasury, GREEN BOOK APPR EV C; Huffman MD, 2017, LANCET, V389, P1055, DOI 10.1016/S0140-6736(17)30553-6; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; McManus RJ, 2005, BMJ-BRIT MED J, V331, P493, DOI 10.1136/bmj.38558.393669.E0; Mehta PA, 2009, HEART, V95, P1851, DOI 10.1136/hrt.2008.156034; Murabito JM, 1997, CIRCULATION, V96, P44; National Centre for Social Research (NCSR) and University College London, DEP EP PUBL HLTH HLT; National Clinical Guideline Centre, 2010, CG94 NAT CLIN GUID C; National Institute for Health and Care Excellence, 2011, CG127 NAT I HLTH CAR, pCG127; NICE, 2014, LIP MOD CARD RISK AS, V181; Office for national statistics (ONS), 2013, MORT STAT DEATHS REG; Office for National Statistics (ONS, 2012, ENGL WAL INT LIF TAB; Palmer S, 2002, COST EFFECTIVENESS M; Patel A, 2014, EUROPEAN J PREVENTIV; Selak V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3318; Sheppard JP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4535; Sheppard JP, 2014, BRIT J GEN PRACT, V64, pE38, DOI 10.3399/bjgp14X676447; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Wiklund Ingela, 1997, Blood Pressure, V6, P357, DOI 10.3109/08037059709062095; Wood D, 2004, HLTH CARE NEEDS ASSE, P373; Youman P, 2003, PHARMACOECONOMICS, V21, P43, DOI 10.2165/00019053-200321001-00005; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2014, EUR HEART J, V35, P353, DOI 10.1093/eurheartj/eht407	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0182625	10.1371/journal.pone.0182625	http://dx.doi.org/10.1371/journal.pone.0182625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873416	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800008
J	Hardy, JJ; Mooney, SR; Pearson, AN; McGuire, D; Correa, DJ; Simon, RP; Meller, R				Hardy, Jimmaline J.; Mooney, Scott. R.; Pearson, Andrea. N.; McGuire, Dawn; Correa, Daniel. J.; Simon, Roger P.; Meller, Robert			Assessing the accuracy of blood RNA profiles to identify patients with post-concussion syndrome: A pilot study in a military patient population	PLOS ONE			English	Article							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; ISCHEMIC-STROKE; RECOVERY; LACUNAR	Mild traumatic brain injury (mTBI) is a complex, neurophysiological condition that can have detrimental outcomes. Yet, to date, no objective method of diagnosis exists. Physical damage to the blood-brain-barrier and normal waste clearance via the lymphatic system may enable the detection of biomarkers of mTBI in peripheral circulation. Here we evaluate the accuracy of whole transcriptome analysis of blood to predict the clinical diagnosis of post-concussion syndrome (PCS) in a military cohort. Sixty patients with clinically diagnosed chronic concussion and controls (no history of concussion) were recruited (retrospective study design). Male patients (46) were split into a training set comprised of 20 long-term concussed (> 6 months and symptomatic) and 12 controls (no documented history of concussion). Models were validated in a testing set (control = 9, concussed = 5). RNA_Seq libraries were prepared from whole blood samples for sequencing using a SOLiD5500XL sequencer and aligned to hg19 reference genome. Patterns of differential exon expression were used for diagnostic modeling using support vector machine classification, and then validated in a second patient cohort. The accuracy of RNA profiles to predict the clinical diagnosis of post-concussion syndrome patients from controls was 86% (sensitivity 80%; specificity 89%). In addition, RNA profiles reveal duration of concussion. This pilot study shows the potential utility of whole transcriptome analysis to establish the clinical diagnosis of chronic concussion syndrome.	[Hardy, Jimmaline J.; Pearson, Andrea. N.; Simon, Roger P.; Meller, Robert] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Mooney, Scott. R.; Correa, Daniel. J.] Dwight D Eisenhower Army Med Ctr, Neurosci & Rehabil Ctr, Ft Gordon, GA USA; [McGuire, Dawn; Simon, Roger P.] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA	Morehouse School of Medicine; United States Department of Defense; United States Army; Morehouse School of Medicine	Meller, R (corresponding author), Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA.	rmeller@msm.edu	Correa, Daniel/AAU-9441-2020; Correa, Daniel José/U-8633-2019	Correa, Daniel José/0000-0002-6490-9331; Hardy, Jimmaline/0000-0002-9292-3894	clinical career development grant [5U54M D007588-05];  [U54NS08393];  [S21MD000101];  [R01NS59588]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS083932, R01NS059588] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101, U54MD007588] Funding Source: NIH RePORTER	clinical career development grant; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study was primarily funded by a clinical career development grant to R Meller (5U54M D007588-05). JH was supported by U54NS08393. Additional support was provided by S21MD000101 and R01NS59588 (RM).	Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dykstra-Aiello C, 2015, TRANSL STROKE RES, V6, P284, DOI 10.1007/s12975-015-0407-9; Gill J, 2015, J HEAD TRAUMA REHABI; Giza CC, 2013, SUMMARY EVIDENCE BAS; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Jickling GC, 2013, ANN NEUROL, V74, P232, DOI 10.1002/ana.23883; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Jickling GC, 2011, ANN NEUROL, V70, P477, DOI 10.1002/ana.22497; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meller R, 2016, ANN CLIN TRANSL NEUR, V3, P70, DOI 10.1002/acn3.272; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Sharp FR, 2007, STROKE, V38, P691, DOI 10.1161/01.STR.0000247940.27518.38; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183113	10.1371/journal.pone.0183113	http://dx.doi.org/10.1371/journal.pone.0183113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863142	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900004
J	Izumi, Y; Inoue, H; Nakayama, Y; Eguchi, K; Yasuoka, Y; Matsuo, N; Nonoguchi, H; Kakizoe, Y; Kuwabara, T; Mukoyama, M				Izumi, Yuichiro; Inoue, Hideki; Nakayama, Yushi; Eguchi, Koji; Yasuoka, Yukiko; Matsuo, Naomi; Nonoguchi, Hiroshi; Kakizoe, Yutaka; Kuwabara, Takashige; Mukoyama, Masashi			TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; UBIQUITIN-PROTEASOME PATHWAY; EPITHELIAL-CELLS; KIDNEY-DISEASE; INTERSTITIAL FIBROSIS; METABOLIC-ACIDOSIS; SERUM BICARBONATE; DOWN-REGULATION; TRANSCRIPTION; ACTIVATION	Metabolic acidosis often results from chronic kidney disease; in turn, metabolic acidosis accelerates the progression of kidney injury. The mechanisms for how acidosis facilitates kidney injury are not fully understood. To investigate whether low pH directly affects the expression of genes controlling local homeostasis in renal tubules, we performed transcription start site sequencing (TSS-Seq) using IN-IC cells, a cell line derived from rat renal collecting duct intercalated cells, with acid loading for 24 h. Peak calling identified 651 upregulated and 128 down-regulated TSSs at pH 7.0 compared with those at pH 7.4. Among them, 424 and 38 TSSs were >= 1.0 and <= -1.0 in Log(2) fold change, which were annotated to 193 up-regulated and 34 down-regulated genes, respectively. We used gene ontology analysis and manual curation to profile the up-regulated genes. The analysis revealed that many up-regulated genes are involved in renal fibrosis, implying potential molecular mechanisms induced by metabolic acidosis. To verify the activity of the ubiquitin-proteasome system (UPS), a candidate pathway activated by acidosis, we examined the expression of proteins from cells treated with a proteasome inhibitor, MG132. The expression of ubiquitinated proteins was greater at pH 7.0 than at pH 7.4, suggesting that low pH activates the UPS. The in vivo study demonstrated that acid loading increased the expression of ubiquitin proteins in the collecting duct cells in mouse kidneys. Motif analysis revealed Egr1, the mRNA expression of which was increased at low pH, as a candidate factor that possibly stimulates gene expression in response to low pH. In conclusion, metabolic acidosis can facilitate renal injury and fibrosis during kidney disease by locally activating various pathways in the renal tubules.	[Izumi, Yuichiro; Inoue, Hideki; Nakayama, Yushi; Eguchi, Koji; Matsuo, Naomi; Kakizoe, Yutaka; Kuwabara, Takashige; Mukoyama, Masashi] Kumamoto Univ, Dept Nephrol, Grad Sch Med Sci, Kumamoto, Japan; [Yasuoka, Yukiko] Kitasato Univ, Dept Physiol, Sch Med, Sagamihara, Kanagawa, Japan; [Nonoguchi, Hiroshi] Kitasato Univ, Dept Internal Med & Educ, Med Ctr, Kitamoto, Japan; [Nonoguchi, Hiroshi] Kitasato Univ, Res Ctr, Med Ctr, Kitamoto, Japan	Kumamoto University; Kitasato University; Kitasato University; Kitasato University	Nakayama, Y (corresponding author), Kumamoto Univ, Dept Nephrol, Grad Sch Med Sci, Kumamoto, Japan.	ynakaya@kumamoto-u.ac.jp		Nonoguchi, Hiroshi/0000-0001-7831-7380; YASUOKA, YUKIKO/0000-0002-9380-1653; Kuwabara, Takashige/0000-0003-3507-4328	Japan Society for the Promotion of the Science (JSPS) KAKENHI [JP26893202]; Grants-in-Aid for Scientific Research [16K08505, 17K09702] Funding Source: KAKEN	Japan Society for the Promotion of the Science (JSPS) KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of the Science (JSPS) KAKENHI Grant Number JP26893202 that YI received. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Cai Q, 2004, AM J PHYSIOL-RENAL, V286, pF58, DOI 10.1152/ajprenal.00037.2003; Chen G, 2008, AM J PHYSIOL-RENAL, V295, pF1528, DOI 10.1152/ajprenal.90482.2008; Cheval L, 2006, PHYSIOL GENOMICS, V27, P271, DOI 10.1152/physiolgenomics.00069.2006; Cui WP, 2013, AM J PHYSIOL-ENDOC M, V304, pE87, DOI 10.1152/ajpendo.00430.2012; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diomedi-Camassei F, 2005, NEPHROL DIAL TRANSPL, V20, P2714, DOI 10.1093/ndt/gfi124; Dobre M, 2013, AM J KIDNEY DIS, V62, P670, DOI 10.1053/j.ajkd.2013.01.017; DUBOSE TD, 1979, J CLIN INVEST, V64, P476, DOI 10.1172/JCI109485; Feng XY, 2015, AM J PHYSIOL-RENAL, V309, pF71, DOI 10.1152/ajprenal.00546.2014; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Goldenstein L, 2014, AM J KIDNEY DIS, V64, P542, DOI 10.1053/j.ajkd.2014.05.009; Goraya N, 2012, KIDNEY INT, V81, P86, DOI 10.1038/ki.2011.313; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; HERZLINGER DA, 1982, J CELL BIOL, V93, P269, DOI 10.1083/jcb.93.2.269; Ho LC, 2016, J MOL MED, V94, P933, DOI 10.1007/s00109-016-1403-6; Izumi Y, 2011, J AM SOC NEPHROL, V22, P673, DOI 10.1681/ASN.2010050468; Jin YM, 2012, NAT MED, V18, P580, DOI 10.1038/nm.2685; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lin CHS, 2016, KIDNEY INT, V89, P1281, DOI 10.1016/j.kint.2016.01.030; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; LOTSPEIC.WD, 1965, AM J PHYSIOL, V208, P1135, DOI 10.1152/ajplegacy.1965.208.6.1135; Lu DM, 2016, KIDNEY INT, V89, P1307, DOI 10.1016/j.kint.2016.03.006; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Memetimin H, 2009, AM J PHYSIOL-RENAL, V297, pF620, DOI 10.1152/ajprenal.90520.2008; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mouri T, 2009, HYPERTENS RES, V32, P358, DOI 10.1038/hr.2009.19; NATH KA, 1991, AM J KIDNEY DIS, V17, P654, DOI 10.1016/S0272-6386(12)80344-1; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Ohmiya H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-269; Padda R, 2006, AM J PHYSIOL-RENAL, V291, pF874, DOI 10.1152/ajprenal.00377.2005; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Qu XL, 2015, KIDNEY INT, V88, P1323, DOI 10.1038/ki.2015.235; Raj S, 2013, AM J PHYSIOL-RENAL, V304, pF41, DOI 10.1152/ajprenal.00128.2012; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ryoo IG, 2015, ARCH PHARM RES, V38, P272, DOI 10.1007/s12272-014-0380-y; Salceda C, 2013, TOXICOL APPL PHARM, V272, P825; Sasai Y, 2012, BIOSCI BIOTECH BIOCH, V76, P1741, DOI 10.1271/bbb.120347; Seki T, 2013, J BIOL CHEM, V288, P17145, DOI 10.1074/jbc.M113.463406; Shah SN, 2009, AM J KIDNEY DIS, V54, P270, DOI 10.1053/j.ajkd.2009.02.014; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stow LR, 2009, J BIOL CHEM, V284, P30087, DOI 10.1074/jbc.M109.030718; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Sun SR, 2014, AM J NEPHROL, V39, P436, DOI 10.1159/000362249; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wesson DE, 2007, KIDNEY INT, V71, P210, DOI 10.1038/sj.ki.5002036; Wesson DE, 1998, AM J PHYSIOL-RENAL, V274, pF97, DOI 10.1152/ajprenal.1998.274.1.F97; Wesson DE, 2015, NEPHROL DIAL TRANSPL, V30, P762, DOI 10.1093/ndt/gfu388; YAMAJI Y, 1994, J CLIN INVEST, V94, P1297, DOI 10.1172/JCI117448; Yang CR, 2015, AM J PHYSIOL-CELL PH, V309, pC799, DOI 10.1152/ajpcell.00214.2015; Yasuoka Y, 2013, CLIN EXP NEPHROL, V17, P783, DOI 10.1007/s10157-013-0783-y	58	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184185	10.1371/journal.pone.0184185	http://dx.doi.org/10.1371/journal.pone.0184185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859164	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500072
J	Ramachandran, S; Lowenthal, A; Ritner, C; Lowenthal, S; Bernstein, HS				Ramachandran, Sweta; Lowenthal, Alexander; Ritner, Carissa; Lowenthal, Shiri; Bernstein, Harold S.			Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; EXTRACELLULAR VESICLES; CHILDREN; MANAGEMENT; MUTATIONS; INFANTS; TRIAL; BMPR2	Biomarkers of heart failure in adults have been extensively studied. However, biomarkers to monitor the progression of heart failure in children with univentricular physiology are less well understood. We proposed that as mediators of diverse pathophysiology, miRNAs contained within circulating microvesicles could serve as biomarkers for the presence and progression of heart failure in univentricular patients. To test this, we studied the association of heart failure with elevations in specific miRNAs isolated from circulating microvesicles in a cohort of children with univentricular heart disease and heart failure. We conducted a single site cross-sectional observational study of 71 children aged 1 month-7 years with univentricular heart disease and heart failure. We demonstrated that levels of miR129-5p isolated from plasma microvesicles were inversely related to the degree of clinical heart failure as assessed by Ross score. We then showed that miR129-5p levels are downregulated in HL1 cells and human embryonic stem cell-derived cardiomyocytes exposed to oxidative stress. We demonstrated that bone morphogenetic protein receptor 2, which has been implicated in the development of pulmonary vascular disease, is a target of miR129-5p, and conversely regulated in response to oxidative stress in cell culture. Levels of miR129-5p were inversely related to the degree of clinical heart failure in patients with univentricular heart disease. This study demonstrates that miR129-5p is a sensitive and specific biomarker for heart failure in univentricular heart disease independent of ventricular morphology or stage of palliation. Further study is warranted to understand the targets affected by miR129-5p with the development of heart failure in patients with univentricular physiology.	[Ramachandran, Sweta; Lowenthal, Alexander; Ritner, Carissa; Lowenthal, Shiri; Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ramachandran, Sweta; Lowenthal, Alexander; Ritner, Carissa; Lowenthal, Shiri; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bernstein, Harold S.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Bernstein, Harold S.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Lowenthal, Alexander] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Bernstein, Harold S.] Merck & Co Inc, Kenilworth, NJ 07033 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Merck & Company	Bernstein, HS (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; Bernstein, HS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Bernstein, HS (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.; Bernstein, HS (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.; Bernstein, HS (corresponding author), Merck & Co Inc, Kenilworth, NJ 07033 USA.	harold.bernstein@merck.com		Ritner, Carissa/0000-0002-4968-6838	Lorraine Newman Fund of the UCSF Division of Pediatric Cardiology; UCSF Clinical and Translational Science Institute [NIH/NCRR UL RR024131]	Lorraine Newman Fund of the UCSF Division of Pediatric Cardiology; UCSF Clinical and Translational Science Institute	This work was supported by funds to H. S.B. from the Lorraine Newman Fund of the UCSF Division of Pediatric Cardiology, and a Strategic Opportunity Award from the UCSF Clinical and Translational Science Institute (NIH/NCRR UL RR024131). The funders provided support in the form of research supplies, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. H.S.B. was an employee of Merck & Co. and received salary and stock shares during part of the preparation of the final manuscript, however, Merck provided no funding for this study, and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bakhshandeh B, 2017, CURR STEM CELL RES T, V12, P31, DOI 10.2174/1574888X11666160709211528; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Botting KJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000531; Cheung YF, 2000, HEART, V83, P420, DOI 10.1136/heart.83.4.420; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Hsu DT, 2010, CIRCULATION, V122, P333, DOI 10.1161/CIRCULATIONAHA.109.927988; JOHNSTONE DE, 1994, CAN J CARDIOL, V10, P613; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Lowenthal A, 2012, CURR BIOMARKER FINDI, V2, p57 ; Lowenthal A, 2012, AM J CARDIOL, V109, P866, DOI 10.1016/j.amjcard.2011.10.049; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Pulliero A, 2016, Microrna, V5, P2; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Rosenthal D, 2004, J HEART LUNG TRANSPL, V23, P1313, DOI 10.1016/j.healun.2004.03.018; ROSS RD, 1992, PEDIATR CARDIOL, V13, P72, DOI 10.1007/BF00798207; Shaddy RE, 2007, JAMA-J AM MED ASSOC, V298, P1171, DOI 10.1001/jama.298.10.1171; Shewchuk LJ, 2010, CAN J PHYSIOL PHARM, V88, P324, DOI 10.1139/Y09-131; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vozel D, 2017, EUR J CLIN INVEST, V47, P305, DOI 10.1111/eci.12733; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121	28	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183624	10.1371/journal.pone.0183624	http://dx.doi.org/10.1371/journal.pone.0183624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859128	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500027
J	Dagnall, CL; Hicks, B; Teshome, K; Hutchinson, AA; Gadalla, SM; Khincha, PP; Yeager, M; Savage, SA				Dagnall, Casey L.; Hicks, Belynda; Teshome, Kedest; Hutchinson, Amy A.; Gadalla, Shahinaz M.; Khincha, Payal P.; Yeager, Meredith; Savage, Sharon A.			Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement	PLOS ONE			English	Article							DNA EXTRACTION METHOD; EPIDEMIOLOGIC RESEARCH; QUANTITATIVE PCR; DISEASE; RISK; CANCER; HEALTH; IMPACT; VARIES	Telomeres, long nucleotide repeats and a protein complex at chromosome ends, shorten with each cell division and are susceptible to oxidative damage. Quantitative PCR (qPCR) is a widely-used technique to measure relative telomere length (RTL) in DNA samples but is challenging to optimize and significant lab-to-lab variability has been reported. In this study, we evaluated factors that may contribute to qPCR RTL measurement variability including DNA extraction methods, methods used for removing potential residual PCR inhibitors, sample storage conditions, and sample location in the PCR plate. Our results show that the DNA extraction and purification techniques, as well as sample storage conditions introduce significant variability in qPCR RTL results. We did not find significant differences in results based on sample location in the PCR plate or qPCR instrument used. These data suggest that lack of reproducibility in published association studies of RTL could be, in part, due to methodological inconsistencies. This study illustrates the importance of uniform sample handling, from DNA extraction through data generation and analysis, in using qPCR to determine RTL.	[Dagnall, Casey L.; Hicks, Belynda; Teshome, Kedest; Hutchinson, Amy A.; Gadalla, Shahinaz M.; Khincha, Payal P.; Yeager, Meredith; Savage, Sharon A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Dagnall, Casey L.; Hicks, Belynda; Teshome, Kedest; Hutchinson, Amy A.; Yeager, Meredith] Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Savage, SA (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	savagesh@mail.nih.gov	Gadalla, Shahinaz/U-2848-2019; Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015; Gadalla, Shahinaz M/C-4005-2015; Yeager, Meredith/AAA-5322-2020	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Gadalla, Shahinaz M/0000-0002-3255-8143; 	Division of Cancer Epidemiology and Genetics, National Cancer Institute; Frederick National Laboratory for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010190] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Authors CLD, BH, KT, AAH, and MY are employees of Leidos Biomedical Research, Inc. a subsidiary of Leidos dedicated to a single contract to the Frederick National Laboratory for Cancer Research, which is sponsored by the National Cancer Institute (https.//www.leidos.cam/about/subsidiaries/leidos-biomedical-research). Leidos Biomedical Research, Inc., did not play a role in study design, data collection or analysis, or preparation of the manuscript.	Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Denham Joshua, 2014, BMC Res Notes, V7, P877, DOI 10.1186/1756-0500-7-877; Eisenberg DTA, 2015, AM J HUM BIOL, V27, P570, DOI 10.1002/ajhb.22690; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gutierrez-Rodrigues F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113747; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hofmann JN, 2014, CANCER EPIDEM BIOMAR, V23, P1129, DOI 10.1158/1055-9965.EPI-14-0145; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Martin-Ruiz CM, 2015, INT J EPIDEMIOLOGY; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Raschenberger J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25398; Roder B, 2010, J CLIN MICROBIOL, V48, P4260, DOI 10.1128/JCM.01230-10; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Seeker LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164046; Tolios A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143889; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897	31	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184098	10.1371/journal.pone.0184098	http://dx.doi.org/10.1371/journal.pone.0184098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886139	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100066
J	Franzo, G; Massi, P; Tucciarone, CM; Barbieri, I; Tosi, G; Fiorentini, L; Ciccozzi, M; Lavazza, A; Cecchinato, M; Moreno, A				Franzo, Giovanni; Massi, Paola; Tucciarone, Claudia Maria; Barbieri, Ilaria; Tosi, Giovanni; Fiorentini, Laura; Ciccozzi, Massimo; Lavazza, Antonio; Cecchinato, Mattia; Moreno, Ana			Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; AVIAN CORONAVIRUS; MUTATION-RATES; STRAIN; RECOMBINATION; CIRCULATION; EMERGENCE; VACCINE; PATHOGENICITY; PERFORMANCE	Infectious bronchitis virus (IBV) represents one of the poultry industry major threats, particularly in high density producing countries. The emergence and spread of new IBV genotypes have frustrated the various disease control efforts implemented over time. Despite that, few comprehensive and large scale studies have been performed to understand the international and local spreading dynamics of this virus. In the present work, these phenomena were evaluated by implementing a Bayesian phylodynamic approach to reconstruct the epidemiological patterns and population history of the QX genotype (currently renamed GI-19 lineage), the most relevant IBV lineage of the Old-World. Our analysis, based on 807 partial S1 sequences of strains collected from 18 countries between 1993 and 2015, demonstrates that this genotype originated in China well before its first identification. After a prolonged local circulation, it started spreading to other European, Asian and Middle East countries in successive waves, which were mirrored by concomitant fluctuations in viral population size. Interestingly, the within-Europe spread was characterized by a higher estimated migration rate compared with the inter-continental one, potentially reflecting the closer geographic and economic relationships among these countries. Nevertheless, the colonization of new states by the GI-19 lineage appeared to occur mostly by single introduction events in both intra and inter-continental spread, likely because of epidemiological factor and health policy combination which seems to prevent the frequent introduction and mixing of different strains. On the other hand, the within Italy QX circulation reconstruction showed a much more intricate connection network among different locations, evidencing the difficulty in controlling IBV spread especially in highly densely poultry populated areas. The presence of several well supported epidemiological links among distantly related Italian regions testifies that animal transportation and indirect transmission routes rather than local airborne diffusion contribute to the QX success and persistence at local scale. Globally, the spreading dynamics and evolution of the QX genotype were reconstructed from its very origin to nowadays, demonstrating the need of more effective direct control measures, particularly within each country. Unfortunately, the incompleteness of available molecular epidemiology data represents an insurmountable limit which leaves many questions currently unsolved, thus highlighting the compulsoriness of a structured monitoring and data sharing system implementation.	[Franzo, Giovanni; Tucciarone, Claudia Maria; Cecchinato, Mattia] Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy; [Massi, Paola; Tosi, Giovanni; Fiorentini, Laura] Ist Sperimentale Lombardia & Emilia Romagna, Sez Forli, Forli, Forli Cesena, Italy; [Barbieri, Ilaria; Lavazza, Antonio; Moreno, Ana] Ist Sperimentale Lombardia & Emilia Romagna, Dept Virol, Brescia, Italy; [Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy	University of Padua; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Franzo, G (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy.; Moreno, A (corresponding author), Ist Sperimentale Lombardia & Emilia Romagna, Dept Virol, Brescia, Italy.	giovanni.franzo@unipd.it; anamaria.morenomartin@izsler.it	Moreno, Ana/Q-2173-2019; Ciccozzi, Massimo/AAC-3271-2022	Moreno, Ana/0000-0002-8497-9708; Ciccozzi, Massimo/0000-0003-3866-9239; Cecchinato, Mattia/0000-0002-2269-7879; Tucciarone, Claudia Maria/0000-0002-0340-8920; Franzo, Giovanni/0000-0003-2991-217X	Ministry of Health (Italy): Progetto di Ricerca Corrente [PCR2015009]	Ministry of Health (Italy): Progetto di Ricerca Corrente	The study was partially funded by the Ministry of Health (Italy): Progetto di Ricerca Corrente PCR2015009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abdel-Moneim AS, S1 GENE SEQUENCE ANA; Abro SH, 2012, VET MICROBIOL, V155, P237, DOI 10.1016/j.vetmic.2011.09.022; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Baele GFAU, 2012, MOL BIOL EVOLUTION J; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Beato MS, 2005, VET REC, V156, P720, DOI 10.1136/vr.156.22.720; Benyeda Z, 2009, AVIAN PATHOL, V38, P449, DOI 10.1080/03079450903349196; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Bochkov YA, 2006, AVIAN PATHOL, V35, P379, DOI 10.1080/03079450600921008; Bozorgmehri-Fard M. H., 2013, IRANIAN J VIROL, V7, P57, DOI DOI 10.21859/isv.7.1.2.57; Cavanagh D, 1999, AVIAN PATHOL, V28, P593, DOI 10.1080/03079459994399; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; Cook JKA, 1999, AVIAN PATHOL, V28, P477, DOI 10.1080/03079459994506; CRINION RAP, 1971, AVIAN DIS, V15, P42, DOI 10.2307/1588386; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Wit J.J., 2017, AVIAN PATHOLOGY; de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260; Dolz R., 2009, VI International Symposium on Avian Corona- and Pneumoviruses and Complicating Pathogens, Rauischholzhausen, Germany, 14-17 June 2009., P27; Domanska-Blicharz K, 2014, AVIAN PATHOL, V43, P406, DOI 10.1080/03079457.2014.949619; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; Franzo G, 2016, VACCINE; Franzo G, 2016, MOL PHYLOGENET EVOL, V100, P269, DOI 10.1016/j.ympev.2016.04.028; Franzo G, 2014, VACCINE, V32, P6765, DOI 10.1016/j.vaccine.2014.10.006; Geerligs HJ, 2011, AVIAN PATHOL, V40, P93, DOI 10.1080/03079457.2010.542742; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gough RE, 2008, VET REC, V162, P99, DOI 10.1136/vr.162.3.99; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall MD, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew003; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Holmes E., 2009, EVOLUTION EMERGENCE; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Hong S-M, 2017, ARCH VIROL; Jackwood MW, 2012, AVIAN DIS, V56, P634, DOI 10.1637/10227-043012-Review.1; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; JONES RC, 1987, VET REC, V120, P617, DOI 10.1136/vr.120.26.617; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kiss I, 2015, ACTA VET HUNG, V63, P382, DOI 10.1556/004.2015.036; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Krapez U, 2010, VIRUS GENES; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Little C, 2010, VET REC, V167, P879, DOI 10.1136/vr.c6702; Maroney Susan A, 2007, Vet Ital, V43, P723; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; McKinley ET, 2011, VIRUS RES, V158, P225, DOI 10.1016/j.virusres.2011.04.006; Moreno A, 2016, AVIAN PATHOL, p1 ; Munster VJ, 2006, GLOBAL PATTERNS INFL, V312, p384 ; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Naqi S, 2003, AVIAN DIS, V47, P594, DOI 10.1637/6087; Ovchinnikova EV, 2011, AVIAN PATHOL, V40, P507, DOI 10.1080/03079457.2011.605782; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A., 2016, VIRUS EVOL, V2; Seger W, 2016, ARCH VIROL, V161, P1229, DOI 10.1007/s00705-016-2790-2; Team RC, 2016, R LANG ENV STAT COMP; Terregino C, 2008, AVIAN PATHOL, V37, P487, DOI 10.1080/03079450802356938; Thor SW, 2011, VIRUSES-BASEL, V3, P1777, DOI 10.3390/v3091777; Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Worthington KJ, 2008, AVIAN PATHOL, V37, P247, DOI 10.1080/03079450801986529; Yu L, 2001, AVIAN DIS, V45, P416, DOI 10.2307/1592981; YuDong W, 1998, CHINESE J ANIMAL QUA, V15, P1	63	35	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184401	10.1371/journal.pone.0184401	http://dx.doi.org/10.1371/journal.pone.0184401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880958	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200065
J	Gainer, PJ; Pound, HL; Larkin, AA; LeCleir, GR; DeBruyn, JM; Zinser, ER; Johnson, ZI; Wilhelm, SW				Gainer, P. Jackson; Pound, Helena L.; Larkin, Alyse A.; LeCleir, Gary R.; DeBruyn, Jennifer M.; Zinser, Erik R.; Johnson, Zackary I.; Wilhelm, Steven W.			Contrasting seasonal drivers of virus abundance and production in the North Pacific Ocean	PLOS ONE			English	Article							DEEP-SEA SEDIMENTS; 16S RIBOSOMAL-RNA; WESTERN PACIFIC; MICROBIAL COMMUNITIES; SARGASSO SEA; AQUATIC ENVIRONMENTS; CONTINENTAL-SHELF; DIEL PERIODICITY; VIRAL PRODUCTION; COASTAL WATERS	The North Pacific Ocean (between approximately 0 degrees N and 50 degrees N) contains the largest continuous ecosystem on Earth. This region plays a vital role in the cycling of globally important nutrients as well as carbon. Although the microbial communities in this region have been assessed, the dynamics of viruses (abundances and production rates) remains understudied. To address this gap, scientific cruises during the winter and summer seasons (2013) covered the North Pacific basin to determine factors that may drive virus abundances and production rates. Along with information on virus particle abundance and production, we collected a spectrum of oceanographic metrics as well as information on microbial diversity. The data suggest that both biotic and abiotic factors affect the distribution of virus particles. Factors influencing virus dynamics did not vary greatly between seasons, although the abundance of viruses was almost an order of magnitude greater in the summer. When considered in the context of microbial community structure, our observations suggest that members of the bacterial phyla Proteobacteria, Planctomycetes, and Bacteroidetes were correlated to both virus abundances and virus production rates: these phyla have been shown to be enriched in particle associated communities. The findings suggest that environmental factors influence virus community functions (e.g., virion particle degradation) and that particle-associated communities may be important drivers of virus activity.	[Gainer, P. Jackson; Pound, Helena L.; LeCleir, Gary R.; Zinser, Erik R.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Larkin, Alyse A.; Johnson, Zackary I.] Duke Univ, Marine Lab, Environm & Biol Dept, Nicholas Sch, Beaufort, NC 28516 USA; [DeBruyn, Jennifer M.] Univ Tennessee, Biosyst Engn & Soil Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Duke University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	DeBruyn, Jennifer M./A-8813-2010; Wilhelm, Steven W/B-8963-2008	DeBruyn, Jennifer M./0000-0002-2993-4144; Wilhelm, Steven W/0000-0001-6283-8077; Johnson, Zackary/0000-0003-0793-8512; LeCleir, Gary/0000-0002-0228-7557; Larkin, Alyse/0000-0003-4466-0791	National Science Foundation [OCE 1030518]; ZIJ [OCE 1031064, OCE14 16665]; Kenneth and Blaire Mossman Endowment; Division Of Ocean Sciences [1416665] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ZIJ; Kenneth and Blaire Mossman Endowment; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation to ERZ and SWW (OCE 1030518) and ZIJ (OCE 1031064 and OCE14 16665). Further support was provided by the Kenneth and Blaire Mossman Endowment to the University of Tennessee (SWW).	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bettarel Y, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv216; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Crespo BG, 2013, MICROBIOLOGYOPEN, V2, P541, DOI 10.1002/mbo3.92; Culley AI, 2002, LIMNOL OCEANOGR, V47, P1508, DOI 10.4319/lo.2002.47.5.1508; Danovaro R, 2000, APPL ENVIRON MICROB, V66, P1857, DOI 10.1128/AEM.66.5.1857-1861.2000; Fontanez KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00469; Fu G., 1998, P 4 PAC OC REM SENS, P73; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Gobler CJ, 1997, LIMNOL OCEANOGR, V42, P1492, DOI 10.4319/lo.1997.42.7.1492; Hagino K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081749; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; HARDING LW, 1981, MAR BIOL, V61, P95, DOI 10.1007/BF00386649; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; Johnson ZI, 2010, J MAR RES, V68, P283, DOI 10.1357/002224010793721433; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jover LF, 2014, NAT REV MICROBIOL, V12, P519, DOI 10.1038/nrmicro3289; Kirchman D, 2001, METHOD MICROBIOL, V30, P227, DOI 10.1016/S0580-9517(01)30047-8; KRAMER JG, 1993, APPL ENVIRON MICROB, V59, P2430, DOI 10.1128/AEM.59.8.2430-2436.1993; Larkin AA, 2016, ISME J, V10, P1555, DOI 10.1038/ismej.2015.244; LeCleir GR, 2014, FEMS MICROBIOL ECOL, V87, P153, DOI 10.1111/1574-6941.12213; LENSKI RE, 1984, J THEOR BIOL, V108, P319, DOI 10.1016/S0022-5193(84)80035-1; Li Y, 2014, BIOGEOSCIENCES, V11, P2531, DOI 10.5194/bg-11-2531-2014; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; MATHIAS CB, 1995, APPL ENVIRON MICROB, V61, P3734, DOI 10.1128/AEM.61.10.3734-3740.1995; Matteson AR, 2010, JOVE-J VIS EXP, V43, pe2196; Matteson AR, 2013, FEMS MICROBIOL ECOL, V84, P223, DOI 10.1111/1574-6941.12060; Matteson AR, 2012, FEMS MICROBIOL ECOL, V79, P709, DOI 10.1111/j.1574-6941.2011.01251.x; Middelboe M, 2006, DEEP-SEA RES PT I, V53, P1, DOI 10.1016/j.dsr.2005.09.008; Middelboe M, 2002, AQUAT MICROB ECOL, V27, P187, DOI 10.3354/ame027187; Mojica KDA, 2014, FEMS MICROBIOL ECOL, V89, P495, DOI 10.1111/1574-6941.12343; Needham DM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.5, 10.1038/nmicrobiol.2016.5]; Nelson CE, 2014, ENVIRON MICROBIOL, V16, P871, DOI 10.1111/1462-2920.12241; Noble RT, 1997, APPL ENVIRON MICROB, V63, P77, DOI 10.1128/AEM.63.1.77-83.1997; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Ortmann Alice C., 2009, V501, P87, DOI 10.1007/978-1-60327-164-6_10; OWENS TG, 1980, MAR BIOL, V59, P71, DOI 10.1007/BF00405456; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rowe JM, 2008, AQUAT MICROB ECOL, V52, P233, DOI 10.3354/ame01231; Rowe JM, 2012, FEMS MICROBIOL ECOL, V79, P359, DOI 10.1111/j.1574-6941.2011.01223.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SUTTLE CA, 1994, MICROBIAL ECOL, V28, P237, DOI 10.1007/BF00166813; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Tsai AY, 2013, BIOGEOSCIENCES, V10, P3055, DOI 10.5194/bg-10-3055-2013; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; WEINBAUER MG, 1995, MICROBIAL ECOL, V30, P25, DOI 10.1007/BF00184511; Weitz JS, 2015, ISME J, V9, P1352, DOI 10.1038/ismej.2014.220; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winget DM, 2005, AQUAT MICROB ECOL, V41, P221, DOI 10.3354/ame041221	62	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184371	10.1371/journal.pone.0184371	http://dx.doi.org/10.1371/journal.pone.0184371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880951	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200060
J	Goods, BA; Hernandez, AL; Lowther, DE; Lucca, LE; Lerner, BA; Gunel, M; Raddassi, K; Coric, V; Hafler, DA; Love, JC				Goods, Brittany A.; Hernandez, Amanda L.; Lowther, Daniel E.; Lucca, Liliana E.; Lerner, Benjamin A.; Gunel, Murat; Raddassi, Khadir; Coric, Vlad; Hafler, David A.; Love, J. Christopher			Functional differences between PD-1(+) and PD-1(-) CD4(+) effector T cells in healthy donors and patients with glioblastoma multiforme	PLOS ONE			English	Article							TUMOR; CD8(+); LYMPHOCYTES; EXPRESSION; EPIDEMIOLOGY; DYSFUNCTION; ANTI-PD-1; SAFETY; GLIOMA	Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) have been highly successful in the treatment of cancer. While PD-1 expression has been widely investigated, its role in CD4(+) effector T cells in the setting of health and cancer remains unclear, particularly in the setting of glioblastoma multiforme (GBM), the most aggressive and common form of brain cancer. We examined the functional and molecular features of PD1 (+)CD4(+)CD25(-)CD127(+)Foxp3(-) effector cells in healthy subjects and in patients with GBM. In healthy subjects, we found that PD-1(+)CD4(+) effector cells are dysfunctional: they do not proliferate but can secrete large quantities of IFN gamma. Strikingly, blocking antibodies against PD-1 did not rescue proliferation. RNA-sequencing revealed features of exhaustion in PD1 (+) CD4 effectors. In the context of GBM, tumors were enriched in PD-1(+)CD4(+) effectors that were similarly dysfunctional and unable to proliferate. Furthermore, we found enrichment of PD-1(+)TIM-3(+)CD4(+) effectors in tumors, suggesting that co-blockade of PD-1 and TIM-3 in GBM may be therapeutically beneficial. RNA-sequencing of blood and tumors from GBM patients revealed distinct differences between CD4(+) effectors from both compartments with enrichment in multiple gene sets from tumor infiltrating PD-1(-)CD4(+) effectors cells. Enrichment of these gene sets in tumor suggests a more metabolically active cell state with signaling through other co-receptors. PD-1 expression on CD4 cells identifies a dysfunctional subset refractory to rescue with PD-1 blocking antibodies, suggesting that the influence of immune checkpoint inhibitors may involve recovery of function in the PD-1(-)CD4(+) T cell compartment. Additionally, co-blockade of PD-1 and TIM-3 in GBM may be therapeutically beneficial.	[Goods, Brittany A.; Love, J. Christopher] MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Goods, Brittany A.; Love, J. Christopher] MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Hernandez, Amanda L.; Lowther, Daniel E.; Lucca, Liliana E.; Lerner, Benjamin A.; Raddassi, Khadir; Hafler, David A.] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Hernandez, Amanda L.; Lowther, Daniel E.; Lucca, Liliana E.; Lerner, Benjamin A.; Raddassi, Khadir; Hafler, David A.] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Gunel, Murat] Yale Sch Med, Dept Genet, New Haven, CT USA; [Gunel, Murat] Yale Sch Med, Dept Neurosurg, New Haven, CT USA; [Coric, Vlad] Bristol Myers Squibb, Wallingford, CT USA; [Hafler, David A.; Love, J. Christopher] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; Yale University; Bristol-Myers Squibb; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Love, JC (corresponding author), MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Love, JC (corresponding author), MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Love, JC (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	clove@mit.edu	Lucca, Liliana/ABA-9188-2021	Love, John/0000-0003-0921-3144; Lucca, Liliana Elisa/0000-0002-5109-0128; /0000-0002-5962-9570	Britstol-Myers Squib; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Britstol-Myers Squib; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A portion of this research was funded by Britstol-Myers Squib. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Cao Y, 2015, SCI TRANSL MED, V7; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Han S, 2014, BRIT J CANCER, V110, P2560, DOI 10.1038/bjc.2014.162; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Igarashi H, 2008, BIOCHEM BIOPH RES CO, V369, P1134, DOI 10.1016/j.bbrc.2008.03.024; Jacobs JFM, 2010, J NEUROIMMUNOL, V225, P195, DOI 10.1016/j.jneuroim.2010.05.020; Kang CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15659; Learn CA, 2006, CLIN CANCER RES, V12, P7306, DOI 10.1158/1078-0432.CCR-06-1727; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-104; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; Mischel PS, 2002, TARGETED MOL THERAPY, P1; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ray S, 2014, ARCH APPL MECH, P1; Razavi SM, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00011; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Ronchetti S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/171520; Rutledge WC, 2013, CLIN CANCER RES, V19, P4951, DOI 10.1158/1078-0432.CCR-13-0551; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Tirosh I, 2016, DISSECTING MULTICELL, P1; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2829, DOI 10.1172/JCI28941E1; Wainwright DA, 2014, CLIN CANCER RES, V20, P5290, DOI 10.1158/1078-0432.CCR-14-0514; Walker DG, 2006, J NEUROIMMUNOL, V175, P59, DOI 10.1016/j.jneuroim.2006.03.006; Wei B, 2014, TUMOR BIOL, V35, P2923, DOI 10.1007/s13277-013-1376-9; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	43	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0181538	10.1371/journal.pone.0181538	http://dx.doi.org/10.1371/journal.pone.0181538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880903	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200005
J	Shiraya, T; Kato, S; Araki, F; Ueta, T; Abe, H; Asai, N				Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi; Abe, Hitoshi; Asai, Nobuharu			Experimental verification of subthreshold laser therapy using conventional pattern scan laser	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; RETINAL PHOTOCOAGULATION	Purpose Leading-edge therapeutic laser technologies are not available at every medical facility; therefore, alternative approaches incorporating novel advances in digital and laser technology into more readily available conventional methods have generated significant research interest. Using a rabbit model, this study investigated whether the algorithm used in the Endpoint Management (EM) software system of the latest devices could enable subthreshold laser treatment in conventional retinal tissue laser therapy systems. Materials and methods Two types of devices were used, the PASCAL Streamline 577 and the MC 500-Vixi T, and the laser method was classified into three categories: EM; single-shot using PASCAL with arbitrary energy settings (PSS-SDM); and MC500-Vixi TM (VX-SDM), which were performed in eight eyes from four Dutch-Belted rabbits. In EM, 100mW (100%) was set as a landmark, and the laser energy parameters were gradually decreased to 80%, 60%, 50%, 40%, 30%, 20%, and 10%, using a 2 x 3 square pattern. In PSS-SDM and VX-SDM, as control, the laser energy was gradually decreased to 100, 80, 60, 50, 40, 30, 20, and 10 mW. The laser settings were fixed at 200 mu m, 20 ms, and a wavelength of 577 mu m. To identify and compare the extent of tissue damage at each spot size, optical coherence tomography (OCT) and histological findings were used to construct a three-dimensional histopathology image using a confocal laser scanning fluorescence microscope. Results The spot size at 50% setting on EM was 7183 mu m(2); PSS-SDM required 50mW (5503 mu m(2)) to 60mW(10279 mu m(2)) and VX-SDM required 50mW(7423 mu m(2)) to create the approximate spot size. Furthermore, at 50mW of PSS-SDM and VX-SDM, the extent of tissue damage in all three methods was generally in accord with the outer nuclear layer by OCT and inner nuclear layer by histopathological imaging. Conclusion These findings suggest that it may be possible to perform subthreshold laser therapy using approximations from the EM algorithm.	[Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi] Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Abe, Hitoshi; Asai, Nobuharu] NIDEK Co Ltd, Gamagori, Japan	Nidek Co., Ltd	Kato, S (corresponding author), Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	katou-s@ka2.so-net.ne.jp			JSPS KAKENHI [JP16K20305]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant Number JP16K20305 (https://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenkranz MS, 2006, RETINA-J RET VIT DIS, V26, P370, DOI 10.1097/00006982-200603000-00024; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Fong DS, 2007, ARCH OPHTHALMOL-CHIC, V125, P469; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Koinzer S, 2013, ACTA OPHTHALMOL, V91, pE603, DOI 10.1111/aos.12188; Lavinsky D, 2011, INVEST OPHTH VIS SCI, V52, P4314, DOI 10.1167/iovs.10-6828; Muqit MMK, 2011, INVEST OPHTH VIS SCI, V52, P994, DOI 10.1167/iovs.10-6309; Ohkoshi K, 2010, AM J OPHTHALMOL, V149, P133, DOI 10.1016/j.ajo.2009.08.010; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Paulus YM, 2008, INVEST OPHTH VIS SCI, V49, P5540, DOI 10.1167/iovs.08-1928; ROIDER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1786, DOI 10.1001/archopht.1992.01080240126045; Roider J, 1999, Semin Ophthalmol, V14, P19, DOI 10.3109/08820539909056059; SCHATZ H, 1991, ARCH OPHTHALMOL-CHIC, V109, P1549, DOI 10.1001/archopht.1991.01080110085041; Sher A, 2013, J NEUROSCI, V33, P6800, DOI 10.1523/JNEUROSCI.1044-12.2013; Shiraya T, 2014, ACTA OPHTHALMOL, V92, pe585, DOI 10.1111/aos.12393; Vujosevic S, 2010, RETINA-J RET VIT DIS, V30, P908, DOI 10.1097/IAE.0b013e3181c96986	17	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184392	10.1371/journal.pone.0184392	http://dx.doi.org/10.1371/journal.pone.0184392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880961	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200063
J	Ortiz, C; Casanova, M; Palacios, P; Vicente, M				Ortiz, Cristina; Casanova, Mercedes; Palacios, Pilar; Vicente, Miguel			The hypermorph FtsA* protein has an in vivo role in relieving the Escherichia coli proto-ring block caused by excess ZapC(+)	PLOS ONE			English	Article							BACTERIAL-CELL-DIVISION; CRYSTAL-STRUCTURE; ZIPA; SEPTUM; ZAPA; BACTERIOPHAGE-T4; LOCALIZATION; MEMBRANE; DIVISOME; PROMOTES	Assembly of the proto-ring, formed by the essential FtsZ, FtsA and ZipA proteins, and its progression into a divisome, are essential events for Escherichia coli division. ZapC is a cytoplasmic protein that belongs to a group of non-essential components that assist FtsZ during proto-ring assembly. Any overproduction of these proteins leads to faulty FtsZ-rings, resulting in a cell division block. We show that ZapC overproduction can be counteracted by an excess of the ZipA-independent hypermorph FtsA* mutant, but not by similar amounts of wild type FtsA(+). An excess of FtsA(+) allowed regular spacing of the ZapC-blocked FtsZ-rings, but failed to promote recruitment of the late-assembling proteins FtsQ, FtsK and FtsN and therefore, to activate constriction. In contrast, overproduction of FtsA*, besides allowing correct FtsZ-ring localization at midcell, restored the ability of FtsQ, FtsK and FtsN to be incorporated into active divisomes.	[Ortiz, Cristina; Casanova, Mercedes; Palacios, Pilar; Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Vicente, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	mvicente@cnb.csic.es		Ortiz, Cristina/0000-0002-4765-8825	Ministerio de Economia Industria y Competitividad [BIO2011-28941-C03-01, BFU2014-52070-C2-1-P]	Ministerio de Economia Industria y Competitividad(Spanish Government)	This work was supported through grants from Ministerio de Economia Industria y Competitividad: BIO2011-28941-C03-01 and BFU2014-52070-C2-1-P (http://www.idi.mineco.gob.es/portal/site/MICINN/) to MV.	Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Buczek MS, 2016, MICROBIOL-SGM, V162, P909, DOI 10.1099/mic.0.000278; Busiek KK, 2014, MOL MICROBIOL, V92, P1212, DOI 10.1111/mmi.12623; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Cabre EJ, 2013, J BIOL CHEM, V288, P26625, DOI 10.1074/jbc.M113.491688; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Daley DO, 2016, SCI REP-UK, V6, DOI 10.1038/srep33138; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEWAR SJ, 1992, J BACTERIOL, V174, P6314, DOI 10.1128/JB.174.19.6314-6316.1992; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Krupka M, NAT COMMUN; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Ortiz C, 2015, FEBS LETT, V589, P3822, DOI 10.1016/j.febslet.2015.11.030; Pazos M, 2013, ENVIRON MICROBIOL, V15, P3282, DOI 10.1111/1462-2920.12225; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Roach EJ, 2016, J BACTERIOL, V198, P1683, DOI 10.1128/JB.00969-15; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Rothfield LI, 1996, CELL, V84, P183, DOI 10.1016/S0092-8674(00)80971-X; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sanchez-Gorostiaga A, 2015, SPRINGER PROTOCOLS H; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x	51	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184184	10.1371/journal.pone.0184184	http://dx.doi.org/10.1371/journal.pone.0184184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877250	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200069
J	Sohirad, S; Wilson, D; Waugh, C; Finnamore, E; Scott, A				Sohirad, Sahand; Wilson, David; Waugh, Charlotte; Finnamore, Evan; Scott, Alexander			Feasibility of using a hand-held device to characterize tendon tissue biomechanics	PLOS ONE			English	Article							PARKINSONS-DISEASE; ACHILLES-TENDON; MUSCLE TONE; STIFFNESS; AGE	Objectives To examine the feasibility of using the MyotonPRO digital palpation device in measuring the transverse stiffness of tendon tissue. Design Experimental study. Methods The MyotonPRO was used to measure the stiffness and related properties of ballistics gel in comparison with an external materials testing system (PCB electronics). The device was then used to measure the same properties of avian Achilles tendons before and after the removal of the overlying skin and subcutaneous tissue. Next, the test-retest reliability of the Achilles and patellar tendons was determined in humans. Finally, the stiffness of the Achilles tendon was measured before and after competitive running races of varying distances (10, 21 and 42 km, total number of athletes analyzed = 66). Results The MyotonPRO demonstrated a high degree of consistency when testing ballistics gel with known viscoelastic properties. The presence of skin overlying the avian Achilles tendon had a statistically significant impact on stiffness (p< 0.01) although this impact was of very small absolute magnitude (with skin; 728 Nm +/- 17 Nm, without skin; Nm 704 Nm +/- 7 Nm). In healthy adults of normal body mass index (BMI), the reliability of stiffness values was excellent both for the patellar tendon (ICC, 0.96) and the Achilles tendon (ICC, 0.96). In the the field study, men had stiffer tendons than women (p< 0.05), and the stiffness of the Achilles tendon tended to increase following running (p = 0.052). Conclusions The MyotonPRO can reliably determine the transverse mechanical properties of tendon tissue. The measured values are influenced by the presence of overlying skin, however this does not appear to compromise the ability of the device to record physiologically and clinically relevant measurements.	[Sohirad, Sahand; Wilson, David; Waugh, Charlotte; Finnamore, Evan; Scott, Alexander] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Wilson, David] Univ British Columbia, Fac Med, Dept Orthopaed, Vancouver, BC, Canada; [Finnamore, Evan; Scott, Alexander] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Scott, A (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.; Scott, A (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada.	ascott@mail.ubc.ca	Wilson, D/T-7980-2019; Waugh, Charlie/J-3687-2015	Waugh, Charlie/0000-0002-3090-046X; Scott, Alex/0000-0003-0366-8404; Wilson, David/0000-0001-6893-0894	National Sciences and Engineering Research Council [402108-2011]; Michael Smith Foundation for Health Research; Marie Curie Actions; National Sciences and Engineering Research Council	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Marie Curie Actions(European Commission); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by a Discovery Grant from the National Sciences and Engineering Research Council to EF (402108-2011). AS received a Clinical Scholar award from the Michael Smith Foundation for Health Research. CMW received an individual fellowship from the Marie Curie Actions 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a Discovery Grant from the National Sciences and Engineering Research Council. AS received a Clinical Scholar award from the Michael Smith Foundation for Health Research. CMW received an individual fellowship from the Marie-Curie Actions 2016. EF received an Undergraduate Student Research Award from the National Sciences and Engineering Research Council.	Agyapong-Badu S, 2016, ARCH GERONTOL GERIAT, V62, P59, DOI 10.1016/j.archger.2015.09.011; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Bizzini M, 2003, CLIN BIOMECH, V18, P459, DOI 10.1016/S0268-0033(03)00042-1; Bohm S, 2015, SPORTS MED OPEN, V1; Marusiak J, 2015, J REHABIL MED, V47, P372, DOI 10.2340/16501977-1931; Marusiak J, 2011, MOVEMENT DISORD, V26, P2119, DOI 10.1002/mds.23841; Nicholar N, 2004, BALLISTIC GELATIN; Pang BSF, 2006, J ULTRAS MED, V25, P1291, DOI 10.7863/jum.2006.25.10.1291; Schneider S, 2015, MED BIOL ENG COMPUT, V53, P57, DOI 10.1007/s11517-014-1211-5; Turan A, 2015, MED ULTRASON, V17, P58, DOI 10.11152/mu.2013.2066.171.ayt; Viir R, 2006, J MECH MED BIOL, V6, P215, DOI 10.1142/S0219519406001856; Zinder SM, 2011, J SPORT REHABIL	12	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184463	10.1371/journal.pone.0184463	http://dx.doi.org/10.1371/journal.pone.0184463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877266	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200106
J	Bass, C; Helkkula, P; De Paola, V; Clopath, C; Bharath, AA				Bass, Cher; Helkkula, Pyry; De Paola, Vincenzo; Clopath, Claudia; Bharath, Anil Anthony			Detection of axonal synapses in 3D two-photon images	PLOS ONE			English	Article							DENDRITIC SPINES; STRUCTURAL DYNAMICS; FEATURE-SELECTION; CELL-TYPE; BOUTONS; FILTER; RECONSTRUCTION; SEGMENTATION	Studies of structural plasticity in the brain often require the detection and analysis of axonal synapses (boutons). To date, bouton detection has been largely manual or semi-automated, relying on a step that traces the axons before detection the boutons. If tracing the axon fails, the accuracy of bouton detection is compromised. In this paper, we propose a new algorithm that does not require tracing the axon to detect axonal boutons in 3D two-photon images taken from the mouse cortex. To find the most appropriate techniques for this task, we compared several well-known algorithms for interest point detection and feature descriptor generation. The final algorithm proposed has the following main steps: (1) a Laplacian of Gaussian (LoG) based feature enhancement module to accentuate the appearance of boutons; (2) a Speeded Up Robust Features (SURF) interest point detector to find candidate locations for feature extraction; (3) non-maximum suppression to eliminate candidates that were detected more than once in the same local region; (4) generation of feature descriptors based on Gabor filters; (5) a Support Vector Machine (SVM) classifier, trained on features from labelled data, and was used to distinguish between bouton and non-bouton candidates. We found that our method achieved a Recall of 95%, Precision of 76%, and F1 score of 84% within a new dataset that we make available for accessing bouton detection. On average, Recall and F1 score were significantly better than the current state-of-the-art method, while Precision was not significantly different. In conclusion, in this article we demonstrate that our approach, which is independent of axon tracing, can detect boutons to a high level of accuracy, and improves on the detection performance of existing approaches. The data and code (with an easy to use GUI) used in this article are available from open source repositories.	[Bass, Cher] Imperial Coll London, Ctr Neurotechnol, South Kensington Campus, London, England; [Bass, Cher; Helkkula, Pyry; Clopath, Claudia; Bharath, Anil Anthony] Imperial Coll London, Dept Bioengn, South Kensington Campus, London, England; [Bass, Cher; De Paola, Vincenzo] Fac Med, MRC Clin Sci Ctr, Hammersmith Campus, London, England	Imperial College London; Imperial College London; Imperial College London	Bass, C (corresponding author), Imperial Coll London, Ctr Neurotechnol, South Kensington Campus, London, England.; Bass, C (corresponding author), Imperial Coll London, Dept Bioengn, South Kensington Campus, London, England.; Bass, C (corresponding author), Fac Med, MRC Clin Sci Ctr, Hammersmith Campus, London, England.	cb2114@ic.ac.uk	Bass, Cher/AAI-9555-2020; de paola, vincenzo/B-4900-2016	Bass, Cher/0000-0002-7928-3394; de paola, vincenzo/0000-0001-9987-8291	Engineering and Physical Sciences Research Council [EP/L016737/1]; Engineering and Physical Sciences Research Council [EP/J021199/1, 1507941] Funding Source: researchfish; EPSRC [EP/J021199/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council [grant number EP/L016737/1], website: https://www.epsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Becker N, 2008, NEURON, V60, P590, DOI 10.1016/j.neuron.2008.09.018; Canny J.F., 1986, COMPUTATIONAL APPROA; Canty AJ, 2013, J NEUROSCI, V33, P10374, DOI 10.1523/JNEUROSCI.0254-13.2013; Chen Hanbo, 2015, Brain Inform, V2, P135; Ciresan D., 2012, ADV NEURAL INF PROCE, V25, P2843; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Grillo FW, 2013, P NATL ACAD SCI USA, V110, pE1514, DOI 10.1073/pnas.1218731110; Harris C., 1988, P ALV VIS C MANCH UK, V15, P147, DOI [10.5244/C.2.23, DOI 10.5244/C.2.23]; JAIN AK, 1991, PATTERN RECOGN, V24, P1167, DOI 10.1016/0031-3203(91)90143-S; Jammalamadaka A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-287; Janoos F, 2009, MED IMAGE ANAL, V13, P167, DOI 10.1016/j.media.2008.06.019; Jurrus E, 2010, MED IMAGE ANAL, V14, P770, DOI 10.1016/j.media.2010.06.002; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kitti T., 2012, INT J MACHINE LEARNI, V2, P462, DOI DOI 10.7763/IJMLC.2012.V2.168; Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945; Kong H, 2013, IEEE T CYBERNETICS, V43, P1719, DOI 10.1109/TSMCB.2012.2228639; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; MEHROTRA R, 1992, PATTERN RECOGN, V25, P1479, DOI 10.1016/0031-3203(92)90121-X; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Peng HC, 2015, NEURON, V87, P252, DOI 10.1016/j.neuron.2015.06.036; Peng HC, 2011, BIOINFORMATICS, V27, pI239, DOI 10.1093/bioinformatics/btr237; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Prodanov D, 2006, J NEUROSCI METH, V151, P168, DOI 10.1016/j.jneumeth.2005.07.011; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Song S, 2015, NEUROINFORMATICS, P9274; Teikari P., 2016, ARXIV160602382, P1; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Weldon TP, 1996, PATTERN RECOGN, V29, P2005, DOI 10.1016/S0031-3203(96)00047-7; Xiao H, 2013, BIOINFORMATICS, V29, P1448, DOI 10.1093/bioinformatics/btt170; Xu Y., 2016, AQUAC RES, P1; Yang J, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-29; Yuan XS, 2009, NEUROINFORMATICS, V7, P213, DOI 10.1007/s12021-009-9057-y; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou HY, 2009, COMPUT VIS IMAGE UND, V113, P345, DOI 10.1016/j.cviu.2008.08.006; Zhou Z, 2016, NEUROINFORMATICS, V14, P41, DOI 10.1007/s12021-015-9278-1	43	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183309	10.1371/journal.pone.0183309	http://dx.doi.org/10.1371/journal.pone.0183309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873436	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800013
J	Robinson, DP; Jabado, RW; Rohner, CA; Pierce, SJ; Hyland, KP; Baverstock, WR				Robinson, David P.; Jabado, Rima W.; Rohner, Christoph A.; Pierce, Simon J.; Hyland, Kevin P.; Baverstock, Warren R.			Satellite tagging of rehabilitated green sea turtles Chelonia mydas from the United Arab Emirates, including the longest tracked journey for the species	PLOS ONE			English	Article							MARINE TURTLES; ASCENSION-ISLAND; LOGGERHEAD TURTLES; CARETTA-CARETTA; INDIAN-OCEAN; HOME-RANGE; CONSERVATION; MOVEMENTS; REGION; GULF	We collected movement data for eight rehabilitated and satellite-tagged green sea turtles Chelonia mydas released off the United Arab Emirates between 2005 and 2013. Rehabilitation periods ranged from 96 to 1353 days (mean = 437 +/- 399 days). Seven of the eight tagged turtles survived after release; one turtle was killed by what is thought to be a postrelease spear gun wound. The majority of turtles (63%) used shallow-water core habitats and established home ranges between Dubai and Abu Dhabi, the same area in which they had originally washed ashore prior to rescue. Four turtles made movements across international boundaries, highlighting that regional cooperation is necessary for the management of the species. One turtle swam from Fujairah to the Andaman Sea, a total distance of 8283 km, which is the longest published track of a green turtle. This study demonstrates that sea turtles can be successfully reintroduced into the wild after sustaining serious injury and undergoing prolonged periods of intense rehabilitation.	[Robinson, David P.; Baverstock, Warren R.] Jumeirah Grp, Dubai, U Arab Emirates; [Jabado, Rima W.] Gulf Elasmo Project, Dubai, U Arab Emirates; [Rohner, Christoph A.; Pierce, Simon J.] Marine Megafauna Fdn, Truckee, CA USA; [Hyland, Kevin P.] Wildlife Protect Off, Dubai, U Arab Emirates		Robinson, DP (corresponding author), Jumeirah Grp, Dubai, U Arab Emirates.	sharkwatcharabia@gmail.com	Pierce, Simon J./A-7621-2010	Pierce, Simon J./0000-0002-9375-5175; Robinson, David/0000-0003-2572-9271; Rohner, Christoph/0000-0001-8760-8972; Jabado, Rima/0000-0001-6239-6723	Jumeriah Group; His Highness Mohammed Bin Rashid Al Maktoum; Dubai Turtle Rehabilitation Project; Jumeirah Group	Jumeriah Group; His Highness Mohammed Bin Rashid Al Maktoum; Dubai Turtle Rehabilitation Project; Jumeirah Group	The Jumeriah Group provided support in the form of research materials and salaries for authors WRB and DPR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section. WRB and DPR acted as independent researchers throughout this study. The journal publication fees for this manuscript were provided by the Jumeirah Group. All other collaborators, had no role in the preparation or decision to publish the manuscript.; This project was kindly supported by His Highness Mohammed Bin Rashid Al Maktoum, Vice -President and Prime Minister of the United Arab Emirates and Ruler of Dubai. We would like to thank the Dubai Falcon Hospital and the Central Veterinary Research Laboratory (CVRL) for their ongoing support of the Dubai Turtle Rehabilitation Project. We thank the Jumeirah Group for providing the funding for satellite tags and data related costs. We would like to thank Kevin Lay from Wildlife Computers for his assistance with satellite tracking. We thank all individuals and organisations who have rescued sick turtles in the UAE and brought them to the DTRP for treatment. We also thank the Dubai Municipality, the Ministry of Climate Change and Environment, Environment Agency Abu Dhabi and the Emirates Marine Environmental Group for their support and for rescuing sea turtles in the UAE. Figures throughout this manuscript were created using ArcGIS software by Esri, please visit wvay. esrLcorn. We acknowledge the use of free vector and raster map data sourced from WWW.naturalearthdata.com.	Al Suweidi Ali Saqer, 2012, Marine Turtle Newsletter, P16; AL-GAHTANI A.S., 2002, P 6 SAUD ENG C, V3, P169; Al-Merghani Mustafa, 2000, Fauna of Arabia, V18, P369; Al-Mohanna SY, 2014, AQUAT CONSERV, V24, P166, DOI 10.1002/aqc.2371; Al-Mohanna SY, 1998, STUDY BIOL MARINE TU, P1; Aloia MD, 2013, ZOOLOGY MIDDLE E, P37; BASSON PW, 1977, BIOTOPES W ARABIAN G; Baverstock Warren, 2008, Wildlife Middle East News, V3, P6; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; Bluvias JE, 2008, MARINE TURTLE TRAUMA; Broderick AC, 2006, GLOBAL ECOL BIOGEOGR, V15, P21, DOI 10.1111/j.1466-822x.2006.00195.x; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Caliendo Valentina, 2010, Journal of Herpetological Medicine and Surgery, V20, P117, DOI 10.5818/1529-9651-20.4.117; Cardona L, 2012, AQUAT CONSERV, V22, P104, DOI 10.1002/aqc.1242; Carpenter K.E., 1997, LIVING MARINE RESOUR; CARR A, 1975, COPEIA, P547; Casale P, 2005, HERPETOL J, V15, P145; Chaloupka M, 1999, MAR ECOL PROG SER, V184, P291, DOI 10.3354/meps184291; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Esteban N, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2581; Frazier J, 2003, CRC MAR BIOL SER, P1; FRAZIER J, 1980, HUM ECOL, V8, P329, DOI 10.1007/BF01560999; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gilbert J, 2011, QUEENSL COAST C AUST; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2003, J EXP MAR BIOL ECOL, V287, P119, DOI 10.1016/S0022-0981(02)00547-6; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hampel Mirjam R., 2008, Wildlife Middle East News, V3, P5; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hays GC, 2010, INT J REMOTE SENS, V22, P37; Hays GC, 2014, CONSERV BIOL, V28, P1636, DOI 10.1111/cobi.12325; Hochscheid S, 2005, BIOL LETTERS, V1, P82, DOI 10.1098/rsbl.2004.0250; Hochscheid S, 2010, J EXP BIOL, V213, P1328, DOI 10.1242/jeb.037184; Hochscheid S, 2007, MAR ECOL PROG SER, V340, P287, DOI 10.3354/meps340287; Hochscheid S, 2014, J EXP MAR BIOL ECOL, V450, P118, DOI 10.1016/j.jembe.2013.10.016; Horikoshi K., 1994, P 14 ANN S SEA TURTL, P1; Horrocks Julia A., 2001, Chelonian Conservation and Biology, V4, P107; Jabado R., 2012, MARINE ECOSYSTEMS UN; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Jeffers VF, 2016, BIOL CONSERV, V199, P172, DOI 10.1016/j.biocon.2016.04.032; Karl SA, 2010, CONSERV BIOL, V13, P990; KOCH AL, 1969, J THEOR BIOL, V22, P163, DOI 10.1016/0022-5193(69)90085-X; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; MacLeod C., 2013, INTRO USING GIS MARI; Makowski C, 2006, MAR BIOL, V148, P1167, DOI 10.1007/s00227-005-0150-y; Mestre F, 2014, MAR BIOL RES, V10, P996, DOI 10.1080/17451000.2013.872801; Miller G, 2012, MARINE COASTAL REPTI; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; MORTIMER JA, 1987, COPEIA, P103, DOI 10.2307/1446043; MROSOVSKY N, 1980, AM ZOOL, V20, P531; Musick John A., 1997, P137; Nadim F, 2008, OCEAN COAST MANAGE, V51, P556, DOI 10.1016/j.ocecoaman.2008.04.007; Nichols WJ, 2000, B MAR SCI, V67, P937; NRC (National Research Council), 1990, DECL SEA TURTL CAUS; Parsons J, 1962, GREEN TURTLE MAN; Pelletier D, 2003, AQUAT LIVING RESOUR, V16, P35, DOI 10.1016/S0990-7440(03)00005-6; Pilcher NJ, 2015, ENDANGER SPECIES RES, V28, P163, DOI 10.3354/esr00688; Pilcher NJ, 2014, J EXP MAR BIOL ECOL, V457, P190, DOI 10.1016/j.jembe.2014.04.002; Pilcher Nicolas J., 2000, Chelonian Conservation and Biology, V3, P730; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Rees A, MARINE BIOL, V160, P519; Rees AF, 2013, CHELONIAN CONSERV BI, V12, P157; Rees AF, 2012, CHELONIAN CONSERV BI, V11, P243, DOI 10.2744/CCB-1000.1; ROSS JP, 1985, J HERPETOL, V19, P459, DOI 10.2307/1564198; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Seminoff JA., 2004, CHELONIA MYDAS IUCN; Sheppard C.R.C., 1992, MARINE ECOLOGY ARABI; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Spotila James R., 1997, P297; Spotila JR, 2004, SEA TURTLES COMPLETE; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Wibbels Thane, 1999, P139; Wilson S., 2002, STATUS CORAL REEFS W, P53	78	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184286	10.1371/journal.pone.0184286	http://dx.doi.org/10.1371/journal.pone.0184286			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873453	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800070
J	Aarts, E; Ederveen, THA; Naaijen, J; Zwiers, MP; Boekhorst, J; Timmerman, HM; Smeekens, SP; Netea, MG; Buitelaar, JK; Franke, B; van Hijum, SAFT; Vasquez, AA				Aarts, Esther; Ederveen, Thomas H. A.; Naaijen, Jilly; Zwiers, Marcel P.; Boekhorst, Jos; Timmerman, Harro M.; Smeekens, Sanne P.; Netea, Mihai G.; Buitelaar, Jan K.; Franke, Barbara; van Hijum, Sacha A. F. T.; Vasquez, Alejandro Arias			Gut microbiome in ADHD and its relation to neural reward anticipation	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; AMINO-ACIDS; DOPAMINE; CHILDREN; PHENYLALANINE; METAANALYSIS; IMPULSIVITY; METABOLISM; MODULATION	Background Microorganisms in the human intestine (i.e. the gut microbiome) have an increasingly recognized impact on human health, including brain functioning. Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder associated with abnormalities in dopamine neurotransmission and deficits in reward processing and its underlying neuro-circuitry including the ventral striatum. The microbiome might contribute to ADHD etiology via the gut-brain axis. In this pilot study, we investigated potential differences in the microbiome between ADHD cases and undiagnosed controls, as well as its relation to neural reward processing. Methods We used 16S rRNA marker gene sequencing (16S) to identify bacterial taxa and their predicted gene functions in 19 ADHD and 77 control participants. Using functional magnetic resonance imaging (fMRI), we interrogated the effect of observed microbiome differences in neural reward responses in a subset of 28 participants, independent of diagnosis. Results For the first time, we describe gut microbial makeup of adolescents and adults diagnosed with ADHD. We found that the relative abundance of several bacterial taxa differed between cases and controls, albeit marginally significant. A nominal increase in the Bifidobacterium genus was observed in ADHD cases. In a hypothesis-driven approach, we found that the observed increase was linked to significantly enhanced 16S-based predicted bacterial gene functionality encoding cyclohexadienyl dehydratase in cases relative to controls. This enzyme is involved in the synthesis of phenylalanine, a precursor of dopamine. Increased relative abundance of this functionality was significantly associated with decreased ventral striatal fMRI responses during reward anticipation, independent of ADHD diagnosis and age. Conclusions Our results show increases in gut microbiome predicted function of dopamine precursor synthesis between ADHD cases and controls. This increase in microbiome function relates to decreased neural responses to reward anticipation. Decreased neural reward anticipation constitutes one of the hallmarks of ADHD.	[Aarts, Esther; Zwiers, Marcel P.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Ederveen, Thomas H. A.; Boekhorst, Jos; van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Naaijen, Jilly; Buitelaar, Jan K.; Vasquez, Alejandro Arias] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Boekhorst, Jos; Timmerman, Harro M.; van Hijum, Sacha A. F. T.] NIZO, Ede, Netherlands; [Smeekens, Sanne P.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Smeekens, Sanne P.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands; [Franke, Barbara; Vasquez, Alejandro Arias] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Psychiat, Med Ctr, Nijmegen, Netherlands; [Franke, Barbara; Vasquez, Alejandro Arias] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Human Genet, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; NIZO Food Research; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Aarts, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, Nijmegen, Netherlands.	e.aarts@donders.ru.nl	van Hijum, Sacha/F-6445-2014; Aarts, Esther/J-2254-2012; Franke, Barbara/D-4836-2009; Smeekens, Sanne/G-8307-2011; Buitelaar, J.K./AAY-7522-2020; Netea, Mihai/N-5155-2014; Ederveen, Thomas HA/G-6294-2016; Zwiers, Marcel P/D-2968-2009; Hassan, Randa/AAW-3624-2021; Smeekens, Sanne/AAZ-2061-2021	Aarts, Esther/0000-0001-6360-6200; Franke, Barbara/0000-0003-4375-6572; Smeekens, Sanne/0000-0002-7835-914X; Ederveen, Thomas HA/0000-0003-0068-1275; Zwiers, Marcel P/0000-0001-5483-2935; Smeekens, Sanne/0000-0002-7835-914X; Naaijen, Jilly/0000-0002-3455-9043; van Hijum, Sacha/0000-0003-0741-2991; Boekhorst, Jos/0000-0002-4807-7838	NIH [RO1MH62873]; NWO Large Investment Grant [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; Aspasia [015.008.009]; European Community's Horizon Program [H2020/2014-2020, 643051]; Netherlands Organization for Scientific Research Program Food, Cognition and Behavior [FCB 057-14-005]; ERC [310372]; European Community's Seventh Framework Programme [278948, 602805]; ZONMW [8083700-98-52029]; Veni grant [016.135.023]; Netherlands Organization for Scientific Research [016-130-669]; NIZO	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO Large Investment Grant; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; Aspasia; European Community's Horizon Program; Netherlands Organization for Scientific Research Program Food, Cognition and Behavior; ERC(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme(European Commission); ZONMW(Netherlands Organization for Health Research and Development); Veni grant; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIZO	The NeuroIMAGE study was supported by NIH Grant RO1MH62873 (www.nih.gov), NWO Large Investment Grant 1750102007010 (www.nwo.n1), and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. This work was funded by an Aspasia grant to BF (grant number 015.008.009) (www.nwan1), and the European Community's Horizon 2020 Program (H2020/2014-2020, https://egeuropa.eu/programmes/horizon2020/) under grant agreement no 643051 (MIND). AAV was supported by the Netherlands Organization for Scientific Research (www.nwo.nl) Program Food, Cognition and Behavior (grant number FCB 057-14-005). EA was supported by a Veni grant (grant number 016.135.023) and BF by a Vici grant (grant 016-130-669) from the Netherlands Organization for Scientific Research (www.nwo.n1), MGN by an ERC Grant (#310372) (https://erc.europleu/). Additional funding for this work came from the European Community's Seventh Framework Programme (FP7/20072013,https://ec.europa.eu/research/fP7/) under grant agreement no. 278948 (TACTICS) and no 602805 (Aggressotype) and from the ZONMW grant 8083700-98-52029 (wwwzonmuni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Commercial company NIZO provided support in the form of salaries for authors JB, HMT and SAFTH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarts E, 2015, BEHAV PHARMACOL, V26, P227, DOI 10.1097/FBP.0000000000000116; Aarts E, 2014, PSYCHOL SCI, V25, P1003, DOI 10.1177/0956797613517240; Antshel KM, 2003, J ABNORM CHILD PSYCH, V31, P565, DOI 10.1023/A:1026239921561; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; BAKER GB, 1991, BIOL PSYCHIAT, V29, P15, DOI 10.1016/0006-3223(91)90207-3; Bergwerff CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151100; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; BORNSTEIN RA, 1990, PSYCHIAT RES, V33, P301, DOI 10.1016/0165-1781(90)90046-8; Broadley KJ, 2010, PHARMACOL THERAPEUT, V125, P363, DOI 10.1016/j.pharmthera.2009.11.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clayton TA, 2012, FEBS LETT, V586, P956, DOI 10.1016/j.febslet.2012.01.049; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Franke B, 2012, MOL PSYCHIATR, V17, P960, DOI 10.1038/mp.2011.138; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Gertsman I, 2015, MOL GENET METAB, V114, P431, DOI 10.1016/j.ymgme.2015.01.005; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Hoogman M, 2011, AM J PSYCHIAT, V168, P1099, DOI 10.1176/appi.ajp.2011.10101446; Institute of Medicine Food and Nutrition Board, DIETARY REFERENCE IN; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Kandel E., 2000, PRINCIPLES NEURAL SC; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Nigg JT, 2012, J AM ACAD CHILD PSY, V51, P86, DOI 10.1016/j.jaac.2011.10.015; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Pakseresht N, 2014, NUCLEIC ACIDS RES, V42, pD38, DOI 10.1093/nar/gkt1082; Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Staller Jud A, 2007, Expert Rev Neurother, V7, P351, DOI 10.1586/14737175.7.4.351; Steegenga WT, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0011-9; Stevenson M, 2013, BRAIN RES BULL, V99, P63, DOI 10.1016/j.brainresbull.2013.10.003; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; von Rhein D, 2015, EUR CHILD ADOLES PSY, V24, P265, DOI 10.1007/s00787-014-0573-4; Vuong HE, 2017, BIOL PSYCHIAT, V81, P411, DOI 10.1016/j.biopsych.2016.08.024; Yang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep45942	48	136	138	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183509	10.1371/journal.pone.0183509	http://dx.doi.org/10.1371/journal.pone.0183509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF3ON	28863139	gold, Green Published			2022-12-26	WOS:000408816900006
J	Arber, C; Angelova, PR; Wiethoff, S; Tsuchiya, Y; Mazzacuva, F; Preza, E; Bhatia, KP; Mills, K; Gout, I; Abramov, AY; Hardy, J; Duce, JA; Houlden, H; Wray, S				Arber, Charles; Angelova, Plamena R.; Wiethoff, Sarah; Tsuchiya, Yugo; Mazzacuva, Francesca; Preza, Elisavet; Bhatia, Kailash P.; Mills, Kevin; Gout, Ivan; Abramov, Andrey Y.; Hardy, John; Duce, James A.; Houlden, Henry; Wray, Selina			iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease	PLOS ONE			English	Article							BRAIN IRON ACCUMULATION; COENZYME-A; PANTOTHENATE; INSIGHTS; METABOLISM; UPDATE; PANK2	Mutations in PANK2 lead to neurodegeneration with brain iron accumulation. PANK2 has a role in the biosynthesis of coenzyme A (CoA) from dietary vitamin B5, but the neuropathological mechanism and reasons for iron accumulation remain unknown. In this study, atypical patient-derived fibroblasts were reprogrammed into induced pluripotent stem cells (iPSCs) and subsequently differentiated into cortical neuronal cells for studying disease mechanisms in human neurons. We observed no changes in PANK2 expression between control and patient cells, but a reduction in protein levels was apparent in patient cells. CoA homeostasis and cellular iron handling were normal, mitochondrial function was affected; displaying activated NADH-related and inhibited FADH-related respiration, resulting in increased mitochondrial membrane potential. This led to increased reactive oxygen species generation and lipid peroxidation in patient-derived neurons. These data suggest that mitochondrial deficiency is an early feature of the disease process and can be explained by altered NADH/FADH substrate supply to oxidative phosphorylation. Intriguingly, iron chelation appeared to exacerbate the mitochondrial phenotype in both control and patient neuronal cells. This raises caution for the use iron chelation therapy in general when iron accumulation is absent.	[Arber, Charles; Angelova, Plamena R.; Wiethoff, Sarah; Preza, Elisavet; Bhatia, Kailash P.; Abramov, Andrey Y.; Hardy, John; Houlden, Henry; Wray, Selina] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Tsuchiya, Yugo; Gout, Ivan] UCL, Inst Struct & Mol Biol, London, England; [Mazzacuva, Francesca; Mills, Kevin] UCL Inst Child Hlth, Ctr Translat Omics, Genet & Genom Med Programme, London, England; [Duce, James A.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England	University of London; University College London; University of London; Birkbeck University London; University College London; University of London; University College London; University of Leeds	Arber, C (corresponding author), UCL, Dept Mol Neurosci, Inst Neurol, London, England.	c.arber@ucl.ac.uk	Stroh, Plamena/K-4444-2013; Hardy, John/C-2451-2009; Abramov, Andrey Y/H-9053-2012; Wray, Selina/C-3682-2009; Houlden, Henry J/C-1532-2008; Abramov, Andrey/AAC-6712-2019; Arber, Charles/L-9989-2015	Stroh, Plamena/0000-0003-4596-9117; Hardy, John/0000-0002-3122-0423; Abramov, Andrey Y/0000-0002-7646-7235; Wray, Selina/0000-0003-3062-7050; Houlden, Henry J/0000-0002-2866-7777; Abramov, Andrey/0000-0002-7646-7235; Arber, Charles/0000-0002-9743-8134; PREZA, ELISAVET/0000-0003-4082-4621	Medical Research Council (MRC UK); Wellcome Trust and Eli Lilly; Brain Research Trust (BRT); NIHR Queen Square Dementia Biomedical Research Unit; NIHR UCLH Biomedical Research Centre (BRC); BBSRC [BB/L010410/1] Funding Source: UKRI; MRC [MR/M02492X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L010410/1] Funding Source: researchfish; Medical Research Council [MR/M02492X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; Rosetrees Trust [M239-F1, M239-F2] Funding Source: researchfish; Worldwide Cancer Research [09-0787] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish	Medical Research Council (MRC UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust and Eli Lilly; Brain Research Trust (BRT); NIHR Queen Square Dementia Biomedical Research Unit; NIHR UCLH Biomedical Research Centre (BRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Worldwide Cancer Research; Muscular Dystrophy UK	This work was supported by the Medical Research Council (MRC UK); a pathfinder grant from the Wellcome Trust and Eli Lilly; the Brain Research Trust (BRT) and also supported by the NIHR Queen Square Dementia Biomedical Research Unit and the NIHR UCLH Biomedical Research Centre (BRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Medical Research Council (MRC UK); a pathfinder grant from the Wellcome Trust and Eli Lilly; the Brain Research Trust (BRT) and also supported by the NIHR Queen Square Dementia Biomedical Research Unit and the NIHR UCLH Biomedical Research Centre (BRC).	Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; ALLRED JB, 1969, ANAL BIOCHEM, V29, P293, DOI 10.1016/0003-2697(69)90312-1; Arber CE, 2016, NEUROPATH APPL NEURO, V42, P220, DOI 10.1111/nan.12242; Bartolome Fernando, 2015, Methods Mol Biol, V1264, P263, DOI 10.1007/978-1-4939-2257-4_23; Brunetti D, 2014, BRAIN, V137, P57, DOI 10.1093/brain/awt325; Brunetti D, 2012, HUM MOL GENET, V21, P5294, DOI 10.1093/hmg/dds380; Campanella A, 2012, HUM MOL GENET, V21, P4049, DOI 10.1093/hmg/dds229; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gregory A, 2014, GENE REV; Hayflick SJ, 2006, AM J NEURORADIOL, V27, P1230; Hogarth P, 2015, J MOV DISORD, V8, P1, DOI 10.14802/jmd.14034; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Keogh MJ, 2012, NEUROGENETICS, V13, P93, DOI 10.1007/s10048-011-0310-9; Khatri D, 2016, SCI REP-UK, V6, DOI 10.1038/srep37660; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kruer MC, 2011, BRAIN, V134, P947, DOI 10.1093/brain/awr042; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099; Li A, 2012, NEUROPATHOL APPL NEU; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Orellana DI, 2016, EMBO MOL MED; PERRY TL, 1985, ANN NEUROL, V18, P482, DOI 10.1002/ana.410180411; Poli M, 2010, NEUROBIOL DIS, V39, P204, DOI 10.1016/j.nbd.2010.04.009; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Santambrogio P, 2015, NEUROBIOL DIS; Schneider SA, 2012, MOVEMENT DISORD, V27, P42, DOI 10.1002/mds.23971; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Srinivasan B, 2015, NAT CHEM BIOL, V11, P784, DOI [10.1038/nchembio.1906, 10.1038/NCHEMBIO.1906]; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Tsuchiya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097693; Wong BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114174; Wray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043099; Wu ZH, 2009, HUM MOL GENET, V18, P3659, DOI 10.1093/hmg/ddp314; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zizioli D, 2016, NEUROBIOL DIS, V85, P35, DOI 10.1016/j.nbd.2015.10.010	47	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184104	10.1371/journal.pone.0184104	http://dx.doi.org/10.1371/journal.pone.0184104			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863176	Green Published, gold			2022-12-26	WOS:000408816900024
J	Homann, S; Hofmann, C; Gorin, AM; Nguyen, HCX; Huynh, D; Hamid, P; Maithel, N; Yacoubian, V; Mu, WL; Kossyvakis, A; Sen Roy, S; Yang, OO; Kelesidis, T				Homann, Stefanie; Hofmann, Christian; Gorin, Aleksandr M.; Huy Cong Xuan Nguyen; Diana Huynh; Hamid, Phillip; Maithel, Neil; Yacoubian, Vahe; Mu, Wenli; Kossyvakis, Athanasios; Sen Roy, Shubhendu; Yang, Otto Orlean; Kelesidis, Theodoros			A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GENE-TRANSFER; HIGHLY EFFICIENT; T-LYMPHOCYTES; PLASMID DNA; EXPRESSION; DELIVERY; ACTIVATION; PROTAMINE; REAGENTS	Transfection is one of the most frequently used techniques in molecular biology that is also applicable for gene therapy studies in humans. One of the biggest challenges to investigate the protein function and interaction in gene therapy studies is to have reliable monospecific detection reagents, particularly antibodies, for all human gene products. Thus, a reliable method that can optimize transfection efficiency based on not only expression of the target protein of interest but also the uptake of the nucleic acid plasmid, can be an important tool in molecular biology. Here, we present a simple, rapid and robust flow cytometric method that can be used as a tool to optimize transfection efficiency at the single cell level while overcoming limitations of prior established methods that quantify transfection efficiency. By using optimized ratios of transfection reagent and a nucleic acid (DNA or RNA) vector directly labeled with a fluorochrome, this method can be used as a tool to simultaneously quantify cellular toxicity of different transfection reagents, the amount of nucleic acid plasmid that cells have taken up during transfection as well as the amount of the encoded expressed protein. Finally, we demonstrate that this method is reproducible, can be standardized and can reliably and rapidly quantify transfection efficiency, reducing assay costs and increasing throughput while increasing data robustness.	[Homann, Stefanie; Hofmann, Christian; Gorin, Aleksandr M.; Huy Cong Xuan Nguyen; Diana Huynh; Hamid, Phillip; Maithel, Neil; Yacoubian, Vahe; Mu, Wenli; Kossyvakis, Athanasios; Sen Roy, Shubhendu; Yang, Otto Orlean; Kelesidis, Theodoros] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kelesidis, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	tkelesidis@mednet.ucla.edu	Kelesidis, Theodoros/AAE-1961-2020	Kelesidis, Theodoros/0000-0002-8463-3811; Yacoubian, Vahe/0000-0003-2861-7603	NIH grants NIH/NCATS [UL1TR000124, NIH K08AI08272]; UCLA AIDS Institute/UCLA Center for AIDS Research (CFAR) [NIH/NIAID AI028697]; National Institutes of Health [UCLA Center for AIDS Research (CFAR)] [NIH/NIAID 5P30 AI028697]; UCLA AIDS Institute; UCLA Council of Bioscience Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI108272, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	NIH grants NIH/NCATS; UCLA AIDS Institute/UCLA Center for AIDS Research (CFAR); National Institutes of Health [UCLA Center for AIDS Research (CFAR)]; UCLA AIDS Institute; UCLA Council of Bioscience Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants NIH/NCATS grant # UL1TR000124, NIH K08AI08272 and by grant from the UCLA AIDS Institute/UCLA Center for AIDS Research (CFAR) (NIH/NIAID AI028697). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Center for AIDS Research Virology Core Lab and the Gene and Cellular Therapy Core that are supported by the National Institutes of Health [UCLA Center for AIDS Research (CFAR) NIH/NIAID 5P30 AI028697] and by the UCLA AIDS Institute and the UCLA Council of Bioscience Resources.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Anderson MT, 1996, P NATL ACAD SCI USA, V93, P8508, DOI 10.1073/pnas.93.16.8508; ARRIO B, 1970, BIOCHEM BIOPH RES CO, V39, P589, DOI 10.1016/0006-291X(70)90244-5; Bell MP, 2001, NAT MED, V7, P1155, DOI 10.1038/nm1001-1155; BERGERON D, 1995, CELL MOL BIOL RES, V41, P155; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ducrest AL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf064; Ebert O, 1997, GENE THER, V4, P296, DOI 10.1038/sj.gt.3300394; FARR A, 1992, NUCLEIC ACIDS RES, V20, P920, DOI 10.1093/nar/20.4.920; Fegan A, 2008, CHEM COMMUN, P2004, DOI 10.1039/b801629a; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Hackett PB, 2005, ADV GENET, V54, P189, DOI 10.1016/S0065-2660(05)54009-4; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang LZ, 2016, NAT PROTOC, V11, P655, DOI 10.1038/nprot.2016.028; Kapoor V, 2009, J IMMUNOL METHODS, V344, P6, DOI 10.1016/j.jim.2009.02.004; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li J, 2014, BIOMATERIALS, V35, P5572, DOI 10.1016/j.biomaterials.2014.03.047; Li XQ, 1999, J BIOL CHEM, V274, P21244, DOI 10.1074/jbc.274.30.21244; Liu YF, 2015, MECH SCI, V6, P15, DOI 10.5194/ms-6-15-2015; Maess M. B., 2014, JOVE-J VIS EXP; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masotti A, 2009, COLLOID SURFACE B, V68, P136, DOI 10.1016/j.colsurfb.2008.09.017; Masuda T, 2005, FEBS LETT, V579, P2143, DOI 10.1016/j.febslet.2005.02.071; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Morachis JM, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/291219; Nickells RW, 2015, EXP EYE RES, V141, P99, DOI 10.1016/j.exer.2015.05.009; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Nybo K, 2012, BIOTECHNIQUES, V52, P351, DOI [10.2144/000113870, 10.2144/000113872]; OMAHONEY JV, 1994, DNA CELL BIOL, V13, P1227, DOI 10.1089/dna.1994.13.1227; Ouyang SD, 2009, ZEBRAFISH, V6, P245, DOI 10.1089/zeb.2009.0589; Ritter SC, 2011, BIOMED OPT EXPRESS, V2, P2012, DOI 10.1364/BOE.2.002012; Romoren K, 2004, BBA-BIOMEMBRANES, V1663, P127, DOI 10.1016/j.bbamem.2004.02.007; Saito G, 2003, GENE THER, V10, P72, DOI 10.1038/sj.gt.3301859; Sandbichler AM, 2013, BIORESEARCH OPEN ACC, V2, P20, DOI 10.1089/biores.2012.0287; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Stoll SM, 2002, CURR OPIN MOL THER, V4, P299; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Teif VB, 2011, PROG BIOPHYS MOL BIO, V105, P208, DOI 10.1016/j.pbiomolbio.2010.07.002; van der Aa MAEM, 2007, PHARM RES-DORDR, V24, P1590, DOI 10.1007/s11095-007-9287-3; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Wang LT, 2007, BIOTECHNOL LETT, V29, P1691, DOI 10.1007/s10529-007-9448-9; WEISS A, 1984, J IMMUNOL, V133, P123; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Xie ZL, 2011, CELL BIOL INT, V35, P187, DOI 10.1042/CBI20100470; Zhou ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22824	55	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0182941	10.1371/journal.pone.0182941	http://dx.doi.org/10.1371/journal.pone.0182941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863132	Green Published, gold			2022-12-26	WOS:000408816900003
J	Kanaporis, G; Treinys, R; Fischmeister, R; Jurevicius, J				Kanaporis, Giedrius; Treinys, Rimantas; Fischmeister, Rodolphe; Jurevicius, Jonas			Metabolic inhibition reduces cardiac L-type Ca2+ channel current due to acidification caused by ATP hydrolysis	PLOS ONE			English	Article							ADRENERGIC-RECEPTOR STIMULATION; HUMAN ATRIAL-FIBRILLATION; RAT VENTRICULAR MYOCYTES; CALCIUM CURRENT; INTRACELLULAR MAGNESIUM; DOWN-REGULATION; ISCHEMIA; MITOCHONDRIA; ACIDOSIS; HEART	Metabolic stress evoked by myocardial ischemia leads to impairment of cardiac excitation and contractility. We studied the mechanisms by which metabolic inhibition affects the activity of L-type Ca2+ channels (LTCCs) in frog ventricular myocytes. Metabolic inhibition induced by the protonophore FCCP (as well as by 2,4-dinitrophenol, sodium azide or antimycin A) resulted in a dose-dependent reduction of LTCC current (I-Ca,L) which was more pronounced during beta-adrenergic stimulation with isoprenaline. ICa, L was still reduced by metabolic inhibition even in the presence of 3 mM intracellular ATP, or when the cell was dialysed with cAMP or ATP-gamma-S to induce irreversible thiophosphorylation of LTCCs, indicating that reduction in ICa, L is not due to ATP depletion and/or reduced phosphorylation of the channels. However, the effect of metabolic inhibition on ICa, L was strongly attenuated when the mitochondrial F1F0-ATP-synthase was blocked by oligomycin or when the cells were dialysed with the non-hydrolysable ATP analogue AMP-PCP. Moreover, increasing the intracellular pH buffering capacity or intracellular dialysis of the myocytes with an alkaline solution strongly attenuated the inhibitory effect of FCCP on ICa, L. Thus, our data demonstrate that metabolic inhibition leads to excessive ATP hydrolysis by the mitochondrial F(1)F(0)ATP-synthase operating in the reverse mode and this results in intracellular acidosis causing the suppression of ICa, L. Limiting ATP break-down by F1F0-ATP-synthase and the consecutive development of intracellular acidosis might thus represent a potential therapeutic approach for maintaining a normal cardiac function during ischemia.	[Kanaporis, Giedrius; Treinys, Rimantas; Jurevicius, Jonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Fischmeister, Rodolphe] Univ Paris Saclay, Univ Paris Sud, INSERM UMR S 1180, Chatenay Malabry, France	Lithuanian University of Health Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Jurevicius, J (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.; Fischmeister, R (corresponding author), Univ Paris Saclay, Univ Paris Sud, INSERM UMR S 1180, Chatenay Malabry, France.	rodolphe.fischmeister@inserm.fr; jonas.jurevicius@lsmuni.lt	Fischmeister, Rodolphe/L-6061-2018	Fischmeister, Rodolphe/0000-0003-2086-9865; Treinys, Rimantas/0000-0002-7590-7606	Research Council of Lithuania [MIP-058/2015]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research is funded by a grant (No. MIP-058/2015) from the Research Council of Lithuania. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauloye C, 2001, CIRC RES, V88, P513, DOI 10.1161/01.RES.88.5.513; Bito Virginie, 2005, Exp Clin Cardiol, V10, P142; Chantawansri C, 2008, BIOPHYS J, V94, P1656, DOI 10.1529/biophysj.107.114892; Chen FH, 2007, AM J PHYSIOL-HEART C, V293, pH2472, DOI 10.1152/ajpheart.00359.2007; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Cheng HW, 2009, J MOL CELL CARDIOL, V46, P75, DOI 10.1016/j.yjmcc.2008.09.709; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; Di Diego JM, 2011, HEART RHYTHM, V8, P1963, DOI 10.1016/j.hrthm.2011.06.036; Fearon IM, 1997, J PHYSIOL-LONDON, V500, P551, DOI 10.1113/jphysiol.1997.sp022041; Florea SM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00141; Fukumoto GH, 2005, CIRC RES, V96, P551, DOI 10.1161/01.RES.0000159388.61313.47; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; GOLDHABER JI, 1991, J PHYSIOL-LONDON, V443, P371, DOI 10.1113/jphysiol.1991.sp018838; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; Grover GJ, 2008, CARDIOVASC THER, V26, P287, DOI 10.1111/j.1755-5922.2008.00065.x; Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818; Hanninen SL, 2010, CARDIOVASC RES, V88, P75, DOI 10.1093/cvr/cvq180; Hersel Joachim, 2002, Basic Research in Cardiology, V97; Hool LC, 2002, CIRC RES, V91, P601, DOI 10.1161/01.RES.0000035528.00678.D5; Hool LC, 2000, CIRC RES, V87, P1164, DOI 10.1161/01.RES.87.12.1164; Kim JC, 2013, BIOCHEM BIOPH RES CO, V431, P239, DOI 10.1016/j.bbrc.2012.12.126; Komukai K, 2002, AM J PHYSIOL-HEART C, V283, pH412, DOI 10.1152/ajpheart.01042.2001; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Lai LP, 1999, J AM COLL CARDIOL, V33, P1231, DOI 10.1016/S0735-1097(99)00008-X; Lancaster MK, 1998, EXP PHYSL, V83; Lascano EC, 2013, J MOL CELL CARDIOL, V60, P172, DOI 10.1016/j.yjmcc.2013.04.018; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Losito VA, 1998, J PHYSIOL-LONDON, V511, P67, DOI 10.1111/j.1469-7793.1998.067bi.x; Louch WE, 2002, AM J PHYSIOL-HEART C, V283, pH800, DOI 10.1152/ajpheart.00020.2002; Mattiazzi A, 2015, J MOL CELL CARDIOL, V79, P69, DOI 10.1016/j.yjmcc.2014.10.011; McHugh D, 1997, J PHYSIOL-LONDON, V500, P311, DOI 10.1113/jphysiol.1997.sp022022; MOCHIZUKI T, 1993, CIRC RES, V73, P550, DOI 10.1161/01.RES.73.3.550; Nguemo F, 2014, STEM CELLS DEV, V23, P1316, DOI 10.1089/scd.2013.0549; O'Neill SC, 2003, J PHYSIOL-LONDON, V550, P413, DOI 10.1113/jphysiol.2003.042846; ONO K, 1992, J PHYSIOL-LONDON, V454, P673, DOI 10.1113/jphysiol.1992.sp019286; Overend CL, 2001, CIRC RES, V88, P181; Rosa AO, 2012, J PHYSIOL-LONDON, V590, P4223, DOI 10.1113/jphysiol.2012.236570; ROUSLIN W, 1990, AM J PHYSIOL, V259, pH1759, DOI 10.1152/ajpheart.1990.259.6.H1759; ROZANSKI GJ, 1995, J MOL CELL CARDIOL, V27, P1781, DOI 10.1016/0022-2828(95)90001-2; Saegusa N, 2011, J GEN PHYSIOL, V138, P537, DOI 10.1085/jgp.201110658; Salameh A, 2002, PHARMACOL RES, V45, P35, DOI 10.1006/phrs.2001.0908; SATOH H, 1995, AM J PHYSIOL-HEART C, V268, pH1239, DOI 10.1152/ajpheart.1995.268.3.H1239; Smith RM, 2013, AM J PHYSIOL-HEART C, V305, pH9, DOI 10.1152/ajpheart.00915.2012; St-Pierre J, 2000, P NATL ACAD SCI USA, V97, P8670, DOI 10.1073/pnas.140093597; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Tanh TL, 1998, EUR J PHARMACOL, V360, P205, DOI 10.1016/S0014-2999(98)00657-8; Tice BM, 2007, EUROPACE, V9, P46, DOI 10.1093/europace/eum204; Tijskens P, 2003, BIOPHYS J, V84, P1079, DOI 10.1016/S0006-3495(03)74924-8; Treinys R, 2016, J PHYSIOL SCI, V66, P327, DOI 10.1007/s12576-015-0430-3; Vinogradov AD, 2000, J EXP BIOL, V203, P41; Walters AM, 2012, CIRC RES, V111, P1222, DOI 10.1161/CIRCRESAHA.112.265660; Wang M, 2004, J PHYSIOL-LONDON, V555, P383, DOI 10.1113/jphysiol.2003.048538; Westermann B, 2015, CURR OPIN CELL BIOL, V35, P1, DOI 10.1016/j.ceb.2015.03.001; WHITE RE, 1988, SCIENCE, V239, P778, DOI 10.1126/science.2448878; Yazawa K, 1997, PFLUG ARCH EUR J PHY, V433, P557, DOI 10.1007/s004240050314; Zhang HL, 2013, J MOL CELL CARDIOL, V65, P51, DOI 10.1016/j.yjmcc.2013.09.002; Zima AV, 2013, AM J PHYSIOL-HEART C, V304, pH983, DOI 10.1152/ajpheart.00932.2012	58	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184246	10.1371/journal.pone.0184246	http://dx.doi.org/10.1371/journal.pone.0184246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859158	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500078
J	van Voss, MRH; Vesuna, F; Bol, GM; Afzal, J; Tantravedi, S; Bergman, Y; Kammers, K; Lehar, M; Malek, R; Ballew, M; ter Hoeve, N; Abou, D; Thorek, D; Berlinicke, C; Yazdankhah, M; Sinha, D; Le, A; Abrahams, R; Tran, PT; van Diest, PJ; Raman, V				van Voss, M. R. Heerma; Vesuna, F.; Bol, G. M.; Afzal, J.; Tantravedi, S.; Bergman, Y.; Kammers, K.; Lehar, M.; Malek, R.; Ballew, M.; ter Hoeve, N.; Abou, D.; Thorek, D.; Berlinicke, C.; Yazdankhah, M.; Sinha, D.; Le, A.; Abrahams, R.; Tran, P. T.; van Diest, P. J.; Raman, V.			Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment	ONCOGENE			English	Article							RNA HELICASE DDX3; BREAST-CANCER; COMPLEX-I; THERAPEUTIC TARGET; TUMOR-SUPPRESSOR; RESISTANCE; PROTEIN; CELLS; METABOLISM; APOPTOSIS	DDX3 is a DEAD box RNA helicase with oncogenic properties. RK-33 is developed as a small-molecule inhibitor of DDX3 and showed potent radiosensitizing activity in preclinical tumor models. This study aimed to assess DDX3 as a target in breast cancer and to elucidate how RK-33 exerts its anti-neoplastic effects. High DDX3 expression was present in 35% of breast cancer patient samples and correlated with markers of aggressiveness and shorter survival. With a quantitative proteomics approach, we identified proteins involved in the mitochondrial translation and respiratory electron transport pathways to be significantly downregulated after RK-33 or DDX3 knockdown. DDX3 localized to the mitochondria and DDX3 inhibition with RK-33 reduced mitochondrial translation. As a consequence, oxygen consumption rates and intracellular ATP concentrations decreased and reactive oxygen species (ROS) increased. RK-33 antagonized the increase in oxygen consumption and ATP production observed after exposure to ionizing radiation and reduced DNA repair. Overall, we conclude that DDX3 inhibition with RK-33 causes radiosensitization in breast cancer through inhibition of mitochondrial translation, which results in reduced oxidative phosphorylation capacity and increased ROS levels, culminating in a bioenergetic catastrophe.	[van Voss, M. R. Heerma; Vesuna, F.; Bol, G. M.; Tantravedi, S.; Bergman, Y.; Abou, D.; Thorek, D.; Raman, V.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [van Voss, M. R. Heerma; Bol, G. M.; ter Hoeve, N.; van Diest, P. J.; Raman, V.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Afzal, J.; Abrahams, R.] Johns Hopkins Univ, Dept Cardiol, Sch Med, Baltimore, MD USA; [Kammers, K.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lehar, M.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Baltimore, MD 21205 USA; [Malek, R.; Ballew, M.; Tran, P. T.] Johns Hopkins Univ, Dept Radiat Oncol, Sch Med, Baltimore, MD USA; [Berlinicke, C.; Yazdankhah, M.; Sinha, D.] Johns Hopkins Univ, Wilmer Eye Inst, Sch Med, Baltimore, MD 21218 USA; [Le, A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Le, A.; Tran, P. T.; van Diest, P. J.; Raman, V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Tran, P. T.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Raman, V (corresponding author), Johns Hopkins Univ, Dept Radiol, Sch Med, 720 Rutland Ave,Traylor 340, Baltimore, MD 21205 USA.	vraman2@jhmi.edu	Vesuna, Farhad/G-3179-2010; Tran, Phuoc/W-2084-2019; Afzal, Junaid/L-3643-2019; Heerma van Voss, Marise/N-5637-2016	Vesuna, Farhad/0000-0002-0356-5096; Tran, Phuoc/0000-0002-0147-0376; Le, Anne/0000-0002-2958-8149; Afzal, Junaid/0000-0002-2877-234X; Heerma van Voss, Marise/0000-0001-8368-9859	Utrecht University Alexandre Suerman Stipend (MRHvV); Dutch Cancer Foundation [UU2013-5851]; NIH [R01CA166348, R01CA193895, R01CA140226, R01CA131250]; FAMRI; Safeway; NATIONAL CANCER INSTITUTE [R01CA166348, R01CA131250, R01CA193895, R01CA140226] Funding Source: NIH RePORTER	Utrecht University Alexandre Suerman Stipend (MRHvV); Dutch Cancer Foundation(KWF Kankerbestrijding); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; Safeway; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bob Cole, Tatiana Boronina and Bob O' Meally of the Johns Hopkins Mass Spectrometry and Proteomics core facility for their help with the proteomics experiments; Tri Nguyen for his help with interpretation of the electron microscopy images; the Dawson Laboratory at the Johns Hopkins School of Medicine for their help with the mitochondrial translation assay; and Beth Rodgers, who kindly provided us with S<SUP>35</SUP>-methionine. This work was financially supported by Utrecht University Alexandre Suerman Stipend (MRHvV), the Dutch Cancer Foundation (UU2013-5851; MRHvV), NIH (R01CA166348 to PTT, R01CA193895 to AL, and R01CA140226 and R01CA131250 to VR), FAMRI (VR) and Safeway (VR).	Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; [Anonymous], 1998, MED RES INV HUM SUBJ; Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Bol GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063548; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chen CY, 2016, HUM MOL GENET, V25, P2905, DOI 10.1093/hmg/ddw143; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen HH, 2015, ONCOGENE, V34, P2790, DOI 10.1038/onc.2014.190; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Eiermann W, 2012, ANN ONCOL, V23, P30, DOI 10.1093/annonc/mds192; Farnie G, 2015, ONCOTARGET, V6, P30472, DOI 10.18632/oncotarget.5401; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fukumura J, 2003, J BIOCHEM, V134, P71, DOI 10.1093/jb/mvg126; Geissler R, 2012, NUCLEIC ACIDS RES, V40, P4998, DOI 10.1093/nar/gks070; Hagerstrand D, 2013, CANCER DISCOV, V3, P1044, DOI 10.1158/2159-8290.CD-12-0592; Huang Z, 2016, INT J CANCER, V139, P23, DOI 10.1002/ijc.29990; Jones RA, 2016, J CLIN INVEST, V126, P3739, DOI 10.1172/JCI81568; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Kondaskar A, 2011, ACS MED CHEM LETT, V2, P252, DOI 10.1021/ml100281b; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Leary SC, 2009, METHODS MOL BIOL, V554, P143, DOI 10.1007/978-1-59745-521-3_10; LeBleu VS, 2014, NAT CELL BIOL, P1001, DOI DOI 10.1038/NCB3039; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Lu CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121046; Matassa DS, 2016, CELL DEATH DIFFER, V23, P1542, DOI 10.1038/cdd.2016.39; Moelans CB, 2009, CELL ONCOL, V31, P1, DOI 10.3233/CLO-2009-0461; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Padmanabhan PK, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.315; Pelicano H, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0434-6; Qin B, 2015, CELL REP, V10, P1324, DOI 10.1016/j.celrep.2015.01.066; Qin LL, 2015, CELL REP, V13, P2056, DOI 10.1016/j.celrep.2015.11.015; Rasband W. S, 2015, IMAGEJ; Sansone P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10442; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Sun MN, 2011, BBA-MOL CELL RES, V1813, P438, DOI 10.1016/j.bbamcr.2011.01.003; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; van Voss MRH, 2015, ONCOTARGET, V6, P28312, DOI 10.18632/oncotarget.4873; Vellinga TT, 2015, CLIN CANCER RES, V21, P2870, DOI 10.1158/1078-0432.CCR-14-2290; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491; WARDMAN P, 1982, INT J RADIAT ONCOL, V8, P399, DOI 10.1016/0360-3016(82)90647-2; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wilky BA, 2016, ONCOGENE, V35, P2574, DOI 10.1038/onc.2015.336; Xie Min, 2016, Cancer Res, V76, P6340; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zhang X, 2012, J RADIAT RES, V53, P257, DOI 10.1269/jrr.11124	63	39	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					63	74		10.1038/onc.2017.308	http://dx.doi.org/10.1038/onc.2017.308			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28869602	Green Accepted			2022-12-26	WOS:000422625000007
J	Rupp, M; Hagenbuchner, J; Rass, B; Fiegl, H; Kiechl-Kohlendorfer, U; Obexer, P; Ausserlechner, MJ				Rupp, M.; Hagenbuchner, J.; Rass, B.; Fiegl, H.; Kiechl-Kohlendorfer, U.; Obexer, P.; Ausserlechner, M. J.			FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3	ONCOGENE			English	Article							FOXO TRANSCRIPTION FACTORS; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; CELLS; AKT; ACTIVATION; MUTATIONS; APOPTOSIS; CANCER; BIM	Forkhead box O class transcription factors are homeostasis regulators that control cell death, longevity and therapy-resistance. In neuroblastoma (NB), nuclear FOXO3 correlates with stage M disease and poor prognosis. To analyze whether FOXO3 contributes to drug-resistance in this childhood cancer, we investigated how different high-stage-derived NB cells respond to the activation of an ectopic FOXO3 allele. We found endogenous FOXO3 mostly localized to the nucleus-upon activation of an ectopic, 4OHTactivated FOXO3(A3) ER fusion protein two of the cell lines underwent apoptosis, whereas in the others FOXO3-activation even increased survival during drug-treatment. In the latter cell type, FOXO3 did not induce the BH3-only protein BCL2L11/BIM due to impaired binding of FOXO3 to the BIM-promoter, but still activated other FOXO3 targets. It was shown before that FOXO3 and TP53 physically interact with each other at two different regions-the TP53-N-terminus binds to the FOXO3-DNA binding domain (DBD) and the FOXO3-C-terminus interacts with the TP53-DBD. Interestingly, cell lines that undergo FOXO3-induced cell death carry homozygous point mutations in the TP53-DBD near the structural hotspot-mutation-site R175H, which abrogated FOXO3-TP53 interaction. In contrast, in FOXO3-death-resistant cells no point mutations in the TP53-DBD were found-in these cells FOXO3-TP53 complexes are formed and FOXO3-binding to the BIM-promoter, but not the induction of the detoxifying protein SESN3, were prevented, which in turn increased chemo-protection in this type of high-stage-derived NB cells. Our combined data suggest that FOXO3 steps in as a death inducer in case of TP53-mutation, whereas functional TP53 alters FOXO3-target-promoter-recognition, which prevents death induction by FOXO3 and instead increases chemo-protection and survival of NB cells. This novel mechanism may explain the low incidence of TP53 mutation in high-stage NB at diagnosis and suggests FOXO3 as a therapeutic target for this childhood malignancy.	[Rupp, M.; Hagenbuchner, J.; Kiechl-Kohlendorfer, U.; Obexer, P.] Med Univ Innsbruck, Dept Pediat 2, A-6020 Innsbruck, Austria; [Rupp, M.; Rass, B.; Ausserlechner, M. J.] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria; [Rupp, M.; Obexer, P.] Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria; [Fiegl, H.] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Hagenbuchner, J; Obexer, P (corresponding author), Med Univ Innsbruck, Dept Pediat 2, A-6020 Innsbruck, Austria.; Ausserlechner, MJ (corresponding author), Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria.; Obexer, P (corresponding author), Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria.	judith.hagenbuchner@i-med.ac.at; petra.obexer@i-med.ac.at; michael.j.ausserlechner@i-med.ac.at	Zeimet, Alain/AFK-2441-2022; Zeimet, Alain/AAF-9688-2022; Fiegl, Heidi/K-4445-2017	Hagenbuchner, Judith/0000-0003-1396-3407; Ausserlechner, Michael/0000-0002-1015-2302; Fiegl, Heidi/0000-0002-1236-6806	intramural funding program of the Medical University Innsbruck for young scientists MUI-START [P2012032014]; Kinderkrebshilfe fur Tirol und Vorarlberg; Sudtiroler Krebshilfe; Kinderkrebshilfe Sudtirol-Regenbogen; Austrian Wirtschaftsservice [PRIZE P1308459]; Provita Kinderleukamiestiftung; MFF-Tirol [246]; Krebshilfe Tirol [16004]; Austrian Science Fund (FWF) [I 3089 - B28]; Tirol-Kliniken GmbH	intramural funding program of the Medical University Innsbruck for young scientists MUI-START; Kinderkrebshilfe fur Tirol und Vorarlberg; Sudtiroler Krebshilfe; Kinderkrebshilfe Sudtirol-Regenbogen; Austrian Wirtschaftsservice; Provita Kinderleukamiestiftung; MFF-Tirol; Krebshilfe Tirol; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Tirol-Kliniken GmbH	We thank Drs Peter Ambros, Todd Waldmann and Andreas Villunger for providing NB cell lines and plasmids. This work was supported by the intramural funding program of the Medical University Innsbruck for young scientists MUI-START (P2012032014), by grants from the 'Kinderkrebshilfe fur Tirol und Vorarlberg', 'Sudtiroler Krebshilfe', 'Kinderkrebshilfe Sudtirol-Regenbogen', the Austrian Wirtschaftsservice (PRIZE P1308459), the 'Provita Kinderleukamiestiftung', the MFF-Tirol (Project Nr. 246), the 'Krebshilfe Tirol (Nr 16004)' the Austrian Science Fund (FWF) (I 3089 - B28) and the 'Tirol-Kliniken GmbH'.	Arden KC, 2002, ARCH BIOCHEM BIOPHYS, V403, P292, DOI 10.1016/S0003-9861(02)00207-2; Ausserlechner MJ, 2012, NEUROBLASTOMA PRESEN, P325; Blagosklonny MV, 1997, ONCOGENE, V15, P1889, DOI 10.1038/sj.onc.1201374; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; de Brachene AC, 2016, CELL MOL LIFE SCI, V73, P1159, DOI 10.1007/s00018-015-2112-y; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; Gaviraghi M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-56; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gomes AR, 2008, CELL CYCLE, V7, P3133, DOI 10.4161/cc.7.20.6920; Grignani F, 1998, CANCER RES, V58, P14; Hagenbuchner J, 2016, ONCOGENE, V35, P2052, DOI 10.1038/onc.2015.264; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; Hagenbuchner J, 2017, ONCOTARGET, V8, P32009, DOI 10.18632/oncotarget.16434; Hagenbuchner Judith, 2016, Oncotarget, V7, P77591, DOI 10.18632/oncotarget.12728; Hagenbuchner J, 2013, ONCOTARGET, V4, P1241, DOI 10.18632/oncotarget.1147; Hagenbuchner J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00147; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Keniry M, 2013, GENE DEV, V27, P916, DOI 10.1101/gad.214049.113; Keshelava N, 2001, CANCER RES, V61, P6185; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Krytska K, 2016, CLIN CANCER RES, V22, P948, DOI 10.1158/1078-0432.CCR-15-0379; Lin Hung-Yu, 2008, Int J Biomed Sci, V4, P248; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyaguchi Y, 2009, CELL BIOL INT, V33, P853, DOI 10.1016/j.cellbi.2009.04.017; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Obexer P, 2009, MOL BIOL CELL, V20, P2041, DOI 10.1091/mbc.E08-07-0699; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; Tweddle DA, 2001, CANCER RES, V61, P8; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang F, 2008, J MOL BIOL, V384, P590, DOI 10.1016/j.jmb.2008.09.025; Wilson MSC, 2011, CURR DRUG TARGETS, V12, P1256; Xie X, 2016, ONCOGENE, V35, P4798, DOI 10.1038/onc.2016.12; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	56	21	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6190	6203		10.1038/onc.2017.288	http://dx.doi.org/10.1038/onc.2017.288			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28869600	hybrid, Green Published			2022-12-26	WOS:000414249800012
J	Kenniston, JA; Taylor, BM; Conley, GP; Cosic, J; Kopacz, KJ; Lindberg, AP; Comeau, SR; Atkins, K; Bullen, J; TenHoor, C; Adelman, BA; Sexton, DJ; Edwards, TE; Nixon, AE				Kenniston, Jon A.; Taylor, Brandy M.; Conley, Gregory P.; Cosic, Janja; Kopacz, Kris J.; Lindberg, Allison P.; Comeau, Stephen R.; Atkins, Kateri; Bullen, Jameson; TenHoor, Christopher; Adelman, Burt A.; Sexton, Daniel J.; Edwards, Thomas E.; Nixon, Andrew E.			Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAVENOUS IMMUNOGLOBULIN; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; HUMAN IGG1; ANTIINFLAMMATORY ACTIVITY; GLOBULIN THERAPY; AUTOIMMUNE; IMMUNE; COMPLEX; BINDING	The neonatal Fc receptor FcRn plays a critical role in the trafficking of IgGs across tissue barriers and in retaining high circulating concentrations of both IgG and albumin. Although generally beneficial from an immunological perspective in maintaining IgG populations, FcRn can contribute to the pathogenesis of autoimmune disorders when an abnormal immune response targets normal biological components. We previously described a monoclonal antibody (DX-2507) that binds to FcRn with high affinity at both neutral and acidic pH, prevents the simultaneous binding of IgG, and reduces circulating IgG levels in preclinical animal models. Here, we report a 2.5 angstrom resolution X-ray crystal structure of an FcRn-DX-2507 Fab complex, revealing a nearly complete overlap of the IgG-Fc binding site in FcRn by complementarity-determining regions in DX-2507. This overlap explains how DX-2507 blocks IgG binding to FcRn and thereby shortens IgG half-life by preventing IgGs from recycling back into circulation. Moreover, the complex structure explains how the DX-2507 interaction is pH-insensitive unlike normal Fc interactions and how serum albumin levels are unaffected by DX-2507 binding. These structural studies could inform antibody-based therapeutic approaches for limiting the effects of IgG-mediated autoimmune disease.	[Kenniston, Jon A.; Kopacz, Kris J.; Sexton, Daniel J.] Shire, 300 Shire Way, Lexington, MA 02421 USA; [Taylor, Brandy M.; Atkins, Kateri; Bullen, Jameson; Edwards, Thomas E.] Beryllium Discovery Corp, Bainbridge Isl, WA 98110 USA; [Kenniston, Jon A.; Conley, Gregory P.; Cosic, Janja; Lindberg, Allison P.; Comeau, Stephen R.; TenHoor, Christopher; Adelman, Burt A.; Nixon, Andrew E.] Dyax Corp, Burlington, MA 01803 USA	Shire Pharmaceuticals Limited	Kenniston, JA (corresponding author), Shire, 300 Shire Way, Lexington, MA 02421 USA.	jkenniston0@shire.com		Nixon, Andrew/0000-0002-6090-0583; Edwards, Thomas/0000-0002-0474-8003	Shire Pharmaceuticals	Shire Pharmaceuticals	This investigation was supported by Dyax Corp., now a wholly owned subsidiary of Shire Pharmaceuticals. J. A. K., G. P. C., J. C., K. J. K., A. P. L., S. R. C., C. T., B. A. A., D. J. S., and A. E. N. were employees of Dyax at the time of the study. J. A. K. and D. J. S. are currently Shire employees.	Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayry J, 2007, NAT CLIN PRACT NEURO, V3, P120, DOI 10.1038/ncpneuro0429; Bleeker WK, 2001, BLOOD, V98, P3136, DOI 10.1182/blood.V98.10.3136; Castillo J, 2009, EXPERT OPIN INV DRUG, V18, P491, DOI [10.1517/13543780902832679, 10.1517/13543780902832679 ]; Challa DK, 2013, MABS-AUSTIN, V5, P655, DOI 10.4161/mabs.25439; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crow AR, 2011, BLOOD, V118, P6403, DOI 10.1182/blood-2011-08-374223; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkan D, 2014, AUTOIMMUN REV, V13, P685, DOI 10.1016/j.autrev.2014.01.053; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; Hansen RJ, 2002, BLOOD, V100, P2087, DOI 10.1182/blood.V100.6.2087.h81802002087_2087_2093; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Huda R, 2014, REV NEUROSCIENCE, V25, P575, DOI 10.1515/revneuro-2014-0021; IMBACH P, 1981, HELV PAEDIATR ACTA, V36, P81; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kessary-Shoham H, 1999, J AUTOIMMUN, V13, P129, DOI 10.1006/jaut.1999.0302; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Liu LM, 2007, J IMMUNOL, V178, P5390, DOI 10.4049/jimmunol.178.8.5390; Liu Z, 1997, J EXP MED, V186, P777, DOI 10.1084/jem.186.5.777; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; McPherson R. A., 2017, HENRYS CLIN DIAGNOSI, pe12; Mezo AR, 2008, P NATL ACAD SCI USA, V105, P2337, DOI 10.1073/pnas.0708960105; Mezo AR, 2010, J BIOL CHEM, V285, P27694, DOI 10.1074/jbc.M110.120667; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Neuber T, 2014, MABS-AUSTIN, V6, P928, DOI 10.4161/mabs.28744; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Nixon AE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00176; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Patel DA, 2011, J IMMUNOL, V187, P1015, DOI 10.4049/jimmunol.1003780; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Roopenian DC, 2016, METHODS MOL BIOL, V1438, P103, DOI 10.1007/978-1-4939-3661-8_6; Sand KMK, 2014, J BIOL CHEM, V289, P17228, DOI 10.1074/jbc.M113.522565; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Sesarman A, 2010, CELL MOL LIFE SCI, V67, P2533, DOI 10.1007/s00018-010-0318-6; Sexton DJ, 2009, BIOCHEM J, V422, P383, DOI 10.1042/BJ20090010; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Szczeklik W, 2013, ANAESTH INTENSIVE TH, V45, P7, DOI 10.5603/AIT.2013.0002; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	55	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17449	17460		10.1074/jbc.M117.807396	http://dx.doi.org/10.1074/jbc.M117.807396			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28878017	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000414009300025
J	Liu, HQ; Zhang, CS; Fan, XX; Duan, YN; Xiao, TQ; Du, GH; Fu, YN; Liu, HG; Wen, H				Liu, Huiqiang; Zhang, Chuanshan; Fan, Xiaoxi; Duan, Yingni; Xiao, Tiqiao; Du, Guohao; Fu, Yanan; Liu, Haigang; Wen, Hao			Robust phase-retrieval-based X-ray tomography for morphological assessment of early hepatic echinococcosis infection in rats	PLOS ONE			English	Article							ALVEOLAR ECHINOCOCCOSIS; CONTRAST TOMOGRAPHY; ATTENUATION DUALITY; FRESNEL REGION; MICROTOMOGRAPHY; HOLOTOMOGRAPHY; OPTIMIZATION; ULTRASOUND; LIVER; IMAGE	Propagation-based phase-contrast computed micro-tomography (PPCT) dominates the non-destructive, three-dimensional inner-structure measurement in synchrotron-based biomedical research due to its simple experimental setup. To quantitatively visualize tiny density variations in soft tissues and organs closely related to early pathological morphology, an experimental study of synchrotron-based X-ray PPCT combined with generalized phase and attenuation duality (PAD) phase retrieval was implemented with the hepatic echinococcosis (HE) infection rat model at different stages. We quantitatively analyzed and evaluated the different pathological characterizations of hepatic echinococcosis during the development of this disease via our PAD-based PPCT and especially provided evidence that hepatic alveolar echinococcosis invades the liver tissue and spreads through blood flow systems with abundant blood supply in the early stage. Additionally, the infiltration of tiny vesicles in HE lesions can be clearly observed by our PAD-PPCT technique due to the striking contrast-to-noise ratio (CNR) and mass density resolution, which cannot be found by the medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, in hospitals. The results demonstrated that our PAD-PPCT technique has a great potential for indicating the subtle structural information of pathological changes in soft biomedical specimens, especially helpful for the research of early micromorphology of diseases.	[Liu, Huiqiang; Fan, Xiaoxi; Duan, Yingni] Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi, Peoples R China; [Zhang, Chuanshan; Wen, Hao] Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China; [Xiao, Tiqiao; Du, Guohao; Fu, Yanan; Liu, Haigang] Chinese Acad Sci, Shanghai Inst Appl Phys, SSRF, Shanghai, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Liu, HQ (corresponding author), Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi, Peoples R China.; Wen, H (corresponding author), Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China.; Liu, HG (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, SSRF, Shanghai, Peoples R China.	hqliu@xjmu.edu.cn; liuhaiguang@sinap.ac.cn; dr.wenhao@163.com			National Natural Science Foundation of China [81660306]; Postdoctoral Science Foundation of Xinjiang Medical University; Technology Foundation for Selected Overseas Chinese Scholar	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of Xinjiang Medical University; Technology Foundation for Selected Overseas Chinese Scholar	This work was supported by the National Natural Science Foundation of China (Grant No. 81660306) to HQL, Postdoctoral Science Foundation of Xinjiang Medical University, and the Technology Foundation for Selected Overseas Chinese Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2015, ABDOM IMAGING, V40, P56, DOI 10.1007/s00261-014-0183-0; Bech M, 2010, Z MED PHYS, V20, P7, DOI 10.1016/j.zemedi.2009.11.003; Bresson-Hadni S, 2006, PARASITOL INT, V55, pS267, DOI 10.1016/j.parint.2005.11.053; Caoduro C, 2013, J NUCL MED, V54, P358, DOI 10.2967/jnumed.112.109942; Ceballos L, 2008, PARASITOL RES, V103, P355, DOI 10.1007/s00436-008-0980-x; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cloetens P, 2006, P NATL ACAD SCI USA, V103, P14626, DOI 10.1073/pnas.0603490103; Coskun A, 2004, ACTA RADIOL, V45, P492, DOI 10.1080/02841850410005912; Czermak BV, 2001, AM J ROENTGENOL, V176, P1207, DOI 10.2214/ajr.176.5.1761207; Donald PM, 2011, PARASITE VECTOR, V4, P196; Engelhardt M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743928; Groso A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207221; Groso A, 2006, OPT EXPRESS, V14, P8103, DOI 10.1364/OE.14.008103; Guigay JP, 2007, OPT LETT, V32, P1617, DOI 10.1364/OL.32.001617; Gureyev TE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226794; Gureyev TE, 2004, OPT COMMUN, V231, P53, DOI 10.1016/j.optcom.2003.12.020; Kern P, 2003, EMERG INFECT DIS, V9, P343, DOI 10.3201/eid0903.020341; Lang S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897225; Langer M, 2010, IEEE T IMAGE PROCESS, V19, P2428, DOI 10.1109/TIP.2010.2048608; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liu HQ, 2015, MED PHYS, V42, P5595, DOI 10.1118/1.4929551; Liu HQ, 2015, APPL OPTICS, V54, P5610, DOI 10.1364/AO.54.005610; Liu HQ, 2012, CHIN OPT LETT, V10, DOI 10.3788/COL201210.121101; Liu Y, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494001; Lovric G, 2014, OPT EXPRESS, V22, P2745, DOI 10.1364/OE.22.002745; Myers GR, 2007, J OPT SOC AM A, V24, P2516, DOI 10.1364/JOSAA.24.002516; Nesterets YI, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038107; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168101; Piscaglia F, 2010, ULTRASOUND MED BIOL, V36, P531, DOI 10.1016/j.ultrasmedbio.2010.01.004; Reuter S, 2008, NUKLEARMED-NUCL MED, V47, P147, DOI 10.3413/nukmed-0139; Revol V, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3465334; Satoshi T, 2007, APPL PHYS LETT, V90; Thuering T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3618672; Wu XZ, 2003, J X-RAY SCI TECHNOL, V11, P33; Wu XZ, 2009, OPT EXPRESS, V17, P11187, DOI 10.1364/OE.17.011187; Wu XZ, 2008, EUR J RADIOL, V68, pS8, DOI 10.1016/j.ejrad.2008.04.027; Wu XZ, 2005, OPT LETT, V30, P379, DOI 10.1364/OL.30.000379; Yang YR, 2007, TROP MED INT HEALTH, V12, P637, DOI 10.1111/j.1365-3156.2007.01834.x; Zanette I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4848595; Zeng HC, 2012, ULTRASOUND MED BIOL, V38, P1982, DOI 10.1016/j.ultrasmedbio.2012.07.007; Zhou T, 2014, P SOC PHOTO-OPT INS, V9033, P131	43	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183396	10.1371/journal.pone.0183396	http://dx.doi.org/10.1371/journal.pone.0183396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886025	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100020
J	Wang, Z; Chang, HH; Gao, YL; Zhang, R; Guo, YM; Holschneider, DP; Rodriguez, LV				Wang, Zhuo; Chang, Harriet H.; Gao, Yunliang; Zhang, Rong; Guo, Yumei; Holschneider, Daniel P.; Rodriguez, Larissa V.			Effects of water avoidance stress on peripheral and central responses during bladder filling in the rat: A multidisciplinary approach to the study of urologic chronic pelvic pain syndrome (MAPP) research network study	PLOS ONE			English	Article							CEREBRAL BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; RESTING-STATE; INTERSTITIAL CYSTITIS; URINARY-BLADDER; INDICATOR FRACTIONATION; SENSORIMOTOR CORTEX; BARRINGTONS NUCLEUS; OVERACTIVE BLADDER; REFLEX MICTURITION	Stress plays a role in the exacerbation and possibly the development of functional lower urinary tract disorders. Chronic water avoidance stress (WAS) in rodents is a model with high construct and face validity to bladder hypersensitive syndromes, such as interstitial cystitis/bladder pain syndrome (IC/BPS), characterized by urinary frequency and bladder hyperalgesia and heightened stress responsiveness. Given the overlap of the brain circuits involved in stress, anxiety, and micturition, we evaluated the effects chronic stress has on bladder function, as well as its effects on regional brain activation during bladder filling. Female Wistar-Kyoto rats were exposed to WAS (10 days) or sham paradigms. One day thereafter, cystometrograms were obtained during titrated bladder dilation, with visceromotor responses (VMR) recorded simultaneously. Cerebral perfusion was assessed during passive bladder distension (20-cmH(2)O) following intravenous administration of [C-14]-iodoantipyrine. Regional cerebral blood flow was quantified by autoradiography and analyzed in 3-dimensionally reconstructed brains with statistical parametric mapping. WAS animals compared to controls demonstrated a decreased pressure threshold and visceromotor threshold triggering the voiding phase. At 20-cmH(2)O, VMR was significantly greater in WAS animals compared to controls. WAS animals showed greater activation in cortical regions of the central micturition circuit, including the posterior cingulate, anterior retrosplenial, somatosensory, posterior insula, orbital, and anterior secondary ("supplementary") motor cortices, as well as in the thalamus, anterior hypothalamus, parabrachial and Barrington nuclei, and striatum. Seed analysis showed increased functional connectivity of WAS compared to control animals of the posterior cingulate cortex to the pontine parabrachial nucleus; of the Barrington nucleus to the anterior dorsal midline and ventrobasilar thalamus and somatosensory and retrosplenial cortices; and of the posterior insula to anterior secondary motor cortex. Our findings show a visceral hypersensitivity during bladder filling in WAS animals, as well as increased engagement of portions of the micturition circuit responsive to urgency, viscerosensory perception and its relay to motor regions coordinating imminent bladder contraction. Results are consistent with recent findings in patients with interstitial cystitis, suggesting that WAS may serve as an animal model to elucidate the mechanisms leading to viscerosensitive brain phenotypes in humans with IC/BPS.	[Wang, Zhuo; Guo, Yumei; Holschneider, Daniel P.] Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA; [Chang, Harriet H.; Gao, Yunliang; Zhang, Rong; Rodriguez, Larissa V.] Univ Southern Calif, Dept Urol, Los Angeles, CA USA; [Gao, Yunliang] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China	University of Southern California; University of Southern California; Central South University	Holschneider, DP (corresponding author), Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA.; Rodriguez, LV (corresponding author), Univ Southern Calif, Dept Urol, Los Angeles, CA USA.	lrodriguez@med.usc.edu; holschne@usc.edu		Wang, Zhuo/0000-0003-1531-8065; Holschneider, Daniel/0000-0002-4297-8280	MAPP Research Network grant from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) [U01 DK082370]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082370] Funding Source: NIH RePORTER	MAPP Research Network grant from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by a MAPP Research Network grant (U01 DK082370) from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH).	Ackerman AL, 2016, AM J PHYSIOL-RENAL, V310, pF628, DOI 10.1152/ajprenal.00297.2015; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Asavasopon S, 2014, J NEUROSCI, V34, P13811, DOI 10.1523/JNEUROSCI.2073-14.2014; Baek K, 2016, BRAIN STRUCT FUNCT, V221, P2801, DOI 10.1007/s00429-015-1073-0; Blok BFM, 1998, BRAIN, V121, P2033, DOI 10.1093/brain/121.11.2033; Brett M, 2002, NEUROIMAGE; Rodriguez MAB, 2013, J UROLOGY, V189, pS66, DOI 10.1016/j.juro.2012.11.019; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; CHEN SY, 1993, AM J PHYSIOL, V265, pF520, DOI 10.1152/ajprenal.1993.265.4.F520; Clemens JQ, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-57; Clemens JQ, 2005, J UROLOGY, V173, P98, DOI 10.1097/01.ju.0000146114.53828.82; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; de Groat WC, 2013, ACTA PHYSIOL, V207, P66, DOI 10.1111/apha.12014; de Groat William C, 2015, Handb Clin Neurol, V130, P61, DOI 10.1016/B978-0-444-63247-0.00005-5; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Deutsch G, 2016, J UROLOGY, V196, P902, DOI 10.1016/j.juro.2016.03.135; Duval ER, 2015, THER CLIN RISK MANAG, V11, P115, DOI 10.2147/TCRM.S48528; Friston K and the Methodology group at the Wellcome Dept. of Cognitive Neurology, 1999, STATISTICAL PARAMETR; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122, DOI 10.1152/ajplegacy.1973.224.1.122; Griffiths D, 2005, J UROLOGY, V174, P1862, DOI 10.1097/01.ju.0000177450.34451.97; Griffiths Derek, 2015, Handb Clin Neurol, V130, P121, DOI 10.1016/B978-0-444-63247-0.00007-9; Hampson JP, 2013, J PAIN, V14, P579, DOI 10.1016/j.jpain.2013.01.767; Herms AMRD, 2006, NEUROIMAGE, V29, P267, DOI 10.1016/j.neuroimage.2005.07.018; Holschneider DP, 2002, AM J PHYSIOL-HEART C, V283, pH1713, DOI 10.1152/ajpheart.00362.2002; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; Jung SC, 2004, NEUROREPORT, V15, P1405, DOI 10.1097/01.wnr.0000131008.36444.2d; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Kilpatrick LA, 2014, J UROLOGY, V192, P947, DOI 10.1016/j.juro.2014.03.093; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KRUSE MN, 1990, BRAIN RES, V532, P182, DOI 10.1016/0006-8993(90)91758-9; Kuhtz-Buschbeck JP, 2007, NEUROIMAGE, V35, P449, DOI 10.1016/j.neuroimage.2006.12.032; Kuhtz-Buschbeck JR, 2009, NEUROIMAGE, V47, P18, DOI 10.1016/j.neuroimage.2009.04.020; Kutch JJ, 2015, NEUROIMAGE-CLIN, V8, P493, DOI 10.1016/j.nicl.2015.05.013; Lai H, 2015, UROLOGY, V85, P1454, DOI 10.1016/j.urology.2015.03.007; Lee UJ, 2015, PHYSIOL BEHAV, V139, P541, DOI 10.1016/j.physbeh.2014.11.045; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Levinthal DJ, 2012, J NEUROSCI, V32, P6726, DOI 10.1523/JNEUROSCI.0406-12.2012; Lim JR, 2007, SCAND J UROL NEPHROL, V41, P403, DOI 10.1080/00365590701303702; LUMB BM, 1987, BRAIN RES, V435, P363, DOI 10.1016/0006-8993(87)91626-X; Lutgendorf SK, 2000, J UROLOGY, V164, P1265, DOI 10.1016/S0022-5347(05)67152-2; MACAULAY AJ, 1987, BRIT MED J, V294, P540, DOI 10.1136/bmj.294.6571.540; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; MALLORY BS, 1991, BRAIN RES, V546, P310, DOI 10.1016/0006-8993(91)91495-M; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; Martucci KT, 2015, PAIN, V156, P1755, DOI 10.1097/j.pain.0000000000000238; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; Mayer EA, 2015, PAIN, V156, pS50, DOI 10.1097/j.pain.0000000000000106; Melzack R., 2005, PAIN PRACT, V5, P85, DOI DOI 10.1111/J.1533-2500.2005.05203.X; Monconduit L, 1999, J NEUROSCI, V19, P9063, DOI 10.1523/JNEUROSCI.19-20-09063.1999; Nardos R, 2014, NEUROUROL URODYNAM, V33, P493, DOI 10.1002/nau.22458; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE FOR THE CARE A; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ness TJ, 2001, J UROLOGY, V165, P968, DOI 10.1016/S0022-5347(05)66586-X; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Nickel JC, 2010, J UROLOGY, V184, P1358, DOI 10.1016/j.juro.2010.06.005; Nickel JC, 2010, J UROLOGY, V183, P167, DOI 10.1016/j.juro.2009.08.133; Nickel JC, 2009, J UROLOGY, V182, P155, DOI 10.1016/j.juro.2009.02.122; Otake K, 1996, NEUROSCI LETT, V209, P97, DOI 10.1016/0304-3940(96)12609-4; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Paxinos G., 2007, THE RAT BRAIN IN STE; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Robbins MT, 2006, J PAIN, V7, P218, DOI 10.1016/j.jpain.2005.10.012; Rogers R, 2008, INT UROGYNECOL J, V19, P1551, DOI 10.1007/s00192-008-0688-6; Rothrock NE, 2001, UROLOGY, V57, P422, DOI 10.1016/S0090-4295(00)00988-2; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Sadler KE, 2016, J UROL; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Seseke S, 2006, NEUROIMAGE, V31, P1399, DOI 10.1016/j.neuroimage.2006.02.012; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; Smith AL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.06.041; Tadic SD, 2010, J UROLOGY, V183, P221, DOI 10.1016/j.juro.2009.08.155; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Valentino RJ, 1995, J COMP NEUROL, V363, P402, DOI 10.1002/cne.903630306; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Vertes RP, 2015, NEUROSCI BIOBEHAV R, V54, P89, DOI 10.1016/j.neubiorev.2015.01.014; Wang Z, 2009, PAIN, V145, P120, DOI 10.1016/j.pain.2009.05.025; Zeng JW, 2012, J UROLOGY, V188, P1027, DOI 10.1016/j.juro.2012.04.101; Zhang H, 2005, NEUROIMAGE, V24, P174, DOI 10.1016/j.neuroimage.2004.08.027	80	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182976	10.1371/journal.pone.0182976	http://dx.doi.org/10.1371/journal.pone.0182976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886046	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100014
J	Cheng, BX; Morales, LD; Zhang, YH; Mito, S; Tsin, A				Cheng, Benxu; Morales, Liza Doreen; Zhang, Yonghong; Mito, Shizue; Tsin, Andrew			Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line	PLOS ONE			English	Article							PROTEASOME SYSTEM; ER STRESS; APOPTOSIS; STAT3; PROLIFERATION; GROWTH; CANCER; AUTOPHAGY; TEMOZOLOMIDE; SUPPRESSION	Glioblastoma is the most common and lethal malignant primary brain tumor for which the development of efficacious chemotherapeutic agents remains an urgent need. The anti-helminthic drug niclosamide, which has long been in use to treat tapeworm infections, has recently attracted renewed interest due to its apparent anticancer effects in a variety of in vitro and in vivo cancer models. However, the mechanism(s) of action remains to be elucidated. In the present study, we found that niclosamide induced cell toxicity in human glioblastoma cells corresponding with increased protein ubiquitination, ER stress and autophagy. In addition, niclosamide treatment led to down-regulation of Wnt/beta-catenin, PI3K/AKT, MAPK/ERK, and STAT3 pro-survival signal transduction pathways to further reduce U-87 MG cell viability. Taken together, these results provide new insights into the glioblastoma suppressive capabilities of niclosamide, showing that niclosamide can target multiple major cell signaling pathways simultaneously to effectively promote cell death in U-87 MG cells. Niclosamide constitutes a new prospect for a therapeutic treatment against human glioblastoma.	[Cheng, Benxu; Tsin, Andrew] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Edinburg, TX 78539 USA; [Morales, Liza Doreen] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Edinburg, TX USA; [Zhang, Yonghong; Mito, Shizue] Univ Texas Rio Grande Valley, Dept Chem, Edinburg, TX USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley	Cheng, BX (corresponding author), Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Edinburg, TX 78539 USA.	benxu.cheng@utrgv.edu		Morales, Liza/0000-0003-1056-9121	Innovative Research and Development Program (Texas State)	Innovative Research and Development Program (Texas State)	This work was supported by funds from Innovative Research and Development Program (Texas State).	Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Blood DC, SAUNDERS COMPREHENSI, V3; CALUMPANG SMF, 1995, B ENVIRON CONTAM TOX, V55, P494, DOI 10.1007/BF00196027; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146931; Czyz O, 2013, J BIOL CHEM, V288, P8419, DOI 10.1074/jbc.M112.425744; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Frayha GJ, 1997, GEN PHARMACOL-VASC S, V28, P273, DOI 10.1016/S0306-3623(96)00149-8; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014410; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Haygood CLW, 2015, INT J GYNECOL CANCER, V25, P1377, DOI 10.1097/IGC.0000000000000506; Helfman DM, 2011, J NATL CANCER I, V103, P991, DOI 10.1093/jnci/djr221; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Joshi AI, 2014, GYNECOL ONCOL, V134, P112; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Kohsaka S, 2012, MOL CANCER THER, V11, P1289, DOI 10.1158/1535-7163.MCT-11-0801; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Lee Y, 2016, LAB INVEST, V96, P137, DOI 10.1038/labinvest.2015.140; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074670; Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003; Li ZH, 2015, ONCOL REP, V33, P1763, DOI 10.3892/or.2015.3766; Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290; Luwor RB, 2013, J CLIN NEUROSCI, V20, P907, DOI 10.1016/j.jocn.2013.03.006; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mercer RW, 2009, BIODRUGS, V23, P25, DOI 10.2165/00063030-200923010-00003; Mukthavaram R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0627-5; Munafo DB, 2001, J CELL SCI, V114, P3619; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Park SJ, 2011, BMB REP, V44, P517, DOI 10.5483/BMBRep.2011.44.8.517; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Roy S, 2015, SOUTH ASIAN J CANCER, V4, P163, DOI 10.4103/2278-330X.175953; Sathornsumetee S, 2011, ANTI-CANCER AGENT ME, V11, P700, DOI 10.2174/187152011797378661; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Solinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076918; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wieland A, 2013, CLIN CANCER RES, V19, P4124, DOI 10.1158/1078-0432.CCR-12-2895; Xiang D, 2015, BIOCHEM BIOPH RES CO, V464, P221, DOI 10.1016/j.bbrc.2015.06.120; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887; Yo YT, 2012, MOL CANCER THER, V11, P1703, DOI 10.1158/1535-7163.MCT-12-0002; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	62	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184324	10.1371/journal.pone.0184324	http://dx.doi.org/10.1371/journal.pone.0184324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877265	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200088
J	Fatsini, E; Rey, S; Ibarra-Zatarain, Z; Mackenzie, S; Duncan, NJ				Fatsini, Elvira; Rey, Sonia; Ibarra-Zatarain, Zohar; Mackenzie, Simon; Duncan, Neil J.			Dominance behaviour in a non-aggressive flatfish, Senegalese sole (Solea senegalensis) and brain mRNA abundance of selected transcripts	PLOS ONE			English	Article							JUVENILE CONVICT CICHLIDS; SALMON SALMO-SALAR; AGGRESSIVE-BEHAVIOR; SOCIAL PLASTICITY; ZEBRAFISH BRAIN; RAINBOW-TROUT; COPING STYLES; PREFERENCE; STRESS; FISH	Dominance is defined as the preferential access to limited resources. The present study aimed to characterise dominance in a non-aggressive flatfish species, the Senegalese sole (Solea senegalensis) by 1) identifying dominance categories and associated behaviours and 2) linking dominance categories (dominant and subordinate) with the abundance of selected mRNA transcripts in the brain. Early juveniles (n = 74, 37 pairs) were subjected to a dyadic dominance test, related to feeding, and once behavioural phenotypes had been described the abundance of ten selected mRNAs related to dominance and aggressiveness was measured in the brain. Late juveniles were subjected to two dyadic dominance tests (n = 34, 17 pairs), related to feeding and territoriality and one group test (n = 24, 4 groups of 6 fish). Sole feeding first were categorized as dominant and sole feeding second or not feeding as subordinate. Three social behaviours (i. "Resting the head" on another fish, ii. "Approaching" another fish, iii. "Swimming above another" fish) were associated with dominance of feeding. Two other variables (i. Total time occupying the preferred area during the last 2 hours of the 24 h test, ii. Organisms occupying the preferred area when the test ended) were representative of dominance in the place preference test. In all tests, dominant fish compared to subordinate fish displayed a significantly higher number of the behaviours "Rest the head" and "Approaches". Moreover, dominant sole dominated the sand at the end of the test, and in the group test dominated the area close to the feed delivery point before feed was delivered. The mRNA abundance of the selected mRNAs related to neurogenesis (nrd2) and neuroplasticity (c-fos) in dominant sole compared to subordinate were significantly different. This is the first study to characterise dominance categories with associated behaviours and mRNA abundance in Senegalese sole and provides tools to study dominance related problems in feeding and reproduction in aquaculture.	[Fatsini, Elvira; Ibarra-Zatarain, Zohar; Duncan, Neil J.] IRTA, Tarragona, Spain; [Rey, Sonia; Mackenzie, Simon] Univ Stirling, Inst Aquaculture, Pathfoot Bldg, Stirling, Scotland; [Ibarra-Zatarain, Zohar] CONACYT UAN CENIT, Calle 3 S-N, Ciudad Ind, Tepic, Mexico	IRTA; University of Stirling	Duncan, NJ (corresponding author), IRTA, Tarragona, Spain.	Neil.duncan@irta.cat	Ibarra-Zatarain, Zohar/G-7431-2019; Fatsini, Elvira/AAK-5802-2020; Duncan, Neil/B-8906-2013; MacKenzie, Simon/Q-2362-2019; Planellas, Sonia Rey/AAG-7820-2021	Fatsini, Elvira/0000-0003-0371-5290; Duncan, Neil/0000-0001-5456-9217; MacKenzie, Simon/0000-0003-1845-6826; Planellas, Sonia Rey/0000-0002-3406-3291	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentacion (INIA) INIA-FEDER Projects [RTA2011-00050, RTA2014-00048]	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentacion (INIA) INIA-FEDER Projects	This work was supported by Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentacion (INIA) INIA-FEDER Projects RTA2011-00050 and RTA2014-00048 coordinated by Dr. Neil J. Duncan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Amorim MCP, 2003, J FISH BIOL, V62, P658, DOI 10.1046/j.1095-8649.2003.00054.x; Andersson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049247; [Anonymous], 2007, BRAIN BEHAV EVOLUT, V70, P215; APROMAR, 2016, AC MAR PEC AS; Barkow G., 1992, MAR BEHAV PHYSL, V22, P157; Berton O, 1999, NEUROSCIENCE, V92, P327, DOI 10.1016/S0306-4522(98)00742-8; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Campbell NA, 1996, BIOLOGY; Carazo I, 2013, PHYSIOL BEHAV, V118, P201, DOI 10.1016/j.physbeh.2013.05.032; Carazo I, 2013, THESIS; Carazo I, INDIAN J SCI TECHNOL; Carazo I, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016144-9108; Cardoso SD, 2015, J EXP BIOL, V218, P140, DOI 10.1242/jeb.106997; Cheney DL, 1991, MONKEYS SEE WORLD; Clement TS, 2005, HORM BEHAV, V47, P336, DOI 10.1016/j.yhbeh.2004.11.014; Coelho JL, 2001, BEHAV BRAIN RES, V124, P161, DOI 10.1016/S0166-4328(01)00227-3; Delicio Helton Carlos, 2006, Journal of Experimental Animal Science, V43, P141, DOI 10.1016/j.jeas.2006.01.001; Driscoll P, 1998, ANN NY ACAD SCI, V851, P501, DOI 10.1111/j.1749-6632.1998.tb09029.x; DUGATKIN LA, 1993, REV FISH BIOL FISHER, V3, P368, DOI 10.1007/BF00043386; English S, 2013, ECOL EVOL, V3, P4401, DOI 10.1002/ece3.820; Filby AL, 2012, ENVIRON SCI TECHNOL, V46, P3472, DOI 10.1021/es204023d; Filby AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-498; Galhardo L, 2009, APPL ANIM BEHAV SCI, V120, P224, DOI 10.1016/j.applanim.2009.07.001; Giaquinto PC, 1997, PHYSIOL BEHAV, V62, P1333, DOI 10.1016/S0031-9384(97)00347-8; Gibson RN, 2005, FLATFISHES: BIOLOGY AND EXPLOITATION, P1, DOI 10.1002/9780470995259; GRAND TC, 1994, ANIM BEHAV, V47, P91, DOI 10.1006/anbe.1994.1010; Grant JWA, 2002, ANIM BEHAV, V63, P323, DOI 10.1006/anbe.2001.1891; Grant JWA, 1997, BEHAV ECOLOGY TELEOS, P360; Griffin D. R., 1984, ANIMAL THINKING; GUHL AM, 1968, ANIM BEHAV, V16, P219, DOI 10.1016/0003-3472(68)90003-1; GUHL AM, 1956, SCI AM, V194, P42, DOI 10.1038/scientificamerican0256-42; Hampel M, 2008, HISTOL HISTOPATHOL, V23, P87, DOI 10.14670/HH-23.87; HOLMES RA, 1983, ANIM BEHAV, V31, P1244, DOI 10.1016/S0003-3472(83)80031-1; HOLMES RA, 1986, J FISH BIOL, V29, P49, DOI 10.1111/j.1095-8649.1986.tb04998.x; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; HUNTINGFORD FA, 1993, ETHOLOGY, V94, P201; Ibarra-Zatarain Z, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160495; Ibarra-Zatarain Z., 2015, THESIS; Ibarra-Zatarain Z, 2015, APPL ANIM BEHAV SCI, V171, P233, DOI 10.1016/j.applanim.2015.08.007; Johnsson JI, 2000, BEHAV ECOL SOCIOBIOL, V48, P373, DOI 10.1007/s002650000244; Killen SS, 2014, FUNCT ECOL, V28, P1367, DOI 10.1111/1365-2435.12296; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korzan WJ, 2006, ACTA ETHOL, V9, P48, DOI 10.1007/s10211-006-0015-5; KRUUK H, 1963, NETH J SEA RES, V2, P1; LIVINGSTON ME, 1987, NEW ZEAL J MAR FRESH, V21, P281, DOI 10.1080/00288330.1987.9516224; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; MacLean A, 2000, AQUACULTURE, V184, P291, DOI 10.1016/S0044-8486(99)00333-6; Martin I.E., 2016, THESIS; Martin I, 2014, AQUACULTURE, V424, P45, DOI 10.1016/j.aquaculture.2013.12.042; Mas-Munoz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021393; Mattioli R, 1998, BRAIN RES BULL, V45, P41, DOI 10.1016/S0361-9230(97)00287-6; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; McCormick MI, 2016, PEERJ, V4, DOI 10.7717/peerj.2198; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; Miczek KA, 2003, HORM BEHAV, V44, P242, DOI 10.1016/j.yhbeh.2003.04.002; Morais S, 2016, REV AQUACULT, V8, P227, DOI 10.1111/raq.12091; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Noakes D.L.G., 1978, P360; Nyman C, 2017, MOL ECOL, V26, P3186, DOI 10.1111/mec.14113; O'Connell LA, 2013, J CHEM NEUROANAT, V47, P106, DOI 10.1016/j.jchemneu.2012.12.007; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2002, HORM BEHAV, V42, P53, DOI 10.1006/hbeh.2002.1796; Pavlidis M, 2011, BEHAV BRAIN RES, V225, P529, DOI 10.1016/j.bbr.2011.08.022; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popma T., 1999, SO REGIONAL AQUACULT, V283, P1; Porta J, 2006, AQUACULTURE, V256, P159, DOI 10.1016/j.aquaculture.2006.02.022; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reebs SG, 2008, AGGRESSION IN FISHES; Rey S, 2013, MOL ECOL, V22, P6100, DOI 10.1111/mec.12556; Rodel HG, 2009, PHYSIOL BEHAV, V97, P495, DOI 10.1016/j.physbeh.2009.04.005; Rozen S, 2000, Methods Mol Biol, V132, P365; RUBENSTEIN DI, 1981, ANIM BEHAV, V29, P155, DOI 10.1016/S0003-3472(81)80162-5; Ruiz-Gomez ML, 2012, J FISH BIOL, V81, P966, DOI 10.1111/j.1095-8649.2012.03340.x; Salas-Leiton E, 2008, AQUACULTURE, V285, P84, DOI 10.1016/j.aquaculture.2008.08.001; Salas-Leiton E, 2010, FISH SHELLFISH IMMUN, V28, P296, DOI 10.1016/j.fsi.2009.11.006; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Teles MC, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00016; Teles MC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1099; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verri T., 2012, FUNCTIONAL GENOMICS, V24, P219; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	87	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184283	10.1371/journal.pone.0184283	http://dx.doi.org/10.1371/journal.pone.0184283			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877259	Green Published, gold			2022-12-26	WOS:000409391200083
J	Nyalwidhe, JO; Grzesik, WJ; Burch, TC; Semeraro, ML; Waseem, T; Gerling, IC; Mirmira, RG; Morris, MA; Nadler, JL				Nyalwidhe, Julius O.; Grzesik, Wojciech J.; Burch, Tanya C.; Semeraro, Michele L.; Waseem, Tayab; Gerling, Ivan C.; Mirmira, Raghavendra G.; Morris, Margaret A.; Nadler, Jerry L.			Comparative quantitative proteomic analysis of disease stratified laser captured microdissected human islets identifies proteins and pathways potentially related to type 1 diabetes	PLOS ONE			English	Article							S100A8/A9; GENE; EXPRESSION; POLYMORPHISM; ACTIVATION; INDUCTION; APOPTOSIS; BIOMARKER; CELLS	Type 1 diabetes (T1D) is a chronic inflammatory disease that is characterized by autoimmune destruction of insulin-producing pancreatic beta cells. The goal of this study was to identify novel protein signatures that distinguish Islets from patients with T1D, patients who are autoantibody positive without symptoms of diabetes, and from individuals with no evidence of disease. High resolution high mass accuracy label free quantitative mass spectrometry analysis was applied to islets isolated by laser capture microdissection from disease stratified human pancreata from the Network for Pancreatic Organ Donors with Diabetes (nPOD), these included donors without diabetes, donors with T1D-associated autoantibodies in the absence of diabetes, and donors with T1D. Thirty-nine proteins were found to be differentially regulated in autoantibody positive cases compared to the no-disease group, with 25 upregulated and 14 downregulated proteins. For the T1D cases, 63 proteins were differentially expressed, with 24 upregulated and 39 downregulated, compared to the no disease controls. We have identified functional annotated enriched gene families and multiple protein-protein interaction clusters of proteins are involved in biological and molecular processes that may have a role in T1D. The proteins that are upregulated in T1D cases include S100A9, S100A8, REG1B, REG3A and C9 amongst others. These proteins have important biological functions, such as inflammation, metabolic regulation, and autoimmunity, all of which are pathways linked to the pathogenesis of T1D. The identified proteins may be involved in T1D development and pathogenesis. Our findings of novel proteins uniquely upregulated in T1D pancreas provides impetus for further investigations focusing on their expression profiles in beta cells/islets to evaluate their role in the disease pathogenesis. Some of these molecules may be novel therapeutic targets T1D.	[Nyalwidhe, Julius O.; Burch, Tanya C.; Waseem, Tayab] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Nyalwidhe, Julius O.; Burch, Tanya C.] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA; [Grzesik, Wojciech J.; Semeraro, Michele L.; Morris, Margaret A.; Nadler, Jerry L.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Gerling, Ivan C.] Univ Tennessee, Hlth Sci Ctr, Div Endocrinol Diabet & Metab, Memphis, TN 38163 USA; [Mirmira, Raghavendra G.] Indiana Univ, Dept Pediat, Ctr Diabet & Metab Dis, Indianapolis, IN 46204 USA; [Nadler, Jerry L.] Eastern Virginia Med Ctr, Strelitz Diabet Ctr, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School; University of Tennessee System; University of Tennessee Health Science Center; Indiana University System; Indiana University-Purdue University Indianapolis	Nyalwidhe, JO (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.; Nyalwidhe, JO (corresponding author), Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA.; Nadler, JL (corresponding author), Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA.; Nadler, JL (corresponding author), Eastern Virginia Med Ctr, Strelitz Diabet Ctr, Norfolk, VA USA.	nyalwijo@evms.edu; nadlerjl@evms.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Waseem, Tayab/0000-0002-0250-2755	Juvenile Diabetes Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) [UC4 DK 104166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512, UC4DK104166] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported funding from the Juvenile Diabetes Research Foundation and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) UC4 DK 104166 to Jerry L Nadler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the Manuscript.	Atallah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029333; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Berthier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040277; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bottini E, 1996, BRIT J OBSTET GYNAEC, V103, P1052, DOI 10.1111/j.1471-0528.1996.tb09571.x; Burch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135663; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Caseiro A, 2013, J PROTEOME RES, V12, P1700, DOI 10.1021/pr3010343; Cheng L, 2013, APPL IMMUNOHISTO M M, V21, P31, DOI 10.1097/PAI.0b013e31824d0519; Choi JH, 2010, BIOL CHEM, V391, P1019, DOI 10.1515/BC.2010.101; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Gallagher RI, 2012, METHODS MOL BIOL, V823, P157, DOI 10.1007/978-1-60327-216-2_11; Geven EJW, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1121-z; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; GLORIABOTTINI F, 1989, HUM BIOL, V61, P571; GLORIABOTTINI F, 1994, HUM BIOL, V66, P1049; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Koike A, 2012, INFLAMMATION, V35, P409, DOI 10.1007/s10753-011-9330-8; Levetan Claresa S, 2008, Endocr Pract, V14, P1075; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Liu NQ, 2012, J MAMMARY GLAND BIOL, V17, P155, DOI 10.1007/s10911-012-9252-6; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; LUCARELLI P, 1978, HUM HERED, V28, P89, DOI 10.1159/000152948; Martens GA, 2016, J TISSUE ENG REGEN M; MIYASAKI KT, 1993, J DENT RES, V72, P517, DOI 10.1177/00220345930720020801; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Nicaise C, 2016, CLIN EXP RHEUMATOL; Nishida Y, 2014, PLOS ONE, V16; ORELLE B, 1992, J CLIN INVEST, V90, P2284, DOI 10.1172/JCI116115; Pepper RJ, 2016, ARTHRITIS RHEUMATOL; Pruenster M, 2016, PHARMACOL THERAPEUT, V167, P120, DOI 10.1016/j.pharmthera.2016.07.015; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Richardson S, 2014, ENDOCR PATHOL, V25, P80, DOI 10.1007/s12022-014-9297-8; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Simard JC, 2011, J IMMUNOL, V186, P3622, DOI 10.4049/jimmunol.1002956; Simard JC, 2010, J LEUKOCYTE BIOL, V87, P905, DOI 10.1189/jlb.1009676; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Singh S, 2015, BIOCHEM BIOPH RES CO, V463, P768, DOI 10.1016/j.bbrc.2015.06.011; Sroussi HY, 2009, FEMS IMMUNOL MED MIC, V55, P55, DOI 10.1111/j.1574-695X.2008.00498.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tjernberg J, 2008, TRANSPLANTATION, V85, P1193, DOI 10.1097/TP.0b013e31816b22f3; Trostrup H, 2016, ARCH DERMATOL RES, V308, P347, DOI 10.1007/s00403-016-1646-7; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0; Yamauchi A, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/173058; Zhang C, AM J PHYSL ENDOCRINO, V310, pE874; Zhang LN, 2017, J PROTEOMICS, V150, P149, DOI 10.1016/j.jprot.2016.09.002	57	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183908	10.1371/journal.pone.0183908	http://dx.doi.org/10.1371/journal.pone.0183908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877242	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200049
J	Okubo, BM; de Matos, AG; Ribeiro, HL; Borges, DD; De Oliveira, RTG; de Castro, MF; Martins, MRA; Goncealves, RP; Bruin, PFC; Pinheiro, RF; Magalhaes, SMM				Okubo, Bruno Memoaria; de Matos, Anacealia Gomes; Ribeiro Junior, Howard Lopes; Borges, Daniela de Paula; De Oliveira, Roberta Taiane Germano; de Castro, Marilena Facundo; Martins, Manoel Ricardo Alves; Goncealves, Romealia Pinheiro; Carvalhedo Bruin, Pedro Felipe; Pinheiro, Ronald Feitosa; Meira Magalhaes, Silvia Maria			Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit?	PLOS ONE			English	Article							SKELETAL-MUSCLE; ANEMIA; IMMUNE; SYSTEM; ADAPTATION	Background/Objectives The ageing process is associated with gradual decline in respiratory system performance. Anemia is highly prevalent among older adults and usually associated with adverse outcomes. Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies with increasing incidence with age and characterized by anemia and other cytopenias. The main objectives of this study were to evaluate respiratory muscle strength and lung function in elderly patients with anemia, compare data between myelodysplastic syndromes and non-clonal anemias and evaluate the influence of serum IL-8 level and NFkB activity on deteriorate pulmonary function in this specific population. Participants Individuals aged 60 and older with anemia secondary to MDS, non-clonal anemia and healthy elderly individuals. Measurements Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio were measured by spirometry. Respiratory muscle strength was evaluated by maximal static respiratory pressures measurement. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. Results Mean Hb concentration was comparable between patients with anemia. Significant differences were detected between all patients with anemia and controls for maximum-effort inspiratory mouth pressure (PImax) and also for maximum-effort expiratory mouth pressure (PEmax). The MDS group recorded a significantly lower PImax and PEmax percent predicted when compared to non-clonal anemia group. For FVC and FEV1, a significant difference was found in anemic patients, with even significantly lower values for FVC and FEV1 in MDS group. No significant differences were detected for PImax and PEmax and spirometry parameters when anemic patients were stratified according to the degree of anemia. A significant negative impact in FVC (% pred), PImax (% pred) and PEmax (% pred) was observed in patients with MDS and higher levels of IL-8 or increased activity of NF-kB. Conclusion A negative impact of anemia, independent of its degree, was demonstrated in respiratory muscle strength and lung function particularly in MDS. The well known elevated proinflammatory cytokines in MDS patients were proposed to play a role as was demonstrated by detrimental effect of higher IL-8 and NF-kB in pulmonary function tests in this population.	[Okubo, Bruno Memoaria; de Matos, Anacealia Gomes; Ribeiro Junior, Howard Lopes; Borges, Daniela de Paula; De Oliveira, Roberta Taiane Germano; Pinheiro, Ronald Feitosa; Meira Magalhaes, Silvia Maria] Univ Fed Ceara, Canc Cytogen Lab, Fortaleza, Ceara, Brazil; [Okubo, Bruno Memoaria; de Matos, Anacealia Gomes; Borges, Daniela de Paula; De Oliveira, Roberta Taiane Germano; Pinheiro, Ronald Feitosa; Meira Magalhaes, Silvia Maria] Univ Fed Ceara, Postgrad Program Med Sci, Fortaleza, Ceara, Brazil; [de Castro, Marilena Facundo; Goncealves, Romealia Pinheiro] Univ Fed Ceara, Dept Clin & Toxicol Anal, Fortaleza, Ceara, Brazil; [Martins, Manoel Ricardo Alves; Carvalhedo Bruin, Pedro Felipe; Pinheiro, Ronald Feitosa; Meira Magalhaes, Silvia Maria] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara	Magalhaes, SMM (corresponding author), Univ Fed Ceara, Canc Cytogen Lab, Fortaleza, Ceara, Brazil.; Magalhaes, SMM (corresponding author), Univ Fed Ceara, Postgrad Program Med Sci, Fortaleza, Ceara, Brazil.; Magalhaes, SMM (corresponding author), Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil.	silviamm@ufc.br	Martins, Manoel R A/W-6021-2019; Patologia, Programa/AAI-4877-2021; RIBEIRO, HOWARD L/C-3283-2014; CARVALHEDO DE BRUIN, PEDRO FELIPE/C-6056-2016	Martins, Manoel R A/0000-0001-7272-9552; RIBEIRO, HOWARD L/0000-0003-2431-4779; de Paula Borges, Daniela/0000-0002-8254-5420; CARVALHEDO DE BRUIN, PEDRO FELIPE/0000-0001-9694-1523	National Counsel of Technological and Scientific Development (CNPq); Foundation for Support of Scientific and Technological Development - Ceara (FUNCAP); Foundation for Support of Scientific and Technological Development-Ceara (FUNCAP)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Support of Scientific and Technological Development - Ceara (FUNCAP); Foundation for Support of Scientific and Technological Development-Ceara (FUNCAP)	This study was conducted with partial support from National Counsel of Technological and Scientific Development (CNPq) and Foundation for Support of Scientific and Technological Development - Ceara (FUNCAP).; This study was conducted with partial support from National Counsel of Technological and Scientific Development (CNPq) and Foundation for Support of Scientific and Technological Development-Ceara (FUNCAP).	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Brazilian Institute of Geography and Statistics D IBGE, BRAZ CENS 2010; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Cesari M, 2004, J GERONTOL A-BIOL, V59, P249; Deveci D, 2001, AM J PHYSIOL-HEART C, V281, pH241, DOI 10.1152/ajpheart.2001.281.1.H241; Ferrari R, 2015, INT J CHRONIC OBSTR, V10, P1553, DOI 10.2147/COPD.S85954; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; GAIL DB, 1990, AM REV RESPIR DIS, V142, P474; Ganan-Gomez I, 2015, LEUKEMIA, V29, P1458, DOI 10.1038/leu.2015.69; Gangat N, 2016, AM J HEMATOL, V91, P76, DOI 10.1002/ajh.24253; Glenthoj A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060944; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; He QP, 2016, CURR OPIN HEMATOL, V23, P18, DOI 10.1097/MOH.0000000000000197; Hepple RT, 2000, MED SCI SPORT EXER, V32, P117; Hyatt RE, 2014, INTERPRETATION PULMO; Jain S, 2014, ACTA MED INT, V1, P3; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Lalley PM, 2013, RESP PHYSIOL NEUROBI, V187, P199, DOI 10.1016/j.resp.2013.03.012; Lipschitz D, 2003, J AM GERIATR SOC, V51, pS10; Mangner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052274; McNicholas WT, 2009, AM J RESP CRIT CARE, V180, P692, DOI 10.1164/rccm.200903-0347PP; Penninx BWJH, 2003, AM J MED, V115, P104, DOI 10.1016/S0002-9343(03)00263-8; Pereira CAC, 2002, J PNEUMOL S3, V28, pS1; Pleguezuelos E, 2016, LUNG, V194, P249, DOI 10.1007/s00408-015-9838-z; Rothstein G, 2003, J AM GERIATR SOC, V51, pS22; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Shahzad Aamir, 2010, Int Arch Med, V3, P11, DOI 10.1186/1755-7682-3-11; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Toledo FO, 2011, VALUE HEALTH, V14, pA329, DOI 10.1016/j.jval.2011.08.532; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Yang LL, 2015, CELL MOL LIFE SCI, V72, P1959, DOI 10.1007/s00018-015-1846-x; Zahid MF, 2016, EUR J HAEMATOL, V97, P313, DOI 10.1111/ejh.12771	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184079	10.1371/journal.pone.0184079	http://dx.doi.org/10.1371/journal.pone.0184079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877261	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200062
J	Camperio, C; Armas, F; Biasibetti, E; Frassanito, P; Giovannelli, C; Spuria, L; D'Agostino, C; Tait, S; Capucchio, MT; Marianelli, C				Camperio, Cristina; Armas, Federica; Biasibetti, Elena; Frassanito, Paolo; Giovannelli, Carlo; Spuria, Liliana; D'Agostino, Claudia; Tait, Sabrina; Capucchio, Maria Teresa; Marianelli, Cinzia			A mouse mastitis model to study the effects of the intramammary infusion of a food-grade Lactococcus lactis strain	PLOS ONE			English	Article							AUREUS-INDUCED MASTITIS; BOVINE MASTITIS; MAMMARY-GLAND; PATHOGENESIS; EFFICACY; CHALLENGE; INFECTION; COWS	Lactococcus lactis is one of the most important microorganisms in the dairy industry and has "generally recognized as safe" (GRAS) status. L. lactis belongs to the group of lactic acid bacteria (LAB) and is encountered in a wide range of environments. Recently, the use of the intramammary infusion of a live culture of LAB has been investigated as a new antibiotic alternative for treating mastitis in dairy ruminants. Controversial results are described in literature regarding its efficacy and safety. In this study we conducted in-depth investigation of the mammary gland immune response induced by intramammary inoculum of a live culture of L. lactis LMG 7930 using the mouse mastitis model. Overnight cultures either of L. lactis (approximate to 10(7) CFU) or of the mastitis pathogens Staphylococcus chromogenes (approximate to 10(5) CFU) or S. aureus (approximate to 10(2) CFU/ml) were injected into the mouse inguinal glands. A double injection, consisting of S. chromogenes first and then L. lactis, was also investigated. Bacterial recovery from the gland and inflammatory cell infiltration were assessed. L. lactis-treated and control glands were analysed for proinflammatory cytokine production. Microbiological results showed that L. lactis was able to survive in the mammary gland 24 h post infection, as were the mastitis pathogens S. chromogenes and S. aureus. L. lactis reduced S. chromogenes survival in the glands and increased its own survival ability by coexisting with the pathogen. Histology showed that L. lactis-treated glands presented variable histological features, ranging from undamaged tissue with no inflammatory cell infiltrate to severe PMN infiltrate with focal areas of tissue damage. S. aureustreated glands showed the most severe histological grade of inflammation despite the fact that the inoculum size was the smallest. In contrast, most S. chromogenes- treated glands showed normal structures with no infiltration or lesions. Significant increases in IL-1 beta and TNF-alpha levels were also found in L. lactis-inoculated glands. The above findings seem to suggest that food-grade L. lactis at a high-inoculum dose such as an overnight culture may elicit a suppurative inflammatory response in the mammary gland, thus becoming a potential mastitis-causing pathogen. Because of the unpredictable potential of L. lactis in acting as a potential mastitis pathogen, this organism cannot be considered a safe treatment for bovine mastitis.	[Camperio, Cristina; Armas, Federica; Frassanito, Paolo; Giovannelli, Carlo; D'Agostino, Claudia; Marianelli, Cinzia] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Rome, Italy; [Camperio, Cristina; Biasibetti, Elena; Spuria, Liliana; Capucchio, Maria Teresa] Univ Turin, Dept Vet Sci, Turin, Italy; [Armas, Federica] Rome Tre Univ, Dept Sci, Rome, Italy; [Tait, Sabrina] Ist Super Sanita, Ctr Gender Specif Med, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Turin; Italfarmaco; Roma Tre University; Istituto Superiore di Sanita (ISS)	Marianelli, C (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Rome, Italy.	cinzia.marianelli@iss.it	Tait, Sabrina/C-6071-2015; Capucchio, Maria/AAA-6589-2022; Biasibetti, Elena/AAB-5005-2022; Marianelli, Cinzia/C-7036-2015	Tait, Sabrina/0000-0001-8029-8625; Biasibetti, Elena/0000-0002-5324-5197; Armas, Federica/0000-0001-8034-2972; Marianelli, Cinzia/0000-0002-5190-4574	Italian Ministry of Health [RF-2010-2313040]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health, grant number RF-2010-2313040. The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Armas F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169543; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Biasibetti E, 2012, ANIMAL, V6, P1839, DOI 10.1017/S175173111200081X; Breyne K, 2015, J DAIRY SCI, V98, P1090, DOI 10.3168/jds.2014-8699; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Brouillette E, 2005, VET IMMUNOL IMMUNOP, V104, P163, DOI 10.1016/j.vetimm.2004.11.006; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; CHANDLER RL, 1970, J MED MICROBIOL, V3, P273, DOI 10.1099/00222615-3-2-273; Chen FG, 2014, FEMS MICROBIOL LETT, V351, P95, DOI 10.1111/1574-6968.12354; Contreras A, 2007, SMALL RUMINANT RES, V68, P145, DOI 10.1016/j.smallrumres.2006.09.011; GREENE WA, 1991, J DAIRY SCI, V74, P2976, DOI 10.3168/jds.S0022-0302(91)78483-X; Haftu R, 2012, TROP ANIM HEALTH PRO, V44, P1765, DOI 10.1007/s11250-012-0135-z; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Ingman WV, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0038-5; Klostermann K, 2008, J DAIRY RES, V75, P365, DOI 10.1017/S0022029908003373; Nazemi S, 2014, J DAIRY RES, V81, P445, DOI 10.1017/S0022029914000454; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; Notebaert S, 2008, COMP IMMUNOL MICROB, V31, P551, DOI 10.1016/j.cimid.2007.10.004; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Ryan MP, 1999, J DAIRY SCI, V82, P2625, DOI 10.3168/jds.S0022-0302(99)75519-0; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; TABACCHIONI S, 1995, RES MICROBIOL, V146, P531, DOI 10.1016/0923-2508(96)80559-6; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; Twomey DP, 2000, J DAIRY SCI, V83, P1981, DOI 10.3168/jds.S0022-0302(00)75075-2; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134797	27	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184218	10.1371/journal.pone.0184218	http://dx.doi.org/10.1371/journal.pone.0184218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873396	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800062
J	Alberini, G; Benfenati, F; Maragliano, L				Alberini, Giulio; Benfenati, Fabio; Maragliano, Luca			A refined model of claudin-15 tight junction paracellular architecture by molecular dynamics simulations	PLOS ONE			English	Article							ADDITIVE FORCE-FIELD; CHARGE SELECTIVITY; ION-CHANNEL; EPITHELIA; PROTEINS; STRANDS; TRANSPORT; INSIGHT; DOMAINS; SYSTEM	Tight-junctions between epithelial cells of biological barriers are specialized molecular structures that regulate the flux of solutes across the barrier, parallel to cell walls. The tight-junction backbone is made of strands of transmembrane proteins from the claudin family, but the molecular mechanism of its function is still not completely understood. Recently, the crystal structure of a mammalian claudin-15 was reported, displaying for the first time the detailed features of transmembrane and extracellular domains. Successively, a structural model of claudin-15-based paracellular channels has been proposed, suggesting a putative assembly that illustrates how claudins associate in the same cell (via cis interactions) and across adjacent cells (via trans interactions). Although very promising, the model offers only a static conformation, with residues missing in the most important extracellular regions and potential steric clashes. Here we present detailed atomic models of paracellular single and double pore architectures, obtained from the putative assembly and refined via structural modeling and all-atom molecular dynamics simulations in double membrane bilayer and water environment. Our results show an overall stable configuration of the complex with a fluctuating pore size. Extracellular residue loops in trans interaction are able to form stable contacts and regulate the size of the pore, which displays a stationary radius of 2.5 - 3.0 angstrom at the narrowest region. The side-by-side interactions of the cis configuration are preserved via stable hydrogen bonds, already predicted by cysteine crosslinking experiments. Overall, this work introduces an improved version of the claudin-15-based paracellular channel model that strengthens its validity and that can be used in further computational studies to understand the structural features of tight-junctions regulation.	[Alberini, Giulio; Benfenati, Fabio; Maragliano, Luca] Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol NSYN UniGe, Largo Rosanna Benzi,10, I-16132 Genoa, Italy; [Alberini, Giulio; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Viale Benedetto XV,3, I-16132 Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa	Benfenati, F; Maragliano, L (corresponding author), Ist Italiano Tecnol, Ctr Synapt Neurosci & Technol NSYN UniGe, Largo Rosanna Benzi,10, I-16132 Genoa, Italy.; Benfenati, F (corresponding author), Univ Genoa, Dept Expt Med, Viale Benedetto XV,3, I-16132 Genoa, Italy.	fabio.benfenati@iit.it; luca.maragliano@iit.it	Maragliano, Luca/A-8294-2010	Maragliano, Luca/0000-0002-5705-6967	EU FP7-ICT-FET-F GRAPHENE Flagship project [604391]	EU FP7-ICT-FET-F GRAPHENE Flagship project	We acknowledge financial support from the EU FP7-ICT-2013-FET-F GRAPHENE Flagship project (no. 604391).	Amasheh S, 2009, ANN NY ACAD SCI, V1165, P211, DOI 10.1111/j.1749-6632.2009.04439.x; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Goiaei A, 2015, ACS CHEM NEUROSCI, V6, P1296, DOI 10.1021/acschemneuro.5b00116; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irudayanathan FJ, 2017, ANN N Y ACAD SCI; Irudayanathan FJ, 2016, J PHYS CHEM B, V120, P77, DOI 10.1021/acs.jpcb.5b09977; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krause G, 2015, SEMIN CELL DEV BIOL, V42, P3, DOI 10.1016/j.semcdb.2015.04.010; Krause G, 2009, ANN NY ACAD SCI, V1165, P34, DOI 10.1111/j.1749-6632.2009.04057.x; Langham A, 2010, METHODS MOL BIOL, V618, P267, DOI 10.1007/978-1-60761-594-1_17; 신웅희, 2014, Biodesign, V2, P1; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Lopez-Blanco JR, 2016, NUCLEIC ACIDS RES, V44, pW395, DOI 10.1093/nar/gkw395; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shinoda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33632; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Suzuki H, 2015, J MOL BIOL, V427, P291, DOI 10.1016/j.jmb.2014.10.020; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Tang VW, 2003, BIOPHYS J, V84, P1660, DOI 10.1016/S0006-3495(03)74975-3; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Valley CC, 1997, BIOPHYS J, V72, P1109; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Weber CR, 2015, ELIFE, V4, DOI 10.7554/eLife.09906; Weber CR, 2012, FASEB J, V26, P1107; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	46	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184190	10.1371/journal.pone.0184190	http://dx.doi.org/10.1371/journal.pone.0184190			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863193	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900036
J	Huff, RD; Hsu, ACY; Nichol, KS; Jones, B; Knight, DA; Wark, PAB; Hansbro, PM; Hirota, JA				Huff, Ryan D.; Hsu, Alan C-Y.; Nichol, Kristy S.; Jones, Bernadette; Knight, Darryl A.; Wark, Peter A. B.; Hansbro, Philip M.; Hirota, Jeremy A.			Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NUCLEOTIDE-BINDING DOMAIN; URBAN PARTICULATE MATTER; REAL-TIME PCR; OXIDASE ACTIVITY; ENDOTHELIAL-CELLS; CIGARETTE-SMOKE; DENDRITIC CELLS; MOUSE MODEL; LARGE-SCALE	Introduction The airway epithelium is a physical and immunological barrier that protects the pulmonary system from inhaled environmental insults. Uric acid has been detected in the respiratory tract and can function as an antioxidant or damage associated molecular pattern. We have demonstrated that human airway epithelial cells are a source of uric acid. Our hypothesis is that uric acid production by airway epithelial cells is induced by environmental stimuli associated with chronic respiratory diseases. We therefore examined how airway epithelial cells regulate uric acid production. Materials and methods Allergen and cigarette smoke mouse models were performed using house dust mite (HDM) and cigarette smoke exposure, respectively, with outcome measurements of lung uric acid levels. Primary human airway epithelial cells isolated from clinically diagnosed patients with asthma and chronic obstructive pulmonary disease (COPD) were grown in submerged cultures and compared to age-matched healthy controls for uric acid release. HBEC-6KT cells, a human airway epithelial cell line, were grown under submerged monolayer conditions for mechanistic and gene expression studies. Results HDM, but not cigarette smoke exposure, stimulated uric acid production in vivo and in vitro. Primary human airway epithelial cells from asthma, but not COPD patients, displayed elevated levels of extracellular uric acid in culture. In HBEC-6KT, production of uric acid was sensitive to the xanthine dehydrogenase (XDH) inhibitor, allopurinol, and the ATP Binding Cassette C4 (ABCC4) inhibitor, MK-571. Lastly, the pro-inflammatory cytokine combination of TNF-alpha and IFN-gamma elevated extracellular uric acid levels and XDH gene expression in HBEC-6KT cells. Conclusions Our results suggest that the active production of uric acid from human airway epithelial cells may be intrinsically altered in asthma and be further induced by pro-inflammatory cytokines.	[Huff, Ryan D.; Hirota, Jeremy A.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [Hsu, Alan C-Y.; Nichol, Kristy S.; Jones, Bernadette; Knight, Darryl A.; Wark, Peter A. B.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; [Hirota, Jeremy A.] McMaster Univ, Dept Med, Div Respirol, Firestone Inst Resp Hlth, Hamilton, ON, Canada	University of British Columbia; Hunter Medical Research Institute; University of Newcastle; McMaster University	Hirota, JA (corresponding author), Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada.; Hirota, JA (corresponding author), McMaster Univ, Dept Med, Div Respirol, Firestone Inst Resp Hlth, Hamilton, ON, Canada.	hirotaja@mcmaster.ca	Hsu, Alan/A-3144-2012; Hansbro, Phil/G-7486-2013; Wark, Peter/G-7037-2013	Hsu, Alan/0000-0002-6640-0846; Hansbro, Phil/0000-0002-4741-3035; Wark, Peter/0000-0001-5676-6126; Huff, Ryan/0000-0002-6038-8217; Jones-Freeman, Bernadette/0000-0003-4613-7865	AllerGen NCE; Canadian Institutes of Health Research New Investigator Salary Award; National Health and Medical Research Council (NHMRC) Principal Research Fellowship; Brawn Fellowship from the Faculty of Health and Medicine, The University of Newcastle	AllerGen NCE; Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (NHMRC) Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Brawn Fellowship from the Faculty of Health and Medicine, The University of Newcastle	The authors would like to acknowledge AllerGen NCE for funding that allowed for Jeremy A. Hirota to travel, receive training, perform experiments, and access to resources at the Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia. JAH is supported by a Canadian Institutes of Health Research New Investigator Salary Award. PMH is supported by a National Health and Medical Research Council (NHMRC) Principal Research Fellowship, and a Brawn Fellowship from the Faculty of Health and Medicine, The University of Newcastle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bazett M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35338; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Cheepala S, 2013, ANNU REV PHARMACOL, V53, P231, DOI 10.1146/annurev-pharmtox-010611-134609; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; DUPONT GP, 1992, J CLIN INVEST, V89, P197, DOI 10.1172/JCI115563; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; FRIEDL HP, 1989, FASEB J, V3, P2512, DOI 10.1096/fasebj.3.13.2806779; Ghio AJ, 2002, AM J PHYSIOL-LUNG C, V283, pL563, DOI 10.1152/ajplung.00413.2000; Gohy ST, 2016, CLIN EXP ALLERGY, V46, P529, DOI 10.1111/cea.12712; Gold MJ, 2016, MUCOSAL IMMUNOL, V9, P809, DOI 10.1038/mi.2015.104; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hansbro PM, 2014, J BIOL CHEM, V289, P18214, DOI 10.1074/jbc.M114.548594; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Haw TJ, 2016, MUCOSAL IMMUNOL, V9, P859, DOI 10.1038/mi.2015.111; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Hirota JA, 2010, CLIN EXP ALLERGY, V40, P820, DOI 10.1111/j.1365-2222.2010.03458.x; Hirota JA, 2009, CLIN EXP ALLERGY, V39, P147, DOI 10.1111/j.1365-2222.2008.03109.x; Hirota JA, 2015, EXP LUNG RES, V41, P353, DOI 10.3109/01902148.2015.1040528; Hirota JA, 2015, AM J RESP CELL MOL, V52, P96, DOI 10.1165/rcmb.2014-0158OC; Hirota JA, 2014, RESPIROLOGY, V19, P881, DOI 10.1111/resp.12316; Hirota JA, 2012, CURR OPIN IMMUNOL, V24, P740, DOI 10.1016/j.coi.2012.08.012; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Hosakote YM, 2016, J VIROL, V90, P9618, DOI 10.1128/JVI.01279-16; Hsu ACY, 2016, AM J RESP CELL MOL, V55, P117, DOI 10.1165/rcmb.2015-0306OC; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Hsu ACY, 2015, AM J RESP CRIT CARE, V191, P1012, DOI 10.1164/rccm.201501-0188OC; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Jones B, 2017, RESPIROLOGY, V22, P21, DOI 10.1111/resp.12908; Kelly FJ, 1996, AM J RESP CRIT CARE, V154, P1700, DOI 10.1164/ajrccm.154.6.8970358; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kong J, 2015, ALLERGY, V70, P495, DOI 10.1111/all.12579; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kouzaki H, 2013, AM J RESP CELL MOL, V49, P741, DOI 10.1165/rcmb.2012-0304OC; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Liu G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86380; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McNally JS, 2005, ARTERIOSCL THROM VAS, V25, P1623, DOI 10.1161/01.ATV.0000170827.16296.6e; Mitchell PD, 2016, CHEST; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moheimani F, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0434-4; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Nishino T, 2000, J INORG BIOCHEM, V82, P43, DOI 10.1016/S0162-0134(00)00165-3; OROWAN E, 1955, NATURE, V175, P683, DOI 10.1038/175683a0; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; PFEFFER KD, 1994, J IMMUNOL, V153, P1789; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Roberts LE, 2007, J CELL BIOCHEM, V101, P1567, DOI 10.1002/jcb.21272; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Scheetz TE, 2004, PHYSIOL GENOMICS, V17, P69, DOI 10.1152/physiolgenomics.00188.2003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; Seymour KJ, 2006, J BIOL CHEM, V281, P8545, DOI 10.1074/jbc.M507349200; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Stanke F, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/463016; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; van den Berge M, 2014, THORAX, V69, P14, DOI 10.1136/thoraxjnl-2012-202878; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	73	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184260	10.1371/journal.pone.0184260	http://dx.doi.org/10.1371/journal.pone.0184260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863172	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900045
J	Hagmann, H; Mangold, N; Rinschen, MM; Koenig, T; Kunzelmann, K; Schermer, B; Benzing, T; Brinkkoetter, PT				Hagmann, Henning; Mangold, Nicole; Rinschen, Markus M.; Koenig, Tim; Kunzelmann, Karl; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.			Proline-dependent and basophilic kinases phosphorylate human TRPC6 at serine 14 to control channel activity through increased membrane expression	FASEB JOURNAL			English	Article						MAPK; cyclin-dependent kinase 5; proteinuria; podocyte; glomerular disease	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; ANGIOTENSIN-II; PHOSPHOPROTEOMIC ANALYSIS; TYROSINE PHOSPHORYLATION; DIABETIC-NEPHROPATHY; CARDIAC-HYPERTROPHY; NEPHROTIC SYNDROME; CATION CHANNELS; ACTIVATION	Signaling via the transient receptor potential (TRP) ion channel C6 plays a pivotal role in hereditary and sporadic glomerular kidney disease. Several studies have identified gain-of-function mutations of TRPC6 and report induced expression and enhanced channel activity of TRPC6 in association with glomerular diseases. Interfering with TRPC6 activity may open novel therapeutic pathways. TRPC6 channel activity is controlled by protein expression and stability as well as intracellular trafficking. Identification of regulatory phosphorylation sites in TRPC6 and corresponding protein kinases is essential to understand the regulation of TRPC6 activity and may result in future therapeutic strategies. In this study, an unbiased phosphoproteomic screen of human TRPC6 identified several novel serine phosphorylation sites. The phosphorylation site at serine 14 of TRPC6 is embedded in a basophilic kinase motif that is highly conserved across species. We confirmed serine 14 as a target of MAPKs and proline-directed kinases like cyclin-dependent kinase 5 (Cdk5) in cell-based as well as in vitro kinase assays and quantitative phosphoproteomic analysis of TRPC6. Phosphorylation of TRPC6 at serine 14 enhances channel conductance by boosting membrane expression of TRPC6, whereas protein stability and multimerization of TRPC6 are not altered, making serine 14 phosphorylation a potential drug target to interfere with TRPC6 channel activity.	[Hagmann, Henning; Mangold, Nicole; Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.] Univ Cologne, Ctr Mol Med Cologne, Dept Internal Med 2, Cologne, Germany; [Rinschen, Markus M.; Koenig, Tim; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Syst Biol Ageing Cologne Sybacol, Cologne, Germany; [Koenig, Tim] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kunzelmann, Karl] Univ Regensburg, Dept Physiol, Regensburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Regensburg	Brinkkoetter, PT (corresponding author), Univ Hosp Cologne, Ctr Mol Med Cologne, Robert Koch St 21, D-50931 Cologne, Germany.	paul.brinkkoetter@uk-koeln.de	Rinschen, Markus/N-7283-2019; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014	Rinschen, Markus/0000-0002-9252-1342; Schermer, Bernhard/0000-0002-5194-9000; Konig, Tim/0000-0002-3484-1196	Koln Fortune Program of the University of Cologne; Deutsche Forschungsgemeinschaft [SFB699A7, SCHE1562/2, 1562/6, SFB635, SFB829, BR2955/4-1]	Koln Fortune Program of the University of Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank A. Koser for technical support. This study was funded by the Koln Fortune Program of the University of Cologne to H.H. K.K. was supported by the Deutsche Forschungsgemeinschaft (SFB699A7). B.S. obtained funding from the Deutsche Forschungsgemeinschaft (SCHE1562/2 and 1562/6). T.B. received funding from the Deutsche Forschungsgemeinschaft (SFB635 and SFB829). P.T.B. received funding from the Deutsche Forschungsgemeinschaft (BR2955/4-1) and the Koln Fortune Program, University of Cologne. The authors declare no conflicts of interest.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ambrus L, 2015, J CELL MOL MED, V19, P2771, DOI 10.1111/jcmm.12660; Bokemeyer D, 1998, KIDNEY INT, V54, pS189, DOI 10.1046/j.1523-1755.1998.06743.x; Bousquet SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018121; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Chen Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.300; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dryer SE, 2010, AM J PHYSIOL-RENAL, V299, pF689, DOI 10.1152/ajprenal.00298.2010; Du JY, 2009, BIOPHYS J, V96, p264A, DOI 10.1016/j.bpj.2008.12.1306; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Elger M, 1998, NEPHROL DIAL TRANSPL, V13, P1368, DOI 10.1093/ndt/13.6.1368; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Huang HT, 2017, CELL PHYSIOL BIOCHEM, V41, P163, DOI 10.1159/000455985; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ilatovskaya D., 2015, FASEB J, V29; Ilatovskaya DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17637; Ilatovskaya DV, 2015, AM J PHYSIOL-RENAL, V309, pF393, DOI 10.1152/ajprenal.00186.2015; Kanda S, 2011, MOL BIOL CELL, V22, P1824, DOI 10.1091/mbc.E10-12-0929; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lepage PK, 2006, J BIOL CHEM, V281, P30356, DOI 10.1074/jbc.M603930200; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Liu BC, 2013, BBA-MOL CELL RES, V1833, P1434, DOI 10.1016/j.bbamcr.2013.02.031; Liu SF, 2010, MOL BIOL REP, V37, P2477, DOI 10.1007/s11033-009-9761-6; Liu Y, 2015, BEHAV BRAIN RES, V294, P186, DOI 10.1016/j.bbr.2015.07.062; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Mottl AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-104; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rinschen MM, 2016, HUM MOL GENET, V25, P1328, DOI 10.1093/hmg/ddw016; Rinschen MM, 2015, PROTEOMICS, V15, P1326, DOI 10.1002/pmic.201400235; Rinschen MM, 2014, J AM SOC NEPHROL, V25, P1509, DOI 10.1681/ASN.2013070760; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; Seo K, 2014, P NATL ACAD SCI USA, V111, P6115, DOI 10.1073/pnas.1405263111; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shi J, 2010, J PHYSIOL-LONDON, V588, P3671, DOI 10.1113/jphysiol.2010.194621; Sonneveld R, 2014, AM J PATHOL, V184, P1715, DOI 10.1016/j.ajpath.2014.02.008; Stambe C, 2003, KIDNEY INT, V64, P2121, DOI 10.1046/j.1523-1755.2003.00324.x; Taniguchi Y, 2012, AM J PHYSIOL-RENAL, V302, pF1161, DOI 10.1152/ajprenal.00614.2011; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LM, 2015, J CLIN INVEST, V125, P1913, DOI 10.1172/JCI76767; Washburn DG, 2013, BIOORG MED CHEM LETT, V23, P4979, DOI 10.1016/j.bmcl.2013.06.047; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Winn MP, 2006, J AM SOC NEPHROL, V17, P378, DOI 10.1681/ASN.2005090962; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang H, 2009, EXP BIOL MED, V234, P1029, DOI 10.3181/0901-RM-11	67	3	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					208	+		10.1096/fj.201700309R	http://dx.doi.org/10.1096/fj.201700309R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28877958	Green Published			2022-12-26	WOS:000419172700020
J	Dirice, E; Ng, RWS; Martinez, R; Hu, J; Wagner, FF; Holson, EB; Wagner, BK; Kulkarni, RN				Dirice, Ercument; Ng, Raymond W. S.; Martinez, Rachael; Hu, Jiang; Wagner, Florence F.; Holson, Edward B.; Wagner, Bridget K.; Kulkarni, Rohit N.			Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROGRAM; BETA-CELL PROLIFERATION; T-CELLS; IN-VITRO; CANCER; TISSUE; MACROPHAGES; CYTOKINES; VIVO	Preservation of insulin-secreting beta-cells is an important goal for therapies aimed at restoring normoglycemia in patients with diabetes. One approach, the inhibition of histone deacetylases (HDACs), has been reported to suppress pancreatic islet inflammation and beta-cell apoptosis in vitro. In this report, we demonstrate the efficacy of HDAC inhibitors (HDACi) in vivo. We show that daily administration of BRD3308, an isoform-selective HDAC3 inhibitor, for 2 weeks to female nonobese diabetic (NOD) mice, beginning at 3 weeks of age, followed by twice-weekly injections until age 25 weeks, protects the animals from diabetes. The preservation of beta-cells was because of a significant decrease in islet infiltration of mononuclear cells. Moreover, the BRD3308 treatment increased basal insulin secretion from islets cultured in vitro. All metabolic tissues tested in vehicle- or BRD3308-treated groups showed virtually no sign of immune cell infiltration, except minimal infiltration in white adipose tissue in animals treated with the highest BRD3308 dose (10 mg/kg), providing additional evidence of protection from immune attack in the treated groups. Furthermore, pancreata from animals treated with 10 mg/kg BRD3308 exhibited significantly decreased numbers of apoptotic beta-cells compared with those treated with vehicle or low-dose BRD3308. Finally, animals treated with 1 or 10 mg/kg BRD3308 had enhanced beta-cell proliferation. These in vivo results point to the potential use of selective HDAC3 inhibitors as a therapeutic approach to suppress pancreatic islet infiltration and prevent beta-cell death with the long-term goal of limiting the progression of type 1 diabetes.	[Dirice, Ercument; Ng, Raymond W. S.; Martinez, Rachael; Hu, Jiang; Kulkarni, Rohit N.] Joslin Diabet Ctr, Dept Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Wagner, Florence F.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Holson, Edward B.; Wagner, Bridget K.] Broad Inst Harvard & MIT, Chem Biol & Therapeut Sci Program, Cambridge, MA 02142 USA; [Kulkarni, Rohit N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Kulkarni, Rohit N.] Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University	Wagner, BK (corresponding author), Broad Inst, Ctr Sci Therapeut, 415 Main St, Cambridge, MA 02142 USA.; Kulkarni, RN (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	bwagner@broadinstitute.org; Kulkarni@joslin.harvard.edu		Dirice, Ercument/0000-0003-2792-7204	Juvenile Diabetes Research Foundation (JDRF) [17-2013-437]; Senior JDRF Fellowship [JDRF-3-APF-2014-220-A-N]; National Institutes of Health [RO1 DK67536, RO1 DK103215]; Stanley Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536, P30DK036836, R01DK103215] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Senior JDRF Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Juvenile Diabetes Research Foundation (JDRF) Grant 17-2013-437 (to B. K. W. and R. N. K.) and Senior JDRF Fellowship JDRF-3-APF-2014-220-A-N (to E. D.). This work was also supported in part by National Institutes of Health Grants RO1 DK67536 and RO1 DK103215 (to R. N. K.). Support was also provided by the Stanley Medical Research Institute (E. B. H. and F. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Chou DHC, 2012, CHEM BIOL, V19, P669, DOI 10.1016/j.chembiol.2012.05.010; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Grant CW, 2012, COMPARATIVE MED, V62, P381; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hsu FC, 2015, J IMMUNOL, V195, P1578, DOI 10.4049/jimmunol.1500435; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Krusche CA, 2005, BREAST CANCER RES TR, V90, P15, DOI 10.1007/s10549-004-1668-2; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Lewis EC, 2011, MOL MED, V17, P369, DOI 10.2119/molmed.2010.00152; Lundh M, 2015, DIABETES OBES METAB, V17, P703, DOI 10.1111/dom.12470; Makino S, 1980, Jikken Dobutsu, V29, P1; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Minamiya Y, 2011, LUNG CANCER, V74, P300, DOI 10.1016/j.lungcan.2011.02.019; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Ozdag H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-90; Patel T, 2011, IMMUNOL CELL BIOL, V89, P640, DOI 10.1038/icb.2010.144; Philips RL, 2016, J IMMUNOL, V197, P541, DOI 10.4049/jimmunol.1502529; Reilly CM, 2008, J AUTOIMMUN, V31, P123, DOI 10.1016/j.jaut.2008.04.020; Summers AR, 2013, J CLIN INVEST, V123, P3112, DOI 10.1172/JCI60806; Thapa P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2580; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Wagner FF, 2016, ACS CHEM BIOL, V11, P363, DOI 10.1021/acschembio.5b00640; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738	33	27	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17598	17608		10.1074/jbc.M117.804328	http://dx.doi.org/10.1074/jbc.M117.804328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28860191	Green Published, hybrid			2022-12-26	WOS:000414013000003
J	Chandler, MR; Keene, KS; Tuomela, JM; Forero-Torres, A; Desmond, R; Vuopala, KS; Harris, KW; Merner, ND; Selander, KS				Chandler, Madison R.; Keene, Kimberly S.; Tuomela, Johanna M.; Forero-Torres, Andres; Desmond, Renee; Vuopala, Katri S.; Harris, Kevin W.; Merner, Nancy D.; Selander, Katri S.			Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; PROSTATE-CANCER; CELLULAR INVASION; ADAPTIVE IMMUNITY; 9 EXPRESSION; POLYMORPHISMS; AGONISTS; CELLS; DNA; INFLAMMATION	Introduction Toll-like receptor 9 (TLR9) is an innate immune system DNA-receptor that regulates tumor invasion and immunity in vitro. Low tumor TLR9 expression has been associated with poor survival in Caucasian patients with triple negative breast cancer (TNBC). African American (AA) patients with TNBC have worse prognosis than Caucasians but whether this is due to differences in tumor biology remains controversial. We studied the prognostic significance of tumor Toll like receptor-9 (TLR9) protein expression among African American (AA) triple negative breast cancer (TNBC) patients. Germline TLR9 variants in European Americans (EAs) and AAs were investigated, to determine their contribution to AA breast cancer risk. Methods TLR9 expression was studied with immunohistochemistry in archival tumors. Exome Variant Server and The Cancer Genome Atlas were used to determine the genetic variation in the general EA and AA populations, and AA breast cancer cases. Minor allele frequencies (MAFs) were compared between EAs (n = 4300), AAs (n = 2203), and/or AA breast cancer cases (n = 131). Results Thirty-two TLR9 variants had a statistically significant MAF difference between general EAs and AAs. Twenty-one of them affect a CpG site. Rs352140, a variant previously associated with protection from breast cancer, is more common in EAs than AAs (p = 2.20E-16). EAs had more synonymous alleles, while AAs had more rare coding alleles. Similar analyses comparing AA breast cancer cases with AA controls did not reveal any variant class differences; however, three previously unreported TLR9 variants were associated with late onset breast cancer. Although not statistically significant, rs352140 was observed less frequently in AA cases compared to controls. Tumor TLR9 protein expression was not associated with prognosis. Conclusions Tumor TLR9 expression is not associated with prognosis in AA TNBC. Significant differences were detected in TLR9 variant MAFs between EAs and AAs. They may affect TLR9 expression and function. Rs352140, which may protect from breast cancer, is 1.6 X more common among EAs. These findings call for a detailed analysis of the contribution of TLR9 to breast cancer pathophysiology and health disparities.	[Chandler, Madison R.] Auburn Univ, Harrison Sch Pharm, Auburn, AL 36849 USA; [Keene, Kimberly S.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Tuomela, Johanna M.] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Forero-Torres, Andres; Harris, Kevin W.] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Forero-Torres, Andres; Desmond, Renee; Harris, Kevin W.; Selander, Katri S.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Desmond, Renee] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Vuopala, Katri S.; Selander, Katri S.] Lapland Cent Hosp, Dept Pathol, Rovaniemi, Finland; [Harris, Kevin W.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Merner, Nancy D.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Selander, Katri S.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	Auburn University System; Auburn University; University of Alabama System; University of Alabama Birmingham; University of Turku; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Auburn University System; Auburn University; University of Alabama System; University of Alabama Birmingham	Selander, KS (corresponding author), Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.; Selander, KS (corresponding author), Lapland Cent Hosp, Dept Pathol, Rovaniemi, Finland.; Selander, KS (corresponding author), Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.	Katriselander@uabmc.edu	Selander, Katri/GWM-8685-2022	Selander, Katri/0000-0003-4812-294X; Merner, Nancy/0000-0002-8954-0155; Tuomela, Johanna/0000-0003-4390-4563	Breast Cancer Research Foundation of Alabama; Maud Kuistila memorial foundation; Orion-Farmos Research foundation; Turku University foundation; Finnish Cultural foundation; Jane and Aatos Erkko Foundation; K. Albin Johansson foundation	Breast Cancer Research Foundation of Alabama; Maud Kuistila memorial foundation; Orion-Farmos Research foundation; Turku University foundation; Finnish Cultural foundation(Finnish Cultural FoundationFinnish IT center for science); Jane and Aatos Erkko Foundation; K. Albin Johansson foundation	This study was supported by grants from Breast Cancer Research Foundation of Alabama (K.S.S.), Maud Kuistila memorial foundation (J.T), Orion-Farmos Research foundation (J.T), Turku University foundation (J.T), Finnish Cultural foundation (J.T), Jane and Aatos Erkko Foundation (J.T.) and K. Albin Johansson foundation (J.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from Breast Cancer Research Foundation of Alabama (K.S.S.), Maud Kuistila memorial foundation (J.T), Orion-Farmos Research foundation (J.T), Turku University foundation (J.T), Finnish Cultural foundation (J.T), Jane and Aatos Erkko Foundation (J.T.) and K. Albin Johansson foundation (J.T). The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Adzhubei I, 2013, CURR PROTOC HUM GENE; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Berger R, 2010, CANCER SCI, V101, P1059, DOI 10.1111/j.1349-7006.2010.01491.x; Carotenuto P, 2010, CRIT REV EUKAR GENE, V20, P17, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.20; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028256; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen KH, 2011, BRIT J SURG, V98, P1252, DOI 10.1002/bjs.7532; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Di JM, 2009, CANCER GENET CYTOGEN, V192, P60, DOI 10.1016/j.cancergencyto.2009.03.006; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoque R, 2012, PANCREAS, V41, P353, DOI 10.1097/MPA.0b013e3182321500; Hyslop T, 2013, BIOMARK MED, V7, P11, DOI [10.2217/bmm.12.114, 10.2217/BMM.12.114]; Ilvesaro JM, 2008, MOL CANCER RES, V6, P1534, DOI 10.1158/1541-7786.MCR-07-2005; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Jukkola-Vuorinen A, 2009, J INNATE IMMUN, V1, P59, DOI 10.1159/000151602; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Karody V, 2016, J MATERN-FETAL NEO M, V29, P2210, DOI 10.3109/14767058.2015.1081590; Kauppila JH, 2011, HISTOPATHOLOGY, V59, P643, DOI 10.1111/j.1365-2559.2011.03991.x; Korvala J, 2014, J ORAL PATHOL MED; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lamphier MS, 2006, ANN NY ACAD SCI, V1082, P31, DOI 10.1196/annals.1348.005; Lange NE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-26; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leppanen J, 2017, VIRCHOWS ARCH; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Lim JS, 2016, BIOCHEM BIOPH RES CO, V481, P219, DOI 10.1016/j.bbrc.2016.10.105; Long MD, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010015; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng YX, 2008, J NEURO-ONCOL, V88, P19, DOI 10.1007/s11060-008-9536-2; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Meseure D, 2016, CANCER MICROENVIRON, V9, P107, DOI 10.1007/s12307-016-0186-1; Mukherjee S, 2014, J INFLAMM RES, V7, P89, DOI 10.2147/JIR.S61365; Nurmenniemi S, 2010, EXP CELL RES, V316, P2676, DOI 10.1016/j.yexcr.2010.05.024; Ogden A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42289; Omar AH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-168; Paul WE, 2011, CELL, V147, P1212, DOI 10.1016/j.cell.2011.11.036; Ronkainen H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-84; Sandholm J, 2014, ONCOL LETT, V8, P266, DOI 10.3892/ol.2014.2095; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Sturtz LA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-62; Takala H, 2011, J INNATE IMMUN, V3, P631, DOI 10.1159/000329115; Tuomela J, 2013, BREAST CANCER RES TR, V142, P477, DOI 10.1007/s10549-013-2762-0; Tuomela J, 2012, BREAST CANCER RES TR, V135, P481, DOI 10.1007/s10549-012-2181-7; U. S. Department of Health and Human Services NIoH National Cancer Institute USA. gov, GDC DATA TRANSFER TO; U. S. Department of Health and Human Services NIoH National Cancer Institute USA. gov, GENOMIC DATA COMMONS; Vaisanen MR, 2013, ONCOL LETT, V5, P1659, DOI 10.3892/ol.2013.1204; Vaisanen MR, 2010, PROSTATE, V70, P817, DOI 10.1002/pros.21115; Wagner H, 2002, CURR OPIN MICROBIOL, V5, P62, DOI 10.1016/S1369-5274(02)00287-4; Wan GX, 2014, ASIAN PAC J CANCER P, V15, P8279, DOI 10.7314/APJCP.2014.15.19.8279; Wang XH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15037641; Zhang LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071785; Zhang PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42796; Zhang YB, 2009, MOL BIOL REP, V36, P1475, DOI 10.1007/s11033-008-9338-9	58	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183832	10.1371/journal.pone.0183832	http://dx.doi.org/10.1371/journal.pone.0183832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886076	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100040
J	Jeong, S; Kim, J; Park, W; Jeon, H; Kim, N				Jeong, Seongmun; Kim, Jiwoong; Park, Won; Jeon, Hongmin; Kim, Namshin			SEXCMD: Development and validation of sex marker sequences for whole-exome/genome and RNA sequencing	PLOS ONE			English	Article							ASSOCIATION	Over the last decade, a large number of nucleotide sequences have been generated by next-generation sequencing technologies and deposited to public databases. However, most of these datasets do not specify the sex of individuals sampled because researchers typically ignore or hide this information. Male and female genomes in many species have distinctive sex chromosomes, XX/XY and ZW/ZZ, and expression levels of many sex-related genes differ between the sexes. Herein, we describe how to develop sex marker sequences from syntenic regions of sex chromosomes and use them to quickly identify the sex of individuals being analyzed. Array-based technologies routinely use either known sex markers or the B-allele frequency of X or Z chromosomes to deduce the sex of an individual. The same strategy has been used with whole-exome/genome sequence data; however, all reads must be aligned onto a reference genome to determine the B-allele frequency of the X or Z chromosomes. SEXCMD is a pipeline that can extract sex marker sequences from reference sex chromosomes and rapidly identify the sex of individuals from whole-exome/genome and RNA sequencing after training with a known dataset through a simple machine learning approach. The pipeline counts total numbers of hits from sex-specific marker sequences and identifies the sex of the individuals sampled based on the fact that XX/ZZ samples do not have Y or W chromosome hits. We have successfully validated our pipeline with mammalian (Homo sapiens; XY) and avian (Gallus gallus; ZW) genomes. Typical calculation time when applying SEXCMD to human whole-exome or RNA sequencing datasets is a few minutes, and analyzing human whole-genome datasets takes about 10 minutes. Another important application of SEXCMD is as a quality control measure to avoid mixing samples before bioinformatics analysis. SEXCMD comprises simple Python and R scripts and is freely available at https://github. com/lovemun/SEXCMD.	[Jeong, Seongmun; Park, Won; Jeon, Hongmin; Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Kim, Jiwoong] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, N (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea.	deepreds@kribb.re.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Jeong, Seongmun/0000-0002-0038-461X	National Research Foundation of Korea [NRF-2011-0030049, NRF-2014M3C9A3064552]; Korea Research Institute of Bioscience and Biotechnology; KRIBB Initiative program	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Institute of Bioscience and Biotechnology; KRIBB Initiative program	This work was supported by grants from the National Research Foundation of Korea, Grant NRF-2011-0030049, NRF-2014M3C9A3064552 (http://www.nrf.re.kr/) and the Korea Research Institute of Bioscience and Biotechnology, NK., KRIBB Initiative program (http://www.kribb.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Research Foundation of Korea (NRF-2011-0030049, NRF-2014M3C9A3064552) and the KRIBB Initiative program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Chaveerach A, 2015, FORENS SCI INT-GEN S, V5, pE390, DOI 10.1016/j.fsigss.2015.09.154; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H., 2013, 13033997V1 ARXIV; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian DC, 2017, BIOINFORMATICS, V33, P561, DOI 10.1093/bioinformatics/btw696; Qu Conghui, 2011, Frontiers in Genetics, V2, P31, DOI 10.3389/fgene.2011.00031; Tzvetkov MV, 2010, PHARMACOGENOMICS, V11, P449, DOI [10.2217/pgs.10.14, 10.2217/PGS.10.14]	14	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184087	10.1371/journal.pone.0184087	http://dx.doi.org/10.1371/journal.pone.0184087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886064	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100065
J	Soeria-Atmadja, S; Osterberg, E; Gustafsson, LL; Dahl, ML; Eriksen, J; Rubin, J; Naver, L				Soeria-Atmadja, Sandra; Osterberg, Emma; Gustafsson, Lars L.; Dahl, Marja-Liisa; Eriksen, Jaran; Rubin, Johanna; Naver, Lars			Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin	PLOS ONE			English	Article							AFRICAN HIV/AIDS PATIENTS; POPULATION PHARMACOKINETICS; HIV-1-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; POLYMORPHISMS; VARIABILITY; METABOLISM; PHARMACOGENETICS; GUIDELINES; NEVIRAPINE	Background Approximately 2.6 million children live with HIV globally, and efavirenz (EFV) is one of the most widely used antiretroviral agents for HIV treatment in children and adults. There are concerns about the appropriateness of current EFV dosing and it has been discussed whether EFV dosing should be adapted according to genotype in children as suggested for adults. Aim To investigate if pediatric EFV dosing should be guided by genetic variation in drug metabolizing enzymes rather than by body weight. Method EFV plasma concentrations measured for clinical purposes from all children less than 18 years old at Karolinska University Hospital, Stockholm, Sweden, treated with EFV were collected retrospectively. They were genotyped for eleven polymorphisms in genes coding for drug-metabolizing enzymes and P-glycoprotein, of potential importance for EFV disposition. Data on country of origin, sex, age, weight, HIV RNA, viral resistance patterns, CD4 cells, adherence to treatment, subjective health status and adverse events were collected from their medical records. Results Thirty-six patients and 182 (mean 5 samples/patient) EFV plasma concentration measurements from children of African, Asian and Latin American origin were included. EFV plasma concentration varied 21-fold between measurements (n = 182) (0.85 - 19.3 mg/L) and 9-fold measured as mean EFV plasma concentration across the subjects (1.55-13.4 mg/L). A multivariate mixed-effects restricted maximum likelihood regression model, including multiple gene polymorphisms, identified CYP2B6*6 T/T (p < 0.0005), CYP2B6*11 G/G (p < 0.0005), CYP2A6*9 A/C (p = 0.001) genotypes, age at treatment initiation (p = 0.002) and time from treatment initiation (p < 0.0005) as independent factors significantly related to log(e) concentration/(dose/weight). The contribution of the model to the intra-and interindividual variation were 6 and 75%, respectively (Bryk/Raudenbush R-squared level). Conclusion Genetic polymorphisms in CYP2B6 and CYP2A6 explained a significant proportion of variability in EFV plasma concentration in HIV-infected children in a multi-ethnic outpatient clinic. Knowledge about individual variants in key drug metabolizing enzyme genes could improve clinical safety and genotype directed dosing could achieve more predictable EFV plasma concentrations in HIV-infected children.	[Soeria-Atmadja, Sandra; Osterberg, Emma; Rubin, Johanna; Naver, Lars] Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden; [Soeria-Atmadja, Sandra; Rubin, Johanna; Naver, Lars] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Gustafsson, Lars L.; Dahl, Marja-Liisa; Eriksen, Jaran] Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Naver, L (corresponding author), Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden.; Naver, L (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.	lars.naver@ki.se	Navér, Lars/E-5085-2013	Eriksen, Jaran/0000-0003-1146-5615; Naver, Lars/0000-0001-6027-0211	Swedish Order of Freemason Foundation for Children; Samariten Foundation; Jerring Foundation; Karolinska Institutet Funds [2013tobi37895]; Swedish Research Council [2011-3440, VR-Link 2012-3466]	Swedish Order of Freemason Foundation for Children; Samariten Foundation; Jerring Foundation; Karolinska Institutet Funds; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Swedish Order of Freemason Foundation for Children (LN), the Samariten Foundation (SSA), the Jerring Foundation (LN), Karolinska Institutet Funds (2013tobi37895) (LN) and the Swedish Research Council (2011-3440 and VR-Link 2012-3466) (LLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by grants from the Swedish Order of Freemason Foundation for Children (LN), the Samariten Foundation (SSA), the Jerring Foundation (LN), Karolinska Institutet Funds (LN) and the Swedish Research Council (2011-3440 and VR-Link 20123466) (LLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin J, 2015, LANCET INFECT DIS, V15, P793, DOI 10.1016/S1473-3099(15)70060-5; Barrett JS, 2002, INT J CLIN PHARM TH, V40, P507; BRYK AS, 1988, PSYCHOL BULL, V104, P396, DOI 10.1037/0033-2909.104.3.396; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Dalgaard LS, 2012, SCAND J INFECT DIS, V44, P108, DOI 10.3109/00365548.2011.616223; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Hirt D, 2009, ANTIMICROB AGENTS CH, V53, P4407, DOI 10.1128/AAC.01594-08; Holzinger ER, 2012, PHARMACOGENET GENOM, V22, P858, DOI 10.1097/FPC.0b013e32835a450b; Hoody Dorie W, 2003, Semin Pediatr Infect Dis, V14, P286, DOI 10.1053/j.spid.2003.09.004; Kwara A, 2009, AIDS, V23, P2101, DOI 10.1097/QAD.0b013e3283319908; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Luo M, 2016, ANTIMICROB AGENTS CH, V60, P3676, DOI 10.1128/AAC.02678-15; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Mirghani RA, 2006, PHARMACOGENET GENOM, V16, P637, DOI 10.1097/01.fpc.0000230411.89973.1b; Moore CB, 2017, AIDS, V31, P1129, DOI 10.1097/QAD.0000000000001463; Mukonzo JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086919; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Mutwa PR, 2012, JAIDS-J ACQ IMM DEF, V60, P400, DOI 10.1097/QAI.0b013e3182569f57; Naidoo P, 2014, EUR J CLIN PHARMACOL, V70, P379, DOI 10.1007/s00228-013-1634-1; Ngaimisi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067946; Pfister M, 2003, ANTIMICROB AGENTS CH, V47, P130, DOI 10.1128/AAC.47.1.130-137.2003; Pinillos F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1381-x; Puthanakit T, ANTIVIR THER; Ren Y, 2007, JAIDS-J ACQ IMM DEF, V45, P133, DOI 10.1097/QAI.0b013e31805c9d52; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rodriguez-Novoa S, 2005, CLIN INFECT DIS, V40, P1358, DOI 10.1086/429327; Saitoh A, 2007, JAIDS-J ACQ IMM DEF, V45, P280; Salem AH, 2014, ANTIMICROB AGENTS CH, V58, P136, DOI 10.1128/AAC.01738-13; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sinxadi PZ, 2015, BRIT J CLIN PHARMACO, V80, P146, DOI 10.1111/bcp.12590; Smith RL, 2021, J INFECT DIS; Stahle L, 2004, THER DRUG MONIT, V26, P267, DOI 10.1097/00007691-200406000-00008; Stohr W, 2008, ANTIVIR THER, V13, P675; Sukasem C, 2014, INFECTION, V42, P469, DOI 10.1007/s15010-013-0560-6; Swart M, 2013, PHARMACOGENET GENOM, V23, P415, DOI 10.1097/FPC.0b013e328363176f; Swart Marelize, 2012, Frontiers in Genetics, V3, P236, DOI 10.3389/fgene.2012.00236; Heine R, 2008, ANTIVIR THER, V13, P779; Usach I, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18567; Van Leth F, 2006, AIDS RES HUM RETROV, V22, P232, DOI 10.1089/aid.2006.22.232; Viljoen M, 2012, EUR J CLIN PHARMACOL, V68, P339, DOI 10.1007/s00228-011-1148-7; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; WHO, CONS US ANT DRUGS TR	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0181316	10.1371/journal.pone.0181316	http://dx.doi.org/10.1371/journal.pone.0181316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886044	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100002
J	Wang, W; Li, K; Yue, SW; Yin, CP; Wei, N				Wang, Wei; Li, Ke; Yue, Shouwei; Yin, Cuiping; Wei, Na			Associations between lower-limb muscle activation and knee flexion in post-stroke individuals: A study on the stance-to-swing phases of gait	PLOS ONE			English	Article							RECTUS FEMORIS; CEREBRAL-PALSY; CHRONIC STROKE; WALKING; EXERCISE; CLASSIFICATION; COORDINATION; HEMIPARESIS; KINEMATICS; STRATEGIES	Reduced knee flexion is a leading feature of post-stroke gait, but the causes have not been well understood. The purpose of this study was to investigate the relationship between the knee flexion and the lower-limb muscle activation within the stance-to-swing phases of gait cycle in the post-stroke hemiplegic patients. Ten stroke patients and 10 age- and gender-matched healthy subjects participated in the experiment. The lower-limb kinematic signals and the surface electromyography (sEMG) signals of the left and right rectus femoris (RF), biceps femoris (BF) and lateral gastrocnemius (GS) were recorded during walking. The angle range (AR) of knee flexion, the root mean square (RMS) and the mean frequency (MNF) of sEMG signals were calculated from the terminal stance (TSt) to the initial swing (ISw) phases of gait cycle. Stroke patients showed lower bilateral AR of knee flexion and lower RMS of GS on the paretic side, but higher MNF of RF on the non-paretic side compared with the controls. Within the stroke patients, significant differences were found between their paretic and non-paretic limbs in the AR of knee flexion, as well as in the RMS and MNF of GS (p < 0.05). Regression analysis showed that the RMS of BF, MNF of BF and MNF of GS explained 82.1% of variations in AR of knee flexion on paretic side (r(2) = 0.821). But the RMS and MNF of all the muscles (including the RF, GS and BF) could explain 65.6% of AR of knee flexion variations on the non-paretic side (r(2) = 0.656), and 45.2% of variations for the healthy subjects (r(2) = 0.452). The reduced knee flexion during gait was associated with altered magnitude and frequency of muscle contractions and with simplified muscle synergy in the post-stroke hemiplegic patients. Identifying the muscles that are responsible for knee stiffness may facilitate improvement of rehabilitation strategy for post-stroke gait.	[Wang, Wei; Li, Ke] Shandong Univ, Sch Control Sci & Engn, Inst Biomed Engn, Lab Motor Control & Rehabil, Jinan, Shandong, Peoples R China; [Yue, Shouwei; Yin, Cuiping] Shandong Univ, Qilu Hosp, Dept Phys Med & Rehabil, Jinan, Shandong, Peoples R China; [Wei, Na] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, K (corresponding author), Shandong Univ, Sch Control Sci & Engn, Inst Biomed Engn, Lab Motor Control & Rehabil, Jinan, Shandong, Peoples R China.	kli@sdu.edu.cn		Li, Ke/0000-0002-8660-0116	National Natural Science Foundation of China [31200744]; Key Research & Development Programs of Shandong Province [KL 2015GSF118127, 2015GSF118127]; China Postdoctoral Science Foundation [KL 2014M560558, 2015T80723, 2014M560558]; Postdoctoral Innovation Foundation of Shandong Province [KL 201401012, 201401012]; Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research & Development Programs of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Innovation Foundation of Shandong Province; Shandong University	Funded by 31200744, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, KL 2015GSF118127, http://www.sdstc.gov.cn/, Key Research & Development Programs of Shandong Province, KL 2014M560558, 2015T80723, http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx, China Postdoctoral Science Foundation, KL 201401012, http://www.sdhrss.gov.cn/, Postdoctoral Innovation Foundation of Shandong Province, KL NA, http://www.sdu.edu.cn, Young Scholars Program of Shandong University, KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (31200744), Key Research & Development Programs of Shandong Province (2015GSF118127), China Postdoctoral Science Foundation (2014M560558, 2015T80723), Postdoctoral Innovation Foundation of Shandong Province (201401012), Young Scholars Program of Shandong University. The authors give thanks to all the stroke patients and healthy subjects for their participation in the experiment.	Alcan V, 2017, TURK J MED SCI, V47, P148, DOI 10.3906/sag-1512-65; Allen JL, 2014, CLIN BIOMECH, V29, P780, DOI 10.1016/j.clinbiomech.2014.06.001; Anderson FC, 2004, J BIOMECH, V37, P731, DOI 10.1016/j.jbiomech.2003.09.018; Boudarham J, 2013, J ELECTROMYOGR KINES, V23, P1036, DOI 10.1016/j.jelekin.2013.07.002; Boudarham J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094138; Burpee JL, 2015, CLIN BIOMECH, V30, P1102, DOI 10.1016/j.clinbiomech.2015.08.018; Chen IH, 2014, CHINESE J PHYSIOL, V57, P128, DOI 10.4077/CJP.2014.BAC204; Cruz AI, 2011, J PEDIATR ORTHOPED, V31, P541, DOI 10.1097/BPO.0b013e31821f818d; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Drefus LC, 2014, GAIT POSTURE, V40, P145, DOI 10.1016/j.gaitpost.2014.03.017; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Francis CA, 2013, GAIT POSTURE, V38, P993, DOI 10.1016/j.gaitpost.2013.05.009; George-Reichley DG, 2010, J APPL BIOMECH, V26, P180, DOI 10.1123/jab.26.2.180; Gray VL, 2015, J ELECTROMYOGR KINES, V25, P959, DOI 10.1016/j.jelekin.2015.09.003; Hill E, 2016, CONCENTRIC MUSCLE AC, V4; Jung H, 2015, INT J PRECIS ENG MAN, V16, P2219, DOI 10.1007/s12541-015-0286-8; Knuppe AE, 2013, GAIT POSTURE, V37, P345, DOI 10.1016/j.gaitpost.2012.07.034; Lamontagne A, 2000, J ELECTROMYOGR KINES, V10, P407, DOI 10.1016/S1050-6411(00)00028-6; Lewek MD, 2014, J APPL BIOMECH, V30, P31, DOI 10.1123/jab.2012-0208; Li JM, 2007, J AM PODIAT MED ASSN, V97, P447, DOI 10.7547/0970447; Lo J, 2017, GAIT POSTURE, V53, P110, DOI 10.1016/j.gaitpost.2017.01.010; Nadiv Y, 2012, J APPL BIOMECH, V28, P139, DOI 10.1123/jab.28.2.139; Ostadal M, 2007, ACTA CHIR ORTHOP TR, V74, P388; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Sarre G, 2005, ACTA PHYSIOL SCAND, V185, P321, DOI 10.1111/j.1365-201X.2005.01490.x; Tennant LM, 2014, J ELECTROMYOGR KINES, V24, P711, DOI 10.1016/j.jelekin.2014.06.011; Wonsetler E.C., 2017, TOP STROKE REHABIL, V21, P1; Wonsetler EC, 2017, TOP STROKE REHABIL, V24, P394, DOI 10.1080/10749357.2017.1282413	28	21	26	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183865	10.1371/journal.pone.0183865	http://dx.doi.org/10.1371/journal.pone.0183865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886079	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100042
J	Illera, JC; Lopez, G; Garcia-Padilla, L; Moreno, A				Carlos Illera, Juan; Lopez, Guillermo; Garcia-Padilla, Laura; Moreno, Angel			Factors governing the prevalence and richness of avian haemosporidian communities within and between temperate mountains	PLOS ONE			English	Article							PIPIT ANTHUS-BERTHELOTII; LEAST-SQUARES REGRESSION; NEVADA SOUTHERN SPAIN; EUROPA NATIONAL-PARK; CLIMATE-CHANGE; MALARIA TRANSMISSION; BLOOD PARASITES; SIERRA-NEVADA; HAPLOTYPE RECONSTRUCTION; LAST DEGLACIATION	Mountains are well-suited systems to disentangle the factors driving distribution of parasites due to their heterogeneity of climatic and habitat conditions. However, the information about the relative importance of environmental factors governing the distribution of avian haemosporidians on temperate mountains is very limited. The main goal of the present study is to identify the factors determining prevalence and richness in avian haemosporidians ( Plasmodium, Haemoproteus and Leucocytozoon) at the community level along elevational gradients on two mountain ranges located around the northern and southern limits of the Iberian Peninsula (Spain). We used samples from 68 avian species and 1,460 breeding individuals caught over widespread woodland and open habitats. Our findings confirmed the importance of climatic variables explaining prevalence and richness on Iberian mountains. However, landscape variables and other factors named host richness and migration behaviour explained more variation than climatic ones. Plasmodium genus preferred open and warm habitats. Water sources were also important for the southern but not for the northern mountain. Haemoproteus and Leucocytozoon showed affinities for woodland areas. Climatic conditions for Haemoproteus and Leucocytozoon were dependent on the mountain range suggesting some adaptation of avian haemosporidian and their invertebrate vectors to the climatic particularities of both mountain massifs. In contrast to Plasmodium and Haemoproteus genera, Leucocytozoon prevalence and richness values were significantly higher in the southern mountain range. Overall, our findings at the community level has enriched the relative weight and effect direction of environmental factors governing the distribution and prevalence of the avian haemosporidian community. Also, our results provide a caution message about the precision of predictive models on parasite distributions based on climatic variables, since such predictions could overestimate the effect of climate change scenarios on the transmission of the haemosporidians.	[Carlos Illera, Juan; Garcia-Padilla, Laura] Oviedo Univ, Res Unit Biodivers, Mieres, Asturias, Spain; [Lopez, Guillermo] Inst Biol Conservac, Malaga, Spain; [Moreno, Angel] Vice Council Environm, Serv Environm Impact, Las Palmas Gran Canaria, Canary Islands, Spain		Illera, JC (corresponding author), Oviedo Univ, Res Unit Biodivers, Mieres, Asturias, Spain.	illerajuan@uniovi.es	Illera, Juan Carlos/C-6583-2014	Illera, Juan Carlos/0000-0002-4389-0264	Spanish Administration of National Parks; Spanish Minister of Agriculture, Food and Environment [375/2011]	Spanish Administration of National Parks; Spanish Minister of Agriculture, Food and Environment	This study was funded by the Spanish Administration of National Parks, Spanish Minister of Agriculture, Food and Environment (Ref.: 375/2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Anderson RS, 2011, QUATERNARY SCI REV, V30, P1615, DOI 10.1016/j.quascirev.2011.03.005; Rojo MA, 2013, BIRD STUDY, V60, P247, DOI 10.1080/00063657.2012.744807; Asghar M, 2015, SCIENCE, V347, P436, DOI 10.1126/science.1261121; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bruford Michael W., 1998, P287; Illera JC, 2015, J BIOGEOGR, V42, P1858, DOI 10.1111/jbi.12548; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Christiansen-Jucht C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0489-3; Clark NJ, 2017, MOL ECOL, V26, P3074, DOI 10.1111/mec.14101; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Currie DC, 2008, HYDROBIOLOGIA, V595, P469, DOI 10.1007/s10750-007-9114-1; Dulle HI, 2016, DIVERS DISTRIB, V22, P288, DOI 10.1111/ddi.12405; Ellisa VA, 2015, P NATL ACAD SCI USA, V112, P11294, DOI 10.1073/pnas.1515309112; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Gonzalez AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100695; Gonzalez-Quevedo C, 2014, J ANIM ECOL, V83, P1091, DOI 10.1111/1365-2656.12214; Goudie Andrew, 2013, HUMAN IMPACT NATURAL; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gutierrez D, 2004, BIOL CONSERV, V115, P379, DOI 10.1016/S0006-3207(03)00154-X; Gutierrez-Lopez R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1903-9; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrigan RJ, 2014, EVOL APPL, V7, P799, DOI 10.1111/eva.12176; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Illera JC, 2008, PARASITOL RES, V103, P1435, DOI 10.1007/s00436-008-1153-7; Ishtiaq F, 2010, J BIOGEOGR, V37, P120, DOI 10.1111/j.1365-2699.2009.02189.x; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; Krizanauskiene A, 2006, J PARASITOL, V92, P1319, DOI 10.1645/GE-873R.1; Laiolo P, 2013, J EVOLUTION BIOL, V26, P2171, DOI 10.1111/jeb.12213; Laiolo P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1808; Laiolo P, 2015, AM NAT, V185, P169, DOI 10.1086/679348; Liao W, 2015, GLOBAL CHANGE BIOL, V21, P4342, DOI 10.1111/gcb.13005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loiseau C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01126; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martins IS, 2014, ACTA OECOL, V61, P41, DOI 10.1016/j.actao.2014.10.005; Melendez L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101942; Melendez L, 2014, IBIS, V156, P276, DOI 10.1111/ibi.12127; Menendez R, 2014, GLOBAL ECOL BIOGEOGR, V23, P646, DOI 10.1111/geb.12142; Moens MAJ, 2016, J ANIM ECOL, V85, P1234, DOI 10.1111/1365-2656.12550; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Moreno A, 2010, J QUATERNARY SCI, V25, P1076, DOI 10.1002/jqs.1265; Outlaw DC, 2016, PARASITOLOGY, V8, P1; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Padilla DP, 2017, INT J PARASITOL, V47, P225, DOI 10.1016/j.ijpara.2016.11.008; Palacios D, 2016, QUATERNARY SCI REV, V150, P110, DOI 10.1016/j.quascirev.2016.08.012; Perez-Rodriguez A, 2014, GLOBAL CHANGE BIOL, V20, P2406, DOI 10.1111/gcb.12542; Perez-Rodriguez A, 2013, GLOBAL CHANGE BIOL, V19, P3245, DOI 10.1111/gcb.12226; Perez-Tris J, 2005, TRENDS PARASITOL, V21, P209, DOI 10.1016/j.pt.2005.03.001; Ploquin EF, 2013, OECOLOGIA, V173, P1649, DOI 10.1007/s00442-013-2731-7; Pointing SB, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.145, 10.1038/NMICROBIOL.2016.145]; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; Scordato ESC, 2014, J ANIM ECOL, V83, P1387, DOI 10.1111/1365-2656.12246; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Spurgin LG, 2012, OECOLOGIA, V168, P691, DOI 10.1007/s00442-011-2149-z; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valkinas G., 2005, AVIAN MALARIA PARASI; Ya'cob Z, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1492-7; Young HS, 2017, TRENDS ECOL EVOL, V32, P41, DOI 10.1016/j.tree.2016.09.008; Zamora R, 2015, ARDEOLA, V62, P3, DOI 10.13157/arla.62.1.2015.3; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	67	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184587	10.1371/journal.pone.0184587	http://dx.doi.org/10.1371/journal.pone.0184587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880919	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200079
J	Deshpande, CN; Xin, V; Lu, Y; Savage, T; Anderson, GJ; Jormakka, M				Deshpande, Chandrika N.; Xin, Vicky; Lu, Yan; Savage, Tom; Anderson, Gregory J.; Jormakka, Mika			Large scale expression and purification of secreted mouse hephaestin	PLOS ONE			English	Article							RECOMBINANT HUMAN HEPHAESTIN; NUCLEAR POLYHEDROSIS-VIRUS; FERROXIDASE ACTIVITY; INSECT CELLS; IRON EFFLUX; NEURODEGENERATIVE DISORDERS; MULTICOPPER OXIDASE; FET3 PROTEIN; BRAIN IRON; CERULOPLASMIN	Hephaestin is a large membrane-anchored multicopper ferroxidase involved in mammalian iron metabolism. Newly absorbed dietary iron is exported across the enterocyte basolateral membrane by the ferrous iron transporter ferroportin, but hephaestin increases the efficiency of this process by oxidizing the transported iron to its ferric form and promoting its release from ferroportin. Deletion or mutation of the hephaestin gene leads to systemic anemia with iron accumulation in the intestinal epithelium. The crystal structure of human ceruloplasmin, another multicopper ferroxidase with 50% sequence identity to hephaestin, has provided a framework for comparative analysis and modelling. However, detailed structural information for hephaestin is still absent, leaving questions relating to metal coordination and binding sites unanswered. To obtain structural information for hephaestin, a reliable protocol for large-scale purification is required. Here, we present an expression and purification protocol of soluble mouse hephaestin, yielding milligram amounts of enzymatically active, purified protein using the baculovirus/insect cell system.	[Deshpande, Chandrika N.; Xin, Vicky; Jormakka, Mika] Centenary Inst, Struct Biol Program, Sydney, NSW, Australia; [Deshpande, Chandrika N.; Xin, Vicky; Jormakka, Mika] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Lu, Yan; Anderson, Gregory J.] QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld, Australia; [Savage, Tom] Univ Sydney, Sch Geosci, Sydney, NSW, Australia; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Sydney; Centenary Institute; University of Sydney; QIMR Berghofer Medical Research Institute; University of Sydney; University of Queensland	Jormakka, M (corresponding author), Centenary Inst, Struct Biol Program, Sydney, NSW, Australia.; Jormakka, M (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	m.jormakka@centenary.org.au	; Anderson, Gregory/G-4148-2013	Deshpande, Chandrika/0000-0002-5557-519X; Anderson, Gregory/0000-0002-8814-5866	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK107309]; National Health and Medical Research Council (NHMRC) [APP1083536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107309] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported primarily by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK107309 and by the National Health and Medical Research Council (NHMRC) (grant No. APP1083536) (to M. J.). The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK, the National Institutes of Health, and NHMRC.	Bruinzeel W, 2002, PROTEIN EXPRES PURIF, V26, P139, DOI 10.1016/S1046-5928(02)00516-8; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; DEXTER DT, 1993, ADV NEUROL, V60, P273; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; Griffiths TAM, 2005, BIOCHEMISTRY-US, V44, P14725, DOI 10.1021/bi051559k; Hancock K, 2008, J IMMUNOL METHODS, V330, P130, DOI 10.1016/j.jim.2007.08.002; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Heppner DE, 2014, J AM CHEM SOC, V136, P17788, DOI 10.1021/ja509150j; JARVIS DL, 1993, J BIOL CHEM, V268, P16754; Jiang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep39470; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Krammer F, 2010, BIOTECHNOL J, V5, P17, DOI 10.1002/biot.200900267; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Ponka P, 2004, ANN NY ACAD SCI, V1012, P267, DOI 10.1196/annals.1306.022; Price KA, 2011, INORG CHEM, V50, P9594, DOI 10.1021/ic201334q; Ranganathan PN, 2012, P NATL ACAD SCI USA, V109, P3564, DOI 10.1073/pnas.1120833109; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Sambrook J., 2001, MOL CLONING LAB MANU; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Syed BA, 2002, PROTEIN ENG, V15, P205, DOI 10.1093/protein/15.3.205; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Vashchenko G, 2012, J BIOL INORG CHEM, V17, P1187, DOI 10.1007/s00775-012-0932-x; Vashchenko G, 2011, ARCH BIOCHEM BIOPHYS, V514, P50, DOI 10.1016/j.abb.2011.07.010; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLKMAN LE, 1986, CURR TOP MICROBIOL, V131, P103; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Wessling-Resnick M, 2006, AM J PHYSIOL-GASTR L, V290, pG1, DOI 10.1152/ajpgi.00415.2005; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; WICKHAM TJ, 1993, BIOTECHNOL PROGR, V9, P25, DOI 10.1021/bp00019a004; YEHUDA S, 1989, AM J CLIN NUTR, V50, P618, DOI 10.1093/ajcn/50.3.618; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184366	10.1371/journal.pone.0184366	http://dx.doi.org/10.1371/journal.pone.0184366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880952	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200059
J	Maes, ME; Schlamp, CL; Nickells, RW				Maes, Margaret E.; Schlamp, Cassandra L.; Nickells, Robert W.			Live-cell imaging to measure BAX recruitment kinetics to mitochondria during apoptosis	PLOS ONE			English	Article							CYTOCHROME-C; BCL-2 FAMILY; MEMBRANE PERMEABILIZATION; PROAPOPTOTIC BAX; OUTER-MEMBRANE; BH3 DOMAINS; PORES; PROTEINS; CYTOSOL; RELEASE	The pro-apoptotic BCL2 gene family member, BAX, plays a pivotal role in the intrinsic apoptotic pathway. Under cellular stress, BAX recruitment to the mitochondria occurs when activated BAX forms dimers, then oligomers, to initiate mitochondria outer membrane permeabilization (MOMP), a process critical for apoptotic progression. The activation and recruitment of BAX to form oligomers has been studied for two decades using fusion proteins with a fluorescent reporter attached in-frame to the BAX N-terminus. We applied highspeed live cell imaging to monitor the recruitment of BAX fusion proteins in dying cells. Data from time-lapse imaging was validated against the activity of endogenous BAX in cells, and analyzed using sigmoid mathematical functions to obtain detail of the kinetic parameters of the recruitment process at individual mitochondrial foci. BAX fusion proteins behave like endogenous BAX during apoptosis. Kinetic studies show that fusion protein recruitment is also minimally affected in cells lacking endogenous BAK or BAX genes, but that the kinetics are moderately, but significantly, different with different fluorescent tags in the fusion constructs. In experiments testing BAX recruitment in 3 different cell lines, our results show that regardless of cell type, once activated, BAX recruitment initiates simultaneously within a cell, but exhibits varying rates of recruitment at individual mitochondrial foci. Very early during BAX recruitment, pro-apoptotic molecules are released in the process of MOMP, but different molecules are released at different times and rates relative to the time of BAX recruitment initiation. These results provide a method for BAX kinetic analysis in living cells and yield greater detail of multiple characteristics of BAX-induced MOMP in living cells that were initially observed in cell free studies.	[Maes, Margaret E.; Schlamp, Cassandra L.; Nickells, Robert W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Maes, Margaret E.] Univ Wisconsin, Sch Med & Publ Hlth, Cellular & Mol Pathol Grad Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Nickells, RW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nickells@wisc.edu		Nickells, Robert/0000-0002-2998-5494; Maes, Margaret/0000-0001-9642-1085	National Eye Institute [R01EY012223, P30 EY016665]; National Institutes of Health [T32GM081061]; Senior Scientist Research Award; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY016665, R01EY012223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senior Scientist Research Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from R01EY012223 and Vision Core Grant P30 EY016665 from the National Eye Institute, the National Institutes of Health grant T32GM081061, and a Senior Scientist Research Award and an unrestricted funding grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bardwell PD, 2009, J IMMUNOL, V182, P7482, DOI 10.4049/jimmunol.0802813; Bleicken S, 2014, MOL CELL, V56, P496, DOI 10.1016/j.molcel.2014.09.022; Bleicken S, 2013, J BIOL CHEM, V288, P33241, DOI 10.1074/jbc.M113.512087; Capano M, 2002, BIOCHEM J, V367, P169, DOI 10.1042/BJ20020805; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gillies LA, 2015, MOL BIOL CELL, V26, P339, DOI 10.1091/mbc.E13-11-0638; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Grosse L, 2016, EMBO J, V35, P402, DOI 10.15252/embj.201592789; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27299; Lartigue L, 2008, J CELL SCI, V121, P3515, DOI 10.1242/jcs.029587; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; McDowall LM, 2006, AM J PHYSIOL-HEART C, V291, pH2003, DOI 10.1152/ajpheart.00219.2006; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Ros U, 2015, J MEMBRANE BIOL, V248, P545, DOI 10.1007/s00232-015-9820-y; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Semaan SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-554; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210; Zhang Z, 2016, EMBO J, V35, P208, DOI 10.15252/embj.201591552	47	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184434	10.1371/journal.pone.0184434	http://dx.doi.org/10.1371/journal.pone.0184434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880942	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200068
J	Fernandez-Carrion, E; Martinez-Aviles, M; Ivorra, B; Martinez-Lopez, B; Ramos, AM; Sanchez-Vizcaino, J				Fernandez-Carrion, Eduardo; Martinez-Aviles, Marta; Ivorra, Benjamin; Martinez-Lopez, Beatriz; Manuel Ramos, Angel; Manuel Sanchez-Vizcaino, Jose			Motion-based video monitoring for early detection of livestock diseases: The case of African swine fever	PLOS ONE			English	Article							MOUTH-DISEASE; EPIDEMIC; VALIDATION	Early detection of infectious diseases can substantially reduce the health and economic impacts on livestock production. Here we describe a system for monitoring animal activity based on video and data processing techniques, in order to detect slowdown and weakening due to infection with African swine fever (ASF), one of the most significant threats to the pig industry. The system classifies and quantifies motion-based animal behaviour and daily activity in video sequences, allowing automated and non-intrusive surveillance in real-time. The aim of this system is to evaluate significant changes in animals' motion after being experimentally infected with ASF virus. Indeed, pig mobility declined progressively and fell significantly below pre-infection levels starting at four days after infection at a confidence level of 95%. Furthermore, daily motion decreased in infected animals by approximately 10% before the detection of the disease by clinical signs. These results show the promise of video processing techniques for real-time early detection of livestock infectious diseases.	[Fernandez-Carrion, Eduardo; Martinez-Aviles, Marta; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Vet Sch, VISAVET Ctr, Madrid, Spain; [Fernandez-Carrion, Eduardo; Martinez-Aviles, Marta; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Vet Sch, Anim Hlth Dept, Madrid, Spain; [Ivorra, Benjamin; Manuel Ramos, Angel] Univ Complutense Madrid, IMI Inst, MOMAT Res Grp, Madrid, Spain; [Ivorra, Benjamin; Manuel Ramos, Angel] Univ Complutense Madrid, Appl Math Dept, Madrid, Spain; [Martinez-Lopez, Beatriz] Univ Calif Davis, Sch Vet Med, CADMS Ctr Anim Dis Modeling & Surveillance, Davis, CA USA	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; University of California System; University of California Davis	Fernandez-Carrion, E (corresponding author), Univ Complutense Madrid, Vet Sch, VISAVET Ctr, Madrid, Spain.; Fernandez-Carrion, E (corresponding author), Univ Complutense Madrid, Vet Sch, Anim Hlth Dept, Madrid, Spain.	eduardofc@ucm.es	Ramos, Angel M/I-1670-2015; Aviles, Marta Martínez/P-5821-2014; Lopez, Beatriz Martinez/AAE-6692-2021; Ivorra, Benjamin/B-3346-2010	Ramos, Angel M/0000-0002-7882-0725; Aviles, Marta Martínez/0000-0002-7880-3829; Ivorra, Benjamin/0000-0002-0536-7149	EU project 'Rapid Field Diagnostics and Screening in Veterinary Medicine' [KBBE.2011.1.3-02]; Spanish Ministry of Economy and Competitiveness [MTM2015-64865-P]; Junta de Andalucia; European Regional Development Fund (ERDF) [P12-TIC301]	EU project 'Rapid Field Diagnostics and Screening in Veterinary Medicine'; Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Regional Development Fund (ERDF)(European Commission)	This study was funded by the EU project 'Rapid Field Diagnostics and Screening in Veterinary Medicine' (Rapidia Field, KBBE.2011.1.3-02, www.rapidia.eu), the Spanish Ministry of Economy and Competitiveness (project MTM2015-64865-P) and the Junta de Andalucia and the European Regional Development Fund (ERDF, project P12-TIC301).; This study was funded by the EU project 'Rapid Field Diagnostics and Screening in Veterinary Medicine' (Rapidia Field, KBBE.2011.1.3-02), the Spanish Ministry of Economy and Competitiveness (project MTM2015-64865-P) and the Junta de Andalucia and the European Regional Development Fund (ERDF, project P12-TIC301). We are grateful to the VISAVET centre staff who helped in the study.	Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Farid H., 1997, Computer Analysis of Images and Patterns. 7th International Conference, CAIP '97. Proceedings, P207, DOI 10.1007/3-540-63460-6_119; Fernandez-Carrion E, 2016, PREV VET MED, V126, P66, DOI 10.1016/j.prevetmed.2016.01.015; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Gibson JJ, 1950, PERCEPTION VISUAL WO; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Karlsson S. M., 2012, P IEEE COMP SOC C CO, P138, DOI [10.1109/CVPRW.2012.6239228, DOI 10.1109/CVPRW.2012.6239228]; Khobragade AS, 2012, INT J INFORM TECHNOL, V5, P9; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Sanchez-Vizcaino JM, 2013, VET MICROBIOL, V165, P45, DOI 10.1016/j.vetmic.2012.11.030; Martinez-Aviles M, 2017, TRANSBOUND EMERG DIS, V64, P364, DOI 10.1111/tbed.12372; Maselyne J, 2014, COMPUT ELECTRON AGR, V102, P10, DOI 10.1016/j.compag.2013.12.015; Matthews SG, 2016, VET J, V217, P43, DOI 10.1016/j.tvjl.2016.09.005; McLaws M, 2009, CAN VET J, V50, P53; Penrith ML, 2000, FOOD AGR ORG, V9; Siuly, 2011, COMPUT METH PROG BIO, V104, P358, DOI 10.1016/j.cmpb.2010.11.014; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; Stegeman A, 2000, VET MICROBIOL, V73, P183, DOI 10.1016/S0378-1135(00)00144-9; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517	22	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183793	10.1371/journal.pone.0183793	http://dx.doi.org/10.1371/journal.pone.0183793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877181	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200044
J	Belaqziz, M; Tan, SP; El-Abbassi, A; Kiai, H; Hafidi, A; O'Donovan, O; McLoughlin, P				Belaqziz, Majdouline; Tan, Shiau Pin; El-Abbassi, Abdelilah; Kiai, Hajar; Hafidi, Abdellatif; O'Donovan, Orla; McLoughlin, Peter			Assessment of the antioxidant and antibacterial activities of different olive processing wastewaters	PLOS ONE			English	Article							MILL WASTE-WATER; PHENOLIC-COMPOUNDS; OIL; EXTRACTS; DEGRADATION; CHEMISTRY; HEALTH	Olive processing wastewaters (OPW), namely olive mill wastewater (OMW) and table-olive wastewaters (TOW) were evaluated for their antibacterial activity against five Gram-positive and two Gram-negative bacteria using the standard disc diffusion and thin layer chromatography (TLC)-bioautography assays. Disc diffusion screening and bioautography of OMW were compared to the phenolic extracts of table-olive brines. Positive activity against S. aureus was demonstrated. The optimization of chromatographic separation revealed that hexane/acetone in the ratio of 4: 6 was the most effective for phenolic compounds separation. A HPLC-MS analysis was performed showing that only two compounds, hydroxytyrosol and tyrosol, were the predominant phenolic compounds in all OPW. The phenolic extract of OMW generated by a semi-modern process showed the highest free radical-scavenging activity (DPPH assay) compared to the other phenolic extracts. It is apparent from the present study that OPW are a rich source of antioxidants suitable for use in food, cosmetic or pharmaceutical applications.	[Belaqziz, Majdouline] Cadi Ayyad Univ, Ctr Anal & Characterizat, Marrakech, Morocco; [Tan, Shiau Pin; O'Donovan, Orla; McLoughlin, Peter] Waterford Inst Technol, PMBRC, Dept Sci, Waterford, Ireland; [El-Abbassi, Abdelilah; Kiai, Hajar; Hafidi, Abdellatif] Cadi Ayyad Univ, Food Sci Lab, Dept Biol, Fac Sci Semlalia, Marrakech, Morocco	Cadi Ayyad University of Marrakech; South East Technological University (SETU); Cadi Ayyad University of Marrakech	Belaqziz, M (corresponding author), Cadi Ayyad Univ, Ctr Anal & Characterizat, Marrakech, Morocco.	belaqzizmajdouline@yahoo.fr	Hafidi, Abdellatif/AAN-4591-2021; ABBASSI, Abdelilah EL/I-6519-2019	Hafidi, Abdellatif/0000-0002-2047-1091; ABBASSI, Abdelilah EL/0000-0002-1516-5030; Tan, Shiau Pin/0000-0002-1459-9996; O' Donovan, Orla/0000-0003-3980-8835; McLoughlin, Peter/0000-0002-1185-9860	European Commission; International Foundation for Sciences (IFS, Sweden) [W4749-1, W4749-2]	European Commission(European CommissionEuropean Commission Joint Research Centre); International Foundation for Sciences (IFS, Sweden)(International Foundation for Science)	Authors acknowledge Averroes Fellowship Program (funded by the European Commission within the framework of Erasmus Mundus) for funding the research stay of Dr. Majdouline Belaqziz in Waterford (Ireland). As well, Prof. Abdelilah El Abbassi greatly thanks the International Foundation for Sciences (IFS, Sweden) for their financial support under the grants number W4749-1 and W4749-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge Averroes Fellowship Program (funded by the European Commission within the framework of Erasmus Mundus) for funding the research stay of Dr. Majdouline Belaqziz in Waterford (Ireland). As well, Prof. Abdelilah El Abbassi greatly thanks the International Foundation for Sciences (IFS, Sweden) for their financial support under the grants number W4749-1 and W4749-2.	Ali HM, 2013, J PURE APPL MICROBIO, V7, P131; Aquilanti L, 2014, INT BIODETER BIODEGR, V88, P162, DOI 10.1016/j.ibiod.2013.12.010; Arroyo-Lopez FN, 2008, INT J FOOD MICROBIOL, V128, P189, DOI 10.1016/j.ijfoodmicro.2008.08.018; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Sanchez-Rangel JC, 2013, ANAL METHODS-UK, V5, P5990, DOI 10.1039/c3ay41125g; Cicerale S, 2009, CRIT REV FOOD SCI, V49, P218, DOI 10.1080/10408390701856223; Cirico TL, 2006, FOOD CHEM TOXICOL, V44, P510, DOI 10.1016/j.fct.2005.08.025; Dammak I, 2015, FOOD SCI TECHNOL RES, V21, P193, DOI 10.3136/fstr.21.193; de la Puerta R, 1999, BIOCHEM PHARMACOL, V57, P445, DOI 10.1016/S0006-2952(98)00320-7; Debo A, 2011, CROP PROT, V30, P1529, DOI 10.1016/j.cropro.2011.08.006; El-Abbassi A, 2017, SCI TOTAL ENVIRON, V576, P10, DOI 10.1016/j.scitotenv.2016.10.032; El-Abbassi A, 2014, J ENVIRON CHEM ENG, V2, P1480, DOI 10.1016/j.jece.2014.06.024; El-Abbassi A, 2012, FOOD CHEM, V132, P406, DOI 10.1016/j.foodchem.2011.11.013; El-Hadrami A., 2004, Journal of Agronomy, V3, P247; Eloff JN, 2008, J ETHNOPHARMACOL, V119, P686, DOI 10.1016/j.jep.2008.07.051; Facino RM, 1999, LIFE SCI, V64, P627, DOI 10.1016/S0024-3205(98)00605-5; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Hanafi F, 2011, J HAZARD MATER, V190, P94, DOI 10.1016/j.jhazmat.2011.02.087; Hanifi S., 2008, Journal of Agronomy, V7, P63; He JR, 2012, FOOD CHEM, V131, P1312, DOI 10.1016/j.foodchem.2011.09.124; Hemali P, 2014, IOSR J PHARM BIOL SC, V9, P28, DOI DOI 10.9790/3008-09512837; Jarboui R, 2010, J HAZARD MATER, V176, P992, DOI 10.1016/j.jhazmat.2009.11.140; Jothy SL, 2011, J MED PLANTS RES, V5, P1941; Kiai H, 2014, LWT-FOOD SCI TECHNOL, V57, P663, DOI 10.1016/j.lwt.2014.02.011; Kim DO, 2003, J AGR FOOD CHEM, V51, P6509, DOI 10.1021/jf0343074; Kusumoto D, 2003, NEW PHYTOL, V159, P167, DOI 10.1046/j.1469-8137.2003.00775.x; Lecci R, 2014, P BIOOL C CORF GREEC, P54; Mantzavinos D, 2005, ENVIRON INT, V31, P289, DOI 10.1016/j.envint.2004.10.005; Masoko P, 2005, AFR J BIOTECHNOL, V4, P1425; Medina E, 2009, J FOOD PROTECT, V72, P2611, DOI 10.4315/0362-028X-72.12.2611; Medini F, 2014, J TAIBAH UNIV SCI, V8, P216, DOI 10.1016/j.jtusci.2014.01.003; NAGEL CW, 1991, AM J ENOL VITICULT, V42, P364; Niaounakis M, 2006, WASTE MANAG SER, V5, P1; Nickavar B, 2014, IRAN J PHARM RES, V13, P127; Obied HK, 2007, FOOD CHEM TOXICOL, V45, P1238, DOI 10.1016/j.fct.2007.01.004; Owen RW, 2004, EUR J CANCER PREV, V13, P319, DOI 10.1097/01.cej.0000130221.19480.7e; Paraskeva CA, 2007, DESALINATION, V213, P218, DOI 10.1016/j.desal.2006.04.087; Pescod MB, 1992, WASTEWATER TREATMENT; Pierantozzi P, 2012, J SCI FOOD AGR, V92, P216, DOI 10.1002/jsfa.4562; Pinto RTP, 2005, FLUID PHASE EQUILIBR, V228, P447, DOI 10.1016/j.fluid.2004.09.005; Rodis PS, 2002, J AGR FOOD CHEM, V50, P596, DOI 10.1021/jf010864j; Sabbah I, 2004, PROCESS BIOCHEM, V39, P1947, DOI 10.1016/j.procbio.2003.09.026; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Soler-Rivas C, 2006, INT BIODETER BIODEGR, V57, P37, DOI 10.1016/j.ibiod.2005.10.007; Souilem S, 2017, OLIVE MILL WASTE: RECENT ADVANCES FOR SUSTAINABLE MANAGEMENT, P1, DOI 10.1016/B978-0-12-805314-0.00001-7; Tafesh A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/431021; Tuck KL, 2002, J NUTR BIOCHEM, V13, P636, DOI 10.1016/S0955-2863(02)00229-2; Tuna S, 2009, NOT BOT HORTI AGROBO, V37, P182; Visioli F, 1999, J AGR FOOD CHEM, V47, P3397, DOI 10.1021/jf9900534; Waterman P.G., 1994, OXF BLACKWELL SCI PU, V8, P73; Zbakh H, 2012, J FUNCT FOODS, V4, P53, DOI 10.1016/j.jff.2012.01.002	51	28	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0182622	10.1371/journal.pone.0182622	http://dx.doi.org/10.1371/journal.pone.0182622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873097	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800007
J	Cao, QY; Ma, J; Chen, CH; Xu, H; Chen, Z; Li, W; Liu, XS				Cao, Qingyi; Ma, Jian; Chen, Chen-Hao; Xu, Han; Chen, Zhi; Li, Wei; Liu, X. Shirley			CRISPR-FOCUS: A web server for designing focused CRISPR screening experiments	PLOS ONE			English	Article							PRIMARY IMMUNE CELLS; GENETIC SCREENS; HUMAN GENOME; GUIDE RNA; ELEMENTS; IDENTIFICATION; SPECIFICITY; NUCLEASES; LIBRARY; TARGETS	The recently developed CRISPR screen technology, based on the CRISPR/Cas9 genome editing system, enables genome-wide interrogation of gene functions in an efficient and costeffective manner. Although many computational algorithms and web servers have been developed to design single-guide RNAs (sgRNAs) with high specificity and efficiency, algorithms specifically designed for conducting CRISPR screens are still lacking. Here we present CRISPR-FOCUS, a web-based platform to search and prioritize sgRNAs for CRISPR screen experiments. With official gene symbols or RefSeq IDs as the only mandatory input, CRISPRFOCUS filters and prioritizes sgRNAs based on multiple criteria, including efficiency, specificity, sequence conservation, isoform structure, as well as genomic variations including Single Nucleotide Polymorphisms and cancer somatic mutations. CRISPR-FOCUS also provides pre-defined positive and negative control sgRNAs, as well as other necessary sequences in the construct (e.g., U6 promoters to drive sgRNA transcription and RNA scaffolds of the CRISPR/Cas9). These features allow users to synthesize oligonucleotides directly based on the output of CRISPR-FOCUS. Overall, CRISPR-FOCUS provides a rational and highthroughput approach for sgRNA library design that enables users to efficiently conduct a focused screen experiment targeting up to thousands of genes.	[Cao, Qingyi; Chen, Zhi] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Coll Med,State Key Lab Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Ma, Jian] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai, Peoples R China; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Tongji University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center	Chen, Z (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Coll Med,State Key Lab Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Li, W; Liu, XS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Li, W; Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Li, W; Liu, XS (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Li, W; Liu, XS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	chenzhi@zju.edu.cn; wli@jimmy.harvard.edu; xsliu@jimmy.harvard.edu		Li, Wei/0000-0002-2163-7903	National Natural Science Foundation of China [31401104, 31329003]; NIH of US [R01 HG008927]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008927] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH of US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by National Natural Science Foundation of China, No. 31401104 (QC), National Natural Science Foundation of China Grant 31329003 and NIH R01 HG008927 of US (to XSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen C, 2017, GENOME RES; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; DIAKOULAKI D, 1995, COMPUT OPER RES, V22, P763, DOI 10.1016/0305-0548(94)00059-H; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0915-2; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Ma J, 2016, BIOINFORMATICS, V32, P3336, DOI 10.1093/bioinformatics/btw476; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Panda SK, 2017, BIOINFORMATICS, V33, P1099, DOI 10.1093/bioinformatics/btw739; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhang F, OPTIMIZED CRISPR DES; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	41	7	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184281	10.1371/journal.pone.0184281	http://dx.doi.org/10.1371/journal.pone.0184281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873439	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800068
J	Marko, O; Brdar, S; Panic, M; Sasic, I; Despotovic, D; Knezevic, M; Crnojevic, V				Marko, Oskar; Brdar, Sanja; Panic, Marko; Sasic, Isidora; Despotovic, Danica; Knezevic, Milivoje; Crnojevic, Vladimir			Portfolio optimization for seed selection in diverse weather scenarios	PLOS ONE			English	Article							GLOBAL SENSITIVITY-ANALYSIS; PRODUCTIVITY; VARIETIES; VARIANCE; MODEL	The aim of this work was to develop a method for selection of optimal soybean varieties for the American Midwest using data analytics. We extracted the knowledge about 174 varieties from the dataset, which contained information about weather, soil, yield and regional statistical parameters. Next, we predicted the yield of each variety in each of 6,490 observed subregions of the Midwest. Furthermore, yield was predicted for all the possible weather scenarios approximated by 15 historical weather instances contained in the dataset. Using predicted yields and covariance between varieties through different weather scenarios, we performed portfolio optimisation. In this way, for each subregion, we obtained a selection of varieties, that proved superior to others in terms of the amount and stability of yield. According to the rules of Syngenta Crop Challenge, for which this research was conducted, we aggregated the results across all subregions and selected up to five soybean varieties that should be distributed across the network of seed retailers. The work presented in this paper was the winning solution for Syngenta Crop Challenge 2017.	[Marko, Oskar; Brdar, Sanja; Panic, Marko; Crnojevic, Vladimir] Univ Novi Sad, BioSense Inst, Novi Sad, Serbia; [Sasic, Isidora; Despotovic, Danica; Knezevic, Milivoje] Univ Novi Sad, Fac Tech Sci, Novi Sad, Serbia	University of Novi Sad; University of Novi Sad	Marko, O (corresponding author), Univ Novi Sad, BioSense Inst, Novi Sad, Serbia.	oskar.marko@uns.ac.rs	Panić, Marko/ABE-8697-2020	Panić, Marko/0000-0002-7993-6826; Brdar, Sanja/0000-0002-2259-4693; Marko, Oskar/0000-0001-6683-7178	Ministry of Education, Science and Technological Development of Republic of Serbia [44006]; Provincial Secretariat for Higher Education and Scientific Research of Vojvodina	Ministry of Education, Science and Technological Development of Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Provincial Secretariat for Higher Education and Scientific Research of Vojvodina	This work was supported by Ministry of Education, Science and Technological Development of Republic of Serbia (www.vtg.mod.gov.rs), through project 44006 - Development in ICT using mathematical methods with application in medicine, telecommunications, power engineering, protection of national heritage and education (O.M., S.B., M.P. and V.C. were funded), and by Provincial Secretariat for Higher Education and Scientific Research of Vojvodina (www.vojvodina.gov.rs/en/provincial-secretariat-higher-education-and-scientific-research), through projects: Sensor technologies for integrated monitoring of agricultural production and Remote sensing in agricultural, water and forest monitoring applications (O.M., S.B., M.P. and V.C. were funded). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MATLAB REL 2015A; Brdar S., 2011, P 2 INT WORKSHOP SEN, P43; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Carpena R, 2010, J HYDROL, V384, P164; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chu-Agor ML, 2012, ECOL MODEL, V224, P33, DOI 10.1016/j.ecolmodel.2011.10.021; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Convertino M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065056; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Delerce S, 2016, PLOS ONE, V11; Dragicevic A, 2016, FOREST POLICY ECON, V64, P25, DOI 10.1016/j.forpol.2015.12.010; Drummond ST, 2003, T ASAE, V46, P5, DOI 10.13031/2013.12541; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; G. A portfolio theory approach to crop planning under environ, 2014, ANN OPERATIONS RES, V219, P243; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez-Sanchez A, 2014, SPAN J AGRIC RES, V12, P313, DOI 10.5424/sjar/2014122-4439; Hassanzadeh F, 2014, INT J PROD ECON, V158, P18, DOI 10.1016/j.ijpe.2014.07.001; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Hengl T, 2016, PLOS ONE IN PRESS; Herman J., 2017, J OPEN SOURC SOFTW, V2, P97, DOI [DOI 10.21105/JOSS.00097, 10.21105/joss.00097]; Herman JD, 2013, HYDROL EARTH SYST SC, V17, P2893, DOI 10.5194/hess-17-2893-2013; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Horna JD, 2007, ENVIRON DEV ECON, V12, P799, DOI 10.1017/S1355770X07003956; IdeaConnection, 2017, SYNG AI CHALL; IdeaConnection, 2017, SYNG CROP CHALL; Jimenez D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150015; Kansiime MK, 2016, J RURAL STUD, V47, P220, DOI 10.1016/j.jrurstud.2016.08.004; Kriesel D., 2007, BRIEF INTRO NEURAL N; Marko O, 2016, COMPUT ELECTRON AGR, V127, P467, DOI 10.1016/j.compag.2016.07.009; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Nalley L. L., 2009, Journal of Agricultural and Applied Economics, V41, P641; Nalley LL, 2010, J AGR RESOUR ECON, V35, P334; OpenStreetMap Contributors, 2017, PLANET DUMP; Porter MG, 2016, 8 INT C ENV MOD SOFT; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rojas R., 2013, NEURAL NETWORKS SYST; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Saltelli A, 2008, GLOBAL SENSITIVITY A, DOI 10.1002/9780470725184; Sawyer JE, 2002, GEN GUIDE CROP NUTRI; Schaetzl RJ, 2012, SOIL SCI, V177, P288, DOI 10.1097/SS.0b013e3182446c88; Shekoofa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097288; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; USDA-NASS, 2014, USDA NAT AGR STAT SE; V. Data mining approach for pre-dictive modeling of agricultural yield data, 2009, P 1 INT WORKSH SENS, p1 ; Vapnik V, 1998, NONLINEAR MODELING, P55; Wu G, 2003, ICML 2003 WORKSH LEA, P49, DOI DOI 10.5753/SBRC.2019.7416; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x	55	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184198	10.1371/journal.pone.0184198	http://dx.doi.org/10.1371/journal.pone.0184198			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863173	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900039
J	Peng, K; Peng, YJ; Wang, J; Yang, MJ; Fu, ZY; Tang, J; Chen, QC				Peng, Kang; Peng, Yu-Jie; Wang, Jing; Yang, Ming-Jian; Fu, Zi-Ying; Tang, Jia; Chen, Qi-Cai			Latency modulation of collicular neurons induced by electric stimulation of the auditory cortex in Hipposideros pratti: In vivo intracellular recording	PLOS ONE			English	Article							BIG BROWN BAT; STIMULUS-SPECIFIC ADAPTATION; MULTIPARAMETRIC CORTICOFUGAL MODULATION; WHOLE-CELL RECORDINGS; INFERIOR COLLICULUS; EPTESICUS-FUSCUS; NERVE FIBERS; AWAKE BATS; 1ST-SPIKE LATENCIES; LATERAL LEMNISCUS	In the auditory pathway, the inferior colliculus (IC) receives and integrates excitatory and inhibitory inputs from the lower auditory nuclei, contralateral IC, and auditory cortex (AC), and then uploads these inputs to the thalamus and cortex. Meanwhile, the AC modulates the sound signal processing of IC neurons, including their latency (i.e., first-spike latency). Excitatory and inhibitory corticofugal projections to the IC may shorten and prolong the latency of IC neurons, respectively. However, the synaptic mechanisms underlying the corticofugal latency modulation of IC neurons remain unclear. Thus, this study probed these mechanisms via in vivo intracellular recording and acoustic and focal electric stimulation. The AC latency modulation of IC neurons is possibly mediated by pre-spike depolarization duration, pre-spike hyperpolarization duration, and spike onset time. This study suggests an effective strategy for the timing sequence determination of auditory information uploaded to the thalamus and cortex.	[Chen, Qi-Cai] Cent China Normal Univ, Sch Life Sci, Wuhan, Hubei, Peoples R China; Cent China Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Chen, QC (corresponding author), Cent China Normal Univ, Sch Life Sci, Wuhan, Hubei, Peoples R China.	chenqc@mail.ccnu.edu.cn	Fu, Ziying/N-7127-2013	Fu, Ziying/0000-0002-0065-8297	National Science Foundation of China [31571232, 31200832, 31000959]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work supported by grants #31571232 to QC-C, #31200832 to ZY-F and #31000959 to JT from National Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the anonymous reviewers for commenting on an earlier version of this manuscript. The work supported by grants (#31571232, #31200832, #31000959) from National Science Foundation of China.	ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; Anderson LA, 2013, EUR J NEUROSCI, V37, P52, DOI 10.1111/ejn.12018; Bledsoe SC, 2003, EXP BRAIN RES, V153, P530, DOI 10.1007/s00221-003-1671-6; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; Covey E, 1996, J NEUROSCI, V16, P3009; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; Fitzpatrick DC, 1995, J NEUROPHYSIOL, V74, P2469, DOI 10.1152/jn.1995.74.6.2469; Fontaine B, 2009, NEURAL NETWORKS, V22, P1372, DOI 10.1016/j.neunet.2009.05.002; Fu ZY, 2014, NEUROSCI LETT, V576, P97, DOI 10.1016/j.neulet.2014.05.061; Galazyuk AV, 2005, J NEUROPHYSIOL, V94, P314, DOI 10.1152/jn.00056.2005; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; Heil P, 2004, CURR OPIN NEUROBIOL, V14, P461, DOI 10.1016/j.conb.2004.07.002; Heil P, 2003, P NATL ACAD SCI USA, V100, P6151, DOI 10.1073/pnas.1030017100; Heil P, 1997, J NEUROPHYSIOL, V78, P2438, DOI 10.1152/jn.1997.78.5.2438; Heil P, 1998, EUR J NEUROSCI, V10, P2831, DOI 10.1111/j.1460-9568.1998.00293.x; Heil P, 2008, HEARING RES, V238, P25, DOI 10.1016/j.heares.2007.09.014; Heil P, 2017, SYNAPSE, V71, P5, DOI 10.1002/syn.21925; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Hurley LM, 2005, J NEUROSCI, V25, P7876, DOI 10.1523/JNEUROSCI.1178-05.2005; Ingham NJ, 2004, J NEUROPHYSIOL, V91, P632, DOI 10.1152/jn.00779.2003; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jen PHS, 1999, BRAIN RES, V841, P184, DOI 10.1016/S0006-8993(99)01786-2; Jen PHS, 1998, J COMP PHYSIOL A, V183, P683, DOI 10.1007/s003590050291; Jen PHS, 2001, EXP BRAIN RES, V137, P292; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Kaya EM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00327; Klug A, 2000, HEARING RES, V148, P107, DOI 10.1016/S0378-5955(00)00146-5; Krishna BS, 2002, J COMPUT NEUROSCI, V13, P71, DOI 10.1023/A:1020116122533; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Li N, 2010, J NEUROSCI, V30, P14573, DOI 10.1523/JNEUROSCI.2228-10.2010; Li YL, 2015, NEUROSCIENCE, V289, P443, DOI 10.1016/j.neuroscience.2015.01.016; Ma XF, 2008, J NEUROPHYSIOL, V100, P1127, DOI 10.1152/jn.90508.2008; Ma XF, 2007, J NEUROPHYSIOL, V97, P3722, DOI 10.1152/jn.01268.2006; Macias S, 2014, HEARING RES, V309, P36, DOI 10.1016/j.heares.2013.11.004; Malinina E S, 2016, Dokl Biol Sci, V470, P209; Malmierca MS, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00019; Malmierca MS, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00113; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Mei HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041311; Nayagam DAX, 2006, J COMP NEUROL, V498, P295, DOI 10.1002/cne.21058; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Perez-Gonzalez D, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00019; Perez-Gonzalez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034297; Qiu Q, 2007, SCI CHINA SER C, V50, P258, DOI 10.1007/s11427-007-0020-6; Sayegh R, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00056; Straka MM, 2015, NEUROSCIENCE, V300, P325, DOI 10.1016/j.neuroscience.2015.05.032; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; Suga N, 2012, NEUROSCI BIOBEHAV R, V36, P969, DOI 10.1016/j.neubiorev.2011.11.006; SUN X, 1989, BRAIN RES, V495, P1, DOI 10.1016/0006-8993(89)91212-2; Sun XD, 1996, NEUROSCI LETT, V212, P131, DOI 10.1016/0304-3940(96)12788-9; Tan AYY, 2007, NEUROSCIENCE, V146, P449, DOI 10.1016/j.neuroscience.2007.01.019; Tan XD, 2008, HEARING RES, V235, P90, DOI 10.1016/j.heares.2007.10.002; Terreros G, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00134; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vater M, 1997, CELL TISSUE RES, V289, P223, DOI 10.1007/s004410050869; Vater M, 2010, J NEUROPHYSIOL, V103, P2339, DOI 10.1152/jn.00517.2009; Voytenko SV, 2008, NEUROSCIENCE, V155, P923, DOI 10.1016/j.neuroscience.2008.06.031; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Xie R, 2008, NEUROSCIENCE, V154, P245, DOI 10.1016/j.neuroscience.2008.02.039; Xie R, 2007, J NEUROSCI, V27, P9469, DOI 10.1523/JNEUROSCI.2865-07.2007; Xu M, 2007, J PHYSIOL-LONDON, V585, P15, DOI 10.1113/jphysiol.2007.142240; Yan J, 2002, EUR J NEUROSCI, V16, P119, DOI 10.1046/j.1460-9568.2002.02046.x; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Yu YQ, 2004, J NEUROSCI, V24, P3060, DOI 10.1523/JNEUROSCI.4897-03.2004; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YK, 2005, J NEUROPHYSIOL, V94, P2676, DOI 10.1152/jn.00549.2005; Zhou XM, 2007, J NEUROPHYSIOL, V98, P2509, DOI 10.1152/jn.00613.2007; Zhou XM, 2000, J NEUROPHYSIOL, V84, P3083, DOI 10.1152/jn.2000.84.6.3083; Zhou Y, 2012, J NEUROSCI, V32, P9969, DOI 10.1523/JNEUROSCI.1384-12.2012	74	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184097	10.1371/journal.pone.0184097	http://dx.doi.org/10.1371/journal.pone.0184097			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863144	gold, Green Submitted, Green Published			2022-12-26	WOS:000408816900023
J	Ruzek, L; Svobodova, K; Olson, LJ; Ludka, O; Cundrle, I				Ruzek, Lukas; Svobodova, Karolina; Olson, Lyle J.; Ludka, Ondrej; Cundrle, Ivan, Jr.			Increased microcirculatory heterogeneity in patients with obstructive sleep apnea	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; MORTALITY; IMPAIRMENT; RISK	Introduction Obstructive sleep apnea (OSA) is the most common form of sleep disordered breathing and has been associated with major cardiovascular comorbidities. We hypothesized that the microcirculation is impaired in patients with OSA and that the magnitude of impairment correlates to OSA severity. Methods Subjects were consecutive patients scheduled for routine diagnostic polysomnography (PSG). OSA was defined by paradoxical rib cage movements together with abdominal excursions and by the apnea-hypopnea index (AHI) (events/hour; no apnea AHI<5; mild apnea 5 <= AHI<15; moderate apnea 15 <= AHI<30; severe apnea AHI >= 30). Sidestream dark-field imaging was used to assess the sublingual microcirculation. Recordings of sublingual microcirculation ( 5 random sites) were performed before and after overnight PSG. Data are summarized as mean (+/- SD); p values <0.05 were considered statistically significant. Results Thirty-three consecutive patients were included. OSA was diagnosed in 16 subjects (4 moderate, 12 severe). There was no significant difference in microcirculation between subjects with moderate OSA and without OSA. However, compared to subjects without OSA, subjects with severe OSA (AHI >= 30) showed a significant decrease of microvascular flow index (-0.07 +/- 0.17 vs. 0.08 +/- 0.14; p = 0.02) and increase of microvascular flow index heterogeneity (0.06 +/- 0.15 vs. - 0.06 +/- 0.11; p = 0.02) overnight. Multiple regression analysis (adjusted for age and gender) showed both decrease of flow and increase of flow heterogeneity associated with AHI (b = -0.41; F = 1.8; p = 0.04 and b = 0.43; F = 1.9; p = 0.03, respectively). Conclusion Acute overnight microcirculatory changes are observed in subjects with severe OSA characterized by decreased flow and increased flow heterogeneity.	[Ruzek, Lukas; Cundrle, Ivan, Jr.] St Annas Univ Hosp Brno, Dept Anaesthesiol & Intens Care, Brno, Czech Republic; [Ruzek, Lukas; Ludka, Ondrej; Cundrle, Ivan, Jr.] St Annas Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Svobodova, Karolina] Masaryk Univ, Fac Med, Brno, Czech Republic; [Olson, Lyle J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Ludka, Ondrej] Univ Hosp Brno, Internal Cardiol Dept, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Mayo Clinic; University Hospital Brno	Cundrle, I (corresponding author), St Annas Univ Hosp Brno, Dept Anaesthesiol & Intens Care, Brno, Czech Republic.; Cundrle, I (corresponding author), St Annas Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic.	Ivan.Cundrle@seznam.cz		Cundrle, Ivan/0000-0002-7709-8021	National Program of Sustainability II (MEYS CR) [LQ1605]; FNUSA-International Clinical Research Center [CZ.1.05/1.1.00/02.0123]; FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]	National Program of Sustainability II (MEYS CR); FNUSA-International Clinical Research Center; FNUSA-ICRC	Supported by the project no. LQ1605 from the National Program of Sustainability II (MEYS CR) and by the project FNUSA-International Clinical Research Center no. CZ.1.05/1.1.00/02.0123 (OP VaVpI).; This work was supported by the project no. LQ1605 from the National Program of Sustainability II (MEYS CR) and by the project FNUSA-ICRC no. CZ.1.05/1.1.00/02.0123 (OP VaVpI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Bisogni V, 2016, J THORAC DIS, V8, P243, DOI 10.3978/j.issn.2072-1439.2015.11.14; Blomster H, 2014, SLEEP BREATH, V18, P177, DOI 10.1007/s11325-013-0867-7; Ciccone MM, 2012, INT J CARDIOL, V158, P383, DOI 10.1016/j.ijcard.2011.01.065; Dababneh Luma, 2014, Ann Am Thorac Soc, V11, P504, DOI 10.1513/AnnalsATS.201308-277OC; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; Deveci D, 2002, EXP PHYSIOL, V87, P287, DOI 10.1113/eph8702377; Djaberi R, 2013, DIABETES VASC DIS RE, V10, P123, DOI 10.1177/1479164112446302; Dodt C, 1997, HYPERTENSION, V30, P71, DOI 10.1161/01.HYP.30.1.71; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI DOI 10.HTTPS://D0I.0RG/10.1155/2013/; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Grote L, 2000, AM J RESP CRIT CARE, V162, P1480, DOI 10.1164/ajrccm.162.4.9912028; Hiestand DM, 2006, CHEST, V130, P780, DOI 10.1378/chest.130.3.780; Ince C, 2005, CRIT CARE, V9, pP72, DOI DOI 10.1186/CC3135; Kasai T, 2011, J AM COLL CARDIOL, V57, P119, DOI 10.1016/j.jacc.2010.08.627; Kato M, 2000, CIRCULATION, V102, P2607; Kohler M, 2013, CHEST, V144, P896, DOI 10.1378/chest.13-0179; Lam JCM, 2009, LUNG, V187, P291, DOI 10.1007/s00408-009-9161-7; Larsson BW, 2008, RESPIRATION, V76, P21, DOI 10.1159/000126492; Mahmood K, 2009, J CLIN SLEEP MED, V5, P215; Marshall NS, 2008, SLEEP, V31, P1079; Nakashima H, 2011, CIRC J, V75, P890, DOI 10.1253/circj.CJ-10-0768; Nazzaro P, 2008, EUR J CLIN INVEST, V38, P766, DOI 10.1111/j.1365-2362.2008.02011.x; Nguyen PK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-50; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; Patt BT, 2010, AM J RESP CRIT CARE, V182, P1540, DOI 10.1164/rccm.201002-0162OC; Pranskunas A, 2012, CRIT CARE, V16, DOI 10.1186/cc11341; Skorjanc A, 2015, ADV PHYSIOL EDUC, V39, P91, DOI 10.1152/advan.00160.2014; Stal PS, 2012, RESPIRATION, V83, P407, DOI 10.1159/000336040; Stal PS, 2009, RESPIRATION, V77, P303, DOI 10.1159/000197975; Struijker-Boudier HAJ, 2012, HYPERTENSION, V60, P523, DOI 10.1161/HYPERTENSIONAHA.111.188482; Vardhan Vasu, 2012, Med J Armed Forces India, V68, P33, DOI 10.1016/S0377-1237(11)60128-7; Vincent PJ-L, 2013, YB INTENSIVE CARE EM; Wiernsperger Nicolas, 2006, Clinics, V61, P253, DOI 10.1590/S1807-59322006000300011; Yacoub S, 2016, J INFECT DIS, V214, P697, DOI 10.1093/infdis/jiw220; Young T, 2008, SLEEP, V31, P1071	37	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184291	10.1371/journal.pone.0184291	http://dx.doi.org/10.1371/journal.pone.0184291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863183	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900046
J	Wang, YH; Yu, WQ; Huo, N; Wang, WB; Guo, YY; Wei, QL; Wang, XL; Zhang, SX; Yang, ZQ; Xiao, S				Wang, Yanhong; Yu, Wanqi; Huo, Na; Wang, Wenbin; Guo, Yuanyuan; Wei, Qiaolin; Wang, Xinglong; Zhang, Shuxia; Yang, Zengqi; Xiao, Sa			Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity	PLOS ONE			English	Article							FUSION PROTEIN; SYNCYTIUM FORMATION; VIRULENCE; CLEAVABILITY; MUTATIONS; MUTANTS	Newcastle disease virus (NDV) is a contagious agent of Newcastle disease in avian species and seriously affects the poultry industry. The cleavage site of the viral F protein (Fcs) is a key determinant of membrane fusion and viral virulence. In this study, we investigated the precise effect of variable amino acid sequences of the Fcs on fusogenic activity. Based on viral pathogenicity, the Fcs sequences of natural isolates (n = 1572) are classified into eight types of virulent Fcs (VFcs) with the motif "G/R/K-R-Q/R/K-R/K-R down arrow F" and ten types of the avirulent Fcs (AFcs) with the motif "G/R/E-R/K/Q-Q-G/E-R down arrow L". The VFcs is only found in the Class II cluster of viral classification and not in Class I. The AFcs exists in both Class I and II isolates. The VFc and AFc types present an evolutionary relationship with temporal distribution and host species. Using a fusion assay in vitro, VFcs-1 "RRQKR down arrow F" and VFcs-2 "RRQRR down arrow F" show the highest efficiency in triggering membrane fusion. The neutral residue Q at the P3 position of the VFcs plays an enhancing role compared to effect of the basic residues R and K. A single residue K at P3 or P5 is less efficient of the fusogenic activity in the VFcs with all basic residues. Moreover, the cleavage efficiencies of F-0 proteins with different types of Fcs motifs do not appear to affect membrane fusion. Our findings offer insight into the effect of amino acid variation of the Fcs on the fusion triggered by NDV.	[Wang, Yanhong; Yu, Wanqi; Huo, Na; Wang, Wenbin; Guo, Yuanyuan; Wei, Qiaolin; Wang, Xinglong; Zhang, Shuxia; Yang, Zengqi; Xiao, Sa] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yang, ZQ; Xiao, S (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	yzq8162@163.com; saxiao@nwafu.edu.cn	Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yuan/HHC-1520-2022	Xiao, Sa/0000-0003-3444-7241	National Natural Science Foundation of China [31572533, 31572538]; Faculty Support Fund of the Northwest AF University [Z111021401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Faculty Support Fund of the Northwest AF University	This work was supported by the National Natural Science Foundation of China (31572533 to SX, 31572538 to ZY) and the Faculty Support Fund of the Northwest A&F University (Z111021401 to SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; de Leeuw OS, 2003, J GEN VIROL, V84, P475, DOI 10.1099/vir.0.18714-0; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Fujii Y, 1999, MICROBIOL IMMUNOL, V43, P133, DOI 10.1111/j.1348-0421.1999.tb02384.x; Gravel KA, 2011, J VIROL, V85, P3486, DOI 10.1128/JVI.02308-10; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; KAWAHARA N, 1992, J GEN VIROL, V73, P583, DOI 10.1099/0022-1317-73-3-583; Kim SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173965; Li ZJ, 1998, J VIROL, V72, P3789, DOI 10.1128/JVI.72.5.3789-3795.1998; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Mayo M A, 2002, Arch Virol, V147, P1071, DOI 10.1007/s007050200036; Murakami M, 2001, EUR J BIOCHEM, V268, P2847, DOI 10.1046/j.1432-1327.2001.02166.x; Nagai Yoshiyuki, 1993, Trends in Microbiology, V1, P81, DOI 10.1016/0966-842X(93)90112-5; Padhi A, 2015, INFECT GENET EVOL, V32, P255, DOI 10.1016/j.meegid.2015.03.019; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; ROEBROEK AJM, 1994, BIOCHIMIE, V76, P210, DOI 10.1016/0300-9084(94)90148-1; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SERGEL T, 1993, VIROLOGY, V193, P717, DOI 10.1006/viro.1993.1180; Subbiah M, 2011, J VIROL, V85, P5394, DOI 10.1128/JVI.02696-10; Tse LV, 2014, J VIROL, V88, P1673, DOI 10.1128/JVI.02648-13; Xiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052751	27	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183923	10.1371/journal.pone.0183923	http://dx.doi.org/10.1371/journal.pone.0183923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863165	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900011
J	Afshari, P; Yao, WD; Middleton, FA				Afshari, Parisa; Yao, Wei-Dong; Middleton, Frank A.			Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia	PLOS ONE			English	Article							NEURONAL GLUTAMATE TRANSPORTER; OBSESSIVE-COMPULSIVE DISORDER; INCREASED OXIDATIVE STRESS; FAMILY-BASED ASSOCIATION; WORKING-MEMORY; PREFRONTAL CORTEX; GLUTATHIONE SYNTHESIS; GENE SLC1A1; APOPTOTIC MECHANISMS; PYRAMIDAL NEURONS	We previously reported a 84-Kb hemi-deletion copy number variant at the SLC1A1 gene locus that reduces its expression and appeared causally linked to schizophrenia. In this report, we characterize the in vivo and in vitro consequences of reduced expression of Slc1a1 in mice. Heterozygous (HET) Slc1a1(+/-) mice, which more closely model the hemi-deletion we found in human subjects, were examined in a series of behavioral, anatomical and biochemical assays. Knockout (KO) mice were also included in the behavioral studies for comparative purposes. Both HET and KO mice exhibited evidence of increased anxiety-like behavior, impaired working memory, decreased exploratory activity and impaired sensorimotor gating, but no changes in overall locomotor activity. The magnitude of changes was approximately equivalent in the HET and KO mice suggesting a dominant effect of the haploinsufficiency. Behavioral changes in the HET mice were accompanied by reduced thickness of the dorsomedial prefrontal cortex. Whole transcriptome RNA-Seq analysis detected expression changes of genes and pathways involved in cytokine signaling and synaptic functions in both brain and blood. Moreover, the brains of Slc1a1(+/-) mice displayed elevated levels of oxidized glutathione, a trend for increased oxidative DNA damage, and significantly increased levels of cytokines. This latter finding was further supported by SLC1A1 knockdown and overexpression studies in differentiated human neuroblastoma cells, which led to decreased or increased cytokine expression, respectively. Taken together, our results suggest that partial loss of the Slc1a1 gene in mice causes haploinsufficiency associated with behavioral, histological and biochemical changes that reflect an altered redox state and may promote the expression of behavioral features and inflammatory states consistent with those observed in schizophrenia.	[Afshari, Parisa; Yao, Wei-Dong; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Yao, Wei-Dong; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	middletf@upstate.edu		Middleton, Frank/0000-0002-3107-7188	National Institutes of Health [DA032283, MH106489, RR026761]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	WDY is supported by grants from the National Institutes of Health (DA032283, MH106489 and RR026761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; Afshari Parisa, 2015, Mol Neuropsychiatry, V1, P125, DOI 10.1159/000433599; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Aoyama K, 2015, MOLECULES, V20, P8742, DOI 10.3390/molecules20058742; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Aoyama K, 2013, AMINO ACIDS, V45, P133, DOI 10.1007/s00726-013-1481-5; Aoyama K, 2012, INT J MOL SCI, V13, P12017, DOI 10.3390/ijms130912017; Aoyama K, 2012, NEUROBIOL DIS, V45, P973, DOI 10.1016/j.nbd.2011.12.016; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; BANNAI S, 1980, J BIOL CHEM, V255, P2372; Barch DM, 2008, BIOL PSYCHIAT, V64, P11, DOI 10.1016/j.biopsych.2008.03.003; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; BOGERTS B, 1990, PSYCHIAT RES-NEUROIM, V35, P1; Bonilha L, 2008, SCHIZOPHR RES, V101, P142, DOI 10.1016/j.schres.2007.11.023; Boskovic M, 2011, CURR NEUROPHARMACOL, V9, P301, DOI 10.2174/157015911795596595; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Bumb JM, 2015, EXPERT OPIN PHARMACO, V16, P1049, DOI 10.1517/14656566.2015.1032248; Cannon TD, 2002, P NATL ACAD SCI USA, V99, P3228, DOI 10.1073/pnas.052023499; Cao L, 2012, NEUROSCIENCE, V220, P85, DOI 10.1016/j.neuroscience.2012.06.044; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Cooper AJL, 1997, BIOL CHEM, V378, P793; Copoglu US, 2015, PSYCHIAT RES, V229, P200, DOI 10.1016/j.psychres.2015.07.036; Costain G, 2014, AM J MED GENET B, V165, P337, DOI 10.1002/ajmg.b.32236; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Ehrlich S, 2012, SCHIZOPHRENIA BULL, V38, P1050, DOI 10.1093/schbul/sbr018; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; GADOW KD, 2010, J AUTISM DEV DISORD, V40, DOI DOI 10.1007/s10803-010-0959-1; Ganzola R, 2014, SCHIZOPHR RES, V156, P76, DOI 10.1016/j.schres.2014.03.030; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; Girgis RR, 2014, BIOL PSYCHIAT, V75, P292, DOI 10.1016/j.biopsych.2013.12.002; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grados MA, 2013, EXPERT OPIN DRUG DIS, V8, P1515, DOI 10.1517/17460441.2013.845553; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Hanna GL, 2002, AM J MED GENET, V114, P541, DOI 10.1002/ajmg.10519; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Horiuchi Y, 2012, AM J MED GENET B, V159B, P30, DOI 10.1002/ajmg.b.31249; Jarskog LF, 2000, BIOL PSYCHIAT, V48, P641, DOI 10.1016/S0006-3223(00)00988-4; Jarskog LF, 2006, CURR OPIN PSYCHIATR, V19, P307, DOI 10.1097/01.yco.0000218603.25346.8f; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Jorgensen A, 2013, PSYCHIAT RES, V209, P417, DOI 10.1016/j.psychres.2013.01.033; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Komada M, 2008, J VIS EXP, Vpii, P1088; Lane MC, 2014, NEUROCHEM INT, V73, P152, DOI 10.1016/j.neuint.2013.11.013; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; Leckman JF, 2006, ARCH GEN PSYCHIAT, V63, P717, DOI 10.1001/archpsyc.63.7.717; Lee S, 2012, J PHARM PHARMACOL, V64, P302, DOI 10.1111/j.2042-7158.2011.01404.x; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lewis DA, 2012, EUR J NEUROSCI, V35, P1871, DOI 10.1111/j.1460-9568.2012.08156.x; Li LL, 2011, J CEREBR BLOOD F MET, V31, P1283, DOI 10.1038/jcbfm.2010.222; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Muller Jacqueline E, 2004, Curr Psychiatry Rep, V6, P255, DOI 10.1007/s11920-004-0074-0; Myles-Worsley M, 2013, AM J MED GENET B, V162B, P87, DOI 10.1002/ajmg.b.32125; Nielsen J, 2015, SCHIZOPHRENIA BULL, V41, P764, DOI 10.1093/schbul/sbu118; Nishioka N, 2004, AM J GERIAT PSYCHIAT, V12, P167, DOI 10.1176/appi.ajgp.12.2.167; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; Porsolt RD, 2010, J PHARMACOL EXP THER, V333, P632, DOI 10.1124/jpet.110.166710; Porton B, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.35; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Priebe L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064035; Qing H, 2003, EUR J NEUROSCI, V17, P1563, DOI 10.1046/j.1460-9568.2003.02590.x; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Rees E, 2014, HUM MOL GENET, V23, P1669, DOI 10.1093/hmg/ddt540; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Samuels J, 2011, AM J MED GENET B, V156B, P472, DOI 10.1002/ajmg.b.31184; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shugart YY, 2009, AM J MED GENET B, V150B, P886, DOI 10.1002/ajmg.b.30914; Smyth AM, 2013, CLIN PSYCHOPHARM NEU, V11, P107, DOI 10.9758/cpn.2013.11.3.107; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steullet P, 2016, SCHIZOPHR RES, V176, P41, DOI 10.1016/j.schres.2014.06.021; Stewart LR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-154; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Upthegrove R, 2014, SCHIZOPHR RES, V155, P101, DOI 10.1016/j.schres.2014.03.005; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Watabe M, 2007, MOL PHARMACOL, V72, P1103, DOI 10.1124/mol.107.039461; Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x; Willour VL, 2004, AM J HUM GENET, V75, P508, DOI 10.1086/423899; Won SJ, 2010, J NEUROSCI, V30, P15409, DOI 10.1523/JNEUROSCI.2084-10.2010; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang JP, 2014, 8TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2014), P1	122	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183854	10.1371/journal.pone.0183854	http://dx.doi.org/10.1371/journal.pone.0183854			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886095	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100041
J	Sewell, DK; Rayner, PJ; Shank, DB; Guy, S; Lilburn, SD; Saber, S; Kashima, Y				Sewell, David K.; Rayner, Peter J.; Shank, Daniel B.; Guy, Sophie; Lilburn, Simon D.; Saber, Saam; Kashima, Yoshihisa			Causal knowledge promotes behavioral self-regulation: An example using climate change dynamics	PLOS ONE			English	Article							DECISION-MAKING; MENTAL MODELS; PEOPLE KNOW; EDUCATED LAYPEOPLE; CARBON-CYCLE; MISPERCEPTIONS; ACCUMULATION; FEEDBACK; POLICIES; INTERVENTIONS	Adopting successful climate change mitigation policies requires the public to choose how to balance the sometimes competing goals of managing CO2 emissions and achieving economic growth. It follows that collective action on climate change depends on members of the public to be knowledgeable of the causes and economic ramifications of climate change. The existing literature, however, shows that people often struggle to correctly reason about the fundamental accumulation dynamics that drive climate change. Previous research has focused on using analogy to improve people's reasoning about accumulation, which has been met with some success. However, these existing studies have neglected the role economic factors might play in shaping people's decisions in relation to climate change. Here, we introduce a novel iterated decision task in which people attempt to achieve a specific economic goal by interacting with a causal dynamic system in which human economic activities, CO2 emissions, and warming are all causally interrelated. We show that when the causal links between these factors are highlighted, people's ability to achieve the economic goal of the task is enhanced in a way that approaches optimal responding, and avoids dangerous levels of warming.	[Sewell, David K.; Shank, Daniel B.; Guy, Sophie; Lilburn, Simon D.; Saber, Saam; Kashima, Yoshihisa] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Sewell, David K.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Rayner, Peter J.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Shank, Daniel B.] Missouri Univ Sci & Technol, Dept Psychol Sci, Rolla, MO USA; [Guy, Sophie] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia	University of Melbourne; University of Queensland; University of Melbourne; University of Missouri System; Missouri University of Science & Technology; University of South Australia	Sewell, DK (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.; Sewell, DK (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	d.sewell@uq.edu.au		Kashima, Yoshihisa/0000-0003-3627-3273; Sewell, David/0000-0002-9966-8232	Australian Research Council Discovery Project Grant [DP130102229]; Australian Research Council Discovery Early Career Research Award fellowship [DE140100772]	Australian Research Council Discovery Project Grant(Australian Research Council); Australian Research Council Discovery Early Career Research Award fellowship(Australian Research Council)	This research was supported by an Australian Research Council Discovery Project Grant (www.arc.gov.au; DP130102229) awarded to Yoshihisa Kashima, Angela Paladino, and David Sewell. David Sewell was supported by an Australian Research Council Discovery Early Career Research Award fellowship (www.arc.gov.au; DE140100772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain PG, 2012, NAT CLIM CHANGE, V2, P600, DOI 10.1038/NCLIMATE1532; Bodman R, 2013, NAT CLIM CHANGE, V3, P725, DOI [10.1038/nclimate1903, 10.1038/NCLIMATE1903]; Bord RJ, 2000, PUBLIC UNDERST SCI, V9, P205, DOI 10.1088/0963-6625/9/3/301; BOSTROM A, 1994, RISK ANAL, V14, P959, DOI 10.1111/j.1539-6924.1994.tb00065.x; Bostrom A, 2012, GLOBAL ENVIRON CHANG, V22, P210, DOI 10.1016/j.gloenvcha.2011.09.012; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burns BD, 2002, Q J EXP PSYCHOL-A, V55, P241, DOI 10.1080/02724980143000262; Clark D., 2013, P 35 ANN M COGN SCI, P2070; Cronin MA, 2009, ORGAN BEHAV HUM DEC, V108, P116, DOI 10.1016/j.obhdp.2008.03.003; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DIEHL E, 1995, ORGAN BEHAV HUM DEC, V62, P198, DOI 10.1006/obhd.1995.1043; DORNER D, 1990, PHILOS T ROY SOC B, V327, P463, DOI 10.1098/rstb.1990.0089; Dutt V, 2012, CLIMATIC CHANGE, V111, P497, DOI 10.1007/s10584-011-0202-x; Dutt V, 2012, J ENVIRON PSYCHOL, V32, P19, DOI 10.1016/j.jenvp.2011.10.003; Fernbach PM, 2013, PSYCHOL SCI, V24, P939, DOI 10.1177/0956797612464058; Gonzalez C, 2003, COGNITIVE SCI, V27, P591, DOI 10.1016/S0364-0213(03)00031-4; Guy S, 2014, EUR J SOC PSYCHOL, V44, P421, DOI 10.1002/ejsp.2039; Guy S, 2013, CLIMATIC CHANGE, V121, P579, DOI 10.1007/s10584-013-0949-3; Hagmayer Y., 2010, OPEN PSYCHOL J, V3, P145, DOI DOI 10.2174/18743501010030; Hagmayer Y, 2013, J EXP PSYCHOL LEARN, V39, P33, DOI 10.1037/a0028643; Kahn ME, 2011, CLIM CHANG ECON, V2, P257, DOI 10.1142/S2010007811000292; Keil FC, 2003, TRENDS COGN SCI, V7, P368, DOI 10.1016/S1364-6613(03)00158-X; KEMPTON W, 1991, GLOBAL ENVIRON CHANG, V1, P183, DOI 10.1016/0959-3780(91)90042-R; Lagnado DA, 2004, J EXP PSYCHOL LEARN, V30, P856, DOI 10.1037/0278-7393.30.4.856; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Moxnes E, 2000, SYST DYNAM REV, V16, P325, DOI 10.1002/sdr.201; Moxnes E, 2009, CLIMATIC CHANGE, V93, P15, DOI 10.1007/s10584-008-9465-2; Newell BR, 2016, TOP COGN SCI, V8, P138, DOI 10.1111/tops.12176; Newell BR, 2014, ANNU REV ENV RESOUR, V39, P443, DOI 10.1146/annurev-environ-010713-094623; O'Connor RE, 2002, SOC SCI QUART, V83, P1, DOI 10.1111/1540-6237.00067; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Osman M, 2010, PSYCHOL BULL, V136, P65, DOI 10.1037/a0017815; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Ranney M.A., 2012, P 34 ANN M COGN SCI, P2228; READ D, 1994, RISK ANAL, V14, P971, DOI 10.1111/j.1539-6924.1994.tb00066.x; Reynolds TW, 2010, RISK ANAL, V30, P1520, DOI 10.1111/j.1539-6924.2010.01448.x; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Rottman BM, 2012, COGNITIVE PSYCHOL, V64, P93, DOI 10.1016/j.cogpsych.2011.10.003; Rottman BM, 2014, PSYCHOL BULL, V140, P109, DOI 10.1037/a0031903; Rozenblit L, 2002, COGNITIVE SCI, V26, P521, DOI 10.1016/S0364-0213(02)00078-2; Sloman Steven A., 2011, Information.Knowledge.Systems Management, V10, P85, DOI 10.3233/IKS-2012-0187; STERMAN JD, 1989, MANAGE SCI, V35, P321, DOI 10.1287/mnsc.35.3.321; Sterman JD, 2002, SYST DYNAM REV, V18, P501, DOI 10.1002/sdr.261; Sterman JD, 2008, SCIENCE, V322, P532, DOI 10.1126/science.1162574; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Steyvers M, 2003, COGNITIVE SCI, V27, P453, DOI 10.1016/S0364-0213(03)00010-7; Sweeney LB, 2000, SYST DYNAM REV, V16, P249, DOI 10.1002/sdr.198; Waldmann MR, 2001, PSYCHON B REV, V8, P600, DOI 10.3758/BF03196196; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253	50	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184480	10.1371/journal.pone.0184480	http://dx.doi.org/10.1371/journal.pone.0184480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880945	gold, Green Accepted, Green Published			2022-12-26	WOS:000409467200073
J	Zhang, W; Zhang, XL; Zhao, JJ; Qiang, Y; Tian, Q; Tang, XX				Zhang, Wei; Zhang, Xiaolong; Zhao, Juanjuan; Qiang, Yan; Tian, Qi; Tang, Xiaoxian			A segmentation method for lung nodule image sequences based on superpixels and density-based spatial clustering of applications with noise	PLOS ONE			English	Article							RAY-COMPUTED-TOMOGRAPHY; NEURAL-NETWORKS; ALGORITHM; DISTANCE; ENTROPY	The fast and accurate segmentation of lung nodule image sequences is the basis of subsequent processing and diagnostic analyses. However, previous research investigating nodule segmentation algorithms cannot entirely segment cavitary nodules, and the segmentation of juxta-vascular nodules is inaccurate and inefficient. To solve these problems, we propose a new method for the segmentation of lung nodule image sequences based on superpixels and density-based spatial clustering of applications with noise (DBSCAN). First, our method uses three-dimensional computed tomography image features of the average intensity projection combined with multi-scale dot enhancement for preprocessing. Hexagonal clustering and morphological optimized sequential linear iterative clustering (HMSLIC) for sequence image oversegmentation is then proposed to obtain superpixel blocks. The adaptive weight coefficient is then constructed to calculate the distance required between superpixels to achieve precise lung nodules positioning and to obtain the subsequent clustering starting block. Moreover, by fitting the distance and detecting the change in slope, an accurate clustering threshold is obtained. Thereafter, a fast DBSCAN superpixel sequence clustering algorithm, which is optimized by the strategy of only clustering the lung nodules and adaptive threshold, is then used to obtain lung nodule mask sequences. Finally, the lung nodule image sequences are obtained. The experimental results show that our method rapidly, completely and accurately segments various types of lung nodule image sequences.	[Zhang, Wei; Zhao, Juanjuan; Qiang, Yan] Taiyuan Univ Technol, Coll Comp Sci & Technol, Jinzhong, Shanxi, Peoples R China; [Zhang, Xiaolong] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [Tian, Qi] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA; [Tang, Xiaoxian] Shanxi Prov Peoples Hosp, Dept PET, CT Ctr, Taiyuan, Shanxi, Peoples R China	Taiyuan University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas at San Antonio (UTSA); Shanxi People's Hospital	Zhao, JJ (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Jinzhong, Shanxi, Peoples R China.	zhaojuanjuan@tyut.edu.cn		Zhang, Xiaolong/0000-0002-6828-4930	ARO [W911NF-15-1-0290]; NEC Laboratories of America; Blippar; National Science Foundation of China (NSFC) [61429201]; National Natural Science Foundation of China [61373100]; State Key Laboratory of Virtual Reality Technology and Systems, Beihang University [BUAA-VR-17KF-14, BUAA-VR-17KF-15]; Shanxi Scholarship Council of China [2016-038]	ARO; NEC Laboratories of America; Blippar; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Virtual Reality Technology and Systems, Beihang University; Shanxi Scholarship Council of China	This work was supported in part to Dr. Qi Tian by ARO grant W911NF-15-1-0290 and Faculty Research Gift Awards by NEC Laboratories of America and Blippar, National Science Foundation of China (NSFC) (61429201), National Natural Science Foundation of China (61373100), the open funding project of the State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (Grant No. BUAA-VR-17KF-14,BUAA-VR-17KF-15) and Research Project Supported by Shanxi Scholarship Council of China (2016-038).	Achanta R., 2010, EPFL; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Chen K, 2014, BIO-MED MATER ENG, V24, P539, DOI 10.3233/BME-130840; CHEN W, 2009, CHIN J CANCER RES, V25, P10, DOI DOI 10.3978/J.ISSN.1000-9604.2012.12.04; Chen Y, 2017, PHYS MED BIOL, V62, P2103, DOI 10.1088/1361-6560/aa5c24; Chen Y, 2016, IEEE T IMAGE PROCESS, V25, P988, DOI 10.1109/TIP.2015.2496279; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Deng Y., 2016, IEEE T FUZZY SYST, P1; Doi K, 2014, BR J RADIOL; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; HEIJMANS HJAM, 1990, COMPUT VISION GRAPH, V50, P245, DOI 10.1016/0734-189X(90)90148-O; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kong YY, 2015, IEEE SIGNAL PROC LET, V22, P573, DOI 10.1109/LSP.2014.2364612; Kuntimad G, 1999, IEEE T NEURAL NETWOR, V10, P591, DOI 10.1109/72.761716; Lee KH, 2008, J DIGIT IMAGING, V21, P422, DOI 10.1007/s10278-007-9067-y; Liang J, 2006, INT J GEN SYST, V35, P641, DOI 10.1080/03081070600687668; Liao XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160556; Liu YC, 2012, LECT NOTES COMPUT SC, V7208, P221; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Ren XF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P10; Sander J, 2011, DENSITY BASED CLUSTE, P270; Sivakumar S, 2012, PROCEDIA ENGINEER, V38, P3064, DOI 10.1016/j.proeng.2012.06.357; Sun SS, 2014, IEEE J BIOMED HEALTH, V18, P1355, DOI 10.1109/JBHI.2014.2303511; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Unnikrishnan R., 2005, 2005 IEEE COMP VIS P, P34, DOI [DOI 10.1109/CVPR.2005.390, 10.1109/CVPR.2005.390]; Wei Y, 2012, J CENT SOUTH UNIV, V19, P3500, DOI 10.1007/s11771-012-1435-1; Xu N, 2002, P SOC PHOTO-OPT INS, V4684, P666, DOI 10.1117/12.467209; Zhao JJ, 2015, INT J BIO-INSPIR COM, V7, P62, DOI 10.1504/IJBIC.2015.067999; Zinoveva O, 2011, LECT NOTES COMPUT SC, V6754, P21, DOI 10.1007/978-3-642-21596-4_3	36	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184290	10.1371/journal.pone.0184290	http://dx.doi.org/10.1371/journal.pone.0184290			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880916	Green Submitted, Green Published, gold			2022-12-26	WOS:000409467200046
J	Jeppesen, M; Hagel, G; Glenthoj, A; Vainer, B; Ibsen, P; Harling, H; Thastrup, O; Jorgensen, LN; Thastrup, J				Jeppesen, Maria; Hagel, Grith; Glenthoj, Anders; Vainer, Ben; Ibsen, Per; Harling, Henrik; Thastrup, Ole; Jorgensen, Lars N.; Thastrup, Jacob			Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine	PLOS ONE			English	Article							DRUG-SENSITIVITY TEST; TUMOR SPHEROIDS; HUMAN-COLON; TISSUE; EXPRESSION; LINES; ESTABLISHMENT; MECHANISMS; PREDICTION; ORGANOIDS	Chemotherapy treatment of cancer remains a challenge due to the molecular and functional heterogeneity displayed by tumours originating from the same cell type. The pronounced heterogeneity makes it difficult for oncologists to devise an effective therapeutic strategy for the patient. One approach for increasing treatment efficacy is to test the chemosensitivity of cancer cells obtained from the patient's tumour. 3D culture represents a promising method for modelling patient tumours in vitro. The aim of this study was therefore to evaluate how closely short-term spheroid cultures of primary colorectal cancer cells resemble the original tumour. Colorectal cancer cells were isolated from human tumour tissue and cultured as spheroids. Spheroid cultures were established with a high success rate and remained viable for at least 10 days. The spheroids exhibited significant growth over a period of 7 days and no difference in growth rate was observed for spheroids of different sizes. Comparison of spheroids with the original tumour revealed that spheroid culture generally preserved adenocarcinoma histology and expression patterns of cytokeratin 20 and carcinoembryonic antigen. Interestingly, spheroids had a tendency to resemble tumour protein expression more closely after 10 days of culture compared to 3 days. Chemosensitivity screening using spheroids from five patients demonstrated individual response profiles. This indicates that the spheroids maintained patient-to-patient differences in sensitivity towards the drugs and combinations most commonly used for treatment of colorectal cancer. In summary, short-term spheroid culture of primary colorectal adenocarcinoma cells represents a promising in vitro model for use in personalized medicine.	[Jeppesen, Maria; Harling, Henrik; Jorgensen, Lars N.] Univ Copenhagen, Bispebjerg Hosp, Digest Dis Ctr, Copenhagen, Denmark; [Hagel, Grith; Thastrup, Ole; Thastrup, Jacob] 2cureX, Birkerod, Denmark; [Glenthoj, Anders; Vainer, Ben] Univ Copenhagen, Rigshosp, Dept Pathol, Copenhagen, Denmark; [Ibsen, Per] Univ Copenhagen, Hvidovre Hosp, Dept Pathol, Copenhagen, Denmark; [Thastrup, Ole] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Thastrup, J (corresponding author), 2cureX, Birkerod, Denmark.	JT@2curex.com		Thastrup, Maria/0000-0001-9950-5911; Thastrup, Jacob/0000-0002-7264-103X; Jorgensen, Lars N/0000-0001-7465-5374	Danish Council for Strategic research [10-092308]	Danish Council for Strategic research(Danske Strategiske Forskningsrad (DSF))	MJ received funding as part of the IndiTreat project funded by the Danish Council for Strategic research (http:/innovationsfonden.dk/ en), File number: 10-092308. The Danish Council for Strategic Research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GH, OT and JT are fulltime employees at 2cureX, Birkerod, Denmark. 2cureX provided support in the form of salaries for authors GH, OT and JT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AG, BV, PI, HH and LNJ received no specific funding for this work.	Ashley N, 2014, J PATHOL, V234, P34, DOI 10.1002/path.4371; Asthana A, 2012, DRUG DISCOV TODAY, V17, P810, DOI 10.1016/j.drudis.2012.03.004; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Melo FDE, 2013, EMBO REP, V14, P686, DOI 10.1038/embor.2013.92; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; EMERMAN JT, 1990, IN VITRO CELL DEV B, V26, P1186; Farrell TM, 2000, CYTOTECHNOLOGY, V34, P205, DOI 10.1023/A:1008131428992; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Gazdar AF, 2010, LUNG CANCER, V68, P309, DOI 10.1016/j.lungcan.2009.12.005; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Giraud S, 2011, ANTICANCER RES, V31, P139; Gospodarowicz MK, 2004, CANCER, V100, P1, DOI 10.1002/cncr.11898; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzog TJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.059; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Tuy HD, 2016, ONCOL LETT, V12, P2752, DOI 10.3892/ol.2016.4937; Huang M, 2014, TRENDS PHARMACOL SCI, V35, P41, DOI 10.1016/j.tips.2013.11.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenke AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055636; Kawamura M, 2007, CANCER CHEMOTH PHARM, V59, P507, DOI 10.1007/s00280-006-0292-8; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Lee SH, 2015, CANCER LETT, V367, P34, DOI 10.1016/j.canlet.2015.06.024; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Loum E, 2010, CYTOTECHNOLOGY, V62, P381, DOI 10.1007/s10616-010-9298-5; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Mitra A, 2013, TRENDS BIOTECHNOL, V31, P347, DOI 10.1016/j.tibtech.2013.03.006; MOLL R, 1992, AM J PATHOL, V140, P427; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Nagourney RA, 2012, ANTICANCER RES, V32, P4453; Oie HK, 1996, J CELL BIOCHEM, P24; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Takamura Y, 2002, INT J CANCER, V98, P450, DOI 10.1002/ijc.10208; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Tong WM, 1998, INT J CANCER, V75, P467, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;467::AID-IJC22&gt;3.0.CO;2-4; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Wang XY, 2013, CANCER BIOMARK, V13, P81, DOI 10.3233/CBM-130344; Weeber F, 2015, P NATL ACAD SCI USA, V112, P13308, DOI 10.1073/pnas.1516689112; Weiswald LB, 2009, BRIT J CANCER, V101, P473, DOI 10.1038/sj.bjc.6605173; Xu X, 2014, BIOTECHNOL ADV, V32, P1256, DOI 10.1016/j.biotechadv.2014.07.009; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamauchi K, 2016, ANTICANCER RES, V36, P2175	56	50	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183074	10.1371/journal.pone.0183074	http://dx.doi.org/10.1371/journal.pone.0183074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877221	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200020
J	Kitagawa, M; Sada, KE; Hinamoto, N; Kimachi, M; Yamamoto, Y; Onishi, Y; Fukuhara, S				Kitagawa, Masashi; Sada, Ken-ei; Hinamoto, Norikazu; Kimachi, Miho; Yamamoto, Yosuke; Onishi, Yoshihiro; Fukuhara, Shunichi			Shorter dialysis session length was not associated with lower mental health and physical functioning in elderly hemodialysis patients: Results from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)	PLOS ONE			English	Article							QUALITY-OF-LIFE; SHORT-FORM 12; NOCTURNAL HEMODIALYSIS; 3 TIMES; MORTALITY; DISEASE; PREDICTORS; TRIALS	Background Health-related quality of life (HRQOL) is often prioritized over long-term survival in elderly patients. Although a longer dialysis session length (DSL) has been shown to reduce mortality, its effects on improving the HRQOL are unknown. Methods Using data from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS), patients aged >= 65 years on maintenance hemodialysis were enrolled. DSL was categorized as short (<210 minutes), medium (210-240 minutes), or long (>240 minutes). The primary outcomes were changes in mental health (Delta MH) and physical functioning (Delta PF) scores assessed using the Japanese version of SF-12, in one year. The differences in the Delta MH and Delta PF among the three groups were assessed via regression (beta) coefficients derived using a linear regression model. Results Of 1,187 patients at baseline, 319 (26.9%) had a short length, 686 (57.8%) a medium length, and 182 (15.3%) a long length. We assessed the.MH data from 793 patients and the Delta PF data from 738. No significant differences in the.MH were noted for the short or long groups compared with the medium group (score difference: 0.26, 95% confidence interval [CI]: -4.17 to 4.69 for short; score difference: -1.15, 95% CI: -6.17 to 3.86 for long). Similarly, no significant differences were noted for these groups versus the medium group in.PF either (score difference: -1.43, 95% CI: -6.73 to 3.87 for short; score difference: -1.71, 95% CI: -7.63 to 4.22 for long). Conclusions A shorter DSL might have no adverse effects on MH or PF for elderly patients.	[Kitagawa, Masashi; Sada, Ken-ei; Hinamoto, Norikazu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Okayama, Japan; [Kimachi, Miho; Yamamoto, Yosuke; Fukuhara, Shunichi] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Healthcare Epidemiol, Kyoto, Kyoto, Japan; [Onishi, Yoshihiro] iHope Int, Inst Hlth Outcomes & Proc Evaluat Res, Kyoto, Kyoto, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Fukushima, Japan	Okayama University; Kyoto University; Fukushima Medical University	Kitagawa, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Okayama, Japan.	masa4_n_r@yahoo.co.jp	YAMAMOTO, Yosuke/HCH-0666-2022	Sada, Ken-ei/0000-0003-1020-0818	Amgen; Kyowa Hakko Kirin; Sanofi/Genzyme; Abbott; Baxter; Vifor Fresenius Renal Pharma	Amgen(Amgen); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Sanofi/Genzyme; Abbott(Abbott Laboratories); Baxter; Vifor Fresenius Renal Pharma	The JDOPPS is Japanese part of The DOPPS. The DOPPS is administered by the Arbor Research Collaborative for Health and is supported by scientific research grants from Amgen (since 1996), Kyowa Hakko Kirin (since 1999, in Japan), Sanofi/Genzyme (since 2009), Abbott (since 2009), Baxter (since 2011), and Vifor Fresenius Renal Pharma (since 2011), without restrictions on publications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present study is supported by scientific research grants from Kyowa Hakko Kirin without restrictions.	Bohlke M, 2008, SAO PAULO MED J, V126, P252, DOI 10.1590/S1516-31802008000500002; Brunelli SM, 2010, KIDNEY INT, V77, P630, DOI 10.1038/ki.2009.523; Davison SN, 2015, KIDNEY INT, V88, P447, DOI 10.1038/ki.2015.110; Flythe JE, 2013, KIDNEY INT, V83, P104, DOI 10.1038/ki.2012.346; Fukuhara S, 2003, KIDNEY INT, V64, P1903, DOI 10.1046/j.1523-1755.2003.00289.x; Fukuhara S., 2004, MANUAL SF 36V2 JAPAN; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Hall YN, 2012, CLIN J AM SOC NEPHRO, V7, P782, DOI 10.2215/CJN.10601011; Hamuro A, 2016, J OBSTET GYNAECOL RE, V42, P707, DOI 10.1111/jog.12952; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Heidenheim AP, 2003, AM J KIDNEY DIS, V42, pS36, DOI 10.1016/S0272-6386(03)00536-5; HELD PJ, 1991, JAMA-J AM MED ASSOC, V265, P871, DOI 10.1001/jama.265.7.871; Honda M, 2015, ANN SURG ONCOL, V22, pS848, DOI 10.1245/s10434-015-4696-8; Ifudu O, 1996, NEW ENGL J MED, V334, P420, DOI 10.1056/NEJM199602153340702; Inoue M, 2017, CLIN RHEUMATOL, V36, P1053, DOI 10.1007/s10067-017-3545-5; Jaber BL, 2010, AM J KIDNEY DIS, V56, P531, DOI 10.1053/j.ajkd.2010.04.019; Kato S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123022; Lacson E, 2010, CLIN J AM SOC NEPHRO, V5, P252, DOI 10.2215/CJN.07231009; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Loosman WL, 2015, NEPHROL DIAL TRANSPL, V30, P1170, DOI 10.1093/ndt/gfv066; Manns BJ, 2009, KIDNEY INT, V75, P542, DOI 10.1038/ki.2008.639; Marshall MR, 2005, KIDNEY INT, V67, P1944, DOI 10.1111/j.1523-1755.2005.00293.x; McPhatter LL, 1999, ADV RENAL REPLACE TH, V6, P358, DOI 10.1016/S1073-4449(99)70048-8; Osthus TBH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-46; Parker SL, 2012, J NEUROSURG-SPINE, V16, P61, DOI 10.3171/2011.8.SPINE1194; Perl J, 2016, NEPHROL DIAL TRANSPL; Perl J, 2017, NEPHROL DIAL TRANSPL, V32, P521, DOI 10.1093/ndt/gfw233; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Shinzato T, 1997, NEPHROL DIAL TRANSPL, V12, P884, DOI 10.1093/ndt/12.5.884; Singh J, 2010, J AM ACAD ORTHOP SUR, V18, P72; Tentori F, 2012, NEPHROL DIAL TRANSPL, V27, P4180, DOI 10.1093/ndt/gfs021; Unruh ML, 2013, AM J KIDNEY DIS, V61, P748, DOI 10.1053/j.ajkd.2012.11.047; Vilagut G, 2013, VALUE HEALTH, V16, P564, DOI 10.1016/j.jval.2013.01.006; Walsh M, 2005, KIDNEY INT, V67, P1500, DOI 10.1111/j.1523-1755.2005.00228.x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yoshida M, 2016, NEUROUROL URODYN	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184019	10.1371/journal.pone.0184019	http://dx.doi.org/10.1371/journal.pone.0184019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877202	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200054
J	Levitz, R; Gao, YJ; Dozmorov, I; Song, R; Wakeland, EK; Kahn, JS				Levitz, Ruth; Gao, Yajing; Dozmorov, Igor; Song, Ran; Wakeland, Edward K.; Kahn, Jeffrey S.			Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus	PLOS ONE			English	Article							STANDARD-BASED ANALYSIS; G-PROTEIN; GENE-EXPRESSION; G-GLYCOPROTEIN; SUBSTANCE-P; BALB/C MICE; CX3C MOTIF; ALVEOLAR MACROPHAGES; CELL RESPONSES; RSV INFECTION	Respiratory syncytial virus (RSV) is a major respiratory pathogen of infants and young children. Multiple strains of both subgroup A and B viruses circulate during each seasonal epidemic. Genetic heterogeneity among RSV genomes, in large part due to the error prone RNA-dependent, RNA polymerase, could mediate variations in pathogenicity. We evaluated clinical strains of RSV for their ability to induce the innate immune response. Subgroup B viruses were used to infect human pulmonary epithelial cells (A549) and primary monocyte-derived human macrophages (MDM) from a variety of donors. Secretions of IL-6 and CCL5 (RANTES) from infected cells were measured following infection. Host and viral transcriptome expression were assessed using RNA-SEQ technology and the genomic sequences of several clinical isolates were determined. There were dramatic differences in the induction of IL-6 and CCL5 in both A549 cells and MDM infected with a variety of clinical isolates of RSV. Transcriptome analyses revealed that the pattern of innate immune activation in MDM was virus-specific and host-specific. Specifically, viruses that induced high levels of secreted IL-6 and CCL5 tended to induce cellular innate immune pathways whereas viruses that induced relatively low level of IL-6 or CCL5 did not induce or suppressed innate immune gene expression. Activation of the host innate immune response mapped to variations in the RSV G gene and the M2-1 gene. Viral transcriptome data indicated that there was a gradient of transcription across the RSV genome though in some strains, RSV G was the expressed in the highest amounts at late times post-infection. Clinical strains of RSV differ in cytokine/chemokine induction and in induction and suppression of host genes expression suggesting that these viruses may have inherent differences in virulence potential. Identification of the genetic elements responsible for these differences may lead to novel approaches to antiviral agents and vaccines.	[Levitz, Ruth; Kahn, Jeffrey S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Gao, Yajing; Dozmorov, Igor; Song, Ran; Wakeland, Edward K.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kahn, Jeffrey S.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kahn, JS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; Kahn, JS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	Jeffrey.Kahn@UTSouthwestern.edu	Gao, Yajing/AAO-5023-2020	Gao, Yajing/0000-0002-8836-4452	Department of Pediatrics and The Sarah M. & Charles E. Seay Chair in Pediatric Infectious Diseases; University of Texas Southwestern Medical Center, Dallas, Texas; National institutes of Health [R21 AI126109-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126109] Funding Source: NIH RePORTER	Department of Pediatrics and The Sarah M. & Charles E. Seay Chair in Pediatric Infectious Diseases; University of Texas Southwestern Medical Center, Dallas, Texas; National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Pediatrics and The Sarah M. & Charles E. Seay Chair in Pediatric Infectious Diseases, The University of Texas Southwestern Medical Center, Dallas, Texas. This work was also supported by the National institutes of Health (grant R21 AI126109-01 (PI: Kahn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; BECKER S, 1991, J IMMUNOL, V147, P4307; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Bose ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120098; Boukhvalova MS, 2009, BIOLOGICALS, V37, P152, DOI 10.1016/j.biologicals.2009.02.017; Boyoglu-Barnum S, 2017, J VIROL, V91, DOI 10.1128/JVI.02059-16; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; Ciencewicki JM, 2014, FASEB J, V28, P1947, DOI 10.1096/fj.13-239855; COLLINS PL, 1983, P NATL ACAD SCI-BIOL, V80, P3208, DOI 10.1073/pnas.80.11.3208; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; de Waal L, 2004, VACCINE, V22, P915, DOI 10.1016/j.vaccine.2003.10.008; Dozmorov I, 2003, BIOINFORMATICS, V19, P204, DOI 10.1093/bioinformatics/19.2.204; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dozmorov IM, 2011, NUCLEIC ACIDS RES, V39, P7881, DOI 10.1093/nar/gkr503; Dozmorov MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012657; El-Far M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054295; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Harker JA, 2014, J VIROL, V88, P604, DOI 10.1128/JVI.02620-13; Harrison AM, 1999, AM J RESP CRIT CARE, V159, P1918, DOI 10.1164/ajrccm.159.6.9805083; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Hornsleth A, 2001, J CLIN VIROL, V21, P163, DOI 10.1016/S1386-6532(01)00159-7; Hotard AL, 2015, J VIROL; Hsiung G.D., 1994, HSIUNGS DIAGNOSTIC V, V4th ed.; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jong VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36603; Larkin EK, 2015, FUTURE VIROL, V10, P883, DOI 10.2217/FVL.15.55; LEARMONT J, 1992, LANCET, V340, P863, DOI 10.1016/0140-6736(92)93281-Q; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Levitz R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-190; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Li XQ, 2006, J VIROL, V80, P537, DOI 10.1128/JVI.80.1.537-540.2006; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Martinello RA, 2002, J INFECT DIS, V186, P839, DOI 10.1086/342414; McDonald JU, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00051-16; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Moore EC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-116; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Muramoto Y, 2014, J VIROL, V88, P8981, DOI 10.1128/JVI.00907-14; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noah TL, 2002, CLIN IMMUNOL, V104, P86, DOI 10.1006/clim.2002.5248; Oshansky CM, 2010, J INFECT DIS, V201, P1201, DOI 10.1086/651431; Oshansky CM, 2009, FUTURE MICROBIOL, V4, P279, DOI 10.2217/FMB.09.1; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Pennings JLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021461; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Ravi LI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-190; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tabarani CM, 2013, PEDIATR INFECT DIS J, V32, pE437, DOI 10.1097/INF.0b013e3182a14407; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; Thompson TM, 2015, CLIN MICROBIOLOGY, V4; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Tripp RA, 2000, J VIROL, V74, P1614, DOI 10.1128/JVI.74.4.1614-1622.2000; Tripp RA, 2000, J VIROL, V74, P6227, DOI 10.1128/JVI.74.13.6227-6229.2000; van den Kieboom CH, 2015, EUR RESPIR J, V45, P718, DOI 10.1183/09031936.00085614; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villenave R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-43; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	78	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184318	10.1371/journal.pone.0184318	http://dx.doi.org/10.1371/journal.pone.0184318			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877226	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200086
J	Borrell, YJ; Miralles, L; Do Huu, H; Mohammed-Geba, K; Garcia-Vazquez, E				Borrell, Yaisel J.; Miralles, Laura; Do Huu, Hoang; Mohammed-Geba, Khaled; Garcia-Vazquez, Eva			DNA in a bottle-Rapid metabarcoding survey for early alerts of invasive species in ports	PLOS ONE			English	Article							ENVIRONMENTAL DNA; BIODIVERSITY ASSESSMENT; MARINE-INVERTEBRATES; DIVERSITY; EDNA	Biota monitoring in ports is increasingly needed for biosecurity reasons and safeguarding marine biodiversity from biological invasion. Present and future international biosecurity directives can be accomplished only if the biota acquired by maritime traffic in ports is controlled. Methodologies for biota inventory are diverse and now rely principally on extensive and labor-intensive sampling along with taxonomic identification by experts. In this study, we employed an extremely simplified environmental DNA (eDNA) sampling methodology from only three 1-L bottles of water per port, followed by metabarcoding (high-throughput sequencing and DNA-based species identification) using 18S rDNA and Cytochrome oxidase I as genetic barcodes. Eight Bay of Biscay ports with available inventory of fouling invertebrates were employed as a case study. Despite minimal sampling efforts, three invasive invertebrates were detected: the barnacle Austrominius modestus, the tubeworm Ficopomatus enigmaticus and the polychaete Polydora triglanda. The same species have been previously found from visual and DNA barcoding (genetic identification of individuals) surveys in the same ports. The current costs of visual surveys, conventional DNA barcoding and this simplified metabarcoding protocol were compared. The results encourage the use of metabarcoding for early biosecurity alerts.	[Borrell, Yaisel J.; Miralles, Laura; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Do Huu, Hoang] Vietnam Acad Sci & Technol, Inst Oceanog, Dept Aquaculture Biotechnol, Nha Trang, Vietnam; [Mohammed-Geba, Khaled] Menoufia Univ, Fac Sci, Genet Engn & Mol Biol Div, Menoufia, Egypt	University of Oviedo; Vietnam Academy of Science & Technology (VAST); Egyptian Knowledge Bank (EKB); Menofia University	Borrell, YJ (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Spain.	borrellyaisel@uniovi.es	Mohammed-Geba, Khaled/AAI-7098-2020; Borrell Pichs, Yaisel/B-2650-2009; Garcia-Vazquez, Eva/Y-7293-2019; Borrell Pichs, Yaisel J./ABC-8904-2020; Do Huu, Hoang/B-8452-2014	Mohammed-Geba, Khaled/0000-0002-0281-816X; Borrell Pichs, Yaisel/0000-0003-2840-4384; Borrell Pichs, Yaisel J./0000-0003-2840-4384; Do Huu, Hoang/0000-0002-4953-0657; Garcia-Vazquez, Eva/0000-0002-8429-838X; Miralles, Laura/0000-0002-7146-9776	government of Principado de Asturias [GRUPIN-2014-093]; Spanish MINECO [CGL-2013-42415-R, CGL-2016-79209-R]	government of Principado de Asturias(Principality of Asturias); Spanish MINECO(Spanish Government)	This study has been funded by the government of Principado de Asturias with the Grant GRUPIN-2014-093, the Spanish MINECO project CGL-2013-42415-R and the Spanish MINECO Project CGL-2016-79209-R.	Amberg JJ, 2015, J GREAT LAKES RES, V41, P367, DOI 10.1016/j.jglr.2015.02.009; Ardura A, 2017, AQUAT CONSERV, V27, P165, DOI 10.1002/aqc.2655; Ardura A, 2016, PEERJ, V4, DOI 10.7717/peerj.2438; Ardura A, 2015, J MOLLUS STUD, V81, P495, DOI 10.1093/mollus/eyv022; Ardura A, 2013, ZOOKEYS, P49, DOI 10.3897/zookeys.365.6409; Awad A., 2014, GUIDANCE PORT BIOLOG; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Blanckenhorn WU, 2016, ENVIRON TOXICOL CHEM, V35, P1970, DOI 10.1002/etc.3275; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Crocetta F, 2015, J MAR BIOL ASSOC UK, V95, P111, DOI 10.1017/S0025315414001027; Darbyson Emily, 2009, Aquatic Invasions, V4, P87, DOI 10.3391/ai.2009.4.1.9; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Drake John M., 2007, Aquatic Invasions, V2, P121, DOI 10.3391/ai.2007.2.2.7; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elbrecht V, 2017, METHODS ECOL EVOL, V8, P1; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Gollasch S, 2015, GLOBAL MARITIME TRAN, V8; Gollasch S, 2011, PROMET-ZAGREB, V23, P397; Grall J, 2003, AQUAT CONSERV, V13, pS55, DOI 10.1002/aqc.568; Guardiola M, 2016, PEERJ, V4, DOI 10.7717/peerj.2807; Hammer H. Q., 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Harper D, 1999, COMPUTER BASED MODEL; HELCOM, 2013, HELC AL 2 NON SPEC P; Hewitt C. L., 2001, 22 CSIRO MAR RES; Hinlo R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179251; Horton T., 2017, WORLD REGISTER MARIN; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Katsanevakis S, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00032; Katsanevakis S, 2014, AQUAT INVASIONS, V9, P391, DOI 10.3391/ai.2014.9.4.01; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kwong S, 2012, CLADISTICS, V28, P639, DOI 10.1111/j.1096-0031.2012.00408.x; Lanzen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179443; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Machler E, 2016, ENVIRON SCI TECHNOL, V50, P305, DOI 10.1021/acs.est.5b04188; Marchini A, 2015, SCI MAR, V79, P355, DOI 10.3989/scimar.04238.03A; Minchin D, 2003, BIOFOULING, V19, P111, DOI 10.1080/0892701021000057891; Minchin D, 2016, MAR POLLUT BULL, V112, P177, DOI 10.1016/j.marpolbul.2016.08.023; Miralles L, 2016, MAR POLLUT BULL, V112, P183, DOI 10.1016/j.marpolbul.2016.08.022; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Nunn JD, 2013, NO IRELAND ENV AGENC; Occhipinti-Ambrogi A, 2016, MAR C 2016 FEB 1 5; Pejovic I, 2016, MAR BIOL RES, V12, P168, DOI 10.1080/17451000.2015.1112016; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Pochon X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073935; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Saitoh S, 2016, GENOME, V59, P705, DOI 10.1139/gen-2015-0228; Smart AS, 2016, METHODS ECOL EVOL, V7, P1291, DOI 10.1111/2041-210X.12598; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Thomas AC, 2016, MOL ECOL RESOUR, V16, P714, DOI 10.1111/1755-0998.12490; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zaiko A, 2016, BIOFOULING, V32, P671, DOI 10.1080/08927014.2016.1186165; Zaiko A, 2015, MAR ENVIRON RES, V112, P64, DOI 10.1016/j.marenvres.2015.07.002	67	50	53	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183347	10.1371/journal.pone.0183347	http://dx.doi.org/10.1371/journal.pone.0183347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873426	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800014
J	Chen, L; Zhang, YH; Wang, SP; Zhang, YH; Huang, T; Cai, YD				Chen, Lei; Zhang, Yu-Hang; Wang, ShaoPeng; Zhang, YunHua; Huang, Tao; Cai, Yu-Dong			Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MESSENGER-RNA EXPRESSION; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; AMINO-ACID TRANSPORTER; BACILLUS-SUBTILIS; FEATURE-SELECTION; ESCHERICHIA-COLI; BINDING PROTEIN; RIBOSOMAL-RNAS	Identifying essential genes in a given organism is important for research on their fundamental roles in organism survival. Furthermore, if possible, uncovering the links between core functions or pathways with these essential genes will further help us obtain deep insight into the key roles of these genes. In this study, we investigated the essential and non-essential genes reported in a previous study and extracted gene ontology (GO) terms and biological pathways that are important for the determination of essential genes. Through the enrichment theory of GO and KEGG pathways, we encoded each essential/non-essential gene into a vector in which each component represented the relationship between the gene and one GO term or KEGG pathway. To analyze these relationships, the maximum relevance minimum redundancy (mRMR) was adopted. Then, the incremental feature selection (IFS) and support vector machine (SVM) were employed to extract important GO terms and KEGG pathways. A prediction model was built simultaneously using the extracted GO terms and KEGG pathways, which yielded nearly perfect performance, with a Matthews correlation coefficient of 0.951, for distinguishing essential and non-essential genes. To fully investigate the key factors influencing the fundamental roles of essential genes, the 21 most important GO terms and three KEGG pathways were analyzed in detail. In addition, several genes was provided in this study, which were predicted to be essential genes by our prediction model. We suggest that this study provides more functional and pathway information on the essential genes and provides a new way to investigate related problems.	[Chen, Lei; Wang, ShaoPeng; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Zhang, Yu-Hang; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Zhang, YunHua] Anhui Agr Univ, Sch Resources & Environm, Anhui Prov Key Lab Farmland Ecol Conversat & Poll, Hefei, Anhui, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Anhui Agricultural University	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Chen, Lei/A-2275-2011; Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015	Chen, Lei/0000-0003-3068-1583; Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31371335]; Natural Science Foundation of Shanghai [17ZR1412500]; Shanghai Sailing Program, The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]; Science Foundation of Anhui [1608085MC58]; Science and Technology Research Projects of Anhui [1604e0302006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Sailing Program, The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS); Science Foundation of Anhui; Science and Technology Research Projects of Anhui	This study was supported by the National Natural Science Foundation of China (31371335), Natural Science Foundation of Shanghai (17ZR1412500), Shanghai Sailing Program, The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245), the Science Foundation of Anhui (1608085MC58) and the Science and Technology Research Projects of Anhui (1604e0302006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (31371335), Natural Science Foundation of Shanghai (17ZR1412500), Shanghai Sailing Program, The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245), the Science Foundation of Anhui (1608085MC58) and the Science and Technology Research Projects of Anhui (1604e0302006).	Appuhamy JADRN, 2011, J NUTR, V141, P1209, DOI 10.3945/jn.110.136143; Bachellerie JP, 1995, BIOCHEM CELL BIOL, V73, P835, DOI 10.1139/o95-091; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; BUSCH RK, 1977, TUMORI, V63, P347, DOI 10.1177/030089167706300406; Cantarero L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10543; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chatterjee R, 2001, LEUKEMIA LYMPHOMA, V41, P213, DOI 10.3109/10428190109057974; Chen L, 2016, MOL GENET GENOMICS, V291, P2065, DOI 10.1007/s00438-016-1240-x; Chen L, 2017, CURR BIOINFORM, V12, P526, DOI 10.2174/1574893611666160618094219; Chen L, 2017, ARTIF INTELL MED, V76, P27, DOI 10.1016/j.artmed.2017.02.001; Chen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159395; Chen L, 2015, AMINO ACIDS, V47, P1485, DOI 10.1007/s00726-015-1974-5; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Comai L, 2000, CELL GROWTH DIFFEREN, V11; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Doxani C, 2013, BIOMARKERS, V18, P425, DOI 10.3109/1354750X.2013.808263; Dozio E, 2009, CURR PROTEIN PEPT SC, V10, P577, DOI 10.2174/138920309789630561; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; Fang YM, 2017, COMB CHEM HIGH T SCR, V20, P140, DOI 10.2174/1386207319666161215142130; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Fujiwara T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.213; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gao PK, 2014, TUMOR BIOL, V35, P9585, DOI 10.1007/s13277-014-2228-y; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Grazziotin AL, 2015, FEBS J, V282, P3395, DOI 10.1111/febs.13350; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Huang T, 2016, ONCOTARGET, V7, P80990, DOI 10.18632/oncotarget.13167; Huang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep32571; Huang T, 2015, PROTEIN CELL, V6, P904, DOI 10.1007/s13238-015-0226-5; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Ji YQ, 2010, INT J HEMATOL, V91, P209, DOI 10.1007/s12185-010-0527-7; Juhas M, 2014, MICROBIOL-SGM, V160, P2341, DOI 10.1099/mic.0.079376-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kashyap MK, 2015, HAEMATOLOGICA, V100, P945, DOI 10.3324/haematol.2014.122069; KATOH I, 1993, J VIROL, V67, P1830, DOI 10.1128/JVI.67.4.1830-1839.1993; Kibria KMK, 2015, HELICOBACTER, V20, P397, DOI 10.1111/hel.12213; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kushev D, 1999, BIOL CHEM, V380, P1287, DOI 10.1515/BC.1999.164; LEBLONDEL G, 1984, RES COMMUN CHEM PATH, V44, P499; Lenzmeier BA, 1997, J VIROL, V71, P2577, DOI 10.1128/JVI.71.3.2577-2580.1997; Li BQ, 2016, CURR BIOINFORM, V11, P22, DOI 10.2174/1574893611666151119215131; Li GS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1115-5; Li XR, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-20; Li ZC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-325; Li Z, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/304029; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Linnane AW, 2007, MITOCHONDRION, V7, P1, DOI 10.1016/j.mito.2006.11.009; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu LL, 2017, J BIOMOL STRUCT DYN, V35, P312, DOI 10.1080/07391102.2016.1138142; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MARTINELLI G, 1995, BRIT J HAEMATOL, V90, P966, DOI 10.1111/j.1365-2141.1995.tb05228.x; Martini A, 2002, BLOOD, V100, p528a; Masiero M, 2011, LEUKEMIA, V25, P588, DOI 10.1038/leu.2010.323; Mata JF, 2010, PEDIATR BLOOD CANCER, V55, P100, DOI 10.1002/pbc.22463; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Maurel S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-64; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakano K, 2013, MICROBES INFECT, V15, P491, DOI 10.1016/j.micinf.2013.03.006; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Negi SS, 2015, ONCOTARGET, V6, P34846, DOI 10.18632/oncotarget.5413; Negi SS, 2015, ONCOTARGET, V6, P18094, DOI 10.18632/oncotarget.4093; Ni Q, 2017, COMBINATORIAL CHEM H; Ning K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-505; Noah JW, 2000, NUCLEIC ACIDS RES, V28, P3785, DOI 10.1093/nar/28.19.3785; O'Neill RS, 2013, GENOME, V56, P753, DOI 10.1139/gen-2013-0210; Palacios F, 2015, LEUKEMIA LYMPHOMA, V56, P10; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park Y, 2015, ONCOGENE, V34, P5037, DOI 10.1038/onc.2014.423; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Ravi S, 2015, J NUTR, V145, P841, DOI 10.3945/jn.114.203216; Robinson KE, 2008, J GEN VIROL, V89, P2851, DOI 10.1099/vir.0.2008/002501-0; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Root-Bernstein R, 2016, J THEOR BIOL, V397, P115, DOI 10.1016/j.jtbi.2016.02.030; Rozovski U, 2013, LEUKEMIA LYMPHOMA, V54, P1364, DOI 10.3109/10428194.2012.742528; Shirafuji N, 1997, BLOOD, V90, P4567, DOI 10.1182/blood.V90.11.4567.4567_4567_4577; Smetana K, 2011, ACTA HISTOCHEM, V113, P58, DOI 10.1016/j.acthis.2009.07.008; Su R, 2016, J MICROSC-OXFORD, V264, P127, DOI 10.1111/jmi.12421; Szikra T, 2007, VISUAL NEUROSCI, V24, P733, DOI 10.1017/S0952523807070587; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Vary TC, 1999, AM J PHYSIOL-ENDOC M, V277, pE1077, DOI 10.1152/ajpendo.1999.277.6.E1077; Volkova OA, 2010, J BIOMOL STRUCT DYN, V27, P611, DOI 10.1080/07391102.2010.10508575; Wang SP, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8351204; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wei LY, 2017, ARTIF INTELL MED, V83, P82, DOI 10.1016/j.artmed.2017.02.005; Wei LY, 2017, IEEE T NANOBIOSCI, V16, P240, DOI 10.1109/TNB.2017.2661756; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wicker-Planquart C, 2015, FEBS LETT, V589, P2080, DOI 10.1016/j.febslet.2015.06.006; Wu YP, 2015, AM J PHYSIOL-REG I, V309, pR747, DOI 10.1152/ajpregu.00148.2015; Xin P, 2011, AFR J MICROBIOL RES, V5, P2245; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107202; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137; Zhang XY, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00151; Zheng Z, 2002, LEUKEMIA, V16, P2429, DOI 10.1038/sj.leu.2402711; Zhong JC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S7	118	114	120	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184129	10.1371/journal.pone.0184129	http://dx.doi.org/10.1371/journal.pone.0184129			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873455	Green Submitted, gold, Green Published			2022-12-26	WOS:000409282800053
J	Wang, T; Liu, Y; Zou, JF; Cheng, ZS				Wang, Ting; Liu, Yuan; Zou, Jing-Feng; Cheng, Zhen-Shun			Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-beta 1 mediated Smad2/3 and ERK1/2 activation	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; FIBROBLAST PROLIFERATION; LIVER FIBROSIS; LUNG-CANCER; EMT; PATHWAYS; PROMOTES; MECHANISMS; RECEPTORS; MIGRATION	Idiopathic pulmonary fibrosis (IPF) is a chronic and usually progressive lung disease and the epithelial-mesenchymal transition (EMT) may play an important role in the pathogenesis of pulmonary fibrosis. IL-17 is a proinflammatory cytokine which promotes EMT profiles in lung inflammatory diseases. In this study, we investigated the effect of IL-17 on EMT in alveolar epithelial cell line A549 and the role of TGF beta 1-Smad and ERK signaling pathways in the process. Morphological observation on the cells was performed under inverted microscope. The mRNA and protein expressions of E-cad and alpha-SMA were detected by quantitative RT-PCR and western blotting. The mRNA and protein expressions of TGF-beta 1 were analyzed via quantitative RT-PCR and ELISA. Expressions of Smad2/3, p-Smad2/3, ERK1/2, p-ERK1/2 and p-JNK were examined by western blotting. The results indicated that IL-17 can induce A549 cells to undergo morphological changes and phenotypic markers changes, such as down-regulated E-cad expression and up-regulated alpha-SMA expression. Additionally, IL-17 enhanced TGF-beta 1 expression and stimulated Smad2/3 and ERK1/2 phosphorylation in A549 cells. However, there were no significant differences in the expression of phosphorylated JNK in A549 cells with or without IL-17 treatment. SB431542 or U0126 treated cells showed inhibited morphological changes and phenotypic markers expression, such as up-regulated E-cad expression and down-regulated alpha-SMA expression. In summary, our results suggest that IL-17 can induce A549 alveolar epithelial cells to undergo EMT via the TGF-beta 1 mediated Smad2/3 and ERK1/2 activation.	[Wang, Ting; Liu, Yuan; Zou, Jing-Feng; Cheng, Zhen-Shun] Wuhan Univ, Zhongnan Hosp, Dept Resp Med, Wuhan, Hubei, Peoples R China	Wuhan University	Cheng, ZS (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Resp Med, Wuhan, Hubei, Peoples R China.	zhenshun_cheng@126.com			Hubei Province Natural Science Foundation [2014CFB299]	Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province)	This work was supported by the Hubei Province Natural Science Foundation (2014CFB299).	Antoniou KM, 2010, J RECEPT SIG TRANSD, V30, P262, DOI 10.3109/10799893.2010.489227; Bartis D, 2014, THORAX, V69, P760, DOI 10.1136/thoraxjnl-2013-204608; Borensztajn K, 2013, RESPIRATION, V86, P441, DOI 10.1159/000357598; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Dong ZX, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0084-x; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Gu K, 2015, AM J CANCER RES, V5, P1169; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Huang Q, 2016, AM J CANCER RES, V6, P440; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ji XY, 2013, INT J CLIN EXP PATHO, V6, P1481; Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Liu L, 2016, EUR CYTOKINE NETW, V27, P34, DOI 10.1684/ecn.2016.0373; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Tan ZM, 2013, J IMMUNOL, V191, P1835, DOI 10.4049/jimmunol.1203013; Valente AJ, 2012, CELL SIGNAL, V24, P560, DOI 10.1016/j.cellsig.2011.10.010; Vittal R, 2013, AM J PHYSIOL-LUNG C, V304, pL401, DOI 10.1152/ajplung.00080.2012; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang IA, 2011, EXPERT OPIN THER TAR, V15, P439, DOI 10.1517/14728222.2011.555400; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang Y.E., 2017, COLD SPRING HARB PER, V9; Zhang YH, 2015, INT UROL NEPHROL, V47, P1965, DOI 10.1007/s11255-015-1115-9	38	29	33	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183972	10.1371/journal.pone.0183972	http://dx.doi.org/10.1371/journal.pone.0183972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873461	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800039
J	Gindele, JA; Mang, S; Pairet, N; Christ, I; Gantner, F; Schymeinsky, J; Lamb, DJ				Gindele, Julia A.; Mang, Samuel; Pairet, Nicolas; Christ, Ingrid; Gantner, Florian; Schymeinsky, Juergen; Lamb, David J.			Opposing effects of in vitro differentiated macrophages sub-type on epithelial wound healing	PLOS ONE			English	Article							HAMSTER TRACHEAL EPITHELIUM; MECHANICAL INJURY; CELL-PROLIFERATION; REGENERATION; VIVO; REPAIR; FIBRONECTIN; RESTITUTION; FIBROSIS; LESIONS	Inappropriate repair responses to pulmonary epithelial injury have been linked to perturbation of epithelial barrier function and airway remodelling in a number of respiratory diseases, including chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. We developed an in vitro mechanical scratch injury model in air-liquid interface differentiated primary human small airway epithelial cells that recapitulates many of the characteristics observed during epithelial wound injury in both human tissue and small animal models. Wound closure was initially associated with de-differentiation of the differentiated apical cells and rapid migration into the wound site, followed by proliferation of apical cells behind the wound edge, together with increases in FAK expression, fibronectin and reduction in PAI-1 which collectively facilitate cell motility and extracellular matrix deposition. Macrophages are intimately involved in wound repair so we sought to investigate the role of macrophage sub-types on this process in a novel primary human co-culture model. M-1 macrophages promoted FAK expression and both M-1 and M-2 macrophages promoted epithelial de-differentiation. Interestingly, M-2a macrophages inhibited both proliferation and fibronectin expression, possibly via the retinoic acid pathway, whereas M-2b and M-2c macrophages prevented fibronectin deposition, possibly via MMP expression. Collectively these data highlight the complex nature of epithelial wound closure, the differential impact of macrophage sub-types on this process, and the heterogenic and non-delineated function of these macrophages.	[Gindele, Julia A.; Mang, Samuel; Pairet, Nicolas; Christ, Ingrid; Schymeinsky, Juergen; Lamb, David J.] Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany; [Gindele, Julia A.; Gantner, Florian] Univ Konstanz, Dept Biol, Constance, Germany; [Mang, Samuel] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Pairet, Nicolas; Schymeinsky, Juergen] Univ Ulm, Dept Gen Physiol, Ulm, Germany; [Gantner, Florian] CH Boehringer Sohn AG & Co KG, Translat Med & Clin Pharmacol, Biberach, Germany	Boehringer Ingelheim; University of Konstanz; Hannover Medical School; Ulm University	Lamb, DJ (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany.	david.lamb@boehringer-ingelheim.com			Boehringer Ingelheim Pharma GmbH Co.	Boehringer Ingelheim Pharma GmbH Co.(Boehringer Ingelheim)	IC, JS and DJL are employees of Boehringer Ingelheim Pharma GmbH & Co. FG is an employee of C. H. Boehringer Sohn AG & Co. KG. SM, JAG and NP receive grant support from Boehringer Ingelheim Pharma GmbH & Co. The funder provided support in the form of salaries for authors [IC, FG, JS, DJL] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Campos SB, 2009, AM J PHYSIOL-RENAL, V296, pF487, DOI 10.1152/ajprenal.00112.2008; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Cui JJ, 2016, INT J ONCOL, V48, P349, DOI 10.3892/ijo.2015.3235; Day A, 2014, EUROPEAN RESP J, V44; ERJEFALT JS, 1995, CELL TISSUE RES, V281, P305, DOI 10.1007/BF00583399; Erjefalt JS, 1997, CLIN EXP ALLERGY, V27, P1344; Erjefalt JS, 1997, THORAX, V52, P1010, DOI 10.1136/thx.52.11.1010; ERJEFALT JS, 1994, MICROVASC RES, V48, P161, DOI 10.1006/mvre.1994.1047; Flevaris P, 2017, SEMIN THROMB HEMOST, V43, P169, DOI 10.1055/s-0036-1586228; Garat C, 1996, AM J PHYSIOL-LUNG C, V271, pL844, DOI 10.1152/ajplung.1996.271.5.L844; Ghosh M, 2013, STEM CELLS, V31, P2767, DOI 10.1002/stem.1440; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Johnson JR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-118; Jurzak M, 2008, ACTA POL PHARM, V65, P85; KEENAN KP, 1982, VIRCHOWS ARCH B, V41, P231, DOI 10.1007/BF02890283; KEENAN KP, 1982, VIRCHOWS ARCH B, V41, P215, DOI 10.1007/BF02890282; KEENAN KP, 1982, VIRCHOWS ARCH B, V41, P193, DOI 10.1007/BF02890281; KIM JS, 1997, AM J PHYSIOL-LUNG C, V273, pL1235; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; MCDOWELL EM, 1987, AM J PATHOL, V129, P511; Pardo-Saganta A, 2015, CELL STEM CELL, V16, P184, DOI 10.1016/j.stem.2015.01.002; Persson CGA, 1996, AM J RESP CRIT CARE, V153, pS9, DOI 10.1164/ajrccm/153.6_Pt_2.S9; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Scita G, 1996, J BIOL CHEM, V271, P6502, DOI 10.1074/jbc.271.11.6502; SHIMIZU T, 1994, AM J RESP CELL MOL, V11, P85, DOI 10.1165/ajrcmb.11.1.7517145; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Ushach I, 2016, J LEUKOCYTE BIOL, V100, P481, DOI 10.1189/jlb.3RU0316-144R; Wang Q, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-67; WILHELM DL, 1953, J PATHOL BACTERIOL, V65, P543, DOI 10.1002/path.1700650226; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yasuhara R, 2010, J BIOL CHEM, V285, P317, DOI 10.1074/jbc.M109.053926; Zhang XR, 2012, CARTILAGE, V3, P267, DOI 10.1177/1947603511435273	36	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184386	10.1371/journal.pone.0184386	http://dx.doi.org/10.1371/journal.pone.0184386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863189	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900056
J	Li, N; Chen, Q; Zhu, J; Wang, X; Huang, JB; Huang, GH				Li, Ni; Chen, Qi; Zhu, Jie; Wang, Xing; Huang, Jian-Bin; Huang, Guo-Hua			Seasonal dynamics and spatial distribution pattern of Parapoynx crisonalis (Lepidoptera: Crambidae) on water chestnuts	PLOS ONE			English	Article							FREQUENCY-DISTRIBUTION; POPULATION-DYNAMICS; AGGREGATION; MOTH; INSECTS; DENSITY; CLIMATE; WALKER; CHINA	Parapoynx crisonalis (Walker, 1859) (Lepidoptera: Crambidae) is a major pest of aquatic vegetables and aquatic landscape plants. It has been responsible for causing considerable economic damage to water chestnut (Trapa natans) plants. In the Changsha vicinity of China, P. crisonalis has five generations a year. Populations of P. crisonalis were relatively low in April and began to rapidly rise at the beginning of May. At the end of July and early August, the population dropped dramatically. A rebound occurred at the end of August and early September, which was referred to as the second population peak. From then, until early November, the P. crisonalis population steadily diminished in preparation for overwintering. The primary factors influencing the seasonal dynamics of P. crisonalis were the climatic conditions, especially the temperature, and secondarily precipitation. Between May and October, the P. crisonalis adults were evenly distributed in the pond. In May and June, the eggs of P. crisonalis were present in an aggregate distribution, due to the effects of environmental heterogeneity. In July and August, however, they were found to be in a uniform distribution.	[Li, Ni; Chen, Qi; Zhu, Jie; Wang, Xing; Huang, Guo-Hua] Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Li, Ni; Chen, Qi; Zhu, Jie; Wang, Xing; Huang, Jian-Bin; Huang, Guo-Hua] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Huang, GH (corresponding author), Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.; Huang, GH (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	ghhuang@hunau.edu.cn			National Major Science and Technology Project of the Twelfth Five-year Plans [2012BAD27B00]; Hunan Provincial Natural Science Foundation for Distinguished Young Scholars of China [14JJ1023]	National Major Science and Technology Project of the Twelfth Five-year Plans; Hunan Provincial Natural Science Foundation for Distinguished Young Scholars of China	This study was supported by the National Major Science and Technology Project of the Twelfth Five-year Plans (2012BAD27B00), and the Hunan Provincial Natural Science Foundation for Distinguished Young Scholars of China (14JJ1023).	Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bennett C.A., 1999, P 10 INT S BIOL CONT, P307; BLACKITH RE, 1961, COMP BIOCHEM PHYSIOL, V3, P99, DOI 10.1016/0010-406X(61)90136-0; CASSIE RM, 1962, J ANIM ECOL, V31, P65, DOI 10.2307/2333; Chen FQ, 2006, AQUAT INSECT, V28, P291, DOI 10.1080/01650420601099204; Chen Q, 2017, AQUAT INSECT, V38, P79, DOI 10.1080/01650424.2017.1330481; Chen Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173380; DAVID FN, 1954, ANN BOT-LONDON, V18, P47, DOI 10.1093/oxfordjournals.aob.a083381; Davis AM, 2012, REV STATUS MICROLEPI, pS12; Ding J, 2007, BIOL CONTROL, V43, P71, DOI 10.1016/j.biocontrol.2007.06.010; Huang G. H., 2013, COLOR HDB INSECT PES, P109; Iwao S., 1968, Researches on Population Ecology Kyoto University, V10, P1, DOI 10.1007/BF02514729; Jumean Z, 2009, ENVIRON ENTOMOL, V38, P1395, DOI 10.1603/022.038.0507; Kuussaari M, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0413; Li Z, 2016, B ENTOMOL RES, V106, P197, DOI 10.1017/S0007485315001017; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Mironidis GK, 2014, B ENTOMOL RES, V104, P751, DOI 10.1017/S0007485314000595; Mokhtar AM, 2016, J AGR SCI TECH-IRAN, V18, P1593; Orsted M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40132; Pena JE, 1997, J ECON ENTOMOL, V90, P458, DOI 10.1093/jee/90.2.458; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Rosser N, 2014, EVOLUTION, V68, P3470, DOI 10.1111/evo.12539; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez NE, 2009, ENVIRON ENTOMOL, V38, P365, DOI 10.1603/022.038.0208; Sedaratian A, 2010, J AGR SCI TECH-IRAN, V12, P275; Tamburini G, 2013, CLIMATIC CHANGE, V121, P701, DOI 10.1007/s10584-013-0966-2; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; WATERS WE, 1959, J ECON ENTOMOL, V52, P1180, DOI 10.1093/jee/52.6.1180; Yen Shen-Horn, 2004, P545; You Ping, 2005, Chinese Bulletin of Entomology, V42, P595; Zainab S, 2017, J ENVIRON BIOL, V38, P291, DOI 10.22438/jeb/38/2/MS-64	32	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184149	10.1371/journal.pone.0184149	http://dx.doi.org/10.1371/journal.pone.0184149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863164	gold, Green Submitted, Green Published			2022-12-26	WOS:000408816900032
J	Khatun, A; Rahman, MS; Ryu, DY; Kwon, WS; Pang, MG				Khatun, Amena; Rahman, Md Saidur; Ryu, Do-Yeal; Kwon, Woo-Sung; Pang, Myung-Geol			Elevated aminopeptidase N affects sperm motility and early embryo development	PLOS ONE			English	Article							SEMINAL PLASMA; HYPERACTIVATED MOTILITY; MOUSE SPERM; ER-BETA; CD13; IDENTIFICATION; CAPACITATION; LOCALIZATION; SPERMATOZOA; FLUID	Aminopeptidase N (APN) is a naturally occurring ectopeptidase present in mammalian semen. Previous studies have demonstrated that APN adversely affects male fertility through the alteration of sperm motility. This enzyme constitutes 0.5 to 1% of the seminal plasma proteins, which can be transferred from the prostasomes to sperms by a fusion process. In the present study, we investigated the molecular mechanism of action of APN and its role in regulating sperm functions and male fertility. In this in vitro study, epididymal mouse spermatozoa were incubated in a capacitating media (pH 7) containing 20 ng/mL of recombinant mouse APN for 90 min. Our results demonstrated that the supplementation of recombinant APN in sperm culture medium significantly increased APN activity, and subsequently altered motility, hyperactivated motility, rapid and medium swimming speeds, viability, and the acrosome reaction of mouse spermatozoa. These effects were potentially caused by increased toxicity in the spermatozoa. Further, altered APN activity in sperm culture medium affected early embryonic development. Interestingly, the effect of elevated APN activity in sperm culture medium was independent of protein tyrosine phosphorylation and protein kinase A activity. On the basis of these results, we concluded that APN plays a significant role in the regulation of several sperm functions and early embryonic development. In addition, increased APN activity could potentially lead to several adverse consequences related to male fertility.	[Khatun, Amena; Rahman, Md Saidur; Ryu, Do-Yeal; Kwon, Woo-Sung; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, South Korea.	mgpang@cau.ac.kr	Pang, Myung-Geol/AAV-2014-2021; Rahman, Mohammad Saifur/GZM-5483-2022; Rahman, Saidur/J-7855-2012; Rahman, Md Saidur/AAT-2972-2020; Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Sohelur/AAJ-7376-2020	Pang, Myung-Geol/0000-0003-2019-3789; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Saidur/0000-0003-4583-8731; Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Sohelur/0000-0002-4489-2202; Khatun, Amena/0000-0001-8013-4743	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) -Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [116172-3]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) -Ministry of Agriculture, Food, and Rural Affairs (MAFRA)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through Agri-Bio Industry Technology Development Program, funded by Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (116172-3).	Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Arienti G, 1997, BBA-GEN SUBJECTS, V1336, P533, DOI 10.1016/S0304-4165(97)00071-8; Balaban B, 2000, FERTIL STERIL, V74, P282, DOI 10.1016/S0015-0282(00)00645-2; Bosler JS, 2014, REPROD SCI, V21, P1334, DOI 10.1177/1933719114536473; Bravo JA, 2011, ANIM REPROD SCI, V129, P22, DOI 10.1016/j.anireprosci.2011.10.005; Buzadzic B, 2015, BRIT J PHARMACOL, V172, P1455, DOI 10.1111/bph.12675; Carlsson L, 2006, INT J ANDROL, V29, P331, DOI 10.1111/j.1365-2605.2005.00601.x; DEMOTT RP, 1992, BIOL REPROD, V46, P779, DOI 10.1095/biolreprod46.5.779; Drabovich AP, 2014, NAT REV UROL, V11, P278, DOI 10.1038/nrurol.2014.74; Elkharaz J, 2013, BBA-MOL BASIS DIS, V1832, P1930, DOI 10.1016/j.bbadis.2013.07.002; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Gawecka JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056385; Gilany Kambiz, 2015, J Reprod Infertil, V16, P61; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Greenhalgh JR, 2009, J ANDROL, V30, P548, DOI 10.2164/jandrol.108.006049; Huang K, 1997, J BIOCHEM, V122, P779; Irazusta J, 2004, J ANDROL, V25, P733; JUNEJA SC, 1995, ENDOCRINE, V3, P69, DOI 10.1007/BF02917451; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; KEW D, 1990, P NATL ACAD SCI USA, V87, P9143, DOI 10.1073/pnas.87.23.9143; Kim J, 2015, ANDROLOGY-US, V3, P544, DOI 10.1111/andr.12006; Kim MS, 2017, BIOCHEM BIOPH RES CO, V484, P348, DOI 10.1016/j.bbrc.2017.01.122; Lee JS, 2015, ANDROLOGY-US, V3, P937, DOI 10.1111/andr.12076; Marquez B, 2004, BIOL REPROD, V70, P1626, DOI 10.1095/biolreprod.103.026476; Maxwell WMC, 1999, THERIOGENOLOGY, V52, P1353, DOI 10.1016/S0093-691X(99)00222-8; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Ni WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094956; Oluwakemi O, 2016, IRAN J BASIC MED SCI, V19, P811; Piva TJ, 2000, J CELL BIOCHEM, V76, P625, DOI 10.1002/(SICI)1097-4644(20000315)76:4<625::AID-JCB11>3.0.CO;2-S; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Rahman MS, 2014, ANDROLOGY-US, V2, P899, DOI 10.1111/j.2047-2927.2014.00273.x; Rahman MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/360986; Rahman MS, 2017, MOL REPROD DEV, V9999, P1; Rajeev SK, 2004, HUM REPROD, V19, P234, DOI 10.1093/humrep/deh066; Simon L, 2014, HUM REPROD, V29, P2402, DOI 10.1093/humrep/deu228; Simon L, 2017, ASIAN J ANDROL, V19, P80, DOI 10.4103/1008-682X.182822; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; SUAREZ SS, 1991, BIOL REPROD, V44, P375, DOI 10.1095/biolreprod44.2.375; SUAREZ SS, 1987, J EXP ZOOL, V244, P331, DOI 10.1002/jez.1402440218; Subiran N, 2008, FERTIL STERIL, V89, P1571, DOI 10.1016/j.fertnstert.2007.06.056; Subiran N, 2010, ASIAN J ANDROL, V12, P899, DOI 10.1038/aja.2010.82; Valcarce DG, 2016, REPRODUCTION, V152, P439, DOI 10.1530/REP-16-0270; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Viudes-De-Castro MP, 2015, WORLD RABBIT SCI, V23, P247, DOI 10.4995/wrs.2015.4064	45	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184294	10.1371/journal.pone.0184294	http://dx.doi.org/10.1371/journal.pone.0184294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859152	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500080
J	Seng, R; Kitti, T; Thummeepak, R; Kongthai, P; Leungtongkam, U; Wannalerdsakun, S; Sitthisak, S				Seng, Rathanin; Kitti, Thawatchai; Thummeepak, Rapee; Kongthai, Phattaraporn; Leungtongkam, Udomluk; Wannalerdsakun, Surat; Sitthisak, Sutthirat			Biofilm formation of methicillin-resistant coagulase negative staphylococci (MR-CoNS) isolated from community and hospital environments	PLOS ONE			English	Article							IDENTIFICATION; EPIDERMIDIS; BAP; ICA; SUSCEPTIBILITY; AUREUS	Methicillin-resistant coagulase negative staphylococci (MR-CoNS) are the major cause of infectious diseases because of their potential ability to form biofilm and colonize the community or hospital environments. This study was designed to investigate the biofilm producing ability, and the presence of mecA, icaAD, bap and fnbA genes in MR-CoNS isolates. The MR-CoNS used in this study were isolated from various samples of community environment and five wards of hospital environments, using mannitol salt agar (MSA) supplemented with 4 mu g/ml of oxacillin. The specie level of Staphylococcus haemolyticus, Staphylococcus epidermidis, Staphylococcus hominis and Staphylococcus warneri was identified by specific primers of groESL (S. haemolyticus), rdr (S. epidermidis) and nuc (S. hominis and S. warneri). The remainder isolates were identified by tuf gene sequencing. Biofilm production was determined using Congo red agar (CRA) and Microtiter plate (MTP) assay. The mecA and biofilm associated genes (icaAD, fnbA and bap) were detected using PCR method. From the 558 samples from community and hospital environments, 292 MR-CoNS were isolated (41 from community environments, and 251 from hospital environments). S. haemolyticus (41.1%) and S. epidermidis (30.1%) were the predominant species in this study. Biofilm production was detected in 265 (90.7%) isolates by CRA, and 260 (88.6%) isolates were detected by MTP assay. The staphylococci isolates derived from hospital environments were more associated with biofilm production than the community-derived isolates. Overall, the icaAD and bap genes were detected in 74 (29.5%) and 14 (5.6%) of all isolates from hospital environments. When tested by MTP, the icaAD gene from hospital environment isolates was associated with biofilm biomass. No association was found between bap gene and biofilm formation. The MR-CoNS isolates obtained from community environments did not harbor the icaAD and bap genes. Conversely, fnbA gene presented in MR-CoNS isolated from both community and hospital environments. The high prevalence of biofilm producing MR-CoNS strains demonstrated in this study indicates the persisting ability in environments, and is useful in developing prevention strategies countering the spread of MR-CoNS.	[Seng, Rathanin; Thummeepak, Rapee; Kongthai, Phattaraporn; Leungtongkam, Udomluk; Sitthisak, Sutthirat] Naresuan Univ, Dept Microbiol & Parasitol, Fac Med Sci, Phitsanulok, Thailand; [Kitti, Thawatchai] Chiang Rai Coll, Fac Oriental Med, Chiang Rai, Thailand; [Wannalerdsakun, Surat] Naresuan Univ, Div Infect Dis, Dept Med, Fac Med, Phitsanulok, Thailand; [Sitthisak, Sutthirat] Naresuan Univ, Ctr Excellence Med Biotechnol, Fac Med Sci, Phitsanulok, Thailand	Naresuan University; Naresuan University; Naresuan University	Sitthisak, S (corresponding author), Naresuan Univ, Dept Microbiol & Parasitol, Fac Med Sci, Phitsanulok, Thailand.; Sitthisak, S (corresponding author), Naresuan Univ, Ctr Excellence Med Biotechnol, Fac Med Sci, Phitsanulok, Thailand.	sutthirats@nu.ac.th	Sitthisak, Sutthirat/AAF-9383-2020; Sitthisak, Sutthirat/ABF-4922-2021	Sitthisak, Sutthirat/0000-0003-4992-7635	Office of the Higher Education Thailand [HERP 2559, R2559A006]; Naresuan University; Royal Golden Jubilee Ph.D. Program [PHD/0031/2558]	Office of the Higher Education Thailand; Naresuan University; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This study was funded by Office of the Higher Education Thailand (HERP 2559) (R2559A006) to SS. RS was supported by the Royal Scholarship under Her Royal Highness Princess Maha Chakri Sirindhorn, 2015 of Naresuan University. RT was supported by The Royal Golden Jubilee Ph.D. Program(PHD/0031/2558).	Arciola Carla Renata, 2002, Expert Rev Mol Diagn, V2, P478, DOI 10.1586/14737159.2.5.478; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Bekir K, 2011, ANN MICROBIOL, V61, P819, DOI 10.1007/s13213-011-0200-2; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Chiang YC, 2012, FOODBORNE PATHOG DIS, V9, P249, DOI 10.1089/fpd.2011.1007; Cramton SE, 2001, METHOD ENZYMOL, V336, P239, DOI 10.1016/S0076-6879(01)36593-X; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; de Silva GDI, 2002, J CLIN MICROBIOL, V40, P382, DOI 10.1128/JCM.40.02.382-388.2002; Du X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062742; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Herman-Bausier P, 2015, MBIO, V6, DOI 10.1128/mBio.00413-15; Hirotaki S, 2011, J CLIN MICROBIOL, V49, P3627, DOI 10.1128/JCM.00488-11; Idzik D, 2014, INT J ENV RES PUB HE, V11, P4619; Kassem II, 2007, ISME J, V1, P265, DOI 10.1038/ismej.2007.36; Kitti T, 2011, SE ASIAN J TROP MED, V42, P1498; Kohner P, 1999, J CLIN MICROBIOL, V37, P2952, DOI 10.1128/JCM.37.9.2952-2961.1999; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Marino M, 2011, J APPL MICROBIOL, V110, P550, DOI 10.1111/j.1365-2672.2010.04909.x; Martini R, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-99462016580011, 10.1590/S1678-9946201658001, 10.1590/s1678-9946201658001]; Melake N.A., 2016, MENOUFIA MED J, V29, P789, DOI [10.4103/1110-2098.202525, DOI 10.4103/1110-2098.202525]; Mkrtchyan HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054223; Morgenstern M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148437; Nasr R.A., 2012, EGYPT J MED HUM GENE, V13, P269, DOI [10.1016/j.ejmhg.2012.04.007, DOI 10.1016/J.EJMHG.2012.04.007]; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Oliveira Adilson, 2010, BMC Res Notes, V3, P260, DOI 10.1186/1756-0500-3-260; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Patel J.B., 2015, PERFORMANCE STANDARD; Pinheiro L, 2014, MEM I OSWALDO CRUZ, V109, P871, DOI 10.1590/0074-0276140120; Ploneczka-Janeczko K, 2014, VET RES COMMUN, V38, P337, DOI 10.1007/s11259-014-9615-0; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; RYFFEL C, 1990, GENE, V94, P137, DOI 10.1016/0378-1119(90)90481-6; Schmidt T, 2015, J DAIRY SCI, V98, P6256, DOI 10.3168/jds.2015-9715; Shobha K L, 2005, Indian J Med Microbiol, V23, P186; Shome BR, 2011, J APPL MICROBIOL, V111, P1349, DOI 10.1111/j.1365-2672.2011.05169.x; Sivri N, 2016, ARCH ENVIRON PROT, V42, P77, DOI 10.1515/aep-2016-0034; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Xu Z, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00947; Yu MH, 2010, EUR J CLIN MICROBIOL, V29, P613, DOI 10.1007/s10096-010-0893-3	41	38	42	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184172	10.1371/journal.pone.0184172	http://dx.doi.org/10.1371/journal.pone.0184172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859149	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500070
J	Maherally, Z; Fillmore, HL; Tan, SL; Tan, SF; Jassam, SA; Quack, FI; Hatherell, KE; Pilkington, GJ				Maherally, Zaynah; Fillmore, Helen L.; Tan, Sim Ling; Tan, Suk Fei; Jassam, Samah A.; Quack, Friederike I.; Hatherell, Kathryn E.; Pilkington, Geoffrey J.			Real-time acquisition of transendothelial electrical resistance in an all-human, in vitro, 3-dimensional, blood-brain barrier model exemplifies tight-junction integrity	FASEB JOURNAL			English	Article						neurovascular unit; extracellular matrix; central nervous system	CENTRAL-NERVOUS-SYSTEM; ASTROCYTE-ENDOTHELIAL INTERACTIONS; HEPARAN-SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; CELL-LINE; FUNCTIONAL-CHARACTERIZATION; GROWTH-FACTOR; BASAL LAMINA; BBB MODEL; PERICYTES	The blood-brain barrier (BBB) consists of endothelial cells, astrocytes, and pericytes embedded in basal lamina (BL). Most in vitro models use nonhuman, monolayer cultures for therapeutic-delivery studies, relying on transendothelial electrical resistance (TEER) measurements without other tight-junction (TJ) formation parameters. We aimed to develop reliable, reproducible, in vitro 3-dimensional (3D) models incorporating relevant human, in vivo cell types and BL proteins. The 3D BBB models were constructed with human brain endothelial cells, human astrocytes, and human brain pericytes in mono-, co-, and tricultures. TEER was measured in 3D models using a volt/ohmmeter and cellZscope. Influence of BL proteins-laminin, fibronectin, collagen type IV, agrin, and perlecan-on adhesion and TEER was assessed using an electric cell-substrate impedance-sensing system. TJ protein expression was assessed by Western blotting (WB) and immunocytochemistry (ICC). Perlecan (10mg/ml) evoked unreportedly high, in vitro TEER values (1200 Omega) and the strongest adhesion. Coculturing endothelial cells with astrocytes yielded the greatest resistance over time. ICC and WB results correlated with resistance levels, with evidence of prominent occludin expression in cocultures. BL proteins exerted differential effects on TEER, whereas astrocytes in contact yielded higher TEER values and TJ expression.	[Maherally, Zaynah; Fillmore, Helen L.; Jassam, Samah A.; Quack, Friederike I.; Hatherell, Kathryn E.; Pilkington, Geoffrey J.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Brain Tumour Res Ctr, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England; [Tan, Sim Ling; Tan, Suk Fei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Serdang, Selangor, Malaysia	University of Portsmouth; Universiti Putra Malaysia	Pilkington, GJ (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Brain Tumour Res Ctr, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.	zaynah.maherally@port.ac.uk	Tan, Suk Fei/AAU-4358-2020	Tan, Suk Fei/0000-0001-7777-5961; Fillmore, Helen/0000-0003-4131-579X; Lamburne, Samah A/0000-0002-5000-0493	Brain Tumour Research and the Dr. Hadwen Trust; Lord Dowding Fund; Research Management Centre, University Putra Malaysia; Higher Committee of Education Development in Iraq	Brain Tumour Research and the Dr. Hadwen Trust; Lord Dowding Fund; Research Management Centre, University Putra Malaysia; Higher Committee of Education Development in Iraq	The authors thank Dr. Pierre-Olivier Couraud (Institut Cochin, Paris, France) for the hCMEC/D3 cells. G.J.P. received grants from Brain Tumour Research and the Dr. Hadwen Trust (which supported H.L.F. and Z.M.), and a grant from the Lord Dowding Fund (which supported K.E.H.). S.L. T. and S.F.T. were visiting doctoral students supported by Research Management Centre, University Putra Malaysia. F.I.Q. was an Erasmus research internship student from Saarland University (Saarbrucken, Germany), and S.A.J. was a doctoral student supported by the Higher Committee of Education Development in Iraq. The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; An Q, 2014, NEURO-ONCOLOGY, V16, P265, DOI 10.1093/neuonc/not202; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; AUMAILLEY M, 1986, J CELL BIOL, V103, P1569, DOI 10.1083/jcb.103.4.1569; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Berzin TM, 2000, NEUROBIOL AGING, V21, P349, DOI 10.1016/S0197-4580(00)00121-4; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deguchi Y, 2002, J NEUROCHEM, V83, P381, DOI 10.1046/j.1471-4159.2002.01129.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Fricker G., 2014, TOPICS MED CHEM, P1; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi K, 2004, REGUL PEPTIDES, V123, P77, DOI 10.1016/j.regpep.2004.05.023; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Isobe I, 1996, NEUROCHEM INT, V28, P523, DOI 10.1016/0197-0186(95)00142-5; Kacem K, 1998, GLIA, V23, P1; Kroger S, 1996, EUR J NEUROSCI, V8, P500, DOI 10.1111/j.1460-9568.1996.tb01234.x; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lee DS, 2006, LIFE SCI, V80, P154, DOI 10.1016/j.lfs.2006.08.039; Maherally Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030691; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Muramatsu R, 2014, NEUROSCI RES, V81-82, P38, DOI 10.1016/j.neures.2014.01.007; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; Roberts J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00155; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Steiner E, 2014, CELL TISSUE RES, V358, P465, DOI 10.1007/s00441-014-1969-7; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tilling T, 1998, J NEUROCHEM, V71, P1151; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilhelm I, 2013, INT J MOL SCI, V14, P1383, DOI 10.3390/ijms14011383; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler S, 2002, J NEUROSCI RES, V69, P477, DOI 10.1002/jnr.10311; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Yamamizu K, 2017, STEM CELL REP, V8, P634, DOI 10.1016/j.stemcr.2017.01.023; YUNG WKA, 1985, J NEURO-ONCOL, V3, P35	59	25	26	3	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					168	182		10.1096/fj.201700162R	http://dx.doi.org/10.1096/fj.201700162R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28883042	Green Published			2022-12-26	WOS:000419172700017
J	Abplanalp, W; DeJarnett, N; Riggs, DW; Conklin, DJ; McCracken, JP; Srivastava, S; Xie, ZZ; Rai, S; Bhatnagar, A; O'Toole, TE				Abplanalp, Wesley; DeJarnett, Natasha; Riggs, Daniel W.; Conklin, Daniel J.; McCracken, James P.; Srivastava, Sanjay; Xie, Zhengzhi; Rai, Shesh; Bhatnagar, Aruni; O'Toole, Timothy E.			Benzene exposure is associated with cardiovascular disease risk	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ENDOTHELIAL PROGENITOR CELLS; VOLATILE ORGANIC-COMPOUNDS; ERYTHROID-DIFFERENTIATION; IN-UTERO; ACROLEIN; METABOLITES; INFLAMMATION; MORTALITY; MECHANISM	Benzene is a ubiquitous, volatile pollutant present at high concentrations in toxins (e.g. tobacco smoke) known to increase cardiovascular disease (CVD) risk. Despite its prevalence, the cardiovascular effects of benzene have rarely been studied. Hence, we examined whether exposure to benzene is associated with increased CVD risk. The effects of benzene exposure in mice were assessed by direct inhalation, while the effects of benzene exposure in humans was assessed in 210 individuals with mild to high CVD risk by measuring urinary levels of the benzene metabolite trans, trans-muconic acid (t, t-MA). Generalized linear models were used to assess the association between benzene exposure and CVD risk. Mice inhaling volatile benzene had significantly reduced levels of circulating angiogenic cells (Flk1 (+)/Sca-1(+)) as well as an increased levels of plasma low-density lipoprotein (LDL) compared with control mice breathing filtered air. In the human cohort, urinary levels of t, t-MA were inversely associated several populations of circulating angiogenic cells (CD31(+)/34(+)/45(+), CD31(+)/34(+)/45(+)/AC133(-), CD34(+)/45(+)/AC133(+)). Although t, t-MA was not associated with plasma markers of inflammation or thrombosis, t, t-MA levels were higher in smokers and in individuals with dyslipidemia. In smokers, t, t-MA levels were positively associated with urinary metabolites of nicotine (cotinine) and acrolein (3-hydroxymercapturic acid). Levels of t, t-MA were also associated with CVD risk as assessed using the Framingham Risk Score and this association was independent of smoking. Thus, benzene exposure is associated with increased CVD risk and deficits in circulating angiogenic cells in both smokers and nonsmokers.	[Abplanalp, Wesley; DeJarnett, Natasha; Riggs, Daniel W.; Conklin, Daniel J.; McCracken, James P.; Srivastava, Sanjay; Xie, Zhengzhi; Bhatnagar, Aruni; O'Toole, Timothy E.] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40292 USA; [Abplanalp, Wesley; Riggs, Daniel W.; Conklin, Daniel J.; McCracken, James P.; Srivastava, Sanjay; Xie, Zhengzhi; Bhatnagar, Aruni; O'Toole, Timothy E.] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [DeJarnett, Natasha] Univ Louisville, Dept Environm & Occupat Hlth Sci, Louisville, KY 40292 USA; [Rai, Shesh] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Rai, Shesh] Univ Louisville, JG Brown Canc Ctr, Biostat Shared Facil, Louisville, KY 40292 USA; [Abplanalp, Wesley] Goethe Univ, Inst Cardiovasc Regenerat, Frankfurt, Germany; [DeJarnett, Natasha] Amer Publ Hlth Assoc, Washington, DC USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; Goethe University Frankfurt	O'Toole, TE (corresponding author), Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40292 USA.; O'Toole, TE (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	tim.otoole@louisville.edu		Abplanalp, Wesley/0000-0001-5996-8997; DeJarnett, Natasha/0000-0003-2638-5028; Riggs, Daniel/0000-0002-3503-0600	 [ES0119217];  [P50 HL120163-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL120163, R01HL122676, P50HL120163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019217] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by ES0119217 and P50 HL120163-01, www.nih.gov.	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; [Anonymous], 2015, EUR HEART J, V36, P1779; APPEL BR, 1990, AM J PUBLIC HEALTH, V80, P560, DOI 10.2105/AJPH.80.5.560; ATSDR, 2005, REG AFTSAD; Badham HJ, 2010, TOXICOL APPL PHARM, V244, P273, DOI 10.1016/j.taap.2010.01.002; Badham HJ, 2010, TOXICOL SCI, V113, P207, DOI 10.1093/toxsci/kfp242; Bard D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100307; BLANK IH, 1985, J INVEST DERMATOL, V85, P522, DOI 10.1111/1523-1747.ep12277325; Charbotel B, 2014, CRIT REV ONCOL HEMAT, V90, P99, DOI 10.1016/j.critrevonc.2013.12.004; Choi YH, 2014, SCI TOTAL ENVIRON, V482, P260, DOI 10.1016/j.scitotenv.2014.02.121; Chow PW, 2015, TOXICOL APPL PHARM, V284, P8, DOI 10.1016/j.taap.2015.01.016; Clayton CA, 1999, J EXPO ANAL ENV EPID, V9, P381, DOI 10.1038/sj.jea.7500055; DeJarnett N, 2015, ARTERIOSCL THROM VAS, V35, P2468, DOI 10.1161/ATVBAHA.115.305724; DeJarnett N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000934; Fraser MP, 1998, ENVIRON SCI TECHNOL, V32, P2051, DOI 10.1021/es970916e; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; HATTEMERFREY HA, 1990, ENVIRON RES, V53, P221, DOI 10.1016/S0013-9351(05)80120-3; Inventory TR, 2016, TOX REL INV TRI DAT; Jacob P, 2013, CANCER EPIDEM BIOMAR, V22, P765, DOI 10.1158/1055-9965.EPI-12-1422; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; LINDSTROM AB, 1994, J EXPO ANAL ENV EPID, V4, P183; Man CN, 2006, J CHROMATOGR B, V844, P322, DOI 10.1016/j.jchromb.2006.07.029; Mansi A, 2012, TOXICOL LETT, V213, P57, DOI 10.1016/j.toxlet.2011.02.001; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Mohamed MF, 2002, CHEMOSPHERE, V47, P863, DOI 10.1016/S0045-6535(02)00107-8; Morello-Frosch RA, 2000, RISK ANAL, V20, P273, DOI 10.1111/0272-4332.202026; Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458; O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679; Pope CA, 2016, CIRC RES, V119, P1204, DOI 10.1161/CIRCRESAHA.116.309279; Pope CA, 2015, CIRC RES, V116, P108, DOI 10.1161/CIRCRESAHA.116.305060; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Ruppert T, 1997, INT ARCH OCC ENV HEA, V69, P247, DOI 10.1007/s004200050143; Sarkar M, 2013, ENVIRON TOXICOL PHAR, V36, P108, DOI 10.1016/j.etap.2013.03.001; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Waidyanatha S, 2004, ANAL BIOCHEM, V327, P184, DOI 10.1016/j.ab.2004.01.008; Weisel CP, 2010, CHEM-BIOL INTERACT, V184, P58, DOI 10.1016/j.cbi.2009.12.030; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; Wiwanitkit Viroj, 2007, Cardiovasc J Afr, V18, P264; Wu XR, 2011, TOXICOL LETT, V203, P190, DOI 10.1016/j.toxlet.2011.03.012	45	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183602	10.1371/journal.pone.0183602	http://dx.doi.org/10.1371/journal.pone.0183602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886060	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100030
J	Chen, XJ; Utheim, OA; Xiao, JX; Adil, MY; Stojanovic, A; Tashbayev, B; Jensen, JL; Utheim, TP				Chen, Xiangjun; Utheim, Oygunn Aass; Xiao, Jiaxin; Adil, Muhammed Yasin; Stojanovic, Aleksandar; Tashbayev, Behzod; Jensen, Janicke Liaaen; Utheim, Tor Paaske			Meibomian gland features in a Norwegian cohort of patients with primary Sjogren 's syndrome	PLOS ONE			English	Article							DRY EYE DISEASE; NONCONTACT INFRARED MEIBOGRAPHY; TEAR FILM; INTERNATIONAL WORKSHOP; DYSFUNCTION REPORT; OCULAR SURFACE; RISK-FACTORS; LIPID LAYER; POPULATION; SUBCOMMITTEE	Purpose To assess the tear film and meibomian gland (MG) features in a Norwegian cohort of patients with primary Sjogren's syndrome (pSS) and in age-and gender-matched control subjects. Methods Thirty-four female patients with pSS (age 52.9 +/- 11.9 years) and 32 female control subjects (age 49.0 +/- 11.5 years) were recruited. After completion of Ocular Surface Disease Index (OSDI) questionnaire and McMonnies Dry Eye Questionaire, participants underwent measurements of tear osmolarity, tear break-up time (TBUT), ocular surface and corneal staining, Schirmer I test, corneal sensitivity, MG expressibility evaluations, and lid margin morphology examination using slitlamp microscopy. Non-contact infrared meibography images were assessed by computer-assisted analysis. The MG loss, calculated as (tarsal area-MG area)/tarsal area, was evaluated in both upper (UL) and lower lids (LL). Results Compared to the control group, pSS patients demonstrated higher MG loss in both UL (33.8 +/- 13.2% vs. 24.4 +/- 8.5%, p<0.01) and LL (52.5 +/- 15.7% vs. 43.0 +/- 9.6%, p<0.05), as well as higher lid abnormality score (0.8 +/- 0.8 vs. 0.2 +/- 0.6, p<0.01). Furthermore, pSS patients showed higher OSDI and McMonnies questionnaire scores, elevated osmolarity, shorter TBUT, shorter blink interval, less wetting in Schirmer I test, more ocular surface staining and more corneal staining. MG loss in UL correlated negatively with TBUT (r = -0.386, p = 0.029) in the pSS group, whereas MG loss in LL correlated negatively with TBUT (r = -0.380, p = 0.035) in the control group. Conclusions Significantly elevated dry eye symptoms and signs were found in the pSS group compared with the control group, which might be attributed to both decreased aqueous tear production and increased tear evaporation.	[Chen, Xiangjun] Vestre Viken Hosp Trust, Dept Ophthalmol, Drammen, Norway; [Utheim, Oygunn Aass] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Xiao, Jiaxin; Adil, Muhammed Yasin; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Xiao, Jiaxin; Adil, Muhammed Yasin] Univ Oslo, Fac Med, Oslo, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Dept Ophthalmol, Tromso, Norway; [Tashbayev, Behzod; Jensen, Janicke Liaaen] Univ Oslo, Dept Oral Surg & Oral Med, Fac Dent, Oslo, Norway; [Utheim, Tor Paaske] Univ Oslo, Dept Oral Biol, Fac Dent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Oslo	Chen, XJ (corresponding author), Vestre Viken Hosp Trust, Dept Ophthalmol, Drammen, Norway.	chenxiangjun1101@gmail.com	Stojanovic, Aleksandar/AAG-9933-2019; Tashbayev, Behzod/AAZ-6268-2020	Chen, Xiangjun/0000-0003-0331-9028; Tashbayev, Behzod/0000-0003-2566-8800; Jensen, Janicke Liaaen/0000-0003-4276-9611	Faculty of Dentistry, University of Oslo	Faculty of Dentistry, University of Oslo	The project is funded by the Faculty of Dentistry, University of Oslo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OCULAR SURFACE, V5, P93; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Baek J, 2015, CORNEA, V34, P1209, DOI 10.1097/ICO.0000000000000575; Baudouin C, 2001, SURV OPHTHALMOL, V45, pS211, DOI 10.1016/S0039-6257(00)00200-9; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Caffery B, 2010, OPTOMETRY VISION SCI, V87, P742, DOI 10.1097/OPX.0b013e3181f32196; Danjo Y, 1997, GRAEF ARCH CLIN EXP, V235, P761, DOI 10.1007/BF02332860; Den S, 2006, CORNEA, V25, P651, DOI 10.1097/01.ico.0000227889.11500.6f; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Finis D, 2015, CURR EYE RES, V40, P982, DOI 10.3109/02713683.2014.971929; Goto E, 2007, AM J OPHTHALMOL, V144, P81, DOI 10.1016/j.ajo.2007.03.055; Greiner JV, 1998, ADV EXP MED BIOL, V438, P339; Guo Y, 2016, J OPHTHALMOLOGY, V2016; Jester JV, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0132-x; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Johnson ME, 2009, OCUL SURF, V7, P199, DOI 10.1016/S1542-0124(12)70187-8; Kim KT, 2015, GRAEF ARCH CLIN EXP, V253, P1355, DOI 10.1007/s00417-015-3080-5; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Kozak I, 2007, CORNEA, V26, P610, DOI 10.1097/ICO.0b013e318041f0d2; Lemp MA, 2007, OCUL SURF, V5, P75; Li JY, 2015, EYE CONTACT LENS, V41, P44, DOI 10.1097/ICL.0000000000000064; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; MATHERS WD, 1993, OPHTHALMOLOGY, V100, P347; McMonnies C W, 1987, J Am Optom Assoc, V58, P588; Menzies KL, 2015, INVEST OPHTH VIS SCI, V56, P836, DOI 10.1167/iovs.14-13864; Nichols KK, 2004, CORNEA, V23, P365, DOI 10.1097/00003226-200405000-00010; NORN MS, 1966, ACTA OPHTHALMOL, V44, P948; Ousler GW, 2008, CORNEA, V27, P509, DOI 10.1097/ICO.0b013e31816583f6; Pflugfelder SC, 2015, INVEST OPHTH VIS SCI, V56, P7545, DOI 10.1167/iovs.15-17627; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE310, DOI 10.1097/OPX.0b013e318244e487; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Ramos-Casals M, 2015, AUTOIMMUN REV, V14, P670, DOI 10.1016/j.autrev.2015.03.008; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; Srinivasan S, 2012, OPTOMETRY VISION SCI, V89, P788, DOI 10.1097/OPX.0b013e318253de93; Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003; Sullivan BD, 2014, ACTA OPHTHALMOL, V92, P161, DOI 10.1111/aos.12012; Sullivan DA, 2003, J RHEUMATOL, V30, P2413; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Tomlinson A, 2005, OCUL SURF, V3, P81, DOI 10.1016/S1542-0124(12)70157-X; Tomlinson A, 2006, INVEST OPHTH VIS SCI, V47, P4309, DOI 10.1167/iovs.05-1504; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Uchino M, 2006, OPTOMETRY VISION SCI, V83, P797, DOI 10.1097/01.opx.0000232814.39651.fa; Villani E, 2011, INVEST OPHTH VIS SCI, V52, P933, DOI 10.1167/iovs.10-5995; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wan KH, 2016, EYE, V30, P1558, DOI 10.1038/eye.2016.186; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013	54	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184284	10.1371/journal.pone.0184284	http://dx.doi.org/10.1371/journal.pone.0184284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886085	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100091
J	Cheng, SHC; Huang, TT; Cheng, YH; Tan, TBK; Horng, CF; Wang, YA; Brian, NS; Shih, LS; Yu, BL				Cheng, Skye Hung-Chun; Huang, Tzu-Ting; Cheng, Yu-Hao; Tan, Tee Benita Kiat; Horng, Chen-Fang; Wang, Yong Alison; Brian, Nicholas Shannon; Shih, Li-Sun; Yu, Ben-Long			Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer	PLOS ONE			English	Article							LOCOREGIONAL RECURRENCE; ADJUVANT CHEMOTHERAPY; PREDICTION; PATTERNS; THERAPY; TUMORS; TRIAL; RISK	We validated an 18-gene classifier (GC) initially developed to predict local/regional recurrence after mastectomy in estimating distant metastasis risk. The 18-gene scoring algorithm defines scores as: < 21, low risk; >= 21, high risk. Six hundred eighty-three patients with primary operable breast cancer and fresh frozen tumor tissues available were included. The primary outcome was the 5-year probability of freedom from distant metastasis (DMFP). Two external datasets were used to test the predictive accuracy of 18-GC. The 5-year rates of DMFP for patients classified as low-risk (n = 146, 21.7%) and high-risk (n = 537, 78.6%) were 96.2% (95% CI, 91.1% -98.8%) and 80.9% (74.6%-81.9%), respectively (median follow-up interval, 71.8 months). The 5-year rates of DMFP of the low-risk group in stage I (n = 62, 35.6%), stage II (n = 66, 20.1%), and stage III (n = 18, 10.3%) were 100%, 94.2% (78.5%-98.5%), and 90.9% (50.8% -98.7%), respectively. Multivariate analysis revealed that 18-GC is an independent prognostic factor of distant metastasis (adjusted hazard ratio, 5.1; 95% CI, 1.8-14.1; p = 0.0017) for scores of >= 21. External validation showed that the 5-year rate of DMFP in the low-and high-risk patients was 94.1% (82.9% -100%) and 80.3% (70.7%-89.9%, p = 0.06) in a Singapore dataset, and 89.5% (81.9%-94.1%) and 73.6% (67.2%-79.0%, p = 0.0039) in the GEO-GSE20685 dataset, respectively. In conclusion, 18-GC is a viable prognostic biomarker for breast cancer to estimate distant metastasis risk.	[Cheng, Skye Hung-Chun] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Cheng, Skye Hung-Chun; Huang, Tzu-Ting; Horng, Chen-Fang] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Res, Taipei, Taiwan; [Cheng, Yu-Hao] Cathy Gen Hosp, Dept Med, Taipei, Taiwan; [Tan, Tee Benita Kiat] Natl Canc Ctr Singapore, Singapore, Singapore; [Tan, Tee Benita Kiat] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Tan, Tee Benita Kiat; Brian, Nicholas Shannon] Natl Univ Singapore, Duke NUS Grad Med Sch, Singapore, Singapore; [Wang, Yong Alison] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Med, Taipei, Taiwan; [Wang, Yong Alison] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Shih, Li-Sun] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Lab & Pathol, Taipei, Taiwan; [Yu, Ben-Long] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Surg, Taipei, Taiwan	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National Yang Ming Chiao Tung University	Cheng, SHC (corresponding author), Koo Fdn, Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei, Taiwan.; Cheng, SHC (corresponding author), Koo Fdn, Sun Yat Sen Canc Ctr, Dept Res, Taipei, Taiwan.	skye@kfsyscc.org		Cheng, Skye Hung Chun/0000-0002-5331-6688	Ministry of Science and Technology of the Republic of China (Taiwan) [NSC 102-3114-Y-368-001]	Ministry of Science and Technology of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of the Republic of China (Taiwan) (https://www.most.gov.tm/en/public), grant number NSC 102-3114-Y-368-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheng SH, 2006, J CLIN ONCOL, V24, P4594, DOI 10.1200/JCO.2005.02.5676; Cheng SH, 2016, EBIOMEDICINE, V5, P74, DOI 10.1016/j.ebiom.2016.02.022; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dubsky P, 2013, BRIT J CANCER, V109, P2959, DOI 10.1038/bjc.2013.671; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; FISHER B, 1989, NEW ENGL J MED, V320, P473, DOI 10.1056/NEJM198902233200801; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Grantzau T, 2014, RADIOTHER ONCOL, V111, P366, DOI 10.1016/j.radonc.2014.05.004; Harris LN, 2016, J CLIN ONCOLOGY; HPAMOHAW TAIWAN, 2012, TAIPEI2015, P68; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Katz SJ, 2013, CANCER-AM CANCER SOC, V119, P3584, DOI 10.1002/cncr.28260; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Naoi Y, 2015, BREAST CANC; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porter ME, 2010, HARVARD BUSINESS SCH; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Rampurwala MM, 2014, BREAST CANCER-BASIC, V8, P125, DOI 10.4137/BCBCR.S9454; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Shibuta K, 2011, BREAST CANCER-TOKYO, V18, P292, DOI 10.1007/s12282-010-0209-6; Sohal D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002965; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	35	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184372	10.1371/journal.pone.0184372	http://dx.doi.org/10.1371/journal.pone.0184372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886126	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100104
J	Kawada, Y; Asahara, S; Sugiura, Y; Sato, A; Furubayashi, A; Kawamura, M; Bartolome, A; Terashi-Suzuki, E; Takai, T; Kanno, A; Koyanagi-Kimura, M; Matsuda, T; Hashimoto, N; Kido, Y				Kawada, Yukina; Asahara, Shun-ichiro; Sugiura, Yumiko; Sato, Ayaka; Furubayashi, Ayuko; Kawamura, Mao; Bartolome, Alberto; Terashi-Suzuki, Emi; Takai, Tomoko; Kanno, Ayumi; Koyanagi-Kimura, Maki; Matsuda, Tomokazu; Hashimoto, Naoko; Kido, Yoshiaki			Histone deacetylase regulates insulin signaling via two pathways in pancreatic beta cells	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MASS; GROWTH; RESISTANCE; SECRETION; MICE; HYPERINSULINEMIA; TRANSCRIPTION; ACETYLATION; DYSFUNCTION	Recent studies demonstrated that insulin signaling plays important roles in the regulation of pancreatic beta cell mass, the reduction of which is known to be involved in the development of diabetes. However, the mechanism underlying the alteration of insulin signaling in pancreatic beta cells remains unclear. The involvement of epigenetic control in the onset of diabetes has also been reported. Thus, we analyzed the epigenetic control of insulin receptor substrate 2 (IRS2) expression in the MIN6 mouse insulinoma cell line. We found concomitant IRS2 up-regulation and enhanced insulin signaling in MIN6 cells, which resulted in an increase in cell proliferation. The H3K9 acetylation status of the Irs2 promoter was positively associated with IRS2 expression. Treatment of MIN6 cells with histone deacetylase inhibitors led to increased IRS2 expression, but this occurred in concert with low insulin signaling. We observed increased IRS2 lysine acetylation as a consequence of histone deacetylase inhibition, a modification that was coupled with a decrease in IRS2 tyrosine phosphorylation. These results suggest that insulin signaling in pancreatic beta cells is regulated by histone dea-cetylases through two novel pathways affecting IRS2: the epigenetic control of IRS2 expression by H3K9 promoter acetylation, and the regulation of IRS2 activity through protein modification. The identification of the histone deacetylase isoform(s) involved in these mechanisms would be a valuable approach for the treatment of type 2 diabetes.	[Kawada, Yukina; Sugiura, Yumiko; Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Div Metab & Dis, Dept Biophys, Kobe, Hyogo, Japan; [Asahara, Shun-ichiro; Terashi-Suzuki, Emi; Takai, Tomoko; Kanno, Ayumi; Koyanagi-Kimura, Maki; Matsuda, Tomokazu; Hashimoto, Naoko; Kido, Yoshiaki] Kobe Univ, Div Diabet & Endocrinol, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan; [Sato, Ayaka; Furubayashi, Ayuko; Kawamura, Mao] Kobe Univ, Med Technol Major, Fac Hlth Sci Major, Grad Sch Med, Kobe, Hyogo, Japan; [Bartolome, Alberto] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	Kobe University; Kobe University; Kobe University; Columbia University	Kido, Y (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Div Metab & Dis, Dept Biophys, Kobe, Hyogo, Japan.; Kido, Y (corresponding author), Kobe Univ, Div Diabet & Endocrinol, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan.	kido@med.kobe-u.ac.jp	Bartolome, Alberto/AAV-1735-2020; Asahara, Shun-ichiro/I-6645-2019	Bartolome, Alberto/0000-0002-3382-0553; Asahara, Shun-ichiro/0000-0001-6661-9402	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26461382]; Uehara Memorial Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; Yamaguchi Endocrine Research Foundation; Honjo International Scholarship Foundation; Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research [16K16277] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Yamaguchi Endocrine Research Foundation; Honjo International Scholarship Foundation(Honjo International Scholarship Foundation); Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Shun-ichiro Asahara (S.A.) Grant number: 26461382; Uehara Memorial Foundation to Yoshiaki Kido (Y.K.) http://www.ueharazadan.or.jp; Takeda Science Foundation to Naoko Hashimoto (N.H.) http://www.takeda-sci.or.jp; Suzuken Memorial Foundation to Naoko Hashimoto (N.H.) http://www.suzukenzaidan.or.jp; Yamaguchi Endocrine Research Foundation to Naoko Hashimoto (N.H.) http://www.yamaguchi-endocrine.org; Honjo International Scholarship Foundation to Shun-ichiro Asahara (S.A.) http://www.hisf.or.jp; and Hyogo Science and Technology Association to Shun-ichiro Asahara (S. A.) http://hyogosta.jp/reconstruction/jyosei.	Asahara S, 2013, DIABETOLOGIA, V56, P1088, DOI 10.1007/s00125-013-2849-5; Asahara S, 2015, P NATL ACAD SCI USA, V112, P8332, DOI 10.1073/pnas.1422104112; Asahara S, 2009, BIOCHEM BIOPH RES CO, V381, P367, DOI 10.1016/j.bbrc.2009.02.047; Cheng K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040868; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daneshpajooh M, 2017, DIABETOLOGIA, V60, P116, DOI 10.1007/s00125-016-4113-2; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Doi T, 2013, INT J CLIN ONCOL, V18, P87, DOI 10.1007/s10147-011-0348-6; Festa A, 2008, DIABETES, V57, P1638, DOI 10.2337/db07-0954; Funato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018950; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Giannini C, 2012, DIABETES, V61, P606, DOI 10.2337/db11-1111; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Inoue T, 2009, BIOMED RES-TOKYO, V30, P325, DOI 10.2220/biomedres.30.325; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kanno A, 2015, BIOCHEM BIOPH RES CO, V458, P681, DOI 10.1016/j.bbrc.2015.02.024; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lee HB, 2007, KIDNEY INT, V72, pS61, DOI 10.1038/sj.ki.5002388; Lenoir O, 2011, DIABETES, V60, P2861, DOI 10.2337/db11-0440; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lundh M, 2012, DIABETOLOGIA, V55, P2421, DOI 10.1007/s00125-012-2615-0; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Meng Z, 2016, ONCOGENE, V35, P2333, DOI 10.1038/onc.2015.293; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Neelankal John A, 2017, J NEUROENDOCRINOL, P29; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang J, 2014, DIABETES, V63, P645, DOI 10.2337/db13-1063; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yamato E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061211; Yoshida Y, 2014, DIABETOL INT, V5, P43, DOI 10.1007/s13340-013-0127-x	49	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184435	10.1371/journal.pone.0184435	http://dx.doi.org/10.1371/journal.pone.0184435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886131	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100122
J	Shimizu, T; Fujibayashi, S; Yamaguchi, S; Otsuki, B; Okuzu, Y; Matsushita, T; Kokubo, T; Matsuda, S				Shimizu, Takayoshi; Fujibayashi, Shunsuke; Yamaguchi, Seiji; Otsuki, Bungo; Okuzu, Yaichiro; Matsushita, Tomiharu; Kokubo, Tadashi; Matsuda, Shuichi			In vivo experimental study of anterior cervical fusion using bioactive polyetheretherketone in a canine model	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; FOLLOW-UP; TITANIUM; SPINE; ARTHRODESIS; IMPLANT; CAGES; DISKECTOMY; NONUNION	Background Polyetheretherketone (PEEK) is a widely accepted biomaterial, especially in the field of spinal surgery. However, PEEK is not able to directly integrate with bone tissue, due to its bioinertness. To overcome this drawback, various studies have described surface coating approaches aimed at increasing the bioactivity of PEEK surfaces. Among those, it has been shown that the recently developed sol-gel TiO2 coating could provide PEEK with the ability to bond with bone tissue in vivo without the use of a bone graft. Objective This in vivo experimental study using a canine model determined the efficacy of bioactive TiO2-coated PEEK for anterior cervical fusion. Methods Sol-gel-derived TiO2 coating, which involves sandblasting and acid treatment, was used to give PEEK bone-bonding ability. The cervical interbody spacer, which was designed to fit the disc space of a beagle, was fabricated using bioactive TiO2-coated PEEK. Both uncoated PEEK (control) and TiO2-coated PEEK spacers were implanted into the cervical intervertebral space of beagles (n = 5 for each type). After the 3-month survival period, interbody fusion success was evaluated based on mu-CT imaging, histology, and manual palpation analyses. Results Manual palpation analyses indicated a 60% (3/5 cases) fusion (no gap between bone and implants) rate for the TiO2-coated PEEK group, indicating clear advantage over the 0% (0/5 cases) fusion rate for the uncoated PEEK group. The bony fusion rate of the TiO2-coated PEEK group was 40% according to mu CT imaging; however, it was 0% of for the uncoated PEEK group. Additionally, the bone-implant contact ratio calculated using histomorphometry demonstrated a better contact ratio for the TiO2-coated PEEK group than for the uncoated PEEK group (mean, 32.6% vs 3.2%; p = 0.017). Conclusions The TiO2-coated bioactive PEEK implant demonstrated better fusion rates and bone-bonding ability than did the uncoated PEEK implant in the canine anterior cervical fusion model. Bioactive PEEK, which has bone-bonding ability, could contribute to further improvements in clinical outcomes for spinal interbody fusion.	[Shimizu, Takayoshi; Fujibayashi, Shunsuke; Otsuki, Bungo; Okuzu, Yaichiro; Matsuda, Shuichi] Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan; [Shimizu, Takayoshi] Columbia Univ, Med Ctr, Spine Hosp, New York Presbyterian Healthcare Syst, New York, NY USA; [Yamaguchi, Seiji; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi, Japan	Kyoto University; Columbia University; NewYork-Presbyterian Hospital; Chubu University	Shimizu, T (corresponding author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan.; Shimizu, T (corresponding author), Columbia Univ, Med Ctr, Spine Hosp, New York Presbyterian Healthcare Syst, New York, NY USA.	takayosh@kuhp.kyoto-u.ac.jp	Matsushita, Tomiharu/AAG-2432-2021		DVM	DVM	We greatly appreciate the technical support of DVM. Masashi Imamura for animal treatment.	[Anonymous], 2014, 233172014 ISO; BAGBY GW, 1988, ORTHOPEDICS, V11, P931; Bishop RC, 1996, J NEUROSURG, V85, P206, DOI 10.3171/jns.1996.85.2.0206; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Chen Y, 2008, J SPINAL DISORD TECH, V21, P489, DOI 10.1097/BSD.0b013e318158de22; COOK SD, 1994, SPINE, V19, P1856, DOI 10.1097/00007632-199408150-00011; Devine DM, 2013, J BIOMED MATER RES B, V101B, P591, DOI 10.1002/jbm.b.32861; Drespe IH, 2005, THE SPINE JOURNAL OF, V5, p209s; Fujibayashi S, 2012, SPINE, V37, pE1197, DOI 10.1097/BRS.0b013e31825d26d7; Johnson JA, 2011, VET SURG, V40, P720, DOI 10.1111/j.1532-950X.2011.00853.x; Kersten RFMR, 2015, SPINE J, V15, P1446, DOI 10.1016/j.spinee.2013.08.030; Khoury J, 2013, NUCL INSTRUM METH B, V307, P630, DOI 10.1016/j.nimb.2012.11.087; Kizuki T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5359-1; Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013; Kuslich SD, 1998, SPINE, V23, P1267, DOI 10.1097/00007632-199806010-00019; McAfee PC, 1999, J BONE JOINT SURG AM, V81A, P859, DOI 10.2106/00004623-199906000-00014; MOSDAL C, 1984, ACTA NEUROCHIR, V70, P207, DOI 10.1007/BF01406650; Olivares-Navarrete R, 2015, SPINE, V40, P399, DOI 10.1097/BRS.0000000000000778; Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735; Rokkum M, 2003, J BONE JOINT SURG BR, V85B, P440, DOI 10.1302/0301-620X.85B3.12834; SHIMA T, 1979, J NEUROSURG, V51, P533, DOI 10.3171/jns.1979.51.4.0533; Shimizu T, 2016, ACTA BIOMATER, V35, P305, DOI 10.1016/j.actbio.2016.02.007; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Takemoto M, 2007, J NEUROSURG-SPINE, V7, P435, DOI 10.3171/SPI-07/10/435; Tanida S, 2016, SPINE, V41, pE1216, DOI 10.1097/BRS.0000000000001605; Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011; Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce; Walsh WR, 2015, SPINE J, V15, P1041, DOI 10.1016/j.spinee.2014.12.018; Weiner BK, 1998, SPINE, V23, P634, DOI 10.1097/00007632-199803010-00020; Wieling A. G. R., 2009, EUR CELLS MATER, V17, P10; Wu GM, 2009, SURF COAT TECH, V203, P2755, DOI 10.1016/j.surfcoat.2009.02.115; Zdeblick TA, 1997, J BONE JOINT SURG AM, V79A, P523, DOI 10.2106/00004623-199704000-00007	32	22	22	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184495	10.1371/journal.pone.0184495	http://dx.doi.org/10.1371/journal.pone.0184495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886118	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100139
J	Xu, WT; Chen, TM; Dong, XC; Kong, M; Lv, XZ; Li, L				Xu, Wenti; Chen, Tianmu; Dong, Xiaochun; Kong, Mei; Lv, Xiuzhi; Li, Lin			Outbreak detection and evaluation of a school-based influenza-like-illness syndromic surveillance in Tianjin, China	PLOS ONE			English	Article							TRANSMISSION; CHANGSHA; DISEASE; VIRUS	School-based influenza-like-illness (ILI) syndromic surveillance can be an important part of influenza community surveillance by providing early warnings for outbreaks and leading to a fast response. From September 2012 to December 2014, syndromic surveillance of ILI was carried out in 4 county-level schools. The cumulative sum methods(CUSUM) was used to detect abnormal signals. A susceptible-exposed-infectious/asymptomatic-recovered (SEIAR) model was fit to the influenza outbreak without control measures and compared with the actual influenza outbreak to evaluate the effectiveness of early control efforts. The ILI incidence rates in 2014 (14.51%) was higher than the incidence in 2013 (5.27%) and 2012 (3.59%). Ten school influenza outbreaks were detected by CUSUM. Each outbreak had high transmissibility with a median R-unc of 4.62. The interventions in each outbreak had high effectiveness and all R-con were 0. The early intervention had high effectiveness within the school-based ILI syndromic surveillance. Syndromic surveillance within schools can play an important role in controlling influenza outbreaks.	[Xu, Wenti; Dong, Xiaochun; Kong, Mei; Li, Lin] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Chen, Tianmu] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Lv, Xiuzhi] Hangu Ctr Dis Control & Prevent, Tianjin, Peoples R China	Tianjin Center for Disease Control & Prevention	Xu, WT (corresponding author), Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China.	wenti_xwt@163.com			Tianjin Health and Family Planning Commission [2009kz043]	Tianjin Health and Family Planning Commission	This work was supported by Tianjin Health and Family Planning Commission (Research Grant number 2009kz043): http://www.tjwsj.gov.cn/html/wsjn/portal/index/index.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Burkom HS, 2004, MMWR-MORBID M      S, V53, pS67; Chan TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1500-4; Chen SC, 2013, EPIDEMIOL INFECT, V141, P2581, DOI 10.1017/S0950268813000423; Chen SL, 2017, EPIDEMIOL INFECT, V145, P368, DOI 10.1017/S0950268816002338; Chen TM, 2017, EPIDEMIOL INFECT, V145, P424, DOI [10.1017/S0950268816002508, 10.1017/s0950268816002508]; Chen TM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3716-3; Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; Crowe S, 2015, MMWR-MORBID MORTAL W, V64, P70; Fan YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112255; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001; Li J, 2015, INT J INFECT DIS, V40, P17, DOI 10.1016/j.ijid.2015.09.013; Liu CD, 2016, 2016 INTERNATIONAL CONFERENCE ON COMPUTER ENGINEERING, INFORMATION SCIENCE AND INTERNET TECHNOLOGY (CII 2016), P111; Liu RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132588; Lober William B, 2014, Online J Public Health Inform, V5, P224, DOI 10.5210/ojphi.v5i3.4938; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Nelesone T, 2006, TROP MED INT HEALTH, V11, P17, DOI 10.1111/j.1365-3156.2005.01534.x; Paterson BJ, 2013, J EPIDEMIOL GLOB HEA, V3, P41, DOI 10.1016/j.jegh.2012.12.005; Rosenkotter N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-905; Siegrist David, 2004, MMWR Suppl, V53, P152; Tan L, 2014, PUBLIC HEALTH, V128, P792, DOI 10.1016/j.puhe.2014.06.004; Timpka T, 2014, EUROSURVEILLANCE, V19, P24, DOI 10.2807/1560-7917.ES2014.19.46.20966	27	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184527	10.1371/journal.pone.0184527	http://dx.doi.org/10.1371/journal.pone.0184527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886143	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100147
J	Ikari, J; Nelson, AJ; Obaid, J; Giron-Martinez, A; Ikari, K; Makino, F; Iwasawa, S; Gunji, Y; Farid, M; Wang, XQ; Basma, H; Demeo, D; Feghali-Bostwick, C; Holz, O; Rabe, K; Liu, XD; Rennard, SI				Ikari, Jun; Nelson, Amy J.; Obaid, Jannah; Giron-Martinez, Alvaro; Ikari, Kumiko; Makino, Fumihiko; Iwasawa, Shunichiro; Gunji, Yoko; Farid, Maha; Wang, Xingqi; Basma, Hesham; Demeo, Dawn; Feghali-Bostwick, Carol; Holz, Olaf; Rabe, Klaus; Liu, Xiangde; Rennard, Stephen I.			Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROSTAGLANDIN E-2; E-PROSTANOID-2 RECEPTOR; CIGARETTE-SMOKE; EMPHYSEMA; COPD; ANGIOGENESIS; MECHANISMS; ASTHMA; INFLAMMATION	Alterations in microRNA (miRNA) expression may contribute to COPD pathogenesis. In COPD, lung fibroblast repair functions are altered in multiple ways, including extracellular mediator release. Our prior study revealed miR-503 expression is decreased in COPD lung fibroblasts, although the exact role played by miR-503 is undetermined. The current study examined a role of miR-503 in cytokine, growth factor and fibronectin production by lung fibroblasts from patients with and without COPD. Primary adult lung fibroblasts were isolated from patients with or without COPD. MiR-503 expression and interleukin (IL)-6, -8, PGE(2), HGF, KGF, VEGF and fibronectin release were examined with or without inflammatory cytokines, IL-1 beta and tumor necrosis factor (TNF)-alpha. MiR-503 expression was decreased in COPD lung fibroblasts. The expression of miR-503 was positively correlated with %FVC, % FEV1, and % DLco as well as IL-6, -8, PGE(2), HGF, KGF, and VEGF in the absence or presence of IL-1 beta/TNF-alpha. In addition, IL-8 and VEGF release from COPD lung fibroblasts were increased compared to those from control. Exogenous miR-503 inhibited VEGF release from primary adult and fetal lung fibroblasts but not IL-8 release. As expected, COPD fibroblasts proliferated more slowly than control fibroblasts. MiR-503 did not affect proliferation of either control or COPD lung fibroblasts. MiR-503 inhibition of VEGF protein production and mRNA was mediated by direct binding to the 3' untranslated region of VEGF mRNA. Endogenous miR-503 was differently regulated by exogenous stimulants associated with COPD pathogenesis, including IL-1 beta/TNF-alpha, TGF-beta 1 and PGE(2). Endogenous miR-503 inhibition augmented VEGF release by IL-1 beta/TNF-alpha and TGF-beta 1 but not by PGE(2), demonstrating selectivity of miR-503 regulation of VEGF. In conclusions, reduced miR-503 augments VEGF release from lung fibroblasts from patients with COPD.	[Ikari, Jun; Nelson, Amy J.; Obaid, Jannah; Giron-Martinez, Alvaro; Ikari, Kumiko; Makino, Fumihiko; Iwasawa, Shunichiro; Gunji, Yoko; Farid, Maha; Wang, Xingqi; Basma, Hesham; Liu, Xiangde; Rennard, Stephen I.] Univ Nebraska Med Ctr, Pulm Crit Care Sleep & Allergy Med, Omaha, NE 68198 USA; [Ikari, Jun] Chiba Univ, Grad Sch Med, Respirol, Chiba, Japan; [Demeo, Dawn] Harvard Med Sch, Channing Lab, Boston, MA USA; [Feghali-Bostwick, Carol] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC USA; [Holz, Olaf] Fraunhofer ITEM, Hannover, Germany; [Holz, Olaf] BREATH, German Ctr Lung Res DZL, Hannover, Germany; [Rabe, Klaus] Lungen Clin Grosshansdorf, ARCN, Grosshansdorf, Germany; [Rabe, Klaus] German Ctr Lung Res, Grosshansdorf, Germany	University of Nebraska System; University of Nebraska Medical Center; Chiba University; Harvard University; Harvard Medical School; Medical University of South Carolina; Grosshansdorf Hospital	Rennard, SI (corresponding author), Univ Nebraska Med Ctr, Pulm Crit Care Sleep & Allergy Med, Omaha, NE 68198 USA.	srennard@unmc.edu	Farid, Maha Mohamed AlAzab Hassan/HDO-0741-2022; Rabe, Klaus F./AAW-6296-2021	Farid, Maha Mohamed AlAzab Hassan/0000-0002-7692-1661; Rabe, Klaus F./0000-0002-7020-1401	AstraZeneca	AstraZeneca(AstraZeneca)	During the completion of this work, Dr. Rennard was an employee of AstraZeneca, which thus provided support financial support in the form of salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Angulo M, 2012, ARCH BRONCONEUMOL, V48, P325, DOI 10.1016/j.arbres.2012.04.011; Annoni R, 2012, EUR RESPIR J, V40, P1362, DOI 10.1183/09031936.00192611; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Barnes PJ, 2014, CHEST, V146, P1135, DOI 10.1378/chest.14-1194; Birk DM, 2008, VASC ENDOVASC SURG, V42, P517, DOI 10.1177/1538574408322755; Caporali A, 2011, TRENDS CARDIOVAS MED, V21, P162, DOI 10.1016/j.tcm.2012.05.003; Chen Y, 2008, RESPIROLOGY, V13, P1014, DOI 10.1111/j.1440-1843.2008.01365.x; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Horowitz JC, 2009, COPD, V6, P201, DOI 10.1080/15412550902905953; Ikari J, 2015, IN VITRO CELL DEV-AN, V51, P390, DOI 10.1007/s11626-014-9820-8; Ikari J, 2013, AM J RESP CELL MOL, V49, P571, DOI 10.1165/rcmb.2013-0004OC; Izzotti A, 2009, FASEB J, V23, P3243, DOI 10.1096/fj.09-135251; Kamio K, 2008, AM J PHYSIOL-LUNG C, V294, pL1226, DOI 10.1152/ajplung.00129.2007; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V327, P393, DOI 10.1016/j.bbrc.2004.12.032; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Montuschi P, 2003, THORAX, V58, P585, DOI 10.1136/thorax.58.7.585; Nakanishi M, 2012, AM J RESP CELL MOL, V46, P217, DOI 10.1165/rcmb.2010-0115OC; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Plantier Laurent, 2007, Int J Chron Obstruct Pulmon Dis, V2, P463; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Puxeddu I, 2005, J ALLERGY CLIN IMMUN, V116, P531, DOI 10.1016/j.jaci.2005.06.007; Rennard Stephen I, 2011, Pneumonol Alergol Pol, V79, P132; Rupani H, 2013, EUR RESPIR J, V41, P695, DOI 10.1183/09031936.00212011; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Wen FQ, 2003, J ALLERGY CLIN IMMUN, V111, P1307, DOI 10.1067/mai.2003.1455; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184039	10.1371/journal.pone.0184039	http://dx.doi.org/10.1371/journal.pone.0184039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880936	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200030
J	Matthews, LT; Burns, BF; Bajunirwe, F; Kabakyenga, J; Bwana, M; Ng, C; Kastner, J; Kembabazi, A; Sanyu, N; Kusasira, A; Haberer, JE; Bangsberg, DR; Kaida, A				Matthews, Lynn T.; Burns, Bridget F.; Bajunirwe, Francis; Kabakyenga, Jerome; Bwana, Mwebesa; Ng, Courtney; Kastner, Jasmine; Kembabazi, Annet; Sanyu, Naomi; Kusasira, Adrine; Haberer, Jessica E.; Bangsberg, David R.; Kaida, Angela			Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care	PLOS ONE			English	Article							ANTIRETROVIRAL PREEXPOSURE PROPHYLAXIS; REPRODUCTIVE HEALTH-SERVICES; RANDOMIZED CONTROLLED-TRIAL; DISCORDANT COUPLES; SEROSTATUS DISCLOSURE; RELATIONSHIP CONTEXT; CONTRACEPTIVE USE; FERTILITY DESIRE; DECISION-MAKING; RISK REDUCTION	Introduction We explored acceptability and feasibility of safer conception methods among HIV-affected couples in Uganda. Methods We recruited HIV-positive men and women on antiretroviral therapy (ART) ('index') from the Uganda Antiretroviral Rural Treatment Outcomes cohort who reported an HIV-negative or unknown-serostatus partner ('partner'), HIV-serostatus disclosure to partner, and personal or partner desire for a child within two years. We conducted in-depth interviews with 40 individuals from 20 couples, using a narrative approach with tailored images to assess acceptability of five safer conception strategies: ART for the infected partner, pre-exposure prophylaxis (PrEP) for the uninfected partner, condomless sex timed to peak fertility, manual insemination, and male circumcision. Translated and transcribed data were analyzed using thematic analysis. Results 11/20 index participants were women, median age of 32.5 years, median of 2 living children, and 80% had HIV-RNA < 400 copies/mL. Awareness of HIV prevention strategies beyond condoms and abstinence was limited and precluded opportunity to explore or validly assess acceptability or feasibility of safer conception methods. Four key partnership communication challenges emerged as primary barriers to engagement in safer conception care, including: (1) HIV-serostatus disclosure: Although disclosure was an inclusion criterion, partners commonly reported not knowing the index partner's HIV status. Similarly, the partner's HIV- serostatus, as reported by the index, was frequently inaccurate. (2) Childbearing intention: Many couples had divergent childbearing intentions and made incorrect assumptions about their partner's desires. (3) HIV risk perception: Participants had disparate understandings of HIV transmission and disagreed on the acceptable level of HIV risk to meet reproductive goals. (4) Partnership commitment: Participants revealed significant discord in perceptions of partnership commitment. All four types of partnership miscommunication introduced constraints to autonomous reproductive decision-making, particularly for women. Such miscommunication was common, as only 2 of 20 partnerships in our sample were mutuallydisclosed with agreement across all four communication themes. Conclusions Enthusiasm for safer conception programming is growing. Our findings highlight the importance of addressing gendered partnership communication regarding HIV disclosure, reproductive goals, acceptable HIV risk, and commitment, alongside technical safer conception advice. Failing to consider partnership dynamics across these domains risks limiting reach, uptake, adherence to, and retention in safer conception programming.	[Matthews, Lynn T.; Burns, Bridget F.; Haberer, Jessica E.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bajunirwe, Francis; Kabakyenga, Jerome; Bwana, Mwebesa; Kembabazi, Annet; Sanyu, Naomi; Kusasira, Adrine] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Ng, Courtney] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kastner, Jasmine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Haberer, Jessica E.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bangsberg, David R.] OHSU PSU Sch Publ Hlth, Portland, OR USA; [Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; McGill University; Harvard University; Massachusetts General Hospital; Simon Fraser University	Matthews, LT (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.; Matthews, LT (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	ltmatthews@mgh.harvard.edu	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	NIH/NICHD [R21-HD069194]; NIH/NIMH [R01-MH54907]; Canada Sub-Saharan Africa AIDS Network; Sullivan Family Foundation;  [K-23 MH095655];  [K-24 MH87227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canada Sub-Saharan Africa AIDS Network; Sullivan Family Foundation; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH/NICHD R21-HD069194 (Kaida), NIH/NIMH R01-MH54907 (Bangsberg), and the Canada Sub-Saharan Africa AIDS Network (Bajunirwe). The work was also supported by K-23 MH095655 (Matthews), K-24 MH87227 (Bangsberg), and the Sullivan Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 1999, J WOMEN HEALTH GEN-B, V8, P587, DOI 10.1089/jwh.1.1999.8.587; ALLAN G, 1980, J MARRIAGE FAM, V42, P205, DOI 10.2307/351948; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barker G, 2010, GLOB PUBLIC HEALTH, V5, P539, DOI 10.1080/17441690902942464; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Bhatia D, 2017, FRONTIERS P IN PRESS; Bott S, 2013, SAHARA J-J SOC ASP H, V10, pS5, DOI 10.1080/02664763.2012.755319; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Campbell JI, 2016, J GEN INTERN MED, V31, P338, DOI 10.1007/s11606-015-3502-4; Cohen MS, 2011, N ENGL J MED; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Conroy AA, 2016, SOC SCI MED, V153, P1, DOI 10.1016/j.socscimed.2016.01.035; Conroy AA, 2015, SOC SCI MED, V144, P28, DOI 10.1016/j.socscimed.2015.09.007; Crankshaw TL, 2016, SOC SCI MED, V166, P169, DOI 10.1016/j.socscimed.2016.08.020; Crankshaw Tamaryn L, 2012, Reprod Health Matters, V20, P50, DOI 10.1016/S0968-8080(12)39639-0; Crankshaw TL, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18832; Darbes LA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-64; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Dyer S, 2008, HUM REPROD, V23, P352, DOI 10.1093/humrep/dem279; Goggin K, 2015, AIDS PATIENT CARE ST, V29, P651, DOI 10.1089/apc.2015.0089; Grabbe K, 2009, J WOMENS HEALTH, V18, P1449, DOI 10.1089/jwh.2008.1160; Greig A, 2008, GENDER AIDS TIME ACT, V22, pS35; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Guthrie BL, 2010, AIDS BEHAV, V14, P1066, DOI 10.1007/s10461-010-9716-x; Heffron R, 2016, CURR HIV AIDS REP; Heffron R, 2016, PREP ART REDUCE HIV; Hertz R., 1995, QUALITATIVE INQUIRY, V1; Higgins JA, 2014, AM J PUBLIC HEALTH, V104, P612, DOI 10.2105/AJPH.2013.301670; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Jiwatram-Negron T, 2014, AIDS BEHAV, V18, P1864, DOI 10.1007/s10461-014-0827-7; Kaida A, 2016, HIGH PLANNED PARTNER; Kaida A, 2014, AIDS RES HUM RETROV, V30, pA61, DOI 10.1089/aid.2014.5110.abstract; Kastner J, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/626120; Kennedy CE, 2015, J INT AIDS SOC, V18, P74, DOI 10.7448/IAS.18.6.20292; Khidir H, 2017, AIDS BEHAV; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Marston M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151877; Matovu JKB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0272-3; Matthews LT, 2015, AIDS BEHAV, V19, P1666, DOI 10.1007/s10461-015-1026-x; Matthews LT, 2017, AIDS BEHAV; Matthews LT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4195762; Matthews LT, 2014, JAIDS-J ACQ IMM DEF, V67, pS210, DOI 10.1097/QAI.0000000000000374; Matthews LT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-843; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mmeje O, 2016, HIV INFERTILITY PRAG; Mmeje O, 2016, AIDS CARE, V28, P750, DOI 10.1080/09540121.2016.1153592; Mmeje O, 2015, AIDS CARE, V27, P10, DOI 10.1080/09540121.2014.946385; Muhindo R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2526-3; Musinguzi N, 2017, AIDS BEHAV, V21, P1735, DOI 10.1007/s10461-016-1447-1; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Ngure K, 2016, AIDS PATIENT CARE ST, V30, P78, DOI 10.1089/apc.2015.0259; Nieves CI, 2015, CONTRACEPTION, V92, P152, DOI 10.1016/j.contraception.2015.04.011; NORMAN GR, 1992, ACAD MED, V67, P557, DOI 10.1097/00001888-199209000-00002; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Phiri S, 2016, J FAM PLAN REPROD H, V42, P17, DOI 10.1136/jfprhc-2013-100816; Pintye J, 2015, AIDS PATIENT CARE ST, V29, P510, DOI 10.1089/apc.2015.0063; Rao A, 2016, FUTURE PREGNANCY INT; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; SCHWARTZ S, 2011, AIDS BEHAV; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Schwartz SR, 2015, INT J STD AIDS; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Stephenson R, 2011, J WOMENS HEALTH, V20, P567, DOI 10.1089/jwh.2010.2113; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Ugandan Ministry of Health, 2016, CONS GUID PREV TRAEA; Ujiji OA, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-13; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Wall KM, 2017, SEX TRANSM INFECT, V93, P259, DOI 10.1136/sextrans-2016-052743; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; West N, 2016, AIDS CARE, V28, P390, DOI 10.1080/09540121.2015.1093596; Whetham J, 2014, AIDS CARE, V26, P332, DOI 10.1080/09540121.2013.819406; WHO (World Health Organization), 2010, POL APPR ENG MEN BOY; World Health Organization, 2009, INT GEND HIV AIDS PR; World Health Organization, 2007, ENG MEN BOYS CHANG G; World Health Organization, 2012, GUID OR PREEXP PROPH; Zafer M, 2016, FERTIL STERIL, V105, P645, DOI 10.1016/j.fertnstert.2015.11.028	84	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183131	10.1371/journal.pone.0183131	http://dx.doi.org/10.1371/journal.pone.0183131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880892	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200014
J	Theisen, S; Palm, HW; Al-Jufaili, SH; Kleinertz, S				Theisen, Stefan; Palm, Harry W.; Al-Jufaili, Sarah H.; Kleinertz, Sonja			Pseudempleurosoma haywardi sp nov (Monogenea: Ancyrocephalidae (sensu lato) Bychowsky & Nagibina, 1968): An endoparasite of croakers (Teleostei: Sciaenidae) from Indonesia	PLOS ONE			English	Article							URINARY-BLADDER; BRAZIL; DACTYLOGYRIDAE; CICHLIDAE; COAST	An endoparasitic monogenean was identified for the first time from Indonesia. The oesophagus and anterior stomach of the croakers Nibea soldado (Lacepede) and Otolithes ruber (Bloch & Schneider) (n = 35 each) sampled from the South Java coast in May 2011 and Johnius amblycephalus (Bleeker) (n = 2) (all Sciaenidae) from Kedonganan fish market, South Bali coast, in November 2016, were infected with Pseudempleurosoma haywardi sp. nov. Prevalences in the first two croakers were 63% and 46%, respectively, and the two J. amblycephalus harboured three and five individuals. All three croakers represent new hosts for this monogenean genus. We provide infection rates, light microscopical observations, 3D confocal microscopical illustrations, and a morphometric comparison with all congeners. The new species differs in body size, the position and shape of the ovary and testes, and especially in the composition of the dorsal anchor complex, with the dorsal bar being anteriorly concave rather than planar or convex as in its congeners. The dorsal and ventral anchors of this new species are the longest in the genus, whereas the male copulatory organ is the smallest. The first DNA sequences for a member of this genus demonstrate the greatest similarity with endoparasitic freshwater monogeneans from African cichlid fishes. This suggests a freshwater origin for these marine endoparasitic monogeneans.	[Theisen, Stefan; Palm, Harry W.; Al-Jufaili, Sarah H.; Kleinertz, Sonja] Univ Rostock, Aquaculture & Sea Ranching, Rostock, Germany; [Palm, Harry W.] Udayana Univ, Ctr Studies Anim Dis, Badung Denpasar, Badung Denpasar, Bali, Indonesia; [Al-Jufaili, Sarah H.] Minist Agr & Fisheries Wealth, Fishery Qual Control Ctr, Lab Microbiol Anal, Al Bustan, Oman	University of Rostock; Universitas Udayana	Theisen, S (corresponding author), Univ Rostock, Aquaculture & Sea Ranching, Rostock, Germany.	Stefan.Theisen@uni-rostock.de			German Academic Exchange Service (DAAD); HIBAH competitive grant; German Federal Ministry for Education and Science (BMBF) [03F0641D]; Deutsche Forschungsgemeinschaft (DFG)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); HIBAH competitive grant; German Federal Ministry for Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by a two year Ph.D. scholarship (ST) from the German Academic Exchange Service (DAAD (https://www.daad.de/en/), budgetary title: 332 4 04 101, code digit: D/09/48018), and the HIBAH competitive grant. Financial support was also provided by the German Federal Ministry for Education and Science (BMBF [https://www.bmbf.de/en/index.html], Grant No. 03F0641D) (SK, HWP) within the framework of the joint Indonesian-German research program SPICE III-MABICO (Science for the Protection of Indonesian Coastal Marine Ecosystems). Open access article processing charge was paid by the open access publication fund of Rostock University, funded by the Deutsche Forschungsgemeinschaft (DFG).	Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Bychowsky B. E, 1970, Parazitologiya, V4, P451; Cepeda PB, 2011, ACTA PARASITOL, V56, P270, DOI 10.2478/s11686-011-0055-5; Cribb TH, 2002, INT J PARASITOL, V32, P321, DOI 10.1016/S0020-7519(01)00333-2; de Carvalho Adriano Reder, 2012, Acta Scientiarum Biological Sciences, V34, P359, DOI 10.4025/actascibiolsci.v34i3.10360; Froese R, FISHBASE WORLD WIDE; Galli P, 2006, J PARASITOL, V92, P395, DOI 10.1645/GE-3544RN.1; Gerasev P.I., 1987, Parazitologicheskii Sbornik, V34, P192; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayward CJ, 1997, FOLIA PARASIT, V44, P173; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Madanire-Moyo GN, 2015, AFR ZOOL, V50, P175, DOI 10.1080/15627020.2015.1048729; Marchiori NC, 2015, FOLIA PARASIT, V62; Mendlova M, 2010, PARASITOL RES, V107, P1405, DOI 10.1007/s00436-010-2008-6; Mendoza-Franco EF, 2011, J PARASITOL, V97, P1020, DOI 10.1645/GE-2727.1; Nematoda Riemann F., 1988, INTRO STUDY MEIOFAUN, P293; Nguyen V. P., 2011, THESIS; PALM H.W., 2014, MARINE FISH PARASITO; Rehulkova A E, 2009, 6 INT S MON; Reimer L., 1990, WISSENSCHAFTLICHE Z, V1, P27; Santos CP, 2001, MEM I OSWALDO CRUZ, V96, P215, DOI 10.1590/S0074-02762001000200013; Stunkard H. W., 1924, Parasitology Cambridge, V16, P436, DOI 10.1017/S0031182000020333; VAUCHER C, 1990, J PARASITOL, V76, P501, DOI 10.2307/3282828; Whittington I. D., 2008, Fish diseases, Volume 2, P683; Wu XY, 2005, FOLIA PARASIT, V52, P231, DOI 10.14411/fp.2005.031; YAMAGUTI SATYU, 1965, PACIFIC SCI, V19, P55	26	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184376	10.1371/journal.pone.0184376	http://dx.doi.org/10.1371/journal.pone.0184376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880928	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200061
J	Yang, SJ; Yang, C; Liao, Q; Zhai, WW; Yu, G; Xiao, L; Wang, QX; Gong, YH; Zhang, SH; Yao, YN; Wang, K; Wang, J; Bian, SC; Liu, Q				Yang, Shujuan; Yang, Chao; Liao, Qiang; Zhai, Wenwen; Yu, Gang; Xiao, Lin; Wang, Qixing; Gong, Yuhan; Zhang, Suhua; Yao, Yongna; Wang, Ke; Wang, Ju; Bian, Shaochao; Liu, Qian			Analysis of HIV prevalence among pregnant women in Liangshan Prefecture, China, from 2009 to 2015	PLOS ONE			English	Article							INJECTION-DRUG USERS; SICHUAN PROVINCE	Background Yi people make up about 50% of the population in Liangshan Prefecture, Sichuan Province, China, but accounted for 88.07% of new HIV cases in the prefecture from 2011 to 2013. This study evaluated HIV prevalence in pregnant women of Liangshan Prefecture using HIV sentinel surveillance (HSS) data over the period of 2009 to 2015. Methods Xichang, Zhaojue County, and Butuo County were selected as HSS sites. We investigated the temporal trends in HIV prevalence in these areas, and the association between demographic and behavioral characteristics and risk of HIV infection. Results Data on a total of 2797 pregnant women in Xichang and 3983 pregnant women in Zhaojue and Butuo was collected for the period 2009 to 2015. There was a fluctuating HIV prevalence among pregnant women of Xichang, with a rate of 0.75% in 2015 (chi(2) (trend) = 2.27, P = 0.13). HIV prevalence among pregnant women of Zhaojue and Butuo was consistently high, varying between 3.4% (9/267, 2011) and 10.3% (82/796, 2012) over the period of 2010 to 2015 (chi(2) (trend) = 0.12, P = 0.73). In Xichang, we found that Yi ethnicity (OR = 11.37, 95% CI = 2.92-44.25) and a husband who used drugs (OR = 32.13, 95% CI = 5.33-193.67) were significantly associated with HIV risk in pregnant women. For Zhaojue and Butuo, we observed that pregnant women had a higher risk of HIV infection when they were over 30 years old (OR = 1.72, 95% CI = 1.17-2.52), when they had a higher number of previous births, when their husbands had a history of migrating for work (OR = 1.56, 95% CI = 1.16- 2.08),and when they had a history of other sexually transmitted infections (OR = 2.19, 95% CI = 1.16-2.08). Compared to those with a primary school education or below, pregnant women with a secondary or high school education level had a lower risk of HIV infection (OR = 0.28, 95% CI = 0.09-0.89). Conclusion Our results indicate that there is a serious HIV epidemic among pregnant Yi women, especially for those with less education, more past births, or a husband with a history of out-migrating for work or STD infection.	[Yang, Shujuan; Zhai, Wenwen; Zhang, Suhua; Yao, Yongna] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China; [Yang, Chao] Southwest Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Luzhou, Peoples R China; [Liao, Qiang; Yu, Gang; Xiao, Lin; Wang, Qixing; Gong, Yuhan; Wang, Ke; Wang, Ju; Bian, Shaochao; Liu, Qian] Liangshan Prefecture Ctr Dis Control & Prevent, Xichang, Peoples R China	Sichuan University; Southwest Medical University	Yang, SJ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China.	rekiny@126.com			Liangshan HIV/AIDS Prevention project [H161236]; Health and Family Planning Commission of Sichuan Province [16PJ259]; Evaluation Model of AIDS Infections in Liangshan Prefecture [2014LSCDC002]	Liangshan HIV/AIDS Prevention project; Health and Family Planning Commission of Sichuan Province; Evaluation Model of AIDS Infections in Liangshan Prefecture	This research was supported by grant funding from the Liangshan HIV/AIDS Prevention project (H161236), the Health and Family Planning Commission of Sichuan Province (16PJ259) and the Evaluation Model of AIDS Infections in Liangshan Prefecture (2014LSCDC002).	CDC LP, 2008, SURV REP HIV AIDS LI; Chen LanXin, 2013, China Tropical Medicine, V13, P1323; China. MoHotPsRo UNAIDS WHO, 2012, CHINESE J AIDS STD, V18, P1; Dai W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2385-y; Gong Y., 2014, CHINESE J DIS CONTRO, V18, P1132; Li L, 2015, AIDS RES HUM RETROV, V31, P479, DOI [10.1089/AID.2014.0120, 10.1089/aid.2014.0120]; Liang L, 2013, J PREV MED INF, V29, P453; Liu G, 2002, J PREV MED INF, V18, P211; Liu L, 2014, CHIN J DIS CONTROL P, V18, P702; Lu Juan, 2012, Bulletin of Disease Control and Prevention, V27, P6; Man ZK, 2013, EXPLORING ED DEV, P33; Qumu A., STUDY PROBLEM POVERT; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Tang XJ, 2014, CHIN J AIDS STD, V20, P176; Tuan Z, 2016, CHIN J AIDS STD, V22, P917; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wang Q., 2008, CHIN J AIDS STD, V14, P351; Wu H., 2009, J PREVENTION MED INF, V25, P638; Wu Z, 1999, GLOB RES NETW M HIV; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang SJ, 2017, CHINESE J AIDS STD, V23, P271, DOI DOI 10.13419/J.CNKI.AIDS.2017.03.28; Yang Y, 2011, MED SOC, V24, P41; Zhang S H, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P486, DOI 10.3760/cma.j.issn.0254-6450.2017.04.015; Zhao HY, 2015, CHIN J DERM VENEREOL, V29, P1265; Zhao J, 2011, LIFE SCI J, V8, P27; Zhou RN, 2012, OPEN TIMES, V2, P145; Zhou Y, 2012, CHIN J AIDS STD, V18, P319; Zhou YB, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0073-x; Zhou YB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-134	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183418	10.1371/journal.pone.0183418	http://dx.doi.org/10.1371/journal.pone.0183418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880917	Green Submitted, gold, Green Published			2022-12-26	WOS:000409467200017
J	Agodi, A; Barchitta, M; Quattrocchi, A; Spera, E; Gallo, G; Auxilia, F; Brusaferro, S; D'Errico, MM; Montagna, MT; Pasquarella, C; Tardivo, S; Mura, I				Agodi, Antonella; Barchitta, Martina; Quattrocchi, Annalisa; Spera, Emiliano; Gallo, Giovanni; Auxilia, Francesco; Brusaferro, Silvio; D'Errico, Marcello Mario; Montagna, Maria Teresa; Pasquarella, Cesira; Tardivo, Stefano; Mura, Ida		GISIO-Siti Working Grp	Preventable proportion of intubation-associated pneumonia: Role of adherence to a care bundle	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; UNIT-ACQUIRED INFECTIONS; PARAMETRIC-G-FORMULA; NETWORK SPIN-UTI; ACINETOBACTER-BAUMANNII; NOSOCOMIAL INFECTIONS; PATIENT; MORTALITY; SURVEILLANCE; HOSPITALS	Objective The aim of the present study was to estimate the preventable proportion of Intubation-Associated Pneumonia (IAP) in the Intensive Care Units (ICUs) participating in the Italian Nosocomial Infections Surveillance in ICUs (SPIN-UTI) network, taking into account differences in intrinsic patients' risk factors, and additionally considering the compliance with the European bundle for IAP prevention. Methods A prospective patient-based survey was conducted and all patients staying in ICU for more than 2 days were enrolled in the surveillance. Compliance with the bundle was assessed using a questionnaire for each intubated patient. A twofold analysis by the parametric g-formula was used to compute the number of infections to be expected if the infection incidence in all ICUs could be reduced to that one of the top-tenth-percentile-ranked ICUs and to that one of the ICU with the highest compliance to all five bundle components. Results A total of 1,840 patients and of 17 ICUs were included in the first analysis showing a preventable proportion of 44% of IAP. In a second analysis on a subset of data, considering compliance with the European bundle, a preventable proportion of 40% of IAP was shown. A significant negative trend of IAP incidences was observed with increasing number of bundle components performed (p<0.001) and a strong negative correlation between these two factors was shown (r = -0.882; p = 0.048). Conclusions The g-formula controlled for time-varying factors is a valuable approach for estimating the preventable proportion of IAP and the impact of interventions, based entirely on an observed population in a real-world setting. However, both the study design that cannot definitively prove a causative relationship between bundle compliance and IAP risk, and the small number of patients included in the care bundle compliance analysis, may represent limits of the study and further and larger studies should be conducted.	[Agodi, Antonella; Barchitta, Martina; Quattrocchi, Annalisa] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy; [Spera, Emiliano; Gallo, Giovanni] Univ Catania, Dept Math & Informat, Catania, Italy; [Auxilia, Francesco] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Brusaferro, Silvio] Univ Udine, Dept Med, Udine, Italy; [D'Errico, Marcello Mario] Polytech Univ Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Montagna, Maria Teresa] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy; [Pasquarella, Cesira] Univ Parma, Dept Med & Surg, Parma, Italy; [Tardivo, Stefano] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy; [Mura, Ida] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [GISIO-Siti Working Grp] Italian Study Grp Hosp Hyg, GISIO SItI Working Grp, Italian Soc Hyg Prevent Med & Publ Hlth, Udine, Italy	University of Catania; University of Catania; University of Milan; University of Udine; Marche Polytechnic University; Universita degli Studi di Bari Aldo Moro; University of Parma; University of Verona; University of Sassari	Agodi, A (corresponding author), Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy.	agodia@unict.it	Quattrocchi, Annalisa/S-8119-2019; Agodi, Antonella/B-3501-2011; Quattrocchi, Annalisa/AAU-5458-2020; Pasquarella, Cesira/S-8637-2019; Agodi, Antonella/AIF-3938-2022; Barchitta, Martina/A-1362-2015	Quattrocchi, Annalisa/0000-0002-5764-6721; Agodi, Antonella/0000-0002-4405-8162; Agodi, Antonella/0000-0002-4405-8162; Barchitta, Martina/0000-0002-0905-5003; Gallo, Giovanni/0000-0002-6701-0620	Italian Ministry of Health [CCM 2012]	Italian Ministry of Health(Ministry of Health, Italy)	Project realized with partial financial support by the Italian Ministry of Health, CCM 2012.	Agodi A, 2014, J HOSP INFECT, V86, P260, DOI 10.1016/j.jhin.2014.02.001; Agodi A, 2013, J HOSP INFECT, V84, P52, DOI 10.1016/j.jhin.2013.02.012; Agodi A, 2010, J HOSP INFECT, V74, P258, DOI 10.1016/j.jhin.2009.08.015; Agodi A, 2015, HOSP HEALTHCARE EURO, P146; Agodi Antonella, 2014, Epidemiol Prev, V38, P153; Agodi Antonella, 2014, Epidemiol Prev, V38, P51; Al-Thaqafy MS, 2014, ANN THORAC MED, V9, P221, DOI 10.4103/1817-1737.140132; Barchitta M, 2009, INT J HYG ENVIR HEAL, V212, P330, DOI 10.1016/j.ijheh.2008.07.001; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Centers for Disease Control and Prevention, 2017, SURV VENT ASS EV; D'Alessandro D, 2014, NURS EDUC TODAY, V34, P191, DOI 10.1016/j.nedt.2013.05.005; European Centre for Disease Prevention and Control, 2010, EUR SURV HEALTHC ASS; European Centre for Disease Prevention and Control (ECDC), 2015, ANN EP REP 2014 ANT; Flodgren G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006559.pub2; Grundmann H, 2005, CRIT CARE MED, V33, P946, DOI 10.1097/01.CCM.0000163223.26234.56; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Hamishehkar H, 2014, J RES PHARM PRACT, V3, P51, DOI 10.4103/2279-042X.137070; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Keil AP, 2014, EPIDEMIOLOGY, V25, P889, DOI 10.1097/EDE.0000000000000160; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2016, JAMA INTERN MED, V176, P1277, DOI 10.1001/jamainternmed.2016.2427; Klompas M, 2010, AM J INFECT CONTROL, V38, P237, DOI 10.1016/j.ajic.2009.10.003; Lambert ML, 2014, INFECT CONT HOSP EP, V35, P494, DOI 10.1086/675824; Lisboa T, 2013, CRIT CARE, V17, DOI 10.1186/cc12590; Masia MD, 2010, J HOSP INFECT, V76, P139, DOI 10.1016/j.jhin.2010.05.013; Mitharwal SM, 2016, AM J INFECT CONTROL, V44, pE113, DOI 10.1016/j.ajic.2016.01.021; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Morrow LE, 2010, CRIT CARE MED, V38, pS352, DOI 10.1097/CCM.0b013e3181e6cc98; Neophytou AM, 2016, EPIDEMIOLOGY, V27, P21, DOI 10.1097/EDE.0000000000000389; Rahmqvist M, 2016, AM J INFECT CONTROL, V44, P500, DOI 10.1016/j.ajic.2016.01.035; Rello J, 2013, CLIN MICROBIOL INFEC, V19, P363, DOI 10.1111/j.1469-0691.2012.03808.x; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0181170	10.1371/journal.pone.0181170	http://dx.doi.org/10.1371/journal.pone.0181170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877171	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200007
J	Bigelow, J; Malone, BJ				Bigelow, James; Malone, Brian J.			Cluster-based analysis improves predictive validity of spike-triggered receptive field estimates	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; WHITE-NOISE ANALYSIS; INFERIOR COLLICULUS; NATURAL SOUNDS; FUNCTIONAL-ORGANIZATION; REVERSE-CORRELATION; NEURONAL RESPONSES; CORTICAL-NEURONS; DYNAMIC SPECTRA; NEURAL ACTIVITY	Spectrotemporal receptive field (STRF) characterization is a central goal of auditory physiology. STRFs are often approximated by the spike-triggered average (STA), which reflects the average stimulus preceding a spike. In many cases, the raw STA is subjected to a threshold defined by gain values expected by chance. However, such correction methods have not been universally adopted, and the consequences of specific gain-thresholding approaches have not been investigated systematically. Here, we evaluate two classes of statistical correction techniques, using the resulting STRF estimates to predict responses to a novel validation stimulus. The first, more traditional technique eliminated STRF pixels (time-frequency bins) with gain values expected by chance. This correction method yielded significant increases in prediction accuracy, including when the threshold setting was optimized for each unit. The second technique was a two-step thresholding procedure wherein clusters of contiguous pixels surviving an initial gain threshold were then subjected to a cluster mass threshold based on summed pixel values. This approach significantly improved upon even the best gain-thresholding techniques. Additional analyses suggested that allowing threshold settings to vary independently for excitatory and inhibitory subfields of the STRF resulted in only marginal additional gains, at best. In summary, augmenting reverse correlation techniques with principled statistical correction choices increased prediction accuracy by over 80% for multi-unit STRFs and by over 40% for single-unit STRFs, furthering the interpretational relevance of the recovered spectrotemporal filters for auditory systems analysis.	[Bigelow, James; Malone, Brian J.] Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; [Bigelow, James; Malone, Brian J.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Malone, Brian J.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bigelow, J (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.; Bigelow, J (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	James.Bigelow@ucsf.edu		Bigelow, James/0000-0002-1658-6021	National Institute on Deafness and Other Communication Disorders [DC011843]; Hearing Research, Inc. (San Francisco); Coleman Memorial Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011843] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hearing Research, Inc. (San Francisco); Coleman Memorial Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by National Institute on Deafness and Other Communication Disorders Grant DC011843, Hearing Research, Inc. (San Francisco), and the Coleman Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Atencio CA, 2016, NEUROSCIENCE, V316, P402, DOI 10.1016/j.neuroscience.2015.12.057; Atencio CA., 2013, STIMULUS CHOICES SPI; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; Atencio CA, 2016, NEUROSCIENCE, V335, P30, DOI 10.1016/j.neuroscience.2016.08.024; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Atencio CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031537; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Atencio CA, 2010, J NEUROPHYSIOL, V103, P192, DOI 10.1152/jn.00624.2009; Bartlett EL, 2011, J NEUROPHYSIOL, V106, P849, DOI 10.1152/jn.00559.2010; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Bialek W, 2005, QBIO0505003 ARXIV; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Chen C, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00062; Cheung SW, 2001, J NEUROPHYSIOL, V85, P1732, DOI 10.1152/jn.2001.85.4.1732; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; David SV, 2013, J NEUROSCI, V33, P19154, DOI 10.1523/JNEUROSCI.2270-13.2013; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; DiCarlo JJ, 1998, J NEUROSCI, V18, P2626; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; Eggermont JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020046; Escabi MA, 2003, J NEUROSCI, V23, P11489; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Escabi MA, 2014, J NEUROPHYSIOL, V112, P1566, DOI 10.1152/jn.00179.2013; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Garcia-Lazaro JA, 2013, J NEUROSCI, V33, P19362, DOI 10.1523/JNEUROSCI.3711-13.2013; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Godey B, 2005, J NEUROPHYSIOL, V94, P1299, DOI 10.1152/jn.00950.2004; Gollisch T, 2006, NETWORK-COMP NEURAL, V17, P103, DOI 10.1080/09548980600569670; Heller R, 2006, NEUROIMAGE, V33, P599, DOI 10.1016/j.neuroimage.2006.04.233; Honey C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134078; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; Hullett PW, 2016, J NEUROSCI, V36, P2014, DOI 10.1523/JNEUROSCI.1779-15.2016; Ing A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098697; Joris PX, 2011, P NATL ACAD SCI USA, V108, P17516, DOI 10.1073/pnas.1105867108; Kayser C, 2010, P NATL ACAD SCI USA, V107, P16976, DOI 10.1073/pnas.1012656107; Kim G, 2011, J NEUROSCI, V31, P16977, DOI 10.1523/JNEUROSCI.2003-11.2011; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Machens CK, 2003, ADV NEURAL INFORM PR, P149; Malone BJ, 2008, J NEUROPHYSIOL, V100, P239, DOI 10.1152/jn.90273.2008; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Malone BJ, 2007, J NEUROPHYSIOL, V97, P407, DOI 10.1152/jn.00830.2006; Malone BJ, 2015, J NEUROSCI, V35, P5904, DOI 10.1523/JNEUROSCI.4833-14.2015; Malone BJ, 2014, J NEUROPHYSIOL, V111, P2244, DOI 10.1152/jn.00878.2013; Malone BJ, 2013, J NEUROSCI, V33, P9431, DOI 10.1523/JNEUROSCI.3073-12.2013; Malone BJ, 2010, J NEUROSCI, V30, P767, DOI 10.1523/JNEUROSCI.4170-09.2010; Massoudi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116118; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Mesgarani N, 2009, J NEUROPHYSIOL, V102, P3329, DOI 10.1152/jn.91128.2008; Montejo N, 2015, J NEUROPHYSIOL, V113, P2998, DOI 10.1152/jn.00785.2014; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Natan RG, 2017, CEREB CORTEX, V27, P2385, DOI 10.1093/cercor/bhw083; Oby ER, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036009; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Ringach D, 2004, COGNITIVE SCI, V28, P147, DOI 10.1016/j.cogsci.2003.11.003; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Rodriguez FA, 2010, J NEUROPHYSIOL, V103, P887, DOI 10.1152/jn.00813.2009; Sahani M, 2003, ADV NEURAL INFORM PR, P125; Sahani M, 2002, ADV NEURAL INFORM PR, V15, P317; SAKAI HM, 1992, PHYSIOL REV, V72, P491, DOI 10.1152/physrev.1992.72.2.491; Schneider DM, 2011, J NEUROSCI, V31, P11867, DOI 10.1523/JNEUROSCI.5790-10.2011; Schumacher JW, 2011, J NEUROPHYSIOL, V106, P500, DOI 10.1152/jn.01072.2010; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Sharpee TO, 2008, J NEUROPHYSIOL, V99, P2496, DOI 10.1152/jn.01397.2007; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Sripati AP, 2006, J NEUROSCI, V26, P2101, DOI 10.1523/JNEUROSCI.3720-05.2006; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P187, DOI 10.1196/annals.1298.020; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Thorson IL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004628; Todorova S, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056005; Valentine PA, 2004, HEARING RES, V196, P119, DOI 10.1016/j.heares.2004.05.011; Versnel H, 2009, J NEUROSCI, V29, P9725, DOI 10.1523/JNEUROSCI.5459-08.2009; Vintch B, 2015, J NEUROSCI, V35, P14829, DOI 10.1523/JNEUROSCI.2815-13.2015; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211	87	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183914	10.1371/journal.pone.0183914	http://dx.doi.org/10.1371/journal.pone.0183914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877194	gold, Green Submitted, Green Published			2022-12-26	WOS:000409391200050
J	Hashiguchi, H; Sheng, ZY; Routh, V; Gerzanich, V; Simard, JM; Bryan, J				Hashiguchi, Hiroshi; Sheng, Zhenyu; Routh, Vanessa; Gerzanich, Volodymyr; Simard, J. Marc; Bryan, Joseph			Direct versus indirect actions of ghrelin on hypothalamic NPY neurons	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; NONSELECTIVE CATION CHANNEL; ACTIVATED PROTEIN-KINASE; NEUROPEPTIDE-Y NEURONS; RAT ARCUATE NUCLEUS; RECEPTOR POTENTIAL CHANNELS; UNION-OF-PHARMACOLOGY; K-ATP CHANNELS; CALCIUM-CHANNELS; EXPRESSING NEURONS	Objectives Assess direct versus indirect action(s) of ghrelin on hypothalamic NPY neurons. Materials and methods Electrophysiology was used to measure ion channel activity in NPY-GFP neurons in slice preparations. Ca2+ imaging was used to monitor ghrelin activation of isolated NPY GFP-labeled neurons. Immunohistochemistry was used to localize Trpm4, SUR1 and Kir6.2 in the hypothalamus. Results Acylated ghrelin depolarized the membrane potential (MP) of NPY-GFP neurons in brain slices. Depolarization resulted from a decreased input resistance (IR) in similar to 70% of neurons (15/22) or an increased IR in the remainder (7/22), consistent with the opening or closing of ion channels, respectively. Although tetrodotoxin (TTX) blockade of presynaptic action potentials reduced ghrelin-induced changes in MP and IR, ghrelin still significantly depolarized the MP and decreased IR in TTX-treated neurons, suggesting that ghrelin directly opens cation channel(s) in NPY neurons. In isolated NPY-GFP neurons, ghrelin produced a sustained rise of [Ca2+](c), with an EC50 similar to 110 pM. Pharmacologic studies confirmed that the direct action of ghrelin was through occupation of the growth hormone secretagogue receptor, GHS-R, and demonstrated the importance of the adenylate cyclase/cAMP/protein kinase A (PKA) and phospholipase C/inositol triphosphate (PLC/IP3) pathways as activators of 5' AMP-activated protein kinase (AMPK). Activation of isolated neurons was not affected by CNQX or TTX, but reducing [Na+](o) suppressed activation, suggesting a role for Na+-permeable cation channels. SUR1 and two channel partners, Kir6.2 and Trpm4, were identified immunologically in NPY-GFP neurons in situ. The actions of SUR1 and Trpm4 modulators were informative: like ghrelin, diazoxide, a SUR1 agonist, elevated [Ca2+](c) and glibenclamide, a SUR1 antagonist, partially suppressed ghrelin action, while 9-phenanthrol and flufenamic acid, selective Trpm4 antagonists, blocked ghrelin actions on isolated neurons. Ghrelin activation was unaffected by nifedipine and.-conotoxin, inhibitors of L-and N-type Ca2+ channels, respectively, while Ni2+, mibefradil, and TTA-P2 completely or partially inhibited ghrelin action, implicating T-type Ca2+ channels. Activation was also sensitive to a spider toxin, SNX-482, at concentrations selective for R-type Ca2+ channels. Nanomolar concentrations of GABA markedly inhibited ghrelin-activation of isolated NPY-GFP neurons, consistent with chronic suppression of ghrelin action in vivo. Conclusions NPY neurons express all the molecular machinery needed to respond directly to ghrelin. Consistent with recent studies, ghrelin stimulates presynaptic inputs that activate NPY-GFP neurons in situ. Ghrelin can also directly activate a depolarizing conductance. Results with isolated NPY-GFP neurons suggest the ghrelin-activated, depolarizing current is a Na+ conductance with the pharmacologic properties of SUR1/Trpm4 non-selective cation channels. In the isolated neuron model, the opening of SUR1/Trpm4 channels activates T-and SNX482-sensitive R-type voltage dependent Ca2+ channels, which could contribute to NPY neuronal activity in situ.	[Hashiguchi, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Endocrinol & Diabet, Kagoshima, Kagoshima, Japan; [Sheng, Zhenyu; Routh, Vanessa] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA; [Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Bryan, Joseph] Pacific Northwest Diabet Res Inst, Seattle, WA USA	Kagoshima University; Rutgers State University Newark; Rutgers State University New Brunswick; University System of Maryland; University of Maryland Baltimore; Pacific Northwest Diabetes Research Institute (PNDRI)	Hashiguchi, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Endocrinol & Diabet, Kagoshima, Kagoshima, Japan.	taisukeh@m3.kufm.kagoshima-u.ac.jp			NIH(National Institutes of Health) [DK084242, CA139063, NS060801]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647] Funding Source: NIH RePORTER	NIH(National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding source: NIH(National Institutes of Health: https://www.nih.gov/) grants DK084242 (JB), CA139063 (VR) and NS060801 (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarouch MY, 2013, NEUROSCI LETT, V541, P105, DOI 10.1016/j.neulet.2013.02.011; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Caffes N, 2015, INT J MOL SCI, V16, P4973, DOI 10.3390/ijms16034973; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Grabauskas G, 2015, J PHYSIOL-LONDON, V593, P3973, DOI 10.1113/JP270788; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Guinamard R, 2014, BRIT J PHARMACOL, V171, P1600, DOI 10.1111/bph.12582; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Hao LH, 2016, BRAIN RES, V1648, P181, DOI 10.1016/j.brainres.2016.07.035; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Harrold JA, 2008, BRAIN RES, V1196, P59, DOI 10.1016/j.brainres.2007.12.055; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; Jordan PM, 2008, J NEUROSCI RES, V86, P35, DOI 10.1002/jnr.21460; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Khanna A, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.10.FOCUS13404; Kimm T, 2014, J NEUROSCI, V34, P9182, DOI 10.1523/JNEUROSCI.0339-14.2014; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Kohno D, 2011, NEUROSCI LETT, V499, P194, DOI 10.1016/j.neulet.2011.05.060; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kuperman Y, 2016, CELL METAB, V23, P1185, DOI 10.1016/j.cmet.2016.04.017; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li Y, 2017, J CEREBR BLOOD F MET, V37, P140, DOI 10.1177/0271678X15621069; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mondal MS, 2005, REGUL PEPTIDES, V126, P55, DOI 10.1016/j.regpep.2004.08.038; Morton GJ, 2001, INT J OBESITY, V25, pS56, DOI 10.1038/sj.ijo.0801915; Mountjoy PD, 2007, DIABETOLOGIA, V50, P168, DOI 10.1007/s00125-006-0473-3; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Muroya S, 2005, NEUROREPORT, V16, P897, DOI 10.1097/00001756-200506210-00005; Muroya S, 1999, NEUROSCI LETT, V264, P113, DOI 10.1016/S0304-3940(99)00185-8; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, ENDOTHELIUM-J ENDOTH, V10, P5, DOI 10.1080/10623320303356; Pomes A, 1996, BIOCHEM BIOPH RES CO, V225, P939, DOI 10.1006/bbrc.1996.1275; Qin F., 2007, V179, P509; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; STANLEY BG, 1986, PEPTIDES, V7, P1189; Syam N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00052; Teruyama R, 2011, J NEUROENDOCRINOL, V23, P1204, DOI 10.1111/j.1365-2826.2011.02211.x; Thaler JP, 2013, DIABETES, V62, P2629, DOI 10.2337/db12-1605; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Van den Top M, 2007, NEUROSCIENCE, V144, P815, DOI 10.1016/j.neuroscience.2006.09.059; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Wang W, 2006, INT J ONCOL, V28, P1393; WHITE J D, 1990, Molecular and Cellular Neuroscience, V1, P41; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang XB, 2016, NAT NEUROSCI, V19, P1341, DOI 10.1038/nn.4372; Zhu ZH, 2006, BRAIN RES, V1114, P1, DOI 10.1016/j.brainres.2006.07.070; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	98	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184261	10.1371/journal.pone.0184261	http://dx.doi.org/10.1371/journal.pone.0184261			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877214	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200080
J	Lanini, J; Duburcq, A; Razavi, H; Le Goff, CG; Ijspeert, AJ				Lanini, Jessica; Duburcq, Alexis; Razavi, Hamed; Le Goff, Camille G.; Ijspeert, Auke Jan			Interactive locomotion: Investigation and modeling of physically-paired humans while walking	PLOS ONE			English	Article							SIDE-BY-SIDE; GAIT	In spite of extensive studies on human walking, less research has been conducted on human walking gait adaptation during interaction with another human. In this paper, we study a particular case of interactive locomotion where two humans carry a rigid object together. Experimental data from two persons walking together, one in front of the other, while carrying a stretcher-like object is presented, and the adaptation of their walking gaits and coordination of the foot-fall patterns are analyzed. It is observed that in more than 70% of the experiments the subjects synchronize their walking gaits; it is shown that these walking gaits can be associated to quadrupedal gaits. Moreover, in order to understand the extent by which the passive dynamics can explain this synchronization behaviour, a simple 2D model, made of two-coupled spring-loaded inverted pendulums, is developed, and a comparison between the experiments and simulations with this model is presented, showing that with this simple model we are able to reproduce some aspects of human walking behaviour when paired with another human.	[Lanini, Jessica; Duburcq, Alexis; Razavi, Hamed; Le Goff, Camille G.; Ijspeert, Auke Jan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lanini, J (corresponding author), Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	jessica.lanini@epfl.ch		Ijspeert, Auke/0000-0003-1417-9980	European Commission project CoglMon [H2020-ICT-2014-1]; European Commission project WALKMAN [FP7-ICT-2013- 10]	European Commission project CoglMon; European Commission project WALKMAN	The authors Jessica Lanini and Auke fispeert received funding from European Commission project CoglMon, H2020-ICT-2014-1 for this work. Author Hamed Razavi received funding from European Commission project WALKMAN, FP7-ICT-2013- 10. Author Alexis Duburcq received no specific funding for this work.	Artemiadis P. K., 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P3103, DOI 10.1109/IROS.2010.5652025; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Dijksterhuis G. B., 2004, PROCRUSTES PROBLEMS, V30; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; HILDEBRA.M, 1965, SCIENCE, V150, P701, DOI 10.1126/science.150.3697.701; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28; Zivotofsky AZ, 2012, HUM MOVEMENT SCI, V31, P1268, DOI 10.1016/j.humov.2012.01.003	14	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0179989	10.1371/journal.pone.0179989	http://dx.doi.org/10.1371/journal.pone.0179989			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877161	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200003
J	Hsu, SC; Chang, SS; Lee, MTG; Lee, SH; Tsai, YW; Lin, SC; Chen, ST; Weng, YC; Porta, L; Wu, JY; Lee, CC				Hsu, Shou-Chien; Chang, Shy-Shin; Lee, Meng-tse Gabriel; Lee, Si-Huei; Tsai, Yi-Wen; Lin, Shen-Che; Chen, Szu-Ta; Weng, Yi-Chieh; Porta, Lorenzo; Wu, Jiunn-Yih; Lee, Chien-Chang			Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; PEPTIC-ULCER; MATRIX-METALLOPROTEINASE; CORNEAL PERFORATION; CIPROFLOXACIN; EXPRESSION; CELLS; LEVOFLOXACIN; TENDINOPATHY; GATIFLOXACIN	Background Fluoroquinolone is a commonly prescribed antimicrobial agent, and up to 20% of its users registers adverse gastroenterological symptoms. We aimed to evaluate the association between use of fluoroquinolone and gastrointestinal tract perforation. Methods We conducted a nested case-control study on a national health insurance claims database between 1998 and 2011. The use of fluoroquinolones was classified into current (< 60 days), past (61-365 days prior to the index date) and any prior year use of fluoroquinolones. We used the conditional logistic regression model to estimate rate ratios (RRs), adjusting or matching by a disease risk score (DRS). Results We identified a cohort of 17,510 individuals diagnosed with gastrointestinal perforation and matched them to 1,751,000 controls. Current use of fluoroquinolone was associated with the greatest increase in risk of gastrointestinal perforations after DRS score adjustment (RR, 1.90; 95% CI, 1.62-2.22). The risk of gastrointestinal perforation was attenuated for past (RR, 1.33; 95% CI, 1.20-1.47) and any prior year use (RR, 1.46; 95% CI, 1.34-1.59). To gain insights into whether the observed association can be explained by unmeasured confounder, we compared the risk of gastrointestinal perforation between fluoroquinolone and macrolide. Use of macrolide, an active comparator, was not associated with a significant increased risk of gastrointestinal perforation (RR, 1.11, 95% CI, 0.15-7.99). Sensitivity analysis focusing on perforation requiring in-hospital procedures also demonstrated an increased risk associated with current use. To mitigate selection bias, we have also excluded people who have never used fluoroquinolone before or people with infectious colitis, enteritis or gastroenteritis. In both of the analysis, a higher risk of gastrointestinal perforation was still associated with the use of fluoroquinolone. Conclusions We found that use of fluoroquinolones was associated with a non-negligible increased risk of gastrointestinal perforation, and physicians should be aware of this possible association.	[Hsu, Shou-Chien; Lin, Shen-Che; Wu, Jiunn-Yih] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan; [Hsu, Shou-Chien; Tsai, Yi-Wen; Lin, Shen-Che; Wu, Jiunn-Yih] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Shy-Shin] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Chang, Shy-Shin] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lee, Meng-tse Gabriel; Weng, Yi-Chieh; Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lee, Si-Huei] Taipei Vet Gen Hosp, Dept Rehabil & Phys Med, Taipei, Taiwan; [Lee, Si-Huei] Natl Yang Ming Univ, Dept Med, Coll Med, Taipei, Taiwan; [Tsai, Yi-Wen] Chang Gung Mem Hosp, Dept Family Med, Keelung, Taiwan; [Lin, Shen-Che] Natl Taiwan Univ Hosp, Dept Pediat, Yun Lin Branch, Touliu, Taiwan; [Chen, Szu-Ta] Natl Taiwan Univ, Dept Pediat, Taipei, Taiwan; [Chen, Szu-Ta] Coll Med, Taipei, Taiwan; [Chen, Szu-Ta] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan; [Porta, Lorenzo] Univ Milan, Dipartimento Sci Biomed & Clin, Osped L Sacco, Milan, Italy	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; University of Milan; Luigi Sacco Hospital	Wu, JY (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.; Wu, JY (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Lee, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	asepsis.wu@msa.hinet.net; cclee100@gmail.com	Lee, Chien-Chang/HHM-5986-2022	LEE, CHIEN-CHANG/0000-0002-1243-2463; Chen, Szu-Ta/0000-0002-9715-1221	Taiwan National Ministry of Science and Technology [MOST 104-2314-B-002 -039 -MY3, MOST 105-2811-B-002-031]	Taiwan National Ministry of Science and Technology	This work is supported by research grant from Taiwan National Ministry of Science and Technology Grants MOST 104-2314-B-002 -039 -MY3, and MOST 105-2811-B-002-031.	Al-Amri AM, 2008, CORNEA, V27, P370, DOI 10.1097/ICO.0b013e31815dcfc4; Alshammari TM, 2014, AM J HEALTH-SYST PH, V71, P37, DOI 10.2146/ajhp130165; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Arihiro S, 2001, HISTOPATHOLOGY, V39, P50, DOI 10.1046/j.1365-2559.2001.01142.x; Badal S, 2015, J BIOL CHEM, V290, P22287, DOI 10.1074/jbc.M115.671222; BURKHARDT JE, 1992, TOXICOL PATHOL, V20, P246, DOI 10.1177/019262339202000211; Chou HW, 2015, CLIN INFECT DIS, V60, P566, DOI 10.1093/cid/ciu914; Chou HW, 2013, CLIN INFECT DIS, V57, P971, DOI 10.1093/cid/cit439; Corps AN, 2002, ARTHRITIS RHEUM, V46, P3034, DOI 10.1002/art.10617; Corrao G, 2006, DRUG SAFETY, V29, P889, DOI 10.2165/00002018-200629100-00006; GABELLA G, 1987, CELL TISSUE RES, V248, P491, DOI 10.1007/BF00216474; GABELLA G, 1981, ANAT EMBRYOL, V163, P135, DOI 10.1007/BF00320672; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gangopadhyay N, 2000, BRIT J OPHTHALMOL, V84, P378, DOI 10.1136/bjo.84.4.378; Germain DP, 2002, ANN VASC SURG, V16, P391, DOI 10.1007/s10016-001-0229-y; Halkin H, 1988, Rev Infect Dis, V10 Suppl 1, pS258; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Kuo SC, 2014, CLIN INFECT DIS, V58, P197, DOI 10.1093/cid/cit708; Lanas A, 1997, GASTROENTEROLOGY, V112, P683, DOI 10.1053/gast.1997.v112.pm9041228; Lee CC, 2015, JAMA INTERN MED, V175, P1839, DOI 10.1001/jamainternmed.2015.5389; Lee MT, 2015, BRIT J DERMATOLOGY; Lefebvre G, 2006, PHARMACOEPIDEM DR S, V15, P304, DOI 10.1002/pds.1201; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; Mallari PLT, 2001, AM J OPHTHALMOL, V131, P131, DOI 10.1016/S0002-9394(00)00642-5; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Mizuki Y, 1996, J ANTIMICROB CHEMOTH, V37, P41, DOI 10.1093/jac/37.suppl_A.41; Mohr JF, 2005, PHARMACOTHERAPY, V25, P1303, DOI 10.1592/phco.2005.25.10.1303; Narum S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004587; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Otani Y, 1997, J CLIN GASTROENTEROL, V25, pS101, DOI 10.1097/00004836-199700001-00017; Owens RC, 2005, CLIN INFECT DIS, V41, pS144, DOI 10.1086/428055; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Pender SL, 2004, CURR OPIN PHARMACOL, V4, P546, DOI 10.1016/j.coph.2004.06.005; Reviglio Victor E, 2003, BMC Ophthalmol, V3, P10, DOI 10.1186/1471-2415-3-10; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Sendzik J, 2010, INT J ANTIMICROB AG, V35, P366, DOI 10.1016/j.ijantimicag.2009.10.009; Shakibaei M, 2000, ANTIMICROB AGENTS CH, V44, P261, DOI 10.1128/AAC.44.2.261-266.2000; Sharma C, 2011, TOXICOL MECH METHOD, V21, P6, DOI 10.3109/15376516.2010.529183; Soreide K, 2014, BRIT J SURG, V101, pE51, DOI 10.1002/bjs.9368; Soreide K, 2015, LANCET, V386, P1288, DOI 10.1016/S0140-6736(15)00276-7; Stephenson AL, 2013, DRUG SAFETY, V36, P709, DOI 10.1007/s40264-013-0089-8; Sutter R, 2015, NEUROLOGY, V85, P1332, DOI 10.1212/WNL.0000000000002023; Svanes C, 2000, WORLD J SURG, V24, P277, DOI 10.1007/s002689910045; SYKES EM, 1984, AM J SURG, V147, P410, DOI 10.1016/0002-9610(84)90179-X; Thorsen K, 2013, WORLD J GASTROENTERO, V19, P347, DOI 10.3748/wjg.v19.i3.347; Tsai WC, 2011, J ORTHOP RES, V29, P67, DOI 10.1002/jor.21196; Turel I, 2002, COORDIN CHEM REV, V232, P27, DOI 10.1016/S0010-8545(02)00027-9; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	52	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183813	10.1371/journal.pone.0183813	http://dx.doi.org/10.1371/journal.pone.0183813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873440	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800029
J	Ortega, A; Garrido, I; Casimiro, I; Espinosa, F				Ortega, Alfonso; Garrido, Inmaculada; Casimiro, Ilda; Espinosa, Francisco			Effects of antimony on redox activities and antioxidant defence systems in sunflower (Helianthus annuus L.) plants	PLOS ONE			English	Article							OXIDATIVE STRESS; REACTIVE OXYGEN; HEAVY-METAL; SUPEROXIDE-DISMUTASE; DITTRICHIA-VISCOSA; NITROSATIVE STRESS; MINING AREA; IN-VITRO; TOLERANCE; ASCORBATE	The alterations induced by the toxicity of antimony (Sb) in the roots and leaves of sunflower plants were determined. The plants were grown hydroponically with different concentrations of Sb, a heavy metal which reduces biomass production and growth. There was preferential accumulation of Sb in the tissues of the roots, with the concentrations in the leaves being much lower. The accumulation of other mineral elements was also altered, especially that of Fe and Zn. Chlorophyll content declined, as also did the photosynthetic efficiency, but the carotenoid content remained unaltered. The total content of phenolics, flavonoids, and phenylpropanoid glycosides rose, evidence of their participation in the defence response. Increases were observed in the amount of superoxide anion in both roots and leaves, and in lipid peroxidation levels, especially with the highest Sb concentration of 1.0 mM. The induced oxidative stress leads to a strong increase in the SOD, POX and APX antioxidant activities, while the GR activity was only increased in the leaves and at the 1.0 mM Sb concentration. In contrast, the DHAR activity increased considerably in both organs. The GSNOR activity increased only in roots, and the total RSNOs increased. The total amount of AsA + DHA increased in roots and remained unaltered in leaves, whereas that of GSH + GSSG decreased considerably in all cases. As a whole, these results are evidence for the development of a strong oxidative stress induced by Sb, with there being a clear imbalance in the content of the compounds that constitute the AsA/GSH cycle. 0.5 mM Sb enhances GST expression, especially in leaves. This, together with the increase that was observed in the amount of GSH, may play an important part in detoxification. This oxidative stress affects both the phenolic and the ROS/RNS metabolic processes, which seems to implicate their involvement in the plant's defence and response to the stress.	[Ortega, Alfonso; Garrido, Inmaculada; Casimiro, Ilda; Espinosa, Francisco] Univ Extremadura, FBCMP Res Grp, Campus Ave Elvas, Badajoz, Spain	Universidad de Extremadura	Espinosa, F (corresponding author), Univ Extremadura, FBCMP Res Grp, Campus Ave Elvas, Badajoz, Spain.	espinosa@unex.es	Espinosa, Francisco/I-8205-2018; Casimiro, Ilda/R-3506-2019	Espinosa, Francisco/0000-0002-6467-0359; 	Junta de Extremadura/FEDER [GR15138, 1616078]	Junta de Extremadura/FEDER	This study was made possible thanks to the Junta de Extremadura/FEDER for the support given to the Research Group FBCMP (GR15138 and 1616078). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum NA, 2014, PROTOPLASMA, V251, P1265, DOI 10.1007/s00709-014-0636-x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525; Arora A, 1998, FREE RADICAL BIO MED, V24, P1355, DOI 10.1016/S0891-5849(97)00458-9; Baroni F, 2000, ENVIRON POLLUT, V109, P347, DOI 10.1016/S0269-7491(99)00240-7; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Benhamdi A, 2014, BIOL TRACE ELEM RES, V158, P96, DOI 10.1007/s12011-014-9917-7; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Borovicka J, 2006, CHEMOSPHERE, V64, P1837, DOI 10.1016/j.chemosphere.2006.01.060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chai LY, 2016, ENVIRON SCI POLLUT R, V23, P7470, DOI 10.1007/s11356-015-5987-0; Chaki M, 2009, PLANT CELL PHYSIOL, V50, P265, DOI 10.1093/pcp/pcn196; Choi YI, 2013, PLANT BIOTECHNOL REP, V7, P175, DOI 10.1007/s11816-012-0246-z; Cidu R, 2014, SCI TOTAL ENVIRON, V497, P319, DOI 10.1016/j.scitotenv.2014.07.117; Clemente R, 2013, HEAVY METALS SOILS T, P494; Corpas FJ, 2008, METHOD ENZYMOL, V437, P561, DOI 10.1016/S0076-6879(07)37028-6; Corpas FJ, 2013, NEW PHYTOL, V199, P633, DOI 10.1111/nph.12380; Corrales I, 2014, J GEOCHEM EXPLOR, V147, P167, DOI 10.1016/j.gexplo.2014.07.002; Cos P, 2002, FREE RADICAL RES, V36, P711, DOI 10.1080/10715760290029182; Council of the European Communities, 1976, OFFICIAL J L, V129; Damian F, 2008, CARPATH J EARTH ENV, V3, P85; De Gara L, 2003, J EXP BOT, V54, P249, DOI [10.1093/jxb/54.381.249, 10.1093/jxb/erg021]; De Gregori I, 2003, J ENVIRON MONITOR, V5, P287, DOI 10.1039/b211469k; de Pinto MC, 1999, PROTOPLASMA, V209, P90, DOI 10.1007/BF01415704; del Rio LA, 2015, J EXP BOT, V66, P2827, DOI 10.1093/jxb/erv099; Dixon DP, 2010, ARABIDOPSIS BOOK, V8, pe0131; Dubey R. S., 2010, REACTIVE OXYGEN SPEC, V15, P177; Espinosa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100132; Ezaki B, 2001, PLANT PHYSIOL, V127, P918, DOI 10.1104/pp.010399; Feigl G, 2015, ANN BOT-LONDON, V116, P613, DOI 10.1093/aob/mcu246; Feng RW, 2013, ENVIRON EXP BOT, V96, P28, DOI 10.1016/j.envexpbot.2013.08.006; Feng RW, 2011, MICROCHEM J, V97, P38, DOI 10.1016/j.microc.2010.05.010; Feng RW, 2009, PLANT SOIL, V317, P93, DOI 10.1007/s11104-008-9790-2; Folwer BA, 1991, METALS THEIR COMPOUN, P743; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Garrido I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046137; GRILL E, 1987, P NATL ACAD SCI USA, V84, P439, DOI 10.1073/pnas.84.2.439; Halliwell B., 2015, FREE RADICALS BIOL M; Hossain MA, 2012, J BOT, V2012; Jana U, 2012, J ENVIRON MANAGE, V110, P188, DOI 10.1016/j.jenvman.2012.06.007; Johnson CA, 2005, J ENVIRON QUAL, V34, P248, DOI 10.2134/jeq2005.0248; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Kapoor D, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00013; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lehotai N, 2012, J EXP BOT, V63, P5677, DOI 10.1093/jxb/ers222; Levresse G, 2012, SCI TOTAL ENVIRON, V427, P115, DOI 10.1016/j.scitotenv.2012.04.020; Lounifi I, 2013, PROTEOMICS, V13, P568, DOI 10.1002/pmic.201200304; Michalak A, 2006, POL J ENVIRON STUD, V15, P523; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Murciego AM, 2007, ENVIRON POLLUT, V145, P15, DOI 10.1016/j.envpol.2006.04.004; NGO TT, 1980, ANAL BIOCHEM, V105, P389, DOI 10.1016/0003-2697(80)90475-3; Pan XL, 2011, WATER AIR SOIL POLL, V215, P517, DOI 10.1007/s11270-010-0496-8; Perez-Sirvent C, 2012, J GEOCHEM EXPLOR, V123, P128, DOI 10.1016/j.gexplo.2012.08.002; Qi CC, 2011, MICROCHEM J, V97, P44, DOI 10.1016/j.microc.2010.05.016; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Ren JH, 2014, SCI TOTAL ENVIRON, V475, P83, DOI 10.1016/j.scitotenv.2013.12.103; Sakamoto A, 2002, FEBS LETT, V515, P20, DOI 10.1016/S0014-5793(02)02414-6; Sandalio LM, 2009, SIGNAL COMMUN PLANTS, P175, DOI 10.1007/978-3-642-00390-5_11; Sgherri C, 2003, PHYSIOL PLANTARUM, V118, P21, DOI 10.1034/j.1399-3054.2003.00068.x; Sharma P, 2012, J BO, V2012; Shtangeeva I, 2011, J GEOCHEM EXPLOR, V110, P40, DOI 10.1016/j.gexplo.2010.07.003; Singh VP, 2015, PROTOPLASMA, V252, P1217, DOI 10.1007/s00709-014-0753-6; SINGLETON VL, 1985, AM J ENOL VITICULT, V36, P50; Srivastava RK, 2014, PROTOPLASMA, V251, P1047, DOI 10.1007/s00709-014-0614-3; Sytar O, 2013, ACTA PHYSIOL PLANT, V35, P985, DOI 10.1007/s11738-012-1169-6; Takahama U, 1997, PHYSIOL PLANTARUM, V101, P845; Telford K, 2009, ENVIRON CHEM, V6, P133, DOI 10.1071/EN08097; THIPYAPONG P, 1995, PHYTOCHEMISTRY, V40, P673, DOI 10.1016/0031-9422(95)00359-F; Tisarum R, 2014, ENVIRON POLLUT, V186, P110, DOI 10.1016/j.envpol.2013.11.033; Tschan M, 2009, ENVIRON CHEM, V6, P106, DOI 10.1071/EN08111; Vaculik M, 2015, ENVIRON SCI POLLUT R, V22, P18699, DOI 10.1007/s11356-015-5069-3; Vaculik M, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1546-9; Vaculikova M, 2014, PLANT PHYSIOL BIOCH, V83, P279, DOI 10.1016/j.plaphy.2014.08.014; Valderrama R, 2007, FEBS LETT, V581, P453, DOI 10.1016/j.febslet.2007.01.006; Volkova LA, 2014, RUSS J PLANT PHYSL+, V61, P255, DOI 10.1134/S1021443714010166; Waskiewicz A, 2014, OXIDATIVE DAMAGE TO PLANTS: ANTIOXIDANT NETWORKS AND SIGNALING, P149, DOI 10.1016/B978-0-12-799963-0.00005-8; Wellburn A.R., 1994, PLANT PHYSIOL, V144, P3, DOI DOI 10.1016/S0176-1617(11)81192-2; World Health Organization, 2003, AL DRINK WAT BACKGR; Xue L, 2015, ENVIRON POLLUT, V201, P150, DOI 10.1016/j.envpol.2015.03.004; YOUNG AJ, 1991, PHYSIOL PLANTARUM, V83, P702; Zayneb C, 2015, ENVIRON SCI POLLUT R, V22, P10679, DOI 10.1007/s11356-015-4270-8; Zhang DY, 2010, J APPL PHYCOL, V22, P479, DOI 10.1007/s10811-009-9482-1	90	27	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183991	10.1371/journal.pone.0183991	http://dx.doi.org/10.1371/journal.pone.0183991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873463	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800040
J	Paxton, AB; Pickering, EA; Adler, AM; Taylor, JC; Peterson, CH				Paxton, Avery B.; Pickering, Emily A.; Adler, Alyssa M.; Taylor, J. Christopher; Peterson, Charles H.			Flat and complex temperate reefs provide similar support for fish: Evidence for a unimodal species-habitat relationship	PLOS ONE			English	Article							BENTHIC COMMUNITY STRUCTURE; NORTH-CAROLINA; STRUCTURAL COMPLEXITY; CONTINENTAL-SHELF; DIVERSITY RELATIONSHIP; SPATIAL HETEROGENEITY; ECOSYSTEM SERVICES; SOUTHEAST FLORIDA; TROPHIC STRUCTURE; VISUAL CENSUS	Structural complexity, a form of habitat heterogeneity, influences the structure and function of ecological communities, generally supporting increased species density, richness, and diversity. Recent research, however, suggests the most complex habitats may not harbor the highest density of individuals and number of species, especially in areas with elevated human influence. Understanding nuances in relationships between habitat heterogeneity and ecological communities is warranted to guide habitat-focused conservation and management efforts. We conducted fish and structural habitat surveys of thirty warm-temperate reefs on the southeastern US continental shelf to quantify how structural complexity influences fish communities. We found that intermediate complexity maximizes fish abundance on natural and artificial reefs, as well as species richness on natural reefs, challenging the current paradigm that abundance and other fish community metrics increase with increasing complexity. Naturally occurring rocky reefs of flat and complex morphologies supported equivalent abundance, biomass, species richness, and community composition of fishes. For flat and complex morphologies of rocky reefs to receive equal consideration as essential fish habitat (EFH), special attention should be given to detecting pavement type rocky reefs because their ephemeral nature makes them difficult to detect with typical seafloor mapping methods. Artificial reefs of intermediate complexity also maximized fish abundance, but human-made structures composed of low-lying concrete and metal ships differed in community types, with less complex, concrete structures supporting lower numbers of fishes classified largely as demersal species and metal ships protruding into the water column harboring higher numbers of fishes, including more pelagic species. Results of this study are essential to the process of evaluating habitat function provided by different types and shapes of reefs on the seafloor so that all EFH across a wide range of habitat complexity may be accurately identified and properly managed.	[Paxton, Avery B.; Pickering, Emily A.; Adler, Alyssa M.; Peterson, Charles H.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA; [Paxton, Avery B.; Peterson, Charles H.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27599 USA; [Taylor, J. Christopher] Natl Ocean & Atmospher Adm, Natl Ctr Coastal Ocean Sci, Natl Ocean Serv, Beaufort, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Paxton, AB (corresponding author), Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA.; Paxton, AB (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27599 USA.	abpaxton@live.unc.edu		Paxton, Avery B./0000-0002-4871-9167; Adler, Alyssa/0000-0002-2657-8156	BOEM [M13AC00006]; NC Coastal Recreational Fishing License Grant [5115]; NSF Graduate Research Fellowship [DGE-1144081]; P.E.O. Foundation	BOEM; NC Coastal Recreational Fishing License Grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); P.E.O. Foundation	Funding was provided by BOEM under cooperative agreement M13AC00006 to CHP, NC Coastal Recreational Fishing License Grant (#5115) to CHP, a NSF Graduate Research Fellowship awarded to ABP under grant no. DGE-1144081, and a P.E.O. Foundation Scholar Award to ABP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1988, N CAR ART REEF MAST; Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P29, DOI 10.3354/meps320029; Arkema KK, 2015, P NATL ACAD SCI USA, V112, P7390, DOI 10.1073/pnas.1406483112; Auguie B, 2017, GRIDEXTRA MISCELLANE; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; BOHNSACK JA, 1997, P 8 INT COR REEF S, V2, P1927; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BROCK RE, 1982, B MAR SCI, V32, P269; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Carnicer J, 2013, P NATL ACAD SCI USA, V110, pE2858, DOI 10.1073/pnas.1222681110; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; Cronk QCB, 1997, BIODIVERS CONSERV, V6, P477, DOI 10.1023/A:1018372910025; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Deaton A. S., 2010, N CAROLINA COASTAL H; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Gazol A, 2013, OECOLOGIA, V173, P545, DOI 10.1007/s00442-013-2623-x; GILINSKY E, 1984, ECOLOGY, V65, P455, DOI 10.2307/1941408; GORMAN OT, 1978, ECOLOGY, V59, P507, DOI 10.2307/1936581; GOTCEITAS V, 1989, OECOLOGIA, V80, P158, DOI 10.1007/BF00380145; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Gregg K., 1994, 38 ATL STAT MAR FISH; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Hortal J, 2013, P NATL ACAD SCI USA, V110, pE2149, DOI 10.1073/pnas.1301663110; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Isaaks E.H., 1989, ISA; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Kendall MS, 2009, B MAR SCI, V84, P265; Kendall MS, 2005, J COASTAL RES, V21, P1154, DOI 10.2112/03-0101R.1; Khanaposhtani MG, 2012, ENVIRON MANAGE, V50, P296, DOI 10.1007/s00267-012-9877-7; Kloser RJ, 2010, CONT SHELF RES, V30, P1772, DOI 10.1016/j.csr.2010.08.004; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kracker L. M., 2011, 130 NOAA NOS NCCOS; Kracker L, 2008, MAR GEOD, V31, P267, DOI 10.1080/01490410802466611; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Parker RO, 1998, T AM FISH SOC, V127, P908, DOI 10.1577/1548-8659(1998)127<0908:CIANCR>2.0.CO;2; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Prada MC, 2008, CORAL REEFS, V27, P297, DOI 10.1007/s00338-007-0328-5; Renaud PE, 1996, MAR ECOL-P S Z N I, V17, P383, DOI 10.1111/j.1439-0485.1996.tb00516.x; Renaud PE, 1999, J EXP MAR BIOL ECOL, V237, P89, DOI 10.1016/S0022-0981(98)00222-6; Renaud PE, 1997, CONT SHELF RES, V17, P37, DOI 10.1016/0278-4343(96)00019-2; Riggs SR, 1996, J SEDIMENT RES, V66, P830; Riggs SR, 1998, J SEDIMENT RES, V68, P155, DOI 10.2110/jsr.68.155; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; ROSS SW, 1995, B MAR SCI, V56, P222; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Schneider KN, 2008, HYDROBIOLOGIA, V610, P235, DOI 10.1007/s10750-008-9438-5; Seiferling I, 2014, ECOLOGY, V95, P2084, DOI 10.1890/13-1344.1; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SIMBERLOFF DS, 1970, ECOLOGY, V51, P934, DOI 10.2307/1933995; Simon T, 2013, MAR ENVIRON RES, V90, P55, DOI 10.1016/j.marenvres.2013.05.012; South Atlantic Fishery Management Council, 2016, SNAPP GROUP MAN COMP, P1; Stallings CD, 2010, ENVIRON BIOL FISH, V88, P389, DOI 10.1007/s10641-010-9655-4; STEPHAN CD, 1989, B MAR SCI, V44, P698; Stick D., 1989, GRAVEYARD ATLANTIC S; Taylor JC, 2012, ACOUST SOC AM P M AC, P1; Taylor JC, 2016, OCS STUDY BOEM; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Venables MN, 2002, MODERN APPL STAT S; Walker BK, 2008, J COASTAL RES, V24, P1138, DOI 10.2112/06-0809.1; Whitfield PE, 2014, MAR ECOL PROG SER, V509, P241, DOI 10.3354/meps10882; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	82	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183906	10.1371/journal.pone.0183906	http://dx.doi.org/10.1371/journal.pone.0183906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873447	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800034
J	Agolory, SG; Auld, AF; Odafe, S; Shiraishi, RW; Dokubo, EK; Swaminathan, M; Dalhatu, I; Onotu, D; Abiri, O; Debem, H; Bashorun, A; Ellerbrock, TV				Agolory, Simon G.; Auld, Andrew F.; Odafe, Solomon; Shiraishi, Ray W.; Dokubo, E. Kainne; Swaminathan, Mahesh; Dalhatu, Ibrahim; Onotu, Dennis; Abiri, Oseni; Debem, Henry; Bashorun, Adebobola; Ellerbrock, Tedd V.			High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MODELS; ADULTS; TRANSMISSION; MORTALITY; INFECTION; TRIAL	Background With about 3.4 million HIV- infected persons, Nigeria has the second highest number of people living with HIV (PLHIV) in the world. However, antiretroviral treatment (ART) coverage in Nigeria remains low with only 748,846 (22%) of PLHIV on ART by the end of 2014. Retention of HIV-infected patients in pre-ART care is essential to ensure timely ART initiation. We assessed outcomes of patients enrolled in Nigeria's pre-ART program during 2004-2012. Methods We conducted a nationally representative retrospective cohort study among adults (>= 15 years old), enrolling in pre-ART programs supported by the U. S. President's Emergency Plan for AIDS Relief in Nigeria. A total of 35 sites enrolling >= 50 patients in pre-ART were selected using probability proportional-to-size sampling; 2,415 eligible medical records at these sites were randomly selected for abstraction. Determinants of loss to follow-up (LTFU) and mortality during pre-ART care were estimated using Cox proportional hazards regression models. Results The median age at enrollment was 32 years (interquartile range (IQR) 27-40). A total of 1,216 (51.4%) initiated ART by the time of data abstraction. Among the remaining 1,199 patients, 898 (74.9%) had been LTFU, 180 (15.0%) were alive and in pre-ART care, 71 (5.9%) had died, 50 (4.2%) had transferred out or stopped care. Baseline markers of advanced disease, including weight < 45 kg (adjusted hazard ration (AHR) = 4.23; 95% confidence interval (CI): 1.51-15.58) and more advanced WHO disease stage, were predictive of pre-ART mortality. Compared with patients aged 15-24, patients aged 35-44 (AHR = 0.67; 95% CI: 1.0.47-0.95) and age 45-54 (AHR = 0.66; 95% CI: 0.48-0.91) had lower LTFU rates. Compared with attending facilities in North Central geopolitical zone, attending facility locations in South East (AHR = 0.44; 95% CI: 0.24-0.83) was protective against LTFU. Conclusions About half of patients enrolling in HIV program during 2004-2012 in Nigeria had not initiated ART by 2013. Key strategies to improve early ART initiation among pre-ART enrollees include implementation of the WHO test and treat guidelines, earlier HIV testing, and better monitoring to improve ART initiation rates. Further research to understand regional variations in pre-ART outcomes is warranted.	[Agolory, Simon G.; Auld, Andrew F.; Shiraishi, Ray W.; Dokubo, E. Kainne; Swaminathan, Mahesh; Ellerbrock, Tedd V.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Odafe, Solomon; Dalhatu, Ibrahim; Onotu, Dennis; Abiri, Oseni; Debem, Henry] US Ctr Dis Control & Prevent, Div Global HIV & TB, Abuja, Nigeria; [Abiri, Oseni] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA; [Bashorun, Adebobola] Fed Minist Hlth, Natl AIDS & STIs Control Program, Abuja, Nigeria	Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health Science Center Houston	Odafe, S (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Abuja, Nigeria.	sfodafe@gmail.com	Agolory, Simon/AIF-4664-2022; Odafe, Solomon/AAJ-2390-2020	Agolory, Simon/0000-0001-5023-5754; Auld, Andrew/0000-0001-5089-9163; Odafe, Solomon/0000-0002-2452-0532; Shiraishi, Ray/0000-0001-7640-0666	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Centers for Disease Control and Prevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the United States Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchessi N, 2016, HEALTH POLICY PLANN, V31, P674, DOI 10.1093/heapol/czv135; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Dorak MT, 2004, LANCET, V363, P2137, DOI 10.1016/S0140-6736(04)16505-7; Federal Republic of Nigeria, 2015, GLOB AIDS RESP COUNT; Feldacker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050871; Fine J, 1991, JAMSTATASSOC, V94, P496; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Hassan AS, 2012, TROP MED INT HEALTH, V17, P82, DOI 10.1111/j.1365-3156.2011.02889.x; Herwehe J, 2012, J AM MED INFORM ASSN, V19, P448, DOI 10.1136/amiajnl-2011-000412; Human Rights Watch, 2005, CYCL VIOL PLAT KAN S; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Kalichman SC, 2002, INT J STD AIDS, V13, P677, DOI 10.1258/095646202760326426; Karita E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134438; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lazarus JV, 2014, TROP MED INT HEALTH, V19, P1198, DOI 10.1111/tmi.12366; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; McGrath N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-601; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; McNaghten AD, 2015, JAIDS-J ACQ IMM DEF, V70, pE140, DOI 10.1097/QAI.0000000000000785; Mendelsohn Joshua B, 2012, Confl Health, V6, P9, DOI 10.1186/1752-1505-6-9; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Nyblade LC, 2001, J ACQ IMMUN DEF SYND, V28, P463, DOI 10.1097/00042560-200112150-00010; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Plazy M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006927; Pyne-Mercier LD, 2011, AIDS CARE, V23, P562, DOI 10.1080/09540121.2010.525615; Rathod Jayesh M, 2016, Seton Hall Law Rev, V46, P813; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; StataCorp, 2016, STPTIM CAL PERS INC; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, GLOB TUB REP GEN; World Health Organization, 2002, SCAL ANT THER RES LT; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183823	10.1371/journal.pone.0183823	http://dx.doi.org/10.1371/journal.pone.0183823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF3ON	28863160	Green Submitted, gold, Green Published			2022-12-26	WOS:000408816900009
J	Teixeira, RS; Terse-Ramos, R; Ferreira, TA; Machado, VR; Perdiz, MI; Lyra, IM; Nascimento, VL; Boa-Sorte, N; Andrade, BB; Ladeia, AM				Teixeira, Rozana Santos; Terse-Ramos, Regina; Ferreira, Tatiane Anunciacao; Machado, Vinicius Ramos; Perdiz, Marya Izadora; Lyra, Isa Menezes; Nascimento, Valma Lopes; Boa-Sorte, Ney; Andrade, Bruno B.; Ladeia, Ana Marice			Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia	PLOS ONE			English	Article							FLOW-MEDIATED VASODILATION; ACUTE CHEST SYNDROME; ULTRASOUND ASSESSMENT; BRACHIAL-ARTERY; DISEASE; HEMOGLOBIN; RESPONSES; HEMOLYSIS; DEATH; AGE	Background Hematological changes can drive damage of endothelial cells, which potentially lead to an early endothelial dysfunction in patients with sickle cell anemia (SCA). An association may exist between endothelial dysfunction and several clinical manifestations of SCA. The present study aims to evaluate the links between changes in endothelial function and clinical and laboratory parameters in children and adolescents with SCA. Methods This study included 40 children and adolescents with stable SCA as well as 25 healthy children; aged 6-18 years. All study subjects were evaluated for endothelial function using Doppler ultrasonography. In addition, a number of laboratory assays were performed, including reticulocyte and leukocyte counts as well as measurement of circulating levels of total bilirubin, C-reactive protein (CRP), glucose, lipoproteins and peripheral oxyhemoglobin saturation. These parameters were also compared between SCA patients who were undertaking hydroxyurea (HU) and those who were not. Results Flow-mediated vasodilation (FMD) values were found to be reduced in SCA patients compared with those detected in healthy controls. SCA individuals with lower FMD values exhibited higher number of hospital admissions due to vaso-occlusive events. Additional analyses revealed that patients who had decreased FMD values exhibited higher odds of acute chest syndrome (ACS) episodes. A preliminary analysis with limited number of individuals failed to demonstrate significant differences in FMD values between SCA individuals who were treated with HU and those who were not. Conclusions Children and adolescents with SCA exhibit impaired endothelial function. Reductions in FMD values are associated with ACS. These findings underline the potential use of FMD as screening strategy of SCA patients with severe prognosis at early stages.	[Teixeira, Rozana Santos; Ferreira, Tatiane Anunciacao; Machado, Vinicius Ramos; Perdiz, Marya Izadora; Boa-Sorte, Ney; Andrade, Bruno B.; Ladeia, Ana Marice] Bahia Fdn Dev Sci Salvador, Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil; [Teixeira, Rozana Santos; Terse-Ramos, Regina; Ferreira, Tatiane Anunciacao] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil; [Lyra, Isa Menezes; Andrade, Bruno B.] Univ Salvador UNIFACS, Laureate Int Univ, Salvador, BA, Brazil; [Nascimento, Valma Lopes] Hematol & Hemotherapy Fdn Bahia, Salvador, BA, Brazil; [Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Andrade, Bruno B.] Brazil Univ Salvador, Salvador, BA, Brazil; [Andrade, Bruno B.] Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil; [Ladeia, Ana Marice] Univ Catolica Salvador, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Salvador (UNIFACS); Fundacao Oswaldo Cruz; Universidade Catolica de Salvador	Teixeira, RS; Andrade, BB (corresponding author), Bahia Fdn Dev Sci Salvador, Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil.; Teixeira, RS (corresponding author), Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Salvador UNIFACS, Laureate Int Univ, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Brazil Univ Salvador, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil.	rozateixeira@bahiana.edu.br; bruno.andrade@bahia.fiocruz.br	Boa-Sorte, Ney A/Q-9902-2018; Andrade, Bruno/AAI-2248-2020; Boa-Sorte, Ney/AAG-8718-2020	Boa-Sorte, Ney/0000-0001-7068-3319; Andrade, Bruno/0000-0001-6833-3811; Ladeia, Ana Marice/0000-0002-2235-7401	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) under (PPSUS) of Bahia [EFP00006943]	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) under (PPSUS) of Bahia	This work was supported by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) under the notice number 020/201-Research Program: shared health management - (PPSUS) of Bahia (award number: EFP00006943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Zelia M de, 2005, J Pediatr (Rio J), V81, P395, DOI 10.2223/1377; Ballas SK, 2012, SCI WORLD J, DOI 10.1100/2012/949535; Cançado Rodolfo D., 2009, Rev. Bras. Hematol. Hemoter., V31, P361; Cartron JP, 2008, TRANSFUS CLIN BIOL, V15, P39, DOI 10.1016/j.tracli.2008.05.001; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; CHARACHE S, 1979, ARCH INTERN MED, V139, P67, DOI 10.1001/archinte.139.1.67; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; de Montalembert M, 2007, HAEMATOLOGICA, V92, P1709, DOI 10.3324/haematol.11253; El-Ghamrawy MK, 2014, J PEDIAT-BRAZIL, V90, P286, DOI 10.1016/j.jped.2013.09.005; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gualandro Sandra F. M., 2007, Rev. Bras. Hematol. Hemoter., V29, P291, DOI 10.1590/S1516-84842007000300020; Hadeed K, 2015, ECHOCARDIOGR-J CARD, V32, P1285, DOI 10.1111/echo.12851; Herrington DM, 2001, J CARDIOVASC RISK, V8, P319, DOI 10.1097/00043798-200110000-00012; Jarvisalo MJ, 2005, VASC HEALTH RISK MAN, V1, P227; Jarvisalo MJ, 2002, AM J PHYSIOL-HEART C, V282, pH87, DOI 10.1152/ajpheart.2002.282.1.H87; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Ladeia AM, 2005, DIABETES CARE, V28, P2048, DOI 10.2337/diacare.28.8.2048; Ladeia AM, 2014, WORLD J DIABETES, V5, P601, DOI 10.4239/wjd.v5.i5.601; Lou TF, 2009, EXP BIOL MED, V234, P1374, DOI 10.3181/0811-RM-339; Ministe A rio da Sau A de SdAaS, 2002, PROT CLIN DIR TER DO; Moens AL, 2005, CHEST, V127, P2254, DOI 10.1378/chest.127.6.2254; Organization WH, 2014, CHILD GROWTH STAND L; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sampaio Raphael Ribeiro, 2013, J Clin Med Res, V5, P294, DOI 10.4021/jocmr1418w; Steinberg MH, 2006, CURR OPIN HEMATOL, V13, P131, DOI 10.1097/01.moh.0000219656.50291.73; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Steinberg MH, 2005, BRIT J HAEMATOL, V129, P465, DOI 10.1111/j.1365-2141.2005.05411.x; Steinberg MH, 2006, TRENDS PHARMACOL SCI, V27, P204, DOI 10.1016/j.tips.2006.02.007; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; Verma S, 2003, CIRCULATION, V108, P2054, DOI 10.1161/01.CIR.0000089191.72957.ED; Vichinsky EP, 1997, BLOOD, V89, P1787, DOI 10.1182/blood.V89.5.1787.1787_1787_1792; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008	41	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184076	10.1371/journal.pone.0184076	http://dx.doi.org/10.1371/journal.pone.0184076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863145	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900021
J	Upton, N; Jackson, DJ; Nikonova, AA; Hingley-Wilson, S; Khaitov, M; del Rosario, A; Traub, S; Trujillo-Torralbo, MB; Habibi, M; Elkin, SL; Kon, OM; Edwards, MR; Mallia, P; Footitt, J; Macintyre, J; Stanciu, LA; Johnston, SL; Sykes, A				Upton, Nadine; Jackson, David J.; Nikonova, Alexandra A.; Hingley-Wilson, Suzie; Khaitov, Musa; del Rosario, Ajerico; Traub, Stephanie; Trujillo-Torralbo, Maria-Belen; Habibi, Max; Elkin, Sarah L.; Kon, Onn M.; Edwards, Michael R.; Mallia, Patrick; Footitt, Joseph; Macintyre, Jonathan; Stanciu, Luminita A.; Johnston, Sebastian L.; Sykes, Annemarie			Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; INFLAMMATION; EXACERBATIONS; INFECTION; CHEMOKINE; DEFICIENT; MACROPHAGES; EXPRESSION; SEVERITY	Rhinovirus infection is associated with the majority of asthma exacerbations. The role of fractalkine in anti-viral (type 1) and pathogenic (type 2) responses to rhinovirus infection in allergic asthma is unknown. To determine whether (1) fractalkine is produced in airway cells and in peripheral blood leucocytes, (2) rhinovirus infection increases production of fractalkine and (3) levels of fractalkine differ in asthmatic compared to non-asthmatic subjects. Fractalkine protein and mRNA levels were measured in bronchoalveolar lavage (BAL) cells and peripheral blood mononuclear cells (PBMCs) from non-asthmatic controls (n = 15) and mild allergic asthmatic (n = 15) subjects. Protein levels of fractalkine were also measured in macrophages polarised ex vivo to give M1 (type 1) and M2 (type 2) macrophages and in BAL fluid obtained from mild (n = 11) and moderate (n = 14) allergic asthmatic and non-asthmatic control (n = 10) subjects pre and post in vivo rhinovirus infection. BAL cells produced significantly greater levels of fractalkine than PBMCs. Rhinovirus infection increased production of fractalkine by BAL cells from non-asthmatic controls (P<0.01) and in M1-polarised macrophages (P<0.05), but not in BAL cells from mild asthmatics or in M2 polarised macrophages. Rhinovirus induced fractalkine in PBMCs from asthmatic (P<0.001) and healthy control subjects (P<0.05). Trends towards induction of fractalkine in moderate asthmatic subjects during in vivo rhinovirus infection failed to reach statistical significance. Fractalkine may be involved in both immunopathological and anti-viral immune responses to rhinovirus infection. Further investigation into how fractalkine is regulated across different cell types and into the effect of stimulation including rhinovirus infection is warranted to better understand the precise role of this unique dual adhesion factor and chemokine in immune cell recruitment.	[Upton, Nadine; Jackson, David J.; del Rosario, Ajerico; Traub, Stephanie; Trujillo-Torralbo, Maria-Belen; Habibi, Max; Edwards, Michael R.; Mallia, Patrick; Footitt, Joseph; Macintyre, Jonathan; Stanciu, Luminita A.; Johnston, Sebastian L.; Sykes, Annemarie] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England; [Upton, Nadine; Jackson, David J.; del Rosario, Ajerico; Traub, Stephanie; Trujillo-Torralbo, Maria-Belen; Habibi, Max; Edwards, Michael R.; Mallia, Patrick; Footitt, Joseph; Macintyre, Jonathan; Stanciu, Luminita A.; Johnston, Sebastian L.; Sykes, Annemarie] MRC, London, England; [Upton, Nadine; Jackson, David J.; del Rosario, Ajerico; Traub, Stephanie; Trujillo-Torralbo, Maria-Belen; Habibi, Max; Edwards, Michael R.; Mallia, Patrick; Footitt, Joseph; Macintyre, Jonathan; Stanciu, Luminita A.; Johnston, Sebastian L.; Sykes, Annemarie] Asthma UK Ctr Allerg Mech Asthma, London, England; [Upton, Nadine] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [del Rosario, Ajerico; Trujillo-Torralbo, Maria-Belen; Habibi, Max; Elkin, Sarah L.; Kon, Onn M.; Mallia, Patrick; Footitt, Joseph; Macintyre, Jonathan; Johnston, Sebastian L.; Sykes, Annemarie] Imperial Coll Healthcare NHS Trust, London, England; [Nikonova, Alexandra A.; Khaitov, Musa] NRC Inst Immunol FMBA, Moscow, Russia; [Nikonova, Alexandra A.] Mechnikov Res Inst Vaccines & Sera, Moscow, Russia; [Hingley-Wilson, Suzie; Habibi, Max] Imperial Coll London, Natl Heart & Lung Inst, Resp Infect Sect, London, England	Imperial College London; University of London; King's College London; University of London; King's College London; Imperial College London; NRC Institute of Immunology FMBA of Russia; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS; Imperial College London	Nikonova, AA (corresponding author), NRC Inst Immunol FMBA, Moscow, Russia.; Nikonova, AA (corresponding author), Mechnikov Res Inst Vaccines & Sera, Moscow, Russia.	aa.nikonova@nrcii.ru	Johnston, Sebastian Lennox/I-2423-2012; Khaitov, Musa R/L-3369-2017; Jackson, David/AAG-8818-2020; Khaitov, Musa/AAC-1516-2021; Stanciu, Luminita A/B-8384-2012; Nikonova, Alexandra/A-4206-2014	Johnston, Sebastian Lennox/0000-0003-3009-9200; Khaitov, Musa R/0000-0003-4961-9640; Khaitov, Musa/0000-0003-4961-9640; Hingley-Wilson, Suzie/0000-0002-6514-1424; Nikonova, Alexandra/0000-0001-9610-0935	Chair from Asthma UK [CH11SJ]; ERC [233015]; Medical Research Council (MRC) [G0601236]; MRC; MRC Centre [G1000758]; National Institute of Health Research (NIHR) Biomedical Research Centre (BRC); NIHR BRC Centre [P26095]; NIHR; Predicta Collaborative Project [260895]; RSF [16-14-10188]; MRC [G0601236, MR/N007328/1, G0700552, G1100238] Funding Source: UKRI; Russian Science Foundation [16-14-10188] Funding Source: Russian Science Foundation; Academy of Medical Sciences (AMS) [AMS-SGCL6-Sykes] Funding Source: researchfish; Medical Research Council [G1100238, G1000758, MR/N007328/1, G0601236, G0700552] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10092] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Chair from Asthma UK; ERC(European Research Council (ERC)European Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); NIHR BRC Centre; NIHR(National Institute for Health Research (NIHR)); Predicta Collaborative Project; RSF(Russian Science Foundation (RSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Science Foundation(Russian Science Foundation (RSF)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	SLJ is supported by a Chair from Asthma UK (CH11SJ). This work was supported by ERC FP7 Advanced grant 233015 (to SLJ), the Medical Research Council (MRC) project grant G0601236, a MRC Clinical Research Fellowship (to AS), MRC Centre Grant G1000758, the National Institute of Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme, NIHR BRC Centre Grant P26095, NIHR Clinical Lecturer Grants (to PM and JF) and the Predicta FP7 Collaborative Project grant 260895. SLJ is a NIHR Senior Investigator. Study of fractalkine secretion by M1 and M2 was performed with the financial support of the RSF Grant No 16-14-10188.	Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Bai J, 2015, PLOS ONE, V10; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Fujimoto K, 2001, AM J RESP CELL MOL, V25, P233, DOI 10.1165/ajrcmb.25.2.4275; Gavala ML, 2011, IMMUNOL REV, V242, P69, DOI 10.1111/j.1600-065X.2011.01031.x; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Gliemann J, 1998, BIOL CHEM, V379, P951; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Laza-Stanca V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002114; Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Mizutani N, 2007, J IMMUNOL, V179, P7478, DOI 10.4049/jimmunol.179.11.7478; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rimaniol AC, 2003, J ALLERGY CLIN IMMUN, V112, P1139, DOI 10.1016/j.jaci.2003.09.041; Schwarz N, 2010, CELL MOL LIFE SCI, V67, P4233, DOI 10.1007/s00018-010-0433-4; Sukkar MB, 2004, AM J PHYSIOL-LUNG C, V287, pL1230, DOI 10.1152/ajplung.00014.2004; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Zdrenghea MT, 2015, REV MED VIROL, V25, P33, DOI 10.1002/rmv.1817; Zhu J, 2014, CHEST, V145, P1219, DOI 10.1378/chest.13-1567	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183864	10.1371/journal.pone.0183864	http://dx.doi.org/10.1371/journal.pone.0183864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859129	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500041
J	Yu, J; Wang, XX; Xu, T; Jin, QH; Duan, JY; Wu, J; Wu, HY; Xu, T; Ye, S				Yu, Jie; Wang, Xiaoxiao; Xu, Tao; Jin, Qiuheng; Duan, Jinyuan; Wu, Jie; Wu, Haiyan; Xu, Ting; Ye, Sheng			A rational approach to enhancing antibody Fc homodimer formation for robust production of antibody mixture in a single cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN POLYCLONAL ANTIBODIES; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; ANTITUMOR-ACTIVITY; NEXT-GENERATION; BISPECIFIC IGG; CANCER; PHARMACOKINETICS; STRATEGIES	Combinations of different antibodies have been shown to be more effective for managing certain diseases than monotherapy. Co-expression of the antibody mixture in a single cell line is key to reducing complexity during antibody development and manufacturing. However, co-transfection of multiple light and heavy chains into cells often leads to production of mismatched, heterodimeric by-products that are inactive, making the development of co-expression systems that robustly and efficiently produce highly active antibody mixtures a high priority. In this study, we modified the CH3 domain interface of the antibody fragment crystallizable (Fc) region by changing several charge pairs to create electrostatic interactions favoring Fc homodimer formation and disfavoring Fc heterodimer formation. When co-expressed, these modified antibodies with altered charge polarity across the Fc dimer interface preferentially formed homodimers that fully preserved the functions of each component, rather than inactive heterodimers whose formation was reduced because of rationally designed repulsive interactions. We designed eight different combinations and experimentally screened the best one, which enabled us to produce a binary antibody mixture against the EGF receptor with a minimal heterodimer contaminant. We further determined the crystal structure of a triple-mutated Fc variant in the best combination, and we elucidated the molecular interactions favoring Fc homodimer over heterodimer formation, which provided a structural basis for further optimization. The approach presented here demonstrates the feasibility of rational antibody modification for efficient and consistent production of monoclonal antibody mixtures in a single cell line and thus broadens our options for manufacturing more effective antibody-based therapeutic agents.	[Yu, Jie; Jin, Qiuheng; Duan, Jinyuan; Ye, Sheng] Zhejiang Univ, Life Sci Inst, 866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Jie; Jin, Qiuheng; Duan, Jinyuan; Ye, Sheng] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Xiaoxiao; Xu, Tao; Wu, Jie; Wu, Haiyan; Xu, Ting] Alphamab Co Ltd, Suzhou 215125, Peoples R China	Zhejiang University; Zhejiang University	Ye, S (corresponding author), Zhejiang Univ, Life Sci Inst, 866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Xu, T (corresponding author), Alphamab Co Ltd, Suzhou 215125, Peoples R China.	tingxu@alphamab.com; sye@zju.edu.cn		Jin, Qiuheng/0000-0002-5869-0310	Ministry of Science and Technology of China [2016YFA0500404, 2014CB910300]; National Natural Science Foundation of China [31525001, 31430019, 31370721]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by Ministry of Science and Technology of China Grants 2016YFA0500404 and 2014CB910300, National Natural Science Foundation of China Grants 31525001, 31430019, and 31370721, and the Fundamental Research Funds for the Central Universities (to S. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baselga J, 2010, CLIN BREAST CANCER, V10, P489, DOI 10.3816/CBC.2010.n.065; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; de Kruif J, 2010, BIOTECHNOL BIOENG, V106, P741, DOI 10.1002/bit.22763; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Demarest SJ, 2011, MABS-AUSTIN, V3, P338, DOI 10.4161/mabs.3.4.16615; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; ELLERSON JR, 1976, J IMMUNOL, V116, P510; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Frandsen TP, 2011, BIOTECHNOL BIOENG, V108, P2171, DOI 10.1002/bit.23166; Fukai J, 2008, CANCER SCI, V99, P2062, DOI 10.1111/j.1349-7006.2008.00945.x; Gan HK, 2012, CANCER RES, V72, P2924, DOI 10.1158/0008-5472.CAN-11-3898; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Ha JH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00394; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P639, DOI 10.1073/pnas.232686499; Jutten B, 2009, RADIOTHER ONCOL, V92, P393, DOI 10.1016/j.radonc.2009.06.021; Logtenberg T, 2007, TRENDS BIOTECHNOL, V25, P390, DOI 10.1016/j.tibtech.2007.07.005; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Nayak SU, 2014, ANTIMICROB AGENTS CH, V58, P5047, DOI 10.1128/AAC.02830-14; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nielsen LS, 2010, MOL BIOTECHNOL, V45, P257, DOI 10.1007/s12033-010-9270-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Perera RM, 2005, CLIN CANCER RES, V11, P6390, DOI 10.1158/1078-0432.CCR-04-2653; Raju TS, 2013, EXPERT OPIN BIOL TH, V13, P1347, DOI 10.1517/14712598.2013.822065; Rasmussen SK, 2007, BIOTECHNOL LETT, V29, P845, DOI 10.1007/s10529-007-9331-8; Rasmussen SK, 2012, ARCH BIOCHEM BIOPHYS, V526, P139, DOI 10.1016/j.abb.2012.07.001; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Skartved NJO, 2011, CLIN CANCER RES, V17, P5962, DOI 10.1158/1078-0432.CCR-11-1209; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiberg FC, 2006, BIOTECHNOL BIOENG, V94, P396, DOI 10.1002/bit.20865	40	1	1	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17885	17896		10.1074/jbc.M116.771188	http://dx.doi.org/10.1074/jbc.M116.771188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28878018	Green Published, hybrid			2022-12-26	WOS:000414013000024
J	Liu, CY; Hutchens, S; Jursa, T; Shawlot, W; Polishchuk, EV; Polishchuk, RS; Dray, BK; Gore, AC; Aschner, M; Smith, DR; Mukhopadhyay, S				Liu, Chunyi; Hutchens, Steven; Jursa, Thomas; Shawlot, William; Polishchuk, Elena V.; Polishchuk, Roman S.; Dray, Beth K.; Gore, Andrea C.; Aschner, Michael; Smith, Donald R.; Mukhopadhyay, Somshuvra			Hypothyroidism induced by loss of the manganese efflux transporter SLC30A10 may be explained by reduced thyroxine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION TRANSPORTER; INTRACELLULAR TRAFFICKING; ZINC TRANSPORTERS; INTELLECTUAL FUNCTION; HEPATIC CIRRHOSIS; DRINKING-WATER; SHIGA TOXIN; IRON UPTAKE; EXPOSURE; ZIP14	SLC30A10 and SLC39A14 are manganese efflux and influx transporters, respectively. Loss-of-function mutations in genes encoding either transporter induce hereditary manganese toxicity. Patients have elevated manganese in the blood and brain and develop neurotoxicity. Liver manganese is increased in patients lacking SLC30A10 but not SLC39A14. These organ-specific changes in manganese were recently recapitulated in knockout mice. Surprisingly, Slc30a10 knockouts also had elevated thyroid manganese and developed hypothyroidism. To determine the mechanisms of manganese-induced hypothyroidism and understand how SLC30A10 and SLC39A14 cooperatively mediate manganese detoxification, here we produced Slc39a14 single and Slc30a10/Slc39a14 double knockout mice and compared their phenotypes with that of Slc30a10 single knockouts. Compared with wild-type controls, Slc39a14 single and Slc30a10/Slc39a14 double knockouts had higher manganese levels in the blood and brain but not in the liver. In contrast, Slc30a10 single knockouts had elevated manganese levels in the liver as well as in the blood and brain. Furthermore, SLC30A10 and SLC39A14 localized to the canalicular and basolateral domains of polarized hepatic cells, respectively. Thus, transport activities of both SLC39A14 and SLC30A10 are required for hepatic manganese excretion. Compared with Slc30a10 single knockouts, Slc39a14 single and Slc30a10/Slc39a14 double knockouts had lower thyroid manganese levels and normal thyroid function. Moreover, intrathyroid thyroxine levels of Slc30a10 single knockouts were lower than those of controls. Thus, the hypothyroidism phenotype of Slc30a10 single knockouts is induced by elevated thyroid manganese, which blocks thyroxine production. These findings provide new insights into the mechanisms of manganese detoxification and manganese-induced thyroid dysfunction.	[Liu, Chunyi; Hutchens, Steven; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Cellular & Mol Biol, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Liu, Chunyi; Hutchens, Steven; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Shawlot, William] Univ Texas Austin, Mouse Genet Engn Facil, Austin, TX 78712 USA; [Jursa, Thomas; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Polishchuk, Elena V.; Polishchuk, Roman S.] Telethon Inst Genet & Med, I-80078 Pozzuoli, Italy; [Dray, Beth K.] MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Dept Vet Sci, Bastrop, TX 78602 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Cruz; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton, Austin, TX 78712 USA.	som@austin.utexas.edu	Liu, Chunyi/AAJ-9340-2021	Polishchuk, Roman/0000-0002-7698-1955	NIEHS, National Institutes of Health [R01-ES024812, R00-ES020844]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024812, R00ES020844] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Grants R01-ES024812 and R00-ES020844 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; Beaudin SA, 2013, NEUROTOXICOL TERATOL, V38, P36, DOI 10.1016/j.ntt.2013.04.004; Bhang SY, 2013, ENVIRON RES, V126, P9, DOI 10.1016/j.envres.2013.05.006; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Bouchard M, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9504; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P138, DOI 10.1289/ehp.1002321; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Braveman L. E., 2013, WERNER INGBARS THYRO; BUTHIEAU AM, 1983, ARCH TOXICOL, V54, P243, DOI 10.1007/BF01239208; BUTHIEAU AM, 1977, CR SOC BIOL, V171, P1024; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Chesi G, 2016, HEPATOLOGY, V63, P1842, DOI 10.1002/hep.28398; Giray B, 2010, J TRACE ELEM MED BIO, V24, P106, DOI 10.1016/j.jtemb.2009.11.003; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Hall J. E., 2016, TXB MED PHYSL, P951; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; KAWADA J, 1985, ENDOCRINOL JAPON, V32, P635; Kern CH, 2010, SYNAPSE, V64, P363, DOI 10.1002/syn.20736; Khan K, 2012, NEUROTOXICOLOGY, V33, P91, DOI 10.1016/j.neuro.2011.12.002; Khan K, 2011, ENVIRON HEALTH PERSP, V119, P1501, DOI 10.1289/ehp.1003397; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Le SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142615; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Misiewicz A, 1993, Endokrynol Pol, V44, P57; Mukhopadhyay S, 2018, NEUROTOXICOLOGY, V64, P278, DOI 10.1016/j.neuro.2017.07.030; Mukhopadhyay S, 2013, MOL BIOL CELL, V24, P2311, DOI 10.1091/mbc.E13-01-0057; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Riojas-Rodriguez H, 2010, ENVIRON HEALTH PERSP, V118, P1465, DOI 10.1289/ehp.0901229; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Xia ZD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006892; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	65	36	38	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16605	16615		10.1074/jbc.M117.804989	http://dx.doi.org/10.1074/jbc.M117.804989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28860195	Green Published, hybrid			2022-12-26	WOS:000412414800021
J	Bobrowiec, PED; Tavares, VD				Bobrowiec, Paulo Estefano D.; Tavares, Valearia da Cunha			Establishing baseline biodiversity data prior to hydroelectric dam construction to monitoring impacts to bats in the Brazilian Amazon	PLOS ONE			English	Article							ASSEMBLAGE STRUCTURE; SPECIES-DIVERSITY; FOREST ISLANDS; FRAGMENTATION; MORPHOLOGY; PATTERNS; CLUTTER; SCALE	The modification of Amazonian rivers by the construction of megaprojects of hydroelectric dams has widely increased over the last decade. Robust monitoring programs have been rarely conducted prior to the establishment of dams to measure to what extent the fauna, and its associated habitats may be affected by upcoming impacts. Using bats as models, we performed analyses throughout the area under the influence of the Santo Antonio hydroelectric dam, Southwestern Brazilian Amazonia before its construction to estimate how the fauna and its associated habitats would be affected by the upcoming impacts. We surveyed bats in 49 plots distributed along the areas going to be inundated by the dam and those remaining dry. As predictors for the species distribution, we tested the variables of vegetation structure and topography. Species composition largely differed between the dry plots and the plots located in areas that will be flooded, and this was strongly associated with the variables of forest basal area and elevation. Vegetation-related variables also had strong influence on the guilds distribution. The flooding of lower elevations areas is expected to negatively affect the species number and abundance of frugivorous species. In contrast, it is likely that animalivores will be less vulnerable to dam-induced flooding, since they were abundant in the areas not expect to be inundated. We urge for the implementation of studies to predict impacts caused by large hydroelectric dams, including tests of the influence of the local conditions that shape diversity to avoid massive losses of the biota, and to build preventive monitoring and management actions.	[Bobrowiec, Paulo Estefano D.] INPA, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Tavares, Valearia da Cunha] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil; [Tavares, Valearia da Cunha] INPA, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Minas Gerais; Institute Nacional de Pesquisas da Amazonia	Bobrowiec, PED (corresponding author), INPA, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	paulobobro@gmail.com	Bobrowiec, Paulo Estefano D./A-2630-2013; Tavares, Valeria/G-4654-2012	Tavares, Valeria/0000-0003-0966-0139; Dineli Bobrowiec, Paulo Estefano/0000-0002-8945-6105	Institute Nacional de Pesquisas da Amazonia; Santo Antonio Energia; Fundacao Amazonica de Defesa da Biosfera; Fundacao de Amparo a Pesquisa do Estado do Amazonas (PEDB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEDB)	Institute Nacional de Pesquisas da Amazonia; Santo Antonio Energia; Fundacao Amazonica de Defesa da Biosfera; Fundacao de Amparo a Pesquisa do Estado do Amazonas (PEDB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEDB)	This work was supported by Institute Nacional de Pesquisas da Amazonia, Santo Antonio Energia, Fundacao Amazonica de Defesa da Biosfera, Fundacao de Amparo a Pesquisa do Estado do Amazonas (PEDB), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEDB).	[Anonymous], 2014, R LANG ENV STAT COMP; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Barton K., 2015, MUMIN MULTIMODEL INF; Bates D., 2015, LME4 LINEAR MIXED EF; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benchimol M, 2015, J ECOL, V103, P408, DOI 10.1111/1365-2745.12371; Bernardes C, 2011, BIOTA NEOTROP, V11, P83, DOI 10.1590/S1676-06032011000300006; Bobrowiec PED, 2010, ANIM CONSERV, V13, P204, DOI 10.1111/j.1469-1795.2009.00322.x; Bobrowiec PED, 2014, BIOTROPICA, V46, P312, DOI 10.1111/btp.12102; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Caras T, 2009, J TROP ECOL, V25, P97, DOI 10.1017/S0266467408005671; Charles-Dominique P., 2001, PATRIMOINES NATURELS, V49, P1; Cintra Renato, 2012, International Journal of Ecology, P1; Cisneros LM, 2015, DIVERS DISTRIB, V21, P523, DOI 10.1111/ddi.12277; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; de Oliveira LQ, 2015, J MAMMAL, V96, P1036, DOI 10.1093/jmammal/gyv108; Dias-Terceiro RG, 2015, BIOTROPICA, V47, P259, DOI 10.1111/btp.12197; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Farneda FZ, 2015, J APPL ECOL, V52, P1381, DOI 10.1111/1365-2664.12490; Fearnside PM, 2013, WATER ALTERN, V6, P313; Fearnside PM, 2014, WATER ALTERN, V7, P256; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fox J, 2016, PACKAGECAR, DOI DOI 10.1177/0049124105277200; Gardner A.L., 2008, MAMMALS S AM MARSUPI; Goulding M, 2003, SMITHSONIAN ATLAS AM; Haugaasen T, 2005, AM J PRIMATOL, V67, P243, DOI 10.1002/ajp.20180; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; IBAMA, 2011, PROGR CONS WILDL FIN; IBGE, 2013, POP RES ENV TRIB CON; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Lim BK, 2001, BIODIVERS CONSERV, V10, P613, DOI 10.1023/A:1016660123189; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marciente R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129560; Marinello MM, 2014, CAN J ZOOL, V92, P141, DOI 10.1139/cjz-2013-0127; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Meyer CFJ, 2008, DIVERS DISTRIB, V14, P644, DOI 10.1111/j.1472-4642.2007.00462.x; Meyer CFJ, 2008, J APPL ECOL, V45, P381, DOI 10.1111/j.1365-2664.2007.01389.x; Michalski LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126114; Moser P, 2014, BIOTROPICA, V46, P367, DOI 10.1111/btp.12111; Moulatlet GM, 2014, BIOTROPICA, V46, P395, DOI 10.1111/btp.12117; Nogueira Marcelo Rodrigues, 2014, Check List, V10, P808; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; Pottmaier D, 2013, RENEW SUST ENERG REV, V19, P678, DOI 10.1016/j.rser.2012.11.063; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Pereira MJR, 2009, J ANIM ECOL, V78, P1163, DOI 10.1111/j.1365-2656.2009.01591.x; Rebelo Hugo, 2009, Endangered Species Research, V8, P61, DOI 10.3354/esr00100; Ritter CD, 2017, BIOL CONSERV, V206, P161, DOI 10.1016/j.biocon.2016.12.031; Robert A, 2003, ECOL MODEL, V167, P287, DOI 10.1016/S0304-3800(03)00200-X; Rocha R, 2016, LANDSCAPE E IN PRESS; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Tavares VD, 2017, ACTA CHIROPTEROL, V19, P93, DOI 10.3161/15081109ACC2017.19.1.007; Tavares Valeria da C., 2013, Chiroptera Neotropical, V19, P57; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; WALSH C., 2013, HIER PART HIERARCHIC; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2	66	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183036	10.1371/journal.pone.0183036	http://dx.doi.org/10.1371/journal.pone.0183036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886029	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100016
J	Britto-Borges, T; Barton, GJ				Britto-Borges, Thiago; Barton, Geoffrey J.			A study of the structural properties of sites modified by the O-linked 6-N-acetylglucosamine transferase	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; X-CHROMOSOME; GLCNACYLATION; PREDICTION; PHOSPHORYLATION; IDENTIFICATION; GLYCOSYLATION; RECOGNITION	Protein O-GlcNAcylation (O-GlcNAc) is an essential post-translational modification (PTM) in higher eukaryotes. The O-linked beta-N-acetylglucosamine transferase (OGT), targets specific Serines and Threonines (S/T) in intracellular proteins. However, unlike phosphorylation, fewer than 25% of known O-GlcNAc sites match a clear sequence pattern. Accordingly, the three-dimensional structures of O-GlcNAc sites were characterised to investigate the role of structure in molecular recognition. From 1,584 O-GlcNAc sites in 620 proteins, 143 were mapped to protein structures determined by X-ray crystallography. The modified S/T were 1.7 times more likely to be annotated in the REM465 field which defines missing residues in a protein structure, while 7 O-GlcNAc sites were solvent inaccessible and unlikely to be targeted by OGT. 132 sites with complete backbone atoms clustered into 10 groups, but these were indistinguishable from clusters from unmodified S/T. This suggests there is no prevalent three-dimensional motif for OGT recognition. Predicted features from the 620 proteins were compared to unmodified S/T in O-GlcNAcylated proteins and globular proteins. The Jpred4 predicted secondary structure shows that modified S/T were more likely to be coils. 5/6 methods to predict intrinsic disorder indicated O-GlcNAcylated S/T to be significantly more disordered than unmodified S/T. Although the analysis did not find a pattern in the site three-dimensional structure, it revealed the residues around the modification site are likely to be disordered and suggests a potential role of secondary structure elements in OGT site recognition.	[Britto-Borges, Thiago; Barton, Geoffrey J.] Univ Dundee, Sch Life Sci, Div Computat Biol, Dundee, Scotland	University of Dundee	Barton, GJ (corresponding author), Univ Dundee, Sch Life Sci, Div Computat Biol, Dundee, Scotland.	g.j.barton@dundee.ac.uk	Barton, Geoffrey J/C-6267-2011	Britto Borges, Thiago/0000-0002-6218-4429; Barton, Geoffrey John/0000-0002-9014-5355	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES process) [1529/12-9]; Wellcome Trust Strategic Awards [WT097945, WT092340, 098439/Z/12/Z]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES process); Wellcome Trust Strategic Awards	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES process 1529/12-9; studentship to T.B.B). Website: http://www.capes.gov.br/. GJB Acknowledges the support of Wellcome Trust Strategic Awards: WT097945, WT092340 and 098439/Z/12/Z. Website https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chen D, 2005, J VIROL, V79, P9381, DOI 10.1128/JVI.79.15.9381-9387.2005; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Duarte ML, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005412; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jia CZ, 2013, MOL BIOSYST, V9, P2909, DOI 10.1039/c3mb70326f; Jochmann R, 2014, BBA-PROTEINS PROTEOM, V1844, P416, DOI 10.1016/j.bbapap.2013.12.002; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kao HJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S10; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu XY, 2014, FASEB J, V28, P3362, DOI 10.1096/fj.13-246850; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McKinney W., 2015, PD TEAM PANDAS POWER, P1625; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; ROQUEMORE EP, 1992, J BIOL CHEM, V267, P555; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151085; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Troshin PV, 2011, BIOINFORMATICS, V27, P2001, DOI 10.1093/bioinformatics/btr304; Velankar S., 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [DOI 10.1093/nar/gkq985, 10.1093/nar/gkq985]; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Wang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-91; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wu HY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S1; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao XW, 2015, J THEOR BIOL, V380, P524, DOI 10.1016/j.jtbi.2015.06.026	49	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184405	10.1371/journal.pone.0184405	http://dx.doi.org/10.1371/journal.pone.0184405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886091	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100107
J	Desvars-Larrive, A; Pascal, M; Gasqui, P; Cosson, JF; Benoit, E; Lattard, V; Crespin, L; Lorvelec, O; Pisanu, B; Teynie, A; Vayssier-Taussat, M; Bonnet, S; Marianneau, P; Lacote, S; Bourhy, P; Berny, P; Pavio, N; Le Poder, S; Gilot-Fromont, E; Jourdain, E; Hammed, A; Fourel, I; Chikh, F; Vourc'h, G				Desvars-Larrive, Amelie; Pascal, Michel; Gasqui, Patrick; Cosson, Jean-Francois; Benoit, Etienne; Lattard, Virginie; Crespin, Laurent; Lorvelec, Olivier; Pisanu, Benoit; Teynie, Alexandre; Vayssier-Taussat, Muriel; Bonnet, Sarah; Marianneau, Philippe; Lacote, Sandra; Bourhy, Pascale; Berny, Philippe; Pavio, Nicole; Le Poder, Sophie; Gilot-Fromont, Emmanuelle; Jourdain, Elsa; Hammed, Abdessalem; Fourel, Isabelle; Chikh, Farid; Vourc'h, Gwenael			Population genetics, community of parasites, and resistance to rodenticides in an urban brown rat (Rattus norvegicus) population	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NORWAY RATS; ANTICOAGULANT RODENTICIDES; COMPUTER-PROGRAM; LEPTOSPIRA; DIFFERENTIATION; IDENTIFICATION; EVOLUTIONARY; CONSEQUENCES; TRANSMISSION	Brown rats are one of the most widespread urban species worldwide. Despite the nuisances they induce and their potential role as a zoonotic reservoir, knowledge on urban rat populations remains scarce. The main purpose of this study was to characterize an urban brown rat population from Chanteraines park (Hauts-de-Seine, France), with regards to haematology, population genetics, immunogenic diversity, resistance to anticoagulant rodenticides, and community of parasites. Haematological parameters were measured. Population genetics was investigated using 13 unlinked microsatellite loci. Immunogenic diversity was assessed for Mhc-Drb. Frequency of the Y139F mutation (conferring resistance to rodenticides) and two linked microsatellites were studied, concurrently with the presence of anticoagulant residues in the liver. Combination of microscopy and molecular methods were used to investigate the occurrence of 25 parasites. Statistical approaches were used to explore multiple parasite relationships and model parasite occurrence. Eighty-six rats were caught. The first haematological data for a wild urban R. norvegicus population was reported. Genetic results suggested high genetic diversity and connectivity between Chanteraines rats and surrounding population(s). We found a high prevalence (55.8%) of the mutation Y139F and presence of rodenticide residues in 47.7% of the sampled individuals. The parasite species richness was high (16). Seven potential zoonotic pathogens were identified, together with a surprisingly high diversity of Leptospira species (4). Chanteraines rat population is not closed, allowing gene flow and making eradication programs challenging, particularly because rodenticide resistance is highly prevalent. Parasitological results showed that co-infection is more a rule than an exception. Furthermore, the presence of several potential zoonotic pathogens, of which four Leptospira species, in this urban rat population raised its role in the maintenance and spread of these pathogens. Our findings should stimulate future discussions about the development of a long-term rat-control management program in Chanteraines urban park.	[Desvars-Larrive, Amelie] Univ Vet Med, Res Inst Wildlife Ecol, Conservat Med, Vienna, Austria; [Pascal, Michel; Lorvelec, Olivier] INRA, Agrocampus Ouest, ESE, JRU, Rennes, France; [Gasqui, Patrick; Crespin, Laurent; Teynie, Alexandre; Jourdain, Elsa; Vourc'h, Gwenael] VetAgro Sup, INRA, Epidemiol Malad Anim & Zoonot EPIA, JRU, St Genes Champanelle, France; [Cosson, Jean-Francois; Vayssier-Taussat, Muriel; Bonnet, Sarah] ENVA, INRA, Agence Natl Securite Sanit Alimentat Environm & T, Biol Mol & Immunol Parasitaire BIPAR,JRU, Maisons Alfort, France; [Cosson, Jean-Francois] SupAgro Montpellier, IRD, INRA, Ctr Cooperat Int & Rech Agronom Dev CIRAD,CBGP,JR, Montpellier, France; [Benoit, Etienne; Lattard, Virginie; Berny, Philippe; Hammed, Abdessalem; Fourel, Isabelle] Lyon Univ, INRA, VetAgro Sup, Rongeurs Sauvages Risques Sanit & Gest Populat RS, Marcy Letoile, France; [Pisanu, Benoit] CNRS, MNHN, AFB, Unite Mixte Serv UMS Patrimoine Nat 2006, Paris, France; [Marianneau, Philippe; Lacote, Sandra] Agence Natl Securite Sanit Alimentat Environm & T, Virol Unit, Lyon, France; [Bourhy, Pascale] Inst Pasteur, Natl Reference Ctr, Biol Spirochetes Unit, Paris, France; [Bourhy, Pascale] WHO Collaborating Ctr Leptospirosis, Paris, France; [Pavio, Nicole; Le Poder, Sophie] ENVA, INRA, Agence Natl Securite Sanit Alimentat Environm & T, JRU Virol, Maisons Alfort, France; [Gilot-Fromont, Emmanuelle] Univ Claude Bernard Lyon 1, CNRS, LBBE, JRU, Marcy Letoile, France; [Chikh, Farid] Conseil Dept Hauts de Seine, Parc Chanteraines, Paris, France	University of Veterinary Medicine Vienna; INRAE; Institut Agro; Agrocampus Ouest; INRAE; VetAgro Sup; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vourc'h, G (corresponding author), VetAgro Sup, INRA, Epidemiol Malad Anim & Zoonot EPIA, JRU, St Genes Champanelle, France.	gwenael.vourch@inra.fr	Berny, Philippe/C-6945-2019; Berny, Philippe/AAU-2581-2020; Bonnet, Sarah I/AAD-4191-2020; Fourel, Isabelle/AAI-1564-2020	Berny, Philippe/0000-0001-5007-3820; Berny, Philippe/0000-0001-5007-3820; Bonnet, Sarah I/0000-0002-6365-6117; Fourel, Isabelle/0000-0001-5470-612X; Le Poder, Sophie/0000-0001-8642-8187; Gilot-Fromont, Emmanuelle/0000-0003-0011-7519; Desvars-Larrive, Amelie/0000-0001-7671-696X; Crespin, Laurent/0000-0001-8930-215X	Institut National de la Recherche Agronomique (INRA Grant); Agence Nationale de la Recherche (RODENT programme) [ANR-2009-CESA-008]	Institut National de la Recherche Agronomique (INRA Grant); Agence Nationale de la Recherche (RODENT programme)(French National Research Agency (ANR))	This project was supported by Conseil Departmental des Hauts-de-Seine, research funds from the Institut National de la Recherche Agronomique (INRA Grant), and the Agence Nationale de la Recherche (RODENT programme, ANR-2009-CESA-008).	Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x; Anderson R. C., 2009, KEYS NEMATODE PARASI; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; BARNETT SA, 1953, J HYG-CAMBRIDGE, V51, P16, DOI 10.1017/S002217240001545X; Barnett Samuel A., 1976, RAT STUDY BEHAV; Battersby SA., 2008, PUBLIC HLTH SIGNIFIC, P387; Beaucournu JC, 1990, FRANCE BASSIN MEDITE; Belkhir K, 2001, LOGICIEL SOUS WINDOW, Vv; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x; Bonnet S, 2007, PARASITOLOGY, V134, P197, DOI 10.1017/S0031182006001545; BOYLE CM, 1960, NATURE, V188, P517, DOI 10.1038/188517a0; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Casanova JC, 2001, PARASITOL RES, V87, P439, DOI 10.1007/s004360100379; Centers for Disease Control and Prevention, 2006, INT PEST MAN COND UR; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clapperton B. K., 2006, REV CURRENT KNOWLEDG; Cornuet JM, 1996, GENETICS, V144, P2001; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; del Rosario Robles Maria, 2008, Comparative Parasitology, V75, P145, DOI 10.1654/4277.1; Desvars A, 2012, AM J TROP MED HYG, V87, P134, DOI 10.4269/ajtmh.2012.12-0102; Durette-Desset MC, 1923, ANN PARASITOL HUM CO, V45, P818; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; Ellegren H, 2016, NAT REV GENET, V17, P422, DOI 10.1038/nrg.2016.58; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Fourel I, 2017, J CHROMATOGR B, V1041, P120, DOI 10.1016/j.jchromb.2016.12.028; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; GARDNER SL, 1985, CAN J ZOOL, V63, P1463, DOI 10.1139/z85-219; Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x; Grandemange A, 2010, PEST MANAG SCI, V66, P270, DOI 10.1002/ps.1869; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guernier V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004733; Guivier E, 2011, MOL ECOL, V20, P3569, DOI 10.1111/j.1365-294X.2011.05199.x; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heiberg AC, 2012, WILDLIFE RES, V39, P202, DOI 10.1071/WR11149; Higgins JA, 2000, AM J TROP MED HYG, V62, P310, DOI 10.4269/ajtmh.2000.62.310; Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654; HOMBERGER FR, 1991, J CLIN MICROBIOL, V29, P2789, DOI 10.1128/JCM.29.12.2789-2793.1991; HUGOT JP, 1985, B MUS NATL HIST NA A, V4, P383; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455; Kampfmann I, 2012, VET CLIN PATH, V41, P228, DOI 10.1111/j.1939-165X.2012.00427.x; Khalil LF, 1994, KEYS CESTODE PARASIT; Klimpel S, 2007, PARASITOL RES, V100, P867, DOI 10.1007/s00436-006-0368-8; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Lehmann JS, 2014, PATHOGENS, V3, P280, DOI 10.3390/pathogens3020280; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-57; Lorvelec O, 2005, BIOL INVASIONS, V7, P135, DOI 10.1007/s10530-004-9643-8; Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006; Makarikov AA, 2013, ACTA PARASITOL, V58, P37, DOI 10.2478/s11686-013-0115-0; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P2830, DOI 10.1128/JCM.30.11.2830-2834.1992; McGuire B, 2006, AM MIDL NAT, V155, P221, DOI 10.1674/0003-0031(2006)155[0221:GEOARP]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meade TM, 2014, J AM ASSOC LAB ANIM, V53, P661; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Michelet L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00103; NEI M, 1978, GENETICS, V89, P583; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Parola P, 2000, T ROY SOC TROP MED H, V94, P707, DOI 10.1016/S0035-9203(00)90243-8; Pascal M, 2006, INVASIONS BIOLOGIQUE; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pojmanska T., 2002, VVolume 1, P31, DOI 10.1079/9780851995472.0031; Postic D, 2000, RES MICROBIOL, V151, P333, DOI 10.1016/S0923-2508(00)00156-X; Psaroulaki A, 2010, T ROY SOC TROP MED H, V104, P733, DOI 10.1016/j.trstmh.2010.08.005; QGIS Development Team, 2016, QGIS GEOGR INF SYST, V2; R Development Core Team, 2016, R LANG ENV STAT COMP; Rats Pascal M., 2011, ENCY BIOL INVASIONS, P571; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Ribas A, 2013, ACTA PARASITOL, V58, P389, DOI 10.2478/s11686-013-0156-4; Richardson JL, 2017, EVOL APPL, V10, P323, DOI 10.1111/eva.12449; Rose N, 2011, COMP IMMUNOL MICROB, V34, P419, DOI 10.1016/j.cimid.2011.07.003; Scialfa E, 2010, REV ARGENT MICROBIOL, V42, P126, DOI 10.1590/S0325-75412010000200012; Seed, 2001, PARASITISM DIVERSITY; Singleton GR, 1999, MONOGRAPH, V59; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smith HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156180; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; STAHL WALTER, 1963, KEIO JOUR MED, V12, P55, DOI 10.2302/kjm.12.55; Storz JF, 2001, EVOLUTION, V55, P1215; Theuerkauf J, 2011, ANN ZOOL FENN, V48, P308, DOI 10.5735/086.048.0505; Tollenaere C, 2016, TRENDS PLANT SCI, V21, P80, DOI 10.1016/j.tplants.2015.10.014; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; TURTON JA, 1989, LAB ANIM, V23, P295, DOI 10.1258/002367789780746006; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Vaumourin E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1167-9; Vaumourin E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00062; Villanueva SYAM, 2010, AM J TROP MED HYG, V82, P889, DOI 10.4269/ajtmh.2010.09-0711; Wang J., 2002, GENETICS, V160; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	104	29	30	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184015	10.1371/journal.pone.0184015	http://dx.doi.org/10.1371/journal.pone.0184015			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886097	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100054
J	Locke, SM; Landy, MS				Locke, Shannon M.; Landy, Michael S.			Temporal causal inference with stochastic audiovisual sequences	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; SYNCHRONY; DETERMINANTS; PERCEPTION; NEURONS; SIGNALS; WINDOW; MODEL; RATS	Integration of sensory information across multiple senses is most likely to occur when signals are spatiotemporally coupled. Yet, recent research on audiovisual rate discrimination indicates that random sequences of light flashes and auditory clicks are integrated optimally regardless of temporal correlation. This may be due to 1) temporal averaging rendering temporal cues less effective; 2) difficulty extracting causal-inference cues from rapidly presented stimuli; or 3) task demands prompting integration without concern for the spatiotemporal relationship between the signals. We conducted a rate-discrimination task (Exp 1), using slower, more random sequences than previous studies, and a separate causal-judgement task (Exp 2). Unisensory and multisensory rate-discrimination thresholds were measured in Exp 1 to assess the effects of temporal correlation and spatial congruence on integration. The performance of most subjects was indistinguishable from optimal for spatiotemporally coupled stimuli, and generally sub-optimal in other conditions, suggesting observers used a multisensory mechanism that is sensitive to both temporal and spatial causal-inference cues. In Exp 2, subjects reported whether temporally uncorrelated (but spatially co-located) sequences were perceived as sharing a common source. A unified percept was affected by click-flash pattern similarity and the maximum temporal offset between individual clicks and flashes, but not on the proportion of synchronous click-flash pairs. A simulation analysis revealed that the stimulus-generation algorithms of previous studies is likely responsible for the observed integration of temporally independent sequences. By combining results from Exps 1 and 2, we found better rate-discrimination performance for sequences that are more likely to be integrated than those that are not. Our results support the principle that multisensory stimuli are optimally integrated when spatiotemporally coupled, and provide insight into the temporal features used for coupling in causal inference.	[Locke, Shannon M.; Landy, Michael S.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Landy, Michael S.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Locke, SM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	shannon.m.locke@nyu.edu	Locke, Shannon/AAP-3302-2020	Locke, Shannon/0000-0003-1787-3345; Landy, Michael/0000-0002-2079-4552	NIH [EY08266]; National Science Foundation-Collaborative Research in Computational Neuroscience [1420262]; NATIONAL EYE INSTITUTE [P30EY013079, R01EY008266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation-Collaborative Research in Computational Neuroscience(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant EY08266 and National Science Foundation-Collaborative Research in Computational Neuroscience Grant 1420262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Stephanie Badde, Elyse Norton, and Pascal Mamassian for helpful comments. This work was supported by NIH Grant EY08266 and National Science Foundation-Collaborative Research in Computational Neuroscience Grant 1420262.	Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Calvert G., 2004, HDB MULTISENSORY PRO; Carpenter B, 2016, J STAT SOFTW, P20; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Collier GL, 2000, MEM COGNITION, V28, P529, DOI 10.3758/BF03201243; Colonius H, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00011; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Denison RN, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00619; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Goldberg H, 2015, I-PERCEPTION, V6, DOI 10.1177/2041669515599332; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Innes-Brown H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006450; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; King AJ, 2005, CURR BIOL, V15, pR339, DOI 10.1016/j.cub.2005.04.022; Kleiner M, 2007, PERCEPTION, V36, P14; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Lewald J, 2001, BEHAV BRAIN RES, V121, P69, DOI 10.1016/S0166-4328(00)00386-7; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, BRAIN RES, V365, P350; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Noesselt T, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00064; Odegaard B, 2016, PSYCHOL SCI, V27, P583, DOI 10.1177/0956797616628860; Otto TU, 2012, CURR BIOL, V22, P1391, DOI 10.1016/j.cub.2012.05.031; Parise CV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11543; Parise CV, 2013, MULTISENS RES, V26, P307, DOI 10.1163/22134808-00002417; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; REGAN D, 1977, PERCEPTION, V6, P133, DOI 10.1068/p060133; Rohde M, 2016, MULTISENS RES, V29, P279, DOI 10.1163/22134808-00002510; Shen Y, 2015, BEHAV RES METHODS, V47, P13, DOI 10.3758/s13428-014-0450-6; Sheppard JP, 2013, J VISION, V13, DOI 10.1167/13.6.4; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 2013, ANN NY ACAD SCI, V1296, P31, DOI 10.1111/nyas.12121; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Van der Burg E, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3083; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Varghese L, 2017, J ACOUST SOC AM, V141, P2474, DOI 10.1121/1.4979470; Vatakis A, 2010, MULTISENSORY OBJECT PERCEPTION IN THE PRIMATE BRAIN, P95, DOI 10.1007/978-1-4419-5615-6_7; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WELCH RB, 1986, PERCEPT PSYCHOPHYS, V39, P294, DOI 10.3758/BF03204939; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329	56	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183776	10.1371/journal.pone.0183776	http://dx.doi.org/10.1371/journal.pone.0183776			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886035	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100037
J	Eichwald, C; Kim, J; Nibert, ML				Eichwald, Catherine; Kim, Jonghwa; Nibert, Max L.			Dissection of mammalian orthoreovirus mu 2 reveals a self-associative domain required for binding to microtubules but not to factory matrix protein mu NS	PLOS ONE			English	Article							REOVIRUS M1 GENE; CORE PROTEIN; TRIPHOSPHATASE ACTIVITIES; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION; INFECTIOUS VIRUS; TOP COMPONENT; RNA-SYNTHESIS; CELL TROPISM; STRANDED-RNA	Mammalian orthoreovirus protein mu 2 is a component of the viral core particle. Its activities include RNA binding and hydrolysis of the.-phosphate from NTPs and RNA 5'-termini, suggesting roles as a cofactor for the viral RNA-dependent RNA polymerase, lambda 3, first enzyme in 5'-capping of viral plus-strand RNAs, and/or prohibitory of RNA-5'-triphosphate-activated antiviral signaling. Within infected cells, mu 2 also contributes to viral factories, cytoplasmic structures in which genome replication and particle assembly occur. By associating with both microtubules (MTs) and viral factory matrix protein mu NS, mu 2 can anchor the factories to MTs, the full effects of which remain unknown. In this study, a protease-hypersensitive region allowed mu 2 to be dissected into two large fragments corresponding to residues 1-282 and 283-736. Fusions with enhanced green fluorescent protein revealed that these aminoand carboxyl-terminal regions of mu 2 associate in cells with either MTs or mu NS, respectively. More exhaustive deletion analysis defined mu 2 residues 1-325 as the minimal contiguous region that associates with MTs in the absence of the self-associating tag. A region involved in mu 2 self-association was mapped to residues 283-325, and self-association involving this region was essential for MT-association as well. Likewise, we mapped that mu NS-binding site in mu 2 relates to residues 290-453 which is independent of mu 2 self-association. These findings suggest that mu 2 monomers or oligomers can bind to MTs and mu NS, but that self-association involving mu 2 residues 283-325 is specifically relevant for MT-association during viral factories formation.	[Eichwald, Catherine; Kim, Jonghwa; Nibert, Max L.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [Eichwald, Catherine] Univ Zurich, Inst Virol, Zurich, Switzerland; [Kim, Jonghwa] Samsung Med Ctr, Lab Gastroenterol, Seoul, South Korea	Harvard University; Harvard Medical School; University of Zurich; Sungkyunkwan University (SKKU); Samsung Medical Center	Eichwald, C (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.; Eichwald, C (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	ceichwald@vetvir.uzh.ch		Eichwald, Catherine/0000-0003-0001-4843	NIH [R01 AI47904, R56 AI067445]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH research grants R01 AI47904 and R56 AI067445 to MLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Brentano L, 1998, J VIROL, V72, P8354, DOI 10.1128/JVI.72.10.8354-8357.1998; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Broering TJ, 2000, J VIROL, V74, P5516, DOI 10.1128/JVI.74.12.5516-5524.2000; Carvalho J, 2007, VIROLOGY, V364, P301, DOI 10.1016/j.virol.2007.03.037; Chandran K, 2003, J VIROL, V77, P13361, DOI 10.1128/JVI.77.24.13361-13375.2003; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Coombs KM, 1996, J VIROL, V70, P4237, DOI 10.1128/JVI.70.7.4237-4245.1996; Coombs KM, 1998, VIROLOGY, V243, P218, DOI 10.1006/viro.1998.9061; Criglar JM, 2014, J VIROL, V88, P786, DOI 10.1128/JVI.03022-13; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GARD G, 1970, J VIROL, V6, P100, DOI 10.1128/JVI.6.1.100-106.1970; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; HALLER BL, 1995, J VIROL, V69, P357, DOI 10.1128/JVI.69.1.357-364.1995; Hermann LL, 2004, J VIROL, V78, P6171, DOI 10.1128/JVI.78.12.6171-6179.2004; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Irvin SC, 2012, J VIROL, V86, P2302, DOI 10.1128/JVI.06236-11; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim J, 2004, VIRUS RES, V101, P15, DOI 10.1016/j.virusres.2003.12.003; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; LEMIEUX R, 1984, J VIROL, V51, P215, DOI 10.1128/JVI.51.1.215-222.1984; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; MATOBA Y, 1991, J CLIN INVEST, V87, P1628, DOI 10.1172/JCI115177; MATOBA Y, 1993, J CLIN INVEST, V92, P2883, DOI 10.1172/JCI116910; Mbisa JL, 2000, VIROLOGY, V272, P16, DOI 10.1006/viro.2000.0362; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2004, J VIROL, V78, P10291, DOI 10.1128/JVI.78.19.10291-10302.2004; Murray KE, 2007, J VIROL, V81, P4572, DOI 10.1128/JVI.02106-06; MUSTOE TA, 1978, VIROLOGY, V89, P594, DOI 10.1016/0042-6822(78)90200-3; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Nguyen CL, 2007, J VIROL, V81, P13533, DOI 10.1128/JVI.01669-07; Nibert ML, 2004, J VIROL, V78, P5528, DOI 10.1128/JVI.78.10.5528-5530.2004; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; Ooms LS, 2012, J VIROL, V86, P10979, DOI 10.1128/JVI.01172-12; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; RHIM JS, 1962, VIROLOGY, V17, P342, DOI 10.1016/0042-6822(62)90125-3; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; Sagar V, 2014, VIRUS RES, V183, P30, DOI 10.1016/j.virusres.2014.01.018; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; SHERRY B, 1989, J VIROL, V63, P4850, DOI 10.1128/JVI.63.11.4850-4856.1989; Sherry B, 1996, J VIROL, V70, P6709, DOI 10.1128/JVI.70.10.6709-6715.1996; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; SPENDLOVE RS, 1963, J IMMUNOL, V90, P548; Stebbing RE, 2014, J VIROL, V88, P2572, DOI 10.1128/JVI.02573-13; Su YP, 2006, J VIROL METHODS, V133, P146, DOI 10.1016/j.jviromet.2005.10.031; Swanson MI, 2002, RAPID COMMUN MASS SP, V16, P2317, DOI 10.1002/rcm.866; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Yin P, 1996, J VIROL, V70, P1223, DOI 10.1128/JVI.70.2.1223-1227.1996; Yin P, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-6; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	74	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184356	10.1371/journal.pone.0184356	http://dx.doi.org/10.1371/journal.pone.0184356			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880890	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000409467200057
J	Sousa, SR; Wingerd, JS; Brust, A; Bladen, C; Ragnarsson, L; Herzig, V; Deuis, JR; Dutertre, S; Vetter, I; Zamponi, GW; King, GF; Alewood, PF; Lewis, RJ				Sousa, Silmara R.; Wingerd, Joshua S.; Brust, Andreas; Bladen, Christopher; Ragnarsson, Lotten; Herzig, Volker; Deuis, Jennifer R.; Dutertre, Sebastien; Vetter, Irina; Zamponi, Gerald W.; King, Glenn F.; Alewood, Paul F.; Lewis, Richard J.			Discovery and mode of action of a novel analgesic beta-toxin from the African spider Ceratogyrus darlingi	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; SCORPION ODONTHOBUTHUS-DORIAE; CALCIUM-CHANNELS; VENOM PEPTIDES; OMEGA-CONOTOXIN; CYSTINE KNOT; DRUG DISCOVERY; VOLTAGE; PAIN; INHIBITION	Spider venoms are rich sources of peptidic ion channel modulators with important therapeutical potential. We screened a panel of 60 spider venoms to find modulators of ion channels involved in pain transmission. We isolated, synthesized and pharmacologically characterized Cd1a, a novel peptide from the venom of the spider Ceratogyrus darlingi. Cd1a reversibly paralysed sheep blowflies (PD50 of 1318 pmol/g) and inhibited human Ca(v)2.2 (IC50 2.6 mu M) but not Ca(v)1.3 or Ca(v)3.1 (IC50 > 30 mu M) in fluorimetric assays. In patch-clamp electrophysiological assays Cd1a inhibited rat Ca(v)2.2 with similar potency (IC50 3 mu M) without influencing the voltage dependence of Ca(v)2.2 activation gating, suggesting that Cd1a doesn't act on Ca(v)2.2 as a classical gating modifier toxin. The Cd1a binding site on Ca(v)2.2 did not overlap with that of the pore blocker omega-conotoxin GVIA, but its activity at Ca(v)2.2-mutant indicated that Cd1a shares some molecular determinants with GVIA and MVIIA, localized near the pore region. Cd1a also inhibited human Na(v)1.1-1.2 and Na(v)1.7-1.8 (IC50 0.1-6.9 mu M) but not Na(v)1.3-1.6 (IC50 > 30 mu M) in fluorimetric assays. In patch-clamp assays, Cd1a strongly inhibited human Na(v)1.7 (IC50 16 nM) and produced a 29 mV depolarising shift in Na(v)1.7 voltage dependence of activation. Cd1a (400 pmol) fully reversed Na(v)1.7-evoked pain behaviours in mice without producing side effects. In conclusion, Cd1a inhibited two anti-nociceptive targets, appearing to interfere with Ca(v)2.2 inactivation gating, associated with the Ca(v)2.2 alpha-subunit pore, while altering the activation gating of Na(v)1.7. Cd1a was inactive at some of the Na-v and Ca-v channels expressed in skeletal and cardiac muscles and nodes of Ranvier, apparently contributing to the lack of side effects at efficacious doses, and suggesting potential as a lead for development of peripheral pain treatments.	[Sousa, Silmara R.; Wingerd, Joshua S.; Brust, Andreas; Ragnarsson, Lotten; Herzig, Volker; Deuis, Jennifer R.; Vetter, Irina; King, Glenn F.; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, IMB Ctr Pain Res, Brisbane, Qld, Australia; [Bladen, Christopher; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Bladen, Christopher; Zamponi, Gerald W.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Dutertre, Sebastien] Univ Montpellier, CNRS, Inst Biomol Max Mousseron, Montpellier, France; [Vetter, Irina] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland; University of Calgary; Alberta Childrens Hospital; University of Calgary; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, IMB Ctr Pain Res, Brisbane, Qld, Australia.	r.lewis@imb.uq.edu.au	Vetter, Irina/A-6035-2010; Deuis, Jennifer/R-2440-2017; Ragnarsson, Lotten/A-8632-2012; Herzig, Volker/A-7177-2008; Lewis, Richard J./E-8674-2013	Vetter, Irina/0000-0002-3594-9588; Deuis, Jennifer/0000-0002-5107-8938; Ragnarsson, Lotten/0000-0002-7137-1656; Herzig, Volker/0000-0003-2514-3983; Lewis, Richard J./0000-0003-3470-923X; Zamponi, Gerald W./0000-0002-0644-9066; Bladen, Christopher/0000-0003-1063-2901; Rodrigues de Sousa, Silmara/0000-0002-2130-4439; King, Glenn/0000-0002-2308-2200	Australian National Health and Medical Council (NHMRC Program Grant) [APP1072113]; University of Queensland International Research Tuition Award (UQIRS) PhD Scholarship; NHMRC Principal Research Fellowships; Australian Research Council Future Fellowship; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)	Australian National Health and Medical Council (NHMRC Program Grant)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland International Research Tuition Award (UQIRS) PhD Scholarship; NHMRC Principal Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	We acknowledge financial support from the Australian National Health and Medical Council (NHMRC Program Grant APP1072113 to RJL, PFA and GFK). SRS was supported by a University of Queensland International Research Tuition Award (UQIRS) PhD Scholarship. RJL, PFA and GFK were supported by NHMRC Principal Research Fellowships; IV was supported by an Australian Research Council Future Fellowship; GWZ was supported by grants from the Canadian Institutes of Health Research and holds a Canada Research Chair. CB was supported by a Studentship from Alberta Innovates Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no financial support for the research, authorship, and/or publication of this article.; This research was facilitated by access to the Australian Proteome Analysis Facility (APAF), supported under the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS). We acknowledge help from Craig Alexander Rathwell with assessment of animal behaviour. We thank members of the Deutsche Arachnologische Gesellschaft (DeArGe), particularly Ingo Wendt and Henrik Krehenwinkel, for providing spiders for milking and Geoff Brown (Department of Agriculture, Fisheries and Forestry, Brisbane) for the supply of blowflies.	AHMAD SN, 1988, BRAIN RES, V453, P247; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bladen C, 2015, ACS CHEM NEUROSCI, V6, P277, DOI 10.1021/cn500206a; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deuis JR, 2016, TOXINS, P8; Dib-Hajj SD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-37; Durek T, 2013, ACS CHEM BIOL, V8, P1215, DOI 10.1021/cb400012k; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; Felix JP, 2004, ASSAY DRUG DEV TECHN, V2, P260, DOI 10.1089/1540658041410696; Feng ZP, 2001, J BIOL CHEM, V276, P15728, DOI 10.1074/jbc.M100406200; Feng ZP, 2001, J BIOL CHEM, V276, P5726, DOI 10.1074/jbc.C000791200; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Herzig V, 2008, NEUROTOXICOLOGY, V29, P471, DOI 10.1016/j.neuro.2008.03.002; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Jalali A, 2005, FEBS LETT, V579, P4181, DOI 10.1016/j.febslet.2005.06.052; Kalia J, 2015, J MOL BIOL, V427, P158, DOI 10.1016/j.jmb.2014.07.027; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Ma ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077758; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Sousa SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059293; Sousa SR, 2013, TOXINS, V5, P286, DOI 10.3390/toxins5020286; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Terstappen GC, 2010, FUTURE MED CHEM, V2, P715, DOI 10.4155/FMC.10.180; Vetter I, 2012, BIOCHEM PHARMACOL, V83, P1562, DOI 10.1016/j.bcp.2012.02.022; WAGNER JA, 1988, J NEUROSCI, V8, P3354; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; Xiao YC, 2014, MOL PHARMACOL, V86, P159, DOI 10.1124/mol.114.092338; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021	54	14	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182848	10.1371/journal.pone.0182848	http://dx.doi.org/10.1371/journal.pone.0182848			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880874	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200010
J	Tao, X; Liang, Y; Yang, XM; Pang, JH; Zhong, ZJ; Chen, XH; Yang, YK; Zeng, K; Kang, RM; Lei, YF; Ying, SC; Gong, JJ; Gu, YR; Lv, XB				Tao, Xuan; Liang, Yan; Yang, Xuemei; Pang, Jianhui; Zhong, Zhijun; Chen, Xiaohui; Yang, Yuekui; Zeng, Kai; Kang, Runming; Lei, Yunfeng; Ying, Sancheng; Gong, Jianjun; Gu, Yiren; Lv, Xuebin			Transcriptomic profiling in muscle and adipose tissue identifies genes related to growth and lipid deposition	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; LONGISSIMUS-DORSI; FATTY-ACID; MEAT QUALITY; PIG BREEDS; NETWORKS; LEPTIN; LIVER; PATHWAYS; FAMILY	Growth performance and meat quality are important traits for the pig industry and consumers. Adipose tissue is the main site at which fat storage and fatty acid synthesis occur. Therefore, we combined high-throughput transcriptomic sequencing in adipose and muscle tissues with the quantification of corresponding phenotypic features using seven Chinese indigenous pig breeds and one Western commercial breed (Yorkshire). We obtained data on 101 phenotypic traits, from which principal component analysis distinguished two groups: one associated with the Chinese breeds and one with Yorkshire. The numbers of differentially expressed genes between all Chinese breeds and Yorkshire were shown to be 673 and 1056 in adipose and muscle tissues, respectively. Functional enrichment analysis revealed that these genes are associated with biological functions and canonical pathways related to oxidoreductase activity, immune response, and metabolic process. Weighted gene coexpression network analysis found more coexpression modules significantly correlated with the measured phenotypic traits in adipose than in muscle, indicating that adipose regulates meat and carcass quality. Using the combination of differential expression, QTL information, gene significance, and module hub genes, we identified a large number of candidate genes potentially related to economically important traits in pig, which should help us improve meat production and quality.	[Tao, Xuan; Liang, Yan; Yang, Xuemei; Zhong, Zhijun; Chen, Xiaohui; Yang, Yuekui; Zeng, Kai; Kang, Runming; Lei, Yunfeng; Ying, Sancheng; Gong, Jianjun; Gu, Yiren; Lv, Xuebin] Sichuan Anim Sci Acad, Anim Breeding & Genet Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Pang, Jianhui] Chengdu Biotechserv Inst, Chengdu, Sichuan, Peoples R China		Gu, YR; Lv, XB (corresponding author), Sichuan Anim Sci Acad, Anim Breeding & Genet Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China.	guyiren1128@163.com; lvxuebinsasa@163.com	chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022		Sichuan Youth Science & Technology Foundation [2016JQ0041, 2017JQ0011]; Science & Technology Support Program of Sichuan [2016NYZ0042, 2016NZ0108]; Program for Pig Industry Technology System Innovation Team of Sichuan Province [SCCXTD-001, SCCXTD-005]; National Swine Industry Technology System Program [CARS-36]; Special Finance of Sichuan [SASA2014CZYX001]; Key Projects in the National Science & Technology Pillar Program [2015BAD03B02-10]; National Natural Science Foundation of China [31301942]; Open Fund of Sichuan Provincial Key Laboratory of Animal Breeding and Genetics [SASA2015A01, 2016YSKY0138]	Sichuan Youth Science & Technology Foundation; Science & Technology Support Program of Sichuan; Program for Pig Industry Technology System Innovation Team of Sichuan Province; National Swine Industry Technology System Program; Special Finance of Sichuan; Key Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of Sichuan Provincial Key Laboratory of Animal Breeding and Genetics	This work was supported by grants from the Sichuan Youth Science & Technology Foundation (2016JQ0041, 2017JQ0011) to Y.R.G., the Science & Technology Support Program of Sichuan (2016NYZ0042, 2016NZ0108) to X.B.L., the Program for Pig Industry Technology System Innovation Team of Sichuan Province (SCCXTD-001, SCCXTD-005) to X.B.L., the National Swine Industry Technology System Program (CARS-36) to X.B.L., the Special Finance of Sichuan (SASA2014CZYX001) to X.B.L., the Key Projects in the National Science & Technology Pillar Program (2015BAD03B02-10) to X.B.L and the National Natural Science Foundation of China (31301942), the Open Fund of Sichuan Provincial Key Laboratory of Animal Breeding and Genetics (SASA2015A01, 2016YSKY0138) to Y.R.G.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Anders S, 2014, BIOINFORMATICS; Nguyen A, 2014, J BIOL CHEM, V289, P1688, DOI 10.1074/jbc.M113.515320; Ayuso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145162; Barb CR, 2005, DOMEST ANIM ENDOCRIN, V29, P186, DOI 10.1016/j.domaniend.2005.02.024; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourneuf E, 2006, GENE, V372, P162, DOI 10.1016/j.gene.2005.12.028; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Davoli Roberta, 2007, Briefings in Functional Genomics & Proteomics, V6, P313, DOI 10.1093/bfgp/elm036; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Fougerousse F, 2002, J MUSCLE RES CELL M, V23, P255, DOI 10.1023/A:1020990825644; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Handley MT, 2014, MOL GENET GENOM MED, V2, P319, DOI 10.1002/mgg3.70; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hou XH, 2016, MOL GENET GENOMICS, V291, P559, DOI 10.1007/s00438-015-1126-3; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Huang YZ, 2010, ANIM BIOTECHNOL, V21, P170, DOI 10.1080/10495391003768813; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim NK, 2010, MAMM GENOME, V21, P307, DOI 10.1007/s00335-010-9264-8; Kogelman LJA, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-57; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li XJ, 2016, ANIM GENET, V47, P324, DOI 10.1111/age.12421; Li XJ, 2012, ANIM GENET, V43, P144, DOI 10.1111/j.1365-2052.2011.02240.x; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Men XM, 2013, ANIMAL, V7, P1486, DOI 10.1017/S1751731113000992; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Ovilo C, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-413, 10.1186/s12863-014-0148-x]; Plastow GS, 2005, MEAT SCI, V70, P409, DOI 10.1016/j.meatsci.2004.06.025; Ponsuksili S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123678; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Robert C, 1998, CAN J ANIM SCI, V78, P473, DOI 10.4141/A98-072; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Shen LY, 2014, ANIM SCI J, V85, P770, DOI 10.1111/asj.12207; Sodhi SS, 2014, MOL BIOL REP, V41, P6305, DOI 10.1007/s11033-014-3513-y; Sohl G, 2003, CELL COMMUN ADHES, V10, P27, DOI 10.1080/15419060390220468; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tang ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15544; The Gene Ontology C, 2014, NUCL ACIDS RES; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Torres-Rovira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066728; Ventanas S, 2006, MEAT SCI, V73, P651, DOI 10.1016/j.meatsci.2006.03.009; Wang ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141138; Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wylie ARG, 2011, ANIMAL, V5, P246, DOI 10.1017/S1751731110001540; Xiao RJ, 1999, ANIM FEED SCI TECH, V79, P119, DOI 10.1016/S0377-8401(98)00282-X; Xing K, 2016, SCI REP-UK, V6, DOI 10.1038/srep23219; Xing K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122396; Yu KF, 2013, INT J BIOL SCI, V9, P108, DOI 10.7150/ijbs.5306; Zhao X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1238-5; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7; Zhou CW, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-75; Zhou SL, 2012, GENET MOL RES, V11, P1254, DOI 10.4238/2012.May.9.4	74	16	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184120	10.1371/journal.pone.0184120	http://dx.doi.org/10.1371/journal.pone.0184120			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877211	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200065
J	Cheng, M; Kato, M; Tseng, C				Cheng, Miao; Kato, Masaharu; Tseng, Chia-huei			Gender and autistic traits modulate implicit motor synchrony	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; PHYSICAL-ACTIVITY; SEX-DIFFERENCES; FUNCTIONING AUTISM; MIMICRY; CHILDREN; EMPATHY; COORDINATION; METAANALYSIS; RECOGNITION	Interpersonal motor synchrony during walking or dancing is universally observed across cultures, and this joint movement was modulated by physical and social parameters. However, human interactions are greatly shaped by our unique traits, and self-related factors are surprisingly little studied in the context of interpersonal motor synchrony. In this study, we investigated two such factors known to be highly associated with motor coordination: gender and autistic traits. We employed a real-world task extending our understanding beyond laboratory tasks. Participants of the same gender were paired up to walk and chat in a natural environment. A cover story was introduced so that participants would not know their walking steps were being recorded and instead believed that their location was being tracked by a global positioning system (GPS), so they would ignore the motor recording. We found that the female pairs' steps were more synchronized than those of the males, and higher autistic tendencies (measured by the autism-spectrum quotient) attenuated synchronous steps. Those who synchronized better had higher impression rating increase for their walking partners (measured by interpersonal judgement scale) than those who synchronized less well. Our results indicated that the participants' joint movements were shaped by predisposed traits and might share similar mechanism with social functions such as empathy.	[Cheng, Miao] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Kato, Masaharu] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Kato, Masaharu] Doshisha Univ, Ctr Baby Sci, Kyoto, Japan; [Tseng, Chia-huei] Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi, Japan	University of Hong Kong; Nippon Telegraph & Telephone Corporation; Doshisha University; Tohoku University	Tseng, C (corresponding author), Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi, Japan.	CH_Tseng@alumni.uci.edu		Cheng, Miao/0000-0003-0611-6170	Cooperative Research Project Program from Research Institute of Electrical Communication at Tohoku University; Seed Funding Programme for Basic Research from the University of Hong Kong; Japan Society for the Promotion of Science Kakenhi [JP17K01923, JP24119006]	Cooperative Research Project Program from Research Institute of Electrical Communication at Tohoku University; Seed Funding Programme for Basic Research from the University of Hong Kong; Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	CT is supported by the Cooperative Research Project Program from Research Institute of Electrical Communication at Tohoku University, and the Seed Funding Programme for Basic Research from the University of Hong Kong. MK is supported by the Japan Society for the Promotion of Science Kakenhi JP17K01923, JP24119006.	Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Bachorowski J.-A., 2008, HDB EMOTIONS, P196; Barnett LM, 2010, RES Q EXERCISE SPORT, V81, P162; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BaronCohen S, 1997, ISRAEL J PSYCHIAT, V34, P174; Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Behrends A, 2012, ART PSYCHOTHER, V39, P107, DOI 10.1016/j.aip.2012.02.003; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Biscaldi M, 2014, EUR CHILD ADOLES PSY, V23, P599, DOI 10.1007/s00787-013-0475-x; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Brasholt M, 2013, PEDIATR RES, V74, P333, DOI 10.1038/pr.2013.99; Butler EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129651; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Chaplin TM, 2013, PSYCHOL BULL, V139, P735, DOI 10.1037/a0030737; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chraif M., 2013, INT J SOCIAL SCI HUM, V3, P147, DOI DOI 10.1080/1357650X.2016.1151024; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Cirelli LK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0400; Cirelli LK, 2014, DEVELOPMENTAL SCI, V17, P1003, DOI 10.1111/desc.12193; Duffy KA, 2015, CURR OPIN BEHAV SCI, V3, P112, DOI 10.1016/j.cobeha.2015.03.002; Fabbri-Destro M, 2013, CLIN NEUROPSYCHIATR, V10, P177; Farley SD, 2014, J NONVERBAL BEHAV, V38, P195, DOI 10.1007/s10919-014-0174-4; Fitzpatrick P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00021; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Forbes PAG, 2016, J AUTISM DEV DISORD, V46, P3788, DOI 10.1007/s10803-016-2930-2; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gernsbacher MA, 2008, J CHILD PSYCHOL PSYC, V49, P43, DOI 10.1111/j.1469-7610.2007.01820.x; Glazebrook CM, 2006, MOTOR CONTROL, V10, P244, DOI 10.1123/mcj.10.3.244; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Gonzalez DA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00023; Hall J., 2006, WOMENS MENS NONVERBA; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; Hall NR, 2012, J NONVERBAL BEHAV, V36, P235, DOI 10.1007/s10919-012-0136-7; Harrison SJ, 2009, J MOTOR BEHAV, V41, P519, DOI 10.3200/35-08-014; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Inzlicht M, 2012, J EXP SOC PSYCHOL, V48, P361, DOI 10.1016/j.jesp.2011.06.007; Jackson DM, 2003, OBES RES, V11, P420, DOI 10.1038/oby.2003.57; Junaid Kathryn A, 2006, Phys Occup Ther Pediatr, V26, P5; Kadak MT, 2014, COMPR PSYCHIAT, V55, P1146, DOI 10.1016/j.comppsych.2014.03.004; Kato M, 2015, 6 BIANN JOINT ACT M; Kawase S, 2015, MUSICAE SCI; KLIN A, 1995, J CHILD PSYCHOL PSYC, V36, P1127, DOI 10.1111/j.1469-7610.1995.tb01361.x; Koehne S, 2016, PSYCHOTHER PSYCHOSOM, V85, P27, DOI 10.1159/000441111; Koehne S, 2016, COGNITION, V146, P8, DOI 10.1016/j.cognition.2015.09.007; Kokal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027272; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Krishnan-Barman S., 2017, NEUROPSYCHOLOGIA; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Launay J, 2013, EXP PSYCHOL, V60, P53, DOI 10.1027/1618-3169/a000173; Lumsden J, 2012, J EXP SOC PSYCHOL, V48, P746, DOI 10.1016/j.jesp.2011.12.007; Marsh KL, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00004; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Miles LK, 2011, EXP BRAIN RES, V211, P495, DOI 10.1007/s00221-011-2641-z; Miles LK, 2010, J EXP SOC PSYCHOL, V46, P457, DOI 10.1016/j.jesp.2009.12.006; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Montoya RM, 2008, J SOC PERS RELAT, V25, P889, DOI 10.1177/0265407508096700; Moran MF, 2013, FRONT INTEGR NEUROSC, V7; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; O'Connor KM, 2005, J APPL BIOMECH, V21, P85, DOI 10.1123/jab.21.1.85; Paxton A, 2013, Q J EXP PSYCHOL, V66, P2092, DOI 10.1080/17470218.2013.853089; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Salmi J, 2013, NEUROIMAGE-CLIN, V3, P489, DOI 10.1016/j.nicl.2013.10.011; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schmidt RC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00633; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHMIDT RC, 1994, ECOL PSYCHOL, V6, P159, DOI 10.1207/s15326969eco0603_1; Schwarzkopf DS, 2014, J NEUROSCI, V34, P2713, DOI 10.1523/JNEUROSCI.4416-13.2014; Sevdalis V, 2014, PSYCHOL SPORT EXERC, V15, P173, DOI 10.1016/j.psychsport.2013.10.013; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; Steeb H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-4; Stel M, 2008, EUR J SOC PSYCHOL, V38, P965, DOI 10.1002/ejsp.472; Tannen D., 1985, LITERACY LANGUAGE LE; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Gaal S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00121; van Schaik JE, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.7016.00321, 10.3389/fpsyg.2016.00321]; WALK RD, 1984, B PSYCHONOMIC SOC, V22, P437; Weinberg MK, 1999, DEV PSYCHOL, V35, P175, DOI 10.1037/0012-1649.35.1.175; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959; Zhao Z, 2015, HUM MOVEMENT SCI, V41, P240, DOI 10.1016/j.humov.2015.03.012	101	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184083	10.1371/journal.pone.0184083	http://dx.doi.org/10.1371/journal.pone.0184083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF8QL	28873419	gold, Green Submitted, Green Published			2022-12-26	WOS:000409282800049
J	Muller, M; Seifert, S; Lubbe, T; Leuschner, C; Finkeldey, R				Mueller, Markus; Seifert, Sarah; Luebbe, Torben; Leuschner, Christoph; Finkeldey, Reiner			De novo transcriptome assembly and analysis of differential gene expression in response to drought in European beech	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; TREE SAPLING ASSEMBLAGES; RNA-SEQ; MICROSATELLITE MARKERS; SPECIES-DIVERSITY; STRESS RESPONSES; LOCAL ADAPTATION; PRECIPITATION; TOOL; PROVENANCES	Despite the ecological and economic importance of European beech (Fagus sylvatica L.) genomic resources of this species are still limited. This hampers an understanding of the molecular basis of adaptation to stress. Since beech will most likely be threatened by the consequences of climate change, an understanding of adaptive processes to climate change-related drought stress is of major importance. Here, we used RNA-seq to provide the first drought stress-related transcriptome of beech. In a drought stress trial with beech saplings, 50 samples were taken for RNA extraction at five points in time during a soil desiccation experiment. De novo transcriptome assembly and analysis of differential gene expression revealed 44,335 contigs, and 662 differentially expressed genes between the stress and normally watered control group. Gene expression was specific to the different time points, and only five genes were significantly differentially expressed between the stress and control group on all five sampling days. GO term enrichment showed that mostly genes involved in lipid-and homeostasis-related processes were upregulated, whereas genes involved in oxidative stress response were downregulated in the stressed seedlings. This study gives first insights into the genomic drought stress response of European beech, and provides new genetic resources for adaptation research in this species.	[Mueller, Markus; Seifert, Sarah; Finkeldey, Reiner] Univ Goettingen, Fac Forest Sci & Forest Ecol, Forest Genet & Forest Tree Breeding, Gottingen, Lower Saxony, Germany; [Luebbe, Torben; Leuschner, Christoph] Univ Goettingen, Albrecht Von Haller Inst Plant Sci, Plant Ecol & Ecosyst Res, Gottingen, Lower Saxony, Germany; [Finkeldey, Reiner] Univ Kassel, Kassel, Hesse, Germany	University of Gottingen; University of Gottingen; Universitat Kassel	Muller, M (corresponding author), Univ Goettingen, Fac Forest Sci & Forest Ecol, Forest Genet & Forest Tree Breeding, Gottingen, Lower Saxony, Germany.	mmuellef@gwdg.de	Finkeldey, Reiner/ABD-4392-2021; Müller, Markus/AAW-8079-2020; Müller, Markus/ABG-6524-2021	Finkeldey, Reiner/0000-0003-3500-5656; Müller, Markus/0000-0001-9990-0719; 	Deutsche Forschungsgemeinschaft [1374, Fi 569/12-2]; Graduiertenkolleg [1086]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg(German Research Foundation (DFG))	This work has been funded by the "Deutsche Forschungsgemeinschaft" through the Priority Program 1374 "Infrastructure-Biodiversity Exploratories" (Fi 569/12-2) and the Graduiertenkolleg 1086 "The role of biodiversity for biogeochemical cycles and biotic interactions in temperate deciduous forests". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda I, 2000, TREES-STRUCT FUNCT, V14, P344, DOI 10.1007/s004680050229; Aranda I, 2015, TREE PHYSIOL, V35, P34, DOI 10.1093/treephys/tpu101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asuka Y, 2004, MOL ECOL NOTES, V4, P101, DOI 10.1046/j.1471-8286.2003.00583.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilela S, 2012, FOREST ECOL MANAG, V275, P60, DOI 10.1016/j.foreco.2012.03.009; Carsjens C, 2014, TREE PHYSIOL, V34, P1348, DOI 10.1093/treephys/tpu093; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Dounavi A, 2016, FOREST ECOL MANAG, V361, P226, DOI 10.1016/j.foreco.2015.11.014; Dulamsuren C, 2017, TREES-STRUCT FUNCT, V31, P673, DOI 10.1007/s00468-016-1499-x; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Fleta-Soriano E, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00143; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Gallois A, 1999, ANN FOREST SCI, V56, P615, DOI 10.1051/forest:19990709; Garg R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19228; Gessler A, 2007, TREES-STRUCT FUNCT, V21, P1, DOI 10.1007/s00468-006-0107-x; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Grene R., 2002, ARABIDOPSIS BOOK, DOI [10.1199/tab.0036.1, DOI 10.1199/TAB.0036.1]; Gugger PF, 2017, TREE PHYSIOL, V37, P632, DOI 10.1093/treephys/tpw122; Hacket-Pain AJ, 2016, EUR J FOREST RES, V135, P897, DOI 10.1007/s10342-016-0982-7; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; Hoban S, 2016, AM NAT, V188, P379, DOI 10.1086/688018; Honaas LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146062; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Intergovernmental Panel on Climate Change (IPCC), 2014, ENGAGING WORLDVIEW 1; Knutzen F, 2017, ECOSYSTEMS; Knutzen F, 2015, TREE PHYSIOL, V35, P949, DOI 10.1093/treephys/tpv057; Kocher P, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008076; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lane T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3052-0; Lesur I, 2015, MOL ECOL RESOUR, V15, P1192, DOI 10.1111/1755-0998.12373; Leuschner C, 2001, FOREST ECOL MANAG, V149, P33, DOI 10.1016/S0378-1127(00)00543-0; Li YJ, 2015, PLANT SCI, V236, P157, DOI 10.1016/j.plantsci.2015.04.002; Liu CC, 2011, ENVIRON EXP BOT, V71, P174, DOI 10.1016/j.envexpbot.2010.11.012; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubbe T, 2016, TREE PHYSL; Lubbe T, 2016, OIKOS, V125, P86, DOI 10.1111/oik.02367; Lubbe T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00857; Meier IC, 2008, TREE PHYSIOL, V28, P297, DOI 10.1093/treephys/28.2.297; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Muller M, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0943-1; Olbrich M, 2008, Z NATURFORSCH C, V63, P574; Pastorelli R, 2003, MOL ECOL NOTES, V3, P76, DOI 10.1046/j.1471-8286.2003.00355.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pechanova O, 2015, INT J MOL SCI, V16, P28429, DOI 10.3390/ijms161226106; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Peuke AD, 2002, NEW PHYTOL, V154, P373, DOI 10.1046/j.1469-8137.2002.00400.x; Rabara RC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1575-4; Rajendra KC, 2014, FOREST ECOL MANAG, V319, P138, DOI 10.1016/j.foreco.2014.02.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Schall P, 2012, FOREST ECOL MANAG, V266, P246, DOI 10.1016/j.foreco.2011.11.017; Schuldt B, 2016, NEW PHYTOL, V210, P443, DOI 10.1111/nph.13798; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Schwanz P, 2001, J EXP BOT, V52, P133, DOI 10.1093/jexbot/52.354.133; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Shi Y, 2014, GENE, V538, P313, DOI 10.1016/j.gene.2014.01.031; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Ueno S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-236; Vornam B, 2004, CONSERV GENET, V5, P561, DOI 10.1023/B:COGE.0000041025.82917.ac; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wu JB, 2016, J EXP BOT, V67, P3339, DOI 10.1093/jxb/erw152; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida S, 2001, PLANT CELL PHYSIOL, V42, P170, DOI 10.1093/pcp/pce021; Zhang JY, 2014, PLANT CELL ENVIRON, V37, P2553, DOI 10.1111/pce.12328; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann J, 2015, ECOSYSTEMS, V18, P560, DOI 10.1007/s10021-015-9849-x	73	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184167	10.1371/journal.pone.0184167	http://dx.doi.org/10.1371/journal.pone.0184167			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873454	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800057
J	Renfro, B; Chadwick, NE				Renfro, Bobbie; Chadwick, Nanette E.			Benthic community structure on coral reefs exposed to intensive recreational snorkeling	PLOS ONE			English	Article							GREAT-BARRIER-REEF; NORTHERN RED-SEA; DIADEMA-ANTILLARUM; CARIBBEAN CORAL; WATER-QUALITY; MONTASTRAEA-ANNULARIS; OCEAN ACIDIFICATION; YUCATAN PENINSULA; MASS MORTALITY; DIVING IMPACTS	Chronic anthropogenic disturbances on coral reefs in the form of overfishing and pollution can shift benthic community composition away from stony corals and toward macroalgae. The use of reefs for recreational snorkeling and diving potentially can lead to similar ecological impacts if not well-managed, but impacts of snorkeling on benthic organisms are not well understood. We quantified variation in benthic community structure along a gradient of snorkeling frequency in an intensively-visited portion of the Mesoamerican Barrier Reef. We determined rates of snorkeling in 6 water sections and rates of beach visitation in 4 adjacent land sections at Akumal Bay, Mexico. For each in-water section at 1-3 m depth, we also assessed the percent cover of benthic organisms including taxa of stony corals and macroalgae. Rates of recreational snorkeling varied from low in the southwestern to very high (> 1000 snorkelers d(-1))in the northeastern sections of the bay. Stony coral cover decreased and macroalgal cover increased significantly with levels of snorkeling, while trends varied among taxa for other organisms such as gorgonians, fire corals, and sea urchins. We conclude that benthic organisms appear to exhibit taxon-specific variation with levels of recreational snorkeling. To prevent further degradation, we recommend limitation of snorkeler visitation rates, coupled with visitor education and in-water guides to reduce reef-damaging behaviors by snorkelers in high-use areas. These types of management activities, integrated with reef monitoring and subsequent readjustment of management, have the potential to reverse the damage potentially inflicted on coral reefs by the expansion of reef-based recreational snorkeling.	[Renfro, Bobbie; Chadwick, Nanette E.] Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci Bldg, Auburn, AL 36849 USA	Auburn University System; Auburn University	Chadwick, NE (corresponding author), Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci Bldg, Auburn, AL 36849 USA.	chadwick@auburn.edu	Renfro, Bobbie/AAT-9986-2020	Renfro, Bobbie/0000-0003-2449-6007; Chadwick, Nanette/0000-0003-3559-2248	Auburn University Graduate Research Fellowship; International Women's Fishing Association Ryan Kelley Memorial Scholarship	Auburn University Graduate Research Fellowship; International Women's Fishing Association Ryan Kelley Memorial Scholarship	This study was funded by an Auburn University Graduate Research Fellowship (http://graduate.auburn.edu/current-student/awards-and-grants/gracuate-research-and-travel-fellowsliips/),and an International Women's Fishing Association Ryan Kelley Memorial Scholarship (https://www.iwaf.org/scholarship), both to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank B. Figueroa-Zavala and the staff of the Centro Ecologico Akumal (CEA) for providing facilities and scientific collaboration. M. L. Becker, S. Lee, and W. Hall assisted in the collection of field data. This study was funded by an Auburn University Graduate Research Fellowship, and an International Women's Fishing Association Ryan Kelley Memorial Scholarship, both to BR. This work was submitted in partial fulfillment of the requirements for an M.Sc. degree to BR. This is publication #164 of the Auburn University Marine Biology Program.	ADEY WH, 1978, SCIENCE, V202, P831, DOI 10.1126/science.202.4370.831; Almada-Villela PC, 2003, MESOAMERICAN BARRIER; Alvarez-Filip L, 2009, B MAR SCI, V84, P295; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Aronson RB, 2000, LIMNOL OCEANOGR, V45, P251, DOI 10.4319/lo.2000.45.1.0251; Aronson RB, 2014, MAR ECOL PROG SER, V504, P159, DOI 10.3354/meps10765; BAK RPM, 1994, CORAL REEFS, V13, P99, DOI 10.1007/BF00300768; Baker DM, 2013, CORAL REEFS, V32, P691, DOI 10.1007/s00338-013-1040-2; Barker NHL, 2004, BIOL CONSERV, V120, P481, DOI 10.1016/j.biocon.2004.03.021; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Brown K, 1997, ENVIRON CONSERV, V24, P316, DOI 10.1017/S0376892997000428; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Cabanillas-Teran N, 2016, ECUADOR PEERJ, V4, pe1578; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; CEA, 2017, JAN FEB 2017 NEWSLET; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Chadwick-Furman N.E., 1997, P91; CHORNESKY EA, 1991, MAR BIOL, V109, P41, DOI 10.1007/BF01320230; Colombara A, 2017, B MAR SCI, V93; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CROQUER A, 2016, PEERJ, V4; CRUZ ICS, 2015, MAR ECOL-EVOL PERSP, V36, P318, DOI DOI 10.1111/maec.12141; DAVIES PS, 1990, MAR POLLUT BULL, V21, P346; Deloach N., 1999, REEF FISH BEHAV FLOR; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Edmunds PJ, 2011, CORAL REEFS, V30, P123, DOI 10.1007/s00338-010-0676-4; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Edmunds PJ, 2010, MAR ECOL PROG SER, V418, P87, DOI 10.3354/meps08823; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Falkenberg LJ, 2013, J APPL ECOL, V50, P51, DOI 10.1111/1365-2664.12019; Flood VS, 2005, MAR POLLUT BULL, V51, P545, DOI 10.1016/j.marpolbul.2005.07.010; Foster NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053283; Galzin R, 2016, CYBIUM REV INT ICHTY, V40, P1; Gil MA, 2015, MAR BIOL, V162, P2225, DOI 10.1007/s00227-015-2748-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Guzner B, 2010, B MAR SCI, V86, P727; Hasler H, 2008, MAR POLLUT BULL, V56, P1788, DOI 10.1016/j.marpolbul.2008.06.002; Hawkins JP, 1999, CONSERV BIOL, V13, P888, DOI 10.1046/j.1523-1739.1999.97447.x; Hernandez-Terrones LM, 2015, CONT SHELF RES, V102, P62, DOI 10.1016/j.csr.2015.04.015; Holles S, 2013, MAR ECOL PROG SER, V485, P295, DOI 10.3354/meps10346; Honey M, 2008, ECOTOUR BK SER, P234, DOI 10.1079/9781845934002.0234; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humann P., 2002, REEF CORAL IDENTIFIC; Iliopoulou-Georgudaki J, 2016, INT J SUST DEV WORLD, V23, P143, DOI 10.1080/13504509.2015.1102780; INEGI, 2010, EST UN MEX; INEGI, 2013, CUAD INF OP REG, V117; INEGI (INSTITUTO NACIONAL DE ESTADISTICA Y GEOGRAFIA), 1970, 9 CENS GEN POBL; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jordan-Garza AG, 2008, CORAL REEFS, V27, P295, DOI 10.1007/s00338-007-0338-3; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Krieger JR, 2013, J COAST CONSERV, V17, P179, DOI 10.1007/s11852-012-0229-9; Lamb JB, 2014, BIOL CONSERV, V178, P88, DOI 10.1016/j.biocon.2014.06.027; Larson Elizabeth A., 2014, Rev. biol. trop, V62, P299; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Lewis JB, 2006, ADV MAR BIOL, V50, P1, DOI 10.1016/S0065-2881(05)50001-4; LITTLER MM, 1991, CORAL REEFS, V10, P199, DOI 10.1007/BF00336775; Lyons PJ, 2015, BIODIVERS CONSERV, V24, P3491, DOI 10.1007/s10531-015-1009-2; Mantelatto MC, 2013, J EXP MAR BIOL ECOL, V449, P129, DOI 10.1016/j.jembe.2013.09.009; Cáceres Silvia Marcela, 2015, Rev. acad. colomb. cienc. exact. fis. nat., V39, P348, DOI 10.18257/raccefyn.195; McClanahan T, 2002, CONSERV ECOL, V6; MCCLANAHAN TR, 1989, J EXP MAR BIOL ECOL, V126, P77, DOI 10.1016/0022-0981(89)90125-1; McClanahan TR, 2000, BIOL CONSERV, V94, P191, DOI 10.1016/S0006-3207(99)00176-7; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Miller MW, 2009, MAR ECOL PROG SER, V387, P147, DOI 10.3354/meps08097; Miller MW, 1996, ECOL MONOGR, V66, P323, DOI 10.2307/2963521; Miller RJ, 2003, CORAL REEFS, V22, P181, DOI 10.1007/s00338-003-0301-x; Hernandez ALM, 2014, MAR ECOL PROG SER, V517, P143, DOI 10.3354/meps11068; Mulcahy N, 2016, J COASTAL RES, P1192, DOI 10.2112/SI75-239.1; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Mutchler T, 2007, ESTUAR COAST SHELF S, V74, P449, DOI 10.1016/j.ecss.2007.04.005; Muthukrishnan R, 2014, CORAL REEFS, V33, P911, DOI 10.1007/s00338-014-1199-1; Oliver LM, 2014, MAR ENVIRON RES, V99, P95, DOI 10.1016/j.marenvres.2014.04.005; R Core Team, 2013, R LANG ENV STAT COMP; Renfro B., 2016, THESIS; Roy RE, 2004, REV BIOL TROP, V52, P869; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Santos GS, 2015, ENVIRON MANAGE, V56, P847, DOI 10.1007/s00267-015-0552-7; Saphier AD, 2005, MAR POLLUT BULL, V51, P590, DOI 10.1016/j.marpolbul.2005.02.033; Shi L., 2005, INT J SUST DEV WORLD, V22, P103; Smith JE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.1985; Stuhldreier I, 2015, PEERJ, V3, DOI 10.7717/peerj.1434; Torres RM, 2005, ANN ASSOC AM GEOGR, V95, P314, DOI 10.1111/j.1467-8306.2005.00462.x; Umezawa Y, 2002, CORAL REEFS, V21, P346, DOI 10.1007/s00338-002-0254-5; Universidad Nacional Autonoma de Mexico (UNAM) Reef System Unit, 2015, SARG; van de Water JAJM, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov032; Wielgus J, 2002, CORAL REEFS, V21, P253, DOI 10.1007/s00338-002-0243-8; Wielgus J, 2010, CONSERV LETT, V3, P38, DOI 10.1111/j.1755-263X.2009.00084.x; Yang SY, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-39; Zakai D, 2002, BIOL CONSERV, V105, P179, DOI 10.1016/S0006-3207(01)00181-1	98	22	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184175	10.1371/journal.pone.0184175	http://dx.doi.org/10.1371/journal.pone.0184175			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873449	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800059
J	Timofeev, V; Bakhteeva, I; Titareva, G; Kopylov, P; Christiany, D; Mokrievich, A; Dyatlov, I; Vergnaud, G				Timofeev, Vitalii; Bakhteeva, Irina; Titareva, Galina; Kopylov, Pavel; Christiany, David; Mokrievich, Alexander; Dyatlov, Ivan; Vergnaud, Gilles			Russian isolates enlarge the known geographic diversity of Francisella tularensis subsp mediasiatica	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; TULAREMIA; NOVICIDA; STRAINS; PHYLOGEOGRAPHY; HOLARCTICA; TAXONOMY; AGENT	Francisella tularensis, a small Gram-negative bacterium, is capable of infecting a wide range of animals, including humans, and causes a plague-like disease called tularemia-a highly contagious disease with a high mortality rate. Because of these characteristics, F. tularensis is considered a potential agent of biological terrorism. Currently, F. tularensis is divided into four subspecies, which differ in their virulence and geographic distribution. Two of them, subsp. tularensis (primarily found in North America) and subsp. holarctica (widespread across the Northern Hemisphere), are responsible for tularemia in humans. Subsp. novicida is almost avirulent in humans. The fourth subspecies, subsp. mediasiatica, is the least studied because of its limited distribution and impact in human health. It is found only in sparsely populated regions of Central Asia. In this report, we describe the first focus of naturally circulating F. tularensis subsp. mediasiatica in Russia. We isolated and characterized 18 strains of this subspecies in the Altai region. All strains were highly virulent in mice. The virulence of subsp. mediasiatica in a vaccinated mouse model is intermediate between that of subsp. tularensis and subsp. holarctica. Based on a multiple-locus variable number tandem repeat analysis (MLVA), we show that the Altaic population of F. tularensis subsp. mediasiatica is genetically distinct from the classical Central Asian population, and probably is endemic to Southern Siberia. We propose to subdivide the mediasiatica subspecies into three phylogeographic groups, M.I, M.II and M.III.	[Timofeev, Vitalii; Bakhteeva, Irina; Titareva, Galina; Kopylov, Pavel; Mokrievich, Alexander; Dyatlov, Ivan] SRCAMB, Obolensk, Moscow Region, Russia; [Christiany, David; Vergnaud, Gilles] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Timofeev, V (corresponding author), SRCAMB, Obolensk, Moscow Region, Russia.; Vergnaud, G (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	timofeev_vitalii@mail.ru; gilles.vergnaud@u-psud.fr	Bakhteeva, Irina/AAA-7780-2022; Vergnaud, Gilles/P-1304-2015; Mokrievich, Alexander N/J-3452-2018; Vergnaud, Gilles/AAC-1162-2020; Timofeev, Vitalii/V-2376-2019	Bakhteeva, Irina/0000-0002-6897-3613; Vergnaud, Gilles/0000-0003-0913-194X; Mokrievich, Alexander N/0000-0003-3675-8780; Vergnaud, Gilles/0000-0003-0913-194X; Timofeev, Vitalii/0000-0002-9501-1380	Sectoral Scientific Program "Problem-oriented research in the epidemiological surveillance of infectious and parasitic diseases" of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing; French Agence Nationalede la Recherche [ANR-14-ASMA-0002]	Sectoral Scientific Program "Problem-oriented research in the epidemiological surveillance of infectious and parasitic diseases" of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing; French Agence Nationalede la Recherche(French National Research Agency (ANR))	This work is supported by the Sectoral Scientific Program "Problem-oriented research in the epidemiological surveillance of infectious and parasitic diseases (2016-2020)" of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) (http://www.rospotrebnadzor.ru/).Research by DC and GV is supported by grant ANR-14-ASMA-0002 from the French Agence Nationalede la Recherche (ANR) project MicroType (http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/).	AIKIMBAEV MA, 1966, REP ACAD SCI KAZ SSR, V5, P42; Birdsell Dawn N, 2009, BMC Res Notes, V2, P223, DOI 10.1186/1756-0500-2-223; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Challacombe JF, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.02589-16, 10.1128/AEM.02589-16]; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Clarridge JE, 1996, J CLIN MICROBIOL, V34, P1995, DOI 10.1128/JCM.34.8.1995-2000.1996; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Garrity, 2003, BERGEYS MANUAL SYSTE, P111; Gurcan S, 2008, JPN J INFECT DIS, V61, P223; Gurcan S, 2014, BALK MED J, V31, P3, DOI 10.5152/balkanmedj.2014.13117; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; Huber B, 2010, INT J SYST EVOL MICR, V60, P1887, DOI 10.1099/ijs.0.015941-0; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2010, INT J SYST EVOL MICR, V60, P1717, DOI 10.1099/ijs.0.022830-0; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kilic S, 2015, EMERG INFECT DIS, V21, P2213, DOI 10.3201/eid2112.150634; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Leelaporn A, 2008, EMERG INFECT DIS, V14, P1935, DOI 10.3201/eid1412.080435; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Mokrievich A.N., 2013, PROBL PARTIC DANGERO, V1, P66, DOI [10.21055/0370-1069-2013-1-66, DOI 10.21055/0370-1069-2013-1-66-69, 10.21055/0370-1069-2013-1-66-69]; Myrtennas Kerstin, 2016, Infection Ecology & Epidemiology, V6, P32838, DOI 10.3402/iee.v6.32838; O'Sullivan MVN, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-148; OLSUFJEV NG, 1983, INT J SYST BACTERIOL, V33, P872, DOI 10.1099/00207713-33-4-872; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Qin AP, 2014, J BACTERIOL, V196, P3571, DOI 10.1128/JB.01359-13; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Rodionova I V, 1970, Lab Delo, V1, P42; SANDSTROM G, 1992, J CLIN MICROBIOL, V30, P172; Sjodin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-268; Sju┬stedt A.B., 2005, BERGEYS MANUAL SYSTE, P200; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Telford SR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00150; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Wang YH, 2014, EMERG INFECT DIS, V20, P1191, DOI 10.3201/eid2007.130931; Whipp MJ, 2003, J MED MICROBIOL, V52, P839, DOI 10.1099/jmm.0.05245-0; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531	43	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183714	10.1371/journal.pone.0183714	http://dx.doi.org/10.1371/journal.pone.0183714			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873421	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800022
J	Wu, W; Pang, X; Lin, JQ; Liu, XM; Wang, R; Lin, JQ; Chen, LX				Wu, Wei; Pang, Xin; Lin, Jianqiang; Liu, Xiangmei; Wang, Rui; Lin, Jianqun; Chen, Linxu			Discovery of a new subgroup of sulfur dioxygenases and characterization of sulfur dioxygenases in the sulfur metabolic network of Acidithiobacillus caldus	PLOS ONE			English	Article							THIOBACILLUS-CALDUS; OXIDIZING BACTERIUM; OXIDATION; SULFIDE; THIOSULFATE; FERROOXIDANS; ETHE1; MICROORGANISMS; OXIDOREDUCTASE; PURIFICATION	Acidithiobacillus caldus is a chemolithoautotrophic sulfur-oxidizing bacterium that is widely used for bioleaching processes. Acidithiobacillus spp. are suggested to contain sulfur dioxygenases (SDOs) that facilitate sulfur oxidation. In this study, two putative sdo genes (A5904_0421 and A5904_1112) were detected in the genome of A. caldus MTH-04 by BLASTP searching with the previously identified SDO (A5904_0790). We cloned and expressed these genes, and detected the SDO activity of recombinant protein A5904_0421 by a GSH-dependent in vitro assay. Phylogenetic analysis indicated that A5904_0421and its homologous SDOs, mainly found in autotrophic bacteria, were distantly related to known SDOs and were categorized as a new subgroup of SDOs. The potential functions of genes A5904_0421 (termed sdo1) and A5904_0790 (termed sdo2) were investigated by generating three knockout mutants (Delta sdo1, Delta sdo2 and Delta sdo1&2), two sdo overexpression strains (OE-sdo1 and OE-sdo2) and two sdo complemented strains (Delta sdo1/sdo1' and Delta sdo2/sdo2') of A. caldus MTH-04. Deletion or overexpression of the sdo genes did not obviously affect growth of the bacteria on S-0, indicating that the SDOs did not play an essential role in the oxidation of extracellular elemental sulfur in A. caldus. The deletion of sdo1 resulted in complete inhibition of growth on tetrathionate, slight inhibition of growth on thiosulfate and increased GSH-dependent sulfur oxidation activity on S-0. Transcriptional analysis revealed a strong correlation between sdo1 and the tetrathionate intermediate pathway. The deletion of sdo2 promoted bacterial growth on tetrathionate and thiosulfate, and overexpression of sdo2 altered gene expression patterns of sulfide: quinone oxidoreductase and rhodanese. Taken together, the results suggest that sdo1 is essential for the survival of A. caldus when tetrathionate is used as the sole energy resource, and sdo2 may also play a role in sulfur metabolism.	[Wu, Wei; Pang, Xin; Lin, Jianqiang; Liu, Xiangmei; Wang, Rui; Lin, Jianqun; Chen, Linxu] Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China	Shandong University	Lin, JQ; Chen, LX (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China.	jianqunlin@sdu.edu.cn; linxuchen@sdu.edu.cn	Lin, Jianqiang/ABC-6345-2021	, Linxu/0000-0001-6620-6798	National Natural Science Foundation of China [31370138, 31570036, 31400093]; National Natural Science Foundation [30800011]; National Basic Research Program of China [2010CB630902]; State Key Laboratory of Microbial Technology Foundation [M2015-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Microbial Technology Foundation	JqiangL received the National Natural Science Foundation of China (grant numbers 31370138, 31570036); LC received the National Natural Science Foundation of China (grant number 31400093); XP received the National Natural Science Foundation (grant number 30800011); JqunL received the National Basic Research Program of China (grant number 2010CB630902) and the State Key Laboratory of Microbial Technology Foundation (M2015-03). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Beard S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00079; Chen LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039470; Christel S, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw057; Dopson M, 1999, APPL ENVIRON MICROB, V65, P36; Edwards KJ, 2000, ENVIRON MICROBIOL, V2, P324, DOI 10.1046/j.1462-2920.2000.00111.x; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Hallberg KB, 1996, J BACTERIOL, V178, P6, DOI 10.1128/jb.178.1.6-11.1996; Hallberg KB, 1996, APPL ENVIRON MICROB, V62, P4243, DOI 10.1128/AEM.62.11.4243-4246.1996; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; JIN SM, 1992, APPL ENVIRON MICROB, V58, P429, DOI 10.1128/AEM.58.1.429-430.1992; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kamimura K, 1999, MICROBIOS, V99, P7; KLETZIN A, 1989, J BACTERIOL, V171, P1638, DOI 10.1128/jb.171.3.1638-1643.1989; Liu HL, 2014, APPL ENVIRON MICROB, V80, P1799, DOI 10.1128/AEM.03281-13; Liu LJ, 2014, J BIOL CHEM, V289, P26949, DOI 10.1074/jbc.M114.591669; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangold S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00017; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Miura Y, 2000, J CHROMATOGR A, V884, P81, DOI 10.1016/S0021-9673(00)00221-1; Okibe N, 2003, APPL ENVIRON MICROB, V69, P1936, DOI 10.1128/AEM.69.4.1936-1943.2003; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Rohwerder T, 2007, ENG LIFE SCI, V7, P301, DOI 10.1002/elsc.200720204; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Rohwerder T, 2008, J SULFUR CHEM, V29, P293, DOI 10.1080/17415990802146972; Sambrook J., 2001, MOL CLONING LAB MANU; Sattler SA, 2015, J BIOL CHEM, V290, P18914, DOI 10.1074/jbc.M115.652537; Shiers DW, 2011, BIOCHEM ENG J, V54, P185, DOI 10.1016/j.bej.2011.02.018; SUGIO T, 1987, J BACTERIOL, V169, P4916, DOI 10.1128/jb.169.11.4916-4922.1987; SUZUKI I, 1959, P NATL ACAD SCI USA, V45, P239, DOI 10.1073/pnas.45.2.239; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van Zyl LJ, 2008, APPL ENVIRON MICROB, V74, P5686, DOI 10.1128/AEM.01235-08; Wakai S, 2004, BIOSCI BIOTECH BIOCH, V68, P2519, DOI 10.1271/bbb.68.2519; Wang HY, 2014, APPL MICROBIOL BIOT, V98, P7511, DOI 10.1007/s00253-014-5830-4; Wang ZB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01755; Yin HQ, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-179; Zhang LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081885	40	15	15	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183668	10.1371/journal.pone.0183668	http://dx.doi.org/10.1371/journal.pone.0183668			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873420	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800020
J	Kim, AY; Frantz, S; Krishnan, P; DeMulder, D; Caridi, T; Lynskey, GE; Spies, JB				Kim, Alexander Y.; Frantz, Shelby; Krishnan, Pranay; DeMulder, Danielle; Caridi, Theresa; Lynskey, George Emmett; Spies, James B.			Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System (R) for the treatment of hepatocellular carcinoma	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PHASE-II TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-TRANSPLANTATION; ANTIREFLUX CATHETER; SURVIVAL ANALYSIS; DOXORUBICIN; BEADS; EMBOLIZATION; EMBOLOTHERAPY	Purpose To review the initial imaging responses after drug-eluting embolic trans-arterial chemoembolization (DEE-TACE) delivered with the Surefire Infusion System (R) for the treatment of hepatocellular carcinoma (HCC). Methods Single center retrospective evaluation of patients who underwent DEE-TACE for HCC, delivered with SIS. Information was gathered from available medical records. Treatment response rates were assessed using the modified Response Evaluation Criteria in Solid Tumors criteria. Assessment of adverse events was categorized per Common Terminology Criteria for Adverse Events version 4.03. Results Twenty-two patients with 39 hepatocellular carcinoma lesions were treated with the surefire infusion system. Complete response was demonstrated in 32% of patients and 54% of lesions after a single treatment session. Overall disease response was demonstrated in 91% of patients and 85% of lesions after a single treatment. No grade 3 or higher elevations in liver function tests were demonstrated in the short-term. Conclusion SIS delivered DEE-TACE leads to a higher than expected initial response in patients with HCC.	[Kim, Alexander Y.; Frantz, Shelby; Krishnan, Pranay; DeMulder, Danielle; Caridi, Theresa; Lynskey, George Emmett; Spies, James B.] Medstar Georgetown Univ Hosp, Div Intervent Radiol, Dept Radiol, Washington, DC 20007 USA	Georgetown University	Kim, AY (corresponding author), Medstar Georgetown Univ Hosp, Div Intervent Radiol, Dept Radiol, Washington, DC 20007 USA.	Alexander.y.kim@gunet.georgetown.edu		Kim, Alexander/0000-0003-1056-4945				Allard MA, 2015, J HEPATOL, V63, P83, DOI 10.1016/j.jhep.2015.01.023; Arepally A, 2013, J VASC INTERV RADIOL, V24, P575, DOI 10.1016/j.jvir.2012.12.018; Brown KT, 2016, J CLIN ONCOL, V34, P2046, DOI 10.1200/JCO.2015.64.0821; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Jin B, 2011, AM J ROENTGENOL, V196, P919, DOI 10.2214/AJR.10.4770; Kim BK, 2015, J HEPATOL, V62, P1304, DOI 10.1016/j.jhep.2015.01.022; Kim BK, 2013, EUR J CANCER, V49, P826, DOI 10.1016/j.ejca.2012.08.022; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473; Liu B, 2015, ONCOLOGY-BASEL, V89, P23, DOI 10.1159/000371522; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Maddala YK, 2004, LIVER TRANSPLANT, V10, P449, DOI 10.1002/lt.20099; Malagari K, 2012, CARDIOVASC INTER RAD, V35, P1119, DOI 10.1007/s00270-012-0394-0; Millonig G, 2007, LIVER TRANSPLANT, V13, P272, DOI 10.1002/lt.21033; Nicolini A, 2010, J VASC INTERV RADIOL, V21, P327, DOI 10.1016/j.jvir.2009.10.038; Pasciak AS, 2015, J VASC INTERV RADIOL, V26, P660, DOI 10.1016/j.jvir.2015.01.029; Pastorelli D, 2006, ANN ONCOL, V17, pV153, DOI 10.1093/annonc/mdj972; Reyes DK, 2009, CANCER J, V15, P526, DOI 10.1097/PPO.0b013e3181c5214b; Rose SC, 2015, AM J ROENTGENOL, V205, P196, DOI 10.2214/AJR.14.13683; Vogl TJ, 2011, AM J ROENTGENOL, V197, pW562, DOI 10.2214/AJR.10.4379; Vogl TJ, 2009, EUR J RADIOL, V72, P505, DOI 10.1016/j.ejrad.2008.08.007; Yao FY, 2015, HEPATOLOGY, V61, P1968, DOI 10.1002/hep.27752	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183861	10.1371/journal.pone.0183861	http://dx.doi.org/10.1371/journal.pone.0183861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863147	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900010
J	Kost, LA; Nikitin, ES; Ivanova, VO; Sung, U; Putintseva, EV; Chudakov, DM; Balaban, PM; Lukyanov, KA; Bogdanov, AM				Kost, Liubov A.; Nikitin, Evgeny S.; Ivanova, Violetta O.; Sung, Uhna; Putintseva, Ekaterina V.; Chudakov, Dmitry M.; Balaban, Pavel M.; Lukyanov, Konstantin A.; Bogdanov, Alexey M.			Insertion of the voltage-sensitive domain into circularly permuted red fluorescent protein as a design for genetically encoded voltage sensor	PLOS ONE			English	Article							MEMBRANE VOLTAGE; LIVING CELLS; PROBE; COMPLEMENTATION; NEURONS; BRIGHT	Visualization of electrical activity in living cells represents an important challenge in context of basic neurophysiological studies. Here we report a new voltage sensitive fluorescent indicator which response could be detected by fluorescence monitoring in a single red channel. To the best of our knowledge, this is the first fluorescent protein-based voltage sensor which uses insertion-into-circular permutant topology to provide an efficient interaction between sensitive and reporter domains. Its fluorescent core originates from red fluorescent protein (FP) FusionRed, which has optimal spectral characteristics to be used in whole body imaging techniques. Indicators using the same domain topology could become a new perspective for the FP-based voltage sensors that are traditionally based on Forster resonance energy transfer (FRET).	[Kost, Liubov A.; Putintseva, Ekaterina V.; Chudakov, Dmitry M.; Lukyanov, Konstantin A.; Bogdanov, Alexey M.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Nikitin, Evgeny S.; Ivanova, Violetta O.; Balaban, Pavel M.] Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Sung, Uhna] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Chudakov, Dmitry M.] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Chudakov, Dmitry M.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Lukyanov, Konstantin A.; Bogdanov, Alexey M.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Institute of Higher Nervous Activity & Neurophysiology of RAS; Korea Institute of Science & Technology (KIST); Masaryk University Brno; Pirogov Russian National Research Medical University; Privolzhsky Research Medical University	Bogdanov, AM (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Bogdanov, AM (corresponding author), Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia.	noobissat@ya.ru	Bogdanov, Alexey/Q-7926-2019; Chudakov, Dmitriy M/G-7741-2014; Bogdanov, Alexey M/S-2759-2018; Kost, Liubov/AAT-9784-2020; Lukyanov, Konstantin A/D-4030-2013; Nikitin, Evgeny S/E-8330-2013; Balaban, Pavel M/I-5811-2014	Bogdanov, Alexey/0000-0002-5346-789X; Chudakov, Dmitriy M/0000-0003-0430-790X; Bogdanov, Alexey M/0000-0002-5346-789X; Lukyanov, Konstantin A/0000-0001-9845-2088; Nikitin, Evgeny S/0000-0003-0149-2054; Balaban, Pavel M/0000-0001-9248-8207; Ivanova, Violetta/0000-0002-6726-3118	Russian Science Foundation [14-25-00129, 14-25-0072]; United States National Institutes of Health [DC005259]; World Class Institute from the National Research Foundation of Korea [2009-003]; Molecular and Cell Biology program of Russian Academy of Sciences; Russian Science Foundation [17-25-00018, 17-25-00015] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class Institute from the National Research Foundation of Korea(National Research Foundation of Korea); Molecular and Cell Biology program of Russian Academy of Sciences; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (http://rscf.ru/) grant 14-25-00129. Electrophysiology experiments were supported by Russian Science Foundation (http://rscf.ru/) grant 14-25-0072. U.S. kindly acknowledges the support from United States National Institutes of Health (https://www.nih.gov/) DC005259 and World Class Institute 2009-003 from the National Research Foundation of Korea. E. S.N. was supported by Molecular and Cell Biology program of Russian Academy of Sciences. Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH).	Abdelfattah AS, 2016, J NEUROSCI, V36, P2458, DOI 10.1523/JNEUROSCI.3484-15.2016; Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Gautam SG, 2009, FRONT NEUROENG, V2, P8; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kaestner L, 2015, INT J MOL SCI, V16, P21626, DOI 10.3390/ijms160921626; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Mishina Y, 2012, BIOPHYS J, V103, P669, DOI 10.1016/j.bpj.2012.07.031; Mutoh H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004555; Perron A, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.005.2009; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Shui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020505; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Storace D, 2016, TRENDS NEUROSCI, V39, P277, DOI 10.1016/j.tins.2016.02.005; Sung U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141585; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235	26	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184225	10.1371/journal.pone.0184225	http://dx.doi.org/10.1371/journal.pone.0184225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863184	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900041
J	Meng, S; Oi, M; Saito, G; Saito, H				Meng, Shuang; Oi, Misato; Saito, Godai; Saito, Hirofumi			The neural correlates of biomechanical constraints in hand laterality judgment task performed from other person's perspective: A near-infrared spectroscopy study	PLOS ONE			English	Article							MENTAL ROTATION; MOTOR IMAGERY; 3RD-PERSON PERSPECTIVES; VISUAL PERSPECTIVE; PREFRONTAL CORTEX; REPRESENTATIONS; NIRS; ACTIVATION; FRAMES; FMRI	Previous studies, mainly using a first-person perspective (1PP), have shown that the judgments of the hand laterality judgment (HLJ) task are dependent on biomechanical constraints (BC). Specifically, differing reaction times (RT) for hand pictures rotated medially or laterally around the mid sagittal plane are attributed to the BC effect on motor imagery. In contrast, we investigated whether the HLJ task is also subject to BC when performed from a third-person perspective (3PP) as well as 1PP using near-infrared spectroscopy (NIRS) to measure the brain activity of prefrontal cortex (PFC) in right-handed participants assigned to 1PP or 3PP groups. The 1PP group judged whether a presented hand was their own left or right hand, and the 3PP group whether it was the other's left or right hand. Using their HLJ task error rates, the 1PP and 3PP groups were subdivided into an Error Group (EG) and No Error Group (NEG). For the 1PP group, both EG and NEG showed a significant Hand Laterality x Orientation interaction for RT, indicating the BC effect on motor imagery. For the 3PP group, however, neither EG nor NEG showed the interaction, even though EG showed a significantly longer RT than NEG. These results suggest that the 3PP EG appropriately followed the 3PP task instruction, while the NEG might have taken 1PP. However, the 3PP EG NIRS profile of left PFC showed a significant Hand Laterality x Orientation interaction, while the 1PP EG did not. More noteworthy is that the left PFC activation of EG showed an interaction between the 1PP and 3PP groups when the left hand was presented. Furthermore, in the NEG, the PFC activation was not influenced by the BC in either the 1PP or 3PP condition. These results indicate that BC interferes with the HLJ task performed from the 1PP and 3PP.	[Meng, Shuang; Saito, Hirofumi] Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan; [Oi, Misato] Kyushu Univ, Fac Arts & Sci, Fukuoka, Japan; [Saito, Godai] Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi, Japan	Nagoya University; Kyushu University; Tohoku University	Saito, H (corresponding author), Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan.	saito@is.nagoya-u.ac.jp	/AAX-7091-2021	/0000-0002-2433-6057				Anquetil T, 2007, BRAIN RES, V1130, P125, DOI 10.1016/j.brainres.2006.10.091; Beste C, 2010, BRAIN COGNITION, V72, P238, DOI 10.1016/j.bandc.2009.09.005; Conson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070734; Conson M, 2012, NEUROSCI LETT, V530, P35, DOI 10.1016/j.neulet.2012.09.051; Conson M, 2009, EXP BRAIN RES, V199, P71, DOI 10.1007/s00221-009-1974-3; Conson M, 2009, NEUROSCI LETT, V452, P176, DOI 10.1016/j.neulet.2009.01.043; Cooper L. A., 1973, VISUAL INFORM PROCES; COOPER LA, 1975, COGNITIVE PSYCHOL, V7, P20, DOI 10.1016/0010-0285(75)90003-1; Cui X, 2012, NEUROIMAGE, V59, P2430, DOI 10.1016/j.neuroimage.2011.09.003; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; EASTON RD, 1995, J EXP PSYCHOL LEARN, V21, P483, DOI 10.1037/0278-7393.21.2.483; HOSHI Y, 1993, J APPL PHYSIOL, V75, P1842, DOI 10.1152/jappl.1993.75.4.1842; Jeannerod M, 2008, SOC NEUROSCI-UK, V3, P356, DOI 10.1080/17470910701563715; Kitada R, 2010, PERCEPTION, V39, P236, DOI 10.1068/p6535; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Liu T, 2012, NEUROSCI LETT, V506, P220, DOI 10.1016/j.neulet.2011.11.009; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Mazzarella E, 2013, SOC NEUROSCI-UK, V8, P248, DOI 10.1080/17470919.2012.761160; Meng S, 2016, NEUROSCI LETT, V627, P211, DOI 10.1016/j.neulet.2016.05.069; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tarr MJ, 1989, COGNITIVE PSYCHOL, V21, P33; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Thayer ZC, 2006, PSYCHOPHYSIOLOGY, V43, P401, DOI 10.1111/j.1469-8986.2006.00404.x; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; Vannuscorps G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00299; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183818	10.1371/journal.pone.0183818	http://dx.doi.org/10.1371/journal.pone.0183818			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF3ON	28863149	Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900008
J	Walsh, AM; Wechalekar, MD; Guo, YX; Yin, XF; Weedon, H; Proudman, SM; Smith, MD; Nagpal, S				Walsh, Alice M.; Wechalekar, Mihir D.; Guo, Yanxia; Yin, Xuefeng; Weedon, Helen; Proudman, Susanna M.; Smith, Malcolm D.; Nagpal, Sunil			Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways	PLOS ONE			English	Article							PLASMA-CELLS; METHOTREXATE; DISEASE; ASSOCIATION; MEMBRANES; THERAPY; TARGET; CSF	Objectives This study sought to investigate the genome-wide transcriptional effects of a combination of disease modifying anti-rheumatic drugs (tDMARD; methotrexate, sulfasalazine and hydroxychloroquine) in synovial tissues obtained from early rheumatoid arthritis (RA) patients. While combination DMARD strategies have been investigated for clinical efficacy, very little data exists on the potential molecular mechanism of action. We hypothesized that tDMARD would impact multiple biological pathways, but the specific pathways were unknown. Methods Paired synovial biopsy samples from early RA patients before and after 6 months of tDMARD therapy were collected by arthroscopy (n = 19). These biopsies as well as those from subjects with normal synovium (n = 28) were profiled by total RNA sequencing. Results Large differences in gene expression between RA and control biopsies (over 5000 genes) were identified. Despite clinical efficacy, the expression of a restricted set of less than 300 genes was reversed after 6 months of treatment. Many genes remained elevated, even in patients who achieved low disease activity. Interestingly, tDMARD downregulated genes included those involved in T cell activation and signaling and plasmablast/plasma cell differentiation and function. Conclusions We have identified transcriptomic signatures that characterize synovial tissue from RA patients with early disease. Analysis after 6 months of tDMARD treatment highlight consistent alterations in expression of genes related to T cell activation and plasmablast/plasma cell differentiation. These results provide novel insight into the biology of early RA and the mechanism of tDMARD action and may help identify novel drug targets to improve rates of treatment-induced disease remission.	[Walsh, Alice M.; Guo, Yanxia; Yin, Xuefeng; Nagpal, Sunil] Janssen Res & Dev LLC, Immunol, Spring House, PA 19002 USA; [Wechalekar, Mihir D.] Repatriat Gen Hosp, Daw Pk, SA, Australia; [Wechalekar, Mihir D.; Weedon, Helen; Smith, Malcolm D.] Flinders Univ S Australia, Adelaide, SA, Australia; [Proudman, Susanna M.] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA, Australia; [Proudman, Susanna M.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Flinders University South Australia; Royal Adelaide Hospital; University of Adelaide	Nagpal, S (corresponding author), Janssen Res & Dev LLC, Immunol, Spring House, PA 19002 USA.; Smith, MD (corresponding author), Flinders Univ S Australia, Adelaide, SA, Australia.	ssmitmd@gmail.com; snagpal2@its.jnj.com	Wechalekar, Mihir/H-8114-2013	Wechalekar, Mihir/0000-0001-6668-9638; Walsh, Alice/0000-0001-5905-5768	Johnson Johnson; National Health and Medical Research Council of Australia	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by funding from Johnson & Johnson. The funder provided support in the form of funding for data generation and salaries for authors [AMW, YG, XY, SN], but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. MDW was supported by a National Health and Medical Research Council of Australia postgraduate scholarship.	Alzabin S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3875; BANKHURST AD, 1976, ARTHRITIS RHEUM, V19, P555, DOI 10.1002/art.1780190307; BELL AL, 1995, RHEUMATOL INT, V14, P177, DOI 10.1007/BF00262295; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Chen SY, 2012, GENE THER, V19, P752, DOI 10.1038/gt.2011.173; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUKE O, 1982, CLIN EXP IMMUNOL, V49, P22; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Hiepe F, 2016, NAT REV NEPHROL, V12, P232, DOI 10.1038/nrneph.2016.20; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; Keating GM, 2013, DRUGS, V73, P1095, DOI 10.1007/s40265-013-0080-9; Kelly S, 2015, ANN RHEUM DIS, V74, P611, DOI 10.1136/annrheumdis-2013-204603; Kerkman PF, 2013, ANN RHEUM DIS, V72, P1259, DOI 10.1136/annrheumdis-2012-202893; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Park JS, 2013, AM J PATHOL, V183, P857, DOI 10.1016/j.ajpath.2013.05.027; Rantalaiho V, 2009, ARTHRITIS RHEUM-US, V60, P1222, DOI 10.1002/art.24447; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Singh JA, 2015, ARTHRITIS RHEUMATOL, V67, DOI 10.1002/art.39480; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; Verweij CL, 2012, GENE EXPRESSION PROF; Woetzel D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4526	37	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183928	10.1371/journal.pone.0183928	http://dx.doi.org/10.1371/journal.pone.0183928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863153	gold, Green Published, Green Submitted			2022-12-26	WOS:000408816900012
J	Liu, L; Luo, C; Luo, Y; Chen, L; Liu, Y; Wang, Y; Han, J; Zhang, Y; Wei, N; Xie, Z; Wu, W; Wu, G; Feng, Y				Liu, L.; Luo, C.; Luo, Y.; Chen, L.; Liu, Y.; Wang, Y.; Han, J.; Zhang, Y.; Wei, N.; Xie, Z.; Wu, W.; Wu, G.; Feng, Y.			MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression	ONCOGENE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-K; MT-CYB; REVEALS; EVENTS; GENES; MECHANISMS; FAILURE; ROLES	MRPL33 gene encodes a large mitoribosomal subunit protein, which may be involved in mitochondrial translation. Although two splice variants of MRPL33 have been described, its splicing regulation remains elusive. Here we observed that inclusion of alternative exon 3 was greatly promoted in a panel of human cancer cells. Depletion of the exon 3-containing long isoform of MRPL33 (MRPL33-L) led to impaired proliferation and increased apoptosis in cancer cell lines and in a xenograft model. MRPL33-L knockdown could also induce mitochondrial dysfunction including increased accumulation of reactive oxygen species, decreased ATP production and 16 S rRNA levels. We further showed that alternative splicing of MRPL33-L pre-mRNA is regulated by hnRNPK and that knocking down hnRNPK could phenocopy MRPL33-L depletion. More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA. Finally, we found that inclusion of MRPL33 exon 3 was promoted in human colorectal cancer tissues and this was correlated with hnRNPK levels. In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells.	[Liu, L.; Luo, C.; Luo, Y.; Chen, L.; Liu, Y.; Wang, Y.; Zhang, Y.; Wei, N.; Xie, Z.; Feng, Y.] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res,Inst Nutr Sci, Shanghai, Peoples R China; [Han, J.; Wu, G.] Fudan Univ, Zhongshan Hosp, Sch Med, Dept Surg, Shanghai, Peoples R China; [Wu, W.] Zhejiang Agr & Forestry Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Linan, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University; Zhejiang A&F University	Wu, G (corresponding author), Fudan Univ, Zhongshan Hosp, Sch Med, Dept Surg, Shanghai, Peoples R China.; Feng, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	wu.guohao@zs-hospital.sh.cn; fengying@sibs.ac.cn		Wu, Guohao/0000-0001-9490-4200; Liu, Yuguo/0000-0002-1421-3854	National Natural Science Foundation [31570818, 31370786, 31601170, 31400677, 81372197]; 'Personalized Medicine-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010100]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 'Personalized Medicine-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences	This work was supported by grants from the National Natural Science Foundation 31570818 to Y Feng and 31370786 to Y Feng and 31601170 to N Wei and 31400677 to W Wu and 81372197 to G Wu and also from the 'Personalized Medicine-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010100).	Barboro P, 2014, CANCER LETT, V352, P152, DOI 10.1016/j.canlet.2014.06.019; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng YM, 2016, MOL CELL BIOL, V36, P1628, DOI 10.1128/MCB.01071-15; Danan-Gotthold M, 2015, NUCLEIC ACIDS RES, V43, P5130, DOI 10.1093/nar/gkv210; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003; Gopisetty G, 2016, GENE, V589, P27, DOI 10.1016/j.gene.2016.05.008; Guha S, 2006, ANIM GENET, V37, P262, DOI 10.1111/j.1365-2052.2006.01421.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747; Nazim M, 2017, NUCLEIC ACIDS RES, V45, P1455, DOI 10.1093/nar/gkw823; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Sebestyen E, 2015, NUCLEIC ACIDS RES, V43, P1345, DOI 10.1093/nar/gku1392; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Wallace L, 2016, TUMOR BIOL, V37, P12465, DOI 10.1007/s13277-016-5101-3; Wei N, 2015, CELL REP, V13, P1647, DOI 10.1016/j.celrep.2015.10.038; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Zhou XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5581; Zhou XX, 2014, NUCLEIC ACIDS RES, V42, P4019, DOI 10.1093/nar/gkt1387	25	29	31	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					86	94		10.1038/onc.2017.314	http://dx.doi.org/10.1038/onc.2017.314			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28869607				2022-12-26	WOS:000422625000009
J	Xu, Z; Gakhar, L; Bain, FE; Spies, M; Fuentes, EJ				Xu, Zhen; Gakhar, Lokesh; Bain, Fletcher E.; Spies, Maria; Fuentes, Ernesto J.			The Tiam1 guanine nucleotide exchange factor is auto-inhibited by its pleckstrin homology coiled-coil extension domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ASSOCIATION RATES; RAC ACTIVATOR TIAM1; RHO GTPASES; RESOLUTION STRUCTURE; REGULATES TIAM1; MOLECULE; BINDING; MECHANISM; DYNAMICS; GEFS	T-cell lymphoma invasion and metastasis 1 (Tiam1) is a Dblfamily guanine nucleotide exchange factor (GEF) that specifically activates the Rho-family GTPase Rac1 in response to upstream signals, thereby regulating cellular processes including cell adhesion and migration. Tiam1 contains multiple domains, including an N-terminal pleckstrin homology coiledcoiled extension (PHn-CC-Ex) and catalytic Dbl homology and C-terminal pleckstrin homology (DH-PHc) domain. Previous studies indicate that larger fragments of Tiam1, such as the region encompassing the N-terminal to C-terminal pleckstrin homology domains (PHn-PHc), are auto-inhibited. However, the domains in this region responsible for inhibition remain unknown. Here, we show that the PHn-CC-Ex domain inhibits Tiam1 GEF activity by directly interacting with the catalytic DH-PHc domain, preventing Rac1 binding and activation. Enzyme kinetics experiments suggested that Tiam1 is auto-inhibited through occlusion of the catalytic site rather than by allostery. Small angle X-ray scattering and ensemble modeling yielded models of the PHn-PHc fragment that indicate it is in equilibrium between "open" and "closed" conformational states. Finally, single-molecule experiments support a model in which conformational sampling between the open and closed states of Tiam1 contributes to Rac1 dissociation. Our results highlight the role of the PHn-CC-Ex domain in Tiam1 GEF regulation and suggest a combinatorial model for GEF inhibition and activation of the Rac1 signaling pathway.	[Xu, Zhen; Gakhar, Lokesh; Bain, Fletcher E.; Spies, Maria; Fuentes, Ernesto J.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Univ Iowa, Prot Crystallog Facil, Iowa City, IA 52242 USA; [Spies, Maria; Fuentes, Ernesto J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Fuentes, EJ (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	ernesto-fuentes@uiowa.edu	Gakhar, Lokesh/F-2113-2010; Xu, Zhen/I-5540-2018	Gakhar, Lokesh/0000-0002-3319-1902; Spies, Maria/0000-0002-7375-8037; Xu, Zhen/0000-0001-8855-0565; Fuentes, Ernesto/0000-0001-5812-8187	DOE Office of Science User Facility [DE-AC02-05CH11231]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108617] Funding Source: NIH RePORTER	DOE Office of Science User Facility(United States Department of Energy (DOE)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members in the Fuentes laboratory for discussions and technical assistance. We thank the staff at the University of Iowa Protein Crystallography Core, BioCAT beamline 18-ID-D at the Argonne National Laboratory and the SIBYLS beamline 12.3.1 at the Berkeley National Laboratory for assistance with SAXS data collection. We thank Dr. Casey Andrews and Shuxiang Li for assistance in the construction of atomic models. We thank Dr. Elizabeth Boehm and Dr. Todd Washington for preliminary single-molecule experiments. We acknowledge that this research used the resources of the Advanced Light Source, which is a DOE Office of Science User Facility under Contract DE-AC02-05CH11231. In addition, this research used the resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; Bain FE, 2016, METHODS, V108, P14, DOI 10.1016/j.ymeth.2016.05.009; Barreira M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004993; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Bustelo Xose R, 2014, Small GTPases, V5, P9, DOI 10.4161/21541248.2014.973757; Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Durand E, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-4; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fuentes EJ, 2003, J BIOL CHEM, V278, P21188, DOI 10.1074/jbc.M211792200; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joo C., 2012, COLD SPRING HARB PRO, V2012, P1104, DOI [DOI 10.1101/PDB.PROT071530, DOI 10.1101/PDB.PR0T071530]; Joshi M, 2013, ACTA CRYSTALLOGR F, V69, P744, DOI 10.1107/S1744309113014206; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mathew E, 2004, J SYNCHROTRON RADIAT, V11, P314, DOI 10.1107/S0909049504014086; Matsuzawa K, 2016, MOL BIOL CELL, V27, P1511, DOI 10.1091/mbc.E15-09-0670; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pugh RA, 2008, J MOL BIOL, V383, P982, DOI 10.1016/j.jmb.2008.09.001; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Randazzo P. A., 2013, CELLULAR LOGISTICS, V3, pe27609, DOI [10.4161/cl.27609, DOI 10.4161/CL.27609]; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Shi XH, 2012, NAT METHODS, V9, P499, DOI [10.1038/NMETH.1954, 10.1038/nmeth.1954]; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Stebel A, 2009, ONCOL REP, V21, P217, DOI 10.3892/or_00000211; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Vagenende V, 2013, ACS CHEM BIOL, V8, P416, DOI 10.1021/cb300440x; Viaud J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5080; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876	79	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17777	17793		10.1074/jbc.M117.799114	http://dx.doi.org/10.1074/jbc.M117.799114			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28882897	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000414013000016
J	Gamage, DG; Leikina, E; Quinn, ME; Ratinov, A; Chernomordik, LV; Millay, DP				Gamage, Dilani G.; Leikina, Eugenia; Quinn, Malgorzata E.; Ratinov, Anthony; Chernomordik, Leonid V.; Millay, Douglas P.			Insights into the localization and function of myomaker during myoblast fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE FORMATION; PLASMA-MEMBRANE; SIGNAL PEPTIDE; CELL-FUSION; RAB GTPASES; PROTEIN; PALMITOYLATION; MECHANISMS; ACYLATION; MYOCYTES	Multinucleated skeletal muscle fibers form through the fusion of myoblasts during development and regeneration. Previous studies identified myomaker (Tmem8c) as a muscle-specific membrane protein essential for fusion. However, the specific function of myomaker and how its function is regulated are unknown. To explore these questions, we first examined the cellular localization of endogenous myomaker. Two independent antibodies showed that whereas myomaker does localize to the plasma membrane in cultured myoblasts, the protein also resides in the Golgi and post-Golgi vesicles. These results raised questions regarding the precise cellular location of myomaker function and mechanisms that govern myomaker trafficking between these cellular compartments. Using a synchronized fusion assay, we demonstrated that myomaker functions at the plasma membrane to drive fusion. Trafficking of myomaker is regulated by palmitoylation of C-terminal cysteine residues that allows Golgi localization. Moreover, dissection of the C terminus revealed that palmitoylation was not sufficient for complete fusogenic activity suggesting a function for other amino acids within this C-terminal region. Indeed, C-terminal mutagenesis analysis highlighted the importance of a C-terminal leucine for function. These data reveal that myoblast fusion requires myomaker activity at the plasma membrane and is potentially regulated by proper myomaker trafficking.	[Gamage, Dilani G.; Quinn, Malgorzata E.; Millay, Douglas P.] Cincinnati Childrens Hosp Med Ctr, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Leikina, Eugenia; Ratinov, Anthony; Chernomordik, Leonid V.] Eunice Kennedy Shriver NICHD, Sect Membrane Biol, NIH, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Millay, DP (corresponding author), 240 Albert Sabin Way,MLC 7020, Cincinnati, OH 45229 USA.	douglas.millay@cchmc.org			Cincinnati Children's Hospital Research Foundation, NIAMD, National Institutes of Health [R01AR068286]; Muscular Dystrophy Association; Pew Charitable Trusts; Eunice Kennedy Shriver NICHD, National Institutes of Health; United States-Israel Binational Science Foundation (BSF) [2013151]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068286] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation, NIAMD, National Institutes of Health; Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Cincinnati Children's Hospital Research Foundation, NIAMD, National Institutes of Health Grant R01AR068286, the Muscular Dystrophy Association, and Pew Charitable Trusts (to D.P.M.) and the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health, and United States-Israel Binational Science Foundation (BF) Grant 2013151 (to L.V.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; COLEMAN J, 1985, CELL, V43, P351, DOI 10.1016/0092-8674(85)90040-6; Di Gioia SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16077; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Landemaine A, 2014, BIOCHEM BIOPH RES CO, V451, P480, DOI 10.1016/j.bbrc.2014.07.093; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Luo W, 2015, INT J MOL SCI, V16, P26186, DOI 10.3390/ijms161125946; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Pierson TC, 2012, STRUCTURE, V20, P200, DOI 10.1016/j.str.2012.01.014; Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schejter ED, 2016, SEMIN CELL DEV BIOL, V60, P112, DOI 10.1016/j.semcdb.2016.07.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smurova K, 2016, CELL REP, V14, P1517, DOI 10.1016/j.celrep.2016.01.027; Vivian JP, 2003, BIOCHEM BIOPH RES CO, V310, P1096, DOI 10.1016/j.bbrc.2003.09.126; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664; Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	33	32	34	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17272	17289		10.1074/jbc.M117.811372	http://dx.doi.org/10.1074/jbc.M117.811372			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860190	Green Published, hybrid			2022-12-26	WOS:000414009300011
J	Takahara, T; Inoue, K; Arai, Y; Kuwata, K; Shibata, H; Maki, M				Takahara, Terunao; Inoue, Kuniko; Arai, Yumika; Kuwata, Keiko; Shibata, Hideki; Maki, Masatoshi			The calcium-binding protein ALG-2 regulates protein secretion and trafficking via interactions with MISSL and MAP1B proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium-binding protein; microtubule-associated protein (MAP); secretion; transport	RETICULUM EXIT SITES; ENDOPLASMIC-RETICULUM; CA2+-DEPENDENT MANNER; MICROTUBULE DYNAMICS; SUBCELLULAR-LOCALIZATION; CA2+-BINDING PROTEINS; TRANSPORT; SEC31A; DYNEIN; COPII	Mobilization of intracellular calcium is essential for a wide range of cellular processes, including signal transduction, apoptosis, and vesicular trafficking. Several lines of evidence have suggested that apoptosis-linked gene 2 (ALG-2, also known as PDCD6), a calcium-binding protein, acts as a calcium sensor linking calcium levels with efficient vesicular trafficking, especially at the endoplasmic reticulum (ER)-to-Golgi transport step. However, how ALG-2 regulates these processes remains largely unclear. Here, we report that MAPK1-interacting and spindle-stabilizing (MISS)-like (MISSL), a previously uncharacterized protein, interacts with ALG-2 in a calcium-dependent manner. Live-cell imaging revealed that upon a rise in intracellular calcium levels, GFP-tagged MISSL (GFP-MISSL) dynamically relocalizes in a punctate pattern and colocalizes with ALG-2. MISSL knockdown caused disorganization of the components of the ER exit site, the ER-Golgi intermediate compartment, and Golgi. Importantly, knockdown of either MISSL or ALG-2 attenuated the secretion of secreted alkaline phosphatase (SEAP), a model secreted cargo protein, with similar reductions in secretion by single- and double-protein knockdowns, suggesting that MISSL and ALG-2 act in the same pathway to regulate the secretion process. Furthermore, ALG-2 or MISSL knockdown delayed ER-to-Golgi transport of procollagen type I. We also found that ALG-2 and MISSL interact with microtubule-associated protein 1B (MAP1B) and that MAP1B knockdown reverts the reduced secretion of SEAP caused by MISSL or ALG-2 depletion. These results suggest that a change in the intracellular calcium level plays a role in regulation of the secretory pathway via interaction of ALG-2 with MISSL and MAP1B.	[Takahara, Terunao; Inoue, Kuniko; Arai, Yumika; Shibata, Hideki; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Kuwata, Keiko] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Takahara, T; Maki, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	takahara@agr.nagoya-u.ac.jp; mmaki@agr.nagoya-u.ac.jp	Kuwata, Keiko/I-6128-2014; Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491	World Premier International Research Center Initiative, Japan	World Premier International Research Center Initiative, Japan	We thank Dr. Sasaki-Osugi and all members of the laboratory of Molecular Cell Regulation for their valuable support and discussion. We also thank Dr. Ayano Satoh for providing HeLa cells stably expressing SEAP. The Institute of Transformative Bio-Molecules is supported by the World Premier International Research Center Initiative, Japan.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Amodio G, 2013, FEBS LETT, V587, P3261, DOI 10.1016/j.febslet.2013.08.021; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Barnat M, 2016, MOL CELL NEUROSCI, V72, P9, DOI 10.1016/j.mcn.2016.01.001; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Goold RG, 1999, J CELL SCI, V112, P3373; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Jimenez-Mateos EM, 2005, BIOCHEM J, V389, P333, DOI 10.1042/BJ20050244; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kanadome T, 2017, FEBS J, V284, P56, DOI 10.1111/febs.13949; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091401; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; McGourty CA, 2016, CELL, V167, P525, DOI 10.1016/j.cell.2016.09.026; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; MIZUNO M, 1994, J CELL SCI, V107, P1321; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Ong YS, 2010, J CELL BIOL, V190, P331, DOI 10.1083/jcb.201003005; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Qin J, 2017, J CELL PHYSIOL, V232, P3067, DOI 10.1002/jcp.25754; Qin J, 2017, ONCOTARGET, V8, P2745, DOI 10.18632/oncotarget.13740; Qin SY, 2012, GLYCOBIOLOGY, V22, P1709, DOI 10.1093/glycob/cws114; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rayl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157227; Sasaki-Osugi K, 2013, J BIOL CHEM, V288, P33361, DOI 10.1074/jbc.M113.497479; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372; Tortosa E, 2013, EMBO J, V32, P1293, DOI 10.1038/emboj.2013.76; Tymanskyj SR, 2012, MOL CELL NEUROSCI, V49, P110, DOI 10.1016/j.mcn.2011.10.003; Villarroel-Campos D, 2014, DEV NEUROBIOL, V74, P953, DOI 10.1002/dneu.22178; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	65	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17057	17072		10.1074/jbc.M117.800201	http://dx.doi.org/10.1074/jbc.M117.800201			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28864773	hybrid, Green Published			2022-12-26	WOS:000413140600025
J	Bhatt, I				Bhatt, Ishan			Increased medial olivocochlear reflex strength in normal-hearing, noise-exposed humans	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; SPEECH-IN-NOISE; AUDITORY-EVOKED POTENTIALS; OTOACOUSTIC EMISSIONS; ACOUSTIC-REFLEX; GUINEA-PIG; EFFERENT SYSTEM; NEURONS; MUSICIANS; TINNITUS	Research suggests that college-aged adults are vulnerable to tinnitus and hearing loss due to exposure to traumatic levels of noise on a regular basis. Recent human studies have associated exposure to high noise exposure background (NEB, i.e., routine noise exposure) with the reduced cochlear output and impaired speech processing ability in subjects with clinically normal hearing sensitivity. While the relationship between NEB and the functions of the auditory afferent neurons are studied in the literature, little is known about the effects of NEB on functioning of the auditory efferent system. The objective of the present study was to investigate the relationship between medial olivocochlear reflex (MOCR) strength and NEB in subjects with clinically normal hearing sensitivity. It was hypothesized that subjects with high NEB would exhibit reduced afferent input to the MOCR circuit which would subsequently lead to reduced strength of the MOCR. In normal-hearing listeners, the study examined (1) the association between NEB and baseline click-evoked otoacoustic emissions (CEOAEs) and (2) the association between NEB and MOCR strength. The MOCR was measured using CEOAEs evoked by 60 dB pSPL linear clicks in a contralateral acoustic stimulation (CAS)-off and CAS-on (a broadband noise at 60 dB SPL) condition. Participants with at least 6 dB signal-to-noise ratio (SNR) in the CAS-off and CAS-on conditions were included for analysis. A normalized CEOAE inhibition index was calculated to express MOCR strength in a percentage value. NEB was estimated using a validated questionnaire. The results showed that NEB was not associated with the baseline CEOAE amplitude (r = -0.112, p = 0.586). Contrary to the hypothesis, MOCR strength was positively correlated with NEB (r = 0.557, p = 0.003). NEB remained a significant predictor of MOCR strength (beta = 2.98, t(19) = 3.474, p = 0.003) after the unstandardized coefficient was adjusted to control for effects of smoking, sound level tolerance (SLT) and tinnitus. These data provide evidence that MOCR strength is associated with NEB. The functional significance of increased MOCR strength is discussed.	[Bhatt, Ishan] No Arizona Univ, Dept Commun Sci & Disorders, Flagstaff, AZ 86011 USA	Northern Arizona University	Bhatt, I (corresponding author), No Arizona Univ, Dept Commun Sci & Disorders, Flagstaff, AZ 86011 USA.	Ishan.Bhatt@nau.edu						Abdala C, 2013, J ACOUST SOC AM, V133, P938, DOI 10.1121/1.4773265; Abdollahi FZ, 2011, IRAN REHABIL J, V9, P22; Alain C, 2014, HEARING RES, V308, P162, DOI 10.1016/j.heares.2013.06.008; Backus B, 2007, P INT S PERF SCI 200, P23; Beim JA, 2016, J ACOUSTICAL SOC AM, V139; Bhatt IS, 2017, INT J AUDIOLOGY 0203, P1; Bidelman GM, 2017, HEARING RES, V344, P275, DOI 10.1016/j.heares.2016.12.001; Bidelman GM, 2014, J ACOUST SOC AM, V136, pEL33, DOI 10.1121/1.4885484; Blaylock J, 2016, J ACOUSTICAL SOC AM, V139; Boh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021458; Boothalingam S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136906; Boothalingam S, 2015, J ACOUST SOC AM, V137, P724, DOI 10.1121/1.4906250; Brashears Shanda M, 2003, J Am Acad Audiol, V14, P314; Breinbauer HA, 2012, LARYNGOSCOPE, V122, P2549, DOI 10.1002/lary.23596; Brown MC, 2013, JARO-J ASSOC RES OTO, V14, P703, DOI 10.1007/s10162-013-0400-5; Brown MC, 1998, J NEUROPHYSIOL, V79, P3088, DOI 10.1152/jn.1998.79.6.3088; Carter L, 2014, EAR HEARING, V35, P491, DOI 10.1097/01.aud.0000451498.92871.20; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; Cody AR, OUTER HAIR CELLS MAM; COLLET L, 1991, ACTA OTO-LARYNGOL, V111, P231, DOI 10.3109/00016489109137380; Cooper NP, 2003, J PHYSIOL-LONDON, V548, P307, DOI 10.1113/jphysiol.2003.039081; Darrow KN, 2012, J COMP NEUROL, V520, P1365, DOI 10.1002/cne.22797; De Venecia RK, 2005, J COMP NEUROL, V487, P345, DOI 10.1002/cne.20550; Feeney MP, 2003, J SPEECH LANG HEAR R, V46, P128, DOI 10.1044/1092-4388(2003/010); Fuente A., 2015, FRONT SYST NEUROSCI, P9; Giraud AL, 1997, NEUROREPORT, V8, P1779, DOI 10.1097/00001756-199705060-00042; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Guinan JJ, 2014, FRONTIERS SYSTEMS NE; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Harkrider Ashley W, 2005, J Am Acad Audiol, V16, P530, DOI 10.3766/jaaa.16.8.2; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Henderson E, 2010, PEDIATRICS; Horvath M, 2003, EUR J NEUROSCI, V18, P1439, DOI 10.1046/j.1460-9568.2003.02870.x; IGARASHI M, 1979, ACTA OTO-LARYNGOL, V87, P429, DOI 10.3109/00016487909126446; Keefe DH, 2010, HEARING RES, V263, P52, DOI 10.1016/j.heares.2009.09.008; Kim S, 2006, SPEECH COMMUN, V48, P855, DOI 10.1016/j.specom.2006.03.004; Knudson IM, 2014, J NEUROPHYSIOL, V112, P3197, DOI 10.1152/jn.00576.2014; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kumar UA, 2004, EAR HEARING, V25, P142, DOI 10.1097/01.AUD.0000120363.56591.E6; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Liberman MC, 2015, SCI AM, V313, P48, DOI 10.1038/scientificamerican0815-48; Liberman MC, 2014, J NEUROSCI, V34, P4599, DOI 10.1523/JNEUROSCI.4923-13.2014; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Megerson SC, THEIS U KANSAS; Meinke DK, 2014, INT J AUDIOL, V53, pS16, DOI 10.3109/14992027.2013.865845; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; Mishra SK, 2016, J ACOUST SOC AM, V140, P1060, DOI 10.1121/1.4960550; Mishra SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085756; Mishra SK, 2013, EAR HEARING, V34, P789, DOI 10.1097/AUD.0b013e3182944c04; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; Mukari SZMS, 2008, AUDIOL NEURO-OTOL, V13, P328, DOI 10.1159/000128978; Mulders WHAM, 2000, HEARING RES, V144, P65, DOI 10.1016/S0378-5955(00)00046-0; Mulders WHAM, 2007, J NEUROPHYSIOL, V97, P3288, DOI 10.1152/jn.01148.2006; Nagaraj V., 2010, AURIS NASUS LARYNX; Nageris BI, 2007, OTOL NEUROTOL, V28, P434, DOI 10.1097/mao.0b013e3180430191; Negandhi J, 2014, HEARING RES, V315, P34, DOI 10.1016/j.heares.2014.06.002; NHANES, AUD DAT DOC; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Oertel D, 2011, HEARING RES, V276, P61, DOI 10.1016/j.heares.2010.10.018; Otsuka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146751; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Paschoal Carolina Pamplona, 2009, Braz. j. otorhinolaryngol., V75, P893; Perrot X, 2014, HEARING RES, V308, P27, DOI 10.1016/j.heares.2013.08.010; Phillips SL, 2010, INT J AUDIOL, V49, P309, DOI 10.3109/14992020903470809; RAJAN R, 1988, BRAIN RES, V459, P241, DOI 10.1016/0006-8993(88)90640-3; Rajan R, 2000, J NEUROSCI, V20, P6684, DOI 10.1523/JNEUROSCI.20-17-06684.2000; Rawool V, 2011, OCCUPATIONAL RECREAT; Rawool V. W., 2012, HEARING CONSERVATION; Rawool VW, 2008, NOISE HEALTH, V10, P1, DOI 10.4103/1463-1741.39002; Shahin A, 2003, J NEUROSCI, V23, P5545; Smith SB, 2017, FRONTIERS NEUROSCIEN, P11; Stamper GC, 2015, EAR HEARING, V36, P172, DOI 10.1097/AUD.0000000000000107; Stuart A, 2012, J AM ACAD AUDIOL, V23, P686, DOI 10.3766/jaaa.23.9.3; Sturm JJ, 2015, J NEUROPHYSIOL, V114, P2551, DOI 10.1152/jn.00948.2014; THOMPSON AM, 1995, BRAIN RES, V695, P263, DOI 10.1016/0006-8993(95)00863-L; THOMPSON AM, 1991, J COMP NEUROL, V303, P267, DOI 10.1002/cne.903030209; Tyler RS, 2003, HYPERAKUSIS, V6, P39; Veuillet E, 2001, ACTA OTO-LARYNGOL, V121, P278; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Vogel I, 2009, MUSIC LISTENING BEHA; Vogel I, 2012, PEDIATRICS, V129, P1097, DOI 10.1542/peds.2011-1948; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wagner W, 2005, LARYNGOSCOPE, V115, P2021, DOI 10.1097/01.MLG.0000181463.16591.A7; Wagner W, 2008, ACTA OTO-LARYNGOL, V128, P53, DOI 10.1080/00016480701361954; Washnik NJ, 2016, NOISE HEALTH, V18, P98, DOI 10.4103/1463-1741.178510; Wild DC, 2005, CLIN OTOLARYNGOL, V30, P517, DOI 10.1111/j.1749-4486.2005.01105.x; Wolpert S, 2014, AUDIOL NEURO-OTOL, V19, P31, DOI 10.1159/000354913; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zhao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018725	92	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184036	10.1371/journal.pone.0184036	http://dx.doi.org/10.1371/journal.pone.0184036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886123	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100055
J	Curtis, PD				Curtis, Patrick D.			Stalk formation of Brevundimonas and how it compares to Caulobacter crescentus	PLOS ONE			English	Article							PROTEIN LOCALIZATION; BACTERIAL ORGANELLE; NUTRIENT-UPTAKE; CELL; POLYSACCHARIDE; INHIBITION; BIOGENESIS; REGULATOR; GENE	The Caulobacter crescentus cell extension known as a stalk represents an unusual bacterial morphology. C. crescentus produces stalks under multiple nutrient conditions, but the length of the stalk is increased in response to phosphate starvation. However, the exact function of the stalk is not known, nor is it known how much stalk biogenesis or function is conserved with other stalked bacteria. Work presented here shows that many organisms in the Caulobacter genus and the next closest genus (Brevundimonas) generally do not synthesize stalks in the relatively-rich PYE growth medium, suggesting that the synthesis of a stalk under nutrient-rich conditions by C. crescentus may be the exception instead of the norm among its phylogenetic group. Brevundimonas subvibrioides can be induced to synthesize stalks by genetically mimicking phosphate starvation conditions, indicating stalk synthesis in this organism may be performed on an as-need basis. This mutation, however, does not appear to increase the incidence of holdfast synthesis. While B. subvibrioides stalks appear to be synthesized with the same polarity with respect to holdfast as C. crescentus stalks, evidence is presented that suggests B. subvibrioides may disassemble stalks when they are no longer needed. Many homologs of C. crescentus genes encoding stalk-associated proteins are absent in the B. subvibrioides genome, and B. subvibrioides PstA-GFP as well as C. crescentus StpX-GFP are able to enter the B. subvibrioides stalk compartment, calling into question the level of compartmentalization of the B. subvibrioides stalk. In summary, this work begins to address how much the C. crescentus model for this unusual morphological adaptation can be extended to related organisms.	[Curtis, Patrick D.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Mississippi	Curtis, PD (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	pdcurtis@olemiss.edu		Curtis, Patrick/0000-0002-4382-7564	United States National Science Foundation CAREER program [1552647]; Direct For Biological Sciences [1552647] Funding Source: National Science Foundation	United States National Science Foundation CAREER program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the United States National Science Foundation CAREER program award 1552647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; BRUN YV, 1992, GENE DEV, V6, P2395, DOI 10.1101/gad.6.12a.2395; Curtis PD, 2014, MOL MICROBIOL, V93, P713, DOI 10.1111/mmi.12686; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; HAARS EG, 1974, J BACTERIOL, V120, P1409, DOI 10.1128/JB.120.3.1409-1416.1974; Hughes HV, 2013, MOL MICROBIOL, V90, P1162, DOI 10.1111/mmi.12422; Hughes HV, 2010, P NATL ACAD SCI USA, V107, P5599, DOI 10.1073/pnas.0909119107; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; Janakiraman RS, 1999, J BACTERIOL, V181, P1118, DOI 10.1128/JB.181.4.1118-1125.1999; Jiang C, 2014, NATURE, V506, P489, DOI 10.1038/nature12900; Klein Eric A, 2013, Commun Integr Biol, V6, pe24561, DOI 10.4161/cib.24561; Kuhn J, 2010, EMBO J, V29, P327, DOI 10.1038/emboj.2009.358; Laus MC, 2006, MOL MICROBIOL, V59, P1704, DOI 10.1111/j.1365-2958.2006.05057.x; Marques MDV, 1997, J BACTERIOL, V179, P5502, DOI 10.1128/jb.179.17.5502-5510.1997; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Wagner JK, 2006, P NATL ACAD SCI USA, V103, P11772, DOI 10.1073/pnas.0602047103; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Xu J, 2013, MOL MICROBIOL, V89, P929, DOI 10.1111/mmi.12321; Xu QP, 2009, J MOL BIOL, V390, P686, DOI 10.1016/j.jmb.2009.05.023; Yakhnina AA, 2013, J BACTERIOL, V195, P4527, DOI 10.1128/JB.00600-13	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184063	10.1371/journal.pone.0184063	http://dx.doi.org/10.1371/journal.pone.0184063			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886080	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100062
J	Erdmann, W; Idzikowski, B; Kowalski, W; Szymanski, B; Kosicki, JZ; Kaczmarek, L				Erdmann, Weronika; Idzikowski, Bogdan; Kowalski, Wojciech; Szymanski, Bogdan; Kosicki, Jakub Z.; Kaczmarek, Lukasz			Can the tardigrade Hypsibius dujardini survive in the absence of the geomagnetic field?	PLOS ONE			English	Article							MAGNETIC-FIELD; MILNESIUM-TARDIGRADUM; RICHTERSIUS-CORONIFER; TOLERANCE; SPACE; EARTH; LIFE; ANHYDROBIOSIS; CRYPTOBIOSIS; DESICCATION	Earth's geomagnetic field has undergone critical changes in the past. Studies on the influence of the magnetic field on Earth's organisms are crucial for the understanding of evolution of life on Earth and astrobiological considerations. Numerous studies conducted both on plants and animals confirmed the significant influence of the geomagnetic field on the metabolism of living organisms. Water bears (Tardigrada), which are a mong the most resistant animals due to their cryptobiotic abilities, show significant resistance to a number of environmental stressors, but the influence of the geomagnetic field on their fitness has not been addressed before. In our studies, we used eutardigrade Hypsibius dujardini to analyse whether isolation from the geomagnetic field had an effect on mortality. We found that Hypsibius dujardini specimens demonstrated relatively high mortality during anhydrobiosis, also in control groups exposed to the normal geomagnetic field. Moreover, similar mortality was observed in anhydrobiotic specimens isolated from the geomagnetic field. However, a significant difference was noted between tardigrade survival and the moment of their isolation from the geomagnetic field. In particular, tardigrade mortality substantially increased in absence of a magnetic field during the process of entering anhydrobiosis and returning to active life. Our results suggest that these processes rely on complex metabolic processes that are critically influenced by the geomagnetic field.	[Erdmann, Weronika; Kaczmarek, Lukasz] Adam Mickiewicz Univ, Fac Biol, Dept Anim Taxon & Ecol, Umultowska 89, Poznan, Poland; [Idzikowski, Bogdan; Kowalski, Wojciech; Szymanski, Bogdan] Polish Acad Sci, Inst Mol Phys, M Smoluchowskiego17, Poznan, Poland; [Kosicki, Jakub Z.] Adam Mickiewicz Univ, Fac Biol, Dept Avian Biol & Ecol, Umultowska 89, Poznan, Poland	Adam Mickiewicz University; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences; Adam Mickiewicz University	Kosicki, JZ (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Avian Biol & Ecol, Umultowska 89, Poznan, Poland.	kubako@amu.edu.pl	Idzikowski, Bogdan/AAE-9311-2021; Kaczmarek, Lukasz/A-2000-2008	Kaczmarek, Lukasz/0000-0002-5260-6253; Kosicki, Jakub/0000-0002-9044-7775; Idzikowski, Bogdan/0000-0003-0159-9839	Diamond Grant program [DI2012 016342]; Polish Ministry of Science and Higher Education via the "Diamond Grant" program [DI2012 016342]	Diamond Grant program; Polish Ministry of Science and Higher Education via the "Diamond Grant" program	Diamond Grant program No: DI2012 016342, "Study of resistance of small invertebrates cryptobiotic (for example Tardigrades). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Polish Ministry of Science and Higher Education via the "Diamond Grant" program (grant: DI2012 016342, "Study of resistance of small invertebrates cryptobiotic (for example tardigrades) to the lack of the geomagnetic field and the survivability of terrestrial organisms beyond our planet"). Studies have been conducted in the framework of activities of BARg (Biodiversity and Astrobiology Research group). The authors also wish to thank Professor Diane R. Nelson, Christine Moissl-Eichinger, Justyna Grzesko-wiak, Mark Ordon and Cambridge Proofreading LLC (http://proofreading.org/) for their linguistic assistance.	[Anonymous], B L ACAD POL SC; [Anonymous], 1955, NATURE; Baumann H., 1922, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V45, P501; BECQUEREL P, 1950, CR HEBD ACAD SCI, V231, P261; Beltran-Pardo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133658; Beltran-Pardo EA, 2013, J LIMNOL, V72, P80, DOI 10.4081/jlimnol.2013.s1.e10; Belyavskaya NA, 2001, ADV SPACE RES, V28, P645, DOI 10.1016/S0273-1177(01)00373-8; Blank M, 1997, BIOELECTROMAGNETICS, V18, P111, DOI 10.1002/(SICI)1521-186X(1997)18:2<111::AID-BEM3>3.0.CO;2-5; Boothby TC, 2015, P NATL ACAD SCI USA, V112, P15976, DOI 10.1073/pnas.1510461112; BULLARD EC, 1949, PROC R SOC LON SER-A, V197, P433, DOI 10.1098/rspa.1949.0074; Clegg J.S., 1973, ANHYDROBIOSIS, P141; Conley CC, 1970, TND5902127 NASA, P1; CREMERBARTELS G, 1984, NATURWISSENSCHAFTEN, V71, P567, DOI 10.1007/BF01189180; Dubrov AP, 2014, GEOMAGNETOBIOLOGY, P318; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Galland P, 2005, J PLANT RES, V118, P371, DOI 10.1007/s10265-005-0246-y; Grohme MA, 2013, BIOINFORM BIOL INSIG, V7, P153, DOI 10.4137/BBI.S11497; Guidetti R, 2008, J EXP BIOL, V211, P2296, DOI 10.1242/jeb.015131; Guidetti R, 2012, PLANET SPACE SCI, V74, P97, DOI 10.1016/j.pss.2012.05.021; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Guidetti R, 2011, ZOOLOGY, V114, P123, DOI 10.1016/j.zool.2010.11.005; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2001, ECOTOX ENVIRON SAFE, V50, P72, DOI 10.1006/eesa.2001.2090; Kondo K, 2015, C MAT 13 INT S TARD, P92; Kopcewicz M, 1999, J APPL PHYS, V85, P4427, DOI 10.1063/1.370363; Lide D.R., 2004, CRC HDB CHEM PHYS, P2475; MARKOV MS, 1994, BIOELECTROCH BIOENER, V35, P57, DOI 10.1016/0302-4598(94)87012-8; Markov MS, 1997, BIOELECTROCH BIOENER, V43, P233, DOI 10.1016/S0302-4598(96)02226-X; Miglierini M, 2002, J PHYS-CONDENS MAT, V14, P1249, DOI 10.1088/0953-8984/14/6/312; Negishi Y, 1999, ADV SPACE RES, V23, P2029, DOI 10.1016/S0273-1177(99)00342-7; NOSSOL B, 1993, BIOELECTROMAGNETICS, V14, P361, DOI 10.1002/bem.2250140408; Ono F, 2008, J PHYS CHEM SOLIDS, V69, P2297, DOI 10.1016/j.jpcs.2008.04.019; R Development Core Team, 2016, R LANG ENV STAT COMP, P499; RAHM P. G., 1926, BIOL ZENTRALBL, V46, P452; Rahm PG, 1924, VERH D ZOOL GES, V29, P106; RAHM PG, 1923, Z ALLG PHYSL, V20, P1; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; RAMLOV H, 1992, CRYOBIOLOGY, V29, P125, DOI 10.1016/0011-2240(92)90012-Q; Rampelotto Pabulo Henrique, 2013, Life-Basel, V3, P482, DOI 10.3390/life3030482; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rebecchi L, 2011, 5 NAT M ISSBB SPAZ N, P17; Rebecchi L, 2011, J ZOOL SYST EVOL RES, V49, P98, DOI 10.1111/j.1439-0469.2010.00606.x; Rebecchi L, 2009, ASTROBIOLOGY, V9, P581, DOI 10.1089/ast.2008.0305; Richaud M, 2015, C MAT 13 INT S TARD, P100; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Rotronic Instrument Corp, 2005, ROTR HUM HDB, P130; Seki K, 1998, NATURE, V395, P853, DOI 10.1038/27576; Shopf JW, 1999, DISCOVERY EARTHS EAR, P369; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Tombarkiewicz B, 2008, ENVIRON TOXICOL PHAR, V26, P75, DOI 10.1016/j.etap.2008.02.003; Vansanthan T, 2015, C MAT 13 INT S TARD, P133; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Worth RJ, 2013, ASTROBIOLOGY, V13, P1155, DOI 10.1089/ast.2013.1028; Wplyw J., 2004, STYMULACJI MAGNETYCZ, V4, P459; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1989, J EXP BIOL, V142, P267; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; ZAR JH, 1999, BIOSTAT ANAL, P123	63	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183380	10.1371/journal.pone.0183380	http://dx.doi.org/10.1371/journal.pone.0183380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886031	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100018
J	Farrell, M; Yoneda, Z; Montgomery, J; Crawford, D; Wray, LL; Xu, M; Kolek, MJ; Richardson, T; Lugo, R; Metawee, M; Michaud, G; Estrada, JC; Saavedra, P; Shen, S; Kanagasundram, A; Ellis, CR; Crossley, G; Roden, D; Shoemaker, MB				Farrell, Maureen; Yoneda, Zachary; Montgomery, Jay; Crawford, Diane; Wray, Lauren Lee; Xu, Meng; Kolek, Matthew J.; Richardson, Travis; Lugo, Ricardo; Metawee, Mohamed; Michaud, Greg; Estrada, Juan Carlos; Saavedra, Pablo; Shen, Sharon; Kanagasundram, Arvindh; Ellis, Christopher R.; Crossley, George; Roden, Dan; Shoemaker, M. Benjamin			Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype	PLOS ONE			English	Article							CATHETER ABLATION	Background Atrial fibrillation (AF) is a mechanistically heterogeneous disorder, and the ability to identify sub-phenotypes ("endophenotypes") of AF would assist in the delivery of personalized medicine. We used the clinical response to pulmonary vein isolation (PVI) to identify a sub-group of patients with non-PV mediated AF and sought to define the clinical associations. Methods Subjects enrolled in the Vanderbilt AF Ablation Registry who underwent a repeat AF ablation due to arrhythmia recurrence were analyzed on the basis of PV reconnection. Subjects who had no PV reconnection were defined as "non-PV mediated AF". A comparison group of subjects were identified who had AF that was treated with PVI-only and experienced no arrhythmia recurrence >12 months. They were considered a group enriched for "PV-mediated AF". Univariate and multivariable binary logistic regression analysis was performed to investigate clinical associations between the PV and non-PV mediated AF groups. Results Two hundred and twenty nine subjects underwent repeat AF ablation and thirty three (14%) had no PV reconnection. They were compared with 91 subjects identified as having PV-mediated AF. Subjects with non-PV mediated AF were older (64 years [IQR 60,71] vs. 60 [52,67], P = 0.01), more likely to have non-paroxysmal AF (82% [N = 27] vs. 35% [N = 32], P< 0.001), and had a larger left atrium (LA) (4.2cm [3.6,4.8] vs. 4.0 [3.3,4.4], P = 0.04). In univariate analysis, age (per decade: OR 1.56 [95% CI: 1.04 to 2.33], P = 0.03), LA size (per cm: OR 1.8 [1.06 to 3.21], P = 0.03) and non-paroxysmal AF (OR 8.3 [3.10 to 22.19], P< 0.001) were all significantly associated with non-PV mediated AF. However, in multivariable analysis only non-paroxysmal AF was independently associated with non-PV mediated AF (OR 7.47 [95% CI 2.62 to 21.29], P<0.001), when adjusted for age (per decade: OR 1.25 [0.81 to 1.94], P = 0.31), male gender (OR 0.48 [0.18 to 1.28], P = 0.14), and LA size (per 1cm: 1.24 [0.65 to 2.33], P = 0.52). Conclusions Non-paroxysmal AF was the only clinical variable found to be independently associated with non-PV mediated AF. We demonstrated that analysis of AF ablation outcomes data can serve as a tool to successfully identify a sub-phenotype of subjects who have non-PV mediated AF.	[Farrell, Maureen; Yoneda, Zachary; Montgomery, Jay; Crawford, Diane; Wray, Lauren Lee; Kolek, Matthew J.; Richardson, Travis; Lugo, Ricardo; Metawee, Mohamed; Michaud, Greg; Estrada, Juan Carlos; Saavedra, Pablo; Shen, Sharon; Kanagasundram, Arvindh; Ellis, Christopher R.; Crossley, George; Roden, Dan; Shoemaker, M. Benjamin] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Xu, Meng] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Roden, Dan] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Roden, Dan] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Yoneda, Z; Shoemaker, MB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	moore.b.shoemaker@vanderbilt.edu; moore.b.shoemaker@vanderbilt.edu	Roden, Dan/ABD-5412-2021; Ellis, Christopher Randall/AAL-3749-2020	Ellis, Christopher Randall/0000-0002-7333-5720; Farrell, Maureen/0000-0003-4728-0233	National Institutes of Health [K23 HL127704]; CTSA from the National Center for Advancing Translational Sciences [UL1TR000445]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL127704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported in part by the National Institutes of Health grant K23 HL127704 (MBS). The project was also supported by CTSA award UL1TR000445 from the National Center for Advancing Translational Sciences awarded to Vanderbilt University. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldinger Samuel H, 2016, JACC Clin Electrophysiol, V2, P723, DOI 10.1016/j.jacep.2016.05.013; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kim TH, 2016, EUROPACE; Kornej J, 2015, CLIN RES CARDIOL, V104, P871, DOI 10.1007/s00392-015-0856-x; Nattel S, 2016, NAT REV CARDIOL, V13, P575, DOI 10.1038/nrcardio.2016.118; Nery Pablo B, 2016, JACC Clin Electrophysiol, V2, P474, DOI 10.1016/j.jacep.2016.02.003; Sadek MM, 2016, HEART RHYTHM, V13, P2174, DOI 10.1016/j.hrthm.2016.08.026; Sawhney N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P243, DOI 10.1161/CIRCEP.109.924878; Shah AJ, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/950763; Shoemaker MB, 2013, AM J CARDIOL, V111, P368, DOI 10.1016/j.amjcard.2012.10.013; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Winkle RA, 2016, HEART RHYTHM, V13, P2119, DOI 10.1016/j.hrthm.2016.07.018	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184354	10.1371/journal.pone.0184354	http://dx.doi.org/10.1371/journal.pone.0184354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880943	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200056
J	Zhou, J; Li, J; Rosenbaum, DM; Zhuang, J; Poon, C; Qin, P; Rivera, K; Lepore, J; Willette, RN; Hu, E; Barone, FC				Zhou, Jin; Li, Jie; Rosenbaum, Daniel M.; Zhuang, Jian; Poon, Carrie; Qin, Pu; Rivera, Katrina; Lepore, John; Willette, Robert N.; Hu, Erding; Barone, Frank C.			The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-ISCHEMIA; STEM-CELLS; HYDROXYLASE INHIBITION; VEGF EXPRESSION; MESSENGER-RNA; HYPOXIA; STROKE; ERYTHROPOIETIN	There is interest in pharmacologic preconditioning for end-organ protection by targeting the HIF system. This can be accomplishe d by inhibition of prolyl 4-hydroxylase (PHD). GSK360A is an orally active PHD inhibitor that has been previously shown to protect the failing heart. We hypothesized that PHD inhibition can also protect the brain from injuries and resulting behavioral deficits that can occur as a result of surgery. Thus, our goal was to investigate the effect of pre-stroke surgery brain protection using a verified GSK360A PHD inhibition paradigm on post-stroke surgery outcomes. Vehicle or an established protective dose (30 mg/kg, p.o.) of GSK360A was administered to male Sprague-Dawley rats. Initially, GSK360A pharmacokinetics and organ distribution were determined, and then PHD-HIF pharmacodynamic markers were measured (i.e., to validate the pharmacological effects of the GSK360A administration regimen). Results obtained using this validated PHD dose-regimen indicated significant improvement by GSK360A (30mg/kg); administered at 18 and 5 hours prior to transient middle cerebral artery occlusion (stroke). GSK360A exposure and plasma, kidney and brain HIF-PHD pharmacodynamics endpoints (e.g., erythropoietin; EPO and Vascular Endothelial Growth Factor; VEGF) were measured. GSK360A provided rapid exposure in plasma (7734 ng/ml), kidney (45-52% of plasma level) and brain (1-4% of plasma level), and increased kidney EPO mRNA (80-fold) and brain VEGF mRNA (2-fold). We also observed that GSK360A increased plasma EPO (300-fold) and VEGF (2-fold). Further assessments indicated that GSK360A reduced post-stroke surgery neurological deficits (47-64%), cognitive dysfunction (60-75%) and brain infarction (30%) 4 weeks later. Thus, PHD inhibition using GSK360A pretreatment produced long-term post-stroke brain protection and improved behavioral functioning. These data support PHD inhibition, specifically by GSK360A, as a potential strategy for pre-surgical use to reduce brain injury and functional decline due to surgery-related cerebral injury.	[Zhou, Jin; Li, Jie; Rosenbaum, Daniel M.; Zhuang, Jian; Poon, Carrie; Barone, Frank C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Robert F Furchgott Fdn, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Qin, Pu; Rivera, Katrina; Lepore, John; Willette, Robert N.; Hu, Erding] GlaxoSmithKline, Heart Failure Discovery Performance Unit, Cardiac Biol, King Of Prussia, PA USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; GlaxoSmithKline	Barone, FC (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.; Barone, FC (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Fdn, Brooklyn, NY 11203 USA.; Barone, FC (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	frank.barone@downstate.edu			GlaxoSmithKline Pharmaceuticals (GSK)	GlaxoSmithKline Pharmaceuticals (GSK)(GlaxoSmithKline)	This work was funded by GlaxoSmithKline Pharmaceuticals (GSK) to test the "chemical preconditioning protection surgical pretreatment hypothesis" as indicated in this paper. Only the persons listed as authors of this manuscript had roles in the study design, the collection and analysis of data, the decision to publish, and/or the preparation of this paper for publication. The funder (GSK) provided support in the form of salaries for authors [JL for Jie Li], provided the background in vitro and in vivo information on GSK360, collaborated on the study design, completed pharmacokinetic and pharmacodynamic data analysis, and helped in editing of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Barone FC, 2004, METH MOLEC MED, V104, P105; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Barone FC, 2010, NEUROPHARMACOLOGY, V59, P650, DOI 10.1016/j.neuropharm.2010.08.016; Bartels K, 2013, CURR OPIN ANESTHESIO, V26, P91, DOI 10.1097/ACO.0b013e32835bf24c; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Bernaudin M, 2002, J BIOL CHEM, V277, P39728, DOI 10.1074/jbc.M204619200; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dreixler JC, 2009, EXP EYE RES, V89, P782, DOI 10.1016/j.exer.2009.07.006; Eckerich C, 2007, INT J CANCER, V121, P276, DOI 10.1002/ijc.22679; Etz CD, 2015, J THORAC CARDIOV SUR, V149, P1074, DOI 10.1016/j.jtcvs.2014.12.025; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ghoneim MM, 2012, EUR J ANAESTH, V29, P409, DOI 10.1097/EJA.0b013e328356bd6e; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gidday JM, 2010, TRANSL STROKE RES, V1, P19, DOI 10.1007/s12975-010-0011-y; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kahle MP, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/374098; Karuppagounder SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac6008; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Knowles HJ, 2004, CIRC RES, V95, P162, DOI 10.1161/01.RES.0000134924.89412.70; Kovalska M, 2012, NEUROCHEM RES, V37, P1568, DOI 10.1007/s11064-012-0752-y; Kurapeev DI, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0206-0; Lai TW, 2012, J MOL CELL BIOL, V4, P184, DOI 10.1093/jmcb/mjs009; Lenhard SC, 2008, PHARMACOLOGY, V81, P1, DOI 10.1159/000107661; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Malhotra S, 2006, J NEUROSCI RES, V83, P19, DOI 10.1002/jnr.20705; Margaritescu O, 2011, ROM J MORPHOL EMBRYO, V52, P1283; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Nishimura M, 2003, J CEREBR BLOOD F MET, V23, P1052, DOI 10.1097/01.WCB.0000084251.20114.65; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Ratan RR, 2007, J MOL MED, V85, P1331, DOI 10.1007/s00109-007-0283-1; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Reischl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084767; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selvan P, 2017, DRUG FUTURE, V42, P215, DOI 10.1358/dof.2017.042.04.2611806; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Troen AM, 2012, J RENAL NUTR, V22, P268, DOI 10.1053/j.jrn.2011.07.009; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Virgintino D, 2003, HISTOCHEM CELL BIOL, V119, P227, DOI 10.1007/s00418-003-0510-y; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang XK, 2000, J NEUROSCI RES, V59, P238, DOI 10.1002/(SICI)1097-4547(20000115)59:2<238::AID-JNR10>3.0.CO;2-G; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wu YG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/537531; Yeh CH, 2010, LIFE SCI, V86, P115, DOI 10.1016/j.lfs.2009.11.022; Zhong Q, 2012, STEM CELLS DEV, V21, P2703, DOI 10.1089/scd.2011.0604; Zhou J, 2005, J CEREBR BLOOD F MET, V25, P878, DOI 10.1038/sj.jcbfm.9600082; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057503; Zhou J, 2011, J CEREBR BLOOD F MET, V31, P924, DOI 10.1038/jcbfm.2010.171	71	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184049	10.1371/journal.pone.0184049	http://dx.doi.org/10.1371/journal.pone.0184049			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880966	Green Submitted, gold, Green Published			2022-12-26	WOS:000409467200032
J	Zuidscherwoude, M; Worah, K; van der Schaaf, A; Buschow, SI; van Spriel, AB				Zuidscherwoude, Malou; Worah, Kuntal; van der Schaaf, Alie; Buschow, Sonja I.; van Spriel, Annemiek B.			Differential expression of tetraspanin superfamily members in dendritic cell subsets	PLOS ONE			English	Article							MHC CLASS-II; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; HLA-DR; COMPLEXES; MOLECULES; CD82; MIGRATION; SURFACE; CD63	Dendritic cells (DCs), which are essential for initiating immune responses, are comprised of different subsets. Tetraspanins organize dendritic cell membranes by facilitating protein-protein interactions within the so called tetraspanin web. In this study we analyzed expression of the complete tetraspanin superfamily in primary murine (CD4+, CD8+, pDC) and human DC subsets (CD1c+, CD141+, pDC) at the transcriptome and proteome level. Different RNA and protein expression profiles for the tetraspanin genes across human and murine DC subsets were identified. Although RNA expression levels of CD37 and CD82 were not significantly different between human DC subsets, CD9 RNA was highly expressed in pDCs, while CD9 protein expression was lower. This indicates that relative RNA and protein expression levels are not always in agreement. Both murine CD8 alpha+ DCs and its regarded human counterpart, CD141+ DCs, displayed relatively high protein levels of CD81. CD53 protein was highly expressed on human pDCs in contrast to the relatively low protein expression of most other tetraspanins. This study demonstrates that tetraspanins are differentially expressed by human and murine DC subsets which provides a valuable resource that will aid the understanding of tetraspanin function in DC biology.	[Zuidscherwoude, Malou; Worah, Kuntal; van der Schaaf, Alie; Buschow, Sonja I.; van Spriel, Annemiek B.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Worah, Kuntal] Radboud Univ Nijmegen, Med Ctr, CMBI, Nijmegen, Netherlands; [Buschow, Sonja I.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	van Spriel, AB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands.	Annemiek.vanSpriel@radboudumc.nl	van Spriel, Annemiek/Q-6044-2019; Buschow, Sonja/AAD-3567-2020; Zuidscherwoude, Malou/AAY-1547-2021	van Spriel, Annemiek/0000-0002-3590-2368; Zuidscherwoude, Malou/0000-0002-5071-9000; Buschow, Sonja/0000-0002-7907-8315	Netherlands Organization (NWO-ALW VIDI) [864.11.006]; Dutch Cancer Society (KWF) [KUN2014-6845, KWO-2009-4402]; European Research Council [724281]; Radboudumc	Netherlands Organization (NWO-ALW VIDI); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); European Research Council(European Research Council (ERC)European Commission); Radboudumc	ABvS is recipient of a Netherlands Organization for Scientific Research Grant (NWO-ALW VIDI grant 864.11.006) http://www.nwo.nl/en/funding/our-funding-instruments/nwo/innovational-research-incentives-scheme/vidi/index.html, a Dutch Cancer Society (KWF) grant (KUN2014-6845) http://www.kwf.nl/english/pages/default.aspx, and was awarded an European Research Council Consolidator Grant (Secret Surface, 724281) https://erc.europa.eu/. KW is supported by a Dutch Cancer Society (KWF) grant KWO-2009-4402. This work is supported by the Radboudumc (PhD Grant to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrena S, 2005, LEUKEMIA, V19, P1376, DOI 10.1038/sj.leu.2403822; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Bosch B, 2013, J BIOL CHEM, V288, P13236, DOI 10.1074/jbc.M112.442640; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Dalgaard J, 2005, J LEUKOCYTE BIOL, V77, P689, DOI 10.1189/jlb.1204711; de Winde CM, 2015, HISTOCHEM CELL BIOL, V144, P133, DOI 10.1007/s00418-015-1326-2; Dutertre CA, 2014, CELL IMMUNOL, V291, P3, DOI 10.1016/j.cellimm.2014.08.006; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127; Ferez M, 2014, J IMMUNOL, V192, P52, DOI 10.4049/jimmunol.1301224; Gartlan KH, 2013, EUR J IMMUNOL, V43, P1208, DOI 10.1002/eji.201242730; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hammond C, 1998, J IMMUNOL, V161, P3282; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jones EL, 2016, J IMMUNOL, V196, P978, DOI 10.4049/jimmunol.1500357; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Mittelbrunn M, 2002, J IMMUNOL, V169, P6691, DOI 10.4049/jimmunol.169.12.6691; Petersen SH, 2011, EUR J IMMUNOL, V41, P2556, DOI 10.1002/eji.201141438; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Segura E, 2010, MOL IMMUNOL, V47, P1765, DOI 10.1016/j.molimm.2010.02.028; Sheng KC, 2009, EUR J IMMUNOL, V39, P50, DOI 10.1002/eji.200838798; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Szollosi J, 1996, J IMMUNOL, V157, P2939; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Tel J, 2013, BLOOD, V121, P459, DOI 10.1182/blood-2012-06-435644; Manh TPV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00260; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; van den Hoorn T, 2012, J CELL SCI, V125, P328, DOI 10.1242/jcs.088047; van Spriel AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003113; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Worah K, 2016, CELL REP, V16, P2953, DOI 10.1016/j.celrep.2016.08.023; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2012, J CELL SCI, V125, P1478, DOI 10.1242/jcs.093963; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang JW, 2014, ONCOTARGET, V5, P12083, DOI 10.18632/oncotarget.2499; Zuidscherwoude M, 2013, J LEUKOCYTE BIOL, V95, p1 ; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	52	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184317	10.1371/journal.pone.0184317	http://dx.doi.org/10.1371/journal.pone.0184317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880937	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200049
J	Copley, TR; Duggavathi, R; Jabaji, S				Copley, Tanya R.; Duggavathi, Raj; Jabaji, Suha			The transcriptional landscape of Rhizoctonia solani AG1-IA during infection of soybean as defined by RNA-seq	PLOS ONE			English	Article							OXALATE DECARBOXYLASE; FUNGAL-INFECTION; OXALIC-ACID; PATHOGENICITY; EXPRESSION; BLIGHT; GENES; RESISTANCE; BIOCONTROL; SEQUENCE	Rhizoctonia solani Kuhn infects most plant families and can cause significant agricultural yield losses worldwide; however, plant resistance to this disease is rare and short-lived, and therefore poorly understood, resulting in the use of chemical pesticides for its control. Understanding the functional responses of this pathogen during host infection can help elucidate the molecular mechanisms that are necessary for successful host invasion. Using the pathosystem model soybean-R. solani anastomosis group AG1-IA, we examined the global transcriptional responses of R. solani during early and late infection stages of soybean by applying an RNA-seq approach. Approximately, 148 million clean paired-end reads, representing 93% of R. solani AG1-IA genes, were obtained from the sequenced libraries. Analysis of R. solani AG1-IA transcripts during soybean invasion revealed that most genes were similarly expressed during early and late infection stages, and only 11% and 15% of the expressed genes were differentially expressed during early and late infection stages, respectively. Analyses of the differentially expressed genes (DEGs) revealed shifts in molecular pathways involved in antibiotics biosynthesis, amino acid and carbohydrate metabolism, as well as pathways involved in antioxidant production. Furthermore, several KEGG pathways were unique to each time point, particularly the up-regulation of genes related to toxin degradation (e.g., nicotinate and nicotinamid metabolism) at onset of necrosis, and those linked to synthesis of anti-microbial compounds and pyridoxine (vitamin B6) biosynthesis 24 h.p.o. of necrosis. These results suggest that particular genes or pathways are required for either invasion or disease development. Overall, this study provides the first insights into R. solani AG1-IA transcriptome responses to soybean invasion providing beneficial information for future targeted control methods of this successful pathogen.	[Copley, Tanya R.; Jabaji, Suha] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Duggavathi, Raj] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	Jabaji, S (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	suha.jabaji@mcgill.ca	Duggavathi, Raj/GSJ-3503-2022		Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN137135-201, RGPIN-2016-04805, RGPIN-371850]; National Sciences and Engineering Research Council of Canada [RGPIN137135-201, RGPIN-2016-04805, RGPIN-371850]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery grant (RGPIN137135-201 and RGPIN-2016-04805) to S. Jabaji and R. Duggavathi (RGPIN-371850) provided by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided as a Discovery grants to S. Jabaji (RGPIN137135-201 and RGPIN-2016-04805) and R. Duggavathi (RGPIN-371850) by the National Sciences and Engineering Research Council of Canada. We thank P. Ceresini for his technical advise on inoculation experiments of detached soybean leaves. A special thanks goes to R. Chamoun for his help in setting up the R. solani detached leaf assay.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson JP, 2016, MOL CELL PROTEOMICS, V15, P1188, DOI 10.1074/mcp.M115.054502; Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; ATKINS JG, 1954, PHYTOPATHOLOGY, V44, P215; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bora P, 2005, AUSTRALAS PLANT PATH, V34, P591, DOI 10.1071/AP05077; Browne RA, 2004, EUR J PLANT PATHOL, V110, P91, DOI 10.1023/B:EJPP.0000010143.20226.21; Carapito R, 2008, FUNGAL GENET BIOL, V45, P738, DOI 10.1016/j.fgb.2007.12.002; Chamoun R, 2011, MYCOLOGIA, V103, P483, DOI 10.3852/10-235; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen JY, 2015, EUR J PLANT PATHOL, V142, P281, DOI 10.1007/s10658-015-0612-0; Ciampi MB, 2008, PHYTOPATHOLOGY, V98, P932, DOI 10.1094/PHYTO-98-8-0932; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Copley T, 2015, NE AM SOC PLANT BIOL; Copley TR, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1020-8; Cottrell TR, 2007, EUKARYOT CELL, V6, P776, DOI 10.1128/EC.00015-07; de Assis JB, 2008, PHYTOPATHOLOGY, V98, P1326, DOI 10.1094/PHYTO-98-12-1326; Divon HH, 2007, FEMS MICROBIOL LETT, V266, P65, DOI 10.1111/j.1574-6968.2006.00504.x; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Fenille RC, 2002, EUR J PLANT PATHOL, V108, P783, DOI 10.1023/A:1020811019189; Foley RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152548; Ghosh S, 2014, CURR GENET, V60, P327, DOI 10.1007/s00294-014-0438-x; Gkarmiri K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1758-z; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; GonzaAlezGarciA V, 1999, SPAN J AGRIC RES, V4, P55; Hamshou M, 2010, FUNGAL BIOL-UK, V114, P34, DOI 10.1016/j.mycres.2009.10.002; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayden KJ, 2014, TREE GENET GENOMES, V10, P489, DOI 10.1007/s11295-014-0698-0; Henson JM, 1999, ANNU REV PHYTOPATHOL, V37, P447, DOI 10.1146/annurev.phyto.37.1.447; Huang XQ, 2012, MICROBIOL RES, V167, P135, DOI 10.1016/j.micres.2011.06.002; Idnurm A, 2002, EUKARYOT CELL, V1, P719, DOI 10.1128/EC.1.5.719-724.2002; Jacob S, 2016, HOST PATHOGEN INTERA, P153; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KATARIA HR, 1991, J PHYTOPATHOL, V133, P121, DOI 10.1111/j.1439-0434.1991.tb00145.x; KATARIA HR, 1976, ANN APPL BIOL, V82, P267, DOI 10.1111/j.1744-7348.1976.tb00562.x; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Keijer J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P149; KELLENS JTC, 1990, J GEN MICROBIOL, V136, P2489, DOI 10.1099/00221287-136-12-2489; Kesarwani M, 2000, J BIOL CHEM, V275, P7230, DOI 10.1074/jbc.275.10.7230; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142221; Kunamneni A, 2007, MICROBIOLOGY SERIES, P233, DOI DOI 10.1007/978-3-030-10480-1_13; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Makela M, 2002, ENZYME MICROB TECH, V30, P542, DOI 10.1016/S0141-0229(02)00012-1; MARSHALL DS, 1980, PHYTOPATHOLOGY, V70, P947, DOI 10.1094/Phyto-70-947; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nagarajkumara M, 2005, MICROBIOL RES, V160, P291, DOI 10.1016/j.micres.2005.02.002; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Samsatly J, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01429; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shelp BJ, 2006, PLANT PHYSIOL, V142, P1350; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Solomon PS, 2004, MOL MICROBIOL, V53, P1065, DOI 10.1111/j.1365-2958.2004.04178.x; Solomon PS, 2002, PLANTA, V214, P414, DOI 10.1007/s004250100632; Stetina KC, 2006, PLANT DIS, V90, P39, DOI 10.1094/PD-90-0039; Tan WanZhong, 2007, Agricultural Sciences in China, V6, P1074, DOI 10.1016/S1671-2927(07)60149-7; Varrot A, 2013, CURR OPIN STRUC BIOL, V23, P678, DOI 10.1016/j.sbi.2013.07.007; Vleeshouwers VGAA, 1999, EUR J PLANT PATHOL, V105, P241, DOI 10.1023/A:1008710700363; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Wanrnes G, 2016, GPLOTS VARIOUS R PRO; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wibberg D, 2014, FUNGAL BIOL-UK, V118, P800, DOI 10.1016/j.funbio.2014.06.007; Wills EA, 2001, MOL MICROBIOL, V40, P610, DOI 10.1046/j.1365-2958.2001.02401.x; YANG XB, 1990, PHYTOPATHOLOGY, V80, P497, DOI 10.1094/Phyto-80-497; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhu C, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00708, 10.3389/fmicb.2016.01840]	79	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184095	10.1371/journal.pone.0184095	http://dx.doi.org/10.1371/journal.pone.0184095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877263	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200063
J	Geissler, K; Markwart, R; Requardt, RP; Weigel, C; Schubert, K; Scherag, A; Rubio, I; Guntinas-Lichius, O				Geissler, Katharina; Markwart, Robby; Requardt, Robert Pascal; Weigel, Cynthia; Schubert, Katja; Scherag, Andre; Rubio, Ignacio; Guntinas-Lichius, Orlando			Functional characterization of T-cells from palatine tonsils in patients with chronic tonsillitis	PLOS ONE			English	Article							TONSILLECTOMY; ACTIVATION; MAINTENANCE; PERSISTENCE; EXHAUSTION; INDUCTION; RESPONSES; CD4(+)	The palatine tonsils, localized in the oropharynx, are easily accessible secondary lymphoid tissue in humans. Inflammation of the palatine tonsils, local and chronic in case of chronic tonsillitis (CT) or acute in the presence of a peritonsillar abscess (PTA), ranks among the most common diseases in otolaryngology. However, the functionality of tonsillar immune cells, notably T-cells, in the context of these immune pathologies is poorly understood. We have examined the functional status of human tonsillar T-cells in CT and compared it to the acute inflammatory setting of a PTA. Patients presenting with CT (n = 10) or unilateral PTA (n = 7) underwent bilateral tonsillectomy and a subgroup of 8 patients underwent additional blood sampling. T-cells were purified via automated magnetic selection and subjected to flow cytometry-based immunophenotyping. In addition, the response to T-cell receptor (TCR) stimulation was assessed at the level of proximal signaling, activation marker expression and proliferation. We observed no difference between the percentage of T helper (CD4 (+)) cells from tonsil tissue in CT and PTA, but observed a trend towards a higher percentage of T helper cells in the blood of patients with PTA versus CT, probably reflecting an acute, systemic bacterial infection in the former cohort. Tonsils from CT harbored more PD1(+) CD4(+) T-cells, pointing to T-cell exhaustion due to chronic infection. This notion was supported by functional studies that showed a tendency to weaker TCR responses of tonsillar T-cells from CT. Intriguingly, tonsillar T-cells recurrently featured a dampened response to T-cell receptor stimulation at the level of receptor proximal signaling steps compared to peripheral T-cells. In sum, our study documents distinct differences in tonsillar T-cell class distribution and function between the various pathological conditions. Our observations are consistent with the concept that tonsillar T-cells react to infections by eliciting specific immunological responses in chronic versus acute settings of inflammation.	[Geissler, Katharina; Guntinas-Lichius, Orlando] Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany; [Geissler, Katharina; Markwart, Robby; Requardt, Robert Pascal; Weigel, Cynthia; Schubert, Katja; Scherag, Andre; Rubio, Ignacio] Jena Univ Hosp, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, Jena, Germany; [Scherag, Andre] Jena Univ Hosp, Res Grp Clin Epidemiol, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, Jena, Germany; [Rubio, Ignacio] Jena Univ Hosp, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Geissler, K (corresponding author), Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany.; Geissler, K; Rubio, I (corresponding author), Jena Univ Hosp, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, Jena, Germany.; Rubio, I (corresponding author), Jena Univ Hosp, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany.	Katharina.Geissler@med.uni-jena.de; Ignacio.Rubio@med.uni-jena.de; Ignacio.Rubio@med.uni-jena.de	Guntinas-Lichius, Orlando/L-1871-2016	Guntinas-Lichius, Orlando/0000-0001-9671-0784; Markwart, Robby/0000-0003-0338-3433; Weigel, Cynthia/0000-0003-3132-4203; Rubio, Ignacio/0000-0002-0251-7711	Federal Ministry of Education and Research (BMBF), Germany; Center for Sepsis Control and Care (CSCC) [FKZ: 01EO1002]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Center for Sepsis Control and Care (CSCC)	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, by a grant from the Center for Sepsis Control and Care (CSCC) (grant # FKZ: 01EO1002 to K.G., A.S. and I.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Joachim Clement for providing access to FACS instrumentation and Ralf Claus for technical assistance. This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, by grant from the Center for Sepsis Control and Care (CSCC) (grant # FKZ: 01EO1002 to K.G., A.S and I.R.).	Arkkila E, 1998, ORL J OTO-RHINO-LARY, V60, P159, DOI 10.1159/000027586; Berg NN, 1998, J IMMUNOL, V161, P2919; Bitar MA, 2015, INT J PEDIATR OTORHI, V79, P1184, DOI 10.1016/j.ijporl.2015.05.016; Blanchard N, 2004, J IMMUNOL, V173, P3062, DOI 10.4049/jimmunol.173.5.3062; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Burton MJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001802.pub2; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chen MM, 2014, JAMA OTOLARYNGOL, V140, P197, DOI 10.1001/jamaoto.2013.6215; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hu Lanye, 2016, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V30, P418; Jartti T, 2014, ALLERGY, V69, P658, DOI 10.1111/all.12396; Ji JG, 2016, J AUTOIMMUN, V72, P1, DOI 10.1016/j.jaut.2016.06.007; Komorowska A, 2005, INT J PEDIATR OTORHI, V69, P937, DOI 10.1016/j.ijporl.2005.01.035; Liu LL, 2015, AM J KIDNEY DIS, V65, P80, DOI 10.1053/j.ajkd.2014.06.036; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Nasrin M, 2012, Bangladesh Med Res Counc Bull, V38, P59; Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210; O'Keefe JP, 2004, P NATL ACAD SCI USA, V101, P9351, DOI 10.1073/pnas.0305965101; Olofsson K, 1998, CLIN EXP IMMUNOL, V111, P36; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; Powell EL, 2013, J ANTIMICROB CHEMOTH, V68, P1941, DOI 10.1093/jac/dkt128; Sada-Ovalle I, 2012, CLIN EXP IMMUNOL, V168, P200, DOI 10.1111/j.1365-2249.2012.04573.x; Simoes Joao Filipe, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-206899; Smigiel KS, 2014, IMMUNOL REV, V259, P40, DOI 10.1111/imr.12170; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Vestergaard H, 2010, INT J CANCER, V127, P633, DOI 10.1002/ijc.24973; Vidal-Rubio B, 2001, BMC Immunol, V2, P2, DOI 10.1186/1471-2172-2-2; Wang XQ, 2008, J IMMUNOL, V180, P6703, DOI 10.4049/jimmunol.180.10.6703; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Weigel C, 2015, J IMMUNOL METHODS, V427, P66, DOI 10.1016/j.jim.2015.10.002; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Windfuhr JP, 2016, LARYNGO RHINO OTOL, V95, pS88, DOI 10.1055/s-0041-109594; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Yu HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143001; Zajac AJ, 1999, J IMMUNOL, V163, P5526; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183214	10.1371/journal.pone.0183214	http://dx.doi.org/10.1371/journal.pone.0183214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877231	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200026
J	Frolking, S; Hagen, S; Braswell, B; Milliman, T; Herrick, C; Peterson, S; Roberts, D; Keller, M; Palace, M				Frolking, Steve; Hagen, Stephen; Braswell, Bobby; Milliman, Tom; Herrick, Christina; Peterson, Seth; Roberts, Dar; Keller, Michael; Palace, Michael			Evaluating multiple causes of persistent low microwave backscatter from Amazon forests after the 2005 drought	PLOS ONE			English	Article							PATTERNS; BIOMASS; MODIS; BAND	Amazonia has experienced large-scale regional droughts that affect forest productivity and biomass stocks. Space-borne remote sensing provides basin-wide data on impacts of meteorological anomalies, an important complement to relatively limited ground observations across the Amazon's vast and remote humid tropical forests. Morning overpass QuikScat Ku-band microwave backscatter from the forest canopy was anomalously low during the 2005 drought, relative to the full instrument record of 1999-2009, and low morning backscatter persisted for 2006-2009, after which the instrument failed. The persistent low backscatter has been suggested to be indicative of increased forest vulnerability to future drought. To better ascribe the cause of the low post-drought backscatter, we analyzed multiyear, gridded remote sensing data sets of precipitation, land surface temperature, forest cover and forest cover loss, and microwave backscatter over the 2005 drought region in the southwestern Amazon Basin (4 degrees-12 degrees S,66 degrees-76 degrees W) and in adjacent 8 degrees x10 degrees regions to the north and east. We found moderate to weak correlations with the spatial distribution of persistent low backscatter for variables related to three groups of forest impacts: the 2005 drought itself, loss of forest cover, and warmer and drier dry seasons in the post-drought vs. the pre-drought years. However, these variables explained only about one quarter of the variability in depressed backscatter across the southwestern drought region. Our findings indicate that drought impact is a complex phenomenon and that better understanding can only come from more extensive ground data and/or analysis of frequent, spatially-comprehensive, high-resolution data or imagery before and after droughts.	[Frolking, Steve; Braswell, Bobby; Milliman, Tom; Herrick, Christina; Palace, Michael] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Frolking, Steve; Palace, Michael] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Hagen, Stephen; Braswell, Bobby] Appl GeoSolut, Newmarket, NH USA; [Peterson, Seth; Roberts, Dar] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Keller, Michael] USDA, Forest Serv, Int Inst Trop Forestry, Rio Piedras, PR USA; [Keller, Michael] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Keller, Michael] Embrapa Agr Informat, Campinas, SP, Brazil	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University of California System; University of California Santa Barbara; United States Department of Agriculture (USDA); United States Forest Service; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Frolking, S (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA.; Frolking, S (corresponding author), Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA.	steve.frolking@unh.edu	Herrick, Christina/O-4873-2019; Keller, Michael/A-8976-2012; Frolking, Steve/ABF-9046-2021; Braswell, Bobby H/D-6411-2016	Herrick, Christina/0000-0002-8384-9450; Keller, Michael/0000-0002-0253-3359; Frolking, Steve/0000-0001-6414-5004; Braswell, Bobby H/0000-0002-4061-9516	National Aeronautics and Space Administration [NNX14AD31G]; NASA's Interdisciplinary Science Program [NNX14AD31G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NASA's Interdisciplinary Science Program(National Aeronautics & Space Administration (NASA))	The research was supported by the National Aeronautics and Space Administration, (https://www.nasa.gov/), grant NNX14AD31G, MP (Ph. The funder provided support in the form of salaries for authors [MP, SF, SH, BB, CH, TM, SP, DR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was supported by grant NNX14AD31G from NASA's Interdisciplinary Science Program (https://www.nasa.gov/). We thank Doug Morton, Katherine Sinacore, and Sassan Saatchi and an anonymous reviewer for helpful input during the development of this manuscript.	Anderson LO, 2010, NEW PHYTOL, V187, P733, DOI 10.1111/j.1469-8137.2010.03355.x; Anderson LO, 2015, GLOBAL BIOGEOCHEM CY, V29, P1739, DOI 10.1002/2014GB005008; Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; Bonal D, 2016, ANN FOREST SCI, V73, P27, DOI 10.1007/s13595-015-0522-5; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bustamante MMC, 2016, GLOBAL CHANGE BIOL, V22, P92, DOI 10.1111/gcb.13087; Craven D, 2013, TREES-STRUCT FUNCT, V27, P639, DOI 10.1007/s00468-012-0818-0; de Carvalho AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054852, 10.1371/journal.pone.0059736]; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Feldpausch TR, 2016, GLOBAL BIOGEOCHEM CY, V30, P964, DOI 10.1002/2015GB005133; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Frolking S., 2005, REMOTE SENS ENVIRON, V115, P897; Frolking S, 2012, IEEE T GEOSCI REMOTE, V50, P2603, DOI 10.1109/TGRS.2011.2182516; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; HUC R, 1994, OECOLOGIA, V99, P297, DOI 10.1007/BF00627742; Huntingford C, 2013, NATURE GEOSCIENCE, P6; Hutyra LR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024981; Jimenez-Munoz JC, 2013, J GEOPHYS RES-ATMOS, V118, P5204, DOI 10.1002/jgrd.50456; Johnson MO, 2016, GLOBAL CHANGE BIOL, V22, P3996, DOI 10.1111/gcb.13315; LEOC Malhi Y, 2007, GEOPHYS RES LETT, V34; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Long D. G., 2001, T AM GEOPHYS UNION, V82, P503, DOI DOI 10.1029/01E000303); LPDAAC, 2004, GLOB 30 ARC 2 EL GTO; Maeda EE, 2015, GEOPHYS RES LETT, V42, P7546, DOI 10.1002/2015GL065252; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; McMichael CH, 2014, J BIOGEOGR, V41, P1733, DOI 10.1111/jbi.12325; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Swenson S, 2006, J HYDROMETEOROL, V7, P252, DOI 10.1175/JHM478.1; Toomey M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049041; Treuhaft R, 2015, IEEE GEOSCI REMOTE S, V12, P239, DOI 10.1109/LGRS.2014.2334140; Ulaby F. T., 2014, MICROWAVE RADAR RADI	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183308	10.1371/journal.pone.0183308	http://dx.doi.org/10.1371/journal.pone.0183308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873422	Green Published, gold			2022-12-26	WOS:000409282800012
J	Theriau, CF; Sauve, OS; Beaudoin, MS; Wright, DC; Connor, MK				Theriau, Christopher F.; Sauve, O'Llenecia S.; Beaudoin, Marie-Soleil; Wright, David C.; Connor, Michael K.			Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation	PLOS ONE			English	Article							BREAST-CANCER CELLS; ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; MITOCHONDRIAL-FUNCTION; LIPID-SYNTHESIS; RAT ADIPOCYTES; ADIPONECTIN; LEPTIN; GROWTH; RISK	Obesity is clearly associated with an increased risk of breast cancer in postmenopausal women. The purpose was to determine if obesity alters the adipocyte adipokine secretion profile, thereby altering the adipose-dependent paracrine/endocrine growth microenvironment surrounding breast cancer cells (MCF7). Additionally, we determined whether resveratrol (RSV) supplementation can counteract any obesity-dependent effects on breast cancer tumor growth microenvironment. Obese ZDF rats received standard chow diet or diet supplemented with 200 mg/kg body weight RSV. Chow-fed Zucker rats served as lean controls. After 6 weeks, conditioned media (CM) prepared from inguinal subcutaneous adipose tissue (scAT) was added to MCF7 cells for 24 hrs. Experiments were also conducted using purified isolated adipocytes to determine whether any endocrine effects could be attributed specifically to the adipocyte component of adipose tissue. scAT from ZDF rats promoted cell cycle entry in MCF7 cells which was counteracted by RSV supplementation. RSV-CM had a higher ratio of ADIPO: LEP compared to ZDF-CM. This altered composition of the CM led to increased levels of pAMPK(T172), p27, p27(T198) and AdipoR1 while decreasing pAkt(T308) in MCF7 cells grown in RSV-CM compared to ZDF-CM. RSV-CM increased number of cells in G0/G1 and decreased cells in S-phase compared to ZDF-CM. Co-culture experiments revealed that these obesity-dependent effects were driven by the adipocyte component of the adipose tissue. Obesity decreased the ratio of adiponectin: leptin secreted by adipocytes, altering the adipose-dependent growth microenvironment resulting in increased breast cancer cell proliferation. Supplementation with RSV reversed these adipose-dependent effects suggesting a potential for RSV as a nutritional supplementation to improve breast cancer treatment in obese patients.	[Theriau, Christopher F.; Sauve, O'Llenecia S.; Connor, Michael K.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Beaudoin, Marie-Soleil; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada	York University - Canada; University of Guelph	Connor, MK (corresponding author), York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.	mconnor@yorku.ca		Wright, David/0000-0003-3867-8901	Natural Sciences and Engineering Research Council of Canada (NSERC Canadian Network for Research and Innovation in Machining Technology) [12722]; Canadian Foundation for Innovation [11331]	Natural Sciences and Engineering Research Council of Canada (NSERC Canadian Network for Research and Innovation in Machining Technology); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC Canadian Network for Research and Innovation in Machining Technology): Michael K. Connor 12722 (http://www.nserc-crsng.gc.ca/Business-Entreprise/How-Comment/Networks-Reseaux/canrimt-canrimt_eng.asp); Canadian Foundation for Innovation: Michael K. Connor 11331 (https://www.innovation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa N, 2010, GYNECOL ONCOL, V119, P65, DOI 10.1016/j.ygyno.2010.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beaudoin MS, 2013, AM J PHYSIOL-REG I, V305, pR542, DOI 10.1152/ajpregu.00200.2013; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Ceddia RB, 2000, EUR J BIOCHEM, V267, P5952, DOI 10.1046/j.1432-1327.2000.01664.x; Chung H, 2015, ONCOGENE, V34, P3504, DOI 10.1038/onc.2014.283; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dieudonne MN, 2002, BIOCHEM BIOPH RES CO, V293, P622, DOI 10.1016/S0006-291X(02)00205-X; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Grossmann ME, 2008, CELL RES, V18, P1154, DOI 10.1038/cr.2008.293; Hausman GJ, 1985, NEW PERSPECTIVES ADI; Hsieh TC, 1999, INT J ONCOL, V15, P245; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lu RQ, 1999, J CELL PHYSIOL, V179, P297, DOI 10.1002/(SICI)1097-4652(199906)179:3<297::AID-JCP7>3.0.CO;2-P; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Serrero G, 2001, ANTIOXID REDOX SIGN, V3, P969, DOI 10.1089/152308601317203512; SNEDDON A, 1968, LANCET, V2, P892; Szkudelska K, 2009, EUR J CLIN INVEST, V39, P899, DOI 10.1111/j.1365-2362.2009.02188.x; Theriau CF, 2016, J APPL PHYSIOL, V121, P139, DOI 10.1152/japplphysiol.00862.2015; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	34	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183897	10.1371/journal.pone.0183897	http://dx.doi.org/10.1371/journal.pone.0183897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873415	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800033
J	Kimura, S; Morizane, Y; Shiode, Y; Hirano, M; Doi, S; Toshima, S; Fujiwara, A; Shiraga, F				Kimura, Shuhei; Morizane, Yuki; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Fujiwara, Atsushi; Shiraga, Fumio			Assessment of tilt and decentration of crystalline lens and intraocular lens relative to the corneal topographic axis using anterior segment optical coherence tomography	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; LIGHT-REFLEX; PUPIL CENTER; SURGERY; EYES; ASTIGMATISM; CENTRATION; SILICONE; DESIGN	Purpose To investigate the tilt and decentration of the crystalline lens and the intraocular lens (IOL) relative to the corneal topographic axis using anterior segment ocular coherence tomography (AS-OCT). Methods A sample set of 100 eyes from 49 subjects (41 eyes with crystalline lenses and 59 eyes with IOLs) were imaged using second generation AS-OCT (CASIA2, TOMEY) in June and July 2016 at Okayama University. Both mydriatic and non-mydriatic images were obtained, and the tilt and decentration of the crystalline lens and the IOL were quantified. The effects of pupil dilation on measurements were also assessed. Results The crystalline lens showed an average tilt of 5.15 degrees towards the inferotemporal direction relative to the corneal topographic axis under non-mydriatic conditions and 5.25 degrees under mydriatic conditions. Additionally, an average decentration of 0.11 mm towards the temporal direction was observed under non-mydriatic conditions and 0.08 mm under mydriatic conditions. The average tilt for the IOL was 4.31 degrees towards the inferotemporal direction relative to the corneal topographic axis under non-mydriatic conditions and 4.65 degrees in the same direction under mydriatic conditions. The average decentration was 0.05 mm towards the temporal direction under non-mydriatic conditions and 0.08 mm in the same direction under mydriatic conditions. A strong correlation was found between the average tilt and decentration values of the crystalline lens and the IOL under both non-mydriatic and mydriatic conditions (all Spearman correlation coefficients, r >= 0.800; all P < 0.001). Conclusion When measured using second generation AS-OCT, both the crystalline lens and the IOL showed an average tilt of 4-6 degrees toward the inferotemporal direction relative to the corneal topographic axis and an average decentration of less than 0.12 mm towards the temporal direction. These results were not influenced by pupil dilation and they showed good repeatability.	[Kimura, Shuhei; Morizane, Yuki; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Fujiwara, Atsushi; Shiraga, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan	Okayama University	Kimura, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan.	shuheik@cc.okayama-u.ac.jp		Kimura, Shuhei/0000-0003-2565-277X				Aizawa N, 2015, CLIN EXP OPHTHALMOL, V43, P92, DOI 10.1111/ceo.12366; Arbelaez MC, 2008, INVEST OPHTH VIS SCI, V49, P5287, DOI 10.1167/iovs.08-2176; Baumeister M, 2005, AM J OPHTHALMOL, V140, P1051, DOI 10.1016/j.ajo.2005.07.026; Baumeister M, 2009, J CATARACT REFR SURG, V35, P1006, DOI 10.1016/j.jcrs.2009.01.023; Camellin M, 2005, J CATARACT REFR SURG, V31, P1719, DOI 10.1016/j.jcrs.2005.04.027; Chang DH, 2014, AM J OPHTHALMOL, V158, P863, DOI 10.1016/j.ajo.2014.06.028; Crnej A, 2011, J CATARACT REFR SURG, V37, P1768, DOI 10.1016/j.jcrs.2011.04.028; Ding XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142556; Eppig T, 2009, J CATARACT REFR SURG, V35, P1091, DOI 10.1016/j.jcrs.2009.01.034; GUYTON DL, 1990, OPHTHALMOLOGY, V97, P1259; Hayashi K, 1997, OPHTHALMOLOGY, V104, P793, DOI 10.1016/S0161-6420(97)30231-0; Hayashi K, 1999, OPHTHALMOLOGY, V106, P878, DOI 10.1016/S0161-6420(99)00504-7; Holladay JT, 2002, J REFRACT SURG, V18, P683; Holladay JT, 1998, J CATARACT REFR SURG, V24, P57, DOI 10.1016/S0886-3350(98)80075-8; Kumar DA, 2011, AM J OPHTHALMOL, V151, P406, DOI 10.1016/j.ajo.2010.09.013; Nishi Y, 2010, J CATARACT REFR SURG, V36, P1529, DOI 10.1016/j.jcrs.2010.03.043; Okamoto S, 2011, J CATARACT REFR SURG, V37, P1951, DOI 10.1016/j.jcrs.2011.05.040; PHILLIPS P, 1988, J CATARACT REFR SURG, V14, P129, DOI 10.1016/S0886-3350(88)80086-5; Porter J, 2006, J CATARACT REFR SURG, V32, P21, DOI 10.1016/j.jcrs.2005.10.027; Sacu S, 2005, J CATARACT REFR SURG, V31, P330, DOI 10.1016/j.jcrs.2004.04.057; Schaeffel F, 2008, INVEST OPHTH VIS SCI, V49, P2216, DOI 10.1167/iovs.07-1022; Visser N, 2012, J CATARACT REFR SURG, V38, P1764, DOI 10.1016/j.jcrs.2012.05.036	22	45	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184066	10.1371/journal.pone.0184066	http://dx.doi.org/10.1371/journal.pone.0184066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863141	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900020
J	Maccarana, M; Svensson, RB; Knutsson, A; Giannopoulos, A; Pelkonen, M; Weis, M; Eyre, D; Warman, M; Kalamajski, S				Maccarana, Marco; Svensson, Rene B.; Knutsson, Anki; Giannopoulos, Antonis; Pelkonen, Mea; Weis, MaryAnn; Eyre, David; Warman, Matthew; Kalamajski, Sebastian			Asporin-deficient mice have tougher skin and altered skin glycosaminoglycan content and structure	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; I COLLAGEN; TARGETED DISRUPTION; CORNEAL OPACITY; NULL MICE; LUMICAN; DECORIN; FIBROMODULIN; EXPRESSION; FIBRILLOGENESIS	The main structural component of connective tissues is fibrillar, cross-linked collagen whose fibrillogenesis can be modulated by Small Leucine-Rich Proteins/Proteoglycans (SLRPs). Not all SLRPs' effects on collagen and extracellular matrix in vivo have been elucidated; one of the less investigated SLRPs is asporin. Here we describe the successful generation of an Aspn(-/-) mouse model and the investigation of the Aspn(-/-) skin phenotype. Functionally, Aspn(-/-) mice had an increased skin mechanical toughness, although there were no structural changes present on histology or immunohistochemistry. Electron microscopy analyses showed 7% thinner collagen fibrils in Aspn(-/-) mice (not statistically significant). Several matrix genes were upregulated, including collagens (Col1a1, Col1a2, Col3a1), matrix metalloproteinases (Mmp2, Mmp3) and lysyl oxidases (Lox, Loxl2), while lysyl hydroxylase (Plod2) was downregulated. Intriguingly no differences were observed in collagen protein content or in collagen cross-linking-related lysine oxidation or hydroxylation. The glycosaminoglycan content and structure in Aspn(-/-) skin was profoundly altered: chondroitin/dermatan sulfate was more than doubled and had an altered composition, while heparan sulfate was halved and had a decreased sulfation. Also, decorin and biglycan were doubled in Aspn(-/-) skin. Overall, asporin deficiency changes skin glycosaminoglycan composition, and decorin and biglycan content, which may explain the changes in skin mechanical properties.	[Maccarana, Marco; Knutsson, Anki; Pelkonen, Mea] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Svensson, Rene B.; Giannopoulos, Antonis] Bispebjerg Hosp, Inst Sports Med, Copenhagen, Denmark; [Svensson, Rene B.; Giannopoulos, Antonis] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Weis, MaryAnn; Eyre, David] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Warman, Matthew] Harvard Med Sch, Howard Hughes Med Inst, Childrens Hosp Boston, Boston, MA USA; [Kalamajski, Sebastian] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Lund University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Uppsala University	Kalamajski, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	sebastian.kalamajski@imbim.uu.se	Svensson, Rene B./AGZ-3181-2022; maccarana, marco/AAB-4764-2021	Svensson, Rene B./0000-0002-1607-5379; Kalamajski, Sebastian/0000-0002-6600-9302; Maccarana, Marco/0000-0003-3549-8921	Swedish Cancer Foundation; Alfred Osterlund Foundation; Danish Council for Independent Research [DFF-1333-00052A]; NIH(NIAMS) [AR037318]; Swedish Research Council [2008-6946]; The Crafoord Foundation; Ake Wiberg Foundation; The Magnus Bergvall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Alfred Osterlund Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); NIH(NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); The Crafoord Foundation; Ake Wiberg Foundation; The Magnus Bergvall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the Swedish Cancer Foundation, http://www.cancerfonden.se, to MM, SK; the Alfred Osterlund Foundation, http://www.alfredosterlundsstiftelse.se/, to MM, SK; the Danish Council for Independent Research, http://ufm.dk/forskning-og-innovation/rad-og-udvalg/detf-fire-forskningsrad, to RBS, grant DFF-1333-00052A; the NIH(NIAMS), http://www.nih.gov, to DE, grant AR037318; the Swedish Research Council, http://www.vr.se, to SK, grant 2008-6946; The Crafoord Foundation, http://en.crafoord.se/, to SK; The Ake Wiberg Foundation, http://ake-wiberg-se/, to SK; and The Magnus Bergvall Foundation, http://www.magnbergvallsstiftelse.nu/, to SK. The funders had no role in study design, data collection and analysis,decision to publish,or preparation of the manuscript.	Awata T, 2015, J DENT RES, V94, P1417, DOI 10.1177/0022034515598507; BERG RA, 1982, METHOD ENZYMOL, V82, P372; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Ding Q, 2015, ONCOL REP, V33, P1783, DOI 10.3892/or.2015.3791; Duval E, 2011, MOL MED, V17, P816, DOI 10.2119/molmed.2011.00052; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kou I, 2007, J BIOL CHEM, V282, P32193, DOI 10.1074/jbc.M706262200; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351; Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Maris P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001871; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Olsson PO, 2016, MOL CANCER THER, V15, P2455, DOI 10.1158/1535-7163.MCT-16-0026; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Reese SP, 2013, MATRIX BIOL, V32, P414, DOI 10.1016/j.matbio.2013.04.004; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roeder BA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005331; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Simkova D., 2016, ONCOTARGET; Song YQ, 2008, AM J HUM GENET, V82, P744, DOI 10.1016/j.ajhg.2007.12.017; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Ueda M, 2016, ARCH ORAL BIOL, V62, P86, DOI 10.1016/j.archoralbio.2015.11.010; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Yeh JT, 2010, BRIT J DERMATOL, V163, P1174, DOI 10.1111/j.1365-2133.2010.10008.x; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010	45	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184028	10.1371/journal.pone.0184028	http://dx.doi.org/10.1371/journal.pone.0184028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859141	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500060
J	Zhang, C; Miller, DJ; Guibao, CD; Donato, DM; Hanks, SK; Zheng, JJ				Zhang, Chi; Miller, Darcie J.; Guibao, Cristina D.; Donato, Dominique M.; Hanks, Steven K.; Zheng, Jie J.			Structural and functional insights into the interaction between the Cas family scaffolding protein p130Cas and the focal adhesion-associated protein paxillin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						focal adhesion; nuclear magnetic resonance (NMR); PTK2 protein tyrosine kinase 2 (PTK2) (focal adhesion kinase) (FAK); scaffold protein; X-ray crystallography; p130Cas; BCAR1; paxillin	LD MOTIFS; 4-HELIX BUNDLE; KINASE; BINDS; LOCALIZATION; RECOGNITION; VINCULIN; DOMAIN	The Cas family scaffolding protein p130Cas is a Src substrate localized in focal adhesions (FAs) and functions in integrin signaling to promote cell motility, invasion, proliferation, and survival. p130Cas targeting to FAs is essential for its tyrosine phosphorylation and downstream signaling. Although the N-terminal SH3 domain is important for p130Cas localization, it has also been reported that the C-terminal region is involved in p130Cas FA targeting. The C-terminal region of p130Cas or Cas family homology domain (CCHD) has been reported to adopt a structure similar to that of the focal adhesion kinase C-terminal focal adhesion-targeting domain. The mechanism by which the CCHD promotes FA targeting of p130Cas, however, remains unclear. In this study, using a calorimetry approach, we identified the first LD motif (LD1) of the FA-associated protein paxillin as the binding partner of the p130Cas CCHD (in a 1:1 stoichiometry with a K-d approximate to 4.2 m) and elucidated the structure of the p130Cas CCHD in complex with the paxillin LD1 motif by X-ray crystallography. Of note, a comparison of the CCHD/LD1 complex with a previously solved structure of CCHD in complex with the SH2-containing protein NSP3 revealed that LD1 had almost identical positioning of key hydrophobic and acidic residues relative to NSP3. Because paxillin is one of the key scaffold molecules in FAs, we propose that the interaction between the p130Cas CCHD and the LD1 motif of paxillin plays an important role in p130Cas FA targeting.	[Zhang, Chi; Zheng, Jie J.] UCLA, David Geffen Sch Med, Dept Ophthalmol, Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA; [Zhang, Chi; Miller, Darcie J.; Guibao, Cristina D.; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhang, Chi; Zheng, Jie J.] Univ Tennessee, Dept Mol Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Donato, Dominique M.; Hanks, Steven K.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Donato, Dominique M.] Leiden Univ, Phys Life Proc, Huygens Kamerlingh Onnes Lab, NL-2300 RE Leiden, Netherlands; [Zheng, Jie J.] UCLA, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Los Angeles	Zheng, JJ (corresponding author), UCLA, David Geffen Sch Med, Dept Ophthalmol, Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.	jzheng@jsei.ucla.edu		Zheng, Jie/0000-0001-6524-6800	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100909] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. We thank Dr. Weixing Zhang and Dr. Christy R. R. Grace for assistance with NMR experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Janostiak R, 2014, CELL MOL LIFE SCI, V71, P727, DOI 10.1007/s00018-013-1450-x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vanarotti MS, 2014, J MOL BIOL, V426, P3985, DOI 10.1016/j.jmb.2014.08.014; Wang CY, 2001, J BIOMOL NMR, V21, P361, DOI 10.1023/A:1013328206498; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200	23	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18281	18289		10.1074/jbc.M117.807271	http://dx.doi.org/10.1074/jbc.M117.807271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28860193	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000414458200025
J	Campanello, GC; Lofgren, M; Yokom, AL; Southworth, DR; Banerjee, R				Campanello, Gregory C.; Lofgren, Michael; Yokom, Adam L.; Southworth, Daniel R.; Banerjee, Ruma			Switch I-dependent allosteric signaling in a G-protein chaperone-B-12 enzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; RADICAL B-12 ENZYME; COENZYME B-12; VITAMIN-B-12 METABOLISM; COMPLEMENTATION GROUP; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GTP HYDROLYSIS; RAS PROTEIN; MMAA GENE	G-proteins regulate various processes ranging from DNA replication and protein synthesis to cytoskeletal dynamics and cofactor assimilation and serve as models for uncovering strategies deployed for allosteric signal transduction. MeaB is a multifunctional G-protein chaperone, which gates loading of the active 5 '-deoxyadenosylcobalamin cofactor onto methylmalonyl-CoA mutase (MCM) and precludes loading of inactive cofactor forms. MeaB also safeguards MCM, which uses radical chemistry, against inactivation and rescues MCM inactivated during catalytic turnover by using the GTP-binding energy to offload inactive cofactor. The conserved switch I and II signaling motifs used by G-proteins are predicted to mediate allosteric regulation in response to nucleotide binding and hydrolysis in MeaB. Herein, we targeted conserved residues in the MeaB switch I motif to interrogate the function of this loop. Unexpectedly, the switch I mutations had only modest effects on GTP binding and on GTPase activity and did not perturb stability of the MCM-MeaB complex. However, these mutations disrupted multiple MeaB chaperone functions, including cofactor editing, loading, and offloading. Hence, although residues in the switch I motif are not essential for catalysis, they are important for allosteric regulation. Furthermore, single-particle EM analysis revealed, for the first time, the overall architecture of the MCM MeaB complex, which exhibits a 2:1 stoichiometry. These EM studies also demonstrate that the complex exhibits considerable conformational flexibility. In conclusion, the switch I element does not significantly stabilize the MCM-MeaB complex or influence the affinity of MeaB for GTP but is required for transducing signals between MeaB and MCM.	[Campanello, Gregory C.; Lofgren, Michael; Yokom, Adam L.; Southworth, Daniel R.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Med Ctr, Life Sci Inst, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Yokom, Adam L.] Univ Michigan, Med Ctr, Life Sci Inst, Grad Program Chem Biol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, 5 F32 GM113405, GM110001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110001, F32GM113405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK45776 (to to R. B.), 5 F32 GM113405 (to G. C. C.), and GM110001 (to D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jost M, 2015, J BIOL CHEM, V290, P26882, DOI 10.1074/jbc.M115.676890; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2006, MOL GENET METAB, V87, P219, DOI 10.1016/j.ymgme.2005.11.011; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; Li Z, 2017, J BIOL CHEM, V292, P3977, DOI 10.1074/jbc.M117.775957; Lofgren M, 2013, J BIOL CHEM, V288, P30980, DOI 10.1074/jbc.M113.499970; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tanpaiboon P, 2005, MOL GENET METAB, V85, P2; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zhang J, 2006, MOL GENET METAB, V87, P315, DOI 10.1016/j.ymgme.2005.12.003	42	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17617	17625		10.1074/jbc.M117.786095	http://dx.doi.org/10.1074/jbc.M117.786095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28882898	Green Published, hybrid			2022-12-26	WOS:000414013000005
J	Goedegebuur, F; Dankmeyer, L; Gualfetti, P; Karkehabadi, S; Hansson, H; Jana, S; Huynh, V; Kelemen, BR; Kruithof, P; Larenas, EA; Teunissen, PJM; Stahlberg, J; Payne, CM; Mitchinson, C; Sandgren, M				Goedegebuur, Frits; Dankmeyer, Lydia; Gualfetti, Peter; Karkehabadi, Saeid; Hansson, Henrik; Jana, Suvamay; Huynh, Vicky; Kelemen, Bradley R.; Kruithof, Paulien; Larenas, Edmund A.; Teunissen, Pauline J. M.; Stahlberg, Jerry; Payne, Christina M.; Mitchinson, Colin; Sandgren, Mats			Improving the thermal stability of cellobiohydrolase Cel7A from Hypocrea jecorina by directed evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; AROMATIC-CARBOHYDRATE INTERACTIONS; STRUCTURE-GUIDED RECOMBINATION; ELECTRON-DENSITY MAPS; MOLECULAR-DYNAMICS; PHANEROCHAETE-CHRYSOSPORIUM; MACROMOLECULAR STRUCTURES; SACCHAROMYCES-CEREVISIAE; GLYCOSIDE HYDROLASES; CRYSTAL-STRUCTURES	Secreted mixtures of Hypocrea jecorina cellulases are able to efficiently degrade cellulosic biomass to fermentable sugars at large, commercially relevant scales. H. jecorina Cel7A, cellobiohydrolase I, from glycoside hydrolase family 7, is the workhorse enzyme of the process. However, the thermal stability of Cel7A limits its use to processes where temperatures are no higher than 50 degrees C. Enhanced thermal stability is desirable to enable the use of higher processing temperatures and to improve the economic feasibility of industrial biomass conversion. Here, we enhanced the thermal stability of Cel7A through directed evolution. Sites with increased thermal stability properties were combined, and a Cel7A variant (FCA398) was obtained, which exhibited a 10.4 degrees C increase in T-m and a 44-fold greater half-life compared with the wild-type enzyme. This Cel7A variant contains 18 mutated sites and is active under application conditions up to at least 75 degrees C. The X-ray crystal structure of the catalytic domain was determined at 2.1 angstrom resolution and showed that the effects of the mutations are local and do not introduce major backbone conformational changes. Molecular dynamics simulations revealed that the catalytic domain of wild-type Cel7A and the FCA398 variant exhibit similar behavior at 300 K, whereas at elevated temperature (475 and 525 K), the FCA398 variant fluctuates less and maintains more native contacts over time. Combining the structural and dynamic investigations, rationales were developed for the stabilizing effect at many of the mutated sites.	[Goedegebuur, Frits; Dankmeyer, Lydia; Kruithof, Paulien] DuPont Ind Biosci, Archimedesweg 30, NL-2333 CN Leiden, Netherlands; [Gualfetti, Peter; Huynh, Vicky; Kelemen, Bradley R.; Larenas, Edmund A.; Mitchinson, Colin] DuPont Ind Biosci, Palo Alto, CA 94304 USA; [Karkehabadi, Saeid; Hansson, Henrik; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, SE-75007 Uppsala, Sweden; [Jana, Suvamay; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA	Swedish University of Agricultural Sciences; University of Kentucky	Goedegebuur, F (corresponding author), DuPont Ind Biosci, Archimedesweg 30, NL-2333 CN Leiden, Netherlands.; Stahlberg, J; Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, SE-75007 Uppsala, Sweden.; Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.	frits.goedegebuur@dupont.com; jerry.stahlberg@slu.se; christy.payne@uky.edu; mats.sandgren@slu.se	Payne, Christina/ABE-8330-2020; Stahlberg, Jerry/D-4163-2013	Payne, Christina/0000-0001-5264-0964; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534; Stahlberg, Jerry/0000-0003-4059-8580	NSF [ACI-1053575, MCB090159]	NSF(National Science Foundation (NSF))	Computing resources were provided by the University of Kentucky and National Science Foundation (NSF) Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by NSF Grant ACI-1053575 (under allocation MCB090159). We thank Dr. Nils Mikkelsen (Swedish University of Agricultural Sciences) for help with X-ray data collection.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; BELL JA, 1992, BIOCHEMISTRY-US, V31, P3590, DOI 10.1021/bi00129a006; Benko Z, 2007, APPL BIOCHEM BIOTECH, V137, P195, DOI 10.1007/s12010-007-9051-5; BERKA RM, 1989, BIOTECHNOL ADV, V7, P127, DOI 10.1016/0734-9750(89)90356-X; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cao QN, 2000, PROTEIN SCI, V9, P991; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Chundawat SPS, 2011, J PROTEOME RES, V10, P4365, DOI 10.1021/pr101234z; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dana CM, 2014, BIOTECHNOL BIOENG, V111, P842, DOI 10.1002/bit.25178; Dana CM, 2012, BIOTECHNOL BIOENG, V109, P2710, DOI 10.1002/bit.24708; Day A., 2014, US Patent, Patent No. [8,637,294B2, 8637294]; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Godbole S, 1999, BIOTECHNOL PROGR, V15, P828, DOI 10.1021/bp9901116; Goedegebuur F, 2002, CURR GENET, V41, P89, DOI 10.1007/s00294-002-0290-2; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.0.CO;2-M; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; Heinzelman P, 2010, PROTEIN ENG DES SEL, V23, P871, DOI 10.1093/protein/gzq063; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hobdey SE, 2016, APPL ENVIRON MICROB, V82, P3395, DOI 10.1128/AEM.00163-16; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang XQ, 2006, BIOPHYS J, V91, P2451, DOI 10.1529/biophysj.106.082891; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Jacobson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070562; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanaya S., 2000, BIOTECHNOLOGY SUSTAI, V14, P186; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim P, 2001, BIOTECHNOL APPL BIOC, V34, P99, DOI 10.1042/BA20010025; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; Laymon RA, 1996, APPL BIOCHEM BIOTECH, V57-8, P389, DOI 10.1007/BF02941718; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Li XL, 2007, FEBS LETT, V581, P4029, DOI 10.1016/j.febslet.2007.07.041; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPherson A, 1982, PREPARATION ANAL PRO; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; MITCHINSON C, 1986, Proteins Structure Function and Genetics, V1, P23, DOI 10.1002/prot.340010106; Momeni MH, 2014, ACTA CRYSTALLOGR D, V70, P2356, DOI 10.1107/S1399004714013844; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Munoz IG, 2003, ACTA CRYSTALLOGR D, V59, P637, DOI 10.1107/S0907444903001938; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muslin EH, 2002, PROTEIN ENG, V15, P29, DOI 10.1093/protein/15.1.29; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okada H, 1998, APPL ENVIRON MICROB, V64, P555; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PENTTILA ME, 1988, GENE, V63, P103, DOI 10.1016/0378-1119(88)90549-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Rignall TR, 2002, APPL BIOCHEM BIOTECH, V98, P383, DOI 10.1385/ABAB:98-100:1-9:383; Sakaue R, 2003, APPL ENVIRON MICROB, V69, P139, DOI 10.1128/AEM.69.1.139-145.2002; SALOHEIMO A, 1994, MOL MICROBIOL, V13, P219, DOI 10.1111/j.1365-2958.1994.tb00417.x; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sammond DW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145848; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Sham YY, 2002, PROTEINS, V46, P308, DOI 10.1002/prot.10040; Sheinerman FB, 1998, J MOL BIOL, V278, P439, DOI 10.1006/jmbi.1998.1688; Smith MA, 2013, ACS SYNTH BIOL, V2, P690, DOI 10.1021/sb400010m; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; SUOMINEN PL, 1993, MOL GEN GENET, V241, P523, DOI 10.1007/BF00279894; Takashima S, 1999, J BIOTECHNOL, V67, P85, DOI 10.1016/S0168-1656(98)00168-0; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; Textor LC, 2013, FEBS J, V280, P56, DOI 10.1111/febs.12049; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; VANDENBURG B, 1993, PROTEIN ENG, V6, P521, DOI 10.1093/protein/6.5.521; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Voutilainen SP, 2009, APPL MICROBIOL BIOT, V83, P261, DOI 10.1007/s00253-008-1848-9; WALSETH CS, 1952, TAPPI, V35, P233; Ward M., 1993, P 2 TRIC S TRICH CEL, V8, P153; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353	102	33	35	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17418	17430		10.1074/jbc.M117.803270	http://dx.doi.org/10.1074/jbc.M117.803270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860192	Green Published, hybrid			2022-12-26	WOS:000414009300023
J	Ishikawa, Y; Holden, P; Bachinger, HP				Ishikawa, Yoshihiro; Holden, Paul; Bachinger, Hans Peter			Heat shock protein 47 and 65-kDa FK506-binding protein weakly but synergistically interact during collagen folding in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX FORMATION; PROLYL 3-HYDROXYLASE 1; OSTEOGENESIS IMPERFECTA; MOLECULAR CHAPERONE; LYSYL HYDROXYLATION; BINDING-PROTEIN; CROSS-LINKING; IV COLLAGEN; IN-VITRO; FKBP65	Collagen is the most abundant protein in the extracellular matrix in humans and is critical to the integrity and function of many musculoskeletal tissues. A molecular ensemble comprising more than 20 molecules is involved in collagen biosynthesis in the rough endoplasmic reticulum. Two proteins, heat shock protein 47 (Hsp47/SERPINH1) and 65-kDa FK506-binding protein (FKBP65/FKBP10), have been shown to play important roles in this ensemble. In humans, autosomal recessive mutations in both genes cause similar osteogenesis imperfecta phenotypes. Whereas it has been proposed that Hsp47 and FKBP65 interact in the rough endoplasmic reticulum, there is neither clear evidence for this interaction nor any data regarding their binding affinities for each other. In this study using purified endogenous proteins, we examined the interaction between Hsp47, FKBP65, and collagen and also determined their binding affinities and functions in vitro. Hsp47 and FKBP65 show a direct but weak interaction, and FKBP65 prefers to interact with Hsp47 rather than type I collagen. Our results suggest that a weak interaction between Hsp47 and FKBP65 confers mutual molecular stability and also allows for a synergistic effect during collagen folding. We also propose that Hsp47 likely acts as a hub molecule during collagen folding and secretion by directing other molecules to reach their target sites on collagens. Our findings may explain why osteogenesis imperfecta-causing mutations in both genes result in similar phenotypes.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Bachinger, Hans Peter] Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital for Children [85100, 85500]	Shriners Hospital for Children	This work was supported by Shriners Hospital for Children Grants 85100 and 85500 (to H. P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Barnes AM, 2013, HUM MUTAT, V34, P1279, DOI 10.1002/humu.22362; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; Bella J, 2017, SUBCELL BIOCHEM, V82, P457, DOI 10.1007/978-3-319-49674-0_14; Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; BOYER B, 1991, EXP GERONTOL, V26, P375, DOI 10.1016/0531-5565(91)90049-R; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; Chen YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46021; Chernorudskiy AL, 2017, J MOL BIOL, V429, P620, DOI 10.1016/j.jmb.2017.01.017; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P917, DOI 10.1139/O10-137; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Duran I, 2017, J BONE MINER RES, V32, P1309, DOI 10.1002/jbmr.3095; Duran I, 2015, HUM MOL GENET, V24, P1918, DOI 10.1093/hmg/ddu608; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Feru J, 2016, EUR J DERMATOL, V26, P350, DOI 10.1684/ejd.2016.2782; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Gjaltema RAF, 2016, P NATL ACAD SCI USA, V113, P7142, DOI 10.1073/pnas.1600074113; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Hong F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169260; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2017, J BIOL CHEM, V292, P9273, DOI 10.1074/jbc.M116.772657; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Islam M, 2013, J BIOL CHEM, V288, P35526, DOI 10.1074/jbc.M113.504530; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; Kersteen EA, 2004, PROTEIN EXPRES PURIF, V38, P279, DOI 10.1016/j.pep.2004.09.008; Knuppel L, 2017, AM J RESP CELL MOL, V57, P77, DOI 10.1165/rcmb.2016-0217OC; Koski MK, 2017, BIOCHEM J, V474, P751, DOI 10.1042/BCJ20161000; Lietman CD, 2014, HUM MOL GENET, V23, P4822, DOI 10.1093/hmg/ddu197; Liu PF, 2009, ANAL BIOCHEM, V389, P165, DOI 10.1016/j.ab.2009.03.028; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Miao M, 2013, BIOCHEMISTRY-US, V52, P7731, DOI 10.1021/bi400760f; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murphy LA, 2011, CELL STRESS CHAPERON, V16, P607, DOI 10.1007/s12192-011-0270-x; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Patterson CE, 2005, CELL STRESS CHAPERON, V10, P285, DOI 10.1379/CSC-118R.1; Paulsson K, 2003, BBA-MOL CELL RES, V1641, P1, DOI 10.1016/S0167-4889(03)00048-X; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Takagi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036809; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	64	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17216	17224		10.1074/jbc.M117.802298	http://dx.doi.org/10.1074/jbc.M117.802298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860186	Green Published, hybrid			2022-12-26	WOS:000414009300006
J	Lemonidis, K; MacLeod, R; Baillie, GS; Chamberlain, LH				Lemonidis, Kimon; MacLeod, Ruth; Baillie, George S.; Chamberlain, Luke H.			Peptide array-based screening reveals a large number of proteins interacting with the ankyrin-repeat domain of the zDHHC17 S-acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; PALMITOYL ACYLTRANSFERASE; SUBSTRATE RECOGNITION; STRUCTURAL BASIS; HUNTINGTONS-DISEASE; MEMBRANE SUPPORTS; HIP14; DIFFERENTIATION; CELLS; MICE	zDHHC S-acyltransferases are enzymes catalyzing protein S-acylation, a common post-translational modification on proteins frequently affecting their membrane targeting and trafficking. The ankyrin repeat (AR) domain of zDHHC17 (HIP14) and zDHHC13 (HIP14L) S-acyltransferases, which is involved in both substrate recruitment and S-acylation-independent functions, was recently shown to bind at least six proteins, by specific recognition of a consensus sequence in them. To further refine the rules governing binding to the AR of zDHHC17, we employed peptide arrays based onz DHHCAR-binding motif(zDABM) sequences of synaptosom-al-associated protein 25 (SNAP25) and cysteine string protein alpha (CSP alpha). Quantitative comparisons of the binding preferences of 400 peptides allowed us to construct a position-specific scoring matrix(PSSM) for zDHHC17 AR binding, with which we predicted and subsequently validated many putative zDHHC17 interactors. We identified 95 human zDABM sequences with unexpected versatility in amino acid usage; these sequences were distributed among 90 proteins, of which 62 have not been previously implicated in zDHHC17/13 binding. These zDABM-containing proteins included all family members of the SNAP25, sprouty, cornifelin, ankyrin, and SLAIN-motif containing families; seven endogenous Gag polyproteins sharing the same binding sequence; and several proteins involved in cytoskeletal organization, cell communication, and regulation of signaling. A dozen of the zDABM-containing proteins had more than one zDABM sequence, whereas isoform-specific binding to the AR of zDHHC17 was identified for the Ena/VASP-like protein. The large number of zDABM sequences within the human proteome suggests that zDHHC17 may be an interaction hub regulating many cellular processes.	[Lemonidis, Kimon; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland; [MacLeod, Ruth; Baillie, George S.] Univ Glasgow, Inst Cardiovasc & Med Sci, Wolfson Link Bldg, Glasgow G12 8QQ, Lanark, Scotland	University of Strathclyde; University of Glasgow	Lemonidis, K; Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	kimon.lemonidis@strath.ac.uk; luke.chamberlain@strath.ac.uk		Baillie, George/0000-0003-2469-6316; Lemonidis, Kimon/0000-0003-1332-6002	Biotechnology and Biological Sciences Research Council [BB/L022087/1, BB/J006432/1]; BBSRC [BB/L022087/1, BB/J006432/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/L022087/1 and BB/J006432/1 (to L.H.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett V, 2016, CURR TOP MEMBR, V77, P143, DOI 10.1016/bs.ctm.2015.10.001; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Butland SL, 2014, HUM MOL GENET, V23, P4142, DOI 10.1093/hmg/ddu137; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Harripaul R, 2018, MOL PSYCHIATR, V23, P973, DOI 10.1038/mp.2017.60; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; Jimenez-Preitner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048767; Jimenez-Preitner M, 2011, CELL METAB, V14, P658, DOI 10.1016/j.cmet.2011.08.008; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Koldehoff M, 2008, INT J HEMATOL, V87, P39, DOI 10.1007/s12185-007-0013-z; Kramer A, 1998, METH MOL B, V87, P25; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Lemonidis K, 2015, J BIOL CHEM, V290, P21939, DOI 10.1074/jbc.M115.657668; Lemonidis K, 2014, MOL BIOL CELL, V25, P3870, DOI 10.1091/mbc.E14-06-1169; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Liu KM, 2015, J INVEST DERMATOL, V135, P2603, DOI 10.1038/jid.2015.240; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Michibata H, 2004, BIOCHEM BIOPH RES CO, V318, P803, DOI 10.1016/j.bbrc.2004.04.109; Milde S, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582338; Milnerwood AJ, 2013, P NATL ACAD SCI USA, V110, P20296, DOI 10.1073/pnas.1222384110; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Montersino A, 2015, MOL MEMBR BIOL, V32, P179, DOI 10.1080/09687688.2016.1182652; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Sanders SS, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0333-7; Shi W, 2015, MOL CELL NEUROSCI, V68, P194, DOI 10.1016/j.mcn.2015.07.005; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Skotte NH, 2017, CELL DEATH DIFFER, V24, P433, DOI 10.1038/cdd.2016.139; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Trela M, 2016, APMIS, V124, P88, DOI 10.1111/apm.12487; Uversky Vladimir N, 2013, Intrinsically Disord Proteins, V1, pe24684, DOI 10.4161/idp.24684; van der Vaart B, 2012, J NEUROSCI, V32, P14722, DOI 10.1523/JNEUROSCI.1240-12.2012; Verardi R, 2017, STRUCTURE, V25, P1337, DOI 10.1016/j.str.2017.06.018; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Wang CY, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862798; Wanner SJ, 2005, GENE EXPR PATTERNS, V5, P423, DOI 10.1016/j.modgep.2004.09.004; Xu C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002979; Yang G, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003727; Yang G, 2011, J NEUROSCI, V31, P11980, DOI 10.1523/JNEUROSCI.2510-11.2011; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Zhang MZM, 2017, BIOCHEM SOC T, V45, P275, DOI 10.1042/BST20160236	55	18	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17190	17202		10.1074/jbc.M117.799650	http://dx.doi.org/10.1074/jbc.M117.799650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28882895	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000414009300004
J	Lopez-Jimenez, AJ; Basak, T; Vanacore, RM				Lopez-Jimenez, Alberto J.; Basak, Trayambak; Vanacore, Roberto M.			Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basement membrane; collagen; enzyme processing; extracellular matrix; lysyl oxidase; posttranslational modification (PTM); protein crosslinking; LOXL2; proteolytic processing	IDIOPATHIC PULMONARY-FIBROSIS; PEPTIDE IDENTIFICATION; AMINE OXIDASE; PROTEIN; EXPRESSION; FAMILY; ENZYME; DISEASE; LOXL2; FORMS	Lysyl oxidase-like-2 (LOXL2) is an enzyme secreted into the extracellular matrix that crosslinks collagens by mediating oxidative deamination of lysine residues. Our previous work demonstrated that this enzyme crosslinks the 7S domain, a structural domain that stabilizes collagen IV scaffolds in the basement membrane. Despite its relevant role in extracellular matrix biosynthesis, little is known about the structural requirements of LOXL2 that enable collagen IV crosslinking. In this study, we demonstrate that LOXL2 is processed extracellularly by serine proteases, generating a 65-kDa form lacking the first two scavenger receptor cysteine-rich domains. Site-specific mutagenesis to prevent proteolytic processing generated a full-length enzyme that is active in vitro toward a soluble substrate, but fails to crosslink insoluble collagen IV within the extracellular matrix. In contrast, the processed form of LOXL2 binds to collagen IV and crosslinks the 7S domain. Together, our data demonstrate that proteolytic processing is an important event that allows LOXL2-mediated crosslinking of basement membrane collagen IV.	[Lopez-Jimenez, Alberto J.; Basak, Trayambak; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Lopez-Jimenez, Alberto J.; Basak, Trayambak; Vanacore, Roberto M.] Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Vanacore, RM (corresponding author), 1161 21st Ave South,B-3113 Med Ctr North, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu	Lopez, Alberto/GWC-5652-2022; Basak, Trayambak/AAB-8534-2020; Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Lopez Jimenez, Alberto Jose/0000-0002-4992-631X; Basak, Trayambak/0000-0001-7683-3189	National Institutes of Health [R01 DK099467]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK099467. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiri G, 2003, CANCER RES, V63, P1657; Anazco C, 2016, J BIOL CHEM, V291, P25999, DOI 10.1074/jbc.M116.738856; Aumiller V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00270-0; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barre O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105984; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; Breyer MD, 2016, NAT REV DRUG DISCOV, V15, P568, DOI 10.1038/nrd.2016.67; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Chien JW, 2014, EUR RESPIR J, V43, P1430, DOI 10.1183/09031936.00141013; Colon S, 2016, J BIOL CHEM, V291, P24009, DOI 10.1074/jbc.M116.745935; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; DENAULT JB, 1995, J CARDIOVASC PHARM, V26, pS47; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Ferguson TEG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159868; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Hutchinson JH, 2017, ACS MED CHEM LETT, V8, P423, DOI 10.1021/acsmedchemlett.7b00014; Ikenaga N, 2017, GUT, V66, P1697, DOI 10.1136/gutjnl-2016-312473; Kagan HM, 2011, BIOL EXTRACELL MATR, P303, DOI 10.1007/978-3-642-16555-9_9; KAGAN HM, 1994, PATHOL RES PRACT, V190, P910; Kim MS, 2003, J BIOL CHEM, V278, P52071, DOI 10.1074/jbc.M308856200; Kim YM, 2011, MOL BIOL REP, V38, P145, DOI 10.1007/s11033-010-0088-0; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Ma L, 2017, MOL CELL, V65, P296, DOI 10.1016/j.molcel.2016.12.002; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Raghu G, 2017, LANCET RESP MED, V5, P22, DOI 10.1016/S2213-2600(16)30421-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	52	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16970	16982		10.1074/jbc.M117.798603	http://dx.doi.org/10.1074/jbc.M117.798603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28864775	Green Published, hybrid			2022-12-26	WOS:000413140600018
J	Bretin, S; Louis, C; Seguin, L; Wagner, S; Thomas, JY; Challal, S; Rogez, N; Albinet, K; Iop, F; Villain, N; Bertrand, S; Krazem, A; Berachochea, D; Billiald, S; Tordjman, C; Cordi, A; Bertrand, D; Lestage, P; Danober, L				Bretin, Sylvie; Louis, Caroline; Seguin, Laure; Wagner, Stephanie; Thomas, Jean-Yves; Challal, Sylvie; Rogez, Nathalie; Albinet, Karine; Iop, Fabrice; Villain, Nadege; Bertrand, Sonia; Krazem, Ali; Berachochea, Daniel; Billiald, Stephanie; Tordjman, Charles; Cordi, Alex; Bertrand, Daniel; Lestage, Pierre; Danober, Laurence			Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors	PLOS ONE			English	Article							SPONTANEOUS-ALTERNATION BEHAVIOR; GLUTAMATE RECEPTORS; POTENTIATORS LY392098; SYNAPTIC PLASTICITY; MOLECULAR-MECHANISM; FUNCTIONAL-ANALYSIS; CELL BIOLOGY; ION-CHANNEL; DRUG DESIGN; IN-VITRO	S 47445 is a novel positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors (AMPA-PAM). S 47445 enhanced glutamate's action at AMPA receptors on human and rat receptors and was inactive at NMDA and kainate receptors. Potentiation did not differ among the different AMPA receptors subtypes (GluA1/2/4 flip and flop variants) (EC50 between 2.5-5.4 mu M), except a higher EC50 value for GluA4 flop (0.7 mu M) and a greater amount of potentiation on GluA1 flop. A low concentration of S 47445 (0.1 mu M) decreased receptor response decay time of GluA1flop/GluA2flip AMPA receptors and increased the sensitivity to glutamate. Furthermore, S 47445 (0.1 and 0.3 mu M) in presence of repetitive glutamate pulses induced a progressive potentiation of the glutamate-evoked currents from the second pulse of glutamate confirming a rapid-enhancing effect of S 47445 at low concentrations. The potentiating effect of S 47445 (1 mu M) was concentration-dependently reversed by the selective AMPA receptor antagonist GYKI52466 demonstrating the selective modulatory effect of S 47445 on AMPA receptors. Using an AMPA-kainate chimera approach, it was confirmed that S 47445 binds to the common binding pocket of AMPA-PAMs. S 47445 did not demonstrate neurotoxic effect against glutamate-mediated excitotoxicity in vitro, in contrast significantly protected rat cortical neurons at 10 mu M. S 47445 was shown to improve both episodic and spatial working memory in adult rodents at 0.3 mg/kg, as measured in the natural forgetting condition of object recognition and T-maze tasks. Finally, no deleterious effect on spontaneous locomotion and general behavior was observed up to 1000 mg/kg of S 47445 given acutely in rodents, neither occurrence of convulsion or tremors. Collectively, these results indicate that S 47445 is a potent and selective AMPA-PAM presenting procognitive and potential neuroprotective properties. This drug is currently evaluated in clinical phase 2 studies in Alzheimer's disease and in Major Depressive Disorder.	[Bretin, Sylvie; Seguin, Laure] Inst Rech Int Servier, Pole Innovat Therapeut Neuropsychiat, Suresnes, France; [Louis, Caroline; Thomas, Jean-Yves; Challal, Sylvie; Rogez, Nathalie; Albinet, Karine; Iop, Fabrice; Villain, Nadege; Lestage, Pierre; Danober, Laurence] Inst Rech Servier, Pole Innovat Therapeut Neuropsychiat, Croissy Sur Seine, France; [Wagner, Stephanie] Neurofit, Illkirch Graffenstaden, France; [Bertrand, Sonia; Bertrand, Daniel] HiQScreen, Vesenaz Geneva, Switzerland; [Krazem, Ali; Berachochea, Daniel] Univ Bordeaux 1, Ctr Neurosci Integrat & Cognit, Talence, France; [Billiald, Stephanie; Tordjman, Charles; Cordi, Alex] Inst Rech Servier, Pole Expertise Rech & Biopharm, Suresnes, France	Servier; Institut de Recherches Internationales Servier; Servier; Institut de Recherches Internationales Servier; UDICE-French Research Universities; Universite de Bordeaux; Servier; Institut de Recherches Internationales Servier	Bretin, S (corresponding author), Inst Rech Int Servier, Pole Innovat Therapeut Neuropsychiat, Suresnes, France.; Danober, L (corresponding author), Inst Rech Servier, Pole Innovat Therapeut Neuropsychiat, Croissy Sur Seine, France.	sylvie.bretin@servier.com; laurence.danober@servier.com		Bretin, Sylvie/0000-0002-4244-3390	Institut de Recherches Internationales Servier; Institut de Recherches Servier; Neurofit; HiQScreen	Institut de Recherches Internationales Servier(Servier); Institut de Recherches Servier; Neurofit; HiQScreen	Institut de Recherches Internationales Servier provided support in the form of salaries for SB and LS. Institut de Recherches Servier provided support in the form of salaries for CL, JYT, SC, NR, KA, FI, NV, SB, CT, CA, PL, and LD. Neurofit provided support in the form of salaries for SW. HiQScreen provided support in the form of salaries for SB and DB. Servier was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Ahmed AH, 2010, BIOCHEMISTRY-US, V49, P2843, DOI 10.1021/bi1000678; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Baumbarger PJ, 2001, J PHARMACOL EXP THER, V298, P86; Beracochea D, 2007, PSYCHOPHARMACOLOGY, V193, P63, DOI 10.1007/s00213-007-0765-4; BERACOCHEA DJ, 1987, BEHAV NEUROSCI, V101, P187, DOI 10.1037/0735-7044.101.2.187; Bernard K, 2010, CNS NEUROSCI THER, V16, pe193, DOI 10.1111/j.1755-5949.2009.00088.x; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Buisson B, 1996, J NEUROSCI, V16, P7880; Calabrese F, 2017, PHARMACOL RES, V121, P59, DOI 10.1016/j.phrs.2017.04.019; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEMBER WN, 1958, PSYCHOL BULL, V55, P412, DOI 10.1037/h0045446; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; Destot-Wong KD, 2009, NEUROPHARMACOLOGY, V57, P277, DOI 10.1016/j.neuropharm.2009.05.010; Dicou E, 2003, BRAIN RES, V970, P221, DOI 10.1016/S0006-8993(03)02357-6; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fleck MW, 1996, J NEUROPHYSIOL, V75, P2322, DOI 10.1152/jn.1996.75.6.2322; Gates M, 2001, NEUROPHARMACOLOGY, V40, P984, DOI 10.1016/S0028-3908(01)00040-5; Giralt A., 2017, NEUROPHARMACOLOGY; Harms JE, 2013, NEUROPHARMACOLOGY, V64, P45, DOI 10.1016/j.neuropharm.2012.06.008; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Koike M, 2000, J NEUROSCI, V20, P2166; Krieger J, 2015, BIOPHYS J, V109, P1136, DOI 10.1016/j.bpj.2015.06.061; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Lynch G, 2006, TRENDS NEUROSCI, V29, P554, DOI 10.1016/j.tins.2006.07.007; Mellor IR, 2010, FUTURE MED CHEM, V2, P877, DOI [10.4155/fmc.10.27, 10.4155/FMC.10.27]; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Morrow JA, 2006, CURR OPIN DRUG DISC, V9, P571; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; O'Neill MJ, 2007, IDRUGS, V10, P185; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Parsons CG, 2005, HANDB EXP PHARM, V169, P249; Partin KM, 2015, CURR OPIN PHARMACOL, V20, P46, DOI 10.1016/j.coph.2014.11.002; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Pirotte B, 2013, EXPERT OPIN THER PAT, V23, P615, DOI 10.1517/13543776.2013.770840; Quirk JC, 2002, CNS DRUG REV, V8, P255; Robbins TW, 2006, TRENDS PHARMACOL SCI, V27, P141, DOI 10.1016/j.tips.2006.01.009; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Timm DE, 2011, MOL PHARMACOL, V80, P267, DOI 10.1124/mol.110.070243; Ward SE, 2010, BRIT J PHARMACOL, V160, P181, DOI 10.1111/j.1476-5381.2010.00726.x; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilding TJ, MOL PHARM; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yamada KA, 1996, BRIT J PHARMACOL, V117, P1663, DOI 10.1111/j.1476-5381.1996.tb15337.x; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zhang QG, 2010, HIPPOCAMPUS, V20, P65, DOI 10.1002/hipo.20593; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	67	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184429	10.1371/journal.pone.0184429	http://dx.doi.org/10.1371/journal.pone.0184429			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886144	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100121
J	Dong, YC; Liu, YH				Dong, Yichen; Liu, Yanhong			Response of Korean pine's functional traits to geography and climate	PLOS ONE			English	Article							LEAF ECONOMICS SPECTRUM; DRY-MATTER CONTENT; NORTHEAST CHINA; SPECIES-RICHNESS; PLANT TRAITS; GROWTH FORM; COMMUNITY; LATITUDE; NITROGEN; AREA	This study analyzed the characteristics of Korean pine (Pinus koraiensis) functional trait responses to geographic and climatic factors in the eastern region of Northeast China (41 degrees-48 degrees N) and the linear relationships among Korean pine functional traits, to explore this species' adaptability and ecological regulation strategies under different environmental conditions. Korean pine samples were collected from eight sites located at different latitudes, and the following factors were determined for each site: geographic factors-latitude, longitude, and altitude; temperature factors-mean annual temperature (MAT), growth season mean temperature (GST), and mean temperature of the coldest month (MTCM); and moisture factors-annual precipitation (AP), growth season precipitation (GSP), and potential evapotranspiration (PET). The Korean pine functional traits examined were specific leaf area (SLA), leaf thickness (LT), leaf dry matter content (LDMC), specific root length (SRL), leaf nitrogen content (LNC), leaf phosphorus content (LPC), root nitrogen content (RNC), and root phosphorus content (RPC). The results showed that Korean pine functional traits were significantly correlated to latitude, altitude, GST, MTCM, AP, GSP, and PET. Among the Korean pine functional traits, SLA showed significant linear relationships with LT, LDMC, LNC, LPC, and RPC, and LT showed significant linear relationships with LDMC, SRL, LNC, LPC, RNC, and RPC; the linear relationships between LNC, LPC, RNC, and RPC were also significant. In conclusion, Korean pine functional trait responses to latitude resulted in its adaptation to geographic and climatic factors. The main limiting factors were precipitation and evapotranspiration, followed by altitude, latitude, GST, and MTCM. The impacts of longitude and MAT were not obvious. Changes in precipitation and temperature were most responsible for the close correlation among Korean pine functional traits, reflecting its adaption to habitat variation.	[Dong, Yichen; Liu, Yanhong] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China	Beijing Forestry University	Liu, YH (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China.	liuyh@bjfu.edu.cn			Key Project of National Key Research and Development Plan Research on protection and restoration of typical small populations of wild plants [2016YFC0503106]; Beijing key disciplines project	Key Project of National Key Research and Development Plan Research on protection and restoration of typical small populations of wild plants; Beijing key disciplines project	The work was supported by Key Project of National Key Research and Development Plan Research on protection and restoration of typical small populations of wild plants (Grant No. 2016YFC0503106); and Beijing key disciplines project.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; [Anonymous], 1992, J NE U; Atkin OK, 2015, NEW PHYTOL, V206, P614, DOI 10.1111/nph.13253; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1106, DOI 10.1111/j.1466-8238.2011.00753.x; Blonder B, 2013, J ECOL, V101, P981, DOI 10.1111/1365-2745.12102; Boucher-Lalonde V, 2016, GLOBAL ECOL BIOGEOGR, V25, P527, DOI 10.1111/geb.12433; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Chen Ying-Ting, 2014, Chinese Journal of Plant Ecology, V38, P1135, DOI 10.3724/SP.J.1258.2014.00108; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 1999, J VEG SCI, V10, P651, DOI 10.2307/3237080; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Fang J.-Y., 1992, ACTA ECOL SIN, V12, P97; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Freschet GT, 2012, FUNCT ECOL, V26, P56, DOI 10.1111/j.1365-2435.2011.01913.x; Gao G., 1956, GEOGRAPHY RES, V25, P378; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Gillman LN, 2015, GLOBAL ECOL BIOGEOGR, V24, P107, DOI 10.1111/geb.12245; Grady KC, 2013, FUNCT ECOL, V27, P428, DOI 10.1111/1365-2435.12060; Han Wei, 2014, Journal of Beijing Forestry University, V36, P47; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hao Zhan-Qing, 2008, Zhiwu Shengtai Xuebao, V32, P238, DOI 10.3773/j.issn.1005-264x.2008.02.002; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; He J.S., 1997, ACTA ECOL SIN, V17, P91; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; [贺伟 He Wei], 2013, [生态学报, Acta Ecologica Sinica], V33, P519; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Li J. Q., 1986, Journal of North-East Forestry University, China, V14, P33; Makoto K, 2007, PHOTOSYNTHETICA, V45, P99, DOI 10.1007/s11099-007-0015-3; [毛伟 Mao Wei], 2012, [中国沙漠, Journal of Desert Research], V32, P33; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Meng Ting-Ting, 2007, Zhiwu Shengtai Xuebao, V31, P150; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Price CA, 2014, FUNCT ECOL, V28, P1330, DOI 10.1111/1365-2435.12298; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; [唐志尧 Tang Zhiyao], 2004, [生物多样性, Chinese Biodiversity], V12, P20; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Wang XP, 2006, J INTEGR PLANT BIOL, V48, P778, DOI 10.1111/j.1744-7909.2006.00294.x; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; Wang XP, 2009, ECOGRAPHY, V32, P133, DOI 10.1111/j.1600-0587.2008.05507.x; Wang YJ, 1995, BROADLEAF PINUS KORA; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; [吴晓莆 Wu Xiaofu], 2004, [生物多样性, Chinese Biodiversity], V12, P174; Xu W-D, 1986, ACTA PHYTOECOLOGICA, V10, P254; Yu ZL, 1996, J JILIN FORESTRY U, V12, P235; Zhang H-Q, 1999, ACTA ECOLOGICA SINIC, V19, P932; Zhang S, 2017, ECOLOGY, V98, P425, DOI 10.1002/ecy.1649; Zhang S, 2016, J ECOL, V104, P1089, DOI 10.1111/1365-2745.12588; Zhu JF, 1958, FORESTRY SCI, V4, P355	57	2	3	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184051	10.1371/journal.pone.0184051	http://dx.doi.org/10.1371/journal.pone.0184051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886053	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100059
J	Quilez, MP; Seral, B; Perez, MA				Paz Quilez, Maria; Seral, Belen; Angeles Perez, Maria			Biomechanical evaluation of tibial bone adaptation after revision total knee arthroplasty: A comparison of different implant systems	PLOS ONE			English	Article							RESURFACED FEMORAL-HEAD; METAPHYSEAL SLEEVES; FINITE-ELEMENT; PROXIMAL TIBIA; FIXATION; REPLACEMENT; CEMENTLESS; COMPONENT; DEFECTS; STEMS	The best methods to manage tibial bone defects following total knee arthroplasty remain under debate. Different fixation systems exist to help surgeons reconstruct knee osseous bone loss (such as tantalum cones, cement, modular metal augments, autografts, allografts and porous metaphyseal sleeves) However, the effects of the various solutions on the long-term outcome remain unknown. In the present work, a bone remodeling mathematical model was used to predict bone remodeling after total knee arthroplasty (TKA) revision. Five different types of prostheses were analyzed: one with a straight stem; two with offset stems, with and without supplements; and two with sleeves, with and without stems. Alterations in tibia bone density distribution and implant Von Mises stresses were quantified. In all cases, the bone density decreased in the proximal epiphysis and medullary channels, and an increase in bone density was predicted in the diaphysis and around stem tips. The highest bone resorption was predicted for the offset prosthesis without the supplement, and the highest bone formation was computed for the straight stem. The highest Von Mises stress was obtained for the straight tibial stem, and the lowest was observed for the stemless metaphyseal sleeves prosthesis. The computational model predicted different behaviors among the five systems. We were able to demonstrate the importance of choosing an adequate revision system and that in silico models may help surgeons choose patient-specific treatments.	[Paz Quilez, Maria; Angeles Perez, Maria] Univ Zaragoza, I3A, Dept Ingn Mecan, M2BE, Zaragoza, Spain; [Seral, Belen] Univ Zaragoza, Univ Clin Hosp Lozano Blesa, Aragon Inst Hlth Sci IACS, Zaragoza, Spain	University of Zaragoza; Lozano Blesa University Clinical Hospital; University of Zaragoza	Perez, MA (corresponding author), Univ Zaragoza, I3A, Dept Ingn Mecan, M2BE, Zaragoza, Spain.	angeles@unizar.es	Perez, Maria Angeles/F-7584-2010	Perez, Maria Angeles/0000-0002-2901-4188	Spanish Ministry of Economy and Competitiveness [DPI2014-53401-C2-1-R]; SECOT	Spanish Ministry of Economy and Competitiveness(Spanish Government); SECOT	The authors gratefully acknowledge the support of the Spanish Ministry of Economy and Competitiveness through research project DPI2014-53401-C2-1-R and the SECOT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, BONE JOINT J, V95B, P1640, DOI 10.1302/0301-620X.95B12.31190; Alexander GE, 2013, J ARTHROPLASTY, V28, P604, DOI 10.1016/j.arth.2012.08.006; Baldini A, 2015, CURR REV MUSCULOSKE, V8, P383, DOI 10.1007/s12178-015-9294-7; Barink M, 2003, P I MECH ENG H, V217, P325, DOI 10.1243/095441103770802487; Barnett SL, 2014, J ARTHROPLASTY, V29, P1219, DOI 10.1016/j.arth.2013.12.026; BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506; Caouette C, 2012, MED ENG PHYS, V34, P559, DOI 10.1016/j.medengphy.2011.08.015; Cawley DT, 2012, CLIN BIOMECH, V27, P390, DOI 10.1016/j.clinbiomech.2011.10.011; Chong DYR, 2011, J BIOMECH, V44, P948, DOI 10.1016/j.jbiomech.2010.11.026; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Completo A, 2007, J BIOMECH ENG-T ASME, V129, P791, DOI 10.1115/1.2768382; Completo A, 2010, CLIN BIOMECH, V25, P159, DOI 10.1016/j.clinbiomech.2009.10.011; Cuckler JM, 2004, J ARTHROPLASTY, V19, P56, DOI 10.1016/j.arth.2004.03.002; Dennis DA, 2007, J ARTHROPLASTY, V22, P32, DOI 10.1016/j.arth.2007.01.001; Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033; Doblare M, 2001, J BIOMECH, V34, P1157, DOI 10.1016/S0021-9290(01)00069-0; Duda GN, 2001, J BIOMECH, V34, P639, DOI 10.1016/S0021-9290(00)00237-2; Fischer KJ, 1997, ANN BIOMED ENG, V25, P261, DOI 10.1007/BF02648040; Garijo N, 2014, COMPUT METHOD APPL M, V271, P253, DOI 10.1016/j.cma.2013.12.014; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; Graichen H, 2015, J ARTHROPLASTY, V30, P2256, DOI 10.1016/j.arth.2015.06.030; HAAS SB, 1995, J BONE JOINT SURG AM, V77A, P1700, DOI 10.2106/00004623-199511000-00009; Hambli R, 2011, FINITE ELEM ANAL DES, V47, P835, DOI 10.1016/j.finel.2011.02.014; Hambli R, 2011, J MECH BEHAV BIOMED, V4, P868, DOI 10.1016/j.jmbbm.2011.03.002; Hambli R, 2011, BIOMECH MODEL MECHAN, V10, P133, DOI 10.1007/s10237-010-0222-x; Huten D, 2013, ORTHOP TRAUMATOL-SUR, V99, pS22, DOI 10.1016/j.otsr.2012.11.009; Jacobs C., 1994, NUMERICAL SIMULATION, P239; Jensen CL, 2012, INT ORTHOP, V36, P1857, DOI 10.1007/s00264-012-1601-y; Kimpton CI, 2013, J ARTHROPLASTY, V28, P971, DOI 10.1016/j.arth.2012.10.007; Kindsfater K, 2014, INT C JOINT REC 2014; Lee Y, 2016, ANN OF JOINT, P1; Mabry TM, 2007, J ARTHROPLASTY, V22, P56, DOI 10.1016/j.arth.2007.02.008; Malinzak RA, 2014, J ARTHROPLASTY, V29, P541, DOI 10.1016/j.arth.2013.08.024; Marton-Hernandez C, 2016, KNEE SURG SPORTS TRA; Mohaghegh K, 2014, COMPUT METHOD APPL M, V273, P255, DOI 10.1016/j.cma.2014.02.003; Moreo P, 2007, COMPUT METHOD APPL M, V196, P3300, DOI 10.1016/j.cma.2007.03.020; Morgan-Jones R, 2015, BONE JOINT J, V97B, P147, DOI 10.1302/0301-620X.97B2.34144; Nyman JS, 2004, J ORTHOPAED RES, V22, P51, DOI 10.1016/S0736-0266(03)00159-1; Perez M, 2010, COMPUT METHOD BIOMEC, V12, P101; Perez MA, 2014, MED ENG PHYS, V36, P185, DOI 10.1016/j.medengphy.2013.10.013; Perez MA, 2013, COMPUT METHOD BIOMEC, V16, P1022, DOI 10.1080/10255842.2011.650635; Perez MA, 2010, ANN BIOMED ENG, V38, P2093, DOI 10.1007/s10439-010-9996-3; Perez MA, 2009, ANN BIOMED ENG, V37, P454, DOI 10.1007/s10439-008-9616-7; Radnay C, 2006, CLIN ORTHOPAEDICS RE, V446; Rothstock S, 2011, J BIOMECH, V44, P1646, DOI 10.1016/j.jbiomech.2011.02.076; Schmitz HCR, 2013, J ARTHROPLASTY, V28, P1556, DOI 10.1016/j.arth.2013.01.028; Small SR, 2013, J ARTHROPLASTY, V28, P179, DOI 10.1016/j.arth.2013.01.004; vanLenthe GH, 1997, J BONE JOINT SURG BR, V79B, P117, DOI 10.1302/0301-620X.79B1.6808; Vasso M, 2014, ARCH ORTHOP TRAUM SU, V134, P543, DOI 10.1007/s00402-014-1941-8; Whittaker JP, 2008, J BONE JOINT SURG BR, V90B, P981, DOI 10.1302/0301-620X.90B8.19948; Wilke BK, 2014, J ARTHROPLASTY, V29, P1005, DOI 10.1016/j.arth.2013.10.025	51	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184361	10.1371/journal.pone.0184361	http://dx.doi.org/10.1371/journal.pone.0184361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886100	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100102
J	Maulucci, G; Cordelli, E; Rizzi, A; De Leva, F; Papi, M; Ciasca, G; Samengo, D; Pani, G; Pitocco, D; Soda, P; Ghirlanda, G; Iannello, G; De Spirito, M				Maulucci, Giuseppe; Cordelli, Ermanno; Rizzi, Alessandro; De Leva, Francesca; Papi, Massimiliano; Ciasca, Gabriele; Samengo, Daniela; Pani, Giovambattista; Pitocco, Dario; Soda, Paolo; Ghirlanda, Giovanni; Iannello, Giulio; De Spirito, Marco			Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus	PLOS ONE			English	Article							LIPID-PEROXIDATION; HUMAN-ERYTHROCYTES; FLUIDITY; CHOLESTEROL; COMPLICATIONS	Glycosylation, oxidation and other post-translational modifications of membrane and transmembrane proteins can alter lipid density, packing and interactions, and are considered an important factor that affects fluidity variation in membranes. Red blood cells (RBC) membrane physical state, showing pronounced alterations in Type 1 diabetes mellitus (T1DM), could be the ideal candidate for monitoring the disease progression and the effects of therapies. On these grounds, the measurement of RBC membrane fluidity alterations can furnish a more sensitive index in T1DM diagnosis and disease progression than Glycosylated hemoglobin (HbA1c), which reflects only the information related to glycosylation processes. Here, through a functional two-photon microscopy approach we retrieved fluidity maps at submicrometric scale in RBC of T1DM patients with and without complications, detecting an altered membrane equilibrium. We found that a phase separation between fluid and rigid domains occurs, triggered by systemic effects on membranes fluidity of glycation and oxidation. The phase separation patterns are different among healthy, T1DM and T1DM with complications patients. Blood cholesterol and LDL content are positively correlated with the extent of the phase separation patterns. To quantify this extent a machine learning approach is employed to develop a Decision-Support-System (DSS) able to recognize different fluidity patterns in RBC. Preliminary analysis shows significant differences(p< 0.001) among healthy, T1DM and T1DM with complications patients. The development of an assay based on Phase separation of the plasma membrane of the Red Blood cells is a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus, and could allow customization and the selection of medical treatments in T1DM in clinical settings, and enable the early detection of complications.	[Maulucci, Giuseppe; Papi, Massimiliano; Ciasca, Gabriele; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Cordelli, Ermanno; Soda, Paolo; Iannello, Giulio] Univ Campus Biomed, Fac Dipartimentale Ingn, Unita Sistemi Elaboraz & Bioinformat, Rome, Italy; [Rizzi, Alessandro; De Leva, Francesca; Pitocco, Dario; Ghirlanda, Giovanni] Fdn Policlin Gemelli, Ist Med Interna, Rome, Italy; [Samengo, Daniela; Pani, Giovambattista] Univ Cattolica Sacro Cuore, Ist Patol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University Campus Bio-Medico - Rome Italy; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maulucci, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	giuseppe.maulucci@unicatt.it	Pani, Giovambattista/AAB-1446-2019; Rizzi, Alessandro AR/K-6721-2016; Ciasca, Gabriele/AAL-4677-2020; Ciasca, Gabriele/D-2447-2013; Papi, Massimiliano/AAC-3657-2022; Rizzi, Alessandro/ABB-8944-2020; Pitocco, Dario/K-4210-2018; De Spirito, Marco/U-3817-2019; Soda, Paolo/K-8126-2016; Maulucci, Giuseppe/C-7400-2009	Rizzi, Alessandro AR/0000-0002-8309-4051; Ciasca, Gabriele/0000-0002-3694-8229; Papi, Massimiliano/0000-0002-0029-1309; De Spirito, Marco/0000-0003-4260-5107; Iannello, Giulio/0000-0003-3864-5800; Pani, Giovambattista/0000-0001-7133-8728; Pitocco, Dario/0000-0002-6220-686X; Soda, Paolo/0000-0003-2621-072X; Maulucci, Giuseppe/0000-0002-2154-319X	Universita Cattolica del Sacro Cuore Linea D1 [R4124500312]; University Cattolica del Sacro Cuore	Universita Cattolica del Sacro Cuore Linea D1; University Cattolica del Sacro Cuore	This work was supported by Universita Cattolica del Sacro Cuore Linea D1 2015 grant number R4124500312.r The authors acknowledge Mario Amici for his excellent Technical support. This work was supported by University Cattolica del Sacro Cuore.	Angelucci C, 2015, BRIT J CANCER, V112, P1675, DOI 10.1038/bjc.2015.135; [Anonymous], 1995, DIABETES, V44, P968; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; BUCALA R, 1994, P NATL ACAD SCI USA, V91, P9441, DOI 10.1073/pnas.91.20.9441; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Chawla NV, 2013, J GEN INTERN MED, V28, pS660, DOI 10.1007/s11606-013-2455-8; Ciasca G, 2015, NANOSCALE, V7, P17030, DOI 10.1039/c5nr03145a; Cohen G, 2013, FREE RADICAL BIO MED, V65, P978, DOI 10.1016/j.freeradbiomed.2013.08.163; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Golfetto O, 2013, BIOPHYS J, V104, P1238, DOI 10.1016/j.bpj.2012.12.057; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Hanson MS, 2008, AM J PHYSIOL-HEART C, V295, pH786, DOI 10.1152/ajpheart.00349.2008; Holzinger A, 2014, INTERACTIVE KNOWLEDG; Holzinger Andreas, 2015, SMART HLTH; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kumar R, 2011, J DIABETES METAB OMI, P2; Kumar R., INDIAN J MED SCI, V66, P131; LANGE Y, 1983, J BIOL CHEM, V258, P6920; Lind M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004412; Mason RP, 2003, BBA-BIOMEMBRANES, V1610, P198, DOI 10.1016/S0005-2736(03)00018-X; Maulucci G, 2016, FREE RADICAL RES, V50, pS40, DOI 10.1080/10715762.2016.1231403; Maulucci G, 2016, MOL ASPECTS MED, V49, P49, DOI 10.1016/j.mam.2016.03.001; Maulucci G, 2014, BBA-GEN SUBJECTS, V1840, P2192, DOI 10.1016/j.bbagen.2014.04.005; Maulucci G, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143pl3; MAZZANTI L, 1992, CLIN BIOCHEM, V25, P41, DOI 10.1016/0009-9120(92)80044-H; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Nordwall M, 2015, DIABETES CARE, V38, P308, DOI 10.2337/dc14-1203; Nosaka R, 2013, ROTATION INVARIANT C, P15; PILCH PF, 1980, P NATL ACAD SCI-BIOL, V77, P915, DOI 10.1073/pnas.77.2.915; Radin MS, 2014, J GEN INTERN MED, V29, P388, DOI 10.1007/s11606-013-2595-x; RICHTER C, 1987, CHEM PHYS LIPIDS, V44, P175, DOI 10.1016/0009-3084(87)90049-1; Soda P, 2009, IEEE T INF TECHNOL B, V13, P322, DOI 10.1109/TITB.2008.2010855; TESTA I, 1988, J CLIN ENDOCR METAB, V67, P1129, DOI 10.1210/jcem-67-6-1129; The Diabetes Control and Complications Trial Research Group, 1996, AM DIABETES ASS, V45, P1289; Vahalkar GS, 2008, INDIAN J CLIN BIOCHE, V23, P223, DOI 10.1007/s12291-008-0050-2; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184109	10.1371/journal.pone.0184109	http://dx.doi.org/10.1371/journal.pone.0184109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880900	gold, Green Submitted, Green Published			2022-12-26	WOS:000409467200034
J	Koch, L; Lunau, K; Wester, P				Koch, Laura; Lunau, Klaus; Wester, Petra			To be on the safe site - Ungroomed spots on the bee's body and their importance for pollination	PLOS ONE			English	Article							POLLEN TRANSFER; ERYTHRONIUM-GRANDIFLORUM; BOMBUS-TERRESTRIS; BUMBLE-BEES; GENE FLOW; ECOLOGY; EVOLUTION; HYMENOPTERA; BEHAVIOR; CONSEQUENCES	Flower-visiting bees collect large quantities of pollen to feed their offspring. Pollen deposited in the bees' transport organs is lost for the flowers' pollination. It has been hypothesised that specific body areas, bees cannot groom, serve as 'safe sites' for pollen transfer between flowers. For the first time, we experimentally demonstrated the position, area and pollen amount of safe sites at the examples of Apis mellifera and Bombus terrestris by combining artificial contamination of the bees' body with pine or sunflower pollen and the subsequent bees' incomplete grooming. We found safe sites on the forehead, the dorsal thorax and waist, and on the dorsal and ventral abdomen of the bees. These areas were less groomed by the bees' legs. The largest amount of pollen was found on the waist, followed by the dorsal areas of thorax and abdomen. At the example of Salvia pratensis, S. officinalis and Borago officinalis, we experimentally demonstrated with fluorescent dye that the flowers' pollen-sacs and stigma contact identical safe sites. These results confirm that pollen deposition on the bees' safe sites improves pollen transfer to stigmas of conspecific flowers sti. Future research will demonstrate the importance of safe sites for plant pollination under field conditions.	[Koch, Laura; Lunau, Klaus; Wester, Petra] Heinrich Heine Univ, Inst Sensory Ecol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wester, P (corresponding author), Heinrich Heine Univ, Inst Sensory Ecol, Dusseldorf, Germany.	Westerpetra3@gmail.com	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201				Armbruster WS, 2009, ANN BOT-LONDON, V103, P1529, DOI 10.1093/aob/mcp095; BEATTIE AJ, 1971, NEW PHYTOL, V70, P343, DOI 10.1111/j.1469-8137.1971.tb02533.x; Bergamo PJ, 2016, FUNCT ECOL, V30, P710, DOI 10.1111/1365-2435.12537; BRANTJES NBM, 1982, PLANT SYST EVOL, V141, P41, DOI 10.1007/BF01006478; Buchmann S.L., 1997, FORGOTTEN POLLINATOR; CANE JH, 1988, ANN ENTOMOL SOC AM, V81, P419, DOI 10.1093/aesa/81.3.419; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; Corbet SA, 1988, FUNCT ECOL, V2, P147, DOI 10.2307/2389689; Cresswell JE, 2002, OIKOS, V98, P375, DOI 10.1034/j.1600-0706.2002.980302.x; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; Danforth B, 2007, CURR BIOL, V17, pR156, DOI 10.1016/j.cub.2007.01.025; De Luca PA, 2013, CURR OPIN PLANT BIOL, V16, P429, DOI 10.1016/j.pbi.2013.05.002; Demchik SM, 1996, AM J BOT, V83, P573, DOI 10.2307/2445915; Endress P. K., 1994, DIVERSITY EVOLUTIONA; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; FAEGRI K, 1979, P244; GREEN TW, 1975, AM J BOT, V62, P379, DOI 10.2307/2442091; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; Harder LD, 1998, ECOLOGY, V79, P2789, DOI 10.1890/0012-9658(1998)079[2789:TCOHTC]2.0.CO;2; Harder LD, 1996, FLORAL BIOL STUDIES, P140, DOI DOI 10.1007/978-1-4613-1165-2_6; Hargreaves AL, 2009, BIOL REV, V84, P259, DOI 10.1111/j.1469-185X.2008.00074.x; HOLSINGER KE, 1994, AM NAT, V144, P799, DOI 10.1086/285707; JANDER R, 1976, PHYSIOL ENTOMOL, V1, P179, DOI 10.1111/j.1365-3032.1976.tb00960.x; Kennedy H., 1978, University of California Publications in Botany, V71; KIMSEY LS, 1984, J ZOOL, V204, P541, DOI 10.1111/j.1469-7998.1984.tb02386.x; KWAK M, 1977, ACTA BOT NEERL, V26, P97, DOI 10.1111/j.1438-8677.1977.tb01103.x; Lukoschus F S, 1957, Z BIENENFORSCHUNG, V4, P1; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau K, 2015, APIDOLOGIE, V46, P144, DOI 10.1007/s13592-014-0310-5; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Luo Z, 2008, FUNCT ECOL, V22, P794, DOI 10.1111/j.1365-2435.2008.01444.x; Macior L.W., 1982, P29; Macior Lazarus Walter, 2001, Plant Species Biology, V16, P83, DOI 10.1046/j.1442-1984.2001.00048.x; MACIOR LW, 1967, AM J BOT, V54, P359, DOI 10.2307/2440764; MACIOR LW, 1968, AM J BOT, V55, P1031, DOI 10.2307/2440468; MACIOR LW, 1968, AM J BOT, V55, P927, DOI 10.2307/2440558; MACIOR LW, 1964, AM J BOT, V51, P96, DOI 10.2307/2440069; MACIOR LW, 1974, ANN MO BOT GARD, V61, P760, DOI 10.2307/2395027; MACIOR LW, 1986, B TORREY BOT CLUB, V113, P101, DOI 10.2307/2995932; MICHENER C D, 1978, University of Kansas Science Bulletin, V51, P575; Michener C. D., 2000, The bees of the world; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Pacini E, 2005, FLORA, V200, P399, DOI 10.1016/j.flora.2005.02.006; Parker AJ, 2015, ARTHROPOD-PLANT INTE, V9, P197, DOI 10.1007/s11829-015-9358-z; Praz CJ, 2008, ECOLOGY, V89, P795, DOI 10.1890/07-0751.1; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlindwein C, 2005, PLANT SYST EVOL, V250, P147, DOI 10.1007/s00606-004-0246-8; STANTON ML, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P62; Thomson J.D., 1983, P451; THOMSON JD, 1986, J ECOL, V74, P329, DOI 10.2307/2260258; Thomson JD, 2001, J APPL ECOL, V38, P1032, DOI 10.1046/j.1365-2664.2001.00657.x; THOMSON JD, 1989, EVOLUTION, V43, P657, DOI 10.1111/j.1558-5646.1989.tb04261.x; Thorp RW, 2000, PLANT SYST EVOL, V222, P211, DOI 10.1007/BF00984103; THORP RW, 1979, ANN MO BOT GARD, V66, P788, DOI 10.2307/2398919; Tutin TG, 1972, FLORA EUROPAEA, V3; Ushimaru A, 2007, AM J BOT, V94, P249, DOI 10.3732/ajb.94.2.249; Wester P, 2007, ANN BOT-LONDON, V100, P401, DOI 10.1093/aob/mcm036; WESTERKAMP C, 1993, PHYTON-ANN REI BOT A, V33, P121; Westerkamp C, 1997, FLORA, V192, P125; Westerkamp C, 1996, BOT ACTA, V109, P325, DOI 10.1111/j.1438-8677.1996.tb00580.x; Westerkamp C, 2007, ANN BOT-LONDON, V100, P361, DOI 10.1093/aob/mcm123; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6	66	35	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182522	10.1371/journal.pone.0182522	http://dx.doi.org/10.1371/journal.pone.0182522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877178	gold, Green Submitted, Green Published			2022-12-26	WOS:000409391200015
J	Hoogeveen, EK; Rothman, KJ; Voskamp, PWM; de Mutsert, R; Halbesma, N; Dekker, FW				Hoogeveen, Ellen K.; Rothman, Kenneth J.; Voskamp, Pauline W. M.; de mutsert, Renee; Halbesma, Nynke; Dekker, Friedo W.		PREPARE-2 Study Grp	Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; MORTALITY; ASSOCIATION; BMI	Background Obesity is associated with increased mortality and accelerated decline in kidney function in the general population. Little is known about the effect of obesity in younger and older predialysis patients. The aim of this study was to assess the extent to which obesity is a risk factor for death or progression to dialysis in younger and older patients on specialized pre-dialysis care. Method In a multicenter Dutch cohort study, 492 incident pre-dialysis patients (> 18y) were included between 2004-2011 and followed until start of dialysis, death or October 2016. We grouped patients into four categories of baseline body mass index (BMI): < 20, 20-24 (reference), 25-29, and-30 (obesity) kg/m(2) and stratified patients into two age categories (<65y or >= 65y). Results The study population comprised 212 patients younger than 65 years and 280 patients 65 years and older; crude cumulative risk of dialysis and mortality at the end of follow-up were 66% and 4% for patients < 65y and 64% and 14%, respectively, for patients >= 65y. Among the < 65y patients, the age-sex standardized combined outcome rate was 2.3 times higher in obese than those with normal BMI, corresponding to an excess rate of 35 events/ 100 patient-years. After multivariable adjustment the hazard ratios (HR) (95% CI) for the combined endpoint by category of increasing BMI were, for patients < 65y, 0.92 (0.41-2.09), 1 (reference), 1.76 (1.16-2.68), and 1.81 (1.17-2.81). For patients >= 65y the BMI-specific HRs were 1.73 (0.97-3.08), 1 (reference), 1.25 (0.91-1.71) and 1.30 (0.79-1.90). In the competing risk analysis, taking dialysis as the event of interest and death as a competing event, the BMI-specific multivariable adjusted subdistribution HRs (95% CI) were, for patients <65y, 0.90 (0.38-2.12), 1 (reference), 1.47 (0.96-2.24) and 1.72 (1.15-2.59). For patients-65y the BMI-specific SHRs (95% CI) were 1.68 (0.93-3.02), 1 (reference), 1.50 (1.05-2.14) and 1.80 (1.23-2.65). Conclusion We found that obesity in younger pre-dialysis patients and being underweight in older pre-dialysis patients are risk factors for starting dialysis and for death, compared with those with a normal BMI.	[Hoogeveen, Ellen K.; Voskamp, Pauline W. M.; de mutsert, Renee; Halbesma, Nynke; Dekker, Friedo W.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Hoogeveen, Ellen K.] Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands; [Rothman, Kenneth J.] RTI Int, RTI Hlth Solut, Res Triangle Pk, NC USA; [Halbesma, Nynke] Univ Edinburgh, Usher Inst Populat Hlth Sci & Med Informat, Edinburgh, Midlothian, Scotland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Jeroen Bosch Ziekenhuis; Research Triangle Institute; University of Edinburgh	Hoogeveen, EK (corresponding author), Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands.; Hoogeveen, EK (corresponding author), Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands.	ellen.hoogeveen@planet.nl	Hoogeveen, Ellen K./I-2947-2019; Dekker, Friedo/B-6452-2011	Hoogeveen, Ellen K./0000-0002-5482-2013; Dekker, Friedo/0000-0002-2433-2494	Dutch Kidney Foundation [SB 110]; Amgen; Baxter	Dutch Kidney Foundation; Amgen(Amgen); Baxter	This study was supported by a grant from the Dutch Kidney Foundation (SB 110) and previously by unrestricted grants from Amgen and Baxter. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; [Anonymous], 2009, ANN REP 2009; [Anonymous], 2011, KINDN DIS IMPR GLOB; Brown RNKL, 2012, NEPHROL DIAL TRANSPL, V27, P2776, DOI 10.1093/ndt/gfr757; Collins AJ, 2015, KIDNEY INT SUPPL, V5, P2, DOI 10.1038/kisup.2015.2; de Goeij MCM, 2012, E COMMUNICATION; de Goeij MCM, 2015, NEPHRON EXTRA, V5, P19, DOI 10.1159/000371410; de Goeij MCM, 2014, NEPHROL DIAL TRANSPL, V29, P1391, DOI 10.1093/ndt/gft533; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645; Dekker FW, 2008, KIDNEY INT, V74, P994, DOI 10.1038/ki.2008.328; Dutch Federation of Nephrology, 2011, MULT GUID PRED; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Garofalo C, 2017, KIDNEY INT, V91, P1224, DOI 10.1016/j.kint.2016.12.013; Hoogeveen EK, 2012, CLIN J AM SOC NEPHRO, V7, P280, DOI 10.2215/CJN.05700611; Hoogeveen EK, 2011, TRANSPLANTATION, V91, P869, DOI 10.1097/TP.0b013e3182100f3a; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Jager KJ, 2010, NEPHROL DIAL TRANSPL, V25, P3836, DOI 10.1093/ndt/gfq540; Jin DC, 2015, KIDNEY INT SUPPL, V5, P8, DOI 10.1038/kisup.2015.3; Kleinbaum DG, 1997, SURVIVAL ANAL SELF L, P133; Lu JL, 2015, LANCET DIABETES ENDO, V3, P704, DOI 10.1016/S2213-8587(15)00128-X; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Mallamaci F, 2011, J AM SOC NEPHROL, V22, P1122, DOI 10.1681/ASN.2010090969; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Pippias M, 2015, CLIN KIDNEY J, V8, P248, DOI 10.1093/ckj/sfv014; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Rosansky SJ, 2013, J AM SOC NEPHROL, V24, P1367, DOI 10.1681/ASN.2013050458; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, Vsecond, P329; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Rothman KJ, 2012, EPIDEMIOLOGY INTRO, V2nd, P198; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; van Dis I, 2009, EUR J CARDIOV PREV R, V16, P729, DOI 10.1097/HJR.0b013e328331dfc0; World Health Organization, 2000, WHO TECH REP SER, V894, P39	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184007	10.1371/journal.pone.0184007	http://dx.doi.org/10.1371/journal.pone.0184007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873467	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800041
J	Cruz, G; Burgos, P; Kilborn, K; Evans, JJ				Cruz, Gabriela; Burgos, Pablo; Kilborn, Kerry; Evans, Jonathan J.			Involvement of the anterior cingulate cortex in time-based prospective memory task monitoring: An EEG analysis of brain sources using Independent Component and Measure Projection Analysis	PLOS ONE			English	Article							WORKING-MEMORY; MULTIPROCESS FRAMEWORK; DYNAMICS; INTERFERENCE; INTENTION; MODEL; REHABILITATION; PERFORMANCE; DEMANDS; COST	Objective Time-based prospective memory (PM), remembering to do something at a particular moment in the future, is considered to depend upon self-initiated strategic monitoring, involving a retrieval mode (sustained maintenance of the intention) plus target checking (intermittent time checks). The present experiment was designed to explore what brain regions and brain activity are associated with these components of strategic monitoring in time-based PM tasks. Method 24 participants were asked to reset a clock every four minutes, while performing a foreground ongoing word categorisation task. EEG activity was recorded and data were decomposed into source-resolved activity using Independent Component Analysis. Common brain regions across participants, associated with retrieval mode and target checking, were found using Measure Projection Analysis. Results Participants decreased their performance on the ongoing task when concurrently performed with the time-based PM task, reflecting an active retrieval mode that relied on withdrawal of limited resources from the ongoing task. Brain activity, with its source in or near the anterior cingulate cortex (ACC), showed changes associated with an active retrieval mode including greater negative ERP deflections, decreased theta synchronization, and increased alpha suppression for events locked to the ongoing task while maintaining a time-based intention. Activity in the ACC was also associated with time-checks and found consistently across participants; however, we did not find an association with time perception processing per se. Conclusion The involvement of the ACC in both aspects of time-based PM monitoring may be related to different functions that have been attributed to it: strategic control of attention during the retrieval mode (distributing attentional resources between the ongoing task and the time-based task) and anticipatory/decision making processing associated with clock-checks.	[Cruz, Gabriela; Kilborn, Kerry] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Cruz, Gabriela; Evans, Jonathan J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Cruz, Gabriela] Univ Chile, Escuela Terapia Ocupac, Santiago, Chile; [Burgos, Pablo] Univ Chile, Dept Kinesiol, Santiago, Chile	University of Glasgow; University of Glasgow; Universidad de Chile; Universidad de Chile	Cruz, G (corresponding author), Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland.; Cruz, G (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.; Cruz, G (corresponding author), Univ Chile, Escuela Terapia Ocupac, Santiago, Chile.	cruz.gabriela@gmail.com		Cruz, Gabriela/0000-0002-6320-7880; Burgos, Pablo/0000-0001-5117-4770	Comision Nacional de Investigacion Ciencia y Tecnologia (CONICYT); Chilean National Commission of Scientific and Technological Research (CONICYT); Swartz Centre for Computational Neuroscience (SCCN), UCSD	Comision Nacional de Investigacion Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Chilean National Commission of Scientific and Technological Research (CONICYT); Swartz Centre for Computational Neuroscience (SCCN), UCSD	This work was funded by Comision Nacional de Investigacion Ciencia y Tecnologia (CONICYT) - GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported through a grant by the Chilean National Commission of Scientific and Technological Research (CONICYT), and through computational resources provided by the Swartz Centre for Computational Neuroscience (SCCN), UCSD.	Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6; Bigdely-Shamlo N., 2013, HIERARCHICAL EVENT D; Bigdely-Shamlo N, 2013, NEUROIMAGE, V72, P287, DOI 10.1016/j.neuroimage.2013.01.040; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Chen Y, 2007, NEUROREPORT, V18, P1951, DOI 10.1097/WNR.0b013e3282f202dd; Chen YZ, 2009, NEUROREPORT, V20, P81, DOI 10.1097/WNR.0b013e32831ac700; Cona G, 2015, NEUROSCI BIOBEHAV R, V52, P21, DOI 10.1016/j.neubiorev.2015.02.007; Cona G, 2014, CEREB CORTEX, V24, P2630, DOI 10.1093/cercor/bht116; Cona G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031659; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Cruz G, 2016, NEUROPSYCHOLOGIA, V91, P173, DOI 10.1016/j.neuropsychologia.2016.08.005; Czernochowski D, 2012, NEUROPSYCHOLOGIA, V50, P67, DOI 10.1016/j.neuropsychologia.2011.10.023; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Doppelmayr MM, 1998, BRAIN TOPOGR, V11, P133, DOI 10.1023/A:1022206622348; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Guynn M. J., 2008, PROSPECTIVE MEMORY C, P53; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; HARRIS JE, 1982, HUM LEARN, V1, P123; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hertzog C., 2008, PROSPECTIVE MEMORY C, P101; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Kinner P. R., 2008, SPSS 15 MADE SIMPLE; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knight JB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.005.2010; Kothe CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056014; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; Mantyla T, 2007, J EXP CHILD PSYCHOL, V96, P1, DOI 10.1016/j.jecp.2006.08.003; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Mioni G, 2014, MEMORY, V22, P536, DOI 10.1080/09658211.2013.801987; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Murtha S, 1996, HUM BRAIN MAPP, V4, P103, DOI 10.1002/(SICI)1097-0193(1996)4:2<103::AID-HBM2>3.0.CO;2-7; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Penny WD, 2002, TRENDS NEUROSCI, V25, P387, DOI 10.1016/S0166-2236(02)02202-6; Pouthas V, 2000, HUM BRAIN MAPP, V10, P49, DOI 10.1002/(SICI)1097-0193(200006)10:2<49::AID-HBM10>3.0.CO;2-8; ROUSSELET GA, 2011, FRONT PSYCHOL, V2; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Rubia K, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P213, DOI 10.1142/9789812707123_0009; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Scolaro A, 2014, INT J PSYCHOPHYSIOL, V93, P298, DOI 10.1016/j.ijpsycho.2014.06.008; Scullin MK, 2013, COGNITIVE PSYCHOL, V67, P55, DOI 10.1016/j.cogpsych.2013.07.001; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; Van Rijn H., 2011, FRONT INTEGR NEUROSC, V5; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 2005, PSYCHOPHYSIOLOGY, V42, P698, DOI 10.1111/j.1469-8986.2005.00361.x; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2011, CAN J EXP PSYCHOL, V65, P38, DOI 10.1037/a0022810	67	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184037	10.1371/journal.pone.0184037	http://dx.doi.org/10.1371/journal.pone.0184037			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863146	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900018
J	Lange, T; Stracke, S; Rettig, R; Lendeckel, U; Kuhn, J; Schluter, R; Rippe, V; Endlich, K; Endlich, N				Lange, Tim; Stracke, Sylvia; Rettig, Rainer; Lendeckel, Uwe; Kuhn, Jana; Schlueter, Rabea; Rippe, Volkhard; Endlich, Karlhans; Endlich, Nicole			Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients	PLOS ONE			English	Article							RENAL FIBROSIS; MICRORNA; BIOMARKER; QUANTIFICATION; BIOGENESIS; VESICLES; PROGRESSION; STRATEGIES; MECHANISM; DISCOVERY	Chronic kidney disease (CKD) is a severe disorder with an increasing incidence worldwide. An early detection may help to prevent its progression and to minimize the risk of cardiovascular diseases as one of the major comorbidities. Recently, extracellular miRNAs like urinary exosomal miRNAs became of great interest as non-invasive biomarkers which can be determined by RT-qPCR. But until now, there is no consensus regarding the normalization of miRNAs isolated from body fluids. The present study analyzed the miRNAs miR-16, miR-92a, miR-21, miR-124a and the small nuclear RNA RNU6B for their applicability as an endogenous reference gene in expression studies of exosomal miRNAs isolated from CKD patients. For this purpose, miRNA expression levels were determined by RT-qPCR after the isolation of urinary exosomes from 33 CKD patients and from 5 healthy controls. Expression data was analyzed with the normalization determination software NormFinder, BestKeeper, GeNorm and DeltaCt. Our results revealed an abundant expression of the four candidate miRNAs in urinary exosomes and no detectable expression of RNU6B. We identified miR-16 as the most stable endogenous reference gene in our data set, making it a suitable endogenous reference gene for miRNA studies of urinary exosomes derived from CKD patients.	[Lange, Tim; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Stracke, Sylvia] Univ Med Greifswald, Dept Internal Med A, Nephrol, Greifswald, Germany; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [Lendeckel, Uwe] Univ Med Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Kuhn, Jana] Karlsburg Hosp Dr Guth GmbH & Co KG, Clin Diabet & Metab Dis, Karlsburg, Germany; [Schlueter, Rabea] Ernst Moritz Arndt Univ Greifswald, Imaging Ctr, Dept Biol, Greifswald, Germany; [Rippe, Volkhard] Univ Bremen, Ctr Human Genet, Bremen, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; University of Bremen	Endlich, N (corresponding author), Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany.	nicole.endlich@uni-greifswald.de	Stracke, Sylvia/ABB-8871-2020	Endlich, Karlhans/0000-0001-6052-6061				Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Bruck K, 2015, J AM SOC NEPHROLOGY; Bryzgunova OE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157566; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fukuda A, 2012, NEPHROL DIAL TRANSPL, V27, P4079, DOI 10.1093/ndt/gfs313; Gao Youhe, 2014, URINE PROTEOMICS KID, P50; Grabe HJ, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-144; Gracia T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40601; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Koga Y, 2011, J GASTROINTEST ONCOL, V2, P215, DOI 10.3978/j.issn.2078-6891.2011.015; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Mall C, 2013, BIOMARK MED, V7, P623, DOI 10.2217/bmm.13.44; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Perez-Hernandez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138618; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaffl MW, QUANTIFICATION STRAT; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Ramezani A, 2015, EUR J CLIN INVEST, V45, P394, DOI 10.1111/eci.12420; Roberts TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089237; Royo F, 2016, CANCERS, V8, DOI 10.3390/cancers8120112; Royo F, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29497; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Sewer Alain, 2014, BMC Res Notes, V7, P302, DOI 10.1186/1756-0500-7-302; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Solayman MHM, 2016, MOL BIOTECHNOL, V58, P179, DOI 10.1007/s12033-015-9912-z; Sole C, 2015, NEPHROL DIAL TRANSPL, V30, P1488, DOI 10.1093/ndt/gfv128; Suo C, 2010, RNA, V16, P2293, DOI 10.1261/rna.2345710; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Whiteside TL, 2016, ADV CLIN CHEM, V74, P103, DOI 10.1016/bs.acc.2015.12.005; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2	52	62	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183435	10.1371/journal.pone.0183435	http://dx.doi.org/10.1371/journal.pone.0183435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859135	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500017
J	Dehn, S; Thorp, EB				Dehn, Shirley; Thorp, Edward B.			Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair	FASEB JOURNAL			English	Article						myocardial infarction; inflammation; monocyte	APOPTOTIC CELLS; TYROSINE KINASE; HEART-DISEASE; FATTY-ACID; CARDIOVASCULAR-DISEASE; NUCLEAR RECEPTORS; IN-VITRO; MACROPHAGES; MONOCYTES; INFLAMMATION	Phagocytosis after myocardial infarction (MI) is a prerequisite to cardiac repair. Recruited monocytes clear necrotic cardiomyocytes and differentiate into cardiac macrophages. Some studies have linked apoptotic cell receptors on cardiac macrophages to tissue repair; however, the contribution of precursor monocyte phagocytic receptors, which are the first to interact with the cardiac parenchyma, is unclear. The scavenger receptor cluster of differentiation (CD) 36 protein was detected on cardiac Ly6cHI monocytes, and bone marrow-derived Cd36 was essential for both early phagocytosis of dying cardiomyocytes and for smaller infarct sizes in female and male mice after permanent coronary ligation. Cd36 deficiency led to reduced expression of phagocytosis receptor Mertk and nuclear receptor Nr4a1 in cardiac macrophages, the latter previously shown to be required for phagocyte survival. Nr4a1 was required for phagocytosis-induced Mertk expression, and Nr4a1 protein directly bound to Mertk gene regulatory elements. To test the overall contribution of the Cd36-Mertk axis, MI was induced in Cd36(-/-) Mertk(-/-) double-knockout mice and led to increases in myocardial rupture. These data implicate monocyte CD36 in the mitigation of early infarct size and transition to Mertk-dependent macrophage function. Increased myocardial rupture in the absence of both Cd36 and Mertk underscore the physiologic significance of phagocytosis during tissue injury.	[Dehn, Shirley; Thorp, Edward B.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, 300 East Super St, Chicago, IL 60611 USA; [Dehn, Shirley; Thorp, Edward B.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Thorp, EB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 300 East Super St, Chicago, IL 60611 USA.	ebthorp@northwestern.edu			Collaborative Learning and Integrated Mentoring in the Biosciences, Cellular, and Molecular Basis of Disease Program [U.S. National Institutes of Health (NIH), National Institute of General Medicine Sciences] [T32GM08061]; NIH National Heart, Lung, and Blood Institute Diversity Supplements [R01HL122309]; Sidney and Bess Eisenberg Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R25GM079300] Funding Source: NIH RePORTER	Collaborative Learning and Integrated Mentoring in the Biosciences, Cellular, and Molecular Basis of Disease Program [U.S. National Institutes of Health (NIH), National Institute of General Medicine Sciences]; NIH National Heart, Lung, and Blood Institute Diversity Supplements; Sidney and Bess Eisenberg Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Matthew DeBerge, Kristofor Glinton (both from Northwestern University), and Terry Means (Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA) for their intellectual contributions. This work was supported by Collaborative Learning and Integrated Mentoring in the Biosciences, Cellular, and Molecular Basis of Disease Program [U.S. National Institutes of Health (NIH), National Institute of General Medicine Sciences Grant T32GM08061], and NIH National Heart, Lung, and Blood Institute Diversity Supplements R01HL122309 (to S.D.) and R01HL122309 (to E.B.T.). Publication of this research was supported by the Sidney and Bess Eisenberg Memorial Fund. The authors declare no conflicts of interest.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Bessi VL, 2012, CARDIOVASC RES, V96, P99, DOI 10.1093/cvr/cvs225; Bonen A, 1998, AM J PHYSIOL-ENDOC M, V275, pE471, DOI 10.1152/ajpendo.1998.275.3.E471; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chang J, 2013, DIAGN HISTOPATHOL, V19, P7, DOI DOI 10.1016/J.MPDHP.2012.11.001; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; CLEMETSON KJ, 1977, BIOCHIM BIOPHYS ACTA, V464, P493, DOI 10.1016/0005-2736(77)90025-6; Dehn S, 2016, J IMMUNOL, V197, P3639, DOI 10.4049/jimmunol.1600402; DeLeon-Pennell KY, 2016, CIRC-CARDIOVASC GENE, V9, P14, DOI 10.1161/CIRCGENETICS.115.001249; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; Grisanti LA, 2016, CIRCULATION, V134, P153, DOI 10.1161/CIRCULATIONAHA.116.022304; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Howangyin KY, 2016, CIRCULATION, V133, P826, DOI 10.1161/CIRCULATIONAHA.115.020857; Huang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32660; Ipseiz N, 2014, J IMMUNOL, V192, P4852, DOI 10.4049/jimmunol.1303377; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lagasse HAD, 2016, J LEUKOCYTE BIOL, V99, P659, DOI 10.1189/jlb.4HI0315-130RRR; Larson SR, 2016, CELL DEATH DIFFER, V23, P997, DOI 10.1038/cdd.2016.24; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Maira M, 1999, MOL CELL BIOL, V19, P7549; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakano Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29601; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Piechota M, 2012, PROTEIN J, V31, P511, DOI 10.1007/s10930-012-9431-8; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Santamaria MH, 2014, MICROVASC RES, V95, P131, DOI 10.1016/j.mvr.2014.08.004; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Teupser D, 2008, CLIN EXP PHARMACOL P, V35, P552, DOI 10.1111/j.1440-1681.2007.04836.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Woo MS, 2016, J BIOL CHEM, V291, P23654, DOI 10.1074/jbc.M116.750018; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhou P, 2011, NEUROBIOL DIS, V42, P292, DOI 10.1016/j.nbd.2011.01.019	66	33	34	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					254	+		10.1096/fj.201700450R	http://dx.doi.org/10.1096/fj.201700450R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28860151	Green Published			2022-12-26	WOS:000419172700024
J	Wang, L; Wang, XJ; Wang, LF; Yousaf, M; Li, J; Zuo, MX; Yang, ZC; Gou, DZ; Bao, BH; Li, L; Xiang, N; Jia, HB; Xu, CQ; Chen, QY; Wang, QK				Wang, Li; Wang, Xiaojing; Wang, Longfei; Yousaf, Muhammad; Li, Jia; Zuo, Mengxia; Yang, Zhongcheng; Gou, Dongzhi; Bao, Binghao; Li, Lei; Xiang, Ning; Jia, Haibo; Xu, Chengqi; Chen, Qiuyun; Wang, Qing Kenneth			Identification of a new adtrp1-tfpi regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis	FASEB JOURNAL			English	Article						hemangioblasts; vascular development; aggf1; coagulation	COLONY-STIMULATING FACTOR; CORONARY-ARTERY-DISEASE; ATHEROSCLEROSIS; PATHWAY; ENDOTHELIUM; INHIBITION; BLOOD; CELLS; TFPI; POLYMORPHISMS	A genomic variant in the human ADTRP [androgen-dependent tissue factor (TF) pathway inhibitor (TFPI) regulating protein] gene increases the risk of coronary artery disease, the leading cause of death worldwide. TFPI is the TF pathway inhibitor that is involved in coagulation. Here, we report that adtrp and tfpi forma regulatory axis that specifies primitive myelopoiesis and definitive hematopoiesis, but not primitive erythropoiesis or vasculogenesis. In zebrafish, there are 2 paralogues for adtrp (i.e., adtrp1 and adtrp2). Knockdown of adtrp1 expression inhibits the specification of hemangioblasts, as shown by decreased expression of the hemangioblast markers, etsrp, fli1a, and scl; blocks primitive hematopoiesis, as shown by decreased expression of pu. 1, mpo, and l-plastin; and disrupts the specification of hematopoietic stem cells (definitive hematopoiesis), as shown by decreased expression of runx1 and c-myb. However, adtrp1 knockdown does not affect erythropoiesis during primitive hematopoiesis (no effect on gata1 or h-bae1) or vasculogenesis (no effect on kdrl, ephb2a, notch3, dab2, or flt4). Knockdown of adtrp2 expression does not have apparent effects on all markers tested. Knockdown of adtrp1 reduced the expression of tfpi, and hematopoietic defects in adtrp1 morphants were rescued by tfpi overexpression. These data suggest that the regulation of tfpi expression is one potential mechanism by which adtrp1 regulates primitive myelopoiesis and definitive hematopoiesis.	[Wang, Li; Wang, Xiaojing; Wang, Longfei; Yousaf, Muhammad; Li, Jia; Zuo, Mengxia; Yang, Zhongcheng; Gou, Dongzhi; Bao, Binghao; Li, Lei; Jia, Haibo; Xu, Chengqi; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ,Cardio X Ctr, Wuhan, Hubei, Peoples R China; [Xiang, Ning] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Lerner Coll Med, Ctr Cardiovasc Genet, Lerner Res Inst,Dept Mol Cardiol, Cleveland, OH 44106 USA; [Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA; [Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Chen, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	qkwang@mail.hust.edu.cn	Wang, Li/AAM-2454-2021	Wang, Li/0000-0002-8969-7427; Li, Jia/0000-0001-7132-2574; Li, Lei/0000-0002-2822-4482; Xu, Chengqi/0000-0002-4269-6830; Wang, Qing/0000-0002-5639-8519	China National Natural Science Foundation [31430047, 81630003, 91439129]; Chinese National Basic Research (973 Programs) [2013CB531101, 2012CB517801]; Hubei Province's Outstanding Medical Academic Leader Program, Hubei Province Natural Science Programs [2016CFB224, 2014CFA074]; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [R01-HL121358, R01-HL126729]; Bayer Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126729, R01HL121358] Funding Source: NIH RePORTER	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese National Basic Research (973 Programs)(National Basic Research Program of China); Hubei Province's Outstanding Medical Academic Leader Program, Hubei Province Natural Science Programs; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the China National Natural Science Foundation (Grants 31430047, 81630003, and 91439129), Chinese National Basic Research (973 Programs 2013CB531101 and 2012CB517801), Hubei Province's Outstanding Medical Academic Leader Program, Hubei Province Natural Science Programs (2016CFB224 and 2014CFA074), and the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (Grants R01-HL121358 and R01-HL126729). Other related research projects on ADTRP in the Q.K.W. Laboratory received funding from Bayer Health.	Aitsebaomo J, 2008, CIRC RES, V103, P929, DOI 10.1161/CIRCRESAHA.108.184937; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Broxmeyer HE, 2012, NAT MED, V18, P1786, DOI 10.1038/nm.2991; Bukrinsky A, 2009, BLOOD, V113, P2038, DOI 10.1182/blood-2008-06-162495; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Butko E, 2015, DEVELOPMENT, V142, P1050, DOI 10.1242/dev.119180; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chinetti-Gbaguidi G, 2015, FEBS LETT, V589, P461, DOI 10.1016/j.febslet.2015.01.002; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Dechamethakun S, 2014, J ATHEROSCLER THROMB, V21, P680; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Gao L. N., 2015, EVID-BASED COMPL ALT, V2015, P1; Gore A. V., 2012, VASCULAR DEV ZEBRAFI; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043732; Haghighat A, 2007, CIRCULATION, V115, P2049, DOI 10.1161/CIRCULATIONAHA.106.665570; Hasegawa H, 2006, BIOCHEM BIOPH RES CO, V344, P370, DOI 10.1016/j.bbrc.2006.03.081; Hsu CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10673; Hu ZH, 2013, INT J MOL SCI, V14, P4805, DOI 10.3390/ijms14034805; Huang EW, 2016, J HUM GENET, V61, P389, DOI 10.1038/jhg.2015.158; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Khurana S, 2013, BLOOD, V121, P2587, DOI 10.1182/blood-2012-09-456715; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Maroney SA, 2015, J THROMB HAEMOST, V13, pS200, DOI 10.1111/jth.12897; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Peraramelli S, 2014, J THROMB HAEMOST, V12, P1826, DOI 10.1111/jth.12713; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Takai H, 2008, J VET MED SCI, V70, P943, DOI 10.1292/jvms.70.943; Tayebi N, 2013, CLIN BIOCHEM, V46, P755, DOI 10.1016/j.clinbiochem.2013.01.004; Thomassen MCLGD, 2015, J THROMB HAEMOST, V13, P92, DOI 10.1111/jth.12766; Uribe RA, 2015, MOL BIOL CELL, V26, P3728, DOI 10.1091/mbc.E15-02-0112; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Ye J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34034; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhou JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25088	50	12	12	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					183	194		10.1096/fj.201700166RR	http://dx.doi.org/10.1096/fj.201700166RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28877957	Green Published			2022-12-26	WOS:000419172700018
J	Groves, D; Fisher, J; Williams, S				Groves, Dawn; Fisher, John; Williams, Sophie			An in vitro simulation method for the tribological assessment of complete natural hip joints	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; ACETABULAR CARTILAGE; SYNOVIAL JOINTS; HYALURONIC-ACID; LUBRICATION; FRICTION; HEMIARTHROPLASTY; OSTEOARTHRITIS; WEAR; PREVENTION	The use of hip joint simulators to evaluate the tribological performance of total hip replacements is widely reported in the literature, however, in vitro simulation studies investigating the tribology of the natural hip joint are limited with heterogeneous methodologies reported. An in vitro simulation system for the complete natural hip joint, enabling the acetabulum and femoral head to be positioned with different orientations whilst maintaining the correct joint centre of rotation, was successfully developed for this study. The efficacy of the simulation system was assessed by testing complete, matched natural porcine hip joints and porcine hip hemiarthroplasty joints in a pendulum friction simulator. The results showed evidence of biphasic lubrication, with a non-linear increase in friction being observed in both groups. Lower overall mean friction factor values in the complete natural joint group that increased at a lower rate over time, suggest that the exudation of fluid and transition to solid phase lubrication occurred more slowly in the complete natural hip joint compared to the hip hemiarthroplasty joint. It is envisaged that this methodology will be used to investigate morphological risk factors for developing hip osteoarthritis, as well as the effectiveness of early interventional treatments for degenerative hip disease.	[Groves, Dawn; Fisher, John; Williams, Sophie] Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds, W Yorkshire, England	University of Leeds	Groves, D (corresponding author), Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds, W Yorkshire, England.	d.groves@leeds.ac.uk	Williams, Sophie/D-4591-2015	Williams, Sophie/0000-0002-6963-965X; Groves-Williams, Dawn/0000-0002-4834-8503	Engineering and Physical Sciences Research Council CASE; DePuy Synthes; EPSRC [EP/N02480X/1, EP/N00941X/1, EP/K029592/1, EP/M028143/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N02480X/1, EP/N00941X/1, EP/M028143/1, EP/K029592/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council CASE(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DePuy Synthes; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an Engineering and Physical Sciences Research Council CASE studentship, which was supported by DePuy Synthes. The manuscript was reviewed by DePuy Synthes. The funder provided a contribution to the studentship awarded to DG (CASE studentship) in relation to this study. JF/SW are paid consultants, however, this is not in relation to this study. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ateshian G.A., 2005, BASIC ORTHOPAEDIC BI, P447; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; Bergmann G, 1999, J BIOMECH, V32, P769, DOI 10.1016/S0021-9290(99)00068-8; BERGMANN G, 1984, J BIOMECH, V17, P907, DOI 10.1016/0021-9290(84)90004-6; Biewener AA., 2003, ANIMAL LOCOMOTION; Bijlsma JWJ, 2007, BEST PRACT RES CL RH, V21, P59, DOI 10.1016/j.berh.2006.08.013; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Chan FW, 1999, T 45 ANN M ORTH RES; Croft P, 2005, RHEUMATOLOGY, V44, P27, DOI 10.1093/rheumatology/kei058; DALLDORF PG, 1995, J BONE JOINT SURG AM, V77A, P877, DOI 10.2106/00004623-199506000-00008; DEVAS M, 1983, J BONE JOINT SURG BR, V65, P548, DOI 10.1302/0301-620X.65B5.6643556; Felson DT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2531; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; Forsey RW, 2006, BIOMATERIALS, V27, P4581, DOI 10.1016/j.biomaterials.2006.04.018; Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167; Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02; Furey M. J., 1997, LUBR SCI, V9, P255, DOI DOI 10.1002/IS.3010090303; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; Groves D., 2015, THESIS; Groves D, 2017, DATA SET ASS IN VITR; Jia LZ, 2013, P I MECH ENG H, V227, P1284, DOI 10.1177/0954411913502156; Katta J, 2007, P I MECH ENG J-J ENG, V221, P175, DOI 10.1243/13506501JET240; Katta J, 2008, MED ENG PHYS, V30, P1349, DOI 10.1016/j.medengphy.2008.09.004; Leunig M, 2014, BONE JOINT J, V96B, P5, DOI 10.1302/0301-620X.96B1.32823; Li JY, 2014, MED ENG PHYS, V36, P1449, DOI 10.1016/j.medengphy.2014.05.014; Lizhang J., 2010, THESIS; Lubbeke A, 2007, J RHEUMATOL, V34, P394; MACIROWSKI T, 1994, J BIOMECH ENG-T ASME, V116, P10, DOI 10.1115/1.2895693; McCann L, 2008, TRIBOL INT, V41, P1126, DOI 10.1016/j.triboint.2008.03.012; McCarthy J, 2003, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000043042.84315.17; McNary SM, 2012, TISSUE ENG PART B-RE, V18, P88, DOI [10.1089/ten.teb.2011.0394, 10.1089/ten.TEB.2011.0394]; Millis MB, 2002, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000038465.05771.02; Mow VC, 1999, CLIN ORTHOP RELAT R, pS204, DOI 10.1097/00003086-199910001-00021; Nuki G, 1999, Z RHEUMATOL, V58, P142, DOI 10.1007/s003930050164; O'Kelly J., 1978, Engineering in Medicine, V7, P73, DOI 10.1243/EMED_JOUR_1978_007_022_02; Palastanga N, 2002, ANATOMY HUMAN MOVEME; Pawaskar SS, 2011, J BIOMECH, V44, P1536, DOI 10.1016/j.jbiomech.2011.02.140; PHILLIPS TW, 1989, J BONE JOINT SURG AM, V71A, P913, DOI 10.2106/00004623-198971060-00016; ROBERTS BJ, 1982, ANN RHEUM DIS, V41, P217, DOI 10.1136/ard.41.3.217; Roter GE, 2002, TRIBOL INTER ENG, V40, P367; Sarma AV, 2001, J ORTHOP RES, V19, P671, DOI 10.1016/S0736-0266(00)00064-4; SCHENAU GJV, 1993, ACTA ANAT, V146, P103, DOI 10.1159/000147429; Simulation Solutions Ltd, 2012, PROSIM FRICT SIM 3 H; Song Y, 2012, J BIOMECH, V45, P524, DOI 10.1016/j.jbiomech.2011.11.044; SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318; Taylor SD, 2012, P I MECH ENG H, V226, P55, DOI 10.1177/0954411911428717; UNSWORTH A, 1975, J LUBRIC TECH-T ASME, V97, P369, DOI 10.1115/1.3452605; WALKER PS, 1968, ANN RHEUM DIS, V27, P512, DOI 10.1136/ard.27.6.512; Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184226	10.1371/journal.pone.0184226	http://dx.doi.org/10.1371/journal.pone.0184226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886084	Green Published, gold			2022-12-26	WOS:000410001100085
J	Poninska, JK; Samolinski, B; Tomaszewska, A; Raciborski, F; Samel-Kowalik, P; Walkiewicz, A; Lipiec, A; Piekarska, B; Krzych-Falta, E; Namyslowski, A; Kostrzewa, G; Pawlik, A; Jasek, M; Wisniewski, A; Kusnierczyk, P; Majewski, S; Ploski, R				Poninska, Joanna Kinga; Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Krzych-Falta, Edyta; Namyslowski, Andrzej; Kostrzewa, Grazyna; Pawlik, Andrzej; Jasek, Monika; Wisniewski, Andrzej; Kusnierczyk, Piotr; Majewski, Slawomir; Ploski, Rafal			Haplotype dependent association of rs7927894 (11q13.5) with atopic dermatitis and chronic allergic rhinitis: A study in ECAP cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CHROMOSOME 11Q13.5; IDENTIFIES 4; METAANALYSIS; FILAGGRIN; VARIANTS; ECZEMA; POLYMORPHISM; DISEASE	The T allele of rs7927894 (at 11q13.5) was associated with atopic dermatitis and other allergic diseases. Our purpose was to replicate the association with allergic phenotypes and explore the role of rs7927894 in predisposing to persistent allergic rhinitis and atopic asthma. We also wanted to explore if other SNPs at 11q13.5 contributed to effect of rs7927894. We studied patients with atopic dermatitis (N = 270), atopic asthma (N = 486), persistent allergic rhinitis (N = 589) and controls matched for age, sex and region (N = 540, N = 372 and N = 1178, respectively). We found that rs7927894 T was associated with atopic dermatitis (OR = 1.39, CI:1.12-1.73, P = 0.003) and independently with persistent allergic rhinitis (OR = 1.24, CI:1.07-1.43, P = 0.0043, P-corrected = 0.013) but not atopic asthma. Analysis of additional tagging SNPs (rs7930763, rs2513517, rs7125552) showed that effect of rs7927894 T was limited to haplotypes encoding G at rs7125552. In conclusion, rs7927894 T is associated not only with atopic dermatitis but also persistent allergic rhinitis. Since these effects are haplotype dependent rs7927894 alone does not account for the association between 11q13.5 and atopic dermatitis/persistent allergic rhinitis.	[Poninska, Joanna Kinga] Inst Cardiol, Dept Med Biol, Warsaw, Poland; [Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Krzych-Falta, Edyta; Namyslowski, Andrzej] Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland; [Kostrzewa, Grazyna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Physiol, Szczecin, Poland; [Jasek, Monika; Wisniewski, Andrzej; Kusnierczyk, Piotr] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Immunogenet, Wroclaw, Poland; [Majewski, Slawomir] Med Univ Warsaw, Dept Dermatol & Venereol, Warsaw, Poland	Institute of Cardiology - Poland; Medical University of Warsaw; Medical University of Warsaw; Pomeranian Medical University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Medical University of Warsaw	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Lipiec, Agnieszka/X-7523-2018; Piekarska, Barbara/AAJ-7354-2020; Tomaszewska, Aneta/X-8906-2018; Kusnierczyk, Piotr/ABB-6734-2020; Samel-Kowalik, Piotr/M-3239-2018	Lipiec, Agnieszka/0000-0003-3037-2326; Piekarska, Barbara/0000-0002-6800-7781; Tomaszewska, Aneta/0000-0001-6730-6352; Samel-Kowalik, Piotr/0000-0002-9047-0414; Jasek, Monika/0000-0001-6778-2615; Krzych-Falta, Edyta/0000-0002-9857-7136; Wisniewski, Andrzej/0000-0002-1919-2298; Raciborski, Filip/0000-0003-0562-0260; Pawlik, Andrzej/0000-0001-6557-1208; Kusnierczyk, Piotr/0000-0002-9224-8921; Poninska, Joanna/0000-0002-0890-611X; Ploski, Rafal/0000-0001-6286-5526	Ministry of Science and Higher Education [6 P05 2005 C/06572]; Medical University of Warsaw [1WY/NK1W/2009]; Ministry of Health; Polish Ministry of Science and Higher Education; Ministry of Health [6P052005C/06572]; Warsaw Medical University [1WY/NK1W/2009]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Medical University of Warsaw; Ministry of Health; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Ministry of Health; Warsaw Medical University	Funded by 6 P05 2005 C/06572 - Ministry of Science and Higher Education (http://www.nauka.gov.pl), Ministry of Health (http://www.mz.gov.pl/), 1WY/NK1W/2009 - Medical University of Warsaw (http://www.wum.edu.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financed by grants from Polish Ministry of Science and Higher Education, Ministry of Health grant No. 6P052005C/06572, and Warsaw Medical University grant No. 1WY/NK1W/2009.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asthma. GIfAGSf, 2008, MAN PREV NHLBI WORKS; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2015, ALLERGY, V70, P1062, DOI 10.1111/all.12637; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Greisenegger EK, 2013, EUR J DERMATOL, V23, P142, DOI 10.1684/ejd.2013.1955; Hahn EL, 2005, IMMUNOL ALLERGY CLIN, V25, P231, DOI 10.1016/j.iac.2005.02.004; JM H, 1980, ACTA DERM-VENEREOL, P44; Kim KW, 2015, J ALLERGY CLIN IMMUN, V136, P678, DOI 10.1016/j.jaci.2015.03.030; Li XN, 2012, J ALLERGY CLIN IMMUN, V129, P575, DOI 10.1016/j.jaci.2011.09.040; Manz J, 2016, J INVEST DERMATOL, V136, P2380, DOI 10.1016/j.jid.2016.07.009; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Nomura Y, 2010, J DERMATOL SCI, V59, P210, DOI 10.1016/j.jdermsci.2010.06.010; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V125, P170, DOI 10.1016/j.jaci.2009.10.046; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pawlik A, 2007, TISSUE ANTIGENS, V70, P314, DOI 10.1111/j.1399-0039.2007.00908.x; Poninska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016933; Probst-Kepper M, 2010, CURR MOL MED, V10, P533; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Spergel JM, 2010, IMMUNOL ALLERGY CLIN, V30, P269, DOI 10.1016/j.iac.2010.06.003; Tang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035334; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433	37	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183922	10.1371/journal.pone.0183922	http://dx.doi.org/10.1371/journal.pone.0183922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886043	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100045
J	Rangrez, AY; Hoppe, P; Kuhn, C; Zille, E; Frank, J; Frey, N; Frank, D				Rangrez, Ashraf Yusuf; Hoppe, Phillip; Kuhn, Christian; Zille, Elisa; Frank, Johanne; Frey, Norbert; Frank, Derk			MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2	PLOS ONE			English	Article							KINASE KNOCKOUT MICE; DILATED CARDIOMYOPATHY; POSITION STATEMENT; TRANSGENIC MICE; RESPONSE FACTOR; WORKING GROUP; CALCINEURIN; HEART; DISRUPTION; EXPRESSION	Calsarcin-1 deficient mice develop dilated cardiomyopathy (DCM) phenotype in pure C57BL/6 genetic background (Cs1-ko) despite severe contractile dysfunction and robust activation of fetal gene program. Here we performed a microRNA microarray to identify the molecular causes of this cardiac phenotype that revealed the dysregulation of several microRNAs including miR-301a, which was highly downregulated in Cs1-ko mice compared to the wild-type littermates. Cofilin-2 (Cfl2) was identified as one of the potential targets of miR-301a using prediction databases, which we validated by luciferase assay and mutation of predicted binding sites. Furthermore, expression of miR-301a contrastingly regulated Cfl2 expression levels in neonatal rat ventricular cardiomyocytes (NRVCM). Along these lines, Cfl2 was significantly upregulated in Cs1-ko mice, indicating the physiological association between miR-301a and Cfl2 in vivo. Mechanistically, we found that Cfl2 activated serum response factor response element (SRF-RE) driven luciferase activity in neonatal rat cardiomyocytes and in C2C12 cells. Similarly, knockdown of miR-301a activated, whereas, its overexpression inhibited the SRF-RE driven luciferase activity, further strengthening physiological interaction between miR-301a and Cfl2. Interestingly, the expression of SRF and its target genes was strikingly increased in Cs1-ko suggesting a possible in vivo correlation between expression levels of Cfl2/miR-301a and SRF activation, which needs to be independently validated. In summary, our data demonstrates that miR-301a regulates Cofilin-2 in vitro in NRVCM, and in vivo in Cs1-ko mice. Our findings provide an additional and important layer of Cfl2 regulation, which we believe has an extended role in cardiac signal transduction and dilated cardiomyopathy presumably due to the reported involvement of Cfl2 in these mechanisms.	[Rangrez, Ashraf Yusuf; Hoppe, Phillip; Kuhn, Christian; Zille, Elisa; Frank, Johanne; Frey, Norbert; Frank, Derk] Univ Med Ctr Kiel, Dept Internal Med Cardiol Angiol Intens Care 3, Kiel, Germany; [Rangrez, Ashraf Yusuf; Kuhn, Christian; Frey, Norbert; Frank, Derk] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research	Frank, D (corresponding author), Univ Med Ctr Kiel, Dept Internal Med Cardiol Angiol Intens Care 3, Kiel, Germany.; Frank, D (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Kiel, Germany.	derk.frank@uksh.de	Rangrez, Ashraf/H-4988-2016; Frey, Norbert/M-7749-2019; Frey, Norbert/A-9695-2010	Rangrez, Ashraf/0000-0003-2630-9754; Frey, Norbert/0000-0001-7611-378X; 	Federal Ministry for Education and Research (BMBF); German Research Foundation (DFG) [FR2554-2]; German Centre for Cardiovascular Research (DZHK); Federal Ministry for Education and Research (eMed SYMBOL-HF)	Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Centre for Cardiovascular Research (DZHK); Federal Ministry for Education and Research (eMed SYMBOL-HF)	This work is funded by Federal Ministry for Education and Research (BMBF; eMed SYMBOL-HF, to DF; https://www.bmbf.de/en/), German Research Foundation (DFG; FR2554-2 to DF and NF; www.dfg.de/en/), and support from German Centre for Cardiovascular Research (DZHK; AYR, NF and DF; https://dzhk.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge excellent technical assistance from K. Stiebeling and L. Christen. This work is funded by Federal Ministry for Education and Research (BMBF; eMed SYMBOL-HF, to DF), German Research Foundation (DFG; FR2554-2 to DF and NF), and support from German Centre for Cardiovascular Research (DZHK; AYR, NF and DF).	Agrawal PB, 2012, HUM MOL GENET, V21, P2341, DOI 10.1093/hmg/dds053; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernardo BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090337; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Cakmak HA, 2015, J CARDIOVASC MED, V16, P431, DOI 10.2459/JCM.0000000000000233; Cengiz M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000693; Cui L, 2016, CELL PHYSIOL BIOCHEM, V40, P230, DOI 10.1159/000452540; Damodaran C, 2016, UROL ONCOL, V34, P336, DOI DOI 10.1016/J.UR0L0NC.2016.03.009; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; El-Armouche A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014263; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frank D, 2014, J MOL CELL CARDIOL, V72, P196, DOI 10.1016/j.yjmcc.2014.03.016; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Gurniak CB, 2014, EUR J CELL BIOL, V93, P252, DOI 10.1016/j.ejcb.2014.01.007; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Heineke J, 2010, J MOL CELL CARDIOL, V48, P1080, DOI 10.1016/j.yjmcc.2009.10.012; Hodgkinson CP, 2015, CIRC RES, V116, P1700, DOI 10.1161/CIRCRESAHA.116.304377; Kamps JAAM, 2016, WORLD J CARDIOL, V8, P163, DOI 10.4330/wjc.v8.i2.163; Kiper C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070512; Kremneva E, 2014, DEV CELL, V31, P215, DOI 10.1016/j.devcel.2014.09.002; Lakdawala NK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P228, DOI 10.1161/CIRCEP.111.962050; Lee TM, 2014, J MOL MED, V92, P43, DOI 10.1007/s00109-013-1103-4; Li D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106318; Li QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148480; Liu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160920; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; Lygate CA, 2009, J MOL CELL CARDIOL, V46, P93, DOI 10.1016/j.yjmcc.2008.09.710; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Ni Z, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027807; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Philippen LE, 2015, MOL THER, V23, P1810, DOI 10.1038/mt.2015.133; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rangrez AY, 2017, BBA-MOL CELL RES, V1864, P634, DOI 10.1016/j.bbamcr.2017.01.004; Rangrez AY, 2016, J BIOL CHEM, V291, P4128, DOI 10.1074/jbc.M115.689620; Rangrez AY, 2013, J CELL BIOL, V203, P643, DOI 10.1083/jcb.201303052; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rustagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139359; Sanford LP, 2000, METH MOL B, V158, P217; Schoensiegel F, 2007, COMPARATIVE MED, V57, P546; Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03; Subramanian K, 2015, J AM COLL CARDIOL, V65, P1199, DOI 10.1016/j.jacc.2015.01.031; Thirion C, 2001, EUR J BIOCHEM, V268, P3473, DOI 10.1046/j.1432-1327.2001.02247.x; Thum T, 2012, EMBO MOL MED, V4, P3, DOI 10.1002/emmm.201100191; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Wang W, 2016, MED SCI MONITOR, V22, P2126, DOI 10.12659/MSM.896832; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zhu HJ, 2015, AM J TRANSL RES, V7, P2661	65	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183901	10.1371/journal.pone.0183901	http://dx.doi.org/10.1371/journal.pone.0183901			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886070	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100044
J	Hwang, JH; An, SM; Kwon, S; Park, DH; Kim, TW; Kang, DG; Yu, GE; Kim, IS; Park, HC; Ha, J; Kim, CW				Hwang, Jung Hye; An, Sang Mi; Kwon, Seulgi; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Yu, Go Eun; Kim, Il-Suk; Park, Hwa Chun; Ha, Jeongim; Kim, Chul Wook			DNA methylation patterns and gene expression associated with litter size in Berkshire pig placenta	PLOS ONE			English	Article							BODY-SPECIFIC METHYLATION; CL-CURRENTS; EFFICIENCY; SELECTION; SWINE; HYPOMETHYLATION; PRODUCTIVITY; METABOLISM; PROMOTER; ENZYMES	Increasing litter size is of great interest to the pig industry. DNA methylation is an important epigenetic modification that regulates gene expression, resulting in livestock phenotypes such as disease resistance, milk production, and reproduction. We classified Berkshire pigs into two groups according to litter size and estimated breeding value: smaller (SLG) and larger (LLG) litter size groups. Genome-wide DNA methylation and gene expression were analyzed using placenta genomic DNA and RNA to identify differentially methylated regions (DMRs) and differentially expressed genes (DEGs) associated with litter size. The methylation levels of CpG dinucleotides in different genomic regions were noticeably different between the groups, while global methylation pattern was similar, and excluding intergenic regions they were found the most frequently in gene body regions. Next, we analyzed RNA-Seq data to identify DEGs between the SLG and LLG groups. A total of 1591 DEGs were identified: 567 were downregulated and 1024 were upregulated in LLG compared to SLG. To identify genes that simultaneously exhibited changes in DNA methylation and mRNA expression, we integrated and analyzed the data from bisulfite-Seq and RNA-Seq. Nine DEGs positioned in DMRs were found. The expression of only three of these genes (PRKG2, CLCA4, and PCK1) was verified by RT-qPCR. Furthermore, we observed the same methylation patterns in blood samples as in the placental tissues by PCR-based methylation analysis. Together, these results provide useful data regarding potential epigenetic markers for selecting hyperprolific sows.	[Hwang, Jung Hye; An, Sang Mi; Kwon, Seulgi; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Yu, Go Eun; Ha, Jeongim; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea; [Kim, Il-Suk] Gyeongnam Natl Univ Sci & Technol, Dept Anim Resource Technol, Jinju, South Korea; [Park, Hwa Chun] Dasan Pig Breeding Co, Namwon, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology	Ha, J; Kim, CW (corresponding author), Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea.	jiha@gntech.ac.kr; cwkim@gntech.ac.kr			Priority Research Centers Program through the National Research Foundation of Korea (NRF) [20090093813, 313012-05]; Gyeongnam National University of Science and Technology	Priority Research Centers Program through the National Research Foundation of Korea (NRF); Gyeongnam National University of Science and Technology	This study was supported by grants from the Priority Research Centers Program (no. 20090093813) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, from the Export Promotion Technology Development Program (no. 313012-05) of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea, and from Gyeongnam National University of Science and Technology Grant 2016. The Dasan Pig Breeding Co. provided support in the form of a salary for author HCP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Bai Y, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-736, 10.1186/1471-2164-15-653]; Ball MP, 2009, NAT BIOTECHNOL, V27, P8; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Calicchio R, 2014, CURR PHARM DESIGN, V20, P1726, DOI 10.2174/13816128113199990517; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Congras A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119610; Coster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031825; DIAMANT YZ, 1976, ISRAEL J MED SCI, V12, P243; DIAMANT YZ, 1975, AM J OBSTET GYNECOL, V121, P58, DOI 10.1016/0002-9378(75)90975-8; Distl O, 2007, REPROD DOMEST ANIM, V42, P10, DOI 10.1111/j.1439-0531.2007.00887.x; FABER JJ, 1992, AM ZOOL, V32, P343; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Freking BA, 2016, ANIM REPROD SCI, V167, P16, DOI 10.1016/j.anireprosci.2016.01.018; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hofmann Franz, 2013, Methods Mol Biol, V1020, P17, DOI 10.1007/978-1-62703-459-3_2; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Kushwaha G, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0071-5; Kwon SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153311; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee DG, 2015, BIOSCI BIOTECH BIOCH, V79, P1414, DOI 10.1080/09168451.2015.1039478; Li C, 2007, PLACENTA, V28, P1200, DOI 10.1016/j.placenta.2007.06.011; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Mesa H, 2003, J ANIM SCI, V81, P74; Mesa H, 2005, J ANIM SCI, V83, P983; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Park SJ, 2015, GENE, V558, P152, DOI 10.1016/j.gene.2014.12.052; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Quinton VM, 2006, LIVEST SCI, V99, P69, DOI 10.1016/j.livprodsci.2005.06.002; Rozance PJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE365, DOI 10.1152/ajpendo.00639.2007; Sergeant GP, 2001, J UROLOGY, V166, P1161, DOI 10.1016/S0022-5347(05)65939-3; Singer M, 2015, NUCLEIC ACIDS RES, V43, P3498, DOI 10.1093/nar/gkv153; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Su JZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks829; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; von der Weid PY, 2008, AM J PHYSIOL-HEART C, V295, pH1989, DOI 10.1152/ajpheart.00007.2008; Wang Y, 2010, C SERIES INTEGRATED; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilson ME, 2001, J REP FER S, P223; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang XY, 2014, J ASSIST REPROD GEN, V31, P1511, DOI 10.1007/s10815-014-0320-2; ZhuGe RH, 1998, J PHYSIOL-LONDON, V513, P711, DOI 10.1111/j.1469-7793.1998.711ba.x	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184539	10.1371/journal.pone.0184539	http://dx.doi.org/10.1371/journal.pone.0184539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880934	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200075
J	Gerovasileiou, V; Dimitriadis, C; Arvanitidis, C; Voultsiadou, E				Gerovasileiou, Vasilis; Dimitriadis, Charalampos; Arvanitidis, Christos; Voultsiadou, Eleni			Taxonomic and functional surrogates of sessile benthic diversity in Mediterranean marine caves	PLOS ONE			English	Article							SPECIES-DIVERSITY; SUBMARINE CAVES; INDO-PACIFIC; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; ECOSYSTEM; SEA; GRADIENT; SPONGES	Hard substrates host globally a rich biodiversity, orders of magnitude higher in species number than that in surrounding soft substrates. Among them, marine caves support unique biodiversity and fragile communities but suffer lack of quantitative data on their structure and function, hindering their conservation status assessment. A first approach to the nondestructive ecological monitoring of marine caves by testing surrogates of structural and functional composition of sessile benthos was attempted in two species-rich Mediterranean marine caves. Photographic sampling was performed in different positions on the cave walls, across the horizontal axis, from the entrance inwards. Eighty-four taxa were identified and assigned to 6 biological traits and 32 modalities related to morphology, behavior and ecological affinities, with sponges being the dominant taxon in species richness and coverage. In quest of possible biological surrogates, we examined the spatial variability of the total community structure and function and separately the sponge community structure and function. The observed patterns of the above metrics were significantly correlated with the distance from the entrance, the small-scale variability and their interaction. A positive correlation was found between all examined pairs of those metrics, supporting that: (i) the developed functional approach could be used for the study of marine cave sessile communities, and (ii) sponges could be used as a surrogate taxon for the structural and functional study of these communities. The suggested method could be tested in other types of hard substrate habitats and in multiple locations of the Mediterranean waters, facilitating monitoring schemes and conservation actions.	[Gerovasileiou, Vasilis; Arvanitidis, Christos] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Greece; [Gerovasileiou, Vasilis; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Thessaloniki, Greece; [Dimitriadis, Charalampos] Natl Marine Pk Zakynthos, Zakynthos, Greece	Hellenic Centre for Marine Research; Aristotle University of Thessaloniki	Gerovasileiou, V (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Greece.; Gerovasileiou, V (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Thessaloniki, Greece.	vgerovas@hcmr.gr	Gerovasileiou, Vasilis/H-6376-2019; Voultsiadou, Eleni/P-9890-2017; Dimitriadis, Charalampos/AAF-6504-2020	Gerovasileiou, Vasilis/0000-0002-9143-7480; Voultsiadou, Eleni/0000-0003-3429-6754; Dimitriadis, Charalampos/0000-0002-8381-4362	EU Social Fund; Greek national funds through the "Heracleitus II" Research Funding Programme	EU Social Fund; Greek national funds through the "Heracleitus II" Research Funding Programme	This study was co-financed by the EU Social Fund and Greek national funds through the "Heracleitus II" Research Funding Programme. VG also benefited from an "AlexanderS. Onassis Public Benefit Foundation" fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141039; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Antoniadou C, 2006, BELG J ZOOL, V136, P69; BALDUZZI A, 1989, Scientia Marina, V53, P387; Beger M, 2007, CONSERV BIOL, V21, P1584, DOI 10.1111/j.1523-1739.2007.00795.x; Bell JJ, 2007, AQUAT CONSERV, V17, P133, DOI 10.1002/aqc.789; Bell JJ, 2017, ECOL INDIC, V78, P470, DOI 10.1016/j.ecolind.2017.03.001; Bell JJ, 2015, MAR POLLUT BULL, V94, P5, DOI 10.1016/j.marpolbul.2015.03.030; Bell James J., 2000, Diversity and Distributions, V6, P283, DOI 10.1046/j.1472-4642.2000.00091.x; Bell JJ, 2001, AQUAT CONSERV, V11, P109, DOI 10.1002/aqc.436; Bianchi CN, 2014, MEDITERR MAR SCI, V15, P482, DOI 10.12681/mms.678; Bianchi C. N., 1994, MEMORIE I ITALIAN 2, V2, P107; BIBILONI MA, 1989, MAR ECOL-P S Z N I, V10, P317, DOI 10.1111/j.1439-0485.1989.tb00076.x; Bolam SG, 2014, MAR ENVIRON RES, V97, P15, DOI 10.1016/j.marenvres.2014.01.008; BREMNER J, 2006, DEV METHODOLOGY INCO; Bussotti S, 2006, MAR ECOL PROG SER, V325, P109, DOI 10.3354/meps325109; Chappuis E, 2014, ESTUAR COAST SHELF S, V147, P113, DOI 10.1016/j.ecss.2014.05.031; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Cinelli F., 1977, European Marine Biology Symposium, P173; Coma R, 1997, MAR ECOL-P S Z N I, V18, P211, DOI 10.1111/j.1439-0485.1997.tb00438.x; Corriero G, 2000, MAR ECOL-P S Z N I, V21, P85, DOI 10.1046/j.1439-0485.2000.00655.x; Darr A, 2014, J SEA RES, V85, P315, DOI 10.1016/j.seares.2013.06.003; Dimitriadis C, 2012, J EXP MAR BIOL ECOL, P426; Doxa A, 2016, ECOL INDIC, V61, P1042, DOI 10.1016/j.ecolind.2015.10.062; Faulwetter Sarah, 2014, Biodivers Data J, pe1024, DOI 10.3897/BDJ.2.e1024; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Fernandes CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151958; FICHEZ R, 1991, MAR BIOL, V108, P167, DOI 10.1007/BF01313485; Francois CM, 2016, FUNCT ECOL, V30, P262, DOI 10.1111/1365-2435.12484; Fraschetti S, 2008, J EXP MAR BIOL ECOL, V366, P109, DOI 10.1016/j.jembe.2008.07.015; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Gatti Giulia, 2012, Advances in Oceanography and Limnology, V3, P51, DOI 10.1080/19475721.2012.671190; Gerovasileiou V, 2015, MEDITERR MAR SCI, V16, P245, DOI 10.12681/mms.1069; Gerovasileiou V, 2013, MAR ECOL PROG SER, V486, P13, DOI 10.3354/meps10374; Gerovasileiou V., 2016, RES IDEAS OUTCOMES, V2, DOI DOI 10.3897/RIO.2.E10451; Gerovasileiou V, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e8692; Gerovasileiou V, 2016, SCI MAR, V80, P279, DOI 10.3989/scimar.04403.14B; Gerovasileiou V, 2016, MAR ECOL-EVOL PERSP, V37, P239, DOI 10.1111/maec.12268; Gerovasileiou V, 2016, J MAR BIOL ASSOC UK, V96, P407, DOI 10.1017/S0025315415000697; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gili Josep-Maria, 1992, Oecologia Aquatica, V10, P243; Gorley R.N., 2006, USER MANUAL TUTORIAL; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Harmelin JG, 1997, MAR ECOL PROG SER, V153, P139, DOI 10.3354/meps153139; HARMELIN JG, 1985, TETHYS, V11, P214; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; ILIFFE TM, 1983, NATURE, V302, P141, DOI 10.1038/302141a0; Janssen J. A. M., 2016, EUROPEAN RED LIST HA; Karakassis I, 2006, MAR ECOL PROG SER, V310, P47, DOI 10.3354/meps310047; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MarLIN, 2006, BIOTIC BIOL TRAITS I; Marti R, 2004, J MAR BIOL ASSOC UK, V84, P557, DOI 10.1017/S0025315404009567h; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Musco L, 2009, MAR ECOL PROG SER, V383, P199, DOI 10.3354/meps07989; Navarro-Barranco C, 2016, MAR BIODIVERS, V46, P105, DOI 10.1007/s12526-015-0328-6; Nepote E, 2017, MAR POLLUT BULL, V114, P35, DOI 10.1016/j.marpolbul.2016.08.006; Olsgard F, 2003, BIODIVERS CONSERV, V12, P1033, DOI 10.1023/A:1022800405253; Olsgard Frode, 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P25, DOI 10.1023/A:1009967313147; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Peres J. M., 1967, Oceanography and Marine Biology, V5, P449; Pouliquen L., 1972, Tethys, V3, P717; Radolovic M, 2015, MEDITERR MAR SCI, V16, P305, DOI 10.12681/mms.1146; Rastorgueff PA, 2015, ECOL INDIC, V54, P137, DOI 10.1016/j.ecolind.2015.02.014; Rastorgueff PA, 2011, MAR ECOL PROG SER, V440, P163, DOI 10.3354/meps09347; RIEDL R, 1966, BIOL MEERESHOHLEN; Sara M., 1962, Pubblicazioni della Stazione Zoologica di Napoli Suppl, V32, P44; Trygonis V, 2012, J EXP MAR BIOL ECOL, V424, P99, DOI 10.1016/j.jembe.2012.04.018; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT; UNEP-MAP-RAC/SPA, 2015, DARK HAB ACT PLAN; Wlodarska-Kowalczuk M, 2007, MAR ECOL PROG SER, V351, P53, DOI 10.3354/meps07127; ZABALA M, 1989, PSZNI MAR ECOL, V10, P271	76	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183707	10.1371/journal.pone.0183707	http://dx.doi.org/10.1371/journal.pone.0183707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877222	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200037
J	Liu, YQ; Fu, XW; Mao, LM; Xing, ZL; Wu, KM				Liu, Yongqiang; Fu, Xiaowei; Mao, Limi; Xing, Zhenlong; Wu, Kongming			Identification of host plant use of adults of a long-distance migratory insect, Mythimna separata	PLOS ONE			English	Article							RADAR OBSERVATIONS; ORIENTAL ARMYWORM; POLLEN MORPHOLOGY; NOCTUIDAE MOTHS; BLACK CUTWORM; DNA BARCODES; LEPIDOPTERA; HERBIVORES; NECTAR; CHINA	Adults of many insect species often become contaminated with pollen grains when feeding. Identification of plant hosts for M. separata moths could increase our understanding of their geographic origin and the coevolution of M. separata moths and their host plants. However, identifying the diet of noctuid moths using traditional direct observation is limited by their nocturnal and flight habits. In this study, we used core barcode markers and pollen morphology to identify pollen species. We found pollen from 13 plant species belonging to nine families on trapped M. separata moths, mainly from Angiosperm, Dicotyledoneae. Pollen was found on 14.4% and 12.3% of females and males, respectively, and the amount of pollen transported varied with the body part, with the most pollen on the proboscis. We were able to determine from this that the moths visited woody plants more than herbaceous plants, but not significantly so, and that they carried more pollen earlier in the migration season. In this study, we clarified the species and frequencies of pollen deposition on M. separata moths. These findings improve our understanding of the coevolution of the moths and their host plants. Identification of plant hosts for adult moths provides a new means of studying noctuid moth-host plant interactions, and informs the development of more efficient management practices for M. separata.	[Liu, Yongqiang; Fu, Xiaowei; Xing, Zhenlong; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Mao, Limi] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Nanjing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Sciences	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	wukongming@caas.cn	zhenlong, xing/U-6291-2019		National Department of Public Benefit Research Foundation [201403031]; China Postdoctoral Science Foundation Funded Project [2016M591298]	National Department of Public Benefit Research Foundation; China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation)	This work supported by the National Department of Public Benefit Research Foundation (201403031) and China Postdoctoral Science Foundation Funded Project (project number 2016M591298).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; BRYANT VM, 1991, J ECON ENTOMOL, V84, P237, DOI 10.1093/jee/84.1.237; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Cao C., 1995, THESIS; Cao YZ, 1991, COMPILATION THESES 1, P422; Chen PH, 2008, J INTEGR PLANT BIOL, V50, P375, DOI 10.1111/j.1744-7909.2007.00624.x; CHEN RL, 1987, INSECT SCI APPL, V8, P571, DOI 10.1017/S1742758400022621; CHEN RL, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P93; CHEN RL, 1989, ECOL ENTOMOL, V14, P149, DOI 10.1111/j.1365-2311.1989.tb00765.x; Cheng D.F., 2005, SCANNING ENTOMOLOGIC; CRAWLEY MJ, 1989, ANNU REV ENTOMOL, V34, P531, DOI 10.1146/annurev.en.34.010189.002531; Cunningham JP, 2004, J EXP BIOL, V207, P87, DOI 10.1242/jeb.00733; FAEGRI K, 1979, P244; Fang J.Y., 2009, ATLAS WOODY PLANT CH; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Flora of China Editorial Committee, 2005, FLORA CHINA; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Guo F, 1964, ACTA ENTOMOL SINICA, V13, P785; Guo F, 1979, INSECTS HORMONE; HEATH RR, 1992, ENVIRON ENTOMOL, V21, P854, DOI 10.1093/ee/21.4.854; HENDRIX WH, 1992, ENVIRON ENTOMOL, V21, P1092, DOI 10.1093/ee/21.5.1092; Hicke JA, 2012, GLOBAL CHANGE BIOL, V18, P7, DOI 10.1111/j.1365-2486.2011.02543.x; HODKINSON ID, 1991, BIOL J LINN SOC, V43, P101, DOI 10.1111/j.1095-8312.1991.tb00587.x; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; Jones Gretchen D., 2001, Neotropical Entomology, V30, P341, DOI 10.1590/S1519-566X2001000300001; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; KEHAT M, 1972, Australian Journal of Zoology, V20, P119, DOI 10.1071/ZO9720119; Khansari E, 2012, FLORA, V207, P203, DOI 10.1016/j.flora.2012.01.006; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lei Zhang, 2006, Acta Entomologica Sinica, V49, P895; Li GB, 1961, REGULARITY OCCURRENC, P446; Li GB, 1987, SCI AGR SIN, P68; Li TX, 2011, ABSTR APPL ANAL, DOI 10.1155/2011/367541; Liu YQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060851; Liu YQ, 2015, ANN ENTOMOL SOC AM, V108, P519, DOI 10.1093/aesa/sav050; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Pang X, 2012, PLANT BIOLOGY, V14, P839, DOI 10.1111/j.1438-8677.2011.00554.x; Pogue MG., 2009, LEPIDOPTERA BIODIVER, P263; Prokopy RJ, 1996, ECOL ENTOMOL, V21, P295, DOI 10.1111/j.1365-2311.1996.tb01247.x; Qin Jun-de, 2001, Acta Entomologica Sinica, V44, P360; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Salmaki Y, 2008, FLORA, V203, P627, DOI 10.1016/j.flora.2007.10.005; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Singh O.P., 1988, Bulletin of Entomology, V29, P168; SPSS Incorporation, 2006, SPSS 13 0 WIND; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; SWIRSKI E, 1980, ENTOMOPHAGA, V25, P415, DOI 10.1007/BF02374704; TINGLE FC, 1992, J CHEM ECOL, V18, P907, DOI 10.1007/BF00988331; UDAYAGIRI S, 1995, ENTOMOL EXP APPL, V76, P59, DOI 10.1007/BF02382311; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Wagner DL, 2001, ENCY BIODIVERSITY, P249; Wang F.X., 1995, POLLEN FLORA CHINA, P1, DOI DOI 10.1016/J.TECTO.2011.04.006; Wang GP, 2006, B ENTOMOL RES, V96, P445, DOI 10.1079/BER2006433; WOOD TK, 1984, ECOL ENTOMOL, V9, P109, DOI 10.1111/j.1365-2311.1984.tb00703.x; Zhang L, 2008, ENVIRON ENTOMOL, V37, P1389, DOI 10.1603/0046-225X-37.6.1389; Zhang Z.T., 1985, ACTA PHYTOPHYL SIN, V12, P93; Zhang Z. T., 1985, ACTA PHYTOPHY SIN, V12, P91; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhao D, 2009, THESIS; ZHU YC, 1993, ENVIRON ENTOMOL, V22, P162, DOI 10.1093/ee/22.1.162; Zou S.W., 1956, ENTOMOL KNOWL, V6, P241	68	19	19	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184116	10.1371/journal.pone.0184116	http://dx.doi.org/10.1371/journal.pone.0184116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873457	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800052
J	Ye, ZX; Liu, HX; Chen, YN; Shu, S; Wu, QS; Wang, SJ				Ye, Zhaoxia; Liu, Hongxing; Chen, Yaning; Shu, Song; Wu, Qiusheng; Wang, Shujie			Analysis of water level variation of lakes and reservoirs in Xinjiang, China using ICESat laser altimetry data (2003-2009)	PLOS ONE			English	Article							TIBETAN PLATEAU; CLIMATE-CHANGE; NORTHWEST CHINA; VOLUME CHANGE; PRECIPITATION; TEMPERATURE; GREENLAND; GLACIERS; STORAGE; RUNOFF	This study utilizes ICESat Release 33 GLA14 data to analyse water level variation of Xinjiang's lakes and reservoirs from 2003 to 2009. By using Landsat images, lakes and reservoirs with area larger than 1 km 2 are numerically delineated with a software tool. Based on ICESat observations, we analyse the characteristics of water level variation in different geographic environments, as well as investigate the reasons for the variation. Results indicate that climatic warming contributes to rising water levels in lakes in mountainous areas, especially for lakes that are recharged by snow and glacial melting. For lakes in oases, the water levels are affected jointly by human activity and climate change, while the water levels of reservoirs are mainly affected by human activity. Comparing the annual average rates of water levels, those of lakes are higher than those of reservoirs in oasis areas. The main reasons for the decreasing water levels in desert regions are the reduction of recharged runoff and high evaporation. By analysing the variation of water levels and water volume in different geologic environments, it is found that water level and volume increased in mountainous regions, and decreased in oasis regions and desert regions. Finding also demonstrate that decreasing volume is greater than increasing volume, which results in decreasing total volume of Xinjiang lakes and reservoirs.	[Ye, Zhaoxia; Chen, Yaning] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Liu, Hongxing; Shu, Song; Wang, Shujie] Univ Cincinnati, Dept Geog & Geog Informat Sci, Cincinnati, OH 45220 USA; [Wu, Qiusheng] SUNY Binghamton, Dept Geog, Binghamton, NY USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Chen, YN (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.; Liu, HX (corresponding author), Univ Cincinnati, Dept Geog & Geog Informat Sci, Cincinnati, OH 45220 USA.	Hongxing.Liu@uc.edu; chenyn@ms.xjb.ac.cn	Wu, Qiusheng/C-7976-2016; Shu, Song/AAV-6083-2020; Chen, Yaning/A-2338-2019; chen, yaning/AAN-8170-2020	Wu, Qiusheng/0000-0001-5437-4073; Wang, Shujie/0000-0002-8055-0234; ye, zhaoxia/0000-0002-9054-7338	National Natural Science Foundation of China [71503248]; "Young Talent Overseas Training Programme" from the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Young Talent Overseas Training Programme" from the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	This research is funded by the National Natural Science Foundation of China (71503248). This research is also supported by the "Young Talent Overseas Training Programme" from the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. ICESat/GLAS data were freely downloaded from the National Snow and Ice Data Center.; This research is funded by the National Natural Science Foundation of China (71503248). This research is also supported by the "Young Talent Overseas Training Programme" from the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. We are grateful to the editors and anonymous reviewers for their constructive suggestions and comments to improve this article. ICESat/GLAS data were freely downloaded from the National Snow and Ice Data Center.	Abshire JB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024028; [Anonymous], 2010, ALTAY DAILY NEWSPAPE; [白瑞东 Bai Ruidong], 2012, [干旱区研究, Arid Zone Research], V29, P561; Department of Water Resources of Xinjiang Uygur Autonomous Region, 2003, WAT RES B XINJ UYG A; Department of Water Resources of Xinjiang Uygur Autonomous Region, 2010, WAT RES B XINJ UYG A; Dyurgerov MB, 2000, P NATL ACAD SCI USA, V97, P1406, DOI 10.1073/pnas.97.4.1406; [王润 Wang Run], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P60; Farrell SL, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005074; Kwok R, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003175; Kwok R, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004753; Kwok R., 2007, J GEOPHYS RES OCEANS, V112; Kwork R, 2004, GEOPHYS RES LETT, V31; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Li BF, 2013, THEOR APPL CLIMATOL, V112, P589, DOI 10.1007/s00704-012-0753-4; Li BF, 2013, FRESEN ENVIRON BULL, V22, P362; Li BF, 2013, J GEOGR SCI, V23, P17, DOI 10.1007/s11442-013-0990-1; Li QH, 2011, J GEOGR SCI, V21, P1007, DOI 10.1007/s11442-011-0896-8; Li X, 2008, GLOBAL PLANET CHANGE, V62, P210, DOI 10.1016/j.gloplacha.2008.02.001; Liu H. X., 2011, Journal of Geographic Information System, V3, P99; Liu XQ, 2008, QUATERNARY RES, V70, P412, DOI 10.1016/j.yqres.2008.06.005; [马龙 MA Long], 2011, [干旱区地理, Arid Land Geography], V34, P649; Ma M, 2007, INT J REMOTE SENS, V28, P5523, DOI 10.1080/01431160601009698; Muskett RR, 2008, EARTH PLANET SC LETT, V265, P345, DOI 10.1016/j.epsl.2007.10.012; Qu Y.G., 1989, RES WATER RESOURCES, P127; [沈永平 Shen Yongping], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P1355; Slobbe DC, 2008, REMOTE SENS ENVIRON, V112, P4204, DOI 10.1016/j.rse.2008.07.004; Slobbe DC, 2009, GEOPHYS J INT, V176, P95, DOI 10.1111/j.1365-246X.2008.03978.x; Smith BE, 2009, J GLACIOL, V55, P573, DOI 10.3189/002214309789470879; Song CQ, 2014, J HYDROL, V514, P131, DOI 10.1016/j.jhydrol.2014.04.018; Song CQ, 2014, HYDROL PROCESS, V28, P2411, DOI 10.1002/hyp.9798; Song CQ, 2013, REMOTE SENS ENVIRON, V135, P25, DOI 10.1016/j.rse.2013.03.013; Statistic Bureau of Xinjiang Uygur Autonomous Region, 2009, XINJ STAT YB; Statistic Bureau of Xinjiang Uygur Autonomous Region, 2004, XINJ STAT YB; Sun HongBo, 2005, Arid Land Geography, V28, P199; Treichler D, 2017, REMOTE SENS ENVIRON, V191, P389, DOI 10.1016/j.rse.2017.01.022; Phan VH, 2012, INT J APPL EARTH OBS, V17, P12, DOI 10.1016/j.jag.2011.09.015; [王前进 Wang Qianjin], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P224; Wang S.M., 1998, LAKES OF CHINA, V1st ed; Wang XW, 2013, REMOTE SENS ENVIRON, V132, P131, DOI 10.1016/j.rse.2013.01.005; Wang XW, 2012, IEEE GEOSCI REMOTE S, V9, P333, DOI 10.1109/LGRS.2011.2167495; [吴敬禄 Wu Jinglu], 2012, [第四纪研究, Quaternary Sciences], V32, P142; [吴敬禄 Wu Jinglu], 2013, [自然资源学报, Journal of Natural Resources], V28, P844; Xu JH, 2008, CHINESE GEOGR SCI, V18, P331, DOI 10.1007/s11769-008-0331-y; Yang Z, 1991, GLACIER WATER RESOUR, P158; Yavasli Dogukan Dogu, 2016, Remote Sensing Applications: Society and Environment, V4, P211, DOI 10.1016/j.rsase.2016.11.004; Zhang GQ, 2011, REMOTE SENS ENVIRON, V115, P1733, DOI 10.1016/j.rse.2011.03.005; Zhou C, 2009, RES DISTRIBUTION CHA; Zhu WB, 2014, REMOTE SENS-BASEL, V6, P10457, DOI 10.3390/rs61110457; Zwally HJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004284; 姚檀栋, 2004, [中国科学. D辑, 地球科学, Science in China], V34, P535	51	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183800	10.1371/journal.pone.0183800	http://dx.doi.org/10.1371/journal.pone.0183800			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873094	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800028
J	Olszewski, M; Spibida, M; Bilek, M; Krawczyk, B				Olszewski, Marcin; Spibida, Marta; Bilek, Maciej; Krawczyk, Beata			Fusion of Taq DNA polymerase with singlestranded DNA binding-like protein of Nanoarchaeum equitans-Expression and characterization	PLOS ONE			English	Article							THERMUS-AQUATICUS; ESCHERICHIA-COLI; CHAIN-REACTION; MULTIPLEX PCR; SSB PROTEIN; PURIFICATION; PROCESSIVITY; CLONING; AMPLIFICATION; ASSAY	DNA polymerases are present in all organisms and are important enzymes that synthesise DNA molecules. They are used in various fields of science, predominantly as essential components for in vitro DNA syntheses, known as PCR. Modern diagnostics, molecular biology and genetic engineering need DNA polymerases which demonstrate improved performance. This study was aimed at obtaining a new NeqSSB-TaqS fusion DNA polymerase from the Taq DNA Stoffel domain and a single-stranded DNA binding-like protein of Nanoarchaeum equitans in order to significantly improve the properties of DNA polymerase. The DNA coding sequence of Taq Stoffel DNA polymerase and the nonspecific DNA-binding protein of Nanoarchaeum equitans (NeqSSB-like protein) were fused. A novel recombinant gene was obtained which was cloned into the pET-30 Ek/LIC vector and introduced into E. coli for expression. The recombinant enzyme was purified and its enzymatic properties including DNA polymerase activity, PCR amplification rate, thermostability, processivity and resistance to inhibitors, were tested. The yield of the target protein reached approximately 18 mg/l after 24 h of the IPTG induction. The specific activity of the polymerase was 2200 U/mg. The recombinant NeqSSB-TaqS exhibited a much higher extension rate (1000 bp template in 20 s), processivity (19 nt), thermostability (half-life 35 min at 95 E C) and higher tolerance to PCR inhibitors (0.3-1.25% of whole blood, 0.84-13.5 mu g of lactoferrin and 4.7- 150 ng of heparin) than Taq Stoffel DNA polymerase. Furthermore, our studies show that NeqSSB-TaqS DNA polymerase has a high level of flexibility in relation to Mg2+ ions (from 1 to 5 mM) and KCl or (NH4)(2)SO4 salts (more than 60 mM and 40 mM, respectively). Using NeqSSB-TaqS DNA polymerase instead of the Taq DNA polymerase could be a better choice in many PCR applications.	[Olszewski, Marcin; Spibida, Marta; Krawczyk, Beata] Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Ul G Narutowicza 11-12, Gdansk, Poland; [Bilek, Maciej] Univ Rzeszow, Dept Food & Agr Prod Engn, Ul Zelwerowicza 4, Rzeszow, Poland	Fahrenheit Universities; Gdansk University of Technology; University of Rzeszow	Krawczyk, B (corresponding author), Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Ul G Narutowicza 11-12, Gdansk, Poland.	beakrawc@pg.gda.pl	Krawczyk, Beata/ABG-4358-2020; Olszewski, Marcin/HFZ-9682-2022	Olszewski, Marcin/0000-0002-5116-2793; Skwarecka, Marta/0000-0002-6779-0962; Krawczyk, Beata/0000-0001-5528-8898; Bilek, Maciej/0000-0003-2232-5511	Statutory research programme in Gdansk University of Technology [4914/E-359/M/2014 DS-030863, 4914/E-359/M/2015 DS-031438, 4914/E-359/M/2016 DS.-031955, 4914/E-359/S/2014-2106]	Statutory research programme in Gdansk University of Technology	Financial support within the framework of Statutory research programme in Gdansk University of Technology (2014-2016): 4914/E-359/M/2014 DS-030863; 4914/E-359/M/2015 DS-031438; 4914/E-359/M/2016 DS.-031955; 4914/E-359/S/2014-2106 (Beata Krawczyk, Marcin Olszewski). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Abu Al-Soud W, 1998, APPL ENVIRON MICROB, V64, P3748; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Barski P, 1996, MOL CELL PROBE, V10, P471, DOI 10.1006/mcpr.1996.0066; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; Dabrowski S, 1999, PROTEIN EXPRES PURIF, V16, P96, DOI 10.1006/prep.1999.1044; Dabrowski S, 1998, PROTEIN EXPRES PURIF, V14, P131, DOI 10.1006/prep.1998.0945; Dabrowski S, 1998, ACTA BIOCHIM POL, V45, P661, DOI 10.18388/abp.1998_4204; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Datta K, 2003, NUCLEIC ACIDS RES, V31, P19; Driscoll MD, 2014, FEBS J, V281, P2042, DOI 10.1111/febs.12760; Elshawadfy AM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00224; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5; HABIG WH, 1974, J BIOL CHEM, V249, P7130; KALEDIN A S, 1980, Biokhimiya, V45, P644; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Kim DJ, 2002, J BIOCHEM MOL BIOL, V35, P320; Kim YJ, 2014, BIOTECHNOL LETT, V36, P985, DOI 10.1007/s10529-013-1441-x; Kozlov AG, 2000, PROTEINS, P8; Lawyer F C, 1993, PCR Methods Appl, V2, P275; Lee JE, 2006, European Patent Office, Patent No. [EP 1934372 B1, 1934372]; Lee JI, 2010, ENZYME MICROB TECH, V47, P147, DOI 10.1016/j.enzmictec.2010.06.003; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Ma CB, 2006, ANAL BIOCHEM, V353, P141, DOI 10.1016/j.ab.2006.02.006; MERKENS LS, 1995, BBA-GENE STRUCT EXPR, V1264, P243, DOI 10.1016/0167-4781(95)00153-8; Nowak M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-91; Olszewski M, 2005, MOL CELL PROBE, V19, P203, DOI 10.1016/j.mcp.2004.11.006; Olszewski M, 2008, ARCH MICROBIOL, V190, P79, DOI 10.1007/s00203-008-0366-6; Olszewski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126563; Oscorbin IP, 2015, APPL BIOCHEM BIOTECH, V176, P1859, DOI 10.1007/s12010-015-1683-2; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Rothwell P. J., 2005, ADV PROTEIN CHEM, V71; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Spibida M, 2017, J APPL GENET, V58, P133, DOI 10.1007/s13353-016-0371-4; Sun SY, 2006, PROTEINS, V65, P231, DOI 10.1002/prot.21088; Tveit H, 2001, ANAL BIOCHEM, V289, P96, DOI 10.1006/abio.2000.4903; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Watson RJ, 2000, CAN J MICROBIOL, V46, P633, DOI 10.1139/cjm-46-7-633; Yokota M, 1999, J CLIN LAB ANAL, V13, P133, DOI 10.1002/(SICI)1098-2825(1999)13:3<133::AID-JCLA8>3.0.CO;2-0; YU KF, 1992, NUCLEIC ACIDS RES, V20, P2606, DOI 10.1093/nar/20.10.2606; Zylicz-Stachula A, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-13; Zylicz-Stachula A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-62	44	3	5	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184162	10.1371/journal.pone.0184162	http://dx.doi.org/10.1371/journal.pone.0184162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863186	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900034
J	Heissler, SM; Chinthalapudi, K; Sellers, JR				Heissler, Sarah M.; Chinthalapudi, Krishna; Sellers, James R.			Kinetic signatures of myosin-5B, the motor involved in microvillus inclusion disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; ATPase; inhibitor; kinetics; myosin; myoVin-1	CLASS-V MYOSINS; DROSOPHILA-MELANOGASTER; PROCESSIVE MOVEMENT; EPITHELIAL-CELLS; ADP DISSOCIATION; MYO5B MUTATIONS; MOLECULAR MOTOR; NECK LENGTH; DUTY RATIO; ACTIN	Myosin-5B is a ubiquitous molecular motor that transports cargo vesicles of the endomembrane system in intracellular recycling pathways. Myosin-5B malfunction causes the congenital enteropathy microvillus inclusion disease, underlining its importance in cellular homeostasis. Here we describe the interaction of myosin-5B with F-actin, nucleotides, and the pyrazolopyrimidine compound myoVin-1. We show that single-headed myosin-5B is an intermediate duty ratio motor with a kinetic ATPase cycle that is rate-limited by the release of phosphate. The presence of a second head generates strain and gating in the myosin-5B dimer that alters the kinetic signature by reducing the actin-activated ADP release rate to become rate-limiting. This kinetic transition into a high-duty ratio motor is a prerequisite for the proposed transport function of myosin-5B in cellular recycling pathways. Moreover, we show that the small molecule compound myoVin-1 inhibits the enzymatic and functional activity of myosin-5B in vitro. Partial inhibition of the actin-activated steady-state ATPase activity and sliding velocity suggests that caution should be used when probing the effect of myoVin-1 on myosin-5-dependent transport processes in cells.	[Heissler, Sarah M.; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3529, Bethesda, MD 20892 USA; [Chinthalapudi, Krishna] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Cell Adhes Lab, Jupiter, FL 33458 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Heissler, SM; Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3529, Bethesda, MD 20892 USA.	sarah.heissler@nih.gov; sellersj@nhlbi.nih.gov	Chinthalapudi, Krishna/B-4550-2018	Chinthalapudi, Krishna/0000-0003-3669-561X	National Heart, Lung, and Blood Institute of the National Institutes of Health [HL004229]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004229, ZIAHL004232, Z01HL004229] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL004229). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamek Nancy, 2014, Exp Suppl, V105, P87, DOI 10.1007/978-3-0348-0856-9_5; Avasthi P, 2014, CURR BIOL, V24, P2025, DOI 10.1016/j.cub.2014.07.038; Bao JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074936; Cheeseman LP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13726; Clayton JE, 2014, MOL BIOL CELL, V25, P66, DOI 10.1091/mbc.E13-04-0200; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Deguchi H, 2016, BLOOD, V128, P1870, DOI 10.1182/blood-2016-03-707679; Dong WJ, 2012, DIGEST DIS SCI, V57, P1247, DOI 10.1007/s10620-011-1989-z; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; GEEVES MA, 1989, BIOCHEMISTRY-US, V28, P5864, DOI 10.1021/bi00440a024; Gramlich MW, 2017, CELL REP, V18, P2096, DOI 10.1016/j.celrep.2017.02.010; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gunther LK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04907; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; Heissler SM, 2016, J MOL BIOL, V428, P1927, DOI 10.1016/j.jmb.2016.01.022; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Heissler SM, 2015, FASEB J, V29, P1456, DOI 10.1096/fj.14-266742; Heissler SM, 2012, FEBS LETT, V586, P3208, DOI 10.1016/j.febslet.2012.07.014; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Islam K, 2010, ANGEW CHEM INT EDIT, V49, P8484, DOI 10.1002/anie.201004026; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Ji HH, 2015, BIOCHEM J, V469, P135, DOI 10.1042/BJ20141330; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Katsimitsoulia Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/781456; Knowles BC, 2014, J CLIN INVEST, V124, P2947, DOI 10.1172/JCI71651; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; Liu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3005; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Miller KE, 2000, J BIOL CHEM, V275, P2598, DOI 10.1074/jbc.275.4.2598; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Olivares AO, 2006, J BIOL CHEM, V281, P31326, DOI 10.1074/jbc.M603898200; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards M, 2015, CURR BIOL, V25, P2325, DOI 10.1016/j.cub.2015.07.045; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Ropars V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12456; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Sckolnick M, 2016, MOL BIOL CELL, V27, P2889, DOI 10.1091/mbc.E15-09-0641; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Silva R, 2003, J MUSCLE RES CELL M, V24, P489, DOI 10.1023/B:JURE.0000009809.69829.74; Sirigu S, 2016, P NATL ACAD SCI USA, V113, pE7448, DOI 10.1073/pnas.1609342113; Sladewski TE, 2016, CURR BIOL, V26, P2202, DOI 10.1016/j.cub.2016.06.029; Szperl AM, 2011, J PEDIATR GASTR NUTR, V52, P307, DOI 10.1097/MPG.0b013e3181eea177; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; van der Velde KJ, 2013, HUM MUTAT, V34, P1597, DOI 10.1002/humu.22440; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Vogel GF, 2017, TRAFFIC, V18, P453, DOI 10.1111/tra.12486; Vogel GF, 2015, J CELL BIOL, V211, P587, DOI 10.1083/jcb.201506112; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Wu XF, 2001, J CELL SCI, V114, P1091; Zorca CE, 2015, P NATL ACAD SCI USA, V112, pE1587, DOI 10.1073/pnas.1502461112	81	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18372	18385		10.1074/jbc.M117.801456	http://dx.doi.org/10.1074/jbc.M117.801456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28882893	hybrid, Green Published			2022-12-26	WOS:000414458200032
J	Nitkin, CR; Bonfield, TL				Nitkin, Christopher R.; Bonfield, Tracey L.			Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophages	PLOS ONE			English	Article							ACUTE LUNG INJURY; BIRTH-WEIGHT INFANTS; PROTEIN-KINASE-C; BRONCHOPULMONARY DYSPLASIA; GENE-EXPRESSION; PPAR-GAMMA; NEONATAL MICE; NRF2 IMPAIRS; NITRIC-OXIDE; ACTIVATION	Rationale The underlying pathophysiology of bronchopulmonary dysplasia includes a macrophagemediated host response orchestrated by anti-inflammatory peroxisome proliferator-activated receptor gamma (PPAR.) and anti-oxidant nuclear factor (erythroid-derived 2)-like 2 (Nrf2). These have not yet been studied in combination. This study tested the hypothesis that combined inflammatory and oxidative stressors would interact and change PPAR.-and Nrf2-regulated gene expression and antioxidant capacity. Therefore, we investigated the effect of dual stimulation with lipopolysaccharide and hyperoxia in murine bone marrowderived macrophages (BMDM). Methods Sub-confluent BMDM from wild-type C57BL/6J mice were treated with lipopolysaccharide (LPS) 1ug/mL for 2 hours followed by room air (21% oxygen) or hyperoxia (95% oxygen) for 24 hours. Taqman real time-polymerase chain reaction gene expression assays, total antioxidant capacity assays, and Luminex assays were performed. Results Supernatants of cultured BMDM contained significant antioxidant capacity. In room air, LPS treatment decreased expression of PPAR. and Nrf2, and increased expression of tumor necrosis factor-alpha and heme oxygenase-1; similar findings were observed under hyperoxic conditions. LPS treatment decreased cellular total antioxidant capacity in room air but not in hyperoxia. Increased expression of sulfiredoxin-1 in response to hyperoxia was not observed in LPS-treated cells. Dual stimulation with LPS treatment and exposure to hyperoxia did not have synergistic effects on gene expression. Cellular total antioxidant capacity was not changed by hyperoxia exposure. Conclusions Our hypothesis was supported and we demonstrate an interaction between inflammatory and oxidative stressors in a model system of bronchopulmonary dysplasia pathogenesis. The protective anti-oxidant effect of cell culture media may have protected the cells from the most deleterious effects of hyperoxia.	[Nitkin, Christopher R.] Rainbow Babies & Childrens Hosp, Dept Pediat, Div Neonatol, Cleveland, OH 44106 USA; [Bonfield, Tracey L.] Case Western Reserve Univ, Dept Pediat, Div Pediat Pulmonol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University	Bonfield, TL (corresponding author), Case Western Reserve Univ, Dept Pediat, Div Pediat Pulmonol, Cleveland, OH 44106 USA.	tlb7@case.edu	Nitkin, Christopher/R-4862-2019; Nitkin, Christopher/AAJ-3981-2021	Nitkin, Christopher/0000-0001-5718-4523; 	Rainbow Babies & Children's Foundation; Little Giraffe Foundation; David and Virginia Baldwin Fund; NIH [5-T32-HD060537-07]	Rainbow Babies & Children's Foundation; Little Giraffe Foundation; David and Virginia Baldwin Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by the Rainbow Babies & Children's Foundation (http.//www.uhhospitals.org/rainbow/about/rainbow-foundation) (CRN), the Little Giraffe Foundation (http://www.littlegiraffefoundation.org/) (CRN), and the David and Virginia Baldwin Fund (TLB). Dr. Nitkin's fellowship training is supported by NIH 5-T32-HD060537-07 (PI Richard J. Martin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2011, FREE RADICAL BIO MED, V51, P107, DOI 10.1016/j.freeradbiomed.2011.03.039; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Bancalari E, 2015, FANAROFF MARTINS NEO, P1157; BARET A, 1983, MUTAT RES, V121, P293, DOI 10.1016/0165-7992(83)90217-8; Bast A, 2010, FREE RADICAL BIO MED, V49, P1881, DOI 10.1016/j.freeradbiomed.2010.09.015; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Brenner S, 2010, TOXICOL IN VITRO, V24, P2090, DOI 10.1016/j.tiv.2010.06.005; Carlson BA, 2011, MOL IMMUNOL, V49, P311, DOI 10.1016/j.molimm.2011.09.001; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Glorieux C, 2015, FREE RADICAL BIO MED, V87, P84, DOI 10.1016/j.freeradbiomed.2015.06.017; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Iliodromiti Z, 2013, J MATERN-FETAL NEO M, V26, P1696, DOI 10.3109/14767058.2013.798284; Johnson TJ, 2013, J PEDIATR-US, V162, P243, DOI 10.1016/j.jpeds.2012.07.013; Keller RL, 2012, AVERYS DIS NEWBORN, P658; Kim H, 2010, J BIOL CHEM, V285, P34419, DOI 10.1074/jbc.M110.126839; Lee HJ, 2014, YONSEI MED J, V55, P99, DOI 10.3349/ymj.2014.55.1.99; Lee JW, 2014, MOL CELL BIOCHEM, V390, P143, DOI 10.1007/s11010-014-1965-y; Leoncini E, 2011, J FOOD SCI, V76, pH175, DOI 10.1111/j.1750-3841.2011.02311.x; Lim YT, 2012, MICROBIOL IMMUNOL, V56, P411, DOI 10.1111/j.1348-0421.2012.00453.x; Liu ZP, 2014, J LIPID RES, V55, P201, DOI 10.1194/jlr.M040394; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Poggi C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/721043; Reddy NRR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129422; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; SANDSTROM BER, 1987, BIOCHIM BIOPHYS ACTA, V929, P148, DOI 10.1016/0167-4889(87)90170-4; Schneider Monika, 2013, Methods Mol Biol, V1031, P37, DOI 10.1007/978-1-62703-481-4_4; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Takeda K, 2009, ANAT REC, V292, P1045, DOI 10.1002/ar.20921; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Wilson-Costello D, 2009, PEDIATRICS, V123, pe430, DOI 10.1542/peds.2008-1928; Zhang X., 2008, CURR PROTOC IMMUNOL; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184469	10.1371/journal.pone.0184469	http://dx.doi.org/10.1371/journal.pone.0184469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886148	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100131
J	Singh, R; De Sarkar, N; Sarkar, S; Roy, R; Chattopadhyay, E; Ray, A; Biswas, NK; Maitra, A; Roy, B				Singh, Richa; De Sarkar, Navonil; Sarkar, Sumanta; Roy, Roshni; Chattopadhyay, Esita; Ray, Anindita; Biswas, Nidhan K.; Maitra, Arindam; Roy, Bidyut			Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy	PLOS ONE			English	Article							CANCER; EXPRESSION; THERAPY	Background Gingivo-buccal squamous cell carcinoma (GBSCC) is one of the most common oral cavity cancers in India with less than 50% patients surviving past 5 years. Here, we report a whole transcriptome profile on a batch of GBSCC tumours with diverse tobacco usage habits. The study provides an entire landscape of altered expression with an emphasis on searching for targets with therapeutic potential. Methods Whole transcriptomes of 12 GBSCC tumours and adjacent normal tissues were sequenced and analysed to explore differential expression of genes. Expression changes were further compared with those in TCGA head and neck cohort (n = 263) data base and validated in an independent set of 10GBSCC samples. Results Differentially expressed genes (n = 2176) were used to cluster the patients based on their tobacco habits, resulting in 3 subgroups. Immune response was observed to be significantly aberrant, along with cell adhesion and lipid metabolism processes. Different modes of immune evasion were seen across 12 tumours with up-regulation or consistent expression of CD47, unlike other immune evasion genes such as PDL1, FUT4, CTLA4 and BTLA which were downregulated in a few samples. Variation in infiltrating immune cell signatures across tumours also indicates heterogeneity in immune evasion strategies. A few actionable genes such as ITGA4, TGFB1 and PTGS1/COX1 were over expressed in most samples. Conclusion This study found expression deregulation of key immune evasion genes, such as CD47 and PDL1, and reasserts their potential as effective immunotherapeutic targets for GBSCC, which requires further clinical studies. Present findings reiterate the idea of using transcriptome profiling to guide precision therapeutic strategies.	[Singh, Richa; De Sarkar, Navonil; Roy, Roshni; Chattopadhyay, Esita; Ray, Anindita; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Sarkar, Sumanta; Biswas, Nidhan K.; Maitra, Arindam] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [De Sarkar, Navonil] Fred Hutchinson Canc Res Ctr, HB Div, 1124 Columbia St, Seattle, WA 98104 USA; [Roy, Roshni] Baylor Scott & White Hlth, CGR, Dallas, TX USA	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Fred Hutchinson Cancer Center; Baylor Health Care System	Roy, B (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.	broy@isical.ac.in	biswas, Nidhan Kumar K/A-4383-2009	biswas, Nidhan Kumar K/0000-0001-7960-3290; Roy, Bidyut/0000-0003-4117-5838; Ray, Anindita/0000-0003-4824-8913				Biswas NK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6835; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen YX, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/bts665; Chocolatewala NM, 2009, J CANCER RES THER, V5, P71, DOI 10.4103/0973-1482.52788; Conway C, 2015, ONCOTARGET, V6, P40186, DOI 10.18632/oncotarget.5529; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; De Sarkar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104839; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hinrichs CS, 2014, IMMUNOL REV, V257, P56, DOI 10.1111/imr.12132; Hurwitz AA, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0062-4; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jadhav KB, 2013, N AM J MED SCI, V5, P671, DOI 10.4103/1947-2714.123239; Jiang Jing-ting, 2007, Journal of Zhejiang University-Science B, V8, P398, DOI 10.1631/jzus.2007.B0398; Jiang JT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-4; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu Q, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1183850; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nicorici D, 2014, BIORXIV; Norwood S, 2010, AM J TRANSL RES, V2, P447; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sun J, 2010, SIGNAL TRANSDUCT, DOI [10.1155/2010/985132, DOI 10.1155/2010/985132]; Takenaka K, 2005, CANCER EPIDEM BIOMAR, V14, P1972, DOI 10.1158/1055-9965.EPI-05-0060; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Roosbroeck K., 2016, CLIN CANC RES; Vargas-Ferreira Fabiana, 2012, Braz. Dent. J., V23, P586, DOI 10.1590/S0103-64402012000500020; Wagner AH, 2016, NUCLEIC ACIDS RES, V44; Wan YJ, 2014, CELL SIGNAL, V26, P2202, DOI 10.1016/j.cellsig.2014.05.015; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183606	10.1371/journal.pone.0183606	http://dx.doi.org/10.1371/journal.pone.0183606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886030	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100031
J	Phillips, BL; Gautam, US; Bucsan, AN; Foreman, TW; Golden, NA; Niu, T; Kaushal, D; Mehra, S				Phillips, Bonnie L.; Gautam, Uma S.; Bucsan, Allison N.; Foreman, Taylor W.; Golden, Nadia A.; Niu, Tianhua; Kaushal, Deepak; Mehra, Smriti			LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model	PLOS ONE			English	Article							T-CELLS; IMMUNE-RESPONSE; RHESUS MACAQUES; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; IFN-GAMMA; INFECTION; MACROPHAGES; ACTIVATION	CD4(+) T-cell mediated Th1 immune responses are critical for immunity to TB. The immunomodulatory protein, lymphocyte activation gene-3 (LAG-3) decreases Th1-type immune responses in T-cells. LAG-3 expression is significantly induced in the lungs of macaques with active TB and correlates with increased bacterial burden. Overproduction of LAG-3 can greatly diminish responses and could lead to uncontrolled Mtb replication. To assess the effect of LAG-3 on the progression of Mtb infection, we developed a co-culture system wherein blood-derived macrophages are infected with Mtb and supplemented with macaque blood or lung derived CD4(+) T-cells. Silencing LAG-3 signaling in macaque lung CD4(+) T-cells enhanced killing of Mtb in co-cultures, accompanied by reduced mitochondrial electron transport and increased IFN-gamma expression. Thus, LAG-3 may modulate adaptive immunity to Mtb infection by interfering with the mitochondrial apoptosis pathway. Better understanding this pathway could allow us to circumvent immune features that promote disease.	[Phillips, Bonnie L.; Gautam, Uma S.; Bucsan, Allison N.; Foreman, Taylor W.; Golden, Nadia A.; Kaushal, Deepak; Mehra, Smriti] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Phillips, Bonnie L.; Bucsan, Allison N.; Foreman, Taylor W.; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Niu, Tianhua] Tulane Univ, Sch Publ Hlth, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Mehra, Smriti] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Phillips, Bonnie L.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA	Tulane University; Tulane University; Tulane University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kaushal, D; Mehra, S (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.; Kaushal, D (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.; Mehra, S (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	dkaushal@tulane.edu; smehra@lsu.edu	Uma S Gautam, MSc/H-3474-2019; GAUTAM, UMA/AAI-1531-2021	Uma S Gautam, MSc/0000-0003-0326-6325; Bucsan, Allison N./0000-0002-0568-1701	NIH grants [P20GM110760, R01A1111943, R01HL106790, R01A1089323, P51OD011104, C06A1058609]; Louisiana State University CoBRE; Tulane National Primate Research Center Office; Louisiana Vaccine Center from the Tulane Office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University CoBRE; Tulane National Primate Research Center Office; Louisiana Vaccine Center from the Tulane Office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH grants P20GM110760, R01A1111943, R01HL106790, R01A1089323, P51OD011104, and C06A1058609, awards from the Louisiana State University CoBRE, the Tulane National Primate Research Center Office of the Director, and Pilot Projects Program, Louisiana Vaccine Center and a Bridge Fund from the Tulane Office of Vice President for Research. The funders had no role in design or interpretation.	Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andreae S, 2002, J IMMUNOL, V168, P3874, DOI 10.4049/jimmunol.168.8.3874; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boros D L, 1978, Prog Allergy, V24, P183, DOI 10.1159/000314417; Cai YH, 2014, J IMMUNOL, V192, P2821, DOI 10.4049/jimmunol.1302269; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Castano D, 2014, TUBERCULOSIS, V94, P207, DOI 10.1016/j.tube.2014.01.001; Darrah PA, 2014, J IMMUNOL; Dutta Noton K, 2014, Trials Vaccinol, V3, P47, DOI 10.1016/j.trivac.2014.02.001; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fenhalls G, 2002, IMMUNOLOGY, V105, P325, DOI 10.1046/j.1365-2567.2002.01378.x; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FLORY CM, 1992, J LEUKOCYTE BIOL, V51, P225, DOI 10.1002/jlb.51.3.225; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Foreman TW, 2016, P NATL ACAD SCI US; Gautam US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095220; Gautam US, 2014, AM J RESP CELL MOL B; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Guirado E, 2015, MBIO, V6, DOI 10.1128/mBio.02537-14; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Hudock TA, 2017, AM J RESP CELL MOL B; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Lin P. L., 2013, ANTIMICROB AGENTS CH; Luo QY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00240; Macon-Lemaitre L, 2005, IMMUNOLOGY, V115, P170, DOI 10.1111/j.1365-2567.2005.02145.x; Martinez AN, 2013, J INFECT DIS, V207, P1253, DOI 10.1093/infdis/jit037; Mehra S, 2015, AM J RESP CRIT CARE; Mehra S, 2013, J INFECT DIS, V207, P1115, DOI 10.1093/infdis/jis778; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; ORME IM, 1992, J IMMUNOL, V148, P189; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Phillips BL, 2015, AM J PATHOL, V185, P820, DOI 10.1016/j.ajpath.2014.11.003; Poirier N, 2011, CLIN EXP IMMUNOL, V164, P265, DOI 10.1111/j.1365-2249.2011.04329.x; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Rojas RE, 1999, INFECT IMMUN, V67, P6461; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2013, CURR OPIN MICROBIOL, V16, P78, DOI 10.1016/j.mib.2012.11.007; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Srivastava S, 2013, J IMMUNOL, V191, P1016, DOI 10.4049/jimmunol.1301236; Tian XL, 2015, J IMMUNOL, V194, P3873, DOI 10.4049/jimmunol.1402176; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185	63	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0180413	10.1371/journal.pone.0180413	http://dx.doi.org/10.1371/journal.pone.0180413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880895	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200003
J	Vogl, F; Bernet, B; Bolognesi, D; Taylor, WR				Vogl, Florian; Bernet, Benjamin; Bolognesi, Daniele; Taylor, William R.			Towards assessing cortical bone porosity using low-frequency quantitative acoustics: A phantom-based study	PLOS ONE			English	Article							ULTRASONIC GUIDED-WAVES; X-RAY ABSORPTIOMETRY; IN-VITRO EXPERIMENTS; AXIAL TRANSMISSION; LONG BONES; 3-DIMENSIONAL SIMULATIONS; VELOCITY-MEASUREMENT; MILLIMETER-SCALE; FEMORAL-NECK; OSTEOPOROSIS	Purpose Cortical porosity is a key characteristic governing the structural properties and mechanical behaviour of bone, and its quantification is therefore critical for understanding and monitoring the development of various bone pathologies such as osteoporosis. Axial transmission quantitative acoustics has shown to be a promising technique for assessing bone health in a fast, non-invasive, and radiation-free manner. One major hurdle in bringing this approach to clinical application is the entanglement of the effects of individual characteristics (e.g. geometry, porosity, anisotropy etc.) on the measured wave propagation. In order to address this entanglement problem, we therefore propose a systematic bottom-up approach, in which only one bone property is varied, before addressing interaction effects. This work therefore investigated the sensitivity of low-frequency quantitative acoustics to changes in porosity as well as individual pore characteristics using specifically designed cortical bone phantoms. Materials and methods 14 bone phantoms were designed with varying pore size, axial-, and radial pore number, resulting in porosities (bone volume fraction) between 0% and 15%, similar to porosity values found in human cortical bone. All phantoms were manufactured using laser sintering, measured using axial-transmission acoustics and analysed using a full-wave approach. Experimental results were compared to theoretical predictions based on a modified Timoshenko theory. Results A clear dependence of phase velocity on frequency and porosity produced by increasing pore size or radial pore number was demonstrated, with the velocity decreasing by between 2-5 m/s per percent of additional porosity, which corresponds to -0.5% to -1.0% of wave speed. While the change in phase velocity due to axial pore number was consistent with the results due to pore size and radial pore number, the relative uncertainties for the estimates were too high to draw any conclusions for this parameter. Conclusions This work has shown the capability of low-frequency quantitative acoustics to reflect changes in porosity and individual pore characteristics and demonstrated that additive manufacturing is an appropriate method that allows the influence of individual bone properties on the wave propagation to be systematically assessed. The results of this work opens perspectives for the efficient development of a multi-frequency, multi-mode approach to screen, diagnose, and monitor bone pathologies in individuals.	[Vogl, Florian; Bernet, Benjamin; Bolognesi, Daniele; Taylor, William R.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Taylor, WR (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	taylorb@ethz.ch	Taylor, William R./F-8692-2010	Taylor, William R./0000-0003-4060-4098	Robert Mathys Foundation, Bettlach, Switzerland	Robert Mathys Foundation, Bettlach, Switzerland	This study was partially funded by the Robert Mathys Foundation, Bettlach, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ATKINSON PJ, 1964, NATURE, V201, P373, DOI 10.1038/201373a0; Bochud N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43628; Bossy E, 2004, J ACOUST SOC AM, V115, P2314, DOI 10.1121/1.1689960; Bossy E, 2004, IEEE T ULTRASON FERR, V51, P71, DOI 10.1109/TUFFC.2004.1268469; Bousson V, 2004, J BONE MINER RES, V19, P794, DOI 10.1359/JBMR.040124; BROWN SD, 1964, J AM CERAM SOC, V47, P320, DOI 10.1111/j.1151-2916.1964.tb12993.x; Camus E, 2000, J ACOUST SOC AM, V108, P3058, DOI 10.1121/1.1290245; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; Chen H, 2013, INT J ENDOCRINOLOGY, V2013; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; Egorov V, 2014, ULTRASONICS, V54, P1170, DOI 10.1016/j.ultras.2013.08.017; FISH HR, 1985, AM FAM PHYSICIAN, V31, P216; Foiret J, 2014, IEEE T ULTRASON FERR, V61, P1478, DOI 10.1109/TUFFC.2014.3062; Foldes AJ, 1996, NEPHROL DIAL TRANSPL, V11, P1318; GARNIR HP, 1987, NUCL INSTRUM METH B, V28, P146, DOI 10.1016/0168-583X(87)90051-6; Graff KF., 1991, WAVE MOTION ELASTIC; Granke M, 2015, ACTA BIOMATER, V12, P207, DOI 10.1016/j.actbio.2014.10.011; Granke M, 2011, BONE, V49, P1020, DOI 10.1016/j.bone.2011.08.002; HASSELMAN DPH, 1963, J AM CERAM SOC, V46, P564, DOI 10.1111/j.1151-2916.1963.tb14615.x; KESHAWARZ NM, 1984, METAB BONE DIS RELAT, V5, P223, DOI 10.1016/0221-8747(84)90063-8; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Krestan CR, 2004, AM J ROENTGENOL, V183, P639, DOI 10.2214/ajr.183.3.1830639; LANDMAN DA, 1982, ASTROPHYS J, V261, P732, DOI 10.1086/160383; Lang C, 2005, MATH METHODEN PHYS; Laugier P, 2011, VARIOUS BONE QUANTIT; LAVALJEANTET AM, 1983, CALCIFIED TISSUE INT, V35, P268, DOI 10.1007/BF02405044; Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2; Malo MKH, 2013, BONE, V53, P451, DOI 10.1016/j.bone.2013.01.015; Moilanen P, 2006, ULTRASOUND MED BIOL, V32, P709, DOI 10.1016/j.ultrasmedbio.2006.02.1402; Moilanen P, 2004, ULTRASOUND MED BIOL, V30, P1517, DOI 10.1016/j.ultrasmedbio.2004.08.017; Moilanen P, 2013, OSTEOPOROSIS INT, V24, P723, DOI 10.1007/s00198-012-2022-x; Moilanen P, 2008, IEEE T ULTRASON FERR, V55, P1277, DOI 10.1109/TUFFC.2008.790; Moilanen P, 2007, J ACOUST SOC AM, V122, P2439, DOI 10.1121/1.2769619; Moilanen P, 2007, J ACOUST SOC AM, V122, P1818, DOI 10.1121/1.2756758; Moilanen P, 2007, ULTRASOUND MED BIOL, V33, P254, DOI 10.1016/j.ultrasmedbio.2006.07.038; Muller M, 2005, ULTRASOUND MED BIOL, V31, P633, DOI 10.1016/j.ultrasmedbio.2005.02.001; Nauleau P, 2016, PHYS MED BIOL, V61, DOI 10.1088/0031-9155/61/13/4746; Newitt DC, 2002, OSTEOPOROSIS INT, V13, P6; Nicholson PHF, 2002, PHYSIOL MEAS, V23, P755, DOI 10.1088/0967-3334/23/4/313; Njeh CF, 1998, MED ENG PHYS, V20, P781, DOI 10.1016/S1350-4533(99)00014-4; Potsika VT, 2016, MATERIALS, V9, DOI 10.3390/ma9030205; Ramos-Grez J, 2008, RAPID PROTOTYPING J, V14, P260, DOI 10.1108/13552540810907929; Raum K, 2005, ULTRASOUND MED BIOL, V31, P1225, DOI 10.1016/j.ultrasmedbio.2005.05.002; Richter P. H., 1995, ESTIMATING ERRORS LE, V122, P42; Ritzel H, 1997, J BONE MINER RES, V12, P89, DOI 10.1359/jbmr.1997.12.1.89; Sarvazyan A, 2009, ULTRASONICS, V49, P331, DOI 10.1016/j.ultras.2008.10.003; Stein MS, 1999, J BONE MINER RES, V14, P624, DOI 10.1359/jbmr.1999.14.4.624; Strelitzki R, 1997, OSTEOPOROSIS INT, V7, P370, DOI 10.1007/BF01623780; Talmant M, 2009, ULTRASOUND MED BIOL, V35, P912, DOI 10.1016/j.ultrasmedbio.2008.12.008; Tatarinov A, 2013, MULTIFREQUENCY AXIAL; THOMPSON DD, 1980, CALCIFIED TISSUE INT, V31, P5, DOI 10.1007/BF02407161; Tuna H, 2008, YONSEI MED J, V49, P436, DOI 10.3349/ymj.2008.49.3.436; Viswanathan HN, 2012, APPL HEALTH ECON HEA, V10, P163, DOI 10.2165/11598590-000000000-00000; Vogl F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152417; Zadik Z, 2005, J CLIN GASTROENTEROL, V39, P120; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	57	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182617	10.1371/journal.pone.0182617	http://dx.doi.org/10.1371/journal.pone.0182617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880868	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200007
J	Charbonneau, D; Sasaki, T; Dornhaus, A				Charbonneau, Daniel; Sasaki, Takao; Dornhaus, Anna			Who needs 'lazy' workers? Inactive workers act as a 'reserve' labor force replacing active workers, but inactive workers are not replaced when they are removed	PLOS ONE			English	Article							DIVISION-OF-LABOR; HONEY-BEE; SOCIAL-ORGANIZATION; TASK-PERFORMANCE; APIS-MELLIFERA; ARGENTINE ANT; TIME BUDGETS; BODY-SIZE; HYMENOPTERA; COLONY	Social insect colonies are highly successful, self-organized complex systems. Surprisingly however, most social insect colonies contain large numbers of highly inactive workers. Although this may seem inefficient, it may be that inactive workers actually contribute to colony function. Indeed, the most commonly proposed explanation for inactive workers is that they form a 'reserve' labor force that becomes active when needed, thus helping mitigate the effects of colony workload fluctuations or worker loss. Thus, it may be that inactive workers facilitate colony flexibility and resilience. However, this idea has not been empirically confirmed. Here we test whether colonies of Temnothorax rugatulus ants replace highly active (spending large proportions of time on specific tasks) or highly inactive (spending large proportions of time completely immobile) workers when they are experimentally removed. We show that colonies maintained pre-removal activity levels even after active workers were removed, and that previously inactive workers became active subsequent to the removal of active workers. Conversely, when inactive workers were removed, inactivity levels decreased and remained lower post-removal. Thus, colonies seem to have mechanisms for maintaining a certain number of active workers, but not a set number of inactive workers. The rapid replacement (within 1 week) of active workers suggests that the tasks they perform, mainly foraging and brood care, are necessary for colony function on short timescales. Conversely, the lack of replacement of inactive workers even 2 weeks after their removal suggests that any potential functions they have, including being a 'reserve', are less important, or auxiliary, and do not need immediate recovery. Thus, inactive workers act as a reserve labor force and may still play a role as food stores for the colony, but a role in facilitating colony-wide communication is unlikely. Our results are consistent with the often cited, but never yet empirically supported hypothesis that inactive workers act as a pool of 'reserve' labor that may allow colonies to quickly take advantage of novel resources and to mitigate worker loss.	[Charbonneau, Daniel] Univ Arizona, Grad Interdisciplinary Program Entomol & Insect S, Biol Sci West, 1041 East Lowell, Tucson, AZ 85721 USA; [Sasaki, Takao] Univ Oxford, Dept Zool, Oxford, England; [Dornhaus, Anna] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	University of Arizona; University of Oxford; University of Arizona	Charbonneau, D (corresponding author), Univ Arizona, Grad Interdisciplinary Program Entomol & Insect S, Biol Sci West, 1041 East Lowell, Tucson, AZ 85721 USA.	charbonneau.daniel@gmail.com		Charbonneau, Daniel/0000-0002-9537-4763	GIDP-EIS; EEB Department at University of Arizona; NSF [IOS-1045239, IOS-0841756, DBI-1262292]	GIDP-EIS; EEB Department at University of Arizona; NSF(National Science Foundation (NSF))	Research supported through the GIDP-EIS and EEB Department at University of Arizona, as well as NSF grants no. IOS-1045239, IOS-0841756, and DBI-1262292 (to A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EH, 2000, IEEE T POWER SYST, V15, P228, DOI 10.1109/59.852126; Arnellos A, 2015, BIOL PHILOS, V30, P333, DOI 10.1007/s10539-015-9484-0; BECKER GS, 1992, Q J ECON, V107, P1137, DOI 10.2307/2118383; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Bengston SE, 2015, BEHAV ECOL SOCIOBIOL, V69, P1265, DOI 10.1007/s00265-015-1939-4; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Bonabeau E, 1998, ECOSYSTEMS, V1, P437, DOI 10.1007/s100219900038; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Breed MD, 2002, J INSECT BEHAV, V15, P319, DOI 10.1023/A:1016261008322; Calabi P., 1988, P237; CALABI P, 1989, J INSECT BEHAV, V2, P663, DOI 10.1007/BF01065785; Charbonneau D, 2015, INSECT SOC, V62, P31, DOI 10.1007/s00040-014-0370-6; Charbonneau D, ANIM BEHAV IN PRESS, V472; Charbonneau D, 2017, INTEGR COMP BIOL; Charbonneau D, 2015, BEHAV ECOL SOCIOBIOL, V69, P1459, DOI 10.1007/s00265-015-1958-1; Charney Davida., 2015, JEWISH RHETORICS HIS, P1; Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [DOI 10.1108/09574090410700275, 10.1108/09574090410700275]; COLE BJ, 1986, BEHAV ECOL SOCIOBIOL, V18, P165, DOI 10.1007/BF00290820; COLE BJ, 1981, SCIENCE, V212, P83, DOI 10.1126/science.212.4490.83; Cook CN, 2013, ANIM BEHAV, V86, P323, DOI 10.1016/j.anbehav.2013.05.021; Dornhaus A, 2008, PLOS BIOL, V6, P2368, DOI 10.1371/journal.pbio.0060285; Dreller C, 2000, ANIM BEHAV, V59, P91, DOI 10.1006/anbe.1999.1303; Duarte A, 2011, ANNU REV ECOL EVOL S, V42, P91, DOI 10.1146/annurev-ecolsys-102710-145017; Durkheim E., 1997, DIVISION LABOR SOC; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Foitzik S, 2001, EVOLUTION, V55, P316, DOI 10.1111/j.0014-3820.2001.tb01296.x; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; GADAGKAR R, 1984, Z TIERPSYCHOL, V64, P15; Gardner KE, 2007, BEHAV ECOL SOCIOBIOL, V61, P783, DOI 10.1007/s00265-006-0309-7; Gerkey BP, 2004, INT J ROBOT RES, V23, P939, DOI 10.1177/0278364904045564; Gordon D.M., 1983, Psyche (Cambridge), V90, P413, DOI 10.1155/1983/60725; GORDON DM, 1986, ANIM BEHAV, V34, P1402, DOI 10.1016/S0003-3472(86)80211-1; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Hasegawa E, 2016, SCI REP, V6; Herbers J.M., 1983, Psyche (Cambridge), V90, P361, DOI 10.1155/1983/52489; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Ishii Y, 2013, J ETHOL, V31, P61, DOI 10.1007/s10164-012-0349-6; Jandt JM, 2012, INSECT SOC, V59, P313, DOI 10.1007/s00040-012-0222-1; Jandt JM, 2014, ANIM BEHAV, V87, P97, DOI 10.1016/j.anbehav.2013.10.017; Jandt JM, 2011, BEHAV ECOL SOCIOBIOL, V65, P2341, DOI 10.1007/s00265-011-1244-9; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jiansheng Zhang, 2011, 2011 2nd International Conference on Artificial Intelligence, Management Science and Electronic Commerce (AIMSEC 2011), P791, DOI 10.1109/AIMSEC.2011.6010239; Johnson BR, 2005, BEHAV ECOL SOCIOBIOL, V58, P219, DOI 10.1007/s00265-005-0949-z; Johnson BR, 2003, P ROY SOC B-BIOL SCI, V270, P147, DOI 10.1098/rspb.2002.2207; Johnson BR, 2002, BEHAV ECOL SOCIOBIOL, V51, P188, DOI 10.1007/s00265-001-0419-1; Johnson S., 2012, EMERGENCE CONNECTED; Kwapich CL, 2016, BEHAV ECOL SOCIOBIOL, V70, P221, DOI 10.1007/s00265-015-2039-1; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; Lach L, 2010, ANT ECOLOGY, P1; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; LENOIR A, 1978, CR ACAD SCI D NAT, V287, P555; Lenoir A., 1979, COMPORTEMENT ALIMENT; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Linksvayer TA, 2012, J EXP ZOOL PART B, V318B, P159, DOI 10.1002/jez.b.22001; Maistrello L, 1999, INSECT SOC, V46, P186, DOI 10.1007/s000400050131; MARKIN GP, 1970, ANN ENTOMOL SOC AM, V63, P1238, DOI 10.1093/aesa/63.5.1238; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MCDONALD P, 1985, J COMP PSYCHOL, V99, P3, DOI 10.1037/0735-7036.99.1.3; McGlynn TP, 2004, OIKOS, V106, P611, DOI 10.1111/j.0030-1299.2004.13135.x; Middleton EJT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1022; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Mitrus S, 2013, EUR J ENTOMOL, V110, P177, DOI 10.14411/eje.2013.026; Modlmeier AP, 2013, PHYSIOL ENTOMOL, V38, P89, DOI 10.1111/phen.12007; MOGLICH MHJ, 1979, BEHAV ECOL SOCIOBIOL, V6, P105, DOI 10.1007/BF00292556; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; NAJJAR W, 1990, IEEE T COMPUT, V39, P174, DOI 10.1109/12.45203; Naug D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1023, DOI 10.1007/s00265-009-0721-x; Nitzberg B, 1997, SIXTH IEEE INTERNATIONAL SYMPOSIUM ON HIGH PERFORMANCE DISTRIBUTED COMPUTING, PROCEEDINGS, P148, DOI 10.1109/HPDC.1997.622371; NONACS P, 1990, ECOLOGY, V71, P1886, DOI 10.2307/1937596; O'Donnell S, 2007, INSECT SOC, V54, P203, DOI 10.1007/s00040-007-0945-6; O'Donnell S, 1998, BEHAVIOUR, V135, P173, DOI 10.1163/156853998793066348; Ostfeld RS, 2010, LYME DIS ECOLOGY COM; Pac MF, 2009, INT J PROD RES, V47, P4281, DOI 10.1080/00207540801930237; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Passera L, 1996, NATURE, V379, P630, DOI 10.1038/379630a0; Pasteels J.M., 1987, IND COLL BEH SOC INS; Pinter-Wollman N, 2012, BEHAV ECOL SOCIOBIOL, V66, P1407, DOI 10.1007/s00265-012-1396-2; PORTER SD, 1985, BEHAV ECOL SOCIOBIOL, V16, P323, DOI 10.1007/BF00295545; REINERT J, 1973, PLANT TISSUE CELL CU, P338; RETANA J, 1990, ETHOLOGY, V84, P105, DOI 10.1111/j.1439-0310.1990.tb00788.x; RETANA J, 1991, ETHOLOGY, V89, P275; RINDERER TE, 1978, J ECON ENTOMOL, V71, P757, DOI 10.1093/jee/71.5.757; Rivera MD, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00050; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robson SK, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P239; Rubenstein M, 2014, SCIENCE, V345, P795, DOI 10.1126/science.1254295; Schmid-Hempel P., 1998, Parasites in social insects.; SCHMIDHEMPEL P, 1992, J EVOLUTION BIOL, V5, P1, DOI 10.1046/j.1420-9101.1992.5010001.x; SCHMIDHEMPEL P, 1990, AM NAT, V135, P501, DOI 10.1086/285059; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Traniello James F.A., 1995, P241; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; WILSON EO, 1983, BEHAV ECOL SOCIOBIOL, V14, P47, DOI 10.1007/BF00366655; Xiaosong Ma, 2002, Proceedings 16th International Parallel and Distributed Processing Symposium, DOI 10.1109/IPDPS.2002.1015511	104	31	32	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184074	10.1371/journal.pone.0184074	http://dx.doi.org/10.1371/journal.pone.0184074			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877229	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200060
J	Fileccia, V; Ruisi, P; Ingraffia, R; Giambalvo, D; Frenda, AS; Martinelli, F				Fileccia, Veronica; Ruisi, Paolo; Ingraffia, Rosolino; Giambalvo, Dario; Frenda, Alfonso Salvatore; Martinelli, Federico			Arbuscular mycorrhizal symbiosis mitigates the negative effects of salinity on durum wheat	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; SALT STRESS; MOLECULAR RESPONSES; PLANT DEHYDRINS; UPTAKE SYSTEM; DROUGHT; FUNGI; TOLERANCE; ARABIDOPSIS; EXPRESSION	Arbuscular mycorrhizal (AM) symbiosis is generally considered to be effective in ameliorating the plant tolerance to salt stress. Unfortunately, the comprehension of the mechanisms implicated in salinity stress alleviation by AM symbiosis is far from being complete. Thus, an experiment was performed by growing durum wheat (Triticum durum Desf.) plants under salt-stress conditions to evaluate the influence of AM symbiosis on both the plant growth and the regulation of a number of genes related to salt stress and nutrient uptake. Durum wheat plants were grown outdoors in pots in absence or in presence of salt stress and with or without AM fungi inoculation. The inoculum consisted of a mixture of spores of Rhizophagus irregularis (formerly Glomus intraradices) and Funneliformis mosseae (formerly G. mosseae). Results indicate that AM symbiosis can alleviate the detrimental effects of salt stress on the growth of durum wheat plants. In fact, under salt stress conditions mycorrhizal plants produced more aboveground and root biomass, had higher N uptake and aboveground N concentration, and showed greater stability of plasma membranes compared to non-mycorrhizal plants. Inoculation with AM fungi had no effect on the expression of the N transporter genes AMT1.1, AMT1.2, and NAR2.2, either under no-stress or salt stress conditions, probably due to the fact that plants were grown under optimal N conditions; on the contrary, NRT1.1 was always upregulated by AM symbiosis. Moreover, the level of expression of the drought stress-related genes AQP1, AQP4, PIP1, DREB5, and DHN15.3 observed in the mycorrhizal stressed plants was markedly lower than that observed in the non-mycorrhizal stressed plants and very close to that observed in the non-stressed plants. Our hypothesis is that, in the present study, AM symbiosis did not increase the plant tolerance to salt stress but instead generated a condition in which plants were subjected to a level of salt stress lower than that of non-mycorrhizal plants.	[Fileccia, Veronica; Ruisi, Paolo; Ingraffia, Rosolino; Giambalvo, Dario; Frenda, Alfonso Salvatore; Martinelli, Federico] Univ Palermo, Dipartimento Sci Agr Alimentari & Forestali, Palermo, Italy	University of Palermo	Martinelli, F (corresponding author), Univ Palermo, Dipartimento Sci Agr Alimentari & Forestali, Palermo, Italy.	federico.martinelli@unipa.it	Ingraffia, Rosolino/AAM-5132-2020; Frenda, Alfonso Salvatore/AAP-4426-2020; Ruisi, Paolo/L-9337-2015	Ingraffia, Rosolino/0000-0001-7553-0389; Ruisi, Paolo/0000-0002-5807-6986; Martinelli, Federico/0000-0002-3981-0567; Frenda, Alfonso Salvatore/0000-0002-2393-4936	MIUR (Italian Ministry for Education, University, and Research) [PON 01_01145-ISCOCEM]	MIUR (Italian Ministry for Education, University, and Research)(Ministry of Education, Universities and Research (MIUR))	This study was funded by MIUR (Italian Ministry for Education, University, and Research) to Universita degli Studi di Palermo (Palermo, Italy) in the framework of the Project "Sviluppo tecnologico e innovazione per la sostenibilita e competitivita della cerealicoltura meridionale (PON 01_01145-ISCOCEM)". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKADIR SM, 1982, J PLANT NUTR, V5, P1141, DOI 10.1080/01904168209363047; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Barea Jose-Miguel, 2008, V7, P143; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Brini F, 2007, PLANT CELL REP, V26, P2017, DOI 10.1007/s00299-007-0412-x; Cantrell IC, 2001, PLANT SOIL, V233, P269, DOI 10.1023/A:1010564013601; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Colla G, 2008, BIOL FERT SOILS, V44, P501, DOI 10.1007/s00374-007-0232-8; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; Drira M, 2016, FUNCT PLANT BIOL, V43, P1048, DOI 10.1071/FP16134; Estrada B, 2013, PLANT CELL ENVIRON, V36, P1771, DOI 10.1111/pce.12082; Feng G, 2002, MYCORRHIZA, V12, P185, DOI 10.1007/s00572-002-0170-0; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Giri B, 2007, MICROB ECOL, V54, P753, DOI 10.1007/s00248-007-9239-9; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z; Hanin M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01787; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Hodge A, 2000, FEMS MICROBIOL ECOL, V32, P91, DOI 10.1111/j.1574-6941.2000.tb00702.x; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Jahromi F, 2008, MICROB ECOL, V55, P45, DOI 10.1007/s00248-007-9249-7; Jayne B, 2014, MYCORRHIZA, V24, P109, DOI 10.1007/s00572-013-0515-x; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kohler B, 2000, PLANT PHYSIOL, V122, P243, DOI 10.1104/pp.122.1.243; Krouk G, 2006, PLANT PHYSIOL, V142, P1075, DOI 10.1104/pp.106.087510; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Kumar M, 2014, J PLANT BIOL, V57, P383, DOI 10.1007/s12374-014-0487-1; Labhilili M, 1995, PLANT SCI, V112, P219, DOI 10.1016/0168-9452(95)04267-9; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; Mohammad MJ, 2003, J PLANT NUTR, V26, P125, DOI 10.1081/PLN-120016500; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Ouziad F, 2006, ENVIRON EXP BOT, V57, P177, DOI 10.1016/j.envexpbot.2005.05.011; Park SY, 2006, J PLANT BIOL, V49, P455, DOI 10.1007/BF03031126; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Porcel R, 2012, AGRON SUSTAIN DEV, V32, P181, DOI 10.1007/s13593-011-0029-x; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Rinaldelli E., 1996, Advances in Horticultural Science, V10, P126; Saia S, 2014, J AGR SCI-CAMBRIDGE, V152, P370, DOI 10.1017/S002185961300004X; Saia S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00815; Saia S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090738; Sairam RK, 1997, J AGRON CROP SCI, V178, P171, DOI 10.1111/j.1439-037X.1997.tb00486.x; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sheng M, 2011, MYCORRHIZA, V21, P423, DOI 10.1007/s00572-010-0353-z; Talaat NB, 2014, ENVIRON EXP BOT, V98, P20, DOI 10.1016/j.envexpbot.2013.10.005; Talaat NB, 2013, ACTA PHYSIOL PLANT, V35, P729, DOI 10.1007/s11738-012-1113-9; Talaat NB, 2011, J PLANT NUTR SOIL SC, V174, P283, DOI 10.1002/jpln.201000051; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Yamato M, 2008, MYCORRHIZA, V18, P241, DOI 10.1007/s00572-008-0177-2; Zhao T, 2012, MOL GENET GENOMICS, V287, P423, DOI 10.1007/s00438-012-0687-7; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163	65	31	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184158	10.1371/journal.pone.0184158	http://dx.doi.org/10.1371/journal.pone.0184158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877207	Green Published, gold			2022-12-26	WOS:000409391200067
J	Park, HJ; Ryu, D; Parmar, M; Giasson, BI; McFarland, NR				Park, Hyo-Jin; Ryu, Daniel; Parmar, Mayur; Giasson, Benoit I.; McFarland, Nikolaus R.			The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; EARLY SECRETORY PATHWAY; PARKINSONS-DISEASE; ENDOPLASMIC-RETICULUM; LEWY BODIES; GAMMA-SECRETASE; UBIQUITIN LIGASE; GOLGI-APPARATUS; RAT MODEL; IN-VIVO	Abnormal accumulation of alpha-synuclein (alpha Syn) has been linked to endoplasmic-reticulum (ER) stress, defective intracellular protein/vesicle trafficking, and cytotoxicity. Targeting factors involved in ER-related protein processing and trafficking may, therefore, be a key to modulating aSyn levels and associated toxicity. Recently retention in endoplasmic reticulum 1 (RER1) has been identified as an important ER retrieval/retention factor for Alzheimer's disease proteins and negatively regulates amyloid-beta peptide levels. Here, we hypothesized that RER1 might also play an important role in retention/retrieval of aSyn and mediate levels. We expressed RER1 and a C-terminal mutant RER1 Delta 25, which lacks the ER retention/retrieval function, in HEK293 and H4 neuroglioma cells. RER1 overexpression significantly decreased levels of both wild type and A30P, A53T, and E46K disease causal mutants of alpha Syn, whereas the RER1 Delta 25 mutant had a significantly attenuated effect on alpha Syn. RER1 effects were specific to alpha Syn and had little to no effect on either beta Syn or the Delta 71-82 alpha Syn mutant, which both lack the NAC domain sequence critical for synuclein fibrillization. Tests with proteasomal and macroautophagy inhibitors further demonstrate that RER1 effects on alpha Syn are primarily mediated through the ubiquitin-proteasome system. RER1 also appears to interact with the ubiquitin ligase NEDD4. RER1 in human diseased brain tissues co-localizes with alpha Syn-positive Lewy bodies. Together, these findings provide evidence that RER1 is a novel and potential important mediator of elevated alpha Syn levels. Further investigation of the mechanism of RER1 and downstream effectors on alpha Syn may yield novel therapeutic targets for modulation in Parkinson disease and related synucleinopathies.	[Park, Hyo-Jin; Ryu, Daniel; Parmar, Mayur; McFarland, Nikolaus R.] Univ Florida, Coll Med, Dept Neurol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Park, Hyo-Jin] Univ Florida, Coll Med, Dept Aging & Geriatr Res, Div Biol Aging, Gainesville, FL 32611 USA; [Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis,McKnight Brai, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Park, HJ; McFarland, NR (corresponding author), Univ Florida, Coll Med, Dept Neurol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.; Park, HJ (corresponding author), Univ Florida, Coll Med, Dept Aging & Geriatr Res, Div Biol Aging, Gainesville, FL 32611 USA.	hyojinpark@ufl.edu; nikolaus.mcfarland@neurology.ufl.edu	Parmar, Mayur S/P-6382-2014; McFarland, Nikolaus R/I-4209-2017	Parmar, Mayur S/0000-0003-4970-9857; McFarland, Nikolaus R/0000-0002-8699-8857	NIH [K08-NS067024]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH K08-NS067024.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Alvarez-Castelao B, 2014, BBA-MOL CELL RES, V1843, P352, DOI 10.1016/j.bbamcr.2013.11.018; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baba M, 1998, AM J PATHOL, V152, P879; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bento CF, 2013, J CELL SCI, V126, P1059, DOI 10.1242/jcs.123075; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bisaglia M, 2006, PROTEIN SCI, V15, P1408, DOI 10.1110/ps.052048706; Boehm J, 1997, J CELL SCI 8, V110; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Chung CY, 2009, P NATL ACAD SCI USA, V106, P22474, DOI 10.1073/pnas.0912193106; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dikiy I, 2012, BBA-BIOMEMBRANES, V1818, P1013, DOI 10.1016/j.bbamem.2011.09.008; Ebrahimi-Fakhari D, 2012, AUTOPHAGY, V8, P281, DOI 10.4161/auto.8.2.18938; Fullekrug J, 1997, EUR J CELL BIOL, V74, P31; Gai WP, 1995, BRAIN, V118, P1447, DOI 10.1093/brain/118.6.1447; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gomez-Tortosa E, 2000, ACTA NEUROPATHOL, V99, P352, DOI 10.1007/s004010051135; Gorbatyuk MS, 2012, MOL THER, V20, P1327, DOI 10.1038/mt.2012.28; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Iwasaki H, 2001, ENDOCR J, V48, P261, DOI 10.1507/endocrj.48.261; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jurisch-Yaksi N, 2013, J CELL BIOL, V200, P709, DOI 10.1083/jcb.201208175; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maeda T, 2009, FEBS J, V276, P5832, DOI 10.1111/j.1742-4658.2009.07264.x; Massaad MJ, 1999, EUR J CELL BIOL, V78, P435, DOI 10.1016/S0171-9335(99)80070-3; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Park HJ, 2012, J BIOL CHEM, V287, P40629, DOI 10.1074/jbc.M112.418442; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.13, 10.1111/ene.14108]; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Sanchez-Lanzas R, 2014, BIOMOLECULES, V4, P1140, DOI 10.3390/biom4041140; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Singleton A, 2011, HUM MOL GENET, V20, pR158, DOI 10.1093/hmg/ddr358; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Tanabe C, 2012, J BIOL CHEM, V287, P44203, DOI 10.1074/jbc.M112.365296; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tetzlaff JE, 2008, J BIOL CHEM; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamasaki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05973	84	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184262	10.1371/journal.pone.0184262	http://dx.doi.org/10.1371/journal.pone.0184262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877262	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200081
J	Kharche, SR; Vigmond, E; Efimov, IR; Dobrzynski, H				Kharche, Sanjay R.; Vigmond, Edward; Efimov, Igor R.; Dobrzynski, Halina			Computational assessment of the functional role of sinoatrial node exit pathways in the human heart	PLOS ONE			English	Article							HUMAN SINUS NODE; ATRIAL-FIBRILLATION; PACEMAKER ACTIVITY; DIFFUSE FIBROSIS; MODEL; DYNAMICS; MODULATION; INSIGHTS; REENTRY; RECONSTRUCTION	Aim The human right atrium and sinoatrial node (SAN) anatomy is complex. Optical mapping experiments suggest that the SAN is functionally insulated from atrial tissue except at discrete SAN-atrial electrical junctions called SAN exit pathways, SEPs. Additionally, histological imaging suggests the presence of a secondary pacemaker close to the SAN. We hypothesise that a) an insulating border-SEP anatomical configuration is related to SAN arrhythmia; and b) a secondary pacemaker, the paranodal area, is an alternate pacemaker but accentuates tachycardia. A 3D electro-anatomical computational model was used to test these hypotheses. Methods A detailed 3D human SAN electro-anatomical mathematical model was developed based on our previous anatomical reconstruction. Electrical activity was simulated using tissue specific variants of the Fenton-Karma action potential equations. Simulation experiments were designed to deploy this complex electro-anatomical system to assess the roles of border-SEPs and paranodal area by mimicking experimentally observed SAN arrhythmia. Robust and accurate numerical algorithms were implemented for solving the mono domain reaction-diffusion equation implicitly, calculating 3D filament traces, and computing dominant frequency among other quantitative measurements. Results A centre to periphery gradient of increasing diffusion was sufficient to permit initiation of pacemaking at the centre of the 3D SAN. Re-entry within the SAN, micro re-entry, was possible by imposing significant SAN fibrosis in the presence of the insulating border. SEPs promoted the micro re-entry to generate more complex SAN-atrial tachycardia. Simulation of macro re-entry, i.e. re-entry around the SAN, was possible by inclusion of atrial fibrosis in the presence of the insulating border. The border shielded the SAN from atrial tachycardia. However, SAN micro-structure intercellular gap junctional coupling and the paranodal area contributed to prolonged atrial fibrillation. Finally, the micro-structure was found to be sufficient to explain shifts of leading pacemaker site location. Conclusions The simulations establish a relationship between anatomy and SAN electrical function. Microstructure, in the form of intercellular gap junction coupling, was found to regulate SAN function and arrhythmia.	[Kharche, Sanjay R.; Dobrzynski, Halina] Univ Manchester, Sch Med Sci, Inst Cardiovasc Sci, Manchester, Lancs, England; [Kharche, Sanjay R.] Univ Bordeaux, IMB, UMR 5251, Talence, France; [Vigmond, Edward] Fdn Bordeaux Univ, Electrophysiol & Heart Modeling Inst, IHU Liryc, Pessac, France; [Efimov, Igor R.] George Washington Univ, Dept Biomed Engn, Washington, DC USA	University of Manchester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; George Washington University	Kharche, SR; Dobrzynski, H (corresponding author), Univ Manchester, Sch Med Sci, Inst Cardiovasc Sci, Manchester, Lancs, England.	Sanjay.Kharche@manchester.ac.uk; Halina.Dobrzynski@manchester.ac.uk	Kharche, Sanjay Ram/I-2130-2014; Efimov, Igor R./AAJ-3234-2021; Efimov, Igor/B-8040-2010	Kharche, Sanjay Ram/0000-0002-2634-4894; Dobrzynski, Halina/0000-0003-4754-5975; Efimov, Igor/0000-0002-1483-5039	British Heart Foundation (GB) [RG/11/29257]; Leducq Foundation Transatlantic Network of Excellence RHYTHM;  [ANR-10-IAHU-04]; British Heart Foundation [PG/17/32/32987] Funding Source: researchfish	British Heart Foundation (GB); Leducq Foundation Transatlantic Network of Excellence RHYTHM(Leducq Foundation); ; British Heart Foundation(British Heart Foundation)	SRK and HD were supported by a British Heart Foundation (GB) grant RG/11/29257. EV and ERI acknowledge support from Leducq Foundation Transatlantic Network of Excellence RHYTHM. EV is also funded by grant ANR-10-IAHU-04 (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.158101; Aslanidi OV, 2012, EUR J PHARM SCI, V46, P209, DOI 10.1016/j.ejps.2011.08.014; Balay S., 2012, PETSC USERS MANUAL; Biktashev VN, 1998, CHAOS, V8, P48, DOI 10.1063/1.166307; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Bray MA, 2002, IEEE T BIO-MED ENG, V49, P1086, DOI 10.1109/TBME.2002.803516; Butters TD, 2010, CIRC RES, V107, P126, DOI 10.1161/CIRCRESAHA.110.219949; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Campbell AS, 2014, J MOL CELL CARDIOL, V77, P147, DOI 10.1016/j.yjmcc.2014.09.030; Chandler N, 2011, ANAT REC, V294, P970, DOI 10.1002/ar.21379; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Cohen S. D., 1996, Computers in Physics, V10, P138; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Csepe TA, 2017, EUR HEART J-CARD IMG, V18, P862, DOI 10.1093/ehjci/jew304; de Jong S, 2011, J CARDIOVASC PHARM, V57, P630, DOI 10.1097/FJC.0b013e318207a35f; Demir SS, 1999, AM J PHYSIOL-HEART C, V276, pH2221, DOI 10.1152/ajpheart.1999.276.6.H2221; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Dobrzynski H, 2013, PHARMACOL THERAPEUT, V139, P260, DOI 10.1016/j.pharmthera.2013.04.010; Efimov IR, 2010, CIRC RES, V106, P255, DOI 10.1161/CIRCRESAHA.109.209841; Fedorov VV, 2006, AM J PHYSIOL-HEART C, V291, pH612, DOI 10.1152/ajpheart.00022.2006; Fedorov VV, 2010, J AM COLL CARDIOL, V56, P1386, DOI 10.1016/j.jacc.2010.03.098; Fedorov VV, 2010, CIRCULATION, V122, P782, DOI 10.1161/CIRCULATIONAHA.109.935288; Fedorov VV, 2009, CIRC RES, V104, P915, DOI 10.1161/CIRCRESAHA.108.193193; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2005, CHAOS, V15, DOI 10.1063/1.1840311; Glukhov AV, 2013, CIRC-ARRHYTHMIA ELEC, V6, P984, DOI 10.1161/CIRCEP.113.000404; Gomez JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106602; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Grandi E, 2009, J MOL CELL CARDIOL, V46, P332, DOI 10.1016/j.yjmcc.2008.12.002; Huang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118623; Inada S, 2009, BIOPHYS J, V97, P2117, DOI 10.1016/j.bpj.2009.06.056; JALIFE J, 1983, CIRC RES, V52, P642, DOI 10.1161/01.RES.52.6.642; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; Kazbanov IV, 2016, SCI REP-UK, V6, DOI 10.1038/srep20835; Kharche SR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731386; Kharche SR, 2014, EUROPACE, V16, P1524, DOI 10.1093/europace/euu084; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Liu J, 2008, PROG BIOPHYS MOL BIO, V96, P294, DOI 10.1016/j.pbiomolbio.2007.07.009; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Morris GM, 2014, CIRC J, V78, P1272, DOI 10.1253/circj.CJ-14-0419; Munoz MA, 2011, AM J PHYSIOL-HEART C, V301, pH1974, DOI 10.1152/ajpheart.00059.2011; Nattel S, 2016, CARDIOVASC RES, V110, P295, DOI 10.1093/cvr/cvw092; Oren RV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001041; Plank G, 2007, IEEE T BIO-MED ENG, V54, P585, DOI 10.1109/TBME.2006.889181; Podziemski P, 2013, J CLIN MONIT COMPUT, V27, P481, DOI 10.1007/s10877-013-9429-6; Roney CH, 2016, EUROPACE, V18, P146, DOI 10.1093/europace/euw365; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Sridhar S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40985; Syunyaev RA, 2011, RUSS J NUMER ANAL M, V26, P575, DOI 10.1515/RJNAMM.2011.034; Tanaka G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052906; Ten Tusscher KHWJ, 2007, EUROPACE, V9, P38, DOI 10.1093/europace/eum206; Trayanova NA, 2015, J PHYSL; Unudurthi SD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00446; Verheule S, 2001, AM J PHYSIOL-HEART C, V280, pH2103, DOI 10.1152/ajpheart.2001.280.5.H2103; Vigmond E, 2016, HEART RHYTHM, V13, P1536, DOI 10.1016/j.hrthm.2016.03.019; Vigmond E, 2009, EXP PHYSIOL, V94, P563, DOI 10.1113/expphysiol.2008.044073; Weber FM, 2011, IEEE T BIO-MED ENG, V58, P2648, DOI 10.1109/TBME.2011.2160453; Winslow R.L., 1994, P COMPUTERS CARDIOLO, P649; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355	59	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183727	10.1371/journal.pone.0183727	http://dx.doi.org/10.1371/journal.pone.0183727			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873427	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800023
J	Liu, YM; Zhao, N; Li, CC; Chang, Q; Liu, XM; Liao, YH; Pan, RL				Liu, Yamin; Zhao, Ning; Li, Chenchen; Chang, Qi; Liu, Xinmin; Liao, Yonghong; Pan, Ruile			Longistyline C acts antidepressant in vivo and neuroprotection in vitro against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK pathway in PC12 cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; PROTEIN-KINASES; NMDA RECEPTORS; DEPRESSION; EXCITOTOXICITY; DYSFUNCTION; DISORDERS; THERAPY; TARGETS	Depressive disorder is a common psychiatric disease which ranks among the leading cause of disability worldwide. The antidepressants presently used had low cure rate and caused a variety of side-effects. The screening of antidepressant drugs is usually used classic behavioural tests and neuroprotective strategy. Longistyline C, a natural stilbene isolated from the leaves of Cajanuscajan (L.) Millsp, was firstly investigated the antidepressant effect using animal behavioural tests, and studied the neuroprotection and its possible signaling pathways on glutamate-induced injury in PC12 cells. The results of animal test demonstrated that longistyline C had the antidepressant activity, which the effect is similar to the positive control. In current study, we investigated the effect of longistyline C on glutamate-induced injury in PC12 cells and explored its possible signaling pathways. The results demonstrated that pretreatment with longistyline C at the concentrations of 2-8 mu mol/L for 24 h had a significant reduction of the cytotoxicity induced by glutamate (15 mmol/L) in PC12 cells using MTT, lactate dehydrogenase (LDH) release assay and Annexin V-PI double staining. Subsequently, we found that pretreatment with longistyline C (8 mu mol/L) could drastically down-regulate the over-expression of NMDAR/NR2B and Ca2+/calmodulin-dependent protein kinase II (CaMKII), up-regulate the expressions of p-ERK and p-CREB and alleviate ER stress. In conclusison, longistyline C is most possibly through regulating NMDAR/NR2B-ERK1/2 related pathway and restoring endoplasmic reticulum function to exert neuroprotective effect against glutamate-induced injury in PC12 cells.	[Liu, Yamin; Zhao, Ning; Li, Chenchen; Chang, Qi; Liu, Xinmin; Liao, Yonghong; Pan, Ruile] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Pan, RL (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China.	rlpan@implad.ac.cn	Liao, Yong-Hong/B-7039-2018	Liao, Yong-Hong/0000-0001-6852-5434	CAMS innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-012]	CAMS innovation Fund for Medical Sciences (CIFMS)	This work was financially supported by CAMS innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTELLI MG, 1995, DEV BRAIN RES, V86, P340, DOI 10.1016/0165-3806(95)00012-3; Bhagwagar Z, 2007, INT C BIP DIS; Bostwick JM, 2010, MAYO CLIN PROC, V85, P538, DOI 10.4065/mcp.2009.0565; Choi AY, 2010, NEUROCHEM INT, V57, P143, DOI 10.1016/j.neuint.2010.05.006; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hindley A, 2002, J CELL SCI, V115, P1575; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; Lamkanfi M, 2004, CELL DEATH DIFFER, V11, P365, DOI 10.1038/sj.cdd.4401364; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Liu YM, 2015, CHIN HERB MED, V7, P238, DOI 10.1016/S1674-6384(15)60045-4; [刘亚旻 Liu Yamin], 2014, [中草药, Chinese Traditional and Herbal Drugs], V45, P466; Mantovani M, 2003, NEUROSCI LETT, V343, P1, DOI 10.1016/S0304-3940(03)00306-9; Mao QQ, 2011, J ETHNOPHARMACOL, V133, P1121, DOI 10.1016/j.jep.2010.11.043; Markan S, 2009, MOL CELL BIOCHEM, V324, P131, DOI 10.1007/s11010-008-9991-2; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Micale V, 2006, EUR NEUROPSYCHOPHARM, V16, P538, DOI 10.1016/j.euroneuro.2006.01.005; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murrough JW, 2012, CLIN PHARMACOL THER, V91, P303, DOI 10.1038/clpt.2011.244; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SODERLING TR, 1995, ADV SEC MESS PHOSPH, V30, P175; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Westbrook Gary L., 1994, Current Opinion in Neurobiology, V4, P337, DOI 10.1016/0959-4388(94)90094-9; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xuejun L G M Z H, BASIC CLIN PHARM TOX, V104, P236; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	41	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183702	10.1371/journal.pone.0183702	http://dx.doi.org/10.1371/journal.pone.0183702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873095	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800021
J	Prieto, DMC; Cheng, YS; Chang, CC; Yu, J; Takada, YK; Takada, Y				Prieto, Dora Maria Cedano; Cheng, Yushen; Chang, Chih-Chieh; Yu, Jessica; Takada, Yoko K.; Takada, Yoshikazu			Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling	PLOS ONE			English	Article							TERNARY COMPLEX-FORMATION; FACTOR-I; DEFECTIVE MUTANT; ALPHA-V-BETA-3; ALPHA-6-BETA-4; ANTAGONIST; CELLS	We have reported that integrins crosstalk with growth factors through direct binding to growth factors (e.g., fibroblast growth factor-1, insulin-like growth factor 1 (IGF1), neuregulin-1, fractalkine) and subsequent ternary complex formation with cognate receptor [e.g., integrin/IGF1/IGF1 receptor (IGF1R)]. IGF1 and IGF2 are overexpressed in cancer and major therapeutic targets. We previously reported that IGF1 binds to integrins alpha v beta 3 and alpha 6 beta 4, and the R36E/R37E mutant in the C-domain of IGF1 is defective integrin binding and signaling functions of IGF1, and acts as an antagonist of IGF1R. We studied if integrins play a role in the signaling functions of IGF2, another member of the IGF family. Here we describe that IGF2 specifically binds to integrins alpha v beta 3 and alpha 6 beta 4, and induced proliferation of CHO cells (IGF1R+) that express alpha v beta 3 or alpha 6 beta 4 (beta 3-or alpha 6 beta 4-CHO cells). Arg residues to Glu at positions 24, 34, 37 and/or 38 in or close to the C-domain of IGF2 play a critical role in binding to integrins and signaling functions. The R24E/R37E/R38E, R34E/R37E/R38E, and R24E/R34E/R37E/R38E mutants were defective in integrin binding and IGF2 signaling. These mutants suppressed proliferation induced by WT IGF2, suggesting that they are dominant-negative antagonists of IGF1R. These results suggest that IGF2 also requires integrin binding for signaling functions, and the IGF2 mutants that cannot bind to integrins act as antagonists of IGF1R. The present study defines the role of the C-domain in integrin binding and signaling.	[Prieto, Dora Maria Cedano; Yu, Jessica; Takada, Yoko K.; Takada, Yoshikazu] UC Davis Sch Med, Dept Dermatol Biochem & Mol Med, Res III Suite,4645 Second Ave, Sacramento, CA 95817 USA; [Cheng, Yushen; Chang, Chih-Chieh; Yu, Jessica; Takada, Yoko K.; Takada, Yoshikazu] Taipei Med Univ, Coll Med Sci & Technol, Taipei, Taiwan; [Yu, Jessica] Acad Sinica, TPP, Sec 2, Taipei, Taiwan	University of California System; University of California Davis; Taipei Medical University; Academia Sinica - Taiwan	Takada, Y (corresponding author), UC Davis Sch Med, Dept Dermatol Biochem & Mol Med, Res III Suite,4645 Second Ave, Sacramento, CA 95817 USA.; Takada, Y (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Taipei, Taiwan.	ytakada@ucdavis.edu		CEDANO-PRIETO, DORA MARIA/0000-0002-4204-2175; takada, yoshikazu/0000-0001-5481-9589	NIH [R33CA196445]; CONACyT-UCMEXUS grant from the Mexican government; Taiwan Protein Project (TPP) [MOST105-0210-01-12-01, MOST106-0210-01-15-04]; NATIONAL CANCER INSTITUTE [P30CA093373, R33CA196445] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT-UCMEXUS grant from the Mexican government; Taiwan Protein Project (TPP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by NIH R33CA196445, CONACyT-UCMEXUS grant from the Mexican government (to DMCP), and by Taiwan Protein Project (TPP), MOST105-0210-01-12-01 and MOST106-0210-01-15-04.	AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chaves J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0b013e32834258a1; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Marelli UK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00222; Mori S., 2013, MED SCI, V1, P20; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170173; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Takada Y., 2007, BIOL, V8, P215, DOI DOI 10.1186/GB-2007-8-5-215; Takada Y, 2017, CYTOKINE GROWTH FACT; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794	20	7	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184285	10.1371/journal.pone.0184285	http://dx.doi.org/10.1371/journal.pone.0184285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873464	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800069
J	Cai, CN; Wang, LK; Zhou, LJ; He, PM; Jiao, BH				Cai, Chuner; Wang, Lingke; Zhou, Lingjie; He, Peimin; Jiao, Binghua			Complete chloroplast genome of green tide algae Ulva flexuosa (Ulvophyceae, Chlorophyta) with comparative analysis	PLOS ONE			English	Article							SUBSP PILIFERA CHLOROPHYTA; SEQUENCE; PHYLOGENIES; EVOLUTION; PROGRAM; BLOCKS; GENES; TOOL; SEA	Ulva flexuosa, one kind of green tide algae, has outbroken in the Yellow Sea of China during the past ten years. In the present study, we sequenced the chloroplast genome of U. flexuosa followed by annotation and comparative analysis. It indicated that the chloroplast genomes had high conservation among Ulva spp., and high rearrangement outside them. Though U. flexuosa was closer to U. linza than U. fasciata in phylogenetic tree, the average Ka/Ks between U. flexuosa and U. linza assessed by 67 protein-coding genes was higher than those between U. flexuosa and other species in Ulva spp., due to the variation of psbZ, psbM and ycf20. Our results laid the foundation for the future studies on the evolution of chloroplast genomes of Ulva, as well as the molecular identification of U. flexuosa varieties.	[Cai, Chuner; Wang, Lingke; Zhou, Lingjie; He, Peimin] Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China; [Cai, Chuner; He, Peimin] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Cai, Chuner; Jiao, Binghua] Second Mil Med Univ, Marine Biomed Inst, Shanghai, Peoples R China; [Zhou, Lingjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Shanghai Ocean University; Shanghai Ocean University; Naval Medical University; University of Connecticut	He, PM (corresponding author), Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China.; He, PM (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Jiao, BH (corresponding author), Second Mil Med Univ, Marine Biomed Inst, Shanghai, Peoples R China.	pmhe@shou.edu.cn; jiaobh@yeah.net	he, peimin/ABG-4220-2021	He, Peimin/0000-0003-3704-7905; Cai, Chuner/0000-0001-9265-6602	National Natural Science Foundation of China [41576163]; National Key R&D Program of China [2016YFC1402105]; Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, S.O.A. [MATHAB2017010]; China Postdoctoral Science Foundation [2015M572743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, S.O.A.; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China (41576163), National Key R&D Program of China (2016YFC1402105), Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, S.O.A., (MATHAB2017010), and General Financial Grant from the China Postdoctoral Science Foundation (2015M572743). The funders did not play a role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Braga MDV, 2011, J COMPUT BIOL, V18, P1167, DOI 10.1089/cmb.2011.0118; Castelar B, 2014, J APPL PHYCOL, V26, P1989, DOI 10.1007/s10811-014-0329-z; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen HH, 2015, RENEW SUST ENERG REV, V47, P427, DOI 10.1016/j.rser.2015.03.086; Coat G, 1998, EUR J PHYCOL, V33, P81, DOI 10.1017/S0967026297001455; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Cui JJ, 2015, MAR POLLUT BULL, V101, P660, DOI 10.1016/j.marpolbul.2015.10.033; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee WH, 2004, BIOINFORMATICS, V20, P2863, DOI 10.1093/bioinformatics/bth301; Leliaert F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1418-3; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Melton JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121020; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Messyasz B, 2013, OCEANOL HYDROBIOL ST, V42, P209, DOI 10.2478/s13545-013-0077-8; Messyasz B, 2013, ACTA SOC BOT POL, V82, P157, DOI 10.5586/asbp.2013.013; NEI M, 1986, MOL BIOL EVOL, V3, P418; OTT FRANKLYN D., 1965, VIRGINIA J SCI, V16, P205; Revanna KV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-316; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rybak A, 2014, EUR J PHYCOL, V49, P471, DOI 10.1080/09670262.2014.976662; Rybak AS, 2015, OCEANOL HYDROBIOL ST, V44, P393, DOI 10.1515/ohs-2015-0037; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Sun L, 2015, SCI REP, V6, P20528; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Whitfield J, 2008, BRIEF BIOINFORM, V9, P547; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Zhang JH, 2015, ESTUAR COAST SHELF S, V164, P418, DOI 10.1016/j.ecss.2015.08.007	36	22	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184196	10.1371/journal.pone.0184196	http://dx.doi.org/10.1371/journal.pone.0184196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863197	Green Submitted, gold, Green Published			2022-12-26	WOS:000408816900037
J	Suliman, M; Santosh, V; Seegar, TCM; Dalton, AC; Schultz, KM; Klug, CS; Barton, WA				Suliman, Muna; Santosh, Vishaka; Seegar, Tom C. M.; Dalton, Annamarie C.; Schultz, Kathryn M.; Klug, Candice S.; Barton, William A.			Directed evolution provides insight into conformational substrate sampling by SrtA	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; GRAM-POSITIVE BACTERIA; PROTEIN-PROTEIN INTERACTIONS; FRAGMENT COMPLEMENTATION ASSAYS; SURFACE-PROTEINS; CELL-WALL; LIVING CELLS; LISTERIA-MONOCYTOGENES; TRANSPEPTIDASE SRTA; CATALYTIC MECHANISM	The Sortase family of transpeptidases are found in numerous gram-positive bacteria and involved in divergent physiological processes including anchoring of surface proteins to the cell wall as well as pili assembly. As essential proteins, sortase enzymes have been the focus of considerable interest for the development of novel anti-microbials, however, more recently their function as unique transpeptidases has been exploited for the synthesis of novel bio-conjugates. Yet, for synthetic purposes, SrtA-mediated conjugation suffers from the enzyme's inherently poor catalytic efficiency. Therefore, to identify SrtA variants with improved catalytic efficiency, we used directed evolution to select a catalytically enhanced SrtA enzyme. An analysis of improved SrtA variants in the context of sequence conservation, NMR and x-ray crystal structures, and kinetic data suggests a novel mechanism for catalysis involving large conformational changes that delivers substrate to the active site pocket. Indeed, using DEER-EPR spectroscopy, we reveal that upon substrate binding, SrtA undergoes a large scissors-like conformational change that simultaneously translates the sort-tag substrate to the active site in addition to repositioning key catalytic residues for esterification. A better understanding of Sortase dynamics will significantly enhance future engineering and drug discovery efforts.	[Suliman, Muna; Santosh, Vishaka; Seegar, Tom C. M.; Dalton, Annamarie C.; Barton, William A.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Schultz, Kathryn M.; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Virginia Commonwealth University; Medical College of Wisconsin	Barton, WA (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23284 USA.	wabarton@vcu.edu			NIH [P41EB001980, S10RR022422, S10OD011937]; National Institutes of Health [F31CA165673]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The EPR data were collected at the National Biomedical EPR Center (supported by NIH grant P41EB001980) on pulsed EPR instrumentation supported by the NIH (S10RR022422 and S10OD011937). ACD is supported by a fellowship from the National Institutes of Health (F31CA165673).	Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Chen I, 2007, J AM CHEM SOC, V129, P6619, DOI 10.1021/ja071013g; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kappel K, 2012, PROTEIN SCI, V21, P1858, DOI 10.1002/pro.2168; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Michnick SW, 2011, METHODS MOL BIOL, V756, P395, DOI 10.1007/978-1-61779-160-4_25; Michnick SW, 2010, METHOD ENZYMOL, V470, P335, DOI 10.1016/S0076-6879(10)70014-8; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Pritz S, 2009, ADV EXP MED BIOL, V611, P107, DOI 10.1007/978-0-387-73657-0_47; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Remy I, 2007, NAT PROTOC, V2, P2120, DOI 10.1038/nprot.2007.266; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shrestha P, 2016, J MOL GRAPH MODEL, V67, P33, DOI 10.1016/j.jmgm.2016.04.006; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Strijbis K, 2012, TRAFFIC, V13, P780, DOI 10.1111/j.1600-0854.2012.01345.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Warshaviak DT, 2013, J MAGN RESON, V232, P53, DOI 10.1016/j.jmr.2013.04.013; Yamamura Y, 2011, CHEM COMMUN, V47, P4742, DOI 10.1039/c0cc05334a; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	46	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184271	10.1371/journal.pone.0184271	http://dx.doi.org/10.1371/journal.pone.0184271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859178	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500079
J	Tran, DDH; Kessler, C; Niehus, SE; Mahnkopf, M; Koch, A; Tamura, T				Tran, D. D. H.; Kessler, C.; Niehus, S. E.; Mahnkopf, M.; Koch, A.; Tamura, T.			Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs	ONCOGENE			English	Article							GENOME; GROWTH; IDENTIFICATION; PROLIFERATION; EXPRESSION; PROGNOSIS; APOPTOSIS; PROTEIN	Hepatocellular carcinoma (HCC) is a frequent form of cancer with a poor prognosis and with limited possibilities for medical intervention. Recent evidence has accumulated that long noncoding RNAs (lncRNAs) are important regulators of disease processes including cancer. Chromatin remodeling in cancer cells may result in an unusual expression of lncRNAs and indeed it has been shown that more than 7000 unannotated lncRNAs are expressed in HCCs. We identified a novel long intergenic noncoding RNA, Linc00176, that plays a role in proliferation and survival of HCC. Linc00176 regulates expression of more than 200 genes by the sponge function for tumor suppressor miRNAs, miR-9 and miR-185. Linc00176 is expressed at a high level only in HCC, and is activated by Myc, Max and AP-4 transcription regulators. Myc also upregulates miR-9 and miR-185. In Linc00176-depleted HCC, these miRNAs were released from Linc00176 and downregulated their target mRNAs. Thus, depletion of Linc00176 disrupted the cell cycle and induced necroptosis in HCC via released tumor suppressor miRNAs. These data indicate that atypically expressed lncRNAs may be useful targets for cancer therapy.	[Tran, D. D. H.; Kessler, C.; Niehus, S. E.; Mahnkopf, M.; Koch, A.; Tamura, T.] Hannover Med Sch, Inst Biochem, OE4310,Carl Neuberg Str 1, D-30623 Hannover, Germany	Hannover Medical School	Tamura, T (corresponding author), Hannover Med Sch, Inst Biochem, OE4310,Carl Neuberg Str 1, D-30623 Hannover, Germany.	Tamura.Teruko@MH-Hannover.de	Tran, Doan Duy Hai/AGU-7573-2022	Tran, Doan Duy Hai/0000-0003-2392-0259	Deutsche Krebshilfe [111153]; DFG [Ta-111/13-3]; Niedersachsische Krebsgesellschaft; DDHT, PhD program Molecular Medicine and Structure Medicine in HBRS; Leistungsorientierte Mittelvergabe; Frauenfaktor from MHH	Deutsche Krebshilfe(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); Niedersachsische Krebsgesellschaft; DDHT, PhD program Molecular Medicine and Structure Medicine in HBRS; Leistungsorientierte Mittelvergabe; Frauenfaktor from MHH	We thank C Bruce Boschek for critically reading the manuscript. This work is a part of thesis of CK. This research was supported by Deutsche Krebshilfe (111153), DFG Ta-111/13-3, Niedersachsische Krebsgesellschaft to AK and DDHT, PhD program Molecular Medicine and Structure Medicine in HBRS and Leistungsorientierte Mittelvergabe with Frauenfaktor from MHH.	Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Cai L, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0228-2; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Dang YW, 2014, ASIAN PAC J CANCER P, V15, P4969, DOI 10.7314/APJCP.2014.15.12.4969; Deng HX, 2011, CANCER BIOL THER, V11, P401, DOI 10.4161/cbt.11.4.14178; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Tran DDH, 2016, CELL SIGNAL, V28, P1872, DOI 10.1016/j.cellsig.2016.09.002; Drakaki A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1562-9; Evans JR, 2016, J CLIN INVEST, V126, P2775, DOI 10.1172/JCI84421; Ferrin G, 2015, HEPATIC MED-EVID RES, V7, P1, DOI 10.2147/HMER.S50161; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Higashi T, 2015, BRIT J CANCER, V113, P252, DOI 10.1038/bjc.2015.170; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Kim HS, 2015, ONCOTARGET, V6, P8089, DOI 10.18632/oncotarget.3512; Levens David, 2008, J Natl Cancer Inst Monogr, P41, DOI 10.1093/jncimonographs/lgn004; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; Qadir XV, 2014, AM J PATHOL, V184, P2355, DOI 10.1016/j.ajpath.2014.05.004; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Saran S, 2016, ONCOGENE, V35, P3872, DOI 10.1038/onc.2015.433; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Steitz JA, 2009, BIOCHEM SOC T, V37, P931, DOI 10.1042/BST0370931; Sun JC, 2015, INT J CLIN EXP MED, V8, P17748; Tamura T, 1999, ONCOGENE, V18, P6488, DOI 10.1038/sj.onc.1203062; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wu WL, 2015, INT J MOL MED, V36, P1713, DOI 10.3892/ijmm.2015.2379; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Yang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14421; Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004; Zhang JB, 2015, ONCOTARGET, V6, P42040, DOI 10.18632/oncotarget.5969; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715; Zhu XC, 2012, INT J MOL MED, V30, P1321, DOI 10.3892/ijmm.2012.1140	38	65	69	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					75	85		10.1038/onc.2017.312	http://dx.doi.org/10.1038/onc.2017.312			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28869604				2022-12-26	WOS:000422625000008
J	Li, S; Wang, D; Zhao, J; Weathington, NM; Shang, D; Zhao, YT				Li, Shuang; Wang, Dan; Zhao, Jing; Weathington, Nathaniel M.; Shang, Dong; Zhao, Yutong			The deubiquitinating enzyme USP48 stabilizes TRAF2 and reduces E-cadherin-mediated adherens junctions	FASEB JOURNAL			English	Article						deubiquitination; phosphorylation; signal pathway; epithelial barrier integrity	NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; TARGETS TRAF2; ACTIVATION; ALPHA; UBIQUITINATION; DEGRADATION; RECEPTOR	The tumor necrosis factor receptor-associated factor 2 (TRAF2) is a second messenger adaptor protein that plays an essential role in propagating TNF-alpha-mediated signaling pathways. Modulation of TRAF2 activity by ubiquitination is well studied; however, the deubiquitinating enzyme (DUB), which regulates TRAF2 stability, has not been identified. Here we reveal USP48 as the first identified DUB to deubiquitinate and stabilize TRAF2 in epithelial cells. Down-regulation of USP48 increases K48-linked polyubiquitination of TRAF2 and reduces TRAF2 protein levels. Interestingly, USP48 only targets the TRAF2 related to JNK pathway, not the TRAF2 related to NF-kappa B and p38 pathways. USP48 is serine phosphorylated in response to TNF-alpha. The phosphorylation is catalyzed by glycogen synthase kinase 3 beta (GSK3 beta), ultimately resulting in increases in USP48 DUB activity. Furthermore, we reveal a new biologic function of TRAF2 that contributes to epithelial barrier dysfunction, which is attenuated by knockdown of USP48. Inhibition of TRAF2/JNK pathway increases E (epithelial)-cadherin expression and enhances epithelial barrier integrity, while knockdown of USP48 attenuates TNF-a/JNK pathway and increases E-cadherin expression and cell-cell junction in epithelial cells. These data, taken together, indicate that USP48 stabilizes TRAF2, which is promoted by GSK3 beta-mediated phosphorylation. Further, down-regulation of USP48 increases E-cadherin expression and epithelial barrier integrity through reducing TRAF2 stability.	[Li, Shuang; Shang, Dong] Dalian Med Univ, Dept Gen Surg, Affiliated Hosp 1, Dalian, Peoples R China; [Li, Shuang; Wang, Dan; Zhao, Jing; Weathington, Nathaniel M.; Zhao, Yutong] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [Wang, Dan] Jilin Univ, Affiliated Hosp 1, Dept Anesthesia, Changchun, Jilin, Peoples R China	Dalian Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jilin University	Zhao, YT (corresponding author), Univ Pittsburgh, Dept Med, 3459 Fifth Ave,MUH NW628, Pittsburgh, PA 15213 USA.	zhaoy3@upmc.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01 HL112791, HL131665]; NIH National Institute of General Medical Sciences [R01GM115389]; American Lung Association Biomedical Research [RG350146]; American Heart Association [16GRNT30660001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131665, R01HL091916, R01HL112791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Lung Association Biomedical Research; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01 HL112791 and HL131665 (to Y.Z.), NIH National Institute of General Medical Sciences Grant R01GM115389 (to J.Z.), American Lung Association Biomedical Research Grant RG350146 (to J.Z.), and American Heart Association Grant 16GRNT30660001 (to Y.Z.). The authors declare no conflicts of interest.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Borghi A, 2016, BIOCHEM PHARMACOL, V116, P1, DOI 10.1016/j.bcp.2016.03.009; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Carayol N, 2002, AM J RESP CELL MOL, V26, P341, DOI 10.1165/ajrcmb.26.3.4684; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong S, 2014, AM J PHYSIOL-CELL PH, V307, pC893, DOI 10.1152/ajpcell.00132.2014; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; He DH, 2009, J BIOL CHEM, V284, P24123, DOI 10.1074/jbc.M109.007393; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Lockhart PJ, 2004, DNA SEQUENCE, V15, P9, DOI 10.1080/10855660310001638197; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Niu WB, 2016, DEVELOPMENT, V143, P1778, DOI 10.1242/dev.132175; Prieto-Garcia E, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0980-8; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schurch C, 2012, J CLIN INVEST, V122, P624, DOI 10.1172/JCI45977; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Schweitzer K, 2015, BBA-MOL CELL RES, V1853, P453, DOI 10.1016/j.bbamcr.2014.11.028; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shkoda A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001376; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu D, 2015, ELIFE, V4, DOI 10.7554/eLife.10510; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhong HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080976	57	21	21	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					230	242		10.1096/fj.201700415RR	http://dx.doi.org/10.1096/fj.201700415RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28874458	Green Published			2022-12-26	WOS:000419172700022
J	Kostrhon, S; Kontaxis, G; Kaufmann, T; Schirghuber, E; Kubicek, S; Konrat, R; Slade, D				Kostrhon, Sebastian; Kontaxis, Georg; Kaufmann, Tanja; Schirghuber, Erika; Kubicek, Stefan; Konrat, Robert; Slade, Dea			A histone-mimicking interdomain linker in a multidomain protein modulates multivalent histone binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; CHROMATIN MODIFICATIONS; INTRINSIC DISORDER; MOLECULAR-BASIS; RECOGNITION; COMPLEX; MIMICRY; POLY(ADP-RIBOSE); TRIMETHYLATION; BROMODOMAIN	N-terminal histone tails are subject to many posttranslational modifications that are recognized by and interact with designated reader domains in histone-binding proteins. BROMO domain adjacent to zinc finger 2B (BAZ2B) is a multidomain histone-binding protein that contains two histone reader modules, a plant homeodomain (PHD) and a bromodomain (BRD), linked by a largely disordered linker. Although previous studies have reported specificity of the PHD domain for the unmodified N terminus of histone H3 and of the BRD domain for H3 acetylated at Lys(14) (H3K14ac), the exact mode of H3 binding by BAZ2B and its regulation are underexplored. Here, using isothermal titration calorimetry and NMR spectroscopy, we report that acidic residues in the BAZ2B PHD domain are essential for H3 binding and that BAZ2B PHD-BRD establishes a polyvalent interaction with H3K14ac. Furthermore, we provide evidence that the disordered interdomain linker modulates the histone-binding affinity by interacting with the PHD domain. In particular, lysine-rich stretches in the linker, which resemble the positively charged N terminus of histone H3, reduce the binding affinity of the PHD finger toward the histone substrate. Phosphorylation, acetylation, or poly(ADP-ribosyl) ation of the linker residues may therefore act as a cellular mechanism to transiently tune BAZ2B histone-binding affinity. Our findings further support the concept of interdomain linkers serving a dual role in substrate binding by appropriately positioning the adjacent domains and by electrostatically modulating substrate binding. Moreover, inhibition of histone binding by a histone-mimicking interdomain linker represents another example of regulation of protein-protein interactions by intramolecular mimicry.	[Kostrhon, Sebastian; Kaufmann, Tanja; Slade, Dea] Univ Vienna, Campus Vienna Bioctr, Max F Perutz Labs, Dept Biochem, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Kontaxis, Georg; Konrat, Robert] Univ Vienna, Campus Vienna Bioctr 5, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Schirghuber, Erika; Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1030 Vienna, Austria; [Schirghuber, Erika; Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Epigenet & Antiinfect, A-1030 Vienna, Austria; [Kostrhon, Sebastian] Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society	Slade, D (corresponding author), Univ Vienna, Campus Vienna Bioctr, Max F Perutz Labs, Dept Biochem, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	dea.slade@univie.ac.at	Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343; Konrat, Robert/0000-0001-6489-4080; Slade, Dea/0000-0002-0052-5910	Max F. Perutz Laboratories (MFPL); Vienna Science and Technology Fund [LS14-001]; Austrian Science Fund [W1258]	Max F. Perutz Laboratories (MFPL); Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by an Max F. Perutz Laboratories (MFPL) start-up grant, Vienna Science and Technology Fund Grant LS14-001, and Austrian Science Fund Grant "DK: Integrative Structural Biology" W1258. The authors declare that they have no conflicts of interest with the contents of this article.	Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Altmeyer M, 2013, CURR OPIN GENET DEV, V23, P156, DOI 10.1016/j.gde.2012.11.001; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Baron R, 2011, STRUCTURE, V19, P212, DOI 10.1016/j.str.2011.01.001; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Bortoluzzi A, 2017, BIOCHEM J, V474, P1633, DOI 10.1042/BCJ20161053; Bua DJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02137; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Chen LH, 2015, P NATL ACAD SCI USA, V112, P4624, DOI 10.1073/pnas.1420833112; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Fischer PM, 2002, J PEPT SCI, V8, P529, DOI 10.1002/psc.413; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lewis AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003376; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; MacAlpine DM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010207; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Qin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4952; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; Tallant C, 2015, STRUCTURE, V23, P80, DOI 10.1016/j.str.2014.10.017; Tauber M, 2015, NUCLEUS-PHILA, V6, P123, DOI 10.1080/19491034.2015.1026022; Teloni F, 2016, NUCLEIC ACIDS RES, V44, P993, DOI 10.1093/nar/gkv1383; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wang ZX, 2011, J BIOL CHEM, V286, P18363, DOI 10.1074/jbc.R111.219139; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	51	9	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17643	17657		10.1074/jbc.M117.801464	http://dx.doi.org/10.1074/jbc.M117.801464			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28864776	hybrid, Green Published			2022-12-26	WOS:000414013000007
J	Hsiao, CY; Chiu, HY; Wang, TS; Tsai, TF				Hsiao, Chuan-Yu; Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang			Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; NECROSIS-FACTOR BLOCKERS; INTERFERON-GAMMA ASSAY; TO-SEVERE PSORIASIS; RHEUMATOID-ARTHRITIS; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID CHEMOPROPHYLAXIS; ACTIVE TUBERCULOSIS; THERAPY; AGENTS	Background There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G) testing in patients treated with ustekinumab is limited. Objectives This study aims to use serial QFT-G testing as a screening method for detecting LTBI in patients with psoriasis from an intermediate tuberculosis burden country. Methods This retrospective review investigated 134 psoriatic patients in whom ustekinumab was prescribed for at least one year between 2010 and 2016 in National Taiwan University Hospital. All patients underwent annular QFT-G testing during ustekinumab therapy. Results Among the 134 enrolled patients, baseline LTBI rate was 13.4% (18/134). Indeterminate QFT-G result was noted in 5.2% (7/134) of patients and 71.4% (5/7) of them turn to be QFT-G negative during the next testing. 81.3% (109/134) of patients had a negative QFT-G at baseline and the seroconversion rate was 7.3% (8/109) in the serial QFT-G. All the patients in the conversion group were referred to a pulmonologist for evaluation and 81.5% (22/27) of them underwent chemoprophylactic therapy while on ustekinumab. No active TB infection was noted during further follow-up with or without chemoprophylaxis. Conclusions This study revealed that psoriatic patients receiving long-term ustekinumab therapy had a low QFT-G conversion rate (7.3%). The clinical significance of QFT-G conversion remains controversial and needs larger scale trials to investigate.	[Hsiao, Chuan-Yu; Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Hsiao, Chuan-Yu; Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan; [Wang, Ting-Shun] Natl Taiwan Univ Hosp, Dept Dermatol, Yun Lin Branch, Touliu, Yunlin, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Tsai, TF (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	tftsai@yahoo.com		TSAI, TSEN-FANG/0000-0002-1498-1474; Chiu, Hsien-Yi/0000-0002-0493-9707				Ahn CS, 2015, J AM ACAD DERMATOL, V73, P420, DOI 10.1016/j.jaad.2015.06.004; Bartalesi F, 2013, J INFECTION, V66, P346, DOI 10.1016/j.jinf.2012.10.017; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Chen DY, 2008, ARTHRIT RHEUM-ARTHR, V59, P800, DOI 10.1002/art.23705; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen YJ, 2013, J AM ACAD DERMATOL, V69, P25, DOI 10.1016/j.jaad.2012.12.966; Cheng CY, 2015, DERMATOL SIN, V33, P124, DOI 10.1016/j.dsi.2014.12.005; Chiu HY, 2011, BRIT J DERMATOL, V164, P553, DOI 10.1111/j.1365-2133.2010.10137.x; de Leon DP, 2008, J RHEUMATOL, V35, P776; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Errichetti E, 2014, EUR J DERMATOL, V24, P508, DOI 10.1684/ejd.2014.2386; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Garcovich S, 2012, J EUR ACAD DERMATOL, V26, P1572, DOI 10.1111/j.1468-3083.2011.04220.x; Gisondi P, 2014, BRIT J DERMATOL, V171, P884, DOI 10.1111/bjd.13130; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Hatzara C, 2015, ANN RHEUM DIS, V74, P1848, DOI 10.1136/annrheumdis-2014-205376; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim KH, 2011, KOREAN J LAB MED, V31, P271, DOI 10.3343/kjlm.2011.31.4.271; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; Mancuso JD, 2013, AM J RESP CRIT CARE, V187, P122, DOI 10.1164/rccm.201211-2033ED; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Powell RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020061; Pratt A, 2007, RHEUMATOLOGY, V46, P1035, DOI 10.1093/rheumatology/kem064; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; Saraceno R, 2014, EXPERT OPIN BIOL TH, V14, P151, DOI 10.1517/14712598.2014.860441; Sauzullo I, 2013, BRIT J DERMATOL, V169, P1133, DOI 10.1111/bjd.12544; Scrivo R, 2013, J RHEUMATOL, V40, P157, DOI 10.3899/jrheum.120688; Sivamani RK, 2013, CLIN REV ALLERG IMMU, V44, P121, DOI 10.1007/s12016-012-8301-7; Tsai TF, 2013, BRIT J DERMATOL, V168, P444, DOI 10.1111/j.1365-2133.2012.11162.x; Tsai TF, 2012, BRIT J DERMATOL, V167, P1145, DOI 10.1111/j.1365-2133.2012.11142.x; Tsai TF, 2011, J DERMATOL SCI, V63, P154, DOI 10.1016/j.jdermsci.2011.05.005	34	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184178	10.1371/journal.pone.0184178	http://dx.doi.org/10.1371/journal.pone.0184178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886099	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100076
J	Pawluski, J; Jego, P; Henry, S; Bruchet, A; Palme, R; Coste, C; Hausberger, M				Pawluski, Jodi; Jego, Patrick; Henry, Severine; Bruchet, Anaelle; Palme, Rupert; Coste, Caroline; Hausberger, Martine			Low plasma cortisol and fecal cortisol metabolite measures as indicators of compromised welfare in domestic horses (Equus caballus)	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; RANDOMIZED CLINICAL-TRIAL; ANIMAL-WELFARE; MANAGEMENT FACTORS; SOCIAL-ISOLATION; CHRONIC STRESS; NOISE STRESS; POOR WELFARE; RISK-FACTORS; BACK-PAIN	The hypothalamic-pituitary-adrenal (HPA) axis response to chronic stress is far from straight forward, particularly with regards to animal welfare. There are reports of no effect as well as both decreases and increases in cortisol after chronic stressors. Therefore, the first aim of the present study was to determine how measures of compromised welfare, such as chronic pain and haematological anomalies, related to cortisol levels in domestic horses (Equus caballus). Domestic horses are an informative model to investigate the impact of chronic stress (due to environment, pain, work, housing conditions...) on the HPA axis. The second aim was to determine whether levels of fecal cortisol metabolites (FCM) may be used as an indicator of welfare measures. The present study used fifty-nine horses (44 geldings and 15 mares), from three riding centres in Brittany, France. The primary findings show that horses whose welfare was clearly compromised (as indicated by an unusual ears backward position, presence of vertebral problems or haematological anomalies, e.g. anaemia) also had lower levels of both FCM and plasma cortisol. This work extends our previous findings showing that withdrawn postures, indicators of depressive-like behavior in horses, are associated with lower plasma cortisol levels. We also found that evening plasma cortisol levels positively correlated with FCM levels in horses. Future research aims to determine the extent to which factors of influence on welfare, such as living conditions (e.g. single stalls versus group housing in pasture or paddocks), early life factors, and human interaction, act as mediators of cortisol levels in horses.	[Pawluski, Jodi] Univ Rennes 1, Irset, INSERM, U1085, Rennes, France; [Jego, Patrick; Henry, Severine; Bruchet, Anaelle; Coste, Caroline] Univ Rennes 1, Stn Biol Paimpont, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Veterinary Medicine Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Pawluski, J (corresponding author), Univ Rennes 1, Irset, INSERM, U1085, Rennes, France.; Hausberger, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	j.pawluski@gmail.com; martine.hausberger@univ-rennes1.fr	Palme, Rupert/A-3499-2008; Pawluski, Jodi L/K-5801-2015	Palme, Rupert/0000-0001-9466-3662; Pawluski, Jodi L/0000-0002-8240-8178	Caisse Centrale de la Mutualite Agricole, University of Rennes 1; Le Centre national de la recherche scientifique (CNRS)	Caisse Centrale de la Mutualite Agricole, University of Rennes 1; Le Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Caisse Centrale de la Mutualite Agricole, University of Rennes 1 and the Le Centre national de la recherche scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the directors and staff of the riding centers for their help with data collection;C. Fureix, L. Dupont and C. Lavertue at the University of Rennes 1 and E Klobetz-Rassam at the University of Veterinary Medicine, Vienna, who aided with sample collection and analyses. This work was funded by the Caisse Centrale de la Mutualite Agricole, University of Rennes 1 and the Le Centre national de la recherche scientifique (CNRS).	Ashley FH, 2005, EQUINE VET J, P37; Bae YJ, 2015, BEST PRACT RES CL EN, V29, P761, DOI 10.1016/j.beem.2015.09.001; BARNETT JL, 1992, APPL ANIM BEHAV SCI, V34, P207, DOI 10.1016/S0168-1591(05)80116-9; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Blokhuis HJ, 2003, ANIM WELFARE, V12, P445; BOTTOMS GD, 1972, AM J VET RES, V33, P785; Brauner S, 2009, WHY TREATING ANIMALS; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Burn CC, 2010, VET J, V186, P385, DOI 10.1016/j.tvjl.2009.09.016; Casamassima D, 2001, SMALL RUMINANT RES, V41, P151, DOI 10.1016/S0921-4488(01)00201-2; Cauvin E, 1997, IN PRACTICE, V19, P522; Cooper J, 2002, ANIMAL WEL, V1, P99; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; deJonge FH, 1996, PHYSIOL BEHAV, V60, P389, DOI 10.1016/0031-9384(96)00013-3; Dickens MJ, 2013, GEN COMP ENDOCR, V191, P177, DOI 10.1016/j.ygcen.2013.06.014; Fisher AD, 1997, ANIM SCI, V64, P53, DOI 10.1017/S135772980001554X; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fraser D, 1993, FOOD ANIMAL WELL-BEING, P37; Fureix C, 2015, APPL ANIM BEHAV SCI, V171, P8, DOI 10.1016/j.applanim.2015.08.036; Fureix C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-3; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Goodwin D, 2002, ANIMAL WEL, V1, P1; Harris PA, 2007, VET J, V173, P252, DOI 10.1016/j.tvjl.2005.12.009; Hausberger A, 2002, APPL ANIM BEHAV SCI, V76, P339, DOI 10.1016/S0168-1591(02)00016-3; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Henry S, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1429-1; HOFFSIS GF, 1970, AM J VET RES, V31, P1379; Houpt K, 2001, ANIM WELFARE, V10, P257; IRVINE CHG, 1994, DOMEST ANIM ENDOCRIN, V11, P227, DOI 10.1016/0739-7240(94)90030-2; JAMES VHT, 1970, J ENDOCRINOL, V48, P319, DOI 10.1677/joe.0.0480319; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; JOHNSON AL, 1986, J ANIM SCI, V63, P169, DOI 10.2527/jas1986.631169x; Juster RP, 2011, PSYCHONEUROENDOCRINO, V36, P797, DOI 10.1016/j.psyneuen.2010.11.001; Kanitz E, 2005, LIVEST PROD SCI, V94, P213, DOI 10.1016/j.livprodsci.2004.12.002; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; KIRKPATRICK JF, 1977, COMP BIOCHEM PHYS A, V57, P179, DOI 10.1016/0300-9629(77)90370-X; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; LADEWIG J, 1989, HORM BEHAV, V23, P344, DOI 10.1016/0018-506X(89)90048-2; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Lebelt D, 1996, PFERDEHEILKUNDE, V12, P411; Lesimple C, 2016, APPL ANIMAL BEHAV SC; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-209; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; LEY SJ, 1991, VET REC, V129, P45, DOI 10.1136/vr.129.3.45; Mateo JM, 2008, NEUROBIOL LEARN MEM, V89, P582, DOI 10.1016/j.nlm.2007.11.002; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Merl S, 2000, J EQUINE VET SCI, V20, P586, DOI 10.1016/S0737-0806(00)70267-X; MEUNIERSALAUN MC, 1987, J ANIM SCI, V64, P1371, DOI 10.2527/jas1987.6451371x; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Muhtz C, 2013, PAIN MED, V14, P498, DOI 10.1111/j.1526-4637.2012.01514.x; Munksgaard L, 1996, J ANIM SCI, V74, P769; Nicol CJ, 2002, VET REC, V151, P658, DOI 10.1136/vr.151.22.658; Nogueira GP, 1997, BRAZ J MED BIOL RES, V30, P1237, DOI 10.1590/S0100-879X1997001000016; Normando S, 2011, APPL ANIM BEHAV SCI, V133, P186, DOI 10.1016/j.applanim.2011.06.012; Otten W, 2004, ANIM SCI, V78, P271, DOI 10.1017/S1357729800054060; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Parker M, 2008, BEHAV BRAIN RES, V191, P137, DOI 10.1016/j.bbr.2008.03.009; PEARCE GP, 1993, APPL ANIM BEHAV SCI, V36, P11, DOI 10.1016/0168-1591(93)90095-7; Pell SM, 1999, APPL ANIM BEHAV SCI, V64, P81, DOI 10.1016/S0168-1591(99)00029-5; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Rochais C, 2016, BEHAV PROCESS, V124, P93, DOI 10.1016/j.beproc.2015.12.010; Rochais C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20117; RUSHEN J, 1991, APPL ANIM BEHAV SCI, V28, P381, DOI 10.1016/0168-1591(91)90170-3; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Selye H, 1956, J BONE JOINT SURG; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; van Reenen CG, 2000, VET MICROBIOL, V75, P135, DOI 10.1016/S0378-1135(00)00211-X; Veissier I, 1997, J ANIM SCI, V75, P356; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; VON BORELL E, 1995, APPL ANIM BEHAV SCI, V44, P219, DOI 10.1016/0168-1591(95)00615-Y; Waring G.H., 2003, HORSE BEHAV, V2; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; [No title captured]	100	47	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182257	10.1371/journal.pone.0182257	http://dx.doi.org/10.1371/journal.pone.0182257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886020	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100005
J	Rahman, MS; Thomas, P				Rahman, Md Saydur; Thomas, Peter			Molecular and biochemical responses of hypoxia exposure in Atlantic croaker collected from hypoxic regions in the northern Gulf of Mexico	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; INDUCED GENE-EXPRESSION; ENVIRONMENTAL HYPOXIA; RAINBOW-TROUT; UP-REGULATION; OXIDATIVE STRESS; NITRIC-OXIDE; HIF-1-ALPHA; FISH; HIF-2-ALPHA	A major impact of global climate change has been the marked increase worldwide in the incidence of coastal hypoxia (dissolved oxygen, DO<2.0 mgl(-1)). However, the extent of hypoxia exposure to motile animals such as fish collected from hypoxic waters as well as their molecular and physiological responses to environmental hypoxia exposure are largely unknown. A suite of potential hypoxia exposure biomarkers was evaluated in Atlantic croaker collected from hypoxic and normoxic regions in the northern Gulf of Mexico (nGOM), and in croaker after laboratory exposure to hypoxia (DO: 1.7 mg l(-1)). Expression of hypoxia-inducible factor-a, hif-alpha; neuronal nitric oxide synthase, nNOS; and insulin-like growth factor binding protein, igfbp mRNAs and protein carbonyl (PC, an oxidative stress indicator) content were elevated several-fold in brain and liver tissues of croaker collected from nGOM hypoxic sites. All of these molecular and biochemical biomarkers were also upregulated -3-10-fold in croaker brain and liver tissues within 1-2 days of hypoxia exposure in controlled laboratory experiments. These results suggest that hif-as, nNOS and igfbp-1 transcripts and PC contents are useful biomarkers of environmental hypoxia exposure and some of its physiological effects, making them important components for improved assessments of long-term impacts of environmental hypoxia on fish populations.	[Rahman, Md Saydur] Univ Texas Rio Grande Valley, Sch Earth Environm & Marine Sci, Brownsville, TX 78520 USA; [Rahman, Md Saydur; Thomas, Peter] Univ Texas Austin, Marine Sci Inst, Port Aransas, TX 78373 USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Austin	Rahman, MS (corresponding author), Univ Texas Rio Grande Valley, Sch Earth Environm & Marine Sci, Brownsville, TX 78520 USA.; Rahman, MS (corresponding author), Univ Texas Austin, Marine Sci Inst, Port Aransas, TX 78373 USA.	md.rahman@utrgv.edu	Rahman, Mohammad Sohelur/AAJ-7376-2020; Thomas, Peter/U-9908-2019; Rahman, Mohammad Saifur/GZM-5483-2022	Rahman, Mohammad Sohelur/0000-0002-4489-2202; Thomas, Peter/0000-0001-6656-4907; Rahman, Mohammad Saifur/0000-0002-9887-4456	NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant [NA06NOS4780131, NA09NOS4780179]; National Science Foundation [IOS-1119242]	NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant; National Science Foundation(National Science Foundation (NSF))	This research work was supported by grants from the NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant nos. NA06NOS4780131 and NA09NOS4780179 (to P.T.), and the National Science Foundation to P.T. and M.S.R. (grant no. IOS-1119242).; This research work was supported by grants from the NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant nos. NA06NOS4780131 and NA09NOS4780179 (to P.T.), and the National Science Foundation to P.T. and M.S.R. (grant no. IOS-1119242). The help of the crew of the RV Pelican, Louisiana Universities Marine Consortium; Dr. John A. Mohan, Department of Marine Sciences, Texas A&M University, Galveston; and Susan Lawson, University of Texas Marine Science Institute, Port Aransas, are gratefully acknowledged. We greatly appreciate the academic editor and three anonymous reviewers for their valuable comments and suggestions on the manuscript.	Abbaraju NV, 2012, FISH PHYSIOL BIOCHEM, V38, P615, DOI 10.1007/s10695-011-9542-8; Baptista RB, 2016, FISH PHYSIOL BIOCHEM, V42, P1307, DOI 10.1007/s10695-016-0219-1; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Catron T, 2001, BIOCHEM BIOPH RES CO, V282, P602, DOI 10.1006/bbrc.2001.4613; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; DUNN JF, 1987, CAN J ZOOL, V65, P1144, DOI 10.1139/z87-179; Froehlich HE, 2015, COMP BIOCHEM PHYS A, V189, P58, DOI 10.1016/j.cbpa.2015.07.016; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Hochachka P.W., 2002, BIOCH ADAPTATION MEC, P1; Kajimura S, 2007, J FISH BIOL, V71, P309, DOI 10.1111/j.1095-8649.2007.01606.x; Kodama K, 2012, MAR POLLUT BULL, V64, P1339, DOI 10.1016/j.marpolbul.2012.05.002; Kodama K, 2012, BIOL LETTERS, V8, P278, DOI 10.1098/rsbl.2011.0887; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNatt RA, 2004, J EXP MAR BIOL ECOL, V311, P147, DOI 10.1016/j.jembe.2004.05.006; McNeill B, 2006, J EXP BIOL, V209, P4214, DOI 10.1242/jeb.02519; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Rahman MS, 2015, COMP BIOCHEM PHYS A, V185, P91, DOI 10.1016/j.cbpa.2015.03.013; Rahman MS, 2013, GEN COMP ENDOCR, V192, P71, DOI 10.1016/j.ygcen.2013.03.001; Rahman MS, 2011, AM J PHYSIOL-ENDOC M, V301, pE637, DOI 10.1152/ajpendo.00168.2011; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Richards JG, 2011, J EXP BIOL, V214, P191, DOI 10.1242/jeb.047951; Rodrigo MC, 2002, J PHARMACOL TOXICOL, V47, P87, DOI 10.1016/S1056-8719(02)00218-6; Ryckman LYC, 2010, THESIS, P1; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Thomas P, 2012, P ROY SOC B-BIOL SCI, V279, P28, DOI 10.1098/rspb.2011.0529; Thomas P, 2009, J EXP MAR BIOL ECOL, V381, pS38, DOI 10.1016/j.jembe.2009.07.008; WRIGHT PA, 1989, J EXP BIOL, V147, P169; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Yu RMK, 2008, AQUAT TOXICOL, V90, P235, DOI 10.1016/j.aquatox.2008.09.004	39	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184341	10.1371/journal.pone.0184341	http://dx.doi.org/10.1371/journal.pone.0184341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886098	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100100
J	Kwiecien, JM; Bassey-Archibong, BI; Dabrowski, W; Rayner, LG; Lucas, AR; Daniel, JM				Kwiecien, Jacek M.; Bassey-Archibong, Blessing I.; Dabrowski, Wojciech; Rayner, Lyndsay G.; Lucas, Alexandra R.; Daniel, Juliet M.			Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PORTAL-VEIN INVASION; HEPATOCELLULAR-CARCINOMA; MATRIX METALLOPROTEINASES; PROMOTES; MIGRATION; GROWTH; INTRAVASATION; PROGRESSION; PHENOTYPE	The metastatic activity of breast carcinomas results from complex genetic changes in epithelial tumor cells and accounts for 90% of deaths in affected patients. Although the invasion of the local lymphatic vessels and veins by malignant breast tumor cells and their subsequent metastasis to the lung, has been recognized, the mechanisms behind the metastatic activity of breast tumor cells to other distal organs and the pathogenesis of metastatic cancer are not well understood. In this study, we utilized derivatives of the well-established and highly metastatic triple negative breast cancer (TNBC) cell line MDA-MB-231 (MDA-231) to study breast tumor metastasis in a mouse model. These MDA-231 derivatives had depleted expression of Kaiso, a POZ-ZF transcription factor that is highly expressed in malignant, triple negative breast cancers. We previously reported that Kaiso depletion attenuates the metastasis of xenografted MDA-231 cells. Herein, we describe the pathological features of the metastatic activity of parental (Kaiso(positive)) versus Kaiso(depleted) MDA-231 cells. Both Kaiso(positive) and Kaiso(depleted) MDA-231 cells metastasized from the original tumor in the mammary fat pad to the lung. However, while Kaiso(positive) cells formed large masses in the lung parenchyma, invaded large pulmonary blood vessels and formed secondary metastases and large tumors in the distal organs, Kaiso(depleted) cells metastasized only to the lung where they formed small metastatic lesions. Importantly, intravascular invasion and secondary metastases in distal organs were not observed in mice xenografted with Kaiso(depleted) cells. It thus appears that the lung may constitute a barrier for less invasive breast tumors such as the Kaiso(depleted) TNBC cells; this barrier may limit tumor growth and prevents Kaiso(depleted) TNBC cells from invading the pulmonary blood vessels and forming secondary metastases in distal organs.	[Kwiecien, Jacek M.] McMaster Univ, Dept Pathol & Mol Med, HSC 1U22D, Hamilton, ON, Canada; [Kwiecien, Jacek M.] Med Univ Lublin, Dept Clin Pathomorphol, Lublin, Poland; [Bassey-Archibong, Blessing I.; Rayner, Lyndsay G.; Daniel, Juliet M.] McMaster Univ, Dept Biol, LSB 331, Hamilton, ON, Canada; [Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesia & Intens Therapy, Lublin, Poland; [Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Tempe, AZ USA	McMaster University; Medical University of Lublin; McMaster University; Medical University of Lublin; Arizona State University; Arizona State University-Tempe	Kwiecien, JM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, HSC 1U22D, Hamilton, ON, Canada.; Kwiecien, JM (corresponding author), Med Univ Lublin, Dept Clin Pathomorphol, Lublin, Poland.	kwiecien@mcmaster.ca	Dabrowski, Wojciech/AAN-8425-2020	Dabrowski, Wojciech/0000-0003-0449-2375	NSERC Discovery Grant [RGPIN6442-15 - JMD]; Canadian Breast Cancer Foundation - JMD; Schlumberger Faculty for the Future Fellowship BIB-A	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Breast Cancer Foundation - JMD; Schlumberger Faculty for the Future Fellowship BIB-A	This work was supported NSERC Discovery Grant # RGPIN6442-15 - JMD; Canadian Breast Cancer Foundation - JMD and the Schlumberger Faculty for the Future Fellowship BIB-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Al-Jarrah Q, 2014, INT J SURG CASE REP, V5, P551, DOI 10.1016/j.ijscr.2014.06.005; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Asrani K, 2013, MOL CANCER RES, V11, P393, DOI 10.1158/1541-7786.MCR-12-0542; Baker EA, 2002, J CLIN PATHOL-MOL PA, V55, P300; Bassey-Archibong BI, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.17; Bassey-Archibong BI, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.92; Bouris P, 2015, MATRIX BIOL, V43, P42, DOI 10.1016/j.matbio.2015.02.008; Cao YW, 2015, KAOHSIUNG J MED SCI, V31, P70, DOI 10.1016/j.kjms.2014.11.008; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; CHUNG JW, 1995, AM J ROENTGENOL, V165, P315, DOI 10.2214/ajr.165.2.7618547; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Ding Z, 2014, ONCOGENE, V33, P2065, DOI 10.1038/onc.2013.166; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Fei F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0277-8; Folkins AK, 2010, MODERN PATHOL, V23, P1073, DOI 10.1038/modpathol.2010.91; Gertler F, 2011, TRENDS CELL BIOL, V21, P81, DOI 10.1016/j.tcb.2010.10.001; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Hsu HH, 2012, J CELL PHYSIOL, V227, P3648, DOI 10.1002/jcp.24072; Hsu HH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-61; Jezierska A, 2009, MED SCI MONITOR, V15; Jin H, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3694; Jones J, 2016, CANCER LETT, V380, P513, DOI 10.1016/j.canlet.2016.06.025; Jones J, 2014, CLIN EXP METASTAS, V31, P497, DOI 10.1007/s10585-014-9644-7; KANEKO T, 1995, ANN SURG, V222, P711, DOI 10.1097/00000658-199512000-00004; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kukko HM, 2010, MODERN PATHOL, V23, P1151, DOI 10.1038/modpathol.2010.100; Lee IJ, 2009, J VASC INTERV RADIOL, V20, P22, DOI 10.1016/j.jvir.2008.09.030; Leung HW, 2015, BBA-MOL CELL RES, V1853, P1827, DOI 10.1016/j.bbamcr.2015.04.020; Li F, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0180-8; Maynadier M, 2013, INT J ONCOL, V43, P1683, DOI 10.3892/ijo.2013.2095; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Mete O, 2011, MODERN PATHOL, V24, P1545, DOI 10.1038/modpathol.2011.119; Murakami E, 2016, ACTA HISTOCHEM CYTOC, V49, P131, DOI 10.1267/ahc.16020; NAKASHIMA T, 1983, CANCER, V51, P863, DOI 10.1002/1097-0142(19830301)51:5<863::AID-CNCR2820510520>3.0.CO;2-D; Patsialou A, 2013, INTRAVITAL, V2, P1; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pierre CC, 2015, BBA-MOL BASIS DIS, V1852, P1846, DOI 10.1016/j.bbadis.2015.06.011; Pignatelli J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005329; Puzovic V, 2014, NEOPLASMA, V61, P439, DOI 10.4149/neo_2014_054; Quaglia A, 2005, ARCH PATHOL LAB MED, V129, P639; Rabi ZA, 2015, CANCER BIOMARK, V15, P45; Rhodes LV, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.27; Rizwani W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100888; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Roussos ET, 2011, CLIN EXP METASTAS, V28, P515, DOI 10.1007/s10585-011-9388-6; Su P, 2014, INT J CLIN EXP PATHO, V7, P3008; Sugino T, 2008, CLIN EXP METASTAS, V25, P835, DOI 10.1007/s10585-008-9199-6; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vucemilo Tiha, 2014, Coll Antropol, V38, P135; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2002, CANCER RES, V62, P6278; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xu Y, 2016, ONCOGENE; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217	63	6	6	10	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183883	10.1371/journal.pone.0183883	http://dx.doi.org/10.1371/journal.pone.0183883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880889	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200026
J	Manuwald, U; Heinke, P; Salzsieder, E; Hegewald, J; Schoffer, O; Kugler, J; Kapellen, TM; Kiess, W; Rothe, U				Manuwald, Ulf; Heinke, Peter; Salzsieder, Eckhard; Hegewald, Janice; Schoffer, Olaf; Kugler, Joachim; Kapellen, Thomas M.; Kiess, Wieland; Rothe, Ulrike			Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany	PLOS ONE			English	Article							BIRTH-WEIGHT; CHILDHOOD; TIME; RISK; POPULATION; GENOTYPES; MELLITUS; REGISTRY; EUROPE; RATES	Aims The aim of this study was to analyze the incidence rates of type 1 diabetes in Saxony before and after the German reunification. Methods The study examined two registries: one until 1990 and one since 1999. Only patients under 15 years of age with type 1 diabetes and living in Saxony were included in the study. Standardized incidence rates were described based on direct age standardization procedures using the Standard European Population for each calendar year between the observation periods 1982-1989 and 1999-2014. Age was grouped into three classes: 0-4, 5-9 and 10-14 years of age. Incidence data were presented as age-standardized incidence rates per 100,000 person-years (PY) with 95% confidence intervals [CI]. Joinpoint regression was used for trend analyses and Poisson regression was used to adjust for the effects of age and sex on the incidence. Results A total number of 2,092 incident cases of type 1 diabetes (1,109 males; 983 females) were included. The age-standardized incidence rates of type 1 diabetes per 100,000 PY was 7.9 [95% CI 6.8; 8.9] in the period from 1982-1989 and 20.1 [95% CI 14.0; 26.1] in the period from 1999-2014. The yearly increase in incidence over the entire time period (1982-2014) was 4.3% according to the average annual percent change (AAPC) method, and estimated to be 4.4% [95% CI 4.0; 4.8%] using a Poisson regression model adjusting for sex and age group. Conclusion In this study, a significantly increasing incidence of type 1 diabetes was observed after reunification. In future studies it would be interesting to follow up on the question of which environmental and lifestyle factors could be causing the increasing type 1 diabetes incidence.	[Manuwald, Ulf; Kugler, Joachim; Rothe, Ulrike] Tech Univ Dresden, Hlth Sci, Publ Hlth, Fac Med Carl Gustav Carus, Dresden, Germany; [Heinke, Peter; Salzsieder, Eckhard] Inst Diabet Gerhardt Katsch Karlsburg, Karlsburg, Germany; [Hegewald, Janice] Tech Univ Dresden, Inst & Policlin Occupat & Social Med, Fac Med Carl Gustav Carus, Dresden, Germany; [Schoffer, Olaf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Kapellen, Thomas M.; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res, Hosp Children & Adolescents, Leipzig, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Leipzig University	Manuwald, U (corresponding author), Tech Univ Dresden, Hlth Sci, Publ Hlth, Fac Med Carl Gustav Carus, Dresden, Germany.	Ulf.Manuwald@tu-dresden.de	Schoffer, Olaf/R-1841-2016	Schoffer, Olaf/0000-0001-6922-7148; Hegewald, Janice/0000-0003-3388-161X; Prof. Rothe, Ulrike/0000-0001-9779-7260	German Research Foundation; Open Access Publication Funds of the TU Dresden	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; Barat P, 2008, DIABETES METAB, V34, P601, DOI 10.1016/j.diabet.2008.06.002; Bendas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132716; Bodin J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/208947; Breslow N E, 1987, IARC Sci Publ, P1; Cardwell CR, 2012, DIABETES CARE, V35, P2215, DOI 10.2337/dc12-0438; Cardwell CR, 2005, DIABETIC MED, V22, P200, DOI 10.1111/j.1464-5491.2005.01369.x; Ehehalt S, 2012, EXP CLIN ENDOCR DIAB, V120, P441, DOI 10.1055/s-0032-1309045; Ehehalt S, 2010, DIABETES CARE, V33, P338, DOI 10.2337/dc09-1503; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA S3, V44, P3; Gulden E, 2015, CLIN IMMUNOL, V159, P143, DOI 10.1016/j.clim.2015.05.013; Hathout EH, 2006, PEDIATR DIABETES, V7, P81, DOI 10.1111/j.1399-543X.2006.00150.x; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4; Kaindl M, 2014, U WIEN, P18; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kramer U, 2010, CLIN EXP ALLERGY, V40, P289, DOI 10.1111/j.1365-2222.2009.03435.x; Kukko M, 2004, DIABETES CARE, V27, P676, DOI 10.2337/diacare.27.3.676; Lehmann I, 2002, ALLERGY, V57, P129, DOI 10.1046/j.0105-4538.2002.00001.x; MICHAELIS D, 1993, DIABETES METAB, V19, P110; Michaelis D, 1993, DIABETES STOFFWECH H, V2, P245; Mohr SB, 2008, DIABETOLOGIA, V51, P1391, DOI 10.1007/s00125-008-1061-5; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Potzsch O, 2012, GEBURTEN DEUTSCHLAND, P11; Schober E, 2008, EUR J PEDIATR, V167, P293, DOI 10.1007/s00431-007-0480-5; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183665	10.1371/journal.pone.0183665	http://dx.doi.org/10.1371/journal.pone.0183665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880877	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200022
J	Flores, SE; Aitchison, A; Day, AS; Keenan, JI				Flores, Sebastian E.; Aitchison, Alan; Day, Andrew S.; Keenan, Jacqueline I.			Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; VACUOLATING CYTOTOXIN; DEFICIENCY ANEMIA; NEISSERIA-MENINGITIDIS; FERRITIN DEGRADATION; VACA; POOL; PATHOGENESIS; EXPRESSION; DISEASE	The iron deficiency anaemia that often accompanies infection with Helicobacter pylori may reflect increased uptake of iron into gastric epithelial cells. Here we show an infection-associated increase in total intracellular iron levels was associated with the redistribution of the transferrin receptor from the cell cytosol to the cell surface, and with increased levels of ferritin, an intracellular iron storage protein that corresponded with a significant increase in lysosomal stores of labile iron. In contrast, the pool of cytosolic labile iron was significantly decreased in infected cells. These changes in intracellular iron distribution were associated with the uptake and trafficking of H. pylori through the cells, and enhanced in strains capable of expressing the cagA virulence gene. We speculate that degradation of lysosomal ferritin may facilitate H. pylori pathogenesis, in addition to contributing to bacterial persistence in the human stomach.	[Flores, Sebastian E.; Aitchison, Alan; Keenan, Jacqueline I.] Univ Otago, Dept Surg, Christchurch, New Zealand; [Day, Andrew S.] Univ Otago, Dept Paediat, Christchurch, New Zealand	University of Otago; University of Otago	Keenan, JI (corresponding author), Univ Otago, Dept Surg, Christchurch, New Zealand.	jacqui.keenan@otago.ac.nz		Aitchison, Alan/0000-0002-0857-1815				Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Backert S, 2016, CANCER RES, V76, P4028, DOI 10.1158/0008-5472.CAN-16-1680; Barabino A, 1999, J PEDIATR GASTR NUTR, V28, P116, DOI 10.1097/00005176-199901000-00027; Bonnah RA, 2004, CELL MICROBIOL, V6, P473, DOI 10.1111/j.1462-5822.2004.00376.x; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chitcholtan K, 2008, CARCINOGENESIS, V29, P2400, DOI 10.1093/carcin/bgn218; Coray DS, 2012, WORLD J MICROB BIOT, V28, P1871, DOI 10.1007/s11274-011-0984-z; COVER TL, 1994, J BIOL CHEM, V269, P10566; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Flores SE, 2015, BIOMETALS, V28, P143, DOI 10.1007/s10534-014-9810-z; Ha YM, 2009, CANCER LETT, V277, P48, DOI 10.1016/j.canlet.2008.11.020; Hardbower DM, 2014, J LEUKOCYTE BIOL, V96, P201, DOI 10.1189/jlb.4BT0214-099R; Huang CH, 2014, WORLD J GASTROENTERO, V20, P1529, DOI 10.3748/wjg.v20.i6.1529; Isomoto H, 2010, TOHOKU J EXP MED, V220, P3, DOI 10.1620/tjem.220.3; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Keenan J, 2000, FEMS MICROBIOL LETT, V182, P259, DOI 10.1111/j.1574-6968.2000.tb08905.x; Keenan J, 2000, INFECT IMMUN, V68, P3337, DOI 10.1128/IAI.68.6.3337-3343.2000; Keenan JI, 2004, HELICOBACTER, V9, P643, DOI 10.1111/j.1083-4389.2004.00278.x; Keown DA, 2012, INFECT IMMUN, V80, P3768, DOI 10.1128/IAI.00534-12; Konno M, 2000, J PEDIATR GASTR NUTR, V31, P52, DOI 10.1097/00005176-200007000-00012; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Larson JA, 2004, MOL MICROBIOL, V53, P807, DOI 10.1111/j.1365-2958.2004.04169.x; Marignani M, 1997, SCAND J GASTROENTERO, V32, P617, DOI 10.3109/00365529709025109; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; PICKART L, 1983, BIOCHEM PHARMACOL, V32, P3868, DOI 10.1016/0006-2952(83)90164-8; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tan SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002050; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; TUMMURU MKR, 1994, INFECT IMMUN, V62, P2609, DOI 10.1128/IAI.62.6.2609-2613.1994; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Weinberg ED, 2008, J ALZHEIMERS DIS, V13, P451; ZDOLSEK JM, 1993, FREE RADICAL BIO MED, V15, P1, DOI 10.1016/0891-5849(93)90120-J; Zhang B, 2012, TUMORI, V98, P800, DOI 10.1700/1217.13506; Zhang YH, 2010, ANTIOXID REDOX SIGN, V13, P999, DOI 10.1089/ars.2010.3129	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184026	10.1371/journal.pone.0184026	http://dx.doi.org/10.1371/journal.pone.0184026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873091	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800042
J	Fergnani, PN; Ruggiero, A				Nilda Fergnani, Paula; Ruggiero, Adriana			The latitudinal diversity gradient in South American mammals revisited using a regional analysis approach: The importance of climate at extra-tropical latitudes and history towards the tropics	PLOS ONE			English	Article							SPECIES-RICHNESS GRADIENTS; FUNCTIONAL DIVERSITY; GLOBAL PATTERNS; NICHE CONSERVATISM; BIOGEOGRAPHY; EVOLUTION; ENERGY; DIVERSIFICATION; PRODUCTIVITY; COEXISTENCE	The latitudinal diversity gradient has been considered a consequence of a shift in the impact of abiotic and biotic factors that limit species distributions from the poles to the equator, thus influencing species richness variation. It has also been considered the outcome of evolutionary processes that vary over geographical space. We used six South American mammal groups to test the association of environmental and evolutionary factors and the ecological structuring of mammal assemblages with spatial variation in taxonomic richness (TR), at a spatial resolution of 110 km x 110 km, at tropical and extra-tropical latitudes. Based on attributes that represent what mammal species do in ecosystems, we estimated ecological diversity (ED) as a mean pairwise ecological distance between all co-occurring taxa. The mean pairwise phylogenetic distance between all co-occurring taxa (AvPD) was used as an estimation of phylogenetic diversity. Geographically Weighted Regression analyses performed separately for each mammal group identified tropical and extra-tropical high R-2 areas where environmental and evolutionary factors strongly accounted for richness variation. Temperature was the most important predictor of TR in high R-2 areas outside the tropics, as was AvPD within the tropics. The proportion of TR variation accounted for by environment (either independently or combined with AvPD) was higher in tropical areas of high richness and low ecological diversity than in tropical areas of high richness and high ecological diversity. In conclusion, we confirmed a shift in the impact of environmental factors, mainly temperature, that best account for mammal richness variation in extra-tropical regions, whereas phylogenetic diversity best accounts for richness variation within the tropics. Environment in combination with evolutionary history explained the coexistence of a high number of ecologically similar species within the tropics. Consideration of the influence of contemporary environmental variables and evolutionary history is crucial to understanding of the latitudinal diversity gradient.	[Nilda Fergnani, Paula; Ruggiero, Adriana] Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, Ctr Reg Univ Bariloche, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Fergnani, PN (corresponding author), Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, Ctr Reg Univ Bariloche, San Carlos De Bariloche, Rio Negro, Argentina.	paulafergnani@gmail.com			CONICET [PIP-114-200901-00089]; Universidad Nacional del Comahue	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Comahue	This work was supported by PIP-114-200901-00089 - CONICET (www.conicet.gov.ar) (National Scientific and Technical Research Council Argentina) (AR); and Universidad Nacional del Comahue (http://www.uncoma.edu.ar/) (AR PNF).	Andrews P, 2000, J ZOOL, V251, P205, DOI 10.1111/j.1469-7998.2000.tb00605.x; Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Belmaker J, 2015, ECOL LETT, V18, P563, DOI 10.1111/ele.12438; Belmaker J, 2012, J BIOGEOGR, V39, P193, DOI 10.1111/j.1365-2699.2011.02591.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brown J. H., 1995, MACROECOLOGY; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Cardillo M, 2002, J ANIM ECOL, V71, P79, DOI 10.1046/j.0021-8790.2001.00577.x; Cunningham HR, 2016, ECOGRAPHY, V39, P1, DOI 10.1111/ecog.01369; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Cusens J, 2012, ECOLOGY, V93, P2241, DOI 10.1890/11-1861.1; Da Silva Cassemiro FADS, 2007, GLOBAL ECOL BIOGEOGR, V16, P820, DOI 10.1111/j.1466-8238.2007.00332.x; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; Davies TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1096, DOI 10.1111/j.1466-8238.2012.00759.x; Davies TJ, 2011, PHILOS T R SOC B, V366, P2526, DOI 10.1098/rstb.2011.0018; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Dobzhansky T., 1950, American Scientist, V38, P209; *ESRI, 2007, ARCGIS 9 2 SOFTW; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Foody GM, 2005, GLOBAL ECOL BIOGEOGR, V14, P99, DOI 10.1111/j.1466-822X.2005.00142.x; Fotheringham AS, 2016, J GEOGR SYST, V18, P303, DOI 10.1007/s10109-016-0239-5; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Galewski T, 2005, MOL PHYLOGENET EVOL, V34, P601, DOI 10.1016/j.ympev.2004.11.015; Gouveia SF, 2013, ECOGRAPHY, V36, P104, DOI 10.1111/j.1600-0587.2012.07553.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Groves C, 2004, INT J PRIMATOL, V25, P1105, DOI 10.1023/B:IJOP.0000043354.36778.55; Harcourt AH, 2006, J BIOGEOGR, V33, P2077, DOI 10.1111/j.1365-2699.2006.01557.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2012, J BIOGEOGR, V39, P825, DOI 10.1111/j.1365-2699.2011.02655.x; Hedges LV, 2014, STAT METHODS META AN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Perez SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068029; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jenkins CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145064; Jetz W, 2005, GLOBAL ECOL BIOGEOGR, V14, P97, DOI 10.1111/j.1466-822X.2004.00129.x; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; Keith SA, 2014, GLOBAL ECOL BIOGEOGR, V23, P517, DOI 10.1111/geb.12132; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Laliberte E, 2010, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lamanna C, 2014, P NATL ACAD SCI USA, V111, P13745, DOI 10.1073/pnas.1317722111; Lowenberg-Neto P, 2014, ZOOTAXA, V3802, P300, DOI 10.11646/zootaxa.3802.2.12; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MacArthur R.H., 1972, pvii; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Machac A, 2017, AM NATURALIST, V189; Maestri R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151895; Marin J, 2016, J BIOGEOGRAPHY; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morales-Castilla I, 2012, AM NAT, V180, P246, DOI 10.1086/666608; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Morrone JJ, 2010, ENVIRON RES ADV, P1; Moura MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152468; Fergnani PN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128264; Oliveira BF, 2016, GLOBAL ECOL BIOGEOGR, V25, P1119, DOI 10.1111/geb.12471; OWEN JG, 1990, J MAMMAL, V71, P1, DOI 10.2307/1381311; PASCUAL R, 1990, J HUM EVOL, V19, P23, DOI 10.1016/0047-2484(90)90011-Y; Pascual R., 1984, QUATERNARY S AM ANTA, V2, P1; Pascual R, 2006, ANN MO BOT GARD, V93, P209, DOI 10.3417/0026-6493(2006)93[209:EAGTBH]2.0.CO;2; Patterson BD, 2003, BAT ECOLOGY, P536; Peixoto FP, 2017, GLOBAL ECOL BIOGEOGR, V26, P573, DOI 10.1111/geb.12561; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pereira MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069245; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Reig OA, 1962, AMEGHINIANA, V1, P131; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rolland J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001775; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Ruggiero A, 2004, ECOGRAPHY, V27, P401, DOI 10.1111/j.0906-7590.2004.03801.x; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schluter D, 2016, AM NAT, V187, P1, DOI 10.1086/684193; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Tognelli MF, 2004, ECOGRAPHY, V27, P427, DOI 10.1111/j.0906-7590.2004.03732.x; Tucker CM, 2013, DIVERS DISTRIB, V19, P845, DOI 10.1111/ddi.12087; Vizcaino SF, 2009, PALEOBIOLOGY, V35, P343, DOI 10.1666/0094-8373-35.3.343; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wheeler D., 2005, J GEOGRAPHICAL SYSTE, V7, P161, DOI [DOI 10.1007/S10109-005-0155-6, 10.1007/s10109-005-0155-6]; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Willmott C. J., 2001, TERRESTRIAL WATER BU; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8; Zurano JP, 2017, J BIOGEOGR, V44, P821, DOI 10.1111/jbi.12984	95	8	9	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184057	10.1371/journal.pone.0184057	http://dx.doi.org/10.1371/journal.pone.0184057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873434	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800046
J	Vanickova, L; Nagy, R; Pompeiano, A; Kalinova, B				Vanickova, Lucie; Nagy, Radka; Pompeiano, Antonio; Kalinova, Blanka			Epicuticular chemistry reinforces the new taxonomic classification of the Bactrocera dorsalis species complex (Diptera: Tephritidae, Dacinae)	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; FRUIT-FLY; DROSOPHILA-MELANOGASTER; MATING COMPATIBILITY; FATTY-ACIDS; IDENTIFICATION; LIPIDS; HYMENOPTERA; CULICIDAE; BEHAVIOR	Bactrocera invadens Drew, Tsuruta & White, Bactrocera papayae Drew & Hancock, and Bactrocera philippinensis Drew & Hancock, key pest species within the Bactrocera dorsalis species complex, have been recently synonymized under the name Bactrocera dorsalis (Hendel). The closely related Bactrocera carambolae Drew & Hancock remains as a discrete taxonomic entity. Although the synonymizations have been accepted by most researchers, debate about the species limits remains. Because of the economic importance of this group of taxa, any new information available to support or deny the synonymizations is valuable. We investigated the chemical epicuticle composition of males and females of B. dorsalis, B. invadens, B. papayae, B. philippinensis, and B. carambolae by means of oneand two-dimensional gas chromatography - mass spectrometry, followed by multiple factor analyses and principal component analysis. Clear segregation of complex cuticule profiles of both B. carambolae sexes from B. dorsalis (Hendel) was observed. In addition to cuticular hydrocarbons, abundant complex mixtures of sex-specific oxygenated lipids (three fatty acids and 22 fatty acid esters) with so far unknown function were identified in epicuticle extracts from females of all species. The data obtained supports both taxonomic synonymization of B. invadens, B. papayae, and B. philippinensis with B. dorsalis, as well as the exclusion of B. carambolae from B. dorsalis.	[Vanickova, Lucie] Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic; [Nagy, Radka; Kalinova, Blanka] Czech Acad Sci, Inst Organ Chem & Biochem, Lab Infochem, Prague, Czech Republic; [Pompeiano, Antonio] St Annes Univ Hosp, Int Clin Res Ctr, Ctr Translat Med, Brno, Czech Republic; [Kalinova, Blanka] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic	Mendel University in Brno; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; St Anne's University Hospital Brno (FNUSA-ICRC); Czech University of Life Sciences Prague	Kalinova, B (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Lab Infochem, Prague, Czech Republic.; Kalinova, B (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic.	blanka@uochb.cas.cz	Pompeiano, Antonio/A-1330-2017; Vanickova, Lucie/L-7034-2016	Pompeiano, Antonio/0000-0001-7375-1014; Vanickova, Lucie/0000-0001-7744-3246	Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague [RVO: 61388963]; FAO/IAEA Coordinated Research Project on Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constrains to SIT and International Trade [17870]; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]	Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague(Czech Academy of Sciences); FAO/IAEA Coordinated Research Project on Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constrains to SIT and International Trade; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC	Funding for this work was provided by the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague (RVO: 61388963): BK, RN; by the FAO/IAEA Coordinated Research Project on Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constrains to SIT and International Trade (contract no. 17870): BK, RN, LV; and by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601)): LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was provided by the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague (RVO: 61388963); by the FAO/IAEA Coordinated Research Project on Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constrains to SIT and International Trade (contract no. 17870); and by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601). We thank for the valuable comments of the two anonymous referees in an earlier version of this manuscript. We acknowledge Prof. Anthony R. Clarke (Queensland University of Technology, Australia) for proofreading and valuable comments on the manuscript.	BAKER R, 1985, EXPERIENTIA, V41, P1484, DOI 10.1007/BF01950049; Benelli G, 2015, INSECTS, V6, P38, DOI 10.3390/insects6010038; Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3; Benelli G, 2014, J INSECT BEHAV, V27, P145, DOI 10.1007/s10905-013-9411-7; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Bonduriansky R, 2015, ECOL LETT, V18, P317, DOI 10.1111/ele.12412; Broza M, 2000, ANN ENTOMOL SOC AM, V93, P1022, DOI 10.1603/0013-8746(2000)093[1022:CHAATS]2.0.CO;2; Calderon-Fernandez GM, 2011, J MED ENTOMOL, V48, P262, DOI 10.1603/ME10141; Canale A, 2015, CHEMOECOLOGY, V25, P147, DOI 10.1007/s00049-014-0183-0; Caputo B, 2005, J MASS SPECTROM, V40, P1595, DOI 10.1002/jms.961; CARLSON DA, 1979, ANN TROP MED PARASIT, V73, P589, DOI 10.1080/00034983.1979.11687301; Chin JSR, 2014, ELIFE, V3, DOI 10.7554/eLife.01751; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Diaz-Fleischer F, 2000, EVOLUTION FRUIT FLY, P811; dos Santos AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145070; Drew R., 2016, KEYS TROPICAL FRUIT; Drew R.A.I., 2013, TROPICAL FRUIT FLIES; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Drew RAI, 2005, AFR ENTOMOL, V13, P149; DREW RAI, 1994, J AUST ENTOMOL SOC, V33, P376; Drew RAI, 2000, PHYLOGENY TRIBE DACI, P491; Drew RAI, 2008, BIOL J LINN SOC, V93, P217, DOI 10.1111/j.1095-8312.2007.00952.x; El-Sayed AM, 2013, PHEROBASE DATABASE I; Espelie KE, 1996, COMP BIOCHEM PHYS B, V113, P193, DOI 10.1016/0305-0491(95)02049-7; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Foundation R, 2014, R LANG ENV STAT COMP; Gemeno C, 2012, B ENTOMOL RES, V102, P624, DOI 10.1017/S0007485312000193; GIBBS A, 1991, J INSECT PHYSIOL, V37, P743, DOI 10.1016/0022-1910(91)90108-C; Gleason JM, 2009, HEREDITY, V103, P416, DOI 10.1038/hdy.2009.79; Golebiowski M, 2008, INSECT BIOCHEM MOLEC, V38, P619, DOI 10.1016/j.ibmb.2008.03.005; Golebiowski M, 2013, J INSECT PHYSIOL, V59, P416, DOI 10.1016/j.jinsphys.2013.02.001; Golebiowski M, 2011, ANAL BIOANAL CHEM, V399, P3177, DOI 10.1007/s00216-010-4439-4; Gutierrez AC, 2015, J ECON ENTOMOL, V108, P752, DOI 10.1093/jee/tou096; HARDY DE, 1969, P HAWAII ENTOMOL SOC, V20, P395; Haverty MI, 1997, COMP BIOCHEM PHYS B, V118, P869, DOI 10.1016/S0305-0491(97)00237-X; Haverty MI, 2000, J CHEM ECOL, V26, P1167, DOI 10.1023/A:1005479826651; Hee AKW, 2015, ZOOKEYS, P323, DOI 10.3897/zookeys.540.6028; Hensel R, 2016, CHEM SOC REV, V45, P323, DOI 10.1039/c5cs00438a; Husson F, 2015, FACTOMINER MULTIVARI; Ingleby FC, 2014, J EVOLUTION BIOL, V27, P700, DOI 10.1111/jeb.12338; Kather R, 2012, PHYSIOL ENTOMOL, V37, P25, DOI 10.1111/j.1365-3032.2011.00826.x; Key M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S10; Khamis FM, 2009, MOL ECOL, V18, P4798, DOI 10.1111/j.1365-294X.2009.04391.x; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Pavkovic-Lucic S, 2016, CHEM BIODIVERS, V13, P224, DOI 10.1002/cbdv.201500064; Schutze MK, 2013, J ECON ENTOMOL, V106, P695, DOI 10.1603/EC12409; Schutze MK, 2015, SYST ENTOMOL, V40, P456, DOI 10.1111/syen.12113; Schutze MK, 2015, SYST ENTOMOL, V40, P472, DOI 10.1111/syen.12114; Schutze MK, 2017, SYSTEMATIC IN PRESS; Seifert B, 2009, MYRMECOL NEWS, V12, P149; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TANAKA N, 1969, J ECON ENTOMOL, V62, P967, DOI 10.1093/jee/62.4.967; ul Haq I, 2016, J ECON ENTOMOL, V109, P148, DOI 10.1093/jee/tov274; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Vanickova L, 2015, J APPL ENTOMOL, V139, P679, DOI 10.1111/jen.12204; Vanickova L, 2014, B ENTOMOL RES, V104, P631, DOI 10.1017/S0007485314000406; Vanickova L, 2015, ZOOKEYS, P193, DOI 10.3897/zookeys.540.9649; Vanickova L, 2012, J CHEM ECOL, V38, P1133, DOI 10.1007/s10886-012-0177-8; Warnes GR, 2015, GPLOTS VARIOUS R PRO	66	10	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184102	10.1371/journal.pone.0184102	http://dx.doi.org/10.1371/journal.pone.0184102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873446	Green Submitted, gold, Green Published			2022-12-26	WOS:000409282800051
J	Che, W; Bao, Y; Tang, F				Che, Wen; Bao, Yun; Tang, Feng			Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells	PLOS ONE			English	Article							CANCER CELLS; TARGETED THERAPIES; SIGNALING PATHWAY; GENE-EXPRESSION; APOPTOSIS; SURVIVAL; MCF-7; INHIBITION; ACTIVATION; AMPLICON	Background Resistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression. C35 is over-expressed in many invasive breast cancer endogenously, and functions as an oncogene in breast cancer cell lines. Methods The current study aims to investigate effects of C35 on cell viability and migration of HER2-positive breast tumor cells and explore possible mechanisms. The protein expression of C35 in BT-474 breast ductal carcinoma cells was interfered by siRNAs. MTT assay was utilized to detect the viability of BT474 breast ductal carcinoma cells after transfection. The migration of BT474 breast ductal carcinoma cells was examined by cell wound scratch assay. Results In addition, the protein expression of C35, HER2, AKT and p-AKT in breast ductal carcinoma cells were detected by Western Blot. The protein expression of C35 was weaker in siRNA1 and siRNA2 groups compared with the control group. The relative expression ratio of C35 to beta-actin decreased significantly in siRNA2 and siRNA1 groups. When C35 expression was interfered by siRNA1 and siRNA2 for 48 h, the viability of BT474 breast ductal carcinoma cells decreased compared with the control group. In addition, the migration of breast ductal carcinoma cells decreased when C35 expression was interfered by siRNA1 for 24 h, and interfered by siRNA1 and siRNA2 for 48 h.	[Che, Wen; Bao, Yun; Tang, Feng] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China	Fudan University	Tang, F (corresponding author), Fudan Univ, Huashan Hosp, Shanghai, Peoples R China.	tangfeng047@sina.com						Akrami H, 2016, CELL BIOCHEM FUNCT, V34, P173, DOI 10.1002/cbf.3176; Amarzguioui M, 2005, FEBS LETT, V579, P5974, DOI 10.1016/j.febslet.2005.08.070; Monteiro IDC, 2015, PHARMACOGENOMICS, V16, P257, DOI 10.2217/pgs.14.133; Delord JP, 2005, ANN ONCOL, V16, P1889, DOI 10.1093/annonc/mdi405; Dias ACD, 2015, MAR DRUGS, V13, P4934, DOI 10.3390/md13084934; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Drotleff AM, 2015, J AGR FOOD CHEM, V63, P8930, DOI 10.1021/acs.jafc.5b04388; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; Fu Z, 2016, FOOD FUNCT, V7, P1014, DOI 10.1039/c5fo01124h; Garrido P, 2015, J CELL PHYSIOL, V230, P191, DOI 10.1002/jcp.24698; Huang Y, 2013, CURR DRUG TARGETS, V14, P889, DOI 10.2174/13894501113149990161; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Librizzi M, 2016, CELL BIOCHEM FUNCT, V34, P7, DOI 10.1002/cbf.3157; McGuire A, 2015, CANCERS, V7, P908, DOI 10.3390/cancers7020815; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Rwigemera A, 2015, ANTICANCER RES, V35, P207; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Xie M, 2015, ONCOTARGET, V6, P29901, DOI 10.18632/oncotarget.4898; Zheng Li, 2004, Zhonghua Zhongliu Zazhi, V26, P594	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183941	10.1371/journal.pone.0183941	http://dx.doi.org/10.1371/journal.pone.0183941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859163	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500049
J	Yoshitomi, H; Tsuru, R; Li, LY; Zhou, JX; Kudo, M; Liu, TH; Gao, M				Yoshitomi, Hisae; Tsuru, Rika; Li, Linyi; Zhou, Jingxin; Kudo, Maya; Liu, Tonghua; Gao, Ming			Cyclocarya paliurus extract activates insulin signaling via Sirtuin1 in C2C12 myotubes and decreases blood glucose level in mice with impaired insulin secretion	PLOS ONE			English	Article							RESISTANCE; AMPK; RECEPTOR; CELLS; PHOSPHORYLATION; ADIPOCYTES; SUBSTRATE; TRANSPORT; PATHWAYS; PROTEIN	Diabetes is caused by the lack of release or action of insulin. Some foods and supplements can compensate for this deficiency; thus, they can aid in the prevention or treatment of diabetes. The aim of this study was to investigate the effects of Cyclocarya paliurus extract (CPE) on insulin signaling and its capacity to correct hyperglycemia in the absence of insulin. To investigate the hypoglycemic effects of CPE, C2C12 cells were exposed to CPE (50 and 100 mu g/mL). CPE promoted 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose (2NBDG) uptake into the cells via translocation of glucose transporter 4 (Glut4) to the plasma membrane. In addition, CPE enhanced tyrosine phosphorylation of insulin receptor substrate and activated phosphatidylinositol 3-kinase and protein kinase B (Akt) via sirtuin1 in C2C12 cells. Moreover, we found that oral administration of CPE (1 g/kg) to streptozotocin-induced hyperglycemic mice produced a progressive decrease in plasma glucose levels at 1 h after single dosing. At that point, CPE significantly increased the expression of skeletal muscle membrane Glut4 and enhanced the phosphorylation of Akt. These results suggest that CPE exerts antidiabetic effects similar to those of insulin, and may be an oral therapeutic alternative for the management of diabetes.	[Yoshitomi, Hisae; Tsuru, Rika; Kudo, Maya; Gao, Ming] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Li, Linyi; Liu, Tonghua] Beijing Univ Chinese Med, Minist Educ, Hlth Cultivat Lab, Beijing, Peoples R China; [Zhou, Jingxin] Beijing Univ Chinese Med, Dongzhimen Hosp Eastern, Beijing, Peoples R China	Mukogawa Women's University; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Gao, M (corresponding author), Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo, Japan.	gaoming@mukogawa-u.ac.jp		Zhou, Jingxin/0000-0003-0471-1961				Abe D, 2006, LIFE SCI, V79, P1027, DOI 10.1016/j.lfs.2006.03.007; Amos AF, 1997, DIABET MED S5, V14, P1; Cordero-Herrera I, 2013, MOL NUTR FOOD RES, V57, P974, DOI 10.1002/mnfr.201200500; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; Gray AM, 1998, J NUTR, V128, P2319, DOI 10.1093/jn/128.12.2319; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jing M, 2008, AM J PHYSIOL-CELL PH, V295, pC1071, DOI 10.1152/ajpcell.00040.2008; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; Kurihara H, 2003, BIOSCI BIOTECH BIOCH, V67, P877, DOI 10.1271/bbb.67.877; Li Lei, 2002, Zhong Yao Cai, V25, P39; Li SA, 2012, PLANTA MED, V78, P290, DOI 10.1055/s-0031-1280411; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shen M. Q., 2002, CHIN J PRACT CHIN MO, V2, P863; Shu Rengeng, 2005, Zhong Yao Cai, V28, P558; Shu RG, 1995, PLANTA MED, V61, P551, DOI 10.1055/s-2006-959369; Siddiqui MA, 2010, TOXICOL IN VITRO, V24, P1592, DOI 10.1016/j.tiv.2010.06.008; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864; Wang QQ, 2013, J ETHNOPHARMACOL, V150, P1119, DOI 10.1016/j.jep.2013.10.040; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974; Zhu KN, 2015, PHYTOMEDICINE, V22, P837, DOI 10.1016/j.phymed.2015.05.058; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8	30	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183988	10.1371/journal.pone.0183988	http://dx.doi.org/10.1371/journal.pone.0183988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859155	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500055
J	Orth, M; Unger, K; Schoetz, U; Belka, C; Lauber, K				Orth, M.; Unger, K.; Schoetz, U.; Belka, C.; Lauber, K.			Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2	ONCOGENE			English	Article							PANCREATIC-CANCER CELLS; X-RAY-SENSITIVITY; KINASE AURORA-A; LUNG-CANCER; INDUCTION CHEMOTHERAPY; RADIATION SENSITIZER; CLONOGENIC SURVIVAL; COLORECTAL-CANCER; TUMOR-GROWTH; HELA-CELLS	Taxane-based radiochemotherapy is a central treatment option for various cancer entities in locally advanced stages. The therapeutic synergism of this combined modality approach due to taxane-mediated radiosensitization of cancer cells is well-known. However, the underlying molecular mechanisms remain largely elusive, and mechanism-derived predictive markers of taxane-based radiochemotherapy are currently not available. Here, we show that clinically relevant doses of Paclitaxel, the prototype taxane, stimulate a tripolar mode of mitosis leading to chromosomal missegregation and aneuploidization rather than interfering with cell cycle progression. This distinct mitotic phenotype was interlinked with Paclitaxel-mediated radiosensitization via overexpression of mitotic Aurora kinase A (AURKA) and its cofactor TPX2 whose knockdown rescued the bipolar mode of cell division and largely attenuated the radiosensitizing effects of Paclitaxel. In the cancer genome atlas (TCGA) lung adenocarcinoma cohort, high expression levels of AURKA and TPX2 were associated with specifically improved overall survival upon taxane-based radiochemotherapy, but not in case of non-taxane-based radiochemotherapy, chemo- or radiotherapy only. Thus, our data provide insights into Paclitaxel-mediated radiosensitization on a mechanistic and molecular level and identify AURKA and TPX2 as the first potential mechanism-based, predictive markers of taxane-based radiochemotherapy.	[Orth, M.; Schoetz, U.; Belka, C.; Lauber, K.] Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Marchioninistr 15, D-81377 Munich, Germany; [Orth, M.; Unger, K.; Schoetz, U.; Belka, C.; Lauber, K.] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany; [Orth, M.; Belka, C.; Lauber, K.] German Canc Consortium DKTK, Munich, Germany; [Orth, M.] German Canc Res Ctr, Heidelberg, Germany; [Unger, K.] Helmholtz Ctr Munich, Res Unit Radiat Cytogenet, Neuherberg, Germany; [Belka, C.] German Ctr Lung Res DZL, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lauber, K (corresponding author), Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Marchioninistr 15, D-81377 Munich, Germany.	kirsten.lauber@med.uni-muenchen.de	Orth, Michael/AAQ-7299-2021; Unger, Kristian/F-3730-2018	Orth, Michael/0000-0002-4608-7151; Unger, Kristian/0000-0002-0374-2320; Schotz, Ulrike/0000-0001-8118-3977	grants of the Friedrich-Baur-Stiftung; Verein zur Forderung von Wissenschaft und Forschung	grants of the Friedrich-Baur-Stiftung; Verein zur Forderung von Wissenschaft und Forschung	We thank Olaf Stemmann for the stably transfected HeLa cell line and the centrin antibody, and Oliver J. Gruss for TPX2 antisera. This work was supported by grants of the Friedrich-Baur-Stiftung and the Verein zur Forderung von Wissenschaft und Forschung to MO and CB.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bian ML, 2010, SCI CHINA LIFE SCI, V53, P1322, DOI 10.1007/s11427-010-4086-1; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Choy H, 2001, Expert Opin Pharmacother, V2, P963, DOI 10.1517/14656566.2.6.963; Choy H, 2001, CRIT REV ONCOL HEMAT, V37, P237, DOI 10.1016/S1040-8428(00)00112-8; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Dey S, 2003, CLIN CANCER RES, V9, P1557; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Eberhardt WEE, 2015, J CLIN ONCOL, V33, P4194, DOI 10.1200/JCO.2015.62.6812; Ernst A, 2015, CANCER LETT, V365, P211, DOI 10.1016/j.canlet.2015.05.024; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Garrido G, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00088; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Giubettini M, 2011, J CELL SCI, V124, P113, DOI 10.1242/jcs.075457; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; HORWITZ SB, 1986, ANN NY ACAD SCI, V466, P733, DOI 10.1111/j.1749-6632.1986.tb38455.x; Huber RM, 2006, J CLIN ONCOL, V24, P4397, DOI 10.1200/JCO.2005.05.4163; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Kinzel L, 2016, ONCOTARGET, V7, P43199, DOI 10.18632/oncotarget.9774; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kurdoglu B, 1999, CLIN CANCER RES, V5, P2580; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; LIEBMANN J, 1994, J NATL CANCER I, V86, P441, DOI 10.1093/jnci/86.6.441; Lin Y, 2012, BRIT J CANCER, V107, P1692, DOI 10.1038/bjc.2012.450; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Martens-de Kemp SR, 2013, CLIN CANCER RES, V19, P1994, DOI 10.1158/1078-0432.CCR-12-2539; Mazumdar A, 2009, HEAD NECK-J SCI SPEC, V31, P625, DOI 10.1002/hed.21007; Mhaidat NM, 2007, MOL CANCER THER, V6, P752, DOI 10.1158/1535-7163.MCT-06-0564; Mignogna C, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0238-7; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Scharer CD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-79; Sehdev V, 2013, CANCER-AM CANCER SOC, V119, P904, DOI 10.1002/cncr.27801; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; STEREN A, 1993, GYNECOL ONCOL, V50, P89, DOI 10.1006/gyno.1993.1169; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Unkel S, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0584-z; Wang H, 2016, ONCOGENE, V35, P2011, DOI 10.1038/onc.2015.304; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Xu J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-200; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zullo KM, 2015, CLIN CANCER RES, V21, P4097, DOI 10.1158/1078-0432.CCR-15-0033	54	21	21	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					52	62		10.1038/onc.2017.304	http://dx.doi.org/10.1038/onc.2017.304			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28869599				2022-12-26	WOS:000422625000006
J	Marchesi, VT				Marchesi, Vincent T.			De novo digenic mutations of telomere-associated proteins and inflammasomes initiate many chronic human diseases: a hypothesis	FASEB JOURNAL			English	Article						inflammation; TERT; NLRP3	DOUBLE-STRAND BREAKS; AUTOINFLAMMATORY DISEASES; CELL-PROLIFERATION; HEMATOPOIETIC STEM; HYPERCHOLESTEROLEMIA; RECRUITMENT; GENETICS	Many age-related human diseases have inflammatory components of uncertain causes. It has been proposed that some may be initiated or sustained by doublymutated immune cells that have both inappropriately activated inflammasomes and enhanced replicative potential. Genes of cells that expressmutant TERT and NLRP3 proteins are presumed to be at increased risk for mutagenesis because they reside in subtelomeric regions of chromatin that are deficient in DNA repair mechanisms. Expanded clones of proinflammatory cells can occur throughout one's lifetime and could represent an alternative explanation for some forms of pathologic scarring that are now attributed to truncated telomeres.	[Marchesi, Vincent T.] Yale Univ, Dept Pathol, 295 Congress Ave, New Haven, CT 06536 USA	Yale University	Marchesi, VT (corresponding author), Yale Univ, Dept Pathol, 295 Congress Ave, New Haven, CT 06536 USA.	vincent.marchesi@yale.edu			Anthony N. Brady Professorship of Yale University	Anthony N. Brady Professorship of Yale University	This work was supported by the Anthony N. Brady Professorship of Yale University.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Bell RJA, 2016, MOL CANCER RES, V14, P315, DOI 10.1158/1541-7786.MCR-16-0003; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Kulkarni A, 2010, MOL CELL BIOL, V30, P578, DOI 10.1128/MCB.01137-09; Leroy C, 2013, EUR J HUM GENET, V21, P602, DOI 10.1038/ejhg.2012.230; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Schaffer AA, 2013, J MED GENET, V50, P641, DOI 10.1136/jmedgenet-2013-101713; Schmidt JC, 2016, CELL, V166, P1188, DOI 10.1016/j.cell.2016.07.033; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; Shao L, 2008, AM J MED GENET A, V146A, P2242, DOI 10.1002/ajmg.a.32399; Silva BA, 2017, DNA REPAIR, V49, P1, DOI 10.1016/j.dnarep.2016.10.008; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Tolani S, 2013, ATHEROSCLEROSIS, V229, P79, DOI 10.1016/j.atherosclerosis.2013.03.031	15	0	0	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					16	19		10.1096/fj.201700388RR	http://dx.doi.org/10.1096/fj.201700388RR			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28864660				2022-12-26	WOS:000419172700003
J	Tanishima, M; Takashima, S; Honda, A; Yasuda, D; Tanikawa, T; Ishii, S; MaruYama, T				Tanishima, Mitsuyoshi; Takashima, Shigeo; Honda, Arata; Yasuda, Daisuke; Tanikawa, Takashi; Ishii, Satoshi; MaruYama, Takashi			Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; ACTIVATION; PATHWAY; OSTEOPETROSIS; TRANSCRIPTION; RECOGNITION; BINDING	Upon stimulation of toll-like receptors with various microbial ligands, induction of a variety of inflammatory genes is elicited by activation of a myeloid differentiation primary-response protein 88 (MyD88)-dependent signaling pathway. Interleukin-1 (IL-1) receptor-associated kinase 1 (IRAK1) plays an essential role in this pathway by activating nuclear factor kappa B (NF-kappa B) and mitogen-activated kinases (MAPKs). Here, we identified optineurin (OPTN) as an IRAK1-binding protein by yeast two-hybrid screening using IRAK1 as bait. A C-terminal fragment of OPTN harboring a ubiquitin-binding domain was co-immunoprecipitated with IRAK1. In reporter analyses, overexpression of OPTN inhibited IL-1 beta-, IRAK1-, and LPS-induced NF-kappa B activation. Consistently, OPTN deficiency resulted in increased NF-kappa B activation in response to IL-1 beta/LPS stimulation. To address the mechanisms underlying the inhibitory effect of OPTN on NF-kappa B signaling, we focused on tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), which is an adaptor protein of IRAK1 and upon polyubiquitination plays a crucial role during NF-kappa Bactivation. Overexpression of OPTN prevented TRAF6 polyubiquitination. Furthermore, OPTN H486R mutant, which is unable to recruit the deubiquitinase CYLD, failed to inhibit IRAK1-induced NF-kappa Bactivation. These results suggest that the IRAK1-binding protein OPTN negatively regulates IL-1 beta/LPS-induced NF-kappa Bactivation by preventing polyubiquitination of TRAF6.	[Tanishima, Mitsuyoshi; MaruYama, Takashi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Takashima, Shigeo] Gifu Univ, Life Sci Res Ctr, Gifu 5011194, Japan; [Honda, Arata] Univ Miyazaki, Org Promot Tenure Track, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Yasuda, Daisuke; Ishii, Satoshi; MaruYama, Takashi] Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan; [Tanikawa, Takashi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan	Tohoku University; Gifu University; University of Miyazaki; Akita University; Teikyo University	MaruYama, T (corresponding author), Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan.	ta-maru@umin.ac.jp	MaruYama, Takashi/N-5994-2014	MaruYama, Takashi/0000-0003-0820-3219; Yasuda, Daisuke/0000-0001-5513-0695	JSPS KAKENHI [JP 16H05136]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant JP 16H05136 (to S. I.). The authors declare that they have no conflicts of interest regarding the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akizuki M, 2013, J NEUROCHEM, V126, P699, DOI 10.1111/jnc.12326; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Fujimoto T, 2004, J BIOL CHEM, V279, P47431, DOI 10.1074/jbc.M408724200; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ohba T, 2012, FEBS J, V279, P211, DOI 10.1111/j.1742-4658.2011.08416.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Sambrook J., 2006, CSH PROTOC, V2006, DOI [10.1101/pdb.prot3880, DOI 10.1101/PDB.PROT3880, DOI 10.1101/PDB.PR0T4455]; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Thomas R, 2005, ARTHRITIS RES THER, V7, P170, DOI 10.1186/ar1784; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	32	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17250	17257		10.1074/jbc.M117.813899	http://dx.doi.org/10.1074/jbc.M117.813899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28882891	Green Published, hybrid			2022-12-26	WOS:000414009300009
J	Sugitani, N; Voehler, MW; Roh, MS; Topolska-Wos, AM; Chazin, WJ				Sugitani, Norie; Voehler, Markus W.; Roh, Michelle S.; Topolska-Wos, Agnieszka M.; Chazin, Walter J.			Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; DNA repair; nuclear magnetic resonance (NMR); nucleotide excision repair; protein-DNA interaction	REPLICATION PROTEIN-A; TRANSCRIPTION-COUPLED REPAIR; DAMAGED-DNA; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; DUAL-INCISION; FACTOR IIH; NMR DATA; RECOGNITION; DOMAIN	Xeroderma pigmentosum (XP) complementation group A (XPA) is an essential scaffolding protein in the multiprotein nucleotide excision repair (NER) machinery. The interaction of XPA with DNA is a core function of this protein; a number of mutations in the DNA-binding domain (DBD) are associated with XP disease. Although structures of the central globular domain of human XPA and data on binding of DNA substrates have been reported, the structural basis for XPA's DNA-binding activity remains unknown. X-ray crystal structures of the central globular domain of yeast XPA (Rad14) with lesion-containing DNA duplexes have provided valuable insights, but the DNA substrates used for this study do not correspond to the substrates of XPA as it functions within the NER machinery. To better understand the DNA-binding activity of human XPA in NER, we used NMR to investigate the interaction of its DBD with a range of DNA substrates. We found that XPA binds different single-stranded/double-stranded junction DNA substrates with a common surface. Comparisons of our NMR-based mapping of binding residues with the previously reported Rad14-DNA crystal structures revealed similarities and differences in substrate binding between XPA and Rad14. This includes direct evidence for DNA contacts to the residues extending C-terminally from the globular core, which are lacking in the Rad14 construct. Moreover, mutation of the XPA residue corresponding to Phe-262 in Rad14, previously reported as being critical for DNA binding, had only a moderate effect on the DNA-binding activity of XPA. The DNA-binding properties of several disease-associated mutations in the DBD were investigated. These results suggest that for XPA mutants exhibiting altered DNA-binding properties, a correlation exists between the extent of reduction in DNA-binding affinity and the severity of symptoms in XP patients.	[Sugitani, Norie; Voehler, Markus W.; Roh, Michelle S.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Topolska-Wos, Agnieszka M.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Sugitani, Norie; Voehler, Markus W.; Topolska-Wos, Agnieszka M.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, 465 21st Ave S,Ste 5140,PMB 407917, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 465 21st Ave S,Ste 5140,PMB 407917, Nashville, TN 37232 USA.	walter.j.chazin@vanderbilt.edu	Classen, Scott/AAY-8176-2020		National Science Foundation [0922862]; National Institutes of Health [S10 RR025677, S10 OD021483]; Vanderbilt University; NATIONAL CANCER INSTITUTE [P30CA068485, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R35GM118089] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021483] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Nicole Eckart from NanoTemper Technologies for the valuable input to optimize and interpret MST data, Dr. Jonathan Sheehan for assistance with construction of the homology model, and Dr. Sarah E. Soss for advice on backbone resonance assignment. NMR instrumentation was acquired with support from the National Science Foundation through Grant 0922862, from the National Institutes of Health through Grant S10 RR025677, and from Vanderbilt University. MST instrumentation was acquired from National Institutes of Health through Grant S10 OD021483.	Alekseev S, 2015, CELL MOL LIFE SCI, V72, P2177, DOI 10.1007/s00018-015-1859-5; Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Breitsprecher D, 2016, METHODS MOL BIOL, V1380, P99, DOI 10.1007/978-1-4939-3197-2_8; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; Buchko GW, 1998, NUCLEIC ACIDS RES, V26, P2779, DOI 10.1093/nar/26.11.2779; Camenisch U, 2007, DNA REPAIR, V6, P1819, DOI 10.1016/j.dnarep.2007.07.011; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cleaver JE, 1997, BIOCHEM J, V328, P1, DOI 10.1042/bj3280001; Daughdrill GW, 2003, NUCLEIC ACIDS RES, V31, P4176, DOI 10.1093/nar/gkg451; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Dusinska M, 2006, MUTAGENESIS, V21, P205, DOI 10.1093/mutage/gel016; Fadda E, 2016, COMPUT STRUCT BIOTEC, V14, P78, DOI 10.1016/j.csbj.2015.11.007; Fuss JO, 2011, DNA REPAIR, V10, P697, DOI 10.1016/j.dnarep.2011.04.028; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Goddard T. D., SPARKY 3; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hermanson-Miller IL, 2002, BIOCHEMISTRY-US, V41, P2402, DOI 10.1021/bi0112863; Hilton B, 2014, BIOSCIENCE REP, V34, P831, DOI 10.1042/BSR20140158; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; Hyberts SG, 2013, J BIOMOL NMR, V55, P167, DOI 10.1007/s10858-012-9698-2; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Hyberts SG, 2009, J BIOMOL NMR, V45, P283, DOI 10.1007/s10858-009-9368-1; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Koch SC, 2015, P NATL ACAD SCI USA, V112, P8272, DOI 10.1073/pnas.1508509112; Krasikova YS, 2010, NUCLEIC ACIDS RES, V38, P8083, DOI 10.1093/nar/gkq649; Kuraoka I, 1996, MUTAT RES-DNA REPAIR, V362, P87, DOI 10.1016/0921-8777(95)00038-0; LEE SH, 1995, J BIOL CHEM, V270, P21800, DOI 10.1074/jbc.270.37.21800; Lehmann AR, 2012, DNA REPAIR, V11, P328, DOI 10.1016/j.dnarep.2011.05.008; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Lembo F, 2003, MOL CELL BIOL, V23, P1656, DOI 10.1128/MCB.23.5.1656-1665.2003; Li CL, 2015, MOL CELL, V59, P1025, DOI 10.1016/j.molcel.2015.08.012; Liu Y, 2005, BIOCHEMISTRY-US, V44, P7361, DOI 10.1021/bi047598y; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Morita EH, 1996, GENES CELLS, V1, P437, DOI 10.1046/j.1365-2443.1996.d01-252.x; Mou TC, 2006, CHIRALITY, V18, P370, DOI 10.1002/chir.20262; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shell SM, 2013, DNA REPAIR, V12, P947, DOI 10.1016/j.dnarep.2013.08.013; Shivji MKK, 1999, METH MOL B, V113, P373; Spivak G, 2016, ARCH TOXICOL, V90, P2583, DOI 10.1007/s00204-016-1820-x; Spivak G, 2015, DNA REPAIR, V36, P13, DOI 10.1016/j.dnarep.2015.09.003; Spivak G, 2014, DNA REPAIR, V19, P64, DOI 10.1016/j.dnarep.2014.03.025; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; States JC, 1998, HUM MUTAT, V12, P103, DOI 10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6; Sugasawa K, 2016, DNA REPAIR, V44, P110, DOI 10.1016/j.dnarep.2016.05.015; Sugitani N, 2016, DNA REPAIR, V44, P123, DOI 10.1016/j.dnarep.2016.05.018; Sugitani N, 2014, J AM CHEM SOC, V136, P10830, DOI 10.1021/ja503020f; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Uchida A, 2002, DNA REPAIR, V1, P449, DOI 10.1016/S1568-7864(02)00031-9; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 2009, NUCLEIC ACIDS RES, V37, P516, DOI 10.1093/nar/gkn964; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Yonemasu R, 2005, DNA REPAIR, V4, P479, DOI 10.1016/j.dnarep.2004.12.004; Ziani S, 2014, J CELL BIOL, V206, P589, DOI 10.1083/jcb.201403096	82	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16847	16857		10.1074/jbc.M117.800078	http://dx.doi.org/10.1074/jbc.M117.800078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28860187	Green Published, hybrid			2022-12-26	WOS:000413140600007
J	Baek, IJ; Moss, DS; Lustig, AJ				Baek, In-Joon; Moss, Daniel S.; Lustig, Arthur J.			The mre11 A470 alleles influence the hereditability and the segregation of telosomes in Saccharomyces cerevisiae	PLOS ONE			English	Article							TELOMERE LENGTH; GENE-EXPRESSION; DNA-BINDING; YEAST; RAP1; ELONGATION; HETEROCHROMATIN; MAINTENANCE; REPLICATION; MECHANISM	Telomeres, the nucleoprotein complexes at the termini of linear chromosomes, are essential for the processes of end replication, end protection, and chromatin segregation. The Mre11 complex is involved in multiple cellular roles in DNA repair and structure in the regulation and function of telomere size homeostasis. In this study, we characterize yeast telomere chromatin structure, phenotypic heritability, and chromatin segregation in both wild-type [ MRE11] and A470 motif alleles. MRE11 strains confer a telomere size of 300 base pairs of G+T irregular simple sequence repeats. This DNA and a portion of subtelomeric DNA is embedded in a telosome: a MNase-resistant non-nucleosomal particle. Chromatin immuno-precipitation shows a three to four-fold lower occupancy of Mre11A470T proteins than wildtype proteins in telosomes. Telosomes containing the Mre11A470T protein confer a greater resistance to MNase digestion than wild-type telosomes. The integration of a wild-type MRE11 allele into an ectopic locus in the genome of an mre11A470T mutant and the introduction of an mre11A470T allele at an ectopic site in a wild-type strain lead to unexpectedly differing results. In each case, the replicated sister chromatids inherit telosomes containing only the protein encoded by the genomic mre11 locus, even in the presence of protein encoded by the opposing ectopic allele. We hypothesize that the telosome segregates by a conservative mechanism. These data support a mechanism for the linkage between sister chromatid replication and maintenance of either identical mutant or identical wild-type telosomes after replication of sister chromatids. These data suggest the presence of an active mechanism for chromatin segregation in yeast.	[Baek, In-Joon; Moss, Daniel S.; Lustig, Arthur J.] Tulane Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70118 USA	Tulane University	Lustig, AJ (corresponding author), Tulane Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70118 USA.	alustig@tulane.edu		Moss, Daniel/0000-0001-7639-7276	NIH [R01GM069943]; School of Medicine of Tulane University; Tulane University Dean of Research Office; Louisiana Consortium for Cancer Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Medicine of Tulane University; Tulane University Dean of Research Office; Louisiana Consortium for Cancer Research	This project was funded by NIH (www.nih.gov) R01GM069943 to AJL and by funds from the School of Medicine of Tulane University, Tulane University Dean of Research Office, and the Louisiana Consortium for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; Antoniacci LM, 2006, CURR BIOL, V16, P902, DOI 10.1016/j.cub.2006.03.060; Ballew BJ, 2013, AGING CELL, V12, P719, DOI 10.1111/acel.12099; Blackburn EH, 1995, TELOMERES, Vx; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cabianca DS, 2016, NUCLEUS-PHILA, V7, P301, DOI 10.1080/19491034.2016.1187354; Cassani C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002387; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Gao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088633; Ghosal G, 2006, BIOCHEM BIOPH RES CO, V343, P1, DOI 10.1016/j.bbrc.2006.02.148; Hecht A, CELL; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Hirashima K, 2015, NUCLEIC ACIDS RES, V43, P2022, DOI 10.1093/nar/gkv063; Houreld NN, 2017, PHOTOMED LASER SURG, V35, P69, DOI 10.1089/pho.2016.4220; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Joseph IS, 2010, GENETICS, V185, P761, DOI 10.1534/genetics.110.117598; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Lansdorp PM, 2012, ANN NY ACAD SCI, V1266, P1, DOI 10.1111/j.1749-6632.2012.06505.x; LEFFAK IM, 1984, NATURE, V307, P82, DOI 10.1038/307082a0; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Liaw H, 2006, MOL CELL BIOL, V26, P7616, DOI 10.1128/MCB.01082-06; LOUIS EJ, 1990, GENETICS, V124, P533; LOUIS EJ, 1992, GENETICS, V131, P559; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Martina M, 2012, MOL CELL BIOL, V32, P1604, DOI 10.1128/MCB.06547-11; Mechin Valerie, 2007, V355, P1; Nakatani Y, 2006, E SCHERING RES FDN W, V57, P89; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Ray A, 1999, MOL CELL BIOL, V19, P31; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Schoeftner S, 2010, SEMIN CELL DEV BIOL, V21, P186, DOI 10.1016/j.semcdb.2009.09.015; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Seifert FU, 2016, EMBO J, V35, P759, DOI 10.15252/embj.201592934; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; SIKORSKI RS, 1989, GENETICS, V122, P19; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sridhar A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004691; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Suzuki K, 2011, RADIAT PROT DOSIM, V143, P279, DOI 10.1093/rpd/ncq533; Toogun OA, 2008, MOL CELL BIOL, V28, P457, DOI 10.1128/MCB.01417-07; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Treco DA, 2001, CURR PROTOC MOL BIOL; Tseng SF, 2009, NUCLEIC ACIDS RES, V37, P3602, DOI 10.1093/nar/gkp235; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Yang CW, 2017, NUCLEIC ACIDS RES, V45, P8314, DOI 10.1093/nar/gkx503; Zaman Z, 2002, CURR BIOL, V12, P930, DOI 10.1016/S0960-9822(02)00865-5	61	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183549	10.1371/journal.pone.0183549	http://dx.doi.org/10.1371/journal.pone.0183549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886051	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100029
J	Moura, RA; Quaresma, C; Vieira, AR; Goncalves, MJ; Polido-Pereira, J; Romao, VC; Martins, N; Canhao, H; Fonseca, JE				Moura, Rita A.; Quaresma, Claudia; Vieira, Ana R.; Goncalves, Maria J.; Polido-Pereira, Joaquim; Romao, Vasco C.; Martins, Nadia; Canhao, Helena; Fonseca, Joao E.			B-cell phenotype and IgD-CD27-memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FAS-MEDIATED APOPTOSIS; REGULATORY T-CELLS; PERIPHERAL-BLOOD; FACTOR-ALPHA; CHEMOATTRACTANT CXCL13; DISEASE PATIENTS; SYNOVIAL-FLUID; FACTOR THERAPY; SOLUBLE CD23	Background The use of TNF-inhibitors and/or the IL-6 receptor antagonist, tocilizumab, in rheumatoid arthritis (RA) have pleiotropic effects that also involve circulating B-cells. The main goal of this study was to assess the effect of TNF-inhibitors and tocilizumab on B-cell phenotype and gene expression in RA. Methods Blood samples were collected from untreated early RA (ERA) patients, established RA patients under methotrexate treatment, established RA patients before and after treatment with TNF-inhibitors and tocilizumab, and healthy donors. B-cell subpopulations were characterized by flow cytometry and B-cell gene expression was analyzed by real-time PCR on isolated B-cells. Serum levels of BAFF, CXCL13 and sCD23 were determined by ELISA. Results The frequency of total CD19+ B cells in circulation was similar between controls and all RA groups, irrespective of treatment, but double negative (DN) IgD-CD27-memory B cells were significantly increased in ERA and established RA when compared to controls. Treatment with TNF-inhibitors and tocilizumab restored the frequency of IgD-CD27-B-cells to normal levels, but did not affect other B cell subpopulations. TACI, CD95, CD5, HLA-DR and TLR9 expression on B-cells significantly increased after treatment with either TNF-inhibitors and/or tocilizumab, but no significant changes were observed in BAFF-R, BCMA, CD69, CD86, CXCR5, CD23, CD38 and IgM expression on B-cells when comparing baseline with post-treatment follow-ups. Alterations in B-cell gene expression of BAFF-R, TACI, TLR9, Fc gamma RIIB, BCL-2, BLIMP-1 and beta 2M were found in ERA and established RA patients, but no significant differences were observed after TNF-inhibitors and tocilizumab treatment when comparing baseline and follow-ups. Serum levels of CXCL13, sCD23 and BAFF were not significantly affected by treatment with TNF-inhibitors and tocilizumab. Conclusions In RA patients, the use of TNF-inhibitors and/or tocilizumab treatment affects B-cell phenotype and IgD-CD27-memory B cells in circulation, but not B-cell gene expression levels.	[Moura, Rita A.; Quaresma, Claudia; Vieira, Ana R.; Goncalves, Maria J.; Polido-Pereira, Joaquim; Romao, Vasco C.; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Med Mol, Rheumatol Res Unit, Lisbon, Portugal; [Goncalves, Maria J.; Polido-Pereira, Joaquim; Romao, Vasco C.; Martins, Nadia; Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, Lisbon Acad Med Ctr, Ctr Hosp Lisboa Norte, EPE,Rheumatol Dept, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Moura, RA (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Rheumatol Res Unit, Lisbon, Portugal.	ritaaguiarmoura@gmail.com	Romão, Vasco C/O-8224-2014; Canhao, Helena/C-9611-2018; Polido-Pereira, Joaquim/AAV-7464-2020; Moura, Rita A./AAI-5024-2020	Romão, Vasco C/0000-0002-5603-9436; Canhao, Helena/0000-0003-1894-4870; Moura, Rita A./0000-0002-9685-6924; Polido Pereira, Joaquim/0000-0002-7188-8516	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [SFRH/6PD/81936/2011]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	RAM was funded by Fundacao para a Ciencia e a Tecnologia (FCT, www.fct.pt) (SFRH/6PD/81936/2011), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivernini S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12970; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; Bugatti S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3742; Bulati M, 2015, J ALZHEIMERS DIS, V44, P1241, DOI 10.3233/JAD-142412; Cambridge G, 2014, J AUTOIMMUN, V50, P67, DOI 10.1016/j.jaut.2013.12.002; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Canhao H, 2012, RHEUMATOLOGY, V51, P2020, DOI 10.1093/rheumatology/kes184; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Carbone G, 2013, INT J BIOL SCI, V9, P279, DOI 10.7150/ijbs.5996; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Catalan D, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2985; CHOMARAT P, 1993, ARTHRITIS RHEUM-US, V36, P234, DOI 10.1002/art.1780360215; Claes N, 2016, J IMMUNOL, V197, P4576, DOI 10.4049/jimmunol.1502448; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Conigliaro P, 2014, CLIN EXP IMMUNOL, V177, P234, DOI 10.1111/cei.12335; Di Sabatino A, 2008, INFLAMM BOWEL DIS, V14, P591, DOI 10.1002/ibd.20374; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Engelmann R, 2015, RHEUMATOLOGY, V54, P545, DOI 10.1093/rheumatology/keu351; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Fekete A, 2007, J AUTOIMMUN, V29, P154, DOI 10.1016/j.jaut.2007.07.002; Gottenberg JE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2773; Hong S, 2015, LIFE SCI, V122, P37, DOI 10.1016/j.lfs.2014.12.008; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jones JD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4552; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; Kamphuis LS, 2013, AM J RESP CRIT CARE, V187, P406, DOI 10.1164/rccm.201206-1024OC; Kanbe K, 2011, CLIN RHEUMATOL, V30, P1407, DOI 10.1007/s10067-011-1833-z; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Karampetsou MP, 2011, CLIN IMMUNOL, V140, P8, DOI 10.1016/j.clim.2011.01.012; Kikuchi J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0526-4; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kobayashi S, 2013, ARTHRITIS RHEUM-US, V65, P3063, DOI 10.1002/art.38173; Li Z, 2015, INFLAMM BOWEL DIS, V21, P2787, DOI 10.1097/MIB.0000000000000554; Loza E, 1999, RHEUMATOLOGY, V38, P325, DOI 10.1093/rheumatology/38.4.325; Magnusson SE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2206; Mahmood Z, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0580-y; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; Michelutti A, 2011, MOL MED, V17, P901, DOI 10.2119/molmed.2011.00034; Moura RA, 2013, J RHEUMATOL, V40, P1293, DOI 10.3899/jrheum.121110; Moura RA, 2012, CLIN REV ALLERG IMMU, V43, P281, DOI 10.1007/s12016-012-8318-y; Moura RA, 2011, RHEUMATOLOGY, V50, P278, DOI 10.1093/rheumatology/keq338; Moura RA, 2010, RHEUMATOLOGY, V49, P1082, DOI 10.1093/rheumatology/keq029; Nakayamada S., 2017, RHEUMATOLOGY; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Parker A, 2007, J RHEUMATOL, V34, P1817; Rapetti L, 2015, ANN RHEUM DIS, V74, P294, DOI 10.1136/annrheumdis-2013-204049; Roll P, 2012, SCAND J RHEUMATOL, V41, P180, DOI 10.3109/03009742.2011.645056; Roll P, 2011, ARTHRITIS RHEUM-US, V63, P1255, DOI 10.1002/art.30242; Romao VC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/279890; Sakurai D, 2007, EUR J IMMUNOL, V37, P110, DOI 10.1002/eji.200636623; Salinas GF, 2013, ANN RHEUM DIS, V72, P1037, DOI 10.1136/annrheumdis-2011-201270; Schmutz C, 2005, ARTHRITIS RES THER, V7, pR217, DOI 10.1186/ar1475; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Snir A, 2011, CLIN EXP RHEUMATOL, V29, P697; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Timmermans WMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160103; Uson J, 1997, J RHEUMATOL, V24, P2069; van der Houwen TB, 2017, RHEUMATOLOGY, V56, P134, DOI 10.1093/rheumatology/kew366; Vasquez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139718; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Wu YCB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00081; Yang J, 2015, INT J RHEUMATIC DIS	69	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182927	10.1371/journal.pone.0182927	http://dx.doi.org/10.1371/journal.pone.0182927			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886017	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100012
J	Sanches, PR; Correa, TD; Ferrari-Marinho, T; Naves, PVF; Ladeia-Frota, C; Caboclo, LO				Sanches, Paula Rodrigues; Correa, Thiago Domingos; Ferrari-Marinho, Taissa; Ferreira Naves, Pedro Vicente; Ladeia-Frota, Carol; Caboclo, Luis Otavio			Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study	PLOS ONE			English	Article							NONCONVULSIVE STATUS EPILEPTICUS; PERIODIC EEG PATTERNS; CRITICALLY-ILL; SEIZURES; TERMINOLOGY; GUIDELINE; PRESSURE; ETIOLOGY	Introduction Nonconvulsive seizures (NCS) are frequent in hospitalized patients and may further aggravate injury in the already damaged brain, potentially worsening outcomes in encephalopathic patients. Therefore, both early seizure recognition and treatment have been advocated to prevent further neurological damage. Objective Evaluate the main EEG patterns seen in patients with impaired consciousness and address the effect of treatment with antiepileptic drugs (AEDs), continuous intravenous anesthetic drugs (IVADs), or the combination of both, on outcomes. Methods This was a single center retrospective cohort study conducted in a private, tertiary care hospital. Consecutive adult patients with altered consciousness submitted to a routine EEG between January 2008 and February 2011 were included in this study. Based on EEG pattern, patients were assigned to one of three groups: Group Interictal Patterns (IP; EEG showing only interictal epileptiform discharges or triphasic waves), Group Rhythmic and Periodic Patterns (RPP; at least one EEG with rhythmic or periodic patterns), and Group Ictal (Ictal; at least one EEG showing ictal pattern). Groups were compared in terms of administered antiepileptic treatment and frequency of unfavorable outcomes (modified Rankin scale >= 3 and in-hospital mortality). Results Two hundred and six patients (475 EEGs) were included in this analysis. Interictal pattern was observed in 35.4% (73/206) of patients, RPP in 53.4% (110/206) and ictal in 11.2% (23/206) of patients. Treatment with AEDs, IVADs or a combination of both was administered in half of the patients. While all Ictal group patients received treatment (AEDs or IVADs), only 24/73 (32.9%) IP group patients and 55/108 (50.9%) RPP group patients were treated (p<0.001). Hospital length of stay (LOS) and frequency of unfavorable outcomes did not differ among the groups. In-hospital mortality was higher in IVADs treated RPP patients compared to AEDs treated RPP patients [11/19 (57.9%) vs. 11/36 (30.6%) patients, respectively, p = 0.049]. Hospital LOS, in-hospital mortality and frequency of unfavorable outcomes did not differ between Ictal patients treated exclusively with AEDs or IVADs. Conclusion In patients with acute altered consciousness and abnormal routine EEG, antiepileptic treatment did not improve outcomes regardless of the presence of periodic, rhythmic or ictal EEG patterns.	[Sanches, Paula Rodrigues; Correa, Thiago Domingos] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; [Ferrari-Marinho, Taissa; Ferreira Naves, Pedro Vicente; Ladeia-Frota, Carol; Caboclo, Luis Otavio] Hosp Israelita Albert Einstein, Dept Clin Neurophysiol, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Correa, TD (corresponding author), Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil.	thiago.correa@einstein.br	Sanches, Paula/N-5040-2014	Sanches, Paula/0000-0001-9329-9010; Domingos Correa, Thiago/0000-0001-9546-3910				Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI [10.1097/WNP.0000000000000806, 10.1097/WNP.0b013e3182784729]; Idro R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-57; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Kaplan PW, 2002, EPILEPSY BEHAV, V3, P122, DOI 10.1006/ebeh.2002.0336; Kaplan PW, 2000, NEUROPHYSIOL CLIN, V30, P377, DOI 10.1016/S0987-7053(00)00238-0; Koren JP, 2016, CLIN NEUROPHYSIOL, V127, P1176, DOI 10.1016/j.clinph.2015.09.135; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; Rossetti AO, 2014, INTENS CARE MED, V40, P1359, DOI 10.1007/s00134-014-3363-z; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Sinha SR, 2016, J CLIN NEUROPHYSIOL, V33, P303, DOI 10.1097/WNP.0000000000000308; Sokic DV, 2009, SEIZURE-EUR J EPILEP, V18, P215, DOI 10.1016/j.seizure.2008.10.002; Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116; Sutter R, 2014, NEUROLOGY, V82, P656, DOI 10.1212/WNL.0000000000000009; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Trinka E, 2015, EPILEPSY BEHAV, V49, P203, DOI 10.1016/j.yebeh.2015.05.005; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Young GB, 1996, NEUROLOGY, V47, P83	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184050	10.1371/journal.pone.0184050	http://dx.doi.org/10.1371/journal.pone.0184050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886073	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100058
J	Chen, Y; Li, XX; Chi, XJ; Wang, S; Ma, YM; Chen, JL				Chen, Ye; Li, Xinxin; Chi, Xiaojuan; Wang, Song; Ma, Yanmei; Chen, Jilong			Comprehensive analysis of the codon usage patterns in the envelope glycoprotein E2 gene of the classical swine fever virus	PLOS ONE			English	Article							TRANSLATIONAL SELECTION; MUTATION PRESSURE; EPIDEMIOLOGY; EVOLUTION; BIAS; INFECTION; VIRULENCE; HOST	The classical swine fever virus (CSFV), circulating worldwide, is a highly contagious virus. Since the emergence of CSFV, it has caused great economic loss in swine industry. The envelope glycoprotein E2 gene of the CSFV is an immunoprotective antigen that induces the immune system to produce neutralizing antibodies. Therefore, it is essential to study the codon usage of the E2 gene of the CSFV. In this study, 140 coding sequences of the E2 gene were analyzed. The value of effective number of codons (ENC) showed low codon usage bias in the E2 gene. Our study showed that codon usage could be described mainly by mutation pressure ENC plot analysis combined with principal component analysis (PCA) and translational selection-correlation analysis between the general average hydropathicity (Gravy) and aromaticity (Aroma), and nucleotides at the third position of codons (A3s, T3s, G3s, C3s and GC3s). Furthermore, the neutrality analysis, which explained the relationship between GC12s and GC3s, revealed that natural selection had a key role compared with mutational bias during the evolution of the E2 gene. These results lay a foundation for further research on the molecular evolution of CSFV.	[Chen, Ye; Li, Xinxin; Chi, Xiaojuan; Wang, Song; Ma, Yanmei; Chen, Jilong] Fujian Agr & Forestry Univ, Coll Anim Sci, Key Lab Fujian Taiwan Anim Pathogen Biol, Fuzhou, Fujian, Peoples R China; [Chen, Jilong] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Ma, YM; Chen, JL (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Key Lab Fujian Taiwan Anim Pathogen Biol, Fuzhou, Fujian, Peoples R China.; Chen, JL (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	89mym@163.com; chenjl@im.ac.cn	Chen, Ji-Long/AAJ-2134-2021	Chen, Ji-Long/0000-0002-4274-0563	Natural Science Foundation of China [U1405216, U1305212, 31402217]; Key National Basic Research Program (973) of China [2015CB910502]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Basic Research Program (973) of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China (U1405216) to XC, National Key National Basic Research Program (973) of China (2015CB910502), and Natural Science Foundation of China (U1305212, 31402217) to JLC and XC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Chen R, 2007, DNA SEQUENCE, V18, P269, DOI 10.1080/10425170601136564; Chen Y, 2014, INFECT GENET EVOL, V28, P95, DOI 10.1016/j.meegid.2014.09.004; Choori P, 2015, VET WORLD, V8, P541, DOI 10.14202/vetworld.2015.541-544; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3; Gupta SK, 2001, GENE, V273, P63, DOI 10.1016/S0378-1119(01)00576-5; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hulst MM, 1997, J GEN VIROL, V78, P2779, DOI 10.1099/0022-1317-78-11-2779; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Ji W, 2014, INFECT GENET EVOL, V25, P69, DOI 10.1016/j.meegid.2014.04.008; Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376; Li GR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3935-8; Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES; Lindenbach BD, 2007, FLAVIVIRUS VIRUSES T; Liu WQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-325; Liu XD, 2010, ARCH VIROL, V155, P685, DOI 10.1007/s00705-010-0631-2; Lowings P, 1996, J GEN VIROL, V77, P1311, DOI 10.1099/0022-1317-77-6-1311; Lu G, 2013, VIRUS GENES, V47, P250, DOI 10.1007/s11262-013-0935-x; MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meyers G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4; Naveen K, 2016, PLOS ONE, V11; Pan CH, 2005, ARCH VIROL, V150, P1101, DOI 10.1007/s00705-004-0485-6; Parmley JL, 2007, DO SYNONYMOUS MUTATI; Peixoto L, 2003, GENE, V320, P109, DOI 10.1016/S0378-1119(03)00815-1; Risatti GR, 2005, VIROLOGY, V343, P116, DOI 10.1016/j.virol.2005.08.015; Risatti GR, 2005, J VIROL, V79, P3787, DOI 10.1128/JVI.79.6.3787-3796.2005; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; Simon G, 2013, VET MICROBIOL, V166, P631, DOI 10.1016/j.vetmic.2013.06.032; Su S, 2017, TRENDS MICROBIOLOGY; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Su S, 2015, J VIROL, V89, P8671, DOI 10.1128/JVI.01034-15; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhao S, 2008, BIOSYSTEMS, V92, P207, DOI 10.1016/j.biosystems.2008.01.006; Zhao YC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3021-7; Zhou H, 2015, INFECT GENET EVOL, V35, P27, DOI 10.1016/j.meegid.2015.07.024; Zhou JH, 2013, INFECT GENET EVOL, V14, P105, DOI 10.1016/j.meegid.2012.09.020; Zhou JH, 2010, VET RES COMMUN, V34, P393, DOI 10.1007/s11259-010-9359-4; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	51	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183646	10.1371/journal.pone.0183646	http://dx.doi.org/10.1371/journal.pone.0183646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880881	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200021
J	Ready, D; Yagiz, K; Amin, P; Yildiz, Y; Funari, V; Bozdag, S; Cinar, B				Ready, Damien; Yagiz, Kader; Amin, Pooneh; Yildiz, Yuksel; Funari, Vincent; Bozdag, Serdar; Cinar, Bekir			Mapping the STK4/Hippo signaling network in prostate cancer cell	PLOS ONE			English	Article							ANDROGEN RECEPTOR; INCREASED SURVIVAL; TUMOR-SUPPRESSOR; HIPPO PATHWAY; HISTONE H2B; KINASE MST1; PHOSPHORYLATION; YAP1; ENZALUTAMIDE; ABIRATERONE	Dysregulation of MST1/STK4, a key kinase component of the Hippo-YAP pathway, is linked to the etiology of many cancers with poor prognosis. However, how STK4 restricts the emergence of aggressive cancer remains elusive. Here, we investigated the effects of STK4, primarily localized in the cytoplasm, lipid raft, and nucleus, on cell growth and gene expression in aggressive prostate cancer. We demonstrated that lipid raft and nuclear STK4 had superior suppressive effects on cell growth in vitro and in vivo compared with cytoplasmic STK4. Using RNA sequencing and bioinformatics analysis, we identified several differentially expressed (DE) genes that responded to ectopic STK4 in all three subcellular compartments. We noted that the number of DE genes observed in lipid raft and nuclear STK4 cells were much greater than cytoplasmic STK4. Our functional annotation clustering showed that these DE genes were commonly associated with oncogenic pathways such as AR, PI3K/AKT, BMP/SMAD, GPCR, WNT, and RAS as well as unique pathways such as JAK/STAT, which emerged only in nuclear STK4 cells. These findings indicate that MST1/STK4/Hippo signaling restricts aggressive tumor cell growth by intersecting with multiple molecular pathways, suggesting that targeting of the STK4/Hippo pathway may have important therapeutic implications for cancer.	[Ready, Damien; Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Yagiz, Kader] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Amin, Pooneh; Cinar, Bekir] Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Yildiz, Yuksel] Adnan Menderes Univ, Dept Physiol, Aydin, Turkey; [Funari, Vincent] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Funari, Vincent] Cedars Sinai Med Ctr, Div Genet, Los Angeles, CA 90048 USA; [Cinar, Bekir] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Marquette University; Cedars Sinai Medical Center; Clark Atlanta University; Adnan Menderes University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Emory University	Bozdag, S (corresponding author), Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA.; Cinar, B (corresponding author), Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.; Cinar, B (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	serdar.bozdag@marquette.edu; bcinar@cau.edu	CİNAR, BEKIR MURAT/AAL-4474-2021	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Cinar, Bekir/0000-0003-4028-7600	NIH/National Center for Advancing Translational Science [UL1TR000124]; NIH/National Institute on Minority Health and Health Disparities and Research Centers in Minority Institution Program [5G12MD007590]; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	NIH/National Center for Advancing Translational Science; NIH/National Institute on Minority Health and Health Disparities and Research Centers in Minority Institution Program; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported in part by the NIH/National Center for Advancing Translational Science (grant #UL1TR000124), and the NIH/National Institute on Minority Health and Health Disparities and Research Centers in Minority Institution Program (grant #5G12MD007590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2015, NUCL ACIDS RES, V43, pD204; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Beer TM, 2014, NEW ENGL J MED, V371, P1755, DOI 10.1056/NEJMc1410239; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; Collak FK, 2012, J BIOL CHEM, V287, P23698, DOI 10.1074/jbc.M112.358713; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Gomez M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-22; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim W, 2016, BMB REP; Kuser-Abali G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9126; Kuser-Abali G, 2014, EPIGENETICS-US, V9, P634, DOI 10.4161/epi.27957; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McNeal AS, 2015, CANCER DISCOV, V5, P1072, DOI 10.1158/2159-8290.CD-15-0196; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Rawat SJ, 2016, CURR BIOL, V26, P1556, DOI 10.1016/j.cub.2016.04.027; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhao B, 2009, CANCER CELL, V16, P363, DOI 10.1016/j.ccr.2009.10.008; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhuang LY, 2002, CANCER RES, V62, P2227	60	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184590	10.1371/journal.pone.0184590	http://dx.doi.org/10.1371/journal.pone.0184590			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880957	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200080
J	Wang, P; Wang, HN; Liu, Q; Tian, X; Shi, YX; Zhang, XC				Wang, Pei; Wang, Huinan; Liu, Qing; Tian, Xia; Shi, Yanxi; Zhang, Xiaocun			QTL mapping of selenium content using a RIL population in wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOTYPIC VARIATION; BIOFORTIFICATION; REGIONS	Selenium (Se) is an essential trace element that plays various roles in human health. Understanding the genetic control of Se content and quantitative trait loci (QTL) mapping provide a basis for Se biofortification of wheat to enhance grain Se content. In the present study, a set of recombinant inbred lines (RILs) derived from two Chinese winter wheat varieties (Tainong18 and Linmai6) was used to detect QTLs for Se content in hydroponic and field trials. In total, 16 QTLs for six Se content-related traits were detected on eight chromosomes, 1B, 2B, 4B, 5A, 5B, 5D, 6A, and 7D. Of these, seven QTLs were detected at the seedling stage and nine at the adult stage. The contribution of each QTL to Se content ranged from 7.37% to 20.22%. QSsece-7D. 2, located between marker loci D-3033829 and D-1668160, had the highest contribution (20.22%). This study helps in understanding the genetic basis for Se contents and will provide a basis for gene mapping of Se content in wheat.	[Wang, Pei; Zhang, Xiaocun] Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China; [Wang, Huinan] Shandong Agr Univ, Coll Agron, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Liu, Qing; Tian, Xia; Shi, Yanxi] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Qingdao Agricultural University	Zhang, XC (corresponding author), Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China.	xczhang@sdau.edu.cn	Zhang, Xiaocun/G-9783-2018	Zhang, Xiaocun/0000-0001-7179-2891	Ministry of Agriculture Public Welfare Special Fund of China [20130316]; Agriculture Research System of Shandong Province, China; Postdoctoral Fund of Shandong Agricultural University [76432]; Youth Innovation Fund of Shandong Agricultural University [24023]	Ministry of Agriculture Public Welfare Special Fund of China; Agriculture Research System of Shandong Province, China; Postdoctoral Fund of Shandong Agricultural University; Youth Innovation Fund of Shandong Agricultural University	This study was supported by the Ministry of Agriculture Public Welfare Special Fund of China (20130316); Agriculture Research System of Shandong Province, China; Postdoctoral Fund of Shandong Agricultural University (76432) and Youth Innovation Fund of Shandong Agricultural University (24023).	[Anonymous], 2000, SCI TOTAL ENVIRON, V249, P347; Ates D., 2016, PLOS ONE, V11; Beladel B, 2013, APPL RADIAT ISOTOPES, V71, P7, DOI 10.1016/j.apradiso.2012.09.009; Blazina T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5717; CHURCHILL GA, 1994, GENETICS, V138, P963; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Eiche E, 2015, SCI TOTAL ENVIRON, V505, P952, DOI 10.1016/j.scitotenv.2014.10.080; Genc Y, 2005, J TRACE ELEM MED BIO, V18, P319, DOI 10.1016/j.jtemb.2005.02.005; Golubkina NA, 1999, J TRACE ELEM MED BIO, V13, P15, DOI 10.1016/S0946-672X(99)80018-2; Guerrero B, 2014, PLANT PHYSIOL BIOCH, V83, P300, DOI 10.1016/j.plaphy.2014.08.009; Haug Anna, 2007, Microbial Ecology in Health and Disease, V19, P209, DOI 10.1080/08910600701698986; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Lyons GH, 2005, J TRACE ELEM MED BIO, V19, P75, DOI 10.1016/j.jtemb.2005.04.005; Poblaciones MJ, 2014, FOOD CHEM, V146, P378, DOI 10.1016/j.foodchem.2013.09.070; Pu ZE, 2014, J INTEGR AGR, V13, P2322, DOI 10.1016/S2095-3119(13)60640-1; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Souza GA, 2014, PLANT SCI, V224, P27, DOI 10.1016/j.plantsci.2014.03.022; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; WHO, 1996, TRAC EL HUM NUTR HLT; Zhang G, 2014, CONSTRUCTION HIGH DE; [张现伟 Zhang Xianwei], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P445; Zhao F, 2007, COMP BIOCHEM PHYS A, V146, pS246, DOI 10.1016/j.cbpa.2007.01.571; Zhao FJ, 2009, J CEREAL SCI, V49, P290, DOI 10.1016/j.jcs.2008.11.007	27	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184351	10.1371/journal.pone.0184351	http://dx.doi.org/10.1371/journal.pone.0184351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880898	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200055
J	Genschow, O; van den Bossche, S; Cracco, E; Bardi, L; Rigoni, D; Brass, M				Genschow, Oliver; van den Bossche, Sofie; Cracco, Emiel; Bardi, Lara; Rigoni, Davide; Brass, Marcel			Mimicry and automatic imitation are not correlated	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; REGULATORY FOCUS; BEHAVIORAL CONSEQUENCES; PERSPECTIVE-TAKING; PRIORI LIKING; AUTISM; MOTOR; MOVEMENT; CHAMELEON; VALIDITY	It is widely known that individuals have a tendency to imitate each other. However, different psychological disciplines assess imitation in different manners. While social psychologists assess mimicry by means of action observation, cognitive psychologists assess automatic imitation with reaction time based measures on a trial-by-trial basis. Although these methods differ in crucial methodological aspects, both phenomena are assumed to rely on similar underlying mechanisms. This raises the fundamental question whether mimicry and automatic imitation are actually correlated. In the present research we assessed both phenomena and did not find a meaningful correlation. Moreover, personality traits such as empathy, autism traits, and traits related to self-versus other-focus did not correlate with mimicry or automatic imitation either. Theoretical implications are discussed.	[Genschow, Oliver] Univ Cologne, Social Cognit Ctr Cologne, Cologne, Germany; [van den Bossche, Sofie] Univ Ghent, Dept Data Anal, Ghent, Belgium; [Cracco, Emiel; Bardi, Lara; Rigoni, Davide; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	University of Cologne; Ghent University; Ghent University	Genschow, O (corresponding author), Univ Cologne, Social Cognit Ctr Cologne, Cologne, Germany.	oliver.genschow@uni-koeln.de	Brass, Marcel/J-7082-2012	Brass, Marcel/0000-0002-3364-4019; Bardi, Lara/0000-0002-1678-647X; Cracco, Emiel/0000-0003-4043-5992; Van Den Bossche, Sofie/0000-0001-9195-2426; Rigoni, Davide/0000-0001-9045-3190	Swiss National Science Foundation [PZ00P1_168007]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (grant number PZ00P1_168007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Butler EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129651; CAPPELLA JN, 1981, HUM COMMUN RES, V7, P117, DOI 10.1111/j.1468-2958.1981.tb00564.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J EXP PSYCHOL HUMAN, V37, P409, DOI 10.1037/a0019325; Chartrand T.L., 2009, PSYCHOL ACTION MECH, VVol. 2, P893; Chartrand T.L., 2005, NEW UNCONSCIOUS, P334, DOI DOI 10.1093/ACPROF:OSO/9780195307696.003; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook J, 2014, PSYCHOL MED, V44, P731, DOI 10.1017/S0033291713001335; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Cracco E, 2017, MOTOR SIMULATION DYA; Cracco E, 2015, J EXP PSYCHOL HUMAN, V41, P1488, DOI 10.1037/a0039737; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Crocker L, 1986, INTRO CLASSICAL MODE; Cronbach Lee J., 1990, ESSENTIALS PSYCHOL T, V5th; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; De Schryver M, 2015, FRONTIERS PSYCHOL, V6; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Dijksterhuis A, 2005, HDB AUTOMATICITY, P207; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farmer H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151835; Frohlich F, 2010, 365 DIERENVERHAALTJE; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Genschow O, 2016, PSYCHON B REV, V23, P1257, DOI 10.3758/s13423-015-0983-4; Genschow O, 2015, J EXP PSYCHOL HUMAN, V41, P265, DOI 10.1037/xhp0000035; Genschow O, 2014, J EXP PSYCHOL HUMAN, V40, P904, DOI 10.1037/a0035430; Genschow O, 2013, J EXP PSYCHOL GEN, V142, P763, DOI 10.1037/a0029795; Giles H., 1975, EUROPEAN MONOGRAPHS; Gowen E, 2008, NEUROPSYCHOLOGIA, V46, P1060, DOI 10.1016/j.neuropsychologia.2007.11.004; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P241, DOI 10.1037/a0021082; Gueguen N, 2009, PSYCHOL FR, V54, P337, DOI 10.1016/j.psfr.2009.09.002; Hall NR, 2012, J NONVERBAL BEHAV, V36, P235, DOI 10.1007/s10919-012-0136-7; Hansen J, J EXPT PSYC IN PRESS; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hofree G, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00364, 10.3389/fnhum.2015.00364]; Hogeveen J, 2011, COGN NEUROSCI-UK, V2, P74, DOI 10.1080/17588928.2010.533164; Horton WS, 2014, ACTA PSYCHOL, V150, P41, DOI 10.1016/j.actpsy.2014.04.006; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jansson E, 2007, EXP BRAIN RES, V182, P549, DOI 10.1007/s00221-007-1013-1; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeffreys H., 1961, THEORY PROBABILITY; Jimenez L, 2012, ACTA PSYCHOL, V141, P96, DOI 10.1016/j.actpsy.2012.07.007; Kavanagh LC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00458; Keysers C, 2010, CURR BIOL, V20, pR353, DOI 10.1016/j.cub.2010.03.013; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Klapper A, 2014, J COGNITIVE NEUROSCI, V26, P2503, DOI 10.1162/jocn_a_00651; Kolb DA, 2014, PERSPECTIVES COGNITI; LaFrance Marianne, 1982, INTERACTION RHYTHMS, P279; Lakens D, 2014, PERSPECT PSYCHOL SCI, V9, P278, DOI 10.1177/1745691614528520; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Leary MR, 2013, J PERS ASSESS, V95, P610, DOI 10.1080/00223891.2013.819511; Leighton J, 2008, NEUROPSYCHOLOGIA, V46, P1041, DOI 10.1016/j.neuropsychologia.2007.11.013; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Liepelt R, 2010, EXP PSYCHOL, V57, P221, DOI 10.1027/1618-3169/a000028; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; Longo MR, 2009, EXP BRAIN RES, V192, P739, DOI 10.1007/s00221-008-1649-5; Love J., 2015, JASP VERSION 07; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Muller BCN, 2013, SCAND J PSYCHOL, V54, P401, DOI 10.1111/sjop.12060; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Osborne JW., 2004, PRACTICAL ASSESSMENT, V9, P1, DOI [10.7275/QF69-7K43, DOI 10.7275/QF69-7K43, 10.7275/qf69-7k43]; Pennington GL, 2003, J EXP SOC PSYCHOL, V39, P563, DOI 10.1016/S0022-1031(03)00058-1; Pfattheicher S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01314; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Press C, 2010, NEUROPSYCHOLOGIA, V48, P3291, DOI 10.1016/j.neuropsychologia.2010.07.012; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Shah J, 1998, J PERS SOC PSYCHOL, V74, P285, DOI 10.1037/0022-3514.74.2.285; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Sonnby-Borgstrom M, 2003, J NONVERBAL BEHAV, V27, P3, DOI 10.1023/A:1023608506243; Spengler S, 2010, BIOL PSYCHIAT, V68, P1148, DOI 10.1016/j.biopsych.2010.09.017; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; Stel M, 2010, EXP PSYCHOL, V57, P412, DOI 10.1027/1618-3169/a000050; Stel M, 2010, EUR J SOC PSYCHOL, V40, P867, DOI 10.1002/ejsp.655; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; Uskul AK, 2009, J EXP SOC PSYCHOL, V45, P535, DOI 10.1016/j.jesp.2008.12.005; van Baaren RB, 2004, J PERS SOC PSYCHOL, V86, P453, DOI 10.1037/0022-3514.86.3.453; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093; van Baaren RB, 2003, J EXP SOC PSYCHOL, V39, P393, DOI 10.1016/S0022-1031(03)00014-3; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; van Baaren RB, 2006, SOC COGNITION, V24, P426, DOI 10.1521/soco.2006.24.4.426; van Leeuwen ML, 2009, NEUROPSYCHOLOGIA, V47, P3265, DOI 10.1016/j.neuropsychologia.2009.06.005; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Wang Y, 2011, BIOL LETTERS, V7, P7, DOI 10.1098/rsbl.2010.0279; Webb J. T., 1972, STUDIES DYADIC COMMU, P115; WEBB JT, 1969, LANG SPEECH, V12, P54, DOI 10.1177/002383096901200105; WEEKS DJ, 1990, J EXP PSYCHOL GEN, V119, P355, DOI 10.1037/0096-3445.119.4.355; Williams JHG, 2004, J AUTISM DEV DISORD, V34, P285, DOI 10.1023/B:JADD.0000029551.56735.3a; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6	110	51	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183784	10.1371/journal.pone.0183784	http://dx.doi.org/10.1371/journal.pone.0183784			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877197	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200043
J	Mumtaz, S; Khan, L; Ahmed, S; Bader, R				Mumtaz, Sidra; Khan, Laiq; Ahmed, Saghir; Bader, Rabiah			Indirect adaptive soft computing based wavelet-embedded control paradigms for WT/PV/SOFC in a grid/charging station connected hybrid power system	PLOS ONE			English	Article							OXIDE FUEL-CELL; WIND TURBINE SYSTEM; ENERGY-CONVERSION; PREDICTIVE CONTROL; GENERATION SYSTEM; CONTROL STRATEGY; MPPT ALGORITHM; POINT; TRACKING; IMPLEMENTATION	This paper focuses on the indirect adaptive tracking control of renewable energy sources in a grid-connected hybrid power system. The renewable energy systems have low efficiency and intermittent nature due to unpredictable meteorological conditions. The domestic load and the conventional charging stations behave in an uncertain manner. To operate the renewable energy sources efficiently for harvesting maximum power, instantaneous nonlinear dynamics should be captured online. A Chebyshev-wavelet embedded NeuroFuzzy indirect adaptive MPPT (maximum power point tracking) control paradigm is proposed for variable speed wind turbine-permanent synchronous generator (VSWT-PMSG). A Hermite-wavelet incorporated NeuroFuzzy indirect adaptive MPPT control strategy for photovoltaic (PV) system to extract maximum power and indirect adaptive tracking control scheme for Solid Oxide Fuel Cell (SOFC) is developed. A comprehensive simulation test-bed for a grid-connected hybrid power system is developed in Matlab/Simulink. The robustness of the suggested indirect adaptive control paradigms are evaluated through simulation results in a grid-connected hybrid power system test-bed by comparison with conventional and intelligent control techniques. The simulation results validate the effectiveness of the proposed control paradigms.	[Mumtaz, Sidra; Khan, Laiq; Ahmed, Saghir; Bader, Rabiah] COMSATS Inst Informat Technol, Dept Elect Engn, Abbottabad, Kpk, Pakistan	COMSATS University Islamabad (CUI)	Mumtaz, S (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Abbottabad, Kpk, Pakistan.	sidramumtaz@ciit.net.pk						Aguiar P, 2005, J POWER SOURCES, V147, P136, DOI 10.1016/j.jpowsour.2005.01.017; Ahmed J, 2015, APPL ENERG, V150, P97, DOI 10.1016/j.apenergy.2015.04.006; Bakic V, 2012, ENERGY, V45, P324, DOI 10.1016/j.energy.2011.11.063; Cao HC, 2016, IEEE T ENERGY CONVER, V31, P603, DOI 10.1109/TEC.2015.2510030; Carre M, 2015, J POWER SOURCES, V282, P498, DOI 10.1016/j.jpowsour.2015.02.053; Chen JW, 2013, IEEE T IND ELECTRON, V60, P2652, DOI 10.1109/TIE.2012.2196901; Chinchilla M, 2006, IEEE T ENERGY CONVER, V21, P130, DOI 10.1109/TEC.2005.853735; Dahbi A, 2016, INT J HYDROGEN ENERG, V41, P9427, DOI 10.1016/j.ijhydene.2016.03.105; Daili Y, 2015, ENERG CONVERS MANAGE, V97, P298, DOI 10.1016/j.enconman.2015.03.062; Daraban S, 2014, ENERGY, V74, P374, DOI 10.1016/j.energy.2014.07.001; Das T, 2013, IEEE T CONTR SYST T, V21, P372, DOI 10.1109/TCST.2011.2181514; Ganesan E, 2016, TURK J ELECTR ENG CO, V24, P4804, DOI 10.3906/elk-1404-409; Ganjefar S, 2014, ENERGY, V67, P444, DOI 10.1016/j.energy.2014.02.023; Guenounou O, 2014, ENERG CONVERS MANAGE, V78, P843, DOI 10.1016/j.enconman.2013.07.093; Gules R, 2008, IEEE T IND ELECTRON, V55, P2674, DOI 10.1109/TIE.2008.924033; Hafiz F, 2016, RENEW ENERG, V92, P136, DOI 10.1016/j.renene.2016.01.100; Hajimolana SA, 2013, ENERGY, V62, P320, DOI 10.1016/j.energy.2013.08.031; Haque ME, 2010, IEEE T IND APPL, V46, P331, DOI 10.1109/TIA.2009.2036550; Haruni AMO, 2013, IEEE T SUSTAIN ENERG, V4, P402, DOI 10.1109/TSTE.2012.2225455; Hassan SZ, 2017, ENERGIES, V10, DOI 10.3390/en10030394; Hosseini M, 2013, J POWER SOURCES, V221, P372, DOI 10.1016/j.jpowsour.2012.08.047; Kim SK, 2008, IEEE T IND ELECTRON, V55, P1677, DOI 10.1109/TIE.2007.907662; Koad RBA, 2017, IEEE T SUSTAIN ENERG, V8, P468, DOI 10.1109/TSTE.2016.2606421; Lin WM, 2011, IEEE T POWER ELECTR, V26, P3571, DOI 10.1109/TPEL.2011.2161775; Mousavi SM, 2012, INT J ELEC POWER, V43, P1144, DOI 10.1016/j.ijepes.2012.05.060; Mumtaz S, 2017, TURK J ELECTR ENG CO, V25, P4341, DOI 10.3906/elk-1702-175; Mumtaz S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173966; Ou TC, 2014, ENERGY, V66, P314, DOI 10.1016/j.energy.2014.01.042; Radjai T, 2014, SOL ENERGY, V110, P325, DOI 10.1016/j.solener.2014.09.014; Ramli MAM, 2015, ENERG BUILDINGS, V103, P175, DOI 10.1016/j.enbuild.2015.06.058; Rizzo SA, 2015, APPL ENERG, V145, P124, DOI 10.1016/j.apenergy.2015.01.077; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Tan K, 2004, IEEE T ENERGY CONVER, V19, P392, DOI 10.1109/TEC.2004.827038; Uzunoglu M, 2009, RENEW ENERG, V34, P509, DOI 10.1016/j.renene.2008.06.009; Wu XJ, 2008, J POWER SOURCES, V179, P232, DOI 10.1016/j.jpowsour.2007.12.036; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Yang J, 2009, J POWER SOURCES, V193, P699, DOI 10.1016/j.jpowsour.2009.04.022; Yin M, 2016, IET RENEW POWER GEN, V11, P501; Zhang SQ, 2016, IEEE T POWER SYST, V31, P1595, DOI 10.1109/TPWRS.2015.2432113; Zhang TJ, 2009, IEEE T FUZZY SYST, V17, P357, DOI 10.1109/TFUZZ.2008.2011135	40	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183750	10.1371/journal.pone.0183750	http://dx.doi.org/10.1371/journal.pone.0183750			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877191	Green Submitted, gold, Green Published			2022-12-26	WOS:000409391200040
J	Singh, RP; Runthala, A; Khan, S; Jha, PN				Singh, Rajnish Prakash; Runthala, Ashish; Khan, Shahid; Jha, Prabhat Nath			Quantitative proteomics analysis reveals the tolerance of wheat to salt stress in response to Enterobacter cloacae SBP-8	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIA; PSEUDOMONAS-PUTIDA UW4; LOW WATER POTENTIALS; XYLOGLUCAN ENDOTRANSGLYCOSYLASE; TRITICUM-AESTIVUM; ABIOTIC STRESS; TOMATO PLANTS; PROTEINS; ARABIDOPSIS; MECHANISMS	Salinity stress adversely affects the plant growth and is a major constraint to agriculture. In the present study, we studied the role of plant growth promoting rhizobacterium (PGPR) Enterobacter cloacae SBP-8 possessing ACC deaminase activity on proteome profile of wheat (Triticum aestivum L.) under high salinity (200 mM NaCl) stress. The aim of study was to investigate the differential expressed protein in selected three (T-1, T-2, T-3) treatments and absolute quantification (MS/MS analysis) was used to detect statistically significant expressed proteins. In this study, we investigated the adaptation mechanisms of wheat seedlings exposed to high concentration of NaCl treatment (200 mM) for 15 days in response to bacterial inoculation based on proteomic data. The identified proteins were distributed in different cellular, biological and molecular functions. Under salt stress, proteins related to ion-transport, metabolic pathway, protein synthesis and defense responsive were increased to a certain extent. A broader comparison of the proteome of wheat plant under different treatments revealed that changes in some of the metabolic pathway may be involved in stress adaption in response to PGPR inoculation. Hierarchical cluster analysis identified the various up-regulated/down-regulated proteins into tested three treatments. Our results suggest that bacterial inoculation enhanced the ability of wheat plant to combat salt stress via regulation of transcription factors, promoting antioxidative activity, induction of defense enzymes, lignin biosynthesis, and acceleration of protein synthesis.	[Singh, Rajnish Prakash; Khan, Shahid; Jha, Prabhat Nath] BITS, Dept Biol Sci, Pilani, Rajasthan, India; [Runthala, Ashish] Indian Inst Sci, Bangalore, Karnataka, India	Birla Institute of Technology & Science Pilani (BITS Pilani); Indian Institute of Science (IISC) - Bangalore	Jha, PN (corresponding author), BITS, Dept Biol Sci, Pilani, Rajasthan, India.	prabhatnjha@gmail.com	Runthala, Ashish/F-5070-2011	Runthala, Ashish/0000-0002-1835-2755	Department of Biotechnology, Government of India, New Delhi [BT/PR14527/AGR/21/326/2010]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	The work was supported by the Department of Biotechnology, Government of India, New Delhi to PNJ; Grant No. BT/PR14527/AGR/21/326/2010.	Ahmad S, 1998, J AGRON CROP SCI, V181, P125, DOI 10.1111/j.1439-037X.1998.tb00407.x; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Annunziata MG, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02035; Bertini L, 2003, PLANT SCI, V164, P1067, DOI 10.1016/S0168-9452(03)00112-2; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Caporale C, 2004, FEBS LETT, V575, P71, DOI 10.1016/j.febslet.2004.07.091; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Cheng ZY, 2007, CAN J MICROBIOL, V53, P912, DOI 10.1139/W07-050; Cheng ZY, 2012, APPL SOIL ECOL, V61, P255, DOI 10.1016/j.apsoil.2011.10.006; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; DeGara L, 1997, PHYSIOL PLANTARUM, V100, P894, DOI 10.1034/j.1399-3054.1997.1000415.x; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Farajzadeh D, 2010, CURR MICROBIOL, V61, P37, DOI 10.1007/s00284-009-9573-x; Fercha A, 2013, J PROTEOMICS, V91, P486, DOI 10.1016/j.jprot.2013.08.010; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Gagne-Bourque F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00584; Gamalero E, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P17, DOI 10.1007/978-3-642-21061-7_2; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Greene TW, 1998, P NATL ACAD SCI USA, V95, P13342, DOI 10.1073/pnas.95.22.13342; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Hincha DK, 2002, GLYCOBIOLOGY, V12, P103, DOI 10.1093/glycob/12.2.103; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; JORRINNOVO JV, 2009, INT J PROTEOMICS, V72, P285, DOI DOI 10.1016/J.JPROT.2009.01.026; Kandasamy S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-47; Kav Nat N. V., 2007, Current Proteomics, V4, P28; Liu F, 2015, J EXP BOT; Mathesius U, 2009, J PROTEOMICS, V72, P353, DOI 10.1016/j.jprot.2008.12.006; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munoz-Bertomeu J, 2013, J PLANT PHYSIOL, V170, P1194, DOI 10.1016/j.jplph.2013.03.015; Ndimba BK, 2005, PROTEOMICS, V5, P4185, DOI 10.1002/pmic.200401282; O'Brien M, 2005, PLANT PHYSIOL, V139, P734, DOI 10.1104/pp.105.066639; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; PRITCHARD J, 1993, J EXP BOT, V44, P1281, DOI 10.1093/jxb/44.8.1281; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Roppolo D, 2014, PLANT PHYSIOL, V165, P1709, DOI 10.1104/pp.114.239137; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; SAALAOUI E, 1990, PLANT SCI, V66, P237, DOI 10.1016/0168-9452(90)90209-7; Sergeeva E, 2006, WORLD J MICROB BIOT, V22, P277, DOI 10.1007/s11274-005-9032-1; Shoji T, 2006, PLANT CELL PHYSIOL, V47, P1158, DOI 10.1093/pcp/pcj090; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; Singh RP, 2015, J PLANT PHYSIOL, V184, P57, DOI 10.1016/j.jplph.2015.07.002; Sivakumar P, 1998, BIOCHEM BIOPH RES CO, V252, P428, DOI 10.1006/bbrc.1998.9666; Sramkova Z, 2009, GENETIC IMPROVEMENT; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tucaliuc RB, 2008, ROM BIOTECH LETT, V13, P3837; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; WIESER H, 1980, Z LEBENSM UNTERS FOR, V170, P17, DOI 10.1007/BF01113461; WILLEY DL, 1984, MOL GEN GENET, V194, P416, DOI 10.1007/BF00425553; WU YJ, 1994, PLANT PHYSIOL, V106, P607, DOI 10.1104/pp.106.2.607; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Zang X, 2007, PHYTOCHEMISTRY, V68, P426, DOI 10.1016/j.phytochem.2006.11.005; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498	63	35	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183513	10.1371/journal.pone.0183513	http://dx.doi.org/10.1371/journal.pone.0183513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877183	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000409391200035
J	Wang, QK; Zhu, Y; Liu, YF; Wang, L; Chen, YF				Wang, Qiuke; Zhu, Yu; Liu, Yifei; Wang, Lei; Chen, Yunfeng			Correlation between classification and secondary screw penetration in proximal humeral fractures	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; LOCKING PLATE; FIBULAR ALLOGRAFT; OPEN REDUCTION; FIXATION; HEAD; COMPLICATIONS; AUGMENTATION; CADAVER	Objectives In this study, we investigated the correlation between fracture classification and secondary screw penetration. Methods We retrospectively identified 189 patients with displaced proximal humeral fractures treated by ORIF at our hospital between June 2006 and June 2013. All fractures were classified radiographically before surgery and follow-up for least 2 years after surgery was recommended. At each follow-up, radiographs were taken in three orthogonal views to evaluate secondary screw penetration. Results The study population consisted of 189 patients. Of these, 70 were male and 119 female, with a mean age of 59.1 years; the mean follow-up time was 28.5 months. Secondary screw penetration occurred in 26 patients. The risk of developing secondary screw penetration was 11.3-fold higher in four-part fractures than two-part fractures (P < 0.05), 8.6-fold higher for type C fractures than type A fractures (P < 0.05) and 11.0-fold higher for medial hinge disruption group than intact medial hinge group fractures (P < 0.05). However there was no difference between three-part fractures and two-part fractures (P = 0.374), and between type B and type A fractures (P = 0.195). Age, gender, time to surgery and the number of screw in humeral head had no influence on the secondary screw penetration rate (P > 0.05). Conclusions Patients with four-part fractures, type C fractures and medial hinges disruption are vulnerable to secondary screw penetration. This allows additional precautions to be instituted and measures to be taken as needed.	[Wang, Qiuke; Zhu, Yu; Liu, Yifei; Wang, Lei; Chen, Yunfeng] Shanghai Jiao Tong Univ, Dept Orthoped Surg, Peoples Hosp 6, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wang, L; Chen, YF (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped Surg, Peoples Hosp 6, Shanghai, Peoples R China.	wanglei2264@126.com; drchenyunfeng@sina.com			Three-year Project for Enhancing Clinical and Innovative Competence of Municipal Hospitals [16CR3042A]; Three-year Project for Enhancing Clinical and Innovative Competence of Municipal Hospitals	Three-year Project for Enhancing Clinical and Innovative Competence of Municipal Hospitals; Three-year Project for Enhancing Clinical and Innovative Competence of Municipal Hospitals	This study was funded by Three-year Project for Enhancing Clinical and Innovative Competence of Municipal Hospitals (16CR3042A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Three-year Project for Enhancing Clinical and Innovative Competence of Municipal Hospitals for the funding support.	Boesmueller S, 2016, INJURY, V47, P350, DOI 10.1016/j.injury.2015.10.001; Charalambous CP, 2007, ARCH ORTHOP TRAUM SU, V127, P205, DOI 10.1007/s00402-006-0256-9; Chow RM, 2012, J SHOULDER ELB SURG, V21, P894, DOI 10.1016/j.jse.2011.04.015; Clavert P, 2010, J SHOULDER ELB SURG, V19, P489, DOI 10.1016/j.jse.2009.09.005; Egol KA, 2008, J ORTHOP TRAUMA, V22, P159, DOI 10.1097/BOT.0b013e318169ef2a; Egol KA, 2012, J SHOULDER ELB SURG, V21, P741, DOI 10.1016/j.jse.2011.09.017; Erasmo R, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.10.022; Erhardt JB, 2012, J ORTHOP TRAUMA, V26, pE188, DOI 10.1097/BOT.0b013e31823db922; Gardner MJ, 2007, J ORTHOP TRAUMA, V21, P185, DOI 10.1097/BOT.0b013e3180333094; Gradl G, 2013, J ORTHOP TRAUMA, V27, P399, DOI 10.1097/BOT.0b013e318278c595; Helwig P, 2009, ACTA ORTHOP, V80, P92, DOI 10.1080/17453670902807417; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; Marsh JL, 2007, J ORTHOP TRAUMA S, V21, pS1, DOI DOI 10.1097/00005131-200711101-00001; Matassi F, 2012, INJURY, V43, P1939, DOI 10.1016/j.injury.2012.08.004; Ong C, 2011, CLIN ORTHOP RELAT R, V469, P3292, DOI 10.1007/s11999-011-1864-4; Owsley KC, 2008, J BONE JOINT SURG AM, V90A, P233, DOI 10.2106/JBJS.F.01351; Ricchetti Eric T, 2010, J Shoulder Elbow Surg, V19, P66, DOI 10.1016/j.jse.2010.01.001; Roderer G, 2011, INT ORTHOP, V35, P425, DOI 10.1007/s00264-010-1015-7; Spross C, 2014, INJURY, V45, P1557, DOI 10.1016/j.injury.2014.05.025; Sproul RC, 2011, INJURY, V42, P408, DOI 10.1016/j.injury.2010.11.058; Thanasas C, 2009, J SHOULDER ELB SURG, V18, P837, DOI 10.1016/j.jse.2009.06.004; Yang HG, 2011, J ORTHOP TRAUMA, V25, P11, DOI 10.1097/BOT.0b013e3181d2d04c	22	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183164	10.1371/journal.pone.0183164	http://dx.doi.org/10.1371/journal.pone.0183164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877198	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200023
J	Chung, YS; Kim, YJ; Lee, I; Lee, JY; Nam, EJ; Kim, S; Kim, SW; Kim, YT				Chung, Young Shin; Kim, Yun-Ji; Lee, Inha; Lee, Jung-Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Kim, Young Tae			Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer	PLOS ONE			English	Article							PRIMARY SURGERY; PHASE-III; DEBULKING SURGERY; PLATINUM; OUTCOMES; NUMBER	Background There is currently no consensus regarding the optimal number of chemotherapy cycles to be administered before and after interval debulking surgery (IDS) in patients with advanced ovarian cancer. This study aimed to evaluate the impact of the number of neoadjuvant chemotherapy (NAC) and postoperative adjuvant chemotherapy (POAC) cycles on the survival of patients with advanced ovarian cancer undergoing NAC/IDS/POAC. Methods We retrospectively reviewed data from 203 patients who underwent NAC/IDS/POAC at Yonsei Cancer Hospital between 2006 and 2016. All patients underwent taxane plus carboplatin chemotherapy for NAC and POAC. The patient outcomes were analyzed according to the number of NAC, POAC, and total chemotherapy (NAC+POAC) cycles. Results Patients who received fewer than 6 cycles of total chemotherapy (n = 8) had poorer progression-free survival (PFS) and overall survival (OS) than those completing at least 6 cycles (p = 0.005 and p<0.001, respectively). Among patients who completed at least 6 cycles of total chemotherapy (n = 189), Kaplan-Meier analysis revealed no significant difference in either PFS or OS according to the number of NAC cycles (1-3 vs. >= 4; p = 0.136 and p = 0.267, respectively). Among patients who experienced complete remission after 3 cycles of POAC (n = 98), the addition of further POAC cycles did not improve the PFS or OS (3 vs. >= 4; p = 0.641 and p = 0.104, respectively). Conclusion IDS after 4 cycles of NAC may be a safe and effective option when completing 6 cycles of total chemotherapy. Furthermore, the addition of more than 3 cycles of POAC does not appear to influence the survival of patients achieving completion remission after 3 cycles of POAC.	[Chung, Young Shin; Kim, Yun-Ji; Lee, Inha; Lee, Jung-Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Kim, Young Tae] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea.	jungyunlee@yuhs.ac		Nam, Eun Ji/0000-0003-0189-3560; Lee, Jung-Yun/0000-0001-7948-1350; Lee, Inha/0000-0003-4869-6281; kim, sunghoon/0000-0002-1570-3230	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03931916]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2016R1D1A1B03931916).	Akladios C, 2016, ONCOLOGY-BASEL, V91, P331, DOI 10.1159/000449203; Bookman MA, 2013, J GYNECOL ONCOL, V24, P105, DOI 10.3802/jgo.2013.24.2.105; Bristow RE, 2007, GYNECOL ONCOL, V104, P480, DOI 10.1016/j.ygyno.2006.11.002; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chi DS, 2009, GYNECOL ONCOL, V114, P26, DOI 10.1016/j.ygyno.2009.03.018; Colombo PE, 2014, GYNECOL ONCOL, V135, P223, DOI 10.1016/j.ygyno.2014.09.002; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eisenhauer EL, 2006, GYNECOL ONCOL, V103, P1083, DOI 10.1016/j.ygyno.2006.06.028; Fagotti A, 2016, EUR J CANCER, V59, P22, DOI 10.1016/j.ejca.2016.01.017; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Lee JY, 2015, EJSO-EUR J SURG ONC, V41, P585, DOI 10.1016/j.ejso.2015.01.006; Lee JY, 2014, J GYNECOL ONCOL, V25, P174, DOI 10.3802/jgo.2014.25.3.174; Lee SJ, 2006, INT J GYNECOL CANCER, V16, P95, DOI 10.1111/j.1525-1438.2006.00282.x; Lim MC, 2013, J GYNECOL ONCOL, V24, P298, DOI 10.3802/jgo.2013.24.4.298; Mei L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007414.pub3; Miranda VD, 2014, GYNECOL ONCOL, V132, P287, DOI 10.1016/j.ygyno.2013.12.002; NCCN, 2017, CLIN PRACT GUID ONC; Onda T, 2016, EUR J CANCER, V64, P22, DOI 10.1016/j.ejca.2016.05.017; Pecorelli S, 2009, J CLIN ONCOL, V27, P4642, DOI 10.1200/JCO.2009.21.9691; Rauh-Hain JA, 2013, GYNECOL ONCOL, V129, P63, DOI 10.1016/j.ygyno.2013.01.009; Schwartz PE, 1999, GYNECOL ONCOL, V72, P93, DOI 10.1006/gyno.1998.5236; Shibata K, 2003, INT J GYNECOL CANCER, V13, P587, DOI 10.1046/j.1525-1438.2003.13388.x; Stoeckle E, 2014, ANN SURG ONCOL, V21, P629, DOI 10.1245/s10434-013-3278-x; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wimberger P, 2007, GYNECOL ONCOL, V106, P69, DOI 10.1016/j.ygyno.2007.02.026; Xu X, 2017, ARCH GYNECOL OBSTET, V295, P451, DOI 10.1007/s00404-016-4256-x	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183754	10.1371/journal.pone.0183754	http://dx.doi.org/10.1371/journal.pone.0183754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873393	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800026
J	Costalonga, EC; de Freitas, LJ; Aragone, DDP; Silva, FMO; Noronha, IL				Costalonga, Elerson C.; de Freitas, Luiza J.; Aragone, Deise da S. P.; Silva, Filipe M. O.; Noronha, Irene L.			Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; TO-MESENCHYMAL TRANSITION; HEMODIALYSIS-PATIENTS; ACETYLATION; SUPPRESSES; TGF-BETA-1; MODEL	Background Progressive fibrous thickening of the peritoneal membrane is a complication of long-term peritoneal dialysis (PD). TGF-beta/Smad pathway activation, inflammation, and neoangiogenesis play important roles in peritoneal membrane (PM) changes induced by PD. Recently, histone deacetilase inhibitors (HDACi) have shown anti-fibrotic and anti-inflammatory effects in different experimental models. These drugs prevent deacetylation of histones causing a loosen chromatin, which in turn induce the expression of some anti-fibrotic genes. In addition, acetylation may increase the activity of proteins involved in tissue fibrosis, such as Smad7. Here, we explored the effect of valproic acid (VPA), an HDACi, on the development of peritoneal fibrosis (PF) in rats. Methods PF was induced by daily intraperitoneal injections of 0.1% chlorhexidine gluconate (CG) for 15 consecutive days. Male Wistar rats (250-300 g) were divided into 3 groups: CONTROL, control rats receiving only vehicle; PF, peritoneal fibrosis induced in rats; PF+ VPA, rats with PF treated with VPA (300 mg/kg/day by gavage). PF was assessed by Masson's trichrome staining. Inflammation and fibrosis-associated factors were assessed by immunohistochemistry, immunofluorescence, multiplex analysis, and qPCR. Results Treatment with VPA significantly reduced PM thickness and the expression of myofibroblasts, besides preventing loss of ultrafiltration capacity of the PM. The upregulation of profibrotic factors (TGF-beta, fibronectin, and Smad3) in the PF group was significantly ameliorated by VPA. VPA modulated the TGF/Smad pathway, inhibiting phosphorylated Smad3 expression and inducing an increased Smad7 expression in the FP+ VPA group. The neoangiogenesis and the expression of proinflammatory cytokines (TNF-alpha, IL-1 beta, MCP-1) observed in the PF group was significantly reduced by VPA. Conclusions Our results indicate that VPA suppressed experimental PF through modulation of the TGF-beta/Smad pathway. Interestingly, VPA treatment induced a higher expression of antifibrotic factors, such as Smad7. These results suggest that VPA may represent a potential strategy for treating long term PD complications.	[Costalonga, Elerson C.; de Freitas, Luiza J.; Aragone, Deise da S. P.; Silva, Filipe M. O.; Noronha, Irene L.] Univ Sao Paulo, Renal Div, Lab Cellular Genet & Mol Nephrol, Med Sch, Sao Paulo, Brazil; [Noronha, Irene L.] Univ Sao Paulo, Ctr Cellular & Mol Studies & Therapy NETCEM, Med Sch, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Costalonga, EC (corresponding author), Univ Sao Paulo, Renal Div, Lab Cellular Genet & Mol Nephrol, Med Sch, Sao Paulo, Brazil.	elersonc@yahoo.com.br	Miranda, Filipe/ABA-9563-2020	Silva, Filipe/0000-0001-7531-7473	Brazilian National Council for Research and Development (CNPq) [401430/2013-8, 457601/2013-2, 461785/2014-5]	Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Brazilian National Council for Research and Development (CNPq, http://cripqbr) grants 401430/2013-8,457601/2013-2, and 461785/2014-5. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112050; Aher JS, 2015, HUM EXP TOXICOL, V34, P44, DOI 10.1177/0960327114531992; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Chen YT, 2014, J AM SOC NEPHROL, V25, P2847, DOI 10.1681/ASN.2013101079; Costalonga EC, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5985903; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; Duan WJ, 2014, AM J PATHOL, V184, P2275, DOI 10.1016/j.ajpath.2014.04.014; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Guo H, 2007, J AM SOC NEPHROL, V18, P2689, DOI 10.1681/ASN.2007010121; Io K, 2015, PERITON DIALYSIS INT, V35, P246, DOI 10.3747/pdi.2013.00089; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Khan S, 2015, EXP MOL PATHOL, V98, P230, DOI 10.1016/j.yexmp.2015.01.003; Khan Sabbir, 2014, J Basic Clin Physiol Pharmacol, P1, DOI 10.1515/jbcpp-2013-0134; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Kumar VA, 2014, KIDNEY INT, V86, P1016, DOI 10.1038/ki.2014.224; Li J, 2015, CHEM GEOL, V406, P10, DOI 10.1016/j.chemgeo.2015.04.010; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Lukowsky LR, 2013, CLIN J AM SOC NEPHRO, V8, P619, DOI 10.2215/CJN.04810512; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Morelle J, 2015, J AM SOC NEPHROL, V26, P2521, DOI 10.1681/ASN.2014090939; Ni J, 2006, KIDNEY INT, V69, P1518, DOI 10.1038/sj.ki.5000285; Nural-Guvener H, 2015, INT J MOL SCI, V16, P11482, DOI 10.3390/ijms160511482; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Rigby RJ, 1998, NEPHROL DIAL TRANSPL, V13, P154, DOI 10.1093/ndt/13.1.154; Sampimon Denise E, 2014, Adv Perit Dial, V30, P21; Simonsson M, 2005, J BIOL CHEM, V280, P21797, DOI 10.1074/jbc.M503134200; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Van Beneden K, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-1; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Wang X, 2010, NEPHROL DIAL TRANSPL, V25, P399, DOI 10.1093/ndt/gfp480; Workeneh B, 2015, INT J NEPHROL, V2015, DOI 10.1155/2015/652953; Wu CM, 2012, DNA CELL BIOL, V31, P592, DOI 10.1089/dna.2011.1401; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	41	7	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184302	10.1371/journal.pone.0184302	http://dx.doi.org/10.1371/journal.pone.0184302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873458	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800072
J	Ogunniyi, AD; Khazandi, M; Stevens, AJ; Sims, SK; Page, SW; Garg, S; Venter, H; Powell, A; White, K; Petrovski, KR; Laven-Law, G; Totoli, EG; Salgado, HR; Pi, HF; Coombs, GW; Shinabarger, DL; Turnidge, JD; Paton, JC; McCluskey, A; Trott, DJ				Ogunniyi, Abiodun D.; Khazandi, Manouchehr; Stevens, Andrew J.; Sims, Sarah K.; Page, Stephen W.; Garg, Sanjay; Venter, Henrietta; Powell, Andrew; White, Karen; Petrovski, Kiro R.; Laven-Law, Geraldine; Totoli, Eliane G.; Salgado, Herida R.; Pi, Hongfei; Coombs, Geoffrey W.; Shinabarger, Dean L.; Turnidge, John D.; Paton, James C.; McCluskey, Adam; Trott, Darren J.			Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; IN-VITRO; STREPTOCOCCUS-PNEUMONIAE; BACTERICIDAL ACTIVITY; CONJUGATE VACCINE; DAPTOMYCIN; TOXICITY; COLONIZATION; EPIDEMIOLOGY; COMBINATIONS	The spread of multidrug resistance among bacterial pathogens poses a serious threat to public health worldwide. Recent approaches towards combating antimicrobial resistance include repurposing old compounds with known safety and development pathways as new antibacterial classes with novel mechanisms of action. Here we show that an analog of the anticoccidial drug robenidine (4,6-bis(2-((E)-4-methylbenzylidene)hydrazinyl)pyrimidin-2-amine; NCL195) displays potent bactericidal activity against Streptococcus pneumoniae and Staphylococcus aureus by disrupting the cell membrane potential. NCL195 was less cytotoxic to mammalian cell lines than the parent compound, showed low metabolic degradation rates by human and mouse liver microsomes, and exhibited high plasma concentration and low plasma clearance rates in mice. NCL195 was bactericidal against Acinetobacter spp and Neisseria meningitidis and also demonstrated potent activity against A. baumannii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Enterobacter spp. in the presence of sub-inhibitory concentrations of ethylenediaminetetraacetic acid (EDTA) and polymyxin B. These findings demonstrate that NCL195 represents a new chemical lead for further medicinal chemistry and pharmaceutical development to enhance potency, solubility and selectivity against serious bacterial pathogens.	[Ogunniyi, Abiodun D.; Khazandi, Manouchehr; Petrovski, Kiro R.; Pi, Hongfei; Turnidge, John D.; Trott, Darren J.] Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Roseworthy, SA, Australia; [Stevens, Andrew J.; McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Chem, Callaghan, NSW, Australia; [Sims, Sarah K.; Laven-Law, Geraldine] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Page, Stephen W.] Neoculi Pty Ltd, Burwood, Vic, Australia; [Garg, Sanjay] Univ South Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Ctr Pharmaceut Innovat & Dev, Adelaide, SA, Australia; [Venter, Henrietta] Univ South Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Powell, Andrew; White, Karen] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic, Australia; [Totoli, Eliane G.; Salgado, Herida R.] Sao Paulo State Univ, Sch Pharmaceut Sci, Dept Drugs & Med, Sao Paulo, Brazil; [Coombs, Geoffrey W.] Fiona Stanley Hosp, Path West Lab Med WA, Dept Microbiol, Murdoch, WA, Australia; [Coombs, Geoffrey W.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Shinabarger, Dean L.] Micromyx LLC, Kalamazoo, MI USA; [Turnidge, John D.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA, Australia; [Paton, James C.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Adelaide; University of Newcastle; University of Adelaide; University of South Australia; University of South Australia; Monash University; Universidade Estadual Paulista; Murdoch University; University of Adelaide; University of Adelaide	Ogunniyi, AD; Trott, DJ (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Roseworthy, SA, Australia.	david.ogunniyi@adelaide.edu.au; darren.trott@adelaide.edu.au	Venter, Rietie/E-4795-2013; Petrovski, Kiro Risto/F-1556-2016; Khazandi, Manouchehr/ABC-5930-2020; Page, Stephen/AAX-2920-2021; Salgado, Herida/AAB-9837-2022; Garg, Sanjay/B-2516-2012	Venter, Rietie/0000-0001-5569-7755; Petrovski, Kiro Risto/0000-0003-4016-2576; Page, Stephen/0000-0001-5312-2149; Salgado, Herida/0000-0002-0385-340X; Garg, Sanjay/0000-0001-7253-2629; Laven-Law, Geraldine/0000-0001-5326-1931; McCluskey, Adam/0000-0001-7125-863X; Ogunniyi, Abiodun/0000-0001-9308-5629; Coombs, Geoffrey/0000-0003-1635-6506; Sims, Sarah/0000-0002-9505-5498; Powell, Andrew/0000-0002-9779-1122	Australian Research Council (ARC) [LP110200770]; Neoculi Pty Ltd; National Health and Medical Research Council of Australia (NHMRC) [565526, 627142]; University of South Australia; Sansom Institute of Health Research; Micromyx LLC	Australian Research Council (ARC)(Australian Research Council); Neoculi Pty Ltd; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia; Sansom Institute of Health Research; Micromyx LLC	This work was supported by an Australian Research Council (ARC; arc.gov.au) Linkage grant (LP110200770) to D.J.T., A.M. and S.W.P. with Neoculi Pty Ltd as the Partner Organization. Additionally, it was funded in part by a grant from the National Health and Medical Research Council of Australia (NHMRC; nhmrc. gov.au) Program Grant 565526 to J.C.P., Project Grant 627142 to J.C.P. and A.D.O., and University of South Australia and the Sansom Institute of Health Research fund to H.V. Micromyx LLC provided support in the form of salary for D.L.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Abraham RJ, 2016, J MED CHEM, V59, P2126, DOI 10.1021/acs.jmedchem.5b01797; Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Brown D, 2015, NAT REV DRUG DISCOV, V14, P821, DOI 10.1038/nrd4675; Bush K., 2015, INT J ANTIMICROB AG, V45, pS10; Bush K, 2015, ACS INFECT DIS, V1, P509, DOI 10.1021/acsinfecdis.5b00100; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Calfee DP, 2012, ANNU REV MED, V63, P359, DOI 10.1146/annurev-med-081210-144458; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Clinical and Laboratory Standards Institute, 2015, M07A10 CLSI, V35, P1; Cotroneo N, 2008, ANTIMICROB AGENTS CH, V52, P2223, DOI 10.1128/AAC.01410-07; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De la Calle C, 2016, EUR J CLIN MICROBIOL; EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2011, EFSA Journal, V9, P2102; Eliopoulos G., 2015, INT J ANTIMICROBI S2, V45, pS5; European Centre for Disease Prevention and Control (ECDC), 2015, ANN REPORT EUROPEAN; Evans SM, 2001, TOXICOL IN VITRO, V15, P579, DOI 10.1016/S0887-2333(01)00064-9; Falgenhauer L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02359-16; GARLE MJ, 1994, TOXICOL IN VITRO, V8, P1303, DOI 10.1016/0887-2333(94)90123-6; Ghafur A, 2013, MED J AUSTRALIA, V198, P251, DOI 10.5694/mja13.10099; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Groves MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146034; Hamoud R, 2014, PHYTOMEDICINE, V21, P443, DOI 10.1016/j.phymed.2013.10.016; Hart J, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-7; Henken S, 2010, ANTIMICROB AGENTS CH, V54, P707, DOI 10.1128/AAC.00943-09; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Hoshino K, 2008, ANTIMICROB AGENTS CH, V52, P65, DOI 10.1128/AAC.00853-07; Jones RN, 2008, ANTIMICROB AGENTS CH, V52, P3763, DOI 10.1128/AAC.00294-08; KANTOR S, 1970, SCIENCE, V168, P373, DOI 10.1126/science.168.3929.373; Klugman KP, 1997, J ANTIMICROB CHEMOTH, V40, P797, DOI 10.1093/jac/40.6.797; Knox J, 2015, EPIDEMIOL INFECT, V143, P354, DOI 10.1017/S0950268814000983; LEE BL, 1991, ANTIMICROB AGENTS CH, V35, P2505, DOI 10.1128/AAC.35.12.2505; Leung MHY, 2011, INFECT GENET EVOL, V11, P1989, DOI 10.1016/j.meegid.2011.09.002; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Liu YF, 2015, J NANOMATER, V2015, DOI 10.1155/2015/792095; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188, DOI 10.2174/138620710790596736; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; O'Neill J., 2015, SECURING NEW DRUGS F, P1; Obach RS, 1999, DRUG METAB DISPOS, V27, P1350; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Palmu AA, 2014, LANCET INFECT DIS, V14, P205, DOI [10.1016, 10.1016/S1473-3099(13)70338-4]; Perez F, 2016, EXPERT OPINION PHARM; Poirel L, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00006-2; Prasad S, 2013, OCCASIONAL PAPER SER, V7; Roberts J, 2015, CLIN ORTHOP RELAT R, V473, P2262, DOI 10.1007/s11999-015-4232-y; Rozengart E V, 2002, Dokl Biochem Biophys, V385, P219, DOI 10.1023/A:1019967524406; Silver LL, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P249; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Smith JR, 2016, ANTIMICROB AGENTS CH, V60, P2352, DOI 10.1128/AAC.03006-15; Thampi N, 2015, AM J INFECT CONTROL, V43, P739, DOI 10.1016/j.ajic.2015.01.031; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vaz LE, 2015, PEDIATRICS, V136, P221, DOI 10.1542/peds.2015-0883; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Wang Y, 2017, BIOORG MED CHEM LETT; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; World Health Organization, 2014, ANT RES GLOB REP SUR	60	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183457	10.1371/journal.pone.0183457	http://dx.doi.org/10.1371/journal.pone.0183457			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873428	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000409282800015
J	Rasse, DP; Budai, A; O'Toole, A; Ma, XZ; Rumpel, C; Abiven, S				Rasse, Daniel P.; Budai, Alice; O'Toole, Adam; Ma, Xingzhu; Rumpel, Cornelia; Abiven, Samuel			Persistence in soil of Miscanthus biochar in laboratory and field conditions	PLOS ONE			English	Article							BLACK CARBON; PYROGENIC CARBON; ORGANIC-MATTER; STABILITY; TEMPERATURE; RESPIRATION; VEGETATION; HYDROCHAR; RESIDUES; DIOXIDE	Evaluating biochars for their persistence in soil under field conditions is an important step towards their implementation for carbon sequestration. Current evaluations might be biased because the vast majority of studies are short-term laboratory incubations of biochars produced in laboratory-scale pyrolyzers. Here our objective was to investigate the stability of a biochar produced with a medium-scale pyrolyzer, first through laboratory characterization and stability tests and then through field experiment. We also aimed at relating properties of this medium-scale biochar to that of a laboratory-made biochar with the same feedstock. Biochars were made of Miscanthus biomass for isotopic C-tracing purposes and produced at temperatures between 600 and 700 degrees C. The aromaticity and degree of condensation of aromatic rings of the medium-scale biochar was high, as was its resistance to chemical oxidation. In a 90-day laboratory incubation, cumulative mineralization was 0.1% for the medium-scale biochar vs. 45% for the Miscanthus feedstock, pointing to the absence of labile C pool in the biochar. These stability results were very close to those obtained for biochar produced at laboratory-scale, suggesting that upscaling from laboratory to mediumscale pyrolyzers had little effect on biochar stability. In the field, the medium-scale biochar applied at up to 25 t C ha(-1) decomposed at an estimated 0.8% per year. In conclusion, our biochar scored high on stability indices in the laboratory and displayed a mean residence time > 100 years in the field, which is the threshold for permanent removal in C sequestration projects.	[Rasse, Daniel P.; Budai, Alice; O'Toole, Adam] Norwegian Inst Bioecon Res, Dept Soil Qual & Climate Change, As, Norway; [Budai, Alice] Norwegian Univ Life Sci, Dept Environm Sci, As, Norway; [Ma, Xingzhu] Heilongjiang Acad Agr Sci, Inst Soil Fertilizer & Environm Resource, Harbin, Heilongjiang, Peoples R China; [Rumpel, Cornelia] CNRS, UMR, INRA, UPMC,IEES,UPEC,IRD ParisAgroTech, Thiverval Grignon, France; [Abiven, Samuel] Univ Zurich, Dept Geog, Zurich, Switzerland	Norwegian Institute of Bioeconomy Research; Norwegian University of Life Sciences; Heilongjiang Academy of Agricultural Sciences; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Zurich	Rasse, DP (corresponding author), Norwegian Inst Bioecon Res, Dept Soil Qual & Climate Change, As, Norway.	daniel.rasse@nibio.no	Rumpel, Cornelia/A-2001-2015; O'Toole, Adam/AAU-1324-2020; Abiven, Samuel/J-5328-2013; Rasse, Daniel/H-7279-2019	Rumpel, Cornelia/0000-0003-2131-9451; Abiven, Samuel/0000-0002-5663-0912; Rasse, Daniel/0000-0002-5977-3863; Budai, Alice/0000-0002-6675-4548	Research Council of Norway (NFR) [NFR197531, NFR/192856]; Norwegian Financial Mechanism with Hungary "Green Industry Innovation" project [HU09-0029-A1-2013]; Norwegian Ministry of Climate and Environment through the NIBIO SIS-Jordkarbon project; MOLTER networking programme of the European Science Foundation [EG/3958]	Research Council of Norway (NFR)(Research Council of Norway); Norwegian Financial Mechanism with Hungary "Green Industry Innovation" project; Norwegian Ministry of Climate and Environment through the NIBIO SIS-Jordkarbon project; MOLTER networking programme of the European Science Foundation	Funding for the research was provided by the Research Council of Norway (NFR) through the project "Advanced Techniques to Evaluate the Long-term Stability and Carbon Sequestration Potential of Different Types of Biochar" NFR197531 and "Creating a scientific basis for an integrated evaluation of soil-borne GHG emissions in Norwegian agriculture" NFR/192856; by the Norwegian Financial Mechanism with Hungary "Green Industry Innovation" project HU09-0029-A1-2013; and by the Norwegian Ministry of Climate and Environment through the NIBIO SIS-Jordkarbon project. Alice Budai received a travel grant (EG/3958) from the MOLTER networking programme of the European Science Foundation for part of this work on BPCA at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2013, PLANT SOIL, V372, P375, DOI 10.1007/s11104-013-1745-6; Brewer CE, 2011, BIOENERG RES, V4, P312, DOI 10.1007/s12155-011-9133-7; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Budai A, 2016, BIOL FERT SOILS, V52, P749, DOI 10.1007/s00374-016-1116-6; Budai A, 2014, J AGR FOOD CHEM, V62, P3791, DOI 10.1021/jf501139f; Cowie AL, 2012, PESQUI AGROPECU BRAS, V47, P637, DOI 10.1590/S0100-204X2012000500002; [EBC EBC European Biochar Certificate], 2016, EUR BIOCH CERT GUID; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Hale SE, 2012, ENVIRON SCI TECHNOL, V46, P2830, DOI 10.1021/es203984k; IBI, 2015, STAND PROD DEF PROD; Jeffery S, 2015, GCB BIOENERGY, V7, P1, DOI 10.1111/gcbb.12132; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kuo LJ, 2008, ORG GEOCHEM, V39, P1466, DOI 10.1016/j.orggeochem.2008.04.026; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Maestrini B, 2014, BIOGEOSCIENCES, V11, P5199, DOI 10.5194/bg-11-5199-2014; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; Moni C, 2014, INT J GREENH GAS CON, V26, P61, DOI 10.1016/j.ijggc.2014.04.010; Naisse C, 2015, GCB BIOENERGY, V7, P488, DOI 10.1111/gcbb.12158; Naisse C, 2013, ORG GEOCHEM, V60, P40, DOI 10.1016/j.orggeochem.2013.04.011; Noble I.R., 2000, LAND USE LAND USE CH, P55; O'Toole A, 2013, J ENVIRON QUAL, V42, P429, DOI 10.2134/jeq2012.0163; O'Toole A, 2016, BIOCHAR SOIL CARBON, P193; Ngo PT, 2013, BIORESOURCE TECHNOL, V148, P401, DOI 10.1016/j.biortech.2013.08.098; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rasse DP, 2006, EUR J SOIL SCI, V57, P530, DOI 10.1111/j.1365-2389.2006.00806.x; Ripberger GD, 2015, AS PAC CONF CHEM ENG, P1950; Rumpel C, 2006, GEODERMA, V130, P35, DOI 10.1016/j.geoderma.2005.01.007; Sagrilo E, 2015, GCB BIOENERGY, V7, P1294, DOI 10.1111/gcbb.12234; Schimmelpfennig S, 2014, AGR ECOSYST ENVIRON, V191, P39, DOI 10.1016/j.agee.2014.03.027; Schimmelpfennig S, 2012, J ENVIRON QUAL, V41, P1001, DOI 10.2134/jeq2011.0146; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schneider MPW, 2011, ORG GEOCHEM, V42, P275, DOI 10.1016/j.orggeochem.2011.01.003; Singh BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141560; Smith P, 2016, GLOBAL CHANGE BIOL, V22, P1315, DOI 10.1111/gcb.13178; Spokas KA, 2013, GCB BIOENERGY, V5, P165, DOI 10.1111/gcbb.12005; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Ventura M, 2015, GCB BIOENERGY, V7, P1150, DOI 10.1111/gcbb.12219; Wang JY, 2016, GCB BIOENERGY, V8, P512, DOI 10.1111/gcbb.12266; Wiedemeier DB, 2015, ORG GEOCHEM, V78, P135, DOI 10.1016/j.orggeochem.2014.10.002; Wiedemeier DB, 2013, J CHROMATOGR A, V1304, P246, DOI 10.1016/j.chroma.2013.06.012; Wiedner K, 2013, ORG GEOCHEM, V54, P91, DOI 10.1016/j.orggeochem.2012.10.006; Wurster CM, 2013, ORG GEOCHEM, V62, P28, DOI 10.1016/j.orggeochem.2013.06.009; Yang F, 2016, ENVIRON SCI TECHNOL, V50, P2264, DOI 10.1021/acs.est.5b03656	47	12	13	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184383	10.1371/journal.pone.0184383	http://dx.doi.org/10.1371/journal.pone.0184383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873471	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000409282800075
J	Stough, JMA; Tang, XM; Krausfeldt, LE; Steffen, MM; Gao, G; Boyer, GL; Wilhelm, SW				Stough, Joshua M. A.; Tang, Xiangming; Krausfeldt, Lauren E.; Steffen, Morgan M.; Gao, Guang; Boyer, Gregory L.; Wilhelm, Steven W.			Molecular prediction of lytic vs lysogenic states for Microcystis phage: Metatranscriptomic evidence of lysogeny during large bloom events	PLOS ONE			English	Article							TOXIC CYANOBACTERIUM; TIME BOMBS; AERUGINOSA; CYANOPHAGE; LAKE; INFECTION; IDENTIFICATION; SEQUENCE; VIRUSES; TRANSCRIPTION	Microcystis aeruginosa is a freshwater bloom-forming cyanobacterium capable of producing the potent hepatotoxin, microcystin. Despite increased interest in this organism, little is known about the viruses that infect it and drive nutrient mobilization and transfer of genetic material between organisms. The genomic complement of sequenced phage suggests these viruses are capable of integrating into the host genome, though this activity has not been observed in the laboratory. While analyzing RNA-sequence data obtained from Microcystis blooms in Lake Tai (Taihu, China), we observed that a series of lysogeny-associated genes were highly expressed when genes involved in lytic infection were down-regulated. This pattern was consistent, though not always statistically significant, across multiple spatial and temporally distinct samples. For example, samples from Lake Tai (2014) showed a predominance of lytic virus activity from late July through October, while genes associated with lysogeny were strongly expressed in the early months (June-July) and toward the end of bloom season (October). Analyses of whole phage genome expression shows that transcription patterns are shared across sampling locations and that genes consistently clustered by co-expression into lytic and lysogenic groups. Expression of lytic-cycle associated genes was positively correlated to total dissolved nitrogen, ammonium concentration, and salinity. Lysogeny-associated gene expression was positively correlated with pH and total dissolved phosphorous. Our results suggest that lysogeny may be prevalent in Microcystis blooms and support the hypothesis that environmental conditions drive switching between temperate and lytic life cycles during bloom proliferation.	[Stough, Joshua M. A.; Krausfeldt, Lauren E.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Tang, Xiangming; Gao, Guang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Steffen, Morgan M.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Boyer, Gregory L.] SUNY Syracuse, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA	University of Tennessee System; University of Tennessee Knoxville; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; James Madison University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	Tang, Xiangming/ABG-7095-2021; Wilhelm, Steven W/B-8963-2008	Tang, Xiangming/0000-0002-2816-1004; Wilhelm, Steven W/0000-0001-6283-8077; Boyer, Gregory/0000-0003-4490-5461; Krausfeldt, Lauren/0000-0001-7405-427X	National Natural Science Foundation of China [41471040, 41230744]; Division of Integrative Organismal Systems [1451528]; Division of Environmental Biology [1240870]; Gordon and Betty Moore Foundation [4971]; Kenneth & Blaire Mossman Endowment; Division Of Environmental Biology [1240870] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1451528] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Kenneth & Blaire Mossman Endowment; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Natural Science Foundation of China, grants 41471040 and 41230744 to GG, the Division of Integrative Organismal Systems, grant 1451528 to SWW, the Division of Environmental Biology, grant 1240870 to SWW, the Gordon and Betty Moore Foundation, grant EMS#4971 to SWW and by the Kenneth & Blaire Mossman Endowment to SWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP CT, 1959, CAN J BIOCHEM PHYS, V37, P453, DOI 10.1139/o59-047; Bobay LM, 2013, MOL BIOL EVOL, V30, P737, DOI 10.1093/molbev/mss279; Boocock MR, 2013, MOBILE DNA-UK, V4, P9; Boyer GL, 2007, LAKE RESERV MANAGE, V23, P153, DOI 10.1080/07438140709353918; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3; Brum JR, 2016, ISME J, V10, P437, DOI 10.1038/ismej.2015.125; Brunberg AK, 1999, FEMS MICROBIOL ECOL, V29, P13, DOI 10.1111/j.1574-6941.1999.tb00594.x; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Carmichael WW, 1996, TOXIC MICROCYSTIS, P1; Clark K.R., 2015, PRIMER V7 USER MANUA; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hargreaves KR, 2013, FEMS MICROBIOL ECOL, V83, P450, DOI 10.1111/1574-6941.12005; Harke MJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02832-16; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Harrell F.E.J., 2020, HMISC HARRELL MISCEL; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jin X., 1990, STANDARD METHODS OBS, P240; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krausfeldt LE, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix024; KROMKAMP J, 1988, J PLANKTON RES, V10, P171, DOI 10.1093/plankt/10.2.171; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuno S, 2010, MICROBES ENVIRON, V25, P295, DOI 10.1264/jsme2.ME10125; Long AM, 2016, ISME J, V10, P1602, DOI 10.1038/ismej.2015.240; Mankiewicz-Boczek J, 2016, MICROB ECOL, V71, P315, DOI 10.1007/s00248-015-0677-5; Matsen FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056859; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McDaniel L, 2005, APPL ENVIRON MICROB, V71, P842, DOI 10.1128/AEM.71.2.842-850.2005; Miller R.V., 2008, BACTERIOPHAGE ECOLOG, P114, DOI DOI 10.1017/CBO9780511541483.008; Ou T, 2015, J GEN VIROL, V96, P3681, DOI 10.1099/jgv.0.000290; Ou Tong, 2013, Virologica Sinica, V28, P266, DOI 10.1007/s12250-013-3340-7; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Payet JP, 2013, LIMNOL OCEANOGR, V58, P465, DOI 10.4319/lo.2013.58.2.0465; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; R Core Team, 2013, R LANG ENV STAT COMP; Roux S, 2016, NATURE, V537, P689, DOI 10.1038/nature19366; Rozon RM, 2013, FRESHWATER BIOL, V58, P2648, DOI 10.1111/fwb.12241; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Shen H, 2011, FRESHWATER BIOL, V56, P1065, DOI 10.1111/j.1365-2427.2010.02551.x; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Steffen MM, 2017, ENVIRON SCI TECHNOL, V51, P6745, DOI 10.1021/acs.est.7b00856; Steffen MM, 2015, APPL ENVIRON MICROB, V81, P3268, DOI 10.1128/AEM.04101-14; Steffen MM, 2014, ISME J, V8, P2080, DOI 10.1038/ismej.2014.78; Steffen MM, 2014, J GREAT LAKES RES, V40, P215, DOI 10.1016/j.jglr.2013.12.012; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Takashima Y, 2007, MICROBES ENVIRON, V22, P207, DOI 10.1264/jsme2.22.207; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Tucker S, 2005, APPL ENVIRON MICROB, V71, P629, DOI 10.1128/AEM.71.2.629-635.2005; Watkins SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087339; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wilson HR, 2002, EMBO J, V21, P4154, DOI 10.1093/emboj/cdf395; Yamaguchi H, 2015, GEN ANNOUNC, P3; Yoshida M, 2008, APPL ENVIRON MICROB, V74, P3269, DOI 10.1128/AEM.02240-07; Yoshida T, 2006, APPL ENVIRON MICROB, V72, P1239, DOI 10.1128/AEM.72.2.1239-1247.2006; Yoshida T, 2008, J BACTERIOL, V190, P1762, DOI 10.1128/JB.01534-07; Yoshida-Takashima Y, 2012, MICROBES ENVIRON, V27, P350, DOI 10.1264/jsme2.ME12037	62	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184146	10.1371/journal.pone.0184146	http://dx.doi.org/10.1371/journal.pone.0184146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873456	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800055
J	Tougard, C; Davila, CRG; Romer, U; Duponchelle, F; Cerqueira, F; Paradis, E; Guinand, B; Chavez, CA; Salas, V; Querouil, S; Sirvas, S; Renno, JF				Tougard, Christelle; Garcia Davila, Carmen R.; Roemer, Uwe; Duponchelle, Fabrice; Cerqueira, Frederique; Paradis, Emmanuel; Guinand, Bruno; Angulo Chavez, Carlos; Salas, Vanessa; Querouil, Sophie; Sirvas, Susana; Renno, Jean-Francois			Tempo and rates of diversification in the South American cichlid genus Apistogramma (Teleostei: Perciformes: Cichlidae)	PLOS ONE			English	Article							FRESH-WATER FISHES; GONDWANA LIFE RAFTS; LUMBRERA FORMATION; MULTILOCUS PHYLOGENY; GEOPHAGINE CICHLIDS; ADAPTIVE RADIATION; LAKE TANGANYIKA; SPECIES FLOCKS; AMAZON RIVER; BIOGEOGRAPHY	Evaluating biodiversity and understanding the processes involved in diversification are noticeable conservation issues in fishes subject to large, sometimes illegal, ornamental trade purposes. Here, the diversity and evolutionary history of the Neotropical dwarf cichlid genus Apistogramma from several South American countries are investigated. Mitochondrial and nuclear markers are used to infer phylogenetic relationships between 31 genetically identified species. The monophyly of Apistogramma is suggested, and Apistogramma species are distributed into four clades, corresponding to three morphological lineages. Divergence times estimated with the Yule process and an uncorrelated lognormal clock dated the Apistogramma origin to the beginning of the Eocene (approximate to 50 Myr) suggesting that diversification might be related to marine incursions. Our molecular dating also suggests that the Quaternary glacial cycles coincide with the phases leading to Apistogramma speciation. These past events did not influence diversification rates in the speciose genus Apistogramma, since diversification appeared low and constant through time. Further characterization of processes involved in recent Apistogramma diversity will be necessary.	[Tougard, Christelle; Cerqueira, Frederique; Paradis, Emmanuel; Guinand, Bruno] ISEM, EPHE, CNRS, UM,UMR 5554,IRD 226,CIRAD 117, Montpellier, France; [Garcia Davila, Carmen R.; Angulo Chavez, Carlos] Inst Invest Amazonia Peruana, Lab Biol & Genet Mol, Iquitos, Peru; [Roemer, Uwe] Univ Trier, Inst Biogeog, Dept Geosci, Trier, Germany; [Duponchelle, Fabrice; Renno, Jean-Francois] UCBN, IRD 207, CNRS 7208, UPMC,MNHN,UMR Biol Organismes & Ecosyst Aquat, Paris, France; [Salas, Vanessa; Sirvas, Susana] Univ Nacl Federico Villareal, Fac Oceanog Pesqueria Ciencias Alimentarias & Agr, Lima, Peru	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universitat Trier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Federico Villarreal	Tougard, C (corresponding author), ISEM, EPHE, CNRS, UM,UMR 5554,IRD 226,CIRAD 117, Montpellier, France.	christelle.tougard@umontpellier.fr	Duponchelle, Fabrice/K-1998-2016	Duponchelle, Fabrice/0000-0003-0497-2264; GUINAND, Bruno/0000-0002-6934-1677; Renno, Jean-Francois/0000-0002-9071-0086; Garcia-Davila, Carmen/0000-0003-4125-5563; Angulo, Carlos/0000-0001-5480-6219	ISEM (Institut des Sciences de (I'Evolution de Montpellier); LMI EDIA (Laboratoire Mixte International - Evolution et Domestication de l'Ichtyofaune Amazonienne.)	ISEM (Institut des Sciences de (I'Evolution de Montpellier); LMI EDIA (Laboratoire Mixte International - Evolution et Domestication de l'Ichtyofaune Amazonienne.)	ISEM (Institut des Sciences de (I'Evolution de Montpellier) and LMI EDIA (Laboratoire Mixte International - Evolution et Domestication de l'Ichtyofaune Amazonienne.) financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.N	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; [Anonymous], 2019, R LANG ENV STAT COMP; Arbour JH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0849; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; Bloom DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098430; Bloom DD, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P137; Boonstra M, 2015, PALAEOGEOGR PALAEOCL, V417, P176, DOI 10.1016/j.palaeo.2014.10.032; Briggs JC, 2003, SYST BIOL, V52, P548, DOI 10.1080/10635150390218385; Brito PM, 2007, CYBIUM, V31, P139; Britzke R, 2014, ZOOTAXA, V3869, P409, DOI 10.11646/zootaxa.3869.4.5; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Chakrabarty P, 2006, MOL PHYLOGENET EVOL, V39, P619, DOI 10.1016/j.ympev.2006.01.014; Chazdon R.L., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CBO9781107415324.004; Colinvaux P. A., 1987, ABRUPT CLIMATIC CHAN, P113; Cronquist A, 1978, BIOSYSTEMATICS AGR, P3; del Papa C, 2010, J S AM EARTH SCI, V29, P327, DOI 10.1016/j.jsames.2009.06.004; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Elmer KR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6168; Engelking B, 2010, VERTEBR ZOOL, V60, P123; Farias IP, 1999, J MOL EVOL, V48, P703, DOI 10.1007/PL00006514; Farias IP, 2000, J EXP ZOOL, V288, P76, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;76::AID-JEZ8&gt;3.0.CO;2-P; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Friedman M, 2014, P R SOC LOND B; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Geiger MF, 2010, MOL PHYLOGENET EVOL, V56, P1011, DOI 10.1016/j.ympev.2010.05.015; Genner MJ, 2005, FISH FISH, V6, P1, DOI 10.1111/j.1467-2679.2005.00173.x; Golonka J, 2000, PALAEOGEOGR PALAEOCL, V161, P49, DOI 10.1016/S0031-0182(00)00117-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P123; Irion G., 2011, AMAZONIAN FLOODPLAIN, VXVIII, P27; Irion G, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P185; Irion G, 2009, HYDROL PROCESS, V23, P3168, DOI 10.1002/hyp.7386; Junk WJ, 2007, AQUAT ECOSYST HEALTH, V10, P153, DOI 10.1080/14634980701351023; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Kusche H, 2014, ECOL EVOL, V4, P1127, DOI 10.1002/ece3.1015; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; Lopez-Fernandez H, 2005, MOL PHYLOGENET EVOL, V34, P227, DOI 10.1016/j.ympev.2004.09.004; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P105; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Lovejoy NR, 2000, EVOLUTION, V54, P1349; Lowe-McConnell RH., 1975, FISH COMMUNITIES TRO; Lundberg John G., 1998, P13; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Malabarba MC, 2006, J VERTEBR PALEONTOL, V26, P267, DOI 10.1671/0272-4634(2006)26[267:PAANFC]2.0.CO;2; Malabarba MC, 2014, J VERTEBR PALEONTOL, V34, P49, DOI 10.1080/02724634.2013.830021; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Matschiner M, 2017, SYST BIOL, V66, P3, DOI 10.1093/sysbio/syw076; McMahan CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071162; Miller M, 2005, DATZ SPECIAL, V12, P24; Moreau MA, 2007, ENVIRON CONSERV, V34, P12, DOI 10.1017/S0376892907003566; Murray AM, 2001, BIOL J LINN SOC, V74, P517, DOI 10.1006/bijl.2001.0599; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; NEI M, 2001, MOL EVOLUTION PHYLOG; Nylander JAA., 2004, BIOINFORMATICS; Ogilvie HA, 2017, MOL BIOL EVOL, V34, P2101, DOI 10.1093/molbev/msx126; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2017, TUTORIAL APE PACKAGE; Paradis E, 2015, J THEOR BIOL, V387, P39, DOI 10.1016/j.jtbi.2015.09.005; Penczak T, 2004, J FISH BIOL, V64, P483, DOI 10.1111/j.0022-1112.2004.00316.x; Perez-Diaz L, 2014, TECTONICS, V33, P1848, DOI 10.1002/2014TC003644; Pialek L, 2012, MOL PHYLOGENET EVOL, V62, P46, DOI 10.1016/j.ympev.2011.09.006; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raftery AE, 2007, BAYESIAN STAT, V8, P1; Rambaut A., 2014, TRACER V1 6; Ready JS, 2006, J EVOLUTION BIOL, V19, P1139, DOI 10.1111/j.1420-9101.2006.01088.x; Reis R. E., 2013, International Zoo Yearbook, V47, P65, DOI 10.1111/izy.12000; Reis RE., 2003, CLOFFSCA CHECK LIST; Romer U, 1996, J FISH BIOL, V48, P714, DOI 10.1111/j.1095-8649.1996.tb01467.x; Romer U., 1995, WORKSH EXH GEF SUSSW; Romer U., 2000, CICHLID ATLAS, V1; Romer U., 2006, CICHLID ATLAS, V2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruber L, 2001, MOL ECOL, V10, P1207, DOI 10.1046/j.1365-294X.2001.01259.x; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schindler I, 2013, VERTEBR ZOOL, V63, P301; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silvestro D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-311; Smith WL, 2008, CLADISTICS, V24, P625, DOI 10.1111/j.1096-0031.2008.00210.x; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Streelman JT, 2002, EVOLUTION, V56, P961; Streelman JT, 1998, MOL BIOL EVOL, V15, P798, DOI 10.1093/oxfordjournals.molbev.a025985; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; Vega GC, 2012, P ROY SOC B-BIOL SCI, V279, P2323, DOI 10.1098/rspb.2012.0075; Wesselingh FP, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P59; Wiens JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9370; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Winemiller KO, 2000, T AM FISH SOC, V129, P451, DOI 10.1577/1548-8659(2000)129<0451:FASIRT>2.0.CO;2; Yang Z., 2016, TUTORIAL BP P VERSIO; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	106	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0182618	10.1371/journal.pone.0182618	http://dx.doi.org/10.1371/journal.pone.0182618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873089	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800006
J	Heers, T; van Neer, A; Becker, A; Grilo, ML; Siebert, U; Abdulmawjood, A				Heers, Teresa; van Neer, Abbo; Becker, Andre; Grilo, Miguel Luca; Siebert, Ursula; Abdulmawjood, Amir			Loop-mediated isothermal amplification (LAMP) assay-A rapid detection tool for identifying red fox (Vulpes vulpes) DNA in the carcasses of harbour porpoises (Phocoena phocoena)	PLOS ONE			English	Article							PREDATOR IDENTIFICATION; HALICHOERUS-GRYPUS; VIRUS	Carcasses of wild animals are often visited by different scavengers. However, determining which scavenger caused certain types of bite marks is particularly difficult and knowledge thereof is lacking. Therefore, a loop-mediated isothermal amplification (LAMP) assay (target sequence cytochrome b) was developed to detect red fox DNA in carcasses of harbour porpoises. The MSwab (TM) method for direct testing without prior DNA isolation was validated. As a detection device, the portable real-time fluorometer Genie (TM) II was used, which yields rapid results and can be used in field studies without huge laboratory equipment. In addition to in vitro evaluation and validation, a stranded and scavenged harbour porpoise carcass was successfully examined for red fox DNA residues. The developed LAMP method is a valuable diagnostic tool for confirming presumable red fox bite wounds in harbour porpoises without further DNA isolation steps.	[Heers, Teresa; Becker, Andre; Abdulmawjood, Amir] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Inst Food Qual & Food Safety, Hannover, Germany; [van Neer, Abbo; Grilo, Miguel Luca; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Abdulmawjood, A (corresponding author), Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Inst Food Qual & Food Safety, Hannover, Germany.	amir.abdulmawjood@tiho-hannover.de	Abdulmawjood, Amir/AAL-5523-2020; Abdulmawjood, Amir/C-6083-2015	Abdulmawjood, Amir/0000-0001-5189-8381; Grilo, Miguel/0000-0001-7364-821X; van Neer, Abbo/0000-0002-3519-0356	Ministry of Energy, Agriculture, Environment and Rural Areas of Schleswig-Holstein, Germany [60079084]	Ministry of Energy, Agriculture, Environment and Rural Areas of Schleswig-Holstein, Germany	The investigations were funded by the Ministry of Energy, Agriculture, Environment and Rural Areas of Schleswig-Holstein, Germany (grant number 60079084). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elsalam K, 2011, INT J MOL SCI, V12, P3459, DOI 10.3390/ijms12063459; Abdulmawjood A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100717; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Blejwas KM, 2006, J WILDLIFE MANAGE, V70, P1087, DOI 10.2193/0022-541X(2006)70[1087:SDECBM]2.0.CO;2; Caniglia R, 2013, FORENSIC SCI INT-GEN, V7, P397, DOI 10.1016/j.fsigen.2012.11.001; Haelters J, 2016, AQUAT MAMM, V42, P227, DOI 10.1578/AM.42.2.2016.227; Haelters J, 2012, AQUAT MAMM, V38, P343, DOI 10.1578/AM.38.4.2012.343; Harms V, 2015, J MAMMAL, V96, P138, DOI 10.1093/jmammal/gyu014; IJsseldijk L, 2016, SCAVENGING MUTILATIO; Jauniaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108993; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460; Lee SY, 2016, FOOD CONTROL, V66, P53, DOI 10.1016/j.foodcont.2016.01.041; Leopold MF, 2014, P ROYAL SOC B, P282; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Schlacher TA, 2015, BIODIVERS CONSERV, V24, P493, DOI 10.1007/s10531-014-0830-3; Sheet OH, 2016, MOL CELL PROBE, V30, P320, DOI 10.1016/j.mcp.2016.08.001; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Stringell T, 2015, AQUAT MAMM, V41, P188, DOI 10.1578/AM.41.2.2015.188; van Bleijswijk JDL, 2014, MAR ECOL PROG SER, V513, P277, DOI 10.3354/meps11004; WHO, 2016, US LOOP MED IS AMPL; Williams C. L., 2004, Sheep & Goat Research Journal, V19, P85; Williams CL, 2003, WILDLIFE SOC B, V31, P926	28	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184349	10.1371/journal.pone.0184349	http://dx.doi.org/10.1371/journal.pone.0184349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863185	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900051
J	Mech, LD; Asa, CS; Callahan, M; Christensen, BW; Smith, F; Young, JK				Mech, L. David; Asa, Cheryl S.; Callahan, Margaret; Christensen, Bruce W.; Smith, Fran; Young, Julie K.			Studies of wolf x coyote hybridization via artificial insemination	PLOS ONE			English	Article							GRAY WOLF; EVOLUTIONARY HISTORY; WOLVES; POPULATIONS; PERSPECTIVE; QUALITY; AMERICA; DNA	Following the production of western gray wolf (Canis lupus) x western coyote (Canis latrans) hybrids via artificial insemination (AI), the present article documents that the hybrids survived in captivity for at least 4 years and successfully bred with each other. It further reports that backcrossing one of the hybrids to a male gray wolf by AI also resulted in the birth of live pups that have survived for at least 10 months. All male hybrids (F1 and F2) produced sperm by about 10 months of age, and sperm quality of the F1 males fell within the fertile range for domestic dogs, but sperm motility and morphology, in particular, were low in F2 males at 10 months but improved in samples taken at 22 months of age. These studies are relevant to a long-standing controversy about the identity of the red wolf (Canis rufus), the existence of a proposed new species (Canis lycaon) of gray wolf, and to the role of hybridization in mammalian evolution.	[Mech, L. David] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Asa, Cheryl S.] St Louis Zoo, Res Dept, St Louis, MO USA; [Callahan, Margaret] Wildlife Sci Ctr, Forest Lake, MN USA; [Christensen, Bruce W.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Smith, Fran] Smith Vet Hosp Inc, Burnsville, MN USA; [Young, Julie K.] Utah State Univ, USDA, Wildlife Serv,Natl Wildlife Res Ctr, Predator Res Facil,Dept Wildland Resources, Logan, UT 84322 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Mech, LD (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.	mechx002@umn.edu			U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	This work was supported by the U.S. Geological Survey. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Asa C, 2007, ANIM CONSERV, V10, P326, DOI 10.1111/j.1469-1795.2007.00116.x; BARONE MA, 1994, J MAMMAL, V75, P150, DOI 10.2307/1382247; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bekoff M., 1978, P97; Hohenlohe PA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602250; Kays R, 2010, BIOL LETTERS, V6, P89, DOI 10.1098/rsbl.2009.0575; Kennelly J.J., 1978, P73; Koblmuller S, 2009, MOL ECOL, V18, P2313, DOI 10.1111/j.1365-294X.2009.04176.x; KOLENOKS.GR, 1971, J MAMMAL, V52, P446, DOI 10.2307/1378689; Kolenosky G.B., 1975, P62; LEHMAN N, 1991, EVOLUTION, V45, P104, DOI 10.1111/j.1558-5646.1991.tb05270.x; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; MECH L D, 1974, Mammalian Species, V37, P1; Mech LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156682; Mech LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088861; Mech LD, 2011, NONGENETIC DATA SUPP; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Nothling JO, 1997, J REPROD FERTIL, P109; Nowak R. M, 1979, N AM QUATERNARY CANI; Nowak Ronald M., 2003, P239; OETTLE EE, 1993, J REPROD FERTIL, P257; Roy MS, 1996, CONSERV BIOL, V10, P1413, DOI 10.1046/j.1523-1739.1996.10051413.x; Rutledge LY, 2012, BIOL CONSERV, V155, P186, DOI 10.1016/j.biocon.2012.05.017; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; vonHoldt B, 2017, J HERED, V108, P341, DOI 10.1093/jhered/esx004; vonHoldt BM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701233; vonHoldt BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501714; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; Wayne Robert K., 2003, P218; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; Wilson PJ, 2000, CAN J ZOOL, V78, P2156, DOI 10.1139/cjz-78-12-2156	33	2	2	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184342	10.1371/journal.pone.0184342	http://dx.doi.org/10.1371/journal.pone.0184342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863171	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900050
J	Sanz, DJ; Hollywood, JA; Scallan, MF; Harrison, PT				Sanz, David J.; Hollywood, Jennifer A.; Scallan, Martina F.; Harrison, Patrick T.			Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA	PLOS ONE			English	Article							CONDUCTANCE REGULATOR GENE; PULMONARY-DISEASE; EPITHELIAL-CELLS; DELTA-F508 CFTR; CAS9 PROTEIN; DOUBLE-BLIND; 3849+10 KB; DNA; IVACAFTOR; VARIANTS	Cystic Fibrosis is an autosomal recessive disorder caused by mutations in the CFTR gene. CRISPR mediated, template-dependent homology-directed gene editing has been used to correct the most common mutation, c.1521_1523delCTT / p.Phe508del (F508del) which affects similar to 70% of individuals, but the efficiency was relatively low. Here, we describe a high efficiency strategy for editing of three different rare CFTR mutations which together account for about 3% of individuals with Cystic Fibrosis. The mutations cause aberrant splicing of CFTR mRNA due to the creation of cryptic splice signals that result in the formation of pseudoexons containing premature stop codons c.1679+1634A>G (1811+1.6kbA>G) and c.3718-2477C>T (3849+10kbC>T), or an out-of-frame 5' extension to an existing exon c.3140-26A>G (3272-26A>G). We designed pairs of Cas9 guide RNAs to create targeted double-stranded breaks in CFTR either side of each mutation which resulted in high efficiency excision of the target genomic regions via non-homologous end-joining repair. When evaluated in a mini-gene splicing assay, we showed that targeted excision restored normal splicing for all three mutations. This approach could be used to correct aberrant splicing signals or remove disruptive transcription regulatory motifs caused by deep-intronic mutations in a range of other genetic disorders.	[Sanz, David J.; Hollywood, Jennifer A.; Harrison, Patrick T.] Univ Coll Cork, BioSci Inst, Dept Physiol, Cork, Ireland; [Hollywood, Jennifer A.; Scallan, Martina F.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Hollywood, Jennifer A.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	University College Cork; University College Cork; University of Auckland	Harrison, PT (corresponding author), Univ Coll Cork, BioSci Inst, Dept Physiol, Cork, Ireland.	p.harrison@ucc.ie	Sanz, David J./AAY-1432-2020; Hollywood, Jennifer/CAA-0514-2022	Sanz, David J./0000-0001-9484-9432; Harrison, Patrick/0000-0002-2319-0949	Cystic Fibrosis Foundation Therapeutics [HARRIS14XX0]; Cystic Fibrosis Trust [VIA011]; Cystic Fibrosis Foundation (Bethesda, MD, USA); Cystic Fibrosis Trust (London, UK)	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Trust; Cystic Fibrosis Foundation (Bethesda, MD, USA); Cystic Fibrosis Trust (London, UK)	This work was supported by the Cystic Fibrosis Foundation Therapeutics, HARRIS14XX0 (https://mw.cftorg/Research/Researcher-Resources/Cystic-Fibrosis-Foundation-Therapeutics/) to PTH and the Cystic Fibrosis Trust, VIA011 (https://www.cysticfibrosis.org.uk) to PTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dieter Gruenert (Department of Otolaryngology-Head and Neck Surgery, UCSF, San Francisco, CA) for the CFTE cell line, and Feng Zhang (Broad Institute, Boston, MA) for the plasmid pSpCas9(BB)-2a-GFP (Addgene PX458). This work was supported by Cystic Fibrosis Foundation (Bethesda, MD, USA) and Cystic Fibrosis Trust (London, UK). The authors would like to thank Ken Martin and Grzegorz Jasionek for excellent technical support.	Alton EWFW, 2017, THORAX, V72, P137, DOI 10.1136/thoraxjnl-2016-208406; Alton EWFW, 2016, PEDIATR PULM, V51, pS5, DOI 10.1002/ppul.23543; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; ANGLANI F, 1990, AM J HUM GENET, V47, P169; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Beck S, 1999, HUM MUTAT, V14, P133, DOI 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T; Bednarski C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161072; Castellani C, 2013, PAEDIATR RESPIR REV, V14, P2, DOI 10.1016/j.prrv.2013.01.006; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chiba-Falek O, 1998, GENOMICS, V53, P276, DOI 10.1006/geno.1998.5517; CHILLON M, 1995, AM J HUM GENET, V56, P623; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Cooney AL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88730; Costantino L, 2013, AM J RESP CELL MOL, V48, P619, DOI 10.1165/rcmb.2012-0371OC; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Goncz KK, 1998, HUM MOL GENET, V7, P1913, DOI 10.1093/hmg/7.12.1913; Goncz KK, 2001, GENE THER, V8, P961, DOI 10.1038/sj.gt.3301476; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harrison PT, 2016, HUM GENET, V135, P983, DOI 10.1007/s00439-016-1693-3; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Hollywood JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32230; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Kunzelmann K, 1996, GENE THER, V3, P859; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Lee M, 2017, AM J HUM GENET, V100, P751, DOI 10.1016/j.ajhg.2017.04.001; McNeer NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7952; Moss RB, 2015, LANCET RESP MED, V3, P524, DOI 10.1016/S2213-2600(15)00201-5; Mutyam V, 2017, J CYST FIBROS, V16, P24, DOI 10.1016/j.jcf.2016.09.005; Nissim-Rafinia M, 2000, HUM MOL GENET, V9, P1771, DOI 10.1093/hmg/9.12.1771; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; OHMAN K, 1993, VIROLOGY, V194, P50, DOI 10.1006/viro.1993.1234; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riordan JR, 1989, SCIENCE, P245; Sanz DJ, 2010, CLIN CANCER RES, V16, P1957, DOI 10.1158/1078-0432.CCR-09-2564; Sharma N, 2014, HUM MUTAT, V35, P1249, DOI 10.1002/humu.22624; Steines B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88728; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; STERN RC, 1995, LANCET, V346, P274, DOI 10.1016/S0140-6736(95)92165-6; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Vaz-Drago R., HUM GENET; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhang L.J., 2009, ETHYLENE IND, V25, P7, DOI DOI 10.1371/J0URNAL.PBI0.1000155	55	49	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184009	10.1371/journal.pone.0184009	http://dx.doi.org/10.1371/journal.pone.0184009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863137	gold, Green Published, Green Submitted			2022-12-26	WOS:000408816900016
J	Sotillo, WS; Villagomez, R; Smiljanic, S; Huang, XL; Malakpour, A; Kempengren, S; Rodrigo, G; Almanza, G; Sterner, O; Oredsson, S				Sotillo, Wendy Soria; Villagomez, Rodrigo; Smiljanic, Sandra; Huang, Xiaoli; Malakpour, Atena; Kempengren, Sebastian; Rodrigo, Gloria; Almanza, Giovanna; Sterner, Olov; Oredsson, Stina			Anti-cancer stem cell activity of a sesquiterpene lactone isolated from Ambrosia arborescens and of a synthetic derivative	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER	New regimens are constantly being pursued in cancer treatment, especially in the context of treatment-resistant cancer stem cells (CSCs) that are assumed to be involved in cancer recurrence. Here, we investigated the anti-cancer activity of sesquiterpene lactones (SLs) isolated from Ambrosia arborescens and of synthetic derivatives in breast cancer cell lines, with a specific focus on activity against CSCs. The breast cancer cell lines MCF-7, JIMT-1, and HCC1937 and the normal-like breast epithelial cell line MCF-10A were treated with the SLs damsin and coronopilin, isolated from A. arborescens, and with ambrosin and dindol-01, synthesized using damsin. Inhibitory concentration 50 (IC50) values were obtained from dose-response curves. Based on IC50 values, doses in the mu M range were used for investigating effects on cell proliferation, cell cycle phase distribution, cell death, micronuclei formation, and cell migration. Western blot analysis was used to investigate proteins involved in cell cycle regulation as well as in the NF-.B pathway since SLs have been shown to inhibit this transcription factor. Specific CSC effects were investigated using three CSC assays. All compounds inhibited cell proliferation; however, damsin and ambrosin were toxic at singledigit micromolar ranges, while higher concentrations were required for coronopilin and din-dol-01. Of the four cell lines, the compounds had the least effect on the normal-like MCF-10A cells. The inhibition of cell proliferation can partly be explained by downregulation of cyclin-dependent kinase 2. All compounds inhibited tumour necrosis factor-a-induced translocation of NF-B from the cytoplasm to the nucleus. Damsin and ambrosin treatment increased the number of micronuclei; moreover, another sign of DNA damage was the increased level of p53. Treatment with damsin and ambrosin decreased the CSC subpopulation and inhibited cell migration. Our results suggest that these compounds should be further investigated to find efficient CSC-inhibiting compounds.	[Sotillo, Wendy Soria; Smiljanic, Sandra; Huang, Xiaoli; Malakpour, Atena; Kempengren, Sebastian; Oredsson, Stina] Lund Univ, Dept Biol, Lund, Sweden; [Sotillo, Wendy Soria; Rodrigo, Gloria] Univ Major San Andres, Mol Biol & Biotechnol Inst, La Paz, Bolivia; [Villagomez, Rodrigo; Sterner, Olov] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden; [Almanza, Giovanna] Univ Major San Andres, Chem Res Inst, La Paz, Bolivia	Lund University; Universidad Mayor de San Andres; Lund University; Universidad Mayor de San Andres	Oredsson, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	stina.oredsson@biol.lu.se		Almanza, Giovanna Rocio/0000-0002-5362-252X; Oredsson, Stina/0000-0003-2529-7106	Swedish International Development Agency (SIDA)	Swedish International Development Agency (SIDA)	The authors are grateful to the Swedish International Development Agency (SIDA) for the support of this study, which is part of the project "Biomolecules" developed between the University of San Andres (UMSA La Paz-Bolivia) and Lund University (Sweden). We also wish to thank Carolina LePrince with the "Kalenderflickorna" and associated sponsors. We thank Ewa Dahlberg for expert technical help.; This work was financially supported by the Swedish International Development Cooperation Agency (SIDA) and by Carolina LePrince with the "Kalenderflickorna" and associated sponsors. The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], 1988, ASSAY GUID MAN, V50, P1; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gasch C, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0601-3; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hale JS, 2012, CELL ADHES MIGR, V6, P346, DOI 10.4161/cam.21294; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HEJCHMAN E, 1995, J MED CHEM, V38, P3407, DOI 10.1021/jm00017a025; Huang XL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2142-3; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Lohberger B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066300; Myhre L, 2008, ANTI-CANCER DRUG, V19, P359, DOI 10.1097/CAD.0b013e3282f7f518; Nguyen NP, 2010, CANCER TREAT REV, V36, P485, DOI 10.1016/j.ctrv.2010.02.016; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saeed M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00267; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Tanner M, 2004, MOL CANCER THER, V3, P1585; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vazquez-Santillan K, 2015, CELL ONCOL, V38, P327, DOI 10.1007/s13402-015-0236-6; Villagomez R, 2015, CHEM NAT COMPD+, V51, P675, DOI 10.1007/s10600-015-1382-9; Villagomez R, 2014, NATURAL SEMISYNTHETI, P833; Villagomez R, 2014, ANTICANCER RES, V34, P503; Villagomez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115819; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	33	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184304	10.1371/journal.pone.0184304	http://dx.doi.org/10.1371/journal.pone.0184304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863191	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900048
J	Barman, S; Ghosh, R; Sengupta, S; Mandal, NC				Barman, Soma; Ghosh, Ranjan; Sengupta, Shreya; Mandal, Narayan C.			Longterm storage of post-packaged bread by controlling spoilage pathogens using Lactobacillus fermentum C14 isolated from homemade curd	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; FOOD; PURIFICATION; ASPERGILLUS; SPECTRUM; STRAINS	One potent lactic acid bacterial strain C14 with strong antifungal activity was isolated from homemade curd. Based on morphological as well as biochemical characters and 16S rDNA sequence homology the strain was identified as Lactobacillus fermentum. It displayed a wide antimicrobial spectrum against both Gram-positive and Gram-negative pathogenic bacteria, and also against number of food spoilage, plant and human pathogenic fungi. The cell free supernatant (CFS) of the strain C14 was also effective against the fungi tested. Inhibition of radial growth of Penicillium digitatum, Trichophyton rubrum and Mucor sp. was noticed in the presence of CFS of C14 even at low concentration (1%). More than 94.3 +/- 1.6% and 91.5 +/- 2.2% inhibition of conidial germination of P. digitatum and Mucor sp. were noticed in the presence of 10-fold-concentrated CFS of C14. Massive deformation of the fungal mycelia was observed by SEM studies, and losses of cellular proteins and DNA are also evident upon its treatment with C14. HPLC analysis revealed the presence of phenyl lactic acid, lactic acid along with some unidentified compounds in the antifungal extract. Challenge experiment showed immense potential of the strain C14 in preventing the spoilage of bread samples caused by Mucor sp. and Bacillus subtilis. The bread samples remained fresh upto 25 days even after inoculation with Mucor sp. (3.7 x 10(4) spores /ml) and B. subtilis (4.6 x 10(4) CFU /ml). Along with the antifungal properties, the isolated lactic acid bacterial strain also showed very good antioxidant activities. Unchanged level of liver enzymes serum glutamic pyruvic transaminase and serum glutamic oxaloacetic transaminase in albino mice upon feeding with C14 also suggested non-toxic nature of the bacterial isolate.	[Barman, Soma; Ghosh, Ranjan; Mandal, Narayan C.] Visva Bharati, Dept Bot, Mycol & Plant Pathol Lab, Santini Ketan, W Bengal, India; [Sengupta, Shreya] Heritage Inst Technol, Anandapur, W Bengal, India	Visva Bharati University; Heritage Institute of Technology (HITK)	Mandal, NC (corresponding author), Visva Bharati, Dept Bot, Mycol & Plant Pathol Lab, Santini Ketan, W Bengal, India.	mandalnc@visva-bharati.ac.in	Mandal, Narayan Chandra/GOP-0560-2022		CSIR [60 (0096)/11/EMR-II]; Council of Scientific and Industrial Research (CSIR), Pusa, New Delhi, India [60 (0096)/11/EMR-II]	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), Pusa, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	The work presented here was initially supported by CSIR [Project No - 60 (0096)/11/EMR-II]. The funders had no role in study design, data collection and analysis,decision to publish,or preparation of the manuscript.; This work was initially funded by Council of Scientific and Industrial Research (CSIR), Pusa, New Delhi- 110012, India, [Project No.- 60 (0096)/11/EMR-II]. The project was terminated on November, 2014. We are thankful to Dr. Amrit Sen, Visva-Bharati [present Professor of Department of English and other Modern European Languages (DEOMEL)] for critically reviewing the text of the MS from its linguistic point of view.	Al-Hazmi Mansour A., 2004, Saudi Journal of Biological Sciences, V11, P177; Avall-Jaaskelainen S, 2005, FEMS MICROBIOL REV, V29, P511, DOI 10.1016/j.femsre.2005.04.003; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Cizeikiene D, 2013, FOOD CONTROL, V31, P539, DOI 10.1016/j.foodcont.2012.12.004; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; De Muynck C, 2004, MICROBIOL RES, V159, P339, DOI 10.1016/j.micres.2004.07.002; De Vuyst L, 2007, J MOL MICROB BIOTECH, V13, P194, DOI 10.1159/000104752; Dewettinck K, 2008, J CEREAL SCI, V48, P243, DOI 10.1016/j.jcs.2008.01.003; ELGENDY SM, 1981, J FOOD PROTECT, V44, P211, DOI 10.4315/0362-028X-44.3.211; FERNANDEZGARAYZABAL JF, 1992, APPL ENVIRON MICROB, V58, P434, DOI 10.1128/AEM.58.1.434-438.1992; Gerbaldo GA, 2012, FEMS MICROBIOL LETT, V332, P27, DOI 10.1111/j.1574-6968.2012.02570.x; Gerez CL, 2013, BIOL CONTROL, V64, P231, DOI 10.1016/j.biocontrol.2012.10.009; Ghosh R, 2015, BIOL CONTROL, V83, P29, DOI 10.1016/j.biocontrol.2014.12.020; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8; Lavermicocca P, 1997, PHYSIOL MOL PLANT P, V50, P129, DOI 10.1006/pmpp.1996.0078; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; Li HJ, 2012, CURR MICROBIOL, V65, P156, DOI 10.1007/s00284-012-0135-2; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Mandal V, 2013, J SCI FOOD AGR, V93, P2445, DOI 10.1002/jsfa.6055; Mandal V, 2010, J FOOD SAFETY, V30, P635, DOI 10.1111/j.1745-4565.2010.00230.x; Masood MI, 2011, CRIT REV MICROBIOL, V37, P91, DOI 10.3109/1040841X.2010.536522; Pascual LM, 2008, CURR MICROBIOL, V56, P397, DOI 10.1007/s00284-007-9094-4; Pepe O, 2003, APPL ENVIRON MICROB, V69, P2321, DOI 10.1128/AEM.69.4.2321-2329.2003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soma Barman, 2014, Food and Nutrition Sciences, V5, P2115, DOI 10.4236/fns.2014.522224; Suh JW, 1997, CLIN CHEM, V43, P2256; Svanstrom Asa, 2013, BMC Res Notes, V6, P464, DOI 10.1186/1756-0500-6-464; Sweeney MJ, 1998, INT J FOOD MICROBIOL, V43, P141, DOI 10.1016/S0168-1605(98)00112-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JM, 1998, J APPL MICROBIOL, V85, P481, DOI 10.1046/j.1365-2672.1998.853512.x; Valerio F, 2008, INT J FOOD MICROBIOL, V122, P328, DOI 10.1016/j.ijfoodmicro.2008.01.005; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]	34	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184020	10.1371/journal.pone.0184020	http://dx.doi.org/10.1371/journal.pone.0184020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859156	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500059
J	Helde-Frankling, M; Hoijer, J; Bergqvist, J; Bjorkhem-Bergman, L				Helde-Frankling, Maria; Hoijer, Jonas; Bergqvist, Jenny; Bjorkhem-Bergman, Linda			Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections-Results from a matched case-control study	PLOS ONE			English	Article							QUALITY-OF-LIFE; 25-HYDROXYVITAMIN D LEVEL; D DEFICIENCY; ASSOCIATION; FATIGUE; BASE; RISK; CARE	Background We previously showed an association between low vitamin D levels and high opioid doses to alleviate pain in palliative cancer patients. The aim of this case-controlled study was to investigate if vitamin D supplementation could improve pain management, quality of life (QoL) and decrease infections in palliative cancer patients. Methods Thirty-nine palliative cancer patients with levels of 25-hydroxyvitamin D < 75 nmol/L were supplemented with vitamin D 4000 IE/day, and were compared to 39 untreated, matched "control"-patients from a previous study at the same ward. Opioid doses, antibiotic consumption and QoL-scores measured with the Edmonton Symptom Assessment Scale (ESAS) were monitored. The primary endpoint was the change from baseline after 1 and 3 months compared between the groups using linear regression with adjustment for a potential cofounding factor. Results After 1 month the vitamin D treated group had a significantly decreased fentanyl dose compared to the untreated group with a difference of 46 mu g/h; 95% CI 24-78, which increased further at 3 months to 91 mu g/h; 95% CI 56-140 mu g/h. The ESAS QoL-score improved in the Vitamin D group the first month; -1.4; 95% CI -2.6 - (-0.21). The vitamin D-treated group had significantly lower consumption of antibiotics after 3 months compared to the untreated group, the difference was -26%; 95% CI -0.41%-(-0.12%). Vitamin D was well tolerated by all patients and no adverse events were reported. Conclusion Vitamin D supplementation to palliative cancer patients is safe and improvement in pain management is noted as early as 1 month after treatment. Decreased infections are noted 3 months after vitamin D treatment. The results from this pilot-study have been used for the power-calculation of a future randomized, placebo-controlled, double-blind study called "Palliative-D" that will start in Nov 2017 and will include 254 palliative cancer patients.	[Helde-Frankling, Maria; Bjorkhem-Bergman, Linda] ASIH Stockholm Sodra, Palliat Home Care & Hosp Ward, Langbro Pk, Alvsjo, Sweden; [Helde-Frankling, Maria; Bjorkhem-Bergman, Linda] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Helde-Frankling, Maria; Bjorkhem-Bergman, Linda] Karolinska Univ Hosp, Stockholm, Sweden; [Hoijer, Jonas] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Bergqvist, Jenny] Capio St Gorans Hosp, Dept Surg, Breast Ctr, Stockholm, Sweden; [Bergqvist, Jenny] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Saint Goran's Hospital; Karolinska Institutet	Bjorkhem-Bergman, L (corresponding author), ASIH Stockholm Sodra, Palliat Home Care & Hosp Ward, Langbro Pk, Alvsjo, Sweden.; Bjorkhem-Bergman, L (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.; Bjorkhem-Bergman, L (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	linda.bjorkhem-bergman@ki.se		Bergqvist, Jenny/0000-0002-9875-7946; Bjorkhem-Bergman, Linda/0000-0003-3505-9283	Regional agreement on training and clinical research (ALF); Swedish Cancer Society and Karolinska Institutet.	Regional agreement on training and clinical research (ALF); Swedish Cancer Society and Karolinska Institutet.	Financial support was provided through the Regional agreement on training and clinical research (ALF) between Karolinska Institutet and Stockholm County Council, The Swedish Cancer Society and Karolinska Institutet.	Amir E, 2010, CANCER-AM CANCER SOC, V116, P284, DOI 10.1002/cncr.24749; Anand S, 2011, NEPHROL DIAL TRANSPL, V26, P3683, DOI 10.1093/ndt/gfr098; Aoun SM, 2014, J PAIN SYMPTOM MANAG, V48, P1222, DOI 10.1016/j.jpainsymman.2014.01.007; Bergman Peter, 2015, BMC Res Notes, V8, P498, DOI 10.1186/s13104-015-1504-2; Bergman P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128223; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Bjorkhem-Bergman L, 2016, BMJ SUPPORT PALLIAT, V6, P287, DOI 10.1136/bmjspcare-2015-000921; Carlberg C, 2009, ANTICANCER RES, V29, P3485; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; CASTRO Francisca DIAS DE, 2015, Arq. Gastroenterol., V52, P260, DOI 10.1590/S0004-28032015000400003; Dev R, 2011, ONCOLOGIST, V16, P1637, DOI 10.1634/theoncologist.2011-0151; Gagnon B, 2015, J PAIN SYMPTOM MANAG, V49, P36, DOI 10.1016/j.jpainsymman.2014.05.015; Gendelman O, 2015, LUPUS, V24, P483, DOI 10.1177/0961203314558676; Gifondorwa DJ, 2016, MUSCLE NERVE, V54, P1120, DOI 10.1002/mus.25146; Heaney RP, 2012, NEW ENGL J MED, V367, P77, DOI 10.1056/NEJMe1206858; Helde-Frankling M, 2016, CANCERS, V8, DOI 10.3390/cancers8090084; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Juzeniene A, 2012, DERM-ENDOCRINOL, V4, P109, DOI 10.4161/derm.20013; Kabbani TCA, 2016, AM J GASTROENTEROL, V111, P712, DOI 10.1038/ajg.2016.53; Kuru P, 2015, RHEUMATOL INT, V35, P315, DOI 10.1007/s00296-014-3099-7; Martinez-Alonso M, 2016, PALLIATIVE MED, V30, P89, DOI 10.1177/0269216315601954; Maser RE, 2015, ENDOCR PRACT, V21, P174, DOI 10.4158/EP14332.OR; Ohta H, 2014, CLIN THER, V36, P225, DOI 10.1016/j.clinthera.2013.12.007; Ovesjo E ML, 2015, BASIC CLIN PHARM TOX; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Sampaio-Barros MM, 2016, REV BRAS REUMATOL, V56, P337, DOI [10.1016/j.rbre.2016.05.006, 10.1016/j.rbr.2016.03.004]; Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289; Sepehrmanesh Z, 2016, J NUTR, V146, P243, DOI 10.3945/jn.115.218883; Shi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086467; Shipton EE, 2015, PAIN THER, V4, P67, DOI 10.1007/s40122-015-0036-8; Straube S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007771.pub3; Straube S, 2009, PAIN, V141, P10, DOI 10.1016/j.pain.2008.11.010; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Watanabe SM, 2012, PSYCHO-ONCOLOGY, V21, P977, DOI 10.1002/pon.1996; Wepner F, 2014, PAIN, V155, P261, DOI 10.1016/j.pain.2013.10.002; Whitehurst JL, 2014, PALLIATIVE MED, V28, P87, DOI 10.1177/0269216313511142; Wu ZQ, 2016, PAIN PHYSICIAN, V19, P415	40	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184208	10.1371/journal.pone.0184208	http://dx.doi.org/10.1371/journal.pone.0184208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859173	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500074
J	Scott, NE; Giogha, C; Pollock, GL; Kennedy, CL; Webb, AI; Williamson, NA; Pearson, JS; Hartland, EL				Scott, Nichollas E.; Giogha, Cristina; Pollock, Georgina L.; Kennedy, Catherine L.; Webb, Andrew I.; Williamson, Nicholas A.; Pearson, Jaclyn S.; Hartland, Elizabeth L.			The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; CITROBACTER-RODENTIUM; SUBSTRATE-SPECIFICITY; UBIQUITINATION SITES; MASS-SPECTROMETRY; PROTEOMICS; RECEPTOR; QUANTIFICATION; IDENTIFICATION; ENRICHMENT	The inhibition of host innate immunity pathways is essential for the persistence of attaching and effacing pathogens such as enteropathogenic Escherichia coli (EPEC) and Citrobacter rodentium during mammalian infections. To subvert these pathways and suppress the antimicrobial response, attaching and effacing pathogens use type III secretion systems to introduce effectors targeting key signaling pathways in host cells. One such effector is the arginine glycosyltransferase NleB1 (NleB(CR) in C. rodentium) that modifies conserved arginine residues in death domain-containing host proteins with N-acetylglucosamine (GlcNAc), thereby blocking extrinsic apoptosis signaling. Ectopically expressed NleB1 modifies the host proteins Fas-associated via death domain (FADD), TNFRSF1A-associated via death domain (TRADD), and receptor-interacting serine/threonine protein kinase 1 (RIPK1). However, the full repertoire of arginine GlcNAcylation induced by pathogen-delivered NleB1 is unknown. Using an affinity proteomic approach for measuring arginine-GlcNAcylated glycopeptides, we assessed the global profile of arginine GlcNAcylation during ectopic expression of NleB1, EPEC infection in vitro, or C. rodentium infection in vivo. NleB overexpression resulted in arginine GlcNAcylation of multiple host proteins. However, NleB delivery during EPEC and C. rodentium infection caused rapid and preferential modification of Arg(117) in FADD. This FADD modification was extremely stable and insensitive to physiological temperatures, glycosidases, or host cell degradation. Despite its stability and effect on the inhibition of apoptosis, arginine GlcNAcylation did not elicit any proteomic changes, even in response to prolonged NleB1 expression. We conclude that, at normal levels of expression during bacterial infection, NleB1/NleB(CR) antagonizes death receptor-induced apoptosis of infected cells by modifying FADD in an irreversible manner.	[Scott, Nichollas E.; Giogha, Cristina; Pollock, Georgina L.; Kennedy, Catherine L.; Pearson, Jaclyn S.; Hartland, Elizabeth L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Williamson, Nicholas A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Scott, NE (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	nichollas.scott@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Hartland, Elizabeth/O-2569-2014	Williamson, Nicholas A/0000-0002-2173-3452; Kennedy, Catherine/0000-0001-6359-6161; Hartland, Elizabeth/0000-0003-4254-2863; Scott, Nichollas/0000-0003-2556-8316; Pearson, Jaclyn/0000-0002-7358-4479; Giogha, Cristina/0000-0002-9075-9840	National Health and Medical Research Council of Australia (NHMRC) [APP1098826, APP1100164]; NHMRC [APP1037373, APP1090108]; University of Melbourne [603107]; Australian postgraduate award; Australian Government Research Training Program scholarship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Australian postgraduate award(Australian Government); Australian Government Research Training Program scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported in part by National Health and Medical Research Council of Australia (NHMRC) Project Grants APP1098826 (to E.L.H.) and APP1100164 (to N.E.S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NHMRC Overseas (Biomedical) Fellowship APP1037373 and University of Melbourne Early Career Researcher Grant Scheme Proposal 603107.; Recipient of an Australian postgraduate award.; Recipient of an Australian Government Research Training Program scholarship.; Supported by NHMRC Early Career Fellowship APP1090108.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Aquino-Gil M, 2017, BIOCHEM SOC T, V45, P365, DOI 10.1042/BST20160404; Blasche S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058937; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Chen Y, 2009, J PROTEOME RES, V8, P3141, DOI 10.1021/pr900172v; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; El Qaidi S, 2017, J BIOL CHEM, V292, P11423, DOI 10.1074/jbc.M117.790675; Gao XF, 2016, J BIOL CHEM, V291, P18232, DOI 10.1074/jbc.M116.738278; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Hartland EL, 1999, MOL MICROBIOL, V32, P151, DOI 10.1046/j.1365-2958.1999.01338.x; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jochim N, 2014, RAPID COMMUN MASS SP, V28, P1089, DOI 10.1002/rcm.6882; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Law RJ, 2016, J PROTEOME RES, V15, P1613, DOI 10.1021/acs.jproteome.6b00074; LEVINE MM, 1978, LANCET, V1, P1119; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Meijer BM, 2017, J BIOL CHEM, V292, P7784, DOI 10.1074/jbc.M117.775940; Mills E, 2013, MBIO, V4, DOI 10.1128/mBio.00303-13; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Mundy R, 2003, MOL MICROBIOL, V48, P795, DOI 10.1046/j.1365-2958.2003.03470.x; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Pallett MA, 2017, MUCOSAL IMMUNOL, V10, P602, DOI 10.1038/mi.2016.77; Pan M, 2014, ANGEW CHEM INT EDIT, V53, P14517, DOI 10.1002/anie.201407824; Pearson JS, 2016, ANNU REV GENET, V50, P493, DOI 10.1146/annurev-genet-120215-035138; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; PEARSON JS, 2017, NAT MICROBIOL, V2; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Pollock GL, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01071-16; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scott NE, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167067; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Stoehr G, 2013, MOL CELL PROTEOMICS, V12, P1436, DOI 10.1074/mcp.M112.024679; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Valguarnera E, 2016, J MOL BIOL, V428, P3206, DOI 10.1016/j.jmb.2016.04.013; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang SY, 2017, CHEM SCI, V8, P2296, DOI 10.1039/c6sc03847f; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zeiser J, 2013, J PROTEOME RES, V12, P1604, DOI 10.1021/pr300973q; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	61	33	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17337	17350		10.1074/jbc.M117.805036	http://dx.doi.org/10.1074/jbc.M117.805036			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860194	Green Published, hybrid			2022-12-26	WOS:000414009300016
J	Galle, R; Urak, I; Nikolett, GS; Hartel, T				Galle, Robert; Urak, Istvan; Nikolett, Galle-Szpisjak; Hartel, Tibor			Sparse trees and shrubs confers a high biodiversity to pastures: Case study on spiders from Transylvania	PLOS ONE			English	Article							WOOD-PASTURES; CONSERVATION VALUE; CARABID BEETLES; INDIVIDUAL-TREE; DIVERSITY; ARANEAE; COMMUNITIES; MANAGEMENT; SCARABAEIDAE; GEOTRUPIDAE	The integration of food production and biodiversity conservation represents a key challenge for sustainability. Several studies suggest that even small structural elements in the landscape can make a substantial contribution to the overall biodiversity value of the agricultural landscapes. Pastures can have high biodiversity potential. However, their intensive and monofunctional use typically erodes its natural capital, including biodiversity. Here we address the ecological value of fine scale structural elements represented by sparsely scattered trees and shrubs for the spider communities in a moderately intensively grazed pasture in Transylvania, Eastern Europe. The pasture was grazed with sheep, cattle and buffalo (ca 1 Livestock Unit ha(-1)) and no chemical fertilizers were applied. Sampling sites covered the open pasture as well as the existing fine-scale heterogeneity created by scattered trees and shrub. 40 sampling locations each being represented by three 1 m(2) quadrats were situated in a stratified design while assuring spatial independency of sampling locations. We identified 140 species of spiders, out of which 18 were red listed and four were new for the Romanian fauna. Spider species assemblages of open pasture, scattered trees, trees and shrubs and the forest edge were statistically distinct. Our study shows that sparsely scattered mature woody vegetation and shrubs substantially increases the ecological value of managed pastures. The structural complexity provided by scattered trees and shrubs makes possible the co-occurrence of high spider diversity with a moderately high intensity grazing possible in this wood-pasture. Our results are in line with recent empirical research showing that sparse trees and shrubs increases the biodiversity potential of pastures managed for commodity production.	[Galle, Robert; Nikolett, Galle-Szpisjak] Univ Szeged, Dept Ecol, Szeged, Hungary; [Urak, Istvan; Hartel, Tibor] Sapientia Hungarian Univ Transylvania, Dept Environm Sci, Ecosyst Serv Lab, Cluj Napoca, Romania; [Hartel, Tibor] Babes Bolyai Univ, Fac Biol, Dept Taxon & Ecol, Cluj Napoca, Romania	Szeged University; Sapientia Hungarian University of Transylvania; Babes Bolyai University from Cluj	Galle, R (corresponding author), Univ Szeged, Dept Ecol, Szeged, Hungary.	galle.robert@gmail.com	Tibor, Hartel/B-3440-2012; Urak, Istvan/AAE-3600-2019; Gallé, Róbert/L-9921-2018	Gallé, Róbert/0000-0002-5516-8623; Urak, Istvan/0000-0003-2130-5068	European Community's Seventh Framework Programme [613520]	European Community's Seventh Framework Programme(European Commission)	This work received support from European Community's Seventh Framework Programme under Grant Agreement No. 613520 (Project AGFORWARD, 2014-present), https://ec.europa.eu/research/fp7/index_en.cfm.r TH received funding from the European Community's Seventh Framework Programme under Grant Agreement No. 613520 (Project AGFORWARD, 2014-present).	Beaufoy G, 2015, BOOKL PROD WOOD PAST; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Bonn A, RIVER RES APPL, P43; Cardoso Pedro, 2011, PLoS One, V6, pe21710, DOI 10.1371/journal.pone.0021710; Cattin MF, 2003, BIOL CONSERV, V113, P179, DOI 10.1016/S0006-3207(02)00297-5; Clarke K. R., 2001, CHANGES MARINE COMMU; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Falk S., 2014, EUROPEAN WOOD PASTUR, P132; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Freese A, 2006, ANIM CONSERV, V9, P388, DOI 10.1111/j.1469-1795.2006.00045.x; Frick H, 2007, ANN ZOOL FENN, V44, P43; GALANTE E, 1995, ENVIRON ENTOMOL, V24, P1063, DOI 10.1093/ee/24.5.1063; GALANTE E, 1991, ENVIRON ENTOMOL, V20, P90, DOI 10.1093/ee/20.1.90; Galle R, 2009, COMMUNITY ECOL, V10, P146, DOI 10.1556/ComEc.10.2009.2.2; Galle R, 2015, BIOLOGIA, V70, P104, DOI 10.1515/biolog-2015-0011; Garcia-Tejero S, 2016, AGR ECOSYST ENVIRON, V233, P192, DOI 10.1016/j.agee.2016.09.004; Halada L, 2011, BIODIVERS CONSERV, V20, P2365, DOI 10.1007/s10531-011-9989-z; Hartel T., 2014, EUROPEAN WOOD PASTUR; Hartel T, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P61, DOI 10.1079/9781780643373.0061; Hartel T, 2014, BASIC APPL ECOL, V15, P385, DOI 10.1016/j.baae.2014.06.007; Heisler GM, 2003, AGR FOREST METEOROL, V120, P113, DOI 10.1016/j.agrformet.2003.08.024; Hothorn T., 2016, SIMULTANEOUS INFEREN; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hsieh YL, 2011, BIODIVERS CONSERV, V20, P2953, DOI 10.1007/s10531-011-0158-1; Jakobsson S, 2017, J APPL ECOL; Kiebacher T, 2017, AGR ECOSYST ENVIRON, V239, P293, DOI 10.1016/j.agee.2017.01.034; Kosulic O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148585; Kosulic O, 2014, ECOL ENG, V68, P133, DOI 10.1016/j.ecoleng.2014.03.030; Lambeets K, 2008, BIODIVERS CONSERV, V17, P3133, DOI 10.1007/s10531-007-9313-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lindenmayer DB, 2017, BIOL REV, V92, P1434, DOI 10.1111/brv.12290; Lindenmayer DB, 2017, BIOL CONSERV; Lindsay EA, 2009, FOREST ECOL MANAG, V258, P178, DOI 10.1016/j.foreco.2009.04.005; llerer O K, 2014, WOOD PASTURE MANAGEM, P219; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Matveinen-Huju K, 2006, FOREST ECOL MANAG, V230, P119, DOI 10.1016/j.foreco.2006.04.025; Mcelhinny C, 2010, AUSTRAL ECOL, V35, P87, DOI 10.1111/j.1442-9993.2009.02016.x; Moreno G, 2016, AGROFOREST SYST, V90, P87, DOI 10.1007/s10457-015-9817-7; Moscaliuc LA, 2014, RED LIST SPIDERS ARA, P118; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; Muff Patrick, 2007, Arachnologische Mitteilungen, P16; Nemet E, 2016, COMMUNITY ECOL, V17, P79, DOI 10.1556/168.2016.17.1.10; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oroszi S., 2004, FOREST MANAGEMENT TR, V63, P1; Paltto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024675; Plieninger T, 2015, BIOL CONSERV, V190, P70, DOI 10.1016/j.biocon.2015.05.014; Ranius T, 2000, J INSECT CONSERV, V4, P23, DOI 10.1023/A:1009682722905; Reyes-Lopez J, 2003, ACTA OECOL, V24, P195, DOI 10.1016/S1146-609X(03)00086-9; Rezac M, 2015, BIOLOGIA, V70, P645, DOI 10.1515/biolog-2015-0079; Rossetti I, 2015, AGR ECOSYST ENVIRON, V202, P203, DOI 10.1016/j.agee.2015.01.008; Ruzicka V, 2002, CATALOGUE SPIDERS CZ; Savannas Mistry J., 2000, PROGR PHYS GEOGRAPHY, V24, P601; Sebek P, 2016, FOREST ECOL MANAG, V380, P172, DOI 10.1016/j.foreco.2016.08.052; Seibold S, 2016, J APPL ECOL, V53, P934, DOI 10.1111/1365-2664.12607; Taboada A, 2006, FOREST ECOL MANAG, V237, P436, DOI 10.1016/j.foreco.2006.09.077; Taboada A, 2006, ENTOMOL FENNICA, V17, P284; Torres-Vila LM, 2017, B ENTOMOL RES; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	58	16	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183465	10.1371/journal.pone.0183465	http://dx.doi.org/10.1371/journal.pone.0183465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886058	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100024
J	Gui, B; Hsieh, CL; Kantoff, PW; Kibel, AS; Jia, L				Gui, Bin; Hsieh, Chen-Lin; Kantoff, Philip W.; Kibel, Adam S.; Jia, Li			Androgen receptor-mediated downregulation of microRNA-221 and-222 in castration-resistant prostate cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PROFILE ANALYSIS; BREAST-CANCER; CELL-LINES; MIR-221; EXPRESSION; PROGRESSION; CARCINOMA; PROLIFERATION; TRANSCRIPTION	MicroRNAs (miRNAs) play important roles in cancer formation and progression by suppressing the production of key functional proteins at the post-transcriptional level in a sequence-specific manner. While differential expression of miRNAs is widely observed in cancers including prostate cancer (PCa), how these miRNAs are transcriptionally regulated is largely unknown. MiRNA-221 and miRNA-222 (miR-221/-222) are well-established oncogenes and overexpressed in breast, liver, pancreas, and lung cancer, but their expression and biological functions in PCa remain controversial. Both up and down regulation have been observed in patient samples. Specifically, studies have demonstrated miR-221/-222 function as oncogenes, and promote PCa cell proliferation and the development of castration-resistant prostate cancer (CRPC). However, the expression level of miR-221/-222 is downregulated in several miRNA expression profiling studies. In this study, we demonstrate miR-221/-222 are androgen receptor (AR)-repressed genes and reside in a long primary transcript (pri-miRNA). Derepression of miR-221/-222 after androgen deprivation therapy (ADT) may enhance PCa cell proliferation potential through promoting G1/S phase transition. This function is likely transient but important in the development of CRPC. Downregulation of miR-221/-222 subsequently occurs once AR activity is restored through AR overexpression in CRPC. Our findings shed light on the complexity of transcriptional regulation of miRNAs in PCa and suggest context-dependent targeting of oncogenic miRNAs.	[Gui, Bin; Kibel, Adam S.; Jia, Li] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Urol, Boston, MA 02115 USA; [Hsieh, Chen-Lin] Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA; [Kantoff, Philip W.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Jia, L (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Urol, Boston, MA 02115 USA.	ljia@bwh.harvard.edu		Kantoff, Philip/0000-0001-7275-0597	Anthony DiNovi Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Anthony DiNovi Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Anthony DiNovi Fund.; This work was supported by Anthony DiNovi Fund. We thank Gerhard Coetzee, Peter Jones, Jeffrey Friedman, Dali Zheng, Zongtai Qi, Kathryn Jacobs, and Kaidi Wang for advice and technical assistance.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bouvy-Liivrand M, 2017, NUCL ACIDS RES; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Coarfa C, 2015, ONCOGENE; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Goto Y, 2015, BRIT J CANCER, V113, P1055, DOI 10.1038/bjc.2015.300; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kneitz B, 2014, CANCER RES, V74, P2591, DOI 10.1158/0008-5472.CAN-13-1606; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun T, 2014, ONCOGENE, V33, P2790, DOI 10.1038/onc.2013.230; Sun T, 2012, PROSTATE, V72, P1093; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THALMANN GN, 1994, CANCER RES, V54, P2577; Tilki D, 2016, EUR UROL FOCUS, V2, P499, DOI 10.1016/j.euf.2016.11.013; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Zheng D, 2016, ONCOGENE, V35, P4807, DOI 10.1038/onc.2016.13; Zheng DL, 2013, MOL CANCER RES, V11, P482, DOI 10.1158/1541-7786.MCR-12-0520	43	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184166	10.1371/journal.pone.0184166	http://dx.doi.org/10.1371/journal.pone.0184166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886115	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100074
J	Liang, J; Shaulov, Y; Savage-Dunn, C; Boissinot, S; Hoque, T				Liang, Jun; Shaulov, Yakov; Savage-Dunn, Cathy; Boissinot, Stephane; Hoque, Tasmia			Chloride intracellular channel proteins respond to heat stress in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; CRYSTAL-STRUCTURE; ION-CHANNEL; CLIC4; DROSOPHILA; CANCER; FAMILY; TRANSLOCATION; MORPHOGEN; HEDGEHOG	Chloride intracellular channel proteins (CLICs) are multi-functional proteins that are expressed in various cell types and differ in their subcellular location. Two CLIC homologs, EXL-1 (excretory canal abnormal like-1) and EXC-4 (excretory canal abnormal-4), are encoded in the Caenorhabditis elegans genome, providing an excellent model to study the functional diversification of CLIC proteins. EXC-4 functions in excretory canal formation during normal animal development. However, to date, the physiological function of EXL-1 remains largely unknown. In this study, we demonstrate that EXL-1 responds specifically to heat stress and translocates from the cytoplasm to the nucleus in intestinal cells and body wall muscle cells under heat shock. In contrast, we do not observe EXC-4 nuclear translocation under heat shock. Full protein sequence analysis shows that EXL-1 bears a non-classic nuclear localization signal (NLS) that EXC-4 is lacking. All mammalian CLIC members have a nuclear localization signal, with the exception of CLIC3. Our phylogenetic analysis of the CLIC gene families across various animal species demonstrates that the duplication of CLICs in protostomes and deuterostomes occurred independently and that the NLS was subsequently lost in amniotes and nematodes, suggesting convergent evolution. We also observe that EXL-1 nuclear translocation occurs in a timely ordered manner in the intestine, from posterior to anterior regions. Finally, we find that exl-1 loss of function mutants are more susceptible to heat stress than wild-type animals, demonstrating functional relevance of the nuclear translocation. This research provides the first link between CLICs and environmental heat stress. We propose that C. elegans CLICs evolved to achieve different physiological functions through subcellular localization change and spatial separation in response to external or internal signals.	[Liang, Jun; Hoque, Tasmia] CUNY, Dept Sci, Borough Manhattan Community Coll, New York, NY 10021 USA; [Shaulov, Yakov; Savage-Dunn, Cathy] CUNY, Dept Biol, Queens Coll, Flushing, NY USA; [Savage-Dunn, Cathy] Grad Ctr, Biol PhD Program, New York, NY USA; [Savage-Dunn, Cathy] Grad Ctr, Biochem PhD Program, New York, NY USA; [Boissinot, Stephane] New York Univ Abu Dhabi, Saadiyat Isl campus, Abu Dhabi, U Arab Emirates	City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Liang, J (corresponding author), CUNY, Dept Sci, Borough Manhattan Community Coll, New York, NY 10021 USA.	Jliang@bmcc.cuny.edu		Boissinot, Stephane/0000-0002-8760-1284; Savage-Dunn, Cathy/0000-0002-3457-0509	National Institute of Health, National Institute on Aging [1 R03AG048578-01]; City University of New York (CUNY) [CIRG 1817]; PSC-CUNY [66184-00 44, 67248-00 45]; NIH Office of Research Infrastructure Program [P40OD010440]; NATIONAL INSTITUTE ON AGING [R03AG048578] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); City University of New York (CUNY); PSC-CUNY; NIH Office of Research Infrastructure Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: National Institute of Health, National Institute on Aging, award number: 1 R03AG048578-01 to JL, https:// www.nia.nin gov/, The City University of New York (CUNY), award number: CIRG 1817 to C.S.D. and J.L., http://www2.cuny.edu/research; PSC-CUNY, award number: 66184-00 44 and 67248-00 45 to J.L., https://www.rfcuny.org/rfwebsite/research/.; C. elegans strains were obtained from the Caenorhabditis Genetics Center, which is supported by the NIH Office of Research Infrastructure Program (P40OD010440). We thank Dr. Iva Greenwald for providing gamma radiation resource for strain integration at Columbia University; we thank Dr. Mara Schvarzstein for providing DAPI staining protocol. We also thank undergraduate students Aijo De Castro and Moufoutahotou Mohamadou from BMCC to help with some experiments.	Aggarwal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/476357; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Andersen EF, 2014, AM J MED GENET A, V164, P1795, DOI 10.1002/ajmg.a.36524; Ashley RH, 2003, MOL MEMBR BIOL, V20, P1, DOI 10.1080/09687680210042746; Bamps S, 2009, MECH AGEING DEV, V130, P762, DOI 10.1016/j.mad.2009.10.001; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Berry KL, 2006, J MOL BIOL, V359, P1316, DOI 10.1016/j.jmb.2006.04.046; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Bhandari P, 2012, GENES BRAIN BEHAV, V11, P387, DOI 10.1111/j.1601-183X.2012.00765.x; BRENNER S, 1974, GENETICS, V77, P71; Coburn C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001613; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; Foehr ML, 2006, DEVELOPMENT, V133, P2887, DOI 10.1242/dev.02476; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Iwasa H, 2013, EXP CELL RES, V319, P931, DOI 10.1016/j.yexcr.2013.01.020; Knowles LM, 2013, MOL CANCER RES, V11, P194, DOI 10.1158/1541-7786.MCR-12-0300; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Liang J, 2013, JOVE-J VIS EXP, DOI 10.3791/4373; Littler DR, 2010, PROTEINS, V78, P1594, DOI 10.1002/prot.22675; Macpherson IR, 2014, J CELL SCI, V127, P3893, DOI 10.1242/jcs.135947; Malik M, 2010, J BIOL CHEM, V285, P23818, DOI 10.1074/jbc.M109.091611; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mi W, 2008, PROTEINS, V71, P509, DOI 10.1002/prot.21922; Molina-Navarro MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079792; Murthi P, 2012, PLACENTA, V33, P741, DOI 10.1016/j.placenta.2012.06.011; Mynott AV, 2011, FEBS J, V278, P1662, DOI 10.1111/j.1742-4658.2011.08086.x; Nadeau SI, 2007, ADV EXP MED BIOL, V594, P100; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2009, TRENDS ENDOCRIN MET, V20, P259, DOI 10.1016/j.tem.2009.03.006; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Strigini M, 1997, DEVELOPMENT, V124, P4697; Suh KS, 2012, CARCINOGENESIS, V33, P986, DOI 10.1093/carcin/bgs115; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, MOL CARCINOGEN, V46, P599, DOI 10.1002/mc.20324; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wirthmueller L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00149; Zhong JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039378; Zou J, 2011, PLANT CELL REP, V30, P2155, DOI 10.1007/s00299-011-1122-y	52	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184308	10.1371/journal.pone.0184308	http://dx.doi.org/10.1371/journal.pone.0184308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886120	gold, Green Published			2022-12-26	WOS:000410001100095
J	Stenbaek, DS; Dam, VH; Fisher, PM; Hansen, N; Hjordt, LV; Frokjaer, VG				Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hansen, Nanna; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe			No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study	PLOS ONE			English	Article							IN-VIVO; POLYMORPHISM 5-HTTLPR; 5-HT1A RECEPTORS; HEALTHY-SUBJECTS; TRANSPORTER AVAILABILITY; MAJOR DEPRESSION; BINDING; PET; ANXIETY; METAANALYSIS	Serotonin (5-HT) brain architecture appears to be implicated in normal personality traits as supported by genetic associations and studies using molecular brain imaging. However, so far, no studies have addressed potential contributions to variation in normal personality traits from in vivo serotonin 4 receptor (5-HT4R) brain availability, which has recently become possible to image with Positron Emission Tomography (PET). This is particularly relevant since availability of 5-HT4R has been shown to adapt to synaptic levels of 5-HT and thus offers information about serotonergic tone in the healthy brain. In 69 healthy participants (18 females), the associations between personality traits assessed with the five-factor NEO Personality Inventory-Revised (NEO PI-R) and regional cerebral 5-HT4R binding in neocortex, amygdala, hippocampus, and anterior cingulate cortex (ACC) were investigated using linear regression models. The associations between each of the five personality traits and a latent variable construct of global 5-HT4R levels were also evaluated using latent variable structural equation models. We found no significant associations between the five NEO personality traits and regional 5-HT4R binding (all p-values >.17) or the latent construct of global 5-HT4R levels (all p-values >.37). Our findings indicate that NEO personality traits and 5-HT4R are not related in healthy participants. Under the assumption that global 5-HT4R levels index 5-HT tone, our data also suggest that 5-HT tone per se is not directly implicated in normal personality traits.	[Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hansen, Nanna; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe] Copenhagen Univ Hosp, Rigshosp, Neurosci Ctr, Neurobiol Res Unit, Copenhagen, Denmark; [Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe] Copenhagen Univ Hosp, Rigshosp, Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark; [Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe] Copenhagen Univ Hosp, Rigshosp, Ctr Expt Med Neuropharmacol, Copenhagen, Denmark; [Hjordt, Liv Vadskjaer] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Stenbaek, DS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Neurosci Ctr, Neurobiol Res Unit, Copenhagen, Denmark.; Stenbaek, DS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark.; Stenbaek, DS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Expt Med Neuropharmacol, Copenhagen, Denmark.	dea@nru.dk	Fisher, Patrick MacDonald/V-8158-2017; Frøkjær, Vibe Gedsø/N-8955-2019	Fisher, Patrick MacDonald/0000-0002-8115-0611; Frøkjær, Vibe Gedsø/0000-0002-9321-2365; Stenbaek, Dea/0000-0002-5439-4637	Danish Council for Independent Research [271-07-0651]; Lundbeck Foundation [R90-A7722]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	The database study was supported by The Danish Council for Independent Research (grant number 271-07-0651, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research) and The Lundbeck Foundation (grant number R90-A7722, http://www.lundbeckfonden.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa J. P. T., 2005, PERSONALITY ADULTHOO; da Cunha-Bang S, 2016, SOC COGN AFFECT NEUR, V11, P548, DOI 10.1093/scan/nsv140; Deyoung CG, 2010, PERSONALITY NEUROSCI, P1165; Domino G., 2006, PSYCHOL TESTING INTR, V2nd ed; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Fisher PM, 2015, HUM BRAIN MAPP, V36, P313, DOI 10.1002/hbm.22630; Fisher PM, 2015, NEUROPSYCHOPHARMACOL, V40, P1510, DOI 10.1038/npp.2014.339; Frokjaer VG, 2008, BIOL PSYCHIAT, V63, P569, DOI 10.1016/j.biopsych.2007.07.009; Frokjaer VG, 2010, NEUROPSYCHOPHARMACOL, V35, P1129, DOI 10.1038/npp.2009.218; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Geldenhuys WJ, 2011, CNS DRUGS, V25, P765, DOI 10.2165/11590190-000000000-00000; Gerretsen P, 2010, SOC NEUROSCI-UK, V5, P375, DOI 10.1080/17470911003589309; Haahr ME, 2014, MOL PSYCHIATR, V19, P427, DOI 10.1038/mp.2013.147; Haahr ME, 2012, HUMAN BRAIN MAPPING; Hirvonen J, 2015, PSYCHIAT RES-NEUROIM, V234, P1, DOI 10.1016/j.pscychresns.2015.04.007; Holst KK, 2013, COMPUTATION STAT, V28, P1385, DOI 10.1007/s00180-012-0344-y; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jones SE, 2011, J CRIM JUST, V39, P329, DOI 10.1016/j.jcrimjus.2011.03.004; Kalbitzer J, 2009, NEUROIMAGE, V45, P280, DOI 10.1016/j.neuroimage.2008.12.001; Karlsson H, 2011, MOL PSYCHIATR, V16, P282, DOI 10.1038/mp.2009.126; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kim JH, 2015, BRAIN RES, V1629, P63, DOI 10.1016/j.brainres.2015.10.006; Knudsen GM, 2016, NEUROIMAGE, V124, P1213, DOI 10.1016/j.neuroimage.2015.04.025; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lehto K, 2015, PROG NEURO-PSYCHOPH, V57, P31, DOI 10.1016/j.pnpbp.2014.10.005; Licht CL, 2009, J NEUROCHEM, V109, P1363, DOI 10.1111/j.1471-4159.2009.06050.x; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; Madsen K, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu034; Madsen K, 2011, J CEREBR BLOOD F MET, V31, P1475, DOI 10.1038/jcbfm.2011.11; Madsen MK, 2016, SOC COGN AFFECT NEUR, V11, P140, DOI 10.1093/scan/nsv098; Malouff JM, 2005, J PSYCHOPATHOL BEHAV, V27, P101, DOI 10.1007/s10862-005-5384-y; Marner L, 2010, NEUROIMAGE, V50, P855, DOI 10.1016/j.neuroimage.2010.01.054; Marner L, 2009, J NUCL MED, V50, P900, DOI 10.2967/jnumed.108.058552; Middeldorp CM, 2007, BEHAV GENET, V37, P294, DOI 10.1007/s10519-006-9139-7; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Muller PC, 2010, HDB BEHAV NEUROBIOLO; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Nielsen K, 2006, SYNAPSE, V59, P270, DOI 10.1002/syn.20240; Olesen OV, 2009, NUCL SCI S NSS MIC; Pinborg LH, 2008, NEUROIMAGE, V40, P1175, DOI 10.1016/j.neuroimage.2007.09.019; Plieger T, 2014, INT J NEUROPSYCHOPH, V17, P851, DOI 10.1017/S1461145713001776; Rabiner EA, 2002, NEUROIMAGE, V15, P620, DOI 10.1006/nimg.2001.0984; Reimold M, 2008, MOL PSYCHIATR, V13, P606, DOI 10.1038/sj.mp.4002149; Selvaraj S, 2014, NEUROSCI BIOBEHAV R, V45, P233, DOI 10.1016/j.neubiorev.2014.06.005; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Skovdahl H. H., 2011, NEO PI R MANUAL KLIN; Soloff PH, 2010, PSYCHIAT RES-NEUROIM, V181, P77, DOI 10.1016/j.pscychresns.2009.08.007; Stenbaek DS, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.674; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Takano A, 2007, BIOL PSYCHIAT, V62, P588, DOI 10.1016/j.biopsych.2006.11.007; Tauscher J, 2001, AM J PSYCHIAT, V158, P1326, DOI 10.1176/appi.ajp.158.8.1326; Tuominen L, 2013, PSYCHOL MED, V43, P881, DOI 10.1017/S003329171200164X; Vidal R, 2009, J NEUROCHEM, V110, P1120, DOI 10.1111/j.1471-4159.2009.06210.x	59	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184403	10.1371/journal.pone.0184403	http://dx.doi.org/10.1371/journal.pone.0184403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880910	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200066
J	Gomez-Moreno, AZ; Pineda-Tenor, D; Jimenez-Sousa, MA; Sanchez-Ruano, JJ; Artaza-Varasa, T; Saura-Montalban, J; Ryan, P; Resino, S				Zaida Gomez-Moreno, Ana; Pineda-Tenor, Daniel; Angeles Jimenez-Sousa, Maria; Jose Sanchez-Ruano, Juan; Artaza-Varasa, Tomas; Saura-Montalban, Jose; Ryan, Pablo; Resino, Salvador			Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study	PLOS ONE			English	Article							VENOUS-PRESSURE GRADIENT; TRANSIENT ELASTOGRAPHY FIBROSCAN; HEPATOCELLULAR-CARCINOMA; PORTAL-HYPERTENSION; CLINICAL-PRACTICE; INITIAL TREATMENT; CIRRHOSIS; INTERFERON-ALPHA-2B; COMPLICATIONS; RIBAVIRIN	The management of patients with chronic hepatitis C (CHC) depends on their clinical stage. Thus, noninvasive early recognition of patients with CHC at high risk for developing liver-related events (LREs) is important because it ensures optimal preventative management strategies may be employed that can affect the course of CHC disease. Our aim was to determine whether liver stiffness measurement (LSM) in hepatitis C virus (HCV)-infected patients is associated with a risk of LREs, particularly in cirrhotic patients. We carried out a retrospective study on 343 HCV-infected patients stratified according to cirrhosis (LSM<12.5 kPa vs. LSM >= 12.5 kPa), and the cirrhotic patient group (LSM >= 12.5 kPa) was divided according to risk of esophageal varices (LSM < 25 kPa vs. LSM >= 25 kPa). For all patients, each incremental unit in the natural logarithm (Ln) of LSM was associated with 14.76 times higher risk of developing LREs (p<0.001). Patients with cirrhosis (LSM >= 12.5 kPa) had a higher risk of LREs than patients without cirrhosis (LSM<12.5 kPa) [ adjusted hazard ratio (aHR) = 30.97; p<0.001]. When only cirrhotic patients were analyzed (n = 60), each incremental unit in the Ln of LSM was associated with 10.56 times higher risk of developing LREs (p = 0.010). Patients with LSM >= 25 kPa had a greater risk for LRE development compared to those with LSM<25 kPa (aHR = 3.65; p = 0.045). The AUROC for predicting the onset of LREs was 0.876 in all patients and 0.729 in cirrhotic patients. In conclusion, LSM was associated with an increased risk of developing LREs in HCV-infected patients, even within the group of cirrhotic patients.	[Zaida Gomez-Moreno, Ana; Jose Sanchez-Ruano, Juan; Artaza-Varasa, Tomas] Hosp Virgen Salud, Serv Digest, Toledo, Spain; [Pineda-Tenor, Daniel] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain; [Angeles Jimenez-Sousa, Maria; Resino, Salvador] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Majadahonda, Spain; [Saura-Montalban, Jose] Complejo Hosp Toledo, Serv Lab Clin, Toledo, Spain; [Ryan, Pablo] Hosp Univ Infanta Leonor, Serv Med Interna, Madrid, Spain	Complejo Hospitalario de Toledo; Hospital Universitario Fuenlabrada; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complejo Hospitalario de Toledo; Hospital Universitario Infanta Leonor	Resino, S (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Majadahonda, Spain.	sresino@isciii.es	Resino, Salvador/B-2430-2008; Jiménez-Sousa, Maria A./I-8725-2012; RYAN, PABLO/GRF-3462-2022; Ryan, Pablo/AAM-1924-2021	Resino, Salvador/0000-0001-8783-0450; Jiménez-Sousa, Maria A./0000-0002-1945-6169; RYAN, PABLO/0000-0002-4212-7419; Ryan, Pablo/0000-0002-4212-7419; Pineda-Tenor, Daniel/0000-0001-6343-5384	Instituto de Salud Carlos III [PI14CIII/00011, CD13/00013]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by grants given by Instituto de Salud Carlos III [grant numbers PI14CIII/00011 and CD13/00013]	Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2015, DIGEST DIS, V33, P498, DOI 10.1159/000374097; Castera L, 2012, J HEPATOL, V56, P696, DOI 10.1016/j.jhep.2011.07.005; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; European Association for the Study of the Liver, 2014, Journal of Hepatology, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Janjua NZ, 2017, J HEPATOL, V66, P504, DOI 10.1016/j.jhep.2016.10.028; Kim JH, 2015, LIVER INT, V35, P1103, DOI 10.1111/liv.12628; Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x; Lee HW, 2016, GUT LIVER, V10, P429, DOI 10.5009/gnl15021; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pang JXQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095776; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Perez-Latorre L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw212; Perez-Latorre L, 2014, CLIN INFECT DIS, V58, P713, DOI 10.1093/cid/cit768; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Pritchett S, 2011, J Viral Hepat, V18, pe75, DOI 10.1111/j.1365-2893.2010.01375.x; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; Serfaty L, 2016, LIVER INT, V36, P67, DOI 10.1111/liv.13016; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi KQ, 2013, LIVER INT, V33, P62, DOI 10.1111/liv.12003; Shiffman ML, 2014, ANN HEPATOL, V13, P340, DOI 10.1016/S1665-2681(19)30840-3; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Sultanik P, 2016, ALIMENT PHARM THER; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Fernandez-Montero JV, 2013, AIDS, V27, P1129, DOI 10.1097/QAD.0b013e32835e063f; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Zipprich A, 2012, LIVER INT, V32, P1407, DOI 10.1111/j.1478-3231.2012.02830.x	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184404	10.1371/journal.pone.0184404	http://dx.doi.org/10.1371/journal.pone.0184404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880930	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200067
J	Puszczalowska-Lizis, E; Bujas, P; Omorczyk, J; Jandzis, S; Zak, M				Puszczalowska-Lizis, Ewa; Bujas, Przemyslaw; Omorczyk, Jaroslaw; Jandzis, Slawomir; Zak, Marek			Feet deformities are correlated with impaired balance and postural stability in seniors over 75	PLOS ONE			English	Article							HALLUX-VALGUS; FUNCTIONAL ABILITY; FOOT PRESSURE; YOUNG; SWAY; VALIDITY; SEX	Objective Understanding the factors and mechanisms that determine balance in seniors appears vital in terms of their self-reliance and overall safety. The study aimed to determine the relationship between the features of feet structure and the indicators of postural stability in the elderly. Methods The study group comprised 80 seniors (41F, 39M; aged 75-85 years). CQ-ST podoscope and the CQ-Stab 2P two-platform posturograph were used as primary research tools. The data were analyzed based on Spearman's rank correlation and forward stepwise regression. Results Analysis of forward stepwise regression identified the left foot length in females and Clarke's angle of the left foot in men as significant and independent predictors of postural up to 30% of the variance of dependent variables. Conclusions Longer feet provide older women with better stability, whereas in men, the lowering of the longitudinal arch results in postural deterioration. In the elderly, the left lower limb shows greater activity in the stabilizing processes in the standing position than the right one. In gerontological rehabilitation special attention should be paid to the individually tailored, gender-specific treatment, with a view to enhancing overall safety and quality of seniors' lives.	[Puszczalowska-Lizis, Ewa; Jandzis, Slawomir] Univ Rzeszow, Inst Physiotherapy, Fac Med, Rzeszow, Poland; [Bujas, Przemyslaw; Omorczyk, Jaroslaw] Univ Sch Phys Educ, Inst Sport, Fac Phys Educ & Sport, Krakow, Poland; [Zak, Marek] Univ Sch Phys Educ, Fac Phys Rehabil, Dept Phys Rehabil Rheumatol & Geriatr, Krakow, Poland	University of Rzeszow; Institute of Sport - National Research Institute	Zak, M (corresponding author), Univ Sch Phys Educ, Fac Phys Rehabil, Dept Phys Rehabil Rheumatol & Geriatr, Krakow, Poland.	mzak1@onet.eu	Bujas, Przemysław/U-1978-2017; ZAK, Marek/AAN-1807-2021; Puszczalowska-Lizis, Ewa/P-7542-2017	Bujas, Przemysław/0000-0003-1047-8481; ZAK, Marek/0000-0003-0881-9232; Puszczalowska-Lizis, Ewa/0000-0003-3737-0622; Omorczyk, Jaroslaw/0000-0002-3979-9855				Anker LC, 2008, GAIT POSTURE, V27, P471, DOI 10.1016/j.gaitpost.2007.06.002; Blaszczyk JW, 2000, J BIOMECH, V33, P1243, DOI 10.1016/S0021-9290(00)00097-X; Bookstein FL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133303; Caderby T, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00127; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Chen KC, 2011, EUR J PEDIATR, V170, P611, DOI 10.1007/s00431-010-1330-4; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Corriveau H, 2004, ARCH GERONTOL GERIAT, V39, P163, DOI 10.1016/j.archger.2004.03.001; Ferrari J, 2005, FOOT ANKLE INT, V26, P739, DOI 10.1177/107110070502600912; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Hill MW, 2016, EUR J APPL PHYSIOL, V116, P1965, DOI 10.1007/s00421-016-3448-1; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Koller U, 2014, J ORTHOP RES, V32, P1688, DOI 10.1002/jor.22707; Kouzaki M, 2012, GAIT POSTURE, V35, P11, DOI 10.1016/j.gaitpost.2011.03.028; Lizis P., 2000, FORMATION LONGITUDIN; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Martinez-Nova A, 2010, GAIT POSTURE, V32, P425, DOI 10.1016/j.gaitpost.2010.06.015; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Menz HB, 2001, J AM PODIAT MED ASSN, V91, P222, DOI 10.7547/87507315-91-5-222; Okuda H, 2014, J EPIDEMIOL, V24, P200, DOI 10.2188/jea.JE20130110; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Pita-Fernandez S, 2015, J EPIDEMIOL, V25, P148, DOI 10.2188/jea.JE20140082; Simoneau M, 1999, J AM GERIATR SOC, V47, P235, DOI 10.1111/j.1532-5415.1999.tb04584.x; Spink MJ, 2011, ARCH PHYS MED REHAB, V92, P68, DOI 10.1016/j.apmr.2010.09.024; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Wen JM, 2012, GAIT POSTURE, V36, P344, DOI 10.1016/j.gaitpost.2012.03.030; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011; Zhou J, 2013, INDIAN J ORTHOP, V47, P278, DOI 10.4103/0019-5413.109875	28	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183227	10.1371/journal.pone.0183227	http://dx.doi.org/10.1371/journal.pone.0183227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877185	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200027
J	Varadarajan, B; Vogt, A; Hartwich, V; Vasireddy, R; Consiglio, J; Hugi-Mayr, B; Eberle, B				Varadarajan, Balamurugan; Vogt, Andreas; Hartwich, Volker; Vasireddy, Rakesh; Consiglio, Jolanda; Hugi-Mayr, Beate; Eberle, Balthasar			An in vitro lung model to assess true shunt fraction by multiple inert gas elimination	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INLET MASS-SPECTROMETRY; PULMONARY SHUNT; VENTILATION; DISTRIBUTIONS; AGREEMENT; RATIOS; VOLUME; OXYGEN	The Multiple Inert Gas Elimination Technique, based on Micropore Membrane Inlet Mass Spectrometry, (MMIMS-MIGET) has been designed as a rapid and direct method to assess the full range of ventilation-to-perfusion (V/Q) ratios. MMIMS-MIGET distributions have not been assessed in an experimental setup with predefined V/Q-distributions. We aimed (I) to construct a novel in vitro lung model (IVLM) for the simulation of predefined V/Q distributions with five gas exchange compartments and (II) to correlate shunt fractions derived from MMIMS-MIGET with preset reference shunt values of the IVLM. Five hollow-fiber membrane oxygenators switched in parallel within a closed extracorporeal oxygenation circuit were ventilated with sweep gas (V) and perfused with human red cell suspension or saline (Q). Inert gas solution was infused into the perfusion circuit of the gas exchange assembly. Sweep gas flow (V) was kept constant and reference shunt fractions (IVLM-S) were established by bypassing one or more oxygenators with perfusate flow (Q). The derived shunt fractions (MM-S) were determined using MIGET by MMIMS from the retention data. Shunt derived by MMIMS-MIGET correlated well with preset reference shunt fractions. The in vitro lung model is a convenient system for the setup of predefined true shunt fractions in validation of MMIMS-MIGET.	[Varadarajan, Balamurugan; Vogt, Andreas; Hartwich, Volker; Vasireddy, Rakesh; Eberle, Balthasar] Univ Bern, Bern Univ Hosp, Inselspital, Dept Anesthesiol & Pain Med, Bern, Switzerland; [Consiglio, Jolanda; Hugi-Mayr, Beate] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiac & Vasc Surg, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Vasireddy, R (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Anesthesiol & Pain Med, Bern, Switzerland.	Radhakrishna.vasireddy@dkf.unibe.ch	Varadarajan, Balamurugan T/E-3749-2016	Varadarajan, Balamurugan T/0000-0002-7124-3953; Vasireddy, Rakesh/0000-0002-7824-0560; Vogt, Andreas/0000-0002-3676-7188	Swiss National Science Foundation, SNSF [320030_133046]	Swiss National Science Foundation, SNSF(Swiss National Science Foundation (SNSF))	The work was supported by Swiss National Science Foundation, SNSF Grant #: 320030_133046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank C. Reid for careful proof read of the manuscript. We thank O. Aeby for his technical support during the construction of the lung model. The work was supported by Swiss National Science Foundation, SNSF Grant #: 320030_133046.	Baumgardner JE, 2000, J APPL PHYSIOL, V89, P1699, DOI 10.1152/jappl.2000.89.5.1699; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borland C, 2006, J APPL PHYSIOL, V100, P1527, DOI 10.1152/japplphysiol.00949.2005; Chen SW, 2016, J CRIT CARE, V31, P139, DOI 10.1016/j.jcrc.2015.11.002; Duenges B, 2009, ANESTH ANALG, V109, P1831, DOI 10.1213/ANE.0b013e3181bbc401; EVANS JW, 1974, J APPL PHYSIOL, V36, P533, DOI 10.1152/jappl.1974.36.5.533; Hartmann EK, 2014, ACTA ANAESTH SCAND, V58, P1032, DOI 10.1111/aas.12378; HLASTALA MP, 1975, J APPL PHYSIOL, V39, P1048, DOI 10.1152/jappl.1975.39.6.1048; Kretzschmar M, 2013, J APPL PHYSL; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; ROCA J, 1994, THORAX, V49, P815, DOI 10.1136/thx.49.8.815; Rush B., 2016, J INTENSIVE CARE MED; Sa RC, 2017, J APPL PHYSL; SATO S, 1993, J APPL PHYSIOL, V74, P951, DOI 10.1152/jappl.1993.74.2.951; Schuerer DJE, 2008, CHEST, V134, P179, DOI 10.1378/chest.07-2512; Neto AS, 2014, LANCET RESP MED, V2, P1007, DOI 10.1016/S2213-2600(14)70228-0; Simon M, 2016, RESP CARE, V61, P316, DOI 10.4187/respcare.04308; Svitek RG, 2008, ANN BIOMED ENG, V36, P992, DOI 10.1007/s10439-008-9482-3; Villar J, 2016, CURR OPIN CRIT CARE, V22, P1, DOI 10.1097/MCC.0000000000000266; WAGNER PD, 1975, J APPL PHYSIOL, V38, P1099, DOI 10.1152/jappl.1975.38.6.1099; Wagner PD, 2008, INTENS CARE MED, V34, P994, DOI 10.1007/s00134-008-1108-6; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Ziebart A, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0101-6	25	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184212	10.1371/journal.pone.0184212	http://dx.doi.org/10.1371/journal.pone.0184212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877216	gold, Green Submitted, Green Published			2022-12-26	WOS:000409391200072
J	Zhang, ZW; Gao, ZH; Wang, Y; Yuan, YH; Dong, J; Yue, TL				Zhang, Zhiwei; Gao, Zhenhong; Wang, Yuan; Yuan, Yahong; Dong, Jing; Yue, Tianli			Transformation products elucidation of forchlorfenuron in postharvest kiwifruit by time-of-flight mass spectrometry	PLOS ONE			English	Article							IN-VITRO; METABOLITES; IDENTIFICATION; WATER; CPPU; SIZE; MS; DISSIPATION; DEGRADATION; PESTICIDES	Forchlorfenuron (1-(2-chloro-4-pyridyl)-3-phenylurea, FCF) is a plant growth regulator, being extensively used for increasing kiwifruit size. The toxicological properties of its may persist in their transformation products (TPs) or even higher toxicity than FCF. TPs elucidation of FCF in postharvest kiwifruit (Actinidia chinensis, Chinese gooseberry) by the liquid chromatography ionization hybrid ion trap and time-of-flight mass spectrometry (LC-ESI-ITTOF/MS) in positive mode was the objective of the present study. Fifteen days after full bloom, kiwifruits were dipped for 5s with high dosage FCF solution (60 mg/L), so that sufficient peaks could be detected. The chemical structure of unknown TPs was analyzed in combination of functions of LCMS-IT-TOF, such as high-accurate MSn, formula predictor, metabolite structural analysis software MetID Solution, profiling solution metabolomics software, and neutral loss, characteristic isotopic patterns of chlorine, the fragmentation pattern and retention time of standard substances, nitrogen rule, chemical components of kiwifruit. Total 17 TPs were detected via comparisons of their accurate MSn data of commercial analytical standards and synthesized standards with high purity, such as 4-amino-2-chloropyridine, phenylurea, 2-hydroxy-FCF, 1-(2-chloro-6-((3, 4, 5-trihydroxy-6-(hydroxymethyl) tetrahydro-2H-pyran-2-yl) oxy) pyridin-4-yl)-3-phenylurea, 1, 3-bis (2-chloropyridin-4-yl) urea, 1,3-diphenylurea, 1-(2-chloropyridin-4-yl) urea, FCF-2-O-beta-D-glucoside, and so on. The major transformation pathways of FCF in kiwifruit were biochemical and photochemical cleavage pathway. The experimental results indicate that LCMS-IT-TOF is powerful and effective tool for identification of FCF TPs.	[Zhang, Zhiwei; Gao, Zhenhong; Wang, Yuan; Yuan, Yahong; Yue, Tianli] Northwest A&F Univ, Coll Food Sci & Engn, Shananxi, Peoples R China; [Zhang, Zhiwei; Gao, Zhenhong] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Peoples R China; [Yuan, Yahong; Yue, Tianli] Minist Agr, Lab Qual & Safety Risk Assessment Agroprod YanLin, Yangling, Shaanxi, Peoples R China; [Yuan, Yahong; Yue, Tianli] Natl Engn Res Ctr Agr Integrat Test Yangling, Yangling, Shaanxi, Peoples R China; [Dong, Jing] Shimadzu Int Trading, Beijing, Peoples R China	Northwest A&F University - China; Qingdao Agricultural University; Ministry of Agriculture & Rural Affairs	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Shananxi, Peoples R China.; Yue, TL (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Agroprod YanLin, Yangling, Shaanxi, Peoples R China.; Yue, TL (corresponding author), Natl Engn Res Ctr Agr Integrat Test Yangling, Yangling, Shaanxi, Peoples R China.	yuetl305@nwsuaf.edu.cn	yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	Investigation and product safety assessment of plant growth regulators in fruits and vegetables [GJFP201601403]; Research on key technology of safety hazard factor identification control in Shaanxi fruit and vegetable food [2016KTCQ03-12]; Qingdao Agricultural University high - level talent fund [6631115045]	Investigation and product safety assessment of plant growth regulators in fruits and vegetables; Research on key technology of safety hazard factor identification control in Shaanxi fruit and vegetable food; Qingdao Agricultural University high - level talent fund	This work was funded by Investigation and product safety assessment of plant growth regulators in fruits and vegetables (GJFP201601403); Research on key technology of safety hazard factor identification control in Shaanxi fruit and vegetable food (2016KTCQ03-12); and Qingdao Agricultural University high - level talent fund (6631115045).	Belfroid AC, 1998, SCI TOTAL ENVIRON, V222, P167, DOI 10.1016/S0048-9697(98)00298-8; BLANK RH, 1992, NEW ZEAL J CROP HORT, V20, P73, DOI 10.1080/01140671.1992.10422328; Chen WJ, 2013, B ENVIRON CONTAM TOX, V90, P756, DOI 10.1007/s00128-013-0979-6; Cruz-Castillo JG, 2002, SCI HORTIC-AMSTERDAM, V95, P23, DOI 10.1016/S0304-4238(01)00384-3; Ferrer I, 2005, ANAL CHEM, V77, P2818, DOI 10.1021/ac048458x; Fu J, 2012, J PHARMACEUT BIOMED, V71, P162, DOI 10.1016/j.jpba.2012.07.028; Garcia-Reyes JF, 2007, ANAL CHEM, V79, P307, DOI 10.1021/ac061402d; Hernandez F, 2008, TRAC-TREND ANAL CHEM, V27, P862, DOI 10.1016/j.trac.2008.08.011; Ibanez M, 2004, ANAL CHEM, V76, P1328, DOI 10.1021/ac035200i; Kim JG, 2006, SCI HORTIC-AMSTERDAM, V110, P219, DOI 10.1016/j.scienta.2006.06.017; Liang Y, 2011, J CHROMATOGR B, V879, P1819, DOI 10.1016/j.jchromb.2011.04.015; Liu Y, 2010, TALANTA, V82, P1200, DOI 10.1016/j.talanta.2010.06.032; Liu ZY, 2010, ANAL BIOANAL CHEM, V396, P1259, DOI 10.1007/s00216-009-3245-3; PATTERSON KJ, 1993, NEW ZEAL J CROP HORT, V21, P253, DOI 10.1080/01140671.1993.9513777; Pesticides A, 2005, EVALUATION NEW ACTIV; Sharma D, 2003, CHEMOSPHERE, V50, P589, DOI 10.1016/S0045-6535(02)00619-7; Shi XM, 2012, J AGR FOOD CHEM, V60, P60, DOI 10.1021/jf204183d; Sirtori C, 2014, ANAL BIOANAL CHEM, V406, P5323, DOI 10.1007/s00216-014-7942-1; Suarez-Pantaleon C, 2008, J AGR FOOD CHEM, V56, P11122, DOI 10.1021/jf802261x; Suarez-Pantaleon C, 2013, BIOSENS BIOELECTRON, V42, P170, DOI 10.1016/j.bios.2012.11.001; Suarez-Pantaleon C, 2010, J AGR FOOD CHEM, V58, P8502, DOI 10.1021/jf101660z; Tixier C, 2002, CHEMOSPHERE, V46, P519, DOI 10.1016/S0045-6535(01)00193-X; Ugare B, 2013, FOOD CHEM, V141, P4208, DOI 10.1016/j.foodchem.2013.06.111; Valverde A, 2007, J ENVIRON SCI HEAL B, V42, P801, DOI 10.1080/03601230701551475; Valverde A, 2010, J AGR FOOD CHEM, V58, P2818, DOI 10.1021/jf904465s; Xu Y, 2011, J CHROMATOGR A, V1218, P6663, DOI 10.1016/j.chroma.2011.07.058; Zhang ZW, 2015, J AGR FOOD CHEM, V63, P3059, DOI 10.1021/acs.jafc.5b01100; Zhu XC, 2014, ANAL CHEM, V86, P1202, DOI 10.1021/ac403385y	28	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184021	10.1371/journal.pone.0184021	http://dx.doi.org/10.1371/journal.pone.0184021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877224	Green Submitted, gold, Green Published			2022-12-26	WOS:000409391200055
J	Han, YJ; Choo, SJ; Kwon, H; Lee, JW; Chung, CH; Kim, H; Kwon, TW; Cho, YP				Han, Youngjin; Choo, Suk Jung; Kwon, Hyunwook; Lee, Jae Won; Chung, Cheol Hyun; Kim, Hyangkyoung; Kwon, Tae-Won; Cho, Yong-Pil			Effects of upper-extremity vascular access creation on cardiac events in patients undergoing coronary artery bypass grafting	PLOS ONE			English	Article							ARTERIOVENOUS-FISTULA; SUBCLAVIAN ARTERY; HEART-FAILURE; STEAL; OUTCOMES; SURGERY; SURVIVAL	The present study was conducted to investigate whether upper-extremity vascular access (VA) creation increases the risk for major adverse cardiac events (MACE) and death in patients undergoing coronary artery bypass grafting (CABG) with an in situ left internal thoracic artery (ITA) graft. A total of 111 patients with CABG with a left ITA graft who underwent upper-extremity VA creation were analyzed retrospectively; 93 patients received left VA creation (83.8%, ipsilateral group) and 18 patients received right VA creation (16.2%, contralateral group). The primary outcome was the occurrence of MACE, and the secondary outcome was the composite of MACE or late death. There were no significant differences in the incidence of primary (P = 0.30) or secondary (P = 0.09) outcomes between the two groups. Multivariate regression analysis indicated that prior cerebrovascular accidents (hazard ratio [HR] 3.30; 95% confidence interval [CI] 1.37-7.97; P = 0.01) and type of VA (HR 3.44; 95% CI 1.34-8.82; P = 0.01) were independently associated with MACE; prior peripheral arterial occlusive disease (HR 4.22; 95% CI 1.62-10.98; P< 0.01) and type of VA (arteriovenous fistula vs. prosthetic arteriovenous grafting) (HR 3.06; 95% CI, 1.42-6.61; P< 0.01) were associated with the composite of MACE or death. The side and location of VA were not associated with MACE or death. Our study showed no definite evidence that ipsilateral VA creation affects the subsequent occurrence of MACE or late death from any cause. The type of VA (a prosthetic arteriovenous grafting) is a significant predictor of the subsequent occurrence of MACE or late death.	[Han, Youngjin; Kwon, Hyunwook; Kwon, Tae-Won; Cho, Yong-Pil] Univ Ulsan, Coll Med, Dept & Surg, Seoul, South Korea; [Han, Youngjin; Choo, Suk Jung; Kwon, Hyunwook; Lee, Jae Won; Chung, Cheol Hyun; Kwon, Tae-Won; Cho, Yong-Pil] Asan Med Ctr, Seoul, South Korea; [Choo, Suk Jung; Lee, Jae Won; Chung, Cheol Hyun] Univ Ulsan, Coll Med, Dept Thorac Surg, Seoul, South Korea; [Kim, Hyangkyoung] Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea	University of Ulsan; University of Ulsan; Chung Ang University; Chung Ang University Hospital	Cho, YP (corresponding author), Univ Ulsan, Coll Med, Dept & Surg, Seoul, South Korea.; Cho, YP (corresponding author), Asan Med Ctr, Seoul, South Korea.	ypcho@amc.seoul.kr						Ahn S, 2017, J VASC ACCESS, V18, P290, DOI 10.5301/jva.5000690; Bavare CS, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/328601; CAMERON A, 1986, CIRCULATION, V74, P30; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coskun I, 2013, THORAC CARDIOV SURG, V61, P663, DOI 10.1055/s-0032-1331464; Elian D, 2002, CARDIOLOGY, V97, P175, DOI 10.1159/000063116; Feldman L, 2017, J VASC ACCESS, V18, P301, DOI 10.5301/jva.5000693; Feldman L, 2014, THER APHER DIAL, V18, P450, DOI 10.1111/1744-9987.12158; From AM, 2010, J AM COLL CARDIOL, V55, P300, DOI 10.1016/j.jacc.2009.12.003; Galle J, 2001, NEPHROL DIAL TRANSPL, V16, P2135, DOI 10.1093/ndt/16.11.2135; Han HJ, 2012, KOREAN CIRC J, V42, P784, DOI 10.4070/kcj.2012.42.11.784; Helgadottir S, 2016, ACTA ANAESTH SCAND, V60, P1230, DOI 10.1111/aas.12758; Kato H, 2003, ANN THORAC SURG, V75, P270, DOI 10.1016/S0003-4975(02)04306-0; Lee PY, 2004, CATHETER CARDIO INTE, V62, P244, DOI 10.1002/ccd.20055; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rahbar R, 2006, ANN THORAC SURG, V81, P145, DOI 10.1016/j.athoracsur.2005.06.018; Redfield MM, 2016, NEW ENGL J MED, V375, P1868, DOI 10.1056/NEJMcp1511175; Rossum AC, 2000, CLIN CARDIOL, V23, P226, DOI 10.1002/clc.4960230321; Takami Y, 2014, J THORAC CARDIOV SUR, V147, P619, DOI 10.1016/j.jtcvs.2013.01.031; Takami Y, 2012, ANN THORAC SURG, V94, P1940, DOI 10.1016/j.athoracsur.2012.07.037; Ura M, 2001, ANN THORAC SURG, V71, P148, DOI 10.1016/S0003-4975(00)01700-8; Vascular Access 2006 Work Group, 2006, Am J Kidney Dis, V48 Suppl 1, pS176; Wong D, 2003, EUR J CARDIO-THORAC, V24, P388, DOI 10.1016/S1010-7940(03)00328-2	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184168	10.1371/journal.pone.0184168	http://dx.doi.org/10.1371/journal.pone.0184168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873444	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800058
J	de Camargo, UM; Somervuo, P; Ovaskainen, O				de Camargo, Ulisses Moliterno; Somervuo, Panu; Ovaskainen, Otso			PROTAX-Sound: A probabilistic framework for automated animal sound identification	PLOS ONE			English	Article							CLASSIFICATION; COMMUNITY; RECOGNITION; BIRDS	Autonomous audio recording is stimulating new field in bioacoustics, with a great promise for conducting cost-effective species surveys. One major current challenge is the lack of reliable classifiers capable of multi-species identification. We present PROTAX-Sound, a statistical framework to perform probabilistic classification of animal sounds. PROTAX-Sound is based on a multinomial regression model, and it can utilize as predictors any kind of sound features or classifications produced by other existing algorithms. PROTAX-Sound combines audio and image processing techniques to scan environmental audio files. It identifies regions of interest (a segment of the audio file that contains a vocalization to be classified), extracts acoustic features from them and compares with samples in a reference database. The output of PROTAX-Sound is the probabilistic classification of each vocalization, including the possibility that it represents species not present in the reference database. We demonstrate the performance of PROTAX-Sound by classifying audio from a species-rich case study of tropical birds. The best performing classifier achieved 68% classification accuracy for 200 bird species. PROTAX-Sound improves the classification power of current techniques by combining information from multiple classifiers in a manner that yields calibrated classification probabilities.	[de Camargo, Ulisses Moliterno; Somervuo, Panu; Ovaskainen, Otso] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ovaskainen, Otso] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway	University of Helsinki; Norwegian University of Science & Technology (NTNU)	de Camargo, UM (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ulisses.camargo@helsinki.fi	Ovaskainen, Otso/AGN-4838-2022; Ovaskainen, Otso/D-9119-2012	Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421; Moliterno de Camargo, Ulisses/0000-0002-3718-3344	Academy of Finland [1273253, 284601]; Research Council of Norway (CoE) [223257]; LUOVA graduate school of the University of Helsinki	Academy of Finland(Academy of Finland); Research Council of Norway (CoE); LUOVA graduate school of the University of Helsinki	The research was funded by the Academy of Finland (grants 1273253 and 284601 to OO), the Research Council of Norway (CoE grant 223257), and the LUOVA graduate school of the University of Helsinki (PhD grant for UC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Klaus Riede and an anonymous reviewer for valuable comments to this work. The research was funded by the Academy of Finland (grants 1273253 and 284601 to OO), the Research Council of Norway (CoE grant 223257), and the LUOVA graduate school of the University of Helsinki (PhD grant for UC).	Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; Anderson SE, 1996, J ACOUST SOC AM, V100, P1209, DOI 10.1121/1.415968; Armitage DW, 2010, ECOL INFORM, V5, P465, DOI 10.1016/j.ecoinf.2010.08.001; Bishop Christopher M., 2006, PATTERN RECOGNITION; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Campos-Cerqueira M, 2016, METHODS ECOL EVOL, V7, P1340, DOI 10.1111/2041-210X.12599; Dankowski T, 2016, STAT MED, V35, P3949, DOI 10.1002/sim.6959; de Oliveira AG, 2015, APPL ACOUST, V98, P34, DOI 10.1016/j.apacoust.2015.04.014; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Fagerlund S.L., 2014, INT C AC SPEECH SIGN; Farmer RG, 2012, AUK, V129, P76, DOI 10.1525/auk.2012.11129; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Fodor G., 2013, MACH LEARN SIGN PROC, P1; Goeau H., 2015, CLEF WORKING NOTES 2; Goeau H., 2016, P CLEF C LABS EVALUA, P428; Henriquez A, 2014, EXPERT SYST APPL, V41, P5451, DOI 10.1016/j.eswa.2014.02.021; Huetz C.A., 2012, SENSORS ECOLOGY INTE; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kroodsma D., 2015, SINGING LIFE BIRDS A; Lasseck M., 2015, CROSS LANG IM RETR T; Lasseck M, 2015, LECT NOTES COMPUT SC, V9283, P364, DOI 10.1007/978-3-319-24027-5_39; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lewis JP, 1994, PROC CANAD IMAG PROC, P120; Luther D, 2009, BEHAV ECOL, V20, P864, DOI 10.1093/beheco/arp074; Neal L, 2011, INT CONF ACOUST SPEE, P2012; Niculescu-Mizil A., 2005, MACH LEARN P 22 INT, P625, DOI 10.1145/1102351.1102430; Ovaskainen O, 2010, FUNGAL ECOL, V3, P274, DOI 10.1016/j.funeco.2010.01.001; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Platt JC, 2000, ADV NEUR IN, P61; Potamitis I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096936; Rabiner L. R., 1978, DIGITAL PROCESSING S; Schroeder M., 2007, SPRINGER HDB ACOUSTI; Somervuo P, 2017, METHODS ECOL EVOL, V8, P398, DOI 10.1111/2041-210X.12721; Somervuo P, 2016, BIOINFORMATICS, V32, P2920, DOI 10.1093/bioinformatics/btw346; Stowell D., 2016, ARXIV160803417CSSD; Stowell D, 2014, PEERJ, V2, DOI 10.7717/peerj.488; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Trifa VM, 2008, J ACOUST SOC AM, V123, P2424, DOI 10.1121/1.2839017; Ventura TM, 2015, EXPERT SYST APPL, V42, P8463, DOI 10.1016/j.eswa.2015.07.002; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Yamaura Y, 2011, J APPL ECOL, V48, P67, DOI 10.1111/j.1365-2664.2010.01922.x	42	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184048	10.1371/journal.pone.0184048	http://dx.doi.org/10.1371/journal.pone.0184048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863178	Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900019
J	Kang, HJ; Kim, SW; Son, SH				Kang, Hye Jin; Kim, Shin-Wook; Son, Seok Hyun			The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; CONFORMAL RADIOTHERAPY; EARLY-STAGE; LOCAL RECURRENCE; CANCER; RISK; PNEUMONITIS; IRRADIATION; MASTECTOMY; IMRT	Purpose We aimed to evaluate the feasibility of the heart block with electron compensation (HBE) technique, based on three-dimensional conformal radiotherapy (3D-CRT) in left-sided breast cancer patients with underlying cardiac or pulmonary disease. Methods Twenty patients with left-sided breast cancer who were treated with whole breast radiotherapy (WBRT) were included in this study. Intensity-modulated radiotherapy (IMRT), 3D-CRT, and HBE treatment plans were generated for each patient. Based on the 3D-CRT plan, the HBE plan included a heart block from the medial tangential field to shield the heart and added an electron beam to compensate for the loss in target volume coverage. The dosimetric parameters for the heart and lung and the target volume between the three treatment types were compared. Results Of the three plans, the HBE plan yielded the most significant reduction in the doses received by the heart and lung (heart Dmean: 5.1 Gy vs. 12.9 Gy vs. 4.0 Gy and lung Dmean: 11.4 Gy vs. 13.2 Gy vs. 10.5 Gy, for 3D-CRT, IMRT, and HBE, respectively). Target coverage with all three techniques was within the acceptable range (Dmean 51.0 Gy vs. 51.2 Gy vs. 50.6 Gy, for 3D-CRT, IMRT, and HBE, respectively). Conclusions The HBE plan effectively reduced the amount of radiation exposure to the heart and lung. It could be beneficial for patients who are vulnerable to radiation-related cardiac or pulmonary toxicities.	[Kang, Hye Jin; Kim, Shin-Wook; Son, Seok Hyun] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea	Catholic University of Korea	Son, SH (corresponding author), Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea.	sonshyun@catholic.ac.kr		Son, Seok Hyun/0000-0002-2577-1915				Abe O, 2005, LANCET, V366, P2087; Ahmed RS, 2008, MED DOSIM, V33, P71, DOI 10.1016/j.meddos.2007.10.001; Allen AM, 2006, INT J RADIAT ONCOL, V65, P640, DOI 10.1016/j.ijrobp.2006.03.012; Ares C, 2010, INT J RADIAT ONCOL, V76, P685, DOI 10.1016/j.ijrobp.2009.02.062; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Formenti SC, 2007, J CLIN ONCOL, V25, P2236, DOI 10.1200/JCO.2006.09.1041; Gagliardi G, 1996, BRIT J RADIOL, V69, P839, DOI 10.1259/0007-1285-69-825-839; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Gerardina S, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160039; Gielda BT, 2011, AM J CLIN ONCOL-CANC, V34, P223, DOI 10.1097/COC.0b013e3181dbb9c1; Gokula K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-268; Goldman UB, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-99; Hardenbergh PH, 2001, INT J RADIAT ONCOL, V49, P1023, DOI 10.1016/S0360-3016(00)01531-5; Hu Y, 2013, ONCOL LETT, V5, P714, DOI 10.3892/ol.2012.1053; JACOBSON JA, 1995, NEW ENGL J MED, V332, P907, DOI 10.1056/NEJM199504063321402; Jaen J, 2006, INT J RADIAT ONCOL, V65, P1381, DOI 10.1016/j.ijrobp.2006.03.008; Jagsi R, 2010, J CLIN ONCOL, V28, P2396, DOI 10.1200/JCO.2009.26.8433; Kahan Z, 2007, INT J RADIAT ONCOL, V68, P673, DOI 10.1016/j.ijrobp.2006.12.016; Kong FM, 2015, SEMIN RADIAT ONCOL, V25, P100, DOI 10.1016/j.semradonc.2014.12.003; Lee TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131736; Lin LL, 2015, ACTA ONCOL, V54, P1032, DOI 10.3109/0284186X.2015.1011756; Lind PA, 2006, INT J RADIAT ONCOL, V64, P765, DOI 10.1016/j.ijrobp.2005.08.011; Lind PARM, 2001, BREAST CANCER RES TR, V68, P199, DOI 10.1023/A:1012292019599; Lohr F, 2009, INT J RADIAT ONCOL, V74, P73, DOI 10.1016/j.ijrobp.2008.07.018; Ma CM, 2003, PHYS MED BIOL, V48, P909, DOI 10.1088/0031-9155/48/7/308; Marks LB, 1997, INT J RADIAT ONCOL, V38, P399, DOI 10.1016/S0360-3016(97)00013-8; Michalski A, 2014, MED DOSIM, V39, P163, DOI 10.1016/j.meddos.2013.12.003; Mulliez T, 2015, RADIOTHER ONCOL, V114, P79, DOI 10.1016/j.radonc.2014.11.038; Offersen BV, 2015, RADIOTHER ONCOL, V114, P3, DOI 10.1016/j.radonc.2014.11.030; Ozawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140437; Poggi MM, 2003, CANCER, V98, P697, DOI 10.1002/cncr.11580; Raj KA, 2006, CANCER J, V12, P309, DOI 10.1097/00130404-200607000-00010; Rudat V, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-26; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Sanuki N, 2012, J RADIAT RES, V53, P110, DOI 10.1269/jrr.110142; Schubert LK, 2011, RADIOTHER ONCOL, V100, P241, DOI 10.1016/j.radonc.2011.01.004; Senkus-Konefka E, 2007, CANCER TREAT REV, V33, P578, DOI 10.1016/j.ctrv.2007.07.011; Swanson T, 2013, AM J CLIN ONCOL-CANC, V36, P24, DOI 10.1097/COC.0b013e31823fe481; Taylor CW, 2009, INT J RADIAT ONCOL, V73, P1061, DOI 10.1016/j.ijrobp.2008.05.066; van Nimwegen FA, 2016, J CLIN ONCOL, V34, P235, DOI 10.1200/JCO.2015.63.4444; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Wollschlager D, 2016, RADIOTHER ONCOL, V119, P65, DOI 10.1016/j.radonc.2016.01.020	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184137	10.1371/journal.pone.0184137	http://dx.doi.org/10.1371/journal.pone.0184137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863179	Green Submitted, gold, Green Published			2022-12-26	WOS:000408816900030
J	Krebs, MP; Collin, GB; Hicks, WL; Yu, MZ; Charette, JR; Shi, LY; Wang, JP; Naggert, JK; Peachey, NS; Nishina, PM				Krebs, Mark P.; Collin, Gayle B.; Hicks, Wanda L.; Yu, Minzhong; Charette, Jeremy R.; Shi, Lan Ying; Wang, Jieping; Naggert, Juergen K.; Peachey, Neal S.; Nishina, Patsy M.			Mouse models of human ocular disease for translational research	PLOS ONE			English	Article							FUKUTIN-RELATED PROTEIN; DOMINANT RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; DYSTROPHIN-ASSOCIATED GLYCOPROTEIN; PHOTORECEPTOR DEGENERATION; RETINAL DEGENERATION; RHODOPSIN MUTATIONS; RIBITOL-PHOSPHATE; CRYSTAL-STRUCTURE; VISUAL FUNCTION	Mouse models provide a valuable tool for exploring pathogenic mechanisms underlying inherited human disease. Here, we describe seven mouse models identified through the Translational Vision Research Models (TVRM) program, each carrying a new allele of a gene previously linked to retinal developmental and/or degenerative disease. The mutations include four alleles of three genes linked to human nonsyndromic ocular diseases (Aipl1(tvrm119), Aipl1(tvrm127), Rpgrip1(tvrm111,) Rho(Tvrm334)) and three alleles of genes associated with human syndromic diseases that exhibit ocular phentoypes (Alms1(tvrm102), Clcn2 (nmf289), Fkrp(tvrm53)). Phenotypic characterization of each model is provided in the context of existing literature, in some cases refining our current understanding of specific disease attributes. These murine models, on fixed genetic backgrounds, are available for distribution upon request and may be useful for understanding the function of the gene in the retina, the pathological mechanisms induced by its disruption, and for testing experimental approaches to treat the corresponding human ocular diseases.	[Krebs, Mark P.; Collin, Gayle B.; Hicks, Wanda L.; Charette, Jeremy R.; Shi, Lan Ying; Wang, Jieping; Naggert, Juergen K.; Nishina, Patsy M.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Dept Ophthalm Res, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Yu, Minzhong; Peachey, Neal S.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Ophthalmol, Cleveland, OH 44106 USA; [Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Res Serv, Cleveland, OH USA	Jackson Laboratory; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org	Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Yu, Minzhong/0000-0002-3115-8930; Krebs, Mark/0000-0001-9017-6066	National Institutes of Health [EY016501, EY011996, HD036878, CA034196]; United States Department of Veterans Affairs; Foundation Fighting Blindness Center; National Institutes of Health-National Eye Institute [IP30EY025585]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); Foundation Fighting Blindness Center; National Institutes of Health-National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by grants from the National Institutes of Health (www.nih.gov/grants-funding) EY016501 (to P.M.N.), EY011996 (to P.M.N.), HD036878 (to J.K.N.), and CA034196 (to The Jackson Laboratory); by a United States Department of Veterans Affairs (www.hsrd.research.va.gov/cdp/res_career_scientist.cfm) Research Career Scientist Award (to N.S.P.); and by a Foundation Fighting Blindness Center Award (www.blindness.org), a National Institutes of Health-National Eye Institute Core Grant (IP30EY025585), and an Unrestricted Grant from The Research to Prevent Blindness (www.rpbusa.org/rpb/?) to the Cole Eye Institute, Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroyd MR, 2009, BRAIN, V132, P439, DOI 10.1093/brain/awn335; Akey DT, 2002, HUM MOL GENET, V11, P2723, DOI 10.1093/hmg/11.22.2723; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arsov T, 2006, MOL ENDOCRINOL, V20, P1610, DOI 10.1210/me.2005-0494; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Beedle AM, 2007, J BIOL CHEM, V282, P16713, DOI 10.1074/jbc.C700061200; Bellingham J, 2015, INVEST OPHTH VIS SCI, V56, P7784, DOI 10.1167/iovs.15-18092; Beutler B, 2008, CURR TOP MICROBIOL, V321, P3; Blaeser A, 2013, HUM GENET, V132, P923, DOI 10.1007/s00439-013-1302-7; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Buchner DA, 2004, MAMM GENOME, V15, P344, DOI 10.1007/s00335-004-2332-1; Budzynski E, 2010, J BIOL CHEM, V285, P14521, DOI 10.1074/jbc.M110.112409; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chang Bo, 2013, Methods Mol Biol, V935, P27, DOI 10.1007/978-1-62703-080-9_2; Charette JR, 2016, ADV EXP MED BIOL, V854, P177, DOI 10.1007/978-3-319-17121-0_24; Chiang WC, 2012, INVEST OPHTH VIS SCI, V53, P7159, DOI 10.1167/iovs.12-10222; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Clark AT, 2004, GENETICA, V122, P51, DOI 10.1007/s10709-004-1436-6; Collin GB, 2012, INVEST OPHTH VIS SCI, V53, P967, DOI 10.1167/iovs.11-8766; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Daiger SP, 1996, RETNET GENES MAPPED; Depienne C, 2013, LANCET NEUROL, V12, P659, DOI 10.1016/S1474-4422(13)70053-X; Di Bella D, 2014, NEUROLOGY, V83, P1217, DOI 10.1212/WNL.0000000000000812; Drenckhahn D, 1996, NEUROSCIENCE, V73, P605, DOI 10.1016/0306-4522(96)00069-3; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Dyer MA, 2004, MOL BRAIN RES, V132, P208, DOI 10.1016/j.molbrainres.2004.10.011; Eblimit A, 2015, HUM MOL GENET, V24, P1584, DOI 10.1093/hmg/ddu573; Edwards MM, 2010, INVEST OPHTH VIS SCI, V51, P3264, DOI 10.1167/iovs.09-4887; Edwards MM, 2010, J BIOL CHEM, V285, P7697, DOI 10.1074/jbc.M109.069575; Emery Patrick, 2007, Methods Mol Biol, V362, P187; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; Fahim A. T., 1993, GENEREVIEWS R; FARRAR GJ, 1991, GENOMICS, V11, P1170; Furnes B, 2007, J PHYSIOL-LONDON, V578, P25, DOI 10.1113/jphysiol.2006.119164; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Goldenring JR, 2015, CURR OPIN CELL BIOL, V35, P117, DOI 10.1016/j.ceb.2015.04.018; Greenwald SH, 2016, AM J PATHOL, V186, P1925, DOI 10.1016/j.ajpath.2016.03.013; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hawes N L, 1999, Mol Vis, V5, P22; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Higuchi R, 1989, AMPLIFICATIONS, V2, P1; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hollingsworth TJ, 2013, J BIOL CHEM, V288, P29047, DOI 10.1074/jbc.M113.495184; Hu PJ, 2014, METHODS, V68, P437, DOI 10.1016/j.ymeth.2014.05.008; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Janz JM, 2003, VISION RES, V43, P2991, DOI 10.1016/j.visres.2003.08.010; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kolandaivelu S, 2014, HUM MOL GENET, V23, P1002, DOI 10.1093/hmg/ddt496; Krag TO, 2015, J NEUROPATH EXP NEUR, V74, P1137, DOI [10.1093/jnen/74.12.1137, 10.1097/NEN.0000000000000260]; Krebs MP, 2016, METHODS MOL BIOL, V1438, P395, DOI 10.1007/978-1-4939-3661-8_20; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Krebs MP, 2009, INVEST OPHTH VIS SCI, V50, P2956, DOI 10.1167/iovs.08-3116; Kutscher Lena M, 2014, WormBook, P1, DOI 10.1895/wormbook.1.167.1; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Li SH, 2014, J BIOL CHEM, V289, P18943, DOI 10.1074/jbc.M114.552117; Li T, 2015, COLD SPRING HARB PER, V5; Liu HQ, 2010, INVEST OPHTH VIS SCI, V51, P1059, DOI 10.1167/iovs.09-3585; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Low BE, 2014, INVEST OPHTH VIS SCI, V55, P387, DOI 10.1167/iovs.13-13278; Lu XR, 2005, INVEST OPHTH VIS SCI, V46, P1882, DOI 10.1167/iovs.04-1286; Luhmann UFO, 2015, HUM MOL GENET, V24, P128, DOI 10.1093/hmg/ddu424; Luhmann UFO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035551; Maguire S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091807; Majumder A, 2013, J BIOL CHEM, V288, P21320, DOI 10.1074/jbc.M113.476242; Malanson KM, 2009, PROG MOL BIOL TRANSL, V88, P1, DOI 10.1016/S1877-1173(09)88001-0; Marshall JD, 2011, CURR GENOMICS, V12, P225, DOI 10.2174/138920211795677912; Marsili S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115723; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McAlear SD, 2010, ADV EXP MED BIOL, V664, P263, DOI 10.1007/978-1-4419-1399-9_30; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; MONTANARO F, 1995, J NEUROSCI RES, V42, P528, DOI 10.1002/jnr.490420411; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nighot PK, 2012, AM J PHYSIOL-CELL PH, V302, pC178, DOI 10.1152/ajpcell.00072.2011; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Omori Y, 2012, J NEUROSCI, V32, P6126, DOI 10.1523/JNEUROSCI.0322-12.2012; Opefi CA, 2013, J BIOL CHEM, V288, P33912, DOI 10.1074/jbc.M113.483032; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park Paul Shin-Hyun, 2014, Adv Pharmacol, V70, P1, DOI 10.1016/B978-0-12-417197-8.00001-8; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; Peachey NS, 2003, DOC OPHTHALMOL, V107, P13, DOI 10.1023/A:1024448314608; Percec I, 2003, GENETICS, V164, P1481; Pinto LH, 2005, VISUAL NEUROSCI, V22, P619, DOI 10.1017/S0952523805225117; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Ramon E, 2014, J BIOL CHEM, V289, P35918, DOI 10.1074/jbc.M114.609958; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Rossmiller B, 2012, MOL VIS, V18, P2479; Rutschmann S, 2008, IMMUNOLOGY, V123, P459, DOI 10.1111/j.1365-2567.2007.02786.x; Sabrautzki S, 2012, MAMM GENOME, V23, P416, DOI 10.1007/s00335-012-9397-z; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Sancho-Pelluz J, 2012, MOL MED, V18, P549, DOI 10.2119/molmed.2011.00475; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sparks S. E., 1993, GENEREVIEWS R; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Stottmann RW, 2011, GENETICS, V188, P615, DOI 10.1534/genetics.111.126862; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; Toki H, 2013, CANCER SCI, V104, P937, DOI 10.1111/cas.12161; Torelli S, 2005, NEUROMUSCULAR DISORD, V15, P836, DOI 10.1016/j.nmd.2005.09.004; Townsend D, 2014, ANAT REC, V297, P1694, DOI 10.1002/ar.22974; van der Knaap MS, 1993, GENEREVIEWS R; van Reeuwijk J, 2010, CLIN GENET, V78, P275, DOI 10.1111/j.1399-0004.2010.01384.x; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; Wansleeben C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019357; Weleber RG., 1993, GENEREVIEWS R; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Won J, 2012, ADV EXP MED BIOL, V723, P391, DOI 10.1007/978-1-4614-0631-0_50; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Won JY, 2009, HUM MOL GENET, V18, P4329, DOI 10.1093/hmg/ddp385; Yagi H, 2016, MOL CELL PROTEOMICS, V15, P3424, DOI 10.1074/mcp.M116.062729; Yang GX, 2014, MOL VIS, V20, P1132; Yu MZ, 2012, EXP EYE RES, V96, P124, DOI 10.1016/j.exer.2011.12.011; Zhang N, 2013, J CLIN INVEST, V123, P121, DOI 10.1172/JCI66176; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	142	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183837	10.1371/journal.pone.0183837	http://dx.doi.org/10.1371/journal.pone.0183837			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859131	Green Published, gold			2022-12-26	WOS:000408740500039
J	Laube, T; Brockmann, C; Lehmann, N; Bornfeld, N				Laube, Thomas; Brockmann, Claudia; Lehmann, Nils; Bornfeld, Norbert			Pseudophakic retinal detachment in youngaged patients	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; CATARACT-SURGERY-OUTCOMES; RISK-FACTORS; SUTURELESS VITRECTOMY; HIGH MYOPIA; LONG-TERM; PHACOEMULSIFICATION; EXTRACTION; POPULATION; EPIDEMIOLOGY	Objective To investigate the incidence and risk factors for retinal detachment (RD) after cataract surgery or refractive lens exchange (RLE) in patients aged below 61 years. Methods Retrospective medical chart review of 7,886 patients (13,925 eyes) who underwent cataract surgery or RLE. Patients aged below 61 years were selected. Age, gender, axial length, follow-up times, and the occurrence of RD were recorded. Additional characteristics documented for RD cases were: history of RD, preexisting retinal findings, laser capsulotomy, status of macula at RD, date and details of RD. Results From a total of 421 patients (677 eyes) aged below 61 years 24 cases of RD were identified, resulting in an overall cumulative incidence per eyes of 3.55%. The mean follow-up time was 45 +/- 32.8 months. Ninety-two % of all RDs occurred within 3.6 years from surgery. Axial length had a significant effect on the risk of RD after cataract/RLE surgery (HR = 1.42, P = 0.0001, 95% CI 1.19-1.69). The highest incidence of RD occurred in the subgroup of 25 to 28.9 mm axial length (10.2%). With an increase in age of ten years, the hazard of postoperative RD was not significantly increased by a factor of 1.50 (P = 0.286, 95% CI 0.71-3.15). The highest incidence of RD occurred in patients aged 50-54 years (5.39%). Compared to females, males had an almost twofold not significant risk of postoperative RD (HR = 1.96, P = 0.123, 95% CI 0.83-4.63). None of the RD cases had a history of RD. Conclusions Axial length is a significant risk factor for pseudophakic RD. The need for cataract surgery or RLE should be carefully considered in patients with axial lengths between 25 and 29 mm, aged 50-54 years, in males, and in case of preexisting retinal findings.	[Laube, Thomas; Brockmann, Claudia] Ctr Ophthalmol Dusseldorf, Dusseldorf, Germany; [Lehmann, Nils] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Bornfeld, Norbert] Univ Duisburg Essen, Dept Ophthalmol, Univ Hosp, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Laube, T (corresponding author), Ctr Ophthalmol Dusseldorf, Dusseldorf, Germany.	thomas.laube@zentrum-augenheilkunde.de						Algvere PV, 1999, GRAEF ARCH CLIN EXP, V237, P137, DOI 10.1007/s004170050208; Alldredge CD, 1998, J CATARACT REFR SURG, V24, P777, DOI 10.1016/S0886-3350(98)80130-2; Bhagwandien ACE, 2006, OPHTHALMOLOGY, V113, P643, DOI 10.1016/j.ophtha.2005.10.056; Bjerrum SS, 2013, OPHTHALMOLOGY, V120, P2573, DOI 10.1016/j.ophtha.2013.07.045; Boberg-Ans G, 2006, ACTA OPHTHALMOL SCAN, V84, P613, DOI 10.1111/j.1600-0420.2006.00719.x; Chambless W S, 1985, J Am Intraocul Implant Soc, V11, P146; Chen SN, 2016, BRIT J OPHTHALMOL, V100, P1216, DOI 10.1136/bjophthalmol-2015-307481; Clark A, 2012, ARCH OPHTHALMOL-CHIC, V130, P882, DOI 10.1001/archophthalmol.2012.164; Clark A, 2011, OPHTHALMOLOGY, V118, P1055, DOI 10.1016/j.ophtha.2010.11.001; Colyer MH, 2010, RETINA-J RET VIT DIS, V30, P1678, DOI 10.1097/IAE.0b013e3181dd6da1; Coppe AM, 2008, CURR OPIN OPHTHALMOL, V19, P239, DOI 10.1097/ICU.0b013e3282fc9c4a; Daien V, 2015, OPHTHALMOLOGY, V122, P2179, DOI 10.1016/j.ophtha.2015.07.014; Day AC, 2016, OPHTHALMOLOGY, V123, P1711, DOI 10.1016/j.ophtha.2016.04.002; EMERY JM, 1978, OPHTHALMOLOGY, V85, P141; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; Go SL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1237, DOI 10.1001/archopht.123.9.1237; Haigis W., 1995, P 9 C GERM INTR LENS, p17 ; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; Haug SJ, 2012, CURR OPIN OPHTHALMOL, V23, P7, DOI 10.1097/ICU.0b013e32834cd653; Hayreh SS, 2004, OPHTHALMOLOGICA, V218, P333, DOI 10.1159/000079476; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Herrmann W, 2011, KLIN MONATSBL AUGENH, V228, P195, DOI 10.1055/s-0029-1246116; HURITE FG, 1979, OPHTHALMOLOGY, V86, P2004; Jakobsson G, 2009, J CATARACT REFR SURG, V35, P1699, DOI 10.1016/j.jcrs.2009.05.028; JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487, DOI 10.1016/s0161-6420(92)31775-0; Kapran Z, 2009, EUR J OPHTHALMOL, V19, P853, DOI 10.1177/112067210901900527; LAATIKAINEN L, 1985, ACTA OPHTHALMOL, V63, P59; Lois N, 2003, SURV OPHTHALMOL, V48, P467, DOI 10.1016/S0039-6257(03)00083-3; Lyle WA, 1996, J CATARACT REFR SURG, V22, P238, DOI 10.1016/S0886-3350(96)80225-2; Neal RE, 2005, EXP EYE RES, V80, P337, DOI 10.1016/j.exer.2004.09.015; Neuhann IM, 2008, J CATARACT REFR SURG, V34, P1644, DOI 10.1016/j.jcrs.2008.06.022; Norregaard JC, 1996, BRIT J OPHTHALMOL, V80, P689, DOI 10.1136/bjo.80.8.689; Olsen G, 2000, J CATARACT REFR SURG, V26, P1017, DOI 10.1016/S0886-3350(00)00304-7; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P361, DOI 10.1111/j.1600-0420.2006.00847.x; Olsen T, 2012, OPEN OPHTHALMOL J, V6, P79, DOI 10.2174/1874364101206010079; Ramos Meisy, 2002, Semin Ophthalmol, V17, P206, DOI 10.1076/soph.17.3.206.14738; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; Russell M, 2006, J CATARACT REFR SURG, V32, P442, DOI 10.1016/j.jcrs.2005.12.095; Sheu SJ, 2007, OPHTHALMOLOGY, V114, P1898, DOI 10.1016/j.ophtha.2007.02.030; Sheu SJ, 2006, RETINA-J RET VIT DIS, V26, P322, DOI 10.1097/00006982-200603000-00011; Sheu SJ, 2010, AM J OPHTHALMOL, V149, P113, DOI 10.1016/j.ajo.2009.08.006; Tuft SJ, 2006, OPHTHALMOLOGY, V113, P650, DOI 10.1016/j.ophtha.2006.01.001; Walter P, 2016, BR J OPHTHALMOL; WILKINSON CP, 1978, OPHTHALMOLOGY, V85, P151	44	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184187	10.1371/journal.pone.0184187	http://dx.doi.org/10.1371/journal.pone.0184187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859157	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500073
J	Wang, YJ; Liu, YS; Fan, ZP; Liu, DY; Wang, F; Zhou, YS				Wang, Yuejun; Liu, Yunsong; Fan, Zhipeng; Liu, Dayong; Wang, Fu; Zhou, Yongsheng			IGFBP2 enhances adipogenic differentiation potentials of mesenchymal stem cells from Wharton's jelly of the umbilical cord via JNK and Akt signaling pathways	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; GROWTH-FACTOR-I; N-TERMINAL KINASE; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; PERIODONTAL-LIGAMENT; GENE-EXPRESSION; MAP KINASE; INSULIN	Mesenchymal stem cell (MSC)-mediated tissue engineering represents a promising strategy to address adipose tissue defects. MSCs derived from Wharton's jelly of the umbilical cord (WJCMSCs) may serve as an ideal source for adipose tissue engineering due to their abundance, safety profile, and accessibility. How to activate the directed differentiation potentials of WJCMSCs is the core point for their clinical applications. A thorough investigation of mechanisms involved in WJCMSC adipogenic differentiation is necessary to support their application in adipose tissue engineering and address shortcomings. Previous study showed, compared with periodontal ligament stem cells (PDLSCs), WJCMSCs had a weakened adipogenic differentiation potentials and lower expression of insulin-like growth factor binding protein 2 (IGFBP2). IGFBP2 may be involved in the adipogenesis of MSCs. Generally, IGFBP2 is involved in regulating biological activity of insulin-like growth factors, however, its functions in human MSCs are unclear. Here, we found IGFBP2 expression was upregulated upon adipogenic induction, and that IGFBP2 enhanced adipogenic differentiation of WJCMSCs and BMSCs. Moreover, IGFBP2 increased phosphorylation of c-Jun N-terminal kinase (p-JNK) and p-Akt, and activated JNK or Akt signaling significantly promoted adipogenic differentiation of MSCs. Furthermore, inhibitor-mediated blockage of either JNK or Akt signaling dramatically reduced IGFBP2-mediated adipogenic differentiation. And the JNK inhibitor, SP600125 markedly blocked IGFBP2-mediated Akt activation. Moreover, IGFBP2 was negatively regulated by BCOR, which inhibited adipogenic differentiation of WJCMSCs. Overall, our results reveal a new function of IGFBP2, providing a novel insight into the mechanism of adipogenic differentiation and identifying a potential target mediator for improving adipose tissue engineering based on WJCMSCs.	[Wang, Yuejun; Liu, Yunsong; Zhou, Yongsheng] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing, Peoples R China; [Fan, Zhipeng; Liu, Dayong] Capital Med Univ, Lab Mol Signaling & Stem Cells Therapy, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Sch Stomatol, Beijing, Peoples R China; [Wang, Fu] Dalian Med Univ, Dept Oral Basic Sci, Sch Stomatol, Dalian, Liaoning, Peoples R China; [Zhou, Yongsheng] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China	Peking University; Capital Medical University; Dalian Medical University	Zhou, YS (corresponding author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing, Peoples R China.; Wang, F (corresponding author), Dalian Med Univ, Dept Oral Basic Sci, Sch Stomatol, Dalian, Liaoning, Peoples R China.; Zhou, YS (corresponding author), Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.	dywangfu@gmail.com; kqzhouysh@hsc.pku.edu.cn	Liu, Dayong/AAT-9061-2021; Liu, Dayong/E-3440-2018; Wang, Fu/P-9950-2019; Liu, Dayong/AAG-4081-2020	Liu, Dayong/0000-0001-8511-2658; Wang, Fu/0000-0001-9615-1038; Liu, Dayong/0000-0001-8511-2658; Zhou, Yongsheng/0000-0002-4332-0878	National Natural Science Foundation of China [81170937]; Culturing Leading Talents in Scientific and Technological Innovation of Beijing [Z171100001117169]; Liaoning Natural Science Foundation [2013023014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Culturing Leading Talents in Scientific and Technological Innovation of Beijing; Liaoning Natural Science Foundation(Natural Science Foundation of Liaoning Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 81170937), the Project for Culturing Leading Talents in Scientific and Technological Innovation of Beijing (Z171100001117169), and the Liaoning Natural Science Foundation (2013023014 to FW).	Aubert J, 1999, J BIOL CHEM, V274, P24965, DOI 10.1074/jbc.274.35.24965; Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BONEY CM, 1994, ENDOCRINOLOGY, V135, P1863, DOI 10.1210/en.135.5.1863; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; BROWN AL, 1990, MOL ENDOCRINOL, V4, P2039, DOI 10.1210/mend-4-12-2039; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Cervelli V, 2012, STEM CELL TRANSL MED, V1, P206, DOI 10.5966/sctm.2011-0052; Chakrabarty S, 2006, CANCER BIOL THER, V5, P189, DOI 10.4161/cbt.5.2.2333; Chen QP, 2016, AM J TRANSL RES, V8, P2534; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Dong R, 2013, EXP CELL RES, V319, P2874, DOI 10.1016/j.yexcr.2013.07.008; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Fu LJ, 2008, BONE, V43, P40, DOI 10.1016/j.bone.2008.03.008; GREEN BN, 1994, ENDOCRINOLOGY, V134, P954, DOI 10.1210/en.134.2.954; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gu HJ, 2015, EXP CELL RES, V339, P112, DOI 10.1016/j.yexcr.2015.08.005; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huynh KD, 2000, GENE DEV, V14, P1810; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lee J, 2010, CELL MOL LIFE SCI, V67, P467, DOI 10.1007/s00018-009-0196-y; Leng L, 2009, POULTRY SCI, V88, P938, DOI 10.3382/ps.2008-00453; Li DR, 2012, CHINESE MED J-PEKING, V125, P4504, DOI 10.3760/cma.j.issn.0366-6999.2012.24.032; Liu DY, 2015, STEM CELLS, V33, P2523, DOI 10.1002/stem.2018; Liu J, 2014, QUEST J, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0085469; Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734; Luchetti F, 2014, J PINEAL RES, V56, P382, DOI 10.1111/jpi.12133; McGuirk JP, 2015, PHARMACEUTICALS, V8, P196, DOI 10.3390/ph8020196; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Patel NG, 2003, DIABETES, V52, P43, DOI 10.2337/diabetes.52.1.43; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Shaw J, 2006, CIRC RES, V98, P7, DOI 10.1161/01.RES.0000200397.22663.b6; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wang LM, 2011, REGEN MED, V6, P95, DOI [10.2217/rme.10.98, 10.2217/RME.10.98]; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yin R, 2006, ACTA PHARMACOL SIN, V27, P1146, DOI 10.1111/j.1745-7254.2006.00359.x; Yu S, 2013, CELLS TISSUES ORGANS, V197, P209, DOI 10.1159/000343740; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018	59	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184182	10.1371/journal.pone.0184182	http://dx.doi.org/10.1371/journal.pone.0184182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859160	Green Submitted, gold, Green Published			2022-12-26	WOS:000408740500071
J	McMahon, DB; Workman, AD; Kohanski, MA; Carey, RM; Freund, JR; Hariri, BM; Chen, B; Doghramji, LJ; Adappa, ND; Palmer, JN; Kennedy, DW; Lee, RJ				McMahon, Derek B.; Workman, Alan D.; Kohanski, Michael A.; Carey, Ryan M.; Freund, Jenna R.; Hariri, Benjamin M.; Chen, Bei; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.			Protease-activated receptor 2 activates airway apical membrane chloride permeability and increases ciliary beating	FASEB JOURNAL			English	Article						trypsin; GPCR; calcium signaling; respiratory epithelial physiology	SEROUS ACINAR-CELLS; DUST MITE EXTRACT; EPITHELIAL-CELLS; FLUID SECRETION; LUNG INFLAMMATION; INNATE IMMUNITY; ION-TRANSPORT; NITRIC-OXIDE; TRYPSIN; RELEASE	Mucociliary clearance, driven by the engine of ciliary beating, is the primary physical airway defense against inhaled pathogens and irritants. Abetter understanding of the regulation of ciliary beating and mucociliary transport is necessary for identifying new receptor targets to stimulate improved clearance in airway diseases, such as cystic fibrosis and chronic rhinosinusitis. In this study, we examined the protease-activated receptor (PAR)-2, a GPCR previously shown to regulate airway cell cytokine and mucus secretion, and transepithelial Cl- current. PAR-2 is activated by proteases secreted by airway neutrophils and pathogens. We cultured various airway cell lines, primary human and mouse sinonasal cells, and human bronchial cells at air-liquid interface and examined them using molecular biology, biochemistry, and live-cell imaging. We found that PAR-2 is expressed basolaterally, where it stimulates both intracellular Ca2+ release and Ca2+ influx, which activates low-levelnitric oxide production, increases apical membrane Cl- permeability similar to 3-5-fold, and increases ciliary beating similar to 20-50%. No molecular or functional evidence of PAR-4 was observed. These data suggest a novel and previously overlooked role of PAR-2 in airway physiology, adding to our understanding of the role of this receptor in airway Ca2+ signaling and innate immunity.	[McMahon, Derek B.; Workman, Alan D.; Kohanski, Michael A.; Carey, Ryan M.; Freund, Jenna R.; Hariri, Benjamin M.; Chen, Bei; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Ravdin Bldg,5th Floor,Suite A,3400 Spruce St, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, RJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Ravdin Bldg,5th Floor,Suite A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@mail.med.upenn.edu	Lee, Robert J./L-4397-2017; Carey, Ryan/AAA-8471-2019	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R03DC01386]; Cystic Fibrosis Foundation [LEER16G0]; Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013862] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank M. Victoria (Perelman School of Medicine) for excellent technical assistance with PCR experiments. This study was supported by grants from U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders (Grant R03DC01386), the Cystic Fibrosis Foundation (Grant LEER16G0), and funding from the Department of Otorhinolaryngology at the University of Pennsylvania (to R.J.L). The authors declare no conflicts of interest.	Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Cho HJ, 2012, J ALLERGY CLIN IMMUN, V129, P529, DOI 10.1016/j.jaci.2011.11.024; Cho HJ, 2010, J CELL BIOCHEM, V109, P1254, DOI 10.1002/jcb.22511; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Chow JM, 2000, BRIT J PHARMACOL, V131, P1584, DOI 10.1038/sj.bjp.0703738; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; Compton SJ, 2000, J BIOL CHEM, V275, P39207, DOI 10.1074/jbc.M007215200; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; de Boer JD, 2014, INNATE IMMUN-LONDON, V20, P618, DOI 10.1177/1753425913503387; DONG YJ, 1995, EMBO J, V14, P2700, DOI 10.1002/j.1460-2075.1995.tb07270.x; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ebert CS, 2014, INT FORUM ALLERGY RH, V4, P266, DOI 10.1002/alr.21295; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Homma T, 2016, AM J RESP CELL MOL, V54, P60, DOI 10.1165/rcmb.2015-0062OC; Jairaman A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32311; Jairaman A, 2015, J IMMUNOL, V195, P2122, DOI 10.4049/jimmunol.1500396; Jung SR, 2016, J GEN PHYSIOL, V147, P255, DOI 10.1085/jgp.201511477; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lan RS, 2002, PHARMACOL THERAPEUT, V95, P239, DOI 10.1016/S0163-7258(02)00237-1; Lee HM, 2007, ANN OTO RHINOL LARYN, V116, P554, DOI 10.1177/000348940711600712; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043188; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Lidington EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1437, DOI 10.1152/ajpcell.00502.2004; Liu CY, 2013, ARCH BIOCHEM BIOPHYS, V535, P234, DOI 10.1016/j.abb.2013.02.013; Matsuwaki Y, 2012, INT ARCH ALLERGY IMM, V158, P19, DOI 10.1159/000337756; O'Grady SM, 2013, J PHYSIOL-LONDON, V591, P4595, DOI 10.1113/jphysiol.2013.254649; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pablo JL, 2017, J GEN PHYSIOL, V149, P37, DOI 10.1085/jgp.201611696; Palmer ML, 2006, AM J PHYSIOL-CELL PH, V290, pC1189, DOI 10.1152/ajpcell.00464.2005; Park MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092726; Peters T, 2009, BRIT J PHARMACOL, V158, P1017, DOI 10.1111/j.1476-5381.2009.00449.x; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sato S, 2005, BRIT J PHARMACOL, V146, P397, DOI 10.1038/sj.bjp.0706330; Sherwood CL, 2014, AM J PHYSIOL-CELL PH, V307, pC718, DOI 10.1152/ajpcell.00257.2014; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Smith Claire M, 2012, Cilia, V1, P14, DOI 10.1186/2046-2530-1-14; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	57	16	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					155	+		10.1096/fj.201700114RRR	http://dx.doi.org/10.1096/fj.201700114RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28874459	Green Published			2022-12-26	WOS:000419172700016
J	Cooney, KA; Molden, BM; Kowalczyk, NS; Russell, S; Baldini, G				Cooney, Kimberly A.; Molden, Brent M.; Kowalczyk, Nicholas S.; Russell, Susan; Baldini, Giulia			Lipid stress inhibits endocytosis of melanocortin-4 receptor from modified clathrin-enriched sites and impairs receptor desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; MODERATE-FAT DIET; HYPOTHALAMIC NEURONS; INSULIN-RESISTANCE; LEPTIN RESISTANCE; LATE ENDOSOMES; CELLS; MC4R; AGONIST; DYNAMIN	Melanocortin-4 receptor (MC4R) is a G-protein-coupled receptor expressed in the brain's hypothalamus where it regulates energy homeostasis. MC4R agonists function to lower food intake and weight. In this respect, although obesity promotes hyperlipidemia and hypothalamic injury, MC4R agonists are nevertheless more effective to reduce food intake within hours of administration in overweight, rather than lean, mice. MC4R undergoes constitutive internalization and recycling to the plasma membrane with agonist binding inducing receptor retention along the intracellular route and, under prolonged exposure, desensitization. Here, we found that, in neuronal cells, lipid stress by exposure to elevated palmitate leaves unchanged the rate by which MC4R and transferrin receptor are constitutively excluded from the cell surface. However, lipid stress disrupted later steps of MC4R and transferrin receptor internalization to endosomes as well as traffic of agonist-occupied MC4R to lysosomes and MC4R desensitization. In the lipid-stressed cells, MC4R and clathrin were redistributed to the plasma membrane where they colocalized to sites that appeared by super-resolution microscopy to be modified and to have higher clathrin content than those of cells not exposed to elevated palmitate. The data suggest that lipid stress disrupts steps of endocytosis following MC4R localization to clathrin-coated sites and exclusion of the receptor from the extracellular medium. We conclude that increased effectiveness of MC4R agonists in obesity may be an unexpected outcome of neuronal injury with disrupted clathrin-dependent endocytosis and impaired receptor desensitization.	[Cooney, Kimberly A.; Molden, Brent M.; Kowalczyk, Nicholas S.; Russell, Susan; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	gbaldini@uams.edu			National Institutes of Health [R01-DK102206, F30 DK095569, UL1TR000039]; University of Arkansas for Medical Sciences College of Medicine Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095569, R01DK102206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083247] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences College of Medicine Research Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01-DK102206 (to G. B.), F30 DK095569 (to B. M. M.), and UL1TR000039 and by intramural funding support from the University of Arkansas for Medical Sciences College of Medicine Research Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah N, 2016, CELL REP, V17, P2966, DOI 10.1016/j.celrep.2016.11.050; ALVAREZ E, 1989, EMBO J, V8, P2231, DOI 10.1002/j.1460-2075.1989.tb08347.x; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bluher S, 2004, DIABETES, V53, P82, DOI 10.2337/diabetes.53.1.82; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Cao H, 2000, J CELL SCI, V113, P1993; Chazotte B., 2011, COLD SPRING HARB PRO; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Clegg DJ, 2005, AM J PHYSIOL-REG I, V288, pR981, DOI 10.1152/ajpregu.00675.2004; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cragle FK, 2014, MOL ENDOCRINOL, V28, P357, DOI 10.1210/me.2013-1357; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Granell S, 2013, P NATL ACAD SCI USA, V110, pE4733, DOI 10.1073/pnas.1219808110; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Irani BG, 2007, ENDOCRINOLOGY, V148, P310, DOI 10.1210/en.2006-1126; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kim GL, 2010, ENDOCRINOLOGY, V151, P5038, DOI 10.1210/en.2010-0521; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McDaniel FK, 2012, J BIOL CHEM, V287, P21873, DOI 10.1074/jbc.M112.346890; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Molden BM, 2015, MOL ENDOCRINOL, V29, P1619, DOI 10.1210/me.2015-1071; MULLER WA, 1983, J CELL BIOL, V96, P29, DOI 10.1083/jcb.96.1.29; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Zhang JH, 2010, CELL RES, V20, P492, DOI 10.1038/cr.2010.33	44	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17731	17745		10.1074/jbc.M117.785758	http://dx.doi.org/10.1074/jbc.M117.785758			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28878020	Green Published, hybrid			2022-12-26	WOS:000414013000013
J	Canesin, G; Evans-Axelsson, S; Hellsten, R; Krzyzanowska, A; Prasad, CP; Bjartell, A; Andersson, T				Canesin, Giacomo; Evans-Axelsson, Susan; Hellsten, Rebecka; Krzyzanowska, Agnieszka; Prasad, Chandra P.; Bjartell, Anders; Andersson, Tommy			Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model	PLOS ONE			English	Article							PROTEIN EXPRESSION; WNT-5A PROTEIN; MIGRATION; INVASION; PROLIFERATION; PROGRESSION; AGGRESSIVENESS; ACTIVATION; MECHANISMS; RESISTANCE	Prostate cancer patients with high WNT5A expression in their tumors have been shown to have more favorable prognosis than those with low WNT5A expression. This suggests that reconstitution of Wnt5a in low WNT5A-expressing tumors might be an attractive therapeutic approach. To explore this idea, we have in the present study used Foxy-5, a WNT5A mimicking peptide, to investigate its impact on primary tumor and metastasis in vivo and on prostate cancer cell viability, apoptosis and invasion in vitro. We used an in vivo orthotopic xenograft mouse model with metastatic luciferase-labeled WNT5A-low DU145 cells and metastatic luciferase-labeled WNT5A-high PC3prostate cancer cells. We provide here the first evidence that Foxy-5 significantly inhibits the initial metastatic dissemination of tumor cells to regional and distal lymph nodes by 90% and 75%, respectively. Importantly, this effect was seen only with the WNT5A-low DU145 cells and not with the WNT5A-high PC3 cells. The inhibiting effect in the DU145-based model occurred despite the fact that no effects were observed on primary tumor growth, apoptosis or proliferation. These findings are consistent with and supported by the in vitro data, where Foxy-5 specifically targets invasion without affecting apoptosis or viability of WNT5A-low prostate cancer cells. To conclude, our data indicate that the WNT5A-mimicking peptide Foxy-5, which has been recently used in a phase 1 clinical trial, is an attractive candidate for complimentary anti-metastatic treatment of prostate cancer patients with tumors exhibiting absent or low WNT5A expression.	[Canesin, Giacomo; Prasad, Chandra P.; Andersson, Tommy] Lund Univ, Skane Univ Hosp Malmo, Clin Res Ctr, Dept Translat Med,Div Cell & Expt Pathol, Malmo, Sweden; [Canesin, Giacomo; Evans-Axelsson, Susan; Hellsten, Rebecka; Krzyzanowska, Agnieszka; Bjartell, Anders] Lund Univ, Skane Univ Hosp Malmo, Dept Translat Med, Div Urol Canc, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Andersson, T (corresponding author), Lund Univ, Skane Univ Hosp Malmo, Clin Res Ctr, Dept Translat Med,Div Cell & Expt Pathol, Malmo, Sweden.	tommy.andersson@med.lu.se	Canesin, Giacomo/H-4541-2019; Prasad, Chandra Prakash/B-6404-2015	Canesin, Giacomo/0000-0002-3318-4550; Evans Axelsson, Susan/0000-0002-4240-0550; Andersson, Tommy/0000-0003-4032-5769; Prasad, Chandra Prakash/0000-0002-4911-7483	Swedish Cancer Foundation [140643, 140274]; Swedish Research Council [B0434701, D0484201]; BioCare program at Lund University; Skane University Hospital Research Foundation; Gunnar Nilsson's Cancer Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF); Royal Physiographic Society	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); BioCare program at Lund University; Skane University Hospital Research Foundation; Gunnar Nilsson's Cancer Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF); Royal Physiographic Society	This work was supported by the Swedish Cancer Foundation (https://www.cancerfonden.se/) to TA (140643) and to AB (140274), the Swedish Research Council (http://www.vr.se/) to TA (B0434701) and to AB (D0484201), the BioCare program at Lund University (https//www.biocare.nu/) to TA, the Skane University Hospital Research Foundation, the Gunnar Nilsson's Cancer Foundation (http://www.cancerstiftelsen.com/) and Governmental Funding of Clinical Research within the National Health Services (ALF) all to TA and AB, and the Royal Physiographic Society (http://www.fysiografen.se/sv/) to GC. The funding sources had no role in the study design, data collection and analysis, the decision to publish, or in the preparation of the manuscript.	Asem MS, 2016, CANCERS, V8, DOI 10.3390/cancers8090079; Bennett LL, 2014, ANN PHARMACOTHER, V48, P530, DOI 10.1177/1060028013518899; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Canesin G., 2014, ONCOGENE; Canesin G, 2015, EUR UROL; Chen C, 2015, PROSTATE, V75, P883, DOI 10.1002/pros.22971; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Doctor SM, 2014, CANCER-AM CANCER SOC, V120, P833, DOI 10.1002/cncr.28494; Endo M, 2015, INT REV CEL MOL BIO, V314, P117, DOI 10.1016/bs.ircmb.2014.10.003; Ganguly SS, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00364; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hellsten R, 2008, PROSTATE, V68, P269, DOI 10.1002/pros.20699; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Jansson M, 2001, J CELL SCI, V114, P2043; Jantscheff P, 2009, PROSTATE, V69, P1151, DOI 10.1002/pros.20964; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Jonsson M, 2002, CANCER RES, V62, P409; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Khaja ASS, 2012, CANCER MED-US, V1, P96, DOI 10.1002/cam4.5; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Linnskog R, 2014, MOL ONCOL, V8, P1365, DOI 10.1016/j.molonc.2014.05.008; Liss Michael A., 2010, Cancer Genomics & Proteomics, V7, P245; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Martin SK, 2014, AM J CLIN EXP UROL, V2, P15; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Mouraviev Vladimir, 2014, Rev Urol, V16, P122; Nandana S, 2014, AM J CLIN EXP UROL, V2, P92; Nouri M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00370; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Peng XH, 2015, ONCOL REP, V34, P1565, DOI 10.3892/or.2015.4098; Prasad CP, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0421-0; Prasad CP, 2013, MOL ONCOL, V7, P870, DOI 10.1016/j.molonc.2013.04.005; Quintela ML, 2015, CANC TREAT REV; Reel B, 2015, J CANCER, V6, P1020, DOI 10.7150/jca.12733; Ren W, 2016, BIOCHEM BIOPH RES CO, V469, P633, DOI 10.1016/j.bbrc.2015.12.054; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Sandsmark E, 2016, ONCOTARGET; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sepulveda L, 2015, CASE REP UROL, V2015; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sridhar SS, 2014, EUR UROL, V65, P289, DOI 10.1016/j.eururo.2013.08.008; Syed Khaja Azharuddin Sajid, 2011, PLoS One, V6, pe26539, DOI 10.1371/journal.pone.0026539; Thiele S, 2015, J BONE MINER RES, V30, P488, DOI 10.1002/jbmr.2362; Thiele S, 2011, J CELL BIOCHEM, V112, P1593, DOI 10.1002/jcb.23070; Tseng JC, 2016, ONCOTARGET, V7, P38010, DOI 10.18632/oncotarget.9380; van Dodewaard-de Jong JM, 2015, CLIN GENITOURIN CANC; Wu J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0650-6; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Zhang CY, 2016, MOL NUTR FOOD RES, V60, P1427, DOI 10.1002/mnfr.201500918; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203; Zobniw CM, 2014, RES REP UROL, V6, P97, DOI 10.2147/RRU.S29003	58	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184418	10.1371/journal.pone.0184418	http://dx.doi.org/10.1371/journal.pone.0184418			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886116	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100114
J	Casula, E; Asuni, GP; Sogos, V; Fadda, S; Delogu, F; Cincotti, A				Casula, Elisa; Asuni, Gino P.; Sogos, Valeria; Fadda, Sarah; Delogu, Francesco; Cincotti, Alberto			Osmotic behaviour of human mesenchymal stem cells: Implications for cryopreservation	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW; MEMBRANE-PERMEABILITY; STEM/PROGENITOR CELLS; DIMETHYL-SULFOXIDE; VOLUME REGULATION; INACTIVE VOLUME; ADIPOSE-TISSUE; PARAMETERS; GLYCEROL	Aimed at providing a contribution to the optimization of cryopreservation processes, the present work focuses on the osmotic behavior of human mesenchymal stem cells (hMSCs). Once isolated from the umbilical cord blood (UCB) of three different donors, hMSCs were characterized in terms of size distribution and their osmotic properties suitably evaluated through the exposure to hypertonic and isotonic aqueous solutions at three different temperatures. More specifically, inactive cell volume and cell permeability to water and di-methyl sulfoxide (DMSO) were measured, being cell size determined using impedance measurements under both equilibrium and dynamic conditions. Experimental findings indicate that positive cell volume excursions are limited by the apparent increase of inactive volume, which occurs during both the shrink-swell process following DMSO addition and the subsequent restoration of isotonic conditions in the presence of hypertonic solutions of impermeant or permeant solutes. Based on this evidence, hMSCs must be regarded as imperfect osmometers, and their osmotic behavior described within a scenario no longer compatible with the simple two-parameter model usually utilized in the literature. In this respect, the activation of mechano-sensitive ion-channels seemingly represents a reasonable hypothesis for rationalizing the observed osmotic behavior of hMSCs from UCB.	[Casula, Elisa; Delogu, Francesco; Cincotti, Alberto] Univ Cagliari, Dipartimento Ingn Meccan Chim & Mat, Cagliari, Italy; [Asuni, Gino P.; Cincotti, Alberto] Univ Cagliari, Ctr Interdipartimentale Ingn & Sci Ambiental, Cagliari, Italy; [Sogos, Valeria] Cittadella Univ, Univ Cagliari, Dipartimento Sci Biomed, Monserrato, Italy; [Fadda, Sarah] Imperial Coll London, Dept Chem Engn, Ctr Proc Syst Engn, London, England	University of Cagliari; University of Cagliari; University of Cagliari; Imperial College London	Cincotti, A (corresponding author), Univ Cagliari, Dipartimento Ingn Meccan Chim & Mat, Cagliari, Italy.; Cincotti, A (corresponding author), Univ Cagliari, Ctr Interdipartimentale Ingn & Sci Ambiental, Cagliari, Italy.	alberto.cincotti@dimcm.unica.it	Sogos, Valeria/B-5471-2012	Sogos, Valeria/0000-0002-4021-1043; Delogu, Francesco/0000-0003-2520-9057; Casula, Elisa/0000-0002-2813-329X; Fadda, Sarah/0000-0002-5919-1409; CINCOTTI, ALBERTO/0000-0001-8121-9415	Regione Autonoma della Sardegna (RAS) [L.7/2007 RAS, CUP F71J12000900002]; Alberto Cincotti	Regione Autonoma della Sardegna (RAS)(Russian Academy of SciencesRegione Sardegna); Alberto Cincotti	The Regione Autonoma della Sardegna (RAS) is gratefully acknowledged for funding this research (Progetto L.7/2007 RAS, Bando 2012, CUP F71J12000900002), Alberto Cincotti, https://www.regione.sardegna.it. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 1999, CRYO-LETT, V20, P315; Barnard JG, 2012, J PHARM SCI-US, V101, P140, DOI 10.1002/jps.22732; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bryan AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029866; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carvalho KAT, 2008, TRANSPL P, V40, P839, DOI 10.1016/j.transproceed.2008.03.004; Casula E, 2015, CHEM ENGINEER TRANS, V43, P265, DOI 10.3303/CET1543045; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fadda S, 2011, CRYOBIOLOGY, V62, P218, DOI 10.1016/j.cryobiol.2011.03.006; Fadda S, 2011, AICHE J, V57, P1075, DOI 10.1002/aic.12320; Fadda S, 2010, AICHE J, V56, P2173, DOI 10.1002/aic.12137; Fernandez JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057268; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; GROVES MR, 1980, IEEE T BIO-MED ENG, V27, P364, DOI 10.1109/TBME.1980.326649; HEMPLING HG, 1984, CRYOBIOLOGY, V21, P133, DOI 10.1016/0011-2240(84)90204-9; Higgins AZ, 2008, CRYOBIOLOGY, V57, P223, DOI 10.1016/j.cryobiol.2008.09.001; Higgins AZ, 2010, CRYOBIOLOGY, V60, P117, DOI 10.1016/j.cryobiol.2009.10.002; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hunt CJ, 2003, CRYOBIOLOGY, V46, P61, DOI 10.1016/S0011-2240(02)00180-3; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Karlsson J.O., 2000, PRINCIPLES TISSUE EN, P293, DOI [10.1007/11749219, DOI 10.1016/B978-012436630-5/50028-3]; Kashuba CM, 2014, CRYOBIOLOGY, V68, P166, DOI 10.1016/j.cryobiol.2013.12.007; Katkov II, 2008, CRYOBIOLOGY, V57, P142, DOI 10.1016/j.cryobiol.2008.07.009; Katkov II, 2011, CRYOBIOLOGY, V62, P232, DOI 10.1016/j.cryobiol.2011.02.006; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Kleinhans FW, 1998, CRYOBIOLOGY, V37, P271, DOI 10.1006/cryo.1998.2135; Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Mukherjee IN, 2007, CRYOBIOLOGY, V55, P10, DOI 10.1016/j.cryobiol.2007.04.002; Parekkadan B, 2007, TISSUE ENG, V13, P2465, DOI 10.1089/ten.2007.0054; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poignard C, 2011, EUR BIOPHYS J BIOPHY, V40, P235, DOI 10.1007/s00249-010-0641-8; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Tarasov AI, 2004, CRYOBIOLOGY, V48, P333, DOI 10.1016/j.cryobiol.2004.02.010; Vian AM, 2014, CRYOBIOLOGY, V68, P35, DOI 10.1016/j.cryobiol.2013.11.004; Wang HY, 2011, CRYOLETTERS, V32, P81; Wang X, 2010, CRYOBIOLOGY, V61, P58, DOI 10.1016/j.cryobiol.2010.05.001; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Xu YQ, 2014, ARCH BIOCHEM BIOPHYS, V550, P67, DOI 10.1016/j.abb.2014.04.010; Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042; Zhurova M, 2014, CRYOBIOLOGY, V68, P379, DOI 10.1016/j.cryobiol.2014.04.002; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	44	16	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184180	10.1371/journal.pone.0184180	http://dx.doi.org/10.1371/journal.pone.0184180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886069	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100077
J	Davidov, DM; Davis, SM; Zhu, MT; Afifi, TO; Kimber, M; Goldstein, AL; Pitre, N; Gurka, KK; Stocks, C				Davidov, Danielle M.; Davis, Stephen M.; Zhu, Motao; Afifi, Tracie O.; Kimber, Melissa; Goldstein, Abby L.; Pitre, Nicole; Gurka, Kelly K.; Stocks, Carol			Intimate partner violence-related hospitalizations in Appalachia and the non-Appalachian United States	PLOS ONE			English	Article							PHYSICAL HEALTH CONSEQUENCES; EMERGENCY-DEPARTMENTS; DOMESTIC VIOLENCE; SUBSTANCE-ABUSE; NATIONAL-SURVEY; RISK-FACTORS; OF-LIFE; PREVALENCE; WOMEN; CARE	The highly rural region of Appalachia faces considerable socioeconomic disadvantage and health disparities that are recognized risk factors for intimate partner violence (IPV). The objective of this study was to estimate the rate of IPV-related hospitalizations in Appalachia and the non-Appalachian United States for 2007-2011 and compare hospitalizations in each region by clinical and sociodemographic factors. Data on IPV-related hospitalizations were extracted from the State Inpatient Databases, which are part of the Healthcare Cost and Utilization Project. Hospitalization day, year, in-hospital mortality, length of stay, average and total hospital charges, sex, age, payer, urban-rural location, income, diagnoses and procedures were compared between Appalachian and non-Appalachian counties. Poisson regression models were constructed to test differences in the rate of IPV-related hospitalizations between both regions. From 2007-2011, there were 7,385 hospitalizations related to IPV, with one-third (2,645) occurring in Appalachia. After adjusting for age and rurality, Appalachian counties had a 22% higher hospitalization rate than non-Appalachian counties (ARR = 1.22, 95% CI: 1.14-1.31). Appalachian residents may be at increased risk for IPV and associated conditions. Exploring disparities in healthcare utilization and costs associated with IPV in Appalachia is critical for the development of programs to effectively target the needs of this population.	[Davidov, Danielle M.; Davis, Stephen M.] West Virginia Univ, Dept Emergency Med & Social & Behav Sci, Morgantown, WV 26506 USA; [Davidov, Danielle M.] West Virginia Univ, Dept Social & Behav Sci, Morgantown, WV 26506 USA; [Zhu, Motao; Gurka, Kelly K.] West Virginia Univ, Dept Epidemiol, Morgantown, WV USA; [Afifi, Tracie O.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Afifi, Tracie O.] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada; [Kimber, Melissa] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Goldstein, Abby L.] Univ Toronto, Dept Appl Psychol & Human Dev, OISE, Toronto, ON, Canada; [Pitre, Nicole] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Stocks, Carol] Agcy Healthcare Res & Qual, Rockville, MD USA; [Zhu, Motao] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Zhu, Motao] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Gurka, Kelly K.] Univ Florida, Dept Epidemiol, Gainesville, FL USA	West Virginia University; West Virginia University; West Virginia University; University of Manitoba; University of Manitoba; McMaster University; University of Toronto; University of Alberta; Agency for Healthcare Research & Quality; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; State University System of Florida; University of Florida	Davidov, DM (corresponding author), West Virginia Univ, Dept Emergency Med & Social & Behav Sci, Morgantown, WV 26506 USA.; Davidov, DM (corresponding author), West Virginia Univ, Dept Social & Behav Sci, Morgantown, WV 26506 USA.	ddavidov@hsc.wvu.edu; carol.stocks@ahrq.hhs.gov	Kimber, Melissa/ABH-5900-2020; Gurka, Kelly K./M-2004-2014	Kimber, Melissa/0000-0002-1255-8947; Gurka, Kelly K./0000-0003-2779-3234; afifi, tracie/0000-0002-3745-9785; zhu, motao/0000-0001-5639-4801; Davidov, Danielle/0000-0002-6754-6724	Canadian Institutes of Health Research Institute of Gender and Health; Institute of Neurosciences Mental Health and Addictions [RDG99326]; National Institute Of General Medical Sciences of the National Institutes of Health [U54GM104942]; National Institute on Minority Health and Health Disparities; Research Manitoba Establishment Award; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); Institute of Neurosciences Mental Health and Addictions; National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Research Manitoba Establishment Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Canadian Institutes of Health Research Institute of Gender and Health and Institute of Neurosciences Mental Health and Addictions to the PreVAiL Preventing Violence Across the Lifespan Research Network) (Centre for Research Development in Gender, Mental Health and Violence across the Lifespan, grant #RDG99326). DD is supported by a grant from the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number U54GM104942 and a Loan Repayment Program Grant from the National Institute on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. TA is supported by a Research Manitoba Establishment Award and a Canadian Institutes of Health Research New Investigator Award. MK is supported by a Women's Health Scholar Post Doctoral Fellowship Award from the Ontario Ministry of Health and Long-Term Care.	ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; Afifi TO, 2009, J INTERPERS VIOLENCE, V24, P1398, DOI 10.1177/0886260508322192; [Anonymous], 2016, DEF PAT CTR MED HOM; [Anonymous], APP REG DAT OV 2010; [Anonymous], 2017, REP HLTH SYST IMPR; [Anonymous], 2015, HCUP CLIN CLASS SOFT; [Anonymous], 2016, HCUP DAT; Appalachian Regional Commission, AB ARC; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Behringer B., 2006, PREV CHRONIC DIS, V3, P1; Bennett L, 2008, VAWNET, V16, P2009; Bonomi AE, 2006, AM J PREV MED, V30, P458, DOI 10.1016/j.amepre.2006.01.015; Bonomi AE, 2009, HEALTH SERV RES, V44, P1052, DOI 10.1111/j.1475-6773.2009.00955.x; Breiding MJ, 2008, AM J PREV MED, V34, P112, DOI 10.1016/j.amepre.2007.10.001; Breiding MJ, 2009, J RURAL HEALTH, V25, P240, DOI 10.1111/j.1748-0361.2009.00225.x; Breiding MatthewJ., 2015, INTIMATE PARTNER VIO; Btoush R, 2008, J EMERG NURS, V34, P419, DOI 10.1016/j.jen.2007.10.015; Btoush R, 2009, WOMEN HEALTH ISS, V19, P253, DOI 10.1016/j.whi.2009.03.004; Bushy A, 1998, J Am Med Womens Assoc (1972), V53, P53; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P527; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; Dunn LL, 2004, JOGNN, V33, P54, DOI 10.1177/0884217503261080; Edwards KM, 2015, TRAUMA VIOLENCE ABUS, V16, P359, DOI 10.1177/1524838014557289; Edwards KM, 2014, AM J COMMUN PSYCHOL, V53, P198, DOI 10.1007/s10464-014-9633-7; El-Bassel N, 2003, WOMEN HEALTH ISS, V13, P16, DOI 10.1016/S1049-3867(02)00142-1; El-Bassel N, 2005, AM J PUBLIC HEALTH, V95, P465, DOI 10.2105/AJPH.2003.023200; Gallup-Black A, 2005, HOMICIDE STUD, V9, P149, DOI 10.1177/1088767904274158; Gold M, 2008, J PUBLIC HEALTH MAN, pS36, DOI 10.1097/01.PHH.0000338385.82436.44; Halverson JA, 2002, ETHNIC DIS, V12, pS3; Halverson JA, 2004, ANAL DISPARITIES HLT; Healthcare Cost and Utilization Project (HCUP), 2016, AGENCY HEALTHCARE RE; Hendryx M, 2008, J RURAL HEALTH, V24, P179, DOI 10.1111/j.1748-0361.2008.00155.x; Hink AB, 2015, J TRAUMA ACUTE CARE, V79, P709, DOI 10.1097/TA.0000000000000856; Kelly U, 2010, WEST J EMERG MED, V11, P247; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; Koss M P, 1992, Arch Fam Med, V1, P53, DOI 10.1001/archfami.1.1.53; Kothari CL, 2015, ADV EMERG MED, V22; Kothari RU, 2014, J TRAUMA ACUTE CARE, V77, P129, DOI 10.1097/TA.0000000000000269; Kramer A, 2004, WOMEN HEALTH ISS, V14, P19, DOI 10.1016/j.whi.2003.12.002; Lane NM, 2012, HLTH CARE COSTS ACCE; LAST JM, 1963, LANCET, V2, P28; Lipsky S, 2004, MATERN CHILD HLTH J, V8, P55, DOI 10.1023/B:MACI.0000025727.68281.aa; Logan TK, 2003, J FAM VIOLENCE, V18, P83, DOI 10.1023/A:1022837114205; Malcoe LH, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-20; Mixer SJ, 2014, J HOSP PALLIAT NURS, V16, P526, DOI 10.1097/NJH.0000000000000114; Morenoff JD, 1997, SOC FORCES, V76, P31, DOI 10.2307/2580317; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peek-Asa C, 2011, J WOMENS HEALTH, V20, P1743, DOI 10.1089/jwh.2011.2891; Plichta SB, 2007, TRAUMA VIOLENCE ABUS, V8, P226, DOI 10.1177/1524838007301220; Roberts GL, 1996, ANN EMERG MED, V27, P747, DOI 10.1016/S0196-0644(96)70194-4; Rudman WJ, 2000, WOMEN HEALTH, V30, P1, DOI 10.1300/J013v30n04_01; Schafer SD, 2008, PUBLIC HEALTH REP, V123, P628, DOI 10.1177/003335490812300513; Seiling S, 2003, CONSUMER INTERESTS A, V49; Shannon Lisa, 2006, Violence Vict, V21, P167, DOI 10.1891/088667006780644226; Smith SG, 2017, NATL INTIMATE PARTNE; Thomson G.E., 2006, EXAMINING HLTH DISPA; U.S. Census Bureau, 2016, POP HOUS UN EST; Wallis AB, 2010, HEALTH CARE WOMEN IN, V31, P113, DOI 10.1080/07399330903042815; Zhang Z A Infante M Meit N English M Dunn and K H Bowers, 2008, ANAL MENTAL HLTH SUB; Zhu MT, 2013, ANN EPIDEMIOL, V23, P377, DOI 10.1016/j.annepidem.2013.04.001	65	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184222	10.1371/journal.pone.0184222	http://dx.doi.org/10.1371/journal.pone.0184222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886119	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100084
J	Wan, X; Liu, YY; Zhao, YY; Sun, XQ; Fan, DX; Guo, L				Wan, Xing; Liu, Yuanyuan; Zhao, Yuyan; Sun, Xiaoqi; Fan, Dongxiao; Guo, Lei			Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1 alpha-dependent and -independent mechanism	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PERIPHERAL-TISSUES; SIGNALING PATHWAY; GASTRIC-CANCER; RECEPTOR; HYPOXIA; EXPRESSION; APOPTOSIS; GROWTH; PROTEIN	Orexins are hypothalamic neuropeptides that regulate feeding, reward, wakefulness and energy homeostasis. The present study sought to characterize the involvement of orexin A in glucose metabolism in HepG2 human hepatocellular carcinoma cells, and investigated the role of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in the response. HepG2 cells were exposed to different concentrations of orexin A (10(-9) to 10(-7) M) in vitro, without or with the orexin receptor 1 (OX1R) inhibitor (SB334867), HIF-1 alpha inhibitor (YC-1) or a combination of both inhibitors. Subsequently, OX1R, HIF-1 alpha expression and localization, glucose uptake, glucose transporter 1 (GLUT1) expression and ATP content were measured. We further investigated the intracellular fate of glucose by measuring the gene expression of pyruvate dehydrogenase kinase 1 (PDK1), lactate dehydrogenase (LDHA) and pyruvate dehydrogenase B (PDHB), as well as metabolite levels including lactate generation and mitochondrial pyruvate dehydrogenase (PDH) activity. The activity of phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway was also assessed. Our results showed that the expression of OX1R was predominantly located in the nucleus in HepG2 cells. Orexin A oxygen-independently promoted the mRNA and protein expression of HIF-1 alpha as well as its nuclear accumulation in HepG2 cells and the elevated HIF-1 alpha protein was associated, at least partly, with the activation of the PI3K/Akt/mTOR pathway. Orexin A stimulated GLUT1 expression, glucose uptake as well as ATP generation in HepG2 cells via OX1R acting through the HIF-1 alpha pathway. Moreover, orexin A inhibited LDHA, PDK1 expression and lactate production, stimulated PDHB expression and PDH enzyme activity independent of HIF-1 alpha. Our results indicated that orexin signaling facilitated the glucose flux into mitochondrial oxidative metabolism rather than glycolysis in HepG2 cells. These findings provide new insight into the regulation of glucose metabolism by orexin A in hepatocellular carcinoma cells.	[Wan, Xing] China Med Univ, Affiliated Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China; [Liu, Yuanyuan; Zhao, Yuyan; Sun, Xiaoqi] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang, Liaoning, Peoples R China; [Fan, Dongxiao; Guo, Lei] China Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Zhao, YY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang, Liaoning, Peoples R China.; Guo, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Shenyang, Liaoning, Peoples R China.	g572@sina.com; guolei@cmu.edu.cn	liu, yuanyuan/GWZ-5838-2022		National Natural Science Foundation of China [81071460, 81271996]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers 81071460, 81271996).r We are thankful to China medical university affiliated hospital laboratory center for kindly providing equipments needed. We thank Ms. Liang Zhang for excellent technical assistance. This work was supported by the National Natural Science Foundation of China (grant numbers 81071460 and 81271996).	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Alexandre D, 2014, EUR J CANCER, V50, P2126, DOI 10.1016/j.ejca.2014.05.008; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Bieganska K, 2012, J MOL NEUROSCI, V48, P706, DOI 10.1007/s12031-012-9799-0; Butterick TA, 2013, REV ENDOCR METAB DIS, V14, P357, DOI 10.1007/s11154-013-9259-3; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Feng Y, 2014, NEUROSCI LETT, V579, P35, DOI 10.1016/j.neulet.2014.07.014; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Han XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100380; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ju SJ, 2014, INT J MOL MED, V34, P153, DOI 10.3892/ijmm.2014.1769; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karteris E, 2003, J PHARMACOL SCI, V93, P126, DOI 10.1254/jphs.93.126; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kishida M, 2012, ONCOL LETT, V3, P525, DOI 10.3892/ol.2011.528; Kodadek T, 2010, MOL BIOSYST, V6, P1366, DOI 10.1039/c003468a; Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232; Leonard CS, 2014, BRIT J PHARMACOL, V171, P294, DOI 10.1111/bph.12296; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Liu YY, 2015, INT J MOL MED, V35, P539, DOI 10.3892/ijmm.2014.2038; Nakabayashi M, 2003, MOL CELL ENDOCRINOL, V205, P43, DOI 10.1016/S0303-7207(03)00206-5; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shen Y, 2013, J STEROID BIOCHEM, V138, P376, DOI 10.1016/j.jsbmb.2013.07.005; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Sikder D, 2007, GENE DEV, V21, P2995, DOI 10.1101/gad.1584307; Skrzypski M, 2011, DIABETOLOGIA, V54, P1841, DOI 10.1007/s00125-011-2152-2; Sokolowska P, 2014, J MOL NEUROSCI, V52, P48, DOI 10.1007/s12031-013-0165-7; Spinazzi R, 2005, J CLIN ENDOCR METAB, V90, P3544, DOI 10.1210/jc.2004-2385; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Tsuneki H, 2015, DIABETES, V64, P459, DOI 10.2337/db14-0695; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu TR, 2013, CELL SIGNAL, V25, P2413, DOI 10.1016/j.cellsig.2013.07.025; Yuan LB, 2011, ANESTHESIOLOGY, V114, P340, DOI 10.1097/ALN.0b013e318206ff6f; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958	50	14	16	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184213	10.1371/journal.pone.0184213	http://dx.doi.org/10.1371/journal.pone.0184213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886081	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100083
J	Bahri, S; Mies, F; Ben Ali, R; Mlika, M; Jameleddine, S; Mc Entee, K; Shlyonsky, V				Bahri, Sana; Mies, Frederique; Ben Ali, Ridha; Mlika, Mona; Jameleddine, Saloua; Mc Entee, Kathleen; Shlyonsky, Vadim			Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SIGNALING PATHWAYS; ROSEMARY EXTRACTS; MOLECULAR TARGETS; CELL-DEATH; IN-VITRO; OFFICINALIS; INHIBITION; GROWTH; P21	Pulmonary fibrosis is characterized by over-population and excessive activation of fibroblasts and myofibroblasts disrupting normal lung structure and functioning. Rosemary extract rich in carnosic acid (CA) and rosmarinic acid (RA) was reported to cure bleomycin( BLM)-induced pulmonary fibrosis. We demonstrate that CA decreased human lung fibroblast (HLF) viability with IC50 value of 17.13-1.06 mu M, while RA had no cytotoxic effect. In the presence of 50 mu M of RA, dose-response for CA shifted to IC50 value of 11.70-1.46 mu M, indicating synergic action. TGF beta-transformed HLF, rat lung fibroblasts and L929 cells presented similar sensitivity to CA and CA+RA (20 mu M+100 mu M, respectively) treatment. Rat alveolar epithelial cells died only under CA+RA treatment, while A549 cells were not affected. Annexin V staining and DNA quantification suggested that HLF are arrested in G0/G1 cell cycle phase and undergo apoptosis. CA caused sustained activation of phospho-Akt and phospho-p38 expression and inhibition of p21 protein. Addition of RA potentiated these effects, while RA added alone had no action. Only triple combination of inhibitors (MAPK-p38, pan-caspase, PI3K/Akt/autophagy) partially attenuated apoptosis; this suggests that cytotoxicity of CA+RA treatment has a complex mechanism involving several parallel signaling pathways. The in vivo antifibrotic effect of CA and RA was compared with that of Vitamine-E in BLM-induced fibrosis model in rats. We found comparable reduction in fibrosis score by CA, RA and CA+RA, attenuation of collagen deposition and normalization of oxidative stress markers. In conclusion, antifibrotic effect of CA+RA is due to synergistic pro-apoptotic action on lung fibroblasts and myofibroblasts.	[Bahri, Sana; Jameleddine, Saloua] Univ Tunis El Manar, Dept Physiol, Tunis, Tunisia; [Bahri, Sana; Mies, Frederique; Mc Entee, Kathleen; Shlyonsky, Vadim] Univ Libre Bruxelles, Dept Physiol & Pharmacol, Brussels, Belgium; [Bahri, Sana; Jameleddine, Saloua] Univ Manouba, Technol Ctr Sidi Thabet, Dept Physiopathol Food & Biomol LR 17 ES 03, Tunis, Tunisia; [Ben Ali, Ridha] Univ Tunis El Manar, Dept Expt Med, Tunis, Tunisia; [Mlika, Mona] Abderhaman Mami Hosp, Dept Anat & Pathol, Ariana, Tunisia	Universite de Tunis-El-Manar; Universite Libre de Bruxelles; Universite de la Manouba; Universite de Tunis-El-Manar; Universite de Tunis-El-Manar; Hopital Abderrahmene Mami	Shlyonsky, V (corresponding author), Univ Libre Bruxelles, Dept Physiol & Pharmacol, Brussels, Belgium.	vshlyons@ulb.ac.be	BAHRI, Sana/HHZ-8752-2022; Mlika, Mona/O-5960-2015	BAHRI, Sana/0000-0001-7801-6668; Mlika, Mona/0000-0003-2470-0012; benali, ridha/0000-0003-4692-7445; Shlyonsky, Vadim/0000-0003-2999-6553	Tunisian Ministry of Higher Education, Scientific Research and Technology; Universite libre de Bruxelles	Tunisian Ministry of Higher Education, Scientific Research and Technology; Universite libre de Bruxelles	This work was supported by the Tunisian Ministry of Higher Education, Scientific Research and Technology to SJ and by Funds from Universite libre de Bruxelles to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bahri Sana, 2017, Pharm Biol, V55, P462, DOI 10.1080/13880209.2016.1247881; Bahri S, 2016, BIOMED PHARMACOTHER, V84, P569, DOI 10.1016/j.biopha.2016.09.067; Bauer J, 2012, J PHARMACOL EXP THER, V342, P169, DOI 10.1124/jpet.112.193847; Bernardes WA, 2010, CHEM BIODIVERS, V7, P1835, DOI 10.1002/cbdv.200900301; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; Bulku E, 2012, CURR NEUROVASC RES, V9, P58, DOI 10.2174/156720212799297083; Chattopadhyay D, 2001, J VIROL, V75, P9844, DOI 10.1128/JVI.75.20.9844-9856.2001; Costa S, 2007, J APPL TOXICOL, V27, P152, DOI 10.1002/jat.1186; Datta A, 2011, BRIT J PHARMACOL, V163, P141, DOI 10.1111/j.1476-5381.2011.01247.x; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Epa AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135266; Fallarini S, 2009, BRIT J PHARMACOL, V157, P1072, DOI 10.1111/j.1476-5381.2009.00213.x; Fekete M, 2012, ANTICANCER RES, V32, P445; Gao QL, 2015, J APPL TOXICOL, V35, P485, DOI 10.1002/jat.3049; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; JANICKBUCKNER D, 1989, TOXICOL APPL PHARM, V100, P474, DOI 10.1016/0041-008X(89)90295-0; Kalra Neetu, 2006, Asian Pac J Cancer Prev, V7, P556; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Khan M, 2015, INT J BIOL SCI, V11, P1100, DOI 10.7150/ijbs.11595; Kilic T, 2014, INFLAMMATION, V37, P1167, DOI 10.1007/s10753-014-9841-1; Kilinc Cumhur, 1993, Journal of Basic and Clinical Physiology and Pharmacology, V4, P249; Kim DS, 2005, BIOCHEM PHARMACOL, V70, P1066, DOI 10.1016/j.bcp.2005.06.026; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li GS, 2010, PHYTOMEDICINE, V17, P282, DOI 10.1016/j.phymed.2009.05.002; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; LOWN JW, 1977, BIOCHEM BIOPH RES CO, V77, P1150; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mukherjee S, 2012, AM J RESP CELL MOL, V46, P757, DOI 10.1165/rcmb.2011-0223OC; Ng L. T., 1997, AM J CHINESE MED, V35, P465; Noble PW, 2003, AM J RESP CELL MOL, V29, pS27; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OHNISHI ST, 1978, ANAL BIOCHEM, V86, P193, DOI 10.1016/0003-2697(78)90334-2; Osakabe N, 2004, BIOFACTORS, V21, P127, DOI 10.1002/biof.552210125; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pertino MW, 2015, MOLECULES, V20, P8666, DOI 10.3390/molecules20058666; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Qiao SL, 2005, FREE RADICAL RES, V39, P995, DOI 10.1080/10715760500231836; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; SAUSVILLE EA, 1976, BIOCHEM BIOPH RES CO, V73, P814, DOI 10.1016/0006-291X(76)90882-2; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SerairiBeji R., 2014, RAT MED CHEM, V4, P611; Shlyonsky V, 2014, PULM CIRC, V4, P471, DOI 10.1086/677362; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sui XY, 2012, FOOD CHEM, V131, P1399, DOI 10.1016/j.foodchem.2011.10.007; Suntres Z. E., 1997, Biomedical and Environmental Sciences, V10, P47; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063872; Yan Q, 1998, J CELL BIOCHEM, V70, P70; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yen FL, 2007, PHYTOTHER RES, V21, P251, DOI 10.1002/ptr.2056; Yesil-Celiktas O, 2010, PLANT FOOD HUM NUTR, V65, P158, DOI 10.1007/s11130-010-0166-4	58	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184368	10.1371/journal.pone.0184368	http://dx.doi.org/10.1371/journal.pone.0184368			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877257	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200093
J	Gunda, NSK; Dasgupta, S; Mitra, SK				Gunda, Naga Siva Kumar; Dasgupta, Saumyadeb; Mitra, Sushanta K.			DipTest: A litmus test for E. coli detection in water	PLOS ONE			English	Article							ESCHERICHIA-COLI; PAPER; BACTERIA	We have developed a new litmus paper test (DipTest) for detecting Escherichia coli (E. coli) in water samples by performing enzymatic reactions directly on the porous paper substrate. The paper strip consists of a long narrow piece of cellulose blotting paper coated with chemoattractant (at bottom edge), wax hydrophobic barrier (at the top edge), and custom formulated chemical reagents (at reaction zone immediately below the wax hydrophobic barrier). When the paper strip is dipped in water, E. coli in the water sample is attracted toward the paper strip due to a chemotaxic mechanism followed by the ascent along the paper strip toward the reaction zone due to a capillary wicking mechanism, and finally the capillary motion is arrested at the top edge of the paper strip by the hydrophobic barrier. The E. coli concentrated at the reaction zone of the paper strip will react with custom formulated chemical reagents to produce a pinkish-red color. Such a color change on the paper strip when dipped into water samples indicates the presence of E. coli contamination in potable water. The performance of the DipTest device has been checked with different known concentrations of E. coli contaminated water samples using different dip and wait times. The DipTest device has also been tested with different interfering bacteria and chemical contaminants. It has been observed that the different interfering contaminants do not have any impact on the DipTest, and it can become a potential solution for screening water samples for E. coli contamination at the point of source.	[Gunda, Naga Siva Kumar; Dasgupta, Saumyadeb; Mitra, Sushanta K.] York Univ, Lassonde Sch Engn, Micro & Nanoscale Transport Lab, Toronto, ON M3J 1P3, Canada; [Gunda, Naga Siva Kumar] Univ Waterloo, Waterloo Inst Nanotechnol, Micro Nanoscale Transport Lab, Waterloo, ON N2L 3G1, Canada	York University - Canada; University of Waterloo	Mitra, SK (corresponding author), York Univ, Lassonde Sch Engn, Micro & Nanoscale Transport Lab, Toronto, ON M3J 1P3, Canada.	sushanta.mitra@lassonde.yorku.ca		Mitra, Sushanta/0000-0003-0792-8314	Kaneff Professorship	Kaneff Professorship	Start-up Grant and Kaneff Professorship, awarded to SKM, are highly acknowledged here.	Abdelrahim KA, 1992, THESIS; Cai JC, 2011, TRANSPORT POROUS MED, V89, P251, DOI 10.1007/s11242-011-9767-0; Das S, 2012, PHYS REV E, V86; Das S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.063005; Dasgupta S, 2016, ENVIRON SCI-WAT RES, V2, P931, DOI [10.1039/c6ew00200e, 10.1039/C6EW00200E]; Fobel R, 2014, ADV MATER, V26, P2838, DOI 10.1002/adma.201305168; Fu EL, 2011, MICROFLUID NANOFLUID, V10, P29, DOI 10.1007/s10404-010-0643-y; Gunda NSK, 2016, ANALYST, V141, P2920, DOI [10.1039/C6AN00400H, 10.1039/c6an00400h]; Gunda NSK, 2014, ANAL METHODS-UK, V6, P6236, DOI [10.1039/c4ay01245c, 10.1039/C4AY01245C]; Haines BM, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046003; Hossain SMZ, 2012, ANAL BIOANAL CHEM, V403, P1567, DOI 10.1007/s00216-012-5975-x; Hsu HH, 2010, PARTICLE MOVEMENT PA; KUBITSCHEK HE, 1990, J BACTERIOL, V172, P94, DOI 10.1128/JB.172.1.94-101.1990; Li CZ, 2011, BIOSENS BIOELECTRON, V26, P4342, DOI 10.1016/j.bios.2011.04.035; Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398; Ma S, 2014, TALANTA, V120, P135, DOI 10.1016/j.talanta.2013.12.007; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Masoodi R., 2012, WICKING POROUS MAT T; Mitra SK, 2017, METHOD APPARATUS DET; Mitra SK, 2014, MICROFLUIDIC DETECTI; Mitra SK, 2014, COLIFORM DETECTION R; Mitra SK, 2015, METHOD APPARATUS DET; Olstadt J, 2007, J WATER HEALTH, V5, P267, DOI 10.2166/wh.2007.008b; Parolo C, 2013, CHEM SOC REV, V42, P450, DOI 10.1039/c2cs35255a; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; RAHIM KAA, 1991, BIOTECHNOL APPL BIOC, V13, P246; Xie D, 1999, PROTEIN SCI, V8, P2460	27	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183234	10.1371/journal.pone.0183234	http://dx.doi.org/10.1371/journal.pone.0183234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877199	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200028
J	Petersen, A; Held, N; Heide, L				Petersen, Albert; Held, Nadja; Heide, Lutz		Difam-EPN Minilab Survey Grp	Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab	PLOS ONE			English	Article							THIN-LAYER-CHROMATOGRAPHY; SUB-SAHARAN AFRICA; QUALITY; ANTIMALARIAL; MALAWI; DRUGS	Background Substandard and falsified medical products present a serious threat to public health, especially in low-and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly trained personnel. Simple, low-cost technologies are required in addition to full pharmacopeial analysis in order to accomplish widespread routine surveillance for poor-quality medicines in low-and middle-income countries. Methods Ten faith-based drug supply organizations in seven countries of Africa and Asia were each equipped with a Minilab of the Global Pharma Health Fund (GPHF, Frankfurt, Germany), suitable for the analysis of about 85 different essential medicines by thin-layer chromatography. Each organization was asked to collect approximately 100 medicine samples from private local medicine outlets, especially from the informal sector. The medicine samples were tested locally according to the Minilab protocols. Medicines which failed Minilab testing were subjected to confirmatory analysis in a WHO-prequalified medicine quality control laboratory in Kenya. Results Out of 869 medicine samples, 21 were confirmed to be substandard or falsified medical products. Twelve did not contain the stated active pharmaceutical ingredient (API), six contained insufficient amounts of the API, and three showed insufficient dissolution of the API. The highest proportion of substandard and falsified medicines was found in Cameroon (7.1%), followed by the Democratic Republic of Congo (2.7%) and Nigeria (1.1%). Antimalarial medicines were most frequently found to be substandard or falsified (9.5% of all antimalarials). Thin-layer chromatography according to the Minilab protocols was found to be specific and reproducible in the identification of medicines which did not contain the stated API. Since only samples which failed Minilab testing were subjected to confirmatory testing using pharmacopeial methods, this study did not assess the sensitivity of the Minilab methodology in the detection of substandard medicines, and may underestimate the prevalence of poor-quality medicines. Conclusions Surveillance for poor-quality medicines can be carried out by local organizations in low-and middle-income countries using a simple, low-cost technology. Such surveillance can identify an important subgroup of the circulating substandard and falsified medical products and can help to prevent them from causing harm in patients. A collaboration of the national drug regulatory authorities with faith-based organizations and other NGOs may therefore represent a promising strategy towards the Sustainable Development Goal of "ensuring access to quality medicines".	[Petersen, Albert] Difam German Inst Med Mission, Tubingen, Germany; [Held, Nadja; Heide, Lutz] Eberhard Karls Univ Tubingen, Inst Pharmaceut, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Petersen, A (corresponding author), Difam German Inst Med Mission, Tubingen, Germany.; Heide, L (corresponding author), Eberhard Karls Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	petersen.amh@difaem.de; heide@uni-tuebingen.de		Heide, Lutz/0000-0001-7809-7453	Brot fur die Welt, Berlin, Germany (grant title: Starkung kirchlicher Gesundheitssysteme in Afrika und Asien mit einem Schwerpunkt in der Pharmazeutischen Entwicklungszusammenarbeit.); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft; University of Tubingen	Brot fur die Welt, Berlin, Germany (grant title: Starkung kirchlicher Gesundheitssysteme in Afrika und Asien mit einem Schwerpunkt in der Pharmazeutischen Entwicklungszusammenarbeit.); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study was financially supported by Brot fur die Welt, Berlin, Germany (grant title: Starkung kirchlicher Gesundheitssysteme in Afrika und Asien mit einem Schwerpunkt in der Pharmazeutischen Entwicklungszusammenarbeit.) We acknowledge support for open access publication by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], 2000, NON TRADITIONAL REF; ATTARAN A, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E7381; Fernandez FM, 2011, ANALYST, V136, P3073, DOI 10.1039/c0an00627k; Global Pharma Health Fund, SIMPL DRUG QUAL VER; Global Pharma Health Fund, EX COUNT MED; Green MD, 2007, J PHARMACEUT BIOMED, V43, P105, DOI 10.1016/j.jpba.2006.06.047; Hajjou M, 2015, AM J TROP MED HYG, V92, P68, DOI 10.4269/ajtmh.14-0535; Hamburg Margaret, 2015, Am J Trop Med Hyg, V92, P1, DOI 10.4269/ajtmh.15-0046; Jahnke R, 2008, CONCISE QUALITY CONT, V1; Jahnke R., 2008, CONCISE QUALITY CONT, VII; Jahnke RW, 2004, PHARM IND, V66, P1187; Jahnke RWO, CONCISE QUALITY CONT, V2; Kaur H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1096-x; Kaur H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125577; Kelesidis T, 2015, CLIN MICROBIOL REV, V28, P443, DOI 10.1128/CMR.00072-14; Khuluza F, 2017, AM J TROP MED HYG, V96, P1124, DOI 10.4269/ajtmh.16-1008; Khuluza F, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1259-9; Nayyar GML, 2015, AM J TROP MED HYG, V92, P2, DOI 10.4269/ajtmh.15-0221; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Pribluda VS, 2014, PHARM REGUL AFF OPEN, V3, P1; Ravinetto RM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3618; Renschler JP, 2015, AM J TROP MED HYG, V92, P119, DOI 10.4269/ajtmh.14-0725; Risha PG, 2008, HEALTH POLICY, V87, P217, DOI 10.1016/j.healthpol.2007.12.010; Sarbartova JT, 2011, SURVEY QUALITY SELEC, P1; Tipke M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-95; Tshilumba PM, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.318.7302; WHO, 2016, WHO TECH REP SER, V996, P1; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, DRUG AL NO 132 FALS; World Health Organization, ASS MED SYST SUBS AF; World Health Organization, 2017, WHO EXC BOARD 140 SE; World Health Organization (WHO), 2017, ATC DDD IND 2017; World Health Organization (WHO), 2016, LIST PREQ QUAL CONTR; World Health Organization (WHO), 2016, LIST PREQ MED PROD; Yu H, 2016, J PHARMACEUT BIOMED, V125, P85, DOI 10.1016/j.jpba.2016.03.018	37	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184165	10.1371/journal.pone.0184165	http://dx.doi.org/10.1371/journal.pone.0184165			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877208	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200068
J	Zhang, XHD; Pechter, D; Yang, LM; Ping, XL; Yao, ZL; Zhang, RM; Shen, XL; Li, NXY; Connick, J; Nawrocki, AR; Chakravarthy, M; Li, C				Zhang, Xiaohua Douglas; Pechter, David; Yang, Liming; Ping, Xiaoli; Yao, Zuliang; Zhang, Rumin; Shen, Xiaolan; Li, Nina Xiaoyan; Connick, Jonathan; Nawrocki, Andrea R.; Chakravarthy, Manu; Li, Cai			Decreased complexity of glucose dynamics preceding the onset of diabetes in mice and rats	PLOS ONE			English	Article							METABOLIC FLEXIBILITY; INSULIN-RESISTANCE; SITAGLIPTIN	Continuous glucose monitoring (CGM) is a platform to measure blood glucose (BG) levels continuously in real time with high enough resolution to document their underlying fluctuations. Multiscale entropy (MSE) analysis has been proposed as a measure of time-series complexity, and when applied to clinical CGM data, MSE analysis revealed that diabetic patients have lower MSE complexity in their BG time series than healthy subjects. To determine if the clinical observations on complexity of glucose dynamics can be back-translated to relevant preclinical species used routinely in diabetes drug discovery, we performed CGM in both mouse (ob/ob) and rat (Zucker Diabetic Fatty, ZDF) models of diabetes. We demonstrate that similar to human data, the complexity of glucose dynamics is also decreased in diabetic mice and rats. We show that low complexity of glucose dynamics is not simply a reflection of high glucose values, but rather reflective of the underlying disease state (i.e. diabetes). Finally, we demonstrate for the first time that the complexity of glucose fluctuations in ZDF rats, as probed by MSE analysis, is decreased prior to the onset of overt diabetes, although complexity undergoes further decline during the transition to frank diabetes. Our study suggests that MSE could serve as a novel biomarker for the progression to diabetes and that complexity studies in preclinical models could offer a new paradigm for early differentiation, and thereby, selection of appropriate clinical candidate molecules to be tested in human clinical trials.	[Zhang, Xiaohua Douglas] Merck Res Labs, Dept BARDS, Kenilworth, NJ USA; [Pechter, David; Yao, Zuliang; Zhang, Rumin; Connick, Jonathan; Nawrocki, Andrea R.; Li, Cai] Merck Res Labs, Dept Pharmacol, Kenilworth, NJ 07033 USA; [Yang, Liming; Li, Nina Xiaoyan] Merck Res Labs, Dept Diabet, Kenilworth, NJ USA; [Ping, Xiaoli; Shen, Xiaolan] Merck Res Labs, Dept Labs Anim Resources, Kenilworth, NJ USA; [Chakravarthy, Manu] Merck Res Labs, Dept Translat Pharmacol, Kenilworth, NJ USA; [Zhang, Xiaohua Douglas] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Zhang, Rumin] Etern Biosci Inc, 2005 Eastpark Blvd, Cranbury, NJ USA; [Nawrocki, Andrea R.] Janssen Pharmaceut, Spring House, PA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; University of Macau; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA	Li, C (corresponding author), Merck Res Labs, Dept Pharmacol, Kenilworth, NJ 07033 USA.	cai.li@merck.com	Chakravarthy, Manu/AAD-7553-2021	Chakravarthy, Manu/0000-0002-3699-150X	Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	The funder (Merck Research Laboratories) provided support in the form of salaries for all authors [XZ, DP, LY, XP, ZY, RZ, XS, NL, JC, AN, MC, and CL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aleppo G, 2017, DIABETES CARE; Ando K, 2014, EXPERT OPIN PHARMACO, V15, P2479, DOI 10.1517/14656566.2014.970531; Ando K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071102; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Brockway Robert, 2015, J Diabetes Sci Technol, V9, P771, DOI 10.1177/1932296815586424; Chen JL, 2014, AM J PHYSIOL-REG I, V307, pR179, DOI 10.1152/ajpregu.00108.2014; Chialvo DR, 2002, NATURE, V419, P263, DOI 10.1038/419263a; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costa MD, 2014, CHAOS, V24, DOI 10.1063/1.4894537; Crenier L, 2016, J CLIN ENDOCR METAB, V101, P1490, DOI 10.1210/jc.2015-4035; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Ho YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018699; Larsen TS, 2008, CARDIOVASC DRUG THER, V22, P91, DOI 10.1007/s10557-008-6083-1; Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976; Lodwig Volker, 2014, J Diabetes Sci Technol, V8, P390; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Rodriguez deCastro C, 2016, DIABETES METABOLISM; Seo C, 2013, DIABETES TECHNOL THE, V15, P378, DOI 10.1089/dia.2012.0262; Thyfault John P, 2006, J Cardiometab Syndr, V1, P184, DOI 10.1111/j.1559-4564.2006.05629.x; Tuzcu V, 2006, EUROPACE, V8, P398, DOI 10.1093/europace/eul031; Uettwiller F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116255; Varela M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9361958	25	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182810	10.1371/journal.pone.0182810	http://dx.doi.org/10.1371/journal.pone.0182810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877180	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200017
J	Cilla, M; Borgiani, E; Martinez, J; Duda, GN; Checa, S				Cilla, Myriam; Borgiani, Edoardo; Martinez, Javier; Duda, Georg N.; Checa, Sara			Machine learning techniques for the optimization of joint replacements: Application to a short-stem hip implant	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE OPTIMIZATION; NANOS SHORT STEM; NEURAL-NETWORKS; LOADING CONDITIONS; DESIGN; ARTHROPLASTY; SELECTION; DENSITY; STRESS	Today, different implant designs exist in the market; however, there is not a clear understanding of which are the best implant design parameters to achieve mechanical optimal conditions. Therefore, the aim of this project was to investigate if the geometry of a commercial short stem hip prosthesis can be further optimized to reduce stress shielding effects and achieve better short-stemmed implant performance. To reach this aim, the potential of machine learning techniques combined with parametric Finite Element analysis was used. The selected implant geometrical parameters were: total stem length (L), thickness in the lateral (R1) and medial (R2) and the distance between the implant neck and the central stem surface (D). The results show that the total stem length was not the only parameter playing a role in stress shielding. An optimized implant should aim for a decreased stem length and a reduced length of the surface in contact with the bone. The two radiuses that characterize the stem width at the distal cross-section in contact with the bone were less influential in the reduction of stress shielding compared with the other two parameters; but they also play a role where thinner stems present better results.	[Cilla, Myriam] Acad Gen Mil, CUD, Zaragoza, Spain; [Cilla, Myriam] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Borgiani, Edoardo; Duda, Georg N.; Checa, Sara] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Martinez, Javier] CUD, Escuela Naval Mil, Marin, Spain; [Duda, Georg N.; Checa, Sara] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Duda, Georg N.; Checa, Sara] Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany	University of Zaragoza; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Checa, S (corresponding author), Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany.; Checa, S (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.; Checa, S (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany.	sara.checa@charite.de	Duda, Georg N/H-2085-2016; Hernández, Myriam Cilla/F-2457-2016; TORRES, JAVIER MARTÍNEZ/C-9400-2013	Duda, Georg N/0000-0001-7605-3908; Hernández, Myriam Cilla/0000-0002-8503-9291; TORRES, JAVIER MARTÍNEZ/0000-0001-6359-895X; Checa, Sara/0000-0002-1444-5858; Borgiani, Edoardo/0000-0002-9645-2524	Smith & Nephew Orthopedic company	Smith & Nephew Orthopedic company	The authors received no specific funding for this work. There was a research support from the Smith & Nephew Orthopedic company since they provided the implant geometry, but there was no funding from them for the development of this specific project.; The authors gratefully acknowledge research support from the Smith & Nephew Orthopedic company.	Amenabar T, 2015, J ORTHOP SURG-HONG K, V23, P90, DOI 10.1177/230949901502300121; Bishop C.M., 1995, NEURAL NETWORKS PATT; Boyle C, 2011, J BIOMECH, V44, P1722, DOI 10.1016/j.jbiomech.2011.03.038; Chang PB, 2001, J BIOMECH ENG-T ASME, V123, P239, DOI 10.1115/1.1372701; Cheung N., 2001, MACHINE LEARNING TEC; Cilla M, 2017, J ORTHOPAED IN PRESS; Cilla M, 2012, IEEE T BIO-MED ENG, V59, P1155, DOI 10.1109/TBME.2012.2185495; CROWNINSHIELD RD, 1980, J BONE JOINT SURG AM, V62, P68, DOI 10.2106/00004623-198062010-00011; Dabirrahmani D, 2010, P I MECH ENG H, V224, P1109, DOI 10.1243/09544119JEIM704; Damm P, TOTAL HIP JOINT PROS; Ettinger M, 2013, TECHNOL HEALTH CARE, V21, P149, DOI 10.3233/THC-130716; Ettinger M, 2011, HIP INT, V21, P583, DOI 10.5301/HIP.2011.8658; Evans B, 1992, CS9206 DEP COMP SCI; Fayyad U, 1993, P 10 INT C MACH LEAR, V1, P112; Fernandes PR, 2004, COMPUT METHOD BIOMEC, V7, P51, DOI 10.1080/10255840410001661637; Franco L, 2000, NEURAL COMPUT, V12, P2405, DOI 10.1162/089976600300014999; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; Gniadecka M, 2004, J INVEST DERMATOL, V122, P443, DOI 10.1046/j.0022-202X.2004.22208.x; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; Handels H, 1999, ARTIF INTELL MED, V16, P283, DOI 10.1016/S0933-3657(99)00005-6; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; Holzwarth UaC Giulio, 2012, JRC SCI POL REP TOT; Huang TM, 2005, ARTIF INTELL MED, V35, P185, DOI 10.1016/j.artmed.2005.01.006; HUISKES R, 1989, J BIOMECH, V22, P793, DOI 10.1016/0021-9290(89)90063-8; Jabbour K., 1987, P IEEE POW ENG SOC S; Kassi J, 2002, MUSCLE ACTIVITY IS E; Katoozian H, 2000, MED ENG PHYS, V22, P243, DOI 10.1016/S1350-4533(00)00030-8; Kononenko I, 2001, ARTIFICIAL INTELLIGE, V23; Kowalczyk P, 2001, J BIOMECH ENG-T ASME, V123, P396, DOI 10.1115/1.1392311; Latham B, 2004, MATER DESIGN, V25, P715, DOI 10.1016/j.matdes.2004.01.012; Liu YH, 2005, PROC INT CONF DOC, P630; Lopez M, 2010, J COMPUT APPL MATH, V234, P1338, DOI 10.1016/j.cam.2010.01.054; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; OECD, 2011, HLTH GLANCE 2011; POLI R, 1991, COMPUTER, V24, P64, DOI 10.1109/2.73514; Ruben RB, 2007, STRUCT MULTIDISCIP O, V34, P261, DOI 10.1007/s00158-006-0072-4; Ruben RB, 2012, J BIOMECH, V45, P239, DOI 10.1016/j.jbiomech.2011.10.038; Scholkpof B., 2002, LEARNING KERNELS SUP; Speirs AD, 2007, CLIN BIOMECH, V22, P431, DOI 10.1016/j.clinbiomech.2006.12.003; Sra S, 2012, OPTIMIZATION FOR MACHINE LEARNING, P1; Stalling Detlev, 2005, AMIRA HIGHLY INTERAC; Stulberg SD, 2013, BONE JOINT J, V95B, P57, DOI 10.1302/0301-620X.95B11.32936; Szwedowski TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036231; Taboada J, 2007, J COMPUT APPL MATH, V204, P84, DOI 10.1016/j.cam.2006.04.030; Tanino H, 2006, J BIOMECH, V39, P1948, DOI 10.1016/j.jbiomech.2005.05.024; Taylor W. R., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P131, DOI 10.1080/10255840410001712108; Taylor WR, 2012, CLIN BIOMECH, V27, P813, DOI 10.1016/j.clinbiomech.2012.05.004; Trepczynski A, 2012, J ORTHOP RES, V30, P408, DOI 10.1002/jor.21540; Weinans H, J BIOMECHANICS, V33, P809; WIDROW B, 1994, COMMUN ACM, V37, P93, DOI 10.1145/175247.175257; Wolff J, 1892, GESETZ TRANSFORMATIO; Wolinsky FD, 1997, AM J PUBLIC HEALTH, V87, P398, DOI 10.2105/AJPH.87.3.398; YOON YS, 1989, J BIOMECH, V22, P1279, DOI 10.1016/0021-9290(89)90231-5	54	25	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183755	10.1371/journal.pone.0183755	http://dx.doi.org/10.1371/journal.pone.0183755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873093	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800027
J	Tsai, CY; Kuo, WW; Shibu, MA; Lin, YM; Liu, CN; Chen, YH; Day, CH; Shen, CY; Viswanadha, VP; Huang, CY				Tsai, Cheng-Yen; Kuo, Wei-Wen; Shibu, Marthandam Asokan; Lin, Yueh-Min; Liu, Chien-Nam; Chen, Yi-Hui; Day, Cecilia-Hsuan; Shen, Chia-Yao; Viswanadha, Vijaya Padma; Huang, Chih-Yang			E2/ER beta inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; HEART-FAILURE; MYOCARDIAL-INFARCTION; ADRENERGIC RESPONSIVENESS; MERIT-HF; CALCINEURIN; RAT; APOPTOSIS; AUTOANTIBODIES; METOPROLOL	Cardiovascular incidences are markedly higher in men than in pre-menstrual women. However, this advantage in women declines with aging and therefore can be correlated with the sex hormone 17 beta-Estradiol (E2) which is reported to protect heart cells by acting though estrogen receptors (ERs). In this study we have determined the effect of E2/ER beta against ISO induced cellular hypertrophy in H9c2 cardiomyoblast cells. The results confirm that ISO induced cardiac-hypertrophy by elevating the levels of hypertrophy associated proteins, ANP and BNP and further by upregulating p-CaMKII, calcineurin, p-GATA4 and NFATc3 which was correlated with a significant enlargement of the H9c2 cardiomyoblast. However, overexpression of ER beta and/or administration of E2 inhibited ISO-induced hypertrophy in H9c2 cells. In addition, E2/ER beta also inhibited ISO-induced NFATc3 translocation, and reduced the protein level of downstream marker, BNP. Furthermore, by testing with the calcineurin inhibitor (CsA), it was confirmed that calcineurin acted as a key mediator for the anti-hypertrophic effect of E2/ER beta. In cells treated with calcium blocker (BATPA), the inhibitory effect of E2/ER beta on ISO-induced Ca2+ influx and hypertrophic effects were totally blocked suggesting that E2/ER beta inhibited calcineurin activity to activate I-1 protein and suppress PP1, then induce PLB protein phosphorylation and activation, resulting in Ca2+ reuptake into sarcoplasmic reticulum through SR Ca2+ cycling modification. In conclusion, E2/ER beta suppresses the Ca2+ influx and calcineurin activity induced by ISO to enhance the PLB protein activity and SR Ca2+ cycling.	[Tsai, Cheng-Yen] China Med Univ, Dept Pediat, Beigang Hosp, Yunlin, Taiwan; [Tsai, Cheng-Yen; Kuo, Wei-Wen] China Med Univ, Dept Biol Sci & Technol, Coll Biopharmaceut & Food Sci, Taichung, Taiwan; [Shibu, Marthandam Asokan; Liu, Chien-Nam; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Chen, Yi-Hui] Asia Univ, Dept M Commerce & Multimedia Applicat, Taichung, Taiwan; [Day, Cecilia-Hsuan; Shen, Chia-Yao] Meiho Univ, Dept Nursing, Pingtung, Taiwan; [Viswanadha, Vijaya Padma] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Changhua Christian Hospital; Asia University Taiwan; Bharathiar University; China Medical University Taiwan; Asia University Taiwan	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw	M. A., Shibu/F-6137-2018; Viswanadha, Vijaya Padma/ABG-4936-2020	M. A., Shibu/0000-0001-6381-3525; Viswanadha, Vijaya Padma/0000-0001-9154-027X; Huang, Chih-Yang/0000-0003-2347-0411	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW106-TDU-B-212-113004]	Taiwan Ministry of Health and Welfare Clinical Trial Center	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Angeloni C, 2017, J NUTR BIOCHEM, V42, P26, DOI 10.1016/j.jnutbio.2016.12.017; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Boknik P, 2000, N-S ARCH PHARMACOL, V362, P222, DOI 10.1007/s002100000283; Briston SJ, 2011, J PHYSIOL-LONDON, V589, P1367, DOI 10.1113/jphysiol.2010.203984; Champion HC, 2004, NAT MED, V10, P239, DOI 10.1038/nm0304-239; Chu SH, 2006, LIFE SCI, V79, P1257, DOI 10.1016/j.lfs.2006.03.037; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dubey RK, 2004, HYPERTENSION, V44, P789, DOI 10.1161/01.HYP.0000145988.95551.28; Dworatzek E, 2017, PHARMACOL RES, V119, P27, DOI 10.1016/j.phrs.2017.01.019; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Goldspink PH, 2001, MOL CELL BIOCHEM, V226, P83, DOI 10.1023/A:1012789819926; Goldstein S, 2001, J AM COLL CARDIOL, V38, P932, DOI 10.1016/S0735-1097(01)01516-9; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hsieh DJY, 2015, CELL PHYSIOL BIOCHEM, V36, P274, DOI 10.1159/000374070; Hsieh SR, 2014, BIOMEDICINE-TAIWAN, V4, P7, DOI 10.7603/s40681-014-0023-0; Jahns R, 2000, J AM COLL CARDIOL, V36, P1280, DOI 10.1016/S0735-1097(00)00881-0; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Korte T, 2005, CIRCULATION, V111, P2282, DOI 10.1161/01.CIR.0000164262.08004.BB; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Liu CJ, 2008, MOL CELL BIOCHEM, V313, P167, DOI 10.1007/s11010-008-9754-0; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luo T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167761; MacDonnell SM, 2007, AM J PHYSIOL-HEART C, V293, pH3122, DOI 10.1152/ajpheart.00687.2007; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2001, CIRC RES, V88, P1220, DOI 10.1161/hh1201.093159; Munch G, 2002, J MOL CELL CARDIOL, V34, P321, DOI 10.1006/jmcc.2001.1515; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Pelzer T, 2005, CIRCULATION, V111, P1492, DOI 10.1161/01.CIR.0000159262.18512.46; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; Snopko RM, 2007, CELL CALCIUM, V41, P13, DOI 10.1016/j.ceca.2006.04.033; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang MJ, 2009, AM J PHYSIOL-REG I, V296, pR972, DOI 10.1152/ajpregu.00045.2009; Wang ZH, 2014, BIOMEDICINE-TAIWAN, V4, P19, DOI 10.7603/s40681-014-0019-9; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	42	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184153	10.1371/journal.pone.0184153	http://dx.doi.org/10.1371/journal.pone.0184153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863192	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900033
J	Akter, H; Adnan, S; Morelli, R; Rempoulakis, P; Taylor, PW				Akter, Humayra; Adnan, Saleh; Morelli, Renata; Rempoulakis, Polychronis; Taylor, Phillip W.			Suppression of cuelure attraction in male Queensland fruit flies provided raspberry ketone supplements as immature adults	PLOS ONE			English	Article							BACTROCERA-TRYONI FROGGATT; STERILE INSECT TECHNIQUE; DIPTERA-TEPHRITIDAE; MALE ANNIHILATION; METHYL EUGENOL; FLY DIPTERA; CUE-LURE; SEXUAL COMPETITIVENESS; MATING-BEHAVIOR; RELEASE	Tephritid fruit flies are amongst the most damaging insect pests of horticulture globally. Some of the key fruit fly species are managed using the sterile insect technique (SIT), whereby millions of sterile males are released to suppress reproduction of pest populations. Male annihilation technique (MAT), whereby sex specific lures are used to attract and kill males, is often used to reduce wild male numbers before SIT programs commence, providing released sterile males an increased numerical advantage. Overall program efficacy might be improved if MAT could be deployed simultaneously with SIT, continuously depleting fertile males from pest populations and replacing them with sterile males. However, such 'male replacement' requires a means of suppressing attraction of released sterile males to lures used in MAT. Previous studies have found that exposure of some fruit flies to lure compounds as mature adults can suppress subsequent response to those lures, raising the possibility of pre-release treatments. However, this approach requires holding flies until after maturation for treatment and then release. The present study takes a novel approach of exposing immature adult male Queensland fruit flies (Bactrocera tryoni, or 'Qfly') to raspberry ketone (RK) mixed in food, forcing these flies to ingest RK at ages far younger than they would naturally. After feeding on RK-supplemented food for two days after emergence, male Qflies exhibited a reduction in attraction to cuelure traps that lasted more than 20 days. This approach to RK exposure is compatible with current practises, in which Qflies are released as immature adults, and also yields advantages of accelerated reproductive development and increased mating propensity at young ages.	[Akter, Humayra; Adnan, Saleh; Morelli, Renata; Rempoulakis, Polychronis; Taylor, Phillip W.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Morelli, Renata] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil	Macquarie University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Rempoulakis, P (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	polychronis.rempoulakis@mq.edu.au	Rempoulakis, Polychronis/P-2731-2019; Taylor, Phillip W/E-4620-2011	Rempoulakis, Polychronis/0000-0002-3947-0064; Taylor, Phillip W/0000-0002-7574-7737; Akter, Dr Humayra/0000-0002-5197-4118; ADNAN, SALEH MOHAMMAD/0000-0003-4448-7626	Hort Frontiers Fruit Fly Fund [161/800]; Macquarie University Research Excellence Scholarship; Mr Saleh Adnan CAPES Foundation; Ministry of Education of Brazil fellowship; CAPES Foundation	Hort Frontiers Fruit Fly Fund; Macquarie University Research Excellence Scholarship; Mr Saleh Adnan CAPES Foundation; Ministry of Education of Brazil fellowship; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Hort Frontiers Fruit Fly Fund, grant no 161/800 to Pr. Phillip Warren Taylor and the Macquarie University Research Excellence Scholarship to Dr.Humayra Akter, Mr Saleh Adnan CAPES Foundation, Ministry of Education of Brazil fellowship to Dr.Renata Morelli. The funders had no role instudy design, data collection and analysis, decision to publish,or preparation of the manuscript.; New South Wales Department of Primary Industries for supplying the flies used in this study. This project is funded by the Hort Frontiers Fruit Fly Fund, part of the Hort Frontiers strategic partnership initiative developed by Hort Innovation, with co-investment from Macquarie University and contributions from the Australian Government. HA and SA were supported by Macquarie University Research Excellence Scholarships. RM was supported by CAPES Foundation, Ministry of Education of Brazil fellowship.	Akter H., 2017, THESIS; Akter H, PEST MANAG IN PRESS; Barclay HJ, 2014, ANN ENTOMOL SOC AM, V107, P97, DOI 10.1603/AN13010; Barclay HJ, 2014, ANN ENTOMOL SOC AM, V107, P81, DOI 10.1603/AN13046; BATEMAN MA, 1966, AUST J AGR RES, V17, P687, DOI 10.1071/AR9660687; BATEMAN MA, 1972, ANNU REV ENTOMOL, V17, P493, DOI 10.1146/annurev.en.17.010172.002425; BEROZA M, 1960, SCIENCE, V131, P1044, DOI 10.1126/science.131.3406.1044; CHAMBERS DL, 1972, J ECON ENTOMOL, V65, P279, DOI 10.1093/jee/65.1.279; Collins SR, 2014, J INSECT PHYSIOL, V61, P51, DOI 10.1016/j.jinsphys.2014.01.002; Dominiak B. C., 2008, Plant Protection Quarterly, V23, P131; Dominiak BC, 2003, AUST J EXP AGR, V43, P519, DOI 10.1071/EA01146; Dominiak BC, 2013, CROP PROT, V51, P57, DOI 10.1016/j.cropro.2013.04.006; Dominiak Bernie C., 2016, General and Applied Entomology, V44, P1; Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Ito Y., 1974, Food and Agriculture Organization; International Atomic Energy Agency: The sterile-insect technique and its field applications. Proceedings of a panel on the practical use of the sterile-male technique for insect control organized by the Joint FAO/IAEA Division of Atomic Energy in Food and Agriculture and held in Vienna, 13-17 November 1972., P45; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; KOYAMA J, 1984, J ECON ENTOMOL, V77, P468, DOI 10.1093/jee/77.2.468; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Kumaran N, 2014, MOL ECOL, V23, P4645, DOI 10.1111/mec.12880; Kumaran N, 2014, J INSECT PHYSIOL, V68, P36, DOI 10.1016/j.jinsphys.2014.06.015; Kumaran N, 2013, ANIM BEHAV, V85, P781, DOI 10.1016/j.anbehav.2013.01.024; Meats A, 2004, B ENTOMOL RES, V94, P517, DOI 10.1079/BER2004332; Meats A., 1998, General and Applied Entomology, V28, P39; Meats AW, 2003, AUST J EXP AGR, V43, P389, DOI 10.1071/EA02064; MONROE J., 1967, AUST J ZOOL, V15, P461, DOI 10.1071/ZO9670461; Orozco-Davila D, 2007, FLA ENTOMOL, V90, P19, DOI 10.1653/0015-4040(2007)90[19:SCACBM]2.0.CO;2; Park SJ, 2016, AUST J CHEM, V69, P1162, DOI 10.1071/CH16073; Park SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155827; Perez-Staples D, 2008, AGR FOREST ENTOMOL, V10, P255, DOI 10.1111/j.1461-9563.2008.00385.x; Perez-Staples D, 2007, PHYSIOL ENTOMOL, V32, P225, DOI 10.1111/j.1365-3032.2007.00568.x; Perez-Staples D, 2011, ENTOMOL EXP APPL, V141, P103, DOI 10.1111/j.1570-7458.2011.01173.x; Perez-Staples D, 2009, ENTOMOL EXP APPL, V131, P159, DOI 10.1111/j.1570-7458.2009.00841.x; Rempoulakis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157679; Reynolds OL, 2014, B ENTOMOL RES, V104, P251, DOI 10.1017/S0007485313000758; SHELLY TE, 1994, FLA ENTOMOL, V77, P201, DOI 10.2307/3495505; Shelly TE, 1997, FLA ENTOMOL, V80, P248, DOI 10.2307/3495557; Shelly TE, 2000, FLA ENTOMOL, V83, P109, DOI 10.2307/3496238; Shelly Todd E., 2007, Proceedings of the Hawaiian Entomological Society, V39, P27; Siciliano P, 2014, INSECT BIOCHEM MOLEC, V48, P51, DOI 10.1016/j.ibmb.2014.02.005; TAN KH, 1995, APPL ENTOMOL ZOOL, V30, P494; Vijaysegaran S., 2002, Journal of Tropical Agriculture and Food Science, V30, P119; Vreysen MJB, 2006, ANN ENTOMOL SOC AM, V99, P607, DOI 10.1603/0013-8746(2006)99[607:MOPMIA]2.0.CO;2; Weldon C, 2007, AUST J ENTOMOL, V46, P160, DOI 10.1111/j.1440-6055.2007.00570.x; Weldon CW, 2008, ENTOMOL EXP APPL, V129, P200, DOI 10.1111/j.1570-7458.2008.00768.x	48	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184086	10.1371/journal.pone.0184086	http://dx.doi.org/10.1371/journal.pone.0184086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859132	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500064
J	Chua, CS; Bai, CH; Shiao, CY; Hsu, CY; Cheng, CW; Yang, KC; Chiu, HW; Hsu, JL				Chua, Chian Sem; Bai, Chyi-Huey; Shiao, Chen-Yu; Hsu, Chien-Yeh; Cheng, Chiao-Wen; Yang, Kuo-Ching; Chiu, Hung-Wen; Hsu, Jung-Lung			Negative correlation of cortical thickness with the severity and duration of abdominal pain in Asian women with irritable bowel syndrome	PLOS ONE			English	Article							BRAIN; DISORDERS; CORTEX; METAANALYSIS; INHIBITION; PREVALENCE; SYSTEM; IBS	Background & aims: Irritable bowel syndrome (IBS) manifests as chronic abdominal pain. One pathophysiological theory states that the brain-gut axis is responsible for pain control in the intestine. Although several studies have discussed the structural changes in the brain of IBS patients, most of these studies have been conducted in Western populations. Different cultures and sexes experience different pain sensations and have different pain responses. Accordingly, we aimed to identify the specific changes in the cortical thickness of Asian women with IBS and to compare these data to those of non-Asian women with IBS. Methods: Thirty Asian female IBS patients (IBS group) and 39 healthy individuals (control group) were included in this study. Brain structural magnetic resonance imaging was performed. We used FreeSurfer to analyze the differences in the cortical thickness and their correlations with patient characteristics. Results: The left cuneus, left rostral middle frontal cortex, left supramarginal cortex, right caudal anterior cingulate cortex, and bilateral insula exhibited cortical thinning in the IBS group compared with those in the controls. Furthermore, the brain cortical thickness correlated negatively the severity as well as duration of abdominal pain. Conclusions: Some of our findings differ from those of Western studies. In our study, all of the significant brain regions in the IBS group exhibited cortical thinning compared with those in the controls. The differences in cortical thickness between the IBS patients and controls may provide useful information to facilitate regulating abdominal pain in IBS patients. These findings offer insights into the association of different cultures and sexes with differences in cortical thinning in patients with IBS.	[Chua, Chian Sem; Chiu, Hung-Wen] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Chua, Chian Sem; Yang, Kuo-Ching] Shin Kong Wu Ho Su Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Chua, Chian Sem] Hosp Lam Wah Ee, Western Med Div, George Town, Malaysia; [Bai, Chyi-Huey] Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Bai, Chyi-Huey] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Shiao, Chen-Yu] Shin Kong Wu Ho Su Mem Hosp, Dept Diagnost Radiol, Taipei, Taiwan; [Hsu, Chien-Yeh] Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan; [Cheng, Chiao-Wen] Natl Chiao Tung Univ, Dept Transportat & Logist Management, Taipei, Taiwan; [Yang, Kuo-Ching] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Hsu, Jung-Lung] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Hsu, Jung-Lung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsu, Jung-Lung] Taipei Med Univ, Grad Inst Humanities Med, Taipei, Taiwan	Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; National Yang Ming Chiao Tung University; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University	Chiu, HW (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.; Hsu, JL (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.; Hsu, JL (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Hsu, JL (corresponding author), Taipei Med Univ, Grad Inst Humanities Med, Taipei, Taiwan.	hwchiu@tmu.edu.tw; tulu@ms36.hinet.net	Chua, Chian Sem/A-6158-2015	Chua, Chian Sem/0000-0002-6740-9797; Chiu, Hung-Wen/0000-0001-6919-8199	Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-102-DR-14]	Shin Kong Wu Ho-Su Memorial Hospital	Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-102-DR-14). The funders had no role iin study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belter I., 2013, SCI CAIRO, V2013; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Chang FY, 2012, ASIA PAC J CLIN NUTR, V21, P594; Dragos D, 2012, J Med Life, V5, P398; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Gwee KA, 2005, NEUROGASTROENT MOTIL, V17, P317, DOI 10.1111/j.1365-2982.2005.00627.x; Haldane M, 2008, J PSYCHOPHARMACOL, V22, P138, DOI 10.1177/0269881107082955; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hobara M, 2005, EUR J PAIN, V9, P389, DOI 10.1016/j.ejpain.2004.09.006; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Khan S, 2010, NAT REV GASTRO HEPAT, V7, P565, DOI 10.1038/nrgastro.2010.137; Liu Mingxia, 2016, Med Image Comput Comput Assist Interv, V9900, P308, DOI 10.1007/978-3-319-46720-7_36; Liu MX, 2016, IEEE T MED IMAGING, V35, P1463, DOI 10.1109/TMI.2016.2515021; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, AM J GASTROENTEROL, V107, P991, DOI 10.1038/ajg.2012.131; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Murrough JW, 2016, HUM BRAIN MAPP, V37, P3214, DOI 10.1002/hbm.23235; Piche M, 2013, J PAIN, V14, P1217, DOI 10.1016/j.jpain.2013.05.009; Schmaal L., 2016, MOL PSYCHIAT; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Silverman DHS, 1997, GASTROENTEROLOGY, V112, P64, DOI 10.1016/S0016-5085(97)70220-8; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wong D L, 1988, Okla Nurse, V33, P8; Xie C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127815	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183960	10.1371/journal.pone.0183960	http://dx.doi.org/10.1371/journal.pone.0183960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859146	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500051
J	Schulte, EM; Smeal, JK; Gearhardt, AN				Schulte, Erica M.; Smeal, Julia K.; Gearhardt, Ashley N.			Foods are differentially associated with subjective effect report questions of abuse liability	PLOS ONE			English	Article							ADDICTION SCALE; DRUG-ADDICTION; EATING-DISORDERS; MEAT CONSUMPTION; SUGAR ADDICTION; PALATABLE FOOD; SUBSTANCE USE; ANIMAL-MODEL; NICOTINE; OBESITY	Objectives The current study investigates which foods may be most implicated in addictive-like eating by examining how nutritionally diverse foods relate to loss of control consumption and various subjective effect reports. Subjective effect reports assess the abuse liabilities of substances and may similarly provide insight into which foods may be reinforcing in a manner that triggers an addictive-like response for some individuals. Design Cross-sectional. Setting Online community. Participants 507 participants (n = 501 used in analyses) recruited through Amazon MTurk. Measurements Participants (n = 501) self-reported how likely they were to experience a loss of control over their consumption of 30 nutritionally diverse foods and rated each food on five subjective effect report questions that assess the abuse liability of substances (liking, pleasure, craving, averseness, intensity). Hierarchical cluster analytic techniques were used to examine how foods grouped together based on each question. Results Highly processed foods, with added fats and/or refined carbohydrates, clustered together and were associated with greater loss of control, liking, pleasure, and craving. The clusters yielded from the subjective effect reports assessing liking, pleasure, and craving were most similar to clusters formed based on loss of control over consumption, whereas the clusters yielded from averseness and intensity did not meaningfully differentiate food items. Conclusion The present work applies methodology used to assess the abuse liability of substances to understand whether foods may vary in their potential to be associated with addictive-like consumption. Highly processed foods (e.g., pizza, chocolate) appear to be most related to an indicator of addictive-like eating (loss of control) and several subjective effect reports (liking, pleasure, craving). Thus, these foods may be particularly reinforcing and capable of triggering an addictive-like response in some individuals. Future research is warranted to understand whether highly processed foods are related to these indicators of abuse liability at a similar magnitude as addictive substances.	[Schulte, Erica M.; Smeal, Julia K.; Gearhardt, Ashley N.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schulte, EM (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	eorenste@umich.edu		LaFata, Erica/0000-0002-8505-6366	NIH [DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work utilized Core Services supported by grant DK089503 of NIH to the University of Michigan.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2013, CURR OPIN CLIN NUTR, V16, P434, DOI 10.1097/MCO.0b013e328361c8b8; [Anonymous], DSM 5; [Anonymous], 2012, SCI STANDARDS STUDIE; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2012, NAT REV NEUROSCI, V13, DOI 10.1038/nrn3212-c1; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Carter LP, 2009, DRUG ALCOHOL DEPEN, V105, pS14, DOI 10.1016/j.drugalcdep.2009.04.003; Cocores JA, 2009, MED HYPOTHESES, V73, P892, DOI 10.1016/j.mehy.2009.06.049; Comer SD, 2008, DRUG ALCOHOL DEPEN, V96, P1, DOI 10.1016/j.drugalcdep.2008.03.001; Corsica JA, 2010, CURR OPIN GASTROEN, V26, P165, DOI 10.1097/MOG.0b013e328336528d; Corwin RL, 2009, J NUTR, V139, P617, DOI 10.3945/jn.108.097691; Corwin RLW, 2014, FRUCTOSE HIGH FRUCTO, P199, DOI DOI 10.1007/978-1-4899-8077-9_13; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Davis C, 2013, PHYSIOL BEHAV, V118, P63, DOI 10.1016/j.physbeh.2013.05.014; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FISCHMAN MW, 1991, BRIT J ADDICT, V86, P1563; Flint AJ, 2014, AM J CLIN NUTR, V99, P578, DOI 10.3945/ajcn.113.068965; Gearhardt AN, 2016, PSYCHOL ADDICT BEHAV, V30, P113, DOI 10.1037/adb0000136; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Gold M.S., 2003, PSYCHIAT ANN; Griffiths RR, 2003, DRUG ALCOHOL DEPEN, V70, pS41, DOI 10.1016/S0376-8716(03)00098-X; Hagan MM, 2003, INT J EAT DISORDER, V34, P183, DOI 10.1002/eat.10168; Hatsukami DK, 2013, NICOTINE TOB RES, V15, P1259, DOI 10.1093/ntr/nts265; Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016; Henchion M, 2014, MEAT SCI, V98, P561, DOI 10.1016/j.meatsci.2014.06.007; HENNINGFIELD JE, 1991, BRIT J ADDICT, V86, P1571; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P887, DOI 10.1016/0091-3057(83)90099-0; HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743; HENNINGFIELD JE, 1988, CHEST, V93, pS37, DOI 10.1378/chest.93.2_Supplement.37S; Ifland J, 2015, J AM COLL NUTR, V34, P240, DOI 10.1080/07315724.2015.1022466; Inc. S, 2016, SPSS STAT MAC; Jaffe J H, 1989, NIDA Res Monogr, V92, P43; Jasinski D R, 1989, NIDA Res Monogr, V92, P73; JASINSKI DR, 1984, TRENDS PHARMACOL SCI, V5, P196, DOI 10.1016/0165-6147(84)90415-2; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; LUDWIG AM, 1974, Q J STUD ALCOHOL, V35, P108; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Meule A., 2014, CURR ADDICT REP, V1, P193, DOI [10.1007/s40429-014-0021-z, DOI 10.1007/S40429-014-0021-Z]; Meule A, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00038, 10.3389/fpsyg.2014.00190]; Morgan CM, 2002, INT J EAT DISORDER, V31, P430, DOI 10.1002/eat.10038; Murphy CM, 2014, APPETITE, V73, P45, DOI 10.1016/j.appet.2013.10.008; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Ozersky Josh, 2010, Time, V175, P43; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Peer K, 2013, DRUG ALCOHOL DEPEN, V127, P215, DOI 10.1016/j.drugalcdep.2012.07.009; Pivarunas B, 2015, EAT BEHAV, V19, P9, DOI 10.1016/j.eatbeh.2015.06.007; Polk SE, 2017, APPETITE, V115, P45, DOI 10.1016/j.appet.2016.11.015; Preston KL, 1998, DRUG ABUSE HDB, P276; Pursey Kirrilly M, 2015, Addict Behav Rep, V2, P41, DOI 10.1016/j.abrep.2015.05.007; Robinson MJF, 2015, NEUROPSYCHOPHARMACOL, V40, P2113, DOI 10.1038/npp.2015.71; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schoedel KA, 2008, CLIN PHARMACOL THER, V83, P622, DOI 10.1038/sj.clpt.6100492; Schulte EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117959; Sonneville KR, 2013, JAMA PEDIATR, V167, P149, DOI 10.1001/2013.jamapediatrics.12; Tanofsky-Kraff M, 2009, INT J EAT DISORDER, V42, P26, DOI 10.1002/eat.20580; Tekol Y, 2006, MED HYPOTHESES, V67, P1233, DOI 10.1016/j.mehy.2006.04.041; Vansickel AR, 2010, CANCER EPIDEM BIOMAR, V19, P1945, DOI 10.1158/1055-9965.EPI-10-0288; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Young SE, 2002, DRUG ALCOHOL DEPEN, V68, P309, DOI 10.1016/S0376-8716(02)00225-9; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	67	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e184220	10.1371/journal.pone.0184220	http://dx.doi.org/10.1371/journal.pone.0184220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859162	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500076
J	Abdala-Roberts, L; Pratt, R; Pratt, JD; Mooney, KA				Abdala-Roberts, Luis; Pratt, Riley; Pratt, Jessica D.; Mooney, Kailen A.			Traits underlying community consequences of plant intra-specific diversity	PLOS ONE			English	Article							ARTHROPOD COMMUNITY; SEX; HERBIVORE; PERFORMANCE; MYCORRHIZAL; RESPONSES; DENSITY; SCALE; ANTS	A plant's performance and interactions with other trophic levels are recorgnized to be contingent upon plant diversity and underlying associational dynamics, but far less is known about the plant traits driving such phenomena. We manipulated diversity in plant traits using pairs of plant and a substitutive design to elucidate the mechanisms underlying diversity effects operating at a fine spatial scale. Specifically, we measured the effects of diversity in sex (sexual monocultures vs. male and female genotypes together) and growth rate (growth rate monocultures vs. fast-and slow-growing genotypes together) on growth of the shrub Baccharis salicifolia and on above-and belowground consumers associated with this plant. We compared effects on associate abundance (# associates per plant) vs. density (# associates per kg plant biomass) to elucidate the mechanisms underlying diversity effects; effects on abundance but not density suggest diversity effects are mediated by resource abundance (i.e. plant biomass) alone, whereas effects on density suggest diversity effects are mediated by plant-based heterogeneity or quality. Sexual diversity increased root growth but reduced the density (but not abundance) of the dietary generalist aphid Aphis gossypii and its associated aphid-tending ants, suggesting sex mixtures were of lower quality to this herbivore (e.g. via reduced plant quality), and that this effect indirectly influenced ants. Sexual diversity had no effect on the abundance or density of parasitoids attacking A. gossypii, the dietary specialist aphid Uroleucon macolai, or mycorrhizae. In contrast, growth rate diversity did not influence plant growth or any associates except for the dietary specialist aphid U. macolai, which increased in both abundance and density at high diversity, suggesting growth rate mixtures were of higher quality to this herbivore. These results highlight that plant associational and diversity effects on consumers are contingent upon the source of plant trait variation, and that the nature of such dynamics may vary both within and among trophic levels.	[Abdala-Roberts, Luis] Univ Autonoma Yucatan, Dept Ecol Trop, Campus Ciencias Biol & Agropecuarias, Merida, Yucatan, Mexico; [Pratt, Riley; Pratt, Jessica D.; Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Pratt, Riley] Irvine Ranch Conservancy, Irvine, CA USA	Universidad Autonoma de Yucatan; University of California System; University of California Irvine	Mooney, KA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	mooneyk@uci.edu			NSF [DEB-1354734, DEB-1120794]; CONACyT repatriation grant [250934]; National Science Foundation [DEB-1354734, DEB-1120794]	NSF(National Science Foundation (NSF)); CONACyT repatriation grant; National Science Foundation(National Science Foundation (NSF))	This work was funded by NSF awards DEB-1354734 and DEB-1120794 to KAM, and LAR was supported by CONACyT repatriation grant 250934.; Victoria Hanna, Hong Chen, Annie Vo, Laura Ashmore, Wen-chi Ho and Rose Chang assisted in the field and lab. The San Joaquin Marsh Reserve of the University of California Natural Reserve System, and the UC-Irvine Greenhouse and Arboretum provided logistical support. National Science Foundation grants DEB-1354734 and DEB-1120794 to KAM	Abdala-Roberts L, 2016, ECOLOGY, V97, P743, DOI 10.1890/15-0444.1; Abdala-Roberts L, 2015, OIKOS, V124, P1527, DOI 10.1111/oik.02033; Abdala-Roberts L, 2014, ECOLOGY, V95, P2879, DOI 10.1890/13-2029.1; Abdala-Roberts L, 2013, OIKOS, V122, P1157, DOI 10.1111/j.1600-0706.2012.00159.x; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Ashman TL, 2005, AM J BOT, V92, P891, DOI 10.3732/ajb.92.5.891; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Bommarco R, 2003, OIKOS, V102, P440, DOI 10.1034/j.1600-0579.2003.12578.x; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; Crawford KM, 2013, ECOLOGY, V94, P1025, DOI 10.1890/12-1468.1; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Delph LF, 1999, GENDER SEXUAL DIMORP, P149, DOI DOI 10.1007/978-3-662-03908-3_6; Fichtner A, 2017, ECOL LETT, V20, P892, DOI 10.1111/ele.12786; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Geber MA, 1999, GENDER SEXUAL DIMORP; Hajek P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00415; Halpern SL, 2014, ECOL ENTOMOL, V39, P217, DOI 10.1111/een.12088; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Hughes AR, 2014, J ECOL, V102, P651, DOI 10.1111/1365-2745.12244; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kim TN, 2015, ECOLOGY, V96, P1431, DOI 10.1890/14-1097.1; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kos M, 2015, ECOLOGY, V96, P164, DOI 10.1890/14-0563.1; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; McArt SH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0639; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Mooney K.A., 2012, TRAIT MEDIATED INDIR, P107; Mooney KA, 2012, ARTHROPOD-PLANT INTE, V6, P553, DOI 10.1007/s11829-012-9204-5; Mooney KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034403; Moreira X, 2016, CURR OPIN INSECT SCI, V14, P1, DOI 10.1016/j.cois.2015.10.003; Moreira X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105438; Moreira X, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0133; Moritz KK, 2016, ECOL EVOL, V6, P1154, DOI 10.1002/ece3.1923; Petry WK, 2013, ECOLOGY, V94, P2055, DOI 10.1890/12-2170.1; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; SAS Institute Inc, 2008, SAS VERS 9 2; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Varga S, 2010, ECOLOGY, V91, P2583, DOI 10.1890/09-1383.1; Vega-Frutis R, 2013, PLANT BIOLOGY, V15, P558, DOI 10.1111/j.1438-8677.2012.00673.x	49	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183493	10.1371/journal.pone.0183493	http://dx.doi.org/10.1371/journal.pone.0183493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886028	gold, Green Published			2022-12-26	WOS:000410001100026
J	Chang, HH; Moro, A; Takakura, K; Su, HY; Mo, A; Nakanishi, M; Waldron, RT; French, SW; Dawson, DW; Hines, OJ; Li, G; Go, VLW; Sinnett-Smith, J; Pandol, SJ; Lugea, A; Gukovskaya, AS; Duff, MO; Rosenberg, DW; Rozengurt, E; Eibl, G				Chang, Hui-Hua; Moro, Aune; Takakura, Kazuki; Su, Hsin-Yuan; Mo, Allen; Nakanishi, Masako; Waldron, Richard T.; French, Samuel W.; Dawson, David W.; Hines, O. Joe; Li, Gang; Go, Vay Liang W.; Sinnett-Smith, James; Pandol, Stephen J.; Lugea, Aurelia; Gukovskaya, Anna S.; Duff, Michael O.; Rosenberg, Daniel W.; Rozengurt, Enrique; Eibl, Guido			Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice	PLOS ONE			English	Article							BODY-MASS INDEX; KRAS(G12D) MOUSE MODEL; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINOMA; TUMOR-GROWTH; AUTOPHAGY; PROGRESSION; OBESITY; CELLS; RISK	Epidemiologic data has linked obesity to a higher risk of pancreatic cancer, but the underlying mechanisms are poorly understood. To allow for detailed mechanistic studies in a relevant model mimicking diet-induced obesity and pancreatic cancer, a high-fat, high-calorie diet (HFCD) was given to P48(+/Cre); LSL-KRAS(G12D) (KC) mice carrying a pancreas-specific oncogenic Kras mutation. The mice were randomly allocated to a HFCD or control diet (CD). Cohorts were sacrificed at 3, 6, and 9 months and tissues were harvested for further analysis. Compared to CD-fed mice, HFCD-fed animals gained significantly more weight. Importantly, the cancer incidence was remarkably increased in HFCD-fed KC mice, particularly in male KC mice. In addition, KC mice fed the HFCD showed more extensive inflammation and fibrosis, and more advanced PanIN lesions in the pancreas, compared to agematched CD-fed animals. Interestingly, we found that the HFCD reduced autophagic flux in PanIN lesions in KC mice. Further, exome sequencing of isolated murine PanIN lesions identified numerous genetic variants unique to the HFCD. These data underscore the role of sustained inflammation and dysregulated autophagy in diet-induced pancreatic cancer development and suggest that diet-induced genetic alterations may contribute to this process. Our findings provide a better understanding of the mechanisms underlying the obesity-cancer link in males and females, and will facilitate the development of interventions targeting obesity-associated pancreatic cancer.	[Chang, Hui-Hua; Moro, Aune; Hines, O. Joe; Eibl, Guido] UCLA, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Takakura, Kazuki; Waldron, Richard T.; Go, Vay Liang W.; Sinnett-Smith, James; Pandol, Stephen J.; Lugea, Aurelia; Gukovskaya, Anna S.; Rozengurt, Enrique] UCLA, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; [Takakura, Kazuki; Waldron, Richard T.; Sinnett-Smith, James; Pandol, Stephen J.; Lugea, Aurelia; Gukovskaya, Anna S.; Rozengurt, Enrique] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Su, Hsin-Yuan; Waldron, Richard T.; Pandol, Stephen J.; Lugea, Aurelia] Cedars Sinai Med Ctr, Dept Med, Pancreat Res Grp, Los Angeles, CA 90048 USA; [Mo, Allen; Nakanishi, Masako; Rosenberg, Daniel W.] UCONN Hlth, Ctr Mol Oncol, Farmington, CT USA; [French, Samuel W.] Harbor UCLA Med Ctr, Dept Pathol, Torrance, CA 90509 USA; [French, Samuel W.] Univ Southern Calif, Southern Calif Res Ctr ALPD & Cirrhosis, Dept Pathol, Keck Sch Med, Los Angeles, CA USA; [Dawson, David W.] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Li, Gang] UCLA, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Duff, Michael O.] UCONN Hlth, Dept Genet & Genome Sci, Farmington, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Eibl, G (corresponding author), UCLA, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.	GEibl@mednet.ucla.edu	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002; Gukovskaya, Anna/0000-0003-3737-5335	National Institute of Health [P01 CM63200, R01 AA019954]; NIDDK [P30DK41301]; Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P50CA211015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019954] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by the National Institute of Health (P01 CM63200 to GE and R01 AA019954 to AL), the NIDDK-supported CURE: Digestive Diseases Research Core Center Grant (P30DK41301 to ER), and the Hirshberg Foundation for Pancreatic Cancer Research (http://pancreatic.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajan M, 2012, J GASTROEN HEPATOL, V27, P10, DOI 10.1111/j.1440-1746.2011.07008.x; Albini A, 2016, CLIN CANCER RES, V22, P4322, DOI 10.1158/1078-0432.CCR-16-0695; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Hertzer KM, 2015, PANCREAS; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2007, MODERN PATHOL, V20, pS61, DOI 10.1038/modpathol.3800685; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kensler TW, 2016, CANCER PREV RES, V9, P2, DOI 10.1158/1940-6207.CAPR-15-0406; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Langhe RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10909; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Luo J, 2008, BRIT J CANCER, V99, P527, DOI 10.1038/sj.bjc.6604487; McAndrews KM, 2015, ACS CHEM BIOL, V10, P1932, DOI 10.1021/acschembio.5b00353; Meyskens Jr F. L., 2016, J NATL CANC I, V108; Mohamed A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00070; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Okumura T, 2017, ONCOTARGET, V8, P18280, DOI 10.18632/oncotarget.15430; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rozengurt E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00357; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; United States, 2014, CANCER RES, V74, P2913; Vongsuvanh R, 2013, CANCER LETT, V330, P1, DOI 10.1016/j.canlet.2012.11.038; Waghray M, 2013, CURR OPIN GASTROEN, V29, P537, DOI 10.1097/MOG.0b013e328363affe; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111	48	71	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184455	10.1371/journal.pone.0184455	http://dx.doi.org/10.1371/journal.pone.0184455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886117	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100125
J	Needell, JC; Ir, D; Robertson, CE; Kroehl, ME; Frank, DN; Zipris, D				Needell, James C.; Ir, Diana; Robertson, Charles E.; Kroehl, Miranda E.; Frank, Daniel N.; Zipris, Danny			Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring	PLOS ONE			English	Article							GUT MICROBIOTA; INFLAMMATORY RESPONSES; INNATE IMMUNITY; KILHAM RAT; VIRUS; METABOLITES; INTERFACE; DISEASE; CELLS	We recently hypothesized that the intestinal microbiota and the innate immune system play key roles in the mechanism of Kilham Rat Virus-induced type 1 diabetes in the LEW1. WR1 rat. We used this animal model to test the hypothesis that maternal therapy with short-chain fatty acids can modulate the intestinal microbiota and reverse virus-induced proinflammatory responses and type 1 diabetes in rat offspring. We observed that administration of short-chain fatty acids to rat breeders via drinking water prior to pregnancy and further treatment of the offspring with short-chain fatty acids after weaning led to disease amelioration. In contrast, rats that were administered short-chain fatty acids beginning at weaning were not protected from type 1 diabetes. Short-chain fatty acid therapy exerted a profound effect on the intestinal microbiome in the offspring reflected by a reduction and an increase in the abundances of Firmicutes and Bacteroidetes taxa, respectively, on day 5 post-infection, and reversed virus-induced alterations in certain bacterial taxa. Principal component analysis and permutation multivariate analysis of variance tests further revealed that short-chain fatty acids induce a distinct intestinal microbiota compared with uninfected animals or rats that receive the virus only. Short-chain fatty acids downregulated Kilham Rat Virus-induced proinflammatory responses in the intestine. Finally, short-chain fatty acids altered the B and T cell compartments in Peyer's patches. These data demonstrate that short-chain fatty acids can reshape the intestinal microbiota and prevent virus-induced islet autoimmunity and may therefore represent a useful therapeutic strategy for disease prevention.	[Needell, James C.; Zipris, Danny] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Microbiome Res Consortium MiRC, Aurora, CO USA; [Kroehl, Miranda E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Kroehl, Miranda E.] Univ Colorado Denver, Aurora, CO USA; [Zipris, Danny] Innate Biotechnol LLC, Denver, CO 80231 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zipris, D (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.; Zipris, D (corresponding author), Innate Biotechnol LLC, Denver, CO 80231 USA.	zdanny@innatebiotechnologies.com		ROBERTSON, CHARLES/0000-0002-4136-4121	NIH/NCATS Colorado CCTSI [UL1 TR001082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH/NCATS Colorado CCTSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NCATS Colorado CCTSI Grant Number UL1 TR001082. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Culina S, 2012, DIABETES METAB, V38, P379, DOI 10.1016/j.diabet.2012.05.005; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; GUBERSKI DL, 1991, SCIENCE, V254, P1010, DOI 10.1126/science.1658938; Hara N, 2013, J MOL MED, P1; Hara N, 2014, INNATE IMMUN-LONDON, V20, P574, DOI 10.1177/1753425913502242; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huang CB, 2011, ARCH ORAL BIOL, V56, P650, DOI 10.1016/j.archoralbio.2011.01.011; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Londono P, 2010, CLIN IMMUNOL, V135, P401, DOI 10.1016/j.clim.2010.01.007; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Myles IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087181; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Toivonen RK, 2014, DIABETOLOGIA, V57, P2183, DOI 10.1007/s00125-014-3325-6; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wolter TR, 2009, CLIN IMMUNOL, V132, P103, DOI 10.1016/j.clim.2009.02.007; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhou YN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6381; Zipris D, 2003, J IMMUNOL, V170, P3592, DOI 10.4049/jimmunol.170.7.3592; Zipris D, 2007, J IMMUNOL, V178, P693, DOI 10.4049/jimmunol.178.2.693	53	33	38	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183786	10.1371/journal.pone.0183786	http://dx.doi.org/10.1371/journal.pone.0183786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886045	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100039
J	Swathy, B; Banerjee, M				Swathy, Babu; Banerjee, Moinak			Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells	PLOS ONE			English	Article							ANTIPSYCHOTIC-DRUG TREATMENT; LIPID-METABOLISM; SCHIZOPHRENIA; RECEPTOR; ASSOCIATION; OLANZAPINE; BRAIN	Introduction Haloperidol has been extensively used in various psychiatric conditions. It has also been reported to induce severe side effects. We aimed to evaluate whether haloperidol can influence host methylome, and if so what are the possible mechanisms for it in neuronal cells. Impact on host methylome and miRNAs can have wide spread alterations in gene expression, which might possibly help in understanding how haloperidol may impact treatment response or induce side effects. Methods SK-N-SH, a neuroblasoma cell line was treated with haloperidol at 10 mu m concentration for 24 hours and global DNA methylation was evaluated. Methylation at global level is maintained by methylation maintenance machinery and certain miRNAs. Therefore, the expression of methylation maintenance genes and their putative miRNA expression profiles were assessed. These global methylation alterations could result in gene expression changes. Therefore genes expressions for neurotransmitter receptors, regulators, ion channels and transporters were determined. Subsequently, we were also keen to identify a strong candidate miRNA based on biological and in-silico approach which can reflect on the pharmacoepigenetic trait of haloperidol and can also target the altered neuroscience panel of genes used in the study. Results Haloperidol induced increase in global DNA methylation which was found to be associated with corresponding increase in expression of various epigenetic modifiers that include DNMT1, DNMT3A, DNMT3B and MBD2. The expression of miR-29b that is known to putatively regulate the global methylation by modulating the expression of epigenetic modifiers was observed to be down regulated by haloperidol. In addition to miR-29b, miR-22 was also found to be downregulated by haloperidol treatment. Both these miRNA are known to putatively target several genes associated with various epigenetic modifiers, pharmacogenes and neurotransmission. Interestingly some of these putative target genes involved in neurotransmission were observed to be upregulated while CHRM2 gene expression was down regulated. Conclusions Haloperidol can influence methylation traits thereby inducing a pharmacoepigenomic response, which seems to be regulated by DNMTs and their putative miRNA expression. Increased methylation seems to influence CHRM2 gene expression while microRNA could influence neurotransmission, pharmacogene expression and methylation events. Altered expression of various therapeutically relevant genes and miRNA expression, could account for their role in therapeutic response or side effects.	[Swathy, Babu; Banerjee, Moinak] Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Banerjee, M (corresponding author), Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India.	moinak_ban@hotmail.com	Banerjee, Moinak/X-4471-2018	Banerjee, Moinak/0000-0002-0842-0398	Dept. of Biotechnology, Government of India	Dept. of Biotechnology, Government of India	SB and MB acknowledges Dept. of Biotechnology, Government of India for providing research fellowship to SB and intramural support to MB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SB and MB acknowledges Dept. of Biotechnology, Government of India for providing research fellowship to SB and intramural support to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feher LZ, 2005, NEUROCHEM INT, V47, P271, DOI 10.1016/j.neuint.2005.04.020; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Inoue A, 1998, MOL BRAIN RES, V55, P285, DOI 10.1016/S0169-328X(98)00009-6; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kornhuber J, 1999, AM J PSYCHIAT, V156, P885, DOI 10.1176/ajp.156.6.885; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; MACGIBBON GA, 1994, MOL BRAIN RES, V23, P21, DOI 10.1016/0169-328X(94)90207-0; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Melka Melkaye G, 2013, J Mol Psychiatry, V1, P19, DOI 10.1186/2049-9256-1-19; Melka MG, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-1; Minet-Ringuet J, 2007, MOL PSYCHIATR, V12, P562, DOI 10.1038/sj.mp.4001948; Miyauchi M, 2016, NEUROPSYCHOBIOLOGY, V74, P60, DOI 10.1159/000452770; Narayan S, 2007, J NEUROSCI RES, V85, P757, DOI 10.1002/jnr.21161; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Santarelli DM, 2013, PSYCHOPHARMACOLOGY, V227, P67, DOI 10.1007/s00213-012-2939-y; Scarr E, 2009, MOL PSYCHIATR, V14, P1017, DOI 10.1038/mp.2008.28; Shi WT, 2012, J PSYCHIATR RES, V46, P198, DOI 10.1016/j.jpsychires.2011.09.010; Shimabukuro M, 2006, BEHAV BRAIN FUNCT, V2, P1, DOI DOI 10.1186/1744-9081-2-1; Swathy B, 2017, EPIGENOMICS-UK, V9, P721, DOI 10.2217/epi-2016-0106; Thomas EA, 2003, MOL PSYCHIATR, V8, P983, DOI 10.1038/sj.mp.4001425	21	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184209	10.1371/journal.pone.0184209	http://dx.doi.org/10.1371/journal.pone.0184209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886082	Green Published, gold			2022-12-26	WOS:000410001100081
J	Gaisberger, H; Kindt, R; Loo, J; Schmidt, M; Bognounou, F; Da, SS; Diallo, OB; Ganaba, S; Gnoumou, A; Lompo, D; Lykke, AM; Mbayngone, E; Nacoulma, BMI; Ouedraogo, M; Ouedraogo, O; Parkouda, C; Porembski, S; Savadogo, P; Thiombiano, A; Zerbo, G; Vinceti, B				Gaisberger, Hannes; Kindt, Roeland; Loo, Judy; Schmidt, Marco; Bognounou, Fidele; Da, Sie Sylvestre; Diallo, Ousmane Boukary; Ganaba, Souleymane; Gnoumou, Assan; Lompo, Djingdia; Lykke, Anne Mette; Mbayngone, Elisee; Nacoulma, Blandine Marie Ivette; Ouedraogo, Moussa; Ouedraogo, Oumarou; Parkouda, Charles; Porembski, Stefan; Savadogo, Patrice; Thiombiano, Adjima; Zerbo, Guibien; Vinceti, Barbara			Spatially explicit multi-threat assessment of food tree species in Burkina Faso: A fine-scale approach	PLOS ONE			English	Article							WEST-AFRICA; LAND-USE; CLIMATE; CONSERVATION; BIODIVERSITY; VEGETATION; CONSENSUS; EXAMPLE; IMPACT; FRUITS	Over the last decades agroforestry parklands in Burkina Faso have come under increasing demographic as well as climatic pressures, which are threatening indigenous tree species that contribute substantially to income generation and nutrition in rural households. Analyzing the threats as well as the species vulnerability to them is fundamental for priority setting in conservation planning. Guided by literature and local experts we selected 16 important food tree species (Acacia macrostachya, Acacia senegal, Adansonia digitata, Annona senegalensis, Balanites aegyptiaca, Bombax costatum, Boscia senegalensis, Detarium microcarpum, Lannea microcarpa, Parkia biglobosa, Sclerocarya birrea, Strychnos spinosa, Tamarindus indica, Vitellaria paradoxa, Ximenia americana, Ziziphus mauritiana) and six key threats to them (overexploitation, overgrazing, fire, cotton production, mining and climate change). We developed a species-specific and spatially explicit approach combining freely accessible datasets, species distribution models (SDMs), climate models and expert survey results to predict, at fine scale, where these threats are likely to have the greatest impact. We find that all species face serious threats throughout much of their distribution in Burkina Faso and that climate change is predicted to be the most prevalent threat in the long term, whereas overexploitation and cotton production are the most important short-term threats. Tree populations growing in areas designated as 'highly threatened' due to climate change should be used as seed sources for ex situ conservation and planting in areas where future climate is predicting suitable habitats. Assisted regeneration is suggested for populations in areas where suitable habitat under future climate conditions coincides with high threat levels due to short-term threats. In the case of Vitellaria paradoxa, we suggest collecting seed along the northern margins of its distribution and considering assisted regeneration in the central part where the current threat level is high due to overexploitation. In the same way, population-specific recommendations can be derived from the individual and combined threat maps of the other 15 food tree species. The approach can be easily transferred to other countries and can be used to analyze general and species specific threats at finer and more local as well as at broader (continental) scales in order to plan more selective and efficient conservation actions in time. The concept can be applied anywhere as long as appropriate spatial data are available as well as knowledgeable experts.	[Gaisberger, Hannes; Loo, Judy; Vinceti, Barbara] Biovers Int, Via Tre Denari 472-A, Rome, Italy; [Kindt, Roeland] World Agroforestry Ctr ICRAF, Nairobi, Kenya; [Schmidt, Marco] Senckenberg Biodivers & Climate Res Ctr, Data & Modelling Ctr, Senckenberganlage 25, Frankfurt, Germany; [Bognounou, Fidele] Univ Quebec, 2600 Blvd Laurier, Ville De Quebec, PQ, Canada; [Da, Sie Sylvestre] West African Sci Serv Ctr Climate Change & Adapte, Blvd Mouammar Kadhafi, Ouagadougou, Burkina Faso; [Diallo, Ousmane Boukary; Ganaba, Souleymane] INERA CNRST, Environm & Agr Res Inst, Ouagadougou, Burkina Faso; [Gnoumou, Assan] Univ Aube Nouvelle, Ouagadougou, Burkina Faso; [Lompo, Djingdia; Ouedraogo, Moussa; Zerbo, Guibien] CNSF, Natl Forest Seed Ctr, Ouagadougou, Burkina Faso; [Lykke, Anne Mette] Aarhus Univ, Vejlsovej 25, Silkeborg, Denmark; [Mbayngone, Elisee] Univ NDjamena, Ave Mobutu, Ndjamena, Chad; [Nacoulma, Blandine Marie Ivette; Ouedraogo, Oumarou; Thiombiano, Adjima] Univ Ouagadougou, Lab Bot & Plant Ecol, Ouagadougou, Burkina Faso; [Parkouda, Charles] DTA, IRSAT CNRST, Dept Food Technol, Ouagadougou, Burkina Faso; [Porembski, Stefan] Univ Rostock, Rostock, Germany; [Savadogo, Patrice] World Agroforestry Ctr, Niamey, Niger; [Savadogo, Patrice] Int Crop Res Inst Semiarid Trop ICRAF ICRISAT, Niamey, Niger	Alliance; Bioversity International; CGIAR; World Agroforestry (ICRAF); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Quebec; Aarhus University; University of Rostock; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Gaisberger, H (corresponding author), Biovers Int, Via Tre Denari 472-A, Rome, Italy.	h.gaisberger@cgiar.org	Bognounou, Fidèle/E-5190-2013; ZERBO, Guibien Cléophas/N-2002-2013; Savadogo, Patrice/AAJ-1116-2020; Lykke, Anne Mette/N-7051-2019; Schmidt, Marco/C-3821-2009; Nacoulma, Blandine Marie Ivette/AAJ-3125-2020; Kindt, Roeland/AAV-3346-2020	Bognounou, Fidèle/0000-0003-2809-6078; Lykke, Anne Mette/0000-0002-4337-8607; Schmidt, Marco/0000-0001-6087-6117; Kindt, Roeland/0000-0002-7672-0712; Gaisberger, Hannes/0000-0002-6023-1236	Austria Development Agency [12610]; CGIAR Research Program on Forests, Trees and Agroforestry; CGIAR Research Program on Forests, Trees and Agroforestry (FTA)	Austria Development Agency; CGIAR Research Program on Forests, Trees and Agroforestry(CGIAR); CGIAR Research Program on Forests, Trees and Agroforestry (FTA)(CGIAR)	This work was supported by Austria Development Agency, Grant 12610, http://www. entwicklung.at/en/, to BV; and CGIAR Research Program on Forests, Trees and Agroforestry, http://foreststreesagroforestry.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Finally, we would like to thank all donors who supported this research through their contributions to the CGIAR Research Program on Forests, Trees and Agroforestry (FTA).	Binam JN, 2015, ENVIRON ECON POLICY, V17, P543, DOI 10.1007/s10018-015-0107-4; Bioversity International, SAFOREN W AFR MAD FO; Boffa J. M., 1999, AGROFORESTRY PARKLAN; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; DGAT, 2010, 1 MIN EC FIN, P456; Dressler S, 2014, TAXON, V63, P1159, DOI [10.12705/635.26, DOI 10.12705/635.26]; Faye M. D., 2011, Forests, Trees and Livelihoods, V20, P113; Fischer C, 2011, FOREST ECOL MANAG, V262, P1532, DOI 10.1016/j.foreco.2011.07.001; Gonzalez P, 2012, J ARID ENVIRON, V78, P55, DOI 10.1016/j.jaridenv.2011.11.001; Henry S, 2004, POPUL ENVIRON, V25, P423, DOI 10.1023/B:POEN.0000036928.17696.e8; Heubes J, 2012, MODELLING IMPACT FUT; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Higgins J, 2010, ECOREGIONAL ASSESSME; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; ICRAF, AGR DAT; ICRAF, 2006, 799 ICRAF IFAD WORLD; IMF (International Monetary Fund), 2014, 14230 IMF; IUCN-CMP (International Union for the Conservation of Nature-Conservation Measures Partnership), 2007, WORKING PAPER; Jamnadass RH, 2011, INT FOREST REV, V13, P338, DOI 10.1505/146554811798293836; Jarvis A, 2010, J NAT CONSERV, V18, P180, DOI 10.1016/j.jnc.2009.08.003; Kindt R., 2015, BIODIVERSITYR PACKAG; Kindt R, 2008, BIODIVERS CONSERV, V17, P1883, DOI 10.1007/s10531-008-9326-3; Lamien N, 1995, USE COMMERCIALIZATIO; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126252; Maranz S, 2004, ECON BOT, V58, P588, DOI 10.1663/0013-0001(2004)058[0588:NVAIPF]2.0.CO;2; Maranz S, 2009, J BIOGEOGR, V36, P1181, DOI 10.1111/j.1365-2699.2008.02081.x; McPherson M., 2008, J CONSERV PLANN, V4, P60; Metcalf SJ, 2013, BIOL CONSERV, V162, P1, DOI 10.1016/j.biocon.2013.03.005; NASA's Earth Observing System Data and Information System (EOSDIS), 2012, FIR INF RES MAN SYST; Ofori DA, 2014, CURR OPIN ENV SUST, V6, P123, DOI 10.1016/j.cosust.2013.11.016; Pare A L., 2001, NEGOTIATING RIGHTS A; Pica-Ciamarra U., 2007, Land Reform, Land Settlement and Cooperatives, P19; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Ranjitkar S, 2016, ENVIRON MODELL SOFTW, V75, P263, DOI 10.1016/j.envsoft.2015.10.027; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Ryan CM, 2011, ECOL APPL, V21, P48, DOI 10.1890/09-1489.1; SAFORGEN Food Tree Species Working Group, 2000, PRIOR FOOD TREE SPEC; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Schmidt Marco, 2012, Biodiversity Ecol, V4, P105, DOI 10.7809/b-e.00065; Some A L, 2013, IFPRI RES MONOGRAPH, P79; Stadlmayr B, 2013, J SCI FOOD AGR, V93, P2627, DOI 10.1002/jsfa.6196; Swenson NG, 2010, ECOLOGY, V91, P2234, DOI 10.1890/09-1743.1; Teklehaimanot Z, 2004, AGROFOREST SYST, V61-2, P207, DOI 10.1023/B:AGFO.0000029000.22293.d1; Terrible PB, 1975, ATLAS HAUTE VOLTA AR; TNC, 2007, CONS ACT PLANN HDB D; TNC (The Nature Conservancy), 2003, SUCCESS; UNDP, 2020, HUM DEV DAT 1990 201; USDA (United States Department of Agriculture), 2015, 2015 W AFR COTT PROD; USGS, 2011, MIN RES DAT SYST MRD; van Breugel P, 2016, ECOSYSTEMS, V19, P369, DOI 10.1007/s10021-015-9938-x; van Zonneveld M, 2014, APPL VEG SCI, V17, P528, DOI 10.1111/avsc.12081; Vieilledent G, 2013, BIOL CONSERV, V166, P11, DOI 10.1016/j.biocon.2013.06.007; Vinceti B, 2013, SUSTAINABILITY-BASEL, V5, P4797, DOI 10.3390/su5114797; Wezel A., 2006, Environment Development and Sustainability, V8, P553, DOI 10.1007/s10668-006-9055-2; World Database on Protected Areas (WDPA), 2010, WDPA IS JOINT PROD U; Zizka A, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-9	58	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184457	10.1371/journal.pone.0184457	http://dx.doi.org/10.1371/journal.pone.0184457			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880962	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000409467200072
J	Poznanski, RR; Cacha, LA; Ali, J; Rizvi, ZH; Yupapin, P; Salleh, SH; Bandyopadhyay, A				Poznanski, R. R.; Cacha, L. A.; Ali, J.; Rizvi, Z. H.; Yupapin, P.; Salleh, S. H.; Bandyopadhyay, A.			Induced mitochondrial membrane potential for modeling solitonic conduction of electrotonic signals	PLOS ONE			English	Article							ELECTRIC-FIELDS; SYNAPTIC-TRANSMISSION; CABLE EQUATION; CAPACITANCE; PROPAGATION; DENDRITES; DIFFUSION; ELECTRODIFFUSION; SYSTEM	A cable model that includes polarization-induced capacitive current is derived for modeling the solitonic conduction of electrotonic potentials in neuronal branchlets with microstructure containing endoplasmic membranes. A solution of the nonlinear cable equation modified for fissured intracellular medium with a source term representing charge 'soakage' is used to show how intracellular capacitive effects of bound electrical charges within mitochondrial membranes can influence electrotonic signals expressed as solitary waves. The elastic collision resulting from a head-on collision of two solitary waves results in localized and non-dispersing electrical solitons created by the nonlinearity of the source term. It has been shown that solitons in neurons with mitochondrial membrane and quasi-electrostatic interactions of charges held by the microstructure (i.e., charge 'soakage') have a slower velocity of propagation compared with solitons in neurons with microstructure, but without endoplasmic membranes. When the equilibrium potential is a small deviation from rest, the nonohmic conductance acts as a leaky channel and the solitons are small compared when the equilibrium potential is large and the outer mitochondrial membrane acts as an amplifier, boosting the amplitude of the endogenously generated solitons. These findings demonstrate a functional role of quasi-electrostatic interactions of bound electrical charges held by microstructure for sustaining solitons with robust self-regulation in their amplitude through changes in the mitochondrial membrane equilibrium potential. The implication of our results indicate that a phenomenological description of ionic current can be successfully modeled with displacement current in Maxwell's equations as a conduction process involving quasi-electrostatic interactions without the inclusion of diffusive current. This is the first study in which solitonic conduction of electrotonic potentials are generated by polarization-induced capacitive current in microstructure and nonohmic mitochondrial membrane current.	[Poznanski, R. R.] Univ Teknol Malaysia, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia; [Cacha, L. A.; Ali, J.; Rizvi, Z. H.] Univ Teknol Malaysia, Ibnu Sina ISIR, Ctr Laser, Johor Baharu 81310, Malaysia; [Yupapin, P.] Ton Duc Thang Univ, CORG, Dist 7, Ho Chi Minh City, Vietnam; [Yupapin, P.] Ton Duc Thang Univ, Fac Elect & Elect Engn, Dist 7, Ho Chi Minh City, Vietnam; [Salleh, S. H.] Univ Teknol Malaysia, Ctr Biomed Engn, Johor Baharu 81310, Johor, Malaysia; [Bandyopadhyay, A.] Natl Inst Mat Sci, Res Ctr Adv Measurement & Characterizat, Tsukuba, Ibaraki 3050047, Japan	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Ton Duc Thang University; Ton Duc Thang University; Universiti Teknologi Malaysia; National Institute for Materials Science	Poznanski, RR (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia.	poznanski@biomedical.utm.my	Bandyopadhyay, Anirban/ABF-1728-2020	Bandyopadhyay, Anirban/0000-0002-8823-4914	UTM Postdoctoral Research Fellowship	UTM Postdoctoral Research Fellowship	L.A. Cacha was supported by UTM Postdoctoral Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research assistance provided by Yaseen M.S. Al-Wesabi in preparation of the manuscript for production is much appreciated. L.A. Cacha was supported by UTM Postdoctoral Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA Y, 1975, PROG THEOR PHYS, V53, P305, DOI 10.1143/PTP.53.305; ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; Bedard C, 2016, GEN CABLE MODELS NEU, P1; Bressloff PC, 2009, PHYS REV E, V79; Christov CI, 1996, PHYS REV E, V54, P3621, DOI 10.1103/PhysRevE.54.3621; Drazin PG., 1996, SOLITONS INTRO; DUBOIS DM, 1974, P NATL ACAD SCI USA, V71, P2858, DOI 10.1073/pnas.71.7.2858; El Hady A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7697; FERNANDEZ JM, 1983, J GEN PHYSIOL, V82, P331, DOI 10.1085/jgp.82.3.331; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; FRANKENHAEUSER B, 1964, J PHYSIOL-LONDON, V171, P302, DOI 10.1113/jphysiol.1964.sp007378; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P393, DOI 10.1113/jphysiol.1983.sp014541; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Ghosh S, 1999, J THEOR BIOL, V200, P299, DOI 10.1006/jtbi.1999.0993; Gonzalez-Perez A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031047; Halnes G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003386; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; Henry BI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.128103; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2015, NAT REV NEUROSCI, V16, P685, DOI 10.1038/nrn4022; Howell B, 2015, J NEURAL ENG, V13; Huxley A., 1959, J PHYSL, V148, p80P; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; Kasevich RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023412; Langlands TAM, 2009, J MATH BIOL, V59, P761, DOI 10.1007/s00285-009-0251-1; Lazarevich IA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062718; Leonetti M, 1999, EUROPHYS LETT, V46, P107, DOI 10.1209/epl/i1999-00568-7; Leonetti M, 1998, EUR PHYS J B, V2, P325, DOI 10.1007/s100510050256; Lindsay KA, 2004, PROG BIOPHYS MOL BIO, V85, P71, DOI 10.1016/j.pbiomolbio.2003.08.001; Maex R, 2017, J INTEGR NEUROSCI, V16, P73, DOI 10.3233/JIN-170008; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; MCILROY D K, 1970, Mathematical Biosciences, V7, P313, DOI 10.1016/0025-5564(70)90131-8; Meier SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122401; Mori Y, 2009, COMM APP MATH COM SC, V4, P85, DOI 10.2140/camcos.2009.4.85; Poznanski RR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01849-3; Poznanski RR, 2012, J INTEGR NEUROSCI, V11, P417, DOI 10.1142/S0219635212500264; Poznanski Roman R., 2004, Journal of Integrative Neuroscience, V3, P267, DOI 10.1142/S0219635204000439; Poznanski RR, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021902; QIAN N, 1989, BIOL CYBERN, V62, P1, DOI 10.1007/BF00217656; Qiu C, 2015, J NEUROSCI, V35, P15800, DOI 10.1523/JNEUROSCI.1045-15.2015; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rall W., COMPR PHYSIOL; Richardson G, 2009, MATH MED BIOL, V26, P201, DOI 10.1093/imammb/dqn027; Ricketts D.S., 2011, ELECT SOLITONS THEOR; RINZEL J, 1973, BIOPHYS J, V13, P1313, DOI 10.1016/S0006-3495(73)86065-5; Scott A., 1977, NEUROPHYSICS; SCOTT AC, 1973, P IEEE, V61, P1443, DOI 10.1109/PROC.1973.9296; Shemer I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000036; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Thompson CJ, 1999, CHAOS SOLITON FRACT, V10, P1825, DOI 10.1016/S0960-0779(98)00131-3; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Tuszynski JA, 2003, INTRO MOL BIOPHYSICS; Wazwaz AM, 2009, NONLINEAR PHYS SCI, P1, DOI 10.1007/978-3-642-00251-9; Zhang MM, 2014, J NEUROSCI, V34, P1409, DOI 10.1523/JNEUROSCI.3877-13.2014	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183677	10.1371/journal.pone.0183677	http://dx.doi.org/10.1371/journal.pone.0183677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880876	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200023
J	Tian, H; Wang, H; Hui, XL; Wang, ZH; Drijber, RA; Liu, JS				Tian, Hui; Wang, Hui; Hui, Xiaoli; Wang, Zhaohui; Drijber, Rhae A.; Liu, Jinshan			Changes in soil microbial communities after 10 years of winter wheat cultivation versus fallow in an organic-poor soil in the Loess Plateau of China	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; NITROGEN-FERTILIZER; MANAGEMENT REGIMES; NORTHEAST CHINA; BIOMASS-C; CARBON; CONSERVATION; PRODUCTIVITY; FUMIGATION; EXTRACTION	Agricultural management methods, such as cultivation or fallowing, have led to significant changes in soil fertility and hence, crop yield. Such changes may have stemmed from changes in soil microbial communities and associated biogeochemical processes. This phenomenon is particularly true in organic-poor soil in the Loess Plateau of China. In this study, we examined three existing soil management regimes as part of a 10-year field experiment and evaluated their effects on fungal and bacterial community structures by performing high-throughput 454 pyrosequencing. These management regimes were (i) fertilized winter wheat (Triticum aestivum L.) (FW), (ii) continuous natural fallow with weeds but without crop grown (NF), and (iii) continuous bare fallow without weeds or crop grown (BF). After 10 years, soil organic carbon (SOC), microbial biomass carbon (MBC), and available potassium (K) concentrations were highest in NF. Soil N behaved differently, with BF obtaining the highest nitrate nitrogen (N). Meanwhile, slight differences in total N (TN) were observed among FW, NF, and BF. Available phosphorus (P) was highest and available K was lowest in FW. Microbial communities were dominated by Ascomycota (59.1% of fungal sequences), and Acidobacteria, Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria (75.7% of bacterial sequences) in FW, NF and BF at the phylum level. Soil management regimes did not affect the fungal and bacterial richness and diversity but significantly modified their community compositions. Compared with FW, the abundances of Ascomycota (fungi phylum) and Alternaria, Gibberella, and Emericella (fungi genus) were increased by NF, whereas the values of Chaetomium, Humicola, and Cryptococcus (fungi genus) were decreased by BF. The abundances of Verrucomicrobia (bacteria phylum), and Steroidobacter (bacteria genus) were increased by NF, and Bacteroides (bacteria genus) was increased by BF. Canonical correspondence analysis showed that SOC, available P, and TN might be the key factors in community formation. Therefore, the decadal absence of plants (BF) affected soil fertility by increased available K and nitrate N, whileas natural fallow (NF) affected soil fertility by increased SOC, available K, and MBC, and they all changed fungal and bacterial community compositions.	[Tian, Hui; Wang, Hui; Hui, Xiaoli; Wang, Zhaohui; Liu, Jinshan] Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agroenvironm Northwest China, Minist Agr, Yangling, Shaanxi, Peoples R China; [Drijber, Rhae A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Nebraska System; University of Nebraska Lincoln	Liu, JS (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agroenvironm Northwest China, Minist Agr, Yangling, Shaanxi, Peoples R China.	jsliu@nwsuaf.edu.cn	LIU, JS/AFQ-6791-2022	Liu, J.S./0000-0001-9268-2595	National Natural Science Foundation of China [41501308, 41201238]; Chinese National Key Basic Research Special Funds [2015BAD23B04]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303104, 201503124]; Research Fund for the Doctoral Program of Higher Education of China [20120204120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research Special Funds(National Basic Research Program of China); Chinese Special Fund for Agro-scientific Research in the Public Interest; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported jointly by grants from the National Natural Science Foundation of China (41501308, 41201238), Chinese National Key Basic Research Special Funds (2015BAD23B04), and Chinese Special Fund for Agro-scientific Research in the Public Interest (201303104, 201503124), Research Fund for the Doctoral Program of Higher Education of China (20120204120012).; This research was supported jointly by grants from the National Natural Science Foundation of China (41501308, 41201238), Chinese National Key Basic Research Special Funds (2015BAD23B04), and Chinese Special Fund for Agro-scientific Research in the Public Interest (201303104, 201503124), Research Fund for the Doctoral Program of Higher Education of China (20120204120012).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; [Anonymous], 1982, CHEM MICROBIOLOGY PR; Bao SD, 2000, PHYS CH EM ANAL SOIL; Barre P, 2010, BIOGEOSCIENCES, V7, P3839, DOI 10.5194/bg-7-3839-2010; Batlle-Aguilar J, 2011, AGRON SUSTAIN DEV, V31, P251, DOI 10.1051/agro/2010007; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P831, DOI 10.1016/0038-0717(85)90143-9; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cederlund H, 2014, APPL SOIL ECOL, V84, P62, DOI 10.1016/j.apsoil.2014.06.003; Cooperative Research Group on Chinese Soil Taxonomy, 2001, CHINESE SOIL TAXONOM; Dang YaAi, 2007, Plant Nutrition and Fertilizer Science, V13, P1020; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diekow J, 2005, PLANT SOIL, V268, P319, DOI 10.1007/s11104-004-0330-4; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Drijber RA, 2000, SOIL BIOL BIOCHEM, V32, P1419, DOI 10.1016/S0038-0717(00)00060-2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; [樊军 Fan Jun], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P85; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gomez-Montano L, 2013, SOIL BIOL BIOCHEM, V65, P50, DOI 10.1016/j.soilbio.2013.04.005; Gong ZiTong, 1999, Pedosphere, V9, P193; Guenet B, 2011, APPL SOIL ECOL, V51, P87, DOI 10.1016/j.apsoil.2011.07.006; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kong AYY, 2010, SOIL BIOL BIOCHEM, V42, P1523, DOI 10.1016/j.soilbio.2010.05.021; Krey T, 2013, EUR J SOIL BIOL, V55, P124, DOI 10.1016/j.ejsobi.2012.12.007; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Liu GB, 1999, AMBIO, V28, P663; Liu JS, 2016, SOIL SCI PLANT NUTR, V62, P263, DOI 10.1080/00380768.2016.1179559; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; Oksanen J, 2013, MULTIVARIATE ANAL EC; OLSEN STERLING R., 1957, SOIL SCI SOC AMER PROC, V21, P144; Pan Y, 2014, FEMS MICROBIOL ECOL, V90, P195, DOI 10.1111/1574-6941.12384; Polyanskaya LM, 2012, EURASIAN SOIL SCI+, V45, P710, DOI 10.1134/S1064229312030088; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi P, 2015, ARCH AGRON SOIL SCI, V61, P1303, DOI 10.1080/03650340.2014.996136; Tardy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130672; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Unger PW., 2008, J CROP PROD, V2, P1, DOI [10.1300/J144v02n02_01, DOI 10.1300/J144V02N02_01]; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang QK, 2014, SOIL BIOL BIOCHEM, V72, P145, DOI 10.1016/j.soilbio.2014.01.020; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Xun WB, 2016, ENVIRON MICROBIOL, V18, P1907, DOI 10.1111/1462-2920.13098; Yang XY, 2012, GEODERMA, V177, P49, DOI 10.1016/j.geoderma.2012.01.033; Zhang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092733; Zhou J, 2016, SOIL BIOL BIOCHEM, V95, P135, DOI 10.1016/j.soilbio.2015.12.012; Zhou ZC, 2006, ECOL MODEL, V198, P263, DOI 10.1016/j.ecolmodel.2006.04.019; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	59	11	12	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184223	10.1371/journal.pone.0184223	http://dx.doi.org/10.1371/journal.pone.0184223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880897	Green Submitted, Green Published, gold			2022-12-26	WOS:000409467200042
J	Zhang, LW; Zeng, YB; Fang, Y				Zhang, Liangwen; Zeng, Yanbing; Fang, Ya			The effect of health status and living arrangements on long term care models among older Chinese: A cross-sectional study	PLOS ONE			English	Article							TRENDS; ADULTS; PEOPLE	Background Currently, there are many studies focusing on the influencing factors of the elderly people's living arrangements or health status, but little is known about the relationship between living arrangements or health status and long-term care models for the old-age, especially the joint effects. Objective We aimed to assess the effects of health status and living arrangements on long-term care models (LTCM) among the elderly of Xiamen, China, especially their cumulative joint effects. Methods A total of 14,373 participants aged >= 60 years by multistage sampling in Xiamen of China were enrolled. Multinomial logistic regression was used to estimate the Odds ratios (ORs) regressing LTCM on health status and living arrangements using the Anderson model as theoretical framework. Results Totally, 14,292 valid questionnaires were obtained, of which 86.37% selected home care. With the increase of disability degree, older people are more likely to choose institutional care, compared to living alone (ORs = 1.75, 2.06, 4.00, 4.01 for the "relatively independent', "mild disability', "moderate disability', and "total disability', respectively, in comparison with "completely independent'). The elderly living with children and other family members preferred to choose home care. (ORs = 0.50, 0.39, 0.40, and 0.43 for the "living with children', "living with spouse', "living with children and spouse', and "living with others', respectively, in comparison with "alone'). Additionally, residence, number of children, education level, and feelings of loneliness were the determinants of the choice of social pension. Conclusion A multitude of older people are trended to choose home care in Xiamen of China. There was an interaction and joint effect between the degree of disability and the living arrangements on LTCM. Therefore, policymakers should pay close attention to care for those living alone, childless, and disabled elders to meet their care needs, especially in home care. In addition, the social construction of facilities for elders in rural areas should be strengthened.	[Zhang, Liangwen; Zeng, Yanbing; Fang, Ya] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China; [Zhang, Liangwen; Zeng, Yanbing; Fang, Ya] Xiamen Univ, Sch Publ Hlth, Key Lab Hlth Technol Assessment, Fujian Prov Univ, Xiamen, Fujian, Peoples R China	Xiamen University; Fuzhou University; Xiamen University	Fang, Y (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China.; Fang, Y (corresponding author), Xiamen Univ, Sch Publ Hlth, Key Lab Hlth Technol Assessment, Fujian Prov Univ, Xiamen, Fujian, Peoples R China.	Fangya@xmu.edu.cn			Center for Health Economics and Policy at the School of Public Health, Xiamen University; Youth Project of National Natural Science Fund [71403229]; project of National Natural Science Fund [81573257]; project of Natural Science Fund of Fujian Province [2017J01133]	Center for Health Economics and Policy at the School of Public Health, Xiamen University; Youth Project of National Natural Science Fund; project of National Natural Science Fund; project of Natural Science Fund of Fujian Province	This study was supported by The Center for Health Economics and Policy at the School of Public Health, Xiamen University, the Youth Project of National Natural Science Fund (No. 71403229), the project of National Natural Science Fund (No. 81573257), and the project of Natural Science Fund of Fujian Province (No. 2017J01133). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2007, LTCM, V25, P86; [Anonymous], 2000, J POPULAT, V3, P30; Bei Z, 2012, RES PROGR LONG TERM; Chen SY, 2009, AGEING INT, V34, P172, DOI 10.1007/s12126-009-9043-6; Chen W, 2015, ASSESSMENT DISABILIT; China NBoSoPsRo, 2015, NAT EC SOC DEV STAT; Chou YC, 2015, EUR J AGEING, V12, P95, DOI 10.1007/s10433-014-0322-z; ChuWHD Song G, 2008, CHINESE HLTH ENTERPR, V23, P836; Arias-Merino ED, 2012, ARCH GERONTOL GERIAT, V54, pE271, DOI 10.1016/j.archger.2012.02.010; Feng W., 2007, POPULATION CHINA BEG, P177; Gaymu J, 2008, EUR J AGEING, V5, P5, DOI 10.1007/s10433-008-0072-x; Gaymu J, 2006, EUR J POPUL, V22, P241, DOI 10.1007/s10680-006-9004-7; Jing Wang MW, 2008, CHINESE GEN PRACTICE; Kim HJ, 2015, J DEV PHYS DISABIL, V27, P307, DOI 10.1007/s10882-014-9418-9; Kuo T T-GFM, 2001, RES AGING; Lefevre T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115064; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Long S FX, 2007, NANJING SOCIAL SCI, P98; Lu L ZG, 2014, HLTH RELATED QUALITY; Ouellette-Kuntz H, 2015, INT REV RES DEV DISA, V48, P151, DOI 10.1016/bs.irrdd.2015.03.004; Peng X SS, 2010, PLOS ONE, V5, P121; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; [苏丽惠 SU Li-hui], 2010, [广东医学, Guangdong Medical Journal], V31, P633; Wang H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067140, 10.1371/journal.pone.0053879, 10.1371/journal.pone.0057030, 10.1371/journal.pone.0062841]; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Yang M., 2012, CHINESE NURSING RES, V26, P37; Zhang WP, 2009, INT C POWER ELECT DR, P159; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zheng H CSL, 2011, SHANGHAI ARCH PSYCHI, V23, P79	29	22	24	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182219	10.1371/journal.pone.0182219	http://dx.doi.org/10.1371/journal.pone.0182219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880887	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200006
J	Jia, JY; Qiao, Y; Pilo, MG; Cigliano, A; Liu, XQ; Shao, ZX; Calvisi, DF; Chen, X				Jia, Jiaoyuan; Qiao, Yu; Pilo, Maria G.; Cigliano, Antonio; Liu, Xianqiong; Shao, Zixuan; Calvisi, Diego F.; Chen, Xin			Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade	PLOS ONE			English	Article							ORGAN SIZE; PATHWAY; YAP; ACTIVATION; PROLIFERATION; ANGIOMOTINS; EXPRESSION; RESISTANCE; INDUCTION; APOPTOSIS	Previous data indicate that Tankyrase inhibitors exert anti-growth functions in many cancer cell lines due to their ability to inactivate the YAP protooncogene. In the present manuscript, we investigated the effect of Tankyrase inhibitors on the growth of hepatocellular carcinoma (HCC) cell lines and the molecular mechanisms involved. For this purpose, we performed cell proliferation assay by colony-forming ability in seven human HCC cells subjected to XAV-939 and G007-LK Tankyrase inhibitors. Noticeably, the two Tankyrase inhibitors suppressed the HCC cell growth in a dose-dependent manner. Furthermore, we found that Tankyrase inhibitors synergized with MEK and AKT inhibitors to suppress HCC cell proliferation. At the molecular level, Tankyrase inhibitors significantly decreased YAP protein levels, reduced the expression of YAP target genes, and inhibited YAP/TEAD luciferase reporter activity. In addition, Tankyrase inhibitors administration was accompanied by upregulation of Angiomotin-like 1 (AMOTL1) and Angiomotin-like 2 (AMOTL2) proteins, two major negative regulators of YAP. Altogether, the present data indicate that XAV-939 and G007-LK Tankyrase inhibitors could suppress proliferation of hepatocellular carcinoma cells and downregulate YAP/TAZ by stabilizing AMOTL1 and AMOTL2 proteins, thus representing new potential anticancer drugs against hepatocellular carcinoma.	[Jia, Jiaoyuan] Jilin Univ, Hosp 2, Dept Hematol & Oncol, Changchun, Jilin, Peoples R China; [Jia, Jiaoyuan; Qiao, Yu; Liu, Xianqiong; Shao, Zixuan; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Jia, Jiaoyuan; Qiao, Yu; Liu, Xianqiong; Shao, Zixuan; Chen, Xin] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Qiao, Yu] Beijing Hosp, Dept Oncol, Natl Ctr Gerontol, Beijing, Peoples R China; [Pilo, Maria G.; Cigliano, Antonio; Calvisi, Diego F.] Univ Med Greifswald, Inst Pathol, Greifswald, Germany; [Liu, Xianqiong; Chen, Xin] Hubei Univ Chinese Med, Sch Pharm, Wuhan, Hubei, Peoples R China; [Shao, Zixuan] Lowell High Sch, San Francisco, CA USA	Jilin University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Beijing Hospital; Greifswald Medical School; Hubei University of Chinese Medicine	Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Chen, X (corresponding author), Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA.; Calvisi, DF (corresponding author), Univ Med Greifswald, Inst Pathol, Greifswald, Germany.; Chen, X (corresponding author), Hubei Univ Chinese Med, Sch Pharm, Wuhan, Hubei, Peoples R China.	diego.calvisi@uni-greifswald.de; xin.chen@ucsf.edu	Cigliano, Antonio/J-4660-2017	Cigliano, Antonio/0000-0002-6408-3613	NIH [R01CA136606, P30DK026743]; China Scholarship Council [201506175181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01CA136606 to XC; P30DK026743 for UCSF Liver Center. This work was also supported by China Scholarship Council (201506175181) to JJ.	Abylkassov R, 2016, ONCOL LETT, V12, P2277, DOI 10.3892/ol.2016.4955; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bae JS, 2017, ONCOTARGET; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Dai XY, 2016, ONCOTARGET, V7, P6933, DOI 10.18632/oncotarget.6903; Ewald F, 2015, J CANCER, V6, P1195, DOI 10.7150/jca.12452; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fitamant J, 2015, CELL REP; Gibault F, 2016, CURR MED CHEM, V23, P1171, DOI 10.2174/0929867323666160316125048; Haikarainen T, 2014, CURR PHARM DESIGN, V20, P6472, DOI 10.2174/1381612820666140630101525; HAN SX, 2014, J IMMUNOL RES, DOI DOI 10.1155/2014/261365; Huo XY, 2013, ONCOL REP, V29, P840, DOI 10.3892/or.2012.2176; Kim MH, 2017, CELL MOL LIFE SCI, V74, P1457, DOI 10.1007/s00018-016-2412-x; Kim W, 2016, BMB REP; Klein PJ, 2006, NEOPLASIA, V8, P1, DOI 10.1593/neo.05373; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Li XL, 2015, ONCOTARGET, V6, P10102, DOI 10.18632/oncotarget.3546; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lum L, 2015, CURR MED CHEM, V22, P4091, DOI 10.2174/0929867322666150827094015; Ma L, 2015, ONCOTARGET, V6, P25390, DOI 10.18632/oncotarget.4455; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Reis H, 2017, PATHOL ONCOL RES, V23, P33, DOI 10.1007/s12253-016-0079-0; Sohn BH, 2016, CLIN CANCER RES, V22, P1256, DOI 10.1158/1078-0432.CCR-15-1447; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Thorvaldsen TE, 2017, BASIC CLIN PHARMACOL, V121, P81, DOI 10.1111/bcpt.12786; Tiruveedi VL, 2016, CURRENT DRUG TARGETS; Tran FH, 2017, PROTEIN SCI, V26, P650, DOI 10.1002/pro.3122; Troilo A, 2016, ONCOTARGET, V7, P28765, DOI 10.18632/oncotarget.9117; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Voronkov A, 2013, J MED CHEM, V56, P3012, DOI 10.1021/jm4000566; Wang C, 2015, MOL MED REP, V11, P4101, DOI 10.3892/mmr.2015.3257; Wang H, 2016, J BIOL CHEM, V291, P15256, DOI 10.1074/jbc.M116.722967; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Weiler SM, 2017, GASTROENTEROLOGY; Wilson JM, 2014, J SURG RES, V191, P280, DOI 10.1016/j.jss.2014.05.083; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Yin H, 2016, J HEPATOL, V64, P899, DOI 10.1016/j.jhep.2015.11.028; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zanconato F, 2016, CURR OPIN PHARMACOL, V29, P26, DOI 10.1016/j.coph.2016.05.002; Zhan P, 2014, MOL BIOSYST, V10, P2783, DOI 10.1039/c4mb00385c	49	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184068	10.1371/journal.pone.0184068	http://dx.doi.org/10.1371/journal.pone.0184068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877210	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200059
J	Koek, MBG; Hopmans, TEM; Soetens, LC; Wille, JC; Geerlings, SE; Vos, MC; van Benthem, BHB; de Greeff, SC				Koek, Mayke B. G.; Hopmans, Titia E. M.; Soetens, Loes C.; Wille, Jan C.; Geerlings, Suzanne E.; Vos, Margreet C.; van Benthem, Birgit H. B.; de Greeff, Sabine C.			Adhering to a national surgical care bundle reduces the risk of surgical site infections	PLOS ONE			English	Article							COLORECTAL SURGERY; IMPROVEMENT PROJECT; PREVENTION; PROGRAM; IMPLEMENTATION; GUIDELINES; EXPERIENCE; REDUCTION; CHECKLIST; OUTCOMES	Background In 2008, a bundle of care to prevent Surgical Site Infections (SSIs) was introduced in the Netherlands. The bundle consisted of four elements: antibiotic prophylaxis according to local guidelines, no hair removal, normothermia and 'hygiene discipline' in the operating room (i.e. number of door movements). Dutch hospitals were advised to implement the bundle and to measure the outcome. This study's goal was to assess how effective the bundle was in reducing SSI risk. Methods Hospitals assessed whether their staff complied with each of the bundle elements and voluntary reported compliance data to the national SSI surveillance network (PREZIES). From PREZIES data, we selected data from 2009 to 2014 relating to 13 types of surgical procedures. We excluded surgeries with missing (non) compliance data, and calculated for each remaining surgery with reported (non) compliance data the level of compliance with the bundle (that is, being compliant with 0, 1, 2, 3, or 4 of the elements). Subsequently, we used this level of compliance to assess the effect of bundle compliance on the SSI risk, using multi-level logistic regression techniques. Results 217 489 surgeries were included, of which 62 486 surgeries (29%) had complete bundle reporting. Within this group, the SSI risk was significantly lower for surgeries with complete bundle compliance compared to surgeries with lower compliance levels. Odds ratios ranged from 0.63 to 0.86 (risk reduction of 14% to 37%), while a 13% risk reduction was demonstrated for each point increase in compliance-level. Sensitivity analysis indicated that due to analysing reported bundles only, we probably underestimated the total effect of implementing the bundle. Conclusions This study demonstrated that adhering to a surgical care bundle significantly reduced the risk of SSIs. Reporting of and compliance with the bundle compliance can, however, still be improved. Therefore an even greater effect might be achieved.	[Koek, Mayke B. G.; Hopmans, Titia E. M.; Soetens, Loes C.; Wille, Jan C.; van Benthem, Birgit H. B.; de Greeff, Sabine C.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Dept Epidemiol & Surveillance, Bilthoven, Netherlands; [Soetens, Loes C.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Geerlings, Suzanne E.] Acad Med Ctr, Dept Infect Dis, Amsterdam, Netherlands; [Vos, Margreet C.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Koek, MBG (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Dept Epidemiol & Surveillance, Bilthoven, Netherlands.	mayke.koek@rivm.nl						Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Berenguer CM, 2010, J AM COLL SURGEONS, V210, P737, DOI 10.1016/j.jamcollsurg.2010.01.029; Berrios-Torres SI, 2017, JAMA SURG; Bull A, 2011, J HOSP INFECT, V78, P297, DOI 10.1016/j.jhin.2011.03.029; Cima R, 2013, J AM COLL SURGEONS, V216, P23, DOI 10.1016/j.jamcollsurg.2012.09.009; Crolla RMPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044599; de Bruijne MC, 2007, PATIENT SAFETY DUTCH; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; Gagliardi AR, 2009, AM J INFECT CONTROL, V37, P398, DOI 10.1016/j.ajic.2008.10.027; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Haraden C., IMPROVEMENT STORIES; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Hedrick TL, 2007, J AM COLL SURGEONS, V205, P432, DOI 10.1016/j.jamcollsurg.2007.04.042; Horan TC., 2004, HOSP EPIDEMIOL INFEC, P1659; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Itani KMF, 2015, JAMA-J AM MED ASSOC, V314, P289, DOI 10.1001/jama.2015.4473; Keenan JE, 2014, JAMA SURG, V149, P1045, DOI 10.1001/jamasurg.2014.346; Koek MB, 2015, EURO SURVEILL, V20; Kurmann A, 2011, BRIT J SURG, V98, P1021, DOI 10.1002/bjs.7496; Larochelle M, 2011, DIS COLON RECTUM, V54, P394, DOI 10.1007/DCR.0b013e318206165b; Leaper DJ, 2015, INT WOUND J, V12, P357, DOI 10.1111/iwj.12243; Liau KH, 2010, SURG INFECT, V11, P151, DOI 10.1089/sur.2008.081; Lutfiyya Waleed, 2012, Perm J, V16, P10; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Meeks DW, 2011, AM J SURG, V201, P76, DOI 10.1016/j.amjsurg.2009.07.050; Pastor C, 2010, DIS COLON RECTUM, V53, P24, DOI 10.1007/DCR.0b013e3181ba782a; Prakken Frederik J, 2011, Ned Tijdschr Geneeskd, V155, pA3269; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Sainani KL, 2014, PM&R, V6, P841, DOI 10.1016/j.pmrj.2014.08.941; SWAB (Stichting Werkgroep Antibioticabeleid), NAT BOOK ANT SURG PR; Tanner J, 2015, SURGERY, V158, P66, DOI 10.1016/j.surg.2015.03.009; Tillman M, 2013, J SURG RES, V184, P150, DOI 10.1016/j.jss.2013.03.048; van Daalen FV, 2016, EUR J CLIN MICROBIOL, V35, P545, DOI 10.1007/s10096-015-2569-5; van der Slegt J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071566; van Kasteren M E, 2000, Ned Tijdschr Geneeskd, V144, P2049; VMS Safety Program, DUTCH HOSP PAT SAF P; Waits SA, 2014, SURGERY, V155, P602, DOI 10.1016/j.surg.2013.12.004; Wick EC, 2008, DIS COLON RECTUM, V51, P1004, DOI 10.1007/s10350-007-9142-y; Wick EC, 2012, J AM COLL SURGEONS, V215, P193, DOI 10.1016/j.jamcollsurg.2012.03.017; Workinggroup Infection Prevention (WIP), 2011, GUID PREV SURG SIT I; World Health Organization, 2016, GLOB GUID PREV SURG; Young B, 2011, ANTIMICROB AGENTS CH, V55, P4659, DOI 10.1128/AAC.00562-11	42	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184200	10.1371/journal.pone.0184200	http://dx.doi.org/10.1371/journal.pone.0184200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877223	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200071
J	Mehanna, P; Gagne, V; Lajoie, M; Spinella, JF; St-Onge, P; Sinnett, D; Brukner, I; Krajinovic, M				Mehanna, Pamela; Gagne, Vincent; Lajoie, Mathieu; Spinella, Jean-Francois; St-Onge, Pascal; Sinnett, Daniel; Brukner, Ivan; Krajinovic, Maja			Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines	PLOS ONE			English	Article							EXTRACHROMOSOMAL CIRCULAR DNA; FRAGMENTATION; APOPTOSIS; ELEMENTS; ARREST	Recently, a new class of extrachromosomal circular DNA, called microDNA, was identified. They are on average 100 to 400 bp long and are derived from unique non-repetitive genomic regions with high gene density. MicroDNAs are thought to arise from DNA breaks associated with RNA metabolism or replication slippage. Given the paucity of information on this entirely novel phenomenon, we aimed to get an additional insight into microDNA features by performing the microDNA analysis in 20 independent human lymphoblastoid cell lines (LCLs) prior and after treatment with chemotherapeutic drugs. The results showed non-random genesis of microDNA clusters from the active regions of the genome. The size periodicity of 190 bp was observed, which matches DNA fragmentation typical for apoptotic cells. The chemotherapeutic drug-induced apoptosis of LCLs increased both number and size of clusters further suggesting that part of microDNAs could result from the programmed cell death. Interestingly, proportion of identified microDNA sequences has common loci of origin when compared between cell line experiments. While compatible with the original observation that microDNAs originate from a normal physiological process, obtained results imply complementary source of its production. Furthermore, non-random genesis of microDNAs depicted by redundancy between samples makes these entities possible candidates for new biomarker generation.	[Mehanna, Pamela; Gagne, Vincent; Lajoie, Mathieu; Spinella, Jean-Francois; St-Onge, Pascal; Sinnett, Daniel; Krajinovic, Maja] Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Sinnett, Daniel; Krajinovic, Maja] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Brukner, Ivan] McGill Univ, Jewish Gen Hosp, Mol Diagnost Lab, Montreal, PQ, Canada; [Krajinovic, Maja] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; Universite de Montreal	Krajinovic, M (corresponding author), Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada.; Krajinovic, M (corresponding author), Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada.; Krajinovic, M (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ, Canada.	maja.krajinovic@umontreal.ca	Brukner, Ivan/AAU-7504-2021; Brukner, Ivan/N-5833-2019; sinnett, daniel/S-4589-2017	Brukner, Ivan/0000-0003-0225-9238; sinnett, daniel/0000-0003-3625-6676	Innovation grant from the Canadian Cancer Society Research Institute [702022]; Canada Foundation for Innovation (CFI) D.S.; NanoQuebec D.S.; RMGA D.S.; Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)D.S.	Innovation grant from the Canadian Cancer Society Research Institute; Canada Foundation for Innovation (CFI) D.S.; NanoQuebec D.S.; RMGA D.S.; Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)D.S.	This study was supported by the Innovation grant from the Canadian Cancer Society Research Institute (702022)D.S M.K. The operation of the Calcul Quebec supercomputer is funded by the Canada Foundation for Innovation (CFI) D.S., NanoQuebec D.S., RMGA D.S. and the Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)D.S.	Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Brukner I, 2005, ANAL BIOCHEM, V339, P345, DOI 10.1016/j.ab.2005.01.005; Cohen S, 2009, CYTOGENET GENOME RES, V124, P327, DOI 10.1159/000218136; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Di Filippo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005010; Dillon LW, 2015, CELL REP, V11, P1749, DOI 10.1016/j.celrep.2015.05.020; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; HOROWITZ H, 1985, MOL CELL BIOL, V5, P2369, DOI 10.1128/MCB.5.9.2369; Hubley R., 2013, REPEATMASKER OPEN 40; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kogel, 2000, MADAME CURIE BIOSCIE; Kumar P, 2017, MOL CANC RES; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Lopez-Lopez E, 2014, PHARMACOGENOMICS, V15, P1383, DOI [10.2217/PGS.14.106, 10.2217/pgs.14.106]; Lu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052919; Maeda T, 2004, BIOCHEM BIOPH RES CO, V319, P1117, DOI 10.1016/j.bbrc.2004.05.093; Navratilova A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-90; Nielsen CH, 2007, CLIN EXP IMMUNOL, V148, P288, DOI 10.1111/j.1365-2249.2007.03335.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2015, NATURE, V393, P396; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Shibata Y, 2012, SCIENCE, V336, P82, DOI 10.1126/science.1213307; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; STANFIELD SW, 1986, NUCLEIC ACIDS RES, V14, P3527, DOI 10.1093/nar/14.8.3527; Ueno T, 1997, LEUKEMIA, V11, P1858, DOI 10.1038/sj.leu.2400834; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049	30	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184365	10.1371/journal.pone.0184365	http://dx.doi.org/10.1371/journal.pone.0184365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877255	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200092
J	Nobeyama, Y; Nakagawa, H				Nobeyama, Yoshimasa; Nakagawa, Hidemi			Silencing of interferon regulatory factor gene 6 in melanoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; ADJUVANT THERAPY; DNA METHYLATION; DIFFERENTIATION; IRF6; LANDSCAPE; MEDIATOR	Background Methylation of a CpG island (CGI; a dense cluster of CpGs) located in the 5' region of a gene suppresses transcription of that gene. Interferon regulatory factor 6 (IRF6) is associated with the expression of interferon, which is used as an effective adjuvant therapy for melanoma, and is regarded as a tumor suppressor. However, little is known about the methylation status of the IRF6 gene in melanoma. Objective The purpose was to determine the methylation status of the CGI located in the 5' region of IRF6 (5' IRF6 CGI) in melanoma. Methods Quantitative real-time methylation-specific PCR (RT-MSP) and bisulfite sequencing were performed to examine IRF6 gene methylation status. Quantitative real-time reverse transcription- PCR (RT-PCR) was performed to examine IRF6 expression. Results The methylation level of the 5' IRF6 CGI was completely inversely correlated with cell sensitivity to interferon-beta in eight examined melanoma cell lines. These methylation levels were high in the melanoma cell lines with suppression of IRF6 expression and were low in the cell lines with IRF6 expression. The methylation levels of the 5' IRF6 CGI ranged widely from 0.0% to 65.4% in 21 clinical melanoma samples but showed a narrow range of low levels between 0.0% to 7.2% in 24 clinical melanocytic nevus samples. These methylation levels were not associated with clinical parameters except for melanoma subtypes. Conclusion IRF6 is aberrantly silenced by DNA methylation of the 5' IRF6 CGI in melanoma. The methylation status of IRF6 is potentially associated with the sensitivity of melanoma to interferon.	[Nobeyama, Yoshimasa; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo, Japan	Jikei University	Nobeyama, Y (corresponding author), Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo, Japan.	nobederm@jikei.ac.jp		Nobeyama, Yoshimasa/0000-0002-0125-8930				Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Duguay D, 2002, CANCER RES, V62, P5148; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Ehrlich M, 2013, EPIGENOMICS-UK, V5, P553, DOI 10.2217/epi.13.43; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hatada S, 1997, GENE, V203, P183, DOI 10.1016/S0378-1119(97)00512-X; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Iwanaszko M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1511-7; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Ke CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12791; Lee CS, 2017, PHARMACOTHERAPY, V37, P319, DOI 10.1002/phar.1895; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Moriyama Y, 2001, CLIN CANCER RES, V7, P1293; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stellacci E, 2004, BIOCHEM J, V377, P367, DOI 10.1042/BJ20031166; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Ushijima T, 2005, CANCER RES, V65, P11; Yamamoto A, 1996, INT J IMMUNOTHER, V12, P73; Zainulabadeen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170025	25	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184444	10.1371/journal.pone.0184444	http://dx.doi.org/10.1371/journal.pone.0184444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877249	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200104
J	Diserens, TA; Borowik, T; Nowak, S; Szewczyk, M; Niedzwiecka, N; Myslajek, RW				Diserens, Tom A.; Borowik, Tomasz; Nowak, Sabina; Szewczyk, Maciej; Niedzwiecka, Natalia; Myslajek, Robert W.			Deficiencies in Natura 2000 for protecting recovering large carnivores: A spotlight on the wolf Canis lupus in Poland	PLOS ONE			English	Article							HABITAT SUITABILITY; CONSERVATION; NETWORK; AREAS; BIODIVERSITY; POPULATION; MANAGEMENT; EFFICIENCY; EUROPE; FOREST	If protected areas are to remain relevant in our dynamic world they must be adapted to changes in species ranges. In the EU one of the most notable such changes is the recent recovery of large carnivores, which are protected by Natura 2000 at the national and population levels. However, the Natura 2000 network was designed prior to their recent recovery, which raises the question whether the network is sufficient to protect the contemporary ranges of large carnivores. To investigate this question we evaluated Natura 2000 coverage of the three wolf Canis lupus populations in Poland. Wolf tracking data showed that wolves have recolonised almost all suitable habitat in Poland (as determined by a recent habitat suitability model), so we calculated the overlap between the Natura 2000 network and all wolf habitat in Poland. On the basis of published Natura 2000 criteria, we used 20% as the minimum required coverage. At the national level, wolves are sufficiently protected (22% coverage), but at the population level, the Baltic and Carpathian populations are far better protected (28 and 47%, respectively) than the endangered Central European Lowland population (12%). As Natura 2000 insufficiently protects the most endangered wolf population in Poland, we recommend expansion of Natura 2000 to protect at least an additional 8% of wolf habitat in western Poland, and discuss which specific forests are most in need of additional coverage. Implementation of these actions will have positive conservation implications and help Poland to fulfil its Habitats Directive obligations. As it is likely that similar gaps in Natura 2000 are arising in other EU member states experiencing large carnivore recoveries, particularly in Central Europe, we make the case for a flexible approach to Natura 2000 and suggest that such coverage evaluations may be beneficial elsewhere.	[Diserens, Tom A.; Szewczyk, Maciej; Myslajek, Robert W.] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland; [Borowik, Tomasz] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Nowak, Sabina; Niedzwiecka, Natalia] Assoc Nat Wolf, Twardorzeczka, Poland	University of Warsaw; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Diserens, TA (corresponding author), Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland.	tom_diserens@hotmail.com	Borowik, Tomasz/W-4008-2018; Szewczyk, Maciej/AAH-1959-2021; Diserens, Tom/ABH-6678-2020; Mysłajek, Robert W./AAD-9569-2022; Diserens, Tom/AAB-1867-2020; Myslajek, Robert/K-8248-2015	Borowik, Tomasz/0000-0003-0321-8200; Szewczyk, Maciej/0000-0001-7424-1120; Myslajek, Robert/0000-0001-9619-2868; Nowak, Sabina/0000-0002-7771-8032	EuroNature (Germany); International Fund for Animal Welfare IFAW (Germany); Wolves and Humans Foundation (UK); National Science Centre (Poland) [DEC-2014/12/S/NZ8/00624]	EuroNature (Germany); International Fund for Animal Welfare IFAW (Germany); Wolves and Humans Foundation (UK); National Science Centre (Poland)	Wolf monitoring conducted by the Association for Nature "Wolf" is supported by EuroNature (Germany) (www.euronatur.org), International Fund for Animal Welfare IFAW (Germany) (www.ifaw.org), and Wolves and Humans Foundation (UK) (www.wolvesandhumans.org). RWM postdoctoral internship was funded by the National Science Centre (Poland) (www.ncn.gov.pl), grant number DEC-2014/12/S/NZ8/00624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2015, BIODIVERS CONSERV, V24, P1377; Andersen LW, 2015, MAMMAL RES, V60, P163, DOI 10.1007/s13364-015-0220-6; [Anonymous], 2016, ENVIRONMENT; [Anonymous], 2016, STAT YB REG POL; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bagella S, 2013, PLANT BIOSYST, V147, P1092, DOI 10.1080/11263504.2013.860055; Balint Miklos, 2011, P189; Boitani L., 2015, KEY ACTIONS LARGE CA, P1; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; D'Amen M, 2013, ANIM CONSERV, V16, P370, DOI 10.1111/acv.12016; De Groot GA, 2016, MAMMAL REV, V46, P44, DOI 10.1111/mam.12052; Dimitrakopoulos PG, 2004, GLOBAL ECOL BIOGEOGR, V13, P199, DOI 10.1111/j.1466-822X.2004.00086.x; EC, 1997, CRIT ASS NAT LISTS P; EC (European Commission), 2016, FITN CHECK EU NAT LE; Epstein Y, 2016, J ENVIRON LAW, V28, P221, DOI 10.1093/jel/eqw006; European Commission (EC), 2017, ACT PLAN NAT PEOPL E; Evans D, 2012, NAT CONSERV-BULGARIA, P11, DOI 10.3897/natureconservation.1.1808; Fechter D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101798; GDEP, 2016, ACC GEOSP DAT; Grand J, 2007, ECOL LETT, V10, P364, DOI 10.1111/j.1461-0248.2007.01025.x; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Huck M, 2010, ACTA THERIOL, V55, P177, DOI 10.4098/j.at.0001-7051.114.2009; Jantke K, 2011, BIODIVERS CONSERV, V20, P581, DOI 10.1007/s10531-010-9968-9; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Jedrzejewski W, 2005, ACTA THERIOL, V50, P417, DOI 10.1007/BF03192636; Jedrzejewski W, 2004, DIVERS DISTRIB, V10, P225, DOI 10.1111/j.1366-9516.2004.00073.x; Jedrzejewski W, 2007, ECOGRAPHY, V30, P66, DOI 10.1111/j.2006.0906-7590.04826.x; Jedrzejewski Wlodzimierz, 2002, Kosmos (Warsaw), V51, P491; Kaczensky P., 2012, STATUS MANAGEMENT DI; Kowalczyk R, 2013, ACTA THERIOL, V58, P391, DOI 10.1007/s13364-013-0136-y; Kujawa A, 2016, FOREST RES PAPERS, V77, P302, DOI DOI 10.1515/frp-2016-0032; Kukkala AS, 2016, BIOL CONSERV, V198, P193, DOI 10.1016/j.biocon.2016.04.016; Linnell J.D., 2008, LARGE CARNIVORE INIT; Lison F, 2013, ANIM CONSERV, V16, P528, DOI 10.1111/acv.12025; Maiorano L, 2015, CONSERV BIOL, V29, P986, DOI 10.1111/cobi.12535; Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x; Mazaris AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059640; Myslajek RW, 2015, FAIRYTALE IN QUESTION: HISTORICAL INTERACTIONS BETWEEN HUMANS AND WOLVES, P247; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Nowak S, 2017, APPL ECOL ENV RES, V15, P187, DOI 10.15666/aeer/1503_187203; Nowak S, 2017, DIVERSITY DISTRIBUTI; Nowak S, 2016, MAMMAL RES, V61, P83, DOI 10.1007/s13364-016-0263-3; OKARMA H, 1993, BIOL CONSERV, V66, P153, DOI 10.1016/0006-3207(93)90001-H; Reinhardt I., 2013, BFN SKRIPTEN 356 REV; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Santini L, 2016, CONSERV SCI PRACT, V15, P122; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Soule ME, 1999, CONTINENTAL CONSERVA, P99; TROCHET A, 2013, NAT CONSERV CRACOW, V4, P35, DOI DOI 10.3897/NATUREC0NSERVATI0N.4.3626; Trouwborst A, 2017, BIODIVERS CONSERV, V26, P37, DOI 10.1007/s10531-016-1238-z; Van Der Sluis Theo, 2016, THEO; Wawrzyniak Piotr, 2010, P223; Wojcik B, 2011, REPORT CHANGES CREAT; Zehetmair T, 2015, J NAT CONSERV, V23, P53, DOI 10.1016/j.jnc.2014.07.003	58	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184144	10.1371/journal.pone.0184144	http://dx.doi.org/10.1371/journal.pone.0184144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873090	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800054
J	Mahmoud, AM; Macias, V; Al-alem, U; Deaton, RJ; Kadjaksy-Balla, A; Gann, PH; Rauscher, GH				Mahmoud, Abeer M.; Macias, Virgilia; Al-alem, Umaima; Deaton, Ryan J.; Kadjaksy-Balla, Andre; Gann, Peter H.; Rauscher, Garth H.			BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays	PLOS ONE			English	Article							ESTROGEN-RECEPTOR STATUS; MUTATION CARRIERS; ANDROGEN; IMMUNOLOCALIZATION; RELIABILITY; CARCINOMAS; PHENOTYPE; PROGNOSIS; PROMOTER; GRADE	Purpose Mutations in BRCA1 are associated with familial as well as sporadic aggressive subtypes of breast cancer, but less is known about whether BRCA1 expression or subcellular localization contributes to progression in population-based settings. Methods We examined BRCA1 expression and subcellular localization in invasive breast cancer tissues from an ethnically diverse sample of 286 patients and 36 normal breast tissue controls. Two different methods were used to label breast cancer tissues for BRCA1: (1) Dual immunofluoresent staining with BRCA1 and cytokeratin 8/18 and (2) immunohistochemical staining using the previously validated MS110 mouse monoclonal antibody. Slides were visualized and quantified using the VECTRA Automated Multispectral Image Analysis System and InForm software. Results BRCA1 staining was more intense in normal than in invasive breast tissue for both cytoplasmic (p < 0.0001) and nuclear (p < 0.01) compartments. BRCA1 nuclear to cytoplasmic ratio was higher in breast cancer cells than in normal mammary epithelial cells. Reduced BRCA1 expression was associated with high tumor grade and negative hormone receptors (estrogen receptor, progesterone receptor and Her2). On the other hand, high BRCA1 expression correlated with basal-like tumors (high CK5/6 and EGFR), and high nuclear androgen receptor staining. Lower nuclear to cytoplasmic ratio of BRCA1 correlated significantly with high Ki67 labeling index (p < 0.05) and family history of breast cancer (p = 0.001). Conclusion Findings of this study indicate that alterations in BRCA1 protein expression and subcellular localization in breast cancer correlate with poor prognostic markers and aggressive tumor features. Further large-scale studies are required to assess the potential relevance of BRCA1 protein expression and localization in routine classification of breast cancer.	[Mahmoud, Abeer M.] Univ Illinois, Coll Appl Hlth Sci, Chicago, IL 60607 USA; [Mahmoud, Abeer M.; Macias, Virgilia; Deaton, Ryan J.; Kadjaksy-Balla, Andre; Gann, Peter H.] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60607 USA; [Mahmoud, Abeer M.] Assiut Univ, South Egypt Canc Inst, Dept Pathol, Assiut, Egypt; [Al-alem, Umaima] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Egyptian Knowledge Bank (EKB); Assiut University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mahmoud, AM (corresponding author), Univ Illinois, Coll Appl Hlth Sci, Chicago, IL 60607 USA.; Mahmoud, AM (corresponding author), Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60607 USA.; Mahmoud, AM (corresponding author), Assiut Univ, South Egypt Canc Inst, Dept Pathol, Assiut, Egypt.	amahmo4@uic.edu	Al-alem, Umaima/AAW-2584-2021; Al-alem, Umaima/AHD-0666-2022	Al-alem, Umaima/0000-0003-2984-076X; Mahmoud, Abeer/0000-0002-0295-6706	National Institute of Health [2P50CA106743-06]; NATIONAL CANCER INSTITUTE [R01CA155301] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health Grant # 2P50CA106743-06 to GHR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archey WB, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0401-2; Cai FF, 2016, ONCOTARGET, V7, P27499, DOI 10.18632/oncotarget.8355; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; de Bock GH, 2001, BRIT J CANCER, V85, P1347; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Downs B, 2015, CANCER GENET-NY, V208, P237, DOI 10.1016/j.cancergen.2015.02.001; Elebro K, 2015, CLIN CANCER RES, V21, P3640, DOI 10.1158/1078-0432.CCR-14-2564; Esposito NN, 2007, MODERN PATHOL, V20, P130, DOI 10.1038/modpathol.3800721; Evans DG, 2016, BREAST CANCER RES TR, V155, P597, DOI 10.1007/s10549-016-3697-z; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Fraser JA, 2003, BRIT J CANCER, V88, P1263, DOI 10.1038/sj.bjc.6600863; Gancberg D, 2002, J CLIN PATHOL, V55, P315, DOI 10.1136/jcp.55.4.315; Goodwin PJ, 2012, J CLIN ONCOL, V30, P19, DOI 10.1200/JCO.2010.33.0068; Henderson BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/796808; Iacopetta Domenico, 2012, Drug Discov Today Dis Mech, V9, pe19; Jarvis EM, 1998, CANCER GENET CYTOGEN, V101, P109, DOI 10.1016/S0165-4608(97)00267-7; Jiang QQ, 2015, J BIOL CHEM, V290, P17724, DOI 10.1074/jbc.R115.667931; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lee WY, 1999, HISTOPATHOLOGY, V34, P106; Magdinier F, 1998, ONCOGENE, V17, P3169, DOI 10.1038/sj.onc.1202248; Oberlander M, 2014, PATHOL ONCOL RES, V20, P719, DOI 10.1007/s12253-014-9752-3; Park JJ, 2000, CANCER RES, V60, P5946; Perez-Valles A, 2001, J CLIN PATHOL, V54, P476, DOI 10.1136/jcp.54.6.476; Pristauz G, 2010, HISTOPATHOLOGY, V57, P877, DOI 10.1111/j.1365-2559.2010.03724.x; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Rauscher GH, 2010, CANCER EPIDEM BIOMAR, V19, P640, DOI 10.1158/1055-9965.EPI-09-0997; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Stuckey AR, 2015, AM J OBSTET GYNECOL, V213, P161, DOI 10.1016/j.ajog.2015.03.003; Taylor J, 1998, INT J CANCER, V79, P334, DOI 10.1002/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W; Troudi W, 2007, EUR J HISTOCHEM, V51, P219; Tulchin N, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-70; Wang HC, 1997, ONCOGENE, V15, P143, DOI 10.1038/sj.onc.1201252; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Yang QF, 2001, CANCER-AM CANCER SOC, V92, P54, DOI 10.1002/1097-0142(20010701)92:1<54::AID-CNCR1291>3.0.CO;2-8; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Zhang DH, 2003, MODERN PATHOL, V16, P79, DOI 10.1097/01.MP.0000047307.96344.93	40	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184385	10.1371/journal.pone.0184385	http://dx.doi.org/10.1371/journal.pone.0184385			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863181	Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900055
J	Pokrzywa, M; Pawelek, K; Kucia, WE; Sarbak, S; Chorell, E; Almqvist, F; Wittung-Stafshede, P				Pokrzywa, Malgorzata; Pawelek, Katarzyna; Kucia, Weronika Elzbieta; Sarbak, Szymon; Chorell, Erik; Almqvist, Fredrik; Wittung-Stafshede, Pernilla			Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease	PLOS ONE			English	Article							DOPA-INDUCED DYSKINESIA; CENTRAL-NERVOUS-SYSTEM; ALPHA-SYNUCLEIN; BIOFILM FORMATION; DRUG DISCOVERY; NEURON LOSS; LOCOMOTOR; PROTEIN; NEUROTOXICITY; MELANOGASTER	Alpha-synuclein (aS) amyloid formation is involved in Parkinson's disease (PD); therefore, small molecules that target aS and affect its aggregation are of interest as future drug candidates. We recently reported modified ring-fused 2-pyridones that modulate aS amyloid formation in vitro. Here, we describe the effects of such molecules on behavioral parameters of a Drosophila model of PD (i.e., flies expressing human aS), using a new approach (implemented in a commercially available FlyTracker system) to quantify fly mobility. FlyTracker allows for automated analysis of walking and climbing locomotor behavior, as it collects large sequences of data over time in an unbiased manner. We found that the molecules per se have no toxic or kinetic effects on normal flies. Feeding aS-expressing flies with the amyloid-promoting molecule FN075, remarkably, resulted in increased fly mobility at early time points; however, this effect switched to reduced mobility at later time points, and flies had shorter life spans than controls. In contrast, an amyloid inhibitor increased both fly kinetics and life span. In agreement with increased aS amyloid formation, the FN075-fed flies had less soluble aS, and in vitro aS-FN075 interactions stimulated aS amyloid formation. In addition to a new quantitative approach to probe mobility (available in FlyTracker), our results imply that aS regulates brain activity such that initial removal (here, by FN075-triggered assembly of aS) allows for increased fly mobility.	[Pokrzywa, Malgorzata; Pawelek, Katarzyna; Kucia, Weronika Elzbieta; Sarbak, Szymon] Airopt Sp Zoo, Poznan, Poland; [Chorell, Erik; Almqvist, Fredrik] Umea Univ, Dept Chem, Umea, Sweden; [Wittung-Stafshede, Pernilla] Chalmers, Dept Biol & Biol Engn, Gothenburg, Sweden; [Kucia, Weronika Elzbieta; Sarbak, Szymon] Adam Mickiewicz Univ, Fac Phys, Poznan, Poland	Umea University; Chalmers University of Technology; Adam Mickiewicz University	Pokrzywa, M (corresponding author), Airopt Sp Zoo, Poznan, Poland.; Wittung-Stafshede, P (corresponding author), Chalmers, Dept Biol & Biol Engn, Gothenburg, Sweden.	malgorzata.pokrzywa@airoptic.pl; pernilla.wittung@chalmers.se	Pokrzywa, Małgorzata/GQA-6257-2022; wittung-stafshede, pernilla/AAV-4392-2021	wittung-stafshede, pernilla/0000-0003-1058-1964; Almqvist, Fredrik/0000-0002-0504-4446	Knut and Alice Wallenberg Foundation; Swedish Research Council; Chalmers Foundation; Goran Gustafsson Foundation; Swedish Foundation for Strategic Research; Michael J. Fox Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Chalmers Foundation; Goran Gustafsson Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Michael J. Fox Foundation	This study was supported by the Knut and Alice Wallenberg Foundation (PWS), the Swedish Research Council (PWS, FA), the Chalmers Foundation (PWS), Goran Gustafsson Foundation (FA), the Swedish Foundation for Strategic Research (FA) and the Michael J. Fox Foundation (FA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg V, 2005, ORG BIOMOL CHEM, V3, P2817, DOI 10.1039/b503294f; Andersson EK, 2013, CHEM BIOL, V20, P1245, DOI 10.1016/j.chembiol.2013.07.017; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barone MC, 2011, DIS MODEL MECH, V4, P701, DOI 10.1242/dmm.007575; Blesa J, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00155; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chen AY, 2014, GENES BRAIN BEHAV, V13, P812, DOI 10.1111/gbb.12172; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chermenina M, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.24; Chesselet Marie-Francoise, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS84, DOI 10.1016/j.parkreldis.2008.04.004; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Cichewicz K, 2017, GENES BRAIN BEHAV, V16, P394, DOI 10.1111/gbb.12353; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eyjolfsdottir E, 2014, LECT NOTES COMPUT SC, V8690, P772, DOI 10.1007/978-3-319-10605-2_50; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Horvath I, 2013, ARCH BIOCHEM BIOPHYS, V532, P84, DOI 10.1016/j.abb.2013.01.012; Horvath I, 2012, J AM CHEM SOC, V134, P3439, DOI 10.1021/ja209829m; Huot P, 2013, PHARMACOL REV, V65, P171, DOI 10.1124/pr.111.005678; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Kohlhoff KJ, 2011, INTEGR BIOL-UK, V3, P755, DOI 10.1039/c0ib00149j; Lassen LB, 2016, BRAIN PATHOL; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Markstein M, 2014, P NATL ACAD SCI USA, V111, P4530, DOI 10.1073/pnas.1401160111; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Navarro JA, 2014, J NEUROCHEM, V131, P369, DOI 10.1111/jnc.12818; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Pendleton RG, 2002, J PHARMACOL EXP THER, V300, P91, DOI 10.1124/jpet.300.1.91; Perdersen MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep10422; Pesah Y, 2005, GENESIS, V41, P154, DOI 10.1002/gene.20106; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Riemensperger T, 2013, CELL REP, V5, P952, DOI 10.1016/j.celrep.2013.10.032; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Siddique Yasir Hasan, 2014, Journal of Dietary Supplements, V11, P121, DOI 10.3109/19390211.2013.859207; Soh JW, 2013, EXP GERONTOL, V48, P229, DOI 10.1016/j.exger.2012.09.007; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	61	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184117	10.1371/journal.pone.0184117	http://dx.doi.org/10.1371/journal.pone.0184117			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863169	Green Submitted, Green Published, gold			2022-12-26	WOS:000408816900026
J	Cappa, F; Campos, V; Giannoni, S; Andino, N				Cappa, Flavio; Campos, Valeria; Giannoni, Stella; Andino, Natalia			The effects of poaching and habitat structure on anti-predator behavioral strategies: A guanaco population in a high cold desert as case study	PLOS ONE			English	Article							REMOTELY-SENSED DATA; LAMA-GUANICOE; HUMAN DISTURBANCE; FLIGHT DISTANCE; PREDATION RISK; MODELS; METAANALYSIS; MANAGEMENT; VIGILANCE; RESPONSES	The effects of poaching on wildlife have been widely studied in conservation biology and can be heterogeneous, particularly on ungulates. These effects can be estimated through different methodologies whose use depends on several conditions such as Flight-initiation distance (FID). Our objectives were: 1- to evaluate whether poaching affects the FID and group structure of a guanaco (Lama guanicoe) population in a high cold desert in San Juan (Argentina); 2- to assess whether habitat structure (slope and vegetation cover) influences FID and group structure in this population. The study area included a site with poaching (unprotected area), and a site without poaching (protected area). We recorded 100 groups of guanacos: 70 in the protected and 30 in the unprotected area. FID and group size were greater in the unprotected than in the protected area, whereas proportions of group categories (with offspring, without offspring and solitary) were similar between areas. Besides, in relation to habitat structure, FID increased when vegetation cover decreased. On the other hand, FID and group size were not affected by slope. Our study shows that guanacos respond to poaching pressure as do other ungulate species, and that other factors such as vegetation cover also affect this behavior. Managers should be aware when interpreting FID due to its relation to habitat structure; the guanaco appears to assume greater risk (lower FID) in areas with high vegetation cover.	[Cappa, Flavio; Campos, Valeria; Giannoni, Stella; Andino, Natalia] Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, INTERBIODES Interacc Biol Desierto, San Juan, Argentina; [Cappa, Flavio; Campos, Valeria; Giannoni, Stella] Consejo Nacl Invest Cient & Tecn, CIGEOBIO CONICET Ctr Invest Geosfera & Biosfera, San Juan, Argentina; [Giannoni, Stella] Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, Inst & Museo Ciencias Nat, San Juan, Argentina	Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan	Cappa, F; Campos, V; Andino, N (corresponding author), Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, INTERBIODES Interacc Biol Desierto, San Juan, Argentina.; Cappa, F; Campos, V (corresponding author), Consejo Nacl Invest Cient & Tecn, CIGEOBIO CONICET Ctr Invest Geosfera & Biosfera, San Juan, Argentina.	flaviocappa@unsj-cuim.edu.ar; valeriaecampos@gmail.com; nandino@unsj-cuim.edu.ar	Campos, Valeria/K-6637-2019; Andino, Natalia/AAU-3763-2020	Giannoni, Stella/0000-0003-3552-6611				Baigun R. J., 2008, MANEJO FAUNA SILVEST; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradley BA, 2012, ECOL MODEL, V244, P57, DOI 10.1016/j.ecolmodel.2012.06.019; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Campos CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162551; de Boer HY, 2004, WILDLIFE BIOL, V10, P35, DOI 10.2981/wlb.2004.007; Donadio E, 2006, BIOL CONSERV, V127, P139, DOI 10.1016/j.biocon.2005.08.004; Estes LD, 2008, REMOTE SENS ENVIRON, V112, P2033, DOI 10.1016/j.rse.2008.01.004; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Franklin WL, 1983, SPEC PUBL AM SOC MAM, P7; Haines AM, 2012, WILDLIFE SOC B, P1; Holmern T, 2016, BEHAV ECOL, V27, P1432, DOI 10.1093/beheco/arw052; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Marino A, 2008, ETHOLOGY, V114, P413, DOI 10.1111/j.1439-0310.2008.01485_1.x; Marino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089060; Marino A, 2012, WILDLIFE RES, V39, P503, DOI 10.1071/WR11174; Marquez J, 1999, MULTEQUINA, V8, P1; Marsett RC, 2006, RANGELAND ECOL MANAG, V59, P530, DOI 10.2111/05-201R.1; Cappa FM, 2014, J ARID ENVIRON, V107, P34, DOI 10.1016/j.jaridenv.2014.04.004; McCullagh P, 1989, CHAPMAN HALL CRC MON, V37; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Montes MC, 2006, J ARID ENVIRON, V64, P616, DOI 10.1016/j.jaridenv.2005.05.008; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Pedrana J, 2009, CAN J ZOOL, V87, P886, DOI 10.1139/Z09-079; Periquet S, 2010, ANIM BEHAV, V79, P665, DOI 10.1016/j.anbehav.2009.12.016; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pinheiro J., 2016, R PACKAGE VERSION, P1; Price MV, 2014, CURR ZOOL, V60, P693, DOI 10.1093/czoolo/60.6.693; R Core Team, 2013, R LANG ENV STAT COMP; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; STEPHENS PW, 1984, HOLARCTIC ECOL, V7, P239; Taraborelli P., 2014, ACTA THERIOL; Taraborelli P, 2012, BEHAV PROCESS, V91, P82, DOI 10.1016/j.beproc.2012.06.002; Tarakini T, 2014, S AFR J WILDL RES, V44, P76, DOI 10.3957/056.044.0110; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Vila B., 2014, ETNOECOLOGICA, V10, P1; WILSON P, 1985, Z TIERPSYCHOL, V69, P305; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2; Zar JH, 1999, BIOSTATISTICAL ANAL	44	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184018	10.1371/journal.pone.0184018	http://dx.doi.org/10.1371/journal.pone.0184018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859147	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500058
J	Synowsky, SA; Shirran, SL; Cooke, FGM; Antoniou, AN; Botting, CH; Powis, SJ				Synowsky, Silvia A.; Shirran, Sally L.; Cooke, Fiona G. M.; Antoniou, Antony N.; Botting, Catherine H.; Powis, Simon J.			The major histocompatibility complex class I immunopeptidome of extracellular vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular vesicles; immunology; major histocompatibility complex (MHC); mass spectrometry (MS); proteomics	NANOPARTICLE TRACKING ANALYSIS; MASS-SPECTROMETRY; EXOSOMES; CANCER; CELLS	Extracellular vesicles (EVs) are released by most cell types and have been associated with multiple immunomodulatory functions. MHC class I molecules have crucial roles in antigen presentation and in eliciting immune responses and are known to be incorporated into EVs. However, the MHC class I immunopeptidome of EVs has not been established. Here, using a small-scale immunoisolation of the antigen serotypes HLA-A*02:01 and HLA-B*27:05 expressed on the Epstein-Barr virus-transformed B cell line Jesthom and MS of the eluted peptides from both cells and EVs, we identified 516 peptides that bind either HLA-A*02:01 or HLA-B*27:05. Of importance, the predicted serotype-binding affinities and peptide-anchor motifs did not significantly differ between the peptide pools isolated from cells or EVs, indicating that during EV biogenesis, no obvious editing of the MHC class I immunopeptidome occurs. These results, for the first time, establish EVs as a source of MHC class I peptides that can be used for the study of the immunopeptidome and in the discovery of potential neoantigens for immunotherapies.	[Synowsky, Silvia A.; Shirran, Sally L.; Botting, Catherine H.] Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland; [Cooke, Fiona G. M.; Powis, Simon J.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Antoniou, Antony N.] UCL, Adv Ctr Biochem Engn, London WC1E 7JE, England	University of St Andrews; University of St Andrews; University of London; University College London	Powis, SJ (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.	sjp10@st-andrews.ac.uk		Shirran, Sally/0000-0003-3516-3507; Powis, Simon/0000-0003-4218-2984; Cooke, Fiona/0000-0002-7167-5481	Melville Trust for the Care and Cure of Cancer, Scotland, UK	Melville Trust for the Care and Cure of Cancer, Scotland, UK	This work was supported by the Melville Trust for the Care and Cure of Cancer, Scotland, UK. The authors declare that they have no conflicts of interest with the contents of this article.	Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; ARAKELYAN A, 2017, SCI REP UK, V7; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Caron E, 2015, MOL CELL PROTEOMICS, V14, P3105, DOI [10.1074/mcp.O115.052431, 10.1074/mcp.M115.052431]; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Gercel-Taylor C, 2012, ANAL BIOCHEM, V428, P44, DOI 10.1016/j.ab.2012.06.004; Hassan C, 2013, MOL CELL PROTEOMICS, V12, P1829, DOI 10.1074/mcp.M112.024810; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Lundberg V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36479; Lynch S, 2009, J IMMUNOL, V183, P1884, DOI 10.4049/jimmunol.0900798; Marino J, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8759; Navabi H, 2005, BLOOD CELL MOL DIS, V35, P149, DOI 10.1016/j.bcmd.2005.06.008; Pitt JM, 2016, J CLIN INVEST, V126, P1224, DOI 10.1172/JCI81137; Soo CY, 2012, IMMUNOLOGY, V136, P192, DOI 10.1111/j.1365-2567.2012.03569.x; Syn NL, 2017, TRENDS BIOTECHNOL, V35, P665, DOI 10.1016/j.tibtech.2017.03.004; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Whiteside TL, 2017, CLIN EXP IMMUNOL, V189, P259, DOI 10.1111/cei.12974; Zheng Y, 2013, EXP CELL RES, V319, P1706, DOI 10.1016/j.yexcr.2012.10.006	22	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17084	17092		10.1074/jbc.M117.805895	http://dx.doi.org/10.1074/jbc.M117.805895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28860189	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000413140600027
J	Chowdhury, MM; Makris, GC; Tarkin, JM; Joshi, FR; Hayes, PD; Rudd, JHF; Coughlin, PA				Chowdhury, Mohammed M.; Makris, Gregory C.; Tarkin, Jason M.; Joshi, Francis R.; Hayes, Paul D.; Rudd, James. H. F.; Coughlin, Patrick A.			Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity	PLOS ONE			English	Article							THORACIC AORTA CALCIFICATION; ALL-CAUSE MORTALITY; COMPUTED-TOMOGRAPHY; CORONARY-ARTERY; VASCULAR CALCIFICATION; MEDICAL THERAPY; SCORING METHOD; RISK; CALCIUM; ATHEROSCLEROSIS	Aims The association of coronary arterial calcification with cardiovascular morbidity and mortality is well-recognized. Lower limb arterial calcification (LLAC) is common in PAD but its impact on subsequent health is poorly described. We aimed to determine the association between a LLAC score and subsequent cardiovascular events in patients with symptomatic peripheral arterial disease (PAD). Methods LLAC scoring, and the established Bollinger score, were derived from a database of unenhanced CT scans, from patients presenting with symptomatic PAD. We determined the association between these scores outcomes. The primary outcome was combined cardiac mortality and morbidity (CM/M) with a secondary outcome of all-cause mortality. Results 220 patients (66% male; median age 69 years) were included with follow-up for a median 46 [IQR 31-64] months. Median total LLAC scores were higher in those patients suffering a primary outcome (6831 vs. 1652; p = 0.012). Diabetes mellitus (p = 0.039), ischaemic heart disease (p = 0.028), chronic kidney disease (p = 0.026) and all-cause mortality (p = 0.012) were more common in patients in the highest quartile of LLAC scores. The area under the curve of the receiver operator curve for the LLAC score was greater (0.929: 95% CI [0.884- 0.974]) than for the Bollinger score (0.824: 95% CI [0.758-0.890]) for the primary outcome. A LLAC score >= 4400 had the best diagnostic accuracy to determine the outcome measure. Conclusion This is the largest study to investigate links between lower limb arterial calcification and cardiovascular events in symptomatic PAD. We describe a straightforward, reproducible, CT-derived measure of calcification-the LLAC score.	[Chowdhury, Mohammed M.; Hayes, Paul D.; Coughlin, Patrick A.] Cambridge Univ Hosp Trust, Div Vasc & Endovasc Surg, Addenbrookes Hosp, Cambridge, England; [Makris, Gregory C.] Oxford Univ Hosp Trust, Div Vasc & Intervent Radiol, John Radcliffe Hosp, Oxford, England; [Tarkin, Jason M.; Rudd, James. H. F.] Cambridge Univ Hosp Trust, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge, England; [Joshi, Francis R.] Rigshosp, Heart Ctr, Copenhagen, Denmark	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Rigshospitalet; University of Copenhagen	Chowdhury, MM (corresponding author), Cambridge Univ Hosp Trust, Div Vasc & Endovasc Surg, Addenbrookes Hosp, Cambridge, England.	mmc59@cam.ac.uk	Makris, Gregory/AAR-4430-2021	Tarkin, Jason/0000-0002-9132-120X; Coughlin, Patrick/0000-0003-1342-1114; Chowdhury, Mohammed M./0000-0003-0384-7197; Rudd, James/0000-0003-2243-3117	Royal College of Surgeons of England Fellowship Programme; British Heart Foundation Research Fellowship [FS/16/29/31957]; Wellcome Trust Research Training Fellowship [104492/Z/14/Z]; NIHR Cambridge Biomedical Research Centre; British Heart Foundation; HEFCE; Wellcome Trust; EPSRC [EP/N014588/1] Funding Source: UKRI; British Heart Foundation [FS/16/29/31957, PG/09/083/27667, FS/12/29/29463] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/N014588/1] Funding Source: researchfish	Royal College of Surgeons of England Fellowship Programme; British Heart Foundation Research Fellowship; Wellcome Trust Research Training Fellowship(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.M.C. is supported by the Royal College of Surgeons of England Fellowship Programme and a British Heart Foundation Research Fellowship award FS/16/29/31957. J.M.T. is supported by a Wellcome Trust Research Training Fellowship (104492/Z/14/Z). J.H.F.R. is part supported by the NIHR Cambridge Biomedical Research Centre, the British Heart Foundation, HEFCE and the Wellcome Trust.; M.M.C is supported by the Royal College of Surgeons of England Fellowship Programme and a British Heart Foundation Research Fellowship award FS/16/29/31957.; J.M.T is supported by a Wellcome Trust Research Training Fellowship (104492/Z/14/Z).; J.H.F.R is part-supported by the NIHR Cambridge Biomedical Research Centre, the British Heart Foundation, HEFCE and the Wellcome Trust.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Akai T, 2014, INT ANGIOL, V33, P426; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Bos D, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003843; Bradbury AW, 2010, J VASC SURG, V51, p5S, DOI 10.1016/j.jvs.2010.01.073; Bradbury AW, 2010, J VASC SURG, V51, p32S, DOI 10.1016/j.jvs.2010.01.075; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Caruana MF, 2005, EUR J VASC ENDOVASC, V29, P443, DOI 10.1016/j.ejvs.2005.01.015; Cleven Arjen H G, 2005, Eur J Gen Pract, V11, P107; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Huang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090201; Hussain MA, 2016, JAMA SURG, V151, P742, DOI 10.1001/jamasurg.2016.0415; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Joshi FR, 2016, J AM COLL CARDIOL, V67, P69, DOI 10.1016/j.jacc.2015.10.050; Kim J, 2013, J NUCL CARDIOL, V20, P375, DOI 10.1007/s12350-013-9675-5; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Matsuo Y, 2012, ATHEROSCLEROSIS, V223, P365, DOI 10.1016/j.atherosclerosis.2012.05.023; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Ohtake T, 2011, J VASC SURG, V53, P676, DOI 10.1016/j.jvs.2010.09.070; Olin JW, 2016, J AM COLL CARDIOL, V67, P1339, DOI 10.1016/j.jacc.2015.12.049; Popovic B, 2009, AM J CARDIOL, V104, P1377, DOI 10.1016/j.amjcard.2009.07.001; Rumberger JA, 1997, J AM COLL CARDIOL, V29, P1542, DOI 10.1016/S0735-1097(97)00093-4; Sampson UKA, 2014, GLOB HEART, V9, P145, DOI 10.1016/j.gheart.2013.12.008; Santos RD, 2010, ATHEROSCLEROSIS, V209, P131, DOI 10.1016/j.atherosclerosis.2009.08.025; Shanahan CM, 2013, NAT REV NEPHROL, V9, P661, DOI 10.1038/nrneph.2013.176; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Singh DK, 2012, DIABETES RES CLIN PR, V97, P158, DOI 10.1016/j.diabres.2012.01.038; Vagnarelli F, 2016, ATHEROSCLEROSIS, V245, P43, DOI 10.1016/j.atherosclerosis.2015.11.014; van Gils MJ, 2013, ATHEROSCLEROSIS, V227, P95, DOI 10.1016/j.atherosclerosis.2012.12.017; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103	34	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182952	10.1371/journal.pone.0182952	http://dx.doi.org/10.1371/journal.pone.0182952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886041	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100013
J	Guzman, JM; Luckenbach, JA; Middleton, MA; Massee, KC; Jensen, C; Goetz, FW; Jasonowicz, AJ; Swanson, P				Guzman, Jose M.; Luckenbach, J. Adam; Middleton, Mollie A.; Massee, Kenneth C.; Jensen, Cortney; Goetz, Frederick W.; Jasonowicz, Andrew J.; Swanson, Penny			Reproductive life history of sablefish (Anoplopoma fimbria) from the US Washington coast	PLOS ONE			English	Article							COD GADUS-MORHUA; GONADAL-STEROIDS; DICENTRARCHUS-LABRAX; OOCYTE DEVELOPMENT; SERUM-LEVELS; SEA BASS; MATURITY; PLASMA; FISHES; CYCLE	Sablefish (Anoplopoma fimbria) is a marine groundfish that supports valuable fisheries in the North Pacific Ocean and holds promise for marine aquaculture. Limited information is available, however, about its reproductive biology. This study aimed to characterize the complete reproductive cycle, including seasonal changes in gonadal development (macroscopic and histological), plasma sex steroid levels (17 beta-estradiol -E2-, and 11-ketotestosterone -11KT-), gonadosomatic and hepatosomatic indices (GSI, and HSI), and condition factor (K) of female and male sablefish captured off the Washington coast. Adult fish (209 females, 159 males) were caught by longline monthly from August 2012 to August 2013. Early signs of recruitment of ovarian follicles into secondary growth, indicated by oocytes containing small yolk granules and cortical alveoli, were first observed in March. Oogenesis progressed during spring and summer, and fully vitellogenic follicles were first observed in July. Vitellogenic growth was correlated with increases in plasma E2, GSI, HSI and K. Perio-vulatory females, indicated by fully-grown oocytes with migrating germinal vesicles and hydrated oocytes, were found from November to February. At this stage, plasma E2 and GSI reached maximal levels. In males, proliferating cysts containing spermatocytes were first observed in April. Testicular development proceeded during spring and summer, a period during which all types of male germ cells were found. The first clusters of spermatozoa appeared in July, concomitant with a 5.2-fold increase in GSI. Spermiating males were observed from November to April; at this time, spermatids were absent or greatly reduced, and testis lobules were filled with spermatozoa. The highest levels of plasma 11KT were found in males at this stage. Postspawning ovaries and testes, and basal steroids levels were found in fish captured from February to April. These results suggest that sablefish in coastal Washington initiate their reproductive cycle in March/April and spawn primarily in January/February.	[Guzman, Jose M.; Luckenbach, J. Adam; Massee, Kenneth C.; Goetz, Frederick W.; Swanson, Penny] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA; [Guzman, Jose M.; Middleton, Mollie A.; Jasonowicz, Andrew J.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Luckenbach, J. Adam; Swanson, Penny] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Jensen, Cortney] Ocean Associates Inc, NOAA, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; Washington State University; National Oceanic Atmospheric Admin (NOAA) - USA	Guzman, JM (corresponding author), NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA.; Guzman, JM (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jmguzman@uw.edu	Middleton, Mollie/Z-2446-2019		National Oceanic and Atmospheric Administration Cooperation Research Program; National Oceanic and Atmospheric Administration Office of Aquaculture; National Academy of Sciences; NOAA Cooperative Research Program; NOAA Office of Aquaculture; NOAA through the National Academy of Sciences	National Oceanic and Atmospheric Administration Cooperation Research Program; National Oceanic and Atmospheric Administration Office of Aquaculture; National Academy of Sciences; NOAA Cooperative Research Program; NOAA Office of Aquaculture; NOAA through the National Academy of Sciences	This research was supported by funding from National Oceanic and Atmospheric Administration Cooperation Research Program and National Oceanic and Atmospheric Administration Office of Aquaculture to FWG and PS. JMG received a postdoctoral fellowship form The National Academy of Sciences. Ocean Associates Inc. provides professional consulting services to government organizations, UN agencies, academia, non-governmental organizations, and the private sector. In the current study NOAH contracted Ocean Associates Inc. to provide a qualified contractor to help in conducting the research project. The funder provided support in the form of salary for author CJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; This research was supported by funding from the NOAA Cooperative Research Program and NOAA Office of Aquaculture. JMG received a National Research Council postdoctoral fellowship funded by NOAA through the National Academy of Sciences. Valuable assistance was provided by Eric Samuelson and the crew of the F/V Playboy Too in collecting sablefish by longline for the study and aging of otoliths was performed by Patrick MacDonald (Pacific States Marine Fisheries). The authors are grateful to Melissa Head and Cara Rodgveller for comments on an earlier draft of this manuscript.	Almeida FFL, 2008, BIOL REPROD, V78, P27, DOI 10.1095/biolreprod.107.063669; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Bell F, 1945, ANOPLOPOMA FIMBRIA, P94; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; CAILLIET GM, 1988, CALIF FISH GAME, V74, P132; Cavaco JEB, 1998, AM J PHYSIOL-REG I, V275, pR1793, DOI 10.1152/ajpregu.1998.275.6.R1793; Chilton DE, 1982, AGE DETERMINATION ME, P60; Dahle R, 2003, COMP BIOCHEM PHYS A, V136, P641, DOI 10.1016/S1095-6433(03)00215-0; FUJIWARA S, 1988, NIPPON SUISAN GAKK, V54, P1333; Gunnarsson A, 2006, J FISH BIOL, V68, P1158, DOI 10.1111/j.0022-1112.2006.00990.x; Guzman JM, 2008, GEN COMP ENDOCR, V156, P285, DOI 10.1016/j.ygcen.2008.02.002; Guzman JM, 2015, GEN COMP ENDOCR, V221, P101, DOI 10.1016/j.ygcen.2015.02.024; Guzman JM, 2013, GEN COMP ENDOCR, V193, P37, DOI 10.1016/j.ygcen.2013.07.007; Hanselman DH, 2011, STOCK ASSESSMENT FIS, P307; HARMIN SA, 1995, MAR BIOL, V121, P601, DOI 10.1007/BF00349295; Haukenes AH, 2008, N AM J AQUACULT, V70, P212, DOI 10.1577/A07-025.1; Head MA, 2014, FISH RES, V159, P56, DOI 10.1016/j.fishres.2014.05.007; HEYAMOTO HIROMU, 1965, COMMERCIAL FISH REV, V27, P1; Hiramatsu N, 2002, FISHERIES SCI, V68, P694, DOI 10.2331/fishsci.68.sup1_694; Hunter JR, 1989, CALIFORNIA COOPERATI, V30, P160; Jamieson B.G.M., 1991, FISH EVOLUTION SYSTE; JOHNSON LL, 1991, J EXP MAR BIOL ECOL, V152, P161, DOI 10.1016/0022-0981(91)90213-G; Junquera S, 2003, ICES J MAR SCI, V60, P767, DOI 10.1016/S1054-3139(03)00073-0; KIMURA DK, 1993, FISH B-NOAA, V91, P271; Kwon JY, 1999, J FISH BIOL, V54, P370, DOI 10.1006/jfbi.1998.0871; Leary S, 2013, AVMA GUIDELINES EUTH, P69; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Luckenbach JA, 2017, AQUACULTURE, V479, P285, DOI 10.1016/j.aquaculture.2017.05.037; Luckenbach JA, 2016, FISH PHYSIOL BIOCHEM, V42, P233, DOI 10.1007/s10695-015-0132-z; MACEWICZ BJ, 1994, CAL COOP OCEAN FISH, V35, P160; MASON JC, 1983, CAN J FISH AQUAT SCI, V40, P2126, DOI 10.1139/f83-247; MATSUYAMA M, 1991, JPN J ICHTHYOL, V37, P381, DOI 10.1007/BF02905364; Miura T, 2002, ZOOL SCI, V19, P321, DOI 10.2108/zsj.19.321; Mori H, 2003, FISHERIES SCI, V69, P910, DOI 10.1046/j.1444-2906.2003.00707.x; Morita SH, 2012, ENVIRON BIOL FISH, V94, P505, DOI 10.1007/s10641-010-9613-1; MOSER HG, 1994, CAL COOP OCEAN FISH, V35, P144; National Marine Service, 2014, FISH EC US, V2016, P163; Orlov AM, 2005, ICES J MAR SCI, V62, P1016, DOI 10.1016/j.icesjms.2005.03.002; Parks N, 1987, NMFSFNWC124 NOAA; Pavlidis M, 2000, GEN COMP ENDOCR, V118, P14, DOI 10.1006/gcen.1999.7440; Phillips JP, 1954, PACIFIC MARINE FISHE, V3, P23; Polzonetti-Magni AM, 2004, INT REV CYTOL, V239, P1, DOI 10.1016/S0074-7696(04)39001-7; PRAT F, 1990, GEN COMP ENDOCR, V78, P361, DOI 10.1016/0016-6480(90)90026-I; Quagio-Grassiotto I, 2011, J MORPHOL, V272, P1290, DOI 10.1002/jmor.10981; R Development Core Team, 2016, R LANG ENV STAT COMP; Rideout RM, 2011, MAR COAST FISH, V3, P176, DOI 10.1080/19425120.2011.556943; Rideout RM, 2000, CAN J ZOOL, V78, P1017, DOI 10.1139/cjz-78-6-1017; Rodgveller CJ, 2016, FISH B-NOAA, V114, P89, DOI 10.7755/FB.114.1.8; Sablefish Maloney N., 2004, MAR FISH REV, V66, P1; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Trippel Edward A., 2003, Journal of Northwest Atlantic Fishery Science, V33, P81, DOI 10.2960/J.v33.a6; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; Weltzien FA, 2002, COMP BIOCHEM PHYS A, V132, P567, DOI 10.1016/S1095-6433(02)00092-2; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199	57	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184413	10.1371/journal.pone.0184413	http://dx.doi.org/10.1371/journal.pone.0184413			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886138	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100112
J	Grell, AS; Frederiksen, SD; Edvinsson, L; Ansar, S				Grell, Anne-Sofie; Frederiksen, Simona Denise; Edvinsson, Lars; Ansar, Saema			Cerebrovascular gene expression in spontaneously hypertensive rats	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; DENSITY-LIPOPROTEIN RECEPTOR-1; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASE-2; EXTRACELLULAR-MATRIX; LECTIN-LIKE; MECHANICAL STRETCH; VASCULAR INJURY; PLASMA-LEVELS; APOPTOSIS	Hypertension is a hemodynamic disorder and one of the most important and well-established risk factors for vascular diseases such as stroke. Blood vessels exposed to chronic shear stress develop structural changes and remodeling of the vascular wall through many complex mechanisms. However, the molecular mechanisms involved are not fully understood. Hypertension-susceptible genes may provide a novel insight into potential molecular mechanisms of hypertension and secondary complications associated with hypertension. The aim of this exploratory study was to identify gene expression differences in the middle cerebral arteries between 12-week-old male spontaneously hypertensive rats and their normotensive Wistar-Kyoto rats using an Affymetrix whole-transcriptome expression profiling. Quantitative PCR and western blotting were used to verify genes of interest. 169 genes were differentially expressed in the middle cerebral arteries from hypertensive compared to normotensive rats. The gene expression of 72 genes was decreased and the gene expression of 97 genes was increased. The following genes with a fold difference >= 1.40 were verified by quantitative PCR; Postn, Olr1, Fas, Vldlr, Mmp2, Timp1, Serpine1, Mmp11, Cd34, Ptgs1 and Ptgs2. The gene expression of Postn, Olr1, Fas, Vldlr, Mmp2, Timp1 and Serpine1 and the protein expression of LOX1 (also known as OLR1) were significantly increased in the middle cerebral arteries from spontaneously hypertensive rats compared to Wistar-Kyoto rats. In conclusion, the identified genes in the middle cerebral arteries from spontaneously hypertensive rats could be possible mediators of the vascular changes and secondary complications associated with hypertension. This study supports the selection of key genes to investigate in the future research of hypertension-induced end-organ damage.	[Grell, Anne-Sofie; Frederiksen, Simona Denise; Edvinsson, Lars] Rigshosp Glostrup, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Edvinsson, Lars; Ansar, Saema] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden	Lund University	Grell, AS (corresponding author), Rigshosp Glostrup, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	anne-sofie.grell@regionh.dk	Frederiksen, Simona Denise/AAN-2233-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Frederiksen, Simona Denise/0000-0002-9207-0350; Edvinsson, Lars/0000-0002-1805-1346	Lundbeckfonden [R59-A5404]; Lundbeck Foundation [R59-2010-5404] Funding Source: researchfish	Lundbeckfonden(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Lundbeckfonden (R59-A5404) to Lars Edvinsson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2010, CIRCULATION, V122, P2058, DOI 10.1161/CIRCULATIONAHA.110.972745; Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; ARGRAVES KM, 1995, J BIOL CHEM, V270, P26550, DOI 10.1074/jbc.270.44.26550; Au A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18224; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861; Briones AM, 2010, CURR OPIN NEPHROL HY, V19, P187, DOI 10.1097/MNH.0b013e328335eec9; Castro MA, 2008, ATHEROSCLEROSIS, V198, P320, DOI 10.1016/j.atherosclerosis.2007.10.011; Chase AJ, 2003, J VASC RES, V40, P329, DOI 10.1159/000072697; Chelladurai P, 2012, EUR RESPIR J, V40, P766, DOI 10.1183/09031936.00209911; Chelluboina B, 2014, MOL NEUROBIOL, V49, P50, DOI 10.1007/s12035-013-8486-7; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Denorme F, 2016, STROKE, V47, P2419, DOI 10.1161/STROKEAHA.116.014091; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; Drake C, 2011, BRAIN BEHAV IMMUN, V25, P1113, DOI 10.1016/j.bbi.2011.02.008; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Furumoto T, 2004, AM J CARDIOL, V93, P997, DOI 10.1016/j.amjcard.2003.12.053; Gonzalez JM, 2008, CLIN SCI, V114, P651, DOI 10.1042/CS20070361; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hamakawa Y, 2004, NEUROL RES, V26, P767, DOI 10.1179/016164104225016074; Hamet P, 1996, CAN J PHYSIOL PHARM, V74, P850, DOI 10.1139/cjpp-74-7-850; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Imanishi T, 2002, CIRC J, V66, P1060, DOI 10.1253/circj.66.1060; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Li YX, 2015, NEUROIMAGE, V111, P329, DOI 10.1016/j.neuroimage.2015.02.053; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Liu XX, 2015, INT J BIOCHEM CELL B, V62, P15, DOI 10.1016/j.biocel.2015.02.009; Marchesi C, 2012, J HYPERTENS, V30, P3, DOI 10.1097/HJH.0b013e32834d249a; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nagase M, 1997, BIOCHEM BIOPH RES CO, V237, P496, DOI 10.1006/bbrc.1997.7176; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Parasuraman S, 2012, J PHARMACOL PHARMACO, V3, P172, DOI 10.4103/0976-500X.95521; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Pravenec M, 2010, CURR HYPERTENS REP, V12, P5, DOI 10.1007/s11906-009-0083-9; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/808353; Rizzoni D, 2000, J HYPERTENS, V18, P885, DOI 10.1097/00004872-200018070-00010; Rosenbaum DM, 2000, J NEUROSCI RES, V61, P686, DOI 10.1002/1097-4547(20000915)61:6<686::AID-JNR12>3.0.CO;2-7; Sharifi AM, 1998, AM J HYPERTENS, V11, P1108, DOI 10.1016/S0895-7061(98)00120-4; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tacken PJ, 2002, ATHEROSCLEROSIS, V162, P103, DOI 10.1016/S0021-9150(01)00697-9; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tsai KL, 2016, J VASC SURG, V63, P204, DOI 10.1016/j.jvs.2014.05.098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Virdis A, 2014, MATURITAS, V78, P179, DOI 10.1016/j.maturitas.2014.04.012; Xu XL, 2014, CELL PHYSIOL BIOCHEM, V33, P88, DOI 10.1159/000356652; Zervoudaki A, 2003, J HUM HYPERTENS, V17, P119, DOI 10.1038/sj.jhh.1001518; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	51	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184233	10.1371/journal.pone.0184233	http://dx.doi.org/10.1371/journal.pone.0184233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880918	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200043
J	Wortinger, LA; Oie, MG; Endestad, T; Wyller, VB				Wortinger, Laura Anne; Oie, Merete Glenne; Endestad, Tor; Wyller, Vegard Bruun			Altered right anterior insular connectivity and loss of associated functions in adolescent chronic fatigue syndrome	PLOS ONE			English	Article							NEUROCOGNITIVE BRAIN NETWORKS; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; CLINICAL SYMPTOMS; ACTIVITY MONITOR; AEROBIC FITNESS; PAIN PERCEPTION; RELIABILITY; INTEROCEPTION; MECHANISMS	Impairments in cognition, pain intolerance, and physical inactivity characterize adolescent chronic fatigue syndrome (CFS), yet little is known about its neurobiology. The right dorsal anterior insular (dAI) connectivity of the salience network provides a motivational context to stimuli. In this study, we examined regional functional connectivity (FC) patterns of the right dAI in adolescent CFS patients and healthy participants. Eighteen adolescent patients with CFS and 18 aged-matched healthy adolescent control participants underwent resting-state functional magnetic resonance imaging. The right dAI region of interest was examined in a seed-to-voxel resting-state FC analysis using SPM and CONN toolbox. Relative to healthy adolescents, CFS patients demonstrated reduced FC of the right dAI to the right posterior parietal cortex (PPC) node of the central executive network. The decreased FC of the right dAI-PPC might indicate impaired cognitive control development in adolescent CFS. Immature FC of the right dAI-PPC in patients also lacked associations with three known functional domains: cognition, pain and physical activity, which were observed in the healthy group. These results suggest a distinct biological signature of adolescent CFS and might represent a fundamental role of the dAI in motivated behavior.	[Wortinger, Laura Anne; Wyller, Vegard Bruun] Akershus Univ Hosp, Dept Paediat & Adolescent Hlth, Nordbyhagen, Norway; [Wortinger, Laura Anne; Oie, Merete Glenne; Endestad, Tor] Univ Oslo, Dept Psychol, Oslo, Norway; [Oie, Merete Glenne] Innlandet Hosp Trust, Res Dept, Lillehammer, Norway	University of Oslo; University of Oslo; Innlandet Hospital Trust	Wortinger, LA (corresponding author), Akershus Univ Hosp, Dept Paediat & Adolescent Hlth, Nordbyhagen, Norway.; Wortinger, LA (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	l.a.w.bakke@medisin.uio.no		Wortinger, Laura/0000-0003-2721-3172; Endestad, Tor/0000-0002-4403-6887	Norwegian Research Council [228874]; South-Eastern Norway Regional Health Authority; University of Oslo (VBW)	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; University of Oslo (VBW)	Norwegian Research Council, http://www.forskningsradet.no/en (VBW, grant number 228874); South-Eastern Norway Regional Health Authority, https://www.helse-sorost.no/south-eastern-norway-regional-health-authority (VBW); and the University of Oslo, http://www.uio.no/english/ (VBW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROG BRAIN RES; [Anonymous], 2004, EV BAS GUID MAN CFS; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Barnden LR, 2016, NEUROIMAGE-CLIN, V11, P530, DOI 10.1016/j.nicl.2016.03.017; Barnden LR, 2015, NMR BIOMED, V28, P404, DOI 10.1002/nbm.3261; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Boissoneault J, 2016, CLIN PHYSL FUNCT IMA; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Burkey AR, 1999, J NEUROSCI, V19, P4169; Castell BD, 2011, CLIN PSYCHOL-SCI PR, V18, P311, DOI 10.1111/j.1468-2850.2011.01262.x; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Chechik G, 1998, NEURAL COMPUT, V10, P1759, DOI 10.1162/089976698300017124; Collin SM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008830; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Dahlgren G, 2010, GAIT POSTURE, V32, P386, DOI 10.1016/j.gaitpost.2010.06.022; Dowd KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047633; Erickson KI, 2015, CURR OPIN BEHAV SCI, V4, P27, DOI 10.1016/j.cobeha.2015.01.005; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Garralda ME, 2005, J CHILD PSYCHOL PSYC, V46, P1143, DOI 10.1111/j.1469-7610.2005.01424.x; Gay CW, 2015, BRAIN CONNECT; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Gordon BA, 2010, CLIN REHABIL, V24, P1072, DOI 10.1177/0269215510371429; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kawatani J, 2011, BRAIN DEV-JPN, V33, P832, DOI 10.1016/j.braindev.2010.12.009; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kurniawan IT, 2013, J NEUROSCI, V33, P6160, DOI 10.1523/JNEUROSCI.4777-12.2013; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Liu X, 2016, NEUROGASTROENT MOTIL, V28, P43, DOI 10.1111/nmo.12695; Lou HC, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.484; Mackenzie C, 2013, PAEDIAT CHILD HLTH, V23, P35, DOI DOI 10.1016/J.PAED.2012.10.001; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Menon V., 2015, BRAIN MAPPING ENCY R, V2, P597, DOI DOI 10.1016/B978-0-12-397025-1.00052-X; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098156; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mizuno K, 2016, NEUROIMAGE-CLIN, V12, P600, DOI 10.1016/j.nicl.2016.09.016; Mizuno K, 2015, NEUROIMAGE-CLIN, V9, P355, DOI 10.1016/j.nicl.2015.09.001; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; National Institute for Health and Clinical Excellence N, 2007, CHRON FAT SYNDR MYAL, P7; Nie HL, 2005, J PAIN, V6, P348, DOI 10.1016/j.jpain.2005.01.352; Nijhof SL, 2014, PSYCHONEUROENDOCRINO, V42, P199, DOI 10.1016/j.psyneuen.2014.01.017; Nijhof SL, 2012, LANCET, V379, P1412, DOI 10.1016/S0140-6736(12)60025-7; Nijhof SL, 2011, PEDIATRICS, V127, pE1169, DOI 10.1542/peds.2010-1147; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Nisenbaum R, 2004, J PSYCHOSOM RES, V56, P171, DOI 10.1016/S0022-3999(03)00039-4; Ohara PT, 2003, J NEUROCYTOL, V32, P131, DOI 10.1023/B:NEUR.0000005598.09647.7f; Padmala S, 2011, J COGNITIVE NEUROSCI, V23, P3419, DOI 10.1162/jocn_a_00011; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Pannekoek JN, 2014, J CHILD PSYCHOL PSYC, V55, P1317, DOI 10.1111/jcpp.12266; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Sulheim D, 2015, ARCH DIS CHILD, V100, P838, DOI 10.1136/archdischild-2014-306764; Sulheim D, 2014, JAMA PEDIATR, V168, P351, DOI 10.1001/jamapediatrics.2013.4647; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Sund AM, 2001, EUR CHILD ADOLES PSY, V10, P222, DOI 10.1007/s007870170011; Supekar K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002374; Tanaka M, 2013, REV NEUROSCIENCE, V24, P617, DOI 10.1515/revneuro-2013-0035; Tanaka M, 2008, PSYCHOL REP, V103, P682, DOI 10.2466/PR0.103.3.682-690; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; Voss M.W., 1985, J APPL PHYSIOL, V111, P1505, DOI DOI 10.1152/JAPPLPHYSI0L.00210.2011; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wechsler D., 2007, NORWEGIAN MANUAL SUP; Weng Y, 2016, BRAIN IMAGING BEHAV; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wiebking C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00082; Winger A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005920; Wortinger LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159351; Wyller VB, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-5; Wyller VB, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-10; Wyller VB, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0873-1; Wyller VB, 2011, EUR J APPL PHYSIOL, V111, P497, DOI 10.1007/s00421-010-1670-9; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012; Zeineh MM, 2015, RADIOLOGY, V274, P517, DOI 10.1148/radiol.14141079	104	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184325	10.1371/journal.pone.0184325	http://dx.doi.org/10.1371/journal.pone.0184325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880891	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000409467200050
J	Costanza, JK; Coulston, JW; Wear, DN				Costanza, Jennifer K.; Coulston, John W.; Wear, David N.			An empirical, hierarchical typology of tree species assemblages for assessing forest dynamics under global change scenarios	PLOS ONE			English	Article							EASTERN UNITED-STATES; CLIMATE-CHANGE; BIOTIC INTERACTIONS; COMMUNITY-LEVEL; MODELS; DISTRIBUTIONS; MACROSYSTEMS; PATTERNS; BIOMES	The composition of tree species occurring in a forest is important and can be affected by global change drivers such as climate change. To inform assessment and projection of global change impacts at broad extents, we used hierarchical cluster analysis and over 120,000 recent forest inventory plots to empirically define forest tree assemblages across the U.S., and identified the indicator and dominant species associated with each. Cluster typologies in two levels of a hierarchy of forest assemblages, with 29 and 147 groups respectively, were supported by diagnostic criteria. Groups in these two levels of the hierarchy were labeled based on the top indicator species in each, and ranged widely in size. For example, in the 29-cluster typology, the sugar maple-red maple assemblage contained the largest number of plots (30,068), while the butternut-sweet birch and sourwood-scarlet oak assemblages were both smallest (6 plots each). We provide a case-study demonstration of the utility of the typology for informing forest climate change impact assessment. For five assemblages in the 29-cluster typology, we used existing projections of changes in importance value (IV) for the dominant species under one low and one high climate change scenario to assess impacts to the assemblages. Results ranged widely for each scenario by the end of the century, with each showing an average decrease in IV for dominant species in some assemblages, including the balsam fir-quaking aspen assemblage, and an average increase for others, like the green ash-American elm assemblage. Future work should assess adaptive capacity of these forest assemblages and investigate local population-and community-level dynamics in places where dominant species may be impacted. This typology will be ideal for monitoring, assessing, and projecting changes to forest communities within the emerging framework of macrosystems ecology, which emphasizes hierarchies and broad extents.	[Costanza, Jennifer K.] North Carolina State Univ, Dept Forestry & Environm Resources, Res Triangle Pk, NC 27695 USA; [Coulston, John W.] US Forest Serv, Southern Res Stn, USDA, Blacksburg, VA USA; [Wear, David N.] US Forest Serv, Southern Res Stn, USDA, Raleigh, NC USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Costanza, JK (corresponding author), North Carolina State Univ, Dept Forestry & Environm Resources, Res Triangle Pk, NC 27695 USA.	jennifer_costanza@ncsu.edu		Costanza, Jennifer/0000-0002-3747-538X	United States Department of Agriculture Forest Service	United States Department of Agriculture Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This work was supported by the United States Department of Agriculture Forest Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2012, REPORT US FISH WILDL; [Anonymous], 2011, SCANNING CONSERVATIO; Arner SL, 2003, USDA FOREST SERVICE; Baselga A, 2009, ECOGRAPHY, V32, P55, DOI 10.1111/j.1600-0587.2009.05856.x; Bechtold WA, ENHANCED FOREST INVE, P85; Blois JL, 2014, ECOGRAPHY, V37, P1095, DOI 10.1111/ecog.00779; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Brandt L, 2014, NRS124 US DEP AGR NO; Clark JS, 2014, ECOL APPL, V24, P990, DOI 10.1890/13-1015.1; Clark JS, 2016, ECOL MONOGR, V87, P1; Copenhaver-Parry PE, 2016, PLANT ECOL, V217, P533, DOI 10.1007/s11258-016-0598-5; Costanza J, 2016, 20161073 US GEOL SUR; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Davis M.B., 1981, FOREST SUCCESSION CO, P132, DOI DOI 10.1007/978-1-4612-5950-3_10; Delcourt H.R., 2000, N AM TERRESTRIAL VEG; Delcourt P.A., 1981, GEOBOTANY, P123; Doherty JM, 2011, ECOL APPL, V21, P2143, DOI 10.1890/10-1534.1; Dufrene M, 1997, ECOL MONOGR, P345; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Embrechts M.J., 2013, ADV INTELLIGENT SIGN, V410, DOI [DOI 10.1007/978-3-642-28696-4_8, 10.1007/978-3-642-28696-4_8]; Eyre F.H., 1980, FOREST COVER TYPES U; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Frieswyk CB, 2007, J GREAT LAKES RES, V33, P125, DOI 10.3394/0380-1330(2007)33[125:IACDPA]2.0.CO;2; Gawler S, 2016, ACER SACCHARUM BETUL; Giunta AD, 2016, FORESTS, V7, DOI 10.3390/f7040080; Heffernan JB, 2014, FRONT ECOL ENVIRON, V12, P5, DOI 10.1890/130017; Hildebrand H, 2008, ECOLOGY, V89, P1510; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Landscape Change Research Group, 2014, CLIM CHANG ATL; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; le Roux PC, 2014, J ECOL, V102, P767, DOI 10.1111/1365-2745.12239; Legendre P., 2012, DEV ENV MODELLING, V3; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Levine JM, 2017, NATURE, V546, P56, DOI 10.1038/nature22898; Maechler M., 2016, CLUSTER CLUSTERANALY; McCune B., 2002, ANAL ECOLOGICAL COMM, V28, P67; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Menard S, 2016, QUERCUS ELLIPSOIDALI; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Nowacki GJ, 2015, GLOBAL CHANGE BIOL, V21, P314, DOI 10.1111/gcb.12663; O'Connell B. M., 2014, FOREST INVENTORY ANA; Oksanen J, 2022, R PACKAGE VERSION; Potter KM, 2013, MATH COMPUT FOR NAT-, V5, P151; Roberts D.W., 2016, LABDSV ORDINATION MU; Rogers BM, 2017, GLOBAL CHANGE BIOL, V23, P3302, DOI 10.1111/gcb.13585; Rose KC, 2016, ECOL LETT; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; Soranno PA, 2014, FRONT ECOL ENVIRON, V12, P65, DOI 10.1890/120366; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P2335, DOI 10.1111/j.1365-2486.2012.02700.x; Swanston C, 2011, GTRNRS82 USDA FOR SE; Terando AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102261; USNVC, 2016, DATABASE; Wear D., 2011, SRS141; Wildi O, 2013, DATA ANALYSIS IN VEGETATION ECOLOGY, 2ND EDITION, P1, DOI 10.1002/9781118562543; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2000, J BIOGEOGR, V27, P585, DOI 10.1046/j.1365-2699.2000.00428.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x; Zolkos SG, 2015, ECOSYSTEMS, V18, P202, DOI 10.1007/s10021-014-9822-0	63	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184062	10.1371/journal.pone.0184062	http://dx.doi.org/10.1371/journal.pone.0184062			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877258	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200058
J	Iwasaki, WM; Innan, H				Iwasaki, Watal M.; Innan, Hideki			Simulation framework for generating intratumor heterogeneity patterns in a cancer cell population	PLOS ONE			English	Article							TUMOR EVOLUTION; MODEL; GROWTH; MICROENVIRONMENT; MORPHOLOGY; INFERENCE; GENOMICS; INVASION; DRIVEN	As cancer cell populations evolve, they accumulate a number of somatic mutations, resulting in heterogeneous subclones in the final tumor. Understanding the mechanisms that produce intratumor heterogeneity is important for selecting the best treatment. Although some studies have involved intratumor heterogeneity simulations, their model settings differed substantially. Thus, only limited conditions were explored in each. Herein, we developed a general framework for simulating intratumor heterogeneity patterns and a simulator (tumopp). Tumopp offers many setting options so that simulations can be carried out under various settings. Setting options include how the cell division rate is determined, how daughter cells are placed, and how driver mutations are treated. Furthermore, to account for the cell cycle, we introduced a gamma function for the waiting time involved in cell division. Tumopp also allows simulations in a hexagonal lattice, in addition to a regular lattice that has been used in previous simulation studies. A hexagonal lattice produces a more biologically reasonable space than a regular lattice. Using tumopp, we investigated how model settings affect the growth curve and intratumor heterogeneity pattern. It was found that, even under neutrality (with no driver mutations), tumopp produced dramatically variable patterns of intratumor heterogeneity and tumor morphology, from tumors in which cells with different genetic background are well intermixed to irregular shapes of tumors with a cluster of closely related cells. This result suggests a caveat in analyzing intratumor heterogeneity with simulations with limited settings, and tumopp will be useful to explore intratumor heterogeneity patterns in various conditions.	[Iwasaki, Watal M.; Innan, Hideki] Grad Univ Adv Studies, SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama 2400193, Japan	Graduate University for Advanced Studies - Japan	Innan, H (corresponding author), Grad Univ Adv Studies, SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama 2400193, Japan.	innan_hideki@soken.ac.jp		Innan, Hideki/0000-0001-6375-9231; Iwasaki, Watal M./0000-0002-4718-7605	JSPS (Japan Society for the Promotion of Science) [23114004]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grant #23114004 JSPS (Japan Society for the Promotion of Science), http://www.jsps.go.jp/index.html.	Almassalha LM, 2016, CANCER RES, V76, P5605, DOI 10.1158/0008-5472.CAN-16-0585; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2009, J MATH BIOL, V58, P579, DOI 10.1007/s00285-008-0210-2; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Beerenwinkel N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004717; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; ENDERLING H, 2013, FRONT ONCOL, V3; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Hong YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012002; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Niknafs N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004416; Poleszczuk J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004025; Rejniak KA, 2007, J THEOR BIOL, V247, P186, DOI 10.1016/j.jtbi.2007.02.019; Ross EM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0929-9; Saadatpour A, 2015, TRENDS GENET, V31, P576, DOI 10.1016/j.tig.2015.07.003; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, CANCER RES, V73, P41, DOI 10.1158/0008-5472.CAN-12-2273; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zhao J, 2014, J THEOR BIOL, V359, P136, DOI 10.1016/j.jtbi.2014.05.027	37	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184229	10.1371/journal.pone.0184229	http://dx.doi.org/10.1371/journal.pone.0184229			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877206	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200076
J	Robert, R; Juglair, L; Lim, EX; Ang, C; Wang, CJH; Ebert, G; Dolezal, O; Mackay, CR				Robert, Remy; Juglair, Laurent; Lim, Ee X.; Ang, Caroline; Wang, Carl J. H.; Ebert, Gregor; Dolezal, Olan; Mackay, Charles R.			A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6	PLOS ONE			English	Article							HUMAN TH17 CELLS; RHEUMATOID-ARTHRITIS; RECEPTOR CCR6; UP-REGULATION; T(H)17 CELLS; CHEMOKINE; INFLAMMATION; RECRUITMENT; MIGRATION; FRAGMENT	Chemokines and their receptors are pivotal for the trafficking of leukocytes during immune responses, and host defense. However, immune cell migration also contributes to a wide variety of autoimmune and chronic inflammatory diseases. Compelling evidence suggests that both CXCR3 and CCR6 chemokine receptors play crucial roles in the migration of pathological Th1 and Th17 cells during the course of certain inflammatory diseases. The use of two or more receptors by pathogenic cells may explain why targeting of individual receptors has proven disappointing in the clinic. We therefore hypothesized that simultaneous targeting of both CXCR3 and CCR6 with a bispecific antibody (BsAb) might result in decreased chemotaxis and/or specific depletion of pro-inflammatory T cell subsets. In this study, we designed and characterized a fully humanized BsAb. We show that the BsAb binds to both chemokine receptors, as demonstrated by Flow Cytometry and Surface Plasmon Resonance analysis. Furthermore, we demonstrate that the BsAb effectively blocks cell chemotaxis and induces specific antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro. Therefore, we propose that dual targeting of CXCR3 and CCR6 with a fully humanized BsAb may display a potent interventional approach for the treatment of inflammatory and autoimmune diseases.	[Robert, Remy; Juglair, Laurent; Lim, Ee X.; Ang, Caroline; Wang, Carl J. H.; Mackay, Charles R.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Robert, Remy] Monash Univ, MATF, Clayton, Vic, Australia; [Ebert, Gregor] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia; [Dolezal, Olan] CSIRO, Mat Sci & Engn, Parkville, Vic, Australia	Monash University; Monash University; Walter & Eliza Hall Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Robert, R (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Robert, R (corresponding author), Monash Univ, MATF, Clayton, Vic, Australia.	remy.robert@monash.edu	Robert, Remy/O-3602-2019; robert, remy/E-6881-2012; Dolezal, Olan/E-1691-2015; Mackay, Charles R/A-9673-2008	Robert, Remy/0000-0003-2416-9268; robert, remy/0000-0003-2416-9268; Mackay, Charles R/0000-0002-6338-7340; Wang, Carl Ji Hao/0000-0003-4564-3125; Ebert, Gregor/0000-0002-5318-3037	NHMRC; Australian National Health and Medical Research Council (NHMRC program grant) [APP1016953]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council (NHMRC program grant)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NHMRC program grant), Grant# APP1016953.; The authors would like to thank Linda Masson for her help writing this manuscript and Meghan Hattarki for her technical help. The Monash University Flowcore platform for their help and technical advises. This work is support by funding from the NHMRC.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P31; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Jenh CH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-2; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; Lee AYS, 2014, IMMUNOL CELL BIOL, V92, P354, DOI 10.1038/icb.2013.97; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Liu HY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00038; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Munitz A, 2006, J ALLERGY CLIN IMMUN, V118, P1082, DOI 10.1016/j.jaci.2006.07.041; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Robert R, 2010, PROTEIN SCI, V19, P299, DOI 10.1002/pro.312; Robert R, 2009, PROTEIN ENG DES SEL, V22, P199, DOI 10.1093/protein/gzn052; Schanzer J, 2011, ANTIMICROB AGENTS CH, V55, P2369, DOI 10.1128/AAC.00215-10; Silacci M, 2016, MABS-AUSTIN, V8, P141, DOI 10.1080/19420862.2015.1093266; Spiess C, 2013, J BIOL CHEM, V288, P26583, DOI 10.1074/jbc.M113.480483; Tao J, 2011, EUR J DERMATOL, V21, P731, DOI 10.1684/ejd.2011.1469; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Wilkinson RW, 2001, J IMMUNOL METHODS, V258, P183, DOI 10.1016/S0022-1759(01)00474-4; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu Q, 2016, IMMUNOL LETT, V179, P68, DOI 10.1016/j.imlet.2016.09.001; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835	37	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184278	10.1371/journal.pone.0184278	http://dx.doi.org/10.1371/journal.pone.0184278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873441	Green Published, gold			2022-12-26	WOS:000409282800067
J	Comstedt, P; Schuler, W; Meinke, A; Lundberg, U				Comstedt, Par; Schuler, Wolfgang; Meinke, Andreas; Lundberg, Urban			The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; OUTER-SURFACE PROTEIN; DISEASE VACCINE; RECOMBINANT OSPA; MICE; TRANSMISSION; ASSOCIATION; ANTIBODIES; GARINII	We have previously shown that the Outer surface protein A (OspA) based Lyme borreliosis vaccine VLA15 induces protective immunity in mice. Herein, we report the induction of protective immunity by VLA15 with mouse models using ticks infected with B. burgdorferi (OspA serotype 1), B. afzelii (OspA serotype 2) and B. bavariensis (OspA serotype 4) or with in vitro grown B. garinii (OspA serotype 5 and 6) for challenge. For B. garinii (OspA serotype 3), we have developed a growth inhibition assay using chicken complement and functional antibodies targeting B. garinii (OspA serotype 3) could be demonstrated after immunization with VLA15. Furthermore, following three priming immunizations, a booster dose was administered five months later and the induction of immunological memory could be confirmed. Thus, the antibody titers after the booster dose were increased considerably compared to those after primary immunization. In addition, the half-lives of anti-OspA serotype specific antibodies after administration of the booster immunization were longer than after primary immunization. Taken together, we could show that VLA15 induced protection in mice against challenge with four different clinically relevant Borrelia species (B. burgdorferi, B. afzelii, B. garinii and B. bavariensis) expressing five of the six OspA serotypes included in the vaccine. The protection data is supported by functional assays showing efficacy against spirochetes expressing any of the six OspA serotypes (1 to 6). To our knowledge, this is the first time a Lyme borreliosis vaccine has been able to demonstrate such broad protection in preclinical studies. These new data provide further promise for the clinical development of VLA15 and supports our efforts to provide a new Lyme borreliosis vaccine available for global use.	[Comstedt, Par; Schuler, Wolfgang; Meinke, Andreas; Lundberg, Urban] Valneva Austria GmbH, Vienna, Austria; [Comstedt, Par] Evax Biotech, Copenhagen, Denmark		Lundberg, U (corresponding author), Valneva Austria GmbH, Vienna, Austria.	urban.lundberg@valneva.com		Lundberg, Urban/0000-0001-9731-840X	Austrian Research Promotion Agency, BorreliaVac; plus Technologie- und Innovationsforderungen fur Wien, Forderprogramm Forschung [821824, ZIT13]; Valneva Austria GmbH	Austrian Research Promotion Agency, BorreliaVac; plus Technologie- und Innovationsforderungen fur Wien, Forderprogramm Forschung; Valneva Austria GmbH	This work was funded by the Austrian Research Promotion Agency (www.ffg.at/en), BorreliaVac; grant 821824 and ZIT13 plus Technologie- und Innovationsforderungen fur Wien 2013-2016, Forderprogramm Forschung, Call From Science to Products 2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are or were employed at Valneva Austria GmbH at the time of this work. Valneva Austria GmbH provided support in the form of salaries for authors PC, WS, AM and UL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Barrett PN, 2013, EXPERT REV VACCINES, V12, P973, DOI 10.1586/14760584.2013.824704; Comstedt P, 2015, VACCINE, V33, P5982, DOI 10.1016/j.vaccine.2015.07.095; Comstedt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113294; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; FIKRIG E, 1995, J EXP MED, V181, P215, DOI 10.1084/jem.181.1.215; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Gern L, 1997, VACCINE, V15, P1551, DOI 10.1016/S0264-410X(97)00066-2; GOLDE WT, 1995, VACCINE, V13, P435, DOI 10.1016/0264-410X(94)00027-K; Grygorczuk S, 2013, ANN AGR ENV MED, V20, P21; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Hanson LS, 2000, INFECT IMMUN, V68, P6457, DOI 10.1128/IAI.68.11.6457-6460.2000; Jahfari S, 2017, INFECT GENET EVOL, V49, P48, DOI 10.1016/j.meegid.2016.12.030; Koide S, 2005, J MOL BIOL, V350, P290, DOI 10.1016/j.jmb.2005.04.066; Kurtenbach K, 2002, INFECT IMMUN, V70, P5893, DOI 10.1128/IAI.70.10.5893-5895.2002; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; MURSIC VP, 1987, EUR J CLIN MICROBIOL, V6, P424, DOI 10.1007/BF02013102; Nigrovic LE, 2007, EPIDEMIOL INFECT, V135, P1, DOI 10.1017/S0950268806007096; Ornstein K, 2001, J CLIN MICROBIOL, V39, P1294, DOI 10.1128/JCM.39.4.1294-1298.2001; Parenti DL, 1998, 704 INF DIS SOC AM D; Plotkin SA, 2011, CLIN INFECT DIS, V52, pS271, DOI 10.1093/cid/ciq119; Poland GA, 2011, CLIN INFECT DIS, V52, pS253, DOI 10.1093/cid/ciq116; Poljak A, 2012, VACCINE, V30, P4398, DOI 10.1016/j.vaccine.2011.10.073; SADZIENE A, 1993, J INFECT DIS, V167, P165, DOI 10.1093/infdis/167.1.165; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwendinger MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079022; Sigal LH, 1998, NEW ENGL J MED, V339, P216, DOI 10.1056/NEJM199807233390402; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stupica D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136600; Van Hoecke C, 1999, CLIN INFECT DIS, V28, P1260, DOI 10.1086/514779; WILSKE B, 1993, J CLIN MICROBIOL, V31, P340, DOI 10.1128/JCM.31.2.340-350.1993; Wressnigg N, 2014, CLIN VACCINE IMMUNOL, V21, P1490, DOI 10.1128/CVI.00406-14; Wressnigg N, 2013, LANCET INFECT DIS, V13, P680, DOI 10.1016/S1473-3099(13)70110-5	35	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184357	10.1371/journal.pone.0184357	http://dx.doi.org/10.1371/journal.pone.0184357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863166	gold, Green Published, Green Submitted			2022-12-26	WOS:000408816900053
J	Maffetone, PB; Malcata, R; Rivera, I; Laursen, PB				Maffetone, Philip B.; Malcata, Rita; Rivera, Ivan; Laursen, Paul B.			The Boston Marathon versus the World Marathon Majors	PLOS ONE			English	Article								The Boston Marathon course is deemed ineligible for world record status due to its unidirectional nature and excessive negative elevation change, yet performance times across the World Marathon Majors (WMM) races have not been compared. Purpose To compare finish times across WMM races for Boston, London, Berlin, Chicago and New York Marathons. Methods Race times of the top 10 male and 10 female finishers were analyzed from 2005 to 2014 using the high-performance mixed linear model procedure in the Statistical Analysis System. Venue-to-venue comparisons, as well as comparisons between Boston and other WMM races, with and without factors of temperature, humidity and altitude change were examined. Results Performance from 2005 to 2014 in the WMM races was found to improve at a rate of similar to 1% each 7 years. Despite its higher variability, comparison between Boston's estimated mean finishing time and all other venues revealed moderate positive differences, indicating the Boston event to be typically slower than other venues. Conclusions Across the 10-year study period, performance times improved similar to 1% each 7 years for both genders for the WMM, with the Boston Marathon being slower on average than other WMM venues. Weather rather than course metrics appeared to impact performance times most.	[Malcata, Rita; Laursen, Paul B.] AUT Univ, SPRINZ, Auckland, New Zealand	Auckland University of Technology	Laursen, PB (corresponding author), AUT Univ, SPRINZ, Auckland, New Zealand.	paul.laursen@aut.ac.nz						Angus SD, 2014, J SPORT SCI, V32, P31, DOI 10.1080/02640414.2013.803592; Barker S., 2014, GET PAID DROP OUT RA; Butcher P., 2004, GUARDIAN; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; IAAF, 2016, PR MON; IAAF, 2016, DK KIM; International Association of Athletics Federations [IAAF], 2015, COMP RUL 2016 2017; Marino RE, 1985, J APPL PHYSIOL, V96, P124; Martin DE, 1999, CHANCE, V12, P20, DOI DOI 10.1080/09332480.1999.10542170; Mehaffey J., 2009, REUTERS; Montain SJ, 2007, SPORTS MED, V37, P320, DOI 10.2165/00007256-200737040-00012; Vihma T, 2010, INT J BIOMETEOROL, V54, P297, DOI 10.1007/s00484-009-0280-x; Wilcock B., 2008, J OLYMPIC HIST, V16, P31	16	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184024	10.1371/journal.pone.0184024	http://dx.doi.org/10.1371/journal.pone.0184024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863152	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900017
J	Hudson, W				Hudson, William			Whole-loop mitochondrial DNA D-loop sequence variability in Egyptian Arabian equine matrilines	PLOS ONE			English	Article							DAM LINES; HORSE; ORIGINS	Background Egyptian Arabian horses have been maintained in a state of genetic isolation for over a hundred years. There is only limited genetic proof that the studbook records of female lines of Egyptian Arabian pedigrees are reliable. This study characterized the mitochondrial DNA (mtDNA) signatures of 126 horses representing 14 matrilines in the Egyptian Agricultural Organization (EAO) horse-breeding program. Findings Analysis of the whole D-loop sequence yielded additional information compared to hypervariable region-1 (HVR1) analysis alone, with 42 polymorphic sites representing ten haplotypes compared to 16 polymorphic sites representing nine haplotypes, respectively. Most EAO haplotypes belonged to ancient haplogroups, suggesting origin from a wide geographical area over many thousands of years, although one haplotype was novel. Conclusions Historical families share haplotypes and some individuals from different strains belonged to the same haplogroup: the classical EAO strain designation is not equivalent to modern monophyletic matrilineal groups. Phylogenetic inference showed that the foundation mares of the historical haplotypes were highly likely to have the same haplotypes as the animals studied (p > 0.998 in all cases), confirming the reliability of EAO studbook records and providing the opportunity for breeders to confirm the ancestry of their horses.	[Hudson, William] Hudson Cardiol PC, William Hudson MD, Atlanta, GA 30309 USA		Hudson, W (corresponding author), Hudson Cardiol PC, William Hudson MD, Atlanta, GA 30309 USA.	whudson@whudsoncardiology.com						Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Bowling AT, 2000, ANIM GENET, V31, P1, DOI 10.1046/j.1365-2052.2000.00558.x; Bowling AT, 1998, J ANIM BREED GENET, V115, P351, DOI 10.1111/j.1439-0388.1998.tb00356.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Edwards JH, 2001, J GENET, P159; Glazewska I, 2007, GENET SEL EVOL, V39, P609, DOI 10.1051/gse:2007025; Glazewska I, 2010, LIVEST SCI, V129, P49, DOI 10.1016/j.livsci.2009.12.009; Hill EW, 2002, ANIM GENET, V33, P287, DOI 10.1046/j.1365-2052.2002.00870.x; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; ISHIDA N, 1994, ANIM GENET, V25, P215, DOI 10.1111/j.1365-2052.1994.tb00196.x; ISHIDA N, 1995, J MOL EVOL, V41, P180, DOI 10.1007/BF00170671; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Khanshour AM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-83; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Moridi M, 2013, ANIM GENET, V44, P209, DOI 10.1111/j.1365-2052.2012.02389.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Zhang T, 2012, ASIAN AUSTRAL J ANIM, V25, P921, DOI 10.5713/ajas.2011.11483	18	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184309	10.1371/journal.pone.0184309	http://dx.doi.org/10.1371/journal.pone.0184309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859174	gold, Green Published, Green Submitted			2022-12-26	WOS:000408740500082
J	Burel, S; Coyan, FC; Lorenzini, M; Meyer, MR; Lichti, CF; Brown, JH; Loussouarn, G; Charpentier, F; Nerbonne, JM; Townsend, RR; Maier, LS; Marionneau, C				Burel, Sophie; Coyan, Fabien C.; Lorenzini, Maxime; Meyer, Matthew R.; Lichti, Cheryl F.; Brown, Joan H.; Loussouarn, Gildas; Charpentier, Flavien; Nerbonne, Jeanne M.; Townsend, R. Reid; Maier, Lars S.; Marionneau, Celine			C-terminal phosphorylation of Na(V)1.5 impairs FGF13-dependent regulation of channel inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HOMOLOGOUS FACTOR; LATE SODIUM CURRENT; HEART-FAILURE; KINASE-II; MASS-SPECTROMETRY; NA+ CHANNELS; QUANTITATIVE-ANALYSIS; MEMBRANE-PROTEINS; STATISTICAL-MODEL; CRYSTAL-STRUCTURE	Voltage-gated Na+ (Na-V) channels are key regulators of myocardial excitability, and Ca2+/calmodulin-dependent protein kinase II (CaMKII)-dependent alterations in Na(V)1.5 channel inactivation are emerging as a critical determinant of arrhythmias in heart failure. However, the global native phosphorylation pattern of Na(V)1.5 subunits associated with these arrhythmogenic disorders and the associated channel regulatory defects remain unknown. Here, we undertook phosphoproteomic analyses to identify and quantify in situ the phosphorylation sites in the Na(V)1.5 proteins purified from adult WT and failing CaMKII delta(c)-overexpressing (CaMKII delta(c)-Tg) mouse ventricles. Of 19 native Na(V)1.5 phosphorylation sites identified, two C-terminal phosphoserines at positions 1938 and 1989 showed increased phosphorylation in the CaMKII delta(c)-Tg compared with the WT ventricles. Wethen tested the hypothesis that phosphorylation at these two sites impairs fibroblast growth factor 13 (FGF13)-dependent regulation of Na(V)1.5 channel inactivation. Whole-cell voltage-clamp analyses in HEK293 cells demonstrated that FGF13 increases Na(V)1.5 channel availability and decreases late Na+ current, two effects that were abrogated with Na(V)1.5 mutants mimicking phosphorylation at both sites. Additional co-immunoprecipitation experiments revealed that FGF13 potentiates the binding of calmodulin to Na(V)1.5 and that phosphomimetic mutations at both sites decrease the interaction of FGF13 and, consequently, of calmodulin with Na(V)1.5. Together, we have identified two novel native phosphorylation sites in the C terminus of Na(V)1.5 that impair FGF13-dependent regulation of channel inactivation and may contribute to CaMKII delta(c)-dependent arrhythmogenic disorders in failing hearts.	[Burel, Sophie; Coyan, Fabien C.; Lorenzini, Maxime; Loussouarn, Gildas; Charpentier, Flavien; Marionneau, Celine] Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France; [Meyer, Matthew R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Nerbonne, Jeanne M.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Lichti, Cheryl F.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Brown, Joan H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Maier, Lars S.] Univ Hosp Regensburg, Univ Heart Ctr, Dept Internal Med 2, D-93042 Regensburg, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg	Marionneau, C (corresponding author), IRS Univ Nantes, CNRS UMR6291, INSERM UMR1087, Inst Thorax, 8 Quai Moncousu,BP 70721, F-44007 Nantes 1, France.	celine.marionneau@univ-nantes.fr	Charpentier, Flavien/D-3586-2015; Loussouarn, Gildas/D-3590-2015; Maier, Lars/AAQ-8313-2021; Loussouarn, Gildas/ABH-6043-2020; Burel, Sophie/D-3583-2015; Marionneau, Céline/D-4011-2015	Charpentier, Flavien/0000-0002-5057-0998; Loussouarn, Gildas/0000-0001-8007-5931; Maier, Lars/0000-0001-9915-4429; Loussouarn, Gildas/0000-0001-8007-5931; Burel, Sophie/0000-0003-0557-3396; Marionneau, Céline/0000-0003-0962-9756; Lichti, Cheryl/0000-0003-4099-4954	Agence Nationale de la Recherche [ANR-15-CE14-0006-01, ANR-12-BSV1-0013-01]; Marie Curie 7th Framework Program of the European Commission [PIRG06-GA-2009-256397]; Fondation d'Entreprise Genavie; National Institutes of Health [UL1 TR000448, P41 GM103422-35, R01 HL034161]; Groupe de Reflexion sur la Recherche Cardiovasculaire-Societe Francaise de Cardiologie Predoctoral Fellowship [eOTP 1518DASS]; Deutsche Forschungsgemeinschaft [Ma 1982/5-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034161, P01HL080101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Marie Curie 7th Framework Program of the European Commission; Fondation d'Entreprise Genavie; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Groupe de Reflexion sur la Recherche Cardiovasculaire-Societe Francaise de Cardiologie Predoctoral Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Agence Nationale de la Recherche Grants ANR-15-CE14-0006-01 (to C. M.) and ANR-12-BSV1-0013-01 (to F. C.), Marie Curie 7th Framework Program of the European Commission Grant PIRG06-GA-2009-256397 (to C. M.), the Fondation d'Entreprise Genavie (to C. M.), National Institutes of Health Grants UL1 TR000448 and P41 GM103422-35 (to R. R. T.) and R01 HL034161 (to J. M. N.), Groupe de Reflexion sur la Recherche Cardiovasculaire-Societe Francaise de Cardiologie Predoctoral Fellowship eOTP 1518DASS (to S. B.), and the Deutsche Forschungsgemeinschaft Ma 1982/5-1 (to L. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 2015, CIRC RES, V116, P1971, DOI 10.1161/CIRCRESAHA.116.305017; Aiba T, 2013, CIRC-ARRHYTHMIA ELEC, V6, P546, DOI 10.1161/CIRCEP.113.000400; Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; Ashpole NM, 2012, J BIOL CHEM, V287, P19856, DOI 10.1074/jbc.M111.322537; Bosch MK, 2015, J NEUROSCI, V35, P6752, DOI 10.1523/JNEUROSCI.2663-14.2015; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Dybkova N, 2014, CARDIOVASC RES, V103, P168, DOI 10.1093/cvr/cvu120; Gabelli SB, 2016, CHANNELS, V10, P45, DOI 10.1080/19336950.2015.1075677; Gabelli SB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6126; Glynn P, 2015, CIRCULATION, V132, P567, DOI 10.1161/CIRCULATIONAHA.114.015218; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Herren AW, 2015, J PROTEOME RES, V14, P2298, DOI 10.1021/acs.jproteome.5b00107; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Koval OM, 2012, CIRCULATION, V126, P2084, DOI 10.1161/CIRCULATIONAHA.112.105320; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Maltsev VA, 2008, PROG BIOPHYS MOL BIO, V96, P421, DOI 10.1016/j.pbiomolbio.2007.07.010; Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007; Marionneau C, 2012, J PROTEOME RES, V11, P5994, DOI 10.1021/pr300702c; Michalski A, 2012, MOL CELL PROTEOMICS, V11, pO111, DOI DOI 10.1074/MCP.0111.013698; Musa H, 2015, P NATL ACAD SCI USA, V112, P12528, DOI 10.1073/pnas.1516430112; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Park DS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12966; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Taverner T, 2012, BIOINFORMATICS, V28, P2404, DOI 10.1093/bioinformatics/bts449; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang C, 2011, CIRC RES, V109, P775, DOI 10.1161/CIRCRESAHA.111.247957; Wang XC, 2017, J MOL CELL CARDIOL, V104, P63, DOI 10.1016/j.yjmcc.2017.01.009; Yan HD, 2017, J GEN PHYSIOL, V149, P277, DOI 10.1085/jgp.201611721; Yang J, 2016, CHANNELS, V10, P410, DOI 10.1080/19336950.2016.1190055; Yu YQ, 2004, RAPID COMMUN MASS SP, V18, P711, DOI 10.1002/rcm.1374; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	45	18	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17431	17448		10.1074/jbc.M117.787788	http://dx.doi.org/10.1074/jbc.M117.787788			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28882890	Green Published, hybrid			2022-12-26	WOS:000414009300024
J	Baguma, R; Penn-Nicholson, A; Smit, E; Erasmus, M; Day, J; Makhethe, L; de Kock, M; Hughes, EJ; van Rooyen, M; Pienaar, B; Stone, L; Hanekom, W; Brennan, MJ; Wallis, RS; Hatherill, M; Scriba, TJ				Baguma, Richard; Penn-Nicholson, Adam; Smit, Erica; Erasmus, Mzwandile; Day, Jonathan; Makhethe, Lebohang; de Kock, Marwou; Hughes, E. Jane; van Rooyen, Michele; Pienaar, Bernadette; Stone, Lynnett; Hanekom, Willem; Brennan, Michael J.; Wallis, Robert S.; Hatherill, Mark; Scriba, Thomas J.			Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population	PLOS ONE			English	Article							CD4 T-CELLS; IN-VITRO; IFN-GAMMA; INTERFERON-GAMMA; INTRACELLULAR GROWTH; BCG VACCINATION; INFECTION; PROTECTION; RESPONSES; BOVIS	The determinants of immunological protection against Mycobacterium tuberculosis (M. tb) infection in humans are not known. Mycobacterial growth inhibition assays have potential utility as in vitro surrogates of in vivo immunological control of M. tb. We evaluated a whole blood growth inhibition assay in a setting with high burden of TB and aimed to identify immune responses that correlate with control of mycobacterial growth. We hypothesized that individuals with underlying M. tb infection will exhibit greater M. tb growth inhibition than uninfected individuals and that children aged 4 to 12 years, an age during which TB incidence is curiously low, will also exhibit greater M. tb growth inhibition than adolescents or adults. Neither M. tb infection status, age of the study participants, nor M. tb strain was associated with differential control of mycobacterial growth. Abundance and function of innate or T cell responses were also not associated with mycobacterial growth. Our data suggest that this assay does not provide a useful measure of age-associated differential host control of M. tb infection in a high TB burden setting. We propose that universally high levels of mycobacterial sensitization (through environmental non-tuberculous mycobacteria and/or universal BCG vaccination) in persons from high TB burden settings may impart broad inhibition of mycobacterial growth, irrespective of M. tb infection status. This sensitization may mask the augmentative effects of mycobacterial sensitization on M. tb growth inhibition that is typical in low burden settings.	[Baguma, Richard; Penn-Nicholson, Adam; Smit, Erica; Erasmus, Mzwandile; Day, Jonathan; Makhethe, Lebohang; de Kock, Marwou; Hughes, E. Jane; van Rooyen, Michele; Pienaar, Bernadette; Stone, Lynnett; Hanekom, Willem; Hatherill, Mark; Scriba, Thomas J.] Univ Cape Town, SATVI, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Baguma, Richard; Penn-Nicholson, Adam; Smit, Erica; Erasmus, Mzwandile; Day, Jonathan; Makhethe, Lebohang; de Kock, Marwou; Hughes, E. Jane; van Rooyen, Michele; Pienaar, Bernadette; Stone, Lynnett; Hanekom, Willem; Hatherill, Mark; Scriba, Thomas J.] Univ Cape Town, Dept Pathol, Div Immunol, Cape Town, South Africa; [Brennan, Michael J.] Aeras, Rockville, MD USA; [Wallis, Robert S.] Aurum Inst, Johannesburg, South Africa	University of Cape Town; University of Cape Town	Penn-Nicholson, A (corresponding author), Univ Cape Town, SATVI, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Penn-Nicholson, A (corresponding author), Univ Cape Town, Dept Pathol, Div Immunol, Cape Town, South Africa.	adam.penn-nicholson@uct.ac.za	Scriba, Thomas/AAH-9413-2020; Scriba, Thomas/GPX-2573-2022; Wallis, Robert S./A-8018-2009	Scriba, Thomas/0000-0002-0641-1359; Baguma, Richard/0000-0002-5106-021X; Penn-Nicholson, Adam/0000-0002-1883-0059; Wallis, Robert S./0000-0001-6152-5183; Hanekom, Willem/0000-0003-3070-6154	European and Developing Countries Clinical Trials Partnership (EDCTP) [TA.2011.40200.010]; US FDA (FDA) [IU18FD004012-01]	European and Developing Countries Clinical Trials Partnership (EDCTP); US FDA (FDA)(United States Department of Health & Human Services)	An author of this publication (Scriba) received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled "Inflammatory determinants of risk of tuberculosis disease" (grant #TA.2011.40200.010). However, EDCTP cannot accept any responsibility for information or views expressed herein. This work was also supported by a grant from the US FDA (FDA grant #IU18FD004012-01, PI Brennan). Aeras provided support in the form of salaries for author MJB, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Blaser N, 2016, EPIDEMICS-NETH, V14, P54, DOI 10.1016/j.epidem.2015.10.001; Boom WH, 1999, MICROBES INFECT, V1, P187, DOI 10.1016/S1286-4579(99)80033-1; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Carpenter E, 1997, IMMUNOL CELL BIOL, V75, P554, DOI 10.1038/icb.1997.86; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141; CHENG SH, 1988, CLIN EXP IMMUNOL, V74, P20; Cheng T, 2017, PLOS PATHOG, V13; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; Denis M, 2004, CELL IMMUNOL, V232, P1, DOI 10.1016/j.cellimm.2005.01.003; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Fine PEM, 1999, A DISCUSSION DOCUMEN, P1; Fletcher HA, 2013, CLIN VACCINE IMMUNOL, V20, P1683, DOI 10.1128/CVI.00427-13; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Houben RMGJ, 2016, PLOS MED, V13; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Kagina BM, 2015, J IMMUNOL METHODS, V417, P22, DOI 10.1016/j.jim.2014.12.003; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Manca C, 1999, J IMMUNOL, V162, P6740; Marais BJ, 2005, ANN TROP PAEDIATR, V25, P79, DOI 10.1179/146532805X45665; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Marsay L, 2013, TUBERCULOSIS, V93, P551, DOI 10.1016/j.tube.2013.04.007; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Parra M, 2009, CLIN VACCINE IMMUNOL, V16, P1025, DOI 10.1128/CVI.00067-09; Penn-Nicholson A, 2015, TUBERCULOSIS, V95, P350, DOI 10.1016/j.tube.2015.03.002; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Silver RF, 1998, J IMMUNOL, V160, P2408; Subbian S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110016; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tanner R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43478; Tena GN, 2003, J INFECT DIS, V187, P1544, DOI 10.1086/374799; Via LE, 2015, ANTIMICROB AGENTS CH, V59, P4181, DOI 10.1128/AAC.00115-15; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; Woodworth JS, 2014, J IMMUNOL, V192, P3247, DOI 10.4049/jimmunol.1300283; Worku S, 2003, INFECT IMMUN, V71, P1763, DOI 10.1128/IAI.71.4.1763-1773.2003; Worku S, 2000, CLIN INFECT DIS, V30, pS257, DOI 10.1086/313887; Yao SY, 2014, J IMMUNOL, V192, P2120, DOI 10.4049/jimmunol.1301373; Zelmer A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1751-4	68	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184563	10.1371/journal.pone.0184563	http://dx.doi.org/10.1371/journal.pone.0184563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886145	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100155
J	Elattar, MA; Vink, LW; van Mourik, MS; Baan, J; van Bavel, ET; Planken, RN; Marquering, HA				Elattar, Mustafa A.; Vink, Leon W.; van Mourik, Martijn S.; Baan, Jan, Jr.; van Bavel, Ed T.; Planken, R. Nils; Marquering, Henk A.			Dynamics of the aortic annulus in 4D CT angiography for transcatheter aortic valve implantation patients	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; ROOT; CALCIFICATION; REPLACEMENT; DIAMETER; DIASTOLE; SYSTOLE; REGURGITATION; SEGMENTATION; DIMENSIONS	Background Transcatheter aortic valve implantation (TAVI) is a well-established treatment for patients with severe aortic valve stenosis. This procedure requires pre-operative planning by assessment of aortic dimensions on CT Angiography (CTA). It is well-known that the aortic root dimensions vary over the heart cycle. However, sizing is commonly performed at either mid-systole or end-diastole only, which has resulted in an inadequate understanding of its full dynamic behavior. Study goal We studied the variation in annulus measurements during the cardiac cycle and determined if this variation is dependent on the amount of calcification at the annulus. Methods We measured and compared aortic root annular dimensions and calcium volume in CTA acquisitions at 10 cardiac cycle phases in 51 aortic stenosis patients. Sub-group analysis was performed based on the volume of calcium by splitting the population into mildly and severely calcified valves subgroups. Results For most annulus measurements, the largest differences were found between 10% and 70 to 80% cardiac cycle phases. Mean difference (+/- standard deviation) in annular minimum diameter, maximum diameter, area, and aspect ratio between mid-systole and end-diastole phases were 1.0 +/- 0.29 mm (p = 0.065), 0.30 +/- 0.24 mm (p = 0.7), 24.1 +/- 7.6 mm(2) (p < 0.001), and 0.041 +/- 0.012 (p = 0.039) respectively. Calcium volume measurements varied strongly during the cardiac cycle. The dynamic annulus area was behaving differently between mildly and severely calcified subgroups (p = 0.02). Furthermore, patients with severe aortic calcification were associated with larger annulus diameters. Conclusion There is a significant variation of annulus area and calcium volume measurement during the cardiac cycle. In our measurements, only the dynamic variation of the annulus area is dependent on the severity of the aortic calcification. For TAVI candidates, the annulus area is significantly larger in mid-systole compared to end-diastole.	[Elattar, Mustafa A.; Vink, Leon W.; van Bavel, Ed T.; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [van Mourik, Martijn S.; Baan, Jan, Jr.] Univ Amsterdam, Acad Med Ctr, Dept Heart Ctr, Amsterdam, Netherlands; [Planken, R. Nils; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Elattar, MA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands.	Mustafa.elattar@gmail.com	Planken, RN/GMX-0438-2022	Elattar, Mustafa/0000-0001-7936-3522; Planken, R. Nils/0000-0003-3940-4670; Marquering, Henk/0000-0002-1414-6313; van Bavel, Ed/0000-0001-8654-986X	Dutch Technology Foundation STW [11630]; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs	This research is supported by the Dutch Technology Foundation STW under grant number of 11630, which is part of the Netherlands Organization for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis or preparation of the manuscript. Approval for publishing the results is granted.	Bekeredjian R, 2015, J INVASIVE CARDIOL, V27, P172; Bell V, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.003039; Bertaso AG, 2012, INT J CARDIOVAS IMAG, V28, P2091, DOI 10.1007/s10554-012-0018-4; Blanke P, 2013, RADIOLOGY, V269, P650, DOI 10.1148/radiol.13120696; Buellesfeld L, 2014, EUROINTERVENTION, V10, P732, DOI 10.4244/EIJV10I6A126; Dagum P, 1999, CIRCULATION, V100, P54; de Heer LM, 2011, INT J CARDIOVAS IMAG, V27, P1195, DOI 10.1007/s10554-011-9838-x; de Vaan J, 2012, EUROINTERVENTION, V7, P1464, DOI 10.4244/EIJV7I12A228; Delgado V, 2011, ANN THORAC SURG, V91, P716, DOI 10.1016/j.athoracsur.2010.09.060; Elattar MA, 2014, MED BIOL ENG COMPUT, V52, P611, DOI 10.1007/s11517-014-1165-7; Eveborn GW, 2012, HEART, P396; Feldmann S., 2014, COREVALVE ASSESSING, P59; Geller G., 2012, AORTIC ANNULUS ANATO; Gnyaneshwar R, 2002, ANN THORAC SURG, V73, P1122, DOI 10.1016/S0003-4975(01)03588-3; Gurvitch R, 2011, JACC-CARDIOVASC INTE, V4, P1235, DOI 10.1016/j.jcin.2011.07.014; Halapas A, 2015, HELL J CARDIOL, V56, P9; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jurencak T, 2015, EUR RADIOL, V25, P1975, DOI 10.1007/s00330-015-3607-5; Kaleschke Gerrit, 2010, EuroIntervention, V6 Suppl G, pG20, DOI 10.4244/; Kazui T, 2006, J HEART VALVE DIS, V15, P617; Khalique OK, 2014, CIRC-CARDIOVASC IMAG, V7, P155, DOI 10.1161/CIRCIMAGING.113.001153; Lansac E, 2002, EUR J CARDIO-THORAC, V22, P497, DOI 10.1016/S1010-7940(02)00405-0; Lu TLC, 2009, EUR RADIOL, V19, P664, DOI 10.1007/s00330-008-1182-8; McEniery CM, 2009, HYPERTENSION, V53, P524, DOI 10.1161/HYPERTENSIONAHA.108.126615; Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063; Morgan-Hughes GJ, 2003, RADIOLOGY, V228, P583, DOI 10.1148/radiol.2282020873; Mylotte D, 2012, ANN CARDIOTHORAC SUR, V1, P206, DOI 10.3978/j.issn.2225-319X.2012.06.08; O'Rourke M, 2008, JACC-CARDIOVASC IMAG, V1, P749, DOI 10.1016/j.jcmg.2008.08.002; ROBERTS WC, 1971, AM J CARDIOL, V27, P497, DOI 10.1016/0002-9149(71)90412-7; Salaun E, 2016, INT J CARDIOL, V208, P28, DOI 10.1016/j.ijcard.2016.01.048; Salgado RA, 2014, RADIOGRAPHICS, V34, P1517, DOI 10.1148/rg.346130149; Shabestari AA, 2013, INT J CARDIOVAS IMAG, V29, P1391, DOI 10.1007/s10554-013-0217-7; Vahanian A, 2008, EUR HEART J, V29, P1463, DOI 10.1093/eurheartj/ehn183; Wiegerinck EMA, 2014, INT J CARDIOVAS IMAG, V30, P399, DOI 10.1007/s10554-013-0343-2; Yankah AC, 2001, EUR J CARDIO-THORAC, V20, P835, DOI 10.1016/S1010-7940(01)00885-5; Ye J, 2010, J THORAC CARDIOV SUR, V139, P1107, DOI 10.1016/j.jtcvs.2009.10.056; Zheng YF, 2012, IEEE T MED IMAGING, V31, P2307, DOI 10.1109/TMI.2012.2216541	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184133	10.1371/journal.pone.0184133	http://dx.doi.org/10.1371/journal.pone.0184133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886071	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100070
J	Ishida, T; Yoshida, T; Shinohara, K; Cao, K; Nakahama, K; Morita, I; Ohno-Matsui, K				Ishida, Tomoka; Yoshida, Takeshi; Shinohara, Kosei; Cao, Kejia; Nakahama, Ken-ichi; Morita, Ikuo; Ohno-Matsui, Kyoko			Potential role of sirtuin 1 in Muller glial cells in mice choroidal neovascularization	PLOS ONE			English	Article							MACULAR DEGENERATION; EXPRESSION; RESVERATROL; VEGF; GROWTH; ACTIN	This study investigated the potential role of sirtuin 1 in Muller glial cells in choroidal neovascularization. In the in vitro study, primary Muller glial cells were cultured and treated with resveratrol, a sirtuin 1 activator. Glial fibrillary acidic protein expression and angiogenesis-related gene expression were examined using quantitative polymerase chain reaction and phagocytosis, as a marker of Muller glial cell function; in addition, a latex bead assay was used to analyze cell function. For the in vivo study, choroidal neovascularization was induced in C57BL/6 mice via laser photocoagulation, and resveratrol was administered intravitreally. Eyecup whole mounts were created to measure choroidal neovascularization volumes on day 7. Immunohistochemical analysis with anti-glial fibrillary acidic protein antibody was used to detect Muller glial cell activation in eyes with choroidal neovascularization on day 1, 3, 5, and 7 after laser surgery. Resveratrol significantly promoted glial fibrillary acidic protein, anti-angiogenic factor, pigment epithelium-derived factor, and thrombospondin-1 expression in the cells as well as the phagocytic activities. Treatment of the choroidal neovascularization model with resveratrol resulted in early activation of Muller glial cells near choroidal neovascularization sites. Resveratrol-activated cells but not the controls migrated to the top of choroidal neovascularization sites and into the lesions from day 3. Resveratrol reduced the choroidal neovascularization size relative to controls. In conclusion, sirtuin 1 activation in Muller glial cells suppressed the development of choroidal neovascularization, and therefore, might be a therapeutic option.	[Ishida, Tomoka; Yoshida, Takeshi; Shinohara, Kosei; Cao, Kejia; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Nakahama, Ken-ichi; Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cellular Physiol Chem, Tokyo, Japan; [Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nanomed DNP, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yoshida, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo, Japan.	takec.oph@tmd.ac.jp			Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder	Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder	The study was funded by a grant provided by the Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder to Takeshi Yoshida from Santen Pharmaceutical. The funding website is http://www.santensogyosya-kikin-jp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cvetkova NP, 2016, CLIN OPHTHALMOL, V10, P1047, DOI 10.2147/OPTH.S101050; Gaustad JV, 2016, ONCOTARGET; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; Johnen S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/863845; Kanavi MR, 2014, MOLECULES, V19, P17578, DOI 10.3390/molecules191117578; Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068; Lassota N, 2008, ACTA OPHTHALMOL, V86, P495, DOI [10.1111/j.1600-0420.2007.01127.x, 10.1111/j.1755-3768.2008.01412.x]; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Machalinska A, 2013, EXP EYE RES, V112, P68, DOI 10.1016/j.exer.2013.04.004; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; Motonishi S, 2015, J AM SOC NEPHROL, V26, P1939, DOI 10.1681/ASN.2014030289; Nagai N, 2014, SCI REP, V11, P29619; Nagai N, 2014, J NUTR BIOCHEM, V25, P1218, DOI 10.1016/j.jnutbio.2014.05.015; Nagineni CN, 2014, AGING DIS, V5, P88, DOI 10.14366/AD.2014.050088; Ohno-Matsui K, 2003, BIOCHEM BIOPH RES CO, V303, P962, DOI 10.1016/S0006-291X(03)00446-7; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ryan SJ, 1994, SUBRETINAL NEOVASCUL, P1027; Said AMA, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0433-3; Saviano Sandro, 2016, Digit J Ophthalmol, V22, P46, DOI 10.5693/djo.01.2014.01.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao Y, 2016, DIABETES-METAB RES, V32, P534, DOI 10.1002/dmrr.2788; Sheu SJ, 2013, INVEST OPHTH VIS SCI, V54, P6426, DOI 10.1167/iovs.13-12024; Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33; Tong Y, 2013, INT J OPHTHALMOL, V9, P1028; Wang XL, 2016, BIOMED PHARMACOTHER, V83, P41, DOI 10.1016/j.biopha.2016.06.009; Weber ML, 2016, DEV OPHTHALMOL, V55, P167, DOI 10.1159/000431194; Xu J, 2012, ANGIOGENESIS, V15, P213, DOI 10.1007/s10456-012-9254-4; Yang SQ, 2016, DRUG DES DEV THER, V10, P1857, DOI 10.2147/DDDT.S97653; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080288; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003; Zhang HM, 2015, CYTOKINE, V76, P549, DOI 10.1016/j.cyto.2015.06.019	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183775	10.1371/journal.pone.0183775	http://dx.doi.org/10.1371/journal.pone.0183775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886036	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100036
J	Noh, JW; Kim, KB; Park, J; Hong, J; Kwon, YD				Noh, Jin-Won; Kim, Kyoung-Beom; Park, Jumin; Hong, Janghun; Kwon, Young Dae			Relationship between the number of family members and stress by gender: Cross-sectional analysis of the fifth Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MULTIPLE ROLES; WOMEN; WORK; DEPRESSION	Background Due to gendered inequalities in the division of domestic work, women with paid employment and family caregiving responsibilities can feel extremely tired with general distress and depression. Therefore, the purpose of this study was to examine the association between the number of family members and stress level by gender among Korean adults using a nationally representative dataset. Methods We used a sample of 6,293 subjects aged 19 or older (3,629 female and 2,264 male) from the fifth Korea National Health and Nutrition Examination Survey. A multivariable logistic regression analysis with sociodemographic and health-related characteristics was conducted. Because there were gender differences, a stratified analysis was performed for each gender. Results Age, number of family members, education level, occupational status, depression, self-rated health status, and chronic diseases were found to have a significant association with stress level in the study subjects (p<0.05). The probability of perceiving stress increased among females from family with two members (OR 1.521), three family members (OR 1.893), or four or more family members without spouse (OR 2.035) compared to those who live alone. Conclusion We found that unmarried women are more likely to be stressed as the number of family members increases. Gender expectations giving women the main responsibility for domestic and care work may become a source of stress. Reconciliation of family and work remains women's responsibility in Korea. As family problems are recently becoming a big issue, our study shows the importance of considering gender difference in studies on stress according to family roles and functions.	[Noh, Jin-Won; Hong, Janghun] Eulji Univ, Dept Healthcare Management, Seongnam, South Korea; [Noh, Jin-Won] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kim, Kyoung-Beom] Korea Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Park, Jumin] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Kwon, Young Dae] Catholic Univ Korea, Dept Humanities & Social Med, Coll Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Eulji University; University of Groningen; Korea University; Korea University Medicine (KU Medicine); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Dept Humanities & Social Med, Coll Med, Seoul, South Korea.; Kwon, YD (corresponding author), Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017; Huiting, Wang/AAC-3216-2019	Kwon, Young Dae/0000-0002-8781-6832; Huiting, Wang/0000-0003-1898-3407; Noh, Jin-Won/0000-0001-5172-4023				APOSTAL RA, 1993, J CAREER DEV, V20, P121, DOI 10.1177/089484539302000203; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Cho Su-Jin, 2008, J Prev Med Public Health, V41, P355, DOI 10.3961/jpmph.2008.41.5.355; Chung JH, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.94; COOMBS RH, 1991, FAM RELAT, V40, P97, DOI 10.2307/585665; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Durand M, 2015, REV INCOME WEALTH, V61, P4, DOI 10.1111/roiw.12156; Edwards JR, 1999, ORGAN BEHAV HUM DEC, V77, P85, DOI 10.1006/obhd.1998.2813; Gallo LC, 2013, J BEHAV MED, V36, P379, DOI 10.1007/s10865-012-9432-2; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; HOFFMAN C, 1990, J PERS SOC PSYCHOL, V58, P197, DOI 10.1037/0022-3514.58.2.197; Honda A, 2015, SAF HEALTH WORK, V6, P114, DOI 10.1016/j.shaw.2014.12.004; International Labour Organization, 2014, WORLD WORK REP 2014; Kim GS, 2005, PUBLIC HEALTH NURS, V22, P389, DOI 10.1111/j.0737-1209.2005.220503.x; Kirby DD, 2004, PARENTING STRESS; Lahelma E, 2002, SOC SCI MED, V54, P727, DOI 10.1016/S0277-9536(01)00105-8; LAW SA, 1983, U PENN LAW REV, V131, P1249, DOI 10.2307/3311870; Lee KJ, 2004, SEX ROLES, V51, P469, DOI 10.1023/B:SERS.0000049235.60839.ef; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Quick H E, 1998, J Occup Health Psychol, V3, P44, DOI 10.1037/1076-8998.3.1.44; Schwartzberg N S, 1996, J Occup Health Psychol, V1, P211, DOI 10.1037/1076-8998.1.2.211; Scott SB, 2014, PSYCHOL AGING, V29, P577, DOI 10.1037/a0037282; Shelton BA, 1996, ANNU REV SOCIOL, V22, P299, DOI 10.1146/annurev.soc.22.1.299; Takeda Y, 2004, SOC SCI MED, V59, P69, DOI 10.1016/j.socscimed.2003.10.003; Vingilis ER, 2002, CAN J PUBLIC HEALTH, V93, P193, DOI 10.1007/BF03404999; Walters V, 2002, SOC SCI MED, V54, P677, DOI 10.1016/S0277-9536(01)00117-4	26	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184235	10.1371/journal.pone.0184235	http://dx.doi.org/10.1371/journal.pone.0184235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886136	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100086
J	Sonntag, R; Braun, S; Al-Salehi, L; Reinders, J; Mueller, U; Kretzer, JP				Sonntag, Robert; Braun, Steffen; Al-Salehi, Loay; Reinders, Joern; Mueller, Ulrike; Kretzer, J. Philippe			Three-dimensional friction measurement during hip simulation	PLOS ONE			English	Article							LOADING CONDITIONS; COBALT-CHROMIUM; HEAD SIZE; WEAR; METAL; LUBRICATION; JOINT; TAPER; ARTHROPLASTY; REPLACEMENTS	Objectives Wear of total hip replacements has been the focus of many studies. However, frictional effects, such as high loading on intramodular connections or the interface to the bone, as well as friction associated squeaking have recently increased interest about the amount of friction that is generated during daily activities. The aim of this study was thus to establish and validate a three-dimensional friction setup under standardized conditions. Materials and methods A standard hip simulator was modified to allow for high precision measurements of small frictional effects in the hip during three-dimensional hip articulation. The setup was verified by an ideal hydrostatic bearing and validated with a static-load physical pendulum and an extension-flexion rotation with a dynamic load profile. Additionally, a pendulum model was proposed for screening measurement of frictional effects based on the damping behavior of the angular oscillation without the need for any force/moment transducer. Finally, three-dimensional friction measurements have been realized for ceramic-on-polyethylene bearings of three different sizes (28, 36 and 40 mm). Results A precision of less than 0.2 Nm during three-dimensional friction measurements was reported, while increased frictional torque (resultant as well as taper torque) was measured for larger head diameters. These effects have been confirmed by simple pendulum tests and the theoretical model. A comparison with current literature about friction measurements is presented. Conclusions This investigation of friction is able to provide more information about a field that has been dominated by the reduction of wear. It should be considered in future pre-clinical testing protocols given by international organizations of standardization.	[Sonntag, Robert; Braun, Steffen; Al-Salehi, Loay; Reinders, Joern; Mueller, Ulrike; Kretzer, J. Philippe] Heidelberg Univ Hosp, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sonntag, R (corresponding author), Heidelberg Univ Hosp, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany.	robert.sonntag@med.uni-heidelberg.de		Reinders, Jorn/0000-0002-8258-7735	Ministry of Art and Science of Baden-Wurttemberg, Germany	Ministry of Art and Science of Baden-Wurttemberg, Germany	The work was funded through the Ministry of Art and Science of Baden-Wurttemberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajjar M, 2013, J BIOMED MATER RES B, V101B, P213, DOI 10.1002/jbm.b.32824; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bishop N, 2007, ANN M GERM BIOM SOC; Bishop NE, 2008, MED ENG PHYS, V30, P1057, DOI 10.1016/j.medengphy.2008.01.001; Bishop NE, 2012, FRICTION IN LAGER DI; Bishop NE, 2013, J ORTHOP RES, V31, P807, DOI 10.1002/jor.22255; Bowsher JG, 2001, WEAR, V250, P167, DOI 10.1016/S0043-1648(01)00619-6; Brockett C, 2007, J BIOMED MATER RES B, V81B, P508, DOI 10.1002/jbm.b.30691; CHARNLEY J, 1960, ANN RHEUM DIS, V19, P10, DOI 10.1136/ard.19.1.10; CHARNLEY J, 1960, BRIT MED J, V1, P821, DOI 10.1136/bmj.1.5176.821; Cooper HJ, 2012, J BONE JOINT SURG AM, V94A, P1655, DOI 10.2106/JBJS.K.01352; Damm P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120438; Damm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078373; DAVIDSON JA, 1988, J BIOMED MATER RES-A, V22, P69; Fabry C, 2013, MED ENG PHYS, V35, P131, DOI 10.1016/j.medengphy.2012.07.014; Flannery M, 2008, WEAR, V265, P1009, DOI 10.1016/j.wear.2008.02.023; Goetz D D, 1993, Iowa Orthop J, V13, P29; Haider H, 2016, P I MECH ENG H, V230, P373, DOI 10.1177/0954411916644476; Halim T, 2014, P I MECH ENG H, V228, P703, DOI 10.1177/0954411914538782; HALL RM, 1994, WEAR, V175, P159, DOI 10.1016/0043-1648(94)90179-1; Jones E. S., 1936, LANCET, V227, P1043, DOI DOI 10.1016/S0140-6736(01)37157-X; Kaddick C, 2015, AM SOC TEST MATER, V1591, P336, DOI 10.1520/STP159120140146; Kurtz SM, 2013, CLIN ORTHOP RELAT R, V471, P3270, DOI 10.1007/s11999-013-3096-2; Liao YS, 2003, BIOMATERIALS, V24, P3047, DOI 10.1061/S01429612(03)00148-0; Liu F, 2006, P I MECH ENG H, V220, P695, DOI 10.1243/09544119JEIM172; MA SM, 1983, J BONE JOINT SURG AM, V65, P366, DOI 10.2106/00004623-198365030-00012; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; O'Kelly J, 1977, EVALUATION ARTIFICIA, P19; Panagiotidou A, 2015, BONE JOINT J, V97B, P463, DOI 10.1302/0301-620X.97B4.34800; Plate Johannes F, 2012, BMC Res Notes, V5, P553, DOI 10.1186/1756-0500-5-553; Rehmer A, 2012, CLIN BIOMECH, V27, P77, DOI 10.1016/j.clinbiomech.2011.08.002; Saikko V, 1992, Proc Inst Mech Eng H, V206, P201, DOI 10.1243/PIME_PROC_1992_206_292_02; Saikko V, 2016, P I MECH ENG H, V230, P366, DOI 10.1177/0954411915610602; Saikko V, 2009, J TRIBOL-T ASME, V131, DOI 10.1115/1.2991121; Schafer R, 1998, J MATER SCI-MATER M, V9, P687, DOI 10.1023/A:1008926213433; Singh SP, 2013, INDIAN J ORTHOP, V47, P443, DOI 10.4103/0019-5413.118198; Sonntag R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071622; Spinelli M, 2010, P I MECH ENG H, V224, P865, DOI 10.1243/09544119JEIM683; Stanton T E, 1923, ENGINEER, V29, P678; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Unsworth A, 2016, P I MECH ENG H, V230, P359, DOI 10.1177/0954411916637382; WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9; Witt F, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01199	43	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184043	10.1371/journal.pone.0184043	http://dx.doi.org/10.1371/journal.pone.0184043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886102	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100056
J	Thirion-Delalande, C; Gervais, F; Fisch, C; Cuine, J; Baron-Bodo, V; Moingeon, P; Mascarell, L				Thirion-Delalande, Catherine; Gervais, Frederic; Fisch, Cecile; Cuine, Jean; Baron-Bodo, Veronique; Moingeon, Philippe; Mascarell, Laurent			Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; ALLERGEN IMMUNOTHERAPY; CLINICAL BENEFIT; MURINE MODEL; MOUSE MODEL; EFFICACY; TOLERANCE; ANTIGEN; TABLETS	Background A comparative characterization of the oral mucosa in various animals is needed to identify the best animal model(s) for nonclinical evaluation of sublingual immunotherapy products. With this aim, we studied the histological characteristics and immune cell infiltrates of oral mucosae from common animal species. Methods Three oral regions (i.e. ventral surface of the tongue, mouth floor and cheek) obtained from eight animal species, including rodents (i.e. mice, rats, hamsters, guinea pigs) and nonrodents (i.e. rabbits, dogs, minipigs and monkeys) were characterized by histology and immunohistology in comparison with a human tongue. Results Rodents exhibit a thin keratinized epithelium with low epithelial extensions, whereas nonrodents, most particularly minipigs and monkeys, display a non-keratinized epithelium with larger rete ridges, similarly to humans. Glycogen-rich cells in the superficial epithelial layers are observed in samples from both minipigs, monkeys and humans. Comparable immune subpopulations detected in the 3 oral regions from rodent and non-rodent species include MHC-II+ antigen presenting cells, mostly CD163(+) macrophages, located in the lamina propria (LP) and muscle tissue in the vicinity of resident CD3(+)CD4(+) T cells. Limited numbers of mast cells are also detected in the LP and muscle tissue from all species. Conclusion The oral mucosae of minipigs and monkeys are closest to that of humans, and the immune networks are quite similar between all rodents and non-rodents. Taking into account the ethical and logistical difficulties of performing research in the latter species, rodents and especially mice, should preferentially be used for pharmacodynamics/efficacy studies. Our data also support the use of minipigs to perform biodistribution and safety studies of sublingual immunotherapy products.	[Thirion-Delalande, Catherine; Gervais, Frederic] CiToxLAB, Evreux, France; [Fisch, Cecile; Cuine, Jean] Stallergenes Greer, Tech Dev Dept, Antony, France; [Baron-Bodo, Veronique; Moingeon, Philippe; Mascarell, Laurent] Stallergenes Greer, Res Dept, Antony, France	Stallergenes Greer; Stallergenes Greer	Mascarell, L (corresponding author), Stallergenes Greer, Res Dept, Antony, France.	lmascarell@stallergenes.com			Stallergenes Greer; CiToxLAB France	Stallergenes Greer; CiToxLAB France	This study was supported by Stallergenes Greer and CiToxLAB France which provided support in the form of salaries for authors [CF, JC, VB, PM and LM work for Stallergenes Greer CT and FG work for CiToxLAB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other specific funding was received for this work.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Allam JP, 2008, ALLERGY, V63, P720, DOI 10.1111/j.1398-9995.2007.01611.x; Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Allam JP, 2014, CURR OPIN ALLERGY CL, V14, P564, DOI 10.1097/ACI.0000000000000118; Allam JP, 2010, J ALLERGY CLIN IMMUN, V126, P638, DOI 10.1016/j.jaci.2010.04.039; Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; [Anonymous], 2007, CLIN IMMUNOL, V120, P1338; Bagnasco M, 2005, INT ARCH ALLERGY IMM, V138, P197, DOI 10.1159/000088719; Bagnasco M, 2001, CLIN EXP ALLERGY, V31, P54, DOI 10.1046/j.1365-2222.2001.00999.x; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Bordas-Le Floch V, 2012, INT ARCH ALLERGY IMM, V158, P157, DOI 10.1159/000331143; Brimnes J, 2007, CLIN EXP ALLERGY, V37, P488, DOI 10.1111/j.1365-2222.2006.02624.x; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Dahl R, 2008, J ALLERGY CLIN IMMUN, V121, P512, DOI 10.1016/j.jaci.2007.10.039; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Gueguen C, 2016, J ALLERGY CLIN IMMUN, V137, P545, DOI 10.1016/j.jaci.2015.09.015; Helm RM, 2002, CURR OPIN ALLERGY CL, V2, P541, DOI 10.1097/00130832-200212000-00011; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Liu LL, 2013, INT ARCH ALLERGY IMM, V161, P205, DOI 10.1159/000346335; Marcucci F, 2007, ALLERGY, V62, P1475, DOI 10.1111/j.1398-9995.2007.01519.x; Mascarell L, 2015, ALLERGY, V70, P408, DOI 10.1111/all.12576; Mascarell L, 2011, MUCOSAL IMMUNOL, V4, P638, DOI 10.1038/mi.2011.28; Mascarell L, 2009, CLIN EXP ALLERGY, V39, P1910, DOI 10.1111/j.1365-2222.2009.03337.x; Mascarell L, 2008, J ALLERGY CLIN IMMUN, V122, P603, DOI 10.1016/j.jaci.2008.06.034; Moingeon P, 2013, J ALLER CL IMM-PRACT, V1, P228, DOI 10.1016/j.jaip.2013.03.013; Nagai Y, 2015, CLIN EXP ALLERGY, V45, P677, DOI 10.1111/cea.12329; Nolte H, 2016, J ALLERGY CLIN IMMUN, V138, P1631, DOI 10.1016/j.jaci.2016.06.044; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494, DOI 10.1016/j.jaci.2014.12.1911; Okamoto Y, 2016, ALLERGY, V72, P435; Razafindratsita A, 2007, J ALLERGY CLIN IMMUN, V120, P278, DOI 10.1016/j.jaci.2007.04.009; Roux M, 2016, J ALLERGY CLIN IMMUN, V138, P451, DOI 10.1016/j.jaci.2016.03.039; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536; Tanaka Y, 2017, MUCOSAL IMMUNOL, V10, P79, DOI 10.1038/mi.2016.46; Tourdot S, 2011, CLIN EXP ALLERGY, V41, P1784, DOI 10.1111/j.1365-2222.2011.03865.x; Tourdot S, 2013, VACCINE, V31, P2628, DOI 10.1016/j.vaccine.2013.03.041; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964; Wahn U, 2009, J ALLERGY CLIN IMMUN, V123, P160, DOI 10.1016/j.jaci.2008.10.009; Wu TF, 2013, CELLS TISSUES ORGANS, V197, P239, DOI 10.1159/000342926; Yu HQ, 2010, INT ARCH ALLERGY IMM, V152, P41, DOI 10.1159/000260082; Zhang CY, 2014, VACCINE, V32, P5669, DOI 10.1016/j.vaccine.2014.08.013	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183398	10.1371/journal.pone.0183398	http://dx.doi.org/10.1371/journal.pone.0183398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886055	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100021
J	Davenport, KA; Hoover, CE; Bian, JF; Telling, GC; Mathiason, CK; Hoover, EA				Davenport, Kristen A.; Hoover, Clare E.; Bian, Jifeng; Telling, Glenn C.; Mathiason, Candace K.; Hoover, Edward A.			PrPC expression and prion seeding activity in the alimentary tract and lymphoid tissue of deer	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; TIME RT-PCR; PROTEIN PRPC; MULE DEER; ODOCOILEUS-HEMIONUS; NERVOUS-SYSTEM; MOUSE SCRAPIE; SPONGIFORM ENCEPHALOPATHY; ORAL-TRANSMISSION	The agent responsible for prion diseases is a misfolded form of a normal protein (PrPC). The prion hypothesis stipulates that PrPC must be present for the disease to manifest. Cervid populations across the world are infected with chronic wasting disease, a horizontally-transmissible prion disease that is likely spread via oral exposure to infectious prions (PrPCWD). Though PrPCWD has been identified in many tissues, there has been little effort to characterize the overall PrPC expression in cervids and its relationship to PrPCWD accumulation. We used immunohistochemistry (IHC), western blot and enzyme-linked immunosorbent assay to describe PrPC expression in naive white-tailed deer. We used real-time, quaking-induced conversion (RT-QuIC) to detect prion seeding activity in CWD-infected deer. We assessed tissues comprising the alimentary tract, alimentary-associated lymphoid tissue and systemic lymphoid tissue from 5 naive deer. PrPC was expressed in all tissues, though expression was often very low compared to the level in the CNS. IHC identified specific cell types wherein PrPC expression is very high. To compare the distribution of PrPC to PrPCWD, we examined 5 deer with advanced CWD infection. Using RT-QuIC, we detected prion seeding activity in all 21 tissues. In 3 subclinical deer sacrificed 4 months post-inoculation, we detected PrPCWD consistently in alimentary-associated lymphoid tissue, irregularly in alimentary tract tissues, and not at all in the brain. Contrary to our hypothesis that PrPC levels dictate prion accumulation, PrPC expression was higher in the lower gastrointestinal tissues than in the alimentary-associated lymphoid system and was higher in salivary glands than in the oropharyngeal lymphoid tissue. These data suggest that PrPC expression is not the sole driver of prion accumulation and that alimentary tract tissues accumulate prions before centrifugal spread from the brain occurs.	[Davenport, Kristen A.; Hoover, Clare E.; Bian, Jifeng; Telling, Glenn C.; Mathiason, Candace K.; Hoover, Edward A.] Colorado State Univ, Microbiol Immunol & Pathol Dept, Prion Res Ctr, Ft Collins, CO 80523 USA	Colorado State University	Hoover, EA (corresponding author), Colorado State Univ, Microbiol Immunol & Pathol Dept, Prion Res Ctr, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu	Davenport, Kristen A/O-3327-2017; Telling, Glenn C/G-1217-2019; Bian, Jifeng/AAE-6262-2019	Telling, Glenn C/0000-0002-6294-1805; Bian, Jifeng/0000-0001-6838-9938; Davenport, Kristen/0000-0003-3496-2454	 [R01-NS-061902];  [HHSN2722010000091-TO-D-05];  [T32-OD0-10437];  [R01-NS-076894];  [R01-AI112956];  [F30-ORIP-118143]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010437, F30OD021442] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding wa s provided by R01-NS-061902 (EAH), HHSN2722010000091-TO-D-05 (EAH), T32-OD0-10437 (CEH), R01-NS-076894 (CKM), R01-AI112956 (CKM), and F30-ORIP-118143 (KAD); https//www.nih.gov/. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Balachandran A, 2010, CAN VET J, V51, P169; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; Clouse MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117935; Davenport KA, 2015, J VIROLOGY; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Department for Environment FaRA Animal and Plant Health Agency, 2016, CERV SPONG ENC NORW; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; GARCIACRESPO D, 2005, BMC VET RES, V1, P1; Glaysher BR, 2007, J IMMUNOL, V178, P3757, DOI 10.4049/jimmunol.178.6.3757; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Haley NJ, 2014, J CLIN MICROBIOLOGY; Heggebo R, 2002, J GEN VIROL, V83, P479, DOI 10.1099/0022-1317-83-2-479; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Henderson DM, 2015, J VIROLOGY; Henderson DM, 2014, J GEN VIROLOGY; Hoover CE, 2017, J VIROLOGY; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; Kang HE, 2012, J BIOL CHEM, V287, P37219, DOI 10.1074/jbc.M112.395921; KIMBERLIN RH, 1983, J NEUROL SCI, V61, P315, DOI 10.1016/0022-510X(83)90165-X; KIMBERLIN RH, 1983, J GEN VIROL, V64, P713, DOI 10.1099/0022-1317-64-3-713; KIMBERLIN RH, 1988, J GEN VIROL, V69, P2953, DOI 10.1099/0022-1317-69-12-2953; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; KIMBERLIN RH, 1989, VIRUS RES, V12, P213, DOI 10.1016/0168-1702(89)90040-3; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; Kyd JM, 2008, VACCINE, V26, P6221, DOI 10.1016/j.vaccine.2008.09.061; Lemaire-Vieille C, 2000, P NATL ACAD SCI USA, V97, P5422, DOI 10.1073/pnas.080081197; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Ning ZY, 2005, ANIM BIOTECHNOL, V16, P55, DOI 10.1081/ABIO-200053404; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Paltrinieri S, 2004, J HISTOCHEM CYTOCHEM, V52, P1639, DOI 10.1369/jhc.4A6441.2004; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Prinz M, 2003, AM J PATHOL, V162, P1103, DOI 10.1016/S0002-9440(10)63907-7; Race B, 2009, J VIROL, V83, P9608, DOI 10.1128/JVI.01127-09; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546; Stewart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050623; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Urayama A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32338; van Keulen LJM, 2002, APMIS, V110, P23, DOI 10.1034/j.1600-0463.2002.100104.x; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	66	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183927	10.1371/journal.pone.0183927	http://dx.doi.org/10.1371/journal.pone.0183927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880938	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200028
J	Matsui, H; Sugie, A				Matsui, Hideaki; Sugie, Atsushi			An optimized method for counting dopaminergic neurons in zebrafish	PLOS ONE			English	Article							PARKINSONS-DISEASE; ANIMAL-MODELS; MEDAKA FISH; DANIO-RERIO; BRAIN; SYSTEM; DEGENERATION; DYSFUNCTION; INHIBITION; DEFICIENCY	In recent years, considerable effort has been devoted to the development of a fish model for Parkinson's disease (PD) to examine the pathological mechanisms of neurodegeneration. To effectively evaluate PD pathology, the ability to accurately and reliably count dopaminergic neurons is important. However, there is currently no such standardized method. Due to the relatively small number of dopaminergic neurons in fish, stereological estimation would not be suitable. In addition, serial sectioning requires proficiency to not lose any sections, and it permits double counting due to the large size of some of the dopaminergic neurons. In this study, we report an optimized protocol for staining dopaminergic neurons in zebrafish and provide a reliable counting method. Finally, using our optimized protocol, we confirmed that administration of 6-hydroxydopamine (a neurotoxin) or the deletion of the PINK1 gene (one of the causative genes of familiar PD) in zebrafish caused significant reduction in the number of dopaminergic and noradrenergic neurons. In summary, this method will serve as an important tool for the appropriate evaluation and establishment of fish PD models.	[Matsui, Hideaki; Sugie, Atsushi] Niigata Univ, Ctr Transdisciplinary Res, Dept Neurosci Dis, Niigatashi, Niigata, Japan; [Matsui, Hideaki; Sugie, Atsushi] Niigata Univ, Brain Res Inst, Niigatashi, Niigata, Japan	Niigata University; Niigata University	Matsui, H (corresponding author), Niigata Univ, Ctr Transdisciplinary Res, Dept Neurosci Dis, Niigatashi, Niigata, Japan.; Matsui, H (corresponding author), Niigata Univ, Brain Res Inst, Niigatashi, Niigata, Japan.	hide0729@bri.niigata-u.ac.jp		Matsui, Hideaki/0000-0003-4908-1035	Japan Intractable Diseases Research Foundation; GSK Japan Research Grant; Takeda Science Foundation Grant; JSPS KAKENHI [JP 17925674]	Japan Intractable Diseases Research Foundation; GSK Japan Research Grant; Takeda Science Foundation Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Intractable Diseases Research Foundation (http:// www.nanbyou.jp), and GSK Japan Research Grant 2015 (http://jp.gsk.com/jp/research/ glaxosmithkine-research-grant/glaxosmithklineresearch-grant-2015/) and Takeda Science Foundation Grant, JSPS KAKENHI grant numbers JP 17925674. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Behrouz B, 2007, NEUROSCIENCE, V147, P592, DOI 10.1016/j.neuroscience.2007.05.007; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Busby ER, 2010, FISH PHYSIOL, V29, P173, DOI 10.1016/S1546-5098(10)02905-5; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Del Tredici K, 2013, J NEUROL NEUROSUR PS, V84, P774, DOI 10.1136/jnnp-2011-301817; Drobysheva D, 2008, J HISTOCHEM CYTOCHEM, V56, P1049, DOI 10.1369/jhc.2008.951137; Filippi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-135; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Flinn LJ, 2013, ANN NEUROL, V74, P837, DOI 10.1002/ana.23999; GUPTA M, 1986, NEUROSCI LETT, V70, P326, DOI 10.1016/0304-3940(86)90573-2; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jay M, 2015, CURR BIOL, V25, P435, DOI 10.1016/j.cub.2014.12.033; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAH O, 1984, NEUROSCI LETT, V48, P293, DOI 10.1016/0304-3940(84)90053-3; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Keatinge M, 2015, HUM MOL GENET, V24, P6640, DOI 10.1093/hmg/ddv369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Matsui H., NEUROSCIENC IN PRESS; Matsui H., DEV GROWTH IN PRESS; Matsui H, 2014, J PARKINSON DIS, V4, P301, DOI 10.3233/JPD-130289; Matsui H, 2013, HUM MOL GENET, V22, P2423, DOI 10.1093/hmg/ddt095; Matsui H, 2013, FEBS LETT, V587, P1316, DOI 10.1016/j.febslet.2013.02.046; Matsui Hideaki, 2012, Exp Neurobiol, V21, P94, DOI 10.5607/en.2012.21.3.94; Matsui H, 2010, J NEUROCHEM, V115, P1150, DOI 10.1111/j.1471-4159.2010.07012.x; Matsui H, 2010, J NEUROCHEM, V115, P178, DOI 10.1111/j.1471-4159.2010.06918.x; Matsui H, 2009, NEUROSCI RES, V65, P263, DOI 10.1016/j.neures.2009.07.010; MEEK J, 1993, J COMP NEUROL, V328, P145, DOI 10.1002/cne.903280111; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Parkinsonism Fahn S., 1995, PARKINSONISM MERRITT, P713; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Sotiriou E, 2010, NEUROBIOL AGING, V31, P2103, DOI 10.1016/j.neurobiolaging.2008.11.010; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Uemura N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005065; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	46	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184363	10.1371/journal.pone.0184363	http://dx.doi.org/10.1371/journal.pone.0184363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880915	Green Submitted, gold, Green Published			2022-12-26	WOS:000409467200058
J	Romoren, M; Gjelstad, S; Lindbaek, M				Romoren, Maria; Gjelstad, Svein; Lindbaek, Morten			A structured training program for health workers in intravenous treatment with fluids and antibiotics in nursing homes: A modified stepped-wedge cluster-randomised trial to reduce hospital admissions	PLOS ONE			English	Article							MULTIFACETED INTERVENTION; ACQUIRED PNEUMONIA; RESIDENTS; OUTCOMES; GUIDELINES; INFECTION; MORTALITY; HAZARDS	Objectives Hospitalization is potentially detrimental to nursing home patients and resource demanding for the specialist health care. This study assessed if a brief training program in administrating intravenous fluids and antibiotics in nursing homes could reduce hospital transfers and ensure high quality care locally. Design A pragmatic and modified cluster randomized stepped-wedge trial with randomization on nursing home level. Participants 330 cases in 296 nursing home residents from 30 nursing homes were included. Cases were patients provided intravenous antibiotics or intravenous fluids, in nursing home or hospital. Primary outcome was localization of treatment, secondary outcomes were number of days treated, days of hospitalization among admitted patients, type of antibiotics used and 30-day mortality. Intervention The nursing homes sequentially received a one-day educational program for the health workers including theory and practical training in intravenous treatment of dehydration and infection, run by two skilled nurses. After completing the training program, the nursing homes had competence to provide intravenous treatment locally. Results The intervention had a highly significant effect on treatment in nursing homes (OR 8.35, 2.08 to 33.6; P<0.01, or RR 2.23, 1.48 to 2.56). The number treated in nursing homes was stable over time; the number treated in hospital gradually decreased (chi square for trend P< 0.001). Among patients receiving intravenous antibiotics in the nursing homes, 50 (46%) died within 30 days, compared to 30 (36%) treated in the hospital (P = 0.19). Among patients receiving intravenous fluids locally, 21 (19%) died within 30 days, compared to 2 (8%) in the hospital group (P = 0.34). Mortality was associated with reduced consciousness and elevated c-reactive protein. Conclusions A brief educational program delivered to nursing home personnel was feasible and effective in reducing acute hospital admissions from nursing homes for treatment of dehydration and infections.	[Romoren, Maria] Vestfold Hosp Trust, Dept Adm, Tonsberg, Norway; [Romoren, Maria; Gjelstad, Svein; Lindbaek, Morten] Univ Oslo, Dept Gen Practice, Inst Hlth & Soc, Oslo, Norway	University of Oslo	Romoren, M (corresponding author), Vestfold Hosp Trust, Dept Adm, Tonsberg, Norway.; Romoren, M (corresponding author), Univ Oslo, Dept Gen Practice, Inst Hlth & Soc, Oslo, Norway.	maria.romoren@medisin.uio.no			South-Eastern Norway Regional Health Authority; University of Oslo, Norway	South-Eastern Norway Regional Health Authority; University of Oslo, Norway	The 3iV project received funding grants from the South-Eastern Norway Regional Health Authority and the University of Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agotnes G, 2016, AGEING INT, V41, P3, DOI 10.1007/s12126-015-9232-4; [Anonymous], 2012, TIDSSKR LAEGEFOREN, DOI DOI 10.4045/TIDSSKR.12.0194; Boockvar KS, 2005, J AM GERIATR SOC, V53, P590, DOI 10.1111/j.1532-5415.2005.53205.x; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Coque T M, 2008, Euro Surveill, V13; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Friedman SM, 2008, GERONTOLOGIST, V48, P537, DOI 10.1093/geront/48.4.537; Graverholt B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-36; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hutt E, 2011, J AM MED DIR ASSOC, V12, P499, DOI 10.1016/j.jamda.2010.03.011; Leontjevas R, 2013, LANCET, V381, P2255, DOI 10.1016/S0140-6736(13)60590-5; Loeb M, 2005, BRIT MED J, V331, P669, DOI 10.1136/bmj.38602.586343.55; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Medical Research Council, 2006, DEV EVALUATING COMPL; Naughton BJ, 2001, J AM GERIATR SOC, V49, P1020, DOI 10.1046/j.1532-5415.2001.49203.x; Nielsen L, 2015, OPEN J MED MICROBIOL, V5, P28, DOI [10.4236/ojmm.2015.51005, DOI 10.4236/OJMM.2015.51005]; Norway Statistics, POPULATION; Norwegian Board of Health Supervision, 2003, PLEIE OMS KOMM TJEN; Norwegian Institute of Public Health, CAUS OF DEATH; Office of the Auditor General of Norway, 2016, RIKSR HELS ETT INNF; Onder G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-5; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Steen Tore Walgaard, 2013, Tidsskr Nor Laegeforen, V133, P1819, DOI 10.4045/tidsskr.12.0935; Stern A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-83; The Norwegian Directorate of Health, 2016, NAT GUID ANT PRESCR; The Norwegian Directorate of Health, 2013, NAT GUID ANT PRESCR; Thiem U, 2009, AGE AGEING, V38, P693, DOI 10.1093/ageing/afp164; van der Steen JT, 2004, J AM GERIATR SOC, V52, P691, DOI 10.1111/j.1532-5415.2004.52204.x; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	30	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182619	10.1371/journal.pone.0182619	http://dx.doi.org/10.1371/journal.pone.0182619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880941	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200008
J	Santos, C; Nelson, CD; Zhebentyayeva, T; Machado, H; Gomes-Laranjo, J; Costa, RL				Santos, Carmen; Nelson, Charles Dana; Zhebentyayeva, Tetyana; Machado, Helena; Gomes-Laranjo, Jose; Costa, Rita Lourenco			First interspecific genetic linkage map for Castanea sativa x Castanea crenata revealed QTLs for resistance to Phytophthora cinnamomi	PLOS ONE			English	Article							EST-SSR MARKERS; PROTEIN; OVEREXPRESSION; ARABIDOPSIS; TRAITS; BLIGHT; PLANTS; CROSS	The Japanese chestnut (Castanea crenata) carries resistance to Phytophthora cinnamomi, the destructive and widespread oomycete causing ink disease. The European chestnut (Castanea sativa), carrying little to no disease resistance, is currently threatened by the presence of the oomycete pathogen in forests, orchards and nurseries. Determining the genetic basis of P. cinnamomi resistance, for further selection of molecular markers and candidate genes, is a prominent issue for implementation of marker assisted selection in the breeding programs for resistance. In this study, the first interspecific genetic linkage map of C. sativa x C. crenata allowed the detection of QTLs for P. cinnamomi resistance. The genetic map was constructed using two independent, control-cross mapping populations. Chestnut populations were genotyped using 452 microsatellite and single nucleotide polymorphism molecular markers derived from the available chestnut transcriptomes. The consensus genetic map spans 498,9 cM and contains 217 markers mapped with an average interval of 2.3 cM. For QTL analyses, the progression rate of P. cinnamomi lesions in excised shoots inoculated was used as the phenotypic metric. Using non-parametric and composite interval mapping approaches, two QTLs were identified for ink disease resistance, distributed in two linkage groups: E and K. The presence of QTLs located in linkage group E regarding P. cinnamomi resistance is consistent with a previous preliminary study developed in American x Chinese chestnut populations, suggesting the presence of common P. cinnamomi defense mechanisms across species. Results presented here extend the genomic resources of Castanea genus providing potential tools to assist the ongoing and future chestnut breeding programs.	[Santos, Carmen; Machado, Helena; Costa, Rita Lourenco] Inst Nacl Invest Agr & Vet, Lab Biol Mol, IP Ave Republ, Oeiras, Portugal; [Nelson, Charles Dana] US Forest Serv, Southern Inst Forest Genet, Southern Res Stn, USDA, Saucier, MS USA; [Nelson, Charles Dana] Univ Kentucky, Forest Hlth Res & Educ Ctr, Lexington, KY USA; [Zhebentyayeva, Tetyana] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Zhebentyayeva, Tetyana] Clemson Univ, Genom & Computat Biol Lab, Clemson, SC USA; [Gomes-Laranjo, Jose] Univ Tras Os Montes & Alto Douro, Ctr Invest & Tecnol Agroambientais & Biol, Vila Real, Portugal; [Costa, Rita Lourenco] Univ Lisboa Tapada Ajuda, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal; [Santos, Carmen] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Ave Republ, Oeiras, Portugal	United States Department of Agriculture (USDA); United States Forest Service; University of Kentucky; Clemson University; Clemson University; University of Tras-os-Montes & Alto Douro; Universidade de Lisboa; Universidade Nova de Lisboa	Costa, RL (corresponding author), Inst Nacl Invest Agr & Vet, Lab Biol Mol, IP Ave Republ, Oeiras, Portugal.; Costa, RL (corresponding author), Univ Lisboa Tapada Ajuda, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal.	rita.lcosta@iniav.pt	MACHADO, HELENA/GVS-1123-2022; Costa, Rita Lourenco/Q-4564-2019; Costa, Rita L/B-5190-2016	Costa, Rita Lourenco/0000-0001-9503-6126; Costa, Rita L/0000-0001-9503-6126; Santos, Carmen/0000-0003-3743-7591; Machado, Helena/0000-0002-1775-0962	Centro de Estudos Florestais (CEF); Fundacao para a Ciencia e Tecnologia I.P. (FCT), Portugal [UID/AGR/00239/2013]; Fundacao para a Ciencia e Tecnologia [PTDC/AGR-CFL/101707/2008];  [SFRH/BD/85140/2012]	Centro de Estudos Florestais (CEF); Fundacao para a Ciencia e Tecnologia I.P. (FCT), Portugal; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); 	Authors acknowledge the funding provided by Centro de Estudos Florestais (CEF), which is a research unit funded by Fundacao para a Ciencia e Tecnologia I.P. (FCT), Portugal (UID/AGR/00239/2013). We acknowledge Fundacao para a Ciencia e Tecnologia through the project PTDC/AGR-CFL/101707/2008 and the PhD grant SFRH/BD/85140/2012 and also Programa ProDere Medida 4.1 Ref 45967 Developing processes and Technologies aiming the production of ink disease resistant. chestnut rootstocks, compatible with national varieties certified with molecular markers and Programa ProDer, Medida 4.1 Ref 53593 Innovation in the production chain of chestnut: competitiveness and sustainability. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostakis SL, 2001, FOREST ECOL MANAG, V152, P225, DOI 10.1016/S0378-1127(00)00605-8; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Bodenes C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-153; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Casasoli M, 2004, PLANT CELL ENVIRON, V27, P1088, DOI 10.1111/j.1365-3040.2004.01214.x; Casasoli M, 2001, THEOR APPL GENET, V102, P1190, DOI 10.1007/s00122-001-0553-1; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Coelho AC, 2011, NZ J FORESTRY SCI, P143; CRANDALL BS, 1945, PHYTOPATHOLOGY, V35, P162; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Fang GC, 2013, TREE GENET GENOMES, V9, P525, DOI 10.1007/s11295-012-0576-6; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Jacobs DF, 2013, NEW PHYTOL, V197, P378, DOI 10.1111/nph.12020; JANSEN RC, 1994, GENETICS, V136, P1447; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kosambi DD, 1944, AM MATH MON, P382, DOI [10.1080/00029890.1944.11999118, DOI 10.1007/978-81-322-3676-4_17, 10.1007/978-81-322-3676-4_17]; Kubisiak TL, 2013, TREE GENET GENOMES, V9, P557, DOI 10.1007/s11295-012-0579-3; Kubisiak TL, 1997, PHYTOPATHOLOGY, V87, P751, DOI 10.1094/PHYTO.1997.87.7.751; Lowe KM, 2006, THEOR APPL GENET, V112, P1582, DOI 10.1007/s00122-006-0264-8; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Santos C, 2015, PLANT PATHOL, V64, P901, DOI 10.1111/ppa.12313; Santos C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00515; Santos C, 2015, SCI HORTIC-AMSTERDAM, V194, P181, DOI 10.1016/j.scienta.2015.07.043; Schlink K, 2010, FUNCT INTEGR GENOMIC, V10, P253, DOI 10.1007/s10142-009-0143-x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Serrazina S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0829-7; Sisco P, 2005, P 3 INT CHESTN C ACT, V693; Staton M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1942-1; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Zhang Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-537; Zhebentyayeva T, 2014, ACTA HORTIC, V1019, P263, DOI 10.17660/ActaHortic.2014.1019.40	34	28	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184381	10.1371/journal.pone.0184381	http://dx.doi.org/10.1371/journal.pone.0184381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880954	Green Published, gold, Green Submitted			2022-12-26	WOS:000409467200062
J	Alsous, M; Abu Farha, R; Alefishat, E; Al Omar, S; Momani, D; Gharabli, A; McElnay, J; Horne, R; Rihani, R				Alsous, Mervat; Abu Farha, Rana; Alefishat, Eman; Al Omar, Suha; Momani, Deema; Gharabli, Alia; McElnay, James; Horne, Robert; Rihani, Rawad			Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SELF-REPORT; MEDICATION ADHERENCE; MAINTENANCE THERAPY; DRUG-THERAPY; CHILDHOOD; MERCAPTOPURINE; ISSUES; AZATHIOPRINE; RELAPSE	Objective Studies on children with Acute Lymphoblastic Leukemia (ALL) reported non-adherence in 2-54% of cases. The primary objective of this study was to assess rates of adherence to 6-MP using two different methods in children and adolescents with ALL. Secondary aim was to identify factors that influence adherence to 6-MP in children with ALL. Methods All eligible children with ALL who are (<= 19) years old and receive 6-MP therapy for at least 1 month were approached to participate in the study. A total of 52 children with ALL and their primary caregivers were recruited. Adherence measures included an objective method (measuring 6-MP metabolites in packed Red Blood Cells (RBCs)) and a subjective method (using parent and child self-report via the Medication Adherence Report Scale; MARS; Adherence was defined as 90% or greater). Results Rates of adherence varied across the measurement methods. Packed RBCs sample analysis indicated forty-four patients (84.6%) to be adherent. Using the MARS questionnaires, a total of 49 children (94.2%) were classified as being adherent according to the parental MARS questionnaire scores, while all the 15 children (100%) who answered the MARS (child) questionnaire were classified as adherent. Overall adherence rate was 80.8% within the studied population. Conclusion MARS scale was shown to overestimate adherence compared to measurement of 6-MP metabolites in the blood. A combination of both methods led to increased detection of non-adherence to thiopurine in children with ALL.	[Alsous, Mervat; Abu Farha, Rana] Appl Sci Private Univ, Dept Clin Pharm & Therapeut, Fac Pharm, Amman, Jordan; [Alefishat, Eman] Univ Jordan, Dept Biopharmaceut & Clin Pharm, Fac Pharm, Amman, Jordan; [Al Omar, Suha; Momani, Deema; Gharabli, Alia] King Hussein Canc Ctr, Clin Pharm Dept, Amman, Jordan; [McElnay, James] Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland; [Horne, Robert] UCL, UCL Sch Pharm, Ctr Behav Med, London, England; [Rihani, Rawad] King Hussein Canc Ctr, Dept Paediat Oncol, Paediat Bone Marrow & Stem Cell Transplantat, Amman, Jordan	University of Jordan; King Hussein Cancer Center; Queens University Belfast; University of London; University College London; University of London School of Pharmacy; King Hussein Cancer Center	Alsous, M (corresponding author), Appl Sci Private Univ, Dept Clin Pharm & Therapeut, Fac Pharm, Amman, Jordan.	m_alsous@asu.edu.jo	Rihani, Rawad/GPC-7700-2022; Alsous, Mervat/AAF-2470-2019; Abu-Farha, Rana/AAA-6119-2019	Abu-Farha, Rana/0000-0001-8298-4071; Alsous, Mervat/0000-0002-6678-670X	Deanship of Scientific Research at The University of Jordan [89/2013-2014]; King Hussein Cancer Centre	Deanship of Scientific Research at The University of Jordan; King Hussein Cancer Centre	This work was supported by the Deanship of Scientific Research at The University of Jordan (Grant No. 89/2013-2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank King Hussein Cancer Centre for their help and support during the study, and Pharmaceutical Research Center, Jordan University of Science and Technology for assistance with the analysis of blood samples. The authors wish also to thank Dr. Lama Nazer for her help and support at KHCC.	Alsous M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171863; Bhatia S, 2012, J CLIN ONCOLOGY JCO; Bhatia S, 2014, BLOOD; Bhatia S, 2015, JAMA ONCOL, V1, P287, DOI 10.1001/jamaoncol.2015.0245; Bruns T, 2009, DIGEST DIS, V27, P394, DOI 10.1159/000228580; Butz Arlene M, 2006, J Pediatr Health Care, V20, P338, DOI 10.1016/j.pedhc.2006.05.003; Jaime-Perez JC, 2009, LEUKEMIA LYMPHOMA, V50, P1843, DOI 10.3109/10428190903216812; Carter S, 2003, QUESTION CHOICE COMP; Cox K, 2002, SYSTEMATIC REV COMMU; Daniels T, 2011, CHEST, V140, P425, DOI 10.1378/chest.09-3074; DAVIES HA, 1995, CANCER TREAT REV, V21, P93, DOI 10.1016/0305-7372(95)90022-5; de Oliveira BM, 2004, ARCH DIS CHILD, V89, P785, DOI 10.1136/adc.2003.030775; FESTA RS, 1992, J PEDIATR-US, V120, P807, DOI 10.1016/S0022-3476(05)80256-2; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Goodfellow NA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0038-7; Hampson S E, 2001, Health Technol Assess, V5, P1; Hawwa AF, 2009, EUR J CLIN PHARMACOL, V65, P1105, DOI 10.1007/s00228-009-0700-1; Kane SV, 2006, ALIMENT PHARM THER, V23, P577, DOI 10.1111/j.1365-2036.2006.02809.x; Kremeike K, 2015, KLIN PADIATR, V227, P329, DOI 10.1055/s-0035-1559788; Landier W, 2017, J CLIN ONCOL, V35, P1730, DOI 10.1200/JCO.2016.71.7579; Landier W, 2017, BLOOD, V129, P1919, DOI 10.1182/blood-2016-07-726893; Lau RCW, 1998, MED PEDIATR ONCOL, V30, P85; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1986, CLIN PHARMACOL THER, V40, P287, DOI 10.1038/clpt.1986.178; LEVINE AM, 1987, J CLIN ONCOL, V5, P1469, DOI 10.1200/JCO.1987.5.9.1469; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Matsui DM, 1997, PEDIATR CLIN N AM, V44, P1, DOI 10.1016/S0031-3955(05)70459-4; Matsui Doreen, 2007, Paediatr Drugs, V9, P283; Modi AC, 2006, J CYST FIBROS, V5, P177, DOI 10.1016/j.jcf.2006.03.002; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pui C, 2003, ANN HEMATOL, V83, pS124; Pui CH, 2010, LEUKEMIA, V24, P371, DOI 10.1038/leu.2009.252; Rifky E, 2015, J CANCER RES THER, V11, P54, DOI 10.4103/0973-1482.147698; Rohan JM, 2016, J PEDIATR PSYCHOL; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Rumbo C, 2004, PEDIATR TRANSPLANT, V8, P606, DOI 10.1111/j.1399-3046.2004.00239.x; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; TEBBI CK, 1986, CANCER, V58, P1179, DOI 10.1002/1097-0142(19860901)58:5<1179::AID-CNCR2820580534>3.0.CO;2-E; Traore F, 2006, PEDIATR BLOOD CANCER, V46, P187, DOI 10.1002/pbc.20518; U.S. FDA, 1998, GUIDANCE IND BIOANAL; Winnick S, 2005, PEDIATRICS, V115, pE718, DOI 10.1542/peds.2004-1133	43	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183119	10.1371/journal.pone.0183119	http://dx.doi.org/10.1371/journal.pone.0183119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877179	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200022
J	Li, AD; Tan, X; Wu, W; Liu, HB; Zhu, J				Li, Aidi; Tan, Xing; Wu, Wei; Liu, Hongbin; Zhu, Jie			Predicting active-layer soil thickness using topographic variables at a small watershed scale	PLOS ONE			English	Article							TERRAIN ATTRIBUTES; SPATIAL PREDICTION; RANDOM FOREST; DEPTH; LANDSCAPE; MODEL; REGION; STOCKS; AREAS	Knowledge about the spatial distribution of active-layer (AL) soil thickness is indispensable for ecological modeling, precision agriculture, and land resource management. However, it is difficult to obtain the details on AL soil thickness by using conventional soil survey method. In this research, the objective is to investigate the possibility and accuracy of mapping the spatial distribution of AL soil thickness through random forest (RF) model by using terrain variables at a small watershed scale. A total of 1113 soil samples collected from the slope fields were randomly divided into calibration (770 soil samples) and validation (343 soil samples) sets. Seven terrain variables including elevation, aspect, relative slope position, valley depth, flow path length, slope height, and topographic wetness index were derived from a digital elevation map (30 m). The RF model was compared with multiple linear regression (MLR), geographically weighted regression (GWR) and support vector machines (SVM) approaches based on the validation set. Model performance was evaluated by precision criteria of mean error (ME), mean absolute error (MAE), root mean square error (RMSE), and coefficient of determination (R-2). Comparative results showed that RF outperformed MLR, GWR and SVM models. The RF gave better values of ME (0.39 cm), MAE (7.09 cm), and RMSE (10.85 cm) and higher R-2 (62%). The sensitivity analysis demonstrated that the DEM had less uncertainty than the AL soil thickness. The outcome of the RF model indicated that elevation, flow path length and valley depth were the most important factors affecting the AL soil thickness variability across the watershed. These results demonstrated the RF model is a promising method for predicting spatial distribution of AL soil thickness using terrain parameters.	[Li, Aidi; Tan, Xing; Liu, Hongbin; Zhu, Jie] Southwest Univ, Coll Resources & Environm, Chongqing, Peoples R China; [Li, Aidi] Chongqing Land Resources & Housing Surveying & Pl, Chongqing, Peoples R China; [Wu, Wei] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Liu, HB (corresponding author), Southwest Univ, Coll Resources & Environm, Chongqing, Peoples R China.	lhbin@swu.edu.cn						Ballabio C, 2009, GEODERMA, V151, P338, DOI 10.1016/j.geoderma.2009.04.022; Bathurst JC, 2007, HYDROL EARTH SYST SC, V11, P569, DOI 10.5194/hess-11-569-2007; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Boer M, 1996, GEODERMA, V72, P99, DOI 10.1016/0016-7061(96)00024-9; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Cimmery V., 2007, USER GUIDE SAGA VERS; Dahlke HE, 2009, HYDROL PROCESS, V23, P3017, DOI 10.1002/hyp.7413; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Emili LA, 2006, CAN J FOREST RES, V36, P2024, DOI 10.1139/X06-104; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Gong Z.T., 2003, CHINESE SOIL TAXONOM; Grimm R, 2008, GEODERMA, V146, P102, DOI 10.1016/j.geoderma.2008.05.008; Heimsath AM, 1999, GEOMORPHOLOGY, V27, P151, DOI 10.1016/S0169-555X(98)00095-6; Ho JY, 2012, ENG GEOL, V124, P38, DOI 10.1016/j.enggeo.2011.09.013; Jia S., 2013, ENGINEERING, V5, P391, DOI DOI 10.4236/eng.2013.510B079; Kuriakose SL, 2009, CATENA, V79, P27, DOI 10.1016/j.catena.2009.05.005; Lark RM, 1999, GEODERMA, V92, P141, DOI 10.1016/S0016-7061(99)00028-2; Lee KT, 2009, J HYDROL, V375, P489, DOI 10.1016/j.jhydrol.2009.06.053; Luo DL, 2014, SCI CHINA EARTH SCI, V57, P1834, DOI 10.1007/s11430-014-4852-1; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Mehnatkesh A, 2013, J MT SCI-ENGL, V10, P163, DOI 10.1007/s11629-013-2427-9; Meyer MD, 2007, PLANT SOIL, V294, P113, DOI 10.1007/s11104-007-9235-3; Mishra U., 2016, GEODERMA; Mishra U, 2014, SOIL SCI SOC AM J, V78, P894, DOI 10.2136/sssaj2013.11.0484; Mishra U, 2012, GEODERMA, V189, P288, DOI 10.1016/j.geoderma.2012.06.022; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Mora-Vallejo A, 2008, CATENA, V76, P44, DOI 10.1016/j.catena.2008.09.008; Ohnuki Y, 2008, HYDROL PROCESS, V22, P1272, DOI 10.1002/hyp.6937; Penizek V, 2006, PLANT SOIL ENVIRON, V52, P424, DOI 10.17221/3461-PSE; Quinn PF, 1997, HYDROLOGICAL PROCESS, V9, P161; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Galiano V, 2015, ORE GEOL REV, V71, P804, DOI 10.1016/j.oregeorev.2015.01.001; Saito T, 2016, WATER-SUI, V8, DOI 10.3390/w8030096; Saulnier GM, 1997, J HYDROL, V202, P158, DOI 10.1016/S0022-1694(97)00059-0; Scarpone C, 2016, GEODERMA, V282, P59, DOI 10.1016/j.geoderma.2016.07.012; Segoni S, 2013, LANDSLIDE SCI PRACTI, P127; Stieglitz M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002041; Talebi A, 2008, HYDROL PROCESS, V22, P546, DOI 10.1002/hyp.6881; Tesfa TK, 2009, WATER RESOUR RES, V45, P1277; Thompson JA, 2001, GEODERMA, V100, P67, DOI 10.1016/S0016-7061(00)00081-1; Thompson JA, 2006, GEODERMA, V133, P57, DOI 10.1016/j.geoderma.2006.03.037; Tromp-van Meerveld HJ, 2006, ADV WATER RESOUR, V29, P293, DOI 10.1016/j.advwatres.2005.02.016; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Were K, 2015, ECOL INDIC, V52, P394, DOI 10.1016/j.ecolind.2014.12.028; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; Wu S, 2008, APPL GEOGR, V28, P210, DOI 10.1016/j.apgeog.2008.02.006; Yang QY, 2014, J SOIL SEDIMENT, V14, P1568, DOI 10.1007/s11368-014-0904-6; Zhang Z, 2013, INTELL AUTOM SOFT CO, V19, P327, DOI 10.1080/10798587.2013.824241; Ziadat FM, 2010, PEDOSPHERE, V20, P361, DOI 10.1016/S1002-0160(10)60025-2	53	10	10	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183742	10.1371/journal.pone.0183742	http://dx.doi.org/10.1371/journal.pone.0183742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877196	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200039
J	Oleksy, R; Giuggioli, L; McKetterick, TJ; Racey, PA; Jones, G				Oleksy, Ryszard; Giuggioli, Luca; McKetterick, Thomas J.; Racey, Paul A.; Jones, Gareth			Flying foxes create extensive seed shadows and enhance germination success of pioneer plant species in deforested Madagascan landscapes	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; FRUIT BATS; RAIN-FOREST; FRAGMENTED LANDSCAPES; EASTERN MADAGASCAR; FRUGIVOROUS BATS; PTEROPUS-RUFUS; GPS TRACKING; FICUS; PATTERNS	Seed dispersal plays a significant role in forest regeneration and maintenance. Flying foxes are often posited as effective long-distance seed dispersers due to their large home ranges and ability to disperse seeds when flying. We evaluate the importance of the Madagascan flying fox Pteropus rufus in the maintenance and regeneration of forests in one of the world's priority conservation areas. We tested germination success of over 20,000 seeds from the figs Ficus polita, F. grevei and F. lutea extracted from bat faeces and ripe fruits under progressively more natural conditions, ranging from petri-dishes to outdoor environments. Seeds from all fig species showed increased germination success after passing through the bats' digestive tracts. Outside, germination success in F. polita was highest in faecal seeds grown under semi-shaded conditions, and seeds that passed through bats showed increased seedling establishment success. We used data from feeding trials and GPS tracking to construct seed shadow maps to visualize seed dispersal patterns. The models use Gaussian probability density functions to predict the likelihood of defecation events occurring after feeding. In captivity, bats had short gut retention times (often <30 mins), but were sometimes able to retain seeds for over 24h. In the wild, bats travelled 3-5 km within 24-280 min after feeding, when defecation of ingested seeds is very likely. They produced extensive seed shadows (11 bats potentially dispersing seeds over 58,000 ha over 45 total days of tracking) when feeding on figs within their large foraging areas and dispersed the seeds in habitats that were often partially shaded and hence would facilitate germination up to 20 km from the feeding tree. Because figs are important pioneer species, P. rufus is an important dispersal vector that makes a vital contribution to the regeneration and maintenance of highly fragmented forest patches in Madagascar.	[Oleksy, Ryszard; Giuggioli, Luca; Jones, Gareth] Univ Bristol, Sch Life Sci, Bristol, Avon, England; [Giuggioli, Luca; McKetterick, Thomas J.] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Racey, Paul A.] Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Cornwall Campus, Penryn, Cornwall, England	University of Bristol; University of Bristol; University of Exeter	Jones, G (corresponding author), Univ Bristol, Sch Life Sci, Bristol, Avon, England.	gareth.jones@bristol.ac.uk	Racey, Paul/I-4541-2019; Giuggioli, Luca/J-2881-2012	Giuggioli, Luca/0000-0002-2325-4682; Jones, Gareth/0000-0002-1904-3735	Engineering and Physical Sciences Research Council [EP/I013717/1]; Conservation, Food and Health Foundation; Rufford Small Grant Foundation; Bat Conservation International; Explorers Club; Sir Richard Stapley Educational Trust; Guinness Trust; Oleg Polunin Memorial Fund; University of Bristol; Allan & Nesta Ferguson Charitable Trust	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Conservation, Food and Health Foundation; Rufford Small Grant Foundation; Bat Conservation International; Explorers Club; Sir Richard Stapley Educational Trust; Guinness Trust; Oleg Polunin Memorial Fund; University of Bristol; Allan & Nesta Ferguson Charitable Trust	Funding was provided by The Engineering and Physical Sciences Research Council (grant EP/I013717/1); The Conservation, Food and Health Foundation; The Rufford Small Grant Foundation; Bat Conservation International; The Explorers Club; The Sir Richard Stapley Educational Trust; The Guinness Trust; The Oleg Polunin Memorial Fund; The University of Bristol and The Allan & Nesta Ferguson Charitable Trust.	Abedi-Lartey M, 2016, GLOB ECOL CONSERV, V7, P12, DOI 10.1016/j.gecco.2016.03.005; Atsalis S, 2000, AM J PRIMATOL, V51, P61, DOI 10.1002/(SICI)1098-2345(200005)51:1<61::AID-AJP5>3.0.CO;2-2; Baldwin JW, 2015, OECOLOGIA, V177, P453, DOI 10.1007/s00442-014-3096-2; Bollen A, 2006, ORYX, V40, P57, DOI 10.1017/S0030605306000111; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; BURNEY DA, 1993, QUATERNARY RES, V40, P98, DOI 10.1006/qres.1993.1060; Cavallero L, 2013, BIOL CONSERV, V158, P342, DOI 10.1016/j.biocon.2012.10.004; Condit IJ, 1969, THE EXOTIC SPECIES; Crowley BE, 2010, QUATERNARY SCI REV, V29, P2591, DOI 10.1016/j.quascirev.2010.06.030; Dewar RE, 2013, P NATL ACAD SCI USA, V110, P12583, DOI 10.1073/pnas.1306100110; Docters van Leeuwen WM, 1935, GARDENS B STRAITS SE, V9, P58; Domene M, 2014, PLOS ONE, V9; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Entwistle AC, 1997, AFR J ECOL, V35, P351, DOI 10.1111/j.1365-2028.1997.092-8900092.x; EVENARI M, 1949, BOT REV, V15, P153, DOI 10.1007/BF02861721; FLEMING TH, 1981, BIOTROPICA, V13, P45, DOI 10.2307/2388069; Fukui Akiko, 1996, Plant Species Biology, V11, P141, DOI 10.1111/j.1442-1984.1996.tb00139.x; Gade DW, 1996, MT RES DEV, V16, P101, DOI 10.2307/3674005; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Goosem S.P., 1995, REPAIRING RAINFOREST; GORCHOV DL, 1993, VEGETATIO, V108, P339; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kays R, 2011, ACTA OECOL, V37, P625, DOI 10.1016/j.actao.2011.06.007; Kim DH, 2015, GEOPHYS RES LETT, V42, P3495, DOI 10.1002/2014GL062777; Kleyheeg E, 2017, J ECOL, V105, P1279, DOI 10.1111/1365-2745.12738; Kuaraksa C, 2013, RESTOR ECOL, V21, P86, DOI 10.1111/j.1526-100X.2011.00853.x; Kuaraksa C, 2012, FOREST ECOL MANAG, V265, P82, DOI 10.1016/j.foreco.2011.10.022; LAMBERT FR, 1991, J ECOL, V79, P793, DOI 10.2307/2260668; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Lobova TA, 2003, AM J BOT, V90, P388, DOI 10.3732/ajb.90.3.388; Long E, 2007, J TROP ECOL, V23, P397, DOI 10.1017/S0266467407004178; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Mueller T, 2014, J APPL ECOL, V51, P684, DOI 10.1111/1365-2664.12247; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nakamoto A, 2009, ECOL RES, V24, P405, DOI 10.1007/s11284-008-0516-y; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Ochoa-Quintero JM, 2015, CONSERV BIOL, V29, P440, DOI 10.1111/cobi.12446; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Phua Poh Boon, 1989, Malayan Nature Journal, V42, P251; Picot M, 2007, AFR J ECOL, V45, P645, DOI 10.1111/j.1365-2028.2007.00788.x; Robledo-Arnuncio JJ, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0016-3; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Shilton LA, 1999, P ROY SOC B-BIOL SCI, V266, P219, DOI 10.1098/rspb.1999.0625; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Tang ZH, 2007, J TROP ECOL, V23, P125, DOI 10.1017/S0266467406003737; TEDMAN RA, 1985, AUST J ZOOL, V33, P625, DOI 10.1071/ZO9850625; Thomas DW, 1998, ECOLOGICAL BEHAV MET, P211; Thornton IWB, 2001, J BIOGEOGR, V28, P1389, DOI 10.1046/j.1365-2699.2001.00636.x; Traveset A, 1998, ECOL EVOL SYST, V1, P151, DOI DOI 10.1078/1433-8319-00057; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; UTZURRUM RCB, 1991, BIOTROPICA, V23, P311, DOI 10.2307/2388211; Vincenot CE, 2017, SCIENCE, V355, P1368, DOI 10.1126/science.aam7582; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Westcott DA, 2008, DIVERS DISTRIB, V14, P432, DOI 10.1111/j.1472-4642.2007.00416.x; Whitehead SR, 2016, OIKOS, V125, P927, DOI 10.1111/oik.02210; WOLTON RJ, 1982, MAMMALIA, V46, P419, DOI 10.1515/mamm.1982.46.4.419	62	29	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184023	10.1371/journal.pone.0184023	http://dx.doi.org/10.1371/journal.pone.0184023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877248	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200056
J	Pokrishevsky, E; Hong, RH; Mackenzie, IR; Cashman, NR				Pokrishevsky, Edward; Hong, Ran Ha; Mackenzie, Ian R.; Cashman, Neil R.			Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells	PLOS ONE			English	Article							PRION-LIKE PROPAGATION; WILD-TYPE; SUPEROXIDE; CYTOTOXICITY; PATHWAY; SPREAD; FORMS	Mutant Cu/Zn superoxide dismutase (SOD1) can confer its misfolding on wild-type SOD1 in living cells; the propagation of misfolding can also be transmitted between cells in vitro. Recent studies identified fluorescently-tagged SOD1 G85R as a promiscuous substrate that is highly prone to aggregate by a variety of templates, in vitro and in vivo. Here, we utilized several SOD1-GFP reporter proteins with G37R, G85R, or G93A mutations in SOD1. We observed that human spinal cord homogenates prepared from SOD1 familial ALS (FALS) can induce significantly more intracellular reporter protein aggregation than spinal cord homogenates from sporadic ALS, Alzheimer's disease, multiple system atrophy or healthy control individuals. We also determined that the induction of reporter protein aggregation by SOD1-FALS tissue homogenates can be attenuated by incubating the cells with the SOD1 misfolding-specific antibody 3H1, or the small molecule 5-fluorouridine. Our study further implicates SOD1 as the seeding particle responsible for the spread of SOD1-FALS neurode-generation from its initial onset site(s), and demonstrates two potential therapeutic strategies for SOD1-mediated disease. This work also comprises a medium-throughput cell-based platform of screening potential therapeutics to attenuate propagated aggregation of SOD1.	[Pokrishevsky, Edward; Hong, Ran Ha; Cashman, Neil R.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Cashman, NR (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	Neil.Cashman@vch.ca			Canadian Institutes of Health Research; ALS Canada; Brain Canada; Webster Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ALS Canada; Brain Canada; Webster Foundation	We thank the Canadian Institutes of Health Research, ALS Canada, Brain Canada and the Webster Foundation for providing us with the funding required for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Ayers JI, 2016, ACTA NEUROPATHOL, V132, P827, DOI 10.1007/s00401-016-1623-4; Ayers JI, 2016, ACTA NEUROPATHOL, V131, P103, DOI 10.1007/s00401-015-1514-0; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Bergh J, 2015, P NATL ACAD SCI USA, V112, P4489, DOI 10.1073/pnas.1419228112; Bidhendi EE, 2016, J CLIN INVEST, V126, P2249, DOI 10.1172/JCI84360; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Da Cruz S, 2017, ACTA NEUROPATHOLOGIC; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Kim J, 2014, J BIOL CHEM, V289, P15094, DOI 10.1074/jbc.M113.542613; McAlary L, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00499; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pokrishevsky E, 2015, AMYOTROPH LAT SCL S1, V16; Pokrishevsky E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22155; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Pratt AJ, 2014, P NATL ACAD SCI USA, V111, pE4568, DOI 10.1073/pnas.1308531111; Proctor EA, 2016, P NATL ACAD SCI USA, V113, P614, DOI 10.1073/pnas.1516725113; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Redler RL, 2014, BIOCHEMISTRY-US, V53, P2423, DOI 10.1021/bi500158w; Sekiguchi T, 2014, J NEUROL NEUROSUR PS, V85, P85, DOI 10.1136/jnnp-2013-305617; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Wright GSA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2750	28	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184384	10.1371/journal.pone.0184384	http://dx.doi.org/10.1371/journal.pone.0184384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877271	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200095
J	Skare, O; Gjessing, HK; Gjerdevik, M; Haaland, OA; Romanowska, J; Lie, RT; Jugessur, A				Skare, Oivind; Gjessing, Hakon K.; Gjerdevik, Miriam; Haaland, Oystein A.; Romanowska, Julia; Lie, Rolv T.; Jugessur, Astanand			A new approach to chromosome-wide analysis of X-linked markers identifies new associations in Asian and European case-parent triads of orofacial clefts	PLOS ONE			English	Article							CAUSE CRANIOFRONTONASAL SYNDROME; WALKER-WARBURG-SYNDROME; FAMILY-BASED DESIGNS; CPX CRITICAL REGION; GENOME-WIDE; OCULOFACIOCARDIODENTAL SYNDROME; GENE; PALATE; MUTATIONS; LIP	Background GWAS discoveries on the X-chromosome are underrepresented in the literature primarily because the analytical tools that have been applied were originally designed for autosomal markers. Our objective here is to employ a new robust and flexible tool for chromosome-wide analysis of X-linked markers in complex traits. Orofacial clefts are good candidates for such analysis because of the consistently observed excess of females with cleft palate only (CPO) and excess of males with cleft lip with or without cleft palate (CL/P). Methods Genotypes for 14,486 X-chromosome SNPs in 1,291 Asian and 1,118 European isolated cleft triads were available from a previously published GWAS. The R-package HAPLIN enables genome-wide-level analyses as well as statistical power simulations for a range of biologic scenarios. We analyzed isolated CL/P and isolated CPO for each ethnicity in HAPLIN, using a sliding-window approach to haplotype analysis and two different statistical models, with and without X-inactivation in females. Results There was a larger number of associations in the Asian versus the European sample, and similar to previous reports that have analyzed the same GWAS dataset using different methods, we identified associations with EFNB1/PJA1 and DMD. In addition, new associations were detected with several other genes, among which KLHL4, TBX22, CPXCR1 and BCOR were noteworthy because of their roles in clefting syndromes. A few of the associations were only detected by one particular X-inactivation model, whereas a few others were only detected in one sex. Discussion/Conclusion We found new support for the involvement of X-linked variants in isolated clefts. The associations were specific for ethnicity, sex and model parameterization, highlighting the need for flexible tools that are capable of detecting and estimating such effects. Further efforts are needed to verify and elucidate the potential roles of EFNB1/PJA1, KLHL4, TBX22, CPXCR1 and BCOR in isolated clefts.	[Skare, Oivind] Natl Inst Occupat Hlth, Dept Occupat Med & Epidemiol, Oslo, Norway; [Gjessing, Hakon K.; Jugessur, Astanand] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway; [Gjessing, Hakon K.; Gjerdevik, Miriam; Haaland, Oystein A.; Romanowska, Julia; Lie, Rolv T.; Jugessur, Astanand] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Gjerdevik, Miriam; Jugessur, Astanand] Norwegian Inst Publ Hlth, Dept Genet Res & Bioinformat, Oslo, Norway; [Haaland, Oystein A.] Norwegian Inst Publ Hlth, Ctr Burden Dis, Oslo, Norway; [Romanowska, Julia] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Lie, Rolv T.] Norwegian Inst Publ Hlth, Dept Hlth Registries, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Bergen; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); University of Bergen; Norwegian Institute of Public Health (NIPH)	Jugessur, A (corresponding author), Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway.; Jugessur, A (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.; Jugessur, A (corresponding author), Norwegian Inst Publ Hlth, Dept Genet Res & Bioinformat, Oslo, Norway.	astanand.jugessur@fhi.no	Gjerdevik, Miriam/ABE-4722-2021; Skare, Øivind/C-6330-2016	Skare, Øivind/0000-0001-8043-2820; Romanowska, Julia/0000-0001-6733-1953	Bergen Medical Research Foundation (BMFS) [807191]; Research Council of Norway [262700]	Bergen Medical Research Foundation (BMFS); Research Council of Norway(Research Council of Norway)	This research was supported by the Bergen Medical Research Foundation (BMFS), grant 807191 to AJ, RTL, and HKG. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the participating families, medical staff and field workers at all the thirteen recruitment sites for helping to make this study possible. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700.	[Anonymous], 2014, R LANG ENV STAT COMP; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Beaty Terri H, 2016, F1000Res, V5, P2800; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Braybrook C, 2001, HUM GENET, V108, P537, DOI 10.1007/s004390100518; Braybrook C, 2001, GENOMICS, V72, P128, DOI 10.1006/geno.2000.6478; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Davoody A, 2012, CLEFT PALATE-CRAN J, V49, pE55, DOI 10.1597/10-256; DERRY JMJ, 1995, GENOMICS, V30, P361, DOI 10.1006/geno.1995.0031; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Fonseca RF, 2015, EUROPEAN J ORAL SCI; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Goyal Manisha, 2015, Contemp Clin Dent, V6, P110, DOI 10.4103/0976-237X.149304; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Harville EW, 2005, AM J EPIDEMIOL, V162, P448, DOI 10.1093/aje/kwi214; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jugessur A., 2012, NORSK EPIDEMIOLOGI, V21, P251, DOI DOI 10.5324/NJE.V21I2.1503; Jugessur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039240; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Mishra L, 1997, ONCOGENE, V15, P2361, DOI 10.1038/sj.onc.1201405; MOORE G, 1988, DEVELOPMENT, V103, P233; Mues G, 2009, J CRANIOFAC SURG, V20, P1652, DOI 10.1097/SCS.0b013e3181b2d3f3; Oberoi S, 2005, AM J MED GENET A, V136A, P275, DOI 10.1002/ajmg.a.30811; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Patel PJ, 2013, EUR J ORAL SCI, V121, P63, DOI 10.1111/eos.12025; Pratap A, 2007, Singapore Med J, V48, pe66; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Richards JE, 2011, THE HUMAN GENOME; Romanovska J, 2017, ANN HUMAN GENETICS; Shi M, 2012, AM J MED GENET A, V158A, P784, DOI 10.1002/ajmg.a.35257; Skare O, 2012, ANN HUM GENET, V76, P221, DOI 10.1111/j.1469-1809.2012.00707.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka K, 2014, DEV BIOL, V387, P28, DOI 10.1016/j.ydbio.2014.01.003; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Vajsar J, 2008, NEUROMUSCULAR DISORD, V18, P675, DOI 10.1016/j.nmd.2008.05.014; Wieland I, 2007, CLIN GENET, V72, P506, DOI 10.1111/j.1399-0004.2007.00905.x; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Wise AS, 2016, FRONT GENET, V7, DOI [10.3330/fgene.2016.00020, 10.3389/fgene.2016.00020]; Wise AS, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00015; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Zhang L, 2008, GENET EPIDEMIOL, V32, P370, DOI 10.1002/gepi.20311	54	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183772	10.1371/journal.pone.0183772	http://dx.doi.org/10.1371/journal.pone.0183772			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877219	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200042
J	Lu, Y; Wei, JY; Yao, DS; Pan, ZM; Yao, Y				Lu, Yan; Wei, Jin-Ying; Yao, De-Sheng; Pan, Zhong-Mian; Yao, Yao			Application of carbon nanoparticles in laparoscopic sentinel lymph node detection in patients with early-stage cervical cancer	PLOS ONE			English	Article							INDOCYANINE GREEN; RADICAL HYSTERECTOMY; ENDOMETRIAL CANCER; CARCINOMA; MALIGNANCIES; MANAGEMENT; UTERINE; SURGERY; BIOPSY	Objective To investigate the value of carbon nanoparticles in identifying sentinel lymph nodes in earlystage cervical cancer. Methods From January 2014 to January 2016, 40 patients with cervical cancer stage IA2-IIA, based on the International Federation of Gynecology and Obstetrics (FIGO) 2009 criteria, were included in this study. The normal cervix around the tumor was injected with a total of 1 mL of carbon nanoparticles (CNP) at 3 and 9 o'clock. All patients then underwent laparoscopic pelvic lymph node dissection and radical hysterectomy. The black-dyed sentinel lymph nodes were removed for routine pathological examination and immunohistochemical staining. Results Among the 40 patients, 38 patients had at least one sentinel lymph node (SLN). The detection rate was 95% (38/40). One hundred seventy-three SLNs were detected with an average of 3.9 SLNs per side. 25 positive lymph nodes, which included 21 positive SLNs, were detected in 8 (20%) patients. Sentinel lymph nodes were localized in the obturator (47.97%), internal lilac (13.87%), external lilac (26.59%), parametrial (1.16%), and common iliac (8.67%) regions. The sensitivity of the SLN detection was 100% (5/5), the accuracy was 97.37% (37/38), and the negative predictive value was 100.0% and the false negative rate was 0%. Conclusions Sentinel lymph nodes can be used to accurately predict the pathological state of pelvic lymph nodes in early cervical cancer. The detection rates and accuracy of sentinel lymph node were high. Carbon nanoparticles can be used to trace the sentinel lymph node in early cervical cancer.	[Lu, Yan; Wei, Jin-Ying; Yao, De-Sheng; Pan, Zhong-Mian; Yao, Yao] Guang Xi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China		Yao, DS (corresponding author), Guang Xi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Peoples R China.	yaodesheng@gxmu.edu.cn						Acharya BC, 2009, J NEPAL MED ASSOC, V48, P287; Benedetti-Panici P, 2000, CANCER, V88, P2267, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2267::AID-CNCR10>3.0.CO;2-9; Bogani G, 2015, INT J GYNECOL CANCER, V25, P741, DOI 10.1097/IGC.0000000000000406; Cibula D, 2012, GYNECOL ONCOL, V124, P496, DOI 10.1016/j.ygyno.2011.11.037; Devaja O, 2012, INT J GYNECOL CANCER, V22, P1044, DOI 10.1097/IGC.0b013e318253a9c9; Diaz JP, 2011, GYNECOL ONCOL, V120, P347, DOI 10.1016/j.ygyno.2010.12.334; Ditto A, 2015, J MINIM INVAS GYN, V22, P132, DOI 10.1016/j.jmig.2014.08.009; Du XL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-157; Fuchs J, 2013, UROLOGE, V52, P1447, DOI 10.1007/s00120-013-3166-9; Holman LL, 2014, J MINIM INVAS GYN, V21, P540, DOI 10.1016/j.jmig.2013.12.095; Imboden S, 2015, ANN SURG ONCOL, V22, P4198, DOI 10.1245/s10434-015-4701-2; Jewell EL, 2014, GYNECOL ONCOL, V133, P274, DOI 10.1016/j.ygyno.2014.02.028; Kraima AC, 2014, GYNECOL ONCOL, V132, P107, DOI 10.1016/j.ygyno.2013.10.030; Leong SPL, 2011, J SURG ONCOL, V104, P361, DOI 10.1002/jso.21964; Liu Kai-jiang, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P150, DOI 10.3881/j.issn.1000-503X.2013.02.005; Miyashiro I, 2014, GASTRIC CANCER, V17, P316, DOI 10.1007/s10120-013-0285-3; Ouldamer L, 2012, SURG ONCOL, V21, pE153, DOI 10.1016/j.suronc.2012.04.003; Robova H, 2013, EXPERT REV ANTICANC, V13, P55, DOI [10.1586/era.12.157, 10.1586/ERA.12.157]; Sadalla JC, 2015, REV ASSOC MED BRAS, V61, P536, DOI 10.1590/1806-9282.61.06.536; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van de Lande J, 2007, GYNECOL ONCOL, V106, P604, DOI 10.1016/j.ygyno.2007.05.010; Wydra D, 2006, INT J GYNECOL CANCER, V16, P649, DOI 10.1111/j.1525-1438.2006.00402.x; Zarganis P, 2009, IN VIVO, V23, P469	23	19	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183834	10.1371/journal.pone.0183834	http://dx.doi.org/10.1371/journal.pone.0183834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873443	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800031
J	Chen, N; Bai, Y; Fan, YL; Liu, TX				Chen, Nan; Bai, Yu; Fan, Yong-Liang; Liu, Tong-Xian			Solid-phase microextraction-based cuticular hydrocarbon profiling for intraspecific delimitation in Acyrthosiphon pisum	PLOS ONE			English	Article							PEA APHID; HEMIPTERA APHIDIDAE; SEX-PHEROMONE; LIPIDS; RESISTANCE; HARRIS; GENE	Insect cuticular hydrocarbons (CHCs) play critical roles in reducing water loss and chemical communication. Species-specific CHC profiles have been used increasingly as an excellent character for species classification. However, considerably less is known about their potential for population delimitation within species. The aims of this study were to develop a solid-phase microextraction (SPME)-based CHC collection method and to investigate whether CHC profiles could serve as potential chemotaxonomic tools for intraspecific delimitation in Acyrthosiphon pisum. Optimization of fibers for SPME sampling revealed that 7 mu m polydimethylsiloxane (PDMS) demonstrated the most efficient adsorption of CHCs among five different tested fibers. SPME sampling showed good reproducibility with repeated collections of CHCs from a single aphid. Validation of SPME was performed by comparing CHC profiles with those from conventional hexane extractions. The two methods showed no qualitative differences in CHCs, although SPME appeared to extract relatively fewer short-chained CHCs. While CHC profiles of a given population differed among developmental stages, wing dimorphism types, and host plants, wingless adult aphids showed very low variance in relative proportions of individual CHC components. Reproducibility of CHC profiles was explored further to classify wingless adult morphs of A. pisum from five different geographic regions that showed no variation in mitochondrial COI gene sequences. Our results demonstrate that CHC profiles are useful in intraspecific delimitation in the field of insect chemotaxonomy.	[Fan, Yong-Liang; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; Northwest A&F Univ, Key Lab Integrated Pest Management Loess Plateau, Minist Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Fan, YL; Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	yfan@nwsuaf.edu.cn; txliu@nwsuaf.edu.cn	Fan, Yongliang/AAP-6127-2020	Fan, Yongliang/0000-0002-7993-2497; Chen, Nan/0000-0002-6509-8331; Liu, Tong-Xian/0000-0002-7686-0686	State Key Laboratory of Integrated Management of Pest Insects and Rodents [Chinese IPM1501, Chinese IPM1717]; Chinese Academy of Sciences	State Key Laboratory of Integrated Management of Pest Insects and Rodents; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the State Key Laboratory of Integrated Management of Pest Insects and Rodents (Grant No.Chinese IPM1501 and Chinese IPM1717), the Chinese Academy of Sciences.There was no additional external funding received for this study.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Akino T, 2002, ZOOL SCI, V19, P1155, DOI 10.2108/zsj.19.1155; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; Bland JM, 2001, J CHROMATOGR A, V932, P119, DOI 10.1016/S0021-9673(01)01239-0; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; CHAPMAN RF, 1995, BIOCHEM SYST ECOL, V23, P383, DOI 10.1016/0305-1978(95)00032-P; Chen N, 2016, INSECT BIOCHEM MOLEC, V76, P84, DOI 10.1016/j.ibmb.2016.07.006; De Pasquale C, 2007, ANAL BIOANAL CHEM, V389, P1259, DOI 10.1007/s00216-007-1503-9; Dronnet S, 2006, J CHEM ECOL, V32, P1027, DOI 10.1007/s10886-006-9043-x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; FEBVAY G, 1992, ARCH INSECT BIOCHEM, V21, P103, DOI 10.1002/arch.940210204; Ferreira-Caliman MJ, 2012, J CHEM ECOL, V38, P418, DOI 10.1007/s10886-012-0109-7; Foley BR, 2011, HEREDITY, V106, P68, DOI 10.1038/hdy.2010.40; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Ginzel MD, 2003, CHEMOECOLOGY, V13, P135, DOI 10.1007/s00049-003-0239-z; Ginzel MD, 2016, EXTRACELLULAR COMPOS, P221, DOI DOI 10.1007/978-3-319-40740-17; HAVERTY MI, 1990, J CHEM ECOL, V16, P2441, DOI 10.1007/BF01017467; Haverty MI, 1997, COMP BIOCHEM PHYS B, V118, P869, DOI 10.1016/S0305-0491(97)00237-X; Haverty MI, 2000, J CHEM ECOL, V26, P1167, DOI 10.1023/A:1005479826651; Hayashi M, 2015, J CHEM ECOL, V41, P1148, DOI 10.1007/s10886-015-0651-1; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ingleby FC, 2015, INSECTS, V6, P732, DOI 10.3390/insects6030732; Kather R, 2012, PHYSIOL ENTOMOL, V37, P25, DOI 10.1111/j.1365-3032.2011.00826.x; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; LOCKEY KH, 1991, INSECT BIOCHEM, V21, P91, DOI 10.1016/0020-1790(91)90068-P; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; MISHLER BD, 1994, AM J PHYS ANTHROPOL, V94, P143, DOI 10.1002/ajpa.1330940111; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Reitz M, 2015, ANAL CHIM ACTA, V854, P47, DOI 10.1016/j.aca.2014.10.056; Romeo John T, 2009, J Chem Ecol, V35, P1383, DOI 10.1007/s10886-009-9733-2; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Schlick-Steiner BC, 2006, MOL PHYLOGENET EVOL, V40, P259, DOI 10.1016/j.ympev.2006.03.005; Simmons RB, 2001, MOL PHYLOGENET EVOL, V20, P196, DOI 10.1006/mpev.2001.0958; STRANSKY K, 1973, COLLECT CZECH CHEM C, V38, P770, DOI 10.1135/cccc19730770; TEAL PEA, 1988, J CHEM ECOL, V14, P2131, DOI 10.1007/BF01014254; Turillazzi S, 1998, ETHOL ECOL EVOL, V10, P293, DOI 10.1080/08927014.1998.9522859; Wang YW, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2994; Williams IS, 2007, APHIDS AS CROP PESTS, P69, DOI 10.1079/9780851998190.0069; Xue HJ, 2016, BEHAV ECOL, V27, P895, DOI 10.1093/beheco/arv238; Young HP, 2000, J CHEM ECOL, V26, P1245, DOI 10.1023/A:1005440212538; Zhang Su-Fang, 2002, Acta Entomologica Sinica, V45, P764	48	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184243	10.1371/journal.pone.0184243	http://dx.doi.org/10.1371/journal.pone.0184243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859151	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500077
J	Lee, JY; Park, JE; Kim, HS; Kim, SO; Oh, JY; Shim, WH; Jung, SC; Choi, CG; Kim, SJ				Lee, Ji Ye; Park, Ji Eun; Kim, Ho Sung; Kim, Seon-Ok; Oh, Joo Young; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon			Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients	PLOS ONE			English	Article							HIGH-SIGNAL INTENSITY; UNENHANCED T1-WEIGHTED IMAGES; DENTATE NUCLEUS; GLOBUS-PALLIDUS; BRAIN; GADOBUTROL; DIMEGLUMINE; DIAGNOSIS; INCREASE	Purpose To determine whether multiple repeated administrations of gadolinium-based macrocyclic ionic MR contrast agent (MICA) are associated with intracranial gadolinium deposition and identify the predisposing factors for deposition in various clinical situations. Materials and methods In this institutional review board-approved retrospective study, 385 consecutive patients who underwent MICA-enhanced MR imaging were enrolled. The dentate nucleus-to-pons (DN/P) and globus pallidus-to-thalamus (GP/Th) signal intensity (SI) ratios on unenhanced T1-weighted images were recorded by 2 independent readers and averaged. The mean DN/P and GP/Th SI ratio difference between the last and the first examinations were tested using the one-sample t-test. Students t-test and stepwise regression analysis were used to identify the predisposing factors for deposition based on the number of administrations, time interval, hepatic and renal function, magnetic field strength, and chemo- or radiation therapy. Results The mean DN/P SI ratio difference was not different from zero (P = .697), even in patients with >= 20 administrations (n = 33). Only patients with abnormal renal function showed an increase in the mean DN/P SI ratio difference (P = .019). The mean DN/P SI ratio difference was not associated with any predisposing factors. However, the mean GP/Th SI ratio difference showed decrease (P < .001), which was associated with age (P = .007), number of administrations (P = .01) and number of radiation therapy sessions (P = .022) on multivariate analysis. Conclusion Multiple repeated administrations of MICA were not associated with increased T1 signal intensity in deep brain nuclei suggestive of Gd deposition in patients with normal renal function.	[Lee, Ji Ye] Soonchunhyang Univ, Bucheon Hosp, Dept Radiol, Bucheon, South Korea; [Park, Ji Eun; Kim, Ho Sung; Oh, Joo Young; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Ji Eun; Kim, Ho Sung; Oh, Joo Young; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Seon-Ok] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Seoul, South Korea	Soonchunhyang University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	radhskim@gmail.com	Lee, Ji Ye/ABA-7830-2021	Kim, Seonok/0000-0001-9010-5460; Kim, Ho Sung/0000-0002-9477-7421; Park, Ji Eun/0000-0002-4419-4682	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2017R1A2A2A05001217]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1090]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: NRF-2017R1A2A2A05001217) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: NRF-2017R1A2A2A05001217) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1090).	Adin ME, 2015, AM J NEURORADIOL, V36, P1859, DOI 10.3174/ajnr.A4378; Agris J, 2016, EUR RADIOL, V26, P816, DOI 10.1007/s00330-015-4019-2; Aime S, 2009, J MAGN RESON IMAGING, V30, P1259, DOI 10.1002/jmri.21969; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Birka M, 2015, ANAL CHEM, V87, P3321, DOI 10.1021/ac504488k; Cao Y, 2016, AM J ROENTGENOL, V206, P414, DOI 10.2214/AJR.15.15327; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; Jost G, 2016, INVEST RADIOL, V51, P83, DOI 10.1097/RLI.0000000000000242; Kanda T, 2015, RADIOLOGY, V275, P803, DOI 10.1148/radiol.14140364; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Malayeri AA, 2016, J AM COLL RADIOL, V13, P237, DOI 10.1016/j.jacr.2015.11.009; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Morcos SK, 2008, EUR J RADIOL, V66, P175, DOI 10.1016/j.ejrad.2008.01.025; Murata N, 2016, INVEST RADIOL, V51, P447, DOI 10.1097/RLI.0000000000000252; Radbruch A, 2015, INVEST RADIOL, V50, P805, DOI 10.1097/RLI.0000000000000227; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Ramalho J, 2016, AM J NEURORADIOL, V37, P1427, DOI 10.3174/ajnr.A4757; Ramalho J, 2016, AM J NEURORADIOL, V37, P1192, DOI 10.3174/ajnr.A4615; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Robert P, 2015, INVEST RADIOL, V50, P473, DOI 10.1097/RLI.0000000000000181; Runge VM, 2016, INVEST RADIOL, V51, P273, DOI 10.1097/RLI.0000000000000273; Stojanov DA, 2016, EUR RADIOL, V26, P818, DOI 10.1007/s00330-015-4020-9; Stojanov DA, 2016, EUR RADIOL, V26, P807, DOI 10.1007/s00330-015-3879-9; Weberling LD, 2015, INVEST RADIOL, V50, P743, DOI 10.1097/RLI.0000000000000206; Welk B, 2016, JAMA-J AM MED ASSOC, V316, P96, DOI 10.1001/jama.2016.8096; Zhang Y, 2016, RADIOLOGY	26	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183916	10.1371/journal.pone.0183916	http://dx.doi.org/10.1371/journal.pone.0183916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859167	gold, Green Submitted, Green Published			2022-12-26	WOS:000408740500047
J	Shepherd, LD				Shepherd, Lara D.			A non-destructive DNA sampling technique for herbarium specimens	PLOS ONE			English	Article							EXTRACTION; EXTINCT; GENUS; AGE	Herbarium specimens are an important source of DNA for plant research but current sampling methods require the removal of material for DNA extraction. This is undesirable for irreplaceable specimens such as rare species or type material. Here I present the first non-destructive sampling method for extracting DNA from herbarium specimens. DNA was successfully retrieved from robust leaves and/or stems of herbarium specimens up to 73 years old.	[Shepherd, Lara D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand		Shepherd, LD (corresponding author), Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand.	Lara.Shepherd@tepapa.govt.nz		Shepherd, Lara/0000-0002-7136-0017	Royal Society of New Zealand [RDF-MNZ1201]	Royal Society of New Zealand(Royal Society of New Zealand)	This study was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (contract number RDF-MNZ1201). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Choi J, 2015, PEERJ, V3, DOI 10.7717/peerj.1087; Chomicki G, 2015, NEW PHYTOL, V205, P526, DOI 10.1111/nph.13163; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Fiddyment S, 2015, P NATL ACAD SCI USA, V112, P15066, DOI 10.1073/pnas.1512264112; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hart ML, 2016, TAXON, V65, P1081, DOI 10.12705/655.9; Jones MR, 2016, MOL ECOL, V25, P185, DOI 10.1111/mec.13304; Lehtonen S, 2010, BIOLOGIA, V65, P204, DOI 10.2478/s11756-010-0008-8; Perrie LR, 2009, MOL PHYLOGENET EVOL, V52, P774, DOI 10.1016/j.ympev.2009.05.030; Perrie LR, 2005, AM FERN J, V95, P1, DOI 10.1640/0002-8444(2005)095[0001:IITBAP]2.0.CO;2; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Shepherd L, 2014, TAXON, V63, P972; Shepherd L, 2012, NATURE, V484, P455, DOI 10.1038/484455b; Shepherd LD, 2011, MOL ECOL, V20, P1389, DOI 10.1111/j.1365-294X.2011.05017.x; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Staats M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069189; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Tennyson Alan J. D., 2015, Bulletin of the British Ornithologists' Club, V135, P267; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Weiss CL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160239; Welch AJ, 2016, MOL PHYLOGENET EVOL, V99, P16, DOI 10.1016/j.ympev.2016.02.024	24	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183555	10.1371/journal.pone.0183555	http://dx.doi.org/10.1371/journal.pone.0183555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859137	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500022
J	Sarwar, S; Ali, A; Pal, M; Chakrabarti, P				Sarwar, Shamila; Ali, Asif; Pal, Mahadeb; Chakrabarti, Pinak			Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholera toxin; ganglioside; infectious disease; microbiology; Vibrio cholerae; ELISA; HT-29 cells; ZnO nanoparticles	VIBRIO-CHOLERAE; ANTIBACTERIAL AGENTS; GOLD NANOPARTICLES; MOLECULE; DIARRHEA; COLONIZATION; ANTIBIOTICS; RESISTANCE; INHIBITOR; VIRULENCE	Vibrio cholerae causes cholera and is the leading cause of diarrhea in developing countries, highlighting the need for the development of new treatment strategies to combat this disease agent. While exploring the possibility of using zinc oxide (ZnO) nanoparticles (NPs) in cholera treatment, we previously found that ZnO NPs reduce fluid accumulation in mouse ileum induced by the cholera toxin (CT) protein. To uncover the mechanism of action of ZnO NPs on CT activity, here we used classical (O395) and El Tor (C6706) V. cholerae biotypes in growth and biochemical assays. We found that a ZnO NP concentration of 10 g/ml did not affect the growth rates of these two strains, nor did we observe that ZnO NPs reduce the expression levels of CT mRNA and protein. It was observed that ZnO NPs form a complex with CT, appear to disrupt the CT secondary structure, and block its interaction with the GM1 ganglioside receptor in the outer leaflet of the plasma membrane in intestinal (HT-29) cells and thereby reduce CT uptake into the cells. In the range of 2.5-10 g/ml, ZnO NPs exhibited no cytotoxicity on kidney (HEK293) and HT-29 cells. We conclude that ZnO NPs prevent the first step in the translocation of cholera toxin into intestinal epithelial cells without exerting measurable toxic effects on HEK293 and HT-29 cells.	[Sarwar, Shamila; Chakrabarti, Pinak] P1 12 CIT Scheme VIIM, Bose Inst, Dept Biochem, Kolkata, India; [Ali, Asif; Pal, Mahadeb] P1 12 CIT Scheme VIIM, Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Sarwar, S; Chakrabarti, P (corresponding author), P1 12 CIT Scheme VIIM, Bose Inst, Dept Biochem, Kolkata, India.	shamilabmb@gmail.com; pinak@jcbose.ac.in			Department of Science and Technology, India; Council of Scientific and Industrial Research, India; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Science and Technology, India, and the Council of Scientific and Industrial Research, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of fellowships from the Council of Scientific and Industrial Research (CSIR), India.	Akanda AS, 2013, AM J TROP MED HYG, V89, P950, DOI 10.4269/ajtmh.12-0492; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Allahverdiyev AM, 2011, EXPERT REV ANTI-INFE, V9, P1035, DOI [10.1586/eri.11.121, 10.1586/ERI.11.121]; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P433; Azman AS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004230; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Benitez JA, 2016, TOXICON, V115, P55, DOI 10.1016/j.toxicon.2016.03.003; CHARANIA Z, 1991, J MICROBIOL METH, V14, P171, DOI 10.1016/0167-7012(91)90020-Q; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Chatterjee T, 2017, BBA-GEN SUBJECTS, V1861, P977, DOI 10.1016/j.bbagen.2017.02.007; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Duggan C, 2004, JAMA-J AM MED ASSOC, V291, P2628, DOI 10.1001/jama.291.21.2628; Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; Kolodziejczak-Radzimska A, 2014, MATERIALS, V7, P2833, DOI 10.3390/ma7042833; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Lam SJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.162, 10.1038/NMICROBIOL.2016.162]; Lockridge O, 2008, J BIOL CHEM, V283, P22582, DOI 10.1074/jbc.M802555200; Mahamud AS, 2012, J INFECT DEV COUNTR, V6, P234, DOI 10.3855/jidc.1966; Mandal J, 2012, J HEALTH POPUL NUTR, V30, P12; Mocz Gabor, 2013, Methods Mol Biol, V1008, P169, DOI 10.1007/978-1-62703-398-5_7; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Negi R, 2015, ACTA PAEDIATR, V104, pe367, DOI 10.1111/apa.12645; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; OHTOMO N, 1976, J INFECT DIS, V133, pS31, DOI 10.1093/infdis/133.Supplement_1.S31; Pang B, 2007, J BACTERIOL, V189, P4837, DOI 10.1128/JB.01959-06; Pariwat P, 2008, J PHARMACOL EXP THER, V324, P798, DOI 10.1124/jpet.107.129288; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Rudramurthy GR, 2016, MOLECULES, V21, DOI 10.3390/molecules21070836; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sarwar S, 2016, NANOMED-NANOTECHNOL, V12, P1499, DOI 10.1016/j.nano.2016.02.006; Seil JT, 2012, INT J NANOMED, V7, P2767, DOI 10.2147/IJN.S24805; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; SHEARS P, 1991, EPIDEMIOL INFECT, V107, P241, DOI 10.1017/S0950268800048895; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Smallman-Raynor MR, 2004, INFECT DIS CLIN N AM, V18, P341, DOI 10.1016/j.idc.2004.01.009; Spagnuolo AM, 2011, J THEOR BIOL, V289, P247, DOI 10.1016/j.jtbi.2011.08.028; Wadhwa N, 2011, J PEDIATR GASTR NUTR, V53, P161, DOI 10.1097/MPG.0b013e318213ca55; Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843	44	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18303	18311		10.1074/jbc.M117.793240	http://dx.doi.org/10.1074/jbc.M117.793240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28882894	hybrid, Green Published			2022-12-26	WOS:000414458200027
J	Hart, G; Gaoue, OG; de la Torre, L; Navarrete, H; Muriel, P; Macia, MJ; Balslev, H; Leon-Yanez, S; Jorgensen, P; Duffy, DC				Hart, G.; Gaoue, Orou G.; de la Torre, Lucia; Navarrete, Hugo; Muriel, Priscilla; Macia, Manuel J.; Balslev, Henrik; Leon-Yanez, Susana; Jorgensen, Peter; Duffy, David Cameron			Availability, diversification and versatility explain human selection of introduced plants in Ecuadorian traditional medicine	PLOS ONE			English	Article							ETHNOBOTANICAL SURVEY; PATTERNS; WEEDS	Globally, a majority of people use plants as a primary source of healthcare and introduced plants are increasingly discussed as medicine. Protecting this resource for human health depends upon understanding which plants are used and how use patterns will change over time. The increasing use of introduced plants in local pharmacopoeia has been explained by their greater abundance or accessibility (availability hypothesis), their ability to cure medical conditions that are not treated by native plants (diversification hypothesis), or as a result of the introduced plants' having many different simultaneous roles (versatility hypothesis). In order to describe the role of introduced plants in Ecuador, and to test these three hypotheses, we asked if introduced plants are over-represented in the Ecuadorian pharmacopoeia, and if their use as medicine is best explained by the introduced plants' greater availability, different therapeutic applications, or greater number of use categories. Drawing on 44,585 plant-use entries, and the checklist of >17,000 species found in Ecuador, we used multi-model inference to test if more introduced plants are used as medicines in Ecuador than expected by chance, and examine the support for each of the three hypotheses above. We find nuanced support for all hypotheses. More introduced plants are utilized than would be expected by chance, which can be explained by geographic distribution, their strong association with cultivation, diversification (except with regard to introduced diseases), and therapeutic versatility, but not versatility of use categories. Introduced plants make a disproportionately high contribution to plant medicine in Ecuador. The strong association of cultivation with introduced medicinal plant use highlights the importance of the maintenance of human-mediated environments such as homegardens and agroforests for the provisioning of healthcare services.	[Hart, G.; Gaoue, Orou G.; Duffy, David Cameron] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Gaoue, Orou G.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa; [de la Torre, Lucia] Pontificia Univ Catolica Ecuador, Herbario QCA, Quito, Ecuador; [Navarrete, Hugo; Muriel, Priscilla; Leon-Yanez, Susana] Pontificia Univ Catolica Ecuador, Escuela Biol, Quito, Ecuador; [Macia, Manuel J.] Univ Autonoma Madrid, Dept Biol, Area Bot, Madrid, Spain; [Balslev, Henrik] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Jorgensen, Peter] Missouri Bot Garden, St Louis, MO USA; [Duffy, David Cameron] Univ Hawaii Manoa, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA; [Gaoue, Orou G.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University of Hawaii System; University of Hawaii Manoa; University of Johannesburg; Pontificia Universidad Catolica del Ecuador; Pontificia Universidad Catolica del Ecuador; Autonomous University of Madrid; Aarhus University; Missouri Botanical Gardens; University of Hawaii System; University of Hawaii Manoa; University of Tennessee System; University of Tennessee Knoxville	Hart, G (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	gmhart@hawaii.edu	Muriel, Priscilla/V-2760-2019; Gaoue, Orou G./B-4932-2011; Navarrete, Hugo/CAJ-3461-2022; Balslev, Hendrik/AAE-4071-2020; Macia, Manuel J/H-4631-2012	Muriel, Priscilla/0000-0002-7874-8057; Gaoue, Orou G./0000-0002-0946-2741; Macia, Manuel J/0000-0002-4676-612X; Navarrete, Hugo/0000-0002-5262-9754				Alchon S.A., 1991, NATIVE SOC DIS COLON; Alencar NL, 2014, REV BRAS FARMACOGN, V24, P506, DOI 10.1016/j.bjp.2014.09.003; Alencar NL, 2010, ECON BOT, V64, P68, DOI 10.1007/s12231-009-9104-5; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Bennett BC, 2008, J ETHNOPHARMACOL, V116, P422, DOI 10.1016/j.jep.2007.12.006; Bjora CS, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0060-0; Bletter N, 2010, PLANTS ADOPTION WHY, P1; Bussmann R, 2015, MED PLANTS THEIR ECO; Bussmann RW, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-47; Cadena-Gonzalez AL, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-23; Cook F. E. M., 1995, Economic botany data collection standard.; Cook Noble David, 1998, BORN DIE DIS NEW WOR; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; da Silva TC, 2014, ETHNOBIOL CONSERV, V3, DOI 10.15451/ec2014-6-3.4-1-12; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; de Almeida CFCBR, 2005, J ARID ENVIRON, V62, P127, DOI 10.1016/j.jaridenv.2004.09.020; de la Torre L, 2012, ECOL SOC, V17, DOI 10.5751/ES-04582-170115; de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026; dos Santos LL, 2014, ECON BOT, V68, P283, DOI 10.1007/s12231-014-9281-8; Elton C. S., 1958, ECOLOGY INVASIONS AN; Eyssartier C, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-25; FEENY D, 1990, HUM ECOL, V18, P1, DOI 10.1007/BF00889070; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Fenn Elizabeth, 2001, POX AM GREAT SMALLPO; Gavin MC, 2009, J APPL ECOL, V46, P1275, DOI 10.1111/j.1365-2664.2009.01713.x; Giovannini P, 2015, J ETHNOPHARMACOL, V164, P78, DOI 10.1016/j.jep.2015.01.038; Gruca M, 2014, J ETHNOPHARMACOL, V155, P1388, DOI 10.1016/j.jep.2014.06.047; Hofmann A., 1979, PLANTS GODS THEIR SA; Jorgensen P., 2018, CATALOGUE VASCULAR P; Jorgensen PM, 2004, CLIM CHANG BIODIVERS, P192; Kirkham WS, 2005, UNDERSTANDING MERREM; Kunwar RM, 2015, J ETHNOPHARMACOL, V163, P210, DOI 10.1016/j.jep.2015.01.035; Kunwar RM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/792789; Lewu FB, 2009, AFR J BIOTECHNOL, V8, P929; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Macia MJ, 2005, J ETHNOPHARMACOL, V97, P337, DOI 10.1016/j.jep.2004.11.022; McClatchey WC, 2009, PHARMACOL THERAPEUT, V123, P239, DOI 10.1016/j.pharmthera.2009.04.002; MOERMAN DE, 1979, J ETHNOPHARMACOL, V1, P111, DOI 10.1016/0378-8741(79)90002-3; Moerman DE, 1996, J ETHNOPHARMACOL, V52, P1, DOI 10.1016/0378-8741(96)01393-1; Muniz de Medeiros P., 2015, EVOLUTIONARY ETHNOBI, P163; Neill D, 2012, REV AMAZONICA CIENCI, V1, P70; Palmer CT, 2004, ECON BOT, V58, pS280, DOI 10.1663/0013-0001(2004)58[S280:TIORIP]2.0.CO;2; Pfeiffer JM, 2008, ENVIRON CONSERV, V35, P281, DOI 10.1017/S0376892908005146; PRANCE G T, 1987, Conservation Biology, V1, P296, DOI 10.1111/j.1523-1739.1987.tb00050.x; Prance G. T., 1998, Plants for food and medicine. Proceedings of the joint conference of the Society for Economic Botany and the International Society for Ethnopharmacology, London, UK, 1-6 July 1996., P185; R Core Team, 2013, R LANG ENV STAT COMP; Robinson M.M., 2011, WORLD MED SITUATION, P27; Soldati GT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/648469; Stepp JR, 2004, J ETHNOPHARMACOL, V92, P163, DOI 10.1016/j.jep.2004.03.002; Stepp JR, 2001, J ETHNOPHARMACOL, V75, P19, DOI 10.1016/S0378-8741(00)00385-8; Turner N., 2014, ANCIENT PATHWAYS ANC, V74; V de la Torre L., 2008, ENCICLOPEDIA PLANTAS; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Voeks RA, 2004, ANN ASSOC AM GEOGR, V94, P868; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yessoufou K, 2015, MOL ECOL RESOUR, V15, P405, DOI 10.1111/1755-0998.12310; Zimdahl R. L., 1999, FUNDAMENTALS WEED SC	57	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184369	10.1371/journal.pone.0184369	http://dx.doi.org/10.1371/journal.pone.0184369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886104	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100103
J	Kong, M; Kim, SM; Ham, DI				Kong, Mingui; Kim, Sung Min; Ham, Don-Il			Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy	PLOS ONE			English	Article							INDOCYANINE GREEN VIDEOANGIOGRAPHY; CENTRAL SEROUS CHORIORETINOPATHY; PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB THERAPY	Eyes with polypoidal choroidal vasculopathy (PCV) were recently reported to have various choroidal thickness, and choroidal thickness might be associated with visual outcome in the treatment of many retinal disorders. The range of subfoveal choroidal thickness (SFCT), clinical features, and 3-month treatment response among three groups having different range of SFCT were investigated in PCV eyes. In 78 treatment-naive eyes with PCV, SFCT was measured using optical coherence tomography. Eyes were classified into thin, medium, and thick groups, using mean and one standard deviation of SFCT. Clinical features and imaging findings were compared among the three groups. Some eyes were treated with three consecutive monthly injection of anti-vascular endothelial growth factor (VEGF) as an initial treatment. They were also classified into three thickness groups, and the short-term post-treatment improvement in visual acuity and central retinal thickness were compared among groups. The mean SFCT was 271.9 +/- 135.6 mu m. Twelve, 53, and 13 eyes were classified into thin (<136.3 mu m), medium (136.3-407.5 mu m), and thick (>407.5 mu m) groups, respectively. The thin group showed older age, lower visual acuity, and a higher prevalence of fundus tessellation than the other two groups (P<0.05). In multiple linear regression analyses, baseline BCVA was correlated with baseline SFCT. Forty-six eyes completed three consecutive anti-VEGF treatments. The thin group showed no visual improvement after treatment (P = 0.141), unlike the other two groups showing visual improvement (P<0.05). Eyes with PCV have a broad range of SFCT, and PCV eyes with a thin choroid manifest worse visual function than eyes with a medium or thick choroid.	[Kong, Mingui] Hangil Eye Hosp, Incheon, South Korea; [Kong, Mingui] Catholic Kwandong Univ, Coll Med, Dept Ophthalmol, Incheon, South Korea; [Kim, Sung Min; Ham, Don-Il] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Catholic Kwandong University; Sungkyunkwan University (SKKU); Samsung Medical Center	Ham, DI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	oculus@naver.com						Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Balaratnasingam C, 2015, RETINA; Byon IS, 2014, OSLI RETINA, V45, P534, DOI 10.3928/23258160-20141118-08; Cho HJ, 2012, EYE, V26, P426, DOI 10.1038/eye.2011.324; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Hikichi T, 2014, BRIT J OPHTHALMOL, V98, P1201, DOI 10.1136/bjophthalmol-2013-304555; Honda S, 2014, OPHTHALMOLOGICA, V232, P92, DOI 10.1159/000360308; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Kim JH, 2013, EYE, V27, P809, DOI 10.1038/eye.2013.78; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Maruko I, 2013, AM J OPHTHALMOL, V156, P548, DOI 10.1016/j.ajo.2013.03.041; Nishide T, 2013, GRAEF ARCH CLIN EXP, V251, P2415, DOI 10.1007/s00417-013-2419-z; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; Rayess N, 2015, AM J OPHTHALMOL, V159, P85, DOI 10.1016/j.ajo.2014.09.033; Sakurada Y, 2016, RETINA; Shin J.Y., 2015, ACTA OPHTHALMOL; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Tateiwa H, 2002, GRAEF ARCH CLIN EXP, V240, P354, DOI 10.1007/s00417-002-0459-x; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Yan YN, 2015, OPHTHALMOLOGY; Yang LH, 2013, RETINA-J RET VIT DIS, V33, P1584, DOI 10.1097/IAE.0b013e318285cbb3; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	31	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184058	10.1371/journal.pone.0184058	http://dx.doi.org/10.1371/journal.pone.0184058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886052	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100060
J	Zheng, ZQ; Sze, CW; Keng, CT; Al-Haddawi, M; Liu, M; Tan, SY; Kwek, HL; Her, ZS; Chan, XY; Barnwal, B; Loh, E; Chang, KTE; Tan, TC; Tan, YJ; Chen, QF				Zheng, Zhiqiang; Sze, Ching Wooen; Keng, Choong Tat; Al-Haddawi, Muthafar; Liu, Min; Tan, Sue Yee; Kwek, Hwee Ling; Her, Zhisheng; Chan, Xue Ying; Barnwal, Bhaskar; Loh, Eva; Chang, Kenneth Tou En; Tan, Thiam Chye; Tan, Yee-Joo; Chen, Qingfeng			Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HCV-RELATED CIRRHOSIS; CD8(+) T-CELLS; HEPATOCELLULAR-CARCINOMA; INTERFERON-ALPHA; VIRAL-HEPATITIS; SERUM; RECURRENCE; INFECTION; EXPANSION	Hepatitis C is a liver disease caused by infection of the Hepatitis C virus (HCV). Many individuals infected by the virus are unable to resolve the viral infection and develop chronic hepatitis, which can lead to formation of liver cirrhosis and cancer. To understand better how initial HCV infections progress to chronic liver diseases, we characterised the long term pathogenic effects of HCV infections with the use of a humanised mouse model (HIL mice) we have previously established. Although HCV RNA could be detected in infected mice up to 9 weeks post infection, HCV infected mice developed increased incidences of liver fibrosis, granulomatous inflammation and tumour formation in the form of hepatocellular adenomas or hepatocellular carcinomas by 28 weeks post infection compared to uninfected mice. We also demonstrated that chronic liver inflammation in HCV infected mice was mediated by the human immune system, particularly by monocytes/macrophages and T cells which exhibited exhaustion phenotypes. In conclusion, HIL mice can recapitulate some of the clinical symptoms such as chronic inflammation, immune cell exhaustion and tumorigenesis seen in HCV patients. Our findings also suggest that persistence of HCV-associated liver disease appear to require initial infections of HCV and immune responses but not long term HCV viraemia.	[Zheng, Zhiqiang; Keng, Choong Tat; Al-Haddawi, Muthafar; Liu, Min; Tan, Sue Yee; Kwek, Hwee Ling; Her, Zhisheng; Chan, Xue Ying; Barnwal, Bhaskar; Tan, Yee-Joo; Chen, Qingfeng] Inst Mol & Cell Biol, Singapore, Singapore; [Sze, Ching Wooen; Tan, Yee-Joo; Chen, Qingfeng] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Loh, Eva; Chang, Kenneth Tou En] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore; [Chang, Kenneth Tou En; Tan, Thiam Chye] Duke NUS Grad Med Sch, Singapore, Singapore; [Tan, Thiam Chye] KK Womens & Childrens Hosp, Dept Obstet & Gynaecol, Singapore, Singapore; [Chen, Qingfeng] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; KK Women's & Children's Hospital; Guangzhou Medical University	Tan, YJ; Chen, QF (corresponding author), Inst Mol & Cell Biol, Singapore, Singapore.; Tan, YJ; Chen, QF (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.; Chen, QF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	yee_joo_tan@nuhs.edu.sg; qchen@imcb.a-star.edu.sg	Sze, Ching Wooen/AAV-4777-2020	Zheng, Zhiqiang/0000-0003-1028-3246; KENG, CHOONG TAT/0000-0003-2898-5924; Tan, Yee-Joo/0000-0002-2278-4497; Sze, Ching Wooen/0000-0003-0913-7567	Joint Council Office Development Programme [1334k00082]; Agency for Science, Technology and Research (A*STAR), Singapore; National Research Foundation Fellowship Singapore [NRF-NRFF2017-03]; Advanced Molecular Pathology Laboratory (Institute of Molecular and Cell Biology, Singapore); IMCB FACS core (Institute of Molecular and Cell Biology, Singapore)	Joint Council Office Development Programme; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Research Foundation Fellowship Singapore(National Research Foundation, Singapore); Advanced Molecular Pathology Laboratory (Institute of Molecular and Cell Biology, Singapore); IMCB FACS core (Institute of Molecular and Cell Biology, Singapore)	"This study was supported by Joint Council Office Development Programme 1334k00082, the Agency for Science, Technology and Research (A*STAR), Singapore. Qingfeng Chen is also supported by National Research Foundation Fellowship Singapore NRF-NRFF2017-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. C. M. Rice (Rockefeller University, USA) for providing the Huh7.5 cell line, Dr. H. Hotta (Kobe University, Japan) for the J6/JFH1-P47 HCV virus, the Advanced Molecular Pathology Laboratory (Institute of Molecular and Cell Biology, Singapore) for the histology support, Dr. V. C. K. Yu (National University of Singapore, Singapore) for CpGODN induced mouse liver tumour samples and the IMCB FACS core (Institute of Molecular and Cell Biology, Singapore) for flow cytometry support.	Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Afdhal NH, 2004, NATURAL HIST HEPATIT; Ara A Kardashian, 2015, Gastroenterol Hepatol (N Y), V11, P458; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Benvegnu LB, 1997, HEPATOLOGY, V25, P211, DOI 10.1002/hep.510250138; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Chen QF, 2013, STEM CELLS, V31, P1160, DOI 10.1002/stem.1359; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chuang EM, 2004, TRENDS BIOTECHNOL, V22, P517, DOI 10.1016/j.tibtech.2004.08.011; Coash M, 2012, J FORMOS MED ASSOC, V111, P3, DOI 10.1016/j.jfma.2011.11.023; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dustin LB, 2014, J LEUKOCYTE BIOL, V96, P535, DOI 10.1189/jlb.4RI0214-126R; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60; HAGIWARA H, 1993, GASTROENTEROLOGY, V104, P877, DOI 10.1016/0016-5085(93)91025-D; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Joseph NM, 2014, MODERN PATHOL, V27, P62, DOI 10.1038/modpathol.2013.114; Keng CT, 2015, GUT; Kosaka K, 2013, BIOCHEM BIOPH RES CO, V441, P230, DOI 10.1016/j.bbrc.2013.10.040; Llovet JM, 2016, NATURE REVIEWS GASTR; McGuinness PH, 2000, GUT, V46, P260, DOI 10.1136/gut.46.2.260; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Mohd-Ismail NK, 2009, J VIROL, V83, P9993, DOI 10.1128/JVI.00509-09; NAITO M, 1994, HEPATOLOGY, V19, P871, DOI 10.1002/hep.1840190411; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Ozaras R, 2004, J CLIN GASTROENTEROL, V38, P449, DOI 10.1097/00004836-200405000-00011; Panasiuk A, 2004, WORLD J GASTROENTERO, V10, P3639, DOI 10.3748/wjg.v10.i24.3639; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pol S., 2016, J HEPATOLOGY; Poordad F, 2012, J VIRAL HEPATITIS, V19, P449, DOI 10.1111/j.1365-2893.2012.01617.x; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Revie D, 2014, WORLD J GASTROENTERO, V20, P2777, DOI 10.3748/wjg.v20.i11.2777; Sempoux C., 2013, INT J HEPATOLOGY, V2013; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Shrivastava S, 2013, J VIROL, V87, P12284, DOI 10.1128/JVI.01962-13; Smith-Palmer J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0748-8; Tassopoulos NC, 1999, J HEPATOL, V31, P193, DOI 10.1016/S0168-8278(99)80400-0; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; van Aalten SM, 2011, J HEPATOL, V55, P120, DOI 10.1016/j.jhep.2010.10.030; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x	59	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184127	10.1371/journal.pone.0184127	http://dx.doi.org/10.1371/journal.pone.0184127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886065	gold, Green Submitted, Green Published			2022-12-26	WOS:000410001100069
J	Patoine, A; Husseini, A; Kasaai, B; Gaumond, MH; Moffatt, P				Patoine, Alexa; Husseini, Abdallah; Kasaai, Bahar; Gaumond, Marie-Helene; Moffatt, Pierre			The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice	PLOS ONE			English	Article							IMPERFECTA TYPE-V; OSTEOBLAST DIFFERENTIATION; FAMILY PROTEINS; DISTINCT ROLES; GENE; EXPRESSION; INFECTION; MUTATION; BRIL; VISUALIZATION	BRIL (bone-restricted IFITM-like), is a short transmembrane protein expressed almost exclusively in osteoblasts. Although much is known about its bone-restricted gene expression pattern and protein biochemical and topological features, little information is available for BRIL physiological function. Two autosomal dominant forms of osteogenesis imperfecta (OI) are caused by distinct, but recurrent mutations in the BRIL gene. Yet, the underlying mechanisms by which those mutations lead to OI are still poorly understood. A previous report indicated that BRIL knockout (KO) mice had bone deformities, shortened long bones, and reproductive problems. Here we generated and systematically analyzed the skeletal phenotype of a new global Bril KO/LacZ knockin mouse model. KO mice reproduced and thrived normally up to 12 month of age. The skeletal phenotype of KO and WT littermates was assessed at embryonic (E13.5 to E18.5) and postnatal (2 days, 3 weeks, 3 months and 8 months) time-points. Embryos from E13.5 through to E18.5 showed significant X-Gal staining in all skeletal elements without any apparent patterning anomalies. Although bone deformities were never observed at any postnatal ages, minor and transient differences were noted in terms of bone length and static uCT parameters, but not systematically across all ages and genders. These changes, however, were not accompanied by significant alteration in bone material properties as assessed by a 3-point bending test. In addition, no changes were detected in circulating serum markers of bone turnover (P1NP, CTX-I, and osteocalcin). Gene expression monitoring also revealed no major impact of the loss of BRIL. Further, when mice were challenged with a surgically-induced fracture in tibia, bones repaired equally well in the KO mice as compared to WT. Finally, we showed that BRIL C-terminus is not a bona fide binding site for calcium. In conclusion, our in depth analysis suggest that skeletal patterning, bone mass accrual and remodeling in mice proceeded independent of BRIL.	[Patoine, Alexa; Husseini, Abdallah; Kasaai, Bahar; Gaumond, Marie-Helene; Moffatt, Pierre] Shriners Hosp Children Canada, Montreal, PQ, Canada; [Moffatt, Pierre] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	McGill University	Moffatt, P (corresponding author), Shriners Hosp Children Canada, Montreal, PQ, Canada.; Moffatt, P (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	pmoffatt@shriners.mcgill.ca		Moffatt, Pierre/0000-0002-5793-1944	Canadian Institutes of Health Research [137102]; Shriners of North America [8022]; RSBO-FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shriners of North America; RSBO-FRQS	PM received funding from the Canadian Institutes of Health Research (137102), and the Shriners of North America (8022). AP received a scholarship from the RSBO-FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Baird JW, 2001, J BIOL CHEM, V276, P9189, DOI 10.1074/jbc.M008354200; Bassano I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3801-8; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Chen WQ, 2015, TRENDS MICROBIOL, V23, P35, DOI 10.1016/j.tim.2014.09.005; Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Farber CR, 2014, J BONE MINER RES; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Hoyer-Kuhn H, 2013, J BONE MINER RES; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kasaai B, 2013, J BIOL CHEM, V288, P13278, DOI 10.1074/jbc.M113.457010; Kawaguchi J, 2002, BIOTECHNIQUES, V32, P66, DOI 10.2144/02321st02; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Lietman CD, 2015, J BONE MINER RES, V30, P498, DOI 10.1002/jbmr.2363; Loughna Siobhan, 2007, V411, P1; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Millan JL, 2016, CALCIFIED TISSUE INT, V98, P398, DOI 10.1007/s00223-015-0079-1; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Patoine A, 2014, J BONE MINER RES, V29, P2004, DOI 10.1002/jbmr.2243; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Plotkin LI, 2015, CELL MOL LIFE SCI, V72, P2853, DOI 10.1007/s00018-015-1963-6; Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tsukamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075831; Wee YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123218	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184568	10.1371/journal.pone.0184568	http://dx.doi.org/10.1371/journal.pone.0184568			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880886	Green Submitted, Green Published, gold			2022-12-26	WOS:000409467200077
J	Weiss, TS; Lupke, M; Ibrahim, S; Buechler, C; Lorenz, J; Ruemmele, P; Hofmann, U; Melter, M; Dayoub, R				Weiss, Thomas S.; Lupke, Madeleine; Ibrahim, Sara; Buechler, Christa; Lorenz, Julia; Ruemmele, Petra; Hofmann, Ute; Melter, Michael; Dayoub, Rania			Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways	PLOS ONE			English	Article							MITOCHONDRIAL INTERMEMBRANE SPACE; ENDOPLASMIC-RETICULUM STRESS; INDUCED OBESE MICE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; SULFHYDRYL OXIDASE; LIPIDOMIC ANALYSIS; METABOLIC DISEASE; FATTY; HEPATOPOIETIN	Nonalcoholic fatty liver disease (NAFLD) covers a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Free fatty acids (FFA) induce steatosis and lipo-toxicity and correlate with severity of NAFLD. In this study we aimed to investigate the role of exogenous and endogenous ALR (augmenter of liver regeneration) for FFA induced ER (endoplasmatic reticulum) - stress and lipoapoptosis. Primary human hepatocytes or hepatoma cells either treated with recombinant human ALR (rhALR, 15kDa) or expressing short form ALR (sfALR, 15kDa) were incubated with palmitic acid (PA) and analyzed for lipo-toxicity, -apoptosis, activation of ER-stress response pathways, triacylglycerides (TAG), mRNA and protein expression of lipid metabolizing genes. Both, exogenous rhALR and cytosolic sfALR reduced PA induced caspase 3 activity and Bax protein expression and therefore lipotoxicity. Endogenous sfALR but not rhALR treatment lowered TAG levels, diminished activation of ER-stress mediators C-Jun N-terminal kinase (JNK), X-box binding protein-1 (XBP1) and proapoptotic transcription factor C/EBP-homologous protein (CHOP), and reduced death receptor 5 protein expression. Cellular ALR exerts its lipid lowering and anti-apoptotic actions by enhancing FABP1, which binds toxic FFA, increasing mitochondrial beta-oxidation by elevating the mitochondrial FFA transporter CPT1 alpha, and decreasing ELOVL6, which delivers toxic FFA metabolites. We found reduced hepatic mRNA levels of ALR in a high fat diet mouse model, and of ALR and FOXA2, a transcription factor inducing ALR expression, in human steatotic as well as NASH liver samples, which may explain increased lipid deposition and reduced beta-oxidation in NASH patients. Present study shows that exogenous and endogenous ALR reduce PA induced lipoapoptosis. Furthermore, cytosolic sfALR changes mRNA and protein expression of genes regulating lipid metabolism, reduces ER-stress finally impeding progression of NASH.	[Weiss, Thomas S.; Lupke, Madeleine; Ibrahim, Sara; Lorenz, Julia; Melter, Michael; Dayoub, Rania] Univ Regensburg, Childrens Univ Hosp, Regensburg, Germany; [Weiss, Thomas S.] Univ Regensburg Hosp, Ctr Liver Cell Res, Regensburg, Germany; [Buechler, Christa] Univ Regensburg Hosp, Dept Internal Med, Regensburg, Germany; [Ruemmele, Petra] Friedrich Alexander Univ Erlangen Nuernberg, Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany; [Hofmann, Ute] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Hofmann, Ute] Univ Tubingen, Stuttgart, Germany; [Dayoub, Rania] Damascus Univ, Fac Pharm, Dept Biochem & Microbiol, Damascus, Syria	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Regensburg; University of Regensburg; University of Erlangen Nuremberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Weiss, TS (corresponding author), Univ Regensburg, Childrens Univ Hosp, Regensburg, Germany.; Weiss, TS (corresponding author), Univ Regensburg Hosp, Ctr Liver Cell Res, Regensburg, Germany.	thomas.weiss@ukr.de	Buechler, Christa/AAH-3004-2020; Dayoub, Rania/ABG-7279-2020; Weiss, Thomas S./G-3989-2012	Dayoub, Rania/0000-0001-5848-5571; Weiss, Thomas S./0000-0003-0336-0581; Hofmann, Ute/0000-0003-0823-9027; Melter, Michael/0000-0002-4194-0758	German Federal Ministry of Education and Research (BMBF); Virtual Liver Network [FKZ 0315753, FKZ 0315755]; LiSyM [FKZ 031L0037]; Robert-Bosch Foundation	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Virtual Liver Network; LiSyM; Robert-Bosch Foundation	This work was supported by the German Federal Ministry of Education and Research (BMBF), Virtual Liver Network, grant FKZ 0315753 (TSW) and FKZ 0315755 (UH), LiSyM grant FKZ 031L0037 (UH), and the Robert-Bosch Foundation (UH).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Banci L, 2013, J MOL BIOL, V425, P594, DOI 10.1016/j.jmb.2012.11.032; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bedossa P, 2017, LIVER INT, V37, P85, DOI 10.1111/liv.13301; Bihlmaier K, 2008, ANN NY ACAD SCI, V1147, P293, DOI 10.1196/annals.1427.005; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Dayoub R, 2013, MOL MED, V19, P237, DOI 10.2119/molmed.2013.00027; Dayoub R, 2011, MOL MED, V17, P221, DOI 10.2119/molmed.2010.00117; Dayoub R, 2010, BIOCHEM BIOPH RES CO, V395, P465, DOI 10.1016/j.bbrc.2010.04.023; Doycheva I, 2017, HEPATOLOGY, V65, P2100, DOI 10.1002/hep.29068; Eisinger K, 2014, EXP MOL PATHOL, V97, P37, DOI 10.1016/j.yexmp.2014.05.002; Eisinger K, 2014, INT J MOL SCI, V15, P2991, DOI 10.3390/ijms15022991; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Fischer M, 2013, MOL BIOL CELL, V24, P2160, DOI 10.1091/mbc.E12-12-0862; Francavilla A, 2014, INT J BIOCHEM CELL B, V53, P343, DOI 10.1016/j.biocel.2014.05.029; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Gandhi CR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-10; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; Ilowski M, 2010, BIOCHEM BIOPH RES CO, V394, P915, DOI 10.1016/j.bbrc.2010.03.074; Jun DW, 2011, LIVER INT, V31, P1315, DOI 10.1111/j.1478-3231.2011.02602.x; Klissenbauer M, 2002, J EXP BIOL, V205, P1979; Krautbauer S, 2013, EXP MOL PATHOL, V95, P330, DOI 10.1016/j.yexmp.2013.10.003; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Li YX, 2005, CELL SIGNAL, V17, P985, DOI 10.1016/j.cellsig.2004.11.016; Li YX, 2004, EXP CELL RES, V300, P379, DOI 10.1016/j.yexcr.2004.07.019; Liao XH, 2012, RENAL FAILURE, V34, P590, DOI 10.3109/0886022X.2012.664470; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Maehara Y, 2015, GASTROENTEROLOGY, V148, P285, DOI 10.1053/j.gastro.2014.12.013; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mantzaris MD, 2011, FEBS J, V278, P519, DOI 10.1111/j.1742-4658.2010.07972.x; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Polimeno L, 2011, FREE RADICAL RES, V45, P534, DOI 10.3109/10715762.2011.555482; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI 10.1016/j.freeradbiomed.2013.08.174; Shi HB, 2015, WORLD J GASTROENTERO, V21, P5250, DOI 10.3748/wjg.v21.i17.5250; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Xu C, 2007, J NUTR, V137, P554, DOI 10.1093/jn/137.3.554; Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685	51	23	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184282	10.1371/journal.pone.0184282	http://dx.doi.org/10.1371/journal.pone.0184282			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877220	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200082
J	Mahmood, E; Knio, ZO; Mahmood, F; Amir, R; Shahul, S; Mahmood, B; Baribeau, Y; Mueller, A; Matyal, R				Mahmood, Eitezaz; Knio, Ziyad O.; Mahmood, Feroze; Amir, Rabia; Shahul, Sajid; Mahmood, Bilal; Baribeau, Yanick; Mueller, Ariel; Matyal, Robina			Preoperative asymptomatic leukocytosis and postoperative outcome in cardiac surgery patients	PLOS ONE			English	Article							BLOOD-CELL COUNT; PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; INFLAMMATORY RESPONSE SYNDROME; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; 2 PARTS; RISK; CANCER; THROMBOLYSIS	Background Despite showing a prognostic value in general surgical patients, preoperative asymptomatic elevated white blood cell (WBC) count is not considered a risk factor for cardiac surgery. Whereas there is sporadic evidence of its value as a preoperative risk marker, it has not been looked at methodically as a specific index of outcome during cardiac surgery. Using a national database we sought to determine the relationship between preoperative WBC count and postoperative outcome in cardiac surgical patients. Methods Cardiac surgeries were extracted from the 2007-2013 American College of Surgeons National Surgical Quality Improvement Program database. Leukocytosis was defined by a preoperative WBC count greater than 11,000 cells/mu L. A univariate analysis compared the incidence of adverse outcomes for patients with and without leukocytosis. A multivariate logistic regression model was constructed in order to test whether leukocytosis was an independent predictor of morbidity and mortality. Results Out of a total of 10,979 cardiac surgery patients 863 (7.8%) had preoperative leukocytosis. On univariate analysis, patients with leukocytosis experienced greater incidences of 30-day mortality, wound complications, and medical complications. Wound complications included surgical site infection as well as wound dehiscence. The medical complications included all other non-surgical causes of increased morbidity and infection leading to urinary tract infection, pneumonia, ventilator dependence, sepsis and septic shock. After stepwise model adjustment, leukocytosis was a strong predictor of medical complications (OR 1.22, 95% CI: 1.09-1.36, p = 0.002) with c-statistic of 0.667. However, after stepwise model adjustment leukocytosis was not a significant predictor of 30-day mortality and wound complications. Conclusion Preoperative leukocytosis is associated with adverse postoperative outcome after cardiac surgery and is an independent predictor of infection-related postoperative complications.	[Mahmood, Eitezaz; Mahmood, Feroze; Amir, Rabia; Shahul, Sajid; Mahmood, Bilal; Baribeau, Yanick; Mueller, Ariel; Matyal, Robina] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Mahmood, Eitezaz] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Knio, Ziyad O.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Cardiac Surg, Dept Surg, Boston, MA USA; [Mahmood, Bilal] Albany Med Coll, Albany, NY 12208 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Albany Medical College	Matyal, R (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	rmatyal1@bidmc.harvard.edu		Knio, Ziyad/0000-0001-5696-873X; Amir, Rabia/0000-0001-5770-8673				Banerjee R, 2013, DIS COLON RECTUM, V56, P1036, DOI 10.1097/DCR.0b013e31829ab0d4; Evora PRB, 2016, ACTA CIR BRAS, V31, P45, DOI 10.1590/S0102-86502016001300010; Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Bozkurt IH, 2015, UROLOGY, V86, P25, DOI 10.1016/j.urology.2015.04.026; Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231; Brown DW, 2001, J CLIN EPIDEMIOL, V54, P316, DOI 10.1016/S0895-4356(00)00296-1; Chen XF, 2016, WORLD J GASTROENTERO, V22, P2818, DOI 10.3748/wjg.v22.i9.2818; Dacey LJ, 2003, ANN THORAC SURG, V76, P760, DOI 10.1016/S0003-4975(03)00675-1; Davies MG, 1997, BRIT J SURG, V84, P920, DOI 10.1002/bjs.1800840707; Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002; Depuydt P, 2008, INTENS CARE MED, V34, P675, DOI 10.1007/s00134-007-0953-z; Dieleman JM, 2017, ANAESTHESIA, V72, P704, DOI 10.1111/anae.13853; Durandy Y, 2014, ARTIF ORGANS, V38, P11, DOI 10.1111/aor.12195; Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9; Elkind MSV, 2005, NEUROLOGY, V64, P2121, DOI 10.1212/01.WNL.0000165989.12122.49; Gogo PB, 2005, AM J CARDIOL, V96, P538, DOI 10.1016/j.amjcard.2005.04.016; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Kumar Satish, 2007, Indian Heart J, V59, P316; Kurtul A, 2014, AM J CARDIOL, V114, P342, DOI 10.1016/j.amjcard.2014.04.045; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Lindner HA, 2016, CRIT CARE MED, V44, P2199, DOI 10.1097/CCM.0000000000001955; Lloyd-Jones DM, 2000, AM HEART J, V139, P867, DOI 10.1016/S0002-8703(00)90019-X; Menon V, 2003, AM J CARDIOL, V92, P368, DOI 10.1016/S0002-9149(03)00651-9; Moghadamyeghaneh Z, 2015, J AM COLL SURGEONS, V221, P207, DOI 10.1016/j.jamcollsurg.2015.03.044; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Rienstra M, 2012, AM J CARDIOL, V109, P533, DOI 10.1016/j.amjcard.2011.09.049; Riley LK, 2015, AM FAM PHYSICIAN, V92, P1004; Sagi HC, 2013, J ORTHOP TRAUMA, V27, P6, DOI 10.1097/BOT.0b013e31825cf382; SHAPIRO MF, 1987, ANN INTERN MED, V106, P65, DOI 10.7326/0003-4819-106-1-65; Strobel RJ, 2016, ANN THORAC SURG, V102, P1213, DOI 10.1016/j.athoracsur.2016.03.074; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Tompkins C, 2013, AM J CARDIOL, V111, P1608, DOI 10.1016/j.amjcard.2013.01.334; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Whitlock RP, 2015, LANCET, V386, P1243, DOI 10.1016/S0140-6736(15)00273-1; Yeh YT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002857	37	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0182118	10.1371/journal.pone.0182118	http://dx.doi.org/10.1371/journal.pone.0182118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873411	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800003
J	Tinne, N; Antonopoulos, GC; Mohebbi, S; Andrade, J; Nolte, L; Meyer, H; Heisterkamp, A; Majdani, O; Ripken, T				Tinne, Nadine; Antonopoulos, Georgios C.; Mohebbi, Saleh; Andrade, Jose; Nolte, Lena; Meyer, Heiko; Heisterkamp, Alexander; Majdani, Omid; Ripken, Tammo			Three-dimensional hard and soft tissue imaging of the human cochlea by scanning laser optical tomography (SLOT)	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; 3D; CT	The present study focuses on the application of scanning laser optical tomography (SLOT) for visualization of anatomical structures inside the human cochlea ex vivo. SLOT is a laser-based highly efficient microscopy technique which allows for tomographic imaging of the internal structure of transparent specimens. Thus, in the field of otology this technique is best convenient for an ex vivo study of the inner ear anatomy. For this purpose, the preparation before imaging comprises decalcification, dehydration as well as optical clearing of the cochlea samples in toto. Here, we demonstrate results of SLOT imaging visualizing hard and soft tissue structures with an optical resolution of down to 15 mu m using extinction and autofluorescence as contrast mechanisms. Furthermore, the internal structure can be analyzed nondestructively and quantitatively in detail by sectioning of the three-dimensional datasets. The method of X-ray Micro Computed Tomography (mu CT) has been previously applied to explanted cochlea and is solely based on absorption contrast. An advantage of SLOT is that it uses visible light for image formation and thus provides a variety of contrast mechanisms known from other light microscopy techniques, such as fluorescence or scattering. We show that SLOT data is consistent with mu CT anatomical data and provides additional information by using fluorescence. We demonstrate that SLOT is applicable for cochlea with metallic cochlear implants (CI) that would lead to significant artifacts in mu CT imaging. In conclusion, the present study demonstrates the capability of SLOT for resolution visualization of cleared human cochleae ex vivo using multiple contrast mechanisms and lays the foundation for a broad variety of additional studies.	[Tinne, Nadine; Antonopoulos, Georgios C.; Nolte, Lena; Meyer, Heiko; Heisterkamp, Alexander; Ripken, Tammo] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany; [Tinne, Nadine; Heisterkamp, Alexander; Majdani, Omid; Ripken, Tammo] Cluster Excellence Hearing4all, Hannover, Germany; [Mohebbi, Saleh; Andrade, Jose; Majdani, Omid] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Meyer, Heiko; Heisterkamp, Alexander; Ripken, Tammo] Biofabricat NIFE, Hannover, Germany; [Heisterkamp, Alexander] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	Hannover Medical School; Leibniz University Hannover	Ripken, T (corresponding author), Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany.; Ripken, T (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.; Ripken, T (corresponding author), Biofabricat NIFE, Hannover, Germany.	t.ripken@lzh.de	Majdani, Omid/J-1372-2019; Mohebbi, Saleh/T-9413-2019; Heisterkamp, Alexander/V-5376-2017	Majdani, Omid/0000-0002-8582-7204; Mohebbi, Saleh/0000-0003-4050-7714; Heisterkamp, Alexander/0000-0001-8770-0859; Ripken, Tammo/0000-0003-3512-9544	DFG Cluster of Excellence part of the BIOFABRICATION FOR NIFE Initiative [EXC 1077/1, VWZN2860]; Ministry of Lower Saxony; VolkswagenStiftung	DFG Cluster of Excellence part of the BIOFABRICATION FOR NIFE Initiative; Ministry of Lower Saxony; VolkswagenStiftung(Volkswagen)	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" (http://hearing4all.eu/EN/) and carried out as an integral part of the BIOFABRICATION FOR NIFE Initiative VWZN2860 (http://www.biofabrication.info/en/home/), which is financially supported by the Ministry of Lower Saxony and the VolkswagenStiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" and carried out as an integral part of the BIOFABRICATION FOR NIFE Initiative VWZN2860, which is financially supported by the Ministry of Lower Saxony and the VolkswagenStiftung. NIFE is the Lower Saxony Center for Biomedical Engineering, Implant Research and Development, a joint translational research centre of the Hannover Medical School, the Leibniz University Hannover, the University of Veterinary Medicine Hannover and the Laser Zentrum Hannover e. V.	Adriaens D, 2010, MICROSC SCI TECHNOL, V2, P1356; Antonopoulos G. C., 2014, P SPIE; Bartels M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818737; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Bellos C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/485783; Brunschwig AS, 1997, HEARING RES, V114, P62, DOI 10.1016/S0378-5955(97)00153-6; Carelsen B, 2007, CLIN OTOLARYNGOL, V32, P46, DOI 10.1111/j.1365-2273.2007.01319.x; Eickhoff R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041236; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Hardie NA, 2004, BRAIN RES, V1000, P200, DOI 10.1016/j.brainres.2003.10.071; Heidrich M, 2011, BIOMED OPT EXPRESS, V2, P2982, DOI 10.1364/BOE.2.002982; Hodez C, 2011, EUR ANN OTORHINOLARY, V128, P65, DOI 10.1016/j.anorl.2010.10.008; Kellner M, 2012, J APPL PHYSIOL, V113, P975, DOI 10.1152/japplphysiol.00026.2012; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lane JI, 2004, AM J NEURORADIOL, V25, P618; Lorbeer RA, 2011, OPT EXPRESS, V19, P5419, DOI 10.1364/OE.19.005419; MacDonald GH, 2008, HEARING RES, V243, P1, DOI 10.1016/j.heares.2008.05.009; Mohebbi S, 2014, BIOMED ENG-BIOMED TE, V59, P564; Nolte L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175431; Postnov A, 2006, ACTA OTO-LARYNGOL, V126, P467, DOI 10.1080/00016480500437377; Reisser C, 1996, AM J OTOL, V17, P473; Santi PA, 2009, BIOTECHNIQUES, V46, P287, DOI 10.2144/000113087; Spalteholz W., 1911, DURCHSICHTIGMACHEN M; Vogel U, 1999, ORL-J OTO-RHIN-LARYN, V61, P259, DOI 10.1159/000027683; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Voie AH, 2002, HEARING RES, V171, P119, DOI 10.1016/S0378-5955(02)00493-8	26	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184069	10.1371/journal.pone.0184069	http://dx.doi.org/10.1371/journal.pone.0184069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873437	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800047
J	Chen, ZL; Yang, J; Li, ST; Lv, M; Shen, YW; Wang, BY; Li, P; Yi, M; Zhao, XA; Zhang, LX; Wang, L; Yang, J				Chen, Zheling; Yang, Jiao; Li, Shuting; Lv, Meng; Shen, Yanwei; Wang, Biyuan; Li, Pan; Yi, Min; Zhao, Xiao'ai; Zhang, Lingxiao; Wang, Le; Yang, Jin			Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma	PLOS ONE			English	Article							OVARIAN-FUNCTION SUPPRESSION; TUMOR CHARACTERISTICS; PREMENOPAUSAL WOMEN; ENDOCRINE THERAPY; SURVIVAL OUTCOMES; CLINICAL-TRIALS; CANCER PATIENTS; LONG-TERM; TAMOXIFEN; FEATURES	The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and infiltrating lobular carcinoma (ILC) are not uniform. The primary objectives of this study were to identify the differences in the clinical characteristics and prognoses between ILC and IDC, and identify the high-risk population based on the hormone receptor status and metastasis sites. The Surveillance, Epidemiology, and End Results Program database was searched and patients diagnosed with ILC or IDC from 1990 to 2013 were identified. In total, 796,335 patients were analyzed, including 85,048 with ILC (10.7%) and 711,287 with-IDC (89.3%). The ILC group was correlated with older age, larger tumor size, later stage, lower grade, metastasis disease (M1) disease, and greater counts of positive lymph node-sandestrogen- receptor-positive (ER)/progesterone receptor-positive (PR) positive nodes. The overall survival showed an early advantage for ILC but a worse outcome after 5 years. Regarding the disease-specific survival, the IDC cohort had advantages over the ILC group, both during the early years and long-term. In hormone status and metastasis site subgroup analyses, the ER+/PR+ subgroup had the best survival, while the ER+/PR-subgroup had the worst outcome, especially the ILC cohort. ILC and IDC had different metastasis patterns. The proportion of bone metastasis was higher in the ILC group (91.52%) than that in the IDC (76.04%), and the ILC group was more likely to have multiple metastasis sites. Survival analyses showed patients with ILC had a higher risk of liver metastasis (disease-specific survival [DSS]; P = 0.046), but had a better overall survival than the bone metastasis group (P<0.0001). We concluded that the long-term prognosis for ILC was poorer than that for IDC, and the ER+/PR-subgroup had the worst outcome. Therefore, the metastasis pattern and prognosis must be seriously evaluated, and a combination of endocrine therapy and chemotherapy should be considered.	[Chen, Zheling; Yang, Jiao; Li, Shuting; Lv, Meng; Shen, Yanwei; Wang, Biyuan; Li, Pan; Yi, Min; Zhao, Xiao'ai; Zhang, Lingxiao; Wang, Le; Yang, Jin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China.	1473106133@qq.com	Chen, Zheling/L-6089-2019					Adachi Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2275-4; Anderson WF, 2006, JNCI-J NATL CANCER I, V98, P948, DOI 10.1093/jnci/djj295; Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767; Azim HA, 2014, WOMENS HEALTH, V10, P511, DOI [10.2217/WHE.14.48, 10.2217/whe.14.48]; Bharat A, 2009, AM J SURG, V198, P516, DOI 10.1016/j.amjsurg.2009.06.005; Biglia N, 2007, ENDOCR-RELAT CANCER, V14, P549, DOI 10.1677/ERC-06-0060; Brouckaert O, 2014, BREAST, V23, P371, DOI 10.1016/j.breast.2014.01.007; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cristofanilli M, 2005, J CLIN ONCOL, V23, P41, DOI 10.1200/JCO.2005.03.111; Dabbs DJ, 2013, AM J SURG PATHOL, V37, pE1, DOI 10.1097/PAS.0b013e3182918a2b; Desmedt C, 2017, SEMIN CANCER BIOL, V44, P98, DOI 10.1016/j.semcancer.2017.03.007; DICOSTANZO D, 1990, AM J SURG PATHOL, V14, P12, DOI 10.1097/00000478-199001000-00002; Fortunato L, 2012, ANN SURG ONCOL, V19, P1107, DOI 10.1245/s10434-011-1907-9; Frank G. A., 2013, Arkhiv Patologii, V75, P53; Garcia-Fernandez A, 2015, BREAST J, V21, P533, DOI 10.1111/tbj.12455; Gnant M, 2015, ANN ONCOL, V26, P313, DOI 10.1093/annonc/mdu544; Gradishar WJ, 2017, J NATL COMPR CANC NE, V15, P433, DOI 10.6004/jnccn.2017.0044; Guiu S, 2014, CRIT REV ONCOL HEMAT, V92, P235, DOI 10.1016/j.critrevonc.2014.07.003; Korhonen T, 2004, BREAST CANCER RES TR, V85, P23, DOI 10.1023/B:BREA.0000021038.97593.8b; Kravchenko J, 2011, BREAST CANCER RES TR, V128, P483, DOI 10.1007/s10549-011-1347-z; Kwast ABG, 2012, BREAST CANCER RES TR, V135, P271, DOI 10.1007/s10549-012-2160-z; Lehr HA, 2000, AM J CLIN PATHOL, V114, P190, DOI 10.1309/CPUX-KWEH-7B26-YE19; Li BQ, 2012, INT J RADIAT ONCOL, V84, P23, DOI 10.1016/j.ijrobp.2011.10.063; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.3.CO;2-O; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Li D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156617; Lobbezoo D, 2016, ONCOTARGET, V7, P29412, DOI 10.18632/oncotarget.8838; Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015; Metzger O, 2015, J CLIN ONCOL, V33, P2772, DOI 10.1200/JCO.2015.60.8133; Mhuircheartaigh JN, 2008, BRIT J SURG, V95, P827, DOI 10.1002/bjs.6042; Morrogh M, 2012, BREAST CANCER RES TR, V132, P641, DOI 10.1007/s10549-011-1860-0; Nelson RA, 2015, ANN SURG ONCOL, V22, P24, DOI 10.1245/s10434-014-3890-4; Pestalozzi BC, 2008, J CLIN ONCOL, V26, P3006, DOI 10.1200/JCO.2007.14.9336; Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009; Reed AEM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0519-x; Ribi K, 2016, J CLIN ONCOL, V34, P1601, DOI 10.1200/JCO.2015.64.8675; Rugo HS, 2016, J ONCOL PRACT, V12, P583, DOI 10.1200/JOP.2016.012914; Santiago RJ, 2005, CANCER-AM CANCER SOC, V103, P2447, DOI 10.1002/cncr.21071; SastreGarau X, 1996, CANCER, V77, P113, DOI 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8; Singletary SE, 2005, ANN SURG, V242, P281, DOI 10.1097/01.sla.0000171306.74366.22; Tevaarwerk AJ, 2014, J CLIN ONCOL, V32, P3948, DOI 10.1200/JCO.2014.55.6993; Uchiyama N, 2001, Radiat Med, V19, P19; Veltman J, 2006, CLIN IMAG, V30, P94, DOI 10.1016/j.clinimag.2005.09.021; Vo TN, 2006, AM J SURG, V192, P552, DOI 10.1016/j.amjsurg.2006.06.020; Wasif N, 2010, ANN SURG ONCOL, V17, P1862, DOI 10.1245/s10434-010-0953-z; Wickerham DL, 2008, SEMIN ONCOL, V35, P522, DOI 10.1053/j.seminoncol.2008.07.005; Winchester DJ, 1998, J AM COLL SURGEONS, V186, P416, DOI 10.1016/S1072-7515(98)00051-9; Wong SM, 2015, CANCER-AM CANCER SOC, V121, P4333, DOI 10.1002/cncr.29687	49	84	85	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0182397	10.1371/journal.pone.0182397	http://dx.doi.org/10.1371/journal.pone.0182397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863134	Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900001
J	Friedman, D; Magnani, J; Paranjpe, D; Sinervo, B				Friedman, Daniel; Magnani, Jacopo; Paranjpe, Dhanashree; Sinervo, Barry			Evolutionary games, climate and the generation of diversity	PLOS ONE			English	Article							FREQUENCY-DEPENDENT SELECTION; SIDE-BLOTCHED LIZARD; CORRELATIONAL SELECTION; MATE CHOICE; DISPERSAL; CYCLES; CONSEQUENCES; OSCILLATIONS; BIODIVERSITY; PREFERENCE	Environmental stochasticity and climate affect outcomes in evolutionary games, which can thereby affect biological diversity. Our maximum likelihood (ML) estimates of replicator dynamics for morph frequency data from control (25 years) and three experimentally perturbed populations (14 years) of side-blotched lizards yield a 3 x 3 payoff matrix in the generalized Rock-Paper-Scissors family; it has intransitive best replies, and each strategy is its own worst reply. ML estimates indicate significant interactive effects of density and temperature on morph frequency. Implied dynamics feature a powerful interior attractor and recover (for the first time) observed 4-5 year oscillations. Our evolutionary experiment on morph frequency confirms that oscillations are driven by frequency dependent selection, but climate entrains the cycles across the perturbed and control populations within 10 generations. Applying the model across the species range, we find that climate also accounts for morph fixation and mating system diversity, suggesting climate may similarly impact ecosystem diversity.	[Friedman, Daniel] Univ Calif Santa Cruz, Dept Econ, Santa Cruz, CA 95064 USA; [Magnani, Jacopo] New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates; [Paranjpe, Dhanashree; Sinervo, Barry] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Friedman, D (corresponding author), Univ Calif Santa Cruz, Dept Econ, Santa Cruz, CA 95064 USA.	dan@ucsc.edu	Paranjpe, Dhanashree/ABI-6351-2020; Paranjpe, Dhanashree/HDM-8972-2022	Paranjpe, Dhanashree/0000-0003-4787-2052; 	NSF [IOS-1022031, EF-1241848]; Direct For Biological Sciences [1241848] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by NSF grants to B. S. from 1989-present, including the most recent IOS-1022031, and EF-1241848.	Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Alonzo SH, 2007, EVOL ECOL RES, V9, P1097; Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Bleay C, 2007, BEHAV ECOL, V18, P304, DOI 10.1093/beheco/arl101; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; Calsbeek R, 2002, P ROY SOC B-BIOL SCI, V269, P157, DOI 10.1098/rspb.2001.1856; Chitty D., 1996, LEMMINGS COMMIT SUIC; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Fitze PS, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00077; Friedman D., 2016, EVOLUTIONARY GAMES N; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Hudson PJ, 2003, POPULATION CYCLES; Huisman J, 2001, ECOLOGY, V82, P2682; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lancaster LT, 2014, AM NAT, V184, P188, DOI 10.1086/676645; Lancaster LT, 2009, BEHAV ECOL, V20, P993, DOI 10.1093/beheco/arp088; Maynard Smith J., 1982, pi; Paranjpe DA, 2013, ECOL EVOL, V3, P1977, DOI 10.1002/ece3.614; PFENNIG DW, 1992, FUNCT ECOL, V6, P167, DOI 10.2307/2389751; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Sandholm WH., 2010, POPULATION GAMES EVO; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Sinervo B., 2002, MICROEVOLUTION RATE, P417; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; Sinervo B, 2006, ANNU REV ECOL EVOL S, V37, P581, DOI 10.1146/annurev.ecolsys.37.091305.110128; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sinervo B, 2006, AM NAT, V168, P88, DOI 10.1086/505765; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184052	10.1371/journal.pone.0184052	http://dx.doi.org/10.1371/journal.pone.0184052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859142	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000408740500062
J	Wang, WW; Shi, WD; Qian, H; Deng, XJ; Wang, T; Li, WZ				Wang, Weiwei; Shi, Weidong; Qian, Hua; Deng, Xijin; Wang, Tong; Li, Wenzhi			Stellate ganglion block attenuates chronic stress induced depression in rats	PLOS ONE			English	Article							CHRONIC MILD STRESS; CORTICOTROPIN-RELEASING-FACTOR; INDUCED ANHEDONIA; MESSENGER-RNA; MODEL; CORTICOSTERONE; HIPPOCAMPUS; BEHAVIOR; MEMORY; BRAIN	Background Stress is a significant factor in the etiology of depression. Stellate ganglion block (SGB) has been shown to maintain the stability of the autonomic system and to affect the neuroendocrine system, including the hypothalamic-ituitary-drenal (HPA) axis. The objective of this study was to determine the antidepressant-like effects of SGB on the autonomic system and the HPA axis, apoptosis-related proteins, related spatial learning and memory impairment, and sensorimotor dysfunction. Methods Forty-eight Sprague Dawley rats were assigned to four experimental groups: control + saline (sham group), control + SGB (SGB group), unpredictable chronic mild stress (UCMS) + saline (UCMS group), and UCMS + SGB (UCSG group). Stress-induced effects and the function of SGB were assessed using measures of body weight, coat state, sucrose consumption, and behavior in open-field and Y-maze tests. Neuronal damage was assessed histologically using the hematoxylin-eosin (HE) staining method, while western blotting was used to investigate changes in the expression of apoptosis-related proteins. Plasma cortico-tropin-releasing factor (CRF), adrenocorticotropic hormone (ACTH), corticosterone (CORT), noradrenaline and adrenaline were measured to evaluate changes in the autonomic system and HPA axis. Results SGB treatment significantly improved sensorimotor dysfunction and spatial learning and memory impairment following UCMS. Moreover, UCMS significantly decreased body weight, sucrose preference and anti-apoptotic protein Bcl-2, and increased scores on measures of coat state, adrenal gland weight, levels of CORT, CRF, ACTH, noradrenaline and adrenaline, as well as increased neuronal loss, cell shrinkage, nuclear condensation, and the pro-apoptotic protein Bax. These symptoms were attenuated by treatment with SGB. Conclusions These findings suggest that SGB can attenuate depression-like behaviors induced by chronic stress. These protective effects appear to be due to an anti-apoptotic mechanism of two stress pathways-the autonomic system and the HPA axis.	[Wang, Weiwei; Shi, Weidong; Qian, Hua; Deng, Xijin; Li, Wenzhi] Harbin Med Univ, Affiliated Hosp 2, Dept Anaesthesiol, Harbin, Heilongjiang, Peoples R China; [Wang, Tong] Harbin Med Univ, Ctr Endem Dis Control, Chinese Ctr Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; Harbin Medical University	Li, WZ (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Anaesthesiol, Harbin, Heilongjiang, Peoples R China.	wenzhili9@126.com						Abdi S, 2005, ANESTH ANALG, V101, P561, DOI 10.1213/01.ANE.0000159169.12425.50; Adachi Mamoru, 2003, Masui, V52, P1293; BLOKLAND A, 1990, PHYSIOL BEHAV, V47, P783, DOI 10.1016/0031-9384(90)90096-M; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Brotto MAD, 2003, J PHARMACOL EXP THER, V306, P1152, DOI 10.1124/jpet.103.052670; Chen YQ, 2016, J CLIN ANESTH, V32, P255, DOI 10.1016/j.jclinane.2016.03.019; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Elias M, 2000, Pain Physician, V3, P294; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; Grippo AJ, 2002, AM J PHYSIOL-REG I, V282, pR1333, DOI 10.1152/ajpregu.00614.2001; Gupta MM, 2005, BRIT J ANAESTH, V95, P669, DOI 10.1093/bja/aei230; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Isingrini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010404; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Kageshima K, 1992, Masui, V41, P1336; Kehne J, 2002, CNS NEUROL DISORD-DR, V1, P467, DOI 10.2174/1568007023339049; Kim GW, 2016, KOREAN J ANESTHESIOL, V69, P171, DOI 10.4097/kjae.2016.69.2.171; Liu YD, 2010, PHARM BIOL, V48, P840, DOI 10.3109/13880200903296154; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Mitchell AJ, 1998, NEUROSCI BIOBEHAV R, V22, P635, DOI 10.1016/S0149-7634(97)00059-6; MOREAU JL, 1994, J PSYCHIATR NEUROSCI, V19, P51; Mulvaney SW, 2014, MIL MED, V179, P1133, DOI 10.7205/MILMED-D-14-00151; Nemeroff CB, 2004, CNS SPECTRUMS, V9, P23, DOI 10.1017/S1092852900025475; Nowak G, 2006, BRIT J PHARMACOL, V149, P581, DOI 10.1038/sj.bjp.0706845; Pan Y, 2006, BIOL PHARM BULL, V29, P2399, DOI 10.1248/bpb.29.2399; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Remus JL, 2015, BEHAV NEUROSCI, V129, P321, DOI 10.1037/bne0000056; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Sarbadhikari SN, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-33; Schurmann M, 2001, CLIN J PAIN, V17, P94, DOI 10.1097/00002508-200103000-00012; Skelton KH, 2004, J NEUROSCI, V24, P9303, DOI 10.1523/JNEUROSCI.1737-04.2004; Spreng M., 2000, Noise Health, V2, P49; Strohle A, 2003, PHARMACOPSYCHIATRY, V36, pS207; Sun CY, 2006, CHINESE MED J-PEKING, V119, P140, DOI 10.1097/00029330-200601020-00008; Szafarczyk A., 1993, Encephale, V19, P137; Tamatani M, 1998, CELL DEATH DIFFER, V5, P911, DOI 10.1038/sj.cdd.4400439; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Uchida K, 2002, MED HYPOTHESES, V59, P446, DOI 10.1016/S0306-9877(02)00158-5; Wang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042828; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	44	9	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183995	10.1371/journal.pone.0183995	http://dx.doi.org/10.1371/journal.pone.0183995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859148	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500056
J	Zhang, J; Shi, KB; Li, ZG; Li, MS; Han, YJ; Wang, L; Zhang, ZC; Yu, CL; Zhang, F; Song, LJ; Dong, JF; La Cava, A; Sheth, KN; Shi, FD				Zhang, Jing; Shi, Kaibin; Li, Zhiguo; Li, Minshu; Han, Yujuan; Wang, Lei; Zhang, Zhecheng; Yu, Changlu; Zhang, Fang; Song, Lijuan; Dong, Jing-Fei; La Cava, Antonio; Sheth, Kevin N.; Shi, Fu-Dong			Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage	FASEB JOURNAL			English	Article						hemorrhagic brain injury; immunosuppression; spleen; infection	ISCHEMIC-STROKE; INJURY; INFECTION; BRAIN; COMPLICATIONS; FINGOLIMOD; MECHANISMS; SPLEEN; SIZE	Severe brain injury significantly influences immune responses; however, the levels at which this influence occurs and which neurogenic pathways are involved are not well defined. Here, we used MRI to measure spleen volume and tissue diffusion changes in patients with intracerebral hemorrhage (ICH). We observed increased capillary exchange and spleen shrinkage by d 3 post-ICH, with recovery by d 14. The extent of spleen shrinkage was associated with brain hematoma size, and a reduced progression of perihematomal edema was observed in the presence of severe spleen shrinkage. At the cellular level, lymphopenia was present in patients with ICH at admission and persisted up to 14 d. Lymphopenia did not parallel the observed spleen alteration. In addition, patients with ICH with infection had significant deficiencies of T and NK cells and poor functional outcomes. Finally, in mouse models of ICH, spleen shrinkage could be related to innervations from adrenergic input and the hypothalamus-pituitary-adrenal (HPA) axis. In sum, the profound impact of ICH on the immune system involves the coordinated actions of sympathetic innervation and the HPA axis, which modulate spleen shrinkage and cellular immunity.	[Zhang, Jing; Shi, Kaibin; Li, Minshu; Zhang, Fang; Shi, Fu-Dong] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin, Peoples R China; [Zhang, Jing; Han, Yujuan; Wang, Lei; Zhang, Zhecheng; Yu, Changlu] Tianjin Third Cent Hosp, Dept Neurol, Tianjin, Peoples R China; [Zhang, Jing; Han, Yujuan; Wang, Lei; Zhang, Zhecheng; Yu, Changlu] Tianjin Third Cent Hosp, Dept Radiol, Tianjin, Peoples R China; [Shi, Kaibin; Li, Zhiguo; Li, Minshu; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA; [Song, Lijuan] Shanxi Univ Tradit Chinese Med, Collaborat Innovat Ctr 2011, Neurobiol Res Ctr, Taiyuan, Shanxi, Peoples R China; [Dong, Jing-Fei] Univ Washington, Sch Med, Dept Med, Div Hematol,Bloodworks Res Inst, Seattle, WA 98195 USA; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University	Shi, FD (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin 300052, Peoples R China.	fshi66@gmail.com	/AAG-9576-2020	/0000-0002-8839-0933	National Basic Research Program of China [2013CB966900]; National Science Foundation of China [81230028, 81301044, 81471535]; Key Project of Tianjin Health Industry [14KG110]; American Heart Association [16SDG27250236]; U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke [R01NS092713]; National Multiple Sclerosis Society [RG-1507-05318]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Tianjin Health Industry; American Heart Association(American Heart Association); U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the patients and healthy volunteers who participated in the study, P. Minick (PM Publications, La Jolla, CA, USA) for editorial assistance, and Dr. Q. Liu (Barrow Neurological Institute) for technical support. This work was supported, in part, by National Basic Research Program of China (Grant 2013CB966900), the National Science Foundation of China (Grants 81230028, 81301044, and 81471535), the Key Project of Tianjin Health Industry 14KG110, the American Heart Association (Grant 16SDG27250236), the U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke (Grant R01NS092713), and the National Multiple Sclerosis Society (Grant RG-1507-05318). The authors declare no conflicts of interest.	Ali M, 2009, EUR J NEUROL, V16, P624, DOI 10.1111/j.1468-1331.2009.02559.x; Diedler J, 2009, CEREBROVASC DIS, V27, P272, DOI 10.1159/000199465; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Fritzsche KH, 2012, METHOD INFORM MED, V51, P441, DOI 10.3414/ME11-02-0031; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Giede-Jeppe A, 2016, STROKE, V47, P1239, DOI 10.1161/STROKEAHA.116.013003; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Illanes S, 2011, NEUROSCI LETT, V490, P170, DOI 10.1016/j.neulet.2010.11.065; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li M., 2016, J CEREB BLOOD FLOW M, V37, P2383; Li YJ, 2015, NEUROSCI BULL, V31, P755, DOI 10.1007/s12264-015-1532-2; Liesz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074839; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Lord AS, 2016, STROKE, V47, P1768, DOI 10.1161/STROKEAHA.116.013229; Lord AS, 2014, STROKE, V45, P3535, DOI 10.1161/STROKEAHA.114.006435; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morotti A, 2017, NEUROCRIT CARE, V26, P160, DOI 10.1007/s12028-016-0367-2; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Sykora M, 2011, STROKE, V42, P1218, DOI 10.1161/STROKEAHA.110.604637; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Vahidy FS, 2016, J CEREBR BLOOD F MET, V36, P1012, DOI 10.1177/0271678X15607880; Walsh KB, 2015, STROKE, V46, P2302, DOI 10.1161/STROKEAHA.115.009880; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wurnig MC, 2015, MAGN RESON MED, V74, P1414, DOI 10.1002/mrm.25506; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yu H, 2013, INT J STROKE, V8, pE57, DOI 10.1111/ijs.12175	38	38	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					220	229		10.1096/fj.201700324R	http://dx.doi.org/10.1096/fj.201700324R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28877956	Green Published			2022-12-26	WOS:000419172700021
J	Clayton, W; Eaton, CJ; Dupont, PY; Gillanders, T; Cameron, N; Saikia, S; Scott, B				Clayton, William; Eaton, Carla Jane; Dupont, Pierre-Yves; Gillanders, Tim; Cameron, Nick; Saikia, Sanjay; Scott, Barry			Analysis of simple sequence repeat (SSR) structure and sequence within Epichloe endophyte genomes reveals impacts on gene structure and insights into ancestral hybridization events	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; MICROSATELLITE MARKERS; PERENNIAL RYEGRASS; INTERACTIVE TREE; LOLIUM-PERENNE; ONLINE TOOL; TALL FESCUE; LIFE ITOL; GRASSES; EVOLUTION	Epichloe grass endophytes comprise a group of filamentous fungi of both sexual and asexual species. Known for the beneficial characteristics they endow upon their grass hosts, the identification of these endophyte species has been of great interest agronomically and scientifically. The use of simple sequence repeat loci and the variation in repeat elements has been used to rapidly identify endophyte species and strains, however, little is known of how the structure of repeat elements changes between species and strains, and where these repeat elements are located in the fungal genome. We report on an in-depth analysis of the structure and genomic location of the simple sequence repeat locus B10, commonly used for Epichloe endophyte species identification. The B10 repeat was found to be located within an exon of a putative bZIP transcription factor, suggesting possible impacts on polypeptide sequence and thus protein function. Analysis of this repeat in the asexual endophyte hybrid Epichloe E uncinata revealed that the structure of B10 alleles reflects the ancestral species that hybridized to give rise to this species. Understanding the structure and sequence of these simple sequence repeats provides a useful set of tools for readily distinguishing strains and for gaining insights into the ancestral species that have undergone hybridization events.	[Clayton, William; Eaton, Carla Jane; Dupont, Pierre-Yves; Saikia, Sanjay; Scott, Barry] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Eaton, Carla Jane; Dupont, Pierre-Yves; Scott, Barry] Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand; [Gillanders, Tim; Cameron, Nick] Cropmark Seeds Ltd, Darfield, New Zealand	Massey University; Massey University	Scott, B (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.; Scott, B (corresponding author), Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand.	d.b.scott@massey.ac.nz		Scott, Barry/0000-0002-2224-2946; Eaton, Carla/0000-0002-0633-1535; Dupont, Pierre-Yves/0000-0002-7384-5181	Cropmark Seeds Ltd.	Cropmark Seeds Ltd.	The funder (Cropmark Seeds Ltd.) provided support in the form of salaries for authors [TG NC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BACON CW, 1995, J ANIM SCI, V73, P861; Bailey J, 2015, AUSTRALAS PLANT PATH, V44, P97, DOI 10.1007/s13313-014-0326-3; Barker GM, 2015, NEW ZEAL J AGR RES, V58, P35, DOI 10.1080/00288233.2014.978480; BYRD AD, 1990, CURR GENET, V18, P347, DOI 10.1007/BF00318216; Card SD, 2014, FEMS MICROBIOL ECOL, V88, P94, DOI 10.1111/1574-6941.12273; CHRISTENSEN MJ, 1993, MYCOL RES, V97, P1083, DOI 10.1016/S0953-7562(09)80509-1; Craven KD, 2001, SYDOWIA, V53, P44; de Jong EV, 2003, GENOME, V46, P277, DOI [10.1139/G03-001, 10.1139/g03-001]; de Llanos R, 2010, YEAST, V27, P549, DOI 10.1002/yea.1799; GALLAGHER RT, 1981, NEW ZEAL VET J, V29, P189, DOI 10.1080/00480169.1981.34843; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Groppe K, 1997, APPL ENVIRON MICROB, V63, P1543, DOI 10.1128/AEM.63.4.1543-1550.1997; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hancock JM, 2005, GENE, V345, P113, DOI 10.1016/j.gene.2004.11.023; Hancock JM, 1995, J MOL EVOL, V41, P1038; Hantula J, 1996, EUR J FOREST PATHOL, V26, P159; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Johnson L.J., 2013, FUNGAL DIVERS, V60, P171, DOI [10.1007/s13225-013-0239-4, DOI 10.1007/S13225-013-0239-4]; Karaoglu H, 2014, AUSTRALAS PLANT PATH, V43, P47, DOI 10.1007/s13313-013-0244-9; Karimi S, 2012, MYCOLOGIA, V104, P1281, DOI 10.3852/11-316; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kirkby KA, 2011, WEED RES, V51, P261, DOI 10.1111/j.1365-3180.2011.00846.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LEUCHTMANN A, 1990, PHYTOPATHOLOGY, V80, P1133, DOI 10.1094/Phyto-80-1133; LEUCHTMANN A, 1993, MYCOLOGIA, V85, P157, DOI 10.2307/3760451; Levdansky Emma, 2008, Fungal Biology Reviews, V22, P85, DOI 10.1016/j.fbr.2008.08.001; Leyva-Madrigal KY, 2014, J MICROBIOL METH, V101, P18, DOI 10.1016/j.mimet.2014.03.011; Li W, 2014, CURR GENET, V60, P237, DOI 10.1007/s00294-014-0428-z; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; Moon CD, 1999, APPL ENVIRON MICROB, V65, P1268; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; ROWAN DD, 1986, J CHEM ECOL, V12, P647, DOI 10.1007/BF01012099; Sampaio P, 2009, ANTON LEEUW INT J G, V96, P395, DOI 10.1007/s10482-009-9352-5; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schardl CL, 2012, FUNGAL ECOL, V5, P331, DOI 10.1016/j.funeco.2011.04.005; SCHARDL CL, 1991, PLANT SYST EVOL, V178, P27, DOI 10.1007/BF00937980; SCHARDL CL, 1994, GENETICS, V136, P1307; Tanaka A, 2012, CURR OPIN PLANT BIOL, V15, P462, DOI 10.1016/j.pbi.2012.03.007; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Young CA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00095	49	5	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183748	10.1371/journal.pone.0183748	http://dx.doi.org/10.1371/journal.pone.0183748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886068	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100034
J	Dam, AEH; van Boxtel, MPJ; Rozendaal, N; Verhey, FRJ; de Vugt, ME				Dam, Alieske E. H.; van Boxtel, Martin P. J.; Rozendaal, Nico; Verhey, Frans R. J.; de Vugt, Marjolein E.			Development and feasibility of Inlife: A pilot study of an online social support intervention for informal caregivers of people with dementia	PLOS ONE			English	Article							HEALTH; NETWORK; BURDEN; SCALE; LONELINESS; PROGRAM	Background Informal caregivers of individuals with dementia have an increased risk to face social isolation due to progression of the disease. Online social media interventions might offer a new opportunity to increase access to social support and enhance positive interactions and openness in dementia care networks. Objective This explorative pilot study describes (1) the development of an online social support intervention Inlife, and (2) the evaluation of the feasibility of this intervention and the measurements to assess its effectiveness. Methods The Medical Research Council (MRC) framework guided the development of the online social support intervention. This is a stepwise approach that integrates potential users' views with the development and validation of the program content. The program was developed by combining (1) individual caregiver interviews (n = 10), (2) focus group sessions with experts and web designers (n = 6), and (3) individual think-aloud tests (n = 2). Subsequently, a pilot study with informal caregivers was conducted (n = 25) to examine the program's feasibility and preliminary effectiveness. Online self-report measures were completed at baseline and at four follow-up time points. Results In total, 23 participants completed the newly developed Inlife intervention. Despite the high number of low-active users (17/23, 73%), Inlife had a good feasibility score of 7.1 (range: 1-10). The Calendar and Timeline were used most frequently and contributed to better care coordination and positive interactions. Conclusions Although the Inlife platform received a sufficient feasibility rating, the uptake was not optimal. Therefore, the Inlife platform was adapted to limit the number of low-active users and improve user friendliness. Recommendations for additional treatment adherence were provided. The development according to the MRC framework and the sufficient feasibility rating of Inlife formed the basis for a future effectiveness study.	[Dam, Alieske E. H.; van Boxtel, Martin P. J.; Rozendaal, Nico; Verhey, Frans R. J.; de Vugt, Marjolein E.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Alzheimer Ctr Limburg, Maastricht, Netherlands	Maastricht University	de Vugt, ME (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Alzheimer Ctr Limburg, Maastricht, Netherlands.	m.devugt@maastrichtuniversity.nl			ZonMw [70-73305-98-611]; Alzheimer Research Centre Limburg	ZonMw(Netherlands Organization for Health Research and Development); Alzheimer Research Centre Limburg	This study was supported by ZonMw (70-73305-98-611). There was no additional external funding received for this study. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the caregivers for their participation in this study and the Alzheimer Research Centre Limburg and ZonMw for the (financial) support of this study.	Aalbers T, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4468; Amieva H, 2010, PSYCHOSOM MED, V72, P905, DOI 10.1097/PSY.0b013e3181f5e121; Baum A., 1984, HDB PSYCHOL HLTH; Beeson RA, 2003, ARCH PSYCHIAT NURS, V17, P135, DOI 10.1016/S0883-9417(03)00057-8; Bennett GG, 2009, ANNU REV PUBL HEALTH, V30, P273, DOI 10.1146/annurev.publhealth.031308.100235; Blom MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116622; Blom MM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-17; Boots LMM, 2014, INT J GERIATR PSYCH, V29, P331, DOI 10.1002/gps.4016; Boots LMM, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5142; Boots LMM, 2015, INT PSYCHOGERIATR, V27, P927, DOI 10.1017/S1041610214002804; BRENNAN PF, 1995, NURS RES, V44, P166; Bujnowska-Fedak MM, 2014, TELEMED E-HEALTH, V20, P696, DOI 10.1089/tmj.2013.0318; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Carbonneau H, 2010, DEMENTIA, V9, P327, DOI DOI 10.1177/1471301210375316; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dam AEH, 2017, INT PSYPCHOGERIATR I, V30, P1; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; De Jong Gierveld J., 1999, MANUAL LONELINESS SC; De Jong Gierveld J., 2016, CAMBRIDGE HDB PERSON, P1; de Vugt M, 2017, AGING MENT HEALTH, V21, P1, DOI 10.1080/13607863.2016.1262822; DROES RM, 1991, BEWEGING PSYCHOSOCIA; Glueckauf RL, 2004, TELEMED J E-HEALTH, V10, P223, DOI 10.1089/1530562041641354; IBM Corp, 2016, IBM SPSS STAT MAC; Jaspers MWM, 2009, INT J MED INFORM, V78, P340, DOI 10.1016/j.ijmedinf.2008.10.002; KEMPEN GIJM, 1995, SOC INDIC RES, V35, P303, DOI 10.1007/BF01079163; Kerkhof YJ, 2016, INT PSYCHOGERIATR, P1; Kim H., 2015, INTERACTIVE J MED RE, V4; Leinonen E, 2001, INT J GERIATR PSYCH, V16, P387, DOI 10.1002/gps.351; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Lund A. M., 2001, MEASURING USABILITY, V12; Meiland Franka, 2017, JMIR Rehabil Assist Technol, V4, pe1, DOI 10.2196/rehab.6376; MONAHAN DJ, 1995, SOC WORK, V40, P305; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Reijnders J, 2015, EDUC GERONTOL, V41, P613, DOI 10.1080/03601277.2015.1024554; Schaller S, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.4354; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Sutherland J, 2011, SCRUM GUIDE DEFINITI; Vernooij-Dassen MJFJ, 1999, J AM GERIATR SOC, V47, P256, DOI 10.1111/j.1532-5415.1999.tb04588.x; Wills T. A., 2000, SOCIAL SUPPORT MEASU, P86, DOI DOI 10.1093/MED:PSYCH/9780195126709.003.0004; Wittenberg-Lyles E, 2014, HEALTH COMMUN, V29, P901, DOI 10.1080/10410236.2013.815111; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wright KB, 2010, COMMUN MONOGR, V77, P500, DOI 10.1080/03637751.2010.502538; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	46	30	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183386	10.1371/journal.pone.0183386	http://dx.doi.org/10.1371/journal.pone.0183386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886056	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100019
J	Delval, A; Defebvre, L; Tard, C				Delval, Arnaud; Defebvre, Luc; Tard, Celine			Freezing during tapping tasks in patients with advanced Parkinson's disease and freezing of gait	PLOS ONE			English	Article							REPETITIVE FINGER MOVEMENTS; QUALITY-OF-LIFE; MOTOR; VARIABILITY; DISORDER; FALLS	Introduction Parkinson's disease patients with freezing of gait also experience sudden motor blocks (freezing) during other repetitive motor tasks. We assessed the proportion of patients with advanced PD and freezing of gait who also displayed segmental "freezing" in tapping tasks. Methods Fifteen Parkinson's disease patients with freezing of gait were assessed. Freezing of gait was evaluated using a standardized gait trajectory with the usual triggers. Patients performed repetitive tapping movements (as described in the MDS-UPDRS task) with the hands or the feet in the presence or absence of a metronome set to 4 Hz. Movements were recorded with a video motion system. The primary endpoint was the occurrence of segmental freezing in these tapping tasks. The secondary endpoints were (i) the relationship between segmental episodic phenomena and FoG severity, and (ii) the reliability of the measurements. Results For the upper limbs, freezing was observed more frequently with a metronome (21% of trials) than without a metronome (5%). For the lower limbs, the incidence of freezing was higher than for the upper limbs, and was again observed more frequently in the presence of an auditory cue (47%) than in its absence (14%). Conclusion Although freezing of the lower limbs was easily assessed during an MDS-UPDRS task with a metronome, it was not correlated with the severity of freezing of gait (as evaluated during a standardized gait trajectory). Only this latter was a reliable measurement in patients with advanced Parkinson's disease.	[Delval, Arnaud; Defebvre, Luc; Tard, Celine] Univ Lille, INSERM, Degenerat & Vasc Cognit Disorders U1171, Lille, France; [Delval, Arnaud; Tard, Celine] Lille Univ, Med Ctr, Clin Neurophysiol Dept, Lille, France; [Delval, Arnaud; Defebvre, Luc; Tard, Celine] Univ Lille, LiCEND, Lille Ctr Excellence Neurodegenerat Dis, Lille, France; [Defebvre, Luc; Tard, Celine] Lille Univ, Med Ctr, Neurol & Movement Disorders Dept, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Delval, A (corresponding author), Univ Lille, INSERM, Degenerat & Vasc Cognit Disorders U1171, Lille, France.; Delval, A (corresponding author), Lille Univ, Med Ctr, Clin Neurophysiol Dept, Lille, France.; Delval, A (corresponding author), Univ Lille, LiCEND, Lille Ctr Excellence Neurodegenerat Dis, Lille, France.	arnaud.delval@chru-lille.fr	Tard, Céline/GRR-8269-2022	Delval, Arnaud/0000-0003-0642-3541	Santelys	Santelys	Celine Tard received a grant from Santelys and has received various honoraria for lectures on neuromuscular disorders. Luc Defebvre served on several Scientific Advisory Boards for Abbvie and Zambon. He has received various honoraria from pharmaceutical companies for consultancy and lectures on Parkinsons disease at symposia. These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thanks Santelys for funding.	Abe K, 2003, BRAIN RES BULL, V61, P219, DOI 10.1016/S0361-9230(03)00119-9; Almeida QJ, 2002, MOVEMENT DISORD, V17, P30, DOI 10.1002/mds.10030; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Bronte-Stewart HM, 2000, MOVEMENT DISORD, V15, P36, DOI 10.1002/1531-8257(200001)15:1<36::AID-MDS1008>3.0.CO;2-M; Delval A, 2016, MOVEMENT DISORD, V31, P1837, DOI 10.1002/mds.26762; GIBB WRG, 1988, POSTGRAD MED J, V64, P345, DOI 10.1136/pgmj.64.751.345; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Gilat M, 2017, NEUROIMAGE, V152, P207, DOI 10.1016/j.neuroimage.2017.02.073; Gilat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066718; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Heremans E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142874; Heremans E, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0350-7; Herman T, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0411-y; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Jones CRG, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00081; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Martens KAE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106561; Matar E, 2013, PARKINSONISM RELAT D, V19, P937, DOI 10.1016/j.parkreldis.2013.06.002; Moore O, 2007, MOVEMENT DISORD, V22, P2192, DOI 10.1002/mds.21659; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Perez-Lloret S, 2014, JAMA NEUROL, V71, P884, DOI 10.1001/jamaneurol.2014.753; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Snijders AH, 2008, MOVEMENT DISORD, V23, pS468, DOI 10.1002/mds.22144; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Stegemoller EL, 2013, NEUROSCI LETT, V552, P135, DOI 10.1016/j.neulet.2013.07.056; Stegemoller EL, 2009, MOVEMENT DISORD, V24, P1162, DOI 10.1002/mds.22535; Tard C, 2015, J PARKINSON DIS, V5, P379, DOI 10.3233/JPD-140498; Vercruysse S, 2014, NEUROSCI BIOBEHAV R, V43, P213, DOI 10.1016/j.neubiorev.2014.04.010; Vercruysse S, 2012, NEUROREHAB NEURAL RE, V26, P636, DOI 10.1177/1545968311431964; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Williams AJ, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/595378; Yahalom G, 2004, PARKINSONISM RELAT D, V10, P143, DOI 10.1016/j.parkreldis.2003.10.001; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0181973	10.1371/journal.pone.0181973	http://dx.doi.org/10.1371/journal.pone.0181973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886015	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100004
J	Dahms, HU; Tseng, LC; Hwang, JS				Dahms, Hans-Uwe; Tseng, Li-Chun; Hwang, Jiang-Shiou			Are vent crab behavioral preferences adaptations for habitat choice?	PLOS ONE			English	Article							HYDROTHERMAL VENTS; TAIWAN; SYSTEM; RIDGE; SEA; BIOACCUMULATION; ENVIRONMENT; VARUNIDAE; BRACHYURA; SEDIMENTS	Hydrothermal vent organisms are adapted to their extreme and patchily distributed habitats. They are expected to have evolved mechanisms that keep them in their specific habitation. Since little is known about the recruitment or habitat selection of HV organisms such as brachyurans, we examined the properties of several hydrothermal vent-associated cues on the behavior of the hydrothermal vent (HV) crab Xenograpsus testudinatus in the laboratory that were contrasted by the offering of non-vent cues. This crab species is endemic and dominates the vent fauna of Turtle Island off the NE coast of Taiwan. HV crabs were separately and in combination offered the following vent-specific cues: (1) sulfuric sediment, (3) airbubbling, (4) elevated temperature, (5) dead settled zooplankton, (7) other crabs, and (8) shade. The non-vent-specific cues were: (2) quarz sediment, (6) dead fish, (8) light. These cues were provided on either side of a two-choice chamber. The movement of individual crabs was monitored: as initial and final choices, and as the proportion of time the crabs spent in each compartment (resident time). Cues were offered alone and no such cue as a control in the same set-up. Sulfuric sediments and dead fish were significantly more attractive to females, and other crabs irrespective of gender were significantly more attractive to males. When compared to expected distributions, crabs, irrespective of gender, significantly avoided light and tended to select other crabs, air-bubbling, sulfuric sediment, elevated temperature, dead fish, dead zooplankton, and quarz sediments in the order of decreasing importance. Data do not support the hypothesis that dead settled zooplankton was particularly attractive nor that the other gender was selected. A combination of several vent-associated cues (sulfuric sediment, elevated temperature, air-bubbling) facilitated the strongest attraction to the crabs as reflected by all response variables. The 'first choice' responses were always consistent with the side of the choice compartment in which they spent the longest amount of time (resident time), but not with the 'final choice' of crabs, suggesting that the 'resident time' in addition to their 'first choice' is more reliable than just the 'final choice'. The present results provide the first indication that several vent-associated habitat cues function as attractors for HV crabs. Habitat choice is also reflected by crab larval distribution in the field which tend to stay near the bottom not to be carried away from their specific habitat.	[Dahms, Hans-Uwe] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Dahms, Hans-Uwe] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; National Taiwan Ocean University	Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan.	jshwang@mail.ntou.edu.tw		Tseng, Li-Chun/0000-0003-0251-565X	Research Center for Environmental Medicine, Kaohsiung Medical University (KMU) [MOST105-2621-M-037-001]	Research Center for Environmental Medicine, Kaohsiung Medical University (KMU)	H.-U. Dahms acknowledges the support of a grant from the Research Center for Environmental Medicine, Kaohsiung Medical University (KMU) and MOST105-2621-M-037-001 to T.H. Shih.; H.-U. Dahms acknowledges the support of a grant from the Research Center for Environmental Medicine, Kaohsiung Medical University (KMU) and MOST105-2621-M-037-001 to T.H. Shih. We thank Prof. Mark Grygier (Lake Biwa Museum, Japan) for further linguistic corrections that are included in this revision. We are thankful for the assistance provided by the captain and crew of "Ocean Research Vessel II", Taiwan. We thank the technicians from J.-S. Hwang's laboratory for their contribution to the field sampling program.	Bauer RT, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P277, DOI 10.1007/978-0-387-77101-4_14; BISCHOFF JL, 1988, GEOCHIM COSMOCHIM AC, V52, P2121, DOI 10.1016/0016-7037(88)90192-5; Chan BKK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148675; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen CTA, 2005, ACTA OCEANOL SIN, V24, P125; Chengsung Wang M-LY, 2000, TAO TERR ATMOS OCEAN, V11, P459; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Colaco A, 2006, CHEMOSPHERE, V65, P2260, DOI 10.1016/j.chemosphere.2006.05.034; Cosson RP, 1997, CAH BIOL MAR, V38, P43; Dahms HU, 2007, AQUACULTURE, V265, P169, DOI 10.1016/j.aquaculture.2007.01.029; Dahms HU, 2007, J EXP MAR BIOL ECOL, V341, P228, DOI 10.1016/j.jembe.2006.10.027; Dahms HU, 2006, ESTUAR COAST SHELF S, V67, P562, DOI 10.1016/j.ecss.2005.12.011; Dahms HU, 2014, J MAR SCI TECH-TAIW, V22, P82, DOI 10.6119/JMST-013-0312-2; Dahms HU, 2005, MAR ECOL PROG SER, V297, P203, DOI 10.3354/meps297203; Desbruyeres DM, 2006, LINZ MUSEUM, P1; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; Epifanio CE, 1999, MAR ECOL PROG SER, V185, P147, DOI 10.3354/meps185147; FISHER CR, 1990, REV AQUAT SCI, V2, P399; German C, 2002, NATURE, V415, P124, DOI 10.1038/415124a; Guinot Daniele, 1997, Zoosystema, V19, P121; Haraguchi K, 2000, SCI TOTAL ENVIRON, V261, P75, DOI 10.1016/S0048-9697(00)00626-4; Hessler R.R., 1983, Systematics Association Special Volume Series, P227; Hsiao SH, 2013, MAR POLLUT BULL, V74, P175, DOI 10.1016/j.marpolbul.2013.07.007; Hwang J-S, 1998, NATL TAIWAN MUSEUM, V10, P1; Hwang JS, 2008, CRUSTACEANA, V81, P375, DOI 10.1163/156854008783564127; Hwang JS, 2003, NE COAST NATL SCEN A, P1; Jeng MS, 2004, NATURE, V432, P969, DOI 10.1038/432969a; Jeng MS, 2004, J CRUSTACEAN BIOL, V24, P188, DOI 10.1651/C-2359; Jinks RN, 1998, CAH BIOL MAR, V39, P309; Ki JS, 2009, COMP BIOCHEM PHYS D, V4, P290, DOI 10.1016/j.cbd.2009.07.002; Lu SY, 2014, MAR POLICY, V48, P21, DOI 10.1016/j.marpol.2014.03.001; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; McLay C, 2007, ZOOTAXA, P1; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; NEWMAN WA, 1985, B BIOL SOC WASH, V6, P231; Ng N.K., 2000, National Taiwan Museum Special Publication Series, V10, P191; ROBIGOU V, 1993, GEOPHYS RES LETT, V20, P1887, DOI 10.1029/93GL01399; Robins PE, 2013, LIMNOL OCEANOGR, V58, P505, DOI 10.4319/lo.2013.58.2.0505; Sarradin PM, 1998, CAH BIOL MAR, V39, P159; Todd CD, 1998, COLONIZATION PHYS CH, V132, P1; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1; Tunnicliffe V, 1998, ADV MARINE BIOL; Van Dover C.L., 1995, BULL BIOL SOC WASH, V6, P223; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vignesh S, 2016, PLOS ONE; Wang L, 2015, J BASIC MICROB, V55, P1308, DOI 10.1002/jobm.201400811; WILLIAMS A B, 1980, Proceedings of the Biological Society of Washington, V93, P443; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469; Zar JH, 1999, BIOSTATISTICAL ANAL	50	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182649	10.1371/journal.pone.0182649	http://dx.doi.org/10.1371/journal.pone.0182649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880871	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200009
J	Karasov, TL; Barrett, L; Hershberg, R; Bergelson, J				Karasov, Talia L.; Barrett, Luke; Hershberg, Ruth; Bergelson, Joy			Similar levels of gene content variation observed for Pseudomonas syringae populations extracted from single and multiple host species	PLOS ONE			English	Article							MICROBIAL PAN-GENOME; ARABIDOPSIS-THALIANA; PATHOGEN METAPOPULATION; PV. PHASEOLICOLA; PLANT; VIRULENCE; DIVERSITY; SYSTEM; VIRIDIFLAVA; VARIABILITY	Bacterial strains of the same species collected from different hosts frequently exhibit differences in gene content. In the ubiquitous plant pathogen Pseudomonas syringae, more than 30% of genes encoded by each strain are not conserved among strains colonizing other host species. Although they are often implicated in host specificity, the role of this large fraction of the genome in host-specific adaptation is largely unexplored. Here, we sought to relate variation in gene content between strains infecting different species to variation that persists between strains on the same host. We fully sequenced a collection of P. syringae strains collected from wild Arabidopsis thaliana populations in the Midwestern United States. We then compared patterns of variation observed in gene content within these A. thaliana-isolated strains to previously published P. syringae sequence from strains collected on a diversity of crop species. We find that strains collected from the same host, A. thaliana, differ in gene content by 21%, 2/3 the level of gene content variation observed across strains collected from different hosts. Furthermore, the frequency with which specific genes are present among strains collected within the same host and among strains collected from different hosts is highly correlated. This implies that most gene content variation is maintained irrespective of host association. At the same time, we identify specific genes whose presence is important for P. syringae's ability to flourish within A. thaliana. Specifically, the A. thaliana strains uniquely share a genomic island encoding toxins active against plants and surrounding microbes, suggesting a role for microbe-microbe interactions in dictating the abundance within this host. Overall, our results demonstrate that while variation in the presence of specific genes can affect the success of a pathogen within its host, the majority of gene content variation is not strongly associated with patterns of host use.	[Karasov, Talia L.; Bergelson, Joy] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Karasov, Talia L.; Barrett, Luke; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA; [Barrett, Luke] CSIRO Agr, Canberra, ACT 2601, Australia; [Hershberg, Ruth] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Genet, Haifa, Israel	University of Chicago; University of Chicago; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bergelson, J (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.; Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Barrett, Luke G/I-5711-2015	Barrett, Luke G/0000-0001-6530-0731; Karasov, Talia/0000-0002-3592-6597; Bergelson, Joy/0000-0001-7893-7387	Graduate Assistance in Areas of National Need (GAANN); NSF DDIG [1311515]; ERC FP7 CIG grant; Yigal Allon Fellowship; Robert J. Shillman Career Advancement Chair;  [NSF345 MCB 0603515]	Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); NSF DDIG(National Science Foundation (NSF)); ERC FP7 CIG grant; Yigal Allon Fellowship; Robert J. Shillman Career Advancement Chair; 	Funded by NSF345 MCB 0603515 to JB. https://www.nsf.gov/. TLK was supported by a Graduate Assistance in Areas of National Need (GAANN) training grant and NSF DDIG 1311515. https://www.nsf.gov/. RH was supported by an ERC FP7 CIG grant (https://erc.europa.eu/), by a Yigal Allon Fellowship (http://www.utdallas.edu/similar to DJL101000/DavidLary/Awards/Entries/1998/10/1_Alon_Fellowships_for_Outstanding_Young_Researchers.html), and by the Robert J. Shillman Career Advancement Chair.	Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2016, MOL PLANT PATHOL; Baltrus DA, 2012, MOL PLANT MICROBE IN, V25, P877, DOI 10.1094/MPMI-08-11-0218; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Bartoli C, 2014, ENVIRON MICROBIOL, V16, P2301, DOI 10.1111/1462-2920.12433; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolotin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35168; Bolotin E, 2015, GENOME BIOL EVOL, V7, P2173, DOI 10.1093/gbe/evv135; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clarke CR, 2010, MOL PLANT MICROBE IN, V23, P198, DOI 10.1094/MPMI-23-2-0198; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Gao LP, 2009, NEW PHYTOL, V184, P485, DOI 10.1111/j.1469-8137.2009.02959.x; Godfrey SAC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002010; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; Haegeman B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-196; HASEGAWA M, 1991, J MOL EVOL, V32, P443, DOI 10.1007/BF02101285; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hockett KL, 2014, MOL PLANT MICROBE IN, V27, P923, DOI 10.1094/MPMI-11-13-0354-R; Horton MW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6320; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Jackson RW, 2000, MOL MICROBIOL, V38, P186, DOI 10.1046/j.1365-2958.2000.02133.x; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karasov TL, 2014, CURR OPIN PLANT BIOL, V18, P24, DOI 10.1016/j.pbi.2013.12.003; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Kniskern JM, 2007, MOL PLANT MICROBE IN, V20, P1512, DOI 10.1094/MPMI-20-12-1512; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Nowell RW, 2014, GENOME BIOL EVOL, V6, P1514, DOI 10.1093/gbe/evu123; Nowell RW, 2016, MOL PLANT PATHOL; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Renick LJ, 2008, PLANT DIS, V92, P372, DOI 10.1094/PDIS-92-3-0372; Sarkar SF, 2008, APPL ENVIRON MICROB, V74, P1961, DOI 10.1128/AEM.02553-07; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184195	10.1371/journal.pone.0184195	http://dx.doi.org/10.1371/journal.pone.0184195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880925	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200039
J	Castagnola, P; Gandolfo, S; Malacarne, D; Aiello, C; Marino, R; Zoppoli, G; Ballestrero, A; Giaretti, W; Pentenero, M				Castagnola, Patrizio; Gandolfo, Sergio; Malacarne, Davide; Aiello, Cinzia; Marino, Roberto; Zoppoli, Gabriele; Ballestrero, Alberto; Giaretti, Walter; Pentenero, Monica			DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; ORAL EPITHELIAL DYSPLASIA; CHROMOSOMAL INSTABILITY; HUMAN CANCER; RISK; PROGRESSION; CARCINOGENESIS; CHALLENGES; CYTOMETRY; LESIONS	The aim of this study was to investigate the relationship between tobacco smoke habit, patient age, DNA aneuploidy and genomic DNA copy number aberrations (CNAs) in oral potentially malignant disorder (OPMD) and oral squamous cell carcinoma (OSCC) patients. DNA aneuploidy was detected by high-resolution DNA flow cytometry (hr DNA-FCM) on DAPI stained nuclei obtained from multiple tissue samples from OPMDs/OSCCs in 220 consecutive patients. Nuclear genomic aberrations were determined in a subset of 65 patients by genome-wide array comparative genomic hybridization (aCGH) using DNA extracted from either diploid or aneuploid nuclei suspension sorted by FCM. DNA aneuploidy and mean nuclear genomic aberrations were associated with patients' age. In particular, DNA aneuploidy strongly associated with age in non-smoker OPMDs/OSCCs patients. OSCCs from smokers showed a lower prevalence of DNA aneuploidy compared to OSCCs from non-smokers. A higher occurrence of DNA aneuploidy (particularly in smokers' OPMDs) was observed in patients characterized by involvement of a single oral subsite. Our study suggests that: 1) DNA aneuploidy in non-smokers is mainly related to aging; 2) OPMDs/OSCCs involving multiple oral subsites in smokers are less likely to develop DNA aneuploidy compared to non-smokers; 3) OSCC development is characterized by both CIN and CIN-independent mechanisms and that the latter are more relevant in smokers. This study provides evidence that DNA diploid OPMDs may be considered at lower risk of cancerization than DNA aneuploid ones in non-smokers but not in smokers.	[Castagnola, Patrizio; Malacarne, Davide; Aiello, Cinzia; Zoppoli, Gabriele; Ballestrero, Alberto; Giaretti, Walter] IRCCS, AOU San Martino IST, Dept Integrated Oncol Therapies, Genoa, Italy; [Gandolfo, Sergio; Marino, Roberto; Pentenero, Monica] Univ Turin, Oral Med & Oral Oncol Unit, Dept Oncol, Turin, Italy; [Zoppoli, Gabriele; Ballestrero, Alberto] Univ Genoa, Dept Internal Med DiMI, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Turin; University of Genoa	Castagnola, P (corresponding author), IRCCS, AOU San Martino IST, Dept Integrated Oncol Therapies, Genoa, Italy.	patrizio.castagnola@hsanmartino.it	Ballestrero, Alberto/K-7546-2016; Castagnola, Patrizio/H-2029-2012; Zoppoli, Gabriele/B-6935-2016	Ballestrero, Alberto/0000-0002-2601-7711; Castagnola, Patrizio/0000-0003-2008-9199; Zoppoli, Gabriele/0000-0002-1619-1708				Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Bradley G, 2010, BRIT J CANCER, V103, P1432, DOI 10.1038/sj.bjc.6605905; Bradley G, 2017, ORAL DIS; Brennan M, 2007, ORAL SURG ORAL MED O, V103, pS19, DOI 10.1016/j.tripleo.2006.10.015; Carlson JM HD, 2009, MSRTR20095337; Castagnola P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142294; Castagnola P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-445; Chen KM, 2013, INT J CANCER, V133, P1300, DOI 10.1002/ijc.28152; Dionne KR, 2015, INT J CANCER, V136, P503, DOI 10.1002/ijc.28754; Donadini A, 2010, CELL ONCOL, V32, P373, DOI 10.3233/CLO-2010-0525; Giaretti W, 2012, CELL ONCOL, V35, P43, DOI 10.1007/s13402-011-0064-2; Giaretti W, 2013, CANCER EPIDEM BIOMAR, V22, P1133, DOI 10.1158/1055-9965.EPI-13-0147; Giaretti W, 2012, FUTURE ONCOL, V8, P1257, DOI [10.2217/fon.12.116, 10.2217/FON.12.116]; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Holgersson H, 2014, J APPL STAT, V41, P233, DOI 10.1080/02664763.2013.838665; Kodama M, 1997, ANTICANCER RES, V17, P433; Lima CF, 2017, J ORAL PATHOL MED; Motgi AA, 2014, J CANCER RES THER, V10, P165, DOI 10.4103/0973-1482.131454; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Navone R, 2008, J ORAL PATHOL MED, V37, P358, DOI 10.1111/j.1600-0714.2008.00636.x; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; OTTO FJ, 1994, METHOD CELL BIOL, V41, P211; Pentenero M, 2009, ORAL ONCOL, V45, P887, DOI 10.1016/j.oraloncology.2009.03.008; Petti S, 2003, ORAL ONCOL, V39, P770, DOI 10.1016/S1368-8375(03)00102-7; Phillips DH, 2012, INT J CANCER, V131, P2733, DOI 10.1002/ijc.27827; Sarode Sachin C, 2014, J Oral Maxillofac Pathol, V18, pS77, DOI 10.4103/0973-029X.141322; Scully C, 2014, ORAL DIS, V20, P1, DOI 10.1111/odi.12208; Souto GR, 2010, J ORAL PATHOL MED, V39, P605, DOI 10.1111/j.1600-0714.2010.00907.x; Sperandio M, 2013, CANCER PREV RES, V6, P822, DOI 10.1158/1940-6207.CAPR-13-0001; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Torres-Rendon A, 2009, ORAL ONCOL, V45, P468, DOI 10.1016/j.oraloncology.2008.07.006; WALDRON CA, 1975, CANCER-AM CANCER SOC, V36, P1386, DOI 10.1002/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7; Warnakulasuriya S, 2005, ORAL ONCOL, V41, P244, DOI 10.1016/j.oraloncology.2004.08.010	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184425	10.1371/journal.pone.0184425	http://dx.doi.org/10.1371/journal.pone.0184425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877236	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200100
J	Duffy, D; Mottez, E; Ainsworth, S; Buivan, TP; Baudin, A; Vray, M; Reed, B; Fontanet, A; Rohel, A; Petrov-Sanchez, V; Abel, L; Theodorou, I; Miele, G; Pol, S; Albert, ML				Duffy, Darragh; Mottez, Estelle; Ainsworth, Shaun; Buivan, Tan-Phuc; Baudin, Aurelie; Vray, Muriel; Reed, Ben; Fontanet, Arnaud; Rohel, Alexandra; Petrov-Sanchez, Ventzislava; Abel, Laurent; Theodorou, Ioannis; Miele, Gino; Pol, Stanislas; Albert, Matthew L.			An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MYCOBACTERIUM-TUBERCULOSIS; HEPATOCELLULAR-CARCINOMA; RIFAMPIN RESISTANCE; GENETIC-VARIATION; TECHNOLOGY; CHALLENGES; CLEARANCE; SIGNATURE	Numerous genetic polymorphisms have been identified as associated with disease or treatment outcome, but the routine implementation of genotyping into actionable medical care remains limited. Point-of-care (PoC) technologies enable rapid and real-time treatment decisions, with great potential for extending molecular diagnostic approaches to settings with limited medical infrastructure (e.g., CLIA certified diagnostic laboratories). With respect to resource-limited settings, there is a need for simple devices to implement biomarker guided treatment strategies. One relevant example is chronic hepatitis C infection, for which several treatment options are now approved. Single nucleotide polymorphisms (SNPs) in the IL-28B / IFNL3 locus have been well described to predict both spontaneous clearance and response to interferon based therapies. We utilized the Genedrive (R) platform to develop an assay for the SNP rs12979860 variants (CC, CT and TT). The assay utilizes a hybrid thermal engine, permitting rapid heating and cooling, enabling an amplification based assay with genetic variants reported using endpoint differential melting cure analysis in less than 60 minutes. We validated this assay using non-invasive buccal swab sampling in a prospective study of 246 chronic HCV patients, achieving 100% sensitivity and 100% specificity (95% exact CI: 98.8-100%)) in 50 minutes as compared to conventional lab based PCR testing. Our results provide proof of concept that precision medicine is feasible in resource-limited settings, offering the first CE-IVD (in vitro diagnostics) validated PoC SNP test. We propose that IL-28B genotyping may be useful for directing patients towards lower cost therapies, and rationing use of costly direct antivirals for use in those individuals showing genetic risk.	[Duffy, Darragh; Pol, Stanislas; Albert, Matthew L.] Inst Pasteur, Immunobiol Dendrit Cells, Paris, France; [Duffy, Darragh; Pol, Stanislas; Albert, Matthew L.] INSERM, U1223, Inst Pasteur, Paris, France; [Duffy, Darragh; Mottez, Estelle; Buivan, Tan-Phuc; Pol, Stanislas; Albert, Matthew L.] Inst Pasteur, Ctr Translat Res, Paris, France; [Mottez, Estelle; Buivan, Tan-Phuc; Pol, Stanislas; Albert, Matthew L.] INSERM, UMS20, Inst Pasteur, Paris, France; [Ainsworth, Shaun; Reed, Ben; Miele, Gino] Genedr Plc, Manchester, Lancs, England; [Buivan, Tan-Phuc; Baudin, Aurelie; Pol, Stanislas] Univ Paris 05, Paris, France; [Buivan, Tan-Phuc; Baudin, Aurelie; Pol, Stanislas] Grp Hosp Cochin Hotel Dieu, Dept Hepatol, Paris, France; [Vray, Muriel; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Vray, Muriel; Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, PARCI Unit, Paris, France; [Vray, Muriel] Inst Pasteur, Unit Epidemiol Infect Dis, Dakar, Senegal; [Rohel, Alexandra; Petrov-Sanchez, Ventzislava] ANRS France Rech Nord & Sud Sida Hiv Hepatites, Paris, France; [Abel, Laurent] INSERM, U1163, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Abel, Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Abel, Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Theodorou, Ioannis] La Pitie Salpetriere, Dept Immunol, AP HP, Paris, France; [Albert, Matthew L.] Genentech Inc, Dept Canc Immunol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Roche Holding; Genentech	Albert, ML (corresponding author), Inst Pasteur, Immunobiol Dendrit Cells, Paris, France.; Albert, ML (corresponding author), INSERM, U1223, Inst Pasteur, Paris, France.; Albert, ML (corresponding author), Inst Pasteur, Ctr Translat Res, Paris, France.; Albert, ML (corresponding author), INSERM, UMS20, Inst Pasteur, Paris, France.; Miele, G (corresponding author), Genedr Plc, Manchester, Lancs, England.	g.miele@epistem.co.uk; albertm@pasteur.fr	Vray, Muriel/M-7947-2018	, arnaud/0000-0002-5239-6110	European Commission FP7 project PoC-HCV [601851]	European Commission FP7 project PoC-HCV	This work was financed by the European Commission FP7 project PoC-HCV (Grant agreement no 601851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Arends JE, 2016, CLIN MICROBIOL INFEC, V22, P846, DOI 10.1016/j.cmi.2016.05.027; Cariani E, 2016, PHARMACOGENOMICS J, V16, P18, DOI 10.1038/tpj.2015.28; Castan P, 2014, J CLIN MICROBIOL, V52, P502, DOI 10.1128/JCM.02209-13; Chang KC, 2015, CLIN GASTROENTEROL H, V13, P1017, DOI 10.1016/j.cgh.2014.10.035; de Bruijn W, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00197; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Fournier PE, 2013, NAT REV MICROBIOL, V11, P574, DOI 10.1038/nrmicro3068; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hingorani AD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5945; Ibrahim MK, 2016, J INTERF CYTOK RES, V36, P698, DOI 10.1089/jir.2016.0042; Kamal SM, 2014, HEPATIC MED-EVID RES, V6, P61, DOI 10.2147/HMER.S41127; Malottki K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004188; Mangia A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3663-6; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Moran-Auth Y, 2016, HUM IMMUNOL, V77, P1280, DOI 10.1016/j.humimm.2016.09.007; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Pepe MS, 2004, STAT EVALUATION MED; Price AA, 2016, P NATL ACAD SCI USA, V113, P10678, DOI 10.1073/pnas.1602319113; Raja S, 2005, CLIN CHEM, V51, P882, DOI 10.1373/clinchem.2004.046474; Rao HY, 2017, J GASTROEN HEPATOL, V32, P244, DOI 10.1111/jgh.13467; St John Andrew, 2014, Clin Biochem Rev, V35, P155; Stattermayer AF, 2015, CURR OPIN VIROL, V14, P50, DOI 10.1016/j.coviro.2015.07.011; Tekola-Ayele F, 2015, PUBLIC HEALTH GENOM, V18, P242, DOI 10.1159/000433518; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thrift AP, 2016, NAT REV GASTROENTERO; Tian C, 2016, BIORXIV	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183084	10.1371/journal.pone.0183084	http://dx.doi.org/10.1371/journal.pone.0183084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877177	Green Published, Green Submitted, gold			2022-12-26	WOS:000409391200021
J	Ofori, BY; Stow, AJ; Baumgartner, JB; Beaumont, LJ				Ofori, Benjamin Y.; Stow, Adam J.; Baumgartner, John B.; Beaumont, Linda J.			Combining dispersal, landscape connectivity and habitat suitability to assess climateinduced changes in the distribution of Cunningham's skink, Egernia cunninghami	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; PSEUDO-ABSENCE DATA; RANGE SHIFTS; EXTINCTION RISK; GLOBAL CHANGE; SELECTING THRESHOLDS; CHANGE IMPACTS; PREDICTION; CONSERVATION; RESPONSES	The ability of species to track their climate niche is dependent on their dispersal potential and the connectivity of the landscape matrix linking current and future suitable habitat. However, studies modeling climate-driven range shifts rarely address the movement of species across landscapes realistically, often assuming "unlimited" or "no" dispersal. Here, we incorporate dispersal rate and landscape connectivity with a species distribution model (Maxent) to assess the extent to which the Cunningham's skink (Egernia cunninghami) may be capable of tracking spatial shifts in suitable habitat as climate changes. Our model was projected onto four contrasting, but equally plausible, scenarios describing futures that are (relative to now) hot/wet, warm/dry, hot/with similar precipitation and warm/wet, at six time horizons with decadal intervals (2020-2070) and at two spatial resolutions: 1 km and 250 m. The size of suitable habitat was projected to decline 23-63% at 1 km and 26-64% at 250 m, by 2070. Combining Maxent output with the dispersal rate of the species and connectivity of the intervening landscape matrix showed that most current populations in regions projected to become unsuitable in the medium to long term, will be unable to shift the distance necessary to reach suitable habitat. In particular, numerous populations currently inhabiting the trailing edge of the species' range are highly unlikely to be able to disperse fast enough to track climate change. Unless these populations are capable of adaptation they are likely to be extirpated. We note, however, that the core of the species distribution remains suitable across the broad spectrum of climate scenarios considered. Our findings highlight challenges faced by philopatric species and the importance of adaptation for the persistence of peripheral populations under climate change.	[Ofori, Benjamin Y.; Stow, Adam J.; Baumgartner, John B.; Beaumont, Linda J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Ofori, Benjamin Y.] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana	Macquarie University; University of Ghana	Ofori, BY (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.; Ofori, BY (corresponding author), Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana.	byofori@yahoo.com	Beaumont, Linda J/D-5499-2012; Baumgartner, John Bruno/S-9047-2017	Beaumont, Linda J/0000-0001-6307-1680; Baumgartner, John Bruno/0000-0002-8898-0300; Ofori, Benjamin Yeboah/0000-0002-3001-4695; Stow, Adam/0000-0002-6796-4854				Aiello-Lammens ME, 2011, GLOBAL CHANGE BIOL, V17, P3644, DOI 10.1111/j.1365-2486.2011.02497.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2004, K I MOD DEV K 1 COUP; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1987, MAP PROJECTIONS WORK; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Arnell N., 2015, SHORT GUIDE CLIMATE; Ashcroft MB, 2009, GLOBAL CHANGE BIOL, V15, P656, DOI 10.1111/j.1365-2486.2008.01762.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; BARWICK RE, 1965, STUDIES SCINCID LIZA; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Beaumont LJ, 2015, CLIM RES, V63, P203, DOI 10.3354/cr01294; Beaumont LJ, 2016, ECOLOGICAL MODELLING, V342, P135; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Braunisch V, 2010, ECOGRAPHY, V33, P826, DOI 10.1111/j.1600-0587.2009.05891.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Brooke C, 2008, CONSERV BIOL, V22, P1471, DOI 10.1111/j.1523-1739.2008.01031.x; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Bureau of Rural Sciences, 2010, US GUID CAV LAND US; Cabrelli AL, 2015, CLIMATIC CHANGE, V130, P223, DOI 10.1007/s10584-015-1358-6; Cabrelli AL, 2014, BIODIVERS CONSERV, V23, P3019, DOI 10.1007/s10531-014-0760-0; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Drielsma M, ECOLOGICAL IN PRESS; Duckett PE, 2013, DIVERS DISTRIB, V19, P964, DOI 10.1111/ddi.12071; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Evans JP, 2014, GEOSCI MODEL DEV, V7, P621, DOI 10.5194/gmd-7-621-2014; FLATO GM, 2005, 3 GENERATION COUPLED; Fordham DA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0198; Fordham DA, 2012, GLOBAL CHANGE BIOL, V18, P1357, DOI 10.1111/j.1365-2486.2011.02614.x; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Gillingham PK, 2012, ECOGRAPHY, V35, P831, DOI 10.1111/j.1600-0587.2011.07434.x; Gordon HB, 2002, CSIRO MK3 CLIMATE SY; Griesser M, 2014, BEHAV ECOL SOCIOBIOL, V68, P485, DOI 10.1007/s00265-013-1663-x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hsu CC, 2007, PARE, V12, P1; Hutchinson M.F., 2013, ANUSPLIN VERSION 4 4; Hutchinson M. F., 2014, METHODOLOGY GENERATI; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Ji F., 2012, 1 NARCLIM CONS, P1; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Langkilde T, 2004, OECOLOGIA, V140, P684, DOI 10.1007/s00442-004-1640-1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Ofori BY, 2017, ECOL EVOL, V7, P48, DOI 10.1002/ece3.2627; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M. L., 2007, CLIMATE CHANGE 2007; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Penman TD, 2010, DIVERS DISTRIB, V16, P109, DOI 10.1111/j.1472-4642.2009.00619.x; Peterson AT, 2004, CAN J ZOOL, V82, P851, DOI 10.1139/Z04-064; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Ruiz-Navarro A, 2016, GLOBAL CHANGE BIOL, V22, P3221, DOI 10.1111/gcb.13230; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Scheffers BR, 2013, BIOTROPICA, V45, P628, DOI 10.1111/btp.12042; Schurr FM, 2012, J BIOGEOGR, V39, P2146, DOI 10.1111/j.1365-2699.2012.02737.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Shabani F, 2016, ECOL EVOL, V6, P5973, DOI 10.1002/ece3.2332; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Stevenson-Holt CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112119; Stocker T.F., 2014, CLIM CHANG 2013 PHYS; Stow AJ, 2004, MOL ECOL, V13, P419, DOI 10.1046/j.1365-294X.2003.02061.x; Stow AJ, 2001, MOL ECOL, V10, P867, DOI 10.1046/j.1365-294X.2001.01253.x; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Walsh RE, 2016, GLOBAL CHANGE BIOL, V22, P3233, DOI 10.1111/gcb.13216; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Watling JI, 2015, ECOL MODEL, V309, P48, DOI 10.1016/j.ecolmodel.2015.03.017; Wilford J, 2012, GEODERMA, V183, P124, DOI 10.1016/j.geoderma.2010.12.022; Wright S, 1943, GENETICS, V28, P114; Xu T., 2011, ANUCLIM VERSION 6 1; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	123	8	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184193	10.1371/journal.pone.0184193	http://dx.doi.org/10.1371/journal.pone.0184193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873398	gold, Green Submitted, Green Published			2022-12-26	WOS:000409282800061
J	Cao, AQ; Jin, J; Li, SQ; Wang, JB				Cao, Aqin; Jin, Jie; Li, Shaoqing; Wang, Jianbo			Integrated analysis of mRNA and miRNA expression profiling in rice backcrossed progenies (BC2F12) with different plant height	PLOS ONE			English	Article							ORYZA-SATIVA L.; TRANSCRIPTOMIC ANALYSIS; CELLULOSE SYNTHESIS; CELL ELONGATION; RESISTANCE GENE; GIBBERELLIN; LONGISTAMINATA; BIOSYNTHESIS; ARABIDOPSIS; HYBRID	Inter-specific hybridization and backcrossing commonly occur in plants. The use of progeny generated from inter-specific hybridization and backcrossing has been developed as a novel model system to explore gene expression divergence. The present study investigated the analysis of gene expression and miRNA regulation in backcrossed introgression lines constructed from cultivated and wild rice. High-throughput sequencing was used to compare gene and miRNA expression profiles in three progeny lines (L1710, L1817 and L1730), with different plant heights resulting from the backcrossing of introgression lines (BC2F12) and their parents (O. sativa and O. longistaminata). A total of 25,387 to 26,139 mRNAs and 379 to 419 miRNAs were obtained in these rice lines. More differentially expressed genes and miRNAs were detected in progeny/O. longistaminata comparison groups than in progeny/O. sativa comparison groups. Approximately 80% of the genes and miRNAs showed expression level dominance to O. sativa, indicating that three progeny lines were closer to the recurrent parent, which might be influenced by their parental genome dosage. Approximately 16% to 64% of the differentially expressed miRNAs possessing coherent target genes were predicted, and many of these miRNAs regulated multiple target genes. Most genes were up-regulated in progeny lines compared with their parents, but down-regulated in the higher plant height line in the comparison groups among the three progeny lines. Moreover, certain genes related to cell walls and plant hormones might play crucial roles in the plant height variations of the three progeny lines. Taken together, these results provided valuable information on the molecular mechanisms of hybrid backcrossing and plant height variations based on the gene and miRNA expression levels in the three progeny lines.	[Cao, Aqin; Jin, Jie; Li, Shaoqing; Wang, Jianbo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China	Wuhan University	Wang, JB (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China.	jbwang@whu.edu.cn			State Key Basic Research and Development Plan of China [2013CB126900]	State Key Basic Research and Development Plan of China(National Basic Research Program of China)	This work was supported by the State Key Basic Research and Development Plan of China (2013CB126900). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the State Key Basic Research and Development Plan of China (2013CB126900).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; An WY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2071-6; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Ayano M, 2014, PLANT CELL ENVIRON, V37, P2313, DOI 10.1111/pce.12377; Biswas S., 2016, PLANT GENE, V6, P82, DOI [10.1016/j.plgene.2016.04.002, DOI 10.1016/J.PLGENE.2016.04.002]; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen FF, 2010, J INTEGR PLANT BIOL, V52, P971, DOI 10.1111/j.1744-7909.2010.00985.x; Chen X, 2015, PLANT J, V82, P302, DOI 10.1111/tpj.12819; Chen ZW, 2009, BREEDING SCI, V59, P441, DOI 10.1270/jsbbs.59.441; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Gao Y, 2013, PLANT MOL BIOL, V81, P363, DOI 10.1007/s11103-013-0009-4; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Guevara DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096158; Hu FY, 2003, P NATL ACAD SCI USA, V100, P4050, DOI 10.1073/pnas.0630531100; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Jan A, 2004, PLANT PHYSIOL, V136, P3670, DOI 10.1104/pp.104.052274; Jiang BA, 2011, PLANT MOL BIOL, V77, P225, DOI 10.1007/s11103-011-9804-y; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Li Q, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0549-7; Li WQ, 2010, PLANTA, V232, P1383, DOI 10.1007/s00425-010-1263-1; Liu X, 2016, PLANT CELL REP, V35, P357, DOI 10.1007/s00299-015-1889-3; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moumeni A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2335-1; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sarkar D, 2017, DNA RES, V24, P235, DOI 10.1093/dnares/dsx003; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shen YY, 2014, PLANT MOL BIOL, V85, P287, DOI 10.1007/s11103-014-0185-x; Song GS, 2010, MOL PLANT, V3, P1012, DOI 10.1093/mp/ssq046; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tong HN, 2014, PLANT CELL, V26, P4376, DOI 10.1105/tpc.114.132092; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; van der Knaap E, 2000, PLANT PHYSIOL, V122, P695, DOI 10.1104/pp.122.3.695; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wen M, 2016, GENOME BIOL EVOL, V8, P3529, DOI 10.1093/gbe/evw252; Wu Y, 2016, J INTEGR PLANT BIOL, V58, P150, DOI 10.1111/jipb.12357; Xu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21580; Xu P, 2015, EUPHYTICA, V205, P95, DOI 10.1007/s10681-015-1402-7; Xu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131846; Yamamuro C IY, 2000, PLANT CELL; Yang Guangxiao, 2004, Genomics Proteomics & Bioinformatics, V2, P77; Yang LY, 2017, G3-GENES GENOM GENET, V7, P2281, DOI 10.1534/g3.117.040808; Ye BY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37416; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668; Zhang JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170330; Zhang YS, 2015, MOL PLANT, V8, P1683, DOI 10.1016/j.molp.2015.08.006; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zhao XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145646; Zong Y, 2014, CROP J, V2, P102, DOI 10.1016/j.cj.2014.03.005	65	6	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184106	10.1371/journal.pone.0184106	http://dx.doi.org/10.1371/journal.pone.0184106			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859136	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500067
J	Luszczki, JJ; Patrzylas, P; Zagaja, M; Andres-Mach, M; Zaluska, K; Kondrat-Wrobel, MW; Szpringer, M; Chmielewski, J; Florek-Luszczki, M				Luszczki, Jarogniew J.; Patrzylas, Pawel; Zagaja, Miroslaw; Andres-Mach, Marta; Zaluska, Katarzyna; Kondrat-Wrobel, Maria W.; Szpringer, Monika; Chmielewski, Jaroslaw; Florek-Luszczki, Magdalena			Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice	PLOS ONE			English	Article							INDUCED SEIZURE MODEL; PENTYLENETETRAZOLE-INDUCED SEIZURE; CB1 RECEPTOR AGONIST; ENDOGENOUS CANNABINOID SYSTEM; ELECTROSHOCK-INDUCED SEIZURES; WIN 55,212-2 MESYLATE; HOT-PLATE TEST; 6 HZ; ISOBOLOGRAPHIC ANALYSIS; ANTICONVULSANT ACTIVITY	Accumulating evidence indicates that cannabinoid CB1 receptor ligands play a pivotal role in seizures, not only in preclinical studies on animals, but also in clinical settings. This study was aimed at characterizing the influence of arachidonyl-2'-chloroethylamide (ACEA-a selective cannabinoid CB1 receptor agonist) co-administered with phenylmethylsulfonyl fluoride (PMSF) on the anticonvulsant potency of various antiepileptic drugs (clobazam, lacosamide, levetiracetam, phenobarbital, tiagabine and valproate) in the 6-Hz corneal stimulation model. Psychomotor seizures in male albino Swiss mice were evoked by a current (32 mA, 6 Hz, 3 s stimulus duration) delivered via corneal electrodes. Potential adverse effects produced by the antiepileptic drugs in combination with ACEA+PMSF were assessed using the chimney test (motor performance), passive avoidance task (remembering and acquisition of learning), and grip-strength test (muscular strength). Brain concentrations of antiepileptic drugs were measured by HPLC to exclude any pharmacokinetic contribution to the observed effect. ACEA (5 mg/kg, i.p.) + PMSF (30 mg/kg, i.p.) significantly potentiated the anticonvulsant potency of levetiracetam (P<0.05), but not that of clobazam, lacosamide, phenobarbital, tiagabine or valproate in the 6-Hz corneal stimulation model. Moreover, ACEA+PMSF did not significantly affect total brain concentrations of levetiracetam in mice. No behavioral side effects were observed in animals receiving combinations of the studied antiepileptic drugs with ACEA+PMSF. In conclusion, the combined administration of ACEA+PMSF with levetiracetam is associated with beneficial anticonvulsant pharmacodynamic interaction in the 6-Hz corneal stimulation model. The selective activation of cannabinoid CB1 receptor-mediated neurotransmission in the brain may enhance levetiracetam-related suppression of seizures in epilepsy patients, contributing to the efficacious treatment of epilepsy in future.	[Luszczki, Jarogniew J.; Zaluska, Katarzyna; Kondrat-Wrobel, Maria W.] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Luszczki, Jarogniew J.; Patrzylas, Pawel; Zagaja, Miroslaw; Andres-Mach, Marta] Inst Rural Hlth, Isobolog Anal Lab, Lublin, Poland; [Patrzylas, Pawel] John Paul II Catholic Univ Lublin, Dept Plant Physiol & Biotechnol, Lublin, Poland; [Szpringer, Monika] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland; [Chmielewski, Jaroslaw] Natl Res Inst, Inst Environm Protect, Warsaw, Poland; [Florek-Luszczki, Magdalena] Inst Rural Hlth, Dept Gerontol, Lublin, Poland	Medical University of Lublin; Institute of Rural Health in Lublin, Poland; Catholic University of Lublin; Jan Kochanowski University; Institute of Environmental Protection - National Research Institute; Institute of Rural Health in Lublin, Poland	Luszczki, JJ (corresponding author), Med Univ Lublin, Dept Pathophysiol, Lublin, Poland.; Luszczki, JJ (corresponding author), Inst Rural Hlth, Isobolog Anal Lab, Lublin, Poland.	jarogniew.luszczki@umlub.pl	Patrzylas, Paweł/U-8817-2018; Zagaja, Mirosław/T-8459-2018; Andres-Mach, Marta/T-8343-2018; Luszczki, Jarogniew J./U-7035-2018; Luszczki, Jarogniew/AAB-1113-2020; FLOREK-LUSZCZKI, MAGDALENA/S-9487-2018	Patrzylas, Paweł/0000-0003-2968-3995; Zagaja, Mirosław/0000-0002-0079-0490; Andres-Mach, Marta/0000-0003-4107-9184; Luszczki, Jarogniew J./0000-0002-3059-0393; Luszczki, Jarogniew/0000-0002-3059-0393; Zaluska-Ogryzek, Katarzyna/0000-0001-5358-8889; FLOREK-LUSZCZKI, MAGDALENA/0000-0003-1489-2399; Zajkowska-Wrobel, Maria/0000-0001-6614-8807; Szpringer, Monika/0000-0002-6510-5714; Chmielewski, Jaroslaw/0000-0003-2606-1656	Institute of Rural Health, Lublin, Poland [14030/2015-2016]; Medical University of Lublin, Poland [DS 474/2016-2017]	Institute of Rural Health, Lublin, Poland; Medical University of Lublin, Poland	This work was supported by Institute of Rural Health, Lublin, Poland [grant number 14030/2015-2016 - M.A.-M.] and Medical University of Lublin, Poland [grant number DS 474/2016-2017 - J.J.L]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x; Andres-Mach M, 2014, DRUG FUTURE, V39, P857, DOI 10.1358/dof.2014.039.012.2243535; Andres-Mach M, 2012, PROG NEURO-PSYCHOPH, V39, P301, DOI 10.1016/j.pnpbp.2012.07.001; Bahremand A, 2008, EPILEPSY RES, V81, P44, DOI 10.1016/j.eplepsyres.2008.04.010; Bahremand A, 2009, EPILEPSY RES, V84, P110, DOI 10.1016/j.eplepsyres.2009.01.003; Barton ME, 2003, EPILEPSY RES, V56, P17, DOI 10.1016/j.eplepsyres.2003.08.001; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Boissier JR, 1960, PHARMACOLOGY, V3, P81; Brodie MJ, 2011, SEIZURE-EUR J EPILEP, V20, P369, DOI 10.1016/j.seizure.2011.01.004; Citraro R, 2016, EUR J PHARMACOL, V791, P523, DOI 10.1016/j.ejphar.2016.09.029; Compton DR, 1997, J PHARMACOL EXP THER, V283, P1138; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Deckers CLP, 2000, EPILEPSIA, V41, P1364, DOI 10.1111/j.1528-1157.2000.tb00111.x; Di Maio R, 2015, NEUROBIOL DIS, V73, P356, DOI 10.1016/j.nbd.2014.10.018; Florek-Luszczki M, 2015, FUND CLIN PHARMACOL, V29, P382, DOI 10.1111/fcp.12123; Florek-Luszczki M, 2015, PHARMACOL BIOCHEM BE, V130, P53, DOI 10.1016/j.pbb.2015.01.003; Florek-Luszczki M, 2014, EPILEPSY RES, V108, P1728, DOI 10.1016/j.eplepsyres.2014.10.004; Florek-Luszczki M, 2014, J NEURAL TRANSM, V121, P707, DOI 10.1007/s00702-014-1173-7; Florek-Luszczki M, 2014, EUR J PHARMACOL, V723, P410, DOI 10.1016/j.ejphar.2013.10.063; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; HARRIS RA, 1982, J NEUROSCI, V2, P443; Hill AJ, 2012, BRIT J PHARMACOL, V167, P1629, DOI 10.1111/j.1476-5381.2012.02207.x; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; KARLER R, 1980, BRIT J PHARMACOL, V68, P479, DOI 10.1111/j.1476-5381.1980.tb14562.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Kondrat-Wrobel MW, 2016, HEALTH PROBL CIVILIZ, V10, P55, DOI 10.5114/hpc.2016.58209; Kozan R, 2009, EPILEPSIA, V50, P1760, DOI 10.1111/j.1528-1167.2009.02098.x; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Luszczki JJ, 2006, EUR J PHARMACOL, V547, P65, DOI 10.1016/j.ejphar.2006.07.037; Luszczki JJ, 2013, EUR J PHARMACOL, V720, P247, DOI 10.1016/j.ejphar.2013.10.020; Luszczki JJ, 2012, PHARMACOL REP, V64, P723; Luszczki JJ, 2011, PHARMACOL BIOCHEM BE, V98, P261, DOI 10.1016/j.pbb.2011.01.002; Luszczki JJ, 2010, PHARMACOL REP, V62, P942; Luszczki JJ, 2010, PROG NEURO-PSYCHOPH, V34, P18, DOI 10.1016/j.pnpbp.2009.09.005; Luszczki JJ, 2009, PHARMACOL REP, V61, P197; Luszczki JJ, 2009, EUR J PHARMACOL, V602, P298, DOI 10.1016/j.ejphar.2008.11.049; Luszczki JJ, 2005, EUR NEUROPSYCHOPHARM, V15, P609, DOI 10.1016/j.euroneuro.2005.03.005; Luszczki JJ, 2005, NEUROPSYCHOPHARMACOL, V30, P958, DOI 10.1038/sj.npp.1300602; Luszczki JJ, 2003, NEUROPSYCHOPHARMACOL, V28, P1817, DOI 10.1038/sj.npp.1300243; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Naderi N, 2012, NEUROCHEM RES, V37, P279, DOI 10.1007/s11064-011-0607-y; Nieoczym D, 2010, EPILEPSIA, V51, P1552, DOI 10.1111/j.1528-1167.2009.02485.x; Reddy DS, 2016, J PHARMACOL EXP THER, V357, P45, DOI 10.1124/jpet.115.230151; Shafaroodi H, 2004, NEUROPHARMACOLOGY, V47, P390, DOI 10.1016/j.neuropharm.2004.04.011; Shandra A, 2013, EPILEPSIA, V54, P1167, DOI 10.1111/epi.12237; VENAULT P, 1986, NATURE, V321, P864, DOI 10.1038/321864a0; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2001, EUR J PHARMACOL, V428, P51, DOI 10.1016/S0014-2999(01)01243-2; Wojda E, 2009, EPILEPSY RES, V86, P163, DOI 10.1016/j.eplepsyres.2009.06.003; Zadroniak A, 2009, PHARMACOL REP, V61, P737, DOI 10.1016/S1734-1140(09)70128-8; Zolkowska D, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.005	54	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183873	10.1371/journal.pone.0183873	http://dx.doi.org/10.1371/journal.pone.0183873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859122	Green Published, gold, Green Submitted			2022-12-26	WOS:000408740500043
J	Beacham, TD; Withler, RE				Beacham, Terry D.; Withler, Ruth E.			Population structure of sea-type and lake-type sockeye salmon and kokanee in the Fraser River and Columbia River drainages	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; LIFE-HISTORY EVOLUTION; ONCORHYNCHUS-NERKA; NONANADROMOUS MORPHS; GENETIC-STRUCTURE; BRITISH-COLUMBIA; PACIFIC SALMON; DIVERGENCE; MICROSATELLITES; CONSERVATION	Population structure of three ecotypes of Oncorhynchus nerka (sea-type Sockeye Salmon, lake-type Sockeye Salmon, and Kokanee) in the Fraser River and Columbia River drainages was examined with microsatellite variation, with the main focus as to whether Kokanee population structure within the Fraser River drainage suggested either a monophyletic or polyphyletic origin of the ecotype within the drainage. Variation at 14 microsatellite loci was surveyed for sea-type and lake-type Sockeye Salmon and Kokanee sampled from 121 populations in the two river drainages. An index of genetic differentiation, F-ST, over all populations and loci was 0.087, with individual locus values ranging from 0.031 to 0.172. Standardized to an ecotype sample size of 275 individuals, the least genetically diverse ecotype was sea-type Sockeye Salmon with 203 alleles, whereas Kokanee displayed the greatest number of alleles (260 alleles), with lake-type Sockeye Salmon intermediate (241 alleles). Kokanee populations from the Columbia River drainage (Okanagan Lake, Kootenay Lake), the South Thompson River (a major Fraser River tributary) drainage populations, and the mid-Fraser River populations all clustered together in a neighbor-joining analysis, indicative of a monophyletic origin of the Kokanee ecotype in these regions, likely reflecting the origin of salmon radiating from a refuge after the last glaciation period. However, upstream of the mid-Fraser River populations, there were closer relationships between the lake-type Sockeye Salmon ecotype and the Kokanee ecotype, indicative of the Kokanee ecotype evolving independently from the lake-type Sockeye Salmon ecotype in parallel radiation. Kokanee population structure within the entire Fraser River drainage suggested a polyphyletic origin of the ecotype within the drainage. Studies employing geographically restricted population sampling may not outline accurately the phylogenetic history of salmonid ecotypes.	[Beacham, Terry D.; Withler, Ruth E.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada	Fisheries & Oceans Canada	Beacham, TD (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.	Terry.Beacham@dfo-mpo.gc.ca			Fisheries and Oceans Canada; Province of British Columbia	Fisheries and Oceans Canada; Province of British Columbia	Funding was provided by Fisheries and Oceans Canada and the Province of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Beacham T.D., 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P227; BEACHAM TD, 1985, ENVIRON BIOL FISH, V14, P97, DOI 10.1007/BF00000818; Beacham TD, 2006, T AM FISH SOC, V135, P174, DOI 10.1577/T05-149.1; Beacham TD, 2004, T AM FISH SOC, V133, P1117, DOI 10.1577/T04-001.1; Beacham TD, 2004, J FISH BIOL, V65, P389, DOI 10.1111/j.0022-1112.2004.00457.x; Beacham TD, 2014, N AM J FISH MANAGE, V34, P335, DOI 10.1080/02755947.2014.880761; Burgner R. L., 1991, PACIFIC SALMON LIFE, P1; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Dodson JJ, 2013, BIOL REV, V88, P602, DOI 10.1111/brv.12019; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Foote CJ, 1999, ENVIRON BIOL FISH, V54, P263, DOI 10.1023/A:1007548807233; Frazer KK, 2013, J EVOLUTION BIOL, V26, P2606, DOI 10.1111/jeb.12250; Godbout L, 2011, CAN J FISH AQUAT SCI, V68, P1590, DOI 10.1139/F2011-089; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gustafson RG, 1999, ECOL FRESHW FISH, V8, P181, DOI 10.1111/j.1600-0633.1999.tb00069.x; Larson WA, 2017, MOL ECOL, V26, P554, DOI 10.1111/mec.13933; Lemay MA, 2015, MOL ECOL, V24, P798, DOI 10.1111/mec.13066; Lewis PO, 2001, GENETIC DATA ANAL GD; McPhail J.D., 1986, P615; Morris DB, 1996, CAN J FISH AQUAT SCI, V53, P120, DOI 10.1139/cjfas-53-1-120; NELSON JS, 1968, J FISH RES BOARD CAN, V25, P409, DOI 10.1139/f68-032; Nelson RJ, 2003, N AM J FISH MANAGE, V23, P703, DOI 10.1577/M01-194; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Nichols KM, 2016, EVOL APPL, V9, P1285, DOI 10.1111/eva.12412; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; RYDER JM, 1990, CAN J EARTH SCI, V27, P1316, DOI 10.1139/e90-142; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; Smith CT, 1998, MOL ECOL, V7, P1614; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; Veale AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01890-2; Veale AJ, 2016, EVOL APPL, V9, P1301, DOI 10.1111/eva.12430; WAPLES RS, 1990, CAN J FISH AQUAT SCI, V47, P968, DOI 10.1139/f90-111; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winans GA, 1996, T AM FISH SOC, V125, P645, DOI 10.1577/1548-8659(1996)125&lt;0645:AVONIT&gt;2.3.CO;2; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; Wood C.C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P12; Wood CC, 1995, AM FISH S S, V17, P195; Wood CC, 1996, EVOLUTION, V50, P1265, DOI [10.1111/j.1558-5646.1996.tb02367.x, 10.2307/2410667]; Wood CC, 2008, EVOL APPL, V1, P207, DOI 10.1111/j.1752-4571.2008.00028.x	40	13	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183713	10.1371/journal.pone.0183713	http://dx.doi.org/10.1371/journal.pone.0183713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886033	Green Published, Green Submitted, gold			2022-12-26	WOS:000410001100033
J	Bisele, M; Bencsik, M; Lewis, MGC; Barnett, CT				Bisele, Maria; Bencsik, Martin; Lewis, Martin G. C.; Barnett, Cleveland T.			Optimisation of a machine learning algorithm in human locomotion using principal component and discriminant function analyses	PLOS ONE			English	Article							GAIT WAVE-FORMS; FEATURE-EXTRACTION; MOVEMENT; CLASSIFICATION; KINEMATICS; BAREFOOT; COORDINATION; VARIABILITY; PATTERNS; FORCES	Assessment methods in human locomotion often involve the description of normalised graphical profiles and/or the extraction of discrete variables. Whilst useful, these approaches may not represent the full complexity of gait data. Multivariate statistical methods, such as Principal Component Analysis (PCA) and Discriminant Function Analysis (DFA), have been adopted since they have the potential to overcome these data handling issues. The aim of the current study was to develop and optimise a specific machine learning algorithm for processing human locomotion data. Twenty participants ran at a selfselected speed across a 15m runway in barefoot and shod conditions. Ground reaction forces (BW) and kinematics were measured at 1000 Hz and 100 Hz, respectively from which joint angles (degrees), joint moments (N. m. kg(-1)) and joint powers (W. kg(-1)) for the hip, knee and ankle joints were calculated in all three anatomical planes. Using PCA and DFA, power spectra of the kinematic and kinetic variables were used as a training database for the development of a machine learning algorithm. All possible combinations of 10 out of 20 participants were explored to find the iteration of individuals that would optimise the machine learning algorithm. The results showed that the algorithm was able to successfully predict whether a participant ran shod or barefoot in 93.5% of cases. To the authors' knowledge, this is the first study to optimise the development of a machine learning algorithm.	[Bisele, Maria; Bencsik, Martin; Lewis, Martin G. C.; Barnett, Cleveland T.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Nottingham Trent University	Barnett, CT (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	cleveland.barnett@ntu.ac.uk	Barnett, Cleveland/D-2884-2013	Barnett, Cleveland/0000-0001-6898-9095; Lewis, Martin G C/0000-0001-5918-3444	Nottingham Trent University	Nottingham Trent University	The authors would like to thank Nottingham Trent University for funding Maria Bisele's Ph.D studentship.	Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; Ali S, 2010, IEEE T PATTERN ANAL, V32, P288, DOI 10.1109/TPAMI.2008.284; Ardestani MM, 2016, J BIOMECH, V49, P2023, DOI 10.1016/j.jbiomech.2016.04.040; Ardestani MM, 2016, GAIT POSTURE, V46, P118, DOI 10.1016/j.gaitpost.2016.02.005; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Barnett C, 2009, PROSTHET ORTHOT INT, V33, P135, DOI 10.1080/03093640902751762; Barton GJ, 2012, HUM MOVEMENT SCI, V31, P284, DOI 10.1016/j.humov.2010.06.003; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Braunstein B, 2010, J BIOMECH, V43, P2120, DOI 10.1016/j.jbiomech.2010.04.001; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chan Herman, 2011, 2011 Seventh International Conference on Natural Computation (ICNC 2011), P588, DOI 10.1109/ICNC.2011.6022097; Chau T, 2001, GAIT POSTURE, V13, P49, DOI 10.1016/S0966-6362(00)00094-1; Chau T, 2001, GAIT POSTURE, V13, P102, DOI 10.1016/S0966-6362(00)00095-3; Cretual A, 2010, GAIT POSTURE, V32, P307, DOI 10.1016/j.gaitpost.2010.05.015; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Deluzio KJ, 1997, HUM MOVEMENT SCI, V16, P201, DOI 10.1016/S0167-9457(96)00051-6; Deluzio KJ, 1999, HUM MOVEMENT SCI, V18, P701, DOI 10.1016/S0167-9457(99)00030-5; Dillmann U, 2014, GAIT POSTURE, V39, P882, DOI 10.1016/j.gaitpost.2013.11.021; Divert C, 2005, INT J SPORTS MED, V26, P593, DOI 10.1055/s-2004-821327; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Federolf P, 2012, J BIOMECH, V45, P1127, DOI 10.1016/j.jbiomech.2012.02.008; Gao F, 2011, IEEE ENG MED BIO, P7340, DOI 10.1109/IEMBS.2011.6091712; Hamill J, 2012, KINESIOLOGY REV, V1, P17; Jeon HS, 2008, IEEE ENG MED BIO, P4672, DOI 10.1109/IEMBS.2008.4650255; Kerrigan DC, 2009, PM&R, V1, P1058, DOI 10.1016/j.pmrj.2009.09.011; Kirtley C, 2006, CLIN GAIT ANAL THEOR; Kobsar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139923; Leardini A, 2011, CLIN BIOMECH, V26, P562, DOI 10.1016/j.clinbiomech.2011.01.015; LeMoyne R, 2015, IEEE ENG MED BIO, P202, DOI 10.1109/EMBC.2015.7318335; Lever J, 2016, NAT METHODS, V13, P703, DOI 10.1038/nmeth.3968; Levine D., 2012, WHITTLES GAIT ANAL; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Mouchnino L, 2006, GAIT POSTURE, V24, P4, DOI 10.1016/j.gaitpost.2005.07.007; Muniz AMS, 2010, INT J NEUROSCI, V120, P609, DOI 10.3109/00207454.2010.504904; Novacheck TF, 2010, ORTHOP CLIN N AM, V41, P469, DOI 10.1016/j.ocl.2010.07.001; Phinyomark A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1013-z; Phinyomark A, 2015, HUM MOVEMENT SCI, V44, P91, DOI 10.1016/j.humov.2015.08.018; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; Robertson G, 2013, HUMAN KINETICS, V2E; Schutte LM, 2000, GAIT POSTURE, V11, P25, DOI 10.1016/S0966-6362(99)00047-8; Soares DP, 2016, PROSTHET ORTHOT INT, V40, P729, DOI 10.1177/0309364615612634; Sugavaneswaran L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046004; von Tscharner V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065063; Williams DSB, 2012, INT J SPORTS PHYS TH, V7, P525; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu JN, 2007, HUM MOVEMENT SCI, V26, P393, DOI 10.1016/j.humov.2007.01.015	47	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183990	10.1371/journal.pone.0183990	http://dx.doi.org/10.1371/journal.pone.0183990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886059	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000410001100051
J	Geng, PL; Tian, S; Yuan, ZM; Hu, XM				Geng, Peiling; Tian, Shen; Yuan, Zhiming; Hu, Xiaomin			Identification and genomic comparison of temperate bacteriophages derived from emetic Bacillus cereus	PLOS ONE			English	Article							TAIL FIBER GENES; PHAGE; SEQUENCE; THURINGIENSIS; DNA; ANTHRACIS; ALIGNMENT; WEIHENSTEPHANENSIS; PATHOGENICITY; VIRULENCE	Cereulide-producing Bacillus cereus isolates can cause serious emetic ( vomiting) syndrome and even acute lethality. As mobile genetic elements, the exploration of prophages derived from emetic B. cereus isolates will help in our understanding of the genetic diversity and evolution of these pathogens. In this study, five temperate phages derived from cereulide-producing B. cereus strains were induced, with four of them undergoing genomic sequencing. Sequencing revealed that they all belong to the Siphoviridae family, but presented in different forms in their hosts. PfNC7401 and PfIS075 have typical icosahedral heads, probably existing alone as phagemids in the host with self-replicating capability in the lysogenic state. PfEFR-4, PfEFR-5, and PfATCC7953 have elongated heads, with the genomes of the former two identified as linear dsDNA, which could be integrated into the host genome during the lysogenic state. Genomic comparison of the four phages with others also derived from emetic B. cereus isolates showed similar genome structures and core genes, thus displaying host spectrum specificity. In addition, phylogenic analysis based on the complete genome and conserved tail fiber proteins of 36 Bacillus species-derived phages confirmed that the phages derived from emetic B. cereus strains were highly similar. Furthermore, one endolysin LysPfEFR-4 was cloned and showed lytic activity against all tested emetic B. cereus strains and cross-lytic activity against some other pathogenic bacteria, implying a potential to control bacterial contamination in the food supply.	[Geng, Peiling; Tian, Shen; Yuan, Zhiming; Hu, Xiaomin] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China; [Geng, Peiling] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, ZM; Hu, XM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.	yzm@wh.iov.cn; huxm@wh.iov.cn	Hu, Xiaomin/GRY-1539-2022		National Natural Science Foundation of China (NFSC) [31170006, 31570007]; NFSC [31170006, 31570007]	National Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC)); NFSC(National Natural Science Foundation of China (NSFC))	The project was supported by a National Natural Science Foundation of China (NFSC) grant 31170006 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A: All information mentioned above has been confirmed and the Financial Disclosure has been edited as "The project was supported by National Natural Science Foundation of China (NFSC) grants 31170006 and 31570007 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."; We would like to thank Pei Zhang from the Core Facility and Technical Support, Wuhan Institute of Virology, for help with producing TEM micrographs. This work was supported by an NFSC grants (31170006 and 31570007).	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Andrup L, 2008, PLASMID, V59, P139, DOI 10.1016/j.plasmid.2007.11.005; Arslan S, 2014, ANAEROBE, V25, P42, DOI 10.1016/j.anaerobe.2013.11.006; Becker SC, 2009, GENE, V443, P32, DOI 10.1016/j.gene.2009.04.023; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Bednarczyk A, 2008, POSTEP MIKROBIOL, V47, P51; Beims H, 2015, APPL ENVIRON MICROB, V81, P5411, DOI 10.1128/AEM.00804-15; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boyd EF, 2012, ADV VIRUS RES, V82, P91, DOI 10.1016/B978-0-12-394621-8.00014-5; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Ferreira R, 2014, HELICOBACTER, V19, P92; Fico S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-259; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Geng PL, 2017, INT J FOOD MICROBIOL, V241, P291, DOI 10.1016/j.ijfoodmicro.2016.10.030; Gillis A, 2014, APPL ENVIRON MICROB, V80, P7620, DOI 10.1128/AEM.01869-14; Gillis A, 2014, VIRUSES-BASEL, V6, P2623, DOI 10.3390/v6072623; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Haaber J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13333; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoton FM, 2009, ENV MICROBIOL REP, V1, P177, DOI 10.1111/j.1758-2229.2009.00028.x; Kolsto AB, 2002, CURR TOP MICROBIOL, V264, P95; Kong M, 2012, J VIROL, V86, P6379, DOI 10.1128/JVI.00706-12; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Kroten MA, 2010, POL J MICROBIOL, V59, P3, DOI 10.33073/pjm-2010-001; Kwon HJ, 2013, VET MICROBIOL, V162, P785, DOI 10.1016/j.vetmic.2012.10.005; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee YD, 2012, J MICROBIOL BIOTECHN, V22, P649, DOI 10.4014/jmb.1110.10065; Lee YD, 2010, FOOD SCI BIOTECHNOL, V19, P1643, DOI 10.1007/s10068-010-0232-6; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Mao JZ, 2013, FEMS MICROBIOL LETT, V342, P30, DOI 10.1111/1574-6968.12104; Mei XF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-149; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Ramisse V, 1996, FEMS MICROBIOL LETT, V145, P9, DOI 10.1016/0378-1097(96)00358-8; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Ravin V, 2002, J BACTERIOL, V184, P2455, DOI 10.1128/JB.184.9.2455-2459.2002; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JA, 2007, VIROLOGY, V368, P405, DOI 10.1016/j.virol.2007.06.043; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorsen L, 2006, APPL ENVIRON MICROB, V72, P5118, DOI 10.1128/AEM.00170-06; Touchon M, 2017, CURR OPIN MICROBIOL, V38, P66, DOI 10.1016/j.mib.2017.04.010; Tsourkas PK, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01120-15; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Verheust C, 2003, MICROBIOL-SGM, V149, P2083, DOI 10.1099/mic.0.26307-0; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; XUE Q, 1995, VIROLOGY, V212, P128, DOI 10.1006/viro.1995.1461; Yu SL, 2000, J BACTERIOL, V182, P5962, DOI 10.1128/JB.182.21.5962-5968.2000; Yuan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037557; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	64	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184572	10.1371/journal.pone.0184572	http://dx.doi.org/10.1371/journal.pone.0184572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886124	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100160
J	Poma, A; Colafarina, S; Aruffo, E; Zarivi, O; Bonfigli, A; Di Bucchianico, S; Di Carlo, P				Poma, Anna; Colafarina, Sabrina; Aruffo, Eleonora; Zarivi, Osvaldo; Bonfigli, Antonella; Di Bucchianico, Sebastiano; Di Carlo, Piero			Effects of ozone exposure on human epithelial adenocarcinoma and normal fibroblasts cells	PLOS ONE			English	Article							CYTOGENETIC DAMAGE; GENE-EXPRESSION; AIR-POLLUTION; INHALATION; MODEL; GENOTOXICITY; POPULATIONS; GROWTH	Previous studies show variable ozone cytotoxicity and genotoxicity in cell cultures, laboratory animals and humans directly exposed to tropospheric ozone. The aim of this study was therefore to investigate and compare the cyto and genotoxic effects of ozone using adenocarcinoma human alveolar basal epithelial cells A549 and normal human fibroblasts Hs27. A cell culture chamber with controlled atmosphere (a simulation reactor) was built to inject a flow of 120 ppb of ozone, which is two times the threshold value for the protection of human health, fixed by the EU legislation. Cell proliferation was evaluated by a luminescent cell viability assay while we assessed the genotoxic potential of ozone by the induction of micronuclei as well as evaluating DNA strand breaks by the induction of micronuclei evaluated by means of the cytokinesis-block micronucleus (CBMN) assay as well as evaluating DNA strand breaks by Alkaline Comet Assay (CA) or Comet Assay. A549 cells viability decreases significantly at 24 hours treatment with 120 ppb of O-3 while at 48 hours and 72 hours O-3 treated cells viability doesn't differ in respect to the control. However a significative decrease of A549 viability is shown at 72 hours vs. 48 hours in both treated and not-treated cells. The viability trend in the Hs27 cells did not show any significant changes in treated samples compared to the control in all conditions. The two genotoxicity biomarkers, the micronucleus and the comet tests, showed in both the cell types exposed to ozone, a significant increase in the number of micronuclei and in the tail DNA % in respect to the control even if at different times/cell type. Moreover, we found that O-3 provokes genotoxic effects more evident in A549 cancer cells than in normal fibroblasts Hs27 ones. We applied a cell growth simulation model referred to ozone treated or not cell lines to confirm that the ozone exposure causes a slackening in the cells replication.	[Poma, Anna; Colafarina, Sabrina; Zarivi, Osvaldo; Bonfigli, Antonella; Di Bucchianico, Sebastiano] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Aruffo, Eleonora; Di Carlo, Piero] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Aruffo, Eleonora; Di Carlo, Piero] Univ Aquila, Ctr Excellence CETEMPS, Laquila, Italy	University of L'Aquila; G d'Annunzio University of Chieti-Pescara; University of L'Aquila	Poma, A (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.	annamariagiuseppina.poma@univaq.it	Di Carlo, Piero/Q-4450-2016; Poma, Anna/AAH-5751-2019; Zarivi, Osvaldo/V-2939-2018; Zarivi, Osvaldo/AAB-2150-2022; Di+Bucchianico, Sebastiano/AHI-8150-2022; Zarivi, Osvaldo/ABG-8795-2021; Di Bucchianico, Sebastiano/AAX-7000-2020	Di Carlo, Piero/0000-0003-4971-4509; Zarivi, Osvaldo/0000-0002-8312-9955; Zarivi, Osvaldo/0000-0002-8312-9955; Di+Bucchianico, Sebastiano/0000-0002-6396-892X; ARUFFO, ELEONORA/0000-0002-9164-7293	DiSPuTer (Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy); Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy	DiSPuTer (Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy); Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy	The research funds of DiSPuTer (Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy) have been supporting the work of EA and PDC and the research funds of Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy have been supporting the work of AP, SC, AB and OZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton C, 2017, MATH BIOSCI ENG, V14, P581, DOI 10.3934/mbe.2017034; Chen C, 2006, MUTAGENESIS, V21, P131, DOI 10.1093/mutage/gel007; Chuang GC, 2009, AM J PHYSIOL-LUNG C, V297, pL209, DOI 10.1152/ajplung.00102.2009; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Di Carlo P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007900; Di Carlo P, 2015, ATMOS POLLUT RES, V6, P29, DOI 10.5094/APR.2015.004; Enderling H, 2014, CURR PHARM DESIGN, V20, P4934; European Environment Agency, 2015, AIR QUALITY EUROPE 2, DOI [10.2800/62459, DOI 10.2800/62459]; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Ganesan S, 2017, COMMUN NONLINEAR SCI, V46, P135, DOI 10.1016/j.cnsns.2016.10.013; Grozdanovski T, 2009, APPL MATH LETT, V22, P1091, DOI 10.1016/j.aml.2008.10.002; HALLAM TG, 1983, J MATH BIOL, V18, P25, DOI 10.1007/BF00275908; Holland N, 2015, ENVIRON MOL MUTAGEN, V56, P378, DOI 10.1002/em.21921; Hoogervorst EM, 2003, CARCINOGENESIS, V24, P613, DOI 10.1093/carcin/24.3.613; Huen K, 2006, ENVIRON MOL MUTAGEN, V47, P236, DOI 10.1002/em.20193; Kurt OK, 2016, CURR OPIN PULM MED, V22, P138, DOI 10.1097/MCP.0000000000000248; Lakey PSJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32916; Lee H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169209; Leroy P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127283; Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209, DOI 10.1016/S0040-1625(99)00022-0; Mudway I. S., 2000, Molecular Aspects of Medicine, V21, P1, DOI 10.1016/S0098-2997(00)00003-0; Nadadur SS, 2005, ENVIRON HEALTH PERSP, V113, P1717, DOI 10.1289/ehp.7413; OECD, 2010, OECD PUBLISHING, P1, DOI [10.1787/9789264095830-en, DOI 10.1787/9789264095830-EN]; OLIVE PL, 1991, CANCER RES, V51, P4671; Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093; Pearl R, 1927, Q REV BIOL, V2, P532, DOI 10.1086/394288; Poma A, 2014, MICROSCOPY ADV SCI R, P275; RAJINI P, 1995, TOXICOL APPL PHARM, V130, P32, DOI 10.1006/taap.1995.1005; Raza A, 2014, EUR HEART J, V35, P861, DOI 10.1093/eurheartj/eht489; Scassellati C, 2017, TOXICOL IN VITRO, V44, P100, DOI 10.1016/j.tiv.2017.06.021; Tang T, 2012, ENVIRON MOL MUTAGEN, V53, P125, DOI 10.1002/em.20695; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Vadasz P, 2005, INT J FOOD MICROBIOL, V102, P257, DOI 10.1016/j.ijfoodmicro.2004.12.018; VANDERWAL WAA, 1994, TOXICOL LETT, V72, P291, DOI 10.1016/0378-4274(94)90040-X; VICTORIN K, 1992, MUTAT RES, V277, P221, DOI 10.1016/0165-1110(92)90045-B; Wang J, 2017, J APPL TOXICOL, V37, P495, DOI 10.1002/jat.3385; Witschi H, 1999, TOXICOL SCI, V52, P162, DOI 10.1093/toxsci/52.2.162; Zavala J, 2016, INHAL TOXICOL, V28, P251, DOI 10.3109/08958378.2016.1157227; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	40	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184519	10.1371/journal.pone.0184519	http://dx.doi.org/10.1371/journal.pone.0184519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886142	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100146
J	Gallay, PA; Chatterji, U; Kirchhoff, A; Gandarilla, A; Gunawardana, M; Pyles, RB; Marzinke, MA; Moss, JA; Baum, MM				Gallay, Philippe A.; Chatterji, Udayan; Kirchhoff, Aaron; Gandarilla, Angel; Gunawardana, Manjula; Pyles, Richard B.; Marzinke, Mark A.; Moss, John A.; Baum, Marc M.			Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HUMAN-IMMUNODEFICIENCY-VIRUS; PREEXPOSURE PROPHYLAXIS; MUCOSAL TRANSMISSION; EXPERIMENTAL-DESIGN; PARTIAL PROTECTION; INTRAVAGINAL RING; AFRICAN WOMEN; ANIMAL-MODEL; BLT MICE	With more than 7,000 new HIV infections daily worldwide, there is an urgent need for non-vaccine biomedical prevention (nBP) strategies that are safe, effective, and acceptable. Clinical trials have demonstrated that pre-exposure prophylaxis (PrEP) with antiretrovirals (ARVs) can be effective at preventing HIV infection. In contrast, other trials using the same ARVs failed to show consistent efficacy. Topical (vaginal and rectal) dosing is a promising regimen for HIV PrEP as it leads to low systematic drug exposure. A series of titration studies were carried out in bone marrow/liver/thymus (BLT) mice aimed at determining the adequate drug concentrations applied vaginally or rectally that offer protection against rectal or vaginal HIV challenge. The dose-response relationship of these agents was measured and showed that topical tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) can offer 100% protection against rectal or vaginal HIV challenges. From the challenge data, EC50 values of 4.6 mu M for TDF and 0.6 mu M for FTC for HIV vaginal administration and 6.1 mu M TDF and 0.18 mu M for FTC for rectal administration were obtained. These findings suggest that the BLT mouse model is highly suitable for studying the dose-response relationship in single and combination ARV studies of vaginal or rectal HIV exposure. Application of this sensitive HIV infection model to more complex binary and ternary ARV combinations, particularly where agents have different mechanisms of action, should allow selection of optimal ARV combinations to be advanced into pre-clinical and clinical development as nBP products.	[Gallay, Philippe A.; Chatterji, Udayan; Kirchhoff, Aaron; Gandarilla, Angel] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Gunawardana, Manjula; Moss, John A.; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA USA; [Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Marzinke, Mark A.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Marzinke, Mark A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Scripps Research Institute; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins University	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	gallay@scripps.edu		Baum, Marc/0000-0003-1558-5649; Moss, John/0000-0001-8091-3245	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [U19AI113048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125365, U19AI113048] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under award number U19AI113048.; We thank Dr. I. Chen for providing the JR-CSF plasmid via the AIDS Research and Reagent Program. We thank Karen J. Clingerman for assistance with the surgeries. We thank Perrin Larton from Advanced Bioscience Resources from providing us with fetal tissues. We greatly thank Cheryl Stoddart, Jose Rivera and Bruce Torbett for helpful discussion and advice for the initial establishment of the humanized BLT mouse model at The Scripps Research Institute. Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI113048. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This is publication no. 29525 from the Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, CA.	[Anonymous], TRUV PROD MON; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Chateau ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060024; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2005, COMPUSYN DRUG COMBIN; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Delany-Moretlwe S, 2014, AIDS RES HUM RETROV, V30, pA281, DOI 10.1089/aid.2014.5637.abstract; Denton PW, 2012, TRENDS MICROBIOL, V20, P268, DOI 10.1016/j.tim.2012.03.007; Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Derdelinckx I, 2006, PLOS MED, V3, P1999, DOI 10.1371/journal.pmed.0030454; Deruaz M, 2013, J INFECT DIS, V208, pS131, DOI 10.1093/infdis/jit318; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta K, 2006, PLOS MED, V3, P181, DOI 10.1371/journal.pmed.0030079; Hendrix CW, 2016, AIDS RES HUM RETROV, V32, P32, DOI [10.1089/aid.2015.0182, 10.1089/AID.2015.0182]; Hendrix CW, 2013, CELL, V155, P515, DOI 10.1016/j.cell.2013.09.030; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Karpel ME, 2015, CURR OPIN VIROL, V13, P75, DOI 10.1016/j.coviro.2015.05.002; Kovarova M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005075; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Landovitz Raphael J, 2007, Top HIV Med, V15, P99; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; Marrazzo JM, 2015, OBSTET GYNECOL SURV, V70, P444, DOI 10.1097/01.ogx.0000466878.37011.6f; Mascolini Mark, 2009, J Int AIDS Soc, V12 Suppl 1, pS4, DOI 10.1186/1758-2652-12-S1-S4; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mesquita PMM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-113; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pauza CD, 1998, AIDS RES HUM RETROV, V14, pS83; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Srinivasan P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157061; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Turpin JA, 2011, DRUG DELIV TRANSL RE, V1, P194, DOI 10.1007/s13346-011-0034-2; Ursell LK, 2014, ANTIVIR RES, V102, P87, DOI 10.1016/j.antiviral.2013.12.004; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; Veazey RS, 2005, NAT MED, V11, P1293, DOI 10.1038/nm1321; Wahl A, 2014, J IMMUNOL METHODS, V410, P28, DOI 10.1016/j.jim.2014.06.009; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; WHO-UNAIDS, 2010, REP GLOB AIDS EP; Williams R, 2008, J NEUROVIROL, V14, P292, DOI 10.1080/13550280802074539; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027	65	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184303	10.1371/journal.pone.0184303	http://dx.doi.org/10.1371/journal.pone.0184303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880948	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200048
J	Christner, M; Dressler, D; Andrian, M; Reule, C; Petrini, O				Christner, Martin; Dressler, Dirk; Andrian, Mark; Reule, Claudia; Petrini, Orlando			Identification of Shiga-Toxigenic Escherichia coli outbreak isolates by a novel data analysis tool after matrix-assisted laser desorption/ionization time-of-flight mass spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MALDI-TOF-MS; BACTERIA; SYSTEM	The fast and reliable characterization of bacterial and fungal pathogens plays an important role in infectious disease control and tracking of outbreak agents. DNA based methods are the gold standard for epidemiological investigations, but they are still comparatively expensive and time-consuming. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a fast, reliable and cost-effective technique now routinely used to identify clinically relevant human pathogens. It has been used for subspecies differentiation and typing, but its use for epidemiological tasks, e.g. for outbreak investigations, is often hampered by the complexity of data analysis. We have analysed publicly available MALDI-TOF mass spectra from a large outbreak of Shiga-Toxigenic Escherichia coli in northern Germany using a general purpose software tool for the analysis of complex biological data. The software was challenged with depauperate spectra and reduced learning group sizes to mimic poor spectrum quality and scarcity of reference spectra at the onset of an outbreak. With high quality formic acid extraction spectra, the software's built in classifier accurately identified outbreak related strains using as few as 10 reference spectra (99.8% sensitivity, 98.0% specificity). Selective variation of processing parameters showed impaired marker peak detection and reduced classification accuracy in samples with high background noise or artificially reduced peak counts. However, the software consistently identified mass signals suitable for a highly reliable marker peak based classification approach (100% sensitivity, 99.5% specificity) even from low quality direct deposition spectra. The study demonstrates that general purpose data analysis tools can effectively be used for the analysis of bacterial mass spectra.	[Christner, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany; [Dressler, Dirk; Reule, Claudia] Biotesys GmbH, Esslingen, Germany; [Andrian, Mark] ArsNova GmbH, Esslingen, Germany; [Petrini, Orlando] POLE Pharma Consulting, Breganzona, Switzerland; [Petrini, Orlando] Swiss Tech Inst Technol, Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf	Dressler, D (corresponding author), Biotesys GmbH, Esslingen, Germany.	d.dressler@biotesys.de	Petrini, Orlando/G-4392-2010; Reule, Dr. Claudia/AAY-5459-2021	Dressler, Dirk/0000-0003-1659-3747	Biotesys GmbH	Biotesys GmbH	The funder (Biotesys GmbH) provided support in the form of salaries for CR and DD, but had no additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. MA is CEO of ARS NOVA and granted access to the software tool but was not involved in the analysis of the data nor the writing of the manuscript. OP is owner of POLE Pharma Consulting and is an advisor of BioTeSys GmbH. He received no specific funding in context with the preparation of the manuscript or analysis of the data. The specific role of these authors is articulated in the "author contribution" section.	Becker PT, 2014, MED MYCOL, V52, P826, DOI 10.1093/mmy/myu064; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; Boggs SR, 2012, J MED MICROBIOL, V61, P640, DOI 10.1099/jmm.0.037978-0; Buchan BW, 2012, J CLIN MICROBIOL, V50, P346, DOI 10.1128/JCM.05021-11; Christner M, 2014, DRYAD DIGITAL REPOSI; Christner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101924; De Carolis E, 2014, MED MYCOL, V52, P123, DOI 10.1093/mmy/myt009; De Respinis S, 2014, J CLIN MICROBIOL, V52, P4286, DOI 10.1128/JCM.02199-14; Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09; Frank C, 2011, EURO SURVEILL, V16; Idelevich EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114834; Kuhns M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040004; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Siegrist TJ, 2007, J MICROBIOL METH, V68, P554, DOI 10.1016/j.mimet.2006.10.012; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002	16	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182962	10.1371/journal.pone.0182962	http://dx.doi.org/10.1371/journal.pone.0182962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877205	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200019
J	Yao, HD; Zhao, X; Fan, RF; Sattar, H; Zhao, JX; Zhao, WC; Zhang, ZW; Li, YF; Xu, SW				Yao, Haidong; Zhao, Xia; Fan, Ruifeng; Sattar, Hamid; Zhao, Jinxin; Zhao, Wenchao; Zhang, Ziwei; Li, Yufeng; Xu, Shiwen			Selenium deficiency-induced alterations in ion profiles in chicken muscle	PLOS ONE			English	Article							RETICULUM RESIDENT SELENOPROTEINS; FRESH-WATER FISH; SPLENIC LYMPHOCYTES; GENE-EXPRESSION; BROILER-CHICKENS; HUMAN-DISEASE; CADMIUM; MERCURY; EXPOSURE; LEVEL	Ion homeostasis plays important roles in development of metabolic diseases. In the present study, we examined the contents and distributions of 25 ions in chicken muscles following treatment with selenium (Se) deficiency for 25 days. The results revealed that in chicken muscles, the top ranked microelements were silicon (Si), iron (Fe), zinc (Zn), aluminum (Al), copper (Cu) and boron (B), showing low contents that varied from 292.89 ppb to 100.27 ppm. After Se deficiency treatment, essential microelements [Cu, chromium (Cr), vanadium (V) and manganese (Mn)], and toxic microelements [cadmium (Cd) and mercury (Hg)] became more concentrated (P < 0.05). Elements distribution images showed generalized accumulation of barium (Ba), cobalt (Co), Cu, Fe and V, while Cr, Mn, and Zn showed pin point accumulations in muscle sections. Thus, the ion profiles were generally influenced by Se deficiency, which suggested a possible role of Se deficiency in muscle dysfunctions caused by these altered ion profiles.	[Yao, Haidong; Zhao, Xia; Fan, Ruifeng; Sattar, Hamid; Zhao, Jinxin; Zhao, Wenchao; Zhang, Ziwei; Xu, Shiwen] Northeast Agr Univ, Dept Vet Med, Harbin, Heilongjiang, Peoples R China; [Li, Yufeng] Chinese Acad Sci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Li, Yufeng] Chinese Acad Sci, Ctr Environm Safety & Hlth, Inst High Energy Phys, Beijing, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Xu, SW (corresponding author), Northeast Agr Univ, Dept Vet Med, Harbin, Heilongjiang, Peoples R China.; Li, YF (corresponding author), Chinese Acad Sci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China.; Li, YF (corresponding author), Chinese Acad Sci, Ctr Environm Safety & Hlth, Inst High Energy Phys, Beijing, Peoples R China.	liyf@ihep.ac.cn; shiwenxu@neau.edu.cn	Li, Yu-Feng/J-1450-2019	Li, Yu-Feng/0000-0002-5013-5849; ziwei, zhang/0000-0002-5705-4611	Youth Fund Projects of National Natural Science Foundation of China [31502134]; National Natural Science Foundation of China [31272626]; International (Regional) Cooperation and Exchange Projects of the National Natural Science Foundation of China [31320103920]	Youth Fund Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International (Regional) Cooperation and Exchange Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Youth Fund Projects of National Natural Science Foundation of China (31502134), National Natural Science Foundation of China (31272626) and the International (Regional) Cooperation and Exchange Projects of the National Natural Science Foundation of China (31320103920). The funders had no role in study design, data collection and analysis,; This study was supported by the Youth Fund Projects of National Natural Science Foundation of China (31502134), National Natural Science Foundation of China (31272626) and the International (Regional) Cooperation and Exchange Projects of the National Natural Science Foundation of China (31320103920). The authors thank the Institute of High Energy Physics, Chinese Academy of Sciences; the Safety and Quality Institute of Agricultural Products, Academy of Agricultural Sciences in Heilongjiang, and Guoyou Chen in helping to detect the ion profiles.	Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Bjerregaard P, 2011, ENVIRON SCI TECHNOL, V45, P9793, DOI 10.1021/es202565g; Cai L, 2015, LIVEST SCI, V172, P43, DOI 10.1016/j.livsci.2014.11.013; CARL GF, 1993, EPILEPSIA, V34, P441, DOI 10.1111/j.1528-1157.1993.tb02584.x; Castets P, 2012, J MOL MED, V90, P1095, DOI 10.1007/s00109-012-0896-x; Chen X, 2012, MOLECULES, V17, P14565, DOI 10.3390/molecules171214565; de Macedo GR, 2015, MAR POLLUT BULL, V94, P284, DOI 10.1016/j.marpolbul.2015.02.033; Erkekoglu P, 2015, J TRACE ELEM MED BIO, V29, P296, DOI 10.1016/j.jtemb.2014.08.002; Fargasova A, 2006, PLANT SOIL ENVIRON, V52, P8, DOI 10.17221/3340-PSE; Hiraga T, 2008, VET J, V178, P109, DOI 10.1016/j.tvjl.2007.06.023; Holben DH, 1999, J AM DIET ASSOC, V99, P836, DOI 10.1016/S0002-8223(99)00198-4; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kalisinska E, 2014, ECOTOX ENVIRON SAFE, V101, P107, DOI 10.1016/j.ecoenv.2013.12.019; Kotyzova D, 2010, BIOL TRACE ELEM RES, V136, P287, DOI 10.1007/s12011-009-8541-4; Kumar P, 2007, B ENVIRON CONTAM TOX, V79, P396, DOI 10.1007/s00128-007-9263-y; Li JL, 2010, BIOMETALS, V23, P695, DOI 10.1007/s10534-010-9334-0; Li YF, 2014, METALLOMICS, V6, P220, DOI 10.1039/c3mt00316g; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; Liu S, 2015, BIOL TRACE ELEM RES, V168, P252, DOI 10.1007/s12011-015-0354-z; Mondal MK, 2007, ANIM FEED SCI TECH, V139, P212, DOI 10.1016/j.anifeedsci.2007.01.014; Pappas AC, 2012, J ANIM PHYSIOL AN N, V96, P385, DOI 10.1111/j.1439-0396.2011.01152.x; Pappas AC, 2008, COMP BIOCHEM PHYS B, V151, P361, DOI 10.1016/j.cbpb.2008.08.009; Rederstorff M, 2006, CELL MOL LIFE SCI, V63, P52, DOI 10.1007/s00018-005-5313-y; Reeuwijk NM, 2013, FOOD ADDIT CONTAM A, V30, P1535, DOI 10.1080/19440049.2013.811297; Sandrine A, 2010, ANTIOXIDANTS REDOX S, V12; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707; Shah AQ, 2010, FOOD CHEM TOXICOL, V48, P1550, DOI 10.1016/j.fct.2010.03.023; Shao JJ, 2012, TOXICOL LETT, V214, P99, DOI 10.1016/j.toxlet.2012.08.011; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038845; TOHNO S, 2006, BIOL TRACE ELEMENT R, V110; Uluozlu OD, 2009, J HAZARD MATER, V163, P982, DOI 10.1016/j.jhazmat.2008.07.050; Watanabe C, 1999, NEUROTOXICOL TERATOL, V21, P83, DOI 10.1016/S0892-0362(98)00036-1; Wu Q, 2014, BIOL TRACE ELEM RES, V161, P167, DOI 10.1007/s12011-014-0092-7; Xu FP, 2015, BIOL TRACE ELEM RES, V165, P214, DOI 10.1007/s12011-015-0254-2; Xu SW, 2013, BIOL TRACE ELEM RES, V151, P225, DOI 10.1007/s12011-012-9552-0; Xu T, 2015, BIOL TRACE ELEMENT R; Yao HD, 2013, J NUTR, V143, P613, DOI 10.3945/jn.112.172395; Yao HD, 2016, ONCOTARGET, V7, P57618, DOI 10.18632/oncotarget.11459; Yao HD, 2014, RSC ADV, V4, P64032, DOI 10.1039/c4ra11502c; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2; Zhao JT, 2014, METALLOMICS, V6, P1951, DOI 10.1039/c4mt00170b; Zhao WC, 2014, BIOL TRACE ELEM RES, V161, P328, DOI 10.1007/s12011-014-0135-0	43	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184186	10.1371/journal.pone.0184186	http://dx.doi.org/10.1371/journal.pone.0184186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877212	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200070
J	Nagata, N; Sakurai, T; Moriyasu, S; Shimbo, T; Okubo, H; Watanabe, K; Yokoi, C; Yanase, M; Akiyama, J; Uemura, N				Nagata, Naoyoshi; Sakurai, Toshiyuki; Moriyasu, Shiori; Shimbo, Takuro; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Uemura, Naomi			Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIRECT ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; ANTITHROMBOTIC AGENTS; CLINICAL MANAGEMENT; RISK; THERAPY; ANTIPLATELET; VALIDATION; HEMORRHAGE	Background Anticoagulant management of acute gastrointestinal bleeding (GIB) during the pre-endoscopic period has not been fully addressed in American, European, or Asian guidelines. This study sought to evaluate the risks of rebleeding and thromboembolism in anticoagulated patients with acute GIB. Methods Baseline, endoscopy, and outcome data were reviewed for 314 patients with acute GIB: 157 anticoagulant users and 157 age-, sex-, and important risk-matched non-users. Data were also compared between direct oral anticoagulants (DOACs) and warfarin users. Results Between anticoagulant users and non-users, of whom 70% underwent early endoscopy, no endoscopy-related adverse events or significant differences were found in the rate of endoscopic therapy need, transfusion need, rebleeding, or thromboembolism. Rebleeding was associated with shock, comorbidities, low platelet count and albumin level, and low-dose aspirin use but not HAS-BLED score, any endoscopic results, heparin bridge, or international normalized ratio (INR) >= 2.5. Risks for thromboembolism were INR >= 2.5, difference in onset and pre-endoscopic INR, reversal agent use, and anticoagulant interruption but not CHA2DS2-VASc score, any endoscopic results, or heparin bridge. In patients without reversal agent use, heparin bridge, or anticoagulant interruption, there was only one rebleeding event and no thromboembolic events. Warfarin users had a significantly higher transfusion need than DOACs users. Conclusion Endoscopy appears to be safe for anticoagulant users with acute GIB compared with non-users. Patient background factors were associated with rebleeding, whereas anticoagulant management factors (e.g. INR correction, reversal agent use, and drug interruption) were associated with thromboembolism. Early intervention without reversal agent use, heparin bridge, or anticoagulant interruption may be warranted for acute GIB.	[Nagata, Naoyoshi; Sakurai, Toshiyuki; Moriyasu, Shiori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Koriyama, Fukushima, Japan; [Uemura, Naomi] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Gastroenterol & Hepatol, Ichikawa, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [29-2001]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant for Research from the National Center for Global Health and Medicine (29-2001). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta RD, 2016, GASTROINTEST ENDOSC, V83, P3, DOI 10.1016/j.gie.2015.09.035; Aoki T, 2016, CLIN GASTROENTEROL H, V14, P1562, DOI 10.1016/j.cgh.2016.05.042; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHOUDARI CP, 1994, GUT, V35, P464, DOI 10.1136/gut.35.4.464; Comerota AJ, 2016, AM J MED SCI, V352, P92, DOI 10.1016/j.amjms.2016.03.018; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Fujishiro M, 2016, DIGEST ENDOSC, V28, P363, DOI 10.1111/den.12639; Harrison L, 1997, ANN INTERN MED, V126, P133, DOI 10.7326/0003-4819-126-2-199701150-00006; Hernandez I, 2015, JAMA INTERN MED, V175, P18, DOI 10.1001/jamainternmed.2014.5398; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Manatsathit W, 2014, CARDIOVASC DIAGN THE, V4, P224, DOI 10.3978/j.issn.2223-3652.2014.03.07; Nagata N, 2017, CLIN GASTRO ENTEROL; Nagata N, 2016, CLIN GASTROENTEROL H, V14, P558, DOI 10.1016/j.cgh.2015.10.011; Nagata N, 2015, J GASTROEN HEPATOL, V30, P292, DOI 10.1111/jgh.12805; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; Ono K, 2016, J ANESTH, V30, P723, DOI 10.1007/s00540-016-2187-0; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Radaelli F, 2015, DIGEST LIVER DIS, V47, P621, DOI 10.1016/j.dld.2015.03.029; Rubin TA, 2003, GASTROINTEST ENDOSC, V58, P369; Sengupta N, 2015, AM J GASTROENTEROL, V110, P328, DOI 10.1038/ajg.2014.398; Thomopoulos KC, 2005, WORLD J GASTROENTERO, V11, P1365, DOI 10.3748/wjg.v11.i9.1365; Tsuruoka N, 2011, J GASTROEN HEPATOL, V26, P1047, DOI 10.1111/j.1440-1746.2010.06610.x; Veitch AM, 2016, GUT, V65, P374, DOI 10.1136/gutjnl-2015-311110; Wolf AT, 2007, AM J GASTROENTEROL, V102, P290, DOI 10.1111/j.1572-0241.2006.00969.x; Yamaguchi D, 2014, HEPATO-GASTROENTEROL, V61, P1055, DOI 10.5754/hge14122; Yamaguchi D, 2015, DIGEST ENDOSC, V27, P30, DOI 10.1111/den.12316	29	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183423	10.1371/journal.pone.0183423	http://dx.doi.org/10.1371/journal.pone.0183423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863196	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900005
J	Hermida-Carrera, C; Fares, MA; Fernandez, A; Gil-Pelegrin, E; Kapralov, MV; Mir, A; Molins, A; Peguero-Pina, JJ; Rocha, J; Sancho-Knapik, D; Galmes, J				Hermida-Carrera, Carmen; Fares, Mario A.; Fernandez, Angel; Gil-Pelegrin, Eustaquio; Kapralov, Maxim V.; Mir, Arnau; Molins, Arantzazu; Peguero-Pina, Jose Javier; Rocha, Jairo; Sancho-Knapik, Domingo; Galmes, Jeroni			Positively selected amino acid replacements within the RuBisCO enzyme of oak trees are associated with ecological adaptations	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; LARGE SUBUNIT; CATALYTIC-PROPERTIES; TEMPERATURE RESPONSE; KINETIC-PROPERTIES; SPECIES VARIATION; DECISION TREE; TOBACCO SMALL; SPECIFICITY; PLANTS	Phylogenetic analysis by maximum likelihood (PAML) has become the standard approach to study positive selection at the molecular level, but other methods may provide complementary ways to identify amino acid replacements associated with particular conditions. Here, we compare results of the decision tree (DT) model method with ones of PAML using the key photosynthetic enzyme RuBisCO as a model system to study molecular adaptation to particular ecological conditions in oaks (Quercus). We sequenced the chloroplast rbcL gene encoding RuBisCO large subunit in 158 Quercus species, covering about a third of the global genus diversity. It has been hypothesized that RuBisCO has evolved differentially depending on the environmental conditions and leaf traits governing internal gas diffusion patterns. Here, we show, using PAML, that amino acid replacements at the residue positions 95, 145, 251, 262 and 328 of the RuBisCO large subunit have been the subject of positive selection along particular Quercus lineages associated with the leaf traits and climate characteristics. In parallel, the DT model identified amino acid replacements at sites 95, 219, 262 and 328 being associated with the leaf traits and climate characteristics, exhibiting partial overlap with the results obtained using PAML.	[Hermida-Carrera, Carmen; Molins, Arantzazu; Galmes, Jeroni] Univ Illes Balears INAGEA, Res Grp Plant Biol Mediterranean Condit, Palma De Mallorca, Balearic Island, Spain; [Fares, Mario A.] Univ Politecn Valencia, CSIC, Integrat & Syst Biol Grp, Dept Abiot Stress Inst Biol Mol & Celular Plantas, Valencia, Spain; [Fares, Mario A.] Univ Dublin, Trinity Coll Dublin, Dept Genet, Dublin 2, Ireland; [Fernandez, Angel; Gil-Pelegrin, Eustaquio; Peguero-Pina, Jose Javier; Sancho-Knapik, Domingo] CITA Aragon, Unidad Recursos Forestales, Zaragoza, Spain; [Kapralov, Maxim V.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Mir, Arnau; Rocha, Jairo] Univ Illes Balears, Dept Math & Comp Sci, Computat Biol & Bioinformat Res Grp, Palma De Mallorca, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Trinity College Dublin; Newcastle University - UK; Universitat de les Illes Balears	Galmes, J (corresponding author), Univ Illes Balears INAGEA, Res Grp Plant Biol Mediterranean Condit, Palma De Mallorca, Balearic Island, Spain.	jeroni.galmes@uib.cat	Gil-Pelegrín, Eustaquio/M-5129-2014; Torres, Arnau Mir/K-3906-2014; Peguero-Pina, José Javier/M-4494-2014; Sancho-Knapik, Domingo/M-6003-2014; Galmés, Jeroni/J-6749-2017; Sancho-Knapik, Domingo/ABH-6332-2020	Gil-Pelegrín, Eustaquio/0000-0002-4053-6681; Torres, Arnau Mir/0000-0001-5282-3699; Peguero-Pina, José Javier/0000-0002-8903-2935; Sancho-Knapik, Domingo/0000-0001-9584-7471; Galmés, Jeroni/0000-0002-7299-9349; Sancho-Knapik, Domingo/0000-0001-9584-7471; Kapralov, Maxim/0000-0001-7966-0295; Hermida-Carrera, Carmen/0000-0003-3272-3054	Spanish Ministry of Science and Innovation [AGL2009-07999, AGL2013-42364-R]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study was financially supported by the Spanish Ministry of Science and Innovation (projects AGL2009-07999 and AGL2013-42364-R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Carmo-Silva AE, 2010, J EXP BOT; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; Corcuera L, 2002, TREES-STRUCT FUNCT, V16, P465, DOI 10.1007/s00468-002-0187-1; DELGADO E, 1995, J EXP BOT, V46, P1775, DOI 10.1093/jxb/46.11.1775; Du YC, 2000, J BIOL CHEM, V275, P19844, DOI 10.1074/jbc.M002321200; Ehleringer J., 1983, Encyclopedia of plant physiology. New Series. Volume 12D. Physiological plant ecology IV. Ecosystem processes: mineral cycling, productivity and man's influence, P205; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Evolution Dutheil J., 2008, EVOLUTION; Fares MA, 2008, EVOL BIOINFORM; Fares MA, 2006, BIOINFORMATICS, V22, P2821, DOI 10.1093/bioinformatics/btl493; Flexas J, 2014, ENVIRON EXP BOT, V103, P12, DOI 10.1016/j.envexpbot.2013.09.002; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Galmes J, 2014, PLANT SCI, V226, P61, DOI 10.1016/j.plantsci.2014.01.008; Galmes J, 2014, PLANT CELL ENVIRON, V37, P1989, DOI 10.1111/pce.12335; Galmes J, 2014, NEW PHYTOL, V203, P989, DOI 10.1111/nph.12858; Galmes J, 2013, PHOTOSYNTH RES, V117, P73, DOI 10.1007/s11120-013-9861-y; Galmes J, 2011, J EXP BOT, V62, P653, DOI 10.1093/jxb/erq303; Genkov T, 2009, J BIOL CHEM, V284, P30105, DOI 10.1074/jbc.M109.044081; Ghannoum O, 2005, PLANT PHYSIOL, V137, P638, DOI 10.1104/pp.104.054759; Gharehchopogh F.S., 2012, INT J COMPUT APPL, V52, DOI [DOI 10.5120/8206-1613, 10.5120/8206-1613]; Govaerts R, 1998, J EXP BOT; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hermida-Carrera C, 2016, PLANT PHYSIOL, V171, P2549, DOI 10.1104/pp.16.01846; Hozain MI, 2010, TREE PHYSIOL, V30, P32, DOI 10.1093/treephys/tpp091; Iida S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004633; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; James G, 2015, INTRO STAT LEARNING, P315; Jiang XW, 2010, EVOLUTION, V64, P1429, DOI 10.1111/j.1558-5646.2009.00903.x; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kapralov MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052974; Kapralov MV, 2011, MOL BIOL EVOL, V28, P1491, DOI 10.1093/molbev/msq335; Kato S, 2011, J PHYCOL, V47, P999, DOI 10.1111/j.1529-8817.2011.01037.x; Kellogg EA, 1997, AM J BOT, V84, P413, DOI 10.2307/2446015; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kubien DS, 2008, J EXP BOT, V59, P1767, DOI 10.1093/jxb/erm283; Makowski M, 2008, J PHYS CHEM B, V112, P11385, DOI 10.1021/jp803896b; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Manos PS, 1997, AM J BOT, V84, P1407, DOI 10.2307/2446139; Miwa H, 2009, GENE, V441, P169, DOI 10.1016/j.gene.2008.11.020; Morita K, 2014, PLANT PHYSIOL, V164, P69, DOI 10.1104/pp.113.228015; Nielsen R, 1998, GENETICS, V148, P929; Occhialini A, 2016, PLANT J, V85, P148, DOI 10.1111/tpj.13098; Orr DJ, 2016, PLANT PHYSIOL, V172, P707, DOI 10.1104/pp.16.00750; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2018, R LANG ENV STAT COMP; Raines CA, 2006, PLANT CELL ENVIRON, V29, P331, DOI 10.1111/j.1365-3040.2005.01488.x; Rambaut A., 2012, FIGTREE 1 4 0; Raven JA, 2000, PHILOS T R SOC B, V355, P833, DOI 10.1098/rstb.2000.0618; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sack L., 2006, PROGR BOT, P385; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Schwabacher M., 2009, P IEEE AER C MAR, P1, DOI DOI 10.1109/AERO.2009; SEEMANN JR, 1984, PLANT PHYSIOL, V74, P791, DOI 10.1104/pp.74.4.791; Sen L, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-29; Sharwood RE, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.186, 10.1038/nplants.2016.186]; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Simard M, 2000, IEEE T GEOSCI REMOTE, V38, P2310, DOI 10.1109/36.868888; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Steinkellner H, 1997, MOL ECOL, V6, P1189, DOI 10.1046/j.1365-294X.1997.00288.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; Ueno S, 2008, GENES GENET SYST, V83, P179, DOI 10.1266/ggs.83.179; Wang MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-266; Weinreich DM, 2005, EVOLUTION, V59, P1165; Whitney SM, 2011, P NATL ACAD SCI USA, V108, P14688, DOI 10.1073/pnas.1109503108; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Yamori W, 2011, PLANT PHYSIOL, V155, P956, DOI 10.1104/pp.110.168435; Yang CC, 2003, AGR SYST, V76, P1101, DOI 10.1016/S0308-521X(02)00051-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YEOH HH, 1980, PLANT PHYSIOL, V66, P1110, DOI 10.1104/pp.66.6.1110; YEOH HH, 1981, PLANT PHYSIOL, V67, P1151, DOI 10.1104/pp.67.6.1151; Young JN, 2012, PHILOS T R SOC B, V367, P483, DOI 10.1098/rstb.2011.0145; Zhang XH, 2011, PLANT SCI, V180, P480, DOI 10.1016/j.plantsci.2010.11.001; Zhu GH, 1998, PHOTOSYNTH RES, V57, P71, DOI 10.1023/A:1006020424581; Zhu XG, 2004, PLANT CELL ENVIRON, V27, P155, DOI 10.1046/j.1365-3040.2004.01142.x	93	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183970	10.1371/journal.pone.0183970	http://dx.doi.org/10.1371/journal.pone.0183970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859145	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000408740500053
J	Linke, M; Broker, F; Ramscar, M; Baayen, H				Linke, Maja; Broeker, Franziska; Ramscar, Michael; Baayen, Harald			Are baboons learning "orthographic" representations? Probably not	PLOS ONE			English	Article							OBJECT RECOGNITION; VISUAL-SEARCH; HUMANS; PAPIO; FEATURES; ENGLISH; MONKEYS; MODELS; HEBREW	The ability of Baboons (papio papio) to distinguish between English words and nonwords has been modeled using a deep learning convolutional network model that simulates a ventral pathway in which lexical representations of different granularity develop. However, given that pigeons (columba livia), whose brain morphology is drastically different, can also be trained to distinguish between English words and nonwords, it appears that a less species-specific learning algorithm may be required to explain this behavior. Accordingly, we examined whether the learning model of Rescorla and Wagner, which has proved to be amazingly fruitful in understanding animal and human learning could account for these data. We show that a discrimination learning network using gradient orientation features as input units and word and nonword units as outputs succeeds in predicting baboon lexical decision behavior-including key lexical similarity effects and the ups and downs in accuracy as learning unfolds-with surprising precision. The models performance, in which words are not explicitly represented, is remarkable because it is usually assumed that lexicality decisions, including the decisions made by baboons and pigeons, are mediated by explicit lexical representations. By contrast, our results suggest that in learning to perform lexical decision tasks, baboons and pigeons do not construct a hierarchy of lexical units. Rather, they make optimal use of low-level information obtained through the massively parallel processing of gradient orientation features. Accordingly, we suggest that reading in humans first involves initially learning a high-level system building on letter representations acquired from explicit instruction in literacy, which is then integrated into a conventionalized oral communication system, and that like the latter, fluent reading involves the massively parallel processing of the low-level features encoding semantic contrasts.	[Linke, Maja] Leibniz Inst Wissensmedien, Tubingen, Germany; [Broeker, Franziska] UCL, Gatsby Computat Neurosci Unit, London, England; [Ramscar, Michael; Baayen, Harald] Univ Tubingen, Dept Linguist, Tubingen, Germany	Leibniz Institut fur Wissensmedien; University of London; University College London; Eberhard Karls University of Tubingen	Linke, M (corresponding author), Leibniz Inst Wissensmedien, Tubingen, Germany.	m.linke@iwm-tuebingen.de		Baayen, Harald/0000-0003-3178-3944	Alexander von Humboldt Professorship [1141527]	Alexander von Humboldt Professorship(Alexander von Humboldt Foundation)	This research was supported by an Alexander von Humboldt Professorship (#1141527) awarded to the last author.; This research was supported by an Alexander von Humboldt Professorship (#1141527) awarded to the last author.	Dunabeitia JA, 2014, PSYCHOL SCI, V25, P1275, DOI 10.1177/0956797614531026; Dunabeitia JA, 2011, J EXP PSYCHOL LEARN, V37, P1143, DOI 10.1037/a0023577; Arnold D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174623; Baayen RH, 2012, LINGUE LINGUAGGIO, V11, P123, DOI 10.1418/38782; Bains W, 2012, SCIENCE, V337, DOI 10.1126/science.1224508; Bitschnau S., 2015, THESIS; Bogen JE, 1969, B LOS ANGELES NEUROL; Deruelle C, 1998, PSYCHON B REV, V5, P476, DOI 10.3758/BF03208825; Fagot J, 1997, J EXP PSYCHOL HUMAN, V23, P429, DOI 10.1037/0096-1523.23.2.429; Fagot J, 2001, J EXP PSYCHOL ANIM B, V27, P316, DOI 10.1037/0097-7403.27.4.316; Fagot J, 1998, Anim Cogn, V1, P123, DOI 10.1007/s100710050017; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Frost R, 2013, PSYCHOL SCI, V24, P1868, DOI 10.1177/0956797613482145; Goris RLT, 2013, PSYCHOL REV, V120, P472, DOI 10.1037/a0033136; Grainger J, 2014, WRIT LANG LIT, V17, P225, DOI 10.1075/wll.17.2.03gra; Grainger J, 2012, SCIENCE, V336, P245, DOI 10.1126/science.1218152; Hannagan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084843; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Keuleers E, 2012, BEHAV RES METHODS, V44, P287, DOI 10.3758/s13428-011-0118-4; Kruschke JK, 2009, PSYCHOL LEARN MOTIV, V51, P153, DOI 10.1016/S0079-7421(09)51005-5; Liberman M., 2012, LANGUAGE LOG    0419; Marra G, 2012, SCAND J STAT, V39, P53, DOI 10.1111/j.1467-9469.2011.00760.x; Marsolek CJ, 2008, TRENDS COGN SCI, V12, P176, DOI 10.1016/j.tics.2008.02.005; Milin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171935; MILLER RR, 1995, PSYCHOL BULL, V117, P363, DOI 10.1037/0033-2909.117.3.363; Norris D, 2008, J EXP PSYCHOL GEN, V137, P434, DOI 10.1037/a0012799; Ramscar M, 2007, TRENDS COGN SCI, V11, P274, DOI 10.1016/j.tics.2007.05.007; Ramscar M, 2013, CHILD DEV, V84, P1308, DOI 10.1111/cdev.12044; Ramscar M, 2013, PSYCHOL SCI, V24, P1017, DOI 10.1177/0956797612460691; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rohatgi A., 2015, TOOL EXTRACT NUMERIC; Scarf D, 2016, P NATL ACAD SCI USA, V113, P11272, DOI 10.1073/pnas.1607870113; Seibert D., 2016, BIORXIV; Serre T, 2005, PROC CVPR IEEE, P994; Siegel S, 1996, PSYCHON B REV, V3, P314, DOI 10.3758/BF03210755; Treisman A, 1988, FEATURE ANAL EARLY V; Trimmer PC, 2012, J THEOR BIOL, V302, P39, DOI 10.1016/j.jtbi.2012.02.014; Velan H, 2007, PSYCHON B REV, V14, P913, DOI 10.3758/BF03194121; Velan H, 2011, COGNITION, V118, P141, DOI 10.1016/j.cognition.2010.11.013; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2015, J R STAT SOC C-APPL, V64, P139, DOI 10.1111/rssc.12068; Wood SN, 2013, BIOMETRIKA, V100, P1005, DOI 10.1093/biomet/ast038; Wood SN, 2013, BIOMETRIKA, V100, P221, DOI 10.1093/biomet/ass048; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971; Ziegler JC, 2013, PSYCHOL SCI, V24, P1609, DOI 10.1177/0956797612474322	49	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183876	10.1371/journal.pone.0183876	http://dx.doi.org/10.1371/journal.pone.0183876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	28859134	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500044
J	Stolwijk, LJ; Weeke, LC; de Vries, LS; van Herwaarden, MYA; van der Zee, DC; van der Werff, DBM; Benders, MJNL; Toet, M; Lemmers, PMA				Stolwijk, Lisanne J.; Weeke, Lauren C.; de Vries, Linda S.; van Herwaarden, Maud Y. A.; van der Zee, David C.; van der Werff, Desiree B. M.; Benders, Manon J. N. L.; Toet, Mona; Lemmers, Petra M. A.			Effect of general anesthesia on neonatal aEEG - A cohort study of patients with non-cardiac congenital anomalies	PLOS ONE			English	Article							AMPLITUDE-INTEGRATED ELECTROENCEPHALOGRAPHY; CHILDREN; SEVOFLURANE; INFANTS; EEG; AGE; SURGERY; CHILDHOOD; INDUCTION; EMERGENCE	Introduction The aim of the current study was to determine the effect of general anesthesia on neonatal brain activity using amplitude-integrated EEG (aEEG). Methods A prospective cohort study of neonates (January 2013-December 2015), who underwent major neonatal surgery for non-cardiac congenital anomalies. Anesthesia was administered at the discretion of the anesthetist. aEEG monitoring was started six hours preoperatively until 24 hours after surgery. Analysis of classes of aEEG background patterns, ranging from continuous normal voltage to flat trace in six classes, and quantitative EEG-measures, using spontaneous activity transients (SATs) and interSATintervals (ISI), was performed. Results In total, 111 neonates were included (36 preterm/75 full-term), age at time of surgery was (median (range) 2 (0-32) days. During anesthesia depression of brain activity was seen, with background patterns ranging from flat trace to discontinuous normal voltage. In most patients brain activity was two background pattern classes lower during anesthesia. After cessation of anesthesia, recovery to preoperative brain activity occurred within 24 hours in 86% of the preterm and 96% of the term infants. Gestational age and the dose of sevoflurane were significantly associated with SAT-rate (F(2,68) = 9.288, p < 0.001) and ISI-durations during surgery (F(3,71) = 12.96, p < 0.001). Background pattern and quantitative EEG-values were not associated with brain lesions (chi(2)(4) = 2.086, ns). Conclusion aEEG shows a variable reduction of brain activity in response to anesthesia in neonates with noncardiac congenital anomalies, with fast recovery after cessation of anesthesia. This reduction is related to gestational age and the dose of sevoflurane. The aEEG offers the opportunity to monitor the depth of anesthesia in the neonate.	[Stolwijk, Lisanne J.; Weeke, Lauren C.; de Vries, Linda S.; Toet, Mona; Lemmers, Petra M. A.] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [Stolwijk, Lisanne J.; Weeke, Lauren C.; de Vries, Linda S.; Benders, Manon J. N. L.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Stolwijk, Lisanne J.; van Herwaarden, Maud Y. A.; van der Zee, David C.] Univ Med Ctr Utrecht, Dept Pediat Surg, Utrecht, Netherlands; [van der Werff, Desiree B. M.] Univ Med Ctr Utrecht, Dept Anesthesiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Lemmers, PMA (corresponding author), Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands.	p.lemmers@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021					Akeju O, 2015, BRIT J ANAESTH, V115, P66, DOI 10.1093/bja/aev114; Backeljauw B, 2015, PEDIATRICS, V136, pE1, DOI 10.1542/peds.2014-3526; Benders MJ, 2015, CEREB CORTEX, V25, P3014, DOI 10.1093/cercor/bhu097; Brinkman EN, 2016, EUR J ANAESTHESIOL; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cornelissen L, 2015, ELIFE, V4, DOI 10.7554/eLife.06513; Davidson AJ, 2006, PEDIATR ANESTH, V16, P374, DOI 10.1111/j.1460-9592.2006.01877.x; Davidson AJ, 2015, LANCET; Davidson AJ, 2008, PEDIATR ANESTH, V18, P60, DOI 10.1111/j.1460-9592.2007.02359.x; Davidson AJ, 2007, CURR OPIN ANESTHESIO, V20, P236, DOI 10.1097/ACO.0b013e3280c60c66; de Vries LS, 2005, ARCH DIS CHILD-FETAL, V90, P201, DOI 10.1136/adc.2004.062745; Ganesh Arjunan, 2004, Curr Opin Anaesthesiol, V17, P229, DOI 10.1097/00001503-200406000-00006; Gischler SJ, 2009, J PEDIATR SURG, V44, P1382, DOI 10.1016/j.jpedsurg.2008.12.034; Gorra AS, 2012, J PEDIATR SURG, V47, P125, DOI 10.1016/j.jpedsurg.2011.10.028; Gunn JK, 2012, INTENS CARE MED, V38, P1539, DOI 10.1007/s00134-012-2608-y; Hayashi K, 2012, NEUROSCI LETT, V517, P87, DOI 10.1016/j.neulet.2012.04.028; Hellstrom-Westas L., 2008, ATLAS AMPLITUDE INTE, V2nd; Istaphanous GK, 2010, BEST PRACT RES-CLIN, V24, P433, DOI 10.1016/j.bpa.2010.02.013; Kim HS, 2005, BRIT J ANAESTH, V95, P362, DOI 10.1093/bja/aei196; Kreuzer I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089191; Kuizenga K, 2001, BRIT J ANAESTH, V86, P354, DOI 10.1093/bja/86.3.354; Laing SR, 2011, J PAEDIATR CHILD H, V47, P140, DOI 10.1111/j.1440-1754.2010.01902.x; LERMAN J, 1994, ANESTHESIOLOGY, V80, P814, DOI 10.1097/00000542-199404000-00014; Lo SS, 2009, PEDIATR ANESTH, V19, P1157, DOI 10.1111/j.1460-9592.2009.03128.x; McKeever S, 2014, PEDIATR ANESTH, V24, P766, DOI 10.1111/pan.12366; Mehta B, 2016, J CHILD NEUROL, V31, P1276, DOI 10.1177/0883073816653781; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Stolwijk LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1728; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Sury MRJ, 2014, BRIT J ANAESTH, V112, P686, DOI 10.1093/bja/aet409; Toet MC, 2008, CLIN PERINATOL, V35, P665, DOI 10.1016/j.clp.2008.07.017; Vakkuri A, 2001, ACTA ANAESTH SCAND, V45, P805, DOI 10.1034/j.1399-6576.2001.045007805.x; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008	33	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183581	10.1371/journal.pone.0183581	http://dx.doi.org/10.1371/journal.pone.0183581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859124	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500023
J	Rohrbeck, A; Holtje, M; Adolf, A; Oms, E; Hagemann, S; Ahnert-Hilger, G; Just, I				Rohrbeck, Astrid; Hoeltje, Markus; Adolf, Andrej; Oms, Elisabeth; Hagemann, Sandra; Ahnert-Hilger, Gudrun; Just, Ingo			The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; MICROVASCULAR ENDOTHELIAL-CELLS; JAPANESE ENCEPHALITIS-VIRUS; FILAMENT PROTEIN VIMENTIN; DISINTEGRIN-LIKE DOMAIN; CLOSTRIDIUM-BOTULINUM; STAPHYLOCOCCUS-AUREUS; CYTOPLASMIC TAIL; EPITHELIAL-CELLS; RGD MOTIF	The Rho ADP-ribosylating C3 exoenzyme (C3bot) is a bacterial protein toxin devoid of a cell-binding or-translocation domain. Nevertheless, C3 can efficiently enter intact cells, including neurons, but the mechanism of C3 binding and uptake is not yet understood. Previously, we identified the intermediate filament vimentin as an extracellular membranous interaction partner of C3. However, uptake of C3 into cells still occurs (although reduced) in the absence of vimentin, indicating involvement of an additional host cell receptor. C3 harbors an Arg-Gly-Asp (RGD) motif, which is the major integrin-binding site, present in a variety of integrin ligands. To check whether the RGD motif of C3 is involved in binding to cells, we performed a competition assay with C3 and RGD peptide or with a monoclonal antibody binding to beta 1-integrin subunit and binding assays in different cell lines, primary neurons, and synaptosomes with C3-RGD mutants. Here, we report that preincubation of cells with the GRGDNP peptide strongly reduced C3 binding to cells. Moreover, mutation of the RGD motif reduced C3 binding to intact cells and also to recombinant vimentin. Anti-integrin antibodies also lowered the C3 binding to cells. Our results indicate that the RGD motif of C3 is at least one essential C3 motif for binding to host cells and that integrin is an additional receptor for C3 besides vimentin.	[Rohrbeck, Astrid; Oms, Elisabeth; Hagemann, Sandra; Just, Ingo] Hannover Med Sch, Inst Toxicol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Hoeltje, Markus; Adolf, Andrej; Ahnert-Hilger, Gudrun] Charite, Inst Integrat Neuroanat, D-10115 Berlin, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohrbeck, A (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	rohrbeck.astrid@mh-hannover.de		Holtje, Markus/0000-0003-3193-4140	Deutsche Forschungsgemeinschaft (DFG) [JU 231/7-1, RO 5129/2-1, AH 67/10-1, HO 3249/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants JU 231/7-1 (to I. J.), RO 5129/2-1 (to A. R.), AH 67/10-1 (to G. A. H.), and HO 3249/5-1 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adolf A, 2016, J NEUROCHEM, V139, P234, DOI 10.1111/jnc.13739; Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; AULLO P, 1993, EMBO J, V12, P921, DOI 10.1002/j.1460-2075.1993.tb05733.x; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Becher A, 1999, J NEUROSCI, V19, P1922; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; Boilard E, 2003, BLOOD, V102, P2901, DOI 10.1182/blood-2002-12-3702; BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Chang IA, 2012, FASEB J, V26, P2401, DOI 10.1096/fj.11-199018; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Eckes B, 2000, J CELL SCI, V113, P2455; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Gianni T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003806; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gilles C, 1999, J CELL SCI, V112, P4615; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Homan SM, 1998, J CELL SCI, V111, P2717; Huet D, 2006, J IMMUNOL, V176, P652, DOI 10.4049/jimmunol.176.1.652; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; INOUE S, 1991, BIOCHEM BIOPH RES CO, V174, P459, DOI 10.1016/0006-291X(91)91438-I; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; JUST I, 1995, BIOCHEMISTRY-US, V34, P334, DOI 10.1021/bi00001a041; JUST I, 1992, J BIOL CHEM, V267, P10274; Khan TA, 2016, BIOCHEMISTRY-US, V55, P2078, DOI 10.1021/acs.biochem.5b01243; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Kim J, 2016, J CELL SCI, V129, P2030, DOI 10.1242/jcs.180315; Kim JK, 2006, J VIROL, V80, P689, DOI 10.1128/JVI.80.2.689-696.2006; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lutschg V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1391; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mak TN, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020018; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pall T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029305; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Podor TJ, 2002, J BIOL CHEM, V277, P7529, DOI 10.1074/jbc.M109675200; PONCZ M, 1990, BLOOD, V75, P1282; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Rohrbeck A, 2016, TOXINS, V8, DOI 10.3390/toxins8040100; Rohrbeck A, 2015, TOXINS, V7, P380, DOI 10.3390/toxins7020380; Rohrbeck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101071; Rotsch J, 2012, N-S ARCH PHARMACOL, V385, P883, DOI 10.1007/s00210-012-0764-9; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sahai E, 2006, METHOD ENZYMOL, V406, P128, DOI 10.1016/S0076-6879(06)06011-3; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shigyo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12055; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Walker LR, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-015-0066-2; Walker LR, 2014, J GEN VIROL, V95, P1770, DOI 10.1099/vir.0.066829-0; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; Xu B, 2004, MOL CELL BIOL, V24, P9198, DOI 10.1128/MCB.24.20.9198-9206.2004; Yang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38372; Yu YTC, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0234-7; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	95	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17668	17680		10.1074/jbc.M117.798231	http://dx.doi.org/10.1074/jbc.M117.798231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28882889	Green Published, hybrid			2022-12-26	WOS:000414013000009
J	Davies, J; Li, SQ; Tong, SY; Baird, RW; Beaman, M; Higgins, G; Cowie, BC; Condon, JR; Davis, JS				Davies, Jane; Li, Shu Qin; Tong, Steven Y.; Baird, Rob W.; Beaman, Miles; Higgins, Geoff; Cowie, Benjamin C.; Condon, John R.; Davis, Joshua S.			Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population	PLOS ONE			English	Article							NORTHERN-TERRITORY; HEPATOCELLULAR-CARCINOMA; VIRUS; VACCINATION; AUSTRALIA; GENOTYPES; EPIDEMIOLOGY; PROTECTION; PROGRAM; PEOPLE	Background Indigenous populations globally are disproportionately affected by chronic hepatitis B virus (HBV) infection however contemporary sero-prevalence data are often absent. In the Indigenous population of the Northern Territory (NT) of Australia the unique C4 sub-genotype of HBV universally circulates. There are no studies of the sero-prevalence, nor the impact of the vaccination program (which has a serotype mismatch compared to C4), at a population-wide level. Methods We examined all available HBV serology results obtained from the three main laboratories serving NT residents between 1991 and 2011. Data were linked with a NT government database to determine Indigenous status and the most recent test results for each individual were extracted as a cross-sectional database including 88,112 unique individuals. The primary aim was to obtain a contemporary estimate of HBsAg positivity for the NT by Indigenous status. Results Based on all tests from 2007-2011 (35,633 individuals), hepatitis B surface antigen (HBsAg) positivity was 3.40% (95% CI 3.19-3.61), being higher in Indigenous (6.08% [5.65%-6.53%]) than non-Indigenous (1.56%[1.38%-1.76%]) Australians, p<0.0001. Birth cohort analysis showed HBsAg positivity fell over time for Indigenous people, with this decrease commencing prior to universal infant vaccination (which commenced in 1990), with an ongoing but slower rate of decline since 1990, (0.23% decrease per year versus 0.17%). Conclusions HBsAg positivity is high in the NT, particularly in the Indigenous population. HBsAg positivity has fallen over time but a substantial part of this decrease is due to factors other than the universal vaccination program.	[Davies, Jane; Tong, Steven Y.; Condon, John R.; Davis, Joshua S.] Menzies Sch Hlth Res, Dept Global & Trop Hlth, Darwin, NT, Australia; [Davies, Jane] Royal Darwin Hosp, Infect Dis Dept, Darwin, NT, Australia; [Li, Shu Qin; Condon, John R.] Northern Terr Dept Hlth, Hlth Gains Planning Branch, Darwin, NT, Australia; [Tong, Steven Y.] Univ Melbourne, Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Tong, Steven Y.; Cowie, Benjamin C.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Baird, Rob W.] Royal Darwin Hosp, Terr Pathol, Darwin, NT, Australia; [Beaman, Miles] Western Diagnost Pathol, Myaree, WA, Australia; [Beaman, Miles] Univ Western Australia, Perth, WA, Australia; [Beaman, Miles] Univ Notre Dame Australia, Fremantle, WA, Australia; [Higgins, Geoff] SA Pathol, Adelaide, SA, Australia; [Cowie, Benjamin C.] Doherty Inst, WHO Collaborating Ctr Viral Hepatitis, Melbourne, Vic, Australia; [Davis, Joshua S.] John Hunter Hosp, New Lambton Hts, NSW, Australia	Charles Darwin University; Menzies School of Health Research; University of Melbourne; Royal Melbourne Hospital; University of Western Australia; University of Notre Dame Australia; SA Pathology; John Hunter Hospital	Davies, J (corresponding author), Menzies Sch Hlth Res, Dept Global & Trop Hlth, Darwin, NT, Australia.; Davies, J (corresponding author), Royal Darwin Hosp, Infect Dis Dept, Darwin, NT, Australia.	Jane.davies@menzies.edu.au	Condon, John R/N-2281-2013; Davies, Jane/AAD-8109-2019; Tong, Steven/N-2353-2013; Cowie, Benjamin/HFZ-9941-2022; Davis, Joshua/N-2288-2013	Condon, John R/0000-0003-4952-0990; Davies, Jane/0000-0002-3843-837X; Tong, Steven/0000-0002-1368-8356; Cowie, Benjamin/0000-0002-7087-5895; Davis, Joshua/0000-0001-9864-5699; baird, robert/0000-0003-2006-5277	Australian National Health & Medical Research Council; Sidney Myer Fund	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sidney Myer Fund	JD, JSD and SYT received salary support from the Australian National Health & Medical Research Council and JD also received salary support from the Sidney Myer Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Western Diagnostic Pathology provided support in the form of salary for MB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section. There was no other specific funding for this project.	[Anonymous], 2011, CENS POP HOUS; Aratchige PE, 2012, N TERRITORY DIS CONT, V19, P1; Australian Bureau of Statistics, 2013, 3412 0 MIGR; Australian Institute of Health and Welfare, 2011, AIHW IND HLTH CHECK; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Cowie B., 2015, HEPATITIS B MAPPING; Davies J, 2013, J GASTROEN HEPATOL, V28, P1234, DOI 10.1111/jgh.12177; Dent E, 2010, COMMUN DIS INTELL, V34, P435; Elkin A P, 1993, ABORIGINAL MEN HIGH; Farrell T, 2016, M UNMET NEED ROAD AL; GARDNER ID, 1992, MED J AUSTRALIA, V156, P638, DOI 10.5694/j.1326-5377.1992.tb121461.x; Gidding HF, 2007, VACCINE, V25, P8637, DOI 10.1016/j.vaccine.2007.07.046; Graham S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-403; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Littlejohn M, 2014, J MED VIROL, V86, P695, DOI 10.1002/jmv.23888; Liu B, 2012, VACCINE, V30, P7309, DOI 10.1016/j.vaccine.2012.09.033; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Morrison J, 1967, Med J Aust, V1, P125; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Parker C, 2014, MED J AUSTRALIA, V201, P470, DOI 10.5694/mja13.11117; Peto TJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-7; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Schultz R, 2008, AUST NZ J PUBL HEAL, V32, P575, DOI 10.1111/j.1753-6405.2008.00313.x; Tew K., 2008, VALIDATION PATIENT D; Trudgen R, 2000, WHY WARRIORS LAY DIE; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000753; Wood N, 2005, COMMUN DIS INTELL, V29, P289	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184082	10.1371/journal.pone.0184082	http://dx.doi.org/10.1371/journal.pone.0184082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886050	Green Published, gold			2022-12-26	WOS:000410001100064
J	Duan, F; Watanabe, K; Yoshimura, Y; Kikuchi, M; Minabe, Y; Aihara, K				Duan, Fang; Watanabe, Katsumi; Yoshimura, Yuko; Kikuchi, Mitsuru; Minabe, Yoshio; Aihara, Kazuyuki			Detection of atypical network development patterns in children with autism spectrum disorder using magnetoencephalography	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; SMALL-WORLD; SYNCHRONIZATION LIKELIHOOD; FRONTAL-CORTEX; EEG; PHASE; MEG; DYNAMICS; RESPONSIVENESS	Autism spectrum disorder (ASD) is a developmental disorder that involves developmental delays. It has been hypothesized that aberrant neural connectivity in ASD may cause atypical brain network development. Brain graphs not only describe the differences in brain networks between clinical and control groups, but also provide information about network development within each group. In the present study, graph indices of brain networks were estimated in children with ASD and in typically developing (TD) children using magnetoencephalography performed while the children viewed a cartoon video. We examined brain graphs from a developmental point of view, and compared the networks between children with ASD and TD children. Network development patterns (NDPs) were assessed by examining the association between the graph indices and the raw scores on the achievement scale or the age of the children. The ASD and TD groups exhibited different NDPs at both network and nodal levels. In the left frontal areas, the nodal degree and efficiency of the ASD group were negatively correlated with the achievement scores. Reduced network connections were observed in the temporal and posterior areas of TD children. These results suggested that the atypical network developmental trajectory in children with ASD is associated with the development score rather than age.	[Duan, Fang; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Watanabe, Katsumi] Waseda Univ, Dept Intermedia Art & Sci, Tokyo, Japan; [Yoshimura, Yuko; Kikuchi, Mitsuru; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan	University of Tokyo; University of Tokyo; Waseda University; Kanazawa University	Duan, F (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	duan@sat.t.u-tokyo.ac.jp		Watanabe, Katsumi/0000-0003-1282-9994	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Japan Science and Technology Agency KAKENHI [15H05707]; Center of Innovation Program	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Science and Technology Agency KAKENHI; Center of Innovation Program	This work was partially supported by Core Research for Evolutional Science and Technology and the Center of Innovation Program, the Japan Science and Technology Agency. This work was also supported by Japan Science and Technology Agency KAKENHI grant number 15H05707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Ahmadlou M, 2012, J NEUROSCI METH, V211, P203, DOI 10.1016/j.jneumeth.2012.08.020; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Alfonso V.C., 2013, ESSENTIALS CROSS BAT; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ansari-Asl K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031916; Baker AEZ, 2008, J AUTISM DEV DISORD, V38, P867, DOI 10.1007/s10803-007-0459-0; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Bollobas B., 1998, MODERN GRAPH THEORY; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Duan F, 2014, BRAIN COGNITION, V86, P10, DOI 10.1016/j.bandc.2014.01.011; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hilton CL, 2010, J AUTISM DEV DISORD, V40, P633, DOI 10.1007/s10803-009-0905-2; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kaufman N.L., 1983, K ABC KAUFMAN ASSESS; Kikuchi M, 2016, PSYCHIAT CLIN NEUROS, V70, P74, DOI 10.1111/pcn.12338; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; Lazar AS, 2010, CLIN NEUROPHYSIOL, V121, P1844, DOI 10.1016/j.clinph.2010.03.054; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Matlis S, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0355-8; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Myers SM, 2007, PEDIATRICS, V120, P1162, DOI 10.1542/peds.2007-2362; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Orekhova EV, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-40; Osterhage H, 2007, INT J NEURAL SYST, V17, P139, DOI 10.1142/S0129065707001019; Pedersen M, 2015, NEUROIMAGE-CLIN, V8, P536, DOI 10.1016/j.nicl.2015.05.009; Richards JE, 2010, DEV REV, V30, P203, DOI 10.1016/j.dr.2010.03.005; Schwartz S, 2017, PEDIATR NEUROL, V67, P7, DOI 10.1016/j.pediatrneurol.2016.10.018; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Velazquez JLP, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00037; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Xue SW, 2013, BRAIN COGNITION, V81, P24, DOI 10.1016/j.bandc.2012.09.004; Yan Z, 2011, NEUROSCI LETT, V499, P199, DOI 10.1016/j.neulet.2011.05.061; Zamoscik V, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00079	64	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184422	10.1371/journal.pone.0184422	http://dx.doi.org/10.1371/journal.pone.0184422			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886147	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100116
J	Raymond, SL; Lopez, MC; Baker, HV; Larson, SD; Efron, PA; Sweeney, TE; Khatri, P; Moldawer, LL; Wynn, JL				Raymond, Steven L.; Lopez, Maria Cecilia; Baker, Henry V.; Larson, Shawn D.; Efron, Philip A.; Sweeney, Timothy E.; Khatri, Purvesh; Moldawer, Lyle L.; Wynn, James L.			Unique transcriptomic response to sepsis is observed among patients of different age groups	PLOS ONE			English	Article							PRETERM INFANTS; IN-VIVO; CHEMOTAXIS; EPIDEMIOLOGY; NEUTROPHILS; MORTALITY; ADHERENCE; IMMUNITY; NETWORK; TIME	Sepsis is a major cause of morbidity and mortality, especially at the extremes of age. To understand the human age-specific transcriptomic response to sepsis, a multi-cohort, pooled analysis was conducted on adults, children, infants, and neonates with and without sepsis. Nine public whole-blood gene expression datasets (636 patients) were employed. Age impacted the transcriptomic host response to sepsis. Gene expression from septic neonates and adults was more dissimilar whereas infants and children were more similar. Neonates showed reductions in inflammatory recognition and signaling pathways compared to all other age groups. Likewise, adults demonstrated decreased pathogen sensing, inflammation, and myeloid cell function, as compared to children. This may help to explain the increased incidence of sepsis-related organ failure and death in adults. The number of dys-regulated genes in septic patients was proportional to age and significantly differed among septic adults, children, infants, and neonates. Overall, children manifested a greater transcriptomic intensity to sepsis as compared to the other age groups. The transcriptomic magnitude for adults and neonates was dramatically reduced as compared to children and infants. These findings suggest that the transcriptomic response to sepsis is age-dependent, and diagnostic and therapeutic efforts to identify and treat sepsis will have to consider age as an important variable.	[Raymond, Steven L.; Larson, Shawn D.; Efron, Philip A.; Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA; [Lopez, Maria Cecilia; Baker, Henry V.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sweeney, Timothy E.; Khatri, Purvesh] Stanford Univ, Dept Med, Div Biomed Informat Res, Sch Med, Stanford, CA 94305 USA; [Khatri, Purvesh] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Wynn, James L.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA; [Wynn, James L.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Stanford University; Stanford University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wynn, JL (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.; Wynn, JL (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	james.wynn@peds.ufl.edu	Larson, Shawn D/AFD-9859-2022; Lopez, Maria/HHC-3659-2022	Larson, Shawn D/0000-0002-8564-0140; Khatri, Purvesh/0000-0002-4143-4708; Wynn, James/0000-0001-7052-4836; Moldawer, Lyle/0000-0002-9041-9838; Sweeney, Timothy/0000-0002-3596-1093	Bill and Melinda Gates Foundation; National Institute of General Medical Sciences [K08 GM106143, R01 GM097531, R01 GM040586, R01 GM113945, P50 GM111152]; National Institute of Allergy and Infectious Diseases [1U19AI109662, U19AI057229, U541117925]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117925, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097531, P50GM111152, K08GM106143, R01GM113945, R01GM040586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Bill and Melinda Gates Foundation, the National Institute of General Medical Sciences (K08 GM106143, R01 GM097531, R01 GM040586, R01 GM113945, and P50 GM111152), and the National Institute of Allergy and Infectious Diseases (1U19AI109662, U19AI057229, and U541117925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 2016, MOL MED, P22; Barton L, 1999, PEDIATRICS, V103, P446, DOI 10.1542/peds.103.2.446; BEKTAS S, 1990, ACTA PAEDIATR SCAND, V79, P1031, DOI 10.1111/j.1651-2227.1990.tb11379.x; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Cuenca AG, 2013, CRIT CARE MED, V41, P1175, DOI 10.1097/CCM.0b013e318277131c; Gentile LF, 2014, J IMMUNOL, V192, P3156, DOI 10.4049/jimmunol.1301726; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Hu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099671; Jones CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114509; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; KRAUSE PJ, 1986, PEDIATR RES, V20, P296, DOI 10.1203/00006450-198604000-00004; Mahajan P, 2016, JAMA-J AM MED ASSOC, V316, P846, DOI 10.1001/jama.2016.9207; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Nacionales DC, 2014, J IMMUNOL, V192, P612, DOI 10.4049/jimmunol.1302109; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ramchandran R, 2008, AM J PHYSIOL-LUNG C, V295, pL363, DOI 10.1152/ajplung.90241.2008; Simon R, 2008, CURR OPIN BIOTECH, V19, P26, DOI 10.1016/j.copbio.2007.10.008; Simon R, 2009, BEST PRACT RES CL HA, V22, P271, DOI 10.1016/j.beha.2009.07.001; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sweeney TE, 2017, CRIT CARE MED, V45, P934, DOI 10.1097/CCM.0000000000002402; Sweeney TE, 2017, CRIT CARE MED, V45, P1, DOI 10.1097/CCM.0000000000002021; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Wynn JL, 2015, MOL MED, V21, P496, DOI 10.2119/molmed.2015.00064; Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169	34	24	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184159	10.1371/journal.pone.0184159	http://dx.doi.org/10.1371/journal.pone.0184159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886074	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100071
J	Roodt, D; Lohaus, R; Sterck, L; Swanepoel, RL; Van de Peer, Y; Mizrachi, E				Roodt, Danielle; Lohaus, Rolf; Sterck, Lieven; Swanepoel, Riaan L.; Van de Peer, Yves; Mizrachi, Eshchar			Evidence for an ancient whole genome duplication in the cycad lineage	PLOS ONE			English	Article							EXTANT GYMNOSPERMS; SEED PLANT; MOLECULAR EVOLUTION; DIVERGENCE TIMES; ORIGIN; DIVERSIFICATION; POLYPLOIDY; PHYLOGENY; EPHEDRA; GENES	Contrary to the many whole genome duplication events recorded for angiosperms (flowering plants), whole genome duplications in gymnosperms (non-flowering seed plants) seem to be much rarer. Although ancient whole genome duplications have been reported for most gymnosperm lineages as well, some are still contested and need to be confirmed. For instance, data for ginkgo, but particularly cycads have remained inconclusive so far, likely due to the quality of the data available and flaws in the analysis. We extracted and sequenced RNA from both the cycad Encephalartos natalensis and Ginkgo biloba. This was followed by transcriptome assembly, after which these data were used to build paralog age distributions. Based on these distributions, we identified remnants of an ancient whole genome duplication in both cycads and ginkgo. The most parsimonious explanation would be that this whole genome duplication event was shared between both species and had occurred prior to their divergence, about 300 million years ago.	[Roodt, Danielle; Swanepoel, Riaan L.; Mizrachi, Eshchar] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag X20, Pretoria, South Africa; [Roodt, Danielle; Swanepoel, Riaan L.; Van de Peer, Yves; Mizrachi, Eshchar] Univ Pretoria, Ctr Bioinformat & Computat Biol, Genom Res Inst, Private Bag X20, Pretoria, South Africa; [Lohaus, Rolf; Sterck, Lieven; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Lohaus, Rolf; Sterck, Lieven; Van de Peer, Yves] VIB Ctr Plant Syst Biol, Ghent, Belgium; [Lohaus, Rolf; Sterck, Lieven; Van de Peer, Yves] Univ Ghent, Bioinformat Inst Ghent, Ghent, Belgium	University of Pretoria; University of Pretoria; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Mizrachi, E (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag X20, Pretoria, South Africa.; Mizrachi, E (corresponding author), Univ Pretoria, Ctr Bioinformat & Computat Biol, Genom Res Inst, Private Bag X20, Pretoria, South Africa.	eshchar.mizrachi@fabi.up.ac.za	Van de Peer, Yves/AAE-7666-2019; Mizrachi, Eshchar/N-3179-2014; Sterck, Lieven/A-9439-2016; Van de Peer, Yves/D-4388-2009	Van de Peer, Yves/0000-0003-4327-3730; Sterck, Lieven/0000-0001-7116-4000; Van de Peer, Yves/0000-0003-4327-3730; Roodt, Danielle/0000-0001-7839-7704; Mizrachi, Eshchar/0000-0002-3126-9593	UP Research Development Programme (RDP); Genomics Research Institute (GRI); Ghent University [01MR0310W]; European Union Seventh Framework Programme (FP7) under European Research Council Advanced Grant [322739 - DOUBLEUP, 322739 -DOUBLEUP]	UP Research Development Programme (RDP); Genomics Research Institute (GRI); Ghent University(Ghent University); European Union Seventh Framework Programme (FP7) under European Research Council Advanced Grant(European Research Council (ERC))	The authors acknowledge the UP Research Development Programme (RDP), the Genomics Research Institute (GRI), Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks' Project (no. 01MR0310W) of Ghent University, and funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739 - DOUBLEUP for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Jason Samson, Philip Rousseau and the Manie van der Schijff Botanical Gardens of the University of Pretoria for plant material and assisting with sampling. EM acknowledges the UP Research Development Programme (RDP) and the Genomics Research Institute (GRI) for support. YVdP acknowledges the Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks' Project (no. 01MR0310W) of Ghent University, and funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739 -DOUBLEUP.	Arrigo N, 2012, CURR OPIN PLANT BIOL, V15, P140, DOI 10.1016/j.pbi.2012.03.010; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Brenner ED, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r78; Burleigh JG, 2012, J BOT, V2012; Calonje M., 2013, WORLD LIST CYCADS; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Chaw SM, 1997, MOL BIOL EVOL, V14, P56, DOI 10.1093/oxfordjournals.molbev.a025702; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Condamine FL, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0347-8; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; De La Torre AR, 2017, MOL BIOL EVOL, V34, P1363, DOI 10.1093/molbev/msx069; de la Torre-Barcena JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005764; Doyle JA, 1996, INT J PLANT SCI, V157, pS3, DOI 10.1086/297401; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gilbert D., 2013, EVIDENTIALGENE MRNA, P1, DOI [10.7490/f1000research.1112594.1, DOI 10.7490/F1000RESEARCH.1112594.1]; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guan R, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0154-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jones, 2002, CYCADS WORLD ANCIENT; KHOSHOO TN, 1959, EVOLUTION, V13, P24, DOI 10.2307/2405943; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li Z, 2017, GENOME BIOL EVOL, V9, P1130, DOI 10.1093/gbe/evx070; Li Z, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501084; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Magallon S, 2002, AM J BOT, V89, P1991, DOI 10.3732/ajb.89.12.1991; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Mayrose I, 2015, NEW PHYTOL, V206, P27, DOI 10.1111/nph.13192; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Ruprecht C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603195; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; VandePeer Y, 2017, NAT REV GENET; Vanneste K, 2015, PLANT CELL, V27, P1567, DOI 10.1105/tpc.15.00157; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vanneste K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0353; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wu CS, 2013, GENOME BIOL EVOL, V5, P243, DOI 10.1093/gbe/evt001; Wu H, 2016, MOL ECOL, V25, P1192, DOI 10.1111/mec.13538; Xi ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080870; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184454	10.1371/journal.pone.0184454	http://dx.doi.org/10.1371/journal.pone.0184454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886111	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100124
J	Tanner, EP; Papes, M; Elmore, RD; Fuhlendorf, SD; Davis, CA				Tanner, Evan P.; Papes, Monica; Elmore, R. Dwayne; Fuhlendorf, Samuel D.; Davis, Craig A.			Incorporating abundance information and guiding variable selection for climate-based ensemble forecasting of species' distributional shifts	PLOS ONE			English	Article							ECOLOGICAL-NICHE MODELS; COLINUS-VIRGINIANUS; EXTINCTION RISK; SCALED QUAIL; HABITAT USE; LAND-COVER; CONSERVATION; RANGE; PREDICTION; WEATHER	Ecological niche models (ENMs) have increasingly been used to estimate the potential effects of climate change on species' distributions worldwide. Recently, predictions of species abundance have also been obtained with such models, though knowledge about the climatic variables affecting species abundance is often lacking. To address this, we used a well-studied guild (temperate North American quail) and the Maxent modeling algorithm to compare model performance of three variable selection approaches: correlation/variable contribution (CVC), biological (i.e., variables known to affect species abundance), and random. We then applied the best approach to forecast potential distributions, under future climatic conditions, and analyze future potential distributions in light of available abundance data and presence-only occurrence data. To estimate species' distributional shifts we generated ensemble forecasts using four global circulation models, four representative concentration pathways, and two time periods (2050 and 2070). Furthermore, we present distributional shifts where 75%, 90%, and 100% of our ensemble models agreed. The CVC variable selection approach outperformed our biological approach for four of the six species. Model projections indicated species-specific effects of climate change on future distributions of temperate North American quail. The Gambel's quail (Callipepla gambelii) was the only species predicted to gain area in climatic suitability across all three scenarios of ensemble model agreement. Conversely, the scaled quail (Callipepla squamata) was the only species predicted to lose area in climatic suitability across all three scenarios of ensemble model agreement. Our models projected future loss of areas for the northern bobwhite (Colinus virginianus) and scaled quail in portions of their distributions which are currently areas of high abundance. Climatic variables that influence local abundance may not always scale up to influence species' distributions. Special attention should be given to selecting variables for ENMs, and tests of model performance should be used to validate the choice of variables.	[Tanner, Evan P.; Elmore, R. Dwayne; Fuhlendorf, Samuel D.; Davis, Craig A.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Papes, Monica] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Tennessee System; University of Tennessee Knoxville	Tanner, EP (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	evan.tannner@okstate.edu	Fuhlendorf, Samuel/A-2931-2011; Tanner, Evan/K-9325-2015	Fuhlendorf, Samuel/0000-0002-8726-9402; Tanner, Evan/0000-0003-0063-7004	Oklahoma Department of Wildlife Conservation [W-161-R]; National Science Foundation [OIA-1301789]; Office Of The Director [1301789] Funding Source: National Science Foundation	Oklahoma Department of Wildlife Conservation; National Science Foundation(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by Oklahoma Department of Wildlife Conservation; Grant W-161-R, https://www.wildlifedepartment.com/; National Science Foundation; Grant OIA-1301789, www.nsf.gov. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1987, MAP PROJECTIONS WORK, DOI DOI 10.3133/PP1395; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; BOTSFORD LW, 1988, J WILDLIFE MANAGE, V52, P469, DOI 10.2307/3801593; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; BRENNAN LA, 1987, CONDOR, V89, P66, DOI 10.2307/1368760; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; BROWN DE, 1979, J WILDLIFE MANAGE, V43, P522, DOI 10.2307/3800365; Brown DE, 1989, ARIZONA GAME BIRDS P; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Bucklin DN, DIVERS DISTRIB; CAMPBELL H, 1968, J WILDLIFE MANAGE, V32, P641, DOI 10.2307/3798952; Campbell H., 1965, Journal of Wildlife Management, V29, P801, DOI 10.2307/3798556; Campbell H, 1973, WILDLIFE MONOGR, V34, P3; Caro TM, 2003, ANIM CONSERV, V6, P171, DOI 10.1017/S1367943003003214; Carroll JM, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00163.1; Church K. E., 1993, P NATL QUAIL S, V3, P44; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crosby AD, 2015, BIOL CONSERV, V186, P233, DOI 10.1016/j.biocon.2015.03.018; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Doherty PF, 2003, ANN ZOOL FENN, V40, P145; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmore RD, 2017, WILDLIFE SOC B, V41, P183, DOI 10.1002/wsb.772; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; FRANCIS WJ, 1970, J WILDLIFE MANAGE, V34, P249, DOI 10.2307/3799009; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; Giuliano WM, 1993, P NATL QUAIL S, V3, P64; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2014, NAT CLIM CHANGE, V4, P175, DOI 10.1038/nclimate2157; GULLION GW, 1960, ECOLOGY, V41, P516; Gullion GW, 1954, P W ASS STATE GAME F, V32, P234; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Guthery F. S., 2002, P NATL QUAIL S, V5, P99; Guthery FS, 2005, WILDLIFE MONOGR, P1; Guthery FS, 2001, J WILDLIFE MANAGE, V65, P850, DOI 10.2307/3803034; Guthery FS, 1997, J WILDLIFE MANAGE, V61, P291, DOI 10.2307/3802584; GUTIERREZ RJ, 1983, AUK, V100, P33, DOI 10.1093/auk/100.1.33; Gutierrez RJ, 1980, LIVING BIRD, V18, P71; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heffelfinger JR, 1999, J WILDLIFE MANAGE, V63; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hosner PA, 2015, J BIOGEOGR, V42, P1883, DOI 10.1111/jbi.12555; HOVICK TJ, 2014, ECOSPHERE, V5; Howard C, 2014, METHODS ECOL EVOL, V5, P506, DOI 10.1111/2041-210X.12184; Hungerford CR, 1960, THESIS; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Jimenez-Valverde A, 2011, GLOBAL ECOL BIOGEOGR, V20, P114, DOI 10.1111/j.1466-8238.2010.00574.x; Johnson Ned K., 1994, Studies in Avian Biology, V15, P27; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Legault A, 2013, BIOL CONSERV, V167, P149, DOI 10.1016/j.biocon.2013.07.041; Lehmann V. W., 1984, BOBWHITES RIO GRANDE; Leyva-Espinosa RI, 2000, THESIS; Li RQ, 2010, INTEGR ZOOL, V5, P154, DOI 10.1111/j.1749-4877.2010.00198.x; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; Lusk JJ, 2001, ECOL MODEL, V146, P3, DOI 10.1016/S0304-3800(01)00292-7; MacArthur R. H., 1972, GEOGRAPHICAL ECOLOGY; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Matala MM, 2013, GLOB CHANGE BIOL, V20; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Monahan WB, 2008, BIOL LETTERS, V4, P595, DOI 10.1098/rsbl.2008.0154; NatureServe, 2015, NATURESERVE EXPL ONL; O'Neill R.V., 1979, Statistical Ecology Series, V9, P59; Oberholser HC, 1974, BIRD LIFE TEXAS; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; Palmer WE, 2011, RANG WID PLAN REC BO; Pardieck KL, 2014, N AM BREEDING BIRD S; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perez RM, 2002, P NATL QUAIL S, V5, P106; Peterjohn B. G., 1994, BIRDING, V26, P386; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pope M, 2002, THESIS; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pyron RA, 2015, BIOL REV, V90, P1248, DOI 10.1111/brv.12154; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; RAITT RJ, 1966, CONDOR, V68, P541, DOI 10.2307/1366263; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Robbins C.S., 1986, BREEDING BIRD SURVEY; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Roseberry J.L., 1984, POPULATION ECOLOGY B; ROSENE W, 1969, BOBWHITE QUAIL ITS L; Sahlean TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091994; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Savage AE, 1974, T WE SECTION WILDLIE, V10, P84; Schemnitz SD, 1961, WILDLIFE MONOGR, V8, P3; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Steen DA, 2015, J WILDLIFE MANAGE, V79, P872, DOI 10.1002/jwmg.897; Stoddard H.L., 1931, BOBWHITE QUAIL ITS H; STROMBERG MR, 1990, CONDOR, V92, P229, DOI 10.2307/1368404; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Sumner E. L., 1935, California Fish and Game, V21, P167; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tanner EP, 2017, GLOB CHANGE BIOL; Tanner EP, 2017, WILSON J ORNITHOL, V129, P354, DOI 10.1676/16-055.1; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2014, ECOGRAPHY, V37, P1155, DOI 10.1111/ecog.00836; Van Couwenberghe R, 2013, ECOGRAPHY, V36, P665, DOI 10.1111/j.1600-0587.2012.07362.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Venier LA, 1999, J BIOGEOGR, V26, P315, DOI 10.1046/j.1365-2699.1999.00273.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilson JW, 2013, BIOL CONSERV, V164, P170, DOI 10.1016/j.biocon.2013.04.021; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zornes M, 2009, W QUAIL CONSERVATION, P1	145	10	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184316	10.1371/journal.pone.0184316	http://dx.doi.org/10.1371/journal.pone.0184316			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886075	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100096
J	Hamama-Raz, Y; Palgi, Y; Leshem, E; Ben-Ezra, M; Lavenda, O				Hamama-Raz, Yaira; Palgi, Yuval; Leshem, Elazar; Ben-Ezra, Menachem; Lavenda, Osnat			Typhoon survivors' subjective wellbeing-A different view of responses to natural disaster	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; RESOURCE LOSS; POSITIVE PSYCHOLOGY; COPING STRATEGIES; SOCIAL SUPPORT; CONSERVATION; SYMPTOMS; HEALTH; PREDICTORS; COMMUNITY	Objective Subjective well-being was evaluated three weeks after Super Typhoon Haiyan struck the Philippines. Based on the Conservation of Resources theory, which focuses on the role of resources in understanding adjustment following trauma, data was collected on lost resources. In line with the Conservation of Resources theory, four categories of resources were defined: objects-residential property; condition-gender health state and witness to injury; personal-coping strategies; energy-relationships. Design and settings Eight hundred thirty-four people from the Philippines filled out self-report measures using an online interview system regarding: socio demographics data, subjective well-being, using the Delighted Terrible Faces Scale (DTS), disaster related experiences, coping strategies, personal relationships, obtained through support sources (close family, relatives and friends, community) and assessing problems with those relationships after Haiyan. Results Subjective well-being was predicted by the following classes of resources: objects (home damage) condition (self-rated health and witness to injury), personal (positive reframing and self-blame coping strategies) and energy resources (relations and problems in relations). Conclusions The results imply the important role individual's resources (i.e. objects, personal characteristics, conditions, and energies) might play in promoting subjective well-being, following natural disaster.	[Hamama-Raz, Yaira; Leshem, Elazar; Ben-Ezra, Menachem; Lavenda, Osnat] Ariel Univ, Sch Social Work, Ariel, Israel; [Palgi, Yuval] Univ Haifa, Dept Gerontol, Haifa, Israel; [Palgi, Yuval] Univ Haifa, Ctr Res & Study Aging, Haifa, Israel	Ariel University; University of Haifa; University of Haifa	Hamama-Raz, Y (corresponding author), Ariel Univ, Sch Social Work, Ariel, Israel.	razizik@bezeqint.net	Lavenda, Osnat/H-5162-2019	Lavenda, Osnat/0000-0002-9678-6532; Ben-Ezra, Menachem/0000-0002-7890-2069; Palgi, Yuval/0000-0002-8675-5513; hamama-raz, yaira/0000-0002-0496-6414	internal research grant of the research authority at Ariel University [803602]; Faculty members at Ariel University	internal research grant of the research authority at Ariel University; Faculty members at Ariel University	The authors report no financial relationships with commercial interests. Supported by internal research grant of the research authority at Ariel University (No. 803602). This is internal Grant for Faculty members at Ariel University. This was awarded to Prof. Ben-Ezra & Dr. Lavenda.	Adams T, 2011, J HOMEL SECUR EMERG, V8; Allison PD, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P631; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andrews F. M., 1991, MEASURES PERSONALITY, P61, DOI DOI 10.1016/B978-0-12-590241-0.50007-1; ANDREWS FM, 1976, SOC INDIC RES, V3, P1, DOI 10.1007/BF00286161; Ben-Shahar T., 2007, HAPPIER LEARN SECRET; Branscombe NR, 2003, BASIC APPL SOC PSYCH, V25, P265, DOI 10.1207/S15324834BASP2504_1; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brown RC, 2013, SOC PSYCH PSYCH EPID, V48, P1721, DOI 10.1007/s00127-013-0684-0; Cahill Shawn P, 2005, Psychiatry (Edgmont), V2, P14; Carver C.S., 2005, HDB POSITIVE PSYCHOL, P231; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Central Intelligence Agency, 2016, WORLD FACTBOOK; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Dirkzwager AJE, 2006, BRIT J PSYCHIAT, V189, P144, DOI 10.1192/bjp.bp.105.017855; Ehrlich M, 2010, J WOMENS HEALTH, V19, P877, DOI 10.1089/jwh.2009.1693; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Fredrickson Barbara L, 1998, Rev Gen Psychol, V2, P300; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; FREEDY JR, 1994, J TRAUMA STRESS, V7, P257, DOI 10.1002/jts.2490070207; FREEDY JR, 1992, J TRAUMA STRESS, V5, P441, DOI 10.1002/jts.2490050308; Glass K, 2009, J SOC CLIN PSYCHOL, V28, P779, DOI 10.1521/jscp.2009.28.6.779; Goble F, 1970, 3 FORCE PSYCHOL A MA; Hamama-Raz Y, 2015, PSYCHIAT QUART, V86, P285, DOI 10.1007/s11126-014-9333-3; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; IBM Corp, 2011, IBM SPSS STAT WIND V; Isserlin L, 2008, AM J ORTHOPSYCHIAT, V78, P423, DOI 10.1037/a0014304; Joseph S, 2005, REV GEN PSYCHOL, V9, P262, DOI 10.1037/1089-2680.9.3.262; Kaniasty K, 2012, PSYCHOL TRAUMA-US, V4, P22, DOI 10.1037/a0021412; Kim SC, 2008, J CLIN NURS, V17, P2335, DOI 10.1111/j.1365-2702.2008.02317.x; Linely SC, 2002, J PERS SOC PSYCHOL, V45, P839; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Littleton H, 2009, VIOLENCE VICTIMS, V24, P669, DOI 10.1891/0886-6708.24.5.669; Maslow A. H., 1954, MOTIVATION PERSONALI; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Mauss IB, 2011, EMOTION, V11, P807, DOI 10.1037/a0022010; Norris FH, 1996, J PERS SOC PSYCHOL, V71, P498, DOI 10.1037/0022-3514.71.3.498; Rateau MR, 2009, ARCH PSYCHIAT NURS, V23, P269, DOI 10.1016/j.apnu.2009.02.001; Robinaugh DJ, 2011, J ANXIETY DISORD, V25, P1072, DOI 10.1016/j.janxdis.2011.07.004; Sattler DN, 2002, J TRAUMA STRESS, V15, P339, DOI 10.1023/A:1020138022300; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seppala E, 2013, SOC RES, V80, P411; Siedlecki KL, 2014, SOC INDIC RES, V117, P561, DOI 10.1007/s11205-013-0361-4; Smith BW, 2000, J TRAUMA STRESS, V13, P349, DOI 10.1023/A:1007745920466; Thomson H, 2001, 5 MRC SOC PUBL HLTH; United States. Department of commerce. Economics and Statistics Administration BUREAU OF THE CENSUS, 1996, EC STAT ADM BUREAU C; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237	51	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184327	10.1371/journal.pone.0184327	http://dx.doi.org/10.1371/journal.pone.0184327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877264	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200089
J	Jung, WM; Ryu, Y; Lee, YS; Wallraven, C; Chae, Y				Jung, Won-Mo; Ryu, Yeonhee; Lee, Ye-Seul; Wallraven, Christian; Chae, Younbyoung			Role of interoceptive accuracy in topographical changes in emotion-induced bodily sensations	PLOS ONE			English	Article							EMPATHY QUOTIENT; ANTERIOR INSULA; EXPERIENCE; AWARENESS; ALEXITHYMIA; CORTEX; REPRESENTATIONS; SENSITIVITY; HEARTBEAT; AUTISM	The emotion-associated bodily sensation map is composed of a specific topographical distribution of bodily sensations to categorical emotions. The present study investigated whether or not interoceptive accuracy was associated with topographical changes in this map following emotion-induced bodily sensations. This study included 31 participants who observed short video clips containing emotional stimuli and then reported their sensations on the body map. Interoceptive accuracy was evaluated with a heartbeat detection task and the spatial patterns of bodily sensations to specific emotions, including anger, fear, disgust, happiness, sadness, and neutral, were visualized using Statistical Parametric Mapping (SPM) analyses. Distinct patterns of bodily sensations were identified for different emotional states. In addition, positive correlations were found between the magnitude of sensation in emotion-specific regions and interoceptive accuracy across individuals. A greater degree of interoceptive accuracy was associated with more specific topographical changes after emotional stimuli. These results suggest that the awareness of one's internal bodily states might play a crucial role as a required messenger of sensory information during the affective process.	[Jung, Won-Mo; Lee, Ye-Seul; Chae, Younbyoung] Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea; [Ryu, Yeonhee] Korea Inst Oriental Med, Div Stand Res, Acupuncture Moxibust & Meridian Res Ctr, Daejeon, South Korea; [Wallraven, Christian] Korea Univ, Dept Brain Cognit Engn, Seoul, South Korea	Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Korea University	Chae, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea.	ybchae@khu.ac.kr	Chae, Younbyoung/AAM-1243-2020	Lee, Ye-Seul/0000-0001-6127-5401; Chae, Younbyoung/0000-0001-6787-2215	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1D1A1A01058033]; Korea Institute of Oriental Medicine [K15070]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Institute of Oriental Medicine	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2015R1D1A1A01058033) and the Korea Institute of Oriental Medicine (no. K15070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Cannon W.B., 1932, WISDOM BODY; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Ernst J, 2014, SOC COGN AFFECT NEUR, V9, P857, DOI 10.1093/scan/nst058; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Hart N, 2013, J PERS DISORD, V27, P506, DOI 10.1521/pedi_2012_26_049; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Hogeveen J, 2016, NEUROPSYCHOLOGIA, V82, P142, DOI 10.1016/j.neuropsychologia.2016.01.021; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Jung WM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006768; Jung WM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00462; Kim J, 2010, PSYCHIAT INVEST, V7, P24, DOI 10.4306/pi.2010.7.1.24; Kim J, 2015, J NEUROSCI, V35, P5655, DOI 10.1523/JNEUROSCI.4059-14.2015; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lee H., 2012, I PERCEPTION 3, P694, DOI [10.1068/if694, DOI 10.1068/IF694]; Levenson RW, 2003, ANN NY ACAD SCI, V1000, P348, DOI 10.1196/annals.1280.016; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Shah P, 2016, CORTEX, V81, P215, DOI 10.1016/j.cortex.2016.03.021; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	30	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183211	10.1371/journal.pone.0183211	http://dx.doi.org/10.1371/journal.pone.0183211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877218	Green Submitted, gold, Green Published			2022-12-26	WOS:000409391200024
J	Stepan, ME; Dehnke, TM; Fenn, KM				Stepan, Michelle E.; Dehnke, Taylor M.; Fenn, Kimberly M.			Sleep and eyewitness memory: Fewer false identifications after sleep when the target is absent from the lineup	PLOS ONE			English	Article							LATE NOCTURNAL SLEEP; SLOW-WAVE SLEEP; DECLARATIVE MEMORY; DECISION-PROCESSES; CONSOLIDATION; INTERFERENCE; HIPPOCAMPUS; PSYCHOLOGY; ACCURATE; RECALL	Inaccurate eyewitness identifications are the leading cause of known false convictions in the United States. Moreover, improving eyewitness memory is difficult and often unsuccessful. Sleep consistently strengthens and protects memory from interference, particularly when a recall test is used. However, the effect of sleep on recognition memory is more equivocal. Eyewitness identification tests are often recognition based, thus leaving open the question of how sleep affects recognition performance in an eyewitness context. In the current study, we investigated the effect of sleep on eyewitness memory. Participants watched a video of a mock-crime and attempted to identify the perpetrator from a simultaneous lineup after a 12-hour retention interval that either spanned a waking day or night of sleep. In Experiment 1, we used a target-present lineup and, in Experiment 2, we used a target-absent lineup in order to investigate correct and false identifications, respectively. Sleep reduced false identifications in the target-absent lineup (Experiment 2) but had no effect on correct identifications in the target-present lineup (Experiment 1). These results are discussed with respect to memory strength and decision making strategies.	[Stepan, Michelle E.; Dehnke, Taylor M.; Fenn, Kimberly M.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA	Michigan State University	Stepan, ME (corresponding author), Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA.	stepanmi@msu.edu						Alger SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012131; Buysse D J, 1989, Psychiatry Res, V28, P193; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003512; DUNNING D, 1994, J PERS SOC PSYCHOL, V67, P818, DOI 10.1037/0022-3514.67.5.818; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004117; Fenn KM, 2015, PSYCHON B REV, V22, P791, DOI 10.3758/s13423-014-0731-1; Fenn KM, 2013, PSYCHON B REV, V20, P501, DOI 10.3758/s13423-012-0366-z; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Ferrara M, 2008, HIPPOCAMPUS, V18, P844, DOI 10.1002/hipo.20444; Flowe H, 2011, APPL COGNITIVE PSYCH, V25, P443, DOI 10.1002/acp.1711; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Horne J. A., 1975, INT J CHRONOBIOL, V4, P97; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Kneller W, 2001, APPL COGNITIVE PSYCH, V15, P659, DOI 10.1002/acp.739; LANDAUER TK, 1974, J VERB LEARN VERB BE, V13, P45, DOI 10.1016/S0022-5371(74)80029-0; Lo JC, 2014, SLEEP, V37, P665, DOI 10.5665/sleep.3564; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; McKeon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049353; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Schonauer M, 2014, SLEEP, V37, P1995, DOI 10.5665/sleep.4258; Stahl L, 2009, 60 MINUTES EYEWITNES; Steblay N, 2001, LAW HUMAN BEHAV, V25, P459, DOI 10.1023/A:1012888715007; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Walker MP, 2009, J CLIN SLEEP MED, V5, pS20; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WELLS GL, 1984, J APPL SOC PSYCHOL, V14, P89, DOI 10.1111/j.1559-1816.1984.tb02223.x; Wells GL, 1998, LAW HUMAN BEHAV, V22, P603, DOI 10.1023/A:1025750605807; Wells GL, 2003, J EXP PSYCHOL-APPL, V9, P42, DOI 10.1037/1076-898X.9.1.42; WELLS GL, 1993, AM PSYCHOL, V48, P553, DOI 10.1037/0003-066X.48.5.553; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	42	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182907	10.1371/journal.pone.0182907	http://dx.doi.org/10.1371/journal.pone.0182907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877169	Green Published, gold			2022-12-26	WOS:000409391200018
J	Tsukamoto, H; Suga, T; Takenaka, S; Takeuchi, T; Tanaka, D; Hamaoka, T; Hashimoto, T; Isaka, T				Tsukamoto, Hayato; Suga, Tadashi; Takenaka, Saki; Takeuchi, Tatsuya; Tanaka, Daichi; Hamaoka, Takafumi; Hashimoto, Takeshi; Isaka, Tadao			An acute bout of localized resistance exercise can rapidly improve inhibitory control	PLOS ONE			English	Article							INTENSITY INTERVAL EXERCISE; MILD COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION; MUSCLE; STROOP; INTERFERENCE; PERFORMANCE; METABOLISM; ACTIVATION; DECLINE	The positive effect of acute resistance exercise on executive function, such as inhibitory control (IC), is poorly understood. Several previous studies have demonstrated this effect using whole-body resistance exercise. However, it remains unclear whether localized resistance exercise performed using only limited muscle groups could also acutely improve IC. Thus, the present study examined the effect of an acute bout of localized resistance exercise on IC. Twelve healthy men performed a color-word Stroop task (CWST) before and immediately after the experimental conditions, which consisted of 2 resistance exercises and a resting control (CON). Bilateral knee extension was used to create 2 resistance exercise conditions: light-intensity resistance exercise (LRE) and high-intensity resistance exercise (HRE) conditions, which were 40% and 80% of one-repetition maximum, respectively. The resistance exercise session was programmed for 6 sets with 10 repetitions per set. The CWST-measured IC was significantly improved immediately after both LRE and HRE, but it did not improve immediately after CON. However, the improved IC was significantly greater in HRE than in LRE. The present findings showed that IC could be rapidly improved by an acute bout of localized resistance exercise, especially with high-intensity. Therefore, we suggest that in addition to whole-body resistance exercise, localized resistance exercise performed using limited muscle groups may be sufficient for improving IC.	[Tsukamoto, Hayato; Hashimoto, Takeshi; Isaka, Tadao] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Suga, Tadashi; Takenaka, Saki; Takeuchi, Tatsuya; Tanaka, Daichi; Hashimoto, Takeshi; Isaka, Tadao] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Hamaoka, Takafumi] Tokyo Med Univ, Sch Med, Tokyo, Japan	Ritsumeikan University; Ritsumeikan University; Tokyo Medical University	Suga, T (corresponding author), Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan.	t-suga@fc.ritsumei.ac.jp	Tsukamoto, Hayato/AAE-9348-2019	Tsukamoto, Hayato/0000-0001-5512-0497	Japanese Ministry of Education, Culture, Sports, Science, and Technology [15J04023, 15K16497, 15K12676, 15H03077]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#15J04023 to Hayato Tsukamoto; #15K16497 to Tadashi Suga; #15K12676 to Takeshi Hashimoto; #15H03077 to Tadao Isaka).; The authors appreciate the time and effort expended by the volunteer subjects. This study was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#15J04023 to HT; #15K16497 to TS; #15K12676 to TakeH; #15H03077 to TI).	Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Berchicci M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00135; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2015, MED SCI SPORT EXER, V47, P159, DOI 10.1249/MSS.0000000000000383; Chang YK, 2009, J SPORT EXERCISE PSY, V31, P640, DOI 10.1123/jsep.31.5.640; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Elmer SJ, 2011, MED SCI SPORT EXER, V43, P1940, DOI 10.1249/MSS.0b013e31821b00c5; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Giuliano C, 2017, INT J CARDIOL, V227, P413, DOI 10.1016/j.ijcard.2016.11.023; Hamaoka T, 1996, J APPL PHYSIOL, V81, P1410; Hung WW, 2009, AM J RESP CRIT CARE, V180, P134, DOI 10.1164/rccm.200902-0276OC; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Ikeda Y, 2010, PERCEPT MOTOR SKILL, V110, P654, DOI 10.2466/PMS.110.2.654-660; Kraemer WJ, 1997, J APPL PHYSIOL, V83, P270, DOI 10.1152/jappl.1997.83.1.270; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Lin TY, 2016, IEEE T NEUR SYS REH, V24, P1, DOI 10.1109/TNSRE.2015.2429655; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Ogoh S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12163; Ogoh S, 2010, EXP PHYSIOL, V95, P678, DOI 10.1113/expphysiol.2010.052340; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; SANDERS AF, 1983, ACTA PSYCHOL, V53, P61, DOI 10.1016/0001-6918(83)90016-1; Scherder E, 2014, AM J GERIAT PSYCHIAT, V22, P782, DOI 10.1016/j.jagp.2012.12.026; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suga T, 2009, J APPL PHYSIOL, V106, P1119, DOI 10.1152/japplphysiol.90368.2008; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Tsai CL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00262; Tsukamoto H, 2016, PHYSIOL BEHAV, V160, P26, DOI 10.1016/j.physbeh.2016.03.029; Tsukamoto H, 2016, PHYSIOL BEHAV, V155, P224, DOI 10.1016/j.physbeh.2015.12.021; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; Venturelli M, 2012, AM J PHYSIOL-HEART C, V302, pH333, DOI 10.1152/ajpheart.00851.2011; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023	41	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184075	10.1371/journal.pone.0184075	http://dx.doi.org/10.1371/journal.pone.0184075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0EG	28877232	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200061
J	Yao, YH; Zheng, XD; Ge, XL; Xiu, YH; Zhang, L; Fang, WF; Zhao, JZ; Gu, F; Zhu, YH				Yao, Yihua; Zheng, Xuedong; Ge, Xianglian; Xiu, Yanghui; Zhang, Liu; Fang, Weifang; Zhao, Junzhao; Gu, Feng; Zhu, Yihua			Identification of a novel GJA3 mutation in a large Chinese family with congenital cataract using targeted exome sequencing	PLOS ONE			English	Article							GAP-JUNCTIONS; CONNEXIN GENES; HEMICHANNELS; MUTANT; GENETICS; CHANNELS; GROWTH; LENS	Autosomal dominant congenital cataract (ADCC) is a clinically and genetically heterogeneous ocular disease in children that results in serious visual impairments or even blindness. Targeted exome sequencing (TES) is an efficient method used for genetic diagnoses of inherited diseases. In the present study, we used a custom-made TES panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts. A novel heterozygous missense mutation c. 443C>T (p. T148I) in GJA3 was identified. The results of the bioinformatic analysis showed that the mutation was deleterious to the structure and hemichannel function of Cx46 encoded by GJA3. Plasmids expressing wildtype and mutant human Cx46 were constructed and ectopically expressed in human lens epithelial cells (HLECs) or human embryonic kidney (HEK-293) cells. Fluorescent images indicated aggregated signals of mutant protein in the cytoplasm, and a higher protein level was also detected in T148I stable cell lines. In summary, we identified a novel mutation in GJA3 for ADCC, which provided molecular insights into the pathogenic mechanism of ADCC.	[Yao, Yihua; Zheng, Xuedong; Xiu, Yanghui; Zhang, Liu; Fang, Weifang; Zhu, Yihua] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Ge, Xianglian; Gu, Feng] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Eye Hosp, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Ge, Xianglian; Gu, Feng] Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Ge, Xianglian; Gu, Feng] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Zhao, Junzhao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Zhao, Junzhao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China	Fujian Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhu, YH (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.; Gu, F (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Eye Hosp, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China.; Gu, F (corresponding author), Minist Hlth, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China.; Gu, F (corresponding author), Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	fgu@mail.eye.ac.cn; zhuyihua209@163.com			Natural Science Foundation of China [81270999/H1204, 81201181/H1818]; Professor Academic Development Fund of Fujian Medical University [JS14019]; Chinese National Program on Key Basic Research Project (973 Program) [2013CB967502]; Zhejiang Provincial & Ministry of Health research fund for medical sciences [201339279]; Wenzhou Medical University PI Start-Up Grant [QTJ12011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Professor Academic Development Fund of Fujian Medical University; Chinese National Program on Key Basic Research Project (973 Program); Zhejiang Provincial & Ministry of Health research fund for medical sciences; Wenzhou Medical University PI Start-Up Grant	This work was supported by grants from Natural Science Foundation of China (81270999/H1204, YHZ, http://www.nsfc.gov.cn/), Professor Academic Development Fund of Fujian Medical University (JS14019, YHZ, http://www.nsfc.gov.cn/), the Chinese National Program on Key Basic Research Project (973 Program, 2013CB967502, FG, http://program.most.gov.cn/), Natural Science Foundation of China (81201181/H1818, FG, http://www.nsfc.gov.cn/), Zhejiang Provincial & Ministry of Health research fund for medical sciences (201339279, FG,http://www.zjkjt.gov.cn/), Wenzhou Medical University PI Start-Up Grant (QTJ12011, FG, http://www.wmu.edu.cn/).	Banerjee D, 2011, J BIOL CHEM, V286, P24519, DOI 10.1074/jbc.M110.217208; Banks EA, 2009, J CELL SCI, V122, P378, DOI 10.1242/jcs.034124; Berthoud VM, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-016-0116-6; Beyer EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00020; Chen C, 2015, GRAEF ARCH CLIN EXP, V253, P915, DOI 10.1007/s00417-015-3019-x; Churchill A, 2011, PHILOS T R SOC B, V366, P1234, DOI 10.1098/rstb.2010.0227; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; Das Sarma J, 2001, J CELL SCI, V114, P4013; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; DuflotDancer A, 1997, ONCOGENE, V15, P2151, DOI 10.1038/sj.onc.1201393; Foster A, 1993, SEMIN OPHTHALMOL, V8, P166; Ge XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04121; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Gu F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20724; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hoang QV, 2010, MOL VIS, V16, P1343; HU DN, 1987, J MED GENET, V24, P584, DOI 10.1136/jmg.24.10.584; Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001; Kumar M, 2013, MOL VIS, V19, P2436; Liu YY, 2015, J GENET, V94, P221; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; Mei R, 2016, GRAEFES ARCH CLIN EX, V255, p131 ; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Messina-Baas O, 2017, MOL SYNDROMOL, V8, P58, DOI 10.1159/000455752; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Ren Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074732; Rubinos C, 2014, AM J PHYSIOL-CELL PH, V306, pC212, DOI 10.1152/ajpcell.00098.2013; Schlingmann B, 2012, J BIOENERG BIOMEMBR, V44, P607, DOI 10.1007/s10863-012-9461-0; Shiels A, 2010, MOL VIS, V16, P2007; Sun WM, 2011, MOL VIS, V17, P1508; Thomas BC, 2008, IOVS, V49; Tong JJ, 2015, J MEMBRANE BIOL, V248, P145, DOI 10.1007/s00232-014-9752-y; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Yao K, 2011, HUM MUTAT, V32, P1367, DOI 10.1002/humu.21552; Yu YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26551; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650; Zhu Y, 2014, PLOS ONE, V9	41	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184440	10.1371/journal.pone.0184440	http://dx.doi.org/10.1371/journal.pone.0184440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877251	gold, Green Submitted, Green Published			2022-12-26	WOS:000409391200103
J	Dharra, R; Talwar, S; Singh, Y; Gupta, R; Cirillo, JD; Pandey, AK; Kulharia, M; Mehta, PK				Dharra, Renu; Talwar, Sakshi; Singh, Yogesh; Gupta, Rani; Cirillo, Jeffrey D.; Pandey, Amit K.; Kulharia, Mahesh; Mehta, Promod K.			Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein	PLOS ONE			English	Article							REACTIVE OXYGEN; TUBERCULOSIS; IDENTIFICATION; INHIBITORS; DEHYDROGENASE; DOCKING; MACROPHAGES; SYNTHASE; PURIFICATION; DISRUPTION	The mycobacterial mel2 locus (mycobacterial enhanced infection locus, Rv1936-1941) is Mycobacterium marinum and M. tuberculosis specific, which can withstand reactive oxygen species (ROS) and reactive nitrogen species (RNS) induced stress. A library of over a million compounds was screened using in silico virtual ligand screening (VLS) to identify inhibitors against the modeled structure of MelF protein expressed by melF of mel2 locus so that M. marinum's ability to withstand ROS/RNS stress could be reduced. The top ranked 1000 compounds were further screened to identify 178 compounds to maximize the scaffold diversity by manually evaluating the interaction of each compound with the target site. M. marinum melF was cloned, expressed and purified as maltose binding protein (MBP)tagged recombinant protein in Escherichia coli. After establishing the flavin dependent oxidoreductase activity of MelF (similar to 84 kDa), the inhibitors were screened for the inhibition of enzyme activity of whole cell lysate (WCL) and the purified MelF. Amongst these, 16 compounds could significantly inhibit the enzyme activity of purified MelF. For the six best inhibitory compounds, the minimal inhibitory concentration (MIC) was determined to be 3.4-19.4 mu M and 13.5-38.8 mu M for M. marinum and M. tuberculosis, respectively. Similarly, the minimal bactericidal concentration (MBC) was determined to be 6.8-38.8 mu M and 27-38.8 mu M against M. marinum and M. tuberculosis, respectively. One compound each in combination with isoniazid (INH) also showed synergistic inhibitory effect against M. marinum and M. tuberculosis with no cytotoxicity in HeLa cells. Interestingly, these inhibitors did not display any non-specific protein-structure destabilizing effect. Such inhibitors targeting the anti-ROS/RNS machinery may facilitate the efficient killing of replicating and nonreplicating mycobacteria inside the host cells.	[Dharra, Renu; Mehta, Promod K.] MDU, Ctr Biotechnol, Rohtak, Haryana, India; [Talwar, Sakshi; Pandey, Amit K.] THSTI, Faridabad, India; [Singh, Yogesh; Gupta, Rani] Univ Delhi, Dept Microbiol, South Campus, New Delhi, India; [Cirillo, Jeffrey D.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA; [Kulharia, Mahesh] Cent Univ Punjab, Sch Basic & Appl Sci, Bathinda, India	Maharshi Dayanand University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); University of Delhi; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Central University of Punjab	Mehta, PK (corresponding author), MDU, Ctr Biotechnol, Rohtak, Haryana, India.; Kulharia, M (corresponding author), Cent Univ Punjab, Sch Basic & Appl Sci, Bathinda, India.	kulharia@gmail.com; pkmehta3@hotmail.com	Cirillo, Jeffrey D./L-4286-2019; Mehta, Promod/AAD-4493-2021	Cirillo, Jeffrey D./0000-0003-3058-2702; Mehta, Promod/0000-0002-9274-4028; Dharra, Renu/0000-0003-0734-4255	Department of Biotechnology (DBT), Govt. of India, New Delhi [BT/PR5641/MED/29/557/2012]; Ramalingaswami Fellowship [BT/RLF/Re-entry/45/2010]; ICMR, New Delhi [3/1/3/JRF-2013/HRD-001]; Indian Council of Medical Research, New Delhi [3/1/3/JRF-2013/HRD-001]	Department of Biotechnology (DBT), Govt. of India, New Delhi(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship; ICMR, New Delhi(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was financially supported by the Department of Biotechnology (DBT), Govt. of India, New Delhi (BT/PR5641/MED/29/557/2012) to PKM and Ramalingaswami Fellowship (BT/RLF/Re-entry/45/2010) to AKP. YS has acknowledged ICMR, New Delhi for providing Senior Research Fellowship (3/1/3/JRF-2013/HRD-001).; This work was financially supported by the Department of Biotechnology (DBT), Govt. of India, New Delhi (BT/PR5641/MED/29/557/2012) to PKM and Ramalingaswami Fellowship (BT/RLF/Re-entry/45/2010) to AKP. YS has acknowledged Indian Council of Medical Research, New Delhi for providing Senior Research Fellowship (3/1/3/JRF-2013/HRD-001). We are thankful to Dr Abhishek Sheoran, Dept of Statistics, MDU, Rohtak and Dr V. Sreenivas, Dept of Biostatistics, All India Institute of Medical Sciences, New Delhi for the statistical analysis.	Andreu N, 2012, J ANTIMICROB CHEMOTH, V67, P404, DOI 10.1093/jac/dkr472; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Arvind A, 2013, INTERDISCIP SCI, V5, P296, DOI 10.1007/s12539-013-0180-y; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Bryk R, 2010, BIOCHEMISTRY-US, V49, P1616, DOI 10.1021/bi9016186; Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779; Chim N, 2011, TB STRUCTURAL GENOMI, P155; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Dastmalchi S, 2016, APPL CASE STUDIES SO, P73; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; El-Etr SH, 2004, INFECT IMMUN, V72, P6902, DOI 10.1128/IAI.72.12.6902-6913.2004; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Pagliotto ADF, 2016, J MICROBIOL IMMUNOL, V49, P980, DOI 10.1016/j.jmii.2015.08.025; Gokhale K, 2015, CURR DRUG TARGETS, V16, P689, DOI 10.2174/1389450116666150416115547; Graczer E, 2014, PROTEIN PEPTIDE LETT, V21, P1295; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Gurumurthy M, 2013, MOL MICROBIOL, V87, P744, DOI 10.1111/mmi.12127; Habel JE, 2010, ACTA CRYSTALLOGR F, V66, P781, DOI 10.1107/S1744309110019536; Huang HL, 2016, J BIOL CHEM, V291, P27421, DOI 10.1074/jbc.M116.750877; Isupov MN, 2015, ACTA CRYSTALLOGR D, V71, P2344, DOI 10.1107/S1399004715017939; Janagama HK, 2013, TUBERCULOSIS, V93, pS83, DOI 10.1016/S1472-9792(13)70016-7; KENDREW SG, 1995, J BIOL CHEM, V270, P17339, DOI 10.1074/jbc.270.29.17339; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Kulharia M, 2009, J MOL GRAPH MODEL, V28, P297, DOI 10.1016/j.jmgm.2009.08.009; Lagorce D, 2011, BIOINFORMATICS, V27, P2018, DOI 10.1093/bioinformatics/btr333; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Liu Y, 2016, TUBERCULOSIS, V97, P38, DOI 10.1016/j.tube.2015.12.003; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Malham R, 2005, J AM CHEM SOC, V127, P17061, DOI 10.1021/ja055454g; Mdluli K, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021154; Moreira W, 2015, MBIO, V6, DOI 10.1128/mBio.00253-15; Nicolaes GAF, 2014, BLOOD, V123, P113, DOI 10.1182/blood-2013-05-503227; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pauli I, 2013, J CHEM INF MODEL, V53, P2390, DOI 10.1021/ci400202t; Petersen GO, 2015, J MOL GRAPH MODEL, V60, P124, DOI 10.1016/j.jmgm.2015.05.001; Sankaranarayanan R, 2009, ACTA CRYSTALLOGR F, V65, P173, DOI 10.1107/S1744309109000360; Saxena S, 2015, EUR J MED CHEM, V92, P401, DOI 10.1016/j.ejmech.2014.12.046; Saxena S, 2014, J MOL GRAPH MODEL, V47, P37, DOI 10.1016/j.jmgm.2013.08.005; Senthilraja P., 2015, J APPL PHARM SCI, V5, P80, DOI [10.7324/JAPS.2015.50313, DOI 10.7324/JAPS.2015.50313]; Setny P, 2010, J CHEM THEORY COMPUT, V6, P2866, DOI 10.1021/ct1003077; Singh N, 2015, J CHEM INF MODEL, V55, P1120, DOI 10.1021/acs.jcim.5b00150; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Singh S, 2014, BIOINFORMATION, V10, P697, DOI 10.6026/97320630010697; Singh Y, 2016, BIOCHEM BIOPH RES CO, V472, P223, DOI 10.1016/j.bbrc.2016.01.189; Subbian S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-4; Subbian S, 2007, INFECT IMMUN, V75, P127, DOI 10.1128/IAI.01000-06; Takara K, 2002, BIOL PHARM BULL, V25, P771, DOI 10.1248/bpb.25.771; Tatum NJ, 2013, ACTA CRYSTALLOGR C, V69, P1243, DOI 10.1107/S0108270113028126; Tian J, 2005, MOL MICROBIOL, V57, P859, DOI 10.1111/j.1365-2958.2005.04741.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WHO, 2016, GLOB TUB REP; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Yano T, 2011, J BIOL CHEM, V286, P10276, DOI 10.1074/jbc.M110.200501; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang YN, 2013, PROTEIN EXPRES PURIF, V92, P1, DOI 10.1016/j.pep.2013.08.012	58	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183060	10.1371/journal.pone.0183060	http://dx.doi.org/10.1371/journal.pone.0183060			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873466	gold, Green Submitted, Green Published			2022-12-26	WOS:000409282800009
J	Lustri, AM; Di Matteo, S; Fraveto, A; Costantini, D; Cantafora, A; Napoletano, C; Bragazzi, MC; Giuliante, F; De Rose, AM; Berloco, PB; Grazi, GL; Carpino, G; Alvaro, D				Lustri, Anna Maria; Di Matteo, Sabina; Fraveto, Alice; Costantini, Daniele; Cantafora, Alfredo; Napoletano, Chiara; Bragazzi, Maria Consiglia; Giuliante, Felice; De Rose, Agostino M.; Berloco, Pasquale B.; Grazi, Gian Luca; Carpino, Guido; Alvaro, Domenico			TGF-beta signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-KINASE CK2; CANCER CELLS; RESISTANCE; INHIBITOR; CX-4945; GROWTH; PHOSPHORYLATION; PROSURVIVAL; PROGRESSION	Cholangiocarcinoma (CCA) and its subtypes (mucin-and mixed-CCA) arise from the neoplastic transformation of cholangiocytes, the epithelial cells lining the biliary tree. CCA has a high mortality rate owing to its aggressiveness, late diagnosis and high resistance to radiotherapy and chemotherapeutics. We have demonstrated that CCA is enriched for cancer stem cells which express epithelial to mesenchymal transition (EMT) traits, with these features being associated with aggressiveness and drug resistance. TGF-beta signaling is upregulated in CCA and involved in EMT. We have recently established primary cell cultures from human mucin-and mixed-intrahepatic CCA. In human CCA primary cultures with different levels of EMT trait expression, we evaluated the anticancer effects of: (i) CX-4945, a casein kinase-2 (CK2) inhibitor that blocks TGF-beta 1-induced EMT; and (ii) LY2157299, a TGF-beta receptor I kinase inhibitor. We tested primary cell lines expressing EMT trait markers (vimentin, N-cadherin and nuclear catenin) but negative for epithelial markers, and cell lines expressing epithelial markers (CK19-positive) in association with EMT traits. Cell viability was evaluated by MTS assays, apoptosis by Annexin V FITC and cell migration by wound-healing assay. Results: at a dose of 10 mu M, CX4945 significantly decreased cell viability of primary human cell cultures from both mucin and mixed CCA, whereas in CK19-positive cell cultures, the effect of CX4945 on cell viability required higher concentrations (>30 mu M). At the same concentrations, CX4945 also induced apoptosis (3-fold increase vs controls) which correlated with the expression level of CK2 in the different CCA cell lines (mucin-and mixed-CCA). Indeed, no apoptotic effects were observed in CK19-positive cells expressing lower CK2 levels. The effects of CX4945 on viability and apoptosis were associated with an increased number of gamma-H2ax (biomarker for DNA double-strand breaks) foci, suggesting the active role of CK2 as a repair mechanism in CCAs. LY2157299 failed to influence cell proliferation or apoptosis but significantly inhibited cell migration. At a 50 mu M concentration, in fact, LY2157299 significantly impaired (at 24, 48 and 120 hrs) the wound-healing of primary cell cultures from both mucin-and mixed-CCA. In conclusion, we demonstrated that CX4945 and LY2157299 exert relevant but distinct anticancer effects against human CCA cells, with CX4945 acting on cell viability and apoptosis, and LY2157299 impairing cell migration. These results suggest that targeting the TGF-beta signaling with a combination of CX-4945 and LY2157299 could have potential benefits in the treatment of human CCA.	[Lustri, Anna Maria; Di Matteo, Sabina; Fraveto, Alice; Costantini, Daniele; Cantafora, Alfredo; Bragazzi, Maria Consiglia] Sapienza Univ Rome, Med Surg Sci & Biotechnol, Rome, Italy; [Napoletano, Chiara] Univ Rome Sapienza, Dept Expt Med, Rome, Italy; [Giuliante, Felice; De Rose, Agostino M.] Catholic Univ, Sacred Heart Sch Med, Rome, Italy; [Berloco, Pasquale B.] Sapienza Univ Rome, Dept Gen Surg & Organ Transplantat, Rome, Italy; [Grazi, Gian Luca] Regina Elena Inst Canc Res, Gastroenterol Unit, Rome, Italy; [Carpino, Guido] Univ Rome Foro Ital, Dept Hlth Sci, Rome, Italy; [Alvaro, Domenico] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Foro Italico University of Rome; Sapienza University Rome	Alvaro, D (corresponding author), Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy.	domenico.alvaro@uniroma1.it	De Rose, Agostino Maria/V-4910-2019; Carpino, Guido/AAB-9692-2019; Napoletano, Chiara/AAO-1691-2021; Grazi, Gian Luca/J-7215-2018; Di Matteo, Sabina/D-1876-2017; GIULIANTE, FELICE/AAC-5066-2020; ALVARO, Domenico/J-8600-2018	De Rose, Agostino Maria/0000-0003-3310-8088; Grazi, Gian Luca/0000-0002-3279-0313; Di Matteo, Sabina/0000-0002-2586-7159; GIULIANTE, FELICE/0000-0003-2087-2589; ALVARO, Domenico/0000-0003-3771-9644	Consorzio Interuniversitario Trapianti d'Organo of Rome; FIRB [RBAP10Z7FS_004]	Consorzio Interuniversitario Trapianti d'Organo of Rome; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	The study was supported by Consorzio Interuniversitario Trapianti d'Organo of Rome and by FIRB grant #RBAP10Z7FS_004 to Prof. Domenico Alvaro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Bian YS, 2015, INT J BIOL SCI, V11, P411, DOI 10.7150/ijbs.10745; Cardinale V, 2015, AM J PATHOL, V185, P1724, DOI 10.1016/j.ajpath.2015.02.010; Cardinale V, 2012, HEPATOLOGY, V56, P1585, DOI 10.1002/hep.25705; Chen YJ, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0016-9, 10.1186/S40659-015-0016-9]; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dituri F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067109; Duangkumpha K, 2014, TUMOR BIOL, V35, P9667, DOI 10.1007/s13277-014-2246-9; Fattore L, 2016, P NATL ACAD SCI USA, V113, pE5005, DOI 10.1073/pnas.1607753113; Fraveto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142124; Gray GK, 2014, ONCOTARGET, V5, P6484, DOI 10.18632/oncotarget.2248; Iuso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051317; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim JE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074458, 10.1371/journal.pone.0069961, 10.1371/journal.pone.0051986, 10.1371/journal.pone.0060505]; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kothari AN, 2014, CLIN TRANSLATIONAL M, V3, P1, DOI DOI 10.1186/2001-1326-3-1; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lanier MH, 2015, MOL BIOL CELL, V26, P4577, DOI 10.1091/mbc.E15-08-0552; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Nevi L, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0492-7; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shuang ZY, 2014, CANCER LETT, V354, P320, DOI 10.1016/j.canlet.2014.08.030; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; So KS, 2015, ANTICANCER RES, V35, P1537; Stein A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1498-0; Strom CE, 2011, DNA REPAIR, V10, P961, DOI 10.1016/j.dnarep.2011.07.004; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wilson C, 2014, ONCOTARGET, V5, P7328, DOI 10.18632/oncotarget.2397; Xu L, 2010, BMC CANCER, V10, P1471; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	38	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183932	10.1371/journal.pone.0183932	http://dx.doi.org/10.1371/journal.pone.0183932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873435	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800037
J	Park, JS; Jung, SW; Ki, JS; Guo, R; Kim, HJ; Lee, KW; Lee, JH				Park, Joon Sang; Jung, Seung Won; Ki, Jang-Seu; Guo, Ruoyu; Kim, Hyun Jung; Lee, Kyun-Woo; Lee, Jin Hwan			Transfer of the small diatoms Thalassiosira proschkinae and T. spinulata to the genus Minidiscus and their taxonomic re-description	PLOS ONE			English	Article							SPECIES BACILLARIOPHYCEAE; PHYLOGENETIC ANALYSIS; COASTAL WATERS; MARINE DIATOMS; DIVERSITY; ESTUARIES; KOREA; RIVER	The marine diatoms Thalassiosira proschkinae and T. spinulata are relatively small in size; their taxonomic identities have been debated owing to the diverse morphological variations. In the present study, we isolated both morphotypes from Korean coastal waters and examined their fine structures and conducted molecular sequence comparisons. The morphological and molecular analyses showed that T. proschkinae and T. spinulata were certainly distinct, and phenotypic plasticity of valve structure was not noted. Based on the morphological similarity and phylogenetic relationship, we transferred T. proschkinae and T. spinulata to another genus Minidiscus within Thalassiosirales that includes small-sized species and proposed new combination names, Minidiscus proschkinae (Makarova) Park & Lee comb. nov. and Minidiscus spinulatus (Takano) Park & Lee comb. nov., respectively. The genus description of Minidiscus was emended.	[Park, Joon Sang; Ki, Jang-Seu; Guo, Ruoyu; Lee, Jin Hwan] Sangmyung Univ, Dept Life Sci, Seoul, South Korea; [Jung, Seung Won; Kim, Hyun Jung] Korea Inst Ocean Sci & Technol, Lib Marine Samples, Geoje, South Korea; [Park, Joon Sang; Lee, Kyun-Woo] Korea Inst Ocean Sci & Technol, Marine Ecosyst & Biol Res Ctr, Ansan, South Korea; [Guo, Ruoyu] Chinese Acad Sci, Qingdao Inst Bioenergy & Biopress Technol, Qingdao, Peoples R China	Sang Myung University; Korea Institute of Ocean Science & Technology (KIOST); Korea Institute of Ocean Science & Technology (KIOST); Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Lee, KW (corresponding author), Korea Inst Ocean Sci & Technol, Marine Ecosyst & Biol Res Ctr, Ansan, South Korea.	kyunu@kiost.ac.kr			KIOST projects "Management and application of marine biotoxins" [PE99515]	KIOST projects "Management and application of marine biotoxins"	This work was supported by the KIOST projects "Management and application of marine biotoxins" (PE99515). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ake-Castillo JA, 2001, CRYPTOGAMIE ALGOL, V22, P101, DOI 10.1016/S0181-1568(00)01051-5; ALVERSON A.J., 2003, ABSTRACTS J PHYCOL S, V39, P1, DOI DOI 10.1111/J.0022-3646.2003.03906001_; Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Alverson AJ, 2006, DIATOM RES, V21, P251; Alverson AJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-125; BELCHER JH, 1986, BRIT PHYCOL J, V21, P139, DOI 10.1080/00071618600650161; Feibicke M, 1990, NOVA HEDWIGIA S, V100, P155; Guiry MD, 2017, ALGAEBASE; HASLE G R, 1968, Nytt Magasin for Botanikk (Oslo), V15, P193; HASLE G R, 1973, Norwegian Journal of Botany, V20, P67; HASLE GR, 1989, PHYCOLOGIA, V28, P120, DOI 10.2216/i0031-8884-28-1-120.1; HASLE GR, 1978, NORW J BOT, V25, P77; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hoppenrath M, 2007, EUR J PHYCOL, V42, P271, DOI 10.1080/09670260701352288; Kaczmarska I, 2006, J PHYCOL, V42, P121, DOI 10.1111/j.1529-8817.2006.00161.x; Kaczmarska I, 2014, AM J BOT, V101, P267, DOI 10.3732/ajb.1300306; Kaczmarska I, 2009, EUR J PHYCOL, V44, P461, DOI 10.1080/09670260902855873; Li Y, 2013, BOT MAR, V56, P83, DOI 10.1515/bot-2011-0045; MAKAROVA I V, 1979, Botanicheskii Zhurnal (St. Petersburg), V64, P921; Makarova I.V., 1988, DIATOMOVYE VODOROSLI; Martin-Cereceda M, 2011, BOT MAR, V54, P563, DOI 10.1515/BOT.2011.063; METZELTIN D, 1996, ANNOTATED DIATOM MIC, V4; Muylaert K, 1996, BOT MAR, V39, P103, DOI 10.1515/botm.1996.39.1-6.103; Park JS, 2016, PHYCOLOGIA, V55, P403, DOI 10.2216/15-66.1; Park JS, 2016, PHYTOTAXA, V245, P1; Park JS, 2014, PHYTOTAXA, V191, P115, DOI 10.11646/phytotaxa.191.1.7; Park Joon Sang, 2009, Algae, V24, P67; Prasad AKSK, 2011, PHYCOLOGIA, V50, P264, DOI 10.2216/09-89.1; Quiroga I, 2004, BOT MAR, V47, P341, DOI 10.1515/BOT.2004.040; Rivera P., 1984, P 7 INT DIAT S, P279; Ross R, 1979, NOVA HEDWIGIA S, V64, P513; Round F.E., 1990, DIATOMS; Sar EA, 2001, NOVA HEDWIGIA, V73, P199; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stachura-Suchoples K, 2009, EUR J PHYCOL, V44, P477, DOI 10.1080/09670260903225431; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Takano H, 1981, B TOKAI REG FISH RES, V105, P31; Theriot Edward, 1994, Diatom Research, V9, P429; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Tremarin PI, 2008, ACTA BOT BRAS, V22, P1101, DOI 10.1590/S0102-33062008000400021	40	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0181980	10.1371/journal.pone.0181980	http://dx.doi.org/10.1371/journal.pone.0181980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873451	gold, Green Published, Green Submitted			2022-12-26	WOS:000409282800001
J	Li, LL; Bannantine, JP; Campo, JJ; Randall, A; Grohn, YT; Katani, R; Schilling, M; Radzio-Basu, J; Kapur, V				Li, Lingling; Bannantine, John P.; Campo, Joseph J.; Randall, Arlo; Grohn, Yrjo T.; Katani, Robab; Schilling, Megan; Radzio-Basu, Jessica; Kapur, Vivek			Identification of sero-reactive antigens for the early diagnosis of Johne's disease in cattle	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; CELLULAR IMMUNE-RESPONSES; MYCOBACTERIUM-PARATUBERCULOSIS; EXPORTED PROTEIN; FECAL CULTURE; INFECTION; SHEEP; IMMUNOGENICITY; PATHOGENESIS; ANTIBODIES	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of Johne's disease (JD), a chronic intestinal inflammatory disease of cattle and other ruminants. JD has a high herd prevalence and causes serious animal health problems and significant economic loss in domesticated ruminants throughout the world. Since serological detection of MAP infected animals during the early stages of infection remains challenging due to the low sensitivity of extant assays, we screened 180 well-characterized serum samples using a whole proteome microarray from Mycobacterium tuberculosis (MTB), a close relative of MAP. Based on extensive testing of serum and milk samples, fecal culture and qPCR for direct detection of MAP, the samples were previously assigned to one of 4 groups: negative low exposure (n = 30, NL); negative high exposure (n = 30, NH); fecal positive, ELISA negative (n = 60, F+E-); and fecal positive, ELISA positive (n = 60, F+E+). Of the 740 reactive proteins, several antigens were serologically recognized early but not late in infection, suggesting a complex and dynamic evolution of the MAP humoral immune response during disease progression. Ordinal logistic regression models identified a subset of 47 candidate proteins with significantly different normalized intensity values (p < 0.05), including 12 in the NH and 23 in F+ E-groups, suggesting potential utility for the early detection of MAP infected animals. Next, the diagnostic utility of four MAP orthologs (MAP1569, MAP2942c, MAP2609, and MAP1272c) was assessed and reveal moderate to high diagnostic sensitivities (range 48.3% to 76.7%) and specificity (range 96.7% to 100%), with a combined 88.3% sensitivity and 96.7% specificity. Taken together, the results of our analyses have identified several candidate MAP proteins of potential utility for the early detection of MAP infection, as well individual MAP proteins that may serve as the foundation for the next generation of well-defined serological diagnosis of JD in cattle.	[Li, Lingling; Katani, Robab; Schilling, Megan; Kapur, Vivek] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Li, Lingling; Katani, Robab; Schilling, Megan; Radzio-Basu, Jessica; Kapur, Vivek] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Bannantine, John P.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA; [Campo, Joseph J.; Randall, Arlo] Antigen Discovery Inc, Irvine, CA USA; [Grohn, Yrjo T.] Cornell Univ, Ithaca, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); Cornell University	Kapur, V (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.; Kapur, V (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	vkapur@psu.edu	Katani, Robab/AAS-1292-2020	Kapur, Vivek/0000-0002-9648-0138; Bannantine, John/0000-0002-5692-7898	United States Department of Agriculture-The National Institute of Food and Agriculture [2015-67015-23177]; Antigen Discovery, Inc; United States Department of Agriculture NIFA [2015-67015-23177]	United States Department of Agriculture-The National Institute of Food and Agriculture; Antigen Discovery, Inc; United States Department of Agriculture NIFA(United States Department of Agriculture (USDA))	This project was funded by United States Department of Agriculture-The National Institute of Food and Agriculture, (http://nifa.usda.gov/)-# 2015-67015-23177. Antigen Discovery, Inc provided support in the form of salaries for authors [JC and AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was supported by a competitive research grant from the United States Department of Agriculture NIFA (2015-67015-23177). We thank Johne's Disease Integrated Program (JDIP, http://mycobacierialdiseases.org) diagnostic standards sample collection project for collecting and testing all of the fecal, milk, and serum samples used in this study.	Bannantine JP, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-5; Bannantine JP, 2008, INFECT IMMUN, V76, P739, DOI 10.1128/IAI.00915-07; Bannantine JP, 2007, CLIN VACCINE IMMUNOL, V14, P312, DOI 10.1128/CVI.00353-06; Bannantine JP, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00081-17; Bannantine JP, 2016, PROTEIN SCI, V25, P840, DOI 10.1002/pro.2884; Bannantine JP, 2012, CLIN VACCINE IMMUNOL, V19, P1083, DOI 10.1128/CVI.00195-12; Bannantine JP, 2010, PROTEIN EXPRES PURIF, V72, P223, DOI 10.1016/j.pep.2010.03.019; Bannantine JP, 2003, MICROBIOL-SGM, V149, P2061, DOI 10.1099/mic.0.26323-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cho D, 2007, PROTEIN EXPRES PURIF, V53, P411, DOI 10.1016/j.pep.2006.12.022; Cho DH, 2006, PROTEOMICS, V6, P5785, DOI 10.1002/pmic.200600207; Cho D, 2006, CLIN VACCINE IMMUNOL, V13, P1155, DOI 10.1128/CVI.00058-06; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Dupont C, 2005, J MED MICROBIOL, V54, P1083, DOI 10.1099/jmm.0.46163-0; ElZaatari FAK, 1997, J CLIN MICROBIOL, V35, P1794, DOI 10.1128/JCM.35.7.1794-1799.1997; Gumber S, 2009, VET MICROBIOL, V137, P290, DOI 10.1016/j.vetmic.2009.01.012; Gurung RB, 2013, CLIN VACCINE IMMUNOL, V20, P1817, DOI 10.1128/CVI.00596-13; He ZG, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-21; Hughes V, 2008, CLIN VACCINE IMMUNOL, V15, P1824, DOI 10.1128/CVI.00099-08; Khol JL, 2014, VET MICROBIOL, V172, P301, DOI 10.1016/j.vetmic.2014.05.022; Kunnath-Velayudhan S, 2012, J INFECT DIS, V206, P697, DOI 10.1093/infdis/jis421; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Leroy B, 2007, PROTEOMICS, V7, P1164, DOI 10.1002/pmic.200600988; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; McNamara M, 2012, INFECT IMMUN, V80, P1868, DOI 10.1128/IAI.06151-11; MILNER AR, 1987, RES VET SCI, V42, P140, DOI 10.1016/S0034-5288(18)30675-1; Nagata R, 2013, VET IMMUNOL IMMUNOP, V155, P253, DOI 10.1016/j.vetimm.2013.06.020; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Paustian ML, 2004, J CLIN MICROBIOL, V42, P2675, DOI 10.1128/JCM.42.6.2675-2681.2004; Plattner BL, 2011, VET PATHOL, V48, P584, DOI 10.1177/0300985810383874; Pribylova R, 2011, INT J FOOD MICROBIOL, V151, P314, DOI 10.1016/j.ijfoodmicro.2011.09.025; Rigden RC, 2006, J MED MICROBIOL, V55, P1735, DOI 10.1099/jmm.0.46785-0; Shafran I, 2002, DIGEST DIS SCI, V47, P2079, DOI 10.1023/A:1019685131692; Shin Sung Jae, 2004, J Vet Sci, V5, P111; Stewart DJ, 2004, VET MICROBIOL, V104, P165, DOI 10.1016/j.vetmic.2004.09.007; USDA, 2008, JOHN DIS US DAIR 199; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Willemsen PTJ, 2006, VET MICROBIOL, V114, P337, DOI 10.1016/j.vetmic.2005.12.005	40	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184373	10.1371/journal.pone.0184373	http://dx.doi.org/10.1371/journal.pone.0184373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863177	Green Published, Green Submitted, gold			2022-12-26	WOS:000408816900054
J	Ruan, Z; Yang, T; Shi, XY; Kong, YY; Xie, XY; Zhang, J				Ruan, Zhi; Yang, Ting; Shi, Xinyan; Kong, Yingying; Xie, Xinyou; Zhang, Jun			Clonality and distribution of clinical Ureaplasma isolates recovered from male patients and infertile couples in China	PLOS ONE			English	Article							MYCOPLASMA-HOMINIS; URINE SPECIMENS; UREALYTICUM; SEMEN; PARVUM; RESISTANCE; SUSCEPTIBILITY; IDENTIFICATION; PREVALENCE	Ureaplasma spp. have gained increasing recognition as pathogens in both adult and neonatal patients with multiple clinical presentations. However, the clonality of this organism in the male population and infertile couples in China is largely unknown. In this study, 96 (53 U. parvum and 43 U. urealyticum) of 103 Ureaplasma spp. strains recovered from genital specimens from male patients and 15 pairs of infertile couples were analyzed using multilocus sequence typing (MLST)/expanded multilocus sequence typing (eMLST) schemes. A total of 39 sequence types (STs) and 53 expanded sequence types (eSTs) were identified, with three predominant STs (ST1, ST9 and ST22) and eSTs (eST16, eST41 and eST82). Moreover, phylogenetic analysis revealed two distinct clusters that were highly congruent with the taxonomic differences between the two Ureaplasma species. We found significant differences in the distributions of both clusters and sub-groups between the male and female patients (P < 0.001). Moreover, 66.7% and 40.0% of the male and female partners of the infertile couples tested positive for Ureaplasma spp. The present study also attained excellent agreement of the identification of both Ureaplasma species between paired urine and semen specimens from the male partners (k > 0.80). However, this concordance was observed only for the detection of U. urealyticum within the infertile couples. In conclusion, the distributions of the clusters and sub-groups significantly differed between the male and female patients. U. urealyticum is more likely to transmit between infertile couples and be associated with clinical manifestations by the specific epidemic clonal lineages.	[Ruan, Zhi; Yang, Ting; Shi, Xinyan; Kong, Yingying; Xie, Xinyou; Zhang, Jun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Ruan, Zhi; Kong, Yingying; Xie, Xinyou; Zhang, Jun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xie, XY; Zhang, J (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China.; Xie, XY; Zhang, J (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou, Zhejiang, Peoples R China.	scottxie@mail.hz.zj.cn; jameszhang2000@163.com	Kong, Yingying/GQP-9865-2022; Ruan, Zhi/P-3987-2015	Ruan, Zhi/0000-0001-8648-4592; Zhang, Jun/0000-0003-3313-6986	National Natural Science Foundation of China [81171629, 81572042]; Zhejiang Provincial Health Bureau Foundation [2014PYA011, 2015DTA008, 2017KY406]; Zhejiang Provincial Innovative Medical Discipline [11-CX18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Health Bureau Foundation; Zhejiang Provincial Innovative Medical Discipline	This study was supported by grants from the National Natural Science Foundation of China (grant no. 81171629 and 81572042), Zhejiang Provincial Health Bureau Foundation (grant no. 2014PYA011, 2015DTA008 and 2017KY406) and Zhejiang Provincial Innovative Medical Discipline (11-CX18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusarah EA, 2013, DIAGN MICR INFEC DIS, V77, P283, DOI 10.1016/j.diagmicrobio.2013.05.018; Al-Daghistani HI, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/409640; Andrade-Rocha FT, 2003, UROL INT, V71, P377, DOI 10.1159/000074089; Beeton ML, 2016, ANTIMICROB AGENTS CH, V60, P52, DOI 10.1128/AAC.00889-15; Bharat A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8419; Capoccia R, 2013, CURR OPIN INFECT DIS, V26, P231, DOI 10.1097/QCO.0b013e328360db58; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fernandez J, 2016, ANTIMICROB AGENTS CH, V60, P4793, DOI 10.1128/AAC.00671-16; Gdoura R, 2008, J ANDROL, V29, P198, DOI 10.2164/jandrol.107.003566; Gimenes F, 2014, NAT REV UROL, V11, P672, DOI 10.1038/nrurol.2014.285; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kallapur SG, 2013, SEMIN PERINATOL, V37, P94, DOI 10.1053/j.semperi.2013.01.005; Knox CL, 2003, FERTIL STERIL, V80, P921, DOI 10.1016/S0015-0282(03)01125-7; Kong FR, 2000, J CLIN MICROBIOL, V38, P1175, DOI 10.1128/JCM.38.3.1175-1179.2000; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Reichart M, 2000, BIOL REPROD, V63, P1041, DOI 10.1095/biolreprod63.4.1041; Schneider SC, 2015, ANTIMICROB AGENTS CH, V59, P6026, DOI 10.1128/AAC.00895-15; Song JJ, 2015, J MED MICROBIOL, V64, P1315, DOI 10.1099/jmm.0.000153; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Waites KB, 2009, SEMIN FETAL NEONAT M, V14, P190, DOI 10.1016/j.siny.2008.11.009; Xie XY, 2006, FEMS MICROBIOL LETT, V259, P181, DOI 10.1111/j.1574-6968.2006.00239.x; Zeighami H, 2009, INT J STD AIDS, V20, P387, DOI 10.1258/ijsa.2008.008334; Zhang J, 2014, EUR J CLIN MICROBIOL, V33, P537, DOI 10.1007/s10096-013-1981-y; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104347; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113771; Zhang QX, 2014, UROLOGY, V84, P87, DOI 10.1016/j.urology.2014.04.014	29	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183947	10.1371/journal.pone.0183947	http://dx.doi.org/10.1371/journal.pone.0183947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859153	Green Submitted, gold, Green Published			2022-12-26	WOS:000408740500050
J	Verstappen, KM; Huijbregts, L; Spaninks, M; Wagenaar, JA; Fluit, AC; Duim, B				Verstappen, Koen M.; Huijbregts, Loes; Spaninks, Mirlin; Wagenaar, Jaap A.; Fluit, Ad C.; Duim, Birgitta			Development of a real-time PCR for detection of Staphylococcus pseudintermedius using a novel automated comparison of whole-genome sequences	PLOS ONE			English	Article							COAGULASE-POSITIVE STAPHYLOCOCCI; INTERMEDIUS GROUP; SPECIES IDENTIFICATION; EMERGENCE; EVOLUTION; INSIGHTS; STRAINS; MATRIX; DOGS	Staphylococcus pseudintermedius is an opportunistic pathogen in dogs and cats and occasionally causes infections in humans. S. pseudintermedius is often resistant to multiple classes of antimicrobials. It requires a reliable detection so that it is not misidentified as S. aureus. Phenotypic and currently-used molecular-based diagnostic assays lack specificity or are labour-intensive using multiplex PCR or nucleic acid sequencing. The aim of this study was to identify a specific target for real-time PCR by comparing whole genome sequences of S. pseudintermedius and non-pseudintermedius. Genome sequences were downloaded from public repositories and supplemented by isolates that were sequenced in this study. A Perl-script was written that analysed 300-nt fragments from a reference genome sequence of S. pseudintermedius and checked if this sequence was present in other S. pseudintermedius genomes (n = 74) and non-pseudintermedius genomes (n = 138). Six sequences specific for S. pseudintermedius were identified (sequence length between 300-500 nt). One sequence, which was located in the spsJgene, was used to develop primers and a probe. The real-time PCR showed 100% specificity when testing for S. pseudintermedius isolates (n = 54), and eight other staphylococcal species (n = 43). In conclusion, a novel approach by comparing whole genome sequences identified a sequence that is specific for S. pseudintermedius and provided a real-time PCR target for rapid and reliable detection of S. pseudintermedius.	[Verstappen, Koen M.; Huijbregts, Loes; Spaninks, Mirlin; Wagenaar, Jaap A.; Duim, Birgitta] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen Biovet Res, Lelystad, Netherlands; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Duim, B (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	b.duim@uu.nl						Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bannoehr J, 2011, INFECT IMMUN, V79, P3074, DOI 10.1128/IAI.00137-11; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Ben Zakour NL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00044; Coughlan H, 2015, DIAGN MICR INFEC DIS, V83, P112, DOI 10.1016/j.diagmicrobio.2015.06.013; Decristophoris P, 2011, SYST APPL MICROBIOL, V34, P45, DOI 10.1016/j.syapm.2010.11.004; Duim B, 2015, J CLIN MICROBIOL; Griffeth GC, 2008, VET DERMATOL, V19, P142, DOI 10.1111/j.1365-3164.2008.00663.x; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; Kadlec K, 2012, VET DERMATOL, V23, P276, DOI 10.1111/j.1365-3164.2012.01056.x; Maiwald M., 2004, MOL MICROBIOLOGY DIA, P379; McCarthy AJ, 2015, J ANTIMICROB CHEMOTH, V70, P997, DOI 10.1093/jac/dku496; Murugaiyan J, 2014, CLIN MICROBIOL INFEC, V20, P1007, DOI 10.1111/1469-0691.12662; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Perreten V, 2013, ANTIMICROB AGENTS CH, V57, P5509, DOI 10.1128/AAC.00738-13; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Riegel P, 2011, INT J MED MICROBIOL, V301, P237, DOI 10.1016/j.ijmm.2010.09.001; Sasaki T, 2007, J CLIN MICROBIOL, V45, P2770, DOI 10.1128/JCM.00360-07; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Savini V, 2013, J CLIN MICROBIOL, V51, P1636, DOI 10.1128/JCM.03310-12; Slettemeas JS, 2010, J VET DIAGN INVEST, V22, P756, DOI 10.1177/104063871002200517; Somayaji R, 2016, DIAGN MICR INFEC DIS, V85, P471, DOI 10.1016/j.diagmicrobio.2016.05.008; Starlander G, 2014, J CLIN MICROBIOL, V52, P3118, DOI 10.1128/JCM.00703-14; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-38; Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Vengust M, 2006, LETT APPL MICROBIOL, V43, P602, DOI 10.1111/j.1472-765X.2006.02018.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183925	10.1371/journal.pone.0183925	http://dx.doi.org/10.1371/journal.pone.0183925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859126	Green Submitted, Green Published, gold			2022-12-26	WOS:000408740500048
J	Dovmark, TH; Hulikova, A; Niederer, SA; Vaughan-Jones, RD; Swietach, P				Dovmark, Tobias H.; Hulikova, Alzbeta; Niederer, Steven A.; Vaughan-Jones, Richard D.; Swietach, Pawel			Normoxic cells remotely regulate the acid-base balance of cells at the hypoxic core of connexin-coupled tumor growths	FASEB JOURNAL			English	Article						homeostasis; gap junctions; bicarbonate transport; pancreatic cancer; metabolic altruism	PANCREATIC-CANCER PROGRESSION; ANABOLIC GLUCOSE-METABOLISM; INTRACELLULAR PH; ANHYDRASE-IX; EXPRESSION; METASTASIS; LINES; ADENOCARCINOMA; MECHANISMS; TRANSPORT	ATP fuels the removal of metabolic end-products, including H+ ions that profoundly modulate biological activities. Energetic resources in hypoxic tumor regions are constrained by low-yielding glycolysis, and any means of reducing the cost of acid extrusion, without compromising pH homeostasis, would therefore be advantageous for cancer cells. Some cancers express connexin channels that allow solute exchange between cells, and we propose that, via this route, normoxic cells supply hypoxic neighbors with acid-neutralizing HCO3- ions. This hypothesis was tested by imaging cytoplasmic pH in spheroidal tissue growths of connexin43-positive pancreatic cancer Colo357 cellsduring light-controlled H+ uncaging at thehypoxic core. Cytoplasmic acid retention at the core was halved in the presence of CO2/HCO3-, but this process requires a restorative HCO3- flux. The effect of CO2/HCO3- was ablated by connexin43 inhibition or knockdown. In connexin-decoupled spheroids, 4,49-diisothiocyano-2,29-stilbenedisulfonic acid (DIDS), an inhibitor of HCO3- uptake, had no effect on cytoplasmic [H+] in the H+-uncaging region, indicating that DIDS-sensitive transport is not an adequate pH-regulatory strategy therein. With intact connexin-coupling, acid retention at the core increased upon DIDS treatment, indicating that HCO3- ions are taken up actively by peripheral cells and then transmitted passively to cells at the hypoxic core. Thus, the energetic burden of pH regulation is of floaded from hypoxic cells onto metabolically altruistic normoxic neighbors.	[Dovmark, Tobias H.; Hulikova, Alzbeta; Vaughan-Jones, Richard D.; Swietach, Pawel] Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England; [Niederer, Steven A.] St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England	University of Oxford; Guy's & St Thomas' NHS Foundation Trust	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473; Niederer, Steven/0000-0002-4612-6982	European Commission through IonTraC Marie Curie Initial Training Network FP7-PEOPLE-ITN [289648]; Royal Society and Worldwide Cancer Research Grant [2012/0027]; EPSRC [EP/M012492/1] Funding Source: UKRI	European Commission through IonTraC Marie Curie Initial Training Network FP7-PEOPLE-ITN; Royal Society and Worldwide Cancer Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Commission through IonTraC Marie Curie Initial Training Network FP7-PEOPLE-2011-ITN Grant 289648, and the Royal Society (to P. S.) and Worldwide Cancer Research Grant 2012/0027 (to P.S. and A.H.). The authors declare no conflicts of interest.	Cardone RA, 2015, NEOPLASIA, V17, P155, DOI 10.1016/j.neo.2014.12.003; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cruz-Monserrate Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04410; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dovmark TH, 2017, ONCOGENE, V36, P4538, DOI 10.1038/onc.2017.71; ELSABBAN ME, 1991, J CELL BIOL, V115, P1375, DOI 10.1083/jcb.115.5.1375; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; Hulikova A, 2016, P NATL ACAD SCI USA, V113, pE5344, DOI 10.1073/pnas.1610954113; Hulikova A, 2014, J BIOL CHEM, V289, P25418, DOI 10.1074/jbc.M114.547844; Hulikova A, 2014, FASEB J, V28, P2762, DOI 10.1096/fj.13-241752; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Kaluz S, 2003, CANCER RES, V63, P917; Kaluz S, 2002, CANCER RES, V62, P4469; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; Kong SC, 2014, BIOCHEM CELL BIOL, V92, P449, DOI 10.1139/bcb-2014-0078; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Lee AH, 1998, CANCER RES, V58, P1901; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Liu MH, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0160-x; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; McIntyre A, 2016, CANCER RES, V76, P3744, DOI 10.1158/0008-5472.CAN-15-1862; Moll W, 2008, J APPL PHYSIOL, V105, P365, DOI 10.1152/japplphysiol.zdg-8016-pcpcomm.2008; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Solan JL, 2012, J MEMBRANE BIOL, V245, P255, DOI 10.1007/s00232-012-9446-2; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Wykoff CC, 2000, CANCER RES, V60, P7075; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang A, 2015, ONCOTARGET, V6, P11640, DOI 10.18632/oncotarget.3449; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948	39	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					83	96		10.1096/fj.201700480R	http://dx.doi.org/10.1096/fj.201700480R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28883041				2022-12-26	WOS:000419172700010
J	Guo, H; Wu, T; Lu, Q; Dong, J; Ren, YF; Nan, KJ; Lv, Y; Zhang, XF				Guo, Hui; Wu, Tao; Lu, Qiang; Dong, Jian; Ren, Yi-Fan; Nan, Ke-Jun; Lv, Yi; Zhang, Xu-Feng			Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults	PLOS ONE			English	Article							CANCER-PATIENTS; SURVIVAL; AGE; DIAGNOSIS; FEATURES; MANAGEMENT; PROGNOSIS; RESECTION; POORER; IMPACT	The number of elderly patients diagnosed with hepatocellular carcinoma (HCC) is expected to increase. The present study aims to evaluate the role of age on treatments and outcome of HCC patients. 1530 patients firstly diagnosed with HCC were retrospectively included and classified as older (>= 65 years, n = 318, 21%) and younger patients (<65 years, n = 1212, 79%). The two groups were compared with clinical characteristics, tumor burden, Barcelona Clinics Liver Cancer (BCLC) stage, treatments and long-term prognosis. Elderly patients were more HCV infected, had more diabetes, poorer performance status, and were less aggressively treated. The proportion of HCC within BCLC stage 0-A, B or C was similar between the two groups, but elderly patients were more presented with BCLC stage D. The overall survival of older patients was poorer compared to younger patients before and after propensity score matching. However, elderly patients were less often effectively treated with surgery and loco-regional therapies across different BCLC stages. After stratified by BCLC stages or treatments, older patients showed comparable long-term outcome to younger patients. Performance status, BCLC stages and effective treatments, rather than age, was independent factors determining prognosis in the whole cohort and only elderly patients by multivariate analysis. In conclusion, older could have comparable survival to younger patients within the same tumor stage or after similar treatments. Thus, equally active treatments should be encouraged to elderly patients.	[Guo, Hui; Lu, Qiang; Dong, Jian; Ren, Yi-Fan; Lv, Yi; Zhang, Xu-Feng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Guo, Hui; Wu, Tao; Nan, Ke-Jun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, Xian, Shaanxi, Peoples R China; [Lu, Qiang; Dong, Jian; Ren, Yi-Fan; Lv, Yi; Zhang, Xu-Feng] Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, XF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.; Zhang, XF (corresponding author), Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	xfzhang125@xjtu.edu.cn	zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022	LU, QIANG/0000-0002-8294-4966				ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Borzio M, 2017, LIVER INT; Chang PE, 2008, J GASTROENTEROL, V43, P881, DOI 10.1007/s00535-008-2238-x; Chang WT, 2012, SURGERY, V152, P809, DOI 10.1016/j.surg.2012.03.024; Cho SJ, 2007, J GASTROEN HEPATOL, V22, P1226, DOI 10.1111/j.1440-1746.2007.04914.x; Cho Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165722; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Haymart MR, 2009, ONCOLOGIST, V14, P216, DOI 10.1634/theoncologist.2008-0194; Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271; Jung YK, 2016, J GASTROEN HEPATOL, V31, P467, DOI 10.1111/jgh.13152; Lee SH, 2011, J AM GERIATR SOC, V59, P241, DOI 10.1111/j.1532-5415.2010.03273.x; Leff DR, 2007, AM SURGEON, V73, P42; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Miki D, 2008, J GASTROENTEROL, V43, P550, DOI 10.1007/s00535-008-2194-5; Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217; Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279; Oishi K, 2009, J GASTROINTEST SURG, V13, P695, DOI 10.1007/s11605-008-0758-6; Ozenne V, 2011, DIGEST LIVER DIS, V43, P1001, DOI 10.1016/j.dld.2011.06.019; Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460; Repetto L, 2002, J CLIN ONCOL, V20, P494, DOI 10.1200/JCO.20.2.494; Su CW, 2012, ARCH SURG-CHICAGO, V147, P137, DOI 10.1001/archsurg.2011.288; Tas F, 2013, ONCOL LETT, V6, P1507, DOI 10.3892/ol.2013.1566; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Zhang WJ, 2015, ONCOTARGET, V6, P633, DOI 10.18632/oncotarget.2719; Zheng LZ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-300	29	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184160	10.1371/journal.pone.0184160	http://dx.doi.org/10.1371/journal.pone.0184160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886106	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100072
J	Kwon, YC; Kim, JJ; Yun, SW; Yu, JJ; Yoon, KL; Lee, KY; Kil, HR; Kim, GB; Han, MK; Song, MS; Lee, HD; Ha, KS; Sohn, S; Ebata, R; Hamada, H; Suzuki, H; Ito, K; Onouchi, Y; Hong, YM; Jang, GY; Lee, JK				Kwon, Young-Chang; Kim, Jae-Jung; Yun, Sin Weon; Yu, Jeong Jin; Yoon, Kyung Lim; Lee, Kyung-Yil; Kil, Hong-Ryang; Kim, Gi Beom; Han, Myung-Ki; Song, Min Seob; Lee, Hyoung Doo; Ha, Kee-Soo; Sohn, Sejung; Ebata, Ryota; Hamada, Hiromichi; Suzuki, Hiroyuki; Ito, Kaoru; Onouchi, Yoshihiro; Hong, Young Mi; Jang, Gi Young; Lee, Jong-Keuk		Korean Kawasaki Dis Genetics Conso	Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FC-GAMMA-RIIA; IMMUNE-RESPONSES; SUSCEPTIBILITY LOCI; ATRIAL-FIBRILLATION; ULCERATIVE-COLITIS; SEMAPHORIN SEMA6A; RECEPTOR FAMILY; IGG SUBCLASSES; IDENTIFIES 3	Kawasaki disease (KD) is an acute systemic vasculitis that can potentially cause coronary artery aneurysms in some children. KD occurs approximately 1.5 times more frequently in males than in females. To identify sex-specific genetic variants that are involved in KD pathogenesis in children, we performed a sex-stratified genome-wide association study (GWAS), using the Illumina HumanOmni1-Quad BeadChip data (249 cases and 1,000 controls) and a replication study for the 34 sex-specific candidate SNPs in an independent sample set (671 cases and 3,553 controls). Male-specific associations were detected in three common variants: rs1801274 in FCGR2A [odds ratio (OR) = 1.40, P = 9.31 x 10(-5)], rs12516652 in SEMA6A (OR = 1.87, P = 3.12 x 10(-4)), and rs5771303 near IL17REL (OR = 1.57, P = 2.53 x 10(-5)). The male-specific association of FCGR2A, but not SEMA6A and IL17REL, was also replicated in a Japanese population (OR = 1.74, P = 1.04 x 10(-4) in males vs. OR = 1.22, P = 0.191 in females). In a meta-analysis with 1,461 cases and 5,302 controls, a very strong association of KD with the nonsynonymous SNP rs1801274 (p.His167Arg, previously assigned as p.His131Arg) in FCGR2A was confirmed in males (OR = 1.48, P = 1.43 x 10(-7)), but not in the females (OR = 1.17, P = 0.055). The present study demonstrates that p.His167Arg, a KD-associated FCGR2A variant, acts as a susceptibility gene in males only. Overall, the gender differences associated with FCGR2A in KD provide a new insight into KD susceptibility.	[Kwon, Young-Chang; Kim, Jae-Jung; Lee, Jong-Keuk] Univ Ulsan, Asan Inst Life Sci, Coll Med, Seoul, South Korea; [Yun, Sin Weon] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea; [Yu, Jeong Jin] Univ Ulsan, Dept Pediat, Asan Med Ctr, Coll Med, Seoul, South Korea; [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea; [Lee, Kyung-Yil] Catholic Univ Korea, Dept Pediat, Daejeon St Marys Hosp, Daejeon, South Korea; [Kil, Hong-Ryang] Chungnam Natl Univ Hosp, Dept Pediat, Daejeon, South Korea; [Kim, Gi Beom] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Han, Myung-Ki] Univ Ulsan, Gangneung Asan Hosp, Dept Pediat, Kangnung, South Korea; [Song, Min Seob] Inje Univ, Dept Pediat, Haeundae Paik Hosp, Busan, South Korea; [Lee, Hyoung Doo] Pusan Natl Univ Hosp, Dept Pediat, Busan, South Korea; [Ha, Kee-Soo; Jang, Gi Young] Univ Korea Hosp, Dept Pediat, Seoul, South Korea; [Sohn, Sejung; Hong, Young Mi] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea; [Ebata, Ryota] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Hamada, Hiromichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Yachiyo, Japan; [Suzuki, Hiroyuki] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Ito, Kaoru; Onouchi, Yoshihiro] RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Onouchi, Yoshihiro] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan	University of Ulsan; Chung Ang University; Chung Ang University Hospital; University of Ulsan; Asan Medical Center; Kyung Hee University; Kyung Hee University Hospital; Catholic University of Korea; Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Inje University; Pusan National University; Pusan National University Hospital; Korea University; Korea University Medicine (KU Medicine); Ewha Womans University; Chiba University; Tokyo Women's Medical University; Wakayama Medical University; RIKEN; Chiba University	Lee, JK (corresponding author), Univ Ulsan, Asan Inst Life Sci, Coll Med, Seoul, South Korea.	cookie_jklee@hotmail.com	Song, Min Seob/R-3075-2019; Ebata, Ryota/AAQ-5832-2021; Ito, Kaoru/AAZ-3440-2021	Ebata, Ryota/0000-0001-8471-1042; Ha, Kee Soo/0000-0001-6753-5411; BYEON, JUNGHYE/0000-0001-5479-2451; Lee, Kyung-Yil/0000-0001-6510-1580	Ministry of Health & Welfare of the Republic of Korea [HI15C1575]; Korea Center for Disease Control and Prevention [2014-ER7402-00]; Grants-in-Aid for Scientific Research [15K09696] Funding Source: KAKEN	Ministry of Health & Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Center for Disease Control and Prevention; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health & Welfare of the Republic of Korea (HI15C1575) and a grant from the Korea Center for Disease Control and Prevention (2014-ER7402-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Becker KG, 2012, AUTISM RES, V5, P77, DOI 10.1002/aur.1227; Bernard F, 2012, GLIA, V60, P1590, DOI 10.1002/glia.22378; BREDIUS RGM, 1994, IMMUNOLOGY, V83, P624; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103329; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gautier G, 2006, AM J PATHOL, V168, P453, DOI 10.2353/ajpath.2006.050288; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GREEN MS, 1992, INT J EPIDEMIOL, V21, P381, DOI 10.1093/ije/21.2.381; Ha S, 2016, J KOREAN MED SCI, V31, P1445, DOI 10.3346/jkms.2016.31.9.1445; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2012, PEDIATR CARDIOL, V33, P513, DOI 10.1007/s00246-011-0143-1; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099; Kuo HC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/564625; Kuo HC, 2015, ARTHRITIS RHEUMATOL, V67, P828, DOI 10.1002/art.38976; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lubitz SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006284; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Moon K.W., 2015, R STAT GRAPHS MED PA; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Nasr A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-110; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; Potiron VA, 2009, CANCER LETT, V273, P1, DOI 10.1016/j.canlet.2008.05.032; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiao JL, 2015, IMMUNOL REV, V268, P241, DOI 10.1111/imr.12370; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Sasaki MM, 2016, INFLAMM BOWEL DIS, V22, P20, DOI 10.1097/MIB.0000000000000610; Singh S, 2015, ARCH DIS CHILD, V100, P1084, DOI 10.1136/archdischild-2014-307536; Smith GD, 1997, BMJ-BRIT MED J, V315, P1610, DOI 10.1136/bmj.315.7122.1610; Voysey M, 2016, VACCINE, V34, P1657, DOI 10.1016/j.vaccine.2016.02.036; Wu BJ, 2011, IMMUNOGENETICS, V63, P835, DOI 10.1007/s00251-011-0554-4; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036	51	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184248	10.1371/journal.pone.0184248	http://dx.doi.org/10.1371/journal.pone.0184248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886140	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100088
J	Miles, SR; Harik, JM; Hundt, NE; Mignogna, J; Pastorek, NJ; Thompson, KE; Freshour, JS; Yu, HJ; Cully, JA				Miles, Shannon R.; Harik, Juliette M.; Hundt, Natalie E.; Mignogna, Joseph; Pastorek, Nicholas J.; Thompson, Karin E.; Freshour, Jessica S.; Yu, Hong J.; Cully, Jeffrey A.			Delivery of mental health treatment to combat veterans with psychiatric diagnoses and TBI histories	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; POSTCONCUSSIVE SYMPTOMS; ENDURING FREEDOM; IRAQI FREEDOM; PTSD; AFGHANISTAN; ASSOCIATION; SOLDIERS	Traumatic brain injury (TBI) and mental health (MH) disorders are prevalent in combat veterans returning from Afghanistan and/or Iraq (hereafter referred to as returning veterans). Accurate estimates of service utilization for veterans with and without TBI exposure (referred to as TBI history) are imperative in order to provide high quality healthcare to returning veterans. We examined associations between TBI history and MH service utilization in a subsample of returning veterans who were newly diagnosed with posttraumatic stress disorder (PTSD), depression, and/or anxiety in the 2010 fiscal year (N = 55,458). Data were extracted from the Veterans Health Administration (VHA) National Patient Care Database. Veterans with MH diagnoses and TBI histories attended significantly more psychotherapy visits, (M = 8.32 visits, SD = 17.15) and were more likely to attend at least 8 psychotherapy visits, (15.7%) than veterans with MH diagnoses but no TBI history (M = 6.48 visits, SD = 12.12; 10.1% attended at least 8 sessions). PTSD and TBI history, but not depression or anxiety, were associated with a greater number of psychotherapy visits when controlling for demographic and clinical variables. PTSD, anxiety, depression, and TBI history were associated with number of psychotropic medication-management visits. TBI history was related to greater MH service utilization, independent of MH diagnoses. Future research should examine what MH services are being utilized and if these services are helping veterans recover from their disorders.	[Miles, Shannon R.] James A Haley Vet Hosp, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, Tampa, FL 33612 USA; [Miles, Shannon R.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Harik, Juliette M.] VA Med Ctr, Natl Ctr PTSD, Execut Div, 116D, White River Jct, VT USA; [Harik, Juliette M.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Hundt, Natalie E.; Thompson, Karin E.; Freshour, Jessica S.; Yu, Hong J.; Cully, Jeffrey A.] Michael E DeBakey VA Med Ctr MEDVAMC 152, VA South Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA; [Hundt, Natalie E.; Thompson, Karin E.; Freshour, Jessica S.; Cully, Jeffrey A.] Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA; [Hundt, Natalie E.; Cully, Jeffrey A.] MEDVAMC 152, VA HSR&D, Houston Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Mignogna, Joseph] Ctr Excellence Res Returning War Vet, Waco, TX USA; [Mignogna, Joseph] TX Texas A&M Hlth Sci Ctr, Cent Texas Vet Healthcare Syst, Temple, TX USA; [Mignogna, Joseph] Texas A&M Hlth Sci Ctr, Temple, TX USA; [Pastorek, Nicholas J.] MEDVAMC, Rehabil & Extended Care Line, Houston, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; Dartmouth College; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Miles, SR (corresponding author), James A Haley Vet Hosp, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, Tampa, FL 33612 USA.; Miles, SR (corresponding author), Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.	shannon.miles@va.gov	Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321; Pastorek, Nicholas/0000-0002-9290-380X	Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC); Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety [CIN 13-413]	Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC); Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety	This research was supported by the Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment, the Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC), and partly supported by resources and facilities of the Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (CIN 13-413). The views expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs/Baylor College of Medicine.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bay E, 2009, CURR TREAT OPTION NE, V11, P377, DOI 10.1007/s11940-009-0042-4; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brooks E, 2012, PSYCHIAT SERV, V63, P862, DOI 10.1176/appi.ps.201100444; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Deb S, 1999, AM J PSYCHIAT, V156, P374; Defense Medical Surveillance System, 2014, DOD NUMB TRAUM BRAIN; Department of Veterans' Affairs, 2016, NOT VET SERV MEMB EV; EPSTEIN RS, 1994, NEUROPSYCHIATRY TRAU, P3; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Griffen J, 2014, HDB NEUROPSYCHOLOGY; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOWARD KI, 1986, AM PSYCHOL, V41, P159, DOI 10.1037/0003-066X.41.2.159; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Maguen S, 2013, J NEUROTRAUM, V30, P1123, DOI 10.1089/neu.2012.2744; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Olfson M, 2010, AM J PSYCHIAT, V167, P1456, DOI 10.1176/appi.ajp.2010.10040570; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rockefeller College, 2004, PAD 705 HANDOUT STAN; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spoont MR, 2010, PSYCHIAT SERV, V61, P58, DOI 10.1176/appi.ps.61.1.58; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Affairs Information Resource Center (VIReC), 2012, DATA QUALITY; Veterans Affairs Information Resource Center (VIReC). VA Information Resource Center (VIReC), 2014, MED SAS DAT DOC; Veterans Health Administration, 2013, AN VA HLTH CAR UT OP; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184265	10.1371/journal.pone.0184265	http://dx.doi.org/10.1371/journal.pone.0184265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886114	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100089
J	Wang, XM; Wen, XY; Zhou, JJ; Qi, Y; Wu, RH; Wang, Y; Kui, YW; Hua, R; Jin, QL				Wang, Xiaomei; Wen, Xiaoyu; Zhou, Jingjing; Qi, Yue; Wu, Ruihong; Wang, Yao; Kui, Yiwen; Hua, Rui; Jin, Qinglong			MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients	PLOS ONE			English	Article							LIVER-INJURY; EXPRESSION; CIRRHOSIS; IDENTIFICATION; BIOMARKERS; BETA; RNAS	Recently, there is ample evidence suggesting the important role of microRNAs (miRNAs) in autoimmune diseases via modulating B cells function. Primary biliary cholangitis (PBC) is a progressive immune-mediated liver disease with unclear pathogenic mechanism. Whether the miRNA in peripheral B cells of PBC involve the mechanisms of pathology and progression is not known. The present study explores miRNA deregulation in peripheral B-cell of PBC from stage I to IV and healthy controls. Peripheral B cells were obtained from 72 PBC patients (stage I, n = 17; stage II, n = 23; stage III, n = 16; stage IV, n = 16) and 15 healthy controls. Initially, in a discovery study, miRNA array analysis was performed, subsequently, in a validation study, quantitative PCR was used to investigate miRNA expression profile in B cells of PBS patients compared to healthy controls. Based on bioinformatics analysis, we identified the potential biological processes and significant signaling pathways affected by these microRNAs, and generated the microRNA-gene network. The discovery study identified 558 miRNAs differentially expressed in B cells of PBC patients compared to controls. Interestingly, among all differentially expressed miRNAs, hsa-miR-223-3p and hsa-miR-215p were the only miRNAs that showed consistent and significant down-regulation from stage I to stage III of PBC. Bioinformatics showed that potential target genes of both miRNAs involved in migration, cell differentiation, apoptosis, and signal transduction pathways. In conclusion, our results suggest that the expression profiles of miRNA in peripheral B cells of PBC patients are closely associated with the disease progression, especially the downregulation of hsa-miR-223-3p and hsa-miR-21-5p. Taken together, our study offers novel perspectives on the role of miRNAs in PBC pathogenesis.	[Wang, Xiaomei; Wen, Xiaoyu; Zhou, Jingjing; Qi, Yue; Wu, Ruihong; Wang, Yao; Kui, Yiwen; Hua, Rui; Jin, Qinglong] Jilin Univ, Dept Hepatol, Hosp 1, Changchun, Jilin, Peoples R China; [Wang, Xiaomei] Minist Educ, Key Lab Zoonosis Res, Changchun, Jilin, Peoples R China	Jilin University	Jin, QL (corresponding author), Jilin Univ, Dept Hepatol, Hosp 1, Changchun, Jilin, Peoples R China.	qinglongjin01@163.com						Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fiorino S, 2016, WORLD J GASTROENTERO, V22, P3907, DOI 10.3748/wjg.v22.i15.3907; Floreani A, 2017, EUROPEAN J INTERNAL; Furer V, 2010, CLIN IMMUNOL, V136, P1, DOI 10.1016/j.clim.2010.02.005; Gulamhusein AF, 2015, SEMIN LIVER DIS, V35, P392, DOI 10.1055/s-0035-1567831; Gustafson D, 2016, BEST PRACT RES CL EN, V30, P563, DOI 10.1016/j.beem.2016.07.002; Kamel Refaat R, 2016, Open Access Maced J Med Sci, V4, P31, DOI 10.3889/oamjms.2016.038; Kar SP, 2013, GENES IMMUN, V14, P179, DOI 10.1038/gene.2013.1; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lleo A, 2008, WORLD J GASTROENTERO, V14, P3328, DOI 10.3748/wjg.14.3328; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Moritoki Y, 2011, CELL IMMUNOL, V268, P16, DOI 10.1016/j.cellimm.2011.01.005; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Park HK, 2016, J VET SCI, V17, P45, DOI 10.4142/jvs.2016.17.1.45; Park SK, 2016, J GASTROEN HEPATOL, V31, P1429, DOI 10.1111/jgh.13300; Qin BD, 2013, J GASTROEN HEPATOL, V28, P543, DOI 10.1111/jgh.12040; Qu B, 2015, INT J MOL SCI, V16, P9557, DOI 10.3390/ijms16059557; Raikhelson KL, 2014, TERAPEVT ARKH, V86, P44; Ray JL, 2017, TOXICOL SCI, V156, P428, DOI 10.1093/toxsci/kfw264; Salvoza NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153497; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Silveira MG, 2010, HEPATOLOGY, V52, P349, DOI 10.1002/hep.23637; Smyk DS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/610504; Takeuchi-Yorimoto A, 2016, TOXICOL LETT; Van Keuren-Jensen KR, 2016, LIVER INT, V36, P334, DOI 10.1111/liv.12919; Volinia S, 2010, BIOINFORMATICS, V26, P91, DOI 10.1093/bioinformatics/btp598; Wolenski FS, 2016, J APPL TOXICOL; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x; Zekri ARN, 2016, TUMOR BIOL, V37, P12273, DOI 10.1007/s13277-016-5097-8; Zhou KS, 2012, LEUKEMIA LYMPHOMA, V53, P1155, DOI 10.3109/10428194.2011.642303	34	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184292	10.1371/journal.pone.0184292	http://dx.doi.org/10.1371/journal.pone.0184292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886078	Green Published, gold, Green Submitted			2022-12-26	WOS:000410001100092
J	Obilade, OA; Akanmu, AS; Pipkin, FB; Afolabi, BB				Obilade, Opeyemi Abayomi; Akanmu, Alani Suleimon; Pipkin, Fiona Broughton; Afolabi, Bosede Bukola			Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy	PLOS ONE			English	Article							PLASMA-VOLUME EXPANSION; HORMONAL CHANGES; HIGH-RISK; DISEASE; WOMEN; OUTCOMES	Background Pregnancy increases the risk of morbidity and mortality in sickle cell disease. We previously showed pregnant women with sickle cell disease to have a relatively low plasma renin concentration in late pregnancy, associated with a lack of the expected plasma volume expansion. We hypothesized this to be due to increased systemic vascular resistance through an imbalance between the vasodilator prostacyclin and vasoconstrictor thromboxane, associated with decreased glomerular filtration rate (GFR). Objective To compare estimated prostacyclin, thromboxane and GFR in non-pregnant and pregnant women with hemoglobin SS (HbSS) and AA (HbAA). Study design Four groups of 20 normotensive, nulliparous women were studied in Lagos, Nigeria: pregnant HbSS or HbAA women at 36-40 weeks gestation; non-pregnant HbSS and HbAA controls. We measured stable metabolites of prostacyclin and thromboxane A(2) by enzymelinked immunosorbent assay; GFR using the Cockcroft-Gault equation. Data analysis was by independent (Student's) t-test or Mann-Whitney U test for comparisons between any two groups of continuous variables, univariate ANOVA for multiple groups and Pearson's correlation coefficient for degree of association between variables. Results HbSS women had lower serum 6-keto-PGF1 alpha concentrations than HbAA, whether pregnant or non-pregnant (P<0.001; P<0.004 respectively). Conversely, pregnant HbSS women had higher serum TxB2 (P<0.001); non-pregnant HbSS women had non-significantly higher TxB2 concentrations. The 6-keto-PGF1a: TxB2 ratio was markedly increased (pro-vasodilatory) in HbAA pregnancy (P<0.001) but reduced in HbSS pregnancy (P = 0.037). GFRs (mL/min) were higher in non-pregnant HbSS than HbAA (P<0.008) but only marginally raised in HbSS women in late pregnancy (P = 0.019) while markedly raised in HbAA pregnancy (P<0.001). Conclusion The lower ratio of prostacyclin-thromboxane metabolites in HbSS pregnancy may indicate endothelial damage and an increased tendency to vasoconstriction and clotting. If confirmed by subsequent longitudinal studies, interventions to increase prostacyclin and reduce thromboxane, such as low dose aspirin, may be potentially useful in their management.	[Obilade, Opeyemi Abayomi; Afolabi, Bosede Bukola] Lagos Univ, Dept Obstet & Gynaecol, Teaching Hosp, Lagos, Nigeria; [Obilade, Opeyemi Abayomi] State House Med Ctr, Dept Obstet & Gynaecol, Asokoro, Abuja, Nigeria; [Akanmu, Alani Suleimon] Univ Lagos, Coll Med, Dept Haematol & Blood Transfus, Lagos, Nigeria; [Akanmu, Alani Suleimon] Lagos Univ, Dept Haematol & Blood Transfus, Teaching Hosp, Lagos, Nigeria; [Pipkin, Fiona Broughton] Univ Nottingham, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Nottingham, England; [Afolabi, Bosede Bukola] Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria	University of Lagos; University of Nottingham; University of Lagos	Afolabi, BB (corresponding author), Lagos Univ, Dept Obstet & Gynaecol, Teaching Hosp, Lagos, Nigeria.; Afolabi, BB (corresponding author), Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria.	bosedeafolabi2003@yahoo.com		Afolabi, Bosede/0000-0002-7511-7567; Akanmu, Alani Sulaimon/0000-0001-7424-6060	OAO as it formed part of the requirements towards the part II Fellowship exam of the Faculty of Obstetrics and Gynaecology of the National Postgraduate Medical College of Nigeria	OAO as it formed part of the requirements towards the part II Fellowship exam of the Faculty of Obstetrics and Gynaecology of the National Postgraduate Medical College of Nigeria	The study was internally funded by OAO as it formed part of the requirements towards the part II Fellowship exam of the Faculty of Obstetrics and Gynaecology of the National Postgraduate Medical College of Nigeria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUDU OO, 1988, J NATL MED ASSOC, V80, P906; Afolabi BB, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316670444; ALLON M, 1988, KIDNEY INT, V34, P500, DOI 10.1038/ki.1988.209; Alper AB, 2011, AM J PERINAT, V28, P425, DOI 10.1055/s-0030-1268712; Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO;2-#; Boafor TK, 2016, BJOG-INT J OBSTET GY, V123, P691, DOI 10.1111/1471-0528.13786; BROWN MA, 1994, CLIN SCI, V86, P575, DOI 10.1042/cs0860575; Chakravorty S, 2015, ARCH DIS CHILD, V100, P48, DOI 10.1136/archdischild-2013-303773; Chavarria ME, 2003, AM J OBSTET GYNECOL, V188, P986, DOI 10.1067/mob.2003.203; Conrad KP, 2015, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 4TH EDITION, P335, DOI 10.1016/B978-0-12-407866-6.00016-X; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P1720, DOI 10.1158/1055-9965.EPI-07-0311; FITZGERALD DJ, 1987, CIRCULATION, V75, P956, DOI 10.1161/01.CIR.75.5.956; Fontana P, 2011, J THROMB HAEMOST, V9, P2109, DOI 10.1111/j.1538-7836.2011.04446.x; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; Lafayette RA, 2011, CLIN NEPHROL, V75, P226, DOI 10.5414/CNP75226; Lewis DF, 2010, AM J REPROD IMMUNOL, V64, P376, DOI 10.1111/j.1600-0897.2010.00861.x; LEWIS PJ, 1980, BRIT MED J, V280, P1581, DOI 10.1136/bmj.280.6231.1581; Morken NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101897; Nielsen CB, 1997, BRIT J CLIN PHARMACO, V44, P471, DOI 10.1046/j.1365-2125.1997.t01-1-00608.x; Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317; Oteng-Ntim E, 2015, BRIT J HAEMATOL, V169, P129, DOI 10.1111/bjh.13270; Pipkin FB, 2012, DEWHURSTS TXB OBSTET, P5; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Salas SP, 2006, HYPERTENSION, V47, P203, DOI 10.1161/01.HYP.0000200042.64517.19; SALAS SP, 1993, OBSTET GYNECOL, V81, P1029; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Tkachenko O, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.14098; Vainio M, 2004, ACTA OBSTET GYN SCAN, V83, P1119, DOI 10.1111/j.0001-6349.2004.00396.x; Vainio M, 1999, ACTA OBSTET GYN SCAN, V78, P82, DOI 10.1034/j.1600-0412.1999.780202.x; von Tempelhoff GF, 2008, CLIN APPL THROMB-HEM, V14, P19, DOI 10.1177/1076029607304748; Walsh S., 2011, PROSTAGLANDINS PREGN, DOI DOI 10.3843/GLOWM.10315; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	36	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184345	10.1371/journal.pone.0184345	http://dx.doi.org/10.1371/journal.pone.0184345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880908	Green Published, gold, Green Accepted			2022-12-26	WOS:000409467200052
J	Zdravevski, E; Stojkoska, BR; Standl, M; Schulz, H				Zdravevski, Eftim; Stojkoska, Biljana Risteska; Standl, Marie; Schulz, Holger			Automatic machine-learning based identification of jogging periods from accelerometer measurements of adolescents under field conditions	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PHYSICAL-ACTIVITY; ACTIVITY MONITORS; TIME; MORTALITY; EXERCISE; HEALTH; CLASSIFICATION; SMARTPHONE; PREVENTION	Background Assessment of health benefits associated with physical activity depend on the activity duration, intensity and frequency, therefore their correct identification is very valuable and important in epidemiological and clinical studies. The aims of this study are: to develop an algorithm for automatic identification of intended jogging periods; and to assess whether the identification performance is improved when using two accelerometers at the hip and ankle, compared to when using only one at either position. Methods The study used diarized jogging periods and the corresponding accelerometer data from thirty-nine, 15-year-old adolescents, collected under field conditions, as part of the GINIplus study. The data was obtained from two accelerometers placed at the hip and ankle. Automated feature engineering technique was performed to extract features from the raw accelerometer readings and to select a subset of the most significant features. Four machine learning algorithms were used for classification: Logistic regression, Support Vector Machines, Random Forest and Extremely Randomized Trees. Classification was performed using only data from the hip accelerometer, using only data from ankle accelerometer and using data from both accelerometers. Results The reported jogging periods were verified by visual inspection and used as golden standard. After the feature selection and tuning of the classification algorithms, all options provided a classification accuracy of at least 0.99, independent of the applied segmentation strategy with sliding windows of either 60s or 180s. The best matching ratio, i.e. the length of correctly identified jogging periods related to the total time including the missed ones, was up to 0.875. It could be additionally improved up to 0.967 by application of post-classification rules, which considered the duration of breaks and jogging periods. There was no obvious benefit of using two accelerometers, rather almost the same performance could be achieved from either accelerometer position. Conclusions Machine learning techniques can be used for automatic activity recognition, as they provide very accurate activity recognition, significantly more accurate than when keeping a diary. Identification of jogging periods in adolescents can be performed using only one accelerometer. Performance-wise there is no significant benefit from using accelerometers on both locations.	[Zdravevski, Eftim; Stojkoska, Biljana Risteska] St Cyril & Methodius Univ, Fac Comp Sci & Engn, Skopje, North Macedonia; [Standl, Marie; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany	Saints Cyril & Methodius University of Skopje; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Zdravevski, E (corresponding author), St Cyril & Methodius Univ, Fac Comp Sci & Engn, Skopje, North Macedonia.	eftim.zdravevski@finki.ukim.mk; marie.standl@helmholtz-muenchen.de	Zdravevski, Eftim/K-5276-2014	Zdravevski, Eftim/0000-0001-7664-0168; Standl, Marie/0000-0002-5345-2049	Faculty of Computer Science and Engineering at the Ss. Cyril and Methodius University in Skopje, Macedonia; European Commission, as part of ERAWEB - Erasmus Mundus Action 2 Partnerships	Faculty of Computer Science and Engineering at the Ss. Cyril and Methodius University in Skopje, Macedonia; European Commission, as part of ERAWEB - Erasmus Mundus Action 2 Partnerships(European CommissionEuropean Commission Joint Research Centre)	This study was part of the 15-year followup of the GINIplus cohort (German Infant Study on the influence of Nutrition Intervention PLUS environmental and genetic influences on allergy development). This study was partially financed by the Faculty of Computer Science and Engineering at the Ss. Cyril and Methodius University in Skopje, Macedonia. This study was partially supported from the European Commission, as part of ERAWEB project (ERASMUS-WESTERN BALKANS), financed by the Erasmus Mundus Action 2 Partnerships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2016, CLIN GERIATR MED, V31, P439; Alves AJ, 2016, WORLD J CARDIOL, V8, P575, DOI 10.4330/wjc.v8.i10.575; [Anonymous], 2010, GLOB REC PHYS ACT HL; Baek SS, 2016, J EXERC REHABIL, V12, P380, DOI 10.12965/jer.1632808.404; Banos O, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S2-S6; Banos O, 2014, SENSORS-BASEL, V14, P6474, DOI 10.3390/s140406474; Bastian T, 2015, J APPL PHYSIOL, V118, P716, DOI 10.1152/japplphysiol.01189.2013; Boulle M, 2015, ACSIS-ANN COMPUT SCI, V5, P389, DOI 10.15439/2015F423; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burley CV, 2016, EXP PHYSIOL, V101, P1178, DOI 10.1113/EP085672; Cooper C, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029736; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dai SF, 2015, J PHYS ACT HEALTH, V12, pS128, DOI 10.1123/jpah.2015-0038; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Fortune E, 2015, PHYSIOL MEAS, V36, P2519, DOI 10.1088/0967-3334/36/12/2519; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gremeaux V, 2012, MATURITAS, V73, P312, DOI 10.1016/j.maturitas.2012.09.012; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; Hosmer D.W., 2013, APPL LOGISTIC REGRES, V398; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Janusz A, 2015, LECT NOTES ARTIF INT, V9437, P429, DOI 10.1007/978-3-319-25783-9_38; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Jefferis BJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0338-1; Jones E, 2017, OPEN SOURCE SCI TOOL; Kahlmeier S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1412-3; Kokkinos P, 2008, ANGIOLOGY, V59, p26S, DOI 10.1177/0003319708318582; Lameski P, 2015, LECT NOTES ARTIF INT, V9437, P464, DOI 10.1007/978-3-319-25783-9_41; Lasek J, 2015, ACSIS-ANN COMPUT SCI, V5, P375, DOI 10.15439/2015F418; Lee D, 2017, I S BIOMED IMAGING, P15, DOI 10.1109/ISBI.2017.7950457; Leutheuser H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075196; Mannini A, 2013, MED SCI SPORT EXER, V45, P2193, DOI 10.1249/MSS.0b013e31829736d6; Martin H, 2013, PERS UBIQUIT COMPUT, V17, P675, DOI 10.1007/s00779-012-0515-4; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Meina M, 2015, ACSIS-ANN COMPUT SCI, V5, P367, DOI 10.15439/2015F426; Merghani A, 2016, TRENDS CARDIOVAS MED, V26, P232, DOI 10.1016/j.tcm.2015.06.005; Munoz-Organero M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091464; Oja P, 2015, BRIT J SPORT MED, V49, P434, DOI 10.1136/bjsports-2014-093885; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfitzner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065192; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Reyes-Ortiz JL, 2016, NEUROCOMPUTING, V171, P754, DOI 10.1016/j.neucom.2015.07.085; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Ruta D, 2014, ACSIS-ANN COMPUT SCI, V2, P375; Shiroma EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145950; Shoaib M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16040426; Shoaib M, 2014, SENSORS-BASEL, V14, P10146, DOI 10.3390/s140610146; Siirtola P, 2012, INT J INTERACT MULTI, V1, P38, DOI 10.9781/ijimai.2012.155; Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135630; Smith MP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0152217; Straczkiewicz M, 2016, PHYSIOL MEAS, V37, P1757, DOI 10.1088/0967-3334/37/10/1757; Strath SJ, 2013, CIRCULATION; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Zagorecki A, 2015, ACSIS-ANN COMPUT SCI, V5, P407, DOI 10.15439/2015F419; Zdravevski E, 2017, IEEE ACCESS, V5, P5262, DOI 10.1109/ACCESS.2017.2684913; Zdravevski E, 2015, ACSIS-ANN COMPUT SCI, V5, P381, DOI 10.15439/2015F420; Zdravevski E, 2015, ACSIS-ANN COMPUT SCI, V5, P169, DOI 10.15439/2015F90; Zwillinger D., 2000, CRC STANDARD PROBABI, DOI 10.1201/b16923	67	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184216	10.1371/journal.pone.0184216	http://dx.doi.org/10.1371/journal.pone.0184216			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880923	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200041
J	Das, SK; Chisti, MJ; Habibur, M; Sarker, R; Das, J; Ahmed, S; Shahunja, KM; Nahar, S; Gibbons, N; Ahmed, T; Faruque, ASG; Rahman, M; Fuchs, GJ; Al Mamun, A; Baker, PJ				Das, Sumon Kumar; Chisti, Mohammod Jobayer; Habibur, Mohammad; Sarker, Rahman; Das, Jui; Ahmed, Shawnawaz; Shahunja, K. M.; Nahar, Shamsun; Gibbons, Nora; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Rahman, Mustafizur; Fuchs, George J., III; Al Mamun, Abdullah; Baker, Peter John			Long-term impact of changing childhood malnutrition on rotavirus diarrhoea: Two decades of adjusted association with climate and socio-demographic factors from urban Bangladesh	PLOS ONE			English	Article							VIBRIO-CHOLERAE; DISEASE; INFECTIONS; SURVEILLANCE; SEASONALITY; VARIABILITY; CHILDREN; VACCINES; BURDEN	Background There is strong association between childhood rotavirus, diarrhoea, climate factors and malnutrition. Conversely, a significant nutritional transition (reduced under-nutrition) with a concurrent increasing trend of rotavirus infection in last decade was also observed among under 5 children, especially in developing countries including Bangladesh. Considering the pathophysiology of rotavirus, there might be an interaction of this nutrition transition which plays a pivotal role in increasing rotavirus infection in addition to climate and other man-made factors in urban areas such as Dhaka, Bangladesh. Methods Relevant monthly data from 1993-2012 were extracted from the archive of the Diarrhoeal Disease Surveillance System of icddr, b and linked with data collected from the Dhaka station of the Bangladesh Meteorological Department (mean temperature, rainfall, sea level pressure and humidity). Seasonal autoregressive integrated moving average time series models were deployed to determine the association between the monthly proportion of rotavirus infection and underweight, stunting and wasting adjusting for climate, socio-demographic and sanitation factors. Finding The proportion of rotavirus cases among all causes diarrhoea increased from 20% in 1993 to 43% in 2012 (Chi squared for trend p = 0.010). In contrast, underweight, stunting and wasting decreased from 59%-29% (p<0.001); 53%-21% (p<0.001) and 32%-22% (p<0.001) respectively over the same period. Mean ambient temperature increased from 25.76 degrees C26.62 degrees C (p = 0.07); mean rainfall, sea level pressure and mean humidity decreased from 234.92-111.75 mm (p = 0.5), 1008.30-1006.61 mm of hg (p = 0.02) and 76.63%-70.26% (p<0.001), respectively. In the adjusted model, a decrease in monthly proportion of underweight [coef.: -0.189 (95% CI:-0.376, -0.003)] and wasting [-0.265 (-0.455, -0.075)] were significantly and inversely associated with rotavirus infection. However, an inverse but insignificant association was observed for stunting [-0.070 (-0.249, 0.109)]. Interpretation The reduction of acute childhood malnutrition is significantly associated with increasing rotavirus diarrhoea among under-5 children. Thus mass vaccination in addition to interventions directed at man-made modifiable predictors for prevention and control is warranted.	[Das, Sumon Kumar; Chisti, Mohammod Jobayer; Habibur, Mohammad; Sarker, Rahman; Das, Jui; Ahmed, Shawnawaz; Shahunja, K. M.; Ahmed, Tahmeed; Faruque, Abu Syed Golam; Rahman, Mustafizur] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Das, Sumon Kumar; Al Mamun, Abdullah] Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia; [Nahar, Shamsun] Jahangirnagar Univ, Dhaka, Bangladesh; [Gibbons, Nora] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Fuchs, George J., III] Univ Kentucky, Coll Med, Lexington, KY USA; [Baker, Peter John] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland; Jahangirnagar University; University of Arkansas System; University of Arkansas Medical Sciences; University of Kentucky; University of Queensland	Das, SK (corresponding author), Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.; Das, SK (corresponding author), Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia.	sumon@icddrb.org	Mamun, Abdullah/HHM-9898-2022; Das, Sumon Kumar/AAD-1551-2019; Shahunja, K M/AAR-6229-2020; Fuchs, George/GLV-1285-2022; Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/T-6384-2019; Baker, Peter J/J-2055-2012; Mamun, Abdullah A/A-4673-2011	Shahunja, K M/0000-0002-9345-206X; Fuchs, George/0000-0002-8679-8265; Baker, Peter J/0000-0002-1241-7263; Mamun, Abdullah A/0000-0002-1535-8086; Sarker, Mohammad Habibur Rahman/0000-0001-9614-0806	icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP	icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP	Hospital surveillance was funded by icddr,b and the Government of the People's Republic of Bangladesh through IHP-HNPRP.; Hospital surveillance was funded by icddr,b and the Government of the People's Republic of Bangladesh through IHP-HNPRP. icddr,b acknowledges with gratitude the commitment of the Government of the People's Republic of Bangladesh to the icddr,b's research efforts. icddr,b also gratefully acknowledges the following donors which provided unrestricted support to icddr,b since 1993 from when the data is used for this study: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development, UK (DFID).	Byomkesh T, 2012, LANDSC ECOL ENG, V8, P45, DOI 10.1007/s11355-010-0147-7; Conover W.J, 1999, PRACTICAL NONPARAMET, Vthird, P250; Corner RJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-13; Das SK, 2014, EPIDEMIOL INFECT, V142, P2530, DOI 10.1017/S095026881400017X; Das S. K., 2013, Food and Nutrition Sciences, V4, P233, DOI 10.4236/fns.2013.43031; Das SK, 2015, PUBLIC HEALTH NUTR, V18, P1718, DOI 10.1017/S136898001500004X; Das SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070402; Dewan A. M., 2008, INT J GEOINFORMATICS, V4; Dewan A.M., 2013, DHAKA MEGACITY GEOSP; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Dewan AM, 2009, APPL GEOGR, V29, P390, DOI 10.1016/j.apgeog.2008.12.005; Enders W, 2010, APPL ECONOMETRIC TIM, P360; Faruque AS, 2014, CHILDHOOD DIARRHEA S; Friel Sharon, 2010, N S W Public Health Bull, V21, P129, DOI 10.1071/NB10019; GUIRALDES E, 1981, PEDIATR RES, V15, P930, DOI 10.1203/00006450-198106000-00010; Hashizume M, 2008, EPIDEMIOL INFECT, V136, P1281, DOI 10.1017/S0950268807009776; Hashizume M, 2008, J WATER HEALTH, V6, P323, DOI 10.2166/wh.2008.062; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Hashizume M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-98; Herrador BRG, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0014-y; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; Institute of Medicine Forum on Microbial T, 2008, GLOB CLIM CHANG EXTR; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Onyango AW., 2008, WHO CHILD GROWTH STA; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Qadri F, 2005, EMERG INFECT DIS, V11, P1104, DOI 10.3201/eid1107.041266; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Reinhardt Kristina, 2014, Front Nutr, V1, P13, DOI 10.3389/fnut.2014.00013; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Sarker MHR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105978; Sharmin S, 2015, T ROYAL SOC TROPICAL; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; Unicomb LE, 1997, PEDIATR INFECT DIS J, V16, P947, DOI 10.1097/00006454-199710000-00008; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS1; World Health Organization, 1987, MAN LAB INV AC ENT I	40	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0179418	10.1371/journal.pone.0179418	http://dx.doi.org/10.1371/journal.pone.0179418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877163	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200002
J	Hu, JY; Xu, XY; Wang, CX; Bing, GX; Sun, HL; Pu, J; Liu, JH; Sun, YP				Hu, Junyi; Xu, Xinyi; Wang, Chenxi; Bing, Guoxia; Sun, Honglei; Pu, Juan; Liu, Jinhua; Sun, Yipeng			Isolation and characterization of H4N6 avian influenza viruses from mallard ducks in Beijing, China	PLOS ONE			English	Article							LIVE POULTRY MARKETS; A VIRUSES; SEROEPIDEMIOLOGICAL EVIDENCE; GENETIC-CHARACTERIZATION; ZHEJIANG PROVINCE; DOMESTIC DUCKS; H7N9 VIRUS; TRANSMISSION; PIGS; H5N1	The novel H7N9 influenza virus, which has caused severe disease in humans in China, is a reassortant with surface genes derived from influenza viruses in wild birds. This highlights the importance of monitoring influenza viruses in these hosts. However, surveillance of influenza virus in wild birds remains very limited in China. In this study, we isolated four H4N6 avian influenza viruses (AIVs) from mallard ducks in Beijing Wetland Park, which is located on the East Asia-Australasia migratory flyway. The gene segments of these Chinese H4N6 viruses were closest to AIVs in wild birds from Mongolia or the Republic of Georgia, indicating the interregional AIV gene flow among these countries. All of our isolates belonged to a novel genotype that was different from other H4N6 viruses isolated in China. We further evaluated the virulence and transmission of two representative H4N6 strains in mammalian models. We found that both of these H4N6 viruses replicated efficiently in mice without adaptation. Additionally, these two strains had a 100% transmission rate in guinea pigs via direct contact, but they had not acquired respiratory droplet transmissibility. These results reveal the potential threat to human health of H4N6 viruses in migratory birds and the need for enhanced surveillance of AIVs in wild birds.	[Hu, Junyi; Xu, Xinyi; Wang, Chenxi; Sun, Honglei; Pu, Juan; Liu, Jinhua; Sun, Yipeng] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol, Beijing, Peoples R China; [Bing, Guoxia] China Anim Dis Control Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Sun, YP (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol, Beijing, Peoples R China.	sypcau@163.com			National Key Research and Development Program of China [2016YFD0501601]; National Natural Science Fund for Outstanding Young Scholars [31522058]; Beijing New-star Plan of Science and Technology [Z161100004916115]; Chang Jiang Scholars Program	National Key Research and Development Program of China; National Natural Science Fund for Outstanding Young Scholars; Beijing New-star Plan of Science and Technology; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Key Research and Development Program of China (2016YFD0501601), National Natural Science Fund for Outstanding Young Scholars (31522058), Beijing New-star Plan of Science and Technology (Z161100004916115), and by grants from the Chang Jiang Scholars Program.	[Anonymous], 2017, HUM INF AV INFL A H7, V4, P5; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Kang HM, 2013, J GEN VIROL, V94, P30, DOI 10.1099/vir.0.046581-0; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Kayali G, 2010, ZOONOSES PUBLIC HLTH, V57, P265, DOI 10.1111/j.1863-2378.2009.01231.x; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026818; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Liang L, 2016, J VIROL, V90, P1455, DOI 10.1128/JVI.02692-15; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Ninomiya A, 2002, VET MICROBIOL, V88, P107, DOI 10.1016/S0378-1135(02)00105-0; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Reed LJ, 1938, AM J EPIDEMIOL, V27; Richard M, 2014, FUTURE VIROL, V9, P513, DOI 10.2217/fvl.14.30; Shi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37843; SHORTRIDGE KF, 1977, B WORLD HEALTH ORGAN, V55, P15; Simulundu E, 2011, J GEN VIROL, V92, P1416, DOI 10.1099/vir.0.030403-0; Su S, 2013, J CLIN MICROBIOL, V51, P601, DOI 10.1128/JCM.02625-12; Sun YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015537; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; Wu HB, 2012, ARCH VIROL, V157, P1131, DOI 10.1007/s00705-012-1259-1; Wu HB, 2012, VIRUS GENES, V44, P441, DOI 10.1007/s11262-012-0716-y; Wu HB, 2015, VIRUS GENES, V51, P347, DOI 10.1007/s11262-015-1245-2; Yang HL, 2016, P NATL ACAD SCI USA, V113, P392, DOI 10.1073/pnas.1522643113; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09	30	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184437	10.1371/journal.pone.0184437	http://dx.doi.org/10.1371/journal.pone.0184437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877243	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200102
J	Le, NK; Riggi, E; Marrone, G; Vu, TV; Izurieta, RO; Nguyen, CKT; Larsson, M; Do, CD				Le, Nicole K.; Riggi, Emilia; Marrone, Gaetano; Tam Van Vu; Izurieta, Ricardo O.; Chuc Kim Thi Nguyen; Larsson, Mattias; Cuong Duy Do			Assessment of WHO criteria for identifying ART treatment failure in Vietnam from 2007 to 2011	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT FAILURE; RESOURCE-LIMITED SETTINGS; VIRAL LOAD; VIROLOGICAL FAILURE; HIV; THERAPY; ADULTS; TRANSMISSION; REGIMEN; AFRICA	Objective We evaluated the sensitivity and specificity of the WHO immunological criteria for detecting antiretroviral therapy (ART) treatment failure in a cohort of Vietnamese patients. We conducted a stratified analysis to determine the effects of BMI, peer support, adherence to antiretroviral (ARV) drugs, age, and gender on the sensitivity and specificity of the WHO criteria. Methods We conducted a retrospective cohort study of 605 HIV-infected patients using data previously collected from a cluster randomized control trial study. We compared the sensitivity and specificity of CD4+ counts to the gold standard of virologic testing as a diagnostic test for ART failure at different time points of 12, 18, and 24 months. Results The sensitivity [95% confidence interval (CI)] of the WHO immunological criteria based on a viral load >= 1000 copies/mL was 12% (5%-23%), 14% (2%-43%), and 12.5% (2%-38%) at 12, 18, and 24 months, respectively. In the same order, the specificity was 93% (90%-96%), 98% (96%-99%), and 98% (96%-100%). The positive predictive values (PPV) at 12, 18, and 24 months were 22% (9%-40%), 20% (3%-56%), and 29% (4%-71%); the negative predictive values (NPV) at the same time points were 87% (84%-90%), 97% (95%-98%), and 96% (93%-98%). The stratified analysis revealed similar sensitivities and specificities. Conclusion The sensitivity of the WHO immunological criteria is poor, but the specificity is high. Although testing costs may increase, we recommend that Vietnam and other similar settings adopt viral load testing as the principal method for determining ART failure.	[Le, Nicole K.] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Riggi, Emilia] Univ Pavia, Med Stat Unit, Dept Brain & Behav Sci, Pavia, Italy; [Marrone, Gaetano; Larsson, Mattias; Cuong Duy Do] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Tam Van Vu] Uong Bi Gen Hosp, Dept Infect Dis, Uong Bi, Quang Ninh, Vietnam; [Izurieta, Ricardo O.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA; [Chuc Kim Thi Nguyen] Hanoi Med Univ, Hanoi, Vietnam; [Cuong Duy Do] Bach Mai Hosp, Infect Dis Dept, Hanoi, Vietnam	State University System of Florida; University of South Florida; University of Pavia; Karolinska Institutet; State University System of Florida; University of South Florida; Hanoi Medical University	Do, CD (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Do, CD (corresponding author), Bach Mai Hosp, Infect Dis Dept, Hanoi, Vietnam.	doduy.cuong@gmail.com	Riggi, Emilia/AAX-2011-2021; Larsson, Mattias/C-6434-2017	Do Duy, Cuong/0000-0002-1565-642X; RIGGI, EMILIA/0000-0001-8878-7060; Larsson, Mattias/0000-0002-0514-7445	CHAIN EU FP7; Global Fund; CDC-Lifegap Project; Health System Research Project of Hanoi Medical University in Vietnam	CHAIN EU FP7; Global Fund; CDC-Lifegap Project; Health System Research Project of Hanoi Medical University in Vietnam	We wish to acknowledge the support and contribution from the board of directors and colleagues at Uong Bi Hospital. We also want to acknowledge the teams' work at the outpatient clinics at the Provincial Hospital in Quang Ninh, Health Centre in Ha Long, and Yen Hung district hospital. In addition, we would like to acknowledge the CHAIN EU FP7, Global Fund, CDC-Lifegap Project, and Health System Research Project of Hanoi Medical University in Vietnam for providing financial and technical support for the original clinical trial. We are grateful to Dr. Nguyen Phuong Hoa, Ms. Nguyen Binh Minh, Dr. Tran Thanh Do, Dr. Nguyen Phuong Thanh, Dr. Hoang Thi Thao, Dr. Nguyen Thi Tuyet Mai, Ms. Pham Thi Tuoi, Mr. Tran Chi Thanh, Prof. Anders Sonnerborg, Prof. Vinod Diwan, all colleagues, health staff, external supporters, and patients in the DOTARV Project. We want to give a special thanks to the study participants as well as to their families for their valuable contribution to the study. Lastly, we would like to thank the Scholarly Concentrations Program at USF Health Morsani College of Medicine for their continued support.	[Anonymous], 2021, LANG ENV STAT COMP; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Castelnuovo B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/736938; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; Cuong DD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2017-x; Cuong DD, 2012, FUTURE VIROL, V7, P923, DOI 10.2217/FVL.12.83; Estill J, 2016, LANCET HIV, V3, pE132, DOI 10.1016/S2352-3018(16)00016-3; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Fhi360 V UNAIDS & PEPFAR, 2015, RES VIETN ART CASC C; Ford N, 2014, AIDS, V28, P2003, DOI 10.1097/QAD.0000000000000406; Gudo ES, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-211; HEPS- Uganda, 2015, VIR LOAD TEST HIV TR; Huong DTM, 2011, INT J STD AIDS, V22, P659, DOI 10.1258/ijsa.2011.010515; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Lynen L, 2010, CURR OPIN HIV AIDS, V5, P1, DOI 10.1097/COH.0b013e3283333762; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Meya D, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-3; Ministry of Health, 2007, NAT GUID US ANT THER; MOH, 2014, VIETN AIDS RESP PROG; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rangarajan S, 2016, J VIRUS ERAD, V2, P94; Rewari BB, 2010, JAIDS-J ACQ IMM DEF, V55, P610, DOI 10.1097/QAI.0b013e3181f43a31; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Stevenson M., 2016, EPIR TOOLS ANAL EPID; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Trinh TT, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/230953; UNAIDS, 2014, 90 90 90 AMB TREATM; Vietnam Authority of HIV/AIDS Control, 2012, VIETN HIV AIDS EST P; WHO, 2010, ANT THER HIV INF AD; WHO, 2016, CONGUID UANT DRU	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182688	10.1371/journal.pone.0182688	http://dx.doi.org/10.1371/journal.pone.0182688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877173	gold, Green Published, Green Submitted			2022-12-26	WOS:000409391200016
J	Nica, DV; Popescu, C; Draghici, GA; Andrica, FM; Privistirescu, IA; Gergen, II; Stoger, R				Nica, Dragos V.; Popescu, Cristina; Draghici, George A.; Andrica, Florina-Maria; Privistirescu, Ionela A.; Gergen, Iosif I.; Stoger, Reinhard			High-level dietary cadmium exposure is associated with global DNA hypermethylation in the gastropod hepatopancreas	PLOS ONE			English	Article							SNAIL HELIX-ASPERSA; GARDEN SNAIL; METHYLATION; CD; SOILS; PB; METALLOTHIONEIN; TRANSCRIPTOME; ACCUMULATION; EPIGENETICS	5-methylcytosine (5mC) is a key epigenetic mark which influences gene expression and phenotype. In vertebrates, this epigenetic mark is sensitive to Cd exposure, but there is no information linking such an event with changes in global 5mC levels in terrestrial gastropods despite their importance as excellentecotoxicological bioindicators of metal contamination. Therefore, we first evaluated total 5mC content in DNA of the hepatopancreas of adult Cantareus aspersus with the aim to determine whether this epigenetic mark is responsive to Cd exposure. The experiment was conducted under laboratory conditions and involved a continuous exposure, multiple dose-and time-point (14, 28, and 56 days) study design. Hepatopancreas cadmium levels were measured using Flame Atomic Absorption Spectrometry and the percentage of 5-mC in samples using an ELISA-based colorimetric assay. Snail death rates were also assessed. Our results, for the first time, reveal the presence of 5mC in C. aspersus and provide evidence for Cd-induced changes in global 5mC levels in DNA of gastropods and mollusks. Although less sensitive than tissue accumulation, DNA methylation levels responded in a dose-and time-dependent manner to dietary cadmium, with exposure dose having a much stronger effect than exposure duration. An obvious trend of increasing 5mC levels was observed starting at 28 days of exposure to the second highest dose and this trend persisted at the two highest treatments for close to one month, when the experiment was terminated after 56 days. Moreover, a strong association was identified between Cd concentrations in the hepatopancreas and DNA methylation levels in this organ. These data indicate an overall trend towards DNA hypermethylation with elevated Cd exposure. No consistent lethal effect was observed, irrespective of time point and Cd-dosage. Overall, our findings suggest that the total 5mC content in DNA of the hepatopancreas of land snails is responsive to sublethal Cd exposure and give new insights into invertebrate environmental epigenetics.	[Nica, Dragos V.; Draghici, George A.; Andrica, Florina-Maria] Victor Babes Univ Med & Pharm, Fac Pharm, P Ta Murgu Eftimie 2, Timisoara, RO, Romania; [Nica, Dragos V.; Popescu, Cristina; Draghici, George A.] Vasile Goldis Western Univ Arad, Inst Life Sci, Arad, RO, Romania; [Popescu, Cristina] Vasile Goldis Western Univ Arad, Fac Pharm, Arad, RO, Romania; [Privistirescu, Ionela A.] Victor Babes Univ Med & Pharm, Fac Med, P Ta Murgu Eftimie 2, Timisoara, RO, Romania; [Gergen, Iosif I.] Banats Univ Agr Sci & Vet Med King Michael, Fac Food Proc Technol, Calea Aradului 119, Timisoara, RO, Romania; [Stoger, Reinhard] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England	Victor Babes University of Medicine & Pharmacy, Timisoara; Vasile Goldis Western University of Arad; Vasile Goldis Western University of Arad; Victor Babes University of Medicine & Pharmacy, Timisoara; Banat University of Agricultural Sciences & Veterinary Medicine; University of Nottingham	Nica, DV (corresponding author), Victor Babes Univ Med & Pharm, Fac Pharm, P Ta Murgu Eftimie 2, Timisoara, RO, Romania.; Nica, DV (corresponding author), Vasile Goldis Western Univ Arad, Inst Life Sci, Arad, RO, Romania.	nicadragos@gmail.com	Drăghici, George Andrei/AAA-4084-2019; Gergen, Iosif/O-3321-2014	Drăghici, George Andrei/0000-0002-8042-0966; Gergen, Iosif/0000-0002-8144-1961; Stoger, Reinhard/0000-0002-2301-0805	Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI, Research Council [PN-II-RU-TE-2014-4-0776]	Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI, Research Council	The present work was supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNCS-UEFISCDI, Research Council, project number PN-II-RU-TE-2014-4-0776 (awarded to DVN).	Agency for Toxic Substances and Disease Registry (ATSDR), 2012, TOX PROF CADM; [Anonymous], 2006, OFFICIAL J EUROPEA L, V364, P5; Baurand PE, 2016, ENVIRON SCI POLLUT R, V23, P3062, DOI 10.1007/s11356-015-5320-y; Baurand PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116004; Beeby Alan, 2002, Ecological Indicators, V1, P261, DOI 10.1016/S1470-160X(02)00022-5; BERGER B, 1989, OECOLOGIA, V79, P60, DOI 10.1007/BF00378240; Bollati V, 2010, HEREDITY, V105, P105, DOI 10.1038/hdy.2010.2; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; Comfort A., 1957, Proceedings of the Malacological Society of London, V32, P219; Dallinger R, 2004, ECOTOXICOLOGY, V13, P757, DOI 10.1007/s10646-003-4474-4; De Vaufleury A, 2006, ENVIRON TOXICOL CHEM, V25, P797, DOI 10.1897/04-560R.1; Fneich S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-167; Gimbert F, 2008, ECOTOX ENVIRON SAFE, V70, P138, DOI 10.1016/j.ecoenv.2007.05.014; Gomot A, 1997, ARCH ENVIRON CON TOX, V33, P209, DOI 10.1007/s002449900245; Gomot-de Vaufleury A, 2000, B ENVIRON CONTAM TOX, V64, P434, DOI 10.1007/s001280000019; Grimm, 2009, IDENTIFYING LAND SNA; Hanna CW, 2012, HUM REPROD, V27, P1401, DOI 10.1093/humrep/des038; Hardy T, 2016, GUT, V65, P1895, DOI 10.1136/gutjnl-2015-311292; Head Jessica A, 2012, Environ Toxicol Chem, V31, P221, DOI 10.1002/etc.1707; Hispard F, 2008, ENVIRON TOXICOL CHEM, V27, P1533, DOI 10.1897/07-232.1; Hockner M, 2011, BIOMETALS, V24, P1079, DOI 10.1007/s10534-011-9466-x; Hodl E, 2010, CELL TISSUE RES, V341, P159, DOI 10.1007/s00441-010-0980-x; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hossain MB, 2012, ENVIRON HEALTH PERSP, V120, P879, DOI 10.1289/ehp.1104600; Itziou A, 2011, SCI TOTAL ENVIRON, V409, P1181, DOI 10.1016/j.scitotenv.2010.12.009; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Joe M., 2013, THESIS; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jordaens K, 2006, SCI TOTAL ENVIRON, V363, P285, DOI 10.1016/j.scitotenv.2005.12.002; Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4; Jurkowska RZ, 2011, METHODS MOL BIOL, V791, P157, DOI 10.1007/978-1-61779-316-5_13; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Laskowski R, 1996, ECOTOX ENVIRON SAFE, V34, P59, DOI 10.1006/eesa.1996.0045; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Marandel L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32187; Menta C, 2001, ENVIRON POLLUT, V115, P205, DOI 10.1016/S0269-7491(01)00110-5; Meyers L. S., 2006, APPL MULTIVARIATE RE; Mleiki A, 2016, SCI TOTAL ENVIRON, V547, P148, DOI 10.1016/j.scitotenv.2015.12.162; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Moroz LL, 2013, METHODS MOL BIOL, V1048, P323, DOI 10.1007/978-1-62703-556-9_21; Mozhui K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118466; Muller R, 2016, J MOLLUS STUD; Nica DV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116397; Notten MJM, 2006, ENVIRON POLLUT, V139, P296, DOI 10.1016/j.envpol.2005.05.007; Pierron F, 2014, ENVIRON SCI TECHNOL, V48, P797, DOI 10.1021/es4048347; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Ruiz-Hernandez A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0055-7; RUSSELL LK, 1981, B ENVIRON CONTAM TOX, V26, P634, DOI 10.1007/BF01622148; Sanchez-Arguello P., 2016, AUSTIN J ENV TOXICOL, V2, P1008; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; SANO H, 1982, P NATL ACAD SCI-BIOL, V79, P3584, DOI 10.1073/pnas.79.11.3584; Scheifler R, 2003, ENVIRON POLLUT, V122, P343, DOI 10.1016/S0269-7491(02)00333-0; Semenchenko V, 2003, AQUAT INVASIONS, V3, P359; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; Toth A, 2016, URBAN ECOSYST, V19, P19, DOI 10.1007/s11252-015-0489-x; Vandegehuchte MB, 2010, COMP BIOCHEM PHYS C, V151, P278, DOI 10.1016/j.cbpc.2009.11.007; Vandegehuchte MB, 2009, ENVIRON INT, V35, P700, DOI 10.1016/j.envint.2009.01.002; Wang B, 2012, CURR MED CHEM, V19, P2611, DOI 10.2174/092986712800492913; WHO (World Health Organization), 2007, HLTH RISKS HEAV MET; WILSON VL, 1983, SCIENCE, V220, P1054; Zhang C, 2013, TOXICOL APPL PHARM, V271, P78, DOI 10.1016/j.taap.2013.04.025	64	24	23	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184221	10.1371/journal.pone.0184221	http://dx.doi.org/10.1371/journal.pone.0184221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877233	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200075
J	Saito, Y; Yamamoto, H; Nakajima, H; Takahashi, O; Komatsu, Y				Saito, Yuki; Yamamoto, Hiroyuki; Nakajima, Hideki; Takahashi, Osamu; Komatsu, Yasuhiro			Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with RAS inhibitors	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; DRUGS	Introduction Renin-angiotensin system (RAS) inhibitors have been increasingly prescribed due to their beneficial effects on end-organ protection. Iatrogenic hyperkalemia is a well-known life-threatening complication of RAS inhibitor use in chronic kidney disease (CKD) patients. We hypothesized that CKD patients treated with RAS inhibitors frequently develop hyperkalemia after hospital discharge even if they were normokalemic during their hospitalization because their lifestyles change substantially after discharge. The present study aimed to examine the incidence of newly diagnosed hyperkalemia, the timing of hyperkalemia, and its risk factors in CKD patients treated with RAS inhibitors at the time of hospital discharge. Methods We retrospectively enrolled patients aged 20 years or older with CKD G3-5 (estimated glomerular filtration rate < 60 mL/min/1.73 m(2)) and who were treated with RAS inhibitors and discharged from St. Luke's International Hospital between July 2011 and December 2015. Patients who were under maintenance dialysis or had hyperkalemic events before discharge were excluded. Data regarding the patients' age, sex, CKD stage, diabetes mellitus status, malignancy status, combined use of RAS inhibitors, concurrent medication, and hyperkalemic events after discharge were extracted from the hospital database. Our primary outcome was hyperkalemia, defined as serum potassium >= 5.5 mEq/L. Multiple logistic regression and Kaplan-Meier analyses were performed to identify the risk factors for and the timing of hyperkalemia, respectively. Results Among the 986 patients, 121 (12.3%) developed hyperkalemia after discharge. In the regression analysis, relative to CKD G3a, G3b [odds ratio (OR): 1.88, 95% confidence interval 1.20-2.97] and G4-5 (OR: 3.40, 1.99-5.81) were significantly associated with hyperkalemia. The use of RAS inhibitor combinations (OR: 1.92, 1.19-3.10), malignancy status (OR: 2.10, 1.14-3.86), and baseline serum potassium (OR: 1.91, 1.23-2.97) were also significantly associated with hyperkalemia. The Kaplan-Meier analysis showed that hyperkalemia was most frequent during the early period after discharge, particularly within one month. Conclusion Hyperkalemia was frequent during the early period after discharge among previously normokalemic CKD patients who were treated with RAS inhibitors. Appropriate follow-up after discharge should be required for these patients, particularly those with advanced CKD or malignancy status, such as hematological malignancy or late-stage malignancy, and those who are treated with multiple RAS inhibitors.	[Saito, Yuki; Yamamoto, Hiroyuki; Komatsu, Yasuhiro] St Lukes Int Hosp, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Saito, Yuki] Keio Univ Hosp, Div Internal Med, Tokyo, Japan; [Yamamoto, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; [Nakajima, Hideki] St Lukes Int Hosp, Informat Syst Ctr, Tokyo, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Dept Internal Med, Div Gen Internal Med, Tokyo, Japan; [Takahashi, Osamu] St Lukes Int Univ, Grad Sch Publ Hlth, Div Clin Epidemiol, Tokyo, Japan	St. Luke's International Hospital; Keio University; University of Tokyo; St. Luke's International Hospital; St. Luke's International Hospital; St. Luke's International Hospital	Yamamoto, H; Komatsu, Y (corresponding author), St Lukes Int Hosp, Dept Internal Med, Div Nephrol, Tokyo, Japan.; Yamamoto, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan.	yama-h@umin.ac.jp; komayasu@luke.ac.jp	Komatsu, Yasuhiro/AAW-1969-2020	Yamamoto, Hiroyuki/0000-0003-3337-7595; Saito, Yuki/0000-0003-2686-9604				Acker CG, 1998, ARCH INTERN MED, V158, P917, DOI 10.1001/archinte.158.8.917; Cairo MS, 2004, BRIT J HAEMATOL, V127, P3, DOI 10.1111/j.1365-2141.2004.05094.x; Christiansen CF, 2011, EUR J INTERN MED, V22, P399, DOI 10.1016/j.ejim.2011.05.005; Drewnowski A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006625; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fleet JL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002011; Hersh AM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000116; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kuijvenhoven MA, 2013, INT J CLIN PHARM-NET, V35, P1099, DOI 10.1007/s11096-013-9830-8; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lafrance JP, 2012, AM J KIDNEY DIS, V60, P82, DOI 10.1053/j.ajkd.2012.02.328; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Perazella MA, 2000, AM J MED, V109, P307, DOI 10.1016/S0002-9343(00)00496-4; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RIMMER JM, 1987, ARCH INTERN MED, V147, P867, DOI 10.1001/archinte.147.5.867; Sarafidis PA, 2012, CLIN J AM SOC NEPHRO, V7, P1234, DOI 10.2215/CJN.01150112; Sica Domenic A, 2006, J Clin Hypertens (Greenwich), V8, P67, DOI 10.1111/j.1524-6175.2006.05139.x; Toto RD, 2010, CURR OPIN NEPHROL HY, V19, P444, DOI 10.1097/MNH.0b013e32833ce6d5; Vest JR, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-88; Weir MA, 2010, CLIN J AM SOC NEPHRO, V5, P1544, DOI 10.2215/CJN.01970310; Weir MR, 2007, CLIN THER, V29, P1803, DOI 10.1016/j.clinthera.2007.09.019; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184402	10.1371/journal.pone.0184402	http://dx.doi.org/10.1371/journal.pone.0184402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877239	gold, Green Submitted, Green Published			2022-12-26	WOS:000409391200098
J	El-Beltagi, HS; El-Senousi, NA; Ali, ZA; Omran, AA				El-Beltagi, Hossam S.; El-Senousi, Naglaa A.; Ali, Zeinab A.; Omran, Azza A.			The impact of using chickpea flour and dried carp fish powder on pizza quality	PLOS ONE			English	Article							SENSORY QUALITY; PROTEIN; DIGESTIBILITY; FROZEN; FOOD; L.	Pizza being the most popular food worldwide, quality and sensory appeal are important considerations during its modification effort. This study was aimed to evaluate the quality of pizza made using two different sources of proteins, chickpea (Cicer arietinum) flour and dried carp fish powder (Cyprinus carpio). Analysis indicated nutrients richness specificity of chickpea flour (higher fiber, energy, iron, zinc, linoleic acid and total nonessential amino acids) and dried carp fish powder (higher contents of protein, fats, ash, oleic acid and total essential amino acids) complementing wheat flour to enhance nutritional value of pizza. Total plate count and thiobarbituric acid were increased (P<0.05) in dried carp fish powder after 45 days of storage, but no Coliform were detected. Wheat flour was substituted with 5, 7.5 and 10% chickpea flour or dried carp fish powder and chemical, textural, sensory and storage evaluation parameters of in pizza were investigated. Dried carp fish powder increased (P<0.05) contents of protein, ash, fats, zinc and protein digestibility of pizza. Chickpea flour increased iron and zinc contents of the pizza. Water activity (a(w)) was decreased in fish powder and chickpea pizza. Pizza firmness and gumminess were significantly (p<0.05) increased at every level of protein source, but cohesiveness was decreased with 10% chickpea flour. Pizza chewiness was the same (P>0.05) across the levels of two protein sources. Springiness was decreased (P<0.05) with high level (10%) dried fish powder and low/intermediate level of chickpea flour. Chickpea and dried carp fish incorporation up to 7.50% in pizza at the expense of wheat flour had no effect (P>0.05) on all sensorial parameters except for odor values. The results could be useful in utilization of chickpea flour and carp fish powder in designing nutritious pizza for consumers.	[El-Beltagi, Hossam S.] Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt; [El-Senousi, Naglaa A.] Agr Res Ctr, Food Technol Res Inst, Dept Meat & Fish Technol Res, Giza, Egypt; [Ali, Zeinab A.; Omran, Azza A.] Agr Res Ctr, Food Technol Res Inst, Dept Crops Technol Res, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	El-Beltagi, HS (corresponding author), Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt.	lbltg@yahoo.com	Omran, Azza A./AAY-3922-2020; El-Beltagi, Hossam/T-2547-2018; El-Beltagi, Hossam S./L-8546-2019; Omran, Azza A. A./ABF-3888-2021	Omran, Azza A./0000-0002-9328-8087; El-Beltagi, Hossam/0000-0003-4433-2034; Omran, Azza A. A./0000-0002-9328-8087	Food Technology Research Institute,Agricultural Research Center	Food Technology Research Institute,Agricultural Research Center	This study was supported by intramural funding from the Food Technology Research Institute, Agricultural Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by intramural funding from the Food Technology Research Institute, Agricultural Research Center and provided facilities necessary by Faculty of Agriculture, Cairo University, Department of Biochemistry to accomplish the objectives of this research. The authors would also like to thank the anonymous reviewers for their comments and Academic Editor for critical reading, corrections and insightful thoughts on this manuscript.	Abbas KA, 2009, J FOOD AGRIC ENVIRON, V7, P86; Abdel-Aal HA, 2014, 4 C CENTR LAB AQ RES, P409; Abdel-Kader ZM, 2001, NAHRUNG, V45, P31, DOI 10.1002/1521-3803(20010101)45:1&lt;31::AID-FOOD31&gt;3.0.CO;2-H; Abou-Zaid A. A. M., 2014, Journal of Applied Sciences Research, V10, P43; Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; AKESON WR, 1964, J NUTR, V83, P257, DOI 10.1093/jn/83.3.257; [Anonymous], 2013, FOOD FEED RES; AOAC, OFFICIAL METHODS ANA; Arannilewa ST, 2005, AFR J BIOTECHNOL, V4, P852; Gularte MA, 2012, FOOD BIOPROCESS TECH, V5, P3142, DOI 10.1007/s11947-011-0642-3; Biase LD, 1996, PANORAMA, V28, P86; Bilgicli N, 2006, J FOOD ENG, V77, P680, DOI 10.1016/j.jfoodeng.2005.07.030; Bingham A, 2013, JUSTICE Q, V30, P594, DOI 10.1080/07418825.2011.619560; Booth MA, 2001, AQUACULTURE, V196, P67, DOI 10.1016/S0044-8486(00)00578-0; BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019; Bourne M, 2011, FOOD TEXTURE VISCOSI; CADDEN AM, 1988, J FOOD SCI, V53, P1150, DOI 10.1111/j.1365-2621.1988.tb13550.x; CHITRA U, 1995, PLANT FOOD HUM NUTR, V47, P163, DOI 10.1007/BF01089266; Dallabona BR, 2013, REV BRAS ZOOTECN, V42, P835, DOI 10.1590/S1516-35982013001200001; de Delahaye EP, 2005, J FOOD ENG, V68, P1, DOI 10.1016/j.jfoodeng.2004.05.048; El-Kholie E. M., 2014, African Journal of Agricultural Research, V9, P2332; Eskin NAM, 2001, FOOD SHELF LIFE STAB, P5; FAO, 2013, FISH STAT PLUS UN SO; Fellows P., 2000, PROCESSING TECHNOLOG, V2; Food and Drug Administration (FDA), 2002, EN ESCH COL COL BACT; Ganesh A, 2006, J FOOD BIOCHEM, V30, P342, DOI 10.1111/j.1745-4514.2006.00068.x; Garcia-Arias MT, 2003, LEBENSM-WISS TECHNOL, V36, P763, DOI 10.1016/S0023-6438(03)00097-5; Harring WF, 1998, LAB METHODS FOOD MIC; Hoseini Marzieh, 2013, AACL Bioflux, V6, P202; James CS, 1995, GEN FOOD STUDIES, p[6, 135]; Jonsson A, 2007, 3207 MAT FOOD RES IN; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; LARSEN DM, 1993, CEREAL CHEM, V70, P647; Latip LD, 2013, J FISH AQUAT SCI, P1; Livsmedelverket, 1996, LIVSM AM; Ljubojevic D., 2013, Bulgarian Journal of Agricultural Science, V19, P62; Mohamed G. F., 2014, World Journal of Dairy & Food Sciences, V9, P242; Pizza Ridgaway D., 2005, 50 TRADITIONAL ALTER; Rodriguez C, 2008, FOOD CHEM, V108, P245, DOI 10.1016/j.foodchem.2007.10.073; Shah H. U., 2011, Sarhad Journal of Agriculture, V27, P279; Shaviklo GR, 2010, J SCI FOOD AGR, V90, P2133, DOI 10.1002/jsfa.4062; Singh P., 2011, American Journal of Food Technology, V6, P202; Smith J. P., 1995, PRINCIPLES MODIFIED, P207; Sulieman A. M. E., 2012, International Journal of Food Science and Nutrition Engineering, V2, P1, DOI 10.5923/j.food.20120201.01; Sze-Tao KWC, 2000, FOOD CHEM, V69, P153, DOI 10.1016/S0308-8146(99)00244-7; Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P507, DOI 10.1016/j.tifs.2003.07.002; Tiwari U, 2013, FOOD RES INT, V50, P497, DOI 10.1016/j.foodres.2011.09.007; Wang N., 2004, CHEM COMPOSITION NUT, P19; Wu T, 2008, FOOD CHEM, V110, P647, DOI 10.1016/j.foodchem.2008.02.058	49	19	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183657	10.1371/journal.pone.0183657	http://dx.doi.org/10.1371/journal.pone.0183657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873098	Green Submitted, gold, Green Published			2022-12-26	WOS:000409282800019
J	Pierce, AA; Duwaerts, CC; Siao, K; Mattis, AN; Goodsell, A; Baron, JL; Maher, JJ				Pierce, Andrew A.; Duwaerts, Caroline C.; Siao, Kevin; Mattis, Aras N.; Goodsell, Amanda; Baron, Jody L.; Maher, Jacquelyn J.			CD18 deficiency improves liver injury in the MCD model of steatohepatitis	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ISCHEMIA-REPERFUSION INJURY; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED-RECEPTOR-ALPHA; DIET-INDUCED OBESITY; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; HUMAN-NEUTROPHILS; MAC-1 CD11B/CD18; PULMONARY INFLAMMATION	Neutrophils and macrophages are important constituents of the hepatic inflammatory infiltrate in non-alcoholic steatohepatitis. These innate immune cells express CD18, an adhesion molecule that facilitates leukocyte activation. In the context of fatty liver, activation of infiltrated leukocytes is believed to enhance hepatocellular injury. The objective of this study was to determine the degree to which activated innate immune cells promote steatohepatitis by comparing hepatic outcomes in wild-type and CD18-mutant mice fed a methionine-choline- deficient (MCD) diet. After 3 weeks of MCD feeding, hepatocyte injury, based on serum ALT elevation, was 40% lower in CD18-mutant than wild-type mice. Leukocyte infiltration into the liver was not impaired in CD18-mutant mice, but leukocyte activation was markedly reduced, as shown by the lack of evidence of oxidant production. Despite having reduced hepatocellular injury, CD18-mutant mice developed significantly more hepatic steatosis than wild-type mice after MCD feeding. This coincided with greater hepatic induction of pro-inflammatory and lipogenic genes as well as a modest reduction in hepatic expression of adipose triglyceride lipase. Overall, the data indicate that CD18 deficiency curbs MCD-mediated liver injury by limiting the activation of innate immune cells in the liver without compromising intrahepatic cytokine activation. Reduced liver injury occurs at the expense of increased hepatic steatosis, which suggests that in addition to damaging hepatocytes, infiltrating leukocytes may influence lipid homeostasis in the liver.	[Pierce, Andrew A.; Duwaerts, Caroline C.; Siao, Kevin; Goodsell, Amanda; Baron, Jody L.; Maher, Jacquelyn J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Pierce, Andrew A.; Duwaerts, Caroline C.; Siao, Kevin; Mattis, Aras N.; Goodsell, Amanda; Baron, Jody L.; Maher, Jacquelyn J.] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Mattis, Aras N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maher, JJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Maher, JJ (corresponding author), Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA.	jacquelyn.maher@ucsf.edu	Mattis, Aras/AID-1427-2022	Mattis, Aras/0000-0002-5813-164X; Pierce, Andrew/0000-0002-2692-4514	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK068450, R56 DK088674, R01 DK093646, K08 DK098270, T32 DK068414, P30 DK026743]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Genome Analysis Core of the Hellen Diller Family Comprehensive Cancer Center [P30 CA082103]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068450, T32DK060414, P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Genome Analysis Core of the Hellen Diller Family Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: R01 DK068450, https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (JJM); R56 DK088674, [https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (JJM); R01 DK093646, https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (JLB); K08 DK098270, https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (ANM); T32 DK068414, https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (CCD); P30 CA082103, https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Genome Analysis Core of the Hellen Diller Family Comprehensive Cancer Center; and P30 DK026743, https://www.niddk.nih.gov/, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (JJM).	Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x; Awaya T, 2008, OBESITY, V16, P1463, DOI 10.1038/oby.2008.68; Babic AM, 2004, MOL MED, V10, P72, DOI 10.2119/2004-00038.Wagner; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bhatia M, 1998, P NATL ACAD SCI USA, V95, P4760, DOI 10.1073/pnas.95.8.4760; Blake KM, 2004, CLIN EXP IMMUNOL, V136, P262, DOI 10.1111/j.1365-2249.2004.02429.x; Bowden RA, 2002, CIRC RES, V90, P562, DOI 10.1161/01.RES.0000013835.53611.97; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Csak T, 2011, AM J PHYSIOL-GASTR L, V300, pG433, DOI 10.1152/ajpgi.00163.2009; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Dong ZM, 1997, P NATL ACAD SCI USA, V94, P7526, DOI 10.1073/pnas.94.14.7526; Egan CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065247; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gujral Jaspreet S, 2004, Comp Hepatol, V3 Suppl 1, pS48, DOI 10.1186/1476-5926-2-S1-S48; Gujral JS, 2004, AM J PHYSIOL-GASTR L, V287, pG243, DOI 10.1152/ajpgi.00287.2003; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Ho JS, 1996, J LEUKOCYTE BIOL, V59, P716, DOI 10.1002/jlb.59.5.716; JAESCHKE H, 1993, HEPATOLOGY, V17, P915, DOI 10.1016/0270-9139(93)90169-N; Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647; Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Klintman D, 2002, J HEPATOL, V36, P53, DOI 10.1016/S0168-8278(01)00226-4; Kobayashi A, 2001, AM J PHYSIOL-GASTR L, V281, pG577, DOI 10.1152/ajpgi.2001.281.2.G577; Kodali P, 2006, AM J PHYSIOL-GASTR L, V291, pG355, DOI 10.1152/ajpgi.00458.2005; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P267, DOI 10.1111/j.1440-1746.2007.05157.x; Lau HY, 2005, BIOCHEM BIOPH RES CO, V327, P509, DOI 10.1016/j.bbrc.2004.12.030; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee GS, 2007, J LIPID RES, V48, P1885, DOI 10.1194/jlr.M700181-JLR200; Li Y, 2012, INT J OBESITY, V36, P1503, DOI 10.1038/ijo.2011.279; Liles WC, 1995, J LEUKOCYTE BIOL, V58, P690, DOI 10.1002/jlb.58.6.690; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mackarel AJ, 2001, J IMMUNOL, V167, P2839, DOI 10.4049/jimmunol.167.5.2839; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Nagaya T, 2010, J HEPATOL, V53, P724, DOI 10.1016/j.jhep.2010.04.033; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Ridger VC, 2001, J IMMUNOL, V166, P3484, DOI 10.4049/jimmunol.166.5.3484; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Rivera CA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-52; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Ruhl CE, 2010, GASTROENTEROLOGY, V138, P1346, DOI 10.1053/j.gastro.2009.12.053; Sahai A, 2006, AM J PHYSIOL-GASTR L, V291, pG55, DOI 10.1152/ajpgi.00360.2005; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Szabo G, 2005, ALCOHOL CLIN EXP RES, V29, p140S, DOI 10.1097/01.alc.0000189287.83544.33; Titova E, 2008, J NEUROSCI RES, V86, P3240, DOI 10.1002/jnr.21762; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Warne JP, 2011, CELL METAB, V14, P791, DOI 10.1016/j.cmet.2011.11.001; WILSON RW, 1993, J IMMUNOL, V151, P1571; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Wolf D, 2017, THROMB HAEMOSTASIS, V117, P325, DOI 10.1160/TH16-07-0553; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108	72	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183912	10.1371/journal.pone.0183912	http://dx.doi.org/10.1371/journal.pone.0183912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873429	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800035
J	Chen, XW; Qin, M; Jiang, WF; Zhang, Y; Liu, X				Chen, Xiaowei; Qin, Mu; Jiang, Weifeng; Zhang, Yu; Liu, Xu			Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias	PLOS ONE			English	Article							REPOLARIZING K+ CURRENTS; MOLECULAR-MECHANISMS; DOWN-REGULATION; HEART-FAILURE; EXPRESSION; CANINE; SUBUNIT	Objective To explore the cardiac electrophysiological characteristics of cardiac hypertrophy and its influence on the occurrence of ventricular tachyarrhythmias. Methods Adult C57BL6 mice were randomly divided into a surgery group and a control group. Thoracic aortic constriction was performed on mice in the surgery group, and cardiac anatomical and ultrasonic evaluations were performed to confirm the success of the cardiac hypertrophy model 4 weeks after the operation. Using the Langendorff method of isolated heart perfusion, monophasic action potentials (MAPs) and the effective refractory period (ERP) at different parts of the heart (including the epi-and endo-myocardium of the left and right ventricles) were measured, and the induction rate of ventricular tachyarrhythmias was observed under programmed electrical stimulus (PES) and burst stimulus. Whole-cell patch-clamp was used to obtain the I-V characteristics of voltage-gated potassium channels in cardiomyocytes of different parts of the heart (including the epi-and endo-myocardium of the left and right ventricles) as well as the channels' properties of steady-state inactivation and recovery from inactivation. Results The ratio of heart weight to body weight and the ratio of left ventricular weight to body weight in the surgery group were significantly higher than those in the control group (P < 0.05). Ultrasonic evaluation revealed that both interventricular septal diameter (IVSD) and left ventricle posterior wall diameter (LVPWD) in the surgery group were significantly larger than those in the control group (P < 0.05). Under PES and burst stimuli, the induction rates of arrhythmias in the surgery group significantly increased, reaching 41.2% and 23.5%, respectively. Both the QT interval and action potential duration (APD) in the surgery group were significantly longer than in the control group (P < 0.01), and the changes showed obvious spatial heterogeneity. Whole-cell patch-clamp recordings demonstrated that the surgery group had significantly lower potassium current densities (I-Peak, I-to, I-Kur, I-ss, and I-K1) at different parts of the heart than the control group (P < 0.01), and there were significant differences in the half-inactivation voltage (V (1/2)) and the inactivation-recovery time constant (tau) of I-to and I-Kur at different parts of the heart (P < 0.01) between the surgery group and the control group. In addition, the surgery group had significantly lower densities of I-Peak, I-to, and I-Kur in cells of the endo-myocardium (P < 0.05), and the changes showed obvious spatial heterogeneity. Conclusion Changes in the current density and function of potassium channels contributed to irregular repolarization in cardiac hypertrophy, and the spatially heterogeneous changes of the channels may increase the occurrence of ventricular arrhythmias that accompany cardiac hypertrophy.	[Chen, Xiaowei; Qin, Mu; Jiang, Weifeng; Zhang, Yu; Liu, Xu] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Qin, M; Liu, X (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China.	qinmu-1001@live.cn; heartlx@sina.com			National Natural Science Foundation of China [81400246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants (Grant No: 81400246).	Adler Arnon, 2016, Card Electrophysiol Clin, V8, P361, DOI 10.1016/j.ccep.2016.02.001; BOYDEN PA, 1995, CARDIOVASC RES, V29, P312, DOI 10.1016/S0008-6363(96)88586-5; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Cordeiro Jonathan M, 2016, Front Biosci (Schol Ed), V8, P143; Furukawa T, 2006, J MOL CELL CARDIOL, V41, P753, DOI 10.1016/j.yjmcc.2006.07.021; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; Hoppe UC, 2000, J CLIN INVEST, V105, P1077, DOI 10.1172/JCI8757; Katholi Richard E, 2011, INT J HYPERTENS, V2011; Kim JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176713; Marban E, 1999, J CARDIOVASC ELECTR, V10, P1425, DOI 10.1111/j.1540-8167.1999.tb00199.x; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Nabauer M, 1998, CARDIOVASC RES, V37, P324, DOI 10.1016/S0008-6363(97)00274-5; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Schoepe M, 2012, METABOLISM, V61, P117, DOI 10.1016/j.metabol.2011.05.023; Shi C, 2013, ACTA PHYSIOL, V208, P95, DOI 10.1111/apha.12071; Stengl M, 2006, CARDIOVASC RES, V72, P90, DOI 10.1016/j.cardiores.2006.07.015; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Volk T, 2001, J PHYSIOL-LONDON, V530, P443, DOI 10.1111/j.1469-7793.2001.0443k.x; Yang KC, 2010, J PHYSIOL-LONDON, V588, P5015, DOI 10.1113/jphysiol.2010.197418; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183671	10.1371/journal.pone.0183671	http://dx.doi.org/10.1371/journal.pone.0183671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863155	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900007
J	Zhao, XF; Kong, F; Wang, L; Zhang, H				Zhao, Xiaofei; Kong, Feng; Wang, Lei; Zhang, Han			c-FLIP and the NOXA/Mcl-1 axis participate in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells	PLOS ONE			English	Article							LUNG-CANCER; DEATH; ABT-737; RADIOTHERAPY; APOPTOSIS; LIFE	Choroidal melanoma is the most common primary malignant intraocular tumor, and very few effective therapies are available to treat it. Our study aimed to understand whether pemetrexed plus cisplatin exerts a beneficial synergistic effect in human choroidal melanoma cells and to delineate the underlying molecular mechanism. To accomplish these aims, we treated choroidal melanoma cells with pemetrexed and cisplatin and assessed cell survival with SRB and MTT assays. Proteins were detected using western blotting analysis. NOXA and CHOP were knocked down with siRNA. We found that pemetrexed or cisplatin alone inhibited survival and induced apoptosis in human choroidal melanoma cells. Furthermore, the expression levels of c-FLIP, an anti-apoptotic protein in the extrinsic apoptosis pathway, and Mcl-1, an anti-apoptotic protein in the intrinsic apoptosis pathway, were decreased by pemetrexed or cisplatin respectively, while the expression of a pro-apoptotic protein in the intrinsic apoptosis pathway, NOXA, was up-regulated. Moreover, pemetrexed or cisplatin alone increased the protein expression of the endoplasmic reticulum stress markers IRE1 alpha, Bip and CHOP. Silencing CHOP expression reduced NOXA expression. These findings suggest that the pemetrexed or cisplatin induced intrinsic apoptosis via activation of the ER stress response. Importantly, combining the two compounds more strongly induced apoptosis. Following the cotreatment, CHOP and NOXA expression increased, while c-FLIP and Mcl-1 expression decreased, and these effects were more pronounced than when using either compound alone. This result suggests that pemetrexed and cisplatin synergistically activate ER stress response-induced apoptosis in choroidal melanoma cells. To summarize, the c-FLIP and NOXA/Mcl-1 axis participated in the synergistic effect of pemetrexed plus cisplatin in human choroidal melanoma cells. Intrinsic apoptosis was induced via activation of the ER stress response. Our study provides important mechanistic insights into potential cancer treatment with pemetrexed plus cisplatin and enriches our understanding of human choroidal melanoma.	[Zhao, Xiaofei; Wang, Lei; Zhang, Han] Shandong Univ, Dept Ophthalmol, Hosp 2, Jinan, Shandong, Peoples R China; [Kong, Feng] Shandong Univ, Dept Cent Res Lab, Hosp 2, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, H (corresponding author), Shandong Univ, Dept Ophthalmol, Hosp 2, Jinan, Shandong, Peoples R China.	sdeyyk@163.com			Seed Fund of the 2nd Hospital of Shandong University [S2014010016]; QILU Hospital; Central Research Laboratory of the Second Hospital of Shandong University	Seed Fund of the 2nd Hospital of Shandong University; QILU Hospital; Central Research Laboratory of the Second Hospital of Shandong University	This work was supported by Seed Fund of the 2nd Hospital of Shandong University (S2014010016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jian Wang of QILU Hospital and the Central Research Laboratory of the Second Hospital of Shandong University for technical assistance and for their generous support.	Allen JE, 2012, MOL CANCER THER, V11, P2087, DOI 10.1158/1535-7163.MCT-12-0366; Augsburger JJ, 2008, T AM OPHTHAL SOC, V106, P35; Bolukbas S, 2011, LUNG CANCER, V71, P75, DOI 10.1016/j.lungcan.2009.08.019; Cheng Hao, 2008, Zhonghua Yan Ke Za Zhi, V44, P705; Feng Y, 2012, INVEST OPHTH VIS SCI, V53, P6793, DOI 10.1167/iovs.12-10326; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hauck P, 2009, MOL CANCER THER, V8, P883, DOI 10.1158/1535-7163.MCT-08-1118; Jin HR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.169; Lan H, 2014, ASIAN PAC J CANCER P, V15, P7137, DOI 10.7314/APJCP.2014.15.17.7137; Li YY, 2014, PATHOG DIS, V72, P111, DOI 10.1111/2049-632X.12189; Malcles A, 2015, ACTA OPHTHALMOL, V93, pE160, DOI 10.1111/aos.12523; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; Mehmood RK, 2014, ONCOL REV, V8, P36, DOI 10.4081/oncol.2014.256; Nemati F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080836; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Safa A. R., 2012, Experimental Oncology, V34, P176; Shields CL, 2014, CURR OPIN OPHTHALMOL, V25, P177, DOI 10.1097/ICU.0000000000000041; Shields CL, 2013, AM J OPHTHALMOL, V156, P3, DOI 10.1016/j.ajo.2013.01.028; Su L, 2011, EUR J CANCER, V47, P2471, DOI 10.1016/j.ejca.2011.06.003; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; WANG B, 2016, MEDICINE, V95, P76021; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang Y, 2013, EXP EYE RES, V113, P128, DOI 10.1016/j.exer.2013.05.013; Wang YC, 2013, INT J NANOMED, V8, P3805, DOI 10.2147/IJN.S48950; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Yan H., 2016, BIOCH BIOPHYS RES CO; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764; Zhao XF, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-3; Zhou X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00201	31	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184135	10.1371/journal.pone.0184135	http://dx.doi.org/10.1371/journal.pone.0184135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	28863158	Green Published, gold, Green Submitted			2022-12-26	WOS:000408816900029
J	Chen, G; Zhang, B; Xu, H; Sun, Y; Shi, Y; Luo, Y; Jia, H; Wang, F				Chen, G.; Zhang, B.; Xu, H.; Sun, Y.; Shi, Y.; Luo, Y.; Jia, H.; Wang, F.			Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis	ONCOGENE			English	Article							STRAND BREAK REPAIR; MITOTIC CATASTROPHE; LYSINE ACETYLATION; ANTITUMOR-ACTIVITY; S-PHASE; KINASE; MK-1775; AZD1775; CYCLE; CHK1	Lung cancer treatment remains a challenge for clinical practice and new therapeutic approaches are urgently needed. Loss of functional WEE1 kinase causes DNA replication stress, DNA damage and unscheduled mitotic entry due to elevated CDK activity. The selective WEE1 inhibitor MK-1775 synergize with DNA-damaging agent to inhibit cancer cell growth. Here we report that inhibition of Sirt1 deacetylase through small interfering RNA or selective inhibitor Ex527 greatly enhances MK-1775-induced growth inhibition and apoptosis in human lung cancer cells. We further demonstrate that Sirt1 interacts and deacetylates homologous recombination (HR) repair machinery proteins, including NBS1 and Rad51. Inhibition of Sirt1 impairs HR repair activity, which causes unrepairable damage when combining MK-1775 and Ex527. Meanwhile, combination of MK-1775 and Ex527 induces cooperative antitumor activity in lung cancer xenograft model in vivo. Thus, our study provides a novel therapeutic strategy to optimize MK-1775 treatment efficiency in lung cancers.	[Chen, G.; Xu, H.; Sun, Y.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Zhang, B.] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Xian, Shaanxi, Peoples R China; [Shi, Y.; Wang, F.] Xidian Univ, Sch Life Sci & Technol, Engn Res Ctr Mol & Neuro Imaging, Minist Educ, Xian, Shaanxi, Peoples R China; [Luo, Y.] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Jia, H.] Agr Univ Hebei, Dept Bioengn, Coll Food Sci & Technol, Baoding, Peoples R China	Emory University; Xi'an Jiaotong University; Xidian University; Naval Medical University; Hebei Agricultural University	Chen, G (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.; Wang, F (corresponding author), Xidian Univ, Sch Life Sci & Technol, Engn Res Ctr Mol & Neuro Imaging, Minist Educ, Xian, Shaanxi, Peoples R China.	guo.chen84@outlook.com; fwang@xidian.edu.cn	Xu, Haidong/Q-1095-2019; Chen, Guo/HGE-9902-2022; Sun, Youwei/I-1265-2018; Wang, Fu/S-7955-2017	Chen, Guo/0000-0001-8886-1873; Wang, Fu/0000-0001-9222-0833; Zhang, Beilei/0000-0003-1384-0175	National Natural Science Foundation of China [81772010, 81571721, 81301214]; National Basic Research and Development Program of China (973 Program) [2013CB733803]; Natural Science Basis Research Plan in Shaanxi Province of China [2016JM8016, 2013JQ4040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); Natural Science Basis Research Plan in Shaanxi Province of China	This work was supported by National Natural Science Foundation of China (No. 81772010, 81571721 and 81301214), The National Basic Research and Development Program of China (973 Program; No. 2013CB733803) and Natural Science Basis Research Plan in Shaanxi Province of China (Program No. 2016JM8016 and 2013JQ4040).	Aarts M, 2015, MOL CANCER THER, V14, P865, DOI 10.1158/1535-7163.MCT-14-0845; Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Carrassa L, 2012, CELL CYCLE, V11, P2507, DOI 10.4161/cc.20899; Chaudhuri L, 2014, HAEMATOLOGICA, V99, P688, DOI 10.3324/haematol.2013.093187; Chen G, 2013, APPL MICROBIOL BIOT, V97, P4393, DOI 10.1007/s00253-012-4321-8; Chen G, 2012, INT J ONCOL, V40, P139, DOI 10.3892/ijo.2011.1210; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chu WK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6931; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Guertin AD, 2013, MOL CANCER THER, V12, P1442, DOI 10.1158/1535-7163.MCT-13-0025; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Jhuraney A, 2016, MOL CANCER THER, V15, P1669, DOI 10.1158/1535-7163.MCT-15-0182; Kreahling JM, 2012, MOL CANCER THER, V11, P174, DOI 10.1158/1535-7163.MCT-11-0529; KREAHLING JM, 2013, PLOS ONE, V8; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leijen S, 2016, J CLIN ONCOL, V34, P4371, DOI 10.1200/JCO.2016.67.5991; Magnussen GI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038254; Mak JPY, 2014, ONCOTARGET, V5, P10546, DOI 10.18632/oncotarget.2508; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Osman AA, 2015, MOL CANCER THER, V14, P608, DOI 10.1158/1535-7163.MCT-14-0735-T; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Vassilopoulos A, 2015, ONCOGENE, V34, P3023, DOI 10.1038/onc.2014.239; Wang G, 2015, CANCER LETT, V356, P656, DOI 10.1016/j.canlet.2014.10.015; Wang LK, 2012, NUCLEIC ACIDS RES, V40, pW376, DOI 10.1093/nar/gks437; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou L, 2015, LEUKEMIA, V29, P807, DOI 10.1038/leu.2014.296	40	37	39	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6863	6872		10.1038/onc.2017.297	http://dx.doi.org/10.1038/onc.2017.297			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28869605				2022-12-26	WOS:000418041800003
J	Yan, F; Shen, N; Pang, J; Zhao, N; Deng, B; Li, B; Yang, Y; Yang, P; Molina, JR; Liu, S				Yan, F.; Shen, N.; Pang, J.; Zhao, N.; Deng, B.; Li, B.; Yang, Y.; Yang, P.; Molina, J. R.; Liu, S.			A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness	ONCOGENE			English	Article							DE-NOVO METHYLATION; C-KIT; PHASE-I; CISPLATIN RESISTANCE; EXPRESSION; DNMT3A; HYPOMETHYLATION; TRANSCRIPTION; CHEMOTHERAPY; DECITABINE	Overexpression of DNMT1 and KIT is prevalent in lung cancer, yet the underlying molecular mechanisms are poorly understood. While the deregulated activation of DNMT1 or KIT has been implicated in lung cancer pathogenesis, whether and how DNMT1 and KIT orchestrate lung tumorigenesis are unclear. Here, using human lung cancer tissue microarrays and fresh frozen tissues, we found that the overexpression of DNMT1 is positively correlated with the upregulation of KIT in tumor tissues. We demonstrated that DNMT1 and KIT form a positive regulatory loop, in which ectopic DNMT1 expression increases, whereas targeted DNMT1 depletion abrogates KIT signaling cascade through Sp1/miR-29b network. Conversely, an increase of KIT levels augments, but a reduction of KIT expression ablates DNMT1 transcription by STAT3 pathway leading to in-parallel modification of the DNA methylation profiles. We provided evidence that KIT inactivation induces global DNA hypomethylation, restores the expression of tumor suppressor p15(INK4B) through promoter demethylation; in turn, DNMT1 dysfunction impairs KIT kinase signaling. Functionally, KIT and DNMT1 co-expression promotes, whereas dual inactivation of them suppresses, lung cancer cell proliferation and metastatic growth in vitro and in vivo, in a synergistic manner. These findings demonstrate the regulatory and functional interplay between DNA methylation and tyrosine kinase signaling in propelling tumorigenesis, providing a widely applicable approach for targeting lung cancer.	[Yan, F.; Shen, N.; Pang, J.; Zhao, N.; Liu, S.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Deng, B.; Yang, Y.; Yang, P.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Li, B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Molina, J. R.] Mayo Clin, Dept Med Oncol, Rochester, MN USA	University of Minnesota System; Mayo Clinic; University of Louisville; Mayo Clinic	Liu, S (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	sliu@umn.edu	Yan, Fei/G-4941-2016; , Bing/A-7536-2016	Yan, Fei/0000-0003-4750-1200; , Bing/0000-0001-5363-7070	Hormel Foundation; National Cancer Institute (Bethesda, MD, USA) [R01CA149623, R21CA155915]; NATIONAL CANCER INSTITUTE [R01CA149623, R21CA155915] Funding Source: NIH RePORTER	Hormel Foundation; National Cancer Institute (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Hormel Foundation (S. Liu) and National Cancer Institute (Bethesda, MD, USA) grants R01CA149623 (S. Liu) and R21CA155915 (S. Liu).	Abidin Aidalena Z, 2010, Ther Adv Med Oncol, V2, P25, DOI 10.1177/1758834009356014; Ansari J, 2009, ANTI-CANCER AGENT ME, V9, P569, DOI 10.2174/187152009788451879; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Bauer C, 2015, J BIOL CHEM, V290, P4801, DOI 10.1074/jbc.M114.605881; Boldrini L, 2004, CLIN CANCER RES, V10, P4101, DOI 10.1158/1078-0432.CCR-03-0664; Carlomagno F, 2005, CURR MED CHEM, V12, P1773, DOI 10.2174/0929867054367266; Crivellari G, 2007, ONCOLOGIST, V12, P79, DOI 10.1634/theoncologist.12-1-79; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Gao XN, 2015, LEUKEMIA, V29, P1730, DOI 10.1038/leu.2015.56; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gauler TC, 2013, EUR J CANCER, V49, P2461, DOI 10.1016/j.ejca.2013.03.029; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Itamochi H, 2014, INT J GYNECOL CANCER, V24, P61, DOI 10.1097/IGC.0000000000000014; Jafri Nazia F., 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P147, DOI 10.1615/JEnvPathToxOncol.v22.i3.10; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Miller AA, 2010, J THORAC ONCOL, V5, P380, DOI 10.1097/JTO.0b013e3181cee36e; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38; Rossi Antonio, 2009, Curr Drug Discov Technol, V6, P91; Schneider BJ, 2010, CLIN LUNG CANCER, V11, P223, DOI 10.3816/CLC.2010.n.028; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Tamborini E, 2004, CLIN CANCER RES, V10, P8214, DOI 10.1158/1078-0432.CCR-04-1013; TSUURA Y, 1994, VIRCHOWS ARCH, V424, P135; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yan F, 2017, LEUKEMIA, V31, P1434, DOI 10.1038/leu.2016.349; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.380; Yan F, 2015, J BIOL CHEM, V290, P18480, DOI 10.1074/jbc.M114.633693; Yu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029450; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008	42	19	19	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6919	6928		10.1038/onc.2017.305	http://dx.doi.org/10.1038/onc.2017.305			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28869603	Green Accepted			2022-12-26	WOS:000418041800008
J	Bourdin, B; Briot, J; Tetreault, MP; Sauve, R; Parent, L				Bourdin, Benoite; Briot, Julie; Tetreault, Marie-Philippe; Sauve, Remy; Parent, Lucie			Negatively charged residues in the first extracellular loop of the L-type Ca(V)1.2 channel anchor the interaction with the Ca-V alpha 2 delta 1 auxiliary subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNELS; CA2+ INFLUX; ALPHA(2)DELTA SUBUNITS; SURFACE EXPRESSION; VOLTAGE SENSORS; BETA-SUBUNITS; DOMAIN; HYPERTROPHY; ARRHYTHMIA; SITE	Voltage-gated L-type Ca(V)1.2 channels in cardiomyocytes exist as heteromeric complexes. Co-expression of Ca-V alpha 2 delta 1 with Ca-V beta/Ca-V alpha 1 proteins reconstitutes the functional properties of native L-type currents, but the interacting domains at the Ca(V)1.2/ Ca-V alpha 2 delta 1 interface are unknown. Here, a homology- based model of Ca(V)1.2 identified protein interfaces between the extracellular domain of Ca-V alpha 2 delta 1 and the extracellular loops of the Ca-V alpha 1 protein in repeats I (IS1S2 and IS5S6), II (IIS5S6), and III (IIIS5S6). Insertion of a 9-residue hemagglutinin epitope in IS1S2, but not in IS5S6 or in IIS5S6, prevented the co-immunoprecipitation of CaV1.2 with Ca-V alpha 2 delta 1. IS1S2 contains a cluster of three conserved negatively charged residues Glu-179, Asp-180, and Asp-181 that could contribute to non-bonded interactions with Ca-V alpha 2 delta 1. Substitutions of CaV1.2 Asp-181 impaired the co-immunoprecipitation of Ca-V beta/Ca(V)1.2 with Ca-V alpha 2 delta 1 and the Ca-V alpha 2 delta 1-dependent shift in voltage-dependent activation gating. In contrast, single substitutions in Ca(V)1.2 in neighboring positions in the same loop (179, 180, and 182-184) did not significantly alter the functional up-regulation of Ca(V)1.2 whole-cell currents. However, a negatively charged residue at position 180 was necessary to convey the Ca-V alpha 2 delta 1-mediated shift in the activation gating. We also found a more modest contribution from the positively charged Arg-1119 in the extracellular pore region in repeat III of Ca(V)1.2. We conclude that Ca(V)1.2 Asp-181 anchors the physical interaction that facilitates the Ca-V alpha 2 delta 1-mediated functional modulation of Ca(V)1.2 currents. By stabilizing the first extracellular loop of Ca(V)1.2, Ca-V alpha 2 delta 1 may up-regulate currents by promoting conformations of the voltage sensor that are associated with the channel's open state.	[Briot, Julie; Sauve, Remy; Parent, Lucie] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ H3C 3J7, Canada; [Bourdin, Benoite; Briot, Julie; Tetreault, Marie-Philippe; Parent, Lucie] Univ Montreal, Ctr Rech, Inst Cardiol Montreal, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca		Parent, Lucie/0000-0002-7932-4264; Briot, Julie/0000-0003-4154-6766	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation [G-15-0009329]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Operating Grant 130256 from the Canadian Institutes of Health Research and Grant-in-aid G-15-0009329 from the Canadian Heart and Stroke Foundation (to L.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Bannister JP, 2012, HYPERTENSION, V60, P1006, DOI 10.1161/HYPERTENSIONAHA.112.199661; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bourdin B, 2016, JOVE-J VIS EXP, DOI 10.3791/54732; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Briot J., 2016, BIOCH MOL BIOL J, V2, P3, DOI [10.21767/2471-8084.100025, DOI 10.21767/2471-8084.100025]; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gonzalez Carlos, 2012, Biophys Rev, V4, P1, DOI 10.1007/s12551-011-0061-8; Hille B., 1992, IONIC CHANNELS EXCIT; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lugenbiel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116395; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Pantazis A, 2014, P NATL ACAD SCI USA, V111, P18381, DOI 10.1073/pnas.1411127112; Parent L., 1997, J MEMBRANE BIOL, V160, p1E; Paxman JJ, 2017, METHODS MOL BIOL, V1549, P209, DOI 10.1007/978-1-4939-6740-7_16; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Richard S, 1998, CARDIOVASC RES, V37, P300, DOI 10.1016/S0008-6363(97)00273-3; Savalli N, 2016, J GEN PHYSIOL, V148, P147, DOI 10.1085/jgp.201611586; Segura E, 2017, J BIOL CHEM, V292, P11109, DOI 10.1074/jbc.M117.784355; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Tuluc P, 2016, STRUCTURE, V24, P261, DOI 10.1016/j.str.2015.11.011; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Voigt A., 2016, NEUROPHOTONICS, V3; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	57	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17236	17249		10.1074/jbc.M117.806893	http://dx.doi.org/10.1074/jbc.M117.806893			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28864774	Green Published, hybrid			2022-12-26	WOS:000414009300008
J	Holloway, IW; Traube, DE; Schrager, SM; Tan, D; Dunlap, S; Kipke, MD				Holloway, Ian W.; Traube, Dorian E.; Schrager, Sheree M.; Tan, Diane; Dunlap, Shannon; Kipke, Michele D.			Psychological distress, health protection, and sexual practices among young men who have sex with men: Using social action theory to guide HIV prevention efforts	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK BEHAVIOR; DRUG-USE; PRELIMINARY EFFICACY; SUBSTANCE-ABUSE; BISEXUAL MEN; MODEL; GAY; INTERVENTION; PEOPLE	The present study addresses gaps in the literature related to theory development for young men who have sex with men (YMSM) sexual practices through the application and modification of Social Action Theory. Data come from the Healthy Young Men study (N = 526), which longitudinally tracked a diverse cohort of YMSM ages 18-24 to characterize risk and protective factors associated with drug use and sexual practices. Structural equation modeling examined the applicability of, and any necessary modifications to a YMSM-focused version of Social Action Theory. The final model displayed excellent fit (CFI = 0.955, TLI = 0.947, RMSEA = 0.037) and suggested concordance between social support and personal capacity for sexual health promotion. For YMSM, practicing health promotion and avoiding practices that may put them at risk for HIV was associated with both social isolation and psychological distress (beta = -0.372, t = -4.601, p<0.001); psychological distress is an internalized response to environmental and cognitive factors and sexual practices are an externalized response. Results point to the utility of Social Action Theory as a useful model for understanding sexual practices among YMSM, the application of which shows health protective sexual practices are a function of sociocognitive factors that are influenced by environmental contexts. Social Action Theory can help prevention scientists better address the needs of this vulnerable population.	[Holloway, Ian W.; Dunlap, Shannon] Univ Calif Los Angeles, Dept Social Welf, Luskin Sch Publ Affairs, Los Angeles, CA USA; [Traube, Dorian E.] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA USA; [Schrager, Sheree M.; Kipke, Michele D.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Tan, Diane] UCLA, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of California System; University of California Los Angeles	Holloway, IW (corresponding author), Univ Calif Los Angeles, Dept Social Welf, Luskin Sch Publ Affairs, Los Angeles, CA USA.	holloway@luskin.ucla.edu	Schrager, Sheree M./AAH-1302-2019	Schrager, Sheree M./0000-0001-6352-5056; Holloway, Courtney Jean/0000-0003-3661-1957	National Institute on Drug Abuse [R03DA024976-02, R01DA015638-05]; National Institute of Mental Health [P30MH058107]; California HIV/AIDS Research Program [RP15-LA-007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California HIV/AIDS Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute on Drug Abuse under Grants R03DA024976-02 and R01DA015638-05, the National Institute of Mental Health under Grant P30MH058107, and the California HIV/AIDS Research Program under Grant RP15-LA-007.	Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bachanas PJ, 2002, J PEDIATR PSYCHOL, V27, P519, DOI 10.1093/jpepsy/27.6.519; Bandura A., 1977, SOCIAL LEARNING THEO; Bauermeister JA, 2015, AIDS BEHAV, V19, P1860, DOI 10.1007/s10461-015-1009-y; Beidas RS, 2012, AIDS PATIENT CARE ST, V26, P366, DOI 10.1089/apc.2011.0418; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; Berger I, 2016, TRANSGENDER AND INTE; Bontempo DE, 2002, J ADOLESCENT HEALTH, V30, P364, DOI 10.1016/S1054-139X(01)00415-3; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107; CDC, 2014, HIV SURV REP; Centers for Disease Control, 2005, YOUTH RISK BEHAVIOR; Centers for Disease Control, 2009, YOUTH RISK BEHAVIOR; Centers for Disease Control, 2008, HIV SURVEILLANCE REP; Centers for Disease Control, 2016, HIV AMONG GAY AND BI; Chen E, 2002, HEALTH PSYCHOL, V21, P16, DOI 10.1037//0278-6133.21.1.16; Clark Leslie F, 2005, J Adolesc Health, V37, P337, DOI 10.1016/j.jadohealth.2004.09.024; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; DiClemente R. J., 2009, EMERGING THEORIES HL, P359; Donenberg GR, 2001, J AM ACAD CHILD PSY, V40, P642, DOI 10.1097/00004583-200106000-00008; Ellickson PL, 2003, AM J PUBLIC HEALTH, V93, P1830, DOI 10.2105/AJPH.93.11.1830; Emlet CA, 2013, GERONTOLOGIST, V53, P963, DOI 10.1093/geront/gns191; Ewart CK, 2004, HA CL HE PS, V3, P249; EWART CK, 1991, AM PSYCHOL, V46, P931, DOI 10.1037/0003-066X.46.9.931; FISHBEIN DH, 1994, ADDICT BEHAV, V19, P583, DOI 10.1016/0306-4603(94)90014-0; FISHER WA, 1995, HEALTH PSYCHOL, V14, P255, DOI 10.1037/0278-6133.14.3.255; Ford WL, 2009, J GAY LESBIAN SOC SE, V21, P357, DOI 10.1080/10538720802498280; Frew PM, 2010, PREV SCI, V11, P207, DOI 10.1007/s11121-009-0162-9; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gore-Felton C, 2005, AIDS EDUC PREV, V17, P21, DOI 10.1521/aeap.17.2.21.58691; Guilamo-Ramos V, 2008, SOC WORK RES, V32, P29, DOI 10.1093/swr/32.1.29; Herek GM, 2007, J SOC ISSUES, V63, P905, DOI 10.1111/j.1540-4560.2007.00544.x; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Huebner DM, 2007, HEALTH PSYCHOL, V26, P627, DOI 10.1037/0278-6133.26.5.627; Janis I., 1982, HDB STRESS THEORETIC, P69; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnson MO, 2008, J CONSULT CLIN PSYCH, V76, P829, DOI 10.1037/0022-006X.76.5.829; Johnson MO, 2003, AIDS PATIENT CARE ST, V17, P645, DOI 10.1089/108729103771928708; Johnson WD, 2005, AIDS EDUC PREV, V17, P568, DOI 10.1521/aeap.2005.17.6.568; Joormann J, 2007, APPL PREV PSYCHOL, V12, P128, DOI 10.1016/j.appsy.2007.09.002; Kalichman SC, 1999, AIDS CARE, V11, P415, DOI 10.1080/09540129947794; Kalichman SC, 2014, EUR J PUBLIC HEALTH, V24, P833, DOI 10.1093/eurpub/ckt172; KIM N, 1997, THE JOURNAL OF ADOLE, V20, P204; Kipke MD, 2007, SUBST USE MISUSE, V42, P1723, DOI 10.1080/10826080701212261; Kline R. B., 2004, PRINCIPLES AND PRACT; Lacefield K, 2015, LGBT HEALTH, V2, P200, DOI 10.1089/lgbt.2014.0069; Laska MN, 2009, PREV SCI, V10, P376, DOI 10.1007/s11121-009-0140-2; Levin KD, 2002, PREVENTING SEXUALLY; Lightfoot M, 2005, BEHAV MODIF, V29, P227, DOI 10.1177/0145445504272599; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorimer K, 2013, AIDS CARE, V25, P133, DOI 10.1080/09540121.2012.699672; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Maisto SA, 2009, J BEHAV MED, V32, P285, DOI 10.1007/s10865-009-9201-z; MARLATT GA, 1975, J ABNORM PSYCHOL, V84, P652, DOI 10.1037/0021-843X.84.6.652; Maulsby C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-625; McConnell EA, 2015, LGBT HEALTH, V2, P55, DOI 10.1089/lgbt.2014.0051; McKay MM, 2014, J CLIN CHILD ADOLESC, V43, P428, DOI 10.1080/15374416.2014.893519; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moore AR, 2007, SOC SCI MED, V64, P1057, DOI 10.1016/j.socscimed.2006.10.004; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Mustanski B, 2007, HEALTH PSYCHOL, V26, P618, DOI 10.1037/0278-6133.26.5.618; Mustanski B, 2015, J SEX RES, V52, P220, DOI 10.1080/00224499.2013.867924; Mustanski B, 2013, AIDS BEHAV, V17, P2999, DOI 10.1007/s10461-013-0507-z; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Needham BL, 2010, J YOUTH ADOLESCENCE, V39, P1189, DOI 10.1007/s10964-010-9533-6; Noar SM, 2005, HEALTH EDUC RES, V20, P275, DOI 10.1093/her/cyg113; NOTT KH, 1995, AIDS CARE, V7, P55, DOI 10.1080/09540129550126966; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Petty R. E., 1986, COMMUN PERSUATION; Protogerou C, 2014, AIDS BEHAV, V18, P1847, DOI 10.1007/s10461-014-0807-y; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reynolds EK, 2010, PSYCHOL ADDICT BEHAV, V24, P311, DOI 10.1037/a0018929; Romer Daniel, 2003, Prev Sci, V4, P39, DOI 10.1023/A:1021734827116; Rosario M, 2006, AIDS EDUC PREV, V18, P444, DOI 10.1521/aeap.2006.18.5.444; Rosenblum A, 2009, SUBST USE MISUSE, V40, P581; Rotheram-Borus M J, 2000, Prev Sci, V1, P15, DOI 10.1023/A:1010071932238; Rounsaville BJ, 2001, CLIN PSYCHOL-SCI PR, V8, P133, DOI 10.1093/clipsy/8.2.133; Ryan C, 2010, J CHILD ADOL PS NURS, V23, P205, DOI 10.1111/j.1744-6171.2010.00246.x; Safren SA, 2010, JAIDS-J ACQ IMM DEF, V55, pS74, DOI 10.1097/QAI.0b013e3181fbc939; Safren SA, 2010, HEALTH PSYCHOL, V29, P215, DOI 10.1037/a0017859; Shepherd J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14070; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Stall R., 2008, UNEQUAL OPPORTUNITY; Sullivan KM, 2017, J ADV NURS, V73, P162, DOI 10.1111/jan.13087; Traube DE, 2012, PSYCHOL ADDICT BEHAV, V26, P78, DOI 10.1037/a0024191; Traube DE, 2011, AIDS CARE, V23, P663, DOI 10.1080/09540121.2010.532532; Weintraub A, 2017, AIDS BEHAV, V21, P129, DOI 10.1007/s10461-016-1337-6; Wong CF, 2010, J ADOLESCENCE, V33, P463, DOI 10.1016/j.adolescence.2009.06.004	91	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184482	10.1371/journal.pone.0184482	http://dx.doi.org/10.1371/journal.pone.0184482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886128	Green Submitted, Green Published, gold			2022-12-26	WOS:000410001100135
J	Ranwez, V; Serra, A; Pot, D; Chantret, N				Ranwez, Vincent; Serra, Audrey; Pot, David; Chantret, Nathalie			Domestication reduces alternative splicing expression variations in sorghum	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PURPLE ACID-PHOSPHATASES; MESSENGER-RNA DECAY; BICOLOR L. MOENCH; GENETIC DIVERSITY; REVEALS; PATTERNS; COMPLEX; EVENTS; WILD	Domestication is known to strongly reduce genomic diversity through population bottlenecks. The resulting loss of polymorphism has been thoroughly documented in numerous cultivated species. Here we investigate the impact of domestication on the diversity of alternative transcript expressions using RNAseq data obtained on cultivated and wild sorghum accessions (ten accessions for each pool). In that aim, we focus on genes expressing two isoforms in sorghum and estimate the ratio between expression levels of those isoforms in each accession. Noticeably, for a given gene, one isoform can either be overexpressed or underexpressed in some wild accessions, whereas in the cultivated accessions, the balance between the two isoforms of the same gene appears to be much more homogenous. Indeed, we observe in sorghum significantly more variation in isoform expression balance among wild accessions than among domesticated accessions. The possibility exists that the loss of nucleotide diversity due to domestication could affect regulatory elements, controlling transcription or degradation of these isoforms. Impact on the isoform expression balance is discussed. As far as we know, this is the first time that the impact of domestication on transcript isoform balance has been studied at the genomic scale. This could pave the way towards the identification of key domestication genes with finely tuned isoform expressions in domesticated accessions while being highly variable in their wild relatives.	[Ranwez, Vincent; Serra, Audrey] UMR AGAP, Montpellier SupAgro, Montpellier, France; [Pot, David] UMR AGAP, CIRAD, Montpellier, France; [Chantret, Nathalie] INRA, UMR AGAP, Montpellier, France	Institut Agro; Montpellier SupAgro; CIRAD; Universite de Montpellier; INRAE; Universite de Montpellier	Chantret, N (corresponding author), INRA, UMR AGAP, Montpellier, France.	nathalie.chantret@inra.fr	Pot, David/AAA-3983-2021; ranwez, vincent/I-5490-2017	ranwez, vincent/0000-0002-9308-7541; Chantret, Nathalie/0000-0002-2512-7644	Agropolis Fondation [ARCAD 0900-001]	Agropolis Fondation	This study was conducted in the framework of ARCAD (http://www.arcad-project.org), a project funded by Agropolis Fondation under the reference ID ARCAD 0900-001.	Bao Y, 2011, P NATL ACAD SCI USA, V108, P21152, DOI 10.1073/pnas.1115926109; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barro-Kondombo C, 2010, THEOR APPL GENET, V120, P1511, DOI 10.1007/s00122-010-1272-2; Bellucci E, 2014, PLANT CELL, V26, P1901, DOI 10.1105/tpc.114.124040; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chuang TJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0431-7; Cieply B, 2015, WIRES RNA, V6, P311, DOI 10.1002/wrna.1276; Clement Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006799; Dall'Osto L, 2015, BBA-BIOENERGETICS, V1847, P861, DOI 10.1016/j.bbabio.2015.02.009; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Feng JL, 2015, MOL PLANT, V8, P1038, DOI 10.1016/j.molp.2015.01.011; Filichkin S, 2015, CURR OPIN PLANT BIOL, V24, P125, DOI 10.1016/j.pbi.2015.02.008; Frere CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023041; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Herritt M, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0072; Huang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1582-5; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Khan MA, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.04.0018; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li DP, 2002, J BIOL CHEM, V277, P27772, DOI 10.1074/jbc.M204183200; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Muraya MM, 2011, THEOR APPL GENET, V122, P1631, DOI 10.1007/s00122-011-1560-5; Mutegi E, 2012, CONSERV GENET, V13, P1059, DOI 10.1007/s10592-012-0353-y; Mutegi E, 2010, GENET RESOUR CROP EV, V57, P243, DOI 10.1007/s10722-009-9466-7; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; Panahi B, 2015, FEBS LETT, V589, P3564, DOI 10.1016/j.febslet.2015.09.023; Panahi B, 2014, PHYSIOL MOL BIOL PLA, V20, P323, DOI 10.1007/s12298-014-0245-3; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Potenza E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1922-5; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Sagnard F, 2011, THEOR APPL GENET, V123, P1231, DOI 10.1007/s00122-011-1662-0; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Sarah G, 2016, MOL ECOLOGY RESOURCE; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Sun Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2128-6; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walters B, 2013, DNA RES, V20, P163, DOI 10.1093/dnares/dss041; Woods DP, 2014, GENETICS, V198, P397, DOI 10.1534/genetics.114.166785; Xia Yanshi, 2012, PLoS One, V7, pe37573, DOI 10.1371/journal.pone.0037573; Yang SM, 2014, INT J MOL SCI, V15, P10424, DOI 10.3390/ijms150610424; Zhang D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004061; Zhang Q, 2011, PLANT BIOLOGY, V13, P7, DOI 10.1111/j.1438-8677.2010.00346.x; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x; Zou HD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1996-0	71	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183454	10.1371/journal.pone.0183454	http://dx.doi.org/10.1371/journal.pone.0183454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886042	Green Submitted, gold, Green Published			2022-12-26	WOS:000410001100023
J	Granados, HM; Draghi, A; Tsurutani, N; Wright, K; Fernandez, ML; Sylvester, FA; Vella, AT				Granados, Hector M.; Draghi, Andrew, II; Tsurutani, Naomi; Wright, Kyle; Fernandez, Marina L.; Sylvester, Francisco A.; Vella, Anthony T.			Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes	PLOS ONE			English	Article							PATHWAY	Background Programmed death cell 1 (PD-1) is an inhibitor of T cell activation and is also functionally linked to glycolysis. We hypothesized that PD-1 expression is defective in activated T cells from children with type 1 diabetes (T1D), resulting in abnormal T cell glucose metabolism. Methods In this pilot study, we enrolled children with new onset T1D within 2 weeks of diagnosis (T1D), unaffected siblings of T1D (SIBS), unaffected, unrelated children (CTRL), children with new onset, and untreated Crohn disease (CD). We repeated the assays 4-6 months post-diagnosis in T1D (T1D follow up). We analyzed anti-CD3/-CD28-stimulated peripheral blood mononuclear cells (PBMC) subsets for PD-1 expression by flow cytometry at baseline and after 24 h in culture. We measured cytokines in the culture medium by multiplex ELISA and glycolytic capacity with a flux analyzer. Results We enrolled 37 children. T cells derived from subjects with T1D had decreased PD-1 expression compared to the other study groups. However, in T1D follow-up T cells expressed PD-1 similarly to controls, but had no differences in PBMC cytokine production. Nonetheless, T1D follow up PBMCs had enhanced glycolytic capacity compared to T1D. Conclusions Activated T cells from T1D fail to upregulate PD-1 upon T-cell receptor stimulation, which may contribute to the pathogenesis of T1D. T1D follow up PBMC expression of PD-1 normalizes, together with a significant increase in glycolysis compared to T1D. Thus, insulin therapy in T1D children is associated with normal PD1 expression and heightened glycolytic capacity in PBMC.	[Granados, Hector M.] Texas Tech Hlth Sci Ctr, Dept Pediat, El Paso, TX USA; [Draghi, Andrew, II; Tsurutani, Naomi; Wright, Kyle; Vella, Anthony T.] Univ Connecticut, Hlth Ctr, Dept Immunol, Farmington, CT 06030 USA; [Fernandez, Marina L.] Connecticut Childrens Med Ctr, Dept Pediat, Hartford, CT USA; [Sylvester, Francisco A.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	Texas Tech University System; Texas Tech University Health Science Center; University of Connecticut; Connecticut Children's Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Vella, AT (corresponding author), Univ Connecticut, Hlth Ctr, Dept Immunol, Farmington, CT 06030 USA.	vella@uchc.edu		Granados, Hector/0000-0003-3911-6732	Connecticut Children's Medical Center	Connecticut Children's Medical Center	This study was supported by Connecticut Children's Medical Center Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Ceeraz S, 2013, TRENDS IMMUNOL, V34, P556, DOI 10.1016/j.it.2013.07.003; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Gupta S, 2014, CLIN IMMUNOL, V151, P146, DOI 10.1016/j.clim.2014.02.007; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pauken KE, 2013, DIABETES, V62, P2859, DOI 10.2337/db12-1475; Rajasalu T, 2010, DIABETES, V59, P1966, DOI 10.2337/db09-1135; Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163; Tsutsumi Y, 2006, DIABETIC MED, V23, P1145, DOI 10.1111/j.1464-5491.2006.01951.x; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Zoka A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/254874	21	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0183887	10.1371/journal.pone.0183887	http://dx.doi.org/10.1371/journal.pone.0183887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877189	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200048
J	Jiang, RF; Dong, XM; Zhu, WZ; Duan, Q; Xue, YJ; Shen, YX; Zhang, GP				Jiang, Rifeng; Dong, Ximin; Zhu, Wenzhen; Duan, Qing; Xue, Yunjing; Shen, Yanxia; Zhang, Guopeng			Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; TARGETED THERAPIES; FDG UPTAKE; NODULES; CT; ADENOCARCINOMAS; FEATURES; LEVEL; CEA	Objective Histological type is important for determining the management of patients with suspicious lung cancers. In this study, PET/CT combined with serum tumor markers were used to evaluate the histological type of lung lesions. Materials and methods Patients with suspicious lung cancers underwent F-18-FDG PET/CT and serum tumor markers detection. SUVmax of the tumor and serum levels of tumor markers were acquired. Differences in SUVmax and serum levels of tumor markers among different histological types of lung cancers and between EGFR mutation statues of adenocarcinoma were compared. The diagnostic efficiencies of SUVmax alone, each serum tumor marker alone, combined tumor markers and the combination of both methods were further assessed and compared. Results SCC had the highest level of SUVmax, followed by SCLC and adenocarcinoma, and benign lesions had a lowest level. CYFRA21-1 and SCC-Ag were significantly higher in SCC, NSE was significantly higher in SCLC (P<0.001), and CEA was higher in adenocarcinoma (P = 0.343). The diagnostic efficiencies in evaluating histological types of suspicious lung cancers were insufficient when using each serum tumor marker or SUVmax alone. When combined, the AUC, sensitivity and specificity increased significantly (P<0.05 for all). Additionally, to adenocarcinoma, no significant difference was found between EGFR mutation statuses in SUVmax or serum tumor markers (P>0.05 for all). Conclusions SUVmax and serum tumor markers show values in evaluating the histological types of suspicious lung cancers. When properly combined, the diagnostic efficiency can increase significantly.	[Jiang, Rifeng; Zhu, Wenzhen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Radiol, Wuhan, Hubei, Peoples R China; [Jiang, Rifeng; Duan, Qing; Xue, Yunjing] Fujian Med Univ, Union Hosp, Dept Radiol, Fuzhou, Fujian, Peoples R China; [Dong, Ximin] Fujian Med Univ, Union Hosp, Cent Sterile Supply Dept, Fuzhou, Fujian, Peoples R China; [Shen, Yanxia; Zhang, Guopeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nucl Med, Wuhan, Hubei, Peoples R China; [Jiang, Rifeng] Fujian Med Univ, Union Hosp, Dept Radiol, Fuzhou, Fujian, Peoples R China	Huazhong University of Science & Technology; Fujian Medical University; Fujian Medical University; Huazhong University of Science & Technology; Fujian Medical University	Shen, YX; Zhang, GP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nucl Med, Wuhan, Hubei, Peoples R China.	yanxiash@126.com; zhgp81@163.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China.	Aquino SL, 2007, INT J MOL MED, V19, P495; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Cortinovis D, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.648; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; Deppen SA, 2014, JAMA-J AM MED ASSOC, V312, P1227, DOI 10.1001/jama.2014.11488; Ferrell B, 2011, SURG CLIN N AM, V91, P403, DOI 10.1016/j.suc.2010.12.003; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Higashi K, 2002, J NUCL MED, V43, P39; Huang CT, 2010, MED ONCOL, V27, P9, DOI 10.1007/s12032-008-9160-1; Johnson BE, 2005, CANCER RES, V65, P7525, DOI 10.1158/0008-5472.CAN-05-1257; Kamiya A, 2014, JPN J RADIOL, V32, P14, DOI 10.1007/s11604-013-0264-y; Kido S, 2002, J COMPUT ASSIST TOMO, V26, P573, DOI 10.1097/01.RCT.0000029045.35986.9F; Kim DH, 2015, CLIN NUCL MED, V40, P708, DOI 10.1097/RLU.0000000000000867; Ko KH, 2014, EUR J NUCL MED MOL I, V41, P1889, DOI 10.1007/s00259-014-2802-y; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Liu LP, 2015, CLIN RESP J; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mak RH, 2011, ONCOLOGIST, V16, P319, DOI 10.1634/theoncologist.2010-0300; Molina R, 2009, TUMOR BIOL, V30, P121, DOI 10.1159/000224628; Molina R, 2008, TUMOR BIOL, V29, P371, DOI 10.1159/000181180; Na II, 2010, LUNG CANCER, V67, P76, DOI 10.1016/j.lungcan.2009.03.010; Nurwidya Fariz, 2016, J Nat Sci Biol Med, V7, P119, DOI 10.4103/0976-9668.184695; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shi PY, 2015, ONCOL LETT, V10, P3123, DOI 10.3892/ol.2015.3673; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shoji F, 2007, CANCER-AM CANCER SOC, V110, P2793, DOI 10.1002/cncr.23101; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Suzawa N, 2011, LUNG CANCER, V72, P191, DOI 10.1016/j.lungcan.2010.08.017; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860	30	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184338	10.1371/journal.pone.0184338	http://dx.doi.org/10.1371/journal.pone.0184338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877268	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200090
J	Redfern, WS; Tse, K; Grant, C; Keerie, A; Simpson, DJ; Pedersen, JC; Rimmer, V; Leslie, L; Klein, SK; Karp, NA; Sillito, R; Chartsias, A; Lukins, T; Heward, J; Vickers, C; Chapman, K; Armstrong, JD				Redfern, William S.; Tse, Karen; Grant, Claire; Keerie, Amy; Simpson, David J.; Pedersen, John C.; Rimmer, Victoria; Leslie, Lauren; Klein, Stephanie K.; Karp, Natasha A.; Sillito, Rowland; Chartsias, Agis; Lukins, Tim; Heward, James; Vickers, Catherine; Chapman, Kathryn; Armstrong, J. Douglas			Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project	PLOS ONE			English	Article							PHARMACOLOGY END-POINTS; SAFETY PHARMACOLOGY; LOCOMOTOR BEHAVIOR; VIDEO TRACKING; SYSTEM; HYPOTHERMIA; TOXICITY; STIMULATION; VALIDATION; ANIMALS	Measuring the activity and temperature of rats is commonly required in biomedical research. Conventional approaches necessitate single housing, which affects their behavior and wellbeing. We have used a subcutaneous radiofrequency identification (RFID) transponder to measure ambulatory activity and temperature of individual rats when group-housed in conventional, rack-mounted home cages. The transponder location and temperature is detected by a matrix of antennae in a baseplate under the cage. An infrared high-definition camera acquires side-view video of the cage and also enables automated detection of vertical activity. Validation studies showed that baseplate-derived ambulatory activity correlated well with manual tracking and with side-view whole-cage video pixel movement. This technology enables individual behavioral and temperature data to be acquired continuously from group-housed rats in their familiar, home cage environment. We demonstrate its ability to reliably detect naturally occurring behavioral effects, extending beyond the capabilities of routine observational tests and conventional monitoring equipment. It has numerous potential applications including safety pharmacology, toxicology, circadian biology, disease models and drug discovery.	[Redfern, William S.; Tse, Karen; Keerie, Amy; Pedersen, John C.; Klein, Stephanie K.] AstraZeneca R&D, Drug Safety & Metab, Babraham Res Campus, Cambridge, England; [Grant, Claire; Simpson, David J.; Rimmer, Victoria; Leslie, Lauren] AstraZeneca R&D, Drug Safety & Metab, Alderley Pk, Macclesfield, Cheshire, England; [Karp, Natasha A.] AstraZeneca, IMED, Quantitat Biol, Darwin Bldg Unit 310,Cambridge Sci Pk, Cambridge, England; [Sillito, Rowland; Chartsias, Agis; Lukins, Tim; Heward, James; Armstrong, J. Douglas] Actual Analyt Ltd, Edinburgh, Midlothian, Scotland; [Vickers, Catherine; Chapman, Kathryn] NC3Rs, London, England; [Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, Appleton Tower, Edinburgh, Midlothian, Scotland; [Keerie, Amy] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England; [Rimmer, Victoria] Univ Manchester, Fac Biol Med & Hlth, Med Device Biol Grp, Manchester, Lancs, England; [Chapman, Kathryn] Univ Cambridge, Milner Therapeut Inst, Cambridge, England	AstraZeneca; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; AstraZeneca; AstraZeneca; University of Edinburgh; University of Sheffield; University of Manchester; University of Cambridge	Redfern, WS (corresponding author), AstraZeneca R&D, Drug Safety & Metab, Babraham Res Campus, Cambridge, England.	will.redfern@astrazeneca.com	PAN, ZEQIANG/X-6341-2018	Karp, Natasha/0000-0002-8404-2907; Keerie, Amy/0000-0001-9389-3802; Armstrong, Douglas/0000-0002-5397-3864; Rimmer, Victoria/0000-0002-8773-8870	National Centre for the 3Rs (NC3Rs), London, UK, CRACK IT scheme [15413-106223]; NC3Rs CRACK IT Scheme; National Centre for the Replacement [NC/C011201/1] Funding Source: researchfish	National Centre for the 3Rs (NC3Rs), London, UK, CRACK IT scheme(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); NC3Rs CRACK IT Scheme(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This work was supported by National Centre for the 3Rs (NC3Rs), London, UK, CRACK IT scheme (2011; 'Rodent Big Brother'), Award number: 15413-106223, https://www.nc3rs.org.uk, CV and KC from NC3Rs are co-authors. The funders had no role in study design, data collection and analysis, or decision to publish. The NC3Rs authors (CV and KC) did contribute to the preparation of the manuscript particularly in reflecting the 3Rs/animal welfare impact of this technology. The specific roles of these authors are articulated in the author contributions' section.; This work was funded in part by the NC3Rs CRACK IT Scheme. Emma O'Callaghan, Ben Allison and David Craig of Actual Analytics contributed to the successful development of this technology. We would like to thank Heiden Bliss and Anthony Carson of BioMark for their assistance in developing the system described here. We thank Chris Pollard and Mark Pilling for helpful comments on the manuscript. We would also like to acknowledge the contribution of various colleagues in Laboratory Animal Sciences (LAS) at AstraZeneca. This publication is dedicated to the memory of Liz Beard (LAS, AstraZeneca), who played a small but crucial role during the early phase of this project.	Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Anderson KB, 2016, THER HYPOTHERMIA TEM, V6, P169, DOI 10.1089/ther.2016.0003; [Anonymous], 2001, GUIDANCE IND ICH S7A; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Balcombe JP, 2006, LAB ANIM-UK, V40, P217, DOI 10.1258/002367706777611488; Baldrick P, 2008, REGUL TOXICOL PHARM, V51, P237, DOI 10.1016/j.yrtph.2008.04.006; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brunner D, 2002, DRUG DISCOV TODAY, V7, pS107, DOI 10.1016/S1359-6446(02)02423-6; BUCHANAN TA, 1991, METABOLISM, V40, P330, DOI 10.1016/0026-0495(91)90118-G; Castagne V, 2012, PHARMACOL BIOCHEM BE, V101, P553, DOI 10.1016/j.pbb.2012.03.001; Celikyurt IK, 2011, PROG NEURO-PSYCHOPH, V35, P528, DOI 10.1016/j.pnpbp.2010.12.009; Clemens LE, 2014, GENES BRAIN BEHAV, V13, P305, DOI 10.1111/gbb.12093; CREESE I, 1973, BRAIN RES, V55, P369, DOI 10.1016/0006-8993(73)90302-8; CROFTON KM, 1991, NEUROTOXICOL TERATOL, V13, P599, DOI 10.1016/0892-0362(91)90043-V; Dunne F, 2007, PROG NEURO-PSYCHOPH, V31, P1456, DOI 10.1016/j.pnpbp.2007.06.023; EMA, 2014, GUID REG ACC 3R REPL; EVANS HL, 1989, J AM COLL TOXICOL, V8, P35, DOI 10.3109/10915818909009092; Ewart L, 2013, J PHARMACOL TOX MET, V68, P30, DOI 10.1016/j.vascn.2013.04.008; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gordon CJ, 2008, TOXICOLOGY, V244, P87, DOI 10.1016/j.tox.2007.10.030; Gordon Christopher J, 2010, Front Biosci (Elite Ed), V2, P293, DOI 10.2741/e91; GORDON CJ, 1991, NEUROSCI BIOBEHAV R, V15, P95, DOI 10.1016/S0149-7634(05)80098-3; Himmel Herbert M., 2008, Journal of Pharmacological and Toxicological Methods, V58, P129, DOI 10.1016/j.vascn.2008.06.001; Hong WZ, 2015, P NATL ACAD SCI USA, V112, pE5351, DOI 10.1073/pnas.1515982112; Howerton CL, 2012, J NEUROSCI METH, V209, P74, DOI 10.1016/j.jneumeth.2012.06.001; Kelley A.E., 1993, METHODS BEHAV PHARM, P499, DOI DOI 10.1016/0165-6147(94)90151-1; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Legos JJ, 2002, J NEUROSCI METH, V113, P159, DOI 10.1016/S0165-0270(01)00488-5; LIVESEY PJ, 1981, BEHAV RES METH INSTR, V13, P331, DOI 10.3758/BF03202023; Luft J, 2002, FUND CLIN PHARMACOL, V16, P91, DOI 10.1046/j.1472-8206.2002.00084.x; Lynch JJ, 2011, J PHARMACOL TOX MET, V64, P74, DOI 10.1016/j.vascn.2011.03.003; Mattsson JL, 1996, J AM COLL TOXICOL, V15, P239, DOI 10.3109/10915819609008716; McDermott C, 2008, PROG NEURO-PSYCHOPH, V32, P1816, DOI 10.1016/j.pnpbp.2008.08.004; MCGOWAN MK, 1992, BEHAV NEUROSCI, V106, P380, DOI 10.1037/0735-7044.106.2.380; Moscardo Elena, 2007, Journal of Pharmacological and Toxicological Methods, V56, P239, DOI 10.1016/j.vascn.2007.03.007; Moser VC, 1989, INT J TOXICOL, V8, P85, DOI DOI 10.3109/10915818909009095; Moser VC, 2011, TOXICOL PATHOL, V39, P36, DOI 10.1177/0192623310385255; Onishchenko N, 2011, NEUROTOX RES, V19, P452, DOI 10.1007/s12640-010-9200-4; Ouhaz Z, 2015, BEHAV BRAIN RES, V292, P219, DOI 10.1016/j.bbr.2015.06.017; Patterson John P., 2005, Journal of Pharmacological and Toxicological Methods, V52, P159, DOI 10.1016/j.vascn.2005.05.003; Patterson-Kane EG, 2002, ANIM WELFARE, V11, P327; POOLE S, 1977, PHYSIOL BEHAV, V18, P203, DOI 10.1016/0031-9384(77)90122-6; Prior H, 2012, J PHARMACOL TOX MET, V66, P192, DOI 10.1016/j.vascn.2012.08.119; Quinn LP, 2003, J NEUROSCI METH, V130, P83, DOI 10.1016/S0165-0270(03)00227-9; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Redfern W. S., 2011, J PHARMACOL TOX MET, V64, P102, DOI DOI 10.HTTPS://D0I.0RG/10.1016/J.VASCN.2011.05.003; Redfern WS, 2015, HANDB EXP PHARMACOL, V229, P353, DOI 10.1007/978-3-662-46943-9_14; Redfern WS, 2013, TOXICOL RES-UK, V2, P209, DOI 10.1039/c3tx20093k; Redfern William S., 2005, Journal of Pharmacological and Toxicological Methods, V52, P77, DOI 10.1016/j.vascn.2005.04.005; Redfern WS, 2006, TOXICOLOGICAL TESTIN, P33; Russel WBR, 1992, PRINCIPLES HUMANE EX; Rusyniak DE, 2005, MED CLIN N AM, V89, P1277, DOI 10.1016/j.mcna.2005.06.002; SANBERG PR, 1985, NEUROBEH TOXICOL TER, V7, P87; Shemesh Y, 2013, ELIFE, V2, DOI [10.7554/eLife.00759, 10.7554/eLife.03602]; Silver R, 2014, EUR J NEUROSCI, V39, P1866, DOI 10.1111/ejn.12593; Spruijt Berry M, 2006, Drug Discov Today Technol, V3, P231, DOI 10.1016/j.ddtec.2006.06.010; Steiner AA, 2002, ANNU REV PHYSIOL, V64, P263, DOI 10.1146/annurev.physiol.64.081501.155856; Terron MP, 2013, PHYSIOL BEHAV, V118, P8, DOI 10.1016/j.physbeh.2013.04.006; TRICKLEBANK MD, 1985, TRENDS PHARMACOL SCI, V6, P403, DOI 10.1016/0165-6147(85)90191-9; Urbach YK, 2014, J NEUROSCI METH, V234, P38, DOI 10.1016/j.jneumeth.2014.06.017; USHIJIMA I, 1984, PHARMACOL BIOCHEM BE, V21, P297; Van de Weerd HA, 2001, BEHAV PROCESS, V53, P11, DOI 10.1016/S0376-6357(00)00135-2; VORHEES CV, 1992, NEUROTOXICOL TERATOL, V14, P43, DOI 10.1016/0892-0362(92)90027-8; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908; Zbinden G., 1984, P 9 INT C PHARM NEW, V1, P43	67	34	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0181068	10.1371/journal.pone.0181068	http://dx.doi.org/10.1371/journal.pone.0181068			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877172	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200006
J	Chen, DD; Zhang, Y; Gao, LP; Geng, NN; Li, XF				Chen, Dandan; Zhang, Yong; Gao, Liangpeng; Geng, Nana; Li, Xuefeng			The impact of rainfall on the temporal and spatial distribution of taxi passengers	PLOS ONE			English	Article							WEATHER; TIME; CABDRIVERS; PATTERNS; BEHAVIOR; DRIVERS; TRACES	This paper focuses on the impact of rainfall on the temporal and spatial distribution of taxi passengers. The main objective is to provide guidance for taxi scheduling on rainy days. To this end, we take the occupied and empty states of taxis as units of analysis. By matching a taxi's GPS data to its taximeter data, we can obtain the taxi's operational time and the taxi driver's income from every unit of analysis. The ratio of taxi operation time to taxi drivers' income is used to measure the quality of taxi passengers. The research results show that the spatio-temporal evolution of urban taxi service demand differs based on rainfall conditions and hours of operation. During non-rush hours, taxi demand in peripheral areas is significantly reduced under increasing precipitation conditions, whereas during rush hours, the demand for highly profitable taxi services steadily increases. Thus, as an intelligent response for taxi operations and dispatching, taxi services should guide cruising taxis to high-demand regions to increase their service time and ride opportunities.	[Chen, Dandan; Zhang, Yong; Gao, Liangpeng; Geng, Nana; Li, Xuefeng] Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Chen, DD (corresponding author), Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China.	seuchendandan@163.com	高, 良鹏/HCI-2098-2022; Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034	National Natural Science Foundation of China [71372198]; Jiangsu Science and Technology Department [BY2015070-25]; Key Technology of Charging Station Network Construction and Operation in Nanjing [Ks1513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science and Technology Department; Key Technology of Charging Station Network Construction and Operation in Nanjing	This study was funded by the National Natural Science Foundation of China (No. 71372198), the Jiangsu Science and Technology Department (BY2015070-25), and the Key Technology of Charging Station Network Construction and Operation in Nanjing (Ks1513) to YZ. The funders had no role instudy design, data collection and analysis,decision to publish, or preparation of the manuscript.	Arana P, 2014, TRANSPORT RES A-POL, V59, P1, DOI 10.1016/j.tra.2013.10.019; Bijleveld F., 2009, INFLUENCE WEATHER CO; Bocker L, 2013, TRANSPORT REV, V33, P71, DOI 10.1080/01441647.2012.747114; Cai H, 2016, PHYSICA A, V457, P590, DOI 10.1016/j.physa.2016.03.047; Camerer C, 1997, Q J ECON, V112, P407, DOI 10.1162/003355397555244; Cohen J.E., 2009, 88 ANN M TRANSP RES; Cools M, 2013, J TRANSP GEOGR, V28, P167, DOI 10.1016/j.jtrangeo.2012.11.002; Cools M, 2010, TRANSPORT RES REC, P22, DOI 10.3141/2157-03; Edwards J. B., 1999, TRANSPORT RES F-TRAF, V2, P1, DOI [10.1016/S1369-8478(99)00003-0, DOI 10.1016/S1369-8478(99)00003-0]; Farber HS, 2015, Q J ECON, V130, P1975, DOI 10.1093/qje/qjv026; Han-wen Chang, 2010, International Journal of Business Intelligence and Data Mining, V5, P3, DOI 10.1504/IJBIDM.2010.030296; He ZB, 2017, COMPUT-AIDED CIV INF, V32, P252, DOI 10.1111/mice.12251; Koetse MJ, 2009, TRANSPORT RES D-TR E, V14, P205, DOI 10.1016/j.trd.2008.12.004; Kong XJ, 2017, IEEE T IND INFORM, V13, P1202, DOI 10.1109/TII.2017.2684163; Lawrence DG, 1996, AIRCRAFT LANDING USI; Lee J, 2008, NCM 2008 : 4TH INTERNATIONAL CONFERENCE ON NETWORKED COMPUTING AND ADVANCED INFORMATION MANAGEMENT, VOL 1, PROCEEDINGS, P199, DOI 10.1109/NCM.2008.24; Li B, 2011, IEEE INT C PERV COMP; Li XL, 2012, FRONT COMPUT SCI-CHI, V6, P111, DOI 10.1007/s11704-011-1192-6; Liu LA, 2010, COMPUT ENVIRON URBAN, V34, P541, DOI 10.1016/j.compenvurbsys.2010.07.004; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040818; Powell Jason W., 2011, Advances in Spatial and Temporal Databases. Proceedings 12th International Symposium (SSTD 2011), P242, DOI 10.1007/978-3-642-22922-0_15; Qin GY, 2017, TRANSPORT RES C-EMER, V79, P103, DOI 10.1016/j.trc.2017.03.013; Singhal A, 2014, TRANSPORT RES A-POL, V69, P379, DOI 10.1016/j.tra.2014.09.008; [孙飞 Sun Fei], 2015, [地球信息科学学报, Journal of Geo-Information Science], V17, P329; Takayama T., 2011, INT J SYST APPL ENG, V5, P224; Theofilatos A, 2014, ACCIDENT ANAL PREV, V72, P244, DOI 10.1016/j.aap.2014.06.017; Veloso M., 2011, P 2011 INT WORKSH TR, P23, DOI [10.1145/2030080.2030086, DOI 10.1145/2030080.2030086]; Wang X, 2016, J WUHAN UNIV TECHNOL, V40, P531; Xiaowei Hu, 2014, Mathematical Problems in Engineering, DOI 10.1155/2014/708482; Yamamoto Kosuke, 2010, International Journal of Knowledge Engineering and Soft Data Paradigms, V2, P57, DOI 10.1504/IJKESDP.2010.030466; Yuan J, 2011, UBICOMP 2011 UB COMP; Zhang DQ, 2015, IEEE T INTELL TRANSP, V16, P123, DOI 10.1109/TITS.2014.2328231; Zhang DQ, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P99; Zhang JQ, 2015, J VISUAL LANG COMPUT, V31, P1, DOI 10.1016/j.jvlc.2015.09.002; Zong F, 2015, J CENT SOUTH UNIV, V22, P3677, DOI 10.1007/s11771-015-2909-8	35	8	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183574	10.1371/journal.pone.0183574	http://dx.doi.org/10.1371/journal.pone.0183574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF8QL	28873430	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800018
J	Musacchia, F; Vasilev, F; Borra, M; Biffali, E; Sanges, R; Santella, L; Chun, JT				Musacchia, Francesco; Vasilev, Filip; Borra, Marco; Biffali, Elio; Sanges, Remo; Santella, Luigia; Chun, Jong Tai			De novo assembly of a transcriptome from the eggs and early embryos of Astropecten aranciacus	PLOS ONE			English	Article							SEA-URCHIN EGGS; STARFISH OOCYTE MATURATION; MOS PROTOONCOGENE PRODUCT; CYCLIC ADP-RIBOSE; PROTEIN-SYNTHESIS; MESSENGER-RNA; MEIOTIC MATURATION; ACTIN CYTOSKELETON; CALCIUM DYNAMICS; CA2+ RESPONSE	Starfish have been instrumental in many fields of biological and ecological research. Oocytes of Astropecten aranciacus, a common species native to the Mediterranean Sea and the East Atlantic, have long been used as an experimental model to study meiotic maturation, fertilization, intracellular Ca2+ signaling, and cell cycle controls. However, investigation of the underlying molecular mechanisms has often been hampered by the overall lack of DNA or protein sequences for the species. In this study, we have assembled a transcriptome for this species from the oocytes, eggs, zygotes, and early embryos, which are known to have the highest RNA sequence complexity. Annotation of the transcriptome identified over 32,000 transcripts including the ones that encode 13 distinct cyclins and as many cyclin-dependent kinases (CDK), as well as the expected components of intracellular Ca2+ signaling toolkit. Although the mRNAs of cyclin and CDK families did not undergo significant abundance changes through the stages from oocyte to early embryo, as judged by real-time PCR, the transcript encoding Mos, a negative regulator of mitotic cell cycle, was drastically reduced during the period of rapid cleavages. Molecular phylogenetic analysis using the homologous amino acid sequences of cytochrome oxidase subunit I from A. aranciacus and 30 other starfish species indicated that Paxillosida, to which A. aranciacus belongs, is not likely to be the most basal order in Asteroidea. Taken together, the first transcriptome we assembled in this species is expected to enable us to perform comparative studies and to design gene-specific molecular tools with which to tackle long-standing biological questions.	[Musacchia, Francesco; Vasilev, Filip; Sanges, Remo; Santella, Luigia; Chun, Jong Tai] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Borra, Marco; Biffali, Elio] Stn Zool Anton Dohrn, Mol Biol & Bioinformat Unit, Naples, Italy; [Musacchia, Francesco] Telethon Inst Genet & Med, Computat Biol Bioinformat Core, Pozzuoli, NA, Italy	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Chun, JT (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.	chun@szn.it	Sanges, Remo/M-9814-2019; Santella, Luigia/AAM-3524-2020; Chun, Jong Tai/AAM-3394-2020; Musacchia, Francesco/AAK-5825-2020	Sanges, Remo/0000-0002-5047-9713; Santella, Luigia/0000-0001-7159-0499; Chun, Jong Tai/0000-0002-6070-4953; Musacchia, Francesco/0000-0001-9440-1080	MIUR (Ministero dell' Istruzione dell'Universita' e della Ricerca)	MIUR (Ministero dell' Istruzione dell'Universita' e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was funded by MIUR (Ministero dell' Istruzione dell'Universita' e della Ricerca) Progetto premiale 2011 - StarTrEgg, http://ww2.gazzettaamministrativa.it/opencms/export/sites/default/_gazzetta_amministrativa/amministrazione_trasparente/_campania/_stazione_zoologica_anton_dohrn_di_napoli/010_dis_gen/020_att_gen/2015/Documenti_1441708217470/1441713592626_szn_pta__2014-2016.pdf.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLAKE DB, 1987, J NAT HIST, V21, P481, DOI 10.1080/00222938700771141; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brandhorst B P, 1985, Dev Biol (N Y 1985), V1, P525; BRANDHORST BP, 1980, DEV BIOL, V79, P139, DOI 10.1016/0012-1606(80)90079-2; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Chia F.S., 1993, Oceanography and Marine Biology an Annual Review, V31, P223; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Chun J.T., 2013, ENCY BIOL CHEM, V2, P640; Chun JT, 2014, BIOCHEM BIOPH RES CO, V450, P1166, DOI 10.1016/j.bbrc.2014.06.057; Chun JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014100; Chun JT, 2009, BIOCHEM BIOPH RES CO, V384, P141, DOI 10.1016/j.bbrc.2009.04.087; CHUN JT, 1995, NEUROCHEM RES, V20, P923, DOI 10.1007/BF00970738; DALE B, 1979, NATURE, V282, P89, DOI 10.1038/282089a0; DANILCHIK MV, 1986, BIOCHEMISTRY-US, V25, P3696, DOI 10.1021/bi00360a033; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; EPEL D, 1967, P NATL ACAD SCI USA, V57, P899, DOI 10.1073/pnas.57.4.899; Foltz DW, 2007, MOL PHYLOGENET EVOL, V43, P627, DOI 10.1016/j.ympev.2006.10.012; FREI RE, 1989, J REPROD FERTIL, V86, P637, DOI 10.1530/jrf.0.0860637; GALAS S, 1993, MOL BIOL CELL, V4, P1295, DOI 10.1091/mbc.4.12.1295; GALE AS, 1987, ZOOL J LINN SOC-LOND, V89, P107, DOI 10.1111/j.1096-3642.1987.tb00652.x; Galecki A, 2013, SPRINGER TEXTS STAT, P3; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; Georgiou I, 2009, HUM MOL GENET, V18, P1221, DOI 10.1093/hmg/ddp022; GOUSTIN AS, 1981, DEV BIOL, V82, P32, DOI 10.1016/0012-1606(81)90426-7; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROSS KW, 1973, P NATL ACAD SCI USA, V70, P2614, DOI 10.1073/pnas.70.9.2614; Hart MW, 1997, EVOLUTION, V51, P1848, DOI 10.1111/j.1558-5646.1997.tb05108.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hennebert E, 2015, J PROTEOMICS, V128, P83, DOI 10.1016/j.jprot.2015.07.002; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; HOUK MS, 1974, DEV BIOL, V40, P298, DOI 10.1016/0012-1606(74)90132-8; Jaffe LA, 2001, SEMIN CELL DEV BIOL, V12, P45, DOI 10.1006/scdb.2000.0216; Jaffe LF, 2002, CELL CALCIUM, V32, P217, DOI 10.1016/S0143416002001574; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Krauchunas AR, 2013, CURR TOP DEV BIOL, V102, P267, DOI 10.1016/B978-0-12-416024-8.00010-6; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LAFAY B, 1995, SYST BIOL, V44, P190, DOI 10.2307/2413706; LAWRENCE JM, 1992, ECHINODERM RESEARCH 1991, P39; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; LEVNER MH, 1974, EXP CELL RES, V85, P296, DOI 10.1016/0014-4827(74)90130-X; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2002, FASEB J, V16, P1050, DOI 10.1096/fj.02-0021com; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Limatola N, 2015, CELL CALCIUM, V58, P500, DOI 10.1016/j.ceca.2015.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035644; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MARTINDALE MQ, 1984, DEV BIOL, V101, P512, DOI 10.1016/0012-1606(84)90164-7; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; MEIJER L, 1986, EXP CELL RES, V163, P489, DOI 10.1016/0014-4827(86)90079-0; MEIJER L, 1984, INT REV CYTOL, V86, P129, DOI 10.1016/S0074-7696(08)60179-5; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; MIYAZAKI SI, 1975, J PHYSIOL-LONDON, V246, P37, DOI 10.1113/jphysiol.1975.sp010879; Moore JC, 2002, MOL CELL BIOL, V22, P4863, DOI 10.1128/MCB.22.13.4863-4875.2002; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; MOREAU M, 1978, NATURE, V272, P251, DOI 10.1038/272251a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morgat A, 2012, NUCLEIC ACIDS RES, V40, pD761, DOI 10.1093/nar/gkr1023; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Musacchia F, 2015, BIOINFORMATICS, V31, P2199, DOI 10.1093/bioinformatics/btv106; NAKANO E, 1958, EXP CELL RES, V14, P236, DOI 10.1016/0014-4827(58)90182-4; Nusco GA, 2002, BIOCHEM BIOPH RES CO, V290, P1015, DOI 10.1006/bbrc.2001.6286; Ochi H, 2016, RNA, V22, P822, DOI 10.1261/rna.054882.115; Okano-Uchida T, 1998, DEV BIOL, V197, P39, DOI 10.1006/dbio.1998.8881; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARIS J, 1990, MOL CELL BIOL, V10, P5634, DOI 10.1128/MCB.10.11.5634; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; POCCIA D, 1985, BIOCHIM BIOPHYS ACTA, V824, P349, DOI 10.1016/0167-4781(85)90042-9; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson O, 2016, MOL BIOL EVOL, V33, P2163, DOI 10.1093/molbev/msw080; ROSENTHAL ET, 1982, DEV BIOL, V91, P215, DOI 10.1016/0012-1606(82)90026-4; ROSENTHAL ET, 1980, CELL, V20, P487, DOI 10.1016/0092-8674(80)90635-2; Ross DJ, 2004, MAR BIOL, V144, P747, DOI 10.1007/s00227-003-1223-4; Roux MM, 2006, DEV BIOL, V300, P416, DOI 10.1016/j.ydbio.2006.09.006; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; SANTELLA L, 1994, BIOCHEM BIOPH RES CO, V203, P674, DOI 10.1006/bbrc.1994.2235; Santella L, 2002, CYCLIC ADP RIBOSE NA, P381; Santella L, 2013, ENCY BIOL CHEM, V1, P331; Santella L, 2014, SEXUAL REPROD ANIMAL, P141; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; Santella L, 2015, BIOCHEM BIOPH RES CO, V460, P104, DOI 10.1016/j.bbrc.2015.03.028; Santella L, 2012, BIOCHEM BIOPH RES CO, V425, P588, DOI 10.1016/j.bbrc.2012.07.159; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHROEDER TE, 1981, J CELL BIOL, V90, P362, DOI 10.1083/jcb.90.2.362; Shiwa M, 2002, AM J PHYSIOL-REG I, V282, pR727, DOI 10.1152/ajpregu.00519.2001; SMITH A B, 1990, Memoirs of the Queensland Museum, V28, P715; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; STRICKER SA, 1994, DEV BIOL, V166, P34, DOI 10.1006/dbio.1994.1295; STRICKER SA, 1995, DEV BIOL, V170, P496, DOI 10.1006/dbio.1995.1232; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swann K, 2016, PHYSIOL REV, V96, P127, DOI 10.1152/physrev.00012.2015; TRIMMER JS, 1986, ANNU REV CELL BIOL, V2, P1; TYLER A, 1956, BIOL BULL-US, V111, P153, DOI 10.2307/1539191; Wada H, 1996, MOL PHYLOGENET EVOL, V6, P97, DOI 10.1006/mpev.1996.0062; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATANABE N, 1989, NATURE, V342, P505, DOI 10.1038/342505a0; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Wessel GM, 2001, INT REV CYTOL, V209, P117; WILT FH, 1973, P NATL ACAD SCI USA, V70, P2345, DOI 10.1073/pnas.70.8.2345; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	121	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184090	10.1371/journal.pone.0184090	http://dx.doi.org/10.1371/journal.pone.0184090			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873438	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800050
J	Orini, M; Tinker, A; Munroe, PB; Lambiase, PD				Orini, Michele; Tinker, Andrew; Munroe, Patricia B.; Lambiase, Pier D.			Long-term intra-individual reproducibility of heart rate dynamics during exercise and recovery in the UK Biobank cohort	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; TREADMILL EXERCISE; CARDIAC DEATH; CARDIOVASCULAR MORTALITY; PREDICTORS; RISK; REHABILITATION; HERITABILITY; ASSOCIATION; PARAMETERS	Background The heart rate (HR) response to exercise provides useful information about the autonomic function and has prognostic value, but its reproducibility over a long period of time, a critical requirement for using it as a clinical biomarker, is undetermined. Aim To determine the intra-individual reproducibility of HR dynamics during sub-maximum exercise and one minute recovery. Methods 1187 individuals from the Cardio physical fitness assessment test of the UK Biobank repeated a standard exercise stress test twice (recall time 34.2 +/- 2.8 months) and were prospectively studied. Results 821 individuals complied with inclusion criteria for reproducibility analysis, including peak workload differences between assessments <= 10 W. Intra-individual correlation between HR profile during the first and the second assessment was very high and higher than inter-individual correlation (0.92 +/- 0.08 vs 0.87 +/- 0.11, p<0.01). Intra-individual correlation of indices describing HR dynamics was: rho = 0.81 for maximum HR during exercise; rho = 0.71 for minimum HR during recovery; rho = 0.70 for HR changes during both exercise and recovery; Intra-individual correlation was higher for these indices of HR dynamics than for resting HR (rho = 0.64). Bland-Altman plots demonstrated good agreement between HR indices estimated during the first and second assessment. A small but consistent bias was registered for all repeated measurements. The intra-individual consistency of abnormal values was about 60-70%. Conclusions The HR dynamics during exercise and recovery are reproducible over a period of 3 years, with moderate to strong intra-individual reproducibility of abnormal values.	[Orini, Michele; Lambiase, Pier D.] UCL, Inst Cardiovasc Sci, London, England; [Orini, Michele; Lambiase, Pier D.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Tinker, Andrew; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	University of London; University College London; University of London; Queen Mary University London; University of London; Queen Mary University London	Orini, M (corresponding author), UCL, Inst Cardiovasc Sci, London, England.; Orini, M (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, London, England.	m.orini@ucl.ac.uk	Orini, Michele/ABF-6272-2020; Lambiase, Pier/L-8534-2019	Orini, Michele/0000-0001-5773-0344; Lambiase, Pier/0000-0002-9055-9267	Medical Research Council [MR/N025083/1]; UCLH Biomedicine NIHR; NIHR Cardiovascular Biomedical Research Unit at Barts and Queen Mary University of London, UK; IEF Marie Curie fellowship; MRC [MR/N025083/1] Funding Source: UKRI; Medical Research Council [MC_qA137853] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH Biomedicine NIHR; NIHR Cardiovascular Biomedical Research Unit at Barts and Queen Mary University of London, UK; IEF Marie Curie fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research has been conducted using the UK Bio bank Resource and supported in part by Medical Research Council grant MR/N025083/1. PD Lambiase acknowledges support from the UCLH Biomedicine NIHR. PB Munroe and A Tinke wish to acknowledge the support of the NIHR Cardiovascular Biomedical Research Unit at Barts and Queen Mary University of London, UK. MO is supported by an IEF 2013 Marie Curie fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2008, AM J CARDIOL, V101, P1437, DOI 10.1016/j.amjcard.2008.01.021; Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Alhalabi L, 2017, AM J CARDIOL, V119, P1003, DOI 10.1016/j.amjcard.2016.11.059; Arbit B, 2015, AM J CARDIOL, V116, P1678, DOI 10.1016/j.amjcard.2015.08.037; Bezzina CR, 2015, CIRC RES, V116, P1919, DOI 10.1161/CIRCRESAHA.116.304030; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Celis-Morales CA, 2016, EUR HEART J, V33, pS379; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Crotti L, 2012, J AM COLL CARDIOL, V60, P2515, DOI 10.1016/j.jacc.2012.08.1009; de Geus EJC, 2003, MED SCI SPORT EXER, V35, P1287, DOI 10.1249/01.MSS.0000079073.20399.11; Dhoble A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000559; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249; Hai JJ, 2010, HEART RHYTHM, V7, P929, DOI 10.1016/j.hrthm.2010.03.023; Hodkinson EC, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00154; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Ingelsson E, 2007, CIRCULATION, V115, P2917, DOI 10.1161/CIRCULATIONAHA.106.683821; Jolly MA, 2011, CIRCULATION, V124, P1520, DOI 10.1161/CIRCULATIONAHA.110.005009; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Kiviniemi AM, 2015, AM J CARDIOL, V116, P1495, DOI 10.1016/j.amjcard.2015.08.014; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Lauer M, 2005, CIRCULATION, V112, P771, DOI 10.1161/CIRCULATIONAHA.105.166543; Munroe PB, 2015, PHYSIOL GENOMICS, V47, P365, DOI 10.1152/physiolgenomics.00004.2015; Nederend I, 2016, EUR J APPL PHYSIOL, V116, P2167, DOI 10.1007/s00421-016-3459-y; Nieminen T, 2008, J HUM HYPERTENS, V22, P537, DOI 10.1038/jhh.2008.38; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Nolte IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15805; Orini M, 2017, PROG BIOPHYS MOL BIO; Orini M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161765; Orini M, 2014, IEEE T BIO-MED ENG, V61, P308, DOI 10.1109/TBME.2013.2289304; Orini M, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-214; Orini M, 2010, MED BIOL ENG COMPUT, V48, P423, DOI 10.1007/s11517-010-0592-3; Ramirez J, 2016, IEEE T BIOMED ENG, P1; Ramirez J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005310; Refaat MM, 2014, ANN NONINVAS ELECTRO, V19, P311, DOI 10.1111/anec.12191; ROBINSON BF, 1966, CIRC RES, V19, P400, DOI 10.1161/01.RES.19.2.400; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Taggart P, 2014, PROG BIOPHYS MOL BIO, V115, P252, DOI 10.1016/j.pbiomolbio.2014.06.004; Tulumen E, 2011, ANN NONINVAS ELECTRO, V16, P365, DOI 10.1111/j.1542-474X.2011.00464.x; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Yawn Barbara P, 2003, Ann Fam Med, V1, P236, DOI 10.1370/afm.37; Zhang DF, 2016, CAN MED ASSOC J, V188, pE53, DOI 10.1503/cmaj.150535	47	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183732	10.1371/journal.pone.0183732	http://dx.doi.org/10.1371/journal.pone.0183732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873397	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800024
J	Pfuhlmann, K; Pfluger, PT; Schriever, SC; Muller, TD; Tschop, MH; Stemmer, K				Pfuhlmann, Katrin; Pfluger, Paul T.; Schriever, Sonja C.; Mueller, Timo D.; Tschop, Matthias H.; Stemmer, Kerstin			Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GUT MICROBIOME; HEPATIC GLUCONEOGENESIS; INTESTINAL MICROBIOTA; KINASE; ACTIVATION; EXPRESSION; DUSP6; MKP3; GENE	Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase, that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation of body weight and glucose homeostasis. We further assessed whether metabolic challenges affect Dusp6 expression in selected brain areas or white adipose tissue. Hypothalamic Dusp6 mRNA levels remained unchanged in chow-fed lean vs. high fat diet (HFD) fed obese C57Bl/6J mice, and in C57Bl/6J mice undergoing prolonged fasting or refeeding with fat free diet (FFD) or HFD. Similarly, Dusp6 expression levels were unchanged in selected brain regions of Lep(ob) mice treated with 1 mg/kg of leptin for 6 days, compared to pair-fed or saline-treated Lep(ob) controls. Dusp6 expression levels remained unaltered in vitro in primary adipocytes undergoing differentiation, but were increased in eWAT of HFD-fed obese C57Bl/6J mice, compared to chow-fed lean controls. Global chow-fed DUSP6 KO mice displayed reduced body weight and lean mass and slightly increased fat mass at a young age, which is indicative for early-age weight retardation. Subsequent exposure to HFD led to a significant increase in lean mass and body weight in DUSP6 deficient mice, compared to WT controls. Nevertheless, after 26 weeks of high-fat diet exposure, we observed comparable body weight, fat and lean mass in DUSP6 WT and KO mice, suggesting overall normal susceptibility to develop obesity. In line with the increased weight gain to compensate for early-age weight retardation, HFD-fed DUSP6 KO displayed increased expression levels of anabolic genes involved in lipid and cholesterol metabolism in the epididymal white adipose tissue (eWAT), compared to WT controls. Glucose tolerance was perturbed in both chow-fed lean or HFD-fed obese DUSP6 KO, compared to their respective WT controls. Overall, our data indicate that DUSP6 deficiency has limited impact on the regulation of energy metabolism, but impairs systemic glucose tolerance. Our data are in conflict to earlier reports that propose protection from diet-induced obesity and glucose intolerance in DUSP6 deficient mice. Reasons for the discrepancies remain elusive, but may entail differential genetic backgrounds, environmental factors such as the type and source of HFD, or alterations in the gut microbiome between facilities.	[Pfuhlmann, Katrin; Pfluger, Paul T.; Schriever, Sonja C.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Res Unit NeuroBiol Diabet, Neuherberg, Germany; [Pfuhlmann, Katrin; Pfluger, Paul T.; Schriever, Sonja C.; Mueller, Timo D.; Tschop, Matthias H.; Stemmer, Kerstin] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Inst Diabet & Obes, Neuherberg, Germany; [Pfuhlmann, Katrin; Pfluger, Paul T.; Schriever, Sonja C.; Mueller, Timo D.; Tschop, Matthias H.; Stemmer, Kerstin] German Ctr Diabet Res DZD, Neuherberg, Germany; [Pfuhlmann, Katrin; Tschop, Matthias H.] Tech Univ Munich, Div Metab Dis, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Stemmer, K (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Inst Diabet & Obes, Neuherberg, Germany.; Stemmer, K (corresponding author), German Ctr Diabet Res DZD, Neuherberg, Germany.	kerstin.stemmer@helmholtz-muenchen.de	Müller, Timo D./AAZ-4445-2020; Pfluger, Paul T/A-3770-2019	Pfluger, Paul T/0000-0002-8118-7588; Stemmer, Kerstin/0000-0002-7526-2326; Muller, Timo/0000-0002-0624-9339	Alexander von Humboldt Foundation (MHT); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases; Helmholtz-Israel-Cooperation in Personalized Medicine; iMed Helmholtz Initiative for Personalized Medicine; Initiative and Networking Fund of the Helmholtz Association	Alexander von Humboldt Foundation (MHT)(Alexander von Humboldt Foundation); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases; Helmholtz-Israel-Cooperation in Personalized Medicine; iMed Helmholtz Initiative for Personalized Medicine; Initiative and Networking Fund of the Helmholtz Association	The work was funded in part by the Alexander von Humboldt Foundation (MHT), by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases (SCS, MHT), by the Helmholtz-Israel-Cooperation in Personalized Medicine (PTP), by the iMed Helmholtz Initiative for Personalized Medicine (MHT), and through the Initiative and Networking Fund of the Helmholtz Association.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Domercq M, 2011, J BIOL CHEM, V286, P11825, DOI 10.1074/jbc.M110.153049; Donzelli E, 2011, J MOL CELL BIOL, V3, P123, DOI 10.1093/jmcb/mjq050; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Feng B, 2014, DIABETES, V63, P2924, DOI 10.2337/db14-0066; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Frisdal E, 2015, DIABETES, V64, P840, DOI 10.2337/db14-0245; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Ham JE, 2015, BIOCHEM BIOPH RES CO, V467, P254, DOI 10.1016/j.bbrc.2015.09.180; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Huan J-W, 2016, NAT MICROBIOL NATURE, V2, P1; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jiao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041168; Karagiannides I, 2008, FEBS J, V275, P4796, DOI 10.1111/j.1742-4658.2008.06619.x; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Klock A, 2002, MECH DEVELOP, V116, P243, DOI 10.1016/S0925-4773(02)00153-3; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Kreznar JH, 2017, CELL REP, V18, P1739, DOI 10.1016/j.celrep.2017.01.062; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Levinthal DJ, 2005, J BIOL CHEM, V280, P5875, DOI 10.1074/jbc.M410771200; Liu B, 2008, J CHILD NEUROL, V23, P624, DOI 10.1177/0883073807313042; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Messina S, 2011, ONCOGENE, V30, P3813, DOI 10.1038/onc.2011.99; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Mori MA, 2010, DIABETES, V59, P2960, DOI 10.2337/db10-0367; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Ngai YF, 2010, ENDOCRINOLOGY, V151, P5226, DOI 10.1210/en.2010-0496; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; O'Connor A, 2014, MAMM GENOME, V25, P583, DOI 10.1007/s00335-014-9540-0; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pfluger PT, 2015, CELL METAB, V22, P838, DOI 10.1016/j.cmet.2015.08.022; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Pauli LSS, 2014, J PHYSIOL-LONDON, V592, P1325, DOI 10.1113/jphysiol.2013.264002; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Ussar S, 2016, MOL METAB, V5, P795, DOI 10.1016/j.molmet.2016.07.004; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walker A, 2014, ISME J, V8, P2380, DOI 10.1038/ismej.2014.79; Wei H, 2015, J LIPID RES, V56, P2337, DOI 10.1194/jlr.M063354; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xu HY, 2005, J BIOL CHEM, V280, P36013, DOI 10.1074/jbc.M508027200; Zhai XL, 2014, MOL MED REP, V10, P3052, DOI 10.3892/mmr.2014.2575	56	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183488	10.1371/journal.pone.0183488	http://dx.doi.org/10.1371/journal.pone.0183488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873424	Green Published, gold, Green Submitted			2022-12-26	WOS:000409282800016
J	Zhou, J; Gao, S; Hsieh, CL; Malla, M; Shemshedini, L				Zhou, Jun; Gao, Shuai; Hsieh, Chen-Lin; Malla, Mamata; Shemshedini, Lirim			Peptide B targets soluble guanylyl cyclase alpha 1 and kills prostate cancer cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; LNCAP; ABIRATERONE; INHIBITION; ACTIVATION; RESISTANCE; GENES; LINE; P53	Among androgen-regulated genes, soluble guanylyl cyclase alpha 1 (sGC alpha 1) is significant in promoting the survival and growth of prostate cancer cells and does so independent of nitric oxide (NO) signaling. Peptides were designed targeting sGC alpha 1 to block its pro-cancer functions and one peptide is discussed here. Peptide B-8R killed both androgen-dependent and androgen-independent prostate cancer cells that expressed sGC alpha 1, but not cells that do not express this gene. Peptide B-8R induced apoptosis of prostate cancer cells. Importantly, Peptide B-8R does not affect nor its cytotoxicity depend on NO signaling, despite the fact that it associates with sGC alpha 1, which dimerizes with sGC beta 1 to form the sGC enzyme. Just as with a previously studied Peptide A-8R, Peptide B-8R induced elevated levels of reactive oxygen species (ROS) in prostate cancer cells, but using a ROS-sequestering agent showed that ROS was not responsible the cytotoxic activity of Peptide B-8R. Interestingly, Peptide B-8R induced elevated levels of p53 and phosphorylated p38, but neither of these changes is the cause of the peptide's cytotoxicity. Additional drugs were used to alter levels of iron levels in cells and these studies showed that Peptide B-8R activity does not depend on Ferroptosis. Thus, future work will be directed at defining the mechanism of cytotoxic action of Peptide B-8R against prostate cancer cells.	[Zhou, Jun; Gao, Shuai; Hsieh, Chen-Lin; Malla, Mamata; Shemshedini, Lirim] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gao, Shuai] Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; [Hsieh, Chen-Lin] AbbVie Genom Res Ctr, N Chicago, IL USA	University System of Ohio; University of Toledo; University of Massachusetts System; University of Massachusetts Boston	Shemshedini, L (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	lirim.shemshedini@utoledo.edu		Gao, Shuai/0000-0002-7304-8801	NIH; University of Toledo	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo	This work was funded by grants from the NIH and the University of Toledo.	Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Bhansali M, 2016, MOL ENDOCRINOL, V30, P13, DOI 10.1210/me.2015-1075; Bhansali M, 2014, MOL ENDOCRINOL, V28, P834, DOI 10.1210/me.2014-1017; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cai CM, 2012, MOL ENDOCRINOL, V26, P292, DOI 10.1210/me.2010-0394; Gao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064189; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jenster G, 1999, SEMIN ONCOL, V26, P407; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; MONTGOMERY BT, 1992, PROSTATE, V21, P63, DOI 10.1002/pros.2990210107; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Nadiminty N, 2012, WORLD J UROL, V30, P287, DOI 10.1007/s00345-011-0771-3; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Pollock CB, 2014, ONCOTARGET, V5, P1683, DOI 10.18632/oncotarget.1849; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shang ZQ, 2014, TUMOR BIOL, V35, P1881, DOI 10.1007/s13277-013-1253-6; Tepper CG, 2002, CANCER RES, V62, P6606; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toren PJ, 2015, MOL CANCER THER, V14, P59, DOI 10.1158/1535-7163.MCT-14-0521; Tung CH, 2003, ADV DRUG DELIVER REV, V55, P281, DOI 10.1016/S0169-409X(02)00183-7; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Wu D, 2015, ACTA BIOCH BIOPH SIN, V47, P857, DOI 10.1093/abbs/gmv086	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0184088	10.1371/journal.pone.0184088	http://dx.doi.org/10.1371/journal.pone.0184088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2PY	28859127	Green Published, Green Submitted, gold			2022-12-26	WOS:000408740500065
J	Wang, Z; He, Y; Deng, W; Lang, L; Yang, H; Jin, B; Kolhe, R; Ding, HF; Zhang, J; Hai, T; Yan, C				Wang, Z.; He, Y.; Deng, W.; Lang, L.; Yang, H.; Jin, B.; Kolhe, R.; Ding, H-F; Zhang, J.; Hai, T.; Yan, C.			Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice	ONCOGENE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; DNA-DAMAGE RESPONSE; RADIATION-INDUCED APOPTOSIS; TUMOR SUPPRESSION; PROTEIN SUPPRESSES; P53-DEFICIENT MICE; CANCER DEVELOPMENT; ADAPTIVE-RESPONSE; P53 PROTEINS; LUNG-CANCER	Mice lacking genes involving in the DNA-damage response (DDR) are often tumor prone owing to genome instability caused by oncogenic challenges. Previous studies demonstrate that activating transcription factor 3 (ATF3), a common stress sensor, can activate the tumor suppressor p53 and regulate expression of p53 target genes upon DNA damage. However, whether ATF3 contributes to the maintenance of genome stability and tumor suppression remains unknown. Here we report that Atf3-deficient (Atf3(-/-)) mice developed spontaneous tumors, and died significantly earlier than wild-type (Atf3(+/+)) mice. Consistent with these results, Atf3(-/-) mouse embryonic fibroblasts (MEFs) had more aberrant chromosomes and micronuclei, and were genetically unstable. Whereas we demonstrated that ATF3 activated p53 and promoted its pro-apoptotic activity in mouse thymi and small intestines, the chromosomal instability caused by Atf3 deficiency was largely dependent on the regulation of p53 by ATF3. Interestingly, loss of Atf3 also promoted spontaneous tumorigenesis in Trp53(+/-) mice, but did not affect tumor formation in Trp53(-/-) mice. Our results thus provide the first genetic evidence linking ATF3 to the suppression of the early development of cancer, and underscore the importance of ATF3 in the maintenance of genome integrity.	[Wang, Z.; He, Y.; Lang, L.; Yang, H.; Ding, H-F; Yan, C.] Augusta Univ, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN2134, Augusta, GA 30912 USA; [Deng, W.] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Jin, B.] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Kolhe, R.; Ding, H-F] Augusta Univ, Dept Pathol, Med Coll Georgia, Augusta, GA USA; [Zhang, J.] Case Western Reserve Univ, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Hai, T.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Yan, C.] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA	University System of Georgia; Augusta University; State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University; University System of Georgia; Augusta University; Case Western Reserve University; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Yan, C (corresponding author), Augusta Univ, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN2134, Augusta, GA 30912 USA.; Deng, W (corresponding author), Sun Yat Sen Univ, Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China.	dengwg@sysucc.org.cn; cyan@augusta.edu	Lang, Liwei/I-7744-2019; Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Yan, Chunhong/0000-0002-3974-7991; KOLHE, RAVINDRA/0000-0002-8283-2403; Lang, Liwei/0000-0002-2374-645X; Ding, Han-Fei/0000-0001-5702-3439	NIH [R01CA139107]; National Science Foundation of China [81472178]; State 973 Program of China [2014CB542005]; NATIONAL CANCER INSTITUTE [R01CA139107, R01CA154625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 973 Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH grant R01CA139107 to CY, and the grants from the National Science Foundation of China (81472178) and the State 973 Program of China (2014CB542005) to WD.	Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Bar J, 2016, NEOPLASIA, V18, P525, DOI 10.1016/j.neo.2016.07.004; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Beleza-Meireles A, 2008, EUR J ENDOCRINOL, V158, P729, DOI 10.1530/EJE-07-0793; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Campbell MR, 2006, ONCOGENE, V25, P2531, DOI 10.1038/sj.onc.1209277; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cui HM, 2016, J BIOL CHEM, V291, P10847, DOI 10.1074/jbc.M115.713099; Cui HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7752; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hai T, 1999, GENE EXPRESSION, V7, P321; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; HARVEY M, 1993, ONCOGENE, V8, P2457; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Ishiguro T, 1996, CANCER RES, V56, P875; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Jan YH, 2012, CANCER RES, V72, P5119, DOI 10.1158/0008-5472.CAN-12-1842; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; MERRITT AJ, 1994, CANCER RES, V54, P614; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Sooraj D, 2016, MOL CANCER THER, V15, P1726, DOI 10.1158/1535-7163.MCT-15-0890; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Taketani K, 2012, ONCOGENE, V31, P2210, DOI 10.1038/onc.2011.397; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Z, 2016, ONCOGENE, V35, P3555, DOI 10.1038/onc.2015.417; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Wang ZY, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1010948; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wei SS, 2014, J BIOL CHEM, V289, P8947, DOI 10.1074/jbc.M113.503755; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Xie JJ, 2014, ONCOTARGET, V5, P8569, DOI 10.18632/oncotarget.2322; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2005, MOL CANCER THER, V4, P233; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yoo YD, 2017, EMBO REP, V18, P150, DOI [10.15252/embr.201642360, 10.15252/embr.201744761]; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhao J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2664-8; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744	69	22	22	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 4	2018	37	1					18	27		10.1038/onc.2017.310	http://dx.doi.org/10.1038/onc.2017.310			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FS7YF	28869597	Green Accepted			2022-12-26	WOS:000422625000003
J	Ang, ZW; Xiong, D; Wu, M; Ding, JL				Ang, Zhiwei; Xiong, Ding; Wu, Min; Ding, Jeak Ling			FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing	FASEB JOURNAL			English	Article						GPCR heteromer; FFA2/GPR43; FFA3/GPR41	RESONANCE ENERGY-TRANSFER; GUT MICROBIOTA; INFLAMMATORY RESPONSES; SIGNALING CASCADES; BETA-ARRESTIN; HUMAN COLON; GPR43; ACTIVATION; INTERNALIZATION; EXPRESSION	Free fatty acid receptors 2 and 3(FFAR2/FFA2/GPR43andFFAR3/FFA3/GPR41) are mammalian receptors for gut microbiota-derived short-chain fatty acids (SCFAs). These receptors are promising drug targets for obesity, colitis, colon cancer, asthma, and arthritis. Here, we demonstrate that FFAR2 and FFAR3 interact to form a heteromer in primary human monocytes and macrophages via proximity ligation assay, and during heterologous expression in HEK293 cells via bimolecular fluorescence complementation and fluorescence resonance energy transfer. The FFAR2-FFAR3 heteromer displayed enhanced cytosolic Ca2+ signaling (1.5-fold increase relative to homomeric FFAR2) and beta-arrestin-2 recruitment (30-fold increase relative to homomeric FFAR3). The enhanced heteromer signaling was attenuated by FFAR2 antagonism (CATPB), G(alpha q) inhibition(YM254890), or G(alpha i) inhibition(pertussis toxin). Unlike homomeric FFAR2/3, the heteromer lacked the ability to inhibit cAMP production but gained the ability to induce p38 phosphorylation in HEK293 and inflammatory monocytes via a CATPB- and YM254890-sensitive mechanism. Our data, taken together, reveal that FFAR2 and FFAR3 may interact to form a receptor heteromer with signaling that is distinct from the parent homomers-a novel pathway for drug targeting.	[Ang, Zhiwei; Xiong, Ding; Wu, Min; Ding, Jeak Ling] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore; [Xiong, Ding; Wu, Min] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore, Singapore; [Wu, Min] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Ding, Jeak/H-8057-2012	Ang, Zhiwei/0000-0001-6583-4733; XIONG, Ding/0000-0002-2232-9013	National Medical Research Council [NMRC/CBRG/0055/2013]; Ministry of Education [MoE 2013-T2-2-007, MoE R-154-000A31-114, MoE 2015-T2-1-122]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education	The authors gratefully acknowledge the kind gifts of YM254890 from Taiho Pharmaceutical (Tokyo, Japan); CATPB from S. Kim (Korean Research Institute of Bioscience and Biotechnology, Daejeon, South Korea); expression plasmids, hFFA2-eYFP and hFFA3-eYFP in pcDNA5/FRT/TO from G. Milligan (University of Glasgow, Glasgow, United Kingdom); pBiFC-VN155(I152L) and pBiFC-VC155 plasmids from C.-D. Hu (27097 and 22011; Addgene; Purdue University, West Lafayette, IN, USA); FFA2-Tango, FFA3-Tango, and P2RY1-Tango plasmids (66281, 66282, 66468; Addgene) and HTLA cells from B. Roth (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA). This work was supported by grants from the National Medical Research Council (NMRC/CBRG/0055/2013) and the Ministry of Education (MoE 2013-T2-2-007 and MoE R-154-000A31- 114 to J.L.D., and MoE 2015-T2-1-122 to M.W.). The authors declare no conflicts of interest.	Ang ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34145; Ang ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08134; Armando S, 2014, FASEB J, V28, P4509, DOI 10.1096/fj.13-242446; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Brantis C. E., 2011, Int. Appl, Patent No. [WO2011092284, 2011092284]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Gao ZG, 2016, BIOCHEM PHARMACOL, V107, P59, DOI 10.1016/j.bcp.2016.03.003; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Gouell S., 2009, MONITORING ACTIVITY; Hansen AH, 2017, J MED CHEM, V60, P5638, DOI 10.1021/acs.jmedchem.7b00338; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hudson BD, 2012, FASEB J, V26, P4951, DOI 10.1096/fj.12-213314; Jacobsen SE, 2017, J BIOL CHEM, V292, P6910, DOI 10.1074/jbc.M116.762385; Joost P, 2002, GENOME BIOL, V3; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee SU, 2013, BIOL PHARM BULL, V36, P1754; Leonard J. N., 2008, Patent, Patent No. [2008/0312277 Al, 20080312277, US20080312277A1]; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016; Navarro G, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0247-4; Ng J, 2010, NEUROSCIENCE, V165, P535, DOI 10.1016/j.neuroscience.2009.10.017; Park BO, 2016, EUR J PHARMACOL, V771, P1, DOI 10.1016/j.ejphar.2015.12.010; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Priyadarshini M, 2015, MOL ENDOCRINOL, V29, P1055, DOI 10.1210/me.2015-1007; Rico AJ, 2017, BRAIN STRUCT FUNCT, V222, P1767, DOI 10.1007/s00429-016-1306-x; Rodriuez-Ruiz M, 2017, MOL NEUROBIOL, V54, P4537, DOI 10.1007/s12035-016-9995-y; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sivaprakasam S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.38; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stoddart L. A., 2007, INVESTIGATION FUNCTI; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112	58	52	52	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					289	+		10.1096/fj.201700252RR	http://dx.doi.org/10.1096/fj.201700252RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28883043	Green Published			2022-12-26	WOS:000419172700027
J	Chandra, A; Wang, LQ; Young, T; Zhong, LL; Tseng, WJ; Levine, MA; Cengel, K; Liu, XS; Zhang, YJ; Pignolo, RJ; Qin, L				Chandra, Abhishek; Wang, Luqiang; Young, Tiffany; Zhong, Leilei; Tseng, Wei-Ju; Levine, Michael A.; Cengel, Keith; Liu, X. Sherry; Zhang, Yejia; Pignolo, Robert J.; Qin, Ling			Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis	FASEB JOURNAL			English	Article						osteoblast; DNA repair; bone; irradiation; apoptosis	DEPENDENT PROTEIN-KINASE; NF-KAPPA-B; MULTIPLE-MYELOMA; DNA-REPAIR; BONE; APOPTOSIS; IRRADIATION; PATHWAY; SYSTEM; TARGET	Bone atrophy and its related fragility fractures are frequent, late side effects of radiotherapy in cancer survivors and have a detrimental impact on their quality of life. In another study, we showed that parathyroid hormone 1-34 andanti-sclerostinantibodyattenuates radiation-induced bonedamagebyacceleratingDNArepair in osteoblasts. DNA damage responses are partially regulated by the ubiquitin proteasome pathway. In the current study, we examined whether proteasome inhibitors have similar bone-protective effects against radiation damage. MG132 treatment greatly reducedradiation-inducedapoptosis inculturedosteoblastic cells. This survival effectwas owing to acceleratedDNArepair as revealed by gamma H2AX foci and comet assays and to the up-regulation ofKu70 and DNA-dependent protein kinase, catalytic subunit, essential DNA repair proteins in the nonhomologous end-joining pathway. Administration of bortezomib (Bzb) reversed the loss of trabecular bone structure and strength in mice at 4 wk after focal radiation. Histomorphometry revealed that Bzb significantly increased the number of osteoblasts and activity in the irradiated area and suppressed the number and activity of osteoclasts, regardless of irradiation. Twoweeks of Bzb treatment acceleratedDNArepair in bone-lining osteoblasts and thus promotedtheir survival. Meanwhile, it also inhibited bone marrow adiposity. Taken together, we demonstrate a novel role of proteasome inhibitors in treating radiation-induced osteoporosis.	[Chandra, Abhishek; Wang, Luqiang; Young, Tiffany; Zhong, Leilei; Tseng, Wei-Ju; Liu, X. Sherry; Zhang, Yejia; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, G14A Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA; [Levine, Michael A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Cengel, Keith] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Zhang, Yejia] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Chandra, Abhishek] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Chandra, Abhishek; Pignolo, Robert J.] Mayo Clin, Dept Med, Rochester, MN USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Ctr Bone Hlth, Philadelphia, PA 19104 USA; [Zhang, Yejia] Corporal Michael J Crescenz Vet Affairs Med Ctr, TMRC, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, G14A Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Liu, Xiaowei Sherry/H-1664-2017; Chandra, Abhishek/AAG-8781-2020; Tseng, Wei-Ju/AAC-2819-2022	Liu, Xiaowei Sherry/0000-0001-7247-2232; Levine, Michael/0000-0003-0036-7809; Chandra, Abhishek/0000-0001-9423-9669	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR066098, P30AR050950, K01AR066743]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095803]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [1K08HD049598]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD049598] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066098, P30AR050950, P30AR069619, K01AR066743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095803] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Martin F. Heyworth (Corporal Michael J. Crescenz Veterans Affairs Medical Center), for critically editing the manuscript. This study was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01AR066098, P30AR050950 (Penn Center for Musculoskeletal Disorders), and K01AR066743 (to X.S.L.); NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK095803 (to L.Q.); and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 1K08HD049598 (to Y.Z.). The authors declare no conflicts of interest.	Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108; Capriani C, 2012, J BONE MINER RES, V27, P2419, DOI 10.1002/jbmr.1800; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Chanda A, 2014, AM ECON J-MACROECON, V6, P1, DOI 10.1257/mac.6.3.1; Chandra A, 2017, J BONE MINER RES, V32, P360, DOI 10.1002/jbmr.2996; Chandra A, 2015, J BIOL CHEM, V290, P157, DOI 10.1074/jbc.M114.608158; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Chargari C, 2016, CANCER METAST REV, V35, P277, DOI 10.1007/s10555-016-9616-2; Chitra S, 2012, INT J RHEUM DIS, V15, P249, DOI 10.1111/j.1756-185X.2012.01737.x; Chouinard L, 2016, REGUL TOXICOL PHARM, V81, P212, DOI 10.1016/j.yrtph.2016.08.010; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dou QP, 2014, CURR CANCER DRUG TAR, V14, P517, DOI 10.2174/1568009614666140804154511; Elliot P J, 1999, Curr Opin Drug Discov Devel, V2, P484; ERGUN H, 1980, CRC CR REV DIAGN IM, V12, P225; Gama V, 2006, EXP CELL RES, V312, P488, DOI 10.1016/j.yexcr.2005.11.016; Goodwin JF, 2014, CANCER DISCOV, V4, P1126, DOI 10.1158/2159-8290.CD-14-0358; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Grundy GJ, 2014, DNA REPAIR, V17, P30, DOI 10.1016/j.dnarep.2014.02.019; GUNGOR T, 1982, ACTA ORTHOP SCAND, V53, P333, DOI 10.3109/17453678208992225; Han ZY, 1996, J BIOL CHEM, V271, P25035, DOI 10.1074/jbc.271.40.25035; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Holt GE, 2005, J BONE JOINT SURG AM, V87A, P315, DOI 10.2106/JBJS.C.01714; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Jiang N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.171; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Oh D, 2014, RADIAT ONCOL J, V32, P213, DOI 10.3857/roj.2014.32.4.213; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Ross GM, 1999, ENDOCR-RELAT CANCER, V6, P41, DOI 10.1677/erc.0.0060041; Sawajiri M, 2003, RADIAT ENVIRON BIOPH, V42, P219, DOI 10.1007/s00411-003-0204-9; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; von Metzler I, 2007, LEUKEMIA, V21, P2025, DOI 10.1038/sj.leu.2404806; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Zangari M, 2016, BONE, V86, P131, DOI 10.1016/j.bone.2016.02.019; Zangari M, 2012, CANCER TREAT REV, V38, P968, DOI 10.1016/j.ctrv.2011.12.007	47	21	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					52	62		10.1096/fj.201700375R	http://dx.doi.org/10.1096/fj.201700375R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28860152	Green Published			2022-12-26	WOS:000419172700007
J	Chen, Z; Gui, B; Zhang, Y; Xie, GJ; Li, WJ; Liu, SM; Xu, BS; Wu, CY; He, L; Yang, JG; Yi, X; Yang, XH; Sun, LY; Liang, J; Shang, YF				Chen, Zhe; Gui, Bin; Zhang, Yu; Xie, Guojia; Li, Wanjin; Liu, Shumeng; Xu, Bosen; Wu, Chongyang; He, Lin; Yang, Jianguo; Yi, Xia; Yang, Xiaohan; Sun, Luyang; Liang, Jing; Shang, Yongfeng			Identification of a 35S U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP) complex intermediate in spliceosome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; ribonuclear protein (RNP); RNA helicase; RNA splicing; spliceosome; Cajal body; snRNP assembly; tri-snRNP	PRE-MESSENGER-RNA; G-PATCH PROTEIN; COMPENSATORY BASE CHANGE; ZINC-FINGER PROTEINS; DEAH BOX ATPASE; CAJAL BODIES; RIBOSOME BIOGENESIS; ELECTRON CRYOMICROSCOPY; BREAST CARCINOGENESIS; CATALYTIC ACTIVATION	The de novo assembly and post-splicing reassembly of the U4/U6.U5 tri-snRNP remain to be investigated. We report here that ZIP, a protein containing a CCCH-type zinc finger and a G-patch domain, as characterized by us previously, regulates pre-mRNA splicing independent of RNA binding. We found that ZIP physically associates with the U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP). Remarkably, the ZIP-containing tri-snRNP, which has a sedimentation coefficient of approximate to 35S, is a tri-snRNP that has not been described previously. We also found that the 35S tri-snRNP contains hPrp24, indicative of a state in which the U4/U6 di-snRNP is integrating with the U5 snRNP. We found that the 35S tri-snRNP is enriched in the Cajal body, indicating that it is an assembly intermediate during 25S tri-snRNP maturation. We showed that the 35S tri-snRNP also contains hPrp43, in which ATPase/RNA helicase activities are stimulated by ZIP. Our study identified, for the first time, a tri-snRNP intermediate, shedding new light on the de novo assembly and recycling of the U4/U6.U5 tri-snRNP.	[Chen, Zhe; Gui, Bin; Zhang, Yu; Xie, Guojia; Li, Wanjin; Liu, Shumeng; Xu, Bosen; Wu, Chongyang; He, Lin; Yang, Jianguo; Yi, Xia; Yang, Xiaohan; Sun, Luyang; Liang, Jing; Shang, Yongfeng] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr,Key Lab Carcinogenesis & Translat Re, Dept Biochem & Mol Biol,Minist Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China; [Shang, Yongfeng] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100069, Peoples R China	Peking University; Tianjin Medical University; Capital Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Chen, Zhe/AAA-3235-2020	Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157	National Natural Science Foundation of China [91219201, 81530073, 81730079]; Ministry of Science and Technology of China [2016YFC1302304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 91219201, 81530073, and 81730079 from the National Natural Science Foundation of China (to Y. S.) and Grant 2016YFC1302304 from the Ministry of Science and Technology of China (to Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; BACH M, 1989, P NATL ACAD SCI USA, V86, P6038, DOI 10.1073/pnas.86.16.6038; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; BINDEREIF A, 1987, EMBO J, V6, P2415, DOI 10.1002/j.1460-2075.1987.tb02520.x; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; Christian H, 2014, NUCLEIC ACIDS RES, V42, P1162, DOI 10.1093/nar/gkt985; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Didychuk AL, 2016, NUCLEIC ACIDS RES, V44, P1398, DOI 10.1093/nar/gkv1374; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Fouraux MA, 2002, RNA, V8, P1428, DOI 10.1017/S1355838202021076; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Klingauf M, 2006, MOL BIOL CELL, V17, P4972, DOI 10.1091/mbc.E06-06-0513; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; KRAMER A, 1984, CELL, V38, P299, DOI 10.1016/0092-8674(84)90551-8; Lebaron S, 2005, MOL CELL BIOL, V25, P9269, DOI 10.1128/MCB.25.21.9269-9282.2005; Lebaron S, 2009, EMBO J, V28, P3808, DOI 10.1038/emboj.2009.335; Leeds NB, 2006, MOL CELL BIOL, V26, P513, DOI 10.1128/MCB.26.2.513-522.2006; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Lin ML, 2009, CANCER SCI, V100, P1443, DOI 10.1111/j.1349-7006.2009.01185.x; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Liu S, 2015, ELIFE, V4, DOI 10.7554/eLife.07320; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayas RM, 2010, P NATL ACAD SCI USA, V107, P10020, DOI 10.1073/pnas.0906022107; Medenbach J, 2004, MOL CELL BIOL, V24, P7392, DOI 10.1128/MCB.24.17.7392-7401.2004; Niu ZY, 2012, FEBS LETT, V586, P977, DOI 10.1016/j.febslet.2012.02.052; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Novotny I, 2011, MOL BIOL CELL, V22, P513, DOI 10.1091/mbc.E10-07-0560; Novotny I, 2015, CELL REP, V10, P429, DOI 10.1016/j.celrep.2014.12.030; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Robert-Paganin J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/931857; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Silverman EJ, 2004, MOL CELL BIOL, V24, P10101, DOI 10.1128/MCB.24.23.10101-10110.2004; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tanaka N, 2007, GENE DEV, V21, P2312, DOI 10.1101/gad.1580507; Tanaka N, 2006, BIOCHEMISTRY-US, V45, P6510, DOI 10.1021/bi052656g; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Theuser M, 2016, P NATL ACAD SCI USA, V113, P7798, DOI 10.1073/pnas.1524616113; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Tsai RT, 2005, GENE DEV, V19, P2991, DOI 10.1101/gad.1377405; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2015, GENE DEV, V29, P94, DOI 10.1101/gad.253070.114; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	85	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18113	18128		10.1074/jbc.M117.797357	http://dx.doi.org/10.1074/jbc.M117.797357			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	28878014	hybrid, Green Published			2022-12-26	WOS:000414458200011
J	Zhong, Y; Yang, J; Xu, WW; Wang, Y; Zheng, CC; Li, B; He, QY				Zhong, Y.; Yang, J.; Xu, W. W.; Wang, Y.; Zheng, C-C; Li, B.; He, Q-Y			KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition	ONCOGENE			English	Article							GASTROINTESTINAL STROMAL TUMORS; CELL-CYCLE; ESOPHAGEAL CANCER; MITOTIC KINASES; AURORA-A; PROGRESSION; CDC25B; PHOSPHORYLATION; ACTIVATION; PROTEOMICS	Cell cycle dysregulation leads to uncontrolled cell proliferation and tumorigenesis. Understanding the molecular mechanisms underlying cell cycle progression can provide clues leading to the identification of key proteins involved in cancer development. In this study, we performed proteomics analysis to identify novel regulators of the cell cycle. We found that potassium channel tetramerization domain containing 12 (KCTD12) was significantly upregulated in M phase compared with S phase. We also found that KCTD12 overexpression not only facilitated the G2/M transition and induced cancer cell proliferation, but also promoted the growth of subcutaneous tumors and Ki-67 proliferation index in mice. Regarding the mechanism underlying these phenomena, cyclin-dependent kinase 1 (CDK1) was identified as an interacting partner of KCTD12 by immunoprecipitation and mass spectrometry analysis, which showed that KCTD12 activated CDK1 and Aurora kinase A (Aurora A) and that the effects of KCTD12 on CDK1 phosphorylation and cell proliferation were abrogated by cell division cycle 25B (CDC25B) silencing. In addition, Aurora A phosphorylated KCTD12 at serine 243, thereby initiating a positive feedback loop necessary for KCTD12 to exert its cancerpromoting effects. Furthermore, we analyzed the expression levels of various genes and the correlations between the expression of these genes and survival using tumor tissue microarray and Gene Expression Omnibus (GEO) data sets. The data showed that KCTD12 expression was significantly upregulated in cervical and lung cancers. More importantly, high KCTD12 expression was associated with larger tumor sizes, higher pathological stages and poor patient survival. Collectively, our study demonstrate that KCTD12 binds to CDC25B and activates CDK1 and Aurora A to facilitate the G2/M transition and promote tumorigenesis and that Aurora A phosphorylates KCTD12 at serine 243 to trigger a positive feedback loop, thereby potentiating the effects of KCTD12. Thus, the KCTD12-CDC25B-CDK1-Aurora A axis has important implications for cancer diagnoses and prognoses.	[Zhong, Y.; Yang, J.; Wang, Y.; Zheng, C-C; Li, B.; He, Q-Y] Jinan Univ, Inst Life & Hlth Engn, Coll Life Sci & Technol, Key Lab Funct Prot Res Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China; [Zhong, Y.] Jinan Univ, Dept Pathol, Coll Med, Guangzhou, Guangdong, Peoples R China; [Xu, W. W.] Jinan Univ, Inst Biomed, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Li, B; He, QY (corresponding author), Jinan Univ, Inst Life & Hlth Engn, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China.	libin2015@jnu.edu.cn; tqyhe@jnu.edu.cn	Wang, Yang/GQH-2363-2022; He, Qing-Yu/H-7078-2014	Wang, Yang/0000-0001-6440-0204; He, Qing-Yu/0000-0003-0503-9492; Li, Bin/0000-0002-8979-610X	National Key Research and Development Program of China [2017YFA0505100]; National Natural Science Foundation of China [31770888, 31570828, 81672953, 81773085]; Guangdong Natural Science Research Grant [S2013030013315, 2016A030313838]; Fundamental Research Funds for the Central Universities [ZX20170413]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Research Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Mr. Xing-Feng Yin and Mr. Zheng-Hua Sun for their technical assistance on mass spectrometry. This work was supported by the National Key Research and Development Program of China (No. 2017YFA0505100), the National Natural Science Foundation of China (31770888, 31570828, 81672953, 81773085), Guangdong Natural Science Research Grant (S2013030013315, 2016A030313838), and the Fundamental Research Funds for the Central Universities (ZX20170413).	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Au FKC, 2017, DEV CELL, V40, P81, DOI 10.1016/j.devcel.2016.11.019; Booker SA, 2017, CEREB CORTEX, V27, P2318, DOI 10.1093/cercor/bhw090; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen XL, 2013, PROTEOMICS, V13, P3030, DOI 10.1002/pmic.201200448; Chen Y, 2013, METHODS MOL BIOL, V1077, P105, DOI 10.1007/978-1-62703-637-5_7; Correale S, 2013, J MOL RECOGNIT, V26, P488, DOI 10.1002/jmr.2291; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; de Freitas AC, 2015, CURR DRUG TARGETS, V16, P77, DOI 10.2174/1389450116666141205150942; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ivankova K, 2013, J BIOL CHEM, V288, P24848, DOI 10.1074/jbc.M113.476770; Jeong AL, 2013, BMB REP, V46, P289, DOI 10.5483/BMBRep.2013.46.6.041; Jullien D, 2011, CANCER RES, V71, P1968, DOI 10.1158/0008-5472.CAN-10-2453; Kang HJ, 2006, PROTEOMICS, V6, P1151, DOI 10.1002/pmic.200500372; Labbe DP, 2012, PROG MOL BIOL TRANSL, V106, P253, DOI 10.1016/B978-0-12-396456-4.00009-2; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Li B, 2017, ONCOGENE, V36, P3986, DOI 10.1038/onc.2017.29; Li B, 2016, CLIN CANCER RES, V22, P1243, DOI 10.1158/1078-0432.CCR-15-1196; Li B, 2014, CLIN CANCER RES, V20, P2651, DOI 10.1158/1078-0432.CCR-13-2735; Li B, 2009, MOL CANCER THER, V8, P2635, DOI 10.1158/1535-7163.MCT-09-0162; Li LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20460; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Ma HT, 2017, METHODS MOL BIOL, V1524, P189, DOI 10.1007/978-1-4939-6603-5_12; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Milewski D, 2017, ONCOGENE, V36, P850, DOI 10.1038/onc.2016.254; Namiki T, 2015, CANCER RES, V75, P2708, DOI 10.1158/0008-5472.CAN-13-3209; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Oh AY, 2016, CANCER RES, V76, P4791, DOI 10.1158/0008-5472.CAN-15-1025; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Resendes BL, 2004, JARO-J ASSOC RES OTO, V5, P185, DOI 10.1007/s10162-003-4042-x; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; Sobczyk GJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4319; Sprenger Adrian, 2013, Methods Mol Biol, V961, P179, DOI 10.1007/978-1-62703-227-8_10; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Taylor William R, 2004, Methods Mol Biol, V281, P293; Turecek R, 2014, NEURON, V82, P1032, DOI 10.1016/j.neuron.2014.04.015; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Wang J, 2015, ONCOTARGET, V6, P1618, DOI 10.18632/oncotarget.2730; Wang Y, 2017, BIOCHEM PHARMACOL, V129, P43, DOI 10.1016/j.bcp.2017.01.006; Wang Y, 2016, APOPTOSIS, V21, P1438, DOI 10.1007/s10495-016-1300-z; Whalley HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8437; Xu WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14399; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690	49	35	36	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 2	2017	36	44					6177	6189		10.1038/onc.2017.287	http://dx.doi.org/10.1038/onc.2017.287			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FL5CU	28869606	hybrid, Green Published			2022-12-26	WOS:000414249800011
J	Scannevin, RH; Alexander, R; Haarlander, TM; Burke, SL; Singer, M; Huo, CF; Zhang, YM; Maguire, D; Spurlino, J; Deckman, I; Carroll, KI; Lewandowski, F; Devine, E; Dzordzorme, K; Tounge, B; Milligan, C; Bayoumy, S; Williams, R; Schalk-Hihi, C; Leonard, K; Jackson, P; Todd, M; Kuo, LC; Rhodes, KJ				Scannevin, Robert H.; Alexander, Richard; Haarlander, Tara Mezzasalma; Burke, Sharon L.; Singer, Monica; Huo, Cuifen; Zhang, Yue-Mei; Maguire, Diane; Spurlino, John; Deckman, Ingrid; Carroll, Karen I.; Lewandowski, Frank; Devine, Eric; Dzordzorme, Keli; Tounge, Brett; Milligan, Cindy; Bayoumy, Shariff; Williams, Robyn; Schalk-Hihi, Celine; Leonard, Kristi; Jackson, Paul; Todd, Matthew; Kuo, Lawrence C.; Rhodes, Kenneth J.			Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROSARCOMA CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MATRIX METALLOPROTEINASE-3 STROMELYSIN; BRAIN-BARRIER DISRUPTION; MONOCLONAL-ANTIBODIES; FOCAL ISCHEMIA; IV COLLAGENASE; GELATINASE-B; SPINAL-CORD; EXPRESSION	Aberrant activation of matrix metalloproteinases (MMPs) is a common feature of pathological cascades observed in diverse disorders, such as cancer, fibrosis, immune dysregulation, and neurodegenerative diseases. MMP-9, in particular, is highly dynamically regulated in several pathological processes. Development of MMP inhibitors has therefore been an attractive strategy for therapeutic intervention. However, a long history of failed clinical trials has demonstrated that broad-spectrum MMP inhibitors have limited clinical utility, which has spurred the development of inhibitors selective for individual MMPs. Attaining selectivity has been technically challenging because of sequence and structural conservation across the various MMPs. Here, through a biochemical and structural screening paradigm, we have identified JNJ0966, a highly selective compound that inhibited activation of MMP-9 zymogen and subsequent generation of catalytically active enzyme. JNJ0966 had no effect on MMP-1, MMP-2, MMP-3, MMP-9, or MMP-14 catalytic activity and did not inhibit activation of the highly related MMP-2 zymogen. The molecular basis for this activity was characterized as an interaction of JNJ0966 with a structural pocket in proximity to the MMP-9 zymogen cleavage site near Arg-106, which is distinct from the catalytic domain. JNJ0966 was efficacious in reducing disease severity in a mouse experimental autoimmune encephalomyelitis model, demonstrating the viability of this therapeutic approach. This discovery reveals an unprecedented pharmacological approach to MMP inhibition, providing an opportunity to improve selectivity of future clinical drug candidates. Targeting zymogen activation in this manner may also allow for pharmaceutical exploration of other enzymes previously viewed as intractable drug targets.	[Scannevin, Robert H.; Alexander, Richard; Haarlander, Tara Mezzasalma; Burke, Sharon L.; Singer, Monica; Huo, Cuifen; Zhang, Yue-Mei; Maguire, Diane; Spurlino, John; Deckman, Ingrid; Carroll, Karen I.; Lewandowski, Frank; Devine, Eric; Dzordzorme, Keli; Tounge, Brett; Milligan, Cindy; Bayoumy, Shariff; Williams, Robyn; Schalk-Hihi, Celine; Leonard, Kristi; Jackson, Paul; Todd, Matthew; Kuo, Lawrence C.; Rhodes, Kenneth J.] Janssen Res & Dev LLC, Spring House, PA 19477 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Scannevin, RH (corresponding author), Yuman Therapeut, 790 Mem Dr, Cambridge, MA 02139 USA.	rscannevin@yumanity.com		Spurlino, John/0000-0003-1308-2570; Scannevin, Robert/0000-0002-5749-2785	companies of the Industrial Macromolecular Crystallography Association; University of Chicago; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	companies of the Industrial Macromolecular Crystallography Association; University of Chicago(University of Chicago); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We sincerely thank H. Moore Arnold for thoughtful assistance in reviewing and editing the manuscript. Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the University of Chicago. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; BU CH, 1995, J BIOL CHEM, V270, P18563, DOI 10.1074/jbc.270.31.18563; Clements JM, 1997, J NEUROIMMUNOL, V74, P85, DOI 10.1016/S0165-5728(96)00210-X; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Duchossoy Y, 2001, MOL CELL NEUROSCI, V17, P945, DOI 10.1006/mcne.2001.0986; Duncan ME, 1998, EUR J BIOCHEM, V258, P37, DOI 10.1046/j.1432-1327.1998.2580037.x; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fabre B, 2014, CHEMBIOCHEM, V15, P399, DOI 10.1002/cbic.201300698; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gege C, 2012, J MED CHEM, V55, P709, DOI 10.1021/jm201152u; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; GOLUB LM, 1995, J CLIN PERIODONTOL, V22, P100; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; King J, 2003, ANTICANCER RES, V23, P639; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Lijnen HR, 1998, BLOOD, V91, P2045, DOI 10.1182/blood.V91.6.2045.2045_2045_2053; Lindberg RLP, 2001, BRAIN, V124, P1743, DOI 10.1093/brain/124.9.1743; Maquoi E, 2002, EXP CELL RES, V275, P110, DOI 10.1006/excr.2002.5489; Zapico JM, 2015, ORG BIOMOL CHEM, V13, P142, DOI 10.1039/c4ob01516a; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park BC, 2007, EUR J PHARMACOL, V567, P193, DOI 10.1016/j.ejphar.2007.04.014; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pirard B, 2007, DRUG DISCOV TODAY, V12, P640, DOI 10.1016/j.drudis.2007.06.003; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; Schnute ME, 2010, BIOORG MED CHEM LETT, V20, P576, DOI 10.1016/j.bmcl.2009.11.081; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Shibayama M, 1997, ACT NEUR S, V70, P220; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/neu.2004.21.1706; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Udi Y, 2013, J MOL BIOL, V425, P2330, DOI 10.1016/j.jmb.2013.04.009; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xu XP, 2007, BIOCHEM J, V406, P147, DOI 10.1042/BJ20070591; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhao Y, 2008, BIOCHEM BIOPH RES CO, V369, P1215, DOI 10.1016/j.bbrc.2008.03.038	59	70	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17963	17974		10.1074/jbc.M117.806075	http://dx.doi.org/10.1074/jbc.M117.806075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	28860188	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000414013000031
J	Otrusinova, O; Demo, G; Padrta, P; Jasenakova, Z; Pekarova, B; Gelova, Z; Szmitkowska, A; Kaderavek, P; Jansen, S; Zachrdla, M; Klumpler, T; Marek, J; Hritz, J; Janda, L; Iwai, H; Wimmerova, M; Hejatko, J; Zidek, L				Otrusinova, Olga; Demo, Gabriel; Padrta, Petr; Jasenakova, Zuzana; Pekarova, Blanka; Gelova, Zuzana; Szmitkowska, Agnieszka; Kaderavek, Pavel; Jansen, Severine; Zachrdla, Milan; Klumpler, Tomas; Marek, Jaromir; Hritz, Jozef; Janda, Lubomir; Iwai, Hideo; Wimmerova, Michaela; Hejatko, Jan; Zidek, Lukas			Conformational dynamics are a key factor in signaling mediated by the receiver domain of a sensor histidine kinase from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MODEL-FREE APPROACH; X-RAY ANALYSIS; PROTEIN CHEY; MACROMOLECULAR CRYSTALLOGRAPHY; RELAXATION EXPERIMENT; CRYSTAL-STRUCTURES; ETHYLENE RECEPTOR; STRUCTURAL BASIS; NMR	Multistep phosphorelay (MSP) cascades mediate responses to a wide spectrum of stimuli, including plant hormonal signaling, but several aspects of MSP await elucidation. Here, we provide first insight into the key step of MSP- mediated phosphotransfer in a eukaryotic system, the phosphorylation of the receiver domain of the histidine kinase CYTOKININ-INDEPENDENT 1 (CKI1(RD)) from Arabidopsis thaliana. We observed that the crystal structures of free, Mg2+-bound, and beryllofluoridated CKI1(RD) (a stable analogue of the labile phosphorylated form) were identical and similar to the active state of receiver domains of bacterial response regulators. However, the three CKI1(RD) variants exhibited different conformational dynamics in solution. NMR studies revealed that Mg2+ binding and beryllofluoridation alter the conformational equilibrium of the beta 3-beta 3 loop close to the phosphorylation site. Mutations that perturbed the conformational behavior of the beta 3-beta 3 loop while keeping the active- site aspartate intact resulted in suppression of CKI1 function. Mechanistically, homology modeling indicated that the beta 3 beta 3 loop directly interacts with the ATP- binding site of the CKI1 histidine kinase domain. The functional relevance of the conformational dynamics observed in the beta 3-beta 3 loop of CKI1(RD) was supported by a comparison with another A. thaliana histidine kinase, ETR1. In contrast to the highly dynamic beta 3- beta 3 loop of CKI1(RD), the corresponding loop of the ETR1 receiver domain (ETR1(RD)) exhibited little conformational exchange and adopted a different orientation in crystals. Biochem-ical data indicated that ETR1(RD) is involved in phosphorylation-independent signaling, implying a direct link between conformational behavior and the ability of eukaryotic receiver domains to participate in MSP.	[Otrusinova, Olga; Demo, Gabriel; Padrta, Petr; Jasenakova, Zuzana; Pekarova, Blanka; Gelova, Zuzana; Szmitkowska, Agnieszka; Kaderavek, Pavel; Jansen, Severine; Zachrdla, Milan; Klumpler, Tomas; Marek, Jaromir; Hritz, Jozef; Janda, Lubomir; Wimmerova, Michaela; Hejatko, Jan; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic; [Otrusinova, Olga; Padrta, Petr; Jasenakova, Zuzana; Pekarova, Blanka; Gelova, Zuzana; Szmitkowska, Agnieszka; Kaderavek, Pavel; Jansen, Severine; Zachrdla, Milan; Janda, Lubomir; Wimmerova, Michaela; Hejatko, Jan; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic; [Iwai, Hideo] Univ Helsinki, Inst Biotechnol, Viikinkaari 1,POB 65, Helsinki 00014, Finland; [Demo, Gabriel] Univ Massachusetts, RNA Therapeut Inst, Sch Med, 368 Plantat St, Worcester, MA 01605 USA; [Kaderavek, Pavel] Ecole Normale Super, Dept Chim, 24 Rue Lhomond, F-75005 Paris, France	Masaryk University Brno; Masaryk University Brno; University of Helsinki; University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Zidek, L (corresponding author), Masaryk Univ, Cent European Inst Technol, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic.; Zidek, L (corresponding author), Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, CZ-62500 Brno, Czech Republic.	lzidek@chemi.muni.cz	Kadeřávek, Pavel/D-7670-2012; Wimmerova, Michaela/A-4114-2010; Hejatko, Jan/AAN-1182-2021; Zidek, Lukas/AAB-6109-2020; Gelová, Zuzana/ABG-5834-2020; Hejatko, Jan/H-4296-2014; Zidek, Lukas/D-7112-2012; Marek, Jaromír/AAU-7603-2021; Iwaï, Hideo/A-6416-2009; Demo, Gabriel/D-7261-2012; Hritz, Jozef/J-6887-2015; Padrta, Petr/AAA-7945-2019; Jansen, Severine/Q-6364-2019; Pekárová, Blanka/E-3560-2012	Wimmerova, Michaela/0000-0002-7108-4198; Zidek, Lukas/0000-0002-8013-0336; Hejatko, Jan/0000-0002-2622-6046; Zidek, Lukas/0000-0002-8013-0336; Marek, Jaromír/0000-0002-6242-7638; Iwaï, Hideo/0000-0001-7376-5264; Demo, Gabriel/0000-0002-5472-9249; Hritz, Jozef/0000-0002-4512-9241; Janda, Lubomir/0000-0002-5406-4208; Gelova, Zuzana/0000-0003-4783-1752	MEYS CR [LM2015043]	MEYS CR	We thank Helmholtz-Zentrum Berlin and EMBL/DESY, operating the DORIS synchrotron, for providing access to their synchrotron data-collection facilities and the allocation of synchrotron radiation beam time, and Dr. Vladimir Rogov of the J.W. Goethe University at Frankfurt for helpful suggestions. CIISB research infrastructure project LM2015043 funded by MEYS CR is gratefully acknowledged for the financial support of the measurements at the Josef Dadok National NMR Centre, CEITEC-Masaryk University.	Banerjee R, 2015, J PHYS CHEM B, V119, P6591, DOI 10.1021/acs.jpcb.5b02582; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; Degtjarik O, 2013, ACTA CRYSTALLOGR F, V69, P158, DOI 10.1107/S174430911205186X; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Ferrage F, 2009, J AM CHEM SOC, V131, P6048, DOI 10.1021/ja809526q; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Grantz AA, 1998, ACTA CRYSTALLOGR D, V54, P690, DOI 10.1107/S0907444997015023; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; HALLE B, 1981, J AM CHEM SOC, V103, P500, DOI 10.1021/ja00393a004; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hung YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160598; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Khalili M, 2008, J PHYS CHEM B, V112, P2456, DOI 10.1021/jp076628e; Klumpler T, 2009, ACTA CRYSTALLOGR F, V65, P478, DOI 10.1107/S1744309109012032; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Long D, 2008, J AM CHEM SOC, V130, P2432, DOI 10.1021/ja710477h; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; Ma L, 2007, J AM CHEM SOC, V129, P10261, DOI 10.1021/ja073059f; McDonald LR, 2013, J MOL BIOL, V425, P2372, DOI 10.1016/j.jmb.2013.04.029; McDonald LR, 2012, STRUCTURE, V20, P1363, DOI 10.1016/j.str.2012.05.008; Morin S, 2014, BIOINFORMATICS, V30, P2219, DOI 10.1093/bioinformatics/btu166; MOY FJ, 1994, BIOCHEMISTRY-US, V33, P10731, DOI 10.1021/bi00201a022; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; Otten R, 2010, J AM CHEM SOC, V132, P17004, DOI 10.1021/ja107410x; Park SY, 2004, P NATL ACAD SCI USA, V101, P11646, DOI 10.1073/pnas.0401038101; Pekarova B, 2016, MOL PLANT, V9, P71, DOI 10.1016/j.molp.2015.11.008; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Podgornaia AI, 2013, STRUCTURE, V21, P1636, DOI 10.1016/j.str.2013.07.005; Pontiggia F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8284; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; Sheftic SR, 2012, BIOCHEMISTRY-US, V51, P6932, DOI 10.1021/bi300922z; Simonovic M, 2001, J BIOL CHEM, V276, P28637, DOI 10.1074/jbc.C100295200; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; Usher KC, 1998, PROTEIN SCI, V7, P403; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vanatta DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8283; Vicha J, 2016, PROTEINS, V84, P686, DOI 10.1002/prot.25019; Villali J, 2014, J MOL BIOL, V426, P1554, DOI 10.1016/j.jmb.2013.12.027; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VOLZ K, 1991, J BIOL CHEM, V266, P15511; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Welch M, 1998, NAT STRUCT BIOL, V5, P25, DOI 10.1038/nsb0198-25; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045	79	4	4	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17525	17540		10.1074/jbc.M117.790212	http://dx.doi.org/10.1074/jbc.M117.790212			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28860196	Green Published, hybrid			2022-12-26	WOS:000414009300032
J	Fernandez-Perez, J; Nanton, A; Ruiz-Ruano, FJ; Camacho, JPM; Mendez, J				Fernandez-Perez, Jenyfer; Nanton, Ana; Ruiz-Ruano, Francisco J.; Camacho, Juan Pedro M.; Mendez, Josefina			First complete female mitochondrial genome in four bivalve species genus Donax and their phylogenetic relationships within the Veneroida order	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; TRANSFER-RNA GENES; DNA CONTROL REGION; MOLLUSCA-BIVALVIA; COELOMACTRA-ANTIQUATA; TANDEM REPEATS; MYTILUS-EDULIS; SOUTHERN PORTUGAL; COMPLETE MTDNA; TRUNCULUS L.	Background Four species of the genus Donax (D. semistriatus, D. trunculus, D. variegatus and D. vittatus) are common on Iberian Peninsula coasts. Nevertheless, despite their economic importance and overexploitation, scarce genetic resources are available. In this work, we newly determined the complete mitochondrial genomes of these four representatives of the family Donacidae, with the aim of contributing to unveil phylogenetic relationships within the Veneroida order, and of developing genetic markers being useful in wedge clam identification and authentication, and aquaculture stock management. Principal findings The complete female mitochondrial genomes of the four species vary in size from 17,044 to 17,365 bp, and encode 13 protein-coding genes ( including the atp8 gene), 2 rRNAs and 22 tRNAs, all located on the same strand. A long non-coding region was identified in each of the four Donax species between cob and cox2 genes, presumably corresponding to the Control Region. The Bayesian and Maximum Likelihood phylogenetic analysis of the Veneroida order indicate that all four species of Donax form a single clade as a sister group of other bivalves within the Tellinoidea superfamily. However, although Tellinoidea is actually monophyletic, none of its families are monophyletic. Conclusions Sequencing of complete mitochondrial genomes provides highly valuable information to establish the phylogenetic relationships within the Veneroida order. Furthermore, we provide here significant genetic resources for further research and conservation of this commercially important fishing resource.	[Fernandez-Perez, Jenyfer; Nanton, Ana; Mendez, Josefina] Univ A Coruna, Grp Xenomar, Dept Biol, Fac Ciencias, Campus A Zapateira, La Coruna, Spain; [Fernandez-Perez, Jenyfer; Nanton, Ana; Mendez, Josefina] Univ A Coruna, CICA, Campus A Zapateira, La Coruna, Spain; [Ruiz-Ruano, Francisco J.; Camacho, Juan Pedro M.] Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain	Universidade da Coruna; Universidade da Coruna; University of Granada	Fernandez-Perez, J (corresponding author), Univ A Coruna, Grp Xenomar, Dept Biol, Fac Ciencias, Campus A Zapateira, La Coruna, Spain.; Fernandez-Perez, J (corresponding author), Univ A Coruna, CICA, Campus A Zapateira, La Coruna, Spain.	jenyfer.fernandez.perez@udc.es	Méndez, Josefina/H-7318-2016; Camacho, Juan Pedro M/L-6869-2014; Ruiz-Ruano, Francisco J./D-8254-2014; Fernandez-Perez, Jenyfer/H-3985-2016	Méndez, Josefina/0000-0002-7567-980X; Camacho, Juan Pedro M/0000-0002-2507-9814; Ruiz-Ruano, Francisco J./0000-0002-5391-301X; Fernandez-Perez, Jenyfer/0000-0001-8417-1541	Ministerio de Economia y Competitividad (Spain) [AGL2016-75288-R AEI/FEDER]	Ministerio de Economia y Competitividad (Spain)	This work was supported by the Ministerio de Economia y Competitividad (Spain) through project AGL2016-75288-R AEI/FEDER, UE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dra D. Martinez Patino and S. Novoa from Centro de Cultivos Marinos de Ribadeo-CIMA (Xunta de Galicia) and Dr. M.B. Gaspar from Instituto Portugues do Mar e da Atmosfera-IPMA (Portugal) for providing specimens. The authors wish to thank the three anonymous reviewers for helpful remarks and suggestions that improved the quality of the manuscript. We also thank Dr. D. Huchon for useful comments during manuscript review. This work was supported by the Ministerio de Economia y Competitividad (Spain) through project AGL2016-75288-R AEI/FEDER, UE.	Ansell A.D., 1983, Developments in Hydrobiology, V19, P607; ANSELL AD, 1980, MAR BIOL, V57, P287, DOI 10.1007/BF00387572; Bao XB, 2016, MITOCHONDRIAL DNA A, V27, P3648, DOI 10.3109/19401736.2015.1079838; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bettinazzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153631; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOORE JL, 1994, GENETICS, V138, P423; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chicharo L, 2002, J MAR BIOL ASSOC UK, V82, P41, DOI 10.1017/S0025315402005167; Combosch DJ, 2017, MOL PHYLOGENET EVOL, V107, P191, DOI 10.1016/j.ympev.2016.11.003; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dong PZ, 2016, MITOCHONDRIAL DNA B, V1, P173, DOI 10.1080/23802359.2016.1149786; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Drummond AJ., 2009, GENEIOUS V4 8 5; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Fernandez A., 2008, REV GAL REC MAR, V2, P1; Fernandez-Perez J, 2017, EST COAST S IN PRESS; Gan HM, 2016, MITOCHONDRIAL DNA A, V27, P3220, DOI 10.3109/19401736.2015.1007355; Gan HM, 2016, MITOCHONDRIAL DNA A, V27, P335, DOI 10.3109/19401736.2014.892104; Gaspar MB, 1999, FISH RES, V41, P309, DOI 10.1016/S0165-7836(99)00017-X; Gaspar MB, 2002, HYDROBIOLOGIA, V477, P73, DOI 10.1023/A:1021009031717; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Glockner G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082857; Gusman A, 2016, PEERJ, V4, DOI 10.7717/peerj.2760; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; He CB, 2011, MOL BIOL REP, V38, P3401, DOI 10.1007/s11033-010-0449-8; HOFFMANN RJ, 1992, GENETICS, V131, P397; Hwang JY, 2016, MITOCHONDRIAL DNA A, V27, P3462, DOI 10.3109/19401736.2015.1066348; Imanishi Y, 2013, FISHERIES SCI, V79, P949, DOI 10.1007/s12562-013-0662-1; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Liu HL, 2016, MITOCHONDRIAL DNA A, V27, P4333, DOI 10.3109/19401736.2015.1089488; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Marie AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep39152; Meng XP, 2012, COMP BIOCHEM PHYS D, V7, P175, DOI 10.1016/j.cbd.2012.02.001; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nanton A, 2015, EUR FOOD RES TECHNOL, V240, P1129, DOI 10.1007/s00217-015-2416-z; Nanton A, 2014, MOL BIOL REP, V41, P5351, DOI 10.1007/s11033-014-3406-0; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ozawa G, 2017, MAR GENOM, V31, P43, DOI 10.1016/j.margen.2016.09.003; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Pereira AM, 2012, FOOD CONTROL, V23, P268, DOI 10.1016/j.foodcont.2011.05.020; Pereira SL, 2000, GENET MOL BIOL, V23, P745, DOI 10.1590/S1415-47572000000400008; Plazzi F, 2016, GENOME BIOL EVOL, V8, P2544, DOI 10.1093/gbe/evw187; Plazzi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-409; Ramon M., 2005, Boletin Instituto Espanol de Oceanografia, V21, P361; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Ren JF, 2009, MITOCHONDR DNA, V20, P78, DOI 10.1080/19401730902964425; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rufino MM, 2010, SCI MAR, V74, P163, DOI 10.3989/scimar.2010.74n1163; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Salas C, 2001, J SEA RES, V46, P43, DOI 10.1016/S1385-1101(01)00064-8; Salas-Casanova C., 1990, P213; Salas-Casanova C., 1987, DONACIDAE BAY MALAGA, V51, P33; Saunier A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0259-z; Shen X, 2016, MITOCHONDRIAL DNA B, V1, P525, DOI 10.1080/23802359.2016.1197064; Shen X, 2014, COMP BIOCHEM PHYS D, V12, P1, DOI 10.1016/j.cbd.2014.08.002; Shen X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-136; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Smith DR, 2007, J MOL EVOL, V65, P380, DOI 10.1007/s00239-007-9016-x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEWART DT, 1995, MOL BIOL EVOL, V12, P735; Sutherland B, 1998, GENETICS, V148, P341; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Thebaud O, 2005, INCIDENCES PISODES E, P88; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Wang HX, 2011, MAR GENOM, V4, P263, DOI 10.1016/j.margen.2011.06.006; Wang HX, 2010, COMP BIOCHEM PHYS D, V5, P256, DOI 10.1016/j.cbd.2010.07.003; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu XY, 2014, GENE, V533, P439, DOI 10.1016/j.gene.2013.09.077; Wu XY, 2012, GENE, V507, P112, DOI 10.1016/j.gene.2012.07.032; Xu XD, 2012, GENE, V494, P17, DOI 10.1016/j.gene.2011.12.002; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; Yuan Y, 2013, GENES GENOM, V35, P693, DOI 10.1007/s13258-013-0120-6; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032353; Yuan Y, 2012, MITOCHONDR DNA, V23, P112, DOI 10.3109/19401736.2011.653802; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zeichen MM, 2002, ESTUAR COAST SHELF S, V54, P971, DOI 10.1006/ecss.2001.0868; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	87	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184464	10.1371/journal.pone.0184464	http://dx.doi.org/10.1371/journal.pone.0184464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886105	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100128
J	Tian, L; Chen, JQ; Zhang, YJ				Tian, Li; Chen, Jiquan; Zhang, Yangjian			Growing season carries stronger contributions to albedo dynamics on the Tibetan plateau	PLOS ONE			English	Article							LAND-SURFACE ALBEDO; QINGHAI-XIZANG PLATEAU; CLIMATE-CHANGE; VEGETATION; SNOW; MODIS; FEEDBACK; IMPACTS; MODELS; CARBON	The Tibetan Plateau has experienced higher-than-global-average climate warming in recent decades, resulting in many significant changes in ecosystem structure and function. Among them is albedo, which bridges the causes and consequences of land surface processes and climate. The plateau is covered by snow/ice and vegetation in the non-growing season (nGS) and growing season (GS), respectively. Based on the MODIS products, we investigated snow/ice cover and vegetation greenness in relation to the spatiotemporal changes of albedo on the Tibetan Plateau from 2000 through 2013. A synchronous relationship was found between the change in GSNDVI and GSalbedo over time and across the Tibetan landscapes. We found that the annual average albedo had a decreasing trend, but that the albedo had slightly increased during the nGS and decreased during the GS. Across the landscapes, the nGSalbedo fluctuated in a synchronous pattern with snow/ice cover. Temporally, monthly snow/ice coverage also had a high correspondence with albedo, except in April and October. We detected clear dependencies of albedo on elevation. With the rise in altitude, the nGSalbedo decreased below 4000 m, but increased for elevations of 4500 - 5500 m. Above 5500 m, the nGSalbedo decreased, which was in accordance with the decreased amount of snow/ice coverage and the increased soil moisture on the plateau. More importantly, the decreasing albedo in the most recent decade appeared to be caused primarily by lowered growing season albedo.	[Tian, Li] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Qianyanzhou Ecol Res Stn, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Tian, Li; Zhang, Yangjian] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Stn, Beijing, Peoples R China; [Chen, Jiquan] Michigan State Univ, CGCEO, E Lansing, MI 48824 USA; [Chen, Jiquan] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Michigan State University; Michigan State University	Tian, L (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Qianyanzhou Ecol Res Stn, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.; Tian, L (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Stn, Beijing, Peoples R China.	tianli@igsnrr.ac.cn	Chen, Jiquan/D-1955-2009	Chen, Jiquan/0000-0003-0761-9458	National Natural Science Foundation of China [41601100]; Project of Science and Technology plan of Institute of Geographic Sciences [Y5V5001JYE]; Project of Natural Resource Research, Chinese Academy of Sciences [Y5V5001JYE]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology plan of Institute of Geographic Sciences; Project of Natural Resource Research, Chinese Academy of Sciences	This research was partially supported by 41601100, www.nsfc.gov.cn, National Natural Science Foundation of China, LT; Y5V5001JYE, the Projects of Science and Technology plan of Institute of Geographic Sciences and Natural Resource Research, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033567; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Blok D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035502; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Brovkin V, 2013, J ADV MODEL EARTH SY, V5, P48, DOI 10.1029/2012MS000169; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; Cierniewski J, 2015, IEEE J-STARS, V8, P493, DOI 10.1109/JSTARS.2014.2330691; Dessler AE, 2013, J CLIMATE, V26, P333, DOI 10.1175/JCLI-D-11-00640.1; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Ghatak D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114008; He T, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021667; He T, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044043; Juszak I, 2014, REMOTE SENS ENVIRON, V153, P79, DOI 10.1016/j.rse.2014.07.021; Lee JY, 2014, J CLIMATE, V27, P3643, DOI 10.1175/JCLI-D-13-00261.1; Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu NF, 2013, HYDROL EARTH SYST SC, V17, P2121, DOI 10.5194/hess-17-2121-2013; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Loarie SR, 2011, NAT CLIM CHANGE, V1, P105, DOI [10.1038/nclimate1067, 10.1038/NCLIMATE1067]; Loranty MM, 2014, GLOBAL CHANGE BIOL, V20, P594, DOI 10.1111/gcb.12391; MacDonald GM, 2008, PHILOS T R SOC B, V363, P2285, DOI 10.1098/rstb.2007.2200; Moore GWK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021046; Myers-Smith IH, 2015, NAT CLIM CHANGE, V5, P887, DOI [10.1038/nclimate2697, 10.1038/NCLIMATE2697]; Nicholas CS, 2001, J CLIMATE, V14, P1360; Oleson KW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016749; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Pistone K, 2014, P NATL ACAD SCI USA, V111, P3322, DOI 10.1073/pnas.1318201111; Pu ZX, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029262; Qin J, 2009, CLIMATIC CHANGE, V97, P321, DOI 10.1007/s10584-009-9733-9; Rangwala I, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024040; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Rangwala I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037245; Refslund J, 2013, IAHS-AISH P, V359, P233; Riihela A, 2013, NAT CLIM CHANGE, V3, P895, DOI [10.1038/NCLIMATE1963, 10.1038/nclimate1963]; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Schaphoff S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014026; Scherrer SC, 2012, THEOR APPL CLIMATOL, V110, P509, DOI 10.1007/s00704-012-0712-0; Seidel DJ, 2014, NAT CLIM CHANGE, V4, P93, DOI 10.1038/NCLIMATE2076; SELLERS PJ, 1995, REMOTE SENS ENVIRON, V51, P3, DOI 10.1016/0034-4257(94)00061-Q; Song CQ, 2013, REMOTE SENS ENVIRON, V135, P25, DOI 10.1016/j.rse.2013.03.013; Sturm M, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000013; Tao J, 2014, THEOR APPL CLIMATOL, V117, P61, DOI 10.1007/s00704-013-0976-z; Tian L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104001; Wang KC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004229; Warren SG, 2013, J GEOPHYS RES-ATMOS, V118, P779, DOI 10.1029/2012JD018476; Xu W, 2016, J CLIMATE; Yang JT, 2013, INT GEOSCI REMOTE SE, P1182, DOI 10.1109/IGARSS.2013.6721377; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yang Q.-Y., 1982, PHYS GEOGRAPHY XIZAN; Yang XG, 2011, AGR SCI CHINA, V10, P585, DOI 10.1016/S1671-2927(11)60040-0; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang WJ, 2015, REMOTE SENS-BASEL, V7, P16607, DOI 10.3390/rs71215847	56	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0180559	10.1371/journal.pone.0180559	http://dx.doi.org/10.1371/journal.pone.0180559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886037	gold, Green Published, Green Submitted			2022-12-26	WOS:000410001100001
J	Chen, LL; Zhu, J; Schumacher, J; Wei, CJ; Ramdas, L; Prieto, VG; Jimenez, A; Velasco, MA; Tripp, SR; Andtbacka, RHI; Gouw, L; Rodgers, GM; Zhang, LS; Chan, BK; Cassidy, PB; Benjamin, RS; Leachman, SA; Frazier, ML				Chen, Lei L.; Zhu, Jing; Schumacher, Jonathan; Wei, Chongjuan; Ramdas, Latha; Prieto, Victor G.; Jimenez, Arnie; Velasco, Marco A.; Tripp, Sheryl R.; Andtbacka, Robert H. I.; Gouw, Launce; Rodgers, George M.; Zhang, Liansheng; Chan, Benjamin K.; Cassidy, Pamela B.; Benjamin, Robert S.; Leachman, Sancy A.; Frazier, Marsha L.			SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally-and spatially-precise nitric oxide to modulate SCF-and or KIT-expressing cell functions	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; CHRONIC MYELOID-LEUKEMIA; TYROSINE-HYDROXYLASE ACTIVITY; RAT ANTERIOR HYPOTHALAMUS; CHRONIC MYELOGENOUS LEUKEMIA; ARTERIAL OCCLUSIVE DISEASE; MIGRATING MOTOR COMPLEX; ENTERIC NERVOUS-SYSTEM; SMOOTH-MUSCLE-CELLS; C-KIT	We demonstrate that SCF-KIT signaling induces synthesis and secretion of endothelin-3 (ET3) in human umbilical vein endothelial cells and melanoma cells in vitro, gastrointestinal stromal tumors, human sun-exposed skin, and myenteric plexus of human colon post-fasting in vivo. This is the first report of a physiological mechanism of ET3 induction. Integrating our finding with supporting data from literature leads us to discover a previously unreported pathway of nitric oxide (NO) generation derived from physiological endothelial NO synthase (eNOS) or neuronal NOS (nNOS) activation (referred to as the KIT-ET3-NO pathway). It involves: (1) SCF-expressing cells communicate with neighboring KIT-expressing cells directly or indirectly (cleaved soluble SCF). (2) SCF-KIT signaling induces timely local ET3 synthesis and secretion. (3) ET3 binds to ETBR on both sides of intercellular space. (4) ET3-binding-initiated-ETBR activation increases cytosolic Ca2+, activates cell-specific eNOS or nNOS. (5) Temporally-and spatially-precise NO generation. NO diffuses into neighboring cells, thus acts in both SCF-and KIT-expressing cells. (6) NO modulates diverse cell-specific functions by NO/cGMP pathway, controlling transcriptional factors, or other mechanisms. We demonstrate the critical physiological role of the KIT-ET3-NO pathway in fulfilling high demand (exceeding basal level) of endothelium-dependent NO generation for coping with atherosclerosis, pregnancy, and aging. The KIT-ET3-NO pathway most likely also play critical roles in other cell functions that involve dual requirement of SCF-KIT signaling and NO. New strategies (e.g. enhancing the KIT-ET3-NO pathway) to harness the benefit of endogenous eNOS and nNOS activation and precise NO generation for correcting pathophysiology and restoring functions warrant investigation.	[Chen, Lei L.; Benjamin, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma, Houston, TX 77030 USA; [Zhu, Jing; Wei, Chongjuan; Frazier, Marsha L.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Schumacher, Jonathan; Tripp, Sheryl R.; Rodgers, George M.] ARUP Labs, Salt Lake City, UT USA; [Ramdas, Latha] Univ Texas MD Anderson Canc Ctr, Res Informat Serv & Technol, Houston, TX 77030 USA; [Prieto, Victor G.] Univ Texas MD Anderson Canc Ctr, Pathol, Houston, TX 77030 USA; [Jimenez, Arnie; Velasco, Marco A.] Vel Lab Res, Missouri City, TX USA; [Andtbacka, Robert H. I.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Gouw, Launce; Rodgers, George M.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Zhang, Liansheng] Lanzhou Univ, Dept Hematol & Oncol, Hosp 2, Lanzhou, Gansu, Peoples R China; [Chan, Benjamin K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Cassidy, Pamela B.; Leachman, Sancy A.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Frazier, Marsha L.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Cassidy, Pamela B.; Leachman, Sancy A.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Lanzhou University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University	Chen, LL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Sarcoma, Houston, TX 77030 USA.	leileichen7@gmail.com	De Velasco, Marco/R-1022-2019; Stefanadis, Christodoulos/ABH-2232-2020	De Velasco, Marco/0000-0002-4011-6572; Stefanadis, Christodoulos/0000-0001-5974-6454				Agaram NP, 2008, CLIN CANCER RES, V14, P3204, DOI 10.1158/1078-0432.CCR-07-1984; Aichberger KJ, 2011, AM J HEMATOL, V86, P533, DOI 10.1002/ajh.22037; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Al-Shboul OA, 2013, SAUDI J GASTROENTERO, V19, P3, DOI 10.4103/1319-3767.105909; Amyere M, 2011, J INVEST DERMATOL, V131, P1234, DOI 10.1038/jid.2011.29; Anita I, 2006, CELL MOL NEUROBIOL, V26, P703, DOI 10.1007/s10571-006-9111-3; Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Ari G, 1996, EUR J PHARMACOL, V307, P69, DOI 10.1016/0014-2999(96)00172-0; AYE MT, 1992, EXP HEMATOL, V20, P523; Bacon CR, 1996, BRIT J PHARMACOL, V117, P986, DOI 10.1111/j.1476-5381.1996.tb15292.x; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Balez R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3806157; Bantubungi K, 2008, MOL CELL NEUROSCI, V37, P454, DOI 10.1016/j.mcn.2007.11.001; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P399, DOI 10.1113/jphysiol.2009.181172; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Bouallegue A, 2007, AM J PHYSIOL-HEART C, V293, pH2072, DOI 10.1152/ajpheart.01097.2006; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; Brand M, 1998, J CLIN INVEST, V101, P549, DOI 10.1172/JCI524; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; BROUDY VC, 1994, BLOOD, V83, P2145; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Casey DP, 2011, J PHYSIOL-LONDON, V589, P1477, DOI 10.1113/jphysiol.2010.203539; Chang HR, 2003, ARCH DERMATOL RES, V295, P293, DOI 10.1007/s00403-003-0433-4; Chen LL, 2008, MODERN PATHOL, V21, P826, DOI 10.1038/modpathol.2008.46; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Coon EA, 2013, AM J HEMATOL, V88, P534, DOI 10.1002/ajh.23442; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Deliu E, 2012, J BIOL CHEM, V287, P41023, DOI 10.1074/jbc.M112.418533; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Desjardins F, 2006, ACTA CLIN BELG, V61, P326, DOI 10.1179/acb.2006.052; Di Nunzio AS, 2002, AM J PHYSIOL-REG I, V283, pR615, DOI 10.1152/ajpregu.00026.2002; Dickson EJ, 2010, AM J PHYSIOL-GASTR L, V298, pG222, DOI 10.1152/ajpgi.00399.2009; Herrera MD, 2010, AGEING RES REV, V9, P142, DOI 10.1016/j.arr.2009.07.002; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Emole J, 2016, BIOL-TARGETS THER, V10, P23, DOI 10.2147/BTT.S67844; EMORI T, 1991, BIOCHEM BIOPH RES CO, V174, P228, DOI 10.1016/0006-291X(91)90510-E; Feng ZC, 2012, DIABETOLOGIA, V55, P2214, DOI 10.1007/s00125-012-2566-5; FUKUDA N, 1990, BIOCHEM BIOPH RES CO, V167, P739, DOI 10.1016/0006-291X(90)92087-G; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia RJ, 2008, J INVEST DERMATOL, V128, P131, DOI 10.1038/sj.jid.5700948; Gil V, 2010, AM J PHYSIOL-GASTR L, V299, pG158, DOI 10.1152/ajpgi.00448.2009; Giri U, 2006, INT J RADIAT ONCOL, V64, P670, DOI 10.1016/j.ijrobp.2005.08.032; Grichnik JM, 1996, J INVEST DERMATOL, V106, P967, DOI 10.1111/1523-1747.ep12338471; Gugliotta G, 2015, HAEMATOLOGICA, V100, P1146, DOI 10.3324/haematol.2015.129221; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hasegawa J, 2008, PIGM CELL MELANOMA R, V21, P687, DOI 10.1111/j.1755-148X.2008.00492.x; Hebeiss K, 1998, NEUROSCIENCE, V82, P623; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herrmann J, 2016, CIRCULATION, V133, P1272, DOI 10.1161/CIRCULATIONAHA.115.018347; Herrmann J, 2014, TRENDS CARDIOVAS MED, V24, P285, DOI 10.1016/j.tcm.2014.07.003; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Holden JA, 2007, AM J CLIN PATHOL, V128, P230, DOI 10.1309/7TEH56K6WWXENNQY; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; Hu CH, 2010, CLIN EXP PHARMACOL P, V37, P551, DOI 10.1111/j.1440-1681.2010.05347.x; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iino S, 2008, NEUROSCIENCE, V152, P437, DOI 10.1016/j.neuroscience.2007.12.044; Ikuta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144561; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Ishii S, 2009, J GASTROENTEROL, V44, P834, DOI 10.1007/s00535-009-0077-z; Ito M, 1999, J INVEST DERMATOL, V112, P796, DOI 10.1046/j.1523-1747.1999.00552.x; Jaureguiberry MS, 2004, PEPTIDES, V25, P1133, DOI 10.1016/j.peptides.2004.04.005; Jezierski A, 2012, J NEUROSCI RES, V90, P2362, DOI 10.1002/jnr.23118; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kapakos G, 2010, CURR CARDIOL REV, V6, P247, DOI 10.2174/157340310793566055; Kawaguchi Y, 2001, J INVEST DERMATOL, V116, P920, DOI 10.1046/j.0022-202x.2001.01370.x; Kim BJ, 2012, CELL PHYSIOL BIOCHEM, V30, P359, DOI 10.1159/000339070; Kim TD, 2013, LEUKEMIA, V27, P1316, DOI 10.1038/leu.2013.70; Kohgami S, 2010, NEUROL RES, V32, P938, DOI 10.1179/016164110X12681290831243; Krishnamurthy M, 2007, ENDOCRINOLOGY, V148, P5520, DOI 10.1210/en.2007-0387; Kristensen Tilde, 2012, Leuk Res Rep, V1, P1, DOI 10.1016/j.lrr.2012.09.002; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Kurohane K.Y., 2013, J PHARM SCI, V123, P295; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Lattmann T, 2005, BIOCHEM BIOPH RES CO, V327, P234, DOI 10.1016/j.bbrc.2004.11.160; Le Coutre P, 2011, J NATL CANCER I, V103, P1347, DOI 10.1093/jnci/djr292; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Lees-Green R, 2014, AM J PHYSIOL-GASTR L, V306, pG711, DOI 10.1152/ajpgi.00449.2013; Levato L, 2013, EUR J HAEMATOL, V90, P531, DOI 10.1111/ejh.12096; Li JM, 2006, INT J BIOCHEM CELL B, V38, P961, DOI 10.1016/j.biocel.2005.08.014; Liang J, 2013, INT J BIOL SCI, V9, P435, DOI 10.7150/ijbs.6087; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; Contreras DL, 2006, PHARMACOL THERAPEUT, V112, P553, DOI 10.1016/j.pharmthera.2006.05.003; MAEDA H, 1992, DEVELOPMENT, V116, P369; Magness RR, 2001, AM J PHYSIOL-HEART C, V280, pH1692, DOI 10.1152/ajpheart.2001.280.4.H1692; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Mathison Y, 1998, BRAIN RES BULL, V45, P15, DOI 10.1016/S0361-9230(97)00274-8; Mathison Y, 2002, CELL MOL NEUROBIOL, V22, P783, DOI 10.1023/A:1021817326632; Mazzuca MQ, 2014, HYPERTENSION, V64, P632, DOI 10.1161/HYPERTENSIONAHA.114.03315; Mazzuca MQ, 2013, BRIT J PHARMACOL, V169, P1335, DOI 10.1111/bph.12225; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; McIlhenny S, 2015, J TISSUE ENG REGEN M, V9, P1277, DOI 10.1002/term.1645; McLean SR, 2005, MOL CANCER THER, V4, P2008, DOI 10.1158/1535-7163.MCT-05-0070; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Mirault T, 2015, EUR J HAEMATOL, V94, P363, DOI 10.1111/ejh.12367; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Morgazo C, 2005, BIOCHEM BIOPH RES CO, V334, P796, DOI 10.1016/j.bbrc.2005.06.168; Mori F, 2000, INVEST OPHTH VIS SCI, V41, P3955; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; NAMIKI A, 1992, LIFE SCI, V50, P677, DOI 10.1016/0024-3205(92)90470-A; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; OWADA A, 1994, J CLIN INVEST, V93, P556, DOI 10.1172/JCI117007; Perfume G, 2008, AM J PHYSIOL-REG I, V294, pR905, DOI 10.1152/ajpregu.00555.2007; Perfume G, 2007, REGUL PEPTIDES, V142, P69, DOI 10.1016/j.regpep.2007.01.011; Picardo M, 2011, J INVEST DERMATOL, V131, P1182, DOI 10.1038/jid.2011.67; Quaschning T, 2005, J HYPERTENS, V23, P979, DOI 10.1097/01.hjh.0000166838.55688.7e; Quintas-Cardama A, 2012, CL LYMPH MYELOM LEUK, V12, P337, DOI 10.1016/j.clml.2012.04.005; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ro S, 2006, AM J PHYSIOL-GASTR L, V290, pG710, DOI 10.1152/ajpgi.00420.2005; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sobrevia L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9782346; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Tasigna [Nilotinib] highlights of prescribing information initial US approval: 2007, 2015, TASIGNA NILOTINIB HI; Tefferi A, 2013, LEUKEMIA, V27, P1939, DOI 10.1038/leu.2013.112; Tefferi A, 2011, AM J HEMATOL, V86, P610, DOI 10.1002/ajh.22051; Tirapelli CR, 2005, BRIT J PHARMACOL, V146, P903, DOI 10.1038/sj.bjp.0706388; Tong WD, 2010, SCAND J GASTROENTERO, V45, P844, DOI 10.3109/00365521003782371; Torihashi S, 1996, BRAIN RES, V738, P323, DOI 10.1016/S0006-8993(96)00935-3; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Valent P, 2015, BLOOD, V125, P901, DOI 10.1182/blood-2014-09-594432; Verma S, 2003, CIRCULATION, V108, P2054, DOI 10.1161/01.CIR.0000089191.72957.ED; Walsh T, 2009, J AM GERIATR SOC, V57, P140, DOI 10.1111/j.1532-5415.2008.02051.x; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Weller R, 2003, AM J PHYSIOL-CELL PH, V284, pC1140, DOI 10.1152/ajpcell.00462.2002; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; WOOD JD, 1973, AM J DIG DIS, V18, P477, DOI 10.1007/BF01076598; Yamada K, 1999, J PHARMACOL EXP THER, V290, P1175; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yetik-Anacak G, 2006, VASC PHARMACOL, V45, P268, DOI 10.1016/j.vph.2006.08.002; YOHN JJ, 1994, BBA-MOL CELL RES, V1224, P454, DOI 10.1016/0167-4889(94)90282-8; Yoshida H, 1996, DEV DYNAM, V207, P222; Zhong WM, 2008, DEV CELL, V15, P635, DOI 10.1016/j.devcel.2008.10.012	149	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184154	10.1371/journal.pone.0184154	http://dx.doi.org/10.1371/journal.pone.0184154			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880927	Green Published, Green Submitted, gold			2022-12-26	WOS:000409467200037
J	Zhang, XB; Zhao, YP; Guo, LP; Qiu, ZD; Huang, LQ; Qu, XB				Zhang, Xiaobo; Zhao, Yuping; Guo, Lanping; Qiu, Zhidong; Huang, Luqi; Qu, Xiaobo			Differences in chemical constituents of Artemisia annua L from different geographical regions in China	PLOS ONE			English	Article								Background Daodi-herb is a part of Chinese culture, which has been naturally selected by traditional Chinese medicine clinical practice for many years. Sweet wormwood herb is a kind of Daodiherb, and comes from Artemisia annua L. Artemisinin is a kind of effective antimalarial drug being extracted from A. annua. Because of artemisinin, Sweet wormwood herb earns a reputation. Based on the Pharmacopoeia of the People's Republic of China (PPRC), Sweet wormwood herb can be used to resolve summerheat-heat, and prevent malaria. Besides, it also has other medical efficacies. A. annua, a medicinal plant that is widely distributed in the world contains many kinds of chemical composition. Research has shown that compatibility of artemisinin, scopoletin, arteannuin B and arteannuic acid has antimalarial effect. Compatibility of scopoletin, arteannuin B and arteannuic acid is conducive to resolving summerheatheat. Chemical constituents in A. annua vary significantly according to geographical locations. So, distribution of A. annua may play a key role in the characteristics of efficacy and chemical constituents of Sweet wormwood herb. It is of great significance to study this relationship. Objectives We mainly analyzed the relationship between the chemical constituents (arteannuin B, artemisinin, artemisinic acid, and scopoletin) with special efficacy in A. annua that come from different provinces in china, and analyzed the relationship between chemical constituents and spatial distribution, in order to find out the relationship between efficacy, chemical constituents and distribution. Methods A field survey was carried out to collect A. annua plant samples. A global positioning system (GPS) was used for obtaining geographical coordinates of sampling sites. Chemical constituents in A. annua were determined by liquid chromatography tandem an atmospheric pressure ionization-electrospray mass spectrometry. Relationship between chemical constituents including proportions, correlation analysis (CoA), principal component analysis (PCA) and cluster analysis (ClA) was displayed through Excel and R software version2.3.2 (R), while the one between efficacy, chemical constituents and spatial distribution was presented through ArcGIS10.0, Excel and R software. Results According to the results of CoA, arteannuin B content presented a strong positive correlation with artemisinic acid content (p = 0), and a strong negative correlation with artemisinin content (p = 0). Scopoletin content presented a strong positive correlation with artemisinin content (p = 0), and a strong negative correlation with artemisinic acid content (p = 0). According to the results of PCA, the first two principal components accounted for 81.57% of the total accumulation contribution rate. The contribution of the first principal component is about 45.12%, manly including arteannuin B and artemisinic acid. The contribution of the second principal component is 36.45% of the total, manly including artemisinin and scopoletin. According to the ClA by using the principal component scores, 19 provinces could be divided into two groups. In terms of provinces in group one, the proportions of artemisinin are all higher than 80%. Based on the results of PCA, ClA, percentages and scatter plot analysis, chemical types are defined as "QHYS type", "INT type" and "QHS type." Conclusion As a conclusion, this paper shows the relationship between efficacy, chemical constituents and distribution. Sweet wormwood herb with high arteannuin B and artemisinic acid content, mainly distributes in northern China. Sweet wormwood herb with high artemisinin and scopoletin content has the medical function of preventing malaria, which mainly distributes in southern China. In this paper, it is proved that Sweet wormwood Daodi herb growing in particular geographic regions, has more significant therapeutical effect and higher chemical constituents compared with other same kind of CMM. And also, it has proved the old saying in China that Sweet wormwood Daodi herb which has been used to resolve summerheatheat and prevent malaria, which distributed in central China. But in modern time, Daodi Sweet wormwood herb mainly has been used to extract artemisinin and prevent malaria, so the Daod-region has transferred to the southern China.	[Zhang, Xiaobo; Qiu, Zhidong; Qu, Xiaobo] Changchun Univ Chinese Med, Coll Pharm, Changchun, Jilin, Peoples R China; [Zhang, Xiaobo; Guo, Lanping; Huang, Luqi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, State Key Lab Breeding Base Dao di Herbs, Beijing, Peoples R China; [Zhao, Yuping] China Acad Chinese Med Sci, Beijing, Peoples R China	Changchun University of Chinese Medicine; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS; China Academy of Chinese Medical Sciences	Qu, XB (corresponding author), Changchun Univ Chinese Med, Coll Pharm, Changchun, Jilin, Peoples R China.; Huang, LQ (corresponding author), China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, State Key Lab Breeding Base Dao di Herbs, Beijing, Peoples R China.	jack110007@163.com; quxiaobo0727@163.com			Independent topics of the Chinese Academy of traditional Chinese Medicine [zz0708121, 2011zdxk]; Science and technology basic work of science and technology [2013FY114500]; Key project at central government level [2060302]	Independent topics of the Chinese Academy of traditional Chinese Medicine; Science and technology basic work of science and technology; Key project at central government level	This study was supported by the Independent topics of the Chinese Academy of traditional Chinese Medicine (No. zz0708121, 2011zdxk), the Science and technology basic work of science and technology (No. 2013FY114500), and Key project at central government level (No. 2060302). The funders played no role in the design of the study, data collection and analysis or the decision to publish and prepare the manuscript.	Chen KJ, 2009, INTEGRATION MED RECO, P1589; China Association Of traditional Chinese Medicine, 2015, 102015 ZGZYXT CHIN A; Chinese Pharmacopoeia Commission, 2015, CHIN PHARM, P198; Ji Xiao-Guang, 2008, Jishengchong Yu Yixue Kunchong Xuebao, V15, P198; Li LF, 2009, CHINESE J EXPT TRADI, V12, P65; Shi KY, 2007, CHINA PHARM, V10, P25; Wang HongBo, 2011, Drugs and Clinic, V26, P430; Wang Huan, 2015, Zhong Yao Cai, V38, P460; Zhang MX, 2015, SCI TECHNOLOGY IND C, V10, P44; Zhang RS, 2008, CHEM IND FOREST PROD, V28, P84; Zhang Xiao-bo, 2011, Yaoxue Xuebao, V46, P472; [张小波 ZHANG Xiaobo], 2011, [生态学报, Acta Ecologica Sinica], V31, P5299	12	18	19	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183047	10.1371/journal.pone.0183047	http://dx.doi.org/10.1371/journal.pone.0183047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880869	gold, Green Published, Green Submitted			2022-12-26	WOS:000409467200012
J	Han, K; Bose, S; Wang, JH; Lim, SK; Chin, YW; Kim, YM; Choi, HS; Kim, H				Han, Kyungsun; Bose, Shambhunath; Wang, Jing-Hua; Lim, Soo-kyoung; Chin, Young-Won; Kim, Young-Mi; Choi, Han-Seok; Kim, Hojun			In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis	PLOS ONE			English	Article							GUT MICROBIOTA; FLAVONOIDS; ROOT; FXR; RECEPTORS	The radix of Scutellaria baicalensis (SB) is a herb widely used in traditional Chinese medicine to treat metabolic diseases. Several main components, including baicalin and wogonoside, possess anti-dyslipidemia, anti-obesity and anti-diabetic effects. We hypothesized that co-administration of SB extract and metformin exerts a better effect on obesity-induced insulin resistance and lipid metabolism than treatment with metformin alone. We compared the effect of metformin (100 mg/10 mL/kg/day) alone with co-administration of metformin (100 mg/5 mL/kg/day) and SB extract (200 mg/5 mL/kg/day) on Otsuka Long Evans Tokushima Fatty rats, a useful model of type II diabetes with obesity, and used Long-Evans Tokushima Otsuka rats as a control. Weight, fasting glucose, oral glucose tolerance test, intraperitoneal insulin tolerance test, and serum total cholesterol were measured after 12 weeks of drug administration. We observed a synergetic effect of metformin and SB on lowering cholesterol level by excretion of bile acid through feces. We found that this accompanied activation of FXR, CYP7A1 and LDLR genes and repression of HMGCR in the liver. Although there were no significant changes in BSH-active gut microbiota due to high variability, functional prediction with 16S sequences showed increased primary and secondary bile acid biosynthesis in the combination treatment group. Further study is needed to find the specific strains of bacteria which contribute to FXR-related cholesterol and bile acid regulations.	[Han, Kyungsun; Wang, Jing-Hua; Lim, Soo-kyoung; Kim, Hojun] Dongguk Univ, Korean Med, Dept Rehabil Med, Goyang, Gyeonggi Do, South Korea; [Han, Kyungsun] Korea Inst Oriental Med, Clin Res Div, Daejeon, South Korea; [Bose, Shambhunath] Appl Surface Technol Inc, Adv Inst Convergence Technol, 11th Floor,Bldg A, Suwon, South Korea; [Chin, Young-Won; Kim, Young-Mi] Dongguk Univ, Coll Pharm, Goyang, Gyeonggi Do, South Korea; [Choi, Han-Seok] Dongguk Univ, Dept Endocrinol, Goyang, Gyeonggi Do, South Korea	Dongguk University; Korea Institute of Oriental Medicine (KIOM); Dongguk University; Dongguk University	Kim, H (corresponding author), Dongguk Univ, Korean Med, Dept Rehabil Med, Goyang, Gyeonggi Do, South Korea.	kimklar@dongguk.ac.kr	Kim, Hojun/AAB-8405-2020; Choi, Han Seok/AAG-1493-2019; Wang, Jing-hua/AAO-2350-2020; Han, Kyungsun/AAG-1044-2020	Wang, Jing-hua/0000-0002-2034-7429; Han, Kyungsun/0000-0002-9710-7845; Bose, Shambunath/0000-0003-0737-5713; Chin, Young-Won/0000-0001-6964-1779; Kim, Hojun/0000-0003-1038-0142	Convergence of Conventional Medicine and Traditional Korean Medicine R&D program - Ministry of Health and Welfare through the KHIDI (Korea Health Industry Development Institute) [HI14C0558]	Convergence of Conventional Medicine and Traditional Korean Medicine R&D program - Ministry of Health and Welfare through the KHIDI (Korea Health Industry Development Institute)	This work was supported by the grant of Convergence of Conventional Medicine and Traditional Korean Medicine R&D program funded by the Ministry of Health and Welfare through the KHIDI (Korea Health Industry Development Institute, HI14C0558). Author Shambhunath Bose receives a salary from Applied Surface Technology, Inc. The specific roles of this author are articulated in the 'author contributions' section. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; FDA, 2005, GUID IND EST MAX SAF; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Heo HJ, 2004, J AGR FOOD CHEM, V52, P4128, DOI 10.1021/jf049953x; Horvath CR, 2005, J CHROMATOGR A, V1062, P199, DOI 10.1016/j.chroma.2004.11.030; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Huang WH, 2003, CHEM PHARM BULL, V51, P339; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jung HS, 2012, J ETHNOPHARMACOL, V141, P345, DOI 10.1016/j.jep.2012.02.044; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim EH, 2009, J ETHNOPHARMACOL, V126, P320, DOI 10.1016/j.jep.2009.08.027; Kovacs G, 2004, CHROMATOGRAPHIA, V60, pS81, DOI 10.1365/s10337-004-0266-0; Kroliczewska B, 2011, J ANIM PHYSIOL AN N, V95, P114, DOI 10.1111/j.1439-0396.2010.01033.x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li GJ, 2012, PROCEDIA ENVIRON SCI, V12, P1180, DOI 10.1016/j.proenv.2012.01.405; Li HB, 2005, J CHROMATOGR A, V1074, P107, DOI 10.1016/j.chroma.2005.03.088; Lien F, 2014, J CLIN INVEST, V124, P1037, DOI 10.1172/JCI68815; Mazuy C, 2015, CELL MOL LIFE SCI, V72, P1631, DOI 10.1007/s00018-014-1805-y; NAGAI T, 1995, ANTIVIR RES, V26, P11, DOI 10.1016/0166-3542(94)00062-D; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Popescu IR, 2010, FEBS LETT, V584, P2845, DOI 10.1016/j.febslet.2010.04.068; Pu P, MOL CELL ENDOCRINOL; Ridlon JM, 2013, GUT MICROBES, V4, P382, DOI 10.4161/gmic.25723; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seo MJ, 2014, FOOD CHEM TOXICOL, V67, P57, DOI 10.1016/j.fct.2014.02.009; Song KH, 2013, PHYTOTHER RES, V27, P244, DOI 10.1002/ptr.4691; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Waisundara VY, 2008, AM J CHINESE MED, V36, P517, DOI 10.1142/S0192415X08005953; Wilson ID, 2009, CURR PHARM DESIGN, V15, P1519, DOI 10.2174/138161209788168173; Woudenberg-Vrenken TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071773; Wulffele MG, 2004, J INTERN MED, V256, P1, DOI 10.1111/j.1365-2796.2004.01328.x; Ye F, 2002, J ALTERN COMPLEM MED, V8, P567, DOI 10.1089/107555302320825075; Zhang X, 2015, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-015-0050-0; Zheng Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-87; 윤혜진, 2010, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V39, P219	42	33	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0182467	10.1371/journal.pone.0182467	http://dx.doi.org/10.1371/journal.pone.0182467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877164	Green Published, gold			2022-12-26	WOS:000409391200014
J	Scrivo, R; Massaro, L; Barbati, C; Vomero, M; Ceccarelli, F; Spinelli, FR; Riccieri, V; Spagnoli, A; Alessandri, C; Desideri, G; Conti, F; Valesini, G				Scrivo, Rossana; Massaro, Laura; Barbati, Cristiana; Vomero, Marta; Ceccarelli, Fulvia; Spinelli, Francesca Romana; Riccieri, Valeria; Spagnoli, Alessandra; Alessandri, Cristiano; Desideri, Giovambattista; Conti, Fabrizio; Valesini, Guido			The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DISEASE-ACTIVITY; AMERICAN-COLLEGE; INVOLVEMENT; AUTOIMMUNE; INDUCTION; RECEPTOR; T(H)17; RISK; DIFFERENTIATION	We aimed at investigating whether the frequency and function of T helper 17 (Th17) and regulatory T cells (Treg) are affected by a restriction of dietary sodium intake in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). We enrolled RA and SLE patients not receiving drugs known to increase urinary sodium excretion. Patients underwent a dietary regimen starting with a restricted daily sodium intake followed by a normal-sodium daily intake. The timepoints were identified at baseline (T0), after 3 weeks of low-sodium dietary regimen (T3), after 2 weeks of normal-sodium dietary regimen (T5). On these visits, we measured the 24-hour urinary sodium excretion, the frequency and function of Th17 and Treg cells in the peripheral blood, the serum levels of cytokines. Analysis of urinary sodium excretion confirmed adherence to the dietary regimen. In RA patients, a trend toward a reduction in the frequencies of Th17 cells over the low-sodium dietary regimen followed by an increase at T5 was observed, while Treg cells exhibited the opposite trend. SLE patients showed a progressive reduction in the percentage of Th17 cells that reached a significance at T5 compared to T0 (p = 0.01) and an increase in the percentage of Treg cells following the low-sodium dietary regimen at both T1 and T3 compared to T0 (p = 0.04 and p = 0.02, respectively). No significant apoptosis or proliferation modulation was found. In RA patients, we found a reduction at T5 compared to T0 in serum levels of both TGF beta (p = 0.0016) and IL-9 (p = 0.0007); serum IL-9 levels were also reduced in SLE patients at T5 with respect to T0 (p = 0.03). This is the first study investigating the effects of dietary sodium intake on adaptive immunity. Based on the results, we hypothesize that a restricted sodium dietary intake may dampen the inflammatory response in RA and SLE patients.	[Scrivo, Rossana; Massaro, Laura; Barbati, Cristiana; Vomero, Marta; Ceccarelli, Fulvia; Spinelli, Francesca Romana; Riccieri, Valeria; Alessandri, Cristiano; Conti, Fabrizio; Valesini, Guido] Sapienza Univ Rome, Rheumatol, Dept Internal Med & Med Specialties, Rome, Italy; [Spagnoli, Alessandra] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Desideri, Giovambattista] Univ Aquila, Dept Life Hlth & Environm Sci, Geriatr Unit, Laquila, Italy	Sapienza University Rome; Sapienza University Rome; University of L'Aquila	Valesini, G (corresponding author), Sapienza Univ Rome, Rheumatol, Dept Internal Med & Med Specialties, Rome, Italy.	guido.valesini@uniroma1.it	Spagnoli, Alessandra/GON-4656-2022; Vomero, Marta/AAC-6074-2022; Desideri, Giovambattista/AAB-5079-2022; Riccieri, Valeria/AAC-6079-2022; Spinelli, Francesca Romana/AAM-7061-2020	Spagnoli, Alessandra/0000-0002-7772-3130; Vomero, Marta/0000-0001-9744-5628; Riccieri, Valeria/0000-0002-7507-5483; Spinelli, Francesca Romana/0000-0003-1969-2097; Scrivo, Rossana/0000-0002-2889-8962; Alessandri, Cristiano/0000-0003-4149-5321; Valesini, Guido/0000-0002-7757-8092; DESIDERI, Giovambattista/0000-0002-0145-1271	Progetti d'Ateneo, Sapienza Universita di Roma [C26H15RWHN]	Progetti d'Ateneo, Sapienza Universita di Roma	This work was supported by Grandi Ricerche Universitarie 2015, prot. C26H15RWHN (Progetti d'Ateneo, Sapienza Universita di Roma). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Amara Suneetha, 2016, Biochem Biophys Rep, V7, P1; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Ciccia F, 2015, RHEUMATOLOGY, V54, P2264, DOI 10.1093/rheumatology/kev252; D'Elia L, 2014, CANCER TREAT RES, V159, P83, DOI 10.1007/978-3-642-38007-5_6; Dantas AT, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/519638; European Heart Network, 2011, DIET PHYS ACT CARD D; Farez MF, 2015, J NEUROL NEUROSUR PS, V86, P26, DOI 10.1136/jnnp-2014-307928; Fukuda M, 2008, J HYPERTENS, V26, P583, DOI 10.1097/HJH.0b013e3282f2fded; Giovannetti A, 2007, J IMMUNOL, P178; Gladman DD, 2002, J RHEUMATOL, V29, P288; Nagy G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/351732; He J, 2016, CLIN RHEUMATOL, V35, P2901, DOI 10.1007/s10067-016-3383-x; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Hucke S, 2016, J AUTOIMMUN, V67, P90, DOI 10.1016/j.jaut.2015.11.001; Kaplan NM, 2000, AM J CLIN NUTR, V71, P1020; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; NAVIS G, 1987, J CARDIOVASC PHARM, V9, P743, DOI 10.1097/00005344-198706000-00016; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Pierdominici M, 2005, J PHARMACOL EXP THER, V315, P1046, DOI 10.1124/jpet.105.086736; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Reddy P, 2009, AM J THER, V16, P74, DOI 10.1097/MJT.0b013e31818d3f67; RENAULD JC, 1993, CANCER INVEST, V11, P635, DOI 10.3109/07357909309011682; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sparks JA, 2014, RHEUM DIS CLIN N AM, V40, P637, DOI 10.1016/j.rdc.2014.07.005; Sundstrom B, 2015, RHEUMATOLOGY, V54, P487, DOI 10.1093/rheumatology/keu330; TAKETAZU F, 1994, LAB INVEST, V70, P620; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Thunhorst RL, 2007, AM J PHYSIOL-REG I, V293, pR1444, DOI 10.1152/ajpregu.00294.2007; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; WAHL SM, 1993, J EXP MED, V177, P225, DOI 10.1084/jem.177.1.225; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang J, 2015, MOL MED, V21, P364, DOI 10.2119/molmed.2014.00237; Zhang WC, 2015, CELL RES, V25, P893, DOI 10.1038/cr.2015.87	45	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184449	10.1371/journal.pone.0184449	http://dx.doi.org/10.1371/journal.pone.0184449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877244	Green Published, gold, Green Submitted			2022-12-26	WOS:000409391200105
J	Waldhoer, T; Heinzl, H				Waldhoer, Thomas; Heinzl, Harald			Exploring the possible relationship between ambient heat and sudden infant death with data from Vienna, Austria	PLOS ONE			English	Article							REGRESSION-MODELS; STRESS	A non-linear relationship between maximum ambient temperature and number of sudden infant death syndrome (SIDS) cases had been reported for Montreal, Canada, for the warm season. In particular, high maximum ambient temperatures were found to be extra-hazardous for infants. The study was replicated with data from Vienna, Austria, applying the same statistical approach. Vienna is roughly comparable to Montreal with regard to temperatures in the warm season, size of population, and number of SIDS cases. Although the Viennese study was powerful enough to detect even smaller effects, the Montrealean results could not be confirmed. The Viennese results do not support the hypothesis of a strong effect of maximum ambient temperature on the risk of SIDS during the warm season.	[Waldhoer, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Epidemiol, Vienna, Austria; [Heinzl, Harald] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Heinzl, H (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	harald.heinzl@meduniwien.ac.at	Waldhoer, Thomas Johannes/I-1215-2019	Waldhoer, Thomas Johannes/0000-0003-2043-8299				AAP TASK FORCE ON SUDDEN INFANT DEATH SYNDROME, 2016, PEDIATRICS, V138; Arnold C, 2015, ENVIRON HEALTH PERSP, V123, pA185, DOI 10.1289/ehp.123-A185; Auger N, 2015, ENVIRON HEALTH PERSP, V123, P712, DOI 10.1289/ehp.1307960; Beckwith JB, 2003, ARCH PEDIAT ADOL MED, V157, P286, DOI 10.1001/archpedi.157.3.286; Byard Roger W, 2007, J Forensic Leg Med, V14, P453, DOI 10.1016/j.jflm.2006.11.003; Carlin RF, 2017, JAMA PEDIATR, V171, P175, DOI 10.1001/jamapediatrics.2016.3345; Chang HP, 2013, PEDIATR INT, V55, P11, DOI 10.1111/j.1442-200X.2012.03723.x; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Guntheroth WG, 2001, PEDIATRICS, V107, P693, DOI 10.1542/peds.107.4.693; Haas R, 2014, MAGISTRATSABTEILUNG; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; KNOBEL HH, 1995, PEDIATRICS, V96, P1106; Lachin JM, 2008, STAT MED, V27, P2509, DOI 10.1002/sim.3057; Leiss JK, 1996, AM J EPIDEMIOL, V144, P111, DOI 10.1093/oxfordjournals.aje.a008897; Mage D., 2015, PUBMED COMMONS; Moon RY, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2940; Pantyley V., 2016, J PUBLIC HLTH NURSIN, P1; Scheers-Masters JR, 2004, PEDIATRICS, V113, pE586, DOI 10.1542/peds.113.6.e586; Statistics Canada, 2011, SERV B ENVIROSTATS, V5, P1; Waldhoer T, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-21; WILLINGER M, 1991, Pediatric Pathology, V11, P677	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2017	12	9							e0184312	10.1371/journal.pone.0184312	http://dx.doi.org/10.1371/journal.pone.0184312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0EG	28877228	Green Submitted, Green Published, gold			2022-12-26	WOS:000409391200085
J	Carreira, BM; Segurado, P; Laurila, A; Rebelo, R				Carreira, Bruno M.; Segurado, Pedro; Laurila, Anssi; Rebelo, Rui			Can heat waves change the trophic role of the world's most invasive crayfish? Diet shifts in Procambarus clarkii	PLOS ONE			English	Article							RED SWAMP CRAYFISH; RAPID EVOLUTION; PHENOTYPIC PLASTICITY; GLOBAL BIODIVERSITY; CLIMATE-CHANGE; TEMPERATURE; IMPACTS; COMMUNITIES; CONSUMPTION; GROWTH	In the Mediterranean basin, the globally increasing temperatures are expected to be accompanied by longer heat waves. Commonly assumed to benefit cold-limited invasive alien species, these climatic changes may also change their feeding preferences, especially in the case of omnivorous ectotherms. We investigated heat wave effects on diet choice, growth and energy reserves in the invasive red swamp crayfish, Procambarus clarkii. In laboratory experiments, we fed juvenile and adult crayfish on animal, plant or mixed diets and exposed them to a short or a long heat wave. We then measured crayfish survival, growth, body reserves and Fulton's condition index. Diet choices of the crayfish maintained on the mixed diet were estimated using stable isotopes (C-13 and N-15). The results suggest a decreased efficiency of carnivorous diets at higher temperatures, as juveniles fed on the animal diet were unable to maintain high growth rates in the long heat wave; and a decreased efficiency of herbivorous diets at lower temperatures, as juveniles in the cold accumulated less body reserves when fed on the plant diet. Heat wave treatments increased the assimilation of plant material, especially in juveniles, allowing them to sustain high growth rates in the long heat wave. Contrary to our expectations, crayfish performance decreased in the long heat wave, suggesting that Mediterranean summer heat waves may have negative effects on P. clarkii and that they are unlikely to boost its populations in this region. Although uncertain, it is possible that the greater assimilation of the plant diet resulted from changes in crayfish feeding preferences, raising the hypotheses that i) heat waves may change the predominant impacts of this keystone species and ii) that by altering species' trophic niches, climate change may alter the main impacts of invasive alien species.	[Carreira, Bruno M.; Rebelo, Rui] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes cE3c, Lisbon, Portugal; [Carreira, Bruno M.; Laurila, Anssi] Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden; [Segurado, Pedro] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal	Universidade de Lisboa; Uppsala University; Universidade de Lisboa	Carreira, BM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes cE3c, Lisbon, Portugal.; Carreira, BM (corresponding author), Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden.	bmcarreira@fc.ul.pt	Segurado, Pedro/A-1145-2011; Carreira, Bruno M./L-8332-2013; Rebelo, Rui/D-7054-2013	Segurado, Pedro/0000-0002-5917-7893; Carreira, Bruno M./0000-0002-5910-4619; Rebelo, Rui/0000-0003-2544-1470	Fundagao para a Ciencia e a Tecnologia [EXPL_BIAANM_0932_2012, SFRH/BD/80341/2011]	Fundagao para a Ciencia e a Tecnologia	The study was funded by Fundagao para a Ciencia e a Tecnologia (http://www.fctpVindex.phtrol.pt) through the project EXPL_BIAANM_0932_2012 of the Exploratory Program 2012 awarded to RR and through a doctoral fellowship (SFRH/BD/80341/2011) awarded to BMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorlo P, 2004, CRUSTACEANA, V77, P435, DOI 10.1163/1568540041643283; Alhazzaa R, 2013, COMP BIOCHEM PHYS A, V165, P243, DOI 10.1016/j.cbpa.2013.03.019; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Banha F, 2015, THESIS; Boersma M, 2016, ECOL LETT, V19, P45, DOI 10.1111/ele.12541; Buswell JM, 2011, J ECOL, V99, P214, DOI 10.1111/j.1365-2745.2010.01759.x; Capinha C, 2012, BIOL INVASIONS, V14, P1737, DOI 10.1007/s10530-012-0187-z; Carreira BM, 2014, HYDROBIOLOGIA, V721, P89, DOI 10.1007/s10750-013-1651-1; Carreira BM, 2016, ECOLOGY; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Chown SL, 2007, P ROY SOC B-BIOL SCI, V274, P2531, DOI 10.1098/rspb.2007.0772; Chucholl C, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011053; Clissold FJ, 2013, J EXP BIOL, V216, P2089, DOI 10.1242/jeb.078782; Correia AM, 2002, ACTA OECOL, V23, P421, DOI 10.1016/S1146-609X(02)01166-9; Correia AM, 1995, THESIS; Croll SL, 2004, J WORLD AQUACULT SOC, V35, P478, DOI 10.1111/j.1749-7345.2004.tb00113.x; Cross WF, 2015, GLOBAL CHANGE BIOL, V21, P1025, DOI 10.1111/gcb.12809; Dasari H.P., 2014, ATMOS CLIM SCI, V4, P841, DOI DOI 10.4236/ACS.2014.45074; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; Gallardo B, 2014, ETHOL ECOL EVOL, V26, P130, DOI 10.1080/03949370.2014.896417; Ilheu M., 1993, Freshwater Crayfish, V9, P359; Jerez S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016576; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; Kelley AL, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou045; Kingsolver JG, 1997, PHYSIOL ZOOL, V70, P631, DOI 10.1086/515872; Krehenwinkel H, 2015, GLOBAL CHANGE BIOL, V21, P4320, DOI 10.1111/gcb.13042; Lee KP, 2015, AM NAT, V186, P212, DOI 10.1086/682072; Leishman MR, 2015, DIVERS DISTRIB, V21, P848, DOI 10.1111/ddi.12338; Lemoine NP, 2012, ECOLOGY, V93, P2483, DOI 10.1890/12-0375.1; Malzahn AM, 2016, LIMNOL OCEANOGR; Martin-Creuzburg D, 2012, OECOLOGIA, V168, P901, DOI 10.1007/s00442-011-2155-1; McCann S, 2014, FUNCT ECOL, V28, P1166, DOI 10.1111/1365-2435.12255; Miller GA, 2009, P ROY SOC B-BIOL SCI, V276, P3581, DOI 10.1098/rspb.2009.1030; Miriti MN, 2007, ECOLOGY, V88, P32, DOI 10.1890/0012-9658(2007)88[32:EDASOD]2.0.CO;2; MOONEY HA, 1970, EVOLUTION, V24, P292, DOI 10.1111/j.1558-5646.1970.tb01762.x; Moreira FD, 2015, BIOL INVASIONS, V17, P273, DOI 10.1007/s10530-014-0725-y; Myrick CA, 2000, FISH PHYSIOL BIOCHEM, V22, P245, DOI 10.1023/A:1007805322097; Nunes AL, 2014, ECOLOGY, V95, P1520, DOI 10.1890/13-1380.1; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perez-Bote JL, 2004, CRUSTACEANA, V77, P1375, DOI 10.1163/1568540043166001; Perkins DM, 2010, HYDROBIOLOGIA, V657, P181, DOI 10.1007/s10750-009-0080-7; Peruzza L, 2015, AQUAT INVASIONS, V10, P199, DOI 10.3391/ai.2015.10.2.08; Powell ML, 2006, COMP BIOCHEM PHYS A, V144, P211, DOI 10.1016/j.cbpa.2006.02.032; PRESTON T, 1983, ANALYST, V108, P971, DOI 10.1039/an9830800971; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Rodriguez CF, 2003, HYDROBIOLOGIA, V506, P421, DOI 10.1023/B:HYDR.0000008626.07042.87; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Seifert LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095046; Souty-Grosset C, 2016, LIMNOLOGICA, V58, P78, DOI 10.1016/j.limno.2016.03.003; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Trigal C, 2007, FRESHWATER BIOL, V52, P2042, DOI 10.1111/j.1365-2427.2007.01805.x; Vejrikova I, 2016, SCI REP-UK, V6, DOI 10.1038/srep39600; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Zhang P, 2016, HYDROBIOLOGIA, P1	71	22	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183108	10.1371/journal.pone.0183108	http://dx.doi.org/10.1371/journal.pone.0183108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873401	Green Submitted, Green Published, gold			2022-12-26	WOS:000409282800010
J	Saito, H; Takeuchi, H; Masuda, T; Noda, T; Yamaoka, S				Saito, Hideki; Takeuchi, Hiroaki; Masuda, Takao; Noda, Takeshi; Yamaoka, Shoji			N-terminally truncated POM121C inhibits HIV1-replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR-PORE COMPLEX; T-CELL LEUKEMIA; NUCLEOPORIN NUP153; NONDIVIDING CELLS; HIV-1 REPLICATION; IMPORTIN-BETA; INFECTION; INTEGRATION; PROTEINS	Recent studies have identified host cell factors that regulate early stages of HIV-1 infection including viral cDNA synthesis and orientation of the HIV-1 capsid (CA) core toward the nuclear envelope, but it remains unclear how viral DNA is imported through the nuclear pore and guided to the host chromosomal DNA. Here, we demonstrate that N-terminally truncated POM121C, a component of the nuclear pore complex, blocks HIV-1 infection. This truncated protein is predominantly localized in the cytoplasm, does not bind to CA, does not affect viral cDNA synthesis, reduces the formation of 2-LTR and diminished the amount of integrated proviral DNA. Studies with an HIV-1-murine leukemia virus (MLV) chimeric virus carrying the MLV-derived Gag revealed that Gag is a determinant of this inhibition. Intriguingly, mutational studies have revealed that the blockade by N-terminally-truncated POM121C is closely linked to its binding to importin-beta/karyopherin subunit beta 1 (KPNB1). These results indicate that N-terminally-truncated POM121C inhibits HIV-1 infection after completion of reverse transcription and before integration, and suggest an important role for KPNB1 in HIV-1 replication.	[Saito, Hideki; Takeuchi, Hiroaki; Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Tokyo, Japan; [Masuda, Takao] Tokyo Med & Dent Univ, Dept Immunotherapeut, Bunkyo Ku, Tokyo, Japan; [Noda, Takeshi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Ultrastruct Virol,Minato Ku, Tokyo, Japan; [Noda, Takeshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Noda, Takeshi] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Ultrastruct Virol, Sakyo Ku, Kyoto, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University	Takeuchi, H; Yamaoka, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Bunkyo Ku, Tokyo, Japan.	htake.molv@tmd.ac.jp; shojimmb@tmd.ac.jp	Takeuchi, Hiroaki/F-9728-2012	Takeuchi, Hiroaki/0000-0002-5689-9858; Noda, Takeshi/0000-0002-0658-4663	Ministry of Education, Culture, Sports, Science, and Technology [26460550, 21390136]; Ministry of Health, Labor, and Welfare in Japan [H22-AIDS-007]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	Funded by grant 26460550 from the Ministry of Education, Culture, Sports, Science, and Technology to H.T., http://www.jsps.go.jp/j-grantsinaid/index.html, grant 21390136 from the Ministry of Education, Culture, Sports, Science, and Technology to S.Y., http://www.jsps.go.jp/j-grantsinaid/index.html, grant H22-AIDS-007 for Young Scientists of HIV/AIDS research from the Ministry of Health, Labor, and Welfare in Japan to H.T., http://www.mhlw.go.jp.	Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brun S, 2010, PROTEINS, V78, P2144, DOI 10.1002/prot.22729; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Ciuffi A, 2006, TRENDS GENET, V22, P388, DOI 10.1016/j.tig.2006.05.006; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Dharan A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005700; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fassati A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-74; Feng WY, 2008, JPN J INFECT DIS, V61, P279; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liu C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10714; MASUDA T, 1995, J VIROL, V69, P6687, DOI 10.1128/JVI.69.11.6687-6696.1995; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Onishi M, 1996, EXP HEMATOL, V24, P324; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; PLANELLES V, 1995, J VIROL, V69, P5883, DOI 10.1128/JVI.69.9.5883-5889.1995; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Takeuchi H, 2002, AIDS RES HUM RETROV, V18, P1127, DOI 10.1089/088922202320567860; Takeuchi H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-3; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Truant R, 1999, MOL CELL BIOL, V19, P1210; Uno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088347; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	47	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0182434	10.1371/journal.pone.0182434	http://dx.doi.org/10.1371/journal.pone.0182434			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873410	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800004
J	Yokota, T; Omachi, K; Suico, MA; Kojima, H; Kamura, M; Teramoto, K; Kaseda, S; Kuwazuru, J; Shuto, T; Kai, H				Yokota, Tsubasa; Omachi, Kohei; Suico, Mary Ann; Kojima, Haruka; Kamura, Misato; Teramoto, Keisuke; Kaseda, Shota; Kuwazuru, Jun; Shuto, Tsuyoshi; Kai, Hirofumi			Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome	PLOS ONE			English	Article							MIGRATING FOCAL SEIZURES; TISSUE GENESIS; TRACE-ELEMENTS; TGF-BETA; PEROXIDASIN; DISEASE; KIDNEY; PROTEIN-7; COLLAGEN; INFANCY	A seminal study recently demonstrated that bromide (Br-) has a critical function in the assembly of type IV collagen in basement membrane (BM), and suggested that Br- supplementation has therapeutic potential for BM diseases. Because salts of bromide (KBr and NaBr) have been used as antiepileptic drugs for several decades, repositioning of Br- for BM diseases is probable. However, the effects of Br- on glomerular basement membrane (GBM) disease such as Alport syndrome (AS) and its impact on the kidney are still unknown. In this study, we administered daily for 16 weeks 75 mg/kg or 250 mg/kg (within clinical dosage) NaBr or NaCl (control) via drinking water to 6-week-old AS mice (mouse model of X-linked AS). Treatment with 75 mg/kg NaBr had no effect on AS progression. Surprisingly, compared with 250 mg/kg NaCl, 250 mg/kg NaBr exacerbated the progressive proteinuria and increased the serum creatinine and blood urea nitrogen in AS mice. Histological analysis revealed that glomerular injury, renal inflammation and fibrosis were exacerbated in mice treated with 250 mg/kg NaBr compared with NaCl. The expressions of renal injury markers (Lcn2, Lysozyme), matrix metalloproteinase (Mmp-12), pro-inflammatory cytokines (Il-6, Il-8, Tnf-alpha, Il-1 beta) and pro-fibrotic genes (Tgf-beta, Col1a1, alpha-Sma) were also exacerbated by 250 mg/kg NaBr treatment. Notably, the exacerbating effects of Br- were not observed in wild-type mice. These findings suggest that Br- supplementation needs to be carefully evaluated for real positive health benefits and for the absence of adverse side effects especially in GBM diseases such as AS.	[Yokota, Tsubasa; Omachi, Kohei; Suico, Mary Ann; Kojima, Haruka; Kamura, Misato; Teramoto, Keisuke; Kaseda, Shota; Kuwazuru, Jun; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Chou Ku, 5-1 Oe Honmachi, Kumamoto, Kumamoto, Japan; [Omachi, Kohei; Kamura, Misato; Teramoto, Keisuke; Kaseda, Shota; Kai, Hirofumi] Kumamoto Univ, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Program Leading Grad Sch, Chou Ku, 5-1 Oe Honmachi, Kumamoto, Kumamoto, Japan	Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Chou Ku, 5-1 Oe Honmachi, Kumamoto, Kumamoto, Japan.; Kai, H (corresponding author), Kumamoto Univ, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Program Leading Grad Sch, Chou Ku, 5-1 Oe Honmachi, Kumamoto, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Omachi, Kohei/ABB-2844-2020; Omachi, Kohei/GPX-9286-2022	Omachi, Kohei/0000-0002-0160-3271; Shuto, Tsuyoshi/0000-0003-1275-4988	Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [26460098]; Japan Society for the Promotion Science (JSPS) [R2803]; Alport Syndrome Foundation (ASF); Pedersen Family; Kidney Foundation of Canada; Pharmaceutical Society of Japan	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alport Syndrome Foundation (ASF); Pedersen Family; Kidney Foundation of Canada; Pharmaceutical Society of Japan	This work was supported by Grants-in-Aid for Science Research from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT) (#26460098 to M.S.). This work was also supported by Japan Society for the Promotion Science (JSPS) program on Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (Grant Number R2803 to H.K.) and Alport Syndrome Foundation (ASF), the Pedersen Family, and the Kidney Foundation of Canada. We are grateful to Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan.	Bai XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20475; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Caraballo R, 2014, SEIZURE-EUR J EPILEP, V23, P899, DOI 10.1016/j.seizure.2014.06.016; Caraballo RH, 2008, J CHILD NEUROL, V23, P497, DOI 10.1177/0883073807309771; Cosgrove D, 2016, MATRIX BIOL J INT SO; Fukuda R, 2016, J AM SOC NEPHROL, V27, P144, DOI 10.1681/ASN.2014111109; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gross O, 2009, KIDNEY INT, V76, P599, DOI 10.1038/ki.2009.223; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Li TT, 2004, CURR OPIN NEPHROL HY, V13, P417, DOI 10.1097/01.mnh.0000133974.24935.fe; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Miura Y, 2002, NUCL INSTRUM METH B, V189, P443, DOI 10.1016/S0168-583X(01)01122-3; Omachi K, 2017, CLIN EXPT NEPHROLOGY; Pavelka S, 2004, PHYSIOL RES, V53, pS81; Perucca P, 2012, LANCET NEUROL, V11, P792, DOI 10.1016/S1474-4422(12)70153-9; Peterfi Z, 2014, TRENDS BIOCHEM SCI, V39, P305, DOI 10.1016/j.tibs.2014.05.005; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Rodgers KD, 2003, KIDNEY INT, V63, P1338, DOI 10.1046/j.1523-1755.2003.00871.x; Savige J, 2014, J PHYSIOL-LONDON, V592, P4013, DOI 10.1113/jphysiol.2014.274449; Schmidt D, 2009, EPILEPSY BEHAV, V15, P56, DOI 10.1016/j.yebeh.2009.02.030; Suico MA, 2014, J BIOL CHEM, V289, P26143, DOI 10.1074/jbc.M114.580209; Ueda Y, 2016, KIDNEY RES CLIN PRAC, V35, P78, DOI 10.1016/j.krcp.2016.02.001; VOSS E, 1961, J PHARM SCI-US, V50, P858, DOI 10.1002/jps.2600501014; WALLAEYS B, 1986, KIDNEY INT, V30, P599, DOI 10.1038/ki.1986.227; Zeisberg M, 2006, NEPHROL DIAL TRANSPL, V21, P568, DOI 10.1093/ndt/gfk010	33	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0183959	10.1371/journal.pone.0183959	http://dx.doi.org/10.1371/journal.pone.0183959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF8QL	28873450	Green Published, Green Submitted, gold			2022-12-26	WOS:000409282800038
